{"meta":{"query_hash":"efd139ecc9ad","filters":{"venue":"British Journal of Haematology"},"cohort_total":778,"direct_labels_cover":1,"predictions_cover":778,"exported":778,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/efd139ecc9ad","api":"https://metacan.xera.ac/api/v1/cohort?venue=British+Journal+of+Haematology"},"results":[{"id":"W1487233123","doi":"10.1111/j.1365-2141.2009.07910.x","title":"15‐deoxy‐Δ<sup>12,14</sup>‐PGJ<sub>2</sub> induces cell cycle arrest and apoptosis of haematopoietic progenitors","year":2009,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Agencia Nacional de Promoción Científica y Tecnológica; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Haematopoiesis; Apoptosis; Progenitor cell; Cell biology; Cell cycle checkpoint; Cell cycle; Biology; Physics; Stem cell; Genetics","score_opus":0.006472575781169075,"score_gpt":0.2089922071717555,"score_spread":0.20251963139058643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1487233123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795251,0.010484583,0.00005340716,0.008522764,0.0007361665,0.0004218537,0.00009944422,0.000020318761,0.00013637453],"genre_scores_gemma":[0.97606015,0.0053346213,0.00069312623,0.0150878355,0.0023631342,0.000030301646,0.00020053702,0.00017256744,0.000057713132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955531,0.0005775277,0.0016345468,0.0007771765,0.0005885102,0.0008691916],"domain_scores_gemma":[0.99683845,0.00009365545,0.0017465685,0.000478355,0.00055882154,0.0002841281],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00043567995,0.0007001855,0.0018653428,0.0004152782,0.00014843237,0.00012045646,0.00082079205,0.0025357462,0.00003275904],"category_scores_gemma":[0.00031030423,0.0007823875,0.0005445454,0.00021499644,0.00060527347,0.00003598994,0.0002456346,0.002303969,0.000010280437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019375257,0.0004061748,0.0006141494,0.0010798533,0.00083245215,0.0071213283,0.00015928003,0.00004632112,0.5414367,0.0000029149735,0.44315913,0.004947989],"study_design_scores_gemma":[0.001310611,0.0007689901,0.00005357836,0.0006909548,0.0002896018,0.056248333,0.00008590591,0.00000501012,0.9118123,0.00018045398,0.027802289,0.0007519865],"about_ca_topic_score_codex":0.000021574298,"about_ca_topic_score_gemma":0.0000101925425,"teacher_disagreement_score":0.41535684,"about_ca_system_score_codex":0.00005015528,"about_ca_system_score_gemma":0.0004506265,"threshold_uncertainty_score":0.99999774},"labels":[],"label_agreement":null},{"id":"W1493859144","doi":"10.1111/j.1365-2141.2011.08973.x","title":"Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Platelet; Medicine; Phosphatidylserine; Apoptosis; Flow cytometry; Immunology; Antibody; Immune thrombocytopenia; Immune system; Platelet activation; Platelet membrane glycoprotein; Chemotherapy; Gastroenterology; Internal medicine; Biology","score_opus":0.01482268090958412,"score_gpt":0.2393378797339692,"score_spread":0.2245151988243851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1493859144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766039,0.021741452,0.000032985798,0.00033086087,0.00023469239,0.00023333631,0.000028364218,0.000015616572,0.00077878346],"genre_scores_gemma":[0.9914211,0.007169801,0.0009093557,0.00034105827,0.000026487305,0.0000058928244,0.000024553989,0.00003053285,0.00007123697],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9980873,0.00010459653,0.0009721839,0.00020477737,0.00021026237,0.000420897],"domain_scores_gemma":[0.99901026,0.00004300475,0.0004601499,0.00015997772,0.00017987152,0.00014675765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002580048,0.00019554928,0.0014350627,0.00026030894,0.00006192589,0.000023490355,0.00020303954,0.00024142681,0.00078947225],"category_scores_gemma":[0.000085699954,0.0001995527,0.00017945777,0.0004065398,0.00011046861,0.00016032597,0.000045606823,0.0005208083,0.00007772204],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032523025,0.008106149,0.034538154,0.00029098106,0.002133465,0.75680214,0.0034107228,0.0000022424604,0.008469824,0.000084815205,0.05076906,0.13214016],"study_design_scores_gemma":[0.018593224,0.0024252161,0.043566033,0.0007010637,0.00044545316,0.8789203,0.0007386569,0.000016697366,0.05058116,0.0014122578,0.0021038472,0.0004960945],"about_ca_topic_score_codex":0.0009937424,"about_ca_topic_score_gemma":0.000045429155,"teacher_disagreement_score":0.13164407,"about_ca_system_score_codex":0.00007511404,"about_ca_system_score_gemma":0.00015063999,"threshold_uncertainty_score":0.8644168},"labels":[],"label_agreement":null},{"id":"W1499879695","doi":"10.1111/bjh.13567","title":"Splenic lymphocyte subtypes in immune thrombocytopenia: increased presence of a subtype of B‐regulatory cells","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health; China Scholarship Council; National Center for Advancing Translational Sciences; Canadian Blood Services","keywords":"FOXP3; Immunology; CD38; Regulatory B cells; Antigen; Population; CD8; Immune system; CD19; Antibody; Lymphocyte; Medicine; Biology; Interleukin 10; CD34; Stem cell","score_opus":0.015290587012916872,"score_gpt":0.25283158674740547,"score_spread":0.23754099973448858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499879695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552832,0.03782787,0.0000035028995,0.005583993,0.00040735598,0.00037653634,0.00008543381,0.000006947234,0.0004251442],"genre_scores_gemma":[0.98880374,0.004063385,0.0004714764,0.0060209064,0.00019825774,0.000006899694,0.00008870989,0.000072963725,0.00027364964],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9967436,0.00030595326,0.0016346567,0.00027580245,0.0006198606,0.000420122],"domain_scores_gemma":[0.99683964,0.00025822158,0.0017795947,0.0003759248,0.00063026714,0.000116342715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005344813,0.00030459173,0.0036050726,0.00048053384,0.00002163529,0.000010682216,0.0003927685,0.0008277197,0.000186935],"category_scores_gemma":[0.0002793507,0.0003086193,0.00039173785,0.00025291738,0.00039473476,0.00012363493,0.00009467047,0.0010726154,0.000011869938],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014012868,0.0009201131,0.00443643,0.0021377492,0.0013208741,0.65096194,0.0001886614,0.0000079575175,0.0029410387,0.000012935741,0.3339855,0.001685496],"study_design_scores_gemma":[0.025024056,0.0022155116,0.020738842,0.010248931,0.0018310334,0.88136804,0.00016586925,0.000029613497,0.02573374,0.0012793889,0.030673275,0.0006917233],"about_ca_topic_score_codex":0.0017718233,"about_ca_topic_score_gemma":0.00016422028,"teacher_disagreement_score":0.30331224,"about_ca_system_score_codex":0.00016388686,"about_ca_system_score_gemma":0.0014912471,"threshold_uncertainty_score":0.9999366},"labels":[],"label_agreement":null},{"id":"W1512582735","doi":"10.1046/j.1365-2141.2001.02632.x","title":"Which children with fever and neutropenia can be safely treated as outpatients?","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neutropenia; Medicine; Cancer; Leukopenia; Chemotherapy; Febrile neutropenia; Intensive care medicine; Internal medicine; Pediatrics","score_opus":0.010532309746658839,"score_gpt":0.2519400703507211,"score_spread":0.24140776060406224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512582735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932087,0.0007858975,0.000015964,0.0028251768,0.00010656299,0.00020957719,0.000009471592,0.000017278644,0.0028213516],"genre_scores_gemma":[0.9972462,0.0010059737,0.00013397333,0.0009290316,0.00009934129,0.000005584016,0.000009919409,0.000024948347,0.00054504676],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9989723,0.00006930796,0.00035879316,0.00016980847,0.00018427895,0.0002455203],"domain_scores_gemma":[0.999062,0.000023973489,0.0002227475,0.00011282449,0.00034939407,0.00022908057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008397829,0.00012822392,0.0005514972,0.00012484936,0.00012369137,0.000041717685,0.000078216486,0.00008683025,0.00030442976],"category_scores_gemma":[0.000046719146,0.000113469374,0.00005900655,0.00023499544,0.00011186196,0.00012533681,0.00002454228,0.00034753012,0.000008119357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006857783,0.0002697645,0.9692582,0.000020153166,0.0004332911,0.018425504,0.000109711684,0.0000052595233,0.00040657967,0.0001366646,0.004214039,0.0060350895],"study_design_scores_gemma":[0.003394075,0.0009084477,0.39314732,0.00016799939,0.00024774144,0.5988002,0.000044776672,7.640559e-7,0.00049071916,0.000030064188,0.0026779857,0.00008992633],"about_ca_topic_score_codex":0.001269993,"about_ca_topic_score_gemma":0.0033371141,"teacher_disagreement_score":0.58037466,"about_ca_system_score_codex":0.000044522094,"about_ca_system_score_gemma":0.00017517184,"threshold_uncertainty_score":0.4627147},"labels":[],"label_agreement":null},{"id":"W1526709380","doi":"10.1111/j.1365-2141.2005.05879.x","title":"Atypical presentation of acute promyelocytic leukaemia","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"Core Research for Evolutional Science and Technology","keywords":"Medicine; Pathology; CD99; Immunohistochemistry","score_opus":0.007593307816003039,"score_gpt":0.2513434094097791,"score_spread":0.24375010159377608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526709380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92798156,0.023854963,0.002779525,0.04224232,0.0012925997,0.0004292223,0.00009465921,0.0000130080425,0.0013121658],"genre_scores_gemma":[0.78548706,0.026187953,0.013588324,0.13918312,0.023002524,0.00006848196,0.0020397229,0.00040904526,0.01003379],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978802,0.0002154706,0.00095213397,0.0002934137,0.0003351726,0.00032358916],"domain_scores_gemma":[0.99808025,0.000039301085,0.001089272,0.00024378819,0.00048462657,0.000062775034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021805124,0.00023187081,0.00077367254,0.00010891073,0.000046501973,0.000032643165,0.00056229765,0.0012111635,0.00008273003],"category_scores_gemma":[0.00017729787,0.00025360452,0.0003499532,0.000079090416,0.00029380427,0.000009809584,0.00010647378,0.0011307795,0.000006817072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017267976,0.000053099586,0.00012877809,0.0004846118,0.000642049,0.019378742,0.00002013035,0.000011820228,0.014652584,0.000010349183,0.9608181,0.003627034],"study_design_scores_gemma":[0.0012992157,0.0006417946,0.00010750538,0.00051244133,0.000570446,0.34004983,0.000021441083,0.000009354023,0.1287427,0.0003041104,0.5273435,0.00039766016],"about_ca_topic_score_codex":0.000007703301,"about_ca_topic_score_gemma":0.000004737945,"teacher_disagreement_score":0.4334746,"about_ca_system_score_codex":0.00003711695,"about_ca_system_score_gemma":0.00056540436,"threshold_uncertainty_score":0.9999916},"labels":[],"label_agreement":null},{"id":"W1531745986","doi":"10.1111/j.1365-2141.2000.02238.x","title":"A history of pernicious anaemia","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pernicious anaemia; Intrinsic factor; Medicine; pernicious anemia; Atrophic gastritis; Vitamin B12; Pediatrics; Psychiatry; Stomach; Gastritis; Gastroenterology; Anemia; Internal medicine","score_opus":0.0052898358066272855,"score_gpt":0.20775318019208647,"score_spread":0.20246334438545918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1531745986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93827933,0.055461995,0.000101007536,0.000045867593,0.00025197968,0.000032159878,0.000005876598,0.0000021927383,0.0058196113],"genre_scores_gemma":[0.9910916,0.006231856,0.00054710754,0.00028503596,0.00010144539,0.0000011054581,0.000006627325,0.000012231443,0.0017230029],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917305,0.000080635116,0.00038135477,0.000108840024,0.00010144904,0.00015465321],"domain_scores_gemma":[0.9994854,0.000007965067,0.00021007305,0.00012368892,0.00010389409,0.00006898604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017274363,0.00007468599,0.00031384145,0.000043144017,0.000016197419,0.0000035756866,0.00020718847,0.00011825763,0.0005435211],"category_scores_gemma":[0.00008562109,0.0000855607,0.00015161815,0.000031518724,0.0001657868,0.000004533888,0.00002035789,0.00010718681,0.000007172633],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010925274,0.0009318856,0.0069061327,0.00020107967,0.00049852283,0.013559972,0.0005003383,0.00016035608,0.13987619,0.0005418294,0.507179,0.32855216],"study_design_scores_gemma":[0.0023397852,0.00050782395,0.006337653,0.00007949001,0.00008926708,0.13598801,0.00013005488,0.000008342488,0.007915957,0.000515277,0.8458211,0.0002672586],"about_ca_topic_score_codex":0.000053179912,"about_ca_topic_score_gemma":0.000032790565,"teacher_disagreement_score":0.33864206,"about_ca_system_score_codex":0.000011670472,"about_ca_system_score_gemma":0.00019540187,"threshold_uncertainty_score":0.59511745},"labels":[],"label_agreement":null},{"id":"W1536143313","doi":"10.1111/j.1365-2141.2010.08477.x","title":"Renal dysfunction in patients with thalassaemia","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Deferasirox; Medicine; Hypercalciuria; Renal function; Creatinine; Albuminuria; Urology; Internal medicine; Nephrotoxicity; Thalassemia; Gastroenterology; Urinary system; Kidney","score_opus":0.008040433559071004,"score_gpt":0.19957076767612902,"score_spread":0.19153033411705803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1536143313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952647,0.0006641798,0.00011484966,0.0001164859,0.0001862019,0.00010182806,9.5331603e-7,0.0000071100194,0.003543685],"genre_scores_gemma":[0.9989281,0.00015315188,0.0006726622,0.00015572943,0.000020325471,0.0000010857322,0.0000029366304,0.000011776209,0.000054175787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991646,0.000046838824,0.00036675445,0.00008762034,0.00015969688,0.00017451285],"domain_scores_gemma":[0.9994629,0.00001268806,0.00019365527,0.000063946405,0.0001758809,0.000090945505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014136604,0.00007066326,0.00035237294,0.0001352504,0.000026838985,0.0000051309785,0.000052114854,0.00013348337,0.00020955806],"category_scores_gemma":[0.00007019604,0.000058833768,0.000055960074,0.00012936203,0.00008103478,0.00008943993,0.000010971576,0.00038865712,0.000009556938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017642303,0.00090059795,0.927212,0.00006318661,0.00014786767,0.040340334,0.00031822268,0.0000045809275,0.000021357406,0.000121700665,0.0034611148,0.025644809],"study_design_scores_gemma":[0.008940359,0.0014512375,0.8657553,0.0007558026,0.0000975282,0.121592924,0.00020225029,0.0000057105535,0.00013416848,0.00022027502,0.0007467786,0.000097629134],"about_ca_topic_score_codex":0.000070249494,"about_ca_topic_score_gemma":0.000048722482,"teacher_disagreement_score":0.08125259,"about_ca_system_score_codex":0.000029719897,"about_ca_system_score_gemma":0.00008208156,"threshold_uncertainty_score":0.23991714},"labels":[],"label_agreement":null},{"id":"W1547137195","doi":"10.1111/j.1365-2141.2005.05494.x","title":"Bone marrow biopsy in thrombocytopenic or anticoagulated patients","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Biopsy; Bone marrow; Hematology; Warfarin; Surgery; Adverse effect; Trephine; Internal medicine","score_opus":0.025771347831330726,"score_gpt":0.2843715951081158,"score_spread":0.2586002472767851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547137195","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7819667,0.0065990784,0.00004457051,0.20917286,0.00074227405,0.0005805428,0.000052930405,0.000028788258,0.0008122959],"genre_scores_gemma":[0.46124163,0.0067609907,0.002325003,0.52664876,0.0015015657,0.00001674114,0.00033354666,0.00017110334,0.0010006814],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99649936,0.00022954372,0.0017415237,0.00034268684,0.00052054005,0.0006663398],"domain_scores_gemma":[0.9977378,0.0005445292,0.00086712,0.00023816408,0.00043838198,0.00017396324],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0002544685,0.00034742168,0.0027605274,0.00043866338,0.000050218532,0.00005084438,0.0002839614,0.001539377,0.0016579092],"category_scores_gemma":[0.0027983482,0.00029993174,0.00035104595,0.00032124273,0.00024083648,0.00011002876,0.00008687983,0.0028643701,0.0000851939],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018697046,0.00048068445,0.007047279,0.00032414022,0.00009248611,0.41222245,0.0000143336465,0.000001396834,0.0000045513407,0.0000062095123,0.57816905,0.0014504914],"study_design_scores_gemma":[0.007096897,0.0012659362,0.026246233,0.0056337,0.00042931087,0.81370276,0.000033406155,0.000022958582,0.0000385324,0.00034651675,0.14465109,0.00053265976],"about_ca_topic_score_codex":0.00007260939,"about_ca_topic_score_gemma":0.00009853828,"teacher_disagreement_score":0.43351793,"about_ca_system_score_codex":0.00009682485,"about_ca_system_score_gemma":0.00035341713,"threshold_uncertainty_score":0.9999453},"labels":[],"label_agreement":null},{"id":"W1547731352","doi":"10.1111/j.1365-2141.2011.09012.x","title":"UK guidelines on the management of iron deficiency in pregnancy","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":607,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"University Hospitals of Leicester NHS Trust; NHS Blood and Transplant","keywords":"Medicine; Guideline; Pregnancy; Malnutrition; Iron deficiency; Intensive care medicine; Public health; Food fortification; Health care; Developed country; Environmental health; Pediatrics; Anemia; Economic growth; Population; Nursing; Psychiatry","score_opus":0.034419341831717506,"score_gpt":0.30794246076016285,"score_spread":0.27352311892844533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547731352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404711,0.04912107,0.00011199528,0.0015019195,0.00031777428,0.00015313686,0.0000013738107,0.00000272411,0.008318924],"genre_scores_gemma":[0.9936176,0.004085059,0.0016352892,0.0004311764,0.00004755522,0.0000034335956,7.058079e-7,0.00000805644,0.00017111219],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988572,0.0000626454,0.0005830192,0.00006400579,0.00021180572,0.00022134045],"domain_scores_gemma":[0.9994387,0.000038704267,0.00024279831,0.0001209584,0.00010374116,0.000055111534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004571739,0.000069874666,0.0003424555,0.00009932171,0.000025799434,0.0000041637095,0.00012513758,0.000050988805,0.00017975862],"category_scores_gemma":[0.00011891,0.000052252304,0.000083986306,0.00011929664,0.00007755794,0.000051434374,0.000028251163,0.00016045563,0.00000966343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009744779,0.0050751045,0.22565047,0.00477086,0.00018236878,0.03691041,0.0020534385,0.00013210622,0.00067847874,0.21438205,0.08522924,0.42396098],"study_design_scores_gemma":[0.013267677,0.0010270575,0.7187752,0.0150735695,0.00090593565,0.22221185,0.007974567,0.0000176298,0.0022878433,0.0056264023,0.012308842,0.00052343315],"about_ca_topic_score_codex":0.000023666547,"about_ca_topic_score_gemma":0.00000976392,"teacher_disagreement_score":0.49312472,"about_ca_system_score_codex":0.000009613212,"about_ca_system_score_gemma":0.000025301872,"threshold_uncertainty_score":0.21307871},"labels":[],"label_agreement":null},{"id":"W1550825447","doi":"10.1111/j.1365-2141.2007.06803.x","title":"Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis","year":2007,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Heart, Lung, and Blood Institute; Leading Edge Endowment Fund","keywords":"Haemolysis; Haematopoiesis; Medicine; Immunology; Disease; Hemolysis; Internal medicine; Stem cell; Biology; Genetics","score_opus":0.012745762413536742,"score_gpt":0.2426172938335001,"score_spread":0.22987153141996333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550825447","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37762693,0.15011144,0.011115124,0.4491849,0.00679201,0.0037116185,0.00028979275,0.00014117268,0.0010270138],"genre_scores_gemma":[0.0833906,0.026141161,0.014266565,0.8484441,0.011678824,0.00019530594,0.0019122591,0.0011318527,0.012839348],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958591,0.00024908743,0.001707007,0.0005056801,0.00074355974,0.0009355877],"domain_scores_gemma":[0.9970614,0.00023843211,0.0012161504,0.00046288938,0.0005148745,0.000506278],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00067337806,0.0005067349,0.0024403092,0.0005325658,0.00017935011,0.00006421702,0.00043944622,0.0016052269,0.0002839413],"category_scores_gemma":[0.0004216481,0.0005176609,0.0016391701,0.00024502887,0.00034279915,0.00009763777,0.000077297984,0.0030072879,0.000038628812],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021229156,0.00034117012,0.00006928714,0.0025909457,0.000853587,0.24918003,0.000054761847,0.0000071883846,0.00003190977,0.0000055998166,0.7415043,0.005148894],"study_design_scores_gemma":[0.0058839833,0.0005383868,0.00017511615,0.003289789,0.0046718917,0.32886252,0.00014137923,0.000049366863,0.0005959179,0.00080476876,0.65436196,0.0006249363],"about_ca_topic_score_codex":0.000044060132,"about_ca_topic_score_gemma":0.00000557134,"teacher_disagreement_score":0.39925918,"about_ca_system_score_codex":0.00009960828,"about_ca_system_score_gemma":0.0005663552,"threshold_uncertainty_score":0.9997275},"labels":[],"label_agreement":null},{"id":"W1559360333","doi":"10.1111/j.1365-2141.2011.08701.x","title":"Low prevalence of <i>JAK2</i> V617F mutation in patients with first unprovoked venous thromboembolism","year":2011,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University; Université de Montréal; Western University; Hôpital du Sacré-Cœur de Montréal; McGill University; Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"JAK2 V617F; Venous thromboembolism; Medicine; Internal medicine; Mutation; Genetics; Thrombosis; Biology; Gene","score_opus":0.008621205634112651,"score_gpt":0.21588955584631903,"score_spread":0.20726835021220638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1559360333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809534,0.0022588538,0.000028306291,0.01506728,0.0003783207,0.000919127,0.00010598462,0.000009886337,0.0002788723],"genre_scores_gemma":[0.9649822,0.0025868472,0.0015633233,0.029948222,0.0004453484,0.000072300594,0.00018036956,0.000101863254,0.00011950074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746186,0.00017235022,0.0011106897,0.00032777307,0.0005516669,0.00037567256],"domain_scores_gemma":[0.9973352,0.00022876891,0.0013692314,0.00023286759,0.00074160774,0.00009230116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017290474,0.00031563814,0.0019622662,0.00031455528,0.00005219719,0.000016954105,0.00020112003,0.0005364906,0.00023755776],"category_scores_gemma":[0.0001843943,0.00027937331,0.0001908996,0.00015543959,0.0002291137,0.00013226795,0.000034359837,0.0011906519,0.000010664074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011984317,0.00677364,0.38157585,0.011309851,0.001712907,0.2723254,0.0012699432,0.000012518534,0.0000038204034,0.00004465953,0.31812808,0.0056448854],"study_design_scores_gemma":[0.015952969,0.009296209,0.80717087,0.023838632,0.0017690826,0.13240808,0.000036967755,0.0000033937647,0.001284164,0.00034185816,0.0073025012,0.00059525995],"about_ca_topic_score_codex":0.00014141262,"about_ca_topic_score_gemma":0.00018239403,"teacher_disagreement_score":0.42559505,"about_ca_system_score_codex":0.00012168597,"about_ca_system_score_gemma":0.0003615316,"threshold_uncertainty_score":0.99996585},"labels":[],"label_agreement":null},{"id":"W1564251925","doi":"10.1046/j.1365-2141.2002.03585.x","title":"Shwachman–Diamond Syndrome","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.020498756971110327,"score_gpt":0.2810316291733023,"score_spread":0.260532872202192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564251925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016421066,0.9969205,0.000026642809,0.000013845033,0.00043958196,0.00019690122,0.00005590146,0.000004533799,0.00069998024],"genre_scores_gemma":[0.0006560109,0.99808586,0.0002629033,0.000050498267,0.00014555834,0.000014252072,0.00009759867,0.000062676016,0.000624626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981274,0.00020458404,0.00088089064,0.00030526597,0.00015322075,0.00032865332],"domain_scores_gemma":[0.99863213,0.000024473928,0.0008362819,0.00025513553,0.000106549545,0.00014543175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014301695,0.00031851008,0.0019361313,0.00012984323,0.000072067276,0.000045851317,0.00043503635,0.0006119783,0.00014145926],"category_scores_gemma":[0.000080636855,0.00031707826,0.0008507281,0.000105642896,0.000111989975,0.0000050331037,0.00010741896,0.00037126357,0.00006047045],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000050937615,0.00030401896,0.000013261391,0.0018870053,0.0010949037,0.056028325,0.000003378771,2.3338428e-7,5.1802584e-7,0.000018912235,0.020165725,0.92047864],"study_design_scores_gemma":[0.00035090663,0.00021889643,0.0000019584425,0.0019387112,0.0005142544,0.42069566,0.0000034421482,6.364663e-8,0.0000030375018,0.000034799956,0.5760776,0.0001606924],"about_ca_topic_score_codex":0.000010723664,"about_ca_topic_score_gemma":0.000022963424,"teacher_disagreement_score":0.92031795,"about_ca_system_score_codex":0.0000158784,"about_ca_system_score_gemma":0.00015650864,"threshold_uncertainty_score":0.9999281},"labels":[],"label_agreement":null},{"id":"W1566407278","doi":"10.1111/bjh.13613","title":"Distinctive genotypes in infants with T‐cell acute lymphoblastic leukaemia","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Lady Tata Memorial Trust; Kay Kendall Leukaemia Fund; CNIB; Leukaemia and Lymphoma Research; European Hematology Association","keywords":"CDKN2A; PTEN; Genotype; Biology; Genetics; In utero; Cancer; Fetus; Gene; Pregnancy","score_opus":0.013813976408568221,"score_gpt":0.2699230648654331,"score_spread":0.25610908845686486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1566407278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245536,0.0015527752,0.0020371026,0.00034305424,0.00020275058,0.00022452645,0.000010703543,0.000016504822,0.0031572368],"genre_scores_gemma":[0.9955129,0.0001788403,0.003568197,0.00023532756,0.00013782326,0.000007586172,0.0000066411208,0.000040562412,0.00031210785],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99776524,0.00016054872,0.000677083,0.00024034258,0.0006402988,0.00051649107],"domain_scores_gemma":[0.99799496,0.00028620497,0.0003458702,0.00018250397,0.0007040453,0.00048639652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004858041,0.00018467453,0.0009271095,0.00032885617,0.000041395444,0.0000350828,0.0002549816,0.00018484257,0.000072189054],"category_scores_gemma":[0.00078147644,0.00016214517,0.00008499793,0.0003829741,0.00032447427,0.00019383794,0.00009713348,0.0005700274,0.000060059436],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009113776,0.0008755104,0.0564372,0.00026153764,0.0006297511,0.90122265,0.0011061244,0.00021272394,0.0012764961,0.00015887221,0.020750534,0.007954806],"study_design_scores_gemma":[0.020160131,0.0021057667,0.021392865,0.00093972,0.00029852166,0.9501249,0.00059357425,0.00063522375,0.0021880495,0.0004854312,0.00082634646,0.00024944203],"about_ca_topic_score_codex":0.00025572404,"about_ca_topic_score_gemma":0.00021545507,"teacher_disagreement_score":0.048902262,"about_ca_system_score_codex":0.0007896415,"about_ca_system_score_gemma":0.002761621,"threshold_uncertainty_score":0.6612088},"labels":[],"label_agreement":null},{"id":"W1570354759","doi":"10.1111/j.1365-2141.2010.08412.x","title":"Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters","year":2010,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research","keywords":"Immune thrombocytopenia; Medicine; Thrombopoietin; Pathophysiology; Intensive care medicine; Mechanism (biology); Immunology; Disease; Romiplostim; Clinical trial; Eltrombopag; Platelet; Pathogenesis; Immune system; Autoimmune disease; Bioinformatics; Antibody; Internal medicine; Biology; Stem cell","score_opus":0.020955932384401733,"score_gpt":0.3110593357585867,"score_spread":0.29010340337418494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1570354759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019685363,0.97883195,0.0000079111505,0.0002722015,0.0005985677,0.0004978602,0.000010230993,0.0000051239604,0.00009077311],"genre_scores_gemma":[0.00045828562,0.9987842,0.00043602477,0.00013873362,0.00006679277,0.000010579106,0.000025118301,0.00004396582,0.000036342924],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99813354,0.00012630154,0.0010391012,0.00024951974,0.00016832938,0.0002832058],"domain_scores_gemma":[0.99841154,0.00009578481,0.001098254,0.00022045602,0.000076811295,0.00009716925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018351758,0.00028824658,0.0044931076,0.00022336637,0.00005616266,0.00003493561,0.00016411832,0.00037700715,0.000069146976],"category_scores_gemma":[0.0000129798245,0.0002486561,0.0004724806,0.00009763345,0.00020984416,0.00012168132,0.00009383443,0.0007141749,0.000013803577],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000349723,0.00024156395,7.6734733e-7,0.013409395,0.00092055585,0.13980961,0.000008656513,7.707576e-8,0.000009215897,0.00006671834,0.00024994687,0.8452485],"study_design_scores_gemma":[0.002551172,0.0010216343,0.000055333752,0.10990653,0.0032407823,0.6330081,0.000049961887,5.18906e-7,0.000017004666,0.00035419074,0.24957946,0.00021528541],"about_ca_topic_score_codex":0.000014305497,"about_ca_topic_score_gemma":0.0000094454745,"teacher_disagreement_score":0.8450332,"about_ca_system_score_codex":0.00007250244,"about_ca_system_score_gemma":0.00013858851,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W1582919185","doi":"10.1111/j.1365-2141.2010.08191.x","title":"Modern management of severe platelet function disorders","year":2010,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Intensive care medicine; Medicine; Intervention (counseling); Platelet; Case management; Internal medicine; Psychiatry","score_opus":0.01805168487697095,"score_gpt":0.2924483891965691,"score_spread":0.2743967043195982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1582919185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045216875,0.9919859,0.00021651635,0.000039553805,0.00061050156,0.00051860145,0.000035556946,0.000011714643,0.0020599621],"genre_scores_gemma":[0.0014025713,0.99735934,0.0007038787,0.00002695738,0.00005145789,0.000013341948,0.000078131045,0.000053976055,0.00031033834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979448,0.0001003915,0.00115304,0.00022990238,0.00029473385,0.00027713075],"domain_scores_gemma":[0.99825877,0.00007235793,0.0012000725,0.00021358965,0.00012151173,0.00013366948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023162372,0.00029208185,0.0033241876,0.00026260084,0.000049942882,0.0000150701735,0.00018531908,0.0005002397,0.00015973335],"category_scores_gemma":[0.00002851964,0.00026721595,0.00079264137,0.00016170528,0.00010390724,0.000079164485,0.00005453421,0.0008252986,0.000022232505],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006644534,0.0003728433,0.000009105132,0.012310271,0.0017420965,0.07820549,0.000008092704,6.7286965e-7,1.0051262e-7,0.00008468008,0.0011777497,0.9060224],"study_design_scores_gemma":[0.001500471,0.00023423343,0.000020067,0.01579083,0.0027706309,0.44615132,0.000017368133,0.0000016708184,2.9383108e-7,0.0009767258,0.5323992,0.00013718639],"about_ca_topic_score_codex":0.000018020954,"about_ca_topic_score_gemma":0.00003946495,"teacher_disagreement_score":0.9058853,"about_ca_system_score_codex":0.000041523697,"about_ca_system_score_gemma":0.00016055717,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W1584887708","doi":"10.1111/j.1365-2141.2011.08586.x","title":"Regulation of the adaptor molecule LAT2, an <i>in vivo</i> target gene of AML1/ETO (<i>RUNX1/RUNX1T1</i>), during myeloid differentiation","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Albert-Ludwigs-Universität Freiburg","keywords":"RUNX1; Biology; Myeloid; RUNX1T1; Downregulation and upregulation; Cancer research; Transcription factor; Retinoic acid; Molecular biology; Immunology; Gene expression; Gene; Genetics","score_opus":0.016897106971341534,"score_gpt":0.24438462493283045,"score_spread":0.22748751796148892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1584887708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794465,0.0007158121,0.00032136135,0.00017613624,0.00014680786,0.0002895579,0.000019536019,0.000008345678,0.00037778274],"genre_scores_gemma":[0.9964708,0.0002528055,0.0029794828,0.0000621371,0.00008504606,0.0000052411024,0.00000576495,0.00003178435,0.000106922416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976493,0.00031638215,0.0010385582,0.00019208736,0.0004894812,0.0003141829],"domain_scores_gemma":[0.9982191,0.00005445484,0.00081203645,0.00031154702,0.00046803168,0.00013485353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051525474,0.00013871706,0.0007531255,0.0002687062,0.00005189071,0.000008134452,0.00032876167,0.00018620843,0.00020777337],"category_scores_gemma":[0.0002730175,0.00012527767,0.00019312896,0.000295326,0.00021001404,0.00021478659,0.0000991738,0.0004543129,0.0000013842371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011550797,0.0006732401,0.060991425,0.0003891418,0.00018171305,0.0025570851,0.00080966303,0.00005544799,0.9317773,0.00032151994,0.0005577368,0.0005306538],"study_design_scores_gemma":[0.0024316728,0.0002383183,0.39846075,0.000387189,0.00006639357,0.024109324,0.00012731194,0.00020772859,0.5734876,0.0003833721,0.000016195614,0.00008417423],"about_ca_topic_score_codex":0.00025026724,"about_ca_topic_score_gemma":0.00016148409,"teacher_disagreement_score":0.35828972,"about_ca_system_score_codex":0.0001262024,"about_ca_system_score_gemma":0.00026681088,"threshold_uncertainty_score":0.51086754},"labels":[],"label_agreement":null},{"id":"W1590498065","doi":"10.1111/j.1365-2141.2011.08810.x","title":"<i>NUP98‐HOXA9</i>‐transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Myeloproliferative neoplasm; Zebrafish; Haematopoiesis; Biology; Myeloid; Cancer research; Transgene; Embryonic stem cell; Progenitor cell; Carcinogenesis; Myeloproliferative Disorders; Downregulation and upregulation; Stem cell; Myelofibrosis; Immunology; Cell biology; Bone marrow; Cancer; Genetics; Gene","score_opus":0.016232276563186456,"score_gpt":0.2497178839117989,"score_spread":0.23348560734861243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1590498065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428585,0.003665554,0.051685687,0.00072785496,0.00010906052,0.0003598741,0.000020008278,0.0000097941165,0.00056363345],"genre_scores_gemma":[0.9658031,0.0018869429,0.03155574,0.0004433379,0.00009853189,0.00002584419,0.00001901289,0.000035604608,0.00013191516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979578,0.00018807141,0.00081616046,0.0003414048,0.00032199986,0.00037452753],"domain_scores_gemma":[0.99826163,0.000058202542,0.00041299214,0.00022479199,0.0005992245,0.00044315588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004625332,0.00019576742,0.00056119566,0.00016135581,0.00010949523,0.000026034417,0.0004775063,0.00030768305,0.000082272556],"category_scores_gemma":[0.00077189424,0.00020592833,0.0001307314,0.0002950488,0.00042857768,0.00002484475,0.00018785673,0.000275784,0.0000059385716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005926979,0.00039879358,0.0009792509,0.00023531516,0.0007146116,0.0013972494,0.0012983893,0.0000010163525,0.91253316,0.0035783707,0.0069629834,0.07130815],"study_design_scores_gemma":[0.0019208175,0.00091603765,0.0040509477,0.00015736448,0.00008598399,0.028787555,0.00021740535,0.000006246607,0.93649226,0.012797214,0.0142491935,0.00031897132],"about_ca_topic_score_codex":0.0002066576,"about_ca_topic_score_gemma":0.000708492,"teacher_disagreement_score":0.070989184,"about_ca_system_score_codex":0.000021695254,"about_ca_system_score_gemma":0.0010842828,"threshold_uncertainty_score":0.83975136},"labels":[],"label_agreement":null},{"id":"W1613302221","doi":"10.1111/j.1365-2141.2011.08588.x","title":"<scp>l</scp>‐asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005‐01 randomized trial","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Asparaginase; Medicine; Randomization; Adverse effect; Internal medicine; Gastroenterology; Randomized controlled trial; Refractory (planetary science); Immunology; Lymphoblastic Leukemia; Leukemia; Biology","score_opus":0.012036325153233041,"score_gpt":0.24650577653568884,"score_spread":0.23446945138245578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1613302221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950193,0.0023337926,0.000046076024,0.0001739953,0.00039702098,0.001566005,0.000046731217,0.000013425903,0.00040362],"genre_scores_gemma":[0.9949719,0.0031905023,0.0011959934,0.00013313699,0.00012763188,0.000025018635,0.000009779818,0.000051602456,0.0002944375],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99444354,0.0012670608,0.0024537293,0.00044516372,0.00065220543,0.0007382996],"domain_scores_gemma":[0.9950689,0.0025149263,0.0014317996,0.00040051684,0.00027501147,0.0003088282],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0025288844,0.00031191288,0.002336956,0.00063065096,0.00006530919,0.00002738874,0.00050202693,0.00046095843,0.0000390265],"category_scores_gemma":[0.009728696,0.0002345524,0.00030411102,0.0005176269,0.0008374043,0.0002166176,0.00020282702,0.0011256303,0.0000038161156],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91681135,0.0016780086,0.0022375693,0.00021235638,0.001011033,0.06383537,0.0018499725,0.000010944135,0.0025476557,0.000021464743,0.009031282,0.0007529866],"study_design_scores_gemma":[0.8001038,0.0010686929,0.0059274924,0.003257556,0.00068159704,0.18057995,0.00031913872,0.00014854952,0.007560475,0.00021008932,0.000030052473,0.00011260046],"about_ca_topic_score_codex":0.001357976,"about_ca_topic_score_gemma":0.00056195585,"teacher_disagreement_score":0.11674458,"about_ca_system_score_codex":0.00032138987,"about_ca_system_score_gemma":0.0015728654,"threshold_uncertainty_score":0.99861276},"labels":[],"label_agreement":null},{"id":"W1616213856","doi":"10.1111/j.1365-2141.2010.08262.x","title":"Development of target‐specific treatments in multiple myeloma","year":2010,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; National Cancer Institute; Celgene; Bristol-Myers Squibb","keywords":"Thalidomide; Bortezomib; Multiple myeloma; Arsenic trioxide; Cancer research; Lenalidomide; Medicine; Histone deacetylase; Protein kinase B; Pharmacology; Panobinostat; Monoclonal antibody; Immunology; Biology; Apoptosis; Histone; Signal transduction; Antibody; Cell biology","score_opus":0.07596536851419747,"score_gpt":0.3565687772379315,"score_spread":0.280603408723734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1616213856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026144687,0.97229266,0.000031252053,0.000014238311,0.00031628867,0.00086335756,0.000044687724,0.000008280668,0.00028452137],"genre_scores_gemma":[0.0013530528,0.96709657,0.031054104,0.0000062603403,0.00009425666,0.000053957287,0.000121097466,0.0000650658,0.00015565525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959724,0.00024675185,0.0023443562,0.00033330676,0.00054956815,0.00055359886],"domain_scores_gemma":[0.99747723,0.00031076034,0.0012716592,0.0002865802,0.00029242988,0.00036136585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050146,0.00039698978,0.004408692,0.0008310393,0.000070864306,0.000021210471,0.00033037248,0.0005796855,0.00029489075],"category_scores_gemma":[0.0004028119,0.00034529553,0.00067644246,0.00032967216,0.00018114726,0.00008304126,0.000094876494,0.0012137146,0.000064222186],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011789468,0.0010004673,0.0008218738,0.0045352164,0.0007567933,0.08503179,0.000066520064,4.6574044e-8,0.000011047596,0.000008480163,0.0002612115,0.9073886],"study_design_scores_gemma":[0.0042624664,0.00021718051,0.0015681323,0.021213315,0.0003148132,0.22445816,0.000028970162,0.0000011880289,0.00009958813,0.000017767565,0.7476232,0.00019521322],"about_ca_topic_score_codex":0.000027489556,"about_ca_topic_score_gemma":0.00015120878,"teacher_disagreement_score":0.9071934,"about_ca_system_score_codex":0.00027829842,"about_ca_system_score_gemma":0.0015076199,"threshold_uncertainty_score":0.9998999},"labels":[],"label_agreement":null},{"id":"W1741176048","doi":"10.1111/j.1365-2141.2011.08872.x","title":"T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency; BC Children's Hospital","funders":"National Institute of Dental and Craniofacial Research; Canadian Institutes of Health Research; Michael Smith Health Research BC; Genome Canada; Leukemia and Lymphoma Society","keywords":"Biology; Progenitor cell; Stem cell; CD34; clone (Java method); Myeloid; Myelodysplastic syndromes; Cancer research; Immunology; Bone marrow; Molecular biology; Genetics; DNA","score_opus":0.01710947392432581,"score_gpt":0.22225848332022255,"score_spread":0.20514900939589675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1741176048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997509,0.0011675294,0.00037181497,0.00024299581,0.00019602028,0.0002911958,0.00008543227,0.000008578754,0.00012741238],"genre_scores_gemma":[0.996839,0.00025096885,0.0025531938,0.0002278981,0.000043659573,0.0000046748937,0.0000124231965,0.000034075136,0.000034140434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980277,0.00020764548,0.000712946,0.00018665603,0.00050858443,0.00035647338],"domain_scores_gemma":[0.9978139,0.00029582015,0.00074372324,0.00026397142,0.00068205025,0.00020056366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026529294,0.00015426773,0.0008891453,0.00011356792,0.000069645015,0.000013309501,0.0003733292,0.00013910788,0.00058472395],"category_scores_gemma":[0.00027071623,0.00010731375,0.00012945247,0.0001719483,0.00046616787,0.00010879478,0.00008505145,0.00058838475,0.000027536707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004257383,0.0016984517,0.63933283,0.00039234688,0.0021553056,0.3305642,0.001331477,0.000006290662,0.008545337,0.00011465547,0.008725953,0.0028757479],"study_design_scores_gemma":[0.0054008504,0.0012842568,0.86363095,0.0014953635,0.00035519226,0.117836796,0.00039377582,0.000008318909,0.009123675,0.00022063528,0.00010937274,0.00014082222],"about_ca_topic_score_codex":0.0004997678,"about_ca_topic_score_gemma":0.000092318915,"teacher_disagreement_score":0.2242981,"about_ca_system_score_codex":0.00007882537,"about_ca_system_score_gemma":0.0003064202,"threshold_uncertainty_score":0.6402317},"labels":[],"label_agreement":null},{"id":"W1798928306","doi":"10.1046/j.1365-2141.2003.03929.x","title":"Novel therapies for multiple myeloma","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"U.S. Public Health Service","keywords":"Stromal cell; Cancer research; Bortezomib; Multiple myeloma; Tumor microenvironment; Growth factor; Medicine; Extracellular matrix; Bone marrow; Immunology; Biology; Cell biology; Internal medicine; Receptor","score_opus":0.10477212268443684,"score_gpt":0.3753771102808782,"score_spread":0.27060498759644136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1798928306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015858658,0.99708295,0.0006794863,0.000115460076,0.00034272092,0.0012319685,0.00019301582,0.00001779436,0.00017803439],"genre_scores_gemma":[0.00016339564,0.98985523,0.008548737,0.000050178827,0.0003905606,0.000101893354,0.000077918034,0.000089367066,0.0007227048],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746794,0.00013402005,0.0012228069,0.0002805954,0.00035885326,0.00053576246],"domain_scores_gemma":[0.9972713,0.0008386819,0.00087968615,0.00023461266,0.00044570267,0.00033002283],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033034172,0.00034265735,0.003758493,0.00038330737,0.00011559353,0.000053815656,0.0002909876,0.00042638063,0.0002413838],"category_scores_gemma":[0.0010909822,0.00028715935,0.0013781261,0.00016484674,0.0001585666,0.00008187694,0.000050087092,0.0006682284,0.000046992485],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008844385,0.00050339627,0.000027988435,0.010502049,0.0018329462,0.029751953,0.000019716908,3.7147196e-8,0.0000016114068,0.000029239785,0.006025725,0.9512169],"study_design_scores_gemma":[0.0028215048,0.0003683383,0.00002962318,0.011821733,0.0007752985,0.41013518,0.000011540484,0.000006839323,0.000001916578,0.000019256337,0.573887,0.00012178825],"about_ca_topic_score_codex":0.000024791943,"about_ca_topic_score_gemma":0.000029837158,"teacher_disagreement_score":0.9510951,"about_ca_system_score_codex":0.00011952986,"about_ca_system_score_gemma":0.0003798027,"threshold_uncertainty_score":0.99995804},"labels":[],"label_agreement":null},{"id":"W1829668511","doi":"10.1111/bjh.13631","title":"<scp>RNA</scp> editing in acute myeloid leukaemia with normal karyotype","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche","keywords":"NPM1; RNA editing; RNA; Karyotype; Myeloid leukemia; Biology; Sanger sequencing; Intron; Mutation; Medicine; Molecular biology; Cancer research; Genetics; Gene; Chromosome","score_opus":0.008262122444222825,"score_gpt":0.2297694973531748,"score_spread":0.22150737490895198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829668511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96072197,0.009153839,0.00033003493,0.023951625,0.0011192856,0.00023779359,0.00010069504,0.000014803388,0.0043699257],"genre_scores_gemma":[0.49848017,0.003777323,0.005589692,0.44587317,0.02587829,0.00006276986,0.0031991932,0.0005546863,0.016584696],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977902,0.00022562544,0.0007369317,0.0003402887,0.0003983632,0.0005085918],"domain_scores_gemma":[0.99818724,0.000044976165,0.0008258451,0.00024154256,0.000500142,0.00020025892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033427565,0.00029293165,0.00074123044,0.00020862209,0.000059191614,0.00007873583,0.00043916138,0.000928818,0.000028332828],"category_scores_gemma":[0.00035673328,0.000307521,0.0002012694,0.00013016432,0.00019098107,0.000019720117,0.000110607,0.0012007519,0.000014807551],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000592731,0.000037838672,0.0022537971,0.00007280349,0.00019422447,0.08003319,0.000019509,0.000048181133,0.0004384492,0.0000045243346,0.91611993,0.0007183021],"study_design_scores_gemma":[0.0026399647,0.0004878022,0.0020610744,0.0004181997,0.00019451753,0.25722858,0.000090032954,0.000013445522,0.0010909261,0.00013904647,0.73540515,0.00023128027],"about_ca_topic_score_codex":0.000033296667,"about_ca_topic_score_gemma":0.00010158555,"teacher_disagreement_score":0.46224183,"about_ca_system_score_codex":0.000045671033,"about_ca_system_score_gemma":0.00068883196,"threshold_uncertainty_score":0.9999377},"labels":[],"label_agreement":null},{"id":"W1874071964","doi":"10.1111/bjh.13634","title":"Evaluation of the International Prognostic Score (IPS‐7) and a Simpler Prognostic Score (IPS‐3) for advanced Hodgkin lymphoma in the modern era","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"ECOG-ACRIN Cancer Research Group; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; American College of Radiology Imaging Network; American Cancer Society","keywords":"Medicine; Internal medicine; Univariate; International Prognostic Index; Oncology; Multivariate analysis; Univariate analysis; Framingham Risk Score; Risk stratification; Stage (stratigraphy); Proportional hazards model; Prognostic model; Prognostic variable; Multivariate statistics; Overall survival; Lymphoma; Disease; Rituximab; Machine learning","score_opus":0.07048132621520345,"score_gpt":0.32302799265549303,"score_spread":0.25254666644028956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874071964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976207,0.0056914003,0.00007431842,0.002638046,0.00030756296,0.0013480557,0.000020617454,0.000004510771,0.00015344494],"genre_scores_gemma":[0.99863416,0.00009913108,0.0006290041,0.00033491306,0.00009413786,0.00017075255,0.000012570304,0.000015038,0.000010319836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797773,0.00025190588,0.0005954482,0.00017380647,0.0007998942,0.00020119917],"domain_scores_gemma":[0.9977689,0.00044940115,0.00045867715,0.00014806703,0.0010919016,0.00008306241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015289973,0.00012833686,0.0004541232,0.00010579824,0.0000539618,0.000039335413,0.00022279579,0.000084262174,0.000011778097],"category_scores_gemma":[0.0031331072,0.000084467225,0.00012791657,0.00012601276,0.00013819465,0.0001269523,0.000054237513,0.000111481226,8.997989e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007151871,0.0019376527,0.6493475,0.0001715369,0.00048237765,0.0027742607,0.0028485502,0.00021956392,0.00014162337,0.00060247234,0.0033629378,0.33739638],"study_design_scores_gemma":[0.02465597,0.0011764318,0.81284803,0.0021743993,0.0012199332,0.13374725,0.0008691691,0.0044475202,0.0006307697,0.017767092,0.0003078967,0.0001555302],"about_ca_topic_score_codex":0.000037736518,"about_ca_topic_score_gemma":0.00024301503,"teacher_disagreement_score":0.33724084,"about_ca_system_score_codex":0.00020717138,"about_ca_system_score_gemma":0.0009526302,"threshold_uncertainty_score":0.37508485},"labels":[],"label_agreement":null},{"id":"W1878883003","doi":"10.1046/j.1365-2141.2003.03883.x","title":"Disseminated fusariosis in a patient with acute leukaemia","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Skin biopsy; White blood cell; Bone marrow; Vincristine; Cytarabine; Leukemia; Absolute neutrophil count; Pathology; Induction chemotherapy; Amphotericin B; Rash; Biopsy; Chemotherapy; Surgery; Gastroenterology; Internal medicine; Dermatology; Cyclophosphamide; Neutropenia","score_opus":0.009444974156630393,"score_gpt":0.23954477623084594,"score_spread":0.23009980207421554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1878883003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449456,0.002939726,0.00007758315,0.00064348476,0.00006329746,0.00011751735,0.0000040460113,0.000008298445,0.0016515183],"genre_scores_gemma":[0.9978935,0.0009008202,0.00069557154,0.00024425177,0.000018085188,0.0000025757784,0.0000019585184,0.0000119777815,0.00023126006],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988167,0.00006376199,0.00051150535,0.00014250283,0.00022420027,0.00024131479],"domain_scores_gemma":[0.99928516,0.00006295036,0.00021246784,0.00011811463,0.00019526856,0.00012603206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014037057,0.00009601849,0.0006000256,0.000113078146,0.000036726527,0.0000145368585,0.000078738696,0.000101972386,0.0004178094],"category_scores_gemma":[0.00017192993,0.000083938234,0.000095005285,0.0002066106,0.00012363936,0.000102038975,0.000016225351,0.00040091257,0.00001225915],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010429127,0.00089471927,0.15025374,0.00013369783,0.00024681468,0.7955855,0.000662023,0.0000030397032,0.0016664211,0.000074347714,0.0119617535,0.03747503],"study_design_scores_gemma":[0.0027370236,0.0014178157,0.10719131,0.0014692288,0.00018651021,0.8831474,0.0005664188,0.000079222074,0.002045668,0.000107482454,0.0008857576,0.00016614539],"about_ca_topic_score_codex":0.000047748763,"about_ca_topic_score_gemma":0.0003746484,"teacher_disagreement_score":0.08756192,"about_ca_system_score_codex":0.00007053053,"about_ca_system_score_gemma":0.000058622358,"threshold_uncertainty_score":0.457472},"labels":[],"label_agreement":null},{"id":"W1884535370","doi":"10.1111/j.1365-2141.2011.08921.x","title":"Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":419,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"British Society for Haematology","keywords":"Hereditary spherocytosis; Splenectomy; Asymptomatic; Spherocytosis; Concomitant; Medicine; Gallstones; General surgery; Pathology; Surgery; Internal medicine","score_opus":0.0994798348855256,"score_gpt":0.3165964413920471,"score_spread":0.21711660650652154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1884535370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.947348,0.041782986,0.003821655,0.004618505,0.0013341575,0.0004934746,0.000022977716,0.0000133916865,0.00056487403],"genre_scores_gemma":[0.7887056,0.14091489,0.06414866,0.0050538955,0.00057939254,0.00008985007,0.000010263959,0.000046067704,0.0004514216],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9990594,0.00004322132,0.00055953517,0.00010548507,0.00009358524,0.00013881766],"domain_scores_gemma":[0.99894243,0.000118772936,0.00030501853,0.000112739726,0.00045306233,0.00006797158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002776729,0.00008212076,0.00046197057,0.000048885217,0.000057078156,0.000003530116,0.00010023717,0.00007720746,0.00048719838],"category_scores_gemma":[0.00008608124,0.000062639214,0.00013943802,0.000043044478,0.00015557212,0.000051157425,0.000042554086,0.00011221886,0.0000057755715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024929605,0.0006513027,0.013046531,0.0016582977,0.002277931,0.018664312,0.00028562662,0.000005271799,0.0002680205,0.002810043,0.7435265,0.21431318],"study_design_scores_gemma":[0.012869104,0.0043597766,0.1525545,0.0028304204,0.0035389795,0.63973385,0.0037482076,0.00014990475,0.008852844,0.007175408,0.16371176,0.000475256],"about_ca_topic_score_codex":0.00006191482,"about_ca_topic_score_gemma":0.000029986651,"teacher_disagreement_score":0.62106955,"about_ca_system_score_codex":0.000006269192,"about_ca_system_score_gemma":0.000023711778,"threshold_uncertainty_score":0.53344804},"labels":[],"label_agreement":null},{"id":"W1895050506","doi":"10.1111/bjh.13586","title":"Classification of non‐Hodgkin lymphoma in South‐eastern Europe: review of 632 cases from the international non‐Hodgkin lymphoma classification project","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; University of Manitoba","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Oncology; Internal medicine","score_opus":0.07000858373368732,"score_gpt":0.3261071172833843,"score_spread":0.256098533549697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895050506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741087,0.020941773,0.00010227575,0.0027827756,0.00044516014,0.0005557006,0.00008913092,0.000007875578,0.000966624],"genre_scores_gemma":[0.9893536,0.008920044,0.0007598271,0.000573933,0.0001821354,0.000039762377,0.00009230264,0.00002576663,0.000052620697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970034,0.00032528737,0.0015688014,0.00026959577,0.0006204614,0.00021246295],"domain_scores_gemma":[0.9965002,0.0003537016,0.0016118127,0.0003469092,0.001069827,0.00011758356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088276,0.0001956902,0.0010028877,0.00020793454,0.000033006476,0.000028666203,0.0004058154,0.00013384645,0.00004838211],"category_scores_gemma":[0.001321326,0.00015651561,0.00022374163,0.0003583422,0.00019330965,0.00016670252,0.00007742051,0.0001117363,0.000021984917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014431166,0.004415741,0.64823866,0.0015690572,0.0009862437,0.019802848,0.002719189,0.000004972232,0.0018017899,0.00038919016,0.038948387,0.2796808],"study_design_scores_gemma":[0.010961354,0.0007821608,0.8966789,0.016626025,0.0005500511,0.061827965,0.0015388,0.000572828,0.0019626117,0.00008227919,0.008208598,0.00020839254],"about_ca_topic_score_codex":0.0011033933,"about_ca_topic_score_gemma":0.00020814386,"teacher_disagreement_score":0.2794724,"about_ca_system_score_codex":0.00029479392,"about_ca_system_score_gemma":0.0012226325,"threshold_uncertainty_score":0.63825214},"labels":[],"label_agreement":null},{"id":"W1909983746","doi":"10.1111/j.1365-2141.2005.05866.x","title":"Arsenic trioxide (AT) is a novel human neutrophil pro‐apoptotic agent: effects of catalase on AT‐induced apoptosis, degradation of cytoskeletal proteins and <i>de novo</i> protein synthesis","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Apoptosis; Arsenic trioxide; Gelsolin; Cell biology; Catalase; Biology; Nicotinamide adenine dinucleotide phosphate; Reactive oxygen species; Chemistry; Biochemistry; Oxidative stress; Actin; Enzyme; Oxidase test","score_opus":0.008687274048559564,"score_gpt":0.23310725470933086,"score_spread":0.2244199806607713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1909983746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682707,0.0021374803,0.00025169886,0.00014993941,0.00004277671,0.00050374836,0.000023564306,0.000004841719,0.000058859554],"genre_scores_gemma":[0.9979461,0.00037365587,0.0012597765,0.00007319573,0.000095560645,0.000051691775,0.000016526617,0.00003356354,0.00014995987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982952,0.00015030344,0.0007313633,0.00029724857,0.00023545699,0.0002904574],"domain_scores_gemma":[0.998569,0.000055107088,0.00084301323,0.00022198058,0.00019126045,0.00011961592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002922937,0.00020721622,0.00058080343,0.000107764165,0.000111836256,0.000015245553,0.0002432893,0.0002647864,0.000013810313],"category_scores_gemma":[0.0003993044,0.00022076357,0.00019452925,0.00008561927,0.00020608676,0.00001556196,0.000113661685,0.00020254058,0.000001829671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025431655,0.00039129704,0.00018487447,0.00084132416,0.00013541976,0.00019537528,0.00005353504,0.000009728552,0.99566054,0.000054822933,0.00014413221,0.0020746451],"study_design_scores_gemma":[0.0017247212,0.000979093,0.00036125854,0.00057613704,0.00012152621,0.013937313,0.000019619727,0.0000072447074,0.9817661,0.00002779489,0.00029495172,0.00018425568],"about_ca_topic_score_codex":0.00003166767,"about_ca_topic_score_gemma":0.00004038052,"teacher_disagreement_score":0.013894444,"about_ca_system_score_codex":0.0000716706,"about_ca_system_score_gemma":0.00017083818,"threshold_uncertainty_score":0.9002477},"labels":[],"label_agreement":null},{"id":"W1919069136","doi":"10.1111/bjh.13801","title":"Factors influencing long‐term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Teva Pharmaceutical Industries; Pfizer","keywords":"Bosutinib; Medicine; Internal medicine; Imatinib; Tolerability; Cumulative incidence; Adverse effect; Discontinuation; Oncology; Gastroenterology; Myeloid leukemia; Nilotinib; Cohort","score_opus":0.055125360430511784,"score_gpt":0.34971217641064417,"score_spread":0.29458681598013237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919069136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99001145,0.008605076,0.000077080265,0.00023616433,0.00021367184,0.00073487574,0.000024850482,0.000021558606,0.00007529057],"genre_scores_gemma":[0.9987537,0.0003291182,0.00061304,0.00007679521,0.00012976759,0.000011682012,0.000012898246,0.000040872623,0.000032072618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623245,0.00025425793,0.0019801373,0.00041639133,0.0005095282,0.00060725835],"domain_scores_gemma":[0.99741936,0.00035141254,0.000812837,0.00038654867,0.00039605147,0.00063381874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093178835,0.00033236414,0.0019559087,0.00038892918,0.000058868594,0.000035737765,0.00026564664,0.00023959242,0.00016317687],"category_scores_gemma":[0.0015728992,0.00029081033,0.00016046969,0.0003911562,0.0003019808,0.00022830217,0.00014776397,0.000664503,0.000005798089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030248152,0.006718738,0.3893031,0.008504567,0.0021039736,0.2080156,0.019239925,0.0007919008,0.0694615,0.00014176816,0.0029734315,0.26249737],"study_design_scores_gemma":[0.09921631,0.017189601,0.6594245,0.012361742,0.0006402276,0.18097238,0.0012085978,0.00027108387,0.027109403,0.00013232668,0.0006727742,0.00080106384],"about_ca_topic_score_codex":0.0005556455,"about_ca_topic_score_gemma":0.0022449265,"teacher_disagreement_score":0.2701214,"about_ca_system_score_codex":0.0038695084,"about_ca_system_score_gemma":0.004595523,"threshold_uncertainty_score":0.99995446},"labels":[],"label_agreement":null},{"id":"W1921751791","doi":"10.1111/bjh.13596","title":"Therapeutic targeting of N‐cadherin is an effective treatment for multiple myeloma","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Royal Adelaide Hospital; Cancer Australia; Leukaemia Foundation; Multiple Myeloma Research Foundation","keywords":"Cadherin; Stromal cell; Bone marrow; Medicine; Multiple myeloma; Extravasation; Small hairpin RNA; Homing (biology); Cancer research; Pathogenesis; Pathology; Internal medicine; Cell culture; Cell; Chemistry; Biology; Gene knockdown","score_opus":0.0663614294524306,"score_gpt":0.3575109046384235,"score_spread":0.2911494751859929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921751791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923553,0.005484213,0.00080765586,0.00026633267,0.00014444618,0.0007761265,0.00004040787,0.000010856275,0.00011467903],"genre_scores_gemma":[0.993711,0.00019872759,0.0057155876,0.000076568176,0.00012179955,0.00004812399,0.000019131989,0.000026507701,0.00008255351],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9985759,0.00018340923,0.00049863616,0.00016830137,0.00025407126,0.0003196754],"domain_scores_gemma":[0.99828666,0.00029647344,0.00031118948,0.00012951395,0.0006152745,0.00036087047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039163002,0.0001391186,0.0007964462,0.00012838093,0.00005490982,0.0000151392,0.00010092856,0.0001041512,0.00004209077],"category_scores_gemma":[0.0005083019,0.00011897196,0.00022769967,0.0000853601,0.000108328146,0.00011675125,0.000018326064,0.00012972279,0.000005964752],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010706395,0.0043844637,0.19144964,0.00044948334,0.0032550856,0.03394486,0.0027853837,0.000021314148,0.012879762,0.00013043892,0.0030958436,0.73689735],"study_design_scores_gemma":[0.11221928,0.05598238,0.20332605,0.0013779576,0.0013306921,0.34205836,0.0041668527,0.0041606864,0.2585001,0.002912056,0.013299441,0.00066614384],"about_ca_topic_score_codex":0.0002344212,"about_ca_topic_score_gemma":0.000072811075,"teacher_disagreement_score":0.7362312,"about_ca_system_score_codex":0.00013879329,"about_ca_system_score_gemma":0.00020623412,"threshold_uncertainty_score":0.4851536},"labels":[],"label_agreement":null},{"id":"W1921878015","doi":"10.1111/bjh.13538","title":"Novel protein C gene mutation in a compound heterozygote resulting in catastrophic thrombosis in early adulthood: diagnosis and long‐term treatment with subcutaneous protein C concentrate","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Purpura fulminans; Thrombophilia; Protein C; Compound heterozygosity; Thrombosis; Deep vein; Protein C deficiency; Surgery; Venous thrombosis; Missense mutation; Protein S deficiency; Protein S; Internal medicine; Gastroenterology; Pediatrics; Mutation; Genetics","score_opus":0.037674407542964,"score_gpt":0.2768049761806689,"score_spread":0.2391305686377049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921878015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764915,0.0017473447,0.0001083824,0.01932549,0.000093052775,0.0021459127,0.000066936744,0.000014466191,0.000006887304],"genre_scores_gemma":[0.9919823,0.00032845873,0.0032197079,0.0038474794,0.0002020685,0.00017207909,0.00015325051,0.000078599856,0.000016061575],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99655104,0.0004310431,0.001427801,0.0005135729,0.0004918389,0.0005846872],"domain_scores_gemma":[0.9981984,0.000095795374,0.0010408134,0.0002076758,0.00029112582,0.00016622669],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042527507,0.00042364828,0.0018785145,0.0006398128,0.000045597222,0.00009631434,0.00014855381,0.0006414212,0.000012398182],"category_scores_gemma":[0.000100485275,0.0004182731,0.00009885629,0.00032250572,0.00016785364,0.00018701567,0.000039244973,0.0015105972,0.000002285274],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018143684,0.0019697098,0.055139292,0.0012320252,0.00053467,0.9224469,0.002506305,0.000054549277,0.0070233825,0.0000152297225,0.0004615441,0.00680201],"study_design_scores_gemma":[0.043909386,0.012169619,0.10145362,0.029532058,0.000548621,0.80382615,0.00031032343,0.00020703506,0.0063961674,0.00026899614,0.00027933906,0.0010986984],"about_ca_topic_score_codex":0.0019852845,"about_ca_topic_score_gemma":0.003724807,"teacher_disagreement_score":0.118620776,"about_ca_system_score_codex":0.00048162384,"about_ca_system_score_gemma":0.00042213022,"threshold_uncertainty_score":0.9998269},"labels":[],"label_agreement":null},{"id":"W1926450100","doi":"10.1111/j.1365-2141.2011.08775.x","title":"Prospective multicentre cohort study of heparin‐induced thrombocytopenia in acute ischaemic stroke patients","year":2011,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Internal medicine; Stroke (engine); Prospective cohort study; Incidence (geometry); Platelet factor 4; Anticoagulant; Cohort; Surgery","score_opus":0.026132309755626765,"score_gpt":0.2779037198846386,"score_spread":0.25177141012901183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1926450100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953038,0.00010957419,0.000006568464,0.00003110569,0.0004673506,0.0017580796,0.000014362446,0.00001810708,0.002291013],"genre_scores_gemma":[0.9990494,0.00017589565,0.0005482456,0.00005494946,0.00003823774,0.000027761515,0.000005350227,0.000046414716,0.000053722106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966858,0.00028844512,0.0015910681,0.00041538096,0.00050878787,0.00051048695],"domain_scores_gemma":[0.9976525,0.00007716695,0.00092152716,0.00035245522,0.0007353291,0.00026105743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004891443,0.00028664074,0.0023744688,0.00039287464,0.00007696396,0.000017925739,0.00037031234,0.00025750403,0.0002990175],"category_scores_gemma":[0.0002784363,0.0002939193,0.00022259704,0.0003412719,0.0001364482,0.00034058077,0.00017220223,0.0008543257,0.000022909022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075014564,0.0056421226,0.9719432,0.000060158483,0.0012604939,0.012863442,0.0032258735,3.867769e-7,0.0029980575,0.00006244251,0.00007339003,0.0011202618],"study_design_scores_gemma":[0.012390309,0.0030955086,0.95319587,0.0004012213,0.0008125484,0.018853985,0.0015595718,0.000007702901,0.009364226,0.000087927765,0.000008530821,0.00022260414],"about_ca_topic_score_codex":0.0018234998,"about_ca_topic_score_gemma":0.0018231673,"teacher_disagreement_score":0.01874736,"about_ca_system_score_codex":0.00018713388,"about_ca_system_score_gemma":0.00025029294,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W1926758277","doi":"10.1111/j.1365-2141.2008.07126.x","title":"Studies in haemoglobin E beta‐thalassaemia","year":2008,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Malaria; Medicine; Hemoglobinopathy; Cohort; Pediatrics; Natural history; Blood transfusion; Beta-thalassaemia; Thalassemia; Hemoglobin E; Immunology; Internal medicine; Hemolytic anemia","score_opus":0.0764617794259594,"score_gpt":0.3776077192738386,"score_spread":0.30114593984787924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1926758277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015631646,0.9956242,0.0000038389862,0.00021420195,0.0011277542,0.0004918642,0.000011425275,0.000019305284,0.0009442329],"genre_scores_gemma":[0.00012506648,0.9988102,0.0003222052,0.00013510873,0.00020322455,0.000014571314,0.000015982605,0.00007357156,0.00030012705],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9959839,0.0004029916,0.002375253,0.00032799906,0.00037172445,0.0005381131],"domain_scores_gemma":[0.99762666,0.00030635254,0.0012700023,0.00023539668,0.000334261,0.0002273286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042212266,0.00043834423,0.0066727228,0.0006955289,0.0000843142,0.000015991829,0.0002970113,0.0009874224,0.00006422989],"category_scores_gemma":[0.00066204375,0.00038302017,0.00119062,0.00055696385,0.0005326155,0.0000894414,0.000104058214,0.0022488532,0.000059414724],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017902186,0.00018671397,0.000040448762,0.011620661,0.0009090099,0.38288963,0.000094057155,6.888481e-7,7.64552e-8,0.00003394027,0.03036333,0.57384354],"study_design_scores_gemma":[0.00079464685,0.00012386203,0.0000063930074,0.047310058,0.00060285756,0.4964665,0.00013627937,2.3436151e-7,4.3381274e-7,0.000030668645,0.45437837,0.00014970511],"about_ca_topic_score_codex":0.000026238142,"about_ca_topic_score_gemma":0.0000335775,"teacher_disagreement_score":0.5736939,"about_ca_system_score_codex":0.00026894792,"about_ca_system_score_gemma":0.0010262539,"threshold_uncertainty_score":0.9998622},"labels":[],"label_agreement":null},{"id":"W1929921628","doi":"10.1111/j.1365-2141.2010.08342.x","title":"The class‐I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6‐independent mechanism","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada)","funders":"National Cancer Institute","keywords":"Proteasome; Cancer research; Proteasome inhibitor; Histone deacetylase; Carfilzomib; HDAC6; Apoptosis; In vivo; Bortezomib; Lymphoma; Biology; Cell culture; Chemistry; Multiple myeloma; Cell biology; Immunology; Histone; Biochemistry; Gene","score_opus":0.004500906008880796,"score_gpt":0.2286580455090533,"score_spread":0.22415713950017252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1929921628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957287,0.0027352874,0.000036188394,0.000540076,0.0004681751,0.0003597537,0.000019693474,0.000008987824,0.00010317547],"genre_scores_gemma":[0.9976946,0.00092358235,0.0005292464,0.00007497768,0.0003942983,0.0000499166,0.000016311174,0.00005441765,0.00026263294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974434,0.00038733138,0.000715501,0.00044292328,0.0004646793,0.0005462144],"domain_scores_gemma":[0.9985382,0.00008355876,0.00044101808,0.00030357882,0.0003427313,0.00029090766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010057169,0.00026667168,0.00048632876,0.00016933364,0.00028104216,0.00018298092,0.00048059615,0.00048634555,0.000014113936],"category_scores_gemma":[0.00031668151,0.00022206645,0.00009745967,0.00017528537,0.00050745223,0.00004384413,0.0001765678,0.00071638933,0.0000031806792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031275413,0.00034164978,0.00041242063,0.000048104783,0.000049161823,0.0011382261,0.00009219819,0.0000027751453,0.98773,0.000058837966,0.004221983,0.00559185],"study_design_scores_gemma":[0.0021297948,0.001027025,0.00021262515,0.000117471216,0.000020093052,0.022119166,0.0004581802,0.000014205935,0.9674904,0.00013419408,0.0059851906,0.00029170583],"about_ca_topic_score_codex":0.00020776481,"about_ca_topic_score_gemma":0.001920472,"teacher_disagreement_score":0.020980941,"about_ca_system_score_codex":0.000033809978,"about_ca_system_score_gemma":0.0003509716,"threshold_uncertainty_score":0.9055607},"labels":[],"label_agreement":null},{"id":"W1939515160","doi":"10.1111/j.1365-2141.2010.08216.x","title":"Stable long‐term risk of leukaemia in patients with severe congenital neutropenia maintained on G‐CSF therapy","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Congenital Neutropenia; Neutropenia; Granulocyte colony-stimulating factor; Filgrastim; Sepsis; Risk factor; Dyskeratosis congenita; Fanconi anemia; Pediatrics; Internal medicine; Myelodysplastic syndromes; Chemotherapy; Bone marrow","score_opus":0.003108226000964866,"score_gpt":0.20130763152807685,"score_spread":0.198199405527112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1939515160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866545,0.00068184553,0.000028604405,0.00002185114,0.00012582126,0.000169827,0.000045637305,0.0000018234858,0.00025912185],"genre_scores_gemma":[0.99912924,0.00037953502,0.00030371847,0.00007093529,0.000028202352,0.0000037681757,0.00003607265,0.000020099482,0.000028409773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990782,0.000074280804,0.0003372847,0.00016789327,0.00012867973,0.00021365525],"domain_scores_gemma":[0.9991992,0.000016489952,0.00035014155,0.00016094334,0.00020086228,0.00007236541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011367336,0.0001312384,0.00035735604,0.00006173071,0.00004126631,0.000018629587,0.00017642516,0.00015366828,0.000051979354],"category_scores_gemma":[0.000044909277,0.000115209914,0.00008471185,0.000058299524,0.00010799223,0.000011278995,0.000032255735,0.0002642986,0.0000019267377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016608008,0.0009600902,0.9844567,0.000010614115,0.00033355728,0.0012829704,0.000019317893,0.00001389464,0.0014057447,0.000039169376,0.0002741314,0.009542972],"study_design_scores_gemma":[0.014944349,0.0029795466,0.9595344,0.0000652895,0.000064610045,0.006777642,0.000025956651,0.0000010110905,0.0150529165,0.00015090177,0.00019991743,0.00020347281],"about_ca_topic_score_codex":0.00009419552,"about_ca_topic_score_gemma":0.0011066563,"teacher_disagreement_score":0.02492235,"about_ca_system_score_codex":0.000007258335,"about_ca_system_score_gemma":0.000093554736,"threshold_uncertainty_score":0.4698124},"labels":[],"label_agreement":null},{"id":"W1946820278","doi":"10.1111/bjh.13790","title":"Myeloma impairs mature osteoblast function but causes early expansion of osteo‐progenitors: temporal changes in bone physiology and gene expression in the KMS12BM model","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University College London; Leukaemia and Lymphoma Research; Leukemia and Lymphoma Research; Cancer Research UK; National Institute for Health and Care Research; Organisation Canadienne des Physiciens Médicaux","keywords":"Osteoblast; Progenitor cell; Osteoclast; Bone resorption; Bone remodeling; Resorption; Cell biology; Stromal cell; Medicine; Biology; Pathology; Cancer research; Internal medicine; Stem cell; In vitro; Receptor; Genetics","score_opus":0.03064421872906813,"score_gpt":0.283161634324778,"score_spread":0.25251741559570984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1946820278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365383,0.0053436784,0.00004233445,0.0004493351,0.000101436286,0.0003667186,0.00001815004,0.000006483739,0.000018013534],"genre_scores_gemma":[0.9982528,0.00046902022,0.0010272381,0.000070300004,0.0001035302,0.000022492326,0.000018255525,0.000017400118,0.000018947445],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99826354,0.0003439496,0.0005158479,0.00019713056,0.00036252462,0.0003169925],"domain_scores_gemma":[0.99903226,0.00009928451,0.00030350656,0.00015520347,0.00023726972,0.00017248701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050239766,0.0001498944,0.00068657426,0.0003234587,0.00004017516,0.000016732296,0.00011018392,0.00022050043,0.000009711049],"category_scores_gemma":[0.00023141892,0.00011146938,0.00006996841,0.00017607513,0.00015992072,0.00015831049,0.00006888815,0.00044582953,0.0000017160609],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0146583095,0.0016110068,0.27000278,0.0007389076,0.00024559887,0.07935565,0.004907835,0.0001361912,0.602121,0.00002472293,0.0019574587,0.024240548],"study_design_scores_gemma":[0.021214478,0.005988906,0.5831835,0.002134827,0.0001486344,0.25763822,0.005652744,0.00088558026,0.12166788,0.0011122182,0.00006401253,0.00030896807],"about_ca_topic_score_codex":0.00032887782,"about_ca_topic_score_gemma":0.0006334289,"teacher_disagreement_score":0.4804531,"about_ca_system_score_codex":0.00004976289,"about_ca_system_score_gemma":0.00017475331,"threshold_uncertainty_score":0.45455894},"labels":[],"label_agreement":null},{"id":"W1963879883","doi":"10.1111/j.1365-2141.2008.07353.x","title":"Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Rituximab; Lymphoma; Medicine; Cancer research; Oligonucleotide; Hodgkin lymphoma; Monoclonal; Internal medicine; Oncology; Monoclonal antibody; Immunology; Chemistry; Antibody; Biochemistry; Gene","score_opus":0.010358930872147341,"score_gpt":0.24942293107160227,"score_spread":0.23906400019945492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963879883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820524,0.0005554779,0.0000051497077,0.000101408914,0.00010037116,0.0009362015,0.000010037631,0.000005821339,0.00008028178],"genre_scores_gemma":[0.99903303,0.00029596497,0.0005333322,0.00005759015,0.000011600124,0.000018977473,0.000014607711,0.000024833413,0.000010031599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979574,0.00016614154,0.0008984605,0.00024712668,0.00043341576,0.00029745031],"domain_scores_gemma":[0.998635,0.0000705742,0.00062121433,0.00016572817,0.00037668005,0.00013078933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017122399,0.00020111814,0.0010799665,0.00044480475,0.00006881155,0.00001041216,0.000096665986,0.00007895569,0.000017852159],"category_scores_gemma":[0.000042288426,0.00017066656,0.000074847114,0.0003127015,0.00012865357,0.0001747191,0.000041362367,0.00015797946,0.0000031619284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004694717,0.16179223,0.75163525,0.00007854052,0.00017129394,0.065303564,0.0019374938,0.000005167148,0.000017791745,0.000002354558,0.00018928555,0.014172289],"study_design_scores_gemma":[0.24585794,0.019839173,0.7164579,0.0009800914,0.00017375323,0.015467747,0.00055401167,0.000052717987,0.00045505498,0.0000027109475,0.000027558075,0.00013136091],"about_ca_topic_score_codex":0.0005813617,"about_ca_topic_score_gemma":0.00078258425,"teacher_disagreement_score":0.24116322,"about_ca_system_score_codex":0.0002073098,"about_ca_system_score_gemma":0.00023021136,"threshold_uncertainty_score":0.6959581},"labels":[],"label_agreement":null},{"id":"W1963910097","doi":"10.1111/bjh.12414","title":"Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Multiple myeloma; Chemotherapy; Cyclophosphamide; Dexamethasone; Bortezomib; Radiation therapy; Internal medicine; Oncology; Surgery; Gastroenterology","score_opus":0.013725923017352431,"score_gpt":0.24364246069732953,"score_spread":0.2299165376799771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963910097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961601,0.0017644513,0.0003367307,0.0007714217,0.00011081107,0.0007725761,0.000016264914,0.000024639816,0.000043036664],"genre_scores_gemma":[0.99839354,0.00032097189,0.0008630722,0.00013944895,0.00010699601,0.000031540512,0.00003706354,0.000042687123,0.00006467309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803966,0.00017390132,0.00051452685,0.0002485454,0.00047402908,0.0005493152],"domain_scores_gemma":[0.99858576,0.000075716016,0.00032904296,0.0001847914,0.00033239686,0.00049226504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019301251,0.00022365479,0.00074899127,0.00013183754,0.0001519262,0.00009543176,0.00013424654,0.00010656822,0.00006921836],"category_scores_gemma":[0.000042896838,0.00017303177,0.00007530982,0.00010885044,0.00023153618,0.0001895686,0.00003363752,0.00033839716,0.0000028677464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012125678,0.0004996096,0.9197899,0.00033372265,0.0013377151,0.0331291,0.0004150876,0.000007883587,0.0005095986,0.000029074212,0.00030084985,0.04243491],"study_design_scores_gemma":[0.012011527,0.0011438519,0.885049,0.0005442881,0.00011432116,0.09965663,0.0004628843,0.0001880693,0.00063137646,0.0000034455272,0.000046755045,0.0001478983],"about_ca_topic_score_codex":0.0011544229,"about_ca_topic_score_gemma":0.00085874397,"teacher_disagreement_score":0.06652752,"about_ca_system_score_codex":0.00021023076,"about_ca_system_score_gemma":0.00028132048,"threshold_uncertainty_score":0.7056031},"labels":[],"label_agreement":null},{"id":"W1964138393","doi":"10.1046/j.1365-2141.2001.03160.x","title":"Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long‐term marrow cultures","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"National Heart, Lung, and Blood Institute","keywords":"Haematopoiesis; Matrix metalloproteinase; Stromal cell; Bone marrow; Biology; Fibroblast; Extracellular matrix; Cell culture; Immunology; Molecular biology; Cell biology; Chemistry; Stem cell; Cancer research; Biochemistry","score_opus":0.004555753348917518,"score_gpt":0.23046732550712123,"score_spread":0.2259115721582037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964138393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95259297,0.04651798,0.00019718782,0.00017171854,0.000084473315,0.000402683,0.000017569293,0.000004294009,0.0000111074005],"genre_scores_gemma":[0.99343365,0.005825396,0.00051902904,0.000021372864,0.000084084655,0.000017616201,0.00002378569,0.000019009043,0.000056047516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986292,0.00018640797,0.000510778,0.00032452896,0.00011722929,0.00023184501],"domain_scores_gemma":[0.9993057,0.000011217757,0.00034307997,0.00010721731,0.00009799442,0.00013477572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044331292,0.00020250861,0.00050012814,0.00011109586,0.00007556006,0.000042430376,0.00007803577,0.00023300304,0.000009476376],"category_scores_gemma":[0.00012539544,0.00019469738,0.000044758228,0.00007318581,0.00027946781,0.000056763336,0.00010785907,0.00021201925,1.4560858e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031181728,0.00009773737,0.0036513098,0.00028436474,0.00007980772,0.00096301985,0.0001373841,0.0000023419714,0.98807037,0.000040341856,0.00018355467,0.006177934],"study_design_scores_gemma":[0.0013119265,0.00093145715,0.002017785,0.0003321337,0.00006657183,0.10429447,0.00023104517,0.000011558007,0.8898358,0.00050514087,0.0002402044,0.00022196058],"about_ca_topic_score_codex":0.000082019964,"about_ca_topic_score_gemma":0.00014519822,"teacher_disagreement_score":0.103331454,"about_ca_system_score_codex":0.00000905698,"about_ca_system_score_gemma":0.000037067457,"threshold_uncertainty_score":0.7939529},"labels":[],"label_agreement":null},{"id":"W1964249329","doi":"10.1046/j.1365-2141.2003.03971.x","title":"The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"Heart and Stroke Foundation of Canada","keywords":"Thrombin; Vincristine; Tissue factor; Thrombomodulin; Downregulation and upregulation; Pharmacology; Cancer research; Coagulation; Chemistry; Medicine; Immunology; Internal medicine; Chemotherapy; Platelet; Cyclophosphamide; Biochemistry","score_opus":0.018761409451240846,"score_gpt":0.26089836508366904,"score_spread":0.24213695563242818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964249329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954319,0.0012899837,0.000054626802,0.0006885594,0.00036753016,0.00022920442,6.406499e-7,0.000003917675,0.0019336394],"genre_scores_gemma":[0.99881464,0.00048905157,0.00010641266,0.0004091266,0.000014453223,0.0000016133362,4.910409e-7,0.00001274058,0.00015148042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987822,0.0002726959,0.00044714444,0.00007877631,0.00029448725,0.00012466972],"domain_scores_gemma":[0.9985162,0.0005664534,0.00055199105,0.0001654454,0.00016046171,0.000039452025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005303777,0.000081828075,0.0004105559,0.0000512353,0.00008023908,0.000009137337,0.00010963895,0.000082743565,0.000111351896],"category_scores_gemma":[0.00026405917,0.000053633477,0.00012873179,0.000109379536,0.000118035474,0.000025249692,0.000007245607,0.00018640538,0.0000048498227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010938479,0.004592084,0.004305983,0.0015693998,0.0016661031,0.0011853405,0.0013118137,0.00020016705,0.7209613,0.22501981,0.019930834,0.018163363],"study_design_scores_gemma":[0.002470211,0.0014016085,0.032813326,0.0008859766,0.00015382971,0.006823499,0.0001633014,0.000054784676,0.94677097,0.007918002,0.00047810908,0.000066374385],"about_ca_topic_score_codex":0.0000056014565,"about_ca_topic_score_gemma":0.000003734421,"teacher_disagreement_score":0.22580972,"about_ca_system_score_codex":0.000013668474,"about_ca_system_score_gemma":0.000052893367,"threshold_uncertainty_score":0.21871097},"labels":[],"label_agreement":null},{"id":"W1964282764","doi":"10.1046/j.1365-2141.2001.02840.x","title":"Identification of both myeloid CD11c<sup>+</sup> and lymphoid CD11c<sup>−</sup> dendritic cell subsets in cord blood","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"CD11c; Myeloid; Immunology; Dendritic cell; Cord blood; CD33; Biology; Lymphatic system; CD80; T cell; Interleukin-3 receptor; Follicular dendritic cells; Antigen-presenting cell; Phenotype; Antigen; Stem cell; Immune system; Cytotoxic T cell; CD40; Cell biology; CD34; In vitro; Gene","score_opus":0.008034873086710024,"score_gpt":0.22709489989909828,"score_spread":0.21906002681238826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964282764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9217574,0.077050015,0.00011188298,0.000230858,0.0003332745,0.0002524416,0.000037881175,0.000022609562,0.00020362613],"genre_scores_gemma":[0.98057187,0.017662847,0.00009562177,0.00014863945,0.000042302054,0.000012972037,0.000030767693,0.000046078105,0.0013888942],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9957973,0.00111964,0.0018972723,0.000382479,0.000121769655,0.000681559],"domain_scores_gemma":[0.99783266,0.0005665776,0.000915272,0.0003464526,0.00027990143,0.00005915352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011093452,0.0003240441,0.0012330484,0.00058624655,0.0002247674,0.0000594516,0.000548668,0.0005606277,0.0005025526],"category_scores_gemma":[0.0003578398,0.00037110827,0.00024937675,0.0003505938,0.00070505764,0.00038543102,0.00009775123,0.0006872402,0.000067647314],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074643497,0.003722635,0.06187455,0.0005543531,0.0014641075,0.020725401,0.0041854954,0.00027870425,0.85617554,0.0006763473,0.0049905423,0.03788796],"study_design_scores_gemma":[0.015840169,0.001617862,0.024827987,0.0009667599,0.0004095154,0.75907737,0.0026701132,0.000091796544,0.18291807,0.0010093426,0.009814499,0.0007565087],"about_ca_topic_score_codex":0.00032821333,"about_ca_topic_score_gemma":0.000053652573,"teacher_disagreement_score":0.73835194,"about_ca_system_score_codex":0.00005592466,"about_ca_system_score_gemma":0.000244995,"threshold_uncertainty_score":0.9998741},"labels":[],"label_agreement":null},{"id":"W1964495651","doi":"10.1046/j.1365-2141.2003.04086.x","title":"Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; National Institutes of Health; Deutsche Krebshilfe","keywords":"BCL6; Biology; Follicular lymphoma; Fluorescence in situ hybridization; Karyotype; Lymphoma; Cytogenetics; Gene rearrangement; Immunohistochemistry; Pathology; Follicular phase; Molecular biology; Cancer research; Chromosome; Genetics; Immunology; B cell; Germinal center; Antibody; Gene; Medicine","score_opus":0.01638694824535327,"score_gpt":0.2833452304685933,"score_spread":0.26695828222324003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964495651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97985816,0.018007023,0.0002520099,0.00090795284,0.00032477485,0.00019674012,0.000008642127,0.000008048923,0.00043667655],"genre_scores_gemma":[0.9983186,0.0009998139,0.00024316984,0.00023766622,0.00006192348,0.000011276988,0.000005576073,0.00001546489,0.000106467436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998414,0.00023915622,0.00071073644,0.00014335045,0.0002979802,0.00019480713],"domain_scores_gemma":[0.9985555,0.00017696289,0.00056653435,0.00022287155,0.00032753605,0.00015059856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057879643,0.000110313864,0.00049568835,0.00008802745,0.00009988423,0.00003446261,0.00012520474,0.00005483321,0.0001245885],"category_scores_gemma":[0.00062296103,0.0000861503,0.00026514783,0.00014374939,0.00013836444,0.00009323,0.000017974917,0.000075326476,0.000014938816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075411214,0.005786722,0.6804787,0.0006338427,0.0023882801,0.15643682,0.00072633266,0.00011987839,0.0027986881,0.041469708,0.018807875,0.089599065],"study_design_scores_gemma":[0.013392104,0.00033751602,0.58028793,0.0012486626,0.0019081844,0.3496697,0.00035823334,0.000080911144,0.03290688,0.0073053194,0.012231624,0.00027293625],"about_ca_topic_score_codex":0.000067902736,"about_ca_topic_score_gemma":0.000025443122,"teacher_disagreement_score":0.19323286,"about_ca_system_score_codex":0.00009096072,"about_ca_system_score_gemma":0.0003292851,"threshold_uncertainty_score":0.35131073},"labels":[],"label_agreement":null},{"id":"W1964751152","doi":"10.1046/j.1365-2141.2002.03365.x","title":"Immunomodulatory gene therapy for haematological malignancies","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Clinical trial; Medicine; Genetic enhancement; Transplantation; Disease; Oncology; Internal medicine; Immunology; Gene; Biology; Genetics","score_opus":0.06095631754002151,"score_gpt":0.3451899757516989,"score_spread":0.2842336582116774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964751152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0131272515,0.98501563,0.00031017003,0.00003744084,0.00048782493,0.000848877,0.0001154351,0.000011017347,0.00004633576],"genre_scores_gemma":[0.00040331006,0.9972873,0.0009024634,0.00014346583,0.00056458893,0.000134902,0.00012227739,0.00013006947,0.0003116623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963268,0.0006665083,0.0014857104,0.0005277702,0.00030930818,0.0006838739],"domain_scores_gemma":[0.9975307,0.00014161316,0.0011362843,0.0005018427,0.00049922755,0.00019034847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093863584,0.00049466663,0.0028755509,0.00023473958,0.00017160985,0.00008232395,0.0011055424,0.000997275,0.00014708927],"category_scores_gemma":[0.00030700365,0.0004619651,0.0015940835,0.00015631749,0.00035297795,0.000008241495,0.00014452555,0.00059980253,0.00002434126],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006136384,0.0003053768,0.0000026308396,0.0022231594,0.0012259777,0.0065116463,0.000009782483,0.0000024342128,0.00088509003,0.000032777996,0.016461378,0.9717261],"study_design_scores_gemma":[0.0010340953,0.0030423251,0.00000108768,0.0016390408,0.0001457075,0.21087515,0.0000067059937,0.0000010341184,0.0016123232,0.00009017658,0.78116643,0.00038591772],"about_ca_topic_score_codex":0.0000030093731,"about_ca_topic_score_gemma":0.0000138381065,"teacher_disagreement_score":0.9713402,"about_ca_system_score_codex":0.000046036606,"about_ca_system_score_gemma":0.0005524815,"threshold_uncertainty_score":0.9997832},"labels":[],"label_agreement":null},{"id":"W1965169783","doi":"10.1111/bjh.12187","title":"<i><scp>BCR</scp>‐<scp>ABL</scp>1</i> transcript at 3 months predicts long‐term outcomes following second generation tyrosine kinase inhibitor therapy in the patients with chronic myeloid leukaemia in chronic phase who failed Imatinib","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Imatinib; Medicine; Tyrosine kinase; Internal medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; ABL; Gastroenterology; Oncology; Immunology; Receptor; Cancer","score_opus":0.017634749593782983,"score_gpt":0.26789628347300787,"score_spread":0.2502615338792249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965169783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96187794,0.034985222,0.000063525025,0.00013906769,0.0007674207,0.0018497395,0.00007604809,0.000035659443,0.00020536415],"genre_scores_gemma":[0.99664354,0.0011937469,0.00020766487,0.0005454578,0.00055993174,0.00015424681,0.00025647003,0.00011625845,0.00032269795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99491906,0.0005501683,0.0017354502,0.0005207001,0.00095566444,0.0013189585],"domain_scores_gemma":[0.99739003,0.0005903285,0.0009065744,0.0005066375,0.00021462579,0.0003917969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009751982,0.0006209532,0.0018000857,0.00045188985,0.00022671241,0.00011180437,0.00042805925,0.0004141123,0.00009979083],"category_scores_gemma":[0.00046030758,0.00049020536,0.0004189611,0.00050593243,0.00021702639,0.0010191115,0.00006462454,0.0010945684,0.000018449316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025238015,0.0030033803,0.94768953,0.00047668727,0.00080884044,0.016324284,0.004594099,0.00008428031,0.009291828,0.000013000612,0.008530039,0.008931631],"study_design_scores_gemma":[0.10429909,0.004295694,0.8484126,0.0025422603,0.0004988253,0.018218637,0.00035590833,0.00023010331,0.018272955,0.00001323489,0.002606815,0.00025388732],"about_ca_topic_score_codex":0.00013289257,"about_ca_topic_score_gemma":0.003442669,"teacher_disagreement_score":0.10404671,"about_ca_system_score_codex":0.0033634023,"about_ca_system_score_gemma":0.0011498523,"threshold_uncertainty_score":0.99975497},"labels":[],"label_agreement":null},{"id":"W1965512384","doi":"10.1111/j.1365-2141.2009.07721.x","title":"Highly increased familial risks for specific lymphoma subtypes","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Socialstyrelsen; National Institutes of Health; McMaster University; World Health Organization","keywords":"Lymphoma; Follicular lymphoma; Etiology; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Population; First-degree relatives; Family history","score_opus":0.027035196651240004,"score_gpt":0.28873266542329595,"score_spread":0.26169746877205596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965512384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869529,0.009646518,0.00017619944,0.0017075692,0.00039227933,0.0002765928,0.000023940547,0.00002036407,0.0008036619],"genre_scores_gemma":[0.99405956,0.0016126899,0.0029771023,0.00084637385,0.00039900898,0.0000083818495,0.000016901453,0.000014975931,0.00006502642],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998688,0.000058492984,0.0005845188,0.00017406647,0.00020492545,0.00028999435],"domain_scores_gemma":[0.99890363,0.00017243814,0.0002983119,0.00013525698,0.00028144813,0.00020894187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002181962,0.00014017639,0.0007721082,0.00012929097,0.000090768524,0.000035125184,0.0001105396,0.0001374367,0.00006105777],"category_scores_gemma":[0.00016158212,0.00013278103,0.0003118011,0.00008776605,0.00007117944,0.00008328584,0.000010395945,0.00007871776,0.000019690653],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039538494,0.005451893,0.044388626,0.00013484182,0.00076758006,0.19818993,0.00019157474,0.0000042733604,0.0018856155,0.0056151124,0.1164459,0.6229708],"study_design_scores_gemma":[0.017594708,0.0024489665,0.50242794,0.00043434172,0.0003597405,0.42852882,0.00007114725,0.000014220473,0.0073005073,0.0022496828,0.038384996,0.00018494896],"about_ca_topic_score_codex":0.00011606685,"about_ca_topic_score_gemma":0.00002148606,"teacher_disagreement_score":0.62278587,"about_ca_system_score_codex":0.00015392063,"about_ca_system_score_gemma":0.00027582794,"threshold_uncertainty_score":0.5414653},"labels":[],"label_agreement":null},{"id":"W1965612700","doi":"10.1046/j.1365-2141.2001.02700.x","title":"Clinical spectrum of hepatitis C‐related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Ribavirin; Haemophilia; Gastroenterology; Internal medicine; Hepatitis C; Liver disease; Cirrhosis; Liver biopsy; Hepatitis C virus; Regimen; Pegylated interferon; Alpha interferon; Haemophilia A; Biopsy; Immunology; Interferon; Surgery; Virus","score_opus":0.029891757076658677,"score_gpt":0.3382607030226073,"score_spread":0.3083689459459486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965612700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99113995,0.0046458007,0.00003847155,0.0035230718,0.00005580547,0.0005135031,0.000036929297,0.0000074883455,0.000038954],"genre_scores_gemma":[0.9774888,0.021713112,0.00029053786,0.00014792758,0.000036787373,0.000010691868,0.0000039454403,0.000025779398,0.00028241726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975866,0.0006300853,0.000892362,0.000289348,0.000286532,0.00031506078],"domain_scores_gemma":[0.99811137,0.00043235347,0.00019917844,0.00018275958,0.00013225847,0.00094210816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006818061,0.00016299092,0.00094000436,0.0003665301,0.00004500796,0.000025008889,0.000087058106,0.00009765609,0.00020297841],"category_scores_gemma":[0.0010381123,0.000133289,0.0000851882,0.0002333776,0.00040821594,0.00013086747,0.0000706049,0.00032330368,0.000005385046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04582884,0.0004987831,0.6573872,0.00008304883,0.00012348521,0.25539786,0.00015590795,0.000002109324,0.000031423224,0.000009616995,0.00014563354,0.040336095],"study_design_scores_gemma":[0.00845448,0.008150481,0.921698,0.0018697359,0.00019027373,0.05776196,0.00003679594,0.00022543372,0.00003793017,0.00011708474,0.0013197404,0.00013808352],"about_ca_topic_score_codex":0.00063742563,"about_ca_topic_score_gemma":0.0038157909,"teacher_disagreement_score":0.26431078,"about_ca_system_score_codex":0.00010949412,"about_ca_system_score_gemma":0.0004627308,"threshold_uncertainty_score":0.5435368},"labels":[],"label_agreement":null},{"id":"W1965641972","doi":"10.1111/j.1365-2141.2008.07309.x","title":"High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Fludarabine; Medicine; Cyclophosphamide; Neutropenia; Internal medicine; Minimal residual disease; Chronic lymphocytic leukemia; Gastroenterology; Toxicity; Chemotherapy; Surgery; Oncology; Leukemia","score_opus":0.00704996961039125,"score_gpt":0.22922121467544762,"score_spread":0.22217124506505637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965641972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916227,0.0074616913,0.00003649901,0.00006552433,0.0000635762,0.00065937755,0.000010012627,0.00001717955,0.000063467254],"genre_scores_gemma":[0.99617,0.0017338768,0.0017916828,0.00006314123,0.00003225336,0.000009453796,0.000024166307,0.000055279448,0.00012018875],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9972083,0.0001436483,0.00096174306,0.00035967169,0.0006749033,0.00065171596],"domain_scores_gemma":[0.9979649,0.0001969348,0.00057899783,0.00028989854,0.00064836326,0.00032085844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031960726,0.00027940693,0.0015285382,0.00028546504,0.000084036525,0.000017324297,0.00022161083,0.00018899018,0.00010542459],"category_scores_gemma":[0.00030413995,0.00023062514,0.00008380162,0.00053214864,0.0008698099,0.00021970435,0.00008689621,0.0004867872,0.000006474094],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.038595915,0.0030339016,0.51534605,0.0025792127,0.002389263,0.41061583,0.0014608529,0.0051620444,0.00025701887,0.00027134962,0.0025519289,0.017736608],"study_design_scores_gemma":[0.23699127,0.008262693,0.3149334,0.005600316,0.00043557506,0.4254962,0.0000833367,0.0009859907,0.0066025634,0.000041530962,0.0001075196,0.00045961936],"about_ca_topic_score_codex":0.0024372595,"about_ca_topic_score_gemma":0.00043829324,"teacher_disagreement_score":0.20041266,"about_ca_system_score_codex":0.0068206294,"about_ca_system_score_gemma":0.01127565,"threshold_uncertainty_score":0.996992},"labels":[],"label_agreement":null},{"id":"W1968020263","doi":"10.1111/bjh.12561","title":"Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric‐based protocol","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Regimen; Induction chemotherapy; Chemotherapy; Acute lymphocytic leukemia; Internal medicine; Maintenance therapy; Surgery; Pediatrics; Lymphoblastic Leukemia; Leukemia","score_opus":0.01307761137033936,"score_gpt":0.28243568657079643,"score_spread":0.26935807520045707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968020263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98024666,0.00008631878,0.0022841953,0.00012989485,0.00006794833,0.017049825,0.000016550362,0.000013900177,0.00010468414],"genre_scores_gemma":[0.9839301,0.00001830259,0.012879232,0.00007704258,0.00011345441,0.0028659524,0.000008965653,0.000055655048,0.000051303152],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9975386,0.00014632594,0.00093217293,0.00022605015,0.0006758401,0.00048100823],"domain_scores_gemma":[0.9971412,0.00026981006,0.0007617859,0.0002239088,0.0012712417,0.00033208443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010779619,0.00022705898,0.0010823079,0.0003403493,0.00007121508,0.000036356505,0.00017847533,0.00018046335,0.00027762487],"category_scores_gemma":[0.00019150745,0.00017621907,0.00020366762,0.00032104348,0.00026407346,0.00019464245,0.000032318316,0.0001858096,0.000018988996],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019533698,0.015522109,0.5039597,0.0030754227,0.005791351,0.27064896,0.00062333205,0.00064635254,0.0049396525,0.00008139422,0.0110438485,0.16413417],"study_design_scores_gemma":[0.15953837,0.048659217,0.088724546,0.0028579659,0.002586068,0.6762778,0.00019625222,0.010313856,0.0084051015,0.0002238184,0.0014079539,0.00080901105],"about_ca_topic_score_codex":0.00034448397,"about_ca_topic_score_gemma":0.000011623072,"teacher_disagreement_score":0.41523516,"about_ca_system_score_codex":0.0007926764,"about_ca_system_score_gemma":0.0023790991,"threshold_uncertainty_score":0.7186005},"labels":[],"label_agreement":null},{"id":"W1968022162","doi":"10.1046/j.1365-2141.2001.02975.x","title":"Persistent polyclonal B‐cell lymphocytosis: further evidence for a genetic disorder associated with B‐cell abnormalities","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Lymphocytosis; Haplotype; Immunology; Biology; Genetics; Human leukocyte antigen; Population; Allele; First-degree relatives; Polyclonal antibodies; Gene; Medicine; Antigen; Internal medicine; Family history","score_opus":0.03328294935528762,"score_gpt":0.29187458145625084,"score_spread":0.2585916321009632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968022162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548383,0.042205617,0.0009889072,0.0008362325,0.00014586182,0.00048222535,0.000012665804,0.000022604705,0.0004675984],"genre_scores_gemma":[0.9915959,0.0034181438,0.0018549742,0.00048433564,0.00017265018,0.000041137566,0.0000072431058,0.000060986167,0.0023645922],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99729747,0.0001915439,0.00077355216,0.00029277962,0.00070657866,0.0007380818],"domain_scores_gemma":[0.99748796,0.00072826346,0.00047616215,0.0002262774,0.00076077663,0.00032058716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000580822,0.00022502754,0.0008723681,0.00019988905,0.00014209293,0.000069235306,0.0003074404,0.00020832116,0.0003193989],"category_scores_gemma":[0.00060779124,0.0002067257,0.00041064227,0.00024864337,0.00033834318,0.00018109269,0.00006132554,0.00032208455,0.000015825877],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03700213,0.009468444,0.18071842,0.0066068647,0.0066853147,0.656592,0.0088620465,0.0026571832,0.0036458818,0.00017255894,0.05477229,0.03281687],"study_design_scores_gemma":[0.05071192,0.0040474455,0.0076664146,0.0037386091,0.0010198605,0.92251825,0.0027572555,0.0029951893,0.0010379107,0.00011407773,0.0029365616,0.0004565081],"about_ca_topic_score_codex":0.0005449876,"about_ca_topic_score_gemma":0.00032747394,"teacher_disagreement_score":0.26592624,"about_ca_system_score_codex":0.002981952,"about_ca_system_score_gemma":0.0055434443,"threshold_uncertainty_score":0.98338324},"labels":[],"label_agreement":null},{"id":"W1968144270","doi":"10.1111/j.1365-2141.2007.06640.x","title":"Molecular analysis of the human thrombin‐activatable fibrinolysis inhibitor gene promoter","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Molecular biology; Transcription factor; Promoter; Binding site; Enhancer; Hepatocyte nuclear factors; Gene; Thrombin; Hepatocyte nuclear factor 4; Biology; Gene expression; Reporter gene; Response element; CAAT box; Transcription (linguistics); Chemistry; Biochemistry; Nuclear receptor","score_opus":0.016788022871631537,"score_gpt":0.28246663036943825,"score_spread":0.2656786074978067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968144270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559706,0.0005934432,0.0026425999,0.00037424895,0.00017214632,0.00014068972,0.0000048566785,0.000009097224,0.00046586394],"genre_scores_gemma":[0.9983206,0.000017630471,0.0012500345,0.00027763838,0.00005225538,9.521422e-7,0.0000049647406,0.00001637938,0.00005953908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831843,0.00010050492,0.0008030211,0.00014718587,0.0003961018,0.00023475316],"domain_scores_gemma":[0.99859685,0.00004227867,0.0006298465,0.00025973006,0.00035945518,0.000111833426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005540926,0.00010899169,0.00091648323,0.00036306996,0.000090194866,0.000015494,0.00017194296,0.00013895967,0.00023682852],"category_scores_gemma":[0.00009775428,0.00009329876,0.0005412963,0.000804186,0.00011446222,0.000059115766,0.00006402866,0.00026939603,0.0000019030854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055966902,0.0006016539,0.01581595,0.000072113355,0.0042667515,0.00513733,0.00016317784,0.00007020139,0.96981615,0.0017712119,0.00032841068,0.0019010638],"study_design_scores_gemma":[0.0012850751,0.00019862578,0.10009219,0.000199727,0.0031742898,0.03520919,0.00009838963,0.000054136908,0.8589069,0.00060808525,0.00007471414,0.000098656245],"about_ca_topic_score_codex":0.00006738433,"about_ca_topic_score_gemma":0.000057213132,"teacher_disagreement_score":0.110909246,"about_ca_system_score_codex":0.000032742206,"about_ca_system_score_gemma":0.00006642017,"threshold_uncertainty_score":0.3804613},"labels":[],"label_agreement":null},{"id":"W1968232397","doi":"10.1111/bjh.12618","title":"Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of <scp>SWOG</scp> S0325, an intergroup randomized <scp>PHASE II</scp> trial in newly diagnosed chronic phase chronic myeloid leukaemia","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Imatinib; Medicine; Internal medicine; Toxicity; Imatinib mesylate; Gastroenterology; Hematology; Phases of clinical research; Chemotherapy; Oncology; Surgery; Myeloid leukemia","score_opus":0.01681967084386809,"score_gpt":0.30572050564883335,"score_spread":0.28890083480496526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968232397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97606593,0.01684672,0.00038374242,0.00045411236,0.0010586937,0.0042710234,0.0002485679,0.00010707954,0.00056410965],"genre_scores_gemma":[0.9911696,0.0031234568,0.0031065028,0.00029941148,0.0007663237,0.0004390432,0.00034868158,0.00021649254,0.00053049845],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98676425,0.0031209893,0.0057633906,0.0012064256,0.0013604907,0.00178447],"domain_scores_gemma":[0.98707324,0.005714371,0.0040785386,0.0012266112,0.00091445394,0.0009927904],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037675765,0.0010897627,0.005742996,0.0013958932,0.00027559465,0.00021710231,0.001210521,0.0010028762,0.00027444333],"category_scores_gemma":[0.018222721,0.0010621841,0.0012566464,0.00086326874,0.0012008072,0.0012740203,0.0003844603,0.0021222325,0.00006866308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38103488,0.025690075,0.0004919029,0.002424081,0.006901484,0.18924604,0.013342167,0.00027777793,0.24476437,0.00048786763,0.044521075,0.090818286],"study_design_scores_gemma":[0.8760308,0.013683086,0.0004405565,0.0037678797,0.0010865796,0.056284133,0.0015156281,0.0011708861,0.044096757,0.00062146457,0.0010136262,0.0002886002],"about_ca_topic_score_codex":0.0020135676,"about_ca_topic_score_gemma":0.0010443351,"teacher_disagreement_score":0.49499592,"about_ca_system_score_codex":0.00209538,"about_ca_system_score_gemma":0.00547011,"threshold_uncertainty_score":0.9991828},"labels":[],"label_agreement":null},{"id":"W1969261714","doi":"10.1111/j.1365-2141.2009.07674.x","title":"Prior rituximab correlates with less acute graft‐versus‐host disease and better survival in B‐cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Rituximab; Internal medicine; Transplantation; Cohort; Gastroenterology; Relative risk; Immunology; Graft-versus-host disease; Lymphoma; Hematopoietic stem cell transplantation; Confidence interval","score_opus":0.0077869163399606,"score_gpt":0.21783098194565167,"score_spread":0.21004406560569108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969261714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995047,0.003692033,0.000013431593,0.00057589734,0.00017598453,0.00033732614,0.000046060555,0.000010286155,0.0001019837],"genre_scores_gemma":[0.9955766,0.0036691767,0.000306819,0.000294798,0.000035808418,0.000009449397,0.000044248154,0.000020520927,0.000042539967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984908,0.00013942602,0.00052717136,0.00026061997,0.00027475925,0.00030719765],"domain_scores_gemma":[0.99909663,0.00009234497,0.00029062724,0.00010354115,0.00015515741,0.00026167484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094309486,0.00021491495,0.0007513569,0.00012161133,0.00008062822,0.000047872214,0.00008461185,0.00011844998,0.000015456277],"category_scores_gemma":[0.0000068582185,0.00019080461,0.000109227265,0.0000996359,0.00008588711,0.0001716407,0.000010322723,0.00013314362,0.0000021988312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068092723,0.0061636283,0.8028646,0.00019539021,0.0003939773,0.15742029,0.00070275686,0.0000063386037,0.0001787189,0.000011189946,0.000119574725,0.025134258],"study_design_scores_gemma":[0.06842689,0.002155243,0.8973685,0.00067927217,0.0015026535,0.028092794,0.00013915199,0.000015382002,0.001375595,0.000017185243,0.000025936408,0.00020141195],"about_ca_topic_score_codex":0.00005487419,"about_ca_topic_score_gemma":0.00015366983,"teacher_disagreement_score":0.12932749,"about_ca_system_score_codex":0.00010670462,"about_ca_system_score_gemma":0.00018322069,"threshold_uncertainty_score":0.7780786},"labels":[],"label_agreement":null},{"id":"W1969292046","doi":"10.1111/j.1365-2141.2007.06840.x","title":"Outcome of haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia in third complete remission: a vital role for graft‐versus‐host‐disease/ graft‐versus‐leukaemia effect in survival","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Disease; Graft-versus-host disease; Internal medicine; Stem cell; Hematology; Confidence interval; Surgery; Pediatrics","score_opus":0.02138057368382721,"score_gpt":0.2935339296157734,"score_spread":0.2721533559319462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969292046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97528255,0.0019322258,0.019123835,0.00017823081,0.0011899235,0.0018530133,0.00022208635,0.000031992236,0.00018612064],"genre_scores_gemma":[0.9957198,0.00046403028,0.0033238886,0.00005062759,0.00013513789,0.00006696473,0.0001258763,0.00007753443,0.000036153924],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950792,0.00036325137,0.0025768785,0.00048494755,0.00068078784,0.0008149239],"domain_scores_gemma":[0.99284935,0.005130755,0.000954009,0.00024758247,0.00037491083,0.00044338402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026805457,0.00042214338,0.0020098079,0.0008531978,0.00009187829,0.000029055129,0.00031357596,0.00043631293,0.00002296454],"category_scores_gemma":[0.00037575592,0.0004481833,0.00064267556,0.0005703958,0.0001550848,0.0002328857,0.000023044517,0.00050530175,0.0000054190373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2557362,0.002813604,0.46349895,0.051844988,0.0015858589,0.1429836,0.0050067795,0.0006432519,0.060490258,0.0020025999,0.00093245984,0.012461461],"study_design_scores_gemma":[0.37218356,0.016316375,0.3147493,0.016247371,0.013210765,0.1489584,0.004810653,0.0037980408,0.103553355,0.002498601,0.00044874588,0.0032248292],"about_ca_topic_score_codex":0.00006730602,"about_ca_topic_score_gemma":0.00039733082,"teacher_disagreement_score":0.14874965,"about_ca_system_score_codex":0.0003497445,"about_ca_system_score_gemma":0.0004089609,"threshold_uncertainty_score":0.999797},"labels":[],"label_agreement":null},{"id":"W1969542486","doi":"10.1046/j.1365-2141.2003.04354.x","title":"Growth regulation by p27<sup>Kip1</sup> is abrogated by multiple mechanisms in aggressive malignant lymphomas","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Jurkat cells; Biology; Cyclin; Cyclin-dependent kinase; Cyclin E; Cyclin D3; Kinase; Cancer research; Cell growth; Lymphoma; Cell biology; Molecular biology; Cell cycle; Cyclin-dependent kinase 2; Cell; Protein kinase A; T cell; Immunology; Biochemistry; Immune system","score_opus":0.006221406325623724,"score_gpt":0.2198142490226897,"score_spread":0.21359284269706597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969542486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97344047,0.01804365,0.0060602096,0.00089178834,0.0003399898,0.00047291678,0.00008549597,0.000037242266,0.0006282191],"genre_scores_gemma":[0.9952344,0.0013997265,0.0021988074,0.0007748193,0.000031984542,0.0000138944715,0.00006348846,0.000063183084,0.00021973747],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9973336,0.00032039813,0.001029807,0.00035031504,0.00046289593,0.0005030104],"domain_scores_gemma":[0.9981302,0.00009856132,0.00088363455,0.0002040756,0.00042032998,0.00026317177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004328928,0.00024244774,0.0009228796,0.00027602317,0.00008718871,0.000034505883,0.00016490281,0.00042002078,0.00043711142],"category_scores_gemma":[0.0009634529,0.0002773033,0.0002094397,0.00037946514,0.00012691933,0.00015954458,0.0000317735,0.00049216324,0.000025807134],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016149608,0.0024069692,0.005848988,0.00053058605,0.0012012619,0.24986249,0.0019772034,0.00032435218,0.31753176,0.0049961656,0.40056416,0.013141086],"study_design_scores_gemma":[0.01647661,0.0007402741,0.00059704983,0.002506181,0.0002515439,0.6157014,0.00043457648,0.0011869965,0.34942284,0.004844448,0.007376956,0.00046115305],"about_ca_topic_score_codex":0.00023139956,"about_ca_topic_score_gemma":0.00005050917,"teacher_disagreement_score":0.3931872,"about_ca_system_score_codex":0.00027596217,"about_ca_system_score_gemma":0.0002920576,"threshold_uncertainty_score":0.99996793},"labels":[],"label_agreement":null},{"id":"W1969593178","doi":"10.1111/j.1365-2141.2007.06690.x","title":"Distinguishing between non‐identical twins: platelet type and type 2B von Willebrand disease","year":2007,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Medicine; Von Willebrand factor; Platelet; Genetic testing; Pediatrics; Immunology; Internal medicine","score_opus":0.019874695440283953,"score_gpt":0.28832925657126623,"score_spread":0.26845456113098226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969593178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94082975,0.01256022,0.000044426386,0.04486443,0.00088809704,0.00027097436,0.00005478092,0.00002091184,0.00046640332],"genre_scores_gemma":[0.84026116,0.005218626,0.0012908301,0.14574991,0.004936189,0.0000038112698,0.00094490027,0.00022949812,0.0013650982],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99763817,0.000089705,0.00092264195,0.0003427573,0.0004638463,0.00054289814],"domain_scores_gemma":[0.9981566,0.0002853428,0.0005431975,0.00018265675,0.00046031503,0.00037187533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030501097,0.00032581147,0.0017737383,0.0002778414,0.0001219887,0.000098563905,0.00017331354,0.0007101109,0.00011700627],"category_scores_gemma":[0.0011587831,0.0003239825,0.00018915244,0.00020220678,0.00023643013,0.00012057308,0.00007738615,0.0019969896,0.000031069332],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023766555,0.00007109513,0.022463731,0.00042415646,0.0005189506,0.6293989,0.000026249765,1.3136837e-7,0.0000021217868,0.0000023212538,0.34369853,0.0031561507],"study_design_scores_gemma":[0.0051499954,0.00076591875,0.032123502,0.0037901667,0.0020792692,0.6229868,0.000027015147,0.000009704056,0.000020312953,0.0008101388,0.33174184,0.00049533136],"about_ca_topic_score_codex":0.00007014714,"about_ca_topic_score_gemma":0.00001581162,"teacher_disagreement_score":0.10088548,"about_ca_system_score_codex":0.00006176387,"about_ca_system_score_gemma":0.00026564588,"threshold_uncertainty_score":0.9999212},"labels":[],"label_agreement":null},{"id":"W1969954034","doi":"10.1111/bjh.12871","title":"Evaluation of allelic strength of human <i><scp>TET</scp>2</i> mutations and cooperation between <i>Tet2</i> knockdown and oncogenic <i>Nras</i> mutation","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute; University of Wisconsin Carbone Cancer Center; National Cancer Institute; National Institutes of Health; Greater Milwaukee Foundation; Leukemia and Lymphoma Society","keywords":"Missense mutation; Genetics; Frameshift mutation; Biology; Mutation; Nonsense mutation; Molecular biology; Allele; Gene; Cancer research","score_opus":0.03862735782896338,"score_gpt":0.3271464282958629,"score_spread":0.2885190704668995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969954034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97253525,0.0081481505,0.00041317474,0.017181627,0.0001390995,0.00089371187,0.00013031243,0.000015383252,0.0005432738],"genre_scores_gemma":[0.9826902,0.0019226791,0.0011649034,0.011506965,0.0012639853,0.00003320557,0.0011345878,0.00010589778,0.00017754492],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9944353,0.001319992,0.001891682,0.00041224126,0.0015348266,0.00040596162],"domain_scores_gemma":[0.9928932,0.0012725325,0.0018754854,0.0002894293,0.0034876526,0.00018168971],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029613897,0.00033124312,0.0018708153,0.00068639294,0.0001574182,0.000055720484,0.00023589886,0.0009189752,0.00004408476],"category_scores_gemma":[0.0022644622,0.00036536437,0.00021333086,0.0002931502,0.00064027065,0.00023152167,0.000089420595,0.0019156701,0.0000035618332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007021808,0.00034193727,0.004775416,0.0036870465,0.002867426,0.010892935,0.0012814414,0.00007060815,0.015361196,0.00008898896,0.90597457,0.054588214],"study_design_scores_gemma":[0.044720147,0.009545371,0.017256662,0.009286613,0.023742506,0.7220694,0.0012954335,0.0021399865,0.054990932,0.005620914,0.108240224,0.0010918002],"about_ca_topic_score_codex":0.0001835757,"about_ca_topic_score_gemma":0.000085337815,"teacher_disagreement_score":0.7977343,"about_ca_system_score_codex":0.0001981205,"about_ca_system_score_gemma":0.0011534996,"threshold_uncertainty_score":0.99987984},"labels":[],"label_agreement":null},{"id":"W1970405391","doi":"10.1111/j.1365-2141.2009.07601.x","title":"Post‐thrombotic syndrome: prevalence, prognostication and need for progress","year":2009,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Post-thrombotic syndrome; Deep vein; Thrombosis; Compression stockings; Complication; Intensive care medicine; Venous thrombosis; Surgery","score_opus":0.02576258481807837,"score_gpt":0.33339186993195485,"score_spread":0.3076292851138765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970405391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020932294,0.9938913,0.000082714454,0.00056078803,0.00032355398,0.0029286619,0.00002632953,0.00002281854,0.000070595765],"genre_scores_gemma":[0.0008365861,0.99552095,0.0029733323,0.00016659599,0.00014888437,0.00014680349,0.00004908422,0.00005288209,0.000104876446],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99766314,0.00014025818,0.001253689,0.00031835953,0.00025727964,0.00036727774],"domain_scores_gemma":[0.99772894,0.00022893776,0.0011814799,0.00019501791,0.0004600377,0.00020556615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052484364,0.0002981542,0.0038272256,0.00035277478,0.00009375646,0.00007950648,0.00021486478,0.0003310035,0.000036728663],"category_scores_gemma":[0.00047245802,0.0002780343,0.00049127184,0.00016192925,0.0001908443,0.0001101293,0.000054352044,0.0003994228,0.000007230968],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015062444,0.0006142806,0.000025032768,0.06593571,0.000622829,0.011734219,0.000020400304,4.804339e-8,8.8016996e-8,0.00053569244,0.0041095144,0.91638714],"study_design_scores_gemma":[0.00087859307,0.0019223971,0.0015400515,0.068552785,0.008011155,0.56803995,0.00002237488,0.0000020459363,3.9291294e-7,0.0002355149,0.35056445,0.00023026441],"about_ca_topic_score_codex":0.0000037532923,"about_ca_topic_score_gemma":0.0000027567764,"teacher_disagreement_score":0.9161569,"about_ca_system_score_codex":0.000062149236,"about_ca_system_score_gemma":0.000325252,"threshold_uncertainty_score":0.99996716},"labels":[],"label_agreement":null},{"id":"W1970909276","doi":"10.1111/j.1365-2141.2005.05770.x","title":"Florid bone marrow haematogones in a child following treatment for acute lymphoblastic leukaemia","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Bone marrow; Terminal deoxynucleotidyl transferase; Pathology; Medicine; Population; CD20; Acute lymphocytic leukemia; Immunology; Leukemia; Lymphoblastic Leukemia; Lymphoma; TUNEL assay","score_opus":0.015941426168312473,"score_gpt":0.3077857726505146,"score_spread":0.29184434648220214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970909276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98471177,0.007221729,0.0008853801,0.0054880837,0.000403718,0.0006695508,0.000017995684,0.000027928536,0.0005738261],"genre_scores_gemma":[0.98778814,0.0016186363,0.008885253,0.0004586057,0.0005828692,0.000072985975,0.00001908598,0.00006741417,0.0005070344],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99738896,0.00010948848,0.0011035183,0.0003078069,0.00036978742,0.00072045455],"domain_scores_gemma":[0.99862194,0.00030976537,0.00032483798,0.00022136344,0.00020617513,0.0003159162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005562416,0.00025463986,0.0015746332,0.00051677605,0.0001317998,0.000046898876,0.00021460181,0.00023997563,0.000082162995],"category_scores_gemma":[0.00049282983,0.0002508348,0.00056377944,0.00027509264,0.000113642534,0.00025074626,0.000055273293,0.00042882905,0.000034154516],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054953066,0.0020539125,0.0068200063,0.0005307244,0.0037251345,0.80056375,0.0010290848,0.00022313737,0.007798608,0.00072705955,0.030110631,0.14092265],"study_design_scores_gemma":[0.021264883,0.0014651578,0.0015558016,0.001546884,0.00070609787,0.95432276,0.00022850622,0.0008904657,0.008063035,0.00023628098,0.009438182,0.0002819633],"about_ca_topic_score_codex":0.00007493716,"about_ca_topic_score_gemma":0.00036859303,"teacher_disagreement_score":0.15375899,"about_ca_system_score_codex":0.0010653897,"about_ca_system_score_gemma":0.0007078987,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W1971050485","doi":"10.1046/j.1365-2141.2001.02554.x","title":"Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"Hungarian Science Foundation; Hungarian Scientific Research Fund; National Science Foundation","keywords":"Calcein; Medicine; Multiple drug resistance; Internal medicine; Oncology; Chemotherapy; Myeloid leukaemia; Immunology; Drug resistance; Biology","score_opus":0.013900299291501045,"score_gpt":0.2700488293259492,"score_spread":0.25614853003444815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971050485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98555267,0.007833182,0.0023934608,0.0030578505,0.00049186667,0.00043077907,0.000029942603,0.000021741052,0.00018853233],"genre_scores_gemma":[0.97898686,0.013004945,0.0041527124,0.0003669028,0.00011918328,0.000020761894,0.000011744627,0.00004714913,0.003289764],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99787444,0.0003418307,0.0008294993,0.00027000127,0.00025165846,0.00043256898],"domain_scores_gemma":[0.9985833,0.00044704333,0.0003286516,0.00015915479,0.00027349248,0.00020833027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025625231,0.0001864897,0.0009621372,0.00022117644,0.00009832663,0.00002898758,0.00015126799,0.00022504794,0.000028035427],"category_scores_gemma":[0.0003809766,0.00017940764,0.00016169627,0.000202347,0.00016383966,0.00015081224,0.00001254609,0.00044131008,0.000001562234],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17146425,0.001376997,0.03871207,0.0007727722,0.0011622483,0.59707826,0.0018388494,0.000037131053,0.13751209,0.0015607182,0.016082484,0.032402102],"study_design_scores_gemma":[0.07292895,0.0033679444,0.44011945,0.00669447,0.00061849854,0.2938301,0.0014893953,0.00028449032,0.030958729,0.006214845,0.1423009,0.0011922459],"about_ca_topic_score_codex":0.00003074984,"about_ca_topic_score_gemma":0.0008978021,"teacher_disagreement_score":0.40140736,"about_ca_system_score_codex":0.00006626493,"about_ca_system_score_gemma":0.000265468,"threshold_uncertainty_score":0.73160315},"labels":[],"label_agreement":null},{"id":"W1971402906","doi":"10.1111/bjh.12642","title":"Single whole‐leg compression ultrasound for exclusion of deep vein thrombosis in symptomatic ambulatory patients: a prospective observational cohort study","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"College of Emergency Medicine; National Institute for Health and Care Research","keywords":"Medicine; Prospective cohort study; Ambulatory; Deep vein; Thrombosis; Confidence interval; Cohort study; Cohort; Adverse effect; Observational study; Surgery; Internal medicine; Emergency medicine","score_opus":0.01952019382695455,"score_gpt":0.2767704098926843,"score_spread":0.25725021606572973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971402906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961025,0.00040016562,0.00032952044,0.00018961958,0.00029034133,0.002537592,0.000007105563,0.000010404266,0.00013271674],"genre_scores_gemma":[0.9982191,0.000067027446,0.0012858567,0.0001717104,0.00004769155,0.00015176852,0.000022395476,0.000023810979,0.000010684809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794716,0.0001331682,0.0010418684,0.00021103339,0.0004288806,0.00023786687],"domain_scores_gemma":[0.9979631,0.0003528962,0.00067015237,0.00014978088,0.00077279523,0.00009132753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004241224,0.00014326055,0.001149047,0.0002091448,0.00008177586,0.000029291778,0.00014650178,0.0000936755,0.0001461374],"category_scores_gemma":[0.00059166504,0.0001407986,0.00013812937,0.00016209864,0.00009350507,0.00026603776,0.00007164793,0.00017713565,0.0000047309395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058159665,0.009068729,0.9824175,0.0002977415,0.0003383729,0.00018478952,0.00083397137,0.000039465227,0.0013115177,0.00009326716,0.0037273278,0.0016291166],"study_design_scores_gemma":[0.004312061,0.001888194,0.9893091,0.0010173686,0.00024791926,0.00093089126,0.0009277225,0.0001308895,0.00027242023,0.00079031376,0.000057456655,0.000115704825],"about_ca_topic_score_codex":0.00022290566,"about_ca_topic_score_gemma":0.00015198595,"teacher_disagreement_score":0.0071805357,"about_ca_system_score_codex":0.00015374299,"about_ca_system_score_gemma":0.000054882334,"threshold_uncertainty_score":0.57416004},"labels":[],"label_agreement":null},{"id":"W1973637908","doi":"10.1046/j.1365-2141.2002.03371.x","title":"Abnormal telomere shortening in leucocytes of children with Shwachman–Diamond syndrome","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Sick Kids Foundation","keywords":"Telomere; Cytopenia; Stem cell; Aplasia; Basophilia; Immunology; Biology; Medicine; Internal medicine; Pathology; Bone marrow; Genetics; Gene","score_opus":0.005793199851881662,"score_gpt":0.19681144405915468,"score_spread":0.191018244207273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973637908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825208,0.016879529,0.00004643925,0.000036536287,0.000038216782,0.00008123019,0.000010879005,0.0000021149451,0.00038420848],"genre_scores_gemma":[0.9980972,0.0009794034,0.00079060724,0.000040853985,0.000021963475,0.0000030170672,0.000011152267,0.00001609076,0.000039725386],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99907833,0.0000520775,0.0003869577,0.00015095477,0.00011280057,0.00021886374],"domain_scores_gemma":[0.9995066,0.00000898461,0.00024223601,0.00010643832,0.000073246796,0.00006250718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008536034,0.00011454339,0.00040209212,0.00009074303,0.000033831977,0.000012623777,0.00016232311,0.00012229967,0.00005542892],"category_scores_gemma":[0.000021205964,0.00011234647,0.00008742694,0.00009368673,0.00011447578,0.000011651103,0.000038586433,0.0001410814,0.000001989292],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013516075,0.00096022617,0.9542023,0.000043522832,0.0007781766,0.019319698,0.000084531704,0.0001064126,0.0015250075,0.000048830912,0.0011732114,0.021622954],"study_design_scores_gemma":[0.0062894993,0.0022675053,0.24860574,0.00031961148,0.00016512963,0.71829516,0.00018630252,0.000026602294,0.023167465,0.00010469626,0.00021402548,0.0003582564],"about_ca_topic_score_codex":0.00007872614,"about_ca_topic_score_gemma":0.0002773906,"teacher_disagreement_score":0.7055965,"about_ca_system_score_codex":0.0000056104377,"about_ca_system_score_gemma":0.000028096147,"threshold_uncertainty_score":0.4581356},"labels":[],"label_agreement":null},{"id":"W1973684446","doi":"10.1046/j.1365-2141.2003.04334.x","title":"Heparin‐induced thrombocytopenia: pathogenesis and management","year":2003,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":542,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Heparin-induced thrombocytopenia; Pathogenesis; Heparin; Medicine; Platelet; Immunology; Intensive care medicine; Internal medicine","score_opus":0.0734778125630492,"score_gpt":0.35235741130732806,"score_spread":0.27887959874427887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973684446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009347544,0.98440474,0.000034429268,0.00008080466,0.0008380132,0.0011374204,0.000019082987,0.000029311295,0.0041086515],"genre_scores_gemma":[0.0011930706,0.9959309,0.0019919067,0.00020239908,0.00017161976,0.000046691828,0.000020840947,0.00014213446,0.00030041387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954811,0.0005818353,0.0021719693,0.0006375491,0.00044646417,0.0006810984],"domain_scores_gemma":[0.9971593,0.00017456301,0.0013521777,0.0005046712,0.0002665308,0.00054278213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008281238,0.0006642598,0.007876667,0.0005820441,0.00018712759,0.00012098403,0.0004116106,0.000845304,0.00026998477],"category_scores_gemma":[0.00013263662,0.0006398506,0.0010440612,0.0004612301,0.00024772246,0.00016992657,0.00024760346,0.0011899844,0.00009072936],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021348596,0.00030730027,0.000044840126,0.020766439,0.0024460286,0.10166165,0.000023668945,2.0901378e-8,0.000012109679,0.0010747964,0.0017236037,0.8719182],"study_design_scores_gemma":[0.0010277277,0.00025044807,0.00022381915,0.016740294,0.0050895973,0.47874254,0.000029645766,1.511675e-7,0.000008787807,0.00009297851,0.49745122,0.00034280337],"about_ca_topic_score_codex":0.000028951757,"about_ca_topic_score_gemma":0.000026234255,"teacher_disagreement_score":0.8715754,"about_ca_system_score_codex":0.00020188365,"about_ca_system_score_gemma":0.0005459254,"threshold_uncertainty_score":0.9996053},"labels":[],"label_agreement":null},{"id":"W1973770267","doi":"10.1111/j.1365-2141.2007.06886.x","title":"Investigation of the interleukin (IL)‐4/IL‐4 receptor system in promyelocytic leukaemia PLB‐985 cells during differentiation toward neutrophil‐like phenotype: mechanism involved in IL‐4‐induced SOCS3 protein expression","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Interleukin 3; Biology; Granulocyte colony-stimulating factor receptor; Molecular biology; Cell biology; Chemistry; Stem cell; IL-2 receptor; Cytotoxic T cell; Biochemistry; Haematopoiesis","score_opus":0.021836028249515027,"score_gpt":0.23664470797483525,"score_spread":0.21480867972532022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973770267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737287,0.00014061824,0.0005015087,0.00028346936,0.0008433011,0.00079744676,0.000010010691,0.000021630207,0.00002914812],"genre_scores_gemma":[0.9990139,0.000023402246,0.0006776779,0.000040852323,0.00015585491,0.00002514415,0.000008683351,0.00003400887,0.000020489368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971473,0.0003126349,0.0015750137,0.00025318575,0.00038146114,0.00033037248],"domain_scores_gemma":[0.99814737,0.00008680883,0.0011441561,0.00020125408,0.00029602795,0.00012440774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078462093,0.0001969798,0.00075772434,0.00046221633,0.00007807984,0.000028981023,0.00022158463,0.00026220156,0.00003434938],"category_scores_gemma":[0.00022949491,0.00017536322,0.0001881579,0.00035860724,0.0000747726,0.00022425849,0.000083058665,0.0008976297,0.0000037549478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040643214,0.000114337214,0.0020108286,0.0007162801,0.000033422588,0.0008344293,0.0011956636,0.000017482489,0.99408966,0.00021926861,0.00004775519,0.00031442574],"study_design_scores_gemma":[0.0028397546,0.00029408943,0.015307154,0.009160415,0.00005001513,0.005895437,0.0014078805,0.00019920267,0.9643622,0.0003216211,0.000015833008,0.00014638671],"about_ca_topic_score_codex":0.00028945156,"about_ca_topic_score_gemma":0.00041966446,"teacher_disagreement_score":0.029727463,"about_ca_system_score_codex":0.0005631621,"about_ca_system_score_gemma":0.00023085016,"threshold_uncertainty_score":0.7151105},"labels":[],"label_agreement":null},{"id":"W1975798779","doi":"10.1046/j.1365-2141.2001.02927.x","title":"Detection and clinical significance of human acute myeloid leukaemia progenitors capable of long‐term proliferation <i>in vitro</i>","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Progenitor cell; Nod; Myeloid; Immunology; Cancer research; Biology; In vitro; Cell culture; Stem cell; Medicine; Cell biology; In vivo; Genetics","score_opus":0.02277607601601483,"score_gpt":0.33292596399756547,"score_spread":0.31014988798155063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975798779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759084,0.0011094129,0.0003702169,0.00018124947,0.00013230012,0.00048857887,0.000005763499,0.000007975144,0.00011368031],"genre_scores_gemma":[0.9973691,0.0016117521,0.00069124874,0.00004991679,0.00016661182,0.000010593072,0.0000057524157,0.00002218313,0.00007285092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974364,0.0002859098,0.0014277451,0.0002142477,0.00034229786,0.0002933889],"domain_scores_gemma":[0.998309,0.0001413997,0.00072463,0.00015284782,0.00050557574,0.0001665355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010596246,0.00012435047,0.0010089506,0.00028126303,0.00005446858,0.000014817051,0.00014344369,0.00025521076,0.000023051256],"category_scores_gemma":[0.00032729396,0.000131535,0.00015564817,0.00027037947,0.00040457112,0.00018715444,0.00004488353,0.0007093796,0.0000013715962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033266365,0.000690985,0.3696418,0.00052626623,0.0004199581,0.03166274,0.00018254758,0.000003908014,0.53732485,0.000019570438,0.00029018396,0.05591053],"study_design_scores_gemma":[0.0072207646,0.0019897728,0.21188036,0.0006453137,0.00030062764,0.32208064,0.00013499153,0.00015271323,0.45525205,0.00012704908,0.000053111842,0.0001626122],"about_ca_topic_score_codex":0.00015825685,"about_ca_topic_score_gemma":0.00026167164,"teacher_disagreement_score":0.2904179,"about_ca_system_score_codex":0.00013360269,"about_ca_system_score_gemma":0.00040985714,"threshold_uncertainty_score":0.5363841},"labels":[],"label_agreement":null},{"id":"W1975995970","doi":"10.1111/j.1365-2141.2004.05292.x","title":"Management of thrombosis in cancer: primary prevention and secondary prophylaxis","year":2005,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Intensive care medicine; Cancer; Clinical trial; Venous thromboembolism; Thrombosis; Population; Anticoagulant; Natural history; Surgery; Internal medicine","score_opus":0.03615422361737279,"score_gpt":0.3532053516392111,"score_spread":0.31705112802183827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975995970","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008364429,0.9888393,0.000011614897,0.000094186355,0.00025884944,0.0010398732,0.000016812073,0.0000062264876,0.0013686639],"genre_scores_gemma":[0.00072388334,0.99737656,0.0014661524,0.000058941154,0.00010414218,0.00007134152,0.000017118638,0.000039646642,0.00014218902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997437,0.00018262264,0.0015758347,0.00026737072,0.00027851388,0.00025867455],"domain_scores_gemma":[0.9983269,0.00005066336,0.0012498825,0.00017306644,0.000102329315,0.00009717165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005253448,0.000246299,0.0040045804,0.0004467577,0.000029913448,0.000018008333,0.00017870216,0.00025900788,0.00022897703],"category_scores_gemma":[0.000015789594,0.0002427362,0.0004290266,0.00023396738,0.00011843302,0.000105332016,0.00014949738,0.0005828529,0.000002895628],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010814631,0.00069679803,0.000041311752,0.06568944,0.0010507262,0.008635685,0.000031305837,4.01144e-7,1.5705513e-7,0.00015202725,0.0014486791,0.92224264],"study_design_scores_gemma":[0.0017554858,0.00087197253,0.0067986986,0.15656787,0.0044062864,0.05262882,0.00008860362,3.3883956e-7,0.0000014564941,0.00015731623,0.7764504,0.00027272725],"about_ca_topic_score_codex":0.00007988134,"about_ca_topic_score_gemma":0.00008684799,"teacher_disagreement_score":0.92196995,"about_ca_system_score_codex":0.00018594932,"about_ca_system_score_gemma":0.00031630087,"threshold_uncertainty_score":0.9898495},"labels":[],"label_agreement":null},{"id":"W1976105963","doi":"10.1111/j.1365-2141.2012.09208.x","title":"Combined modality therapy <i>versus</i> chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis","year":2012,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Life expectancy; Quality of life (healthcare); Chemotherapy; Primary central nervous system lymphoma; Regimen; Oncology; Internal medicine; Quality-adjusted life year; Lymphoma; Chemotherapy regimen; Pediatrics; Cost effectiveness; Population","score_opus":0.0422187700926106,"score_gpt":0.3316830743338724,"score_spread":0.2894643042412618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976105963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.106468275,0.89015794,0.00032060567,0.00013128063,0.0011220925,0.0016147678,0.00007709962,0.00004332024,0.00006460043],"genre_scores_gemma":[0.018815184,0.97789747,0.0017224463,0.00014362874,0.0006281136,0.00016104116,0.0004917003,0.000110554305,0.00002984296],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99587464,0.0004635538,0.0019125582,0.00053207594,0.00055904407,0.0006581373],"domain_scores_gemma":[0.9958383,0.00047890953,0.002115467,0.0005653342,0.00046038587,0.0005416102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082886947,0.000566752,0.006097871,0.000587414,0.0001774916,0.00009396884,0.00032525265,0.00074210536,0.000059443424],"category_scores_gemma":[0.00006871446,0.00048859225,0.0024266883,0.00062133576,0.00011446008,0.00024629128,0.000039402414,0.0002791431,0.000008689699],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024247754,0.002342818,0.00014046214,0.003093258,0.009012844,0.005473794,0.0000522413,9.507177e-7,6.510467e-7,0.00010828101,0.0006440684,0.97670585],"study_design_scores_gemma":[0.040035598,0.004589966,0.013729617,0.016545782,0.049217816,0.43949452,0.00018116362,0.000016943113,0.00003090216,0.00016213354,0.43500772,0.0009878194],"about_ca_topic_score_codex":0.0003252099,"about_ca_topic_score_gemma":0.00004274408,"teacher_disagreement_score":0.975718,"about_ca_system_score_codex":0.0012846873,"about_ca_system_score_gemma":0.00086227,"threshold_uncertainty_score":0.9997566},"labels":[],"label_agreement":null},{"id":"W1976379188","doi":"10.1111/j.1365-2141.2007.06750.x","title":"Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myeloma","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Research; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Multiple myeloma; Fluorescence in situ hybridization; Chromosome; Biology; Internal medicine; Overall survival; Multivariate analysis; Medicine; Pathology; Gene; Genetics","score_opus":0.011883053470565716,"score_gpt":0.2629970046912819,"score_spread":0.25111395122071617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976379188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977394,0.0005060422,0.00074388995,0.00022871167,0.000081485734,0.0005097716,0.000017572052,0.0000098586315,0.00016327303],"genre_scores_gemma":[0.995554,0.000051107192,0.0040594446,0.00017361864,0.000051764768,0.000007677568,0.000025409034,0.000025459936,0.000051570867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816376,0.00005230159,0.00059465365,0.00019266503,0.0005044059,0.00049224176],"domain_scores_gemma":[0.99867886,0.00020070233,0.00025482828,0.00012059508,0.00046271476,0.00028229345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039670634,0.00014059145,0.00055640686,0.00031625936,0.000054033797,0.000021822749,0.00009901083,0.00012389055,0.0001499491],"category_scores_gemma":[0.0006460132,0.00012456201,0.000089829446,0.00025025735,0.00011239805,0.0001468073,0.00003141029,0.0003806091,0.000018753726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023650464,0.0014696565,0.94013226,0.00008571613,0.0001711776,0.035198286,0.00006358913,8.0903675e-7,0.00014559367,0.000006703333,0.00029960487,0.020061536],"study_design_scores_gemma":[0.016006703,0.0011194438,0.9245955,0.0007537067,0.000051775954,0.056642506,0.00004029638,0.00005558048,0.00032722874,0.000015532907,0.0002916825,0.00010007216],"about_ca_topic_score_codex":0.00011066461,"about_ca_topic_score_gemma":0.0003828389,"teacher_disagreement_score":0.02144422,"about_ca_system_score_codex":0.00012454914,"about_ca_system_score_gemma":0.00014625443,"threshold_uncertainty_score":0.5079491},"labels":[],"label_agreement":null},{"id":"W1976995655","doi":"10.1111/j.1365-2141.2005.05406.x","title":"A third course of anti‐thymocyte globulin in aplastic anaemia is only beneficial in previous responders","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Anti-thymocyte globulin; Medicine; Refractory (planetary science); Internal medicine; Gastroenterology; Incidence (geometry); Retrospective cohort study; Aplastic anemia; Globulin; Toxicity; Limiting; Surgery; Bone marrow","score_opus":0.012581946145246487,"score_gpt":0.2823659465268515,"score_spread":0.269784000381605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976995655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207866,0.005655001,0.00029450754,0.0011329469,0.00015714078,0.00025932692,0.000017542552,0.000008363389,0.00039649283],"genre_scores_gemma":[0.99588656,0.0021136487,0.0015782198,0.00029153476,0.00007505698,0.0000022060299,0.0000052174832,0.000020884794,0.000026660855],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9975372,0.00020810202,0.0013987178,0.00019261817,0.00033522063,0.00032813914],"domain_scores_gemma":[0.9987961,0.0003104191,0.0004616291,0.00013163484,0.00017484727,0.00012538546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007914431,0.00015060641,0.0010931594,0.00041463465,0.00002032103,0.000010664742,0.00015676243,0.00023974977,0.0001283623],"category_scores_gemma":[0.0002621015,0.00016762002,0.00014217742,0.0003493596,0.00012450376,0.00012292308,0.000015059677,0.00049179106,0.000011980075],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077019427,0.004360711,0.55647856,0.0039177835,0.00058049447,0.30502385,0.01067684,0.0015080248,0.011265926,0.0010386428,0.005199622,0.092247605],"study_design_scores_gemma":[0.014075233,0.00089303945,0.3925709,0.007827091,0.00033299983,0.56847167,0.0012584425,0.0008183167,0.0121521605,0.00030185352,0.00094621273,0.00035208266],"about_ca_topic_score_codex":0.00015083661,"about_ca_topic_score_gemma":0.0018499532,"teacher_disagreement_score":0.26344782,"about_ca_system_score_codex":0.00009921046,"about_ca_system_score_gemma":0.00057349796,"threshold_uncertainty_score":0.6835346},"labels":[],"label_agreement":null},{"id":"W1977273659","doi":"10.1111/bjh.12222","title":"The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and <scp>S</scp>tanford <scp>V</scp> in older <scp>H</scp>odgkin lymphoma patients: a comprehensive analysis from the <scp>N</scp>orth <scp>A</scp>merican intergroup trial <scp>E</scp>2496","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Dacarbazine; Vinblastine; Medicine; Internal medicine; ABVD; Bleomycin; Vincristine; Tolerability; Gastroenterology; Hodgkin's lymphoma; Chemotherapy; Etoposide; Oncology; Surgery; Adverse effect; Cyclophosphamide","score_opus":0.009635228307854288,"score_gpt":0.23920548102576533,"score_spread":0.22957025271791104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977273659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96617776,0.02431978,0.0002252938,0.0004869139,0.001630572,0.0045220195,0.0006473375,0.00015511687,0.0018352034],"genre_scores_gemma":[0.9855498,0.008525563,0.0010065386,0.0017154373,0.0010275841,0.0005536128,0.0004984759,0.00029613302,0.00082684634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98305947,0.0025225144,0.006308113,0.0025325,0.002501196,0.0030761894],"domain_scores_gemma":[0.9400064,0.047426064,0.0054879817,0.0021201416,0.0031693322,0.0017901062],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019869942,0.0022318906,0.0072595053,0.0014297178,0.001034722,0.0009138227,0.0019260648,0.001321539,0.000047204434],"category_scores_gemma":[0.03409843,0.0017458135,0.0019047135,0.0030045197,0.0025226,0.00109022,0.0012502475,0.0019351259,0.00007232117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041201906,0.011463362,0.7463935,0.00066364964,0.013551963,0.007803468,0.013451128,0.00020447472,0.00062888616,0.00025432027,0.18480764,0.020365559],"study_design_scores_gemma":[0.07577506,0.0044958047,0.83212316,0.0018808506,0.005866844,0.010003991,0.019307703,0.0007282962,0.001519788,0.00061341946,0.047506534,0.00017857342],"about_ca_topic_score_codex":0.0052812747,"about_ca_topic_score_gemma":0.0029357483,"teacher_disagreement_score":0.13730112,"about_ca_system_score_codex":0.0008038369,"about_ca_system_score_gemma":0.0010780025,"threshold_uncertainty_score":0.99997497},"labels":[],"label_agreement":null},{"id":"W1977321797","doi":"10.1111/j.1365-2141.2008.07111.x","title":"Myeloblastic transformation of chronic neutrophilic leukaemia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Neutrophilia; Medicine; Monocytosis; Pathology; Bone marrow; Lymphocytosis; Trisomy 8; Cytopenia; Imatinib mesylate; Bone marrow examination; Absolute neutrophil count; White blood cell; Immunology; Gastroenterology; Internal medicine; Neutropenia; Chemotherapy; Myeloid leukemia; Imatinib; Biology; Cytogenetics","score_opus":0.013749263385858631,"score_gpt":0.2408666348970103,"score_spread":0.22711737151115166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977321797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011225,0.0067552864,0.0005699659,0.000894586,0.00019640468,0.00011354622,0.0000034936556,0.000009256591,0.0013452402],"genre_scores_gemma":[0.99615496,0.00338003,0.00019905162,0.00009431337,0.00007415741,0.000001494217,0.0000038643384,0.000012800919,0.000079347155],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987107,0.000049311944,0.0007343634,0.000083361345,0.00023157088,0.00019071362],"domain_scores_gemma":[0.9992318,0.00005066543,0.00030941513,0.0000930979,0.00021329954,0.00010167965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001424763,0.00009033176,0.0006962122,0.00016334449,0.00005930334,0.000004532074,0.000102435995,0.00010743635,0.00018932659],"category_scores_gemma":[0.00008755419,0.000091727044,0.00019748724,0.00013800879,0.00022369329,0.00013727133,0.000009360885,0.00025718255,0.000009861587],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025000987,0.0071855364,0.023136502,0.008892266,0.0028211582,0.49624923,0.0118489545,0.0009602816,0.047720794,0.014712881,0.05495521,0.3290171],"study_design_scores_gemma":[0.0029784525,0.0014208901,0.026710203,0.00064406864,0.000121249344,0.96434027,0.00017113001,0.00012259983,0.0015306862,0.00047923962,0.0013829089,0.00009830596],"about_ca_topic_score_codex":0.00002873931,"about_ca_topic_score_gemma":0.000019939887,"teacher_disagreement_score":0.46809104,"about_ca_system_score_codex":0.000043854623,"about_ca_system_score_gemma":0.00030766905,"threshold_uncertainty_score":0.37405205},"labels":[],"label_agreement":null},{"id":"W1977477282","doi":"10.1111/j.1365-2141.2012.09109.x","title":"Human bone marrow stromal cells simultaneously support <scp>B</scp> and <scp>T</scp>/<scp>NK</scp> lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; University of Toronto","keywords":"Lymphopoiesis; Stromal cell; Haematopoiesis; Bone marrow; Biology; Stem cell; Immunology; Progenitor cell; Stem cell factor; Cell biology; Cancer research","score_opus":0.011268792670791741,"score_gpt":0.23676514745199692,"score_spread":0.22549635478120517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977477282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790706,0.016134651,0.00024229196,0.000026424543,0.0031451269,0.00071914075,0.00004528471,0.00008704488,0.0005294574],"genre_scores_gemma":[0.99026275,0.000358451,0.0008311209,0.00018029433,0.00037482576,0.0000880371,0.00028385824,0.00010448482,0.007516202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99523175,0.00050111266,0.002124732,0.0006038495,0.00020238824,0.0013361488],"domain_scores_gemma":[0.99591666,0.002054435,0.0011306184,0.00029529186,0.0003773451,0.00022562798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011530154,0.0005750038,0.0015309064,0.0005765842,0.0006791737,0.00020505882,0.00046658644,0.00094808254,0.00016754541],"category_scores_gemma":[0.0012760949,0.0006463024,0.0003638171,0.00020272977,0.0003890445,0.0006513916,0.00021574559,0.0010152948,0.00013910292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118077856,0.0027989177,0.021443706,0.0007686995,0.002013573,0.0076254457,0.016114354,0.000032965898,0.8404653,0.00023781658,0.105209455,0.003171713],"study_design_scores_gemma":[0.00660253,0.0011059054,0.0073255417,0.0008709666,0.0003788179,0.11177295,0.010342339,0.000032559175,0.54609174,0.000094955285,0.31515938,0.00022235773],"about_ca_topic_score_codex":0.00020848893,"about_ca_topic_score_gemma":0.0002693046,"teacher_disagreement_score":0.29437357,"about_ca_system_score_codex":0.00021175068,"about_ca_system_score_gemma":0.0003090105,"threshold_uncertainty_score":0.9995988},"labels":[],"label_agreement":null},{"id":"W1977655193","doi":"10.1111/j.1365-2141.2004.04932.x","title":"Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia","year":2004,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacogenetics; Oncology; Acute lymphocytic leukemia; Lymphoblastic Leukemia; Internal medicine; Leukemia; Genotype; Biology; Genetics; Gene","score_opus":0.04590820009750595,"score_gpt":0.3899198462341808,"score_spread":0.34401164613667484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977655193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030397126,0.9680642,0.00008629167,0.000023162685,0.00056895375,0.0007072103,0.00006198757,0.000010804088,0.00008029786],"genre_scores_gemma":[0.0061605633,0.99232256,0.0010146338,0.00006221927,0.00013955892,0.000024250488,0.000013549122,0.00012182813,0.00014082286],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99353427,0.00040657693,0.0040451805,0.00042045623,0.00080824044,0.00078527903],"domain_scores_gemma":[0.9959369,0.0006537586,0.0022247226,0.0003565183,0.0004206546,0.00040747743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080223824,0.0005129873,0.0073416624,0.0012128067,0.000038247425,0.00002489916,0.0007742681,0.0007589315,0.00019822503],"category_scores_gemma":[0.0009561995,0.00048232952,0.0011232353,0.0006917592,0.00044109716,0.0001026485,0.00022906187,0.0013367996,0.00006504621],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015911025,0.00032949346,0.0008298438,0.04513801,0.00073276873,0.44426674,0.000028106351,0.000004198146,0.000006312148,0.000007012623,0.0004988997,0.5079995],"study_design_scores_gemma":[0.005910024,0.00048421216,0.00014333145,0.09131102,0.0034517895,0.87008,0.00001147867,0.000019976125,0.00005089476,0.00005237497,0.028178988,0.0003058866],"about_ca_topic_score_codex":0.00009879394,"about_ca_topic_score_gemma":0.00003699766,"teacher_disagreement_score":0.50769365,"about_ca_system_score_codex":0.001716654,"about_ca_system_score_gemma":0.0066564875,"threshold_uncertainty_score":0.99976283},"labels":[],"label_agreement":null},{"id":"W1977886211","doi":"10.1111/j.1365-2141.2004.05194.x","title":"Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Cumulative incidence; Follicular lymphoma; Lymphoma; Total body irradiation; Internal medicine; Surgery; Transplantation; Incidence (geometry); Bone marrow; Gastroenterology; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.005038763484335681,"score_gpt":0.21835521181074105,"score_spread":0.21331644832640537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977886211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248314,0.0063707014,0.00025811774,0.0003074957,0.00016383672,0.00028600116,0.000096184165,0.00000839687,0.000026098895],"genre_scores_gemma":[0.9976299,0.0011210195,0.0009699198,0.00012611004,0.0000322068,0.000021115691,0.000068220346,0.000022772492,0.00000875331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985954,0.000056172066,0.00054309913,0.0001737591,0.00040649212,0.00022506171],"domain_scores_gemma":[0.9989245,0.00003827266,0.00033721927,0.00018500682,0.00028823628,0.00022678376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083356856,0.00015418866,0.00067006354,0.000105675645,0.000035916066,0.000011645983,0.00009522142,0.000072957344,0.000052463274],"category_scores_gemma":[0.00004161016,0.00013265814,0.00020312016,0.00009334559,0.00010948805,0.00013474481,0.0000149465595,0.00005618439,0.0000028594736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045101834,0.0022709628,0.820621,0.00033450665,0.00040415733,0.15990646,0.000090202666,0.000034832672,0.000058997917,0.000055650908,0.000023300328,0.01168973],"study_design_scores_gemma":[0.02459226,0.00087360764,0.93233955,0.0011362712,0.0006815287,0.038958214,0.0000103523125,2.8724708e-7,0.0011190011,0.00014884607,0.000025086736,0.00011496593],"about_ca_topic_score_codex":0.000028823926,"about_ca_topic_score_gemma":0.0001729186,"teacher_disagreement_score":0.12094825,"about_ca_system_score_codex":0.00013339224,"about_ca_system_score_gemma":0.00027883658,"threshold_uncertainty_score":0.5409642},"labels":[],"label_agreement":null},{"id":"W1977996697","doi":"10.1046/j.1365-2141.2003.04685.x","title":"Transcobalamin deficiency due to activation of an intra exonic cryptic splice site","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Exon; Splice site mutation; Intron; RNA splicing; Biology; Point mutation; Genetics; splice; Mutation; Vitamin B12; Gene; Genetic disorder; Frameshift mutation; Alternative splicing; Endocrinology; RNA","score_opus":0.0169455679132093,"score_gpt":0.2959083558901258,"score_spread":0.27896278797691654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977996697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959647,0.0009168078,0.0014943006,0.00039700218,0.00008176329,0.000184093,0.0000028519598,0.0000064874453,0.0009519918],"genre_scores_gemma":[0.9968561,0.00016718564,0.0026803566,0.00017922875,0.000035111087,0.0000024530566,0.0000029034452,0.000014743333,0.00006192424],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99850726,0.00016850662,0.00055862,0.00014542422,0.00033232913,0.00028786532],"domain_scores_gemma":[0.9990224,0.00008871031,0.00016245546,0.00014218377,0.00037463364,0.0002096076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056176155,0.00008953978,0.00053878146,0.00025992608,0.000048556045,0.000013615029,0.00012543121,0.00011730839,0.00024590018],"category_scores_gemma":[0.00049421896,0.000092417344,0.00010362808,0.00034997717,0.00008555437,0.00018637093,0.00000999161,0.0003344887,0.000020912545],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017611858,0.0046665957,0.0076177223,0.0015575481,0.00040330904,0.11732773,0.0029509235,0.00014180633,0.7044403,0.0048944964,0.0038649512,0.15037346],"study_design_scores_gemma":[0.0046794,0.0046248888,0.063733004,0.0011644152,0.00018605634,0.7634099,0.0009184648,0.00012665249,0.15840042,0.0008559547,0.00162985,0.00027101644],"about_ca_topic_score_codex":0.00008059269,"about_ca_topic_score_gemma":0.000060029175,"teacher_disagreement_score":0.64608216,"about_ca_system_score_codex":0.000045369234,"about_ca_system_score_gemma":0.00023973233,"threshold_uncertainty_score":0.376867},"labels":[],"label_agreement":null},{"id":"W1979916062","doi":"10.1111/j.1365-2141.2009.07889.x","title":"A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft <i>versus</i> host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Cancer Institute; University of Utah","keywords":"Cumulative incidence; Medicine; Sirolimus; Transplantation; Internal medicine; Immunosuppression; Tacrolimus; Hematopoietic stem cell transplantation; Hazard ratio; Graft-versus-host disease; Population; Cohort; Total body irradiation; Gastroenterology; Surgery; Chemotherapy; Cyclophosphamide; Confidence interval","score_opus":0.008794542205020473,"score_gpt":0.27337090894777377,"score_spread":0.2645763667427533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979916062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649626,0.0010762222,0.00017770685,0.00048528227,0.00016894352,0.0013629207,0.00020637995,0.0000058397272,0.000020461468],"genre_scores_gemma":[0.9987593,0.0007391243,0.00021006823,0.00017711829,0.000047105885,0.000018476612,0.000007712706,0.000026565069,0.000014470722],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99639875,0.0006638225,0.0014337333,0.00030687862,0.0008038024,0.00039303242],"domain_scores_gemma":[0.9975388,0.000610813,0.0008285983,0.00037742368,0.00037893603,0.0002654369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058705657,0.00024357629,0.0010589602,0.00037296995,0.0000869949,0.000012256713,0.00040661547,0.00015570078,0.00002765313],"category_scores_gemma":[0.00059767853,0.0001779297,0.00027378215,0.000835434,0.00029889029,0.0001152411,0.00012395755,0.0004194813,8.987454e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3996728,0.06814973,0.060376663,0.009939843,0.0033991684,0.13905156,0.033867974,0.0037189256,0.22783288,0.00012661505,0.0018692701,0.05199458],"study_design_scores_gemma":[0.1426188,0.029040271,0.74342716,0.0030227662,0.004751058,0.052751794,0.0010177604,0.0003865418,0.022212101,0.00018886047,0.000053803567,0.0005290986],"about_ca_topic_score_codex":0.00007447667,"about_ca_topic_score_gemma":0.00009040977,"teacher_disagreement_score":0.68305045,"about_ca_system_score_codex":0.00020103733,"about_ca_system_score_gemma":0.0006872932,"threshold_uncertainty_score":0.7255763},"labels":[],"label_agreement":null},{"id":"W1980168719","doi":"10.1111/bjh.13004","title":"Long‐term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Mayo Clinic","keywords":"Bortezomib; Multiple myeloma; Medicine; Dexamethasone; Cyclophosphamide; Induction therapy; Oncology; Internal medicine; Chemotherapy","score_opus":0.018039258852553048,"score_gpt":0.26081894217098844,"score_spread":0.24277968331843539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980168719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860613,0.0018809517,0.00014226332,0.010618539,0.000223449,0.000987422,0.000029139936,0.000018157341,0.00003882416],"genre_scores_gemma":[0.98148364,0.0016530501,0.0013658492,0.014361625,0.0005510188,0.000048775997,0.0003200312,0.00013342357,0.00008258028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965608,0.0006452761,0.0007909692,0.00044523086,0.0008665604,0.00069118],"domain_scores_gemma":[0.9974321,0.00061763177,0.00077998004,0.000303836,0.0005822836,0.00028413284],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00042870452,0.00044610427,0.001809396,0.0004901214,0.00011913901,0.00008246615,0.00020037242,0.00066408777,0.000055156037],"category_scores_gemma":[0.00037045858,0.00035053398,0.00012387612,0.00024264668,0.00037363148,0.00020746296,0.00004193095,0.0029586197,0.0000046579253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045262934,0.0005388777,0.7698908,0.00024974343,0.00073735934,0.15176521,0.000064489,0.000001307527,0.0000036044567,3.4689762e-7,0.0069392975,0.06528266],"study_design_scores_gemma":[0.037165735,0.004442699,0.88679725,0.0017421173,0.00014706317,0.06781542,0.000020651898,0.0000028299603,0.00005172525,0.0000118222315,0.0015097405,0.00029296847],"about_ca_topic_score_codex":0.00080843945,"about_ca_topic_score_gemma":0.0008314071,"teacher_disagreement_score":0.11690642,"about_ca_system_score_codex":0.00014654077,"about_ca_system_score_gemma":0.0002906515,"threshold_uncertainty_score":0.9998947},"labels":[],"label_agreement":null},{"id":"W1980318916","doi":"10.1046/j.1365-2141.2003.04583.x","title":"The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Medicine; Neutropenia; Granulocyte; Transplantation; Surgery; Aspergillosis; Incidence (geometry); Granulocyte colony-stimulating factor; Internal medicine; Autologous stem-cell transplantation; Stem cell; Hematopoietic stem cell transplantation; Chemotherapy; Toxicity; Gastroenterology; Immunology","score_opus":0.02211683054496075,"score_gpt":0.2634044771101646,"score_spread":0.24128764656520388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980318916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930931,0.0018842191,0.004338366,0.00013578957,0.00015890396,0.00029294557,0.00004474578,0.00000412631,0.000047844944],"genre_scores_gemma":[0.995974,0.0033214006,0.00053316,0.0000474517,0.000010149327,0.0000055841615,0.0000021888945,0.000008709102,0.00009738124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984808,0.00027688395,0.00074068096,0.00012076756,0.00021151193,0.00016938387],"domain_scores_gemma":[0.99878436,0.0002833708,0.00024414266,0.00014296446,0.00043357498,0.00011157652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033557566,0.00009046969,0.00044471934,0.00008138917,0.0000814693,0.000009264456,0.000071820854,0.00009086673,0.0000558824],"category_scores_gemma":[0.00009867632,0.000075506476,0.0001922823,0.00020829079,0.00012678641,0.00008567446,0.0000051081292,0.00022548287,0.0000015861187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013733663,0.008919608,0.7647364,0.00556772,0.0013362269,0.029570749,0.00886874,0.0047837105,0.07228981,0.00067254505,0.005531953,0.08398885],"study_design_scores_gemma":[0.006033859,0.0037183042,0.7435294,0.0054066074,0.0015650165,0.17017747,0.0012848015,0.000053935284,0.061356362,0.00039189585,0.0059923776,0.0004900073],"about_ca_topic_score_codex":0.000041849173,"about_ca_topic_score_gemma":0.00069055526,"teacher_disagreement_score":0.14060672,"about_ca_system_score_codex":0.000023516795,"about_ca_system_score_gemma":0.00015769286,"threshold_uncertainty_score":0.30790648},"labels":[],"label_agreement":null},{"id":"W1980917241","doi":"10.1111/j.1365-2141.2007.06503.x","title":"Higher thrombin concentrations are required to induce platelet apoptosis than to induce platelet activation","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Platelet; Thrombin; Apoptosis; Coagulation; Inducer; Platelet activation; Chemistry; Immunology; Pharmacology; Cell biology; Endocrinology; Medicine; Internal medicine; Biochemistry; Biology","score_opus":0.04151526672540003,"score_gpt":0.3051665391745776,"score_spread":0.2636512724491776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980917241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98443687,0.00010863333,0.0050248113,0.008184193,0.0009614486,0.00048418963,0.000009818053,0.000047802976,0.0007422258],"genre_scores_gemma":[0.9917587,0.000033760734,0.0034363759,0.0042385967,0.0003035339,0.000008742367,0.000016882355,0.000038479895,0.00016492906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977552,0.00010795245,0.00093319314,0.00028017838,0.00046189714,0.0004615442],"domain_scores_gemma":[0.99809474,0.00013533594,0.00052483927,0.00021062412,0.00052194315,0.0005125123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006057511,0.0001957769,0.0008281453,0.0003523542,0.00016316806,0.000063115134,0.00019125271,0.00032143816,0.000342711],"category_scores_gemma":[0.00036254144,0.00022082338,0.00013725995,0.00054469204,0.000052382034,0.00027532602,0.00005263681,0.00047837527,0.00007031196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015072073,0.0019516482,0.005333734,0.00018545163,0.0010886629,0.0121364845,0.0024337992,0.00007730106,0.8581265,0.018546391,0.062522635,0.03609016],"study_design_scores_gemma":[0.0040383157,0.000984047,0.08768917,0.0012873072,0.00012887675,0.045747045,0.00096925336,0.0000056255058,0.85077184,0.001197329,0.0068052476,0.00037595414],"about_ca_topic_score_codex":0.00007232443,"about_ca_topic_score_gemma":0.00010349569,"teacher_disagreement_score":0.08235543,"about_ca_system_score_codex":0.00013115958,"about_ca_system_score_gemma":0.0001485699,"threshold_uncertainty_score":0.9004916},"labels":[],"label_agreement":null},{"id":"W1981102741","doi":"10.1111/j.1365-2141.2004.04814.x","title":"Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Multiple Myeloma Research Foundation","keywords":"Fibroblast growth factor receptor 3; Molecular biology; Cancer research; Multiple myeloma; Biology; Cell culture; Chromosomal translocation; Tyrosine kinase; Fibroblast growth factor receptor; Fibroblast growth factor; Signal transduction; Receptor; Cell biology; Immunology; Biochemistry","score_opus":0.06970726264567276,"score_gpt":0.369823338292175,"score_spread":0.3001160756465022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981102741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855305,0.009557382,0.00007335518,0.0012152323,0.00014434604,0.00033412498,0.000025429632,0.0000101930145,0.00008687916],"genre_scores_gemma":[0.9929051,0.002138006,0.0046823816,0.00011503616,0.00007079437,0.000010944448,0.0000062227086,0.000022174876,0.00004936585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786115,0.00020459908,0.000976737,0.00019742802,0.00038465383,0.00037541625],"domain_scores_gemma":[0.9983311,0.00046137397,0.00037431988,0.0001292543,0.00048381978,0.00022013222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003121449,0.00015450137,0.001102368,0.00023909751,0.000048666647,0.000011275099,0.00015942017,0.00015028838,0.0001895116],"category_scores_gemma":[0.002861608,0.00013659958,0.00023508588,0.00018695738,0.00033581408,0.00012645684,0.000059269976,0.00046124007,0.000033322554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009207033,0.007600302,0.7446892,0.002094856,0.0051998356,0.1520167,0.0030239015,0.000051292882,0.024447002,0.0008319657,0.001599479,0.0492384],"study_design_scores_gemma":[0.04661111,0.008513383,0.64031225,0.0068703694,0.00017414993,0.21960042,0.001686887,0.00003261855,0.06619375,0.009039272,0.0005544828,0.00041129882],"about_ca_topic_score_codex":0.00018488965,"about_ca_topic_score_gemma":0.00019566242,"teacher_disagreement_score":0.10437699,"about_ca_system_score_codex":0.00012353924,"about_ca_system_score_gemma":0.00036273507,"threshold_uncertainty_score":0.55703694},"labels":[],"label_agreement":null},{"id":"W1982060371","doi":"10.1111/j.1365-2141.2005.05387.x","title":"Incidence and spectrum of non‐Hodgkin lymphoma in Chinese migrants to British Columbia","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Incidence (geometry); Medicine; Lymphoma; Demography; Standardized rate; Follicular lymphoma; Non-Hodgkin's lymphoma; Population; Internal medicine; Pediatrics; Epidemiology; Environmental health","score_opus":0.005149361932843713,"score_gpt":0.25333741115138453,"score_spread":0.24818804921854082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982060371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222463,0.0058975117,0.000016203128,0.0012685388,0.00011050075,0.00023532227,0.00001584123,0.000005605115,0.0002258507],"genre_scores_gemma":[0.9955867,0.0014784766,0.0021940926,0.0005236431,0.000091275644,0.000008579682,0.000001937707,0.000015336736,0.00009995201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847275,0.00005896768,0.0007607596,0.00019341573,0.00023694054,0.00027717947],"domain_scores_gemma":[0.9991629,0.00010702056,0.00026715588,0.00011673266,0.00011812706,0.00022803234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026854072,0.000103473474,0.0009292765,0.0001317576,0.00004156377,0.000062864965,0.00011505979,0.00010461261,0.00015025656],"category_scores_gemma":[0.00025621854,0.00014197682,0.00011259819,0.00022735471,0.00010384147,0.00013250452,0.000057043202,0.0000991453,0.000007766686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010932844,0.0008787643,0.8039289,0.000076382334,0.00008069195,0.069076836,0.00021244503,0.000004707049,0.0001592143,0.0000042704137,0.003958647,0.12150978],"study_design_scores_gemma":[0.0042060018,0.00040315444,0.664445,0.0010649144,0.000041840958,0.32893693,0.000037584883,0.00001863004,0.00027206843,0.000118017204,0.00038114184,0.000074731775],"about_ca_topic_score_codex":0.020396894,"about_ca_topic_score_gemma":0.14898604,"teacher_disagreement_score":0.2598601,"about_ca_system_score_codex":0.00013822386,"about_ca_system_score_gemma":0.00021375918,"threshold_uncertainty_score":0.98612636},"labels":[],"label_agreement":null},{"id":"W1982278453","doi":"10.1111/j.1365-2141.2007.06575.x","title":"Chronic and severe haemolytic anaemia caused by co‐inheritance of <i>β</i>‐thalassaemia and triplicated <i>α</i>‐globin genes","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Microcytosis; Anisocytosis; Ineffective erythropoiesis; Medicine; Bilirubin; Internal medicine; Molecular biology; Biology; Gastroenterology; Anemia; Erythropoiesis; Iron deficiency","score_opus":0.00703357624607732,"score_gpt":0.2495829985776503,"score_spread":0.24254942233157298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982278453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86847824,0.12970707,0.00014294179,0.0007926024,0.00012711667,0.00023136388,0.000018755534,0.000015576004,0.0004863302],"genre_scores_gemma":[0.9806588,0.018583586,0.0002510034,0.00024024607,0.000069539914,0.0000015820492,0.0000089702025,0.000029220671,0.00015702663],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.998202,0.00006945781,0.0008820457,0.0002283307,0.0002300744,0.00038804626],"domain_scores_gemma":[0.99872947,0.00011974079,0.0005045571,0.00013628323,0.00022283701,0.00028709014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005173688,0.00018109649,0.0009426265,0.00013062949,0.00008351949,0.000016343904,0.000103329054,0.0003481846,0.00003459758],"category_scores_gemma":[0.00013239348,0.00018247218,0.00009673202,0.0002225612,0.0004592028,0.00010267208,0.000034644065,0.0004841393,0.0000016666357],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018977461,0.0010534548,0.15580662,0.0038889728,0.0017989314,0.11399211,0.00080712774,0.000017694249,0.2909024,0.0003061816,0.12051436,0.3090144],"study_design_scores_gemma":[0.01588873,0.0019087692,0.037362996,0.002315368,0.00059025135,0.8680651,0.00089520955,0.000062059094,0.046118725,0.0002786268,0.02599919,0.0005149719],"about_ca_topic_score_codex":0.000074466654,"about_ca_topic_score_gemma":0.00007169169,"teacher_disagreement_score":0.75407296,"about_ca_system_score_codex":0.00006954479,"about_ca_system_score_gemma":0.00021023439,"threshold_uncertainty_score":0.7441},"labels":[],"label_agreement":null},{"id":"W1982308436","doi":"10.1111/j.1365-2141.2012.09177.x","title":"Impact of rituximab on treatment outcomes of patients with diffuse large b‐cell lymphoma: a population‐based analysis","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto General Hospital; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; St. Michael's Hospital; Princess Margaret Cancer Centre; Niagara Health System","funders":"Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Rituximab; Medicine; CHOP; Diffuse large B-cell lymphoma; Vincristine; Internal medicine; Population; Hazard ratio; Prednisone; Lymphoma; Cyclophosphamide; Oncology; Chemotherapy; Surgery; Gastroenterology; Confidence interval","score_opus":0.009586511896449226,"score_gpt":0.2774775081604935,"score_spread":0.2678909962640443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982308436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985851,0.0008453201,0.00003798076,0.000045572877,0.000052482224,0.00020742712,0.00016111581,0.0000050312574,0.000059992224],"genre_scores_gemma":[0.99919534,0.00005703324,0.0005573354,0.00004382935,0.000016494254,0.000007172405,0.000089835885,0.000015859112,0.000017083199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849975,0.00009295555,0.0006732242,0.00011744223,0.00033848544,0.00027812985],"domain_scores_gemma":[0.99836105,0.00016421772,0.00081591203,0.00020560021,0.00025810074,0.00019510055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010596935,0.00018443783,0.0015427691,0.00039191064,0.000037198435,0.0000066444795,0.00006323004,0.000083420346,0.00010865557],"category_scores_gemma":[0.00005762088,0.00011986083,0.00072518503,0.00026723844,0.000040381914,0.00008758453,0.00001116395,0.000040616516,0.000003168211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006030682,0.06150962,0.93166935,0.000035751404,0.00319556,0.000878757,0.00009289104,0.00001618858,0.0000019786457,0.000020045514,0.000057764617,0.0019190124],"study_design_scores_gemma":[0.050741874,0.0028287696,0.94136953,0.00010957622,0.0034032767,0.0010938541,0.000018791701,0.000014826481,0.00031576367,0.0000049184187,0.0000151403565,0.0000836657],"about_ca_topic_score_codex":0.0007579408,"about_ca_topic_score_gemma":0.00009681949,"teacher_disagreement_score":0.05868085,"about_ca_system_score_codex":0.0004054269,"about_ca_system_score_gemma":0.00016608904,"threshold_uncertainty_score":0.4887783},"labels":[],"label_agreement":null},{"id":"W1982852792","doi":"10.1046/j.1365-2141.2000.01941.x","title":"Management Of Thrombotic Thrombocytopenic Purpura","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Fulminant; Microangiopathic hemolytic anemia; Thrombotic microangiopathy; Schistocyte; Disease; Autopsy; Pediatrics; Microangiopathy; Hyaline; Dermatology; Pathology; Internal medicine; Platelet; Diabetes mellitus","score_opus":0.041494225971076944,"score_gpt":0.3255488402267257,"score_spread":0.28405461425564876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982852792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009655107,0.9949784,0.000017619344,0.000014750732,0.0014299019,0.00074663083,0.00013979395,0.00002031876,0.001687057],"genre_scores_gemma":[0.0016117255,0.9974279,0.0001369532,0.000012570059,0.00004550393,0.000028728547,0.00010301972,0.00005619186,0.00057740626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99529403,0.0009827527,0.0027601137,0.0003466678,0.00011967007,0.00049678585],"domain_scores_gemma":[0.99662197,0.0002849038,0.0024339124,0.00045895486,0.00014950715,0.000050751954],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048386538,0.00041993367,0.005131724,0.00035673365,0.00010518435,0.00002725198,0.0012272269,0.00047329132,0.0064335843],"category_scores_gemma":[0.00003722824,0.00041300262,0.0012634548,0.00025565433,0.00036985,0.00010553305,0.00023570292,0.0006626863,0.00050382485],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003095299,0.00038282608,0.0000068708914,0.02423619,0.0047908,0.021022731,0.00002005424,7.7146825e-7,0.000001925027,0.00092007586,0.01981545,0.9287714],"study_design_scores_gemma":[0.0007386656,0.00013755933,0.000025062423,0.041477848,0.0027657787,0.27100122,0.000057304827,1.8527595e-8,0.0000061152796,0.00017647575,0.68337125,0.00024268709],"about_ca_topic_score_codex":0.000022406512,"about_ca_topic_score_gemma":0.000008756611,"teacher_disagreement_score":0.92852867,"about_ca_system_score_codex":0.00008755369,"about_ca_system_score_gemma":0.00026785876,"threshold_uncertainty_score":0.99983215},"labels":[],"label_agreement":null},{"id":"W1983430343","doi":"10.1111/bjh.12042","title":"The immunophenotype of <scp>T</scp> ‐lymphoblastic lymphoma in children and adolescents: a <scp>C</scp> hildren's <scp>O</scp> ncology <scp>G</scp> roup report","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute","keywords":"Immunophenotyping; Lymphoma; Lymphoblastic lymphoma; Flow cytometry; Medicine; T cell; Myeloid; Immunology; Immune system","score_opus":0.007669832411063022,"score_gpt":0.25108691984258413,"score_spread":0.2434170874315211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983430343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569045,0.03685356,0.0005797811,0.00021259862,0.0016455585,0.0015328273,0.00009315197,0.00010639767,0.0020716817],"genre_scores_gemma":[0.9877174,0.006857507,0.0010116751,0.00071411557,0.0011865008,0.000086001324,0.000098860386,0.00029823883,0.0020297072],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.98740685,0.0014408078,0.004275914,0.0012145225,0.0021291326,0.0035327799],"domain_scores_gemma":[0.9808017,0.011136525,0.0033990017,0.001359635,0.0017889424,0.0015142189],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004221123,0.001132039,0.003714847,0.0013119903,0.000609373,0.00024267922,0.0017138389,0.0014937059,0.000022164173],"category_scores_gemma":[0.05028539,0.0010485278,0.000741054,0.0014700263,0.0023251409,0.0008471175,0.0011556414,0.0021492853,0.00013490459],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002771553,0.005689822,0.6770852,0.0013555572,0.004343888,0.08347308,0.005098628,0.000082472114,0.004008505,0.0013685044,0.20608884,0.011128341],"study_design_scores_gemma":[0.0136019485,0.0012048912,0.4375781,0.0017711994,0.0007077734,0.52872115,0.0030440625,0.00014649684,0.0016455564,0.0006522585,0.010830419,0.0000961037],"about_ca_topic_score_codex":0.00085036363,"about_ca_topic_score_gemma":0.00019120135,"teacher_disagreement_score":0.4452481,"about_ca_system_score_codex":0.0015135063,"about_ca_system_score_gemma":0.0031232694,"threshold_uncertainty_score":0.9998026},"labels":[],"label_agreement":null},{"id":"W1983883292","doi":"10.1111/bjh.12315","title":"Renal function is independently associated with red cell distribution width in kidney transplant recipients: a potential new auxiliary parameter for the clinical evaluation of patients with chronic kidney disease","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal function; Kidney disease; Internal medicine; Red blood cell distribution width; Comorbidity; Wasting; Gastroenterology","score_opus":0.017447721097760566,"score_gpt":0.2693170002689205,"score_spread":0.25186927917116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983883292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919155,0.00051565876,0.0037343372,0.0011650755,0.00039692485,0.0018952052,0.00035922177,0.000010137166,0.000007904261],"genre_scores_gemma":[0.9982952,0.00009479776,0.00025799585,0.00040494543,0.000099160374,0.000096520496,0.00070704677,0.000026247431,0.000018108143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967814,0.00053133327,0.0011509932,0.00027891487,0.0009357022,0.00032164477],"domain_scores_gemma":[0.9965889,0.00021965009,0.001051363,0.00020377568,0.0013981111,0.0005381918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013867089,0.00018319224,0.00059422205,0.00011652998,0.00008744891,0.000033634635,0.00016410249,0.00020545069,0.00029977004],"category_scores_gemma":[0.0015719825,0.00013643665,0.00024318366,0.0002047441,0.00021328058,0.00027845305,0.000020300216,0.00038545273,0.00000222937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017356934,0.0017015135,0.9303584,0.00023577634,0.0011067261,0.0006491089,0.000055727887,0.000044051754,0.000039036633,0.000003182056,0.032699727,0.015749797],"study_design_scores_gemma":[0.0262072,0.0015133363,0.96208906,0.002708639,0.0033158346,0.000674222,0.000015485655,0.0027035465,0.00011958322,0.00037976855,0.000114832445,0.00015851697],"about_ca_topic_score_codex":0.000048564307,"about_ca_topic_score_gemma":0.00004139293,"teacher_disagreement_score":0.032584894,"about_ca_system_score_codex":0.00026599143,"about_ca_system_score_gemma":0.0020498014,"threshold_uncertainty_score":0.5563725},"labels":[],"label_agreement":null},{"id":"W1984035634","doi":"10.1046/j.1365-2141.2000.02000.x","title":"A single nucleotide polymorphism at nucleotide −1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Single-nucleotide polymorphism; Von Willebrand factor; Linkage disequilibrium; SNP; Biology; Platelet; Molecular biology; Glycoprotein; Nucleotide; Genetics; Genotype; Immunology; Gene","score_opus":0.020486983990414598,"score_gpt":0.23225101807058698,"score_spread":0.2117640340801724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984035634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216044,0.0013883936,0.0000024172705,0.0027592583,0.00010282233,0.0003067208,0.00003286322,0.000022532458,0.0032245615],"genre_scores_gemma":[0.9970572,0.00049208855,0.00006509723,0.0015666,0.000051216295,0.0000045567535,0.000013192283,0.00004684154,0.000703231],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99788344,0.00022477731,0.0006905457,0.0002705669,0.0004511942,0.00047947647],"domain_scores_gemma":[0.99886423,0.00018133355,0.00045409807,0.00022359744,0.00011471629,0.00016203952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020494842,0.00024058737,0.0010498367,0.00018793042,0.00019014203,0.000047380498,0.00020471326,0.00021644676,0.00060405367],"category_scores_gemma":[0.0001040866,0.00019498903,0.00020043225,0.000265697,0.0002382409,0.00021133087,0.000022110507,0.00044990052,0.00003549074],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027611842,0.003032308,0.07710151,0.00009107559,0.0014093426,0.8452265,0.0028628337,0.000012872217,0.0009124287,0.00012745433,0.028615156,0.03784732],"study_design_scores_gemma":[0.015198572,0.0014164185,0.19347024,0.0019261979,0.0003571077,0.7760321,0.00029843705,0.000026107306,0.0014954812,0.00037833955,0.009046031,0.00035499778],"about_ca_topic_score_codex":0.00017593193,"about_ca_topic_score_gemma":0.0013716151,"teacher_disagreement_score":0.11636873,"about_ca_system_score_codex":0.00015533682,"about_ca_system_score_gemma":0.00015580116,"threshold_uncertainty_score":0.7951422},"labels":[],"label_agreement":null},{"id":"W1985256998","doi":"10.1046/j.1365-2141.2003.04033.x","title":"Fcγ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Canadian Blood Services; University of Toronto; Hospital for Sick Children","funders":"Medical Research Council; University of Toronto; Canadian Blood Services","keywords":"Thrombocytopenic purpura; Immunology; Receptor; Autoantibody; Genotype; Immune system; Platelet; Allele; Antibody; Allele frequency; Immunoglobulin G; Medicine; Internal medicine; Biology; Genetics; Gene","score_opus":0.010917906366171399,"score_gpt":0.2284805917841781,"score_spread":0.2175626854180067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985256998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95350295,0.043479603,0.000005498578,0.0017841448,0.00018426224,0.00016899958,0.000005991754,0.0000092757755,0.00085924915],"genre_scores_gemma":[0.99101394,0.007940133,0.00049049954,0.0002746246,0.000039801307,0.0000034960415,0.000005682979,0.000019765235,0.00021203951],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99875313,0.0000488342,0.00059111835,0.00016038235,0.0001561803,0.00029038108],"domain_scores_gemma":[0.9994101,0.000043413158,0.00024255858,0.00010843981,0.00005974959,0.0001357538],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014087485,0.0001341344,0.000977315,0.00017264829,0.000064686574,0.000024292032,0.0000967861,0.0001353699,0.0009586029],"category_scores_gemma":[0.000102961174,0.00013342284,0.0001143806,0.0001480541,0.00010973389,0.00014607814,0.00004002701,0.00035582596,0.00004579813],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041282602,0.004698966,0.080291994,0.00012945714,0.0012121418,0.68822014,0.0015143007,0.000001899017,0.0036953392,0.00050148886,0.016571475,0.20274998],"study_design_scores_gemma":[0.008427817,0.0006007703,0.15598616,0.00058133015,0.00012008686,0.8317504,0.00010673964,0.000014800333,0.0005350973,0.0006698301,0.0010564845,0.0001504766],"about_ca_topic_score_codex":0.000111799796,"about_ca_topic_score_gemma":0.00006244827,"teacher_disagreement_score":0.2025995,"about_ca_system_score_codex":0.000036945286,"about_ca_system_score_gemma":0.000036350306,"threshold_uncertainty_score":0.99995464},"labels":[],"label_agreement":null},{"id":"W1985605429","doi":"10.1111/bjh.13146","title":"A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Alberta; Sunnybrook Health Science Centre; Canadian Blood Services; Health Sciences Centre; ErinoakKids Centre for Treatment and Development; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Leukapheresis; Internal medicine; Hydroxycarbamide; Hazard ratio; Retrospective cohort study; Myeloid leukaemia; White blood cell; Cohort; Myeloid; Gastroenterology; Chemotherapy; Confidence interval; Stem cell","score_opus":0.024058456871464837,"score_gpt":0.2904321657146944,"score_spread":0.26637370884322953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985605429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967499,0.00005567222,0.0010338917,0.00030401975,0.00006744448,0.00088674825,0.000016019536,0.000017532735,0.0008688157],"genre_scores_gemma":[0.99385715,0.00002301194,0.0057352385,0.00010017533,0.00010562346,0.000028483524,0.0000120664945,0.00004711481,0.000091169415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725735,0.00023547943,0.0007193253,0.00035837496,0.001007549,0.00042190403],"domain_scores_gemma":[0.99661875,0.00014149335,0.0006389254,0.00026912955,0.0021024432,0.00022927596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004503244,0.0002212635,0.0011289839,0.0003741007,0.0001310134,0.00006430536,0.00031871436,0.00010155097,0.00004495352],"category_scores_gemma":[0.00031961995,0.0001848502,0.00008713672,0.000511637,0.0002462203,0.00044776747,0.00012588559,0.0006662595,0.0000047510457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004558318,0.0016464194,0.9702583,0.00017851994,0.0025333874,0.013732746,0.0031163578,0.00021932025,0.00042796912,0.0004953391,0.0011208047,0.001712536],"study_design_scores_gemma":[0.009118717,0.00828046,0.93919915,0.00049243576,0.00053563365,0.03633029,0.004858544,0.00005517248,0.00055971515,0.00028551498,0.000067735775,0.0002166503],"about_ca_topic_score_codex":0.00031971568,"about_ca_topic_score_gemma":0.00028133468,"teacher_disagreement_score":0.03105915,"about_ca_system_score_codex":0.00028844006,"about_ca_system_score_gemma":0.00046424574,"threshold_uncertainty_score":0.75379723},"labels":[],"label_agreement":null},{"id":"W1986060736","doi":"10.1111/bjh.12880","title":"Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medical diagnosis; Medicine; Referral; Lymphoma; Follicular lymphoma; Biopsy; Pediatrics; Internal medicine; Radiology; Family medicine","score_opus":0.009490982908465806,"score_gpt":0.278075712845727,"score_spread":0.26858472993726124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986060736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839378,0.015167709,0.0000024473557,0.00046581688,0.00012942014,0.00017182996,0.000021826125,0.0000064444516,0.000096734344],"genre_scores_gemma":[0.99240583,0.00697124,0.00012932462,0.00039126276,0.00006228914,0.0000034765637,0.000013585203,0.000016500588,0.000006465206],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861336,0.00023445353,0.0005773326,0.00017718354,0.00018583465,0.0002118382],"domain_scores_gemma":[0.9986283,0.0002638647,0.00047295395,0.0001468273,0.00021579709,0.00027222058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019414721,0.00014585417,0.00077342615,0.00011061144,0.00006269624,0.000011596013,0.00006992251,0.00014657776,0.00008376746],"category_scores_gemma":[0.00026212723,0.00011530102,0.0001729854,0.0000648554,0.00008269055,0.000099642304,0.000043816402,0.00010702142,0.0000069188945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006583187,0.00064551085,0.43169326,0.00018868338,0.00017245431,0.008761803,0.00071568484,0.000009092821,0.00011680624,0.00013064766,0.0039687566,0.552939],"study_design_scores_gemma":[0.011995547,0.010131549,0.78265566,0.0045932443,0.00057412067,0.16102836,0.0005086926,0.000038186994,0.021325078,0.00021354633,0.006685369,0.00025065063],"about_ca_topic_score_codex":0.00011909015,"about_ca_topic_score_gemma":0.00002253258,"teacher_disagreement_score":0.5526883,"about_ca_system_score_codex":0.0002300953,"about_ca_system_score_gemma":0.00008818813,"threshold_uncertainty_score":0.4701839},"labels":[],"label_agreement":null},{"id":"W1986114335","doi":"10.1111/j.1365-2141.2006.05960.x","title":"Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Ximelagatran; Factor V Leiden; Internal medicine; Population; Placebo; Risk factor; Thrombophilia; Warfarin; Venous thrombosis; Thrombosis; Atrial fibrillation; Dabigatran; Pathology","score_opus":0.01624886341386555,"score_gpt":0.28003570661110105,"score_spread":0.2637868431972355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986114335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482924,0.0012563168,0.00043824269,0.00007375302,0.00090068835,0.002220439,0.000102465594,0.000018713565,0.00016011455],"genre_scores_gemma":[0.9960177,0.0022527124,0.0013579914,0.000029086546,0.00014589056,0.00004288454,0.00006472554,0.00006991891,0.000019084358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955275,0.00039161267,0.0024826936,0.0004504284,0.00053114985,0.00061663875],"domain_scores_gemma":[0.9964466,0.0004940159,0.0021891904,0.00028362757,0.00042647345,0.00016009483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013778079,0.00034911025,0.0029618712,0.0009488748,0.00012572786,0.000029779601,0.0002957462,0.00033675486,0.0001322459],"category_scores_gemma":[0.0009124039,0.00033114335,0.0003751323,0.0005885267,0.0001317841,0.00035868975,0.000097156924,0.00071386085,0.0000021849933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005742899,0.02338934,0.833158,0.0038343656,0.0016356377,0.0020512994,0.00799689,0.0017227693,0.00073213055,0.00033415042,0.0021749064,0.11722759],"study_design_scores_gemma":[0.008665537,0.0056106145,0.9762382,0.0042688227,0.0008535589,0.0010468883,0.00042813725,0.00003963782,0.0010953562,0.0014259078,0.00004001668,0.00028735312],"about_ca_topic_score_codex":0.0011547315,"about_ca_topic_score_gemma":0.004155418,"teacher_disagreement_score":0.14308015,"about_ca_system_score_codex":0.00028860613,"about_ca_system_score_gemma":0.0003195678,"threshold_uncertainty_score":0.99991405},"labels":[],"label_agreement":null},{"id":"W1986890987","doi":"10.1046/j.1365-2141.2003.04141.x","title":"Molecular pathology of haemophilia B in Turkish patients: identification of a large deletion and 33 independent point mutations","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Haemophilia B; Point mutation; Haplotype; Haemophilia; Haemophilia A; Mutation; Molecular pathology; Genetics; Turkish; Medicine; Mutation testing; Gene; Biology; Genotype","score_opus":0.009451106273514859,"score_gpt":0.2859079934200352,"score_spread":0.27645688714652034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986890987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968631,0.0017920303,0.00057110534,0.000320999,0.00007920383,0.00024997225,0.00001931657,0.0000023325201,0.00010189413],"genre_scores_gemma":[0.99903977,0.0004838244,0.0003855809,0.000033967422,0.0000064665383,0.000005651162,0.000019795289,0.000009529578,0.00001542918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827987,0.00031405495,0.0008450005,0.00012936376,0.00025609005,0.00017563687],"domain_scores_gemma":[0.9988263,0.000075426564,0.00040892675,0.0000989346,0.0005133316,0.00007705076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080344477,0.000074191004,0.0004922631,0.00034736947,0.00002639226,0.000006121028,0.000055989243,0.00013167529,0.00003805467],"category_scores_gemma":[0.0009176361,0.0000757943,0.00008403676,0.00018549224,0.00014341596,0.00008396229,0.000019694648,0.00022305743,0.0000013824147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006496847,0.007114211,0.81692934,0.0012229828,0.0004900785,0.06374666,0.002104139,0.00004934357,0.08208565,0.007925986,0.00046511288,0.017216807],"study_design_scores_gemma":[0.014908036,0.0016004652,0.73660207,0.000965729,0.00029185505,0.1396325,0.0012032222,0.000116581556,0.09627638,0.008051426,0.00014923896,0.00020249678],"about_ca_topic_score_codex":0.000020857671,"about_ca_topic_score_gemma":0.000037773767,"teacher_disagreement_score":0.080327265,"about_ca_system_score_codex":0.000038535556,"about_ca_system_score_gemma":0.00011043555,"threshold_uncertainty_score":0.30908018},"labels":[],"label_agreement":null},{"id":"W1987057326","doi":"10.1046/j.1365-2141.2002.03718.x","title":"Gender‐specific phenotypic expression and screening strategies in C282Y‐linked haemochromatosis: a study of 9396 French people","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Transferrin saturation; Penetrance; Medicine; Hemochromatosis; Population; Ferritin; Genotype; Internal medicine; Hereditary hemochromatosis; Family history; Logistic regression; Phlebotomy; Pediatrics; Genetics; Phenotype; Biology; Serum ferritin; Gene","score_opus":0.03018450554651474,"score_gpt":0.26423804935686257,"score_spread":0.23405354381034782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987057326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663324,0.032077875,0.00054762955,0.00010206409,0.00012675035,0.00020220847,0.0000024450403,0.000011422955,0.00059720327],"genre_scores_gemma":[0.9950428,0.002504992,0.0023068169,0.000041243744,0.000055491626,0.000005631756,0.000001696214,0.000019042342,0.000022306973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815804,0.00020287682,0.0008560134,0.00020490322,0.00031101485,0.00026717733],"domain_scores_gemma":[0.9990997,0.00008674085,0.00039442463,0.00015659814,0.0001417831,0.00012077815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029375526,0.00014853329,0.00097560097,0.00032305342,0.00006998783,0.000035743305,0.00013172721,0.00012826988,0.00028018845],"category_scores_gemma":[0.00010427338,0.00015077484,0.00007897624,0.00022969051,0.000108424596,0.00023584809,0.000052376105,0.00036848278,0.0000024047567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001383775,0.013760642,0.6671155,0.0029296894,0.0004736056,0.077698864,0.068010114,0.0003739409,0.023548223,0.0010880659,0.019793395,0.123824164],"study_design_scores_gemma":[0.018089361,0.001084155,0.8162672,0.00118881,0.00023429329,0.1014433,0.05972422,0.00015736332,0.00035174133,0.0009420028,0.00020703906,0.00031052236],"about_ca_topic_score_codex":0.00022548971,"about_ca_topic_score_gemma":0.00035546155,"teacher_disagreement_score":0.14915167,"about_ca_system_score_codex":0.000009449107,"about_ca_system_score_gemma":0.000043565185,"threshold_uncertainty_score":0.61484194},"labels":[],"label_agreement":null},{"id":"W1987137332","doi":"10.1111/bjh.13460","title":"Effect of anticoagulant therapy on cell-derived microparticles and pregnancy outcome in women with pregnancy loss","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Department of Science and Technology, Government of Kerala; Council of Scientific and Industrial Research, India; Department of Science and Technology, Ministry of Science and Technology, India; Leukemia and Lymphoma Society of Canada","keywords":"Pregnancy; Medicine; Obstetrics; Anticoagulant therapy; Outcome (game theory); Gynecology; Internal medicine; Biology","score_opus":0.022192344151698542,"score_gpt":0.27809886463494854,"score_spread":0.25590652048325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987137332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87758,0.10998427,0.000005563654,0.011486906,0.00015692807,0.00061008125,0.000021003134,0.000010907803,0.00014437744],"genre_scores_gemma":[0.97571677,0.014777213,0.00017524108,0.0089951465,0.0001302454,0.000047397163,0.0000066007046,0.00006374646,0.000087664965],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.997223,0.0005779667,0.00097257155,0.00031110496,0.00039376173,0.00052160135],"domain_scores_gemma":[0.99814117,0.00044217493,0.000848346,0.00025459315,0.00020216343,0.00011156536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042542344,0.0003698321,0.0024904797,0.0002524544,0.00004364971,0.000020484347,0.00020477691,0.0004587568,0.000017875178],"category_scores_gemma":[0.00014809644,0.00027974707,0.00012611778,0.00012453595,0.00041154024,0.00008172409,0.000058655147,0.0014672411,0.0000022227368],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006758237,0.0007733854,0.2014947,0.0129705025,0.0015021529,0.6778067,0.0038805646,0.00000398888,0.0017175544,0.000005191708,0.036243137,0.05684392],"study_design_scores_gemma":[0.061077997,0.04104683,0.07520832,0.2414627,0.001109162,0.5271816,0.00022807228,0.000004799478,0.04186009,0.0005449607,0.008775581,0.0014998592],"about_ca_topic_score_codex":0.00003501605,"about_ca_topic_score_gemma":0.000011091797,"teacher_disagreement_score":0.22849219,"about_ca_system_score_codex":0.00006181107,"about_ca_system_score_gemma":0.0001390945,"threshold_uncertainty_score":0.9999655},"labels":[],"label_agreement":null},{"id":"W1987248979","doi":"10.1046/j.1365-2141.2001.03167.x","title":"Acute event‐related anaemia","year":2001,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Iron deficiency; Medicine; Soluble transferrin receptor; Erythropoiesis; Sepsis; Rheumatoid arthritis; Ferritin; Hepcidin; Anemia; Inflammation; Immunology; Transferrin; Serum iron; Physiology; Internal medicine; Iron status","score_opus":0.025031195972559733,"score_gpt":0.3388105507021678,"score_spread":0.31377935472960805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987248979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013798624,0.9941737,0.0001531615,0.00034826965,0.00097161,0.0005557849,0.000011943532,0.000028989318,0.0036185614],"genre_scores_gemma":[0.00003234629,0.9965257,0.00036749203,0.00028811852,0.00014091264,0.00000974451,0.000039564693,0.00006100051,0.0025351248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716574,0.00020653462,0.0017024999,0.00024656157,0.00032966014,0.00034902562],"domain_scores_gemma":[0.9983064,0.00006330632,0.00094831176,0.00022928926,0.00018045526,0.0002722651],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003843519,0.00029513118,0.0037896386,0.00044348653,0.000060173417,0.000027881031,0.00028351304,0.00053149235,0.0012399558],"category_scores_gemma":[0.000069173766,0.0002748997,0.0012403505,0.00042452427,0.00009653435,0.00006212326,0.000060563838,0.0012490447,0.00012457016],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014676063,0.00016659813,0.0000019792058,0.0044471,0.0017981442,0.2660037,0.000007624988,6.278418e-8,9.12401e-8,0.00014913637,0.022410905,0.705],"study_design_scores_gemma":[0.00090767874,0.00013345107,0.0000037943398,0.017105922,0.004979821,0.46543962,0.00000754881,2.7653996e-7,2.4214677e-7,0.000049119622,0.5112689,0.000103605074],"about_ca_topic_score_codex":0.00001426407,"about_ca_topic_score_gemma":0.0000137214065,"teacher_disagreement_score":0.7048964,"about_ca_system_score_codex":0.00007190307,"about_ca_system_score_gemma":0.00034638157,"threshold_uncertainty_score":0.9999703},"labels":[],"label_agreement":null},{"id":"W1987647282","doi":"10.1111/j.1365-2141.2004.04856.x","title":"Improved survival in steroid‐refractory acute graft <i>versus</i> host disease after non‐myeloablative allogeneic transplantation using a daclizumab‐based strategy with comprehensive infection prophylaxis","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Daclizumab; Regimen; Internal medicine; Fludarabine; Transplantation; Gastroenterology; Cyclophosphamide; Surgery; Graft-versus-host disease; Busulfan; Hematopoietic stem cell transplantation; Chemotherapy; Tacrolimus","score_opus":0.02025438556785252,"score_gpt":0.2780161506530109,"score_spread":0.25776176508515836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987647282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97045636,0.00043214683,0.027884923,0.000088854074,0.00028371534,0.0007214429,0.00008260103,0.000019846402,0.000030134044],"genre_scores_gemma":[0.99704653,0.0004070392,0.0022205005,0.000107124506,0.000060633836,0.000026410948,0.0000816082,0.00004665381,0.000003498095],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99779344,0.00026770608,0.0008328219,0.00032552736,0.0004063587,0.0003741668],"domain_scores_gemma":[0.9984751,0.00016576513,0.00047621978,0.00015141616,0.00046394218,0.00026759572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021521763,0.00027749772,0.000815912,0.000368875,0.0000752726,0.000044400582,0.00008419826,0.00019588995,0.00003136495],"category_scores_gemma":[0.000028487631,0.00027630138,0.00016260103,0.00032766105,0.00020430965,0.00036697276,0.000007501036,0.00053374434,0.000002587958],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.102818914,0.0032155905,0.11577177,0.0056935083,0.0020525,0.5917737,0.0039298427,0.009787863,0.16127734,0.0000500193,0.0000099980325,0.0036189577],"study_design_scores_gemma":[0.069219984,0.0083095385,0.7010382,0.0072757397,0.002830909,0.1833441,0.0007112775,0.0012889749,0.024878241,0.00013010508,0.000021682972,0.00095123606],"about_ca_topic_score_codex":0.00063843565,"about_ca_topic_score_gemma":0.0018361658,"teacher_disagreement_score":0.5852664,"about_ca_system_score_codex":0.0002416515,"about_ca_system_score_gemma":0.0008320487,"threshold_uncertainty_score":0.99996895},"labels":[],"label_agreement":null},{"id":"W1987866391","doi":"10.1111/bjh.13081","title":"Mechanisms of plasma non‐transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institutes of Health; Georgia Clinical and Translational Science Alliance; University College London; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute for Health and Care Research","keywords":"Hepcidin; Erythropoiesis; Transferrin; Ineffective erythropoiesis; Diamond–Blackfan anemia; Transferrin receptor; Medicine; Immunology; Erythropoietin; Ferroportin; Anemia; Internal medicine; Endocrinology; Biology; Biochemistry; Gene; RNA","score_opus":0.006267389681336669,"score_gpt":0.1922002352447814,"score_spread":0.18593284556344472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987866391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927113,0.00086361216,0.005038543,0.00012092792,0.00019913349,0.00021100628,0.000007894564,0.000009390938,0.00083821063],"genre_scores_gemma":[0.99798,0.0004567037,0.0013465388,0.0000986329,0.00004553987,0.0000021187618,0.000026788377,0.0000273849,0.000016297456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856937,0.00010489868,0.00062884146,0.00020802298,0.0002778913,0.00021099373],"domain_scores_gemma":[0.9991759,0.000062720566,0.00025870564,0.00012195386,0.00018590009,0.00019483078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112292546,0.00017035566,0.0008401127,0.00011459684,0.00010649144,0.000028072289,0.00009641004,0.00023011271,0.00003271834],"category_scores_gemma":[0.000022341277,0.00015182952,0.00008893223,0.00010066944,0.00019526212,0.00012322557,0.000013657076,0.00040544593,0.0000018880015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008494379,0.009064065,0.3568301,0.0045777652,0.0033436702,0.039348997,0.022760171,0.0030250798,0.47555953,0.0043662484,0.007251493,0.06537852],"study_design_scores_gemma":[0.12657392,0.017312529,0.21773574,0.006316929,0.004096044,0.07498898,0.0037306785,0.025379775,0.51481575,0.0048627052,0.0020155327,0.0021714089],"about_ca_topic_score_codex":0.00022161295,"about_ca_topic_score_gemma":0.00060144445,"teacher_disagreement_score":0.13909435,"about_ca_system_score_codex":0.00002384498,"about_ca_system_score_gemma":0.00008218948,"threshold_uncertainty_score":0.61914283},"labels":[],"label_agreement":null},{"id":"W1988286071","doi":"10.1111/bjh.12262","title":"Gene methylation and silencing of <i><scp>SOCS</scp>3</i> in mantle cell lymphoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Mantle cell lymphoma; Cyclin D1; Gene silencing; Methylation; Biology; Cancer research; Cell culture; Cell growth; Molecular biology; Cell; Cell cycle; Lymphoma; Gene; Immunology; Genetics","score_opus":0.011381695726558061,"score_gpt":0.23899844757114042,"score_spread":0.22761675184458235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988286071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936933,0.004411536,0.0003614628,0.00014436533,0.00016371586,0.000110358575,0.0000038402895,0.0000049847763,0.0011064276],"genre_scores_gemma":[0.9969749,0.0006619039,0.0020717548,0.00012196582,0.00006341259,0.0000029040987,0.0000026072726,0.000011935659,0.000088618064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897605,0.00006418373,0.0005858377,0.00009720063,0.00012635288,0.00015039415],"domain_scores_gemma":[0.99904644,0.00020827439,0.00035960597,0.00006711665,0.00023559369,0.00008294106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022215743,0.00007343176,0.0004647357,0.00019943951,0.000029482344,0.000015900969,0.00005199236,0.000084873966,0.00007750101],"category_scores_gemma":[0.00026021223,0.000077387354,0.0000826176,0.00011121733,0.000055416178,0.00015983752,0.000022512597,0.00016357344,0.0000072407615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023002322,0.00052307633,0.011995463,0.00028282337,0.000078725505,0.005658789,0.00070633827,0.000032250467,0.94641924,0.00007444719,0.0064716055,0.027734239],"study_design_scores_gemma":[0.0034570436,0.00038665513,0.038879186,0.00079332123,0.00009337018,0.20043623,0.001111081,0.0004017444,0.7526116,0.00063290464,0.0011368693,0.000060045673],"about_ca_topic_score_codex":0.0005691409,"about_ca_topic_score_gemma":0.00004083535,"teacher_disagreement_score":0.19477744,"about_ca_system_score_codex":0.00002705741,"about_ca_system_score_gemma":0.000073257586,"threshold_uncertainty_score":0.3155765},"labels":[],"label_agreement":null},{"id":"W1988489929","doi":"10.1111/bjh.12545","title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade <scp>III</scp>–<scp>IV</scp> acute graft‐versus‐host disease","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Medicine; Refractory (planetary science); Steroid; Graft-versus-host disease; Mesenchymal stem cell; Gastroenterology; Transplantation; Internal medicine; Incidence (geometry); Cumulative incidence; Surgery; Pathology; Biology","score_opus":0.015354533651776813,"score_gpt":0.27013575938298545,"score_spread":0.25478122573120865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988489929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953278,0.0018523091,0.00008059882,0.00038707993,0.00026207994,0.0014961995,0.000060466966,0.000033769564,0.00049973297],"genre_scores_gemma":[0.99661034,0.0008075961,0.0010121918,0.00008377827,0.00018142443,0.000036320467,0.00005594698,0.00008746019,0.0011249301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944389,0.00062572566,0.0016166787,0.0005920734,0.0014690179,0.001257624],"domain_scores_gemma":[0.9939828,0.0017912537,0.0011045315,0.0005547471,0.0010316069,0.0015350756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078430114,0.00047081383,0.0016663946,0.00083194475,0.00019028489,0.00010024848,0.00068908616,0.00044036392,0.00012502026],"category_scores_gemma":[0.0037245103,0.0004235076,0.00033081058,0.0007502662,0.0005351491,0.00057351904,0.00035893783,0.0018147008,0.000033693632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015893681,0.004502431,0.6661676,0.0008439763,0.0020076865,0.083209395,0.001736711,0.00006972529,0.20363614,0.000114673865,0.03224902,0.0038732754],"study_design_scores_gemma":[0.028338525,0.004191049,0.8523306,0.002271678,0.000670346,0.06852723,0.0048168004,0.0004405427,0.03690693,0.00012661036,0.0011289789,0.00025071163],"about_ca_topic_score_codex":0.0010154414,"about_ca_topic_score_gemma":0.00016153176,"teacher_disagreement_score":0.186163,"about_ca_system_score_codex":0.00021683745,"about_ca_system_score_gemma":0.0010375242,"threshold_uncertainty_score":0.99982166},"labels":[],"label_agreement":null},{"id":"W1988589898","doi":"10.1046/j.1365-2141.2002.34771.x","title":"Prolonged complete remission in two cases of acute promyelocytic leukaemia treated with atra alone","year":2002,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pancytopenia; Acute promyelocytic leukemia; Medicine; Chemotherapy; Gastroenterology; Internal medicine; Dexamethasone; Methotrexate; Bone marrow; Bone marrow suppression; Retinoic acid; Immunology; Biology; Cell culture","score_opus":0.013459920454041294,"score_gpt":0.24868979302633576,"score_spread":0.23522987257229447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988589898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822483,0.012153005,0.000105277126,0.004638248,0.0001227125,0.00035813145,0.00007340153,0.000008282277,0.00029261434],"genre_scores_gemma":[0.9851566,0.004017658,0.0015436163,0.006951201,0.00084448163,0.000027262102,0.0004973757,0.00012238197,0.00083940086],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9972783,0.00034056557,0.0010887732,0.00045477747,0.00035665501,0.0004809627],"domain_scores_gemma":[0.9978285,0.00006355682,0.0012462493,0.00032777264,0.00044661268,0.0000873079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002501766,0.00037819133,0.0013213712,0.00020607881,0.000059703358,0.00003326786,0.00053773564,0.00078653276,0.000056011195],"category_scores_gemma":[0.0001421636,0.0003546357,0.0002350603,0.00019279729,0.00038635335,0.000011634901,0.000085572006,0.0013931752,0.0000025561606],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012602777,0.0002733445,0.0073450403,0.0018526845,0.0014305669,0.5837766,0.00007116413,0.00004955485,0.05585994,0.000003710077,0.34512895,0.0029481875],"study_design_scores_gemma":[0.004676704,0.001952032,0.00026743903,0.0025175929,0.00061422633,0.83829385,0.000026276846,0.000024139526,0.098049745,0.000055085344,0.052881002,0.00064190966],"about_ca_topic_score_codex":0.00011071887,"about_ca_topic_score_gemma":0.00006716225,"teacher_disagreement_score":0.29224795,"about_ca_system_score_codex":0.000064971304,"about_ca_system_score_gemma":0.00040251453,"threshold_uncertainty_score":0.99989057},"labels":[],"label_agreement":null},{"id":"W1988781800","doi":"10.1111/bjh.12640","title":"Subcutaneous protein C concentrate in the management of severe protein C deficiency – experience from 12 centres","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Subcutaneous injection; Protein C deficiency; Incidence (geometry); Protein C; Pediatrics; Surgery; Internal medicine; Thrombosis; Venous thrombosis","score_opus":0.015540227276811447,"score_gpt":0.2512115927190119,"score_spread":0.23567136544220044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988781800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959994,0.00087778043,0.0007025219,0.00057507504,0.00009835186,0.00052468036,0.0000034026468,0.000007326691,0.0012114547],"genre_scores_gemma":[0.9967544,0.00008141193,0.002870271,0.00019341084,0.000028152008,0.000014969001,0.0000023633754,0.000009157213,0.0000458505],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"case_report","domain_scores_codex":[0.99846494,0.00022777887,0.00060214713,0.00014506665,0.00034031144,0.00021973545],"domain_scores_gemma":[0.999255,0.000042904172,0.00037558135,0.00016477727,0.00009733743,0.000064370644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032549654,0.00009789802,0.00045726413,0.000057896814,0.000045023255,0.00002120678,0.00023507324,0.000075366384,0.0001699277],"category_scores_gemma":[0.000053698688,0.00008182156,0.000082766994,0.00012002929,0.00011019391,0.000066019216,0.000031905933,0.00020843808,0.0000050045596],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035167644,0.00807315,0.025233356,0.0032954998,0.0011322399,0.2779451,0.017547641,0.00024755608,0.13515878,0.37843415,0.0013712228,0.14804453],"study_design_scores_gemma":[0.025368012,0.005215714,0.109318845,0.018742496,0.00083107664,0.6212159,0.024687948,0.00078699953,0.12381915,0.06396984,0.004852141,0.0011918948],"about_ca_topic_score_codex":0.00012706776,"about_ca_topic_score_gemma":0.00007419339,"teacher_disagreement_score":0.34327078,"about_ca_system_score_codex":0.000017872017,"about_ca_system_score_gemma":0.000038534567,"threshold_uncertainty_score":0.33365867},"labels":[],"label_agreement":null},{"id":"W1989191461","doi":"10.1046/j.1365-2141.2000.02126.x","title":"Porcine von Willebrand factor and thrombin induce the activation of c‐Jun amino‐terminal kinase (JNK/SAPK) whereas only thrombin induces activation of extracellular signal‐related kinase 2 (ERK2) in human platelets","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"Bayer Canada; Canadian Hemophilia Society","keywords":"Platelet activation; Kinase; Thrombin; MAPK/ERK pathway; Chemistry; Cell biology; Glycoprotein Ib; p38 mitogen-activated protein kinases; Platelet; Platelet membrane glycoprotein; Thrombin receptor; Mitogen-activated protein kinase; Molecular biology; Biochemistry; Biology; Receptor; Immunology","score_opus":0.01493880839794132,"score_gpt":0.2588660599708924,"score_spread":0.2439272515729511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989191461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969276,0.0017534794,0.000010484982,0.00047559495,0.00005252827,0.00046099565,0.000013380565,0.00000917358,0.00029673864],"genre_scores_gemma":[0.9989592,0.00071356003,0.000058308095,0.000046740122,0.000024274521,0.0000046290006,0.00004311379,0.000029321203,0.00012085913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770004,0.00023598067,0.001142242,0.00025777964,0.0003673947,0.00029654335],"domain_scores_gemma":[0.9984644,0.0001793293,0.00088011683,0.00017205412,0.00018868873,0.00011542362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003162907,0.0002507881,0.0011685443,0.00030026378,0.000112889626,0.000024189701,0.0001473431,0.00032278927,0.00059383747],"category_scores_gemma":[0.000097617594,0.00021519164,0.00013073871,0.00030351998,0.00028786933,0.00040066423,0.000025186704,0.00057618227,0.0000017131396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022100192,0.0057487683,0.03972302,0.0005865222,0.0010503258,0.051673703,0.0037720401,0.000047019734,0.778303,0.00041429952,0.00048632183,0.115984924],"study_design_scores_gemma":[0.01871354,0.0029926149,0.3409709,0.0039821747,0.00040014402,0.18780176,0.00096444774,0.00009631849,0.4399147,0.0036668982,0.00009005276,0.00040643857],"about_ca_topic_score_codex":0.00070410216,"about_ca_topic_score_gemma":0.00009206905,"teacher_disagreement_score":0.33838832,"about_ca_system_score_codex":0.0000622443,"about_ca_system_score_gemma":0.00015114497,"threshold_uncertainty_score":0.87752604},"labels":[],"label_agreement":null},{"id":"W1989261711","doi":"10.1111/j.1365-2141.2009.07617.x","title":"Virchow’s triad","year":2009,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Triad (sociology); Eponym; Medicine; Presentation (obstetrics); Subject (documents); Wish; Classics; Philosophy; Psychoanalysis; History; Psychology; Surgery; Computer science; Literature; Library science","score_opus":0.016014880700962162,"score_gpt":0.2598574068674097,"score_spread":0.24384252616644755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989261711","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007250496,0.062099576,0.0033376075,0.9040531,0.00160979,0.000517862,0.000036033874,0.00007925946,0.021016303],"genre_scores_gemma":[0.013783839,0.0062496094,0.0027675834,0.96447736,0.008948333,0.0000150366905,0.00023033538,0.0001346451,0.0033932799],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9977845,0.0002090563,0.00092645147,0.00024034308,0.0004912162,0.00034843915],"domain_scores_gemma":[0.99824625,0.00015310464,0.00056593237,0.0003936661,0.0005051273,0.00013588885],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00038973172,0.00020827033,0.0016753805,0.00039964562,0.00007948359,0.00005601289,0.00027839484,0.000984492,0.0002426551],"category_scores_gemma":[0.00045224832,0.00023102484,0.0013744935,0.00019821852,0.00010799708,0.000064006585,0.000033458302,0.0034674427,0.0000917096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030591313,0.00005100302,0.000014521538,0.00007315928,0.0006358983,0.21805921,0.000009152409,0.0000014523735,0.000008913981,0.000026475303,0.7691958,0.011893857],"study_design_scores_gemma":[0.0013759764,0.000116745985,0.00037039683,0.0006235201,0.0007232105,0.5121549,0.000003669865,0.000001341106,0.000012153515,0.0005486964,0.483967,0.000102383005],"about_ca_topic_score_codex":0.000035746805,"about_ca_topic_score_gemma":0.0000041400717,"teacher_disagreement_score":0.2940957,"about_ca_system_score_codex":0.00007951187,"about_ca_system_score_gemma":0.00033515695,"threshold_uncertainty_score":0.99883157},"labels":[],"label_agreement":null},{"id":"W1989740966","doi":"10.1111/j.1365-2141.2008.07573.x","title":"Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose‐modification guideline","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Takeda Oncology","keywords":"Medicine; Bortezomib; Peripheral neuropathy; Multiple myeloma; Internal medicine; Guideline; Surgery; Gastroenterology; Oncology; Diabetes mellitus; Pathology; Endocrinology","score_opus":0.030424365386935357,"score_gpt":0.361632983993509,"score_spread":0.33120861860657363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989740966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976618,0.0005980214,0.00012813974,0.0004492089,0.000035459685,0.0010382809,0.000017969958,0.0000045694546,0.00006652959],"genre_scores_gemma":[0.9986946,0.000104626255,0.0010575881,0.000055250974,0.00004187535,0.000009117995,0.000021415895,0.000009861143,0.0000056484723],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99703836,0.00057006057,0.0014819122,0.00018392557,0.00043889717,0.0002868437],"domain_scores_gemma":[0.99824977,0.0002681076,0.0007303227,0.00028269805,0.00035240233,0.000116687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012643539,0.00014495516,0.0010150999,0.00027429906,0.000030869505,0.00001097399,0.00020748316,0.00009528508,0.000044327146],"category_scores_gemma":[0.0013177714,0.00010119422,0.00022691209,0.00039503525,0.00015550072,0.00011227504,0.000013820916,0.00038978408,5.8301276e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.525521,0.02940449,0.19602494,0.00050456944,0.00077144935,0.119610354,0.00362699,0.00044617846,0.017944548,0.000062099054,0.001974946,0.104108445],"study_design_scores_gemma":[0.38184232,0.014973159,0.5334686,0.0008189531,0.00015316036,0.06270134,0.00048827913,0.004678361,0.0005592283,0.00017266576,0.000010232956,0.0001337247],"about_ca_topic_score_codex":0.00062200316,"about_ca_topic_score_gemma":0.00026161675,"teacher_disagreement_score":0.33744365,"about_ca_system_score_codex":0.00013316848,"about_ca_system_score_gemma":0.00041624205,"threshold_uncertainty_score":0.41265807},"labels":[],"label_agreement":null},{"id":"W1990067788","doi":"10.1046/j.1365-2141.2001.03154.x","title":"Comparison of five platforms for enumeration of residual leucocytes in leucoreduced blood components","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Stichting Sanquin Bloedvoorziening","keywords":"Hemocytometer; Enumeration; Coefficient of variation; Fluorometer; Staining; Chromatography; Cell counting; Mathematics; Nuclear medicine; Pathology; Chemistry; Medicine; Fluorescence; Physics; Biochemistry; Cell","score_opus":0.03968919738181159,"score_gpt":0.33025570047647534,"score_spread":0.29056650309466375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990067788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964401,0.0024586301,0.00040232405,0.00021349239,0.00014539286,0.00025628757,0.000012477413,0.0000036016838,0.000067666355],"genre_scores_gemma":[0.9975674,0.00044910208,0.0018399501,0.000027889613,0.000060074726,0.0000033782408,0.000024270714,0.000011693256,0.000016222653],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984718,0.000030419018,0.0010231789,0.00010386004,0.00020322118,0.00016751466],"domain_scores_gemma":[0.9989334,0.00013743615,0.0005091232,0.00007572299,0.00028221324,0.00006213213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028466067,0.00008684287,0.00093197194,0.00019943943,0.000031834483,0.000005146725,0.000086672044,0.00013255357,0.000026368925],"category_scores_gemma":[0.0001223429,0.00008670809,0.00013095418,0.00011866167,0.000088545195,0.00010590748,0.000012348888,0.00022143032,3.9671443e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008919161,0.00862544,0.70303786,0.0017026123,0.0010304415,0.0126041155,0.0033496448,0.00039917382,0.23127532,0.0018597967,0.0016122964,0.025584137],"study_design_scores_gemma":[0.034028925,0.005076713,0.34201115,0.0038017565,0.00091180624,0.2000332,0.0017448646,0.0012525438,0.40830067,0.0023542345,0.00021048042,0.00027365616],"about_ca_topic_score_codex":0.00023700224,"about_ca_topic_score_gemma":0.00031549286,"teacher_disagreement_score":0.36102673,"about_ca_system_score_codex":0.000012612736,"about_ca_system_score_gemma":0.00007667484,"threshold_uncertainty_score":0.35358533},"labels":[],"label_agreement":null},{"id":"W1990147363","doi":"10.1111/bjh.12882","title":"Outcome for children and young people with <scp>E</scp>arly <scp>T</scp>‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, <scp>UKALL</scp> 2003","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Hospital for Sick Children; Leukaemia and Lymphoma Research","keywords":"Medicine; Pediatrics; Acute lymphocytic leukemia; Internal medicine; Lymphoblastic Leukemia; Leukemia","score_opus":0.012569722151836707,"score_gpt":0.26992127646455827,"score_spread":0.25735155431272155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990147363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96298355,0.0007190824,0.0035228226,0.00018505284,0.00030662323,0.02684259,0.00024018153,0.00014568411,0.005054415],"genre_scores_gemma":[0.9724774,0.00021733162,0.004926782,0.0010417417,0.00074046873,0.009412399,0.00020017632,0.00044681886,0.010536906],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9932532,0.0005903161,0.002066091,0.0010728941,0.001314416,0.0017030822],"domain_scores_gemma":[0.99054146,0.004263489,0.0016223376,0.0006565255,0.0016752456,0.0012409615],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013588351,0.00089182064,0.0029533347,0.00077359175,0.00039173957,0.00031460956,0.0007859416,0.000801657,0.00001484539],"category_scores_gemma":[0.009461771,0.0007871399,0.00039967784,0.0008451119,0.0006619713,0.0005515182,0.00021598206,0.0012750217,0.000075681295],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014848285,0.0026164805,0.35891166,0.002439456,0.0034548414,0.026556361,0.0020830045,0.000051231804,0.0018113961,0.00043735697,0.5985688,0.0015845856],"study_design_scores_gemma":[0.091920264,0.020782365,0.17603767,0.0038634972,0.0021080424,0.6694129,0.0012863469,0.0021919585,0.009078632,0.00036854585,0.022582723,0.00036706144],"about_ca_topic_score_codex":0.00032774472,"about_ca_topic_score_gemma":0.00018807192,"teacher_disagreement_score":0.64285654,"about_ca_system_score_codex":0.00063000614,"about_ca_system_score_gemma":0.00234757,"threshold_uncertainty_score":0.99945796},"labels":[],"label_agreement":null},{"id":"W1990236086","doi":"10.1111/bjh.13408","title":"A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; University of Ottawa; Vancouver General Hospital; Western University","funders":"","keywords":"Medicine; Rituximab; Refractory (planetary science); Thrombotic thrombocytopenic purpura; Thrombotic microangiopathy; ADAMTS13; Internal medicine; Surgery; Gastroenterology; Platelet; Lymphoma","score_opus":0.0456436938502634,"score_gpt":0.28647971145365597,"score_spread":0.24083601760339257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990236086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996313,0.0013569596,0.00002316555,0.000074755306,0.00043939386,0.0015061751,0.00014201619,0.000042020216,0.00010253621],"genre_scores_gemma":[0.9994078,0.000025606989,0.00015869684,0.000024018898,0.00003975981,0.00005539477,0.00006341984,0.00005007381,0.00017521116],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9964634,0.0010189413,0.0012082983,0.00042169983,0.00025921382,0.0006284332],"domain_scores_gemma":[0.99717563,0.00016951072,0.0012390408,0.00036249048,0.00088376435,0.0001695562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036551195,0.000350367,0.0014885388,0.0002994466,0.0002554795,0.00005396611,0.00048308368,0.00016161658,0.0003054667],"category_scores_gemma":[0.00024754842,0.0003041085,0.00011621205,0.00023289323,0.00028508328,0.00047908773,0.00029844203,0.00037144416,0.00001959515],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03172954,0.0827276,0.4115984,0.0011093956,0.01668354,0.35846442,0.024131577,0.00025114877,0.0066999355,0.00008838148,0.06076117,0.0057548797],"study_design_scores_gemma":[0.12765065,0.052460123,0.014492969,0.0013365673,0.0023170032,0.7763546,0.0152225075,0.000007879706,0.005438342,0.00003612639,0.0037684795,0.0009147535],"about_ca_topic_score_codex":0.00086929405,"about_ca_topic_score_gemma":0.003999364,"teacher_disagreement_score":0.4178902,"about_ca_system_score_codex":0.00010611565,"about_ca_system_score_gemma":0.00021753235,"threshold_uncertainty_score":0.9999411},"labels":[],"label_agreement":null},{"id":"W1990637676","doi":"10.1046/j.1365-2141.2003.04509.x","title":"The IgG subclasses of platelet‐associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Subclass; Autoantibody; Thrombocytopenic purpura; Medicine; Antibody; Immunology; Platelet; Polyclonal antibodies","score_opus":0.007045957135056416,"score_gpt":0.22511186464404132,"score_spread":0.2180659075089849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990637676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916558,0.0068494612,0.0000065873705,0.0001824544,0.00021577103,0.0005654237,0.000021563024,0.000027174105,0.00047575502],"genre_scores_gemma":[0.9976413,0.0020009414,0.00014869729,0.00008022789,0.000010068497,0.000010481396,0.00002267447,0.0000388124,0.000046748075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734986,0.00032068172,0.0010814054,0.00023470738,0.0004785874,0.0005347544],"domain_scores_gemma":[0.99804527,0.00014106931,0.0009509853,0.0002035852,0.00053225877,0.00012682314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005019118,0.0002599567,0.0015856886,0.00019547068,0.00019604228,0.000044962217,0.00020227821,0.00022434902,0.000023893936],"category_scores_gemma":[0.00089976395,0.00019243303,0.00016987466,0.00041834044,0.0003038595,0.00018778197,0.000032767253,0.00057406974,0.0000053623567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004052349,0.0057739443,0.7401406,0.00039963485,0.0034821585,0.22233926,0.0006137137,0.00003887256,0.00061548606,0.00051510165,0.0014703452,0.020558544],"study_design_scores_gemma":[0.042172246,0.003986694,0.840419,0.005240135,0.0003948463,0.09750516,0.00048633575,0.000039445935,0.0069817672,0.0009806039,0.0011983895,0.00059539697],"about_ca_topic_score_codex":0.00011869534,"about_ca_topic_score_gemma":0.00075414125,"teacher_disagreement_score":0.1248341,"about_ca_system_score_codex":0.00011984394,"about_ca_system_score_gemma":0.0003634823,"threshold_uncertainty_score":0.7847191},"labels":[],"label_agreement":null},{"id":"W1990750943","doi":"10.1111/j.1365-2141.2006.06209.x","title":"Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with <scp>l</scp>‐asparaginase: an <i>in vitro</i> study","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; BC Children's Hospital; Children's Hospital of Western Ontario; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; Hospital for Sick Children; Stollery Children's Hospital","funders":"AstraZeneca","keywords":"Antithrombin; Heparin; Anticoagulant; Thrombin; Low molecular weight heparin; Medicine; Direct thrombin inhibitor; Pharmacology; Immunology; Cancer research; Internal medicine; Platelet; Warfarin","score_opus":0.006391049969286977,"score_gpt":0.2547941345499197,"score_spread":0.24840308458063276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990750943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978402,0.0009862481,0.000047252073,0.000017708968,0.000040399103,0.0010167053,0.000010008712,0.000012331644,0.000029135015],"genre_scores_gemma":[0.9996523,0.000026788237,0.00022690745,0.000016963737,0.000010870641,0.000014562743,0.000013561289,0.000036214034,0.000001792015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969967,0.00076330843,0.0010401753,0.00036863127,0.0004608859,0.0003702733],"domain_scores_gemma":[0.99864054,0.0001571143,0.0006838993,0.00028101695,0.00013050201,0.000106908294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000544627,0.00028599537,0.0019446295,0.00043539237,0.000045110344,0.000028392229,0.0002139436,0.00015073134,0.0000022382333],"category_scores_gemma":[0.0000646523,0.00021038073,0.00007751784,0.0007917088,0.00029686658,0.00019629824,0.000049165228,0.00027134287,2.1563453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059119525,0.0039642774,0.8143925,0.00008920446,0.00013888742,0.004483406,0.00026472946,0.00019549658,0.17570716,0.000029710129,0.000007941245,0.00013548012],"study_design_scores_gemma":[0.012462201,0.00510447,0.6064414,0.000945496,0.00038911533,0.02682027,0.00020467443,0.0007711393,0.34674862,0.000022884622,8.1218985e-8,0.00008970338],"about_ca_topic_score_codex":0.0012578248,"about_ca_topic_score_gemma":0.0020600636,"teacher_disagreement_score":0.20795114,"about_ca_system_score_codex":0.00006357646,"about_ca_system_score_gemma":0.00017315132,"threshold_uncertainty_score":0.8579077},"labels":[],"label_agreement":null},{"id":"W1991218989","doi":"10.1111/j.1365-2141.2006.06398.x","title":"Transmission of a follicular lymphoma by allogeneic bone marrow transplantation – evidence to support the existence of lymphoma progenitor cells","year":2006,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Bone marrow; Transplantation; Cyclophosphamide; Lymph node biopsy; Chemotherapy; Pathology; Internal medicine","score_opus":0.013590459816493303,"score_gpt":0.25336617452760457,"score_spread":0.23977571471111125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991218989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86174124,0.047910653,0.0013539337,0.086585194,0.0006537635,0.0012260323,0.00031875656,0.000019552737,0.00019088804],"genre_scores_gemma":[0.8872765,0.01925111,0.0026601169,0.08800307,0.0007627822,0.00008889526,0.00035265845,0.00019995538,0.0014049384],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9963909,0.00031243195,0.0015899696,0.00032884994,0.0009181909,0.0004596944],"domain_scores_gemma":[0.99741536,0.00018837933,0.0014734062,0.00024838088,0.00053787435,0.00013659587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053083396,0.00031425062,0.0016187287,0.00022384501,0.00007607936,0.000022197699,0.00041719712,0.0007520841,0.00010036104],"category_scores_gemma":[0.00006937755,0.00027340042,0.0006618851,0.00030009952,0.00024372093,0.000112292684,0.000017166856,0.0004116634,0.000003947884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007694397,0.00031081328,0.00038440787,0.002409743,0.00040481632,0.047386765,0.00027052287,0.000012105461,0.031605694,0.000002151139,0.88917875,0.027264807],"study_design_scores_gemma":[0.019288247,0.0067537455,0.0026219415,0.021585181,0.006114281,0.4445607,0.0003876634,0.000025902067,0.19559282,0.00038777772,0.30140176,0.0012799681],"about_ca_topic_score_codex":0.00054007256,"about_ca_topic_score_gemma":0.00005219562,"teacher_disagreement_score":0.58777696,"about_ca_system_score_codex":0.00014597295,"about_ca_system_score_gemma":0.00080497866,"threshold_uncertainty_score":0.9999718},"labels":[],"label_agreement":null},{"id":"W1991637447","doi":"10.1111/bjh.12066","title":"Activation of caspases‐9, ‐3 and ‐8 in human platelets triggered by <scp>BH</scp>3‐only mimetic <scp>ABT</scp>‐737 and calcium ionophore A23187: caspase‐8 is activated via bypass of the death receptors","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; Pediatric Oncology Group; St. Michael's Hospital","funders":"","keywords":"Apoptosis; Caspase; Cell biology; Platelet activation; Chemistry; Platelet; Intrinsic apoptosis; Mitochondrion; Caspase-9; Calcium; Programmed cell death; Biochemistry; Biology; Immunology","score_opus":0.010195320994965191,"score_gpt":0.23836542512728065,"score_spread":0.22817010413231545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991637447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324656,0.0057899244,0.00034590153,0.00006300954,0.00022355637,0.00023872902,0.00003063458,0.000003052239,0.00005866518],"genre_scores_gemma":[0.9985158,0.0009405372,0.0001888909,0.000060632283,0.00007399379,0.000004279424,0.00003986719,0.000027275164,0.00014871673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831563,0.00022898772,0.000703387,0.00022945016,0.00019636055,0.00032619355],"domain_scores_gemma":[0.9985616,0.00012132912,0.00082078815,0.00017236685,0.00018952964,0.00013434746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039151922,0.00019661599,0.000559875,0.00013574204,0.000106569685,0.000018735938,0.0001575227,0.000412293,0.000008398216],"category_scores_gemma":[0.00026996783,0.00017814297,0.00011773161,0.00015442097,0.00017896052,0.00003112595,0.00009851861,0.0002471303,2.5185622e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003825491,0.0002535059,0.00676697,0.000097021955,0.00013614974,0.000063220876,0.00025384763,0.000015348583,0.9868884,0.00005545073,0.0025858458,0.0028459881],"study_design_scores_gemma":[0.001577198,0.00034735916,0.019328551,0.00019305425,0.000090498426,0.012522461,0.00034911817,0.000048367026,0.9630003,0.00021613204,0.0022584174,0.0000685161],"about_ca_topic_score_codex":0.00024312832,"about_ca_topic_score_gemma":0.000045958448,"teacher_disagreement_score":0.02388807,"about_ca_system_score_codex":0.00002340613,"about_ca_system_score_gemma":0.00007434444,"threshold_uncertainty_score":0.726446},"labels":[],"label_agreement":null},{"id":"W1992672718","doi":"10.1111/bjh.13347","title":"Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; BC Children's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Transplantation; Internal medicine; Chemotherapy; Langerhans cell histiocytosis; Refractory (planetary science); Total body irradiation; Hematopoietic stem cell transplantation; Surgery; Cytarabine; Oncology; Alemtuzumab; Stem cell; Gastroenterology; Cyclophosphamide; Disease; Biology","score_opus":0.029074524984725993,"score_gpt":0.2787062183879791,"score_spread":0.2496316934032531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992672718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890006,0.0045213844,0.0046938923,0.00023852673,0.00031366732,0.0002399621,0.00011273011,0.000012328485,0.00086686853],"genre_scores_gemma":[0.9976828,0.00018133639,0.0013345021,0.00015174426,0.000025802701,0.000008669154,0.00007429033,0.000019524065,0.0005212971],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9987486,0.0000529898,0.0006925136,0.00012538518,0.00020720558,0.00017331561],"domain_scores_gemma":[0.9986323,0.000090400965,0.00053402025,0.0000886023,0.0004905481,0.00016412292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024524017,0.000111023655,0.00074470555,0.00010057046,0.000048993636,0.000010552152,0.00007507236,0.00011714091,0.000027780956],"category_scores_gemma":[0.00005063731,0.000115872404,0.00016037362,0.00005898746,0.000094647025,0.0000918014,0.0000068067066,0.00015775827,0.000007270659],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012037678,0.016354313,0.18443517,0.019528361,0.0024877402,0.14298032,0.018309193,0.00014563026,0.02693096,0.0008346009,0.543829,0.032126993],"study_design_scores_gemma":[0.097371295,0.012809606,0.011653875,0.0052880547,0.008583993,0.6735045,0.018447362,0.00039105254,0.14032044,0.0026941781,0.027455945,0.0014797628],"about_ca_topic_score_codex":0.00007657767,"about_ca_topic_score_gemma":0.000019243518,"teacher_disagreement_score":0.53052413,"about_ca_system_score_codex":0.00009533328,"about_ca_system_score_gemma":0.00015909177,"threshold_uncertainty_score":0.47251394},"labels":[],"label_agreement":null},{"id":"W1992778934","doi":"10.1111/j.1365-2141.2008.07224.x","title":"Functional interaction between mutations in the granulocyte colony‐stimulating factor receptor in severe congenital neutropenia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; KWF Kankerbestrijding; Deakin University","keywords":"Congenital Neutropenia; Neutrophil extracellular traps; Granulocyte colony-stimulating factor; Neutropenia; Mutation; Granulocyte; Granulocyte colony-stimulating factor receptor; Neutrophil elastase; Elastase; Extracellular; Immunology; Cancer research; Biology; Medicine; Internal medicine; Genetics; Gene; Chemotherapy; Biochemistry; Inflammation; Enzyme","score_opus":0.023320976975964452,"score_gpt":0.2620051258489669,"score_spread":0.23868414887300246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992778934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983841,0.00083191297,0.000101116035,0.00020967184,0.00015960076,0.00012731958,0.000025629402,0.0000017962977,0.00015881131],"genre_scores_gemma":[0.9993279,0.00014769909,0.00020344423,0.000092999784,0.00008771649,0.0000084647645,0.00008779648,0.000009068794,0.00003490785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990837,0.00016427769,0.00037317516,0.00012595189,0.000103872706,0.00014904278],"domain_scores_gemma":[0.99957794,0.000066098335,0.0001755312,0.000063849,0.00008349078,0.00003309701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001041539,0.0000856841,0.00022296574,0.000070764865,0.00009239445,0.000018188462,0.00011009854,0.00010400296,0.000046823872],"category_scores_gemma":[0.00009894204,0.00008066859,0.000080427926,0.000093673734,0.000072257484,0.000017868837,0.000023166036,0.00021484237,0.0000067103038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003122197,0.0005029378,0.97900826,0.000014592465,0.00022650148,0.0049657654,0.0004389405,0.00053303986,0.003179054,0.000023523855,0.0033189552,0.007476237],"study_design_scores_gemma":[0.0059002563,0.0006718037,0.8924665,0.00007388968,0.000054567143,0.095555775,0.00069027103,0.000024969353,0.002341205,0.00017343486,0.0018194502,0.00022791847],"about_ca_topic_score_codex":0.00014325623,"about_ca_topic_score_gemma":0.0007605623,"teacher_disagreement_score":0.09059001,"about_ca_system_score_codex":0.000018096407,"about_ca_system_score_gemma":0.0000735316,"threshold_uncertainty_score":0.32895696},"labels":[],"label_agreement":null},{"id":"W1992881313","doi":"10.1111/j.1365-2141.2008.07467.x","title":"CP‐4055 and CP‐4126 are active in ara‐C and gemcitabine‐resistant lymphoma cell lines","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Chemistry; Nucleoside; Cell culture; Nucleoside analogue; Pharmacology; Biochemistry; Cancer research; Cancer; Biology; Medicine; Internal medicine","score_opus":0.01039855139209381,"score_gpt":0.22326354454984726,"score_spread":0.21286499315775345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992881313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8194102,0.029038524,0.0000048442453,0.15014839,0.0002982673,0.0003547472,0.000056566532,0.000015979373,0.00067250436],"genre_scores_gemma":[0.62304395,0.124943994,0.00834923,0.20299545,0.0052709933,0.0001292861,0.00057270646,0.0005317067,0.034162648],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99753195,0.00017360308,0.0009822238,0.00042068565,0.00038760144,0.0005039328],"domain_scores_gemma":[0.9983553,0.0002552472,0.0007849408,0.00015883484,0.00025984447,0.00018579997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016647704,0.00041635285,0.001952767,0.0005742263,0.0001057952,0.0000466933,0.00013457114,0.0007411099,0.000058559537],"category_scores_gemma":[0.00014189036,0.0004044116,0.00017438142,0.0001592143,0.0002896243,0.0001266454,0.0000823237,0.0010844489,0.000010733581],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002917789,0.00021642182,0.006643669,0.0005507532,0.0003156487,0.5322686,0.00032506863,1.1591437e-7,0.000033638644,0.000001867471,0.45439827,0.004954177],"study_design_scores_gemma":[0.009503037,0.00029788283,0.038106054,0.0035096172,0.0004696451,0.6770475,0.00035661465,0.0000031933532,0.000583922,0.00015006203,0.2694789,0.0004935993],"about_ca_topic_score_codex":0.0000688142,"about_ca_topic_score_gemma":0.00016562219,"teacher_disagreement_score":0.19636619,"about_ca_system_score_codex":0.00015758119,"about_ca_system_score_gemma":0.00035872182,"threshold_uncertainty_score":0.9998408},"labels":[],"label_agreement":null},{"id":"W1992979998","doi":"10.1111/bjh.12325","title":"D(T)<scp>PACE</scp> as salvage therapy for aggressive or refractory multiple myeloma","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Salvage therapy; Internal medicine; Regimen; Etoposide; Multiple myeloma; Surgery; Refractory (planetary science); Hematopoietic stem cell transplantation; Dexamethasone; Cohort; Autologous stem-cell transplantation; Transplantation; Oncology; Chemotherapy","score_opus":0.02862974617409571,"score_gpt":0.31976015781796086,"score_spread":0.29113041164386516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992979998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856213,0.011079118,0.00021593919,0.00077898975,0.0002967323,0.0012352098,0.000032017673,0.000031678752,0.0007090244],"genre_scores_gemma":[0.9865559,0.004744713,0.0047745076,0.0006998425,0.00032234137,0.0001428067,0.000029716382,0.000064573294,0.0026656056],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9977685,0.00017749856,0.0006814652,0.00027132404,0.00043724207,0.000663964],"domain_scores_gemma":[0.9962309,0.0013998253,0.0007323481,0.00023614679,0.00085283414,0.000547941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002794253,0.0002282434,0.00095446134,0.00023229452,0.00017069573,0.00008282474,0.00024176504,0.00023270282,0.00052504614],"category_scores_gemma":[0.0051234104,0.00018114744,0.00032433323,0.0001423015,0.00021280163,0.00029542902,0.00004720588,0.00047194157,0.00017855372],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030187469,0.0027142644,0.04145301,0.00040019688,0.0024727678,0.24489985,0.00067482935,0.0000020724976,0.010296477,0.00009084567,0.25075498,0.44322196],"study_design_scores_gemma":[0.03778083,0.008552089,0.14553073,0.0015096738,0.00017269133,0.70453185,0.0012804592,0.000207298,0.016558673,0.0013089394,0.08235123,0.00021552457],"about_ca_topic_score_codex":0.00024333574,"about_ca_topic_score_gemma":0.000087454115,"teacher_disagreement_score":0.459632,"about_ca_system_score_codex":0.00008583041,"about_ca_system_score_gemma":0.0004241892,"threshold_uncertainty_score":0.7386978},"labels":[],"label_agreement":null},{"id":"W1993428041","doi":"10.1111/j.1365-2141.2005.05646.x","title":"Rapid and specific detection of clinically significant haemoglobinopathies using electrospray mass spectrometry–mass spectrometry","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Mass spectrometry; False positive paradox; Population; Sickle cell trait; Medicine; Newborn screening; Disease; Biology; Genetics; Chemistry; Internal medicine; Chromatography; Computer science","score_opus":0.01470429998857489,"score_gpt":0.2591213296336968,"score_spread":0.24441702964512188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993428041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94615686,0.030611405,0.021119691,0.0007852375,0.00042496636,0.00026660715,0.000008503157,0.000030290035,0.0005964188],"genre_scores_gemma":[0.9369742,0.022719169,0.03970369,0.0001558054,0.00035818256,0.000001348498,0.000002428026,0.000046144818,0.000038977323],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9963567,0.0002464336,0.0019642694,0.00036054777,0.00047995875,0.0005920829],"domain_scores_gemma":[0.99765396,0.00021639268,0.0011835861,0.00023516931,0.00040249643,0.00030837982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012421791,0.00027269564,0.0014799109,0.00066875684,0.00014587172,0.000050965376,0.00018812506,0.000432185,0.00020910345],"category_scores_gemma":[0.0005171869,0.00027518973,0.00036304464,0.0006830313,0.0004970596,0.00020836398,0.000037494417,0.0011741343,0.000008234236],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097063236,0.00047670194,0.005922926,0.00024097289,0.00045094956,0.011785678,0.00011496134,0.00003093033,0.93570167,0.00019539174,0.00039696874,0.0437122],"study_design_scores_gemma":[0.009860977,0.006527085,0.014106472,0.001485613,0.000945954,0.66176987,0.001507517,0.0007252054,0.29572448,0.0019028629,0.0046752696,0.0007686953],"about_ca_topic_score_codex":0.000026478885,"about_ca_topic_score_gemma":0.000006636828,"teacher_disagreement_score":0.6499842,"about_ca_system_score_codex":0.0001546011,"about_ca_system_score_gemma":0.00022288441,"threshold_uncertainty_score":0.99997},"labels":[],"label_agreement":null},{"id":"W1993803161","doi":"10.1046/j.1365-2141.2003.04236.x","title":"The impact of Asian descent on the incidence of acquired severe aplastic anaemia in children","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; BC Children's Hospital","funders":"","keywords":"Incidence (geometry); Descent (aeronautics); Medicine; African descent; Demography; Population; Ethnic group; Pediatrics; Geography; Environmental health; History; Genealogy","score_opus":0.011143643491276363,"score_gpt":0.269209780094355,"score_spread":0.2580661366030786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993803161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770117,0.00093881215,0.00018966192,0.00023539412,0.00007215017,0.00025199415,0.0000065526774,0.0000023521181,0.0006019022],"genre_scores_gemma":[0.99925184,0.00051407825,0.00016433255,0.00003380826,0.000013457614,0.0000022067545,0.0000013364112,0.000010834406,0.000008079603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983042,0.00036727384,0.00075457775,0.00009004717,0.00028077542,0.00020311784],"domain_scores_gemma":[0.9984921,0.0006285259,0.0004888639,0.00015623348,0.00016293472,0.00007129155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086216,0.00009751151,0.00050670764,0.00009827013,0.00004623355,0.000008690597,0.00017300455,0.000089761816,0.00008380554],"category_scores_gemma":[0.00091443333,0.00006226113,0.00015878813,0.00019623086,0.00019336499,0.0000433587,0.000008180284,0.00018808857,0.0000028315674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010121516,0.0006361855,0.97377074,0.00028761433,0.00060190796,0.0076889494,0.0012368143,0.00033280515,0.003748459,0.0030629835,0.0014952172,0.0061261468],"study_design_scores_gemma":[0.0017419603,0.0005354251,0.68392295,0.0018274762,0.00008811393,0.3034933,0.0003270727,0.00002994881,0.0074040038,0.0005580538,0.0000053117897,0.00006640307],"about_ca_topic_score_codex":0.00012209616,"about_ca_topic_score_gemma":0.00006323552,"teacher_disagreement_score":0.29580435,"about_ca_system_score_codex":0.000060781993,"about_ca_system_score_gemma":0.0002817957,"threshold_uncertainty_score":0.25389352},"labels":[],"label_agreement":null},{"id":"W1994137642","doi":"10.1111/j.1365-2141.2007.06608.x","title":"Leukaemia‐related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman–Diamond syndrome","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Population Health Research Institute; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Bone marrow; Haematopoiesis; Cytopenia; Bone marrow failure; Cancer research; Myelodysplastic syndromes; Peripheral blood mononuclear cell; Leukemia; Biology; Myeloid; Carcinogenesis; Telomerase; Gene; Immunology; Pathology; Medicine; Stem cell; Genetics","score_opus":0.0023769683668472654,"score_gpt":0.18630519264697545,"score_spread":0.1839282242801282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994137642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652357,0.012562168,0.00033708307,0.00007713548,0.0001616093,0.00020978895,0.000031192274,0.000004242414,0.0000932385],"genre_scores_gemma":[0.99852115,0.00047430632,0.0006576539,0.0001185106,0.000025825115,0.0000056205786,0.000096776974,0.000030082156,0.000070071306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857247,0.00011128622,0.00051420956,0.00026038536,0.00019952867,0.00034214547],"domain_scores_gemma":[0.9991799,0.000043032203,0.00037199556,0.00020080185,0.00010682194,0.00009742339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021248948,0.00018025198,0.00038966472,0.00007174196,0.0000878367,0.000025141355,0.00024685913,0.00025027213,0.000041663745],"category_scores_gemma":[0.000030145766,0.00014060232,0.0001051756,0.00011600696,0.0001349126,0.000015353698,0.000081615726,0.00028144033,0.000005896389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022072664,0.004029727,0.7873237,0.000068271314,0.0010525468,0.045328006,0.00040317696,0.0004013366,0.119878724,0.000018803283,0.009655447,0.029633002],"study_design_scores_gemma":[0.031367995,0.0031662916,0.578374,0.0007755737,0.00041946844,0.06058659,0.00067480915,0.000016365799,0.31733844,0.0009904075,0.005086844,0.0012031804],"about_ca_topic_score_codex":0.00013904777,"about_ca_topic_score_gemma":0.00079079694,"teacher_disagreement_score":0.20894966,"about_ca_system_score_codex":0.000019059065,"about_ca_system_score_gemma":0.00005607953,"threshold_uncertainty_score":0.5733596},"labels":[],"label_agreement":null},{"id":"W1994681393","doi":"10.1111/j.1365-2141.2007.06777.x","title":"Picogram doses of lipopolysaccharide exacerbate antibody‐mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"Université Laval","keywords":"Antibody; In vivo; Immunology; Lipopolysaccharide; Medicine; Exacerbation; Platelet; Immune thrombocytopenia; Immune system; Thrombocytopenic purpura; Biology","score_opus":0.014394297593551885,"score_gpt":0.3026471258258413,"score_spread":0.2882528282322894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994681393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751577,0.02388833,0.000052689444,0.00039760067,0.00011898446,0.00026138194,0.0000068410845,0.0000050481326,0.00011142042],"genre_scores_gemma":[0.99410146,0.0054744063,0.00027188275,0.000100312755,0.000020607587,9.255042e-7,0.0000059217236,0.000015167772,0.00000930668],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984394,0.00010077294,0.00087402156,0.00012909491,0.00018903668,0.00026769706],"domain_scores_gemma":[0.9986822,0.00040955166,0.00056251854,0.00012116163,0.000152959,0.00007161424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005614541,0.00012829294,0.0010197512,0.00016126598,0.00004074781,0.000011239615,0.00015379628,0.00012446899,0.000029978848],"category_scores_gemma":[0.00020049505,0.00010091094,0.00010602145,0.00019722892,0.000352066,0.00006634526,0.000034435332,0.00031751898,0.000001526468],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066239443,0.0063945325,0.07471981,0.0006237883,0.0026349416,0.16179019,0.0038127457,0.000012635976,0.48835668,0.0005530458,0.00019543286,0.25428227],"study_design_scores_gemma":[0.013085075,0.0017028077,0.49152768,0.0013080803,0.00046064766,0.42254567,0.0014125672,0.000016102982,0.066853926,0.0007448133,0.00015501725,0.00018761017],"about_ca_topic_score_codex":0.0006421558,"about_ca_topic_score_gemma":0.0002111406,"teacher_disagreement_score":0.42150274,"about_ca_system_score_codex":0.000022145325,"about_ca_system_score_gemma":0.0001140662,"threshold_uncertainty_score":0.4115029},"labels":[],"label_agreement":null},{"id":"W1994818750","doi":"10.1046/j.1365-2141.2000.02162.x","title":"Lymphocyte function antigen 1 (LFA‐1) mediates early tumour necrosis factor α‐induced leucocyte adhesion in venules","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Intravital microscopy; Cell adhesion molecule; CD18; Tumor necrosis factor alpha; CD11a; Lymphocyte function-associated antigen 1; Cremaster muscle; Lymphocyte; High endothelial venules; Microcirculation; Biology; Necrosis; Adhesion; Immunology; Pathology; Chemistry; Intercellular Adhesion Molecule-1; Medicine; Flow cytometry; Integrin alpha M; Internal medicine","score_opus":0.022703635694187815,"score_gpt":0.2806299941961842,"score_spread":0.25792635850199636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994818750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340695,0.0052443813,0.000017351733,0.00045196374,0.0002498889,0.00023962512,0.000007625801,0.000023704557,0.00035847927],"genre_scores_gemma":[0.9941641,0.004818985,0.00024172157,0.00020155292,0.00017010991,0.0000068483123,0.000009832985,0.00004529569,0.00034155924],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99737006,0.00028721112,0.0009031659,0.00028933046,0.0006231229,0.00052710064],"domain_scores_gemma":[0.9987763,0.00017207318,0.00027582643,0.0001853097,0.00027087505,0.00031961332],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042711393,0.00019348772,0.0008702293,0.000456457,0.000096890915,0.00006498116,0.00023514632,0.00026807637,0.0018957217],"category_scores_gemma":[0.00036452807,0.00020519827,0.00023751639,0.00037504674,0.000114926086,0.00022582346,0.000048017093,0.00065892615,0.00025011768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004628215,0.0008940193,0.07158856,0.00029246014,0.00024023622,0.13865511,0.000695997,0.000020233705,0.4437654,0.000018067998,0.0027888524,0.33641285],"study_design_scores_gemma":[0.006975482,0.0016373013,0.7781945,0.0012218073,0.00008183866,0.123134986,0.000117768075,0.00010424145,0.08393414,0.00029507084,0.0040001287,0.00030272178],"about_ca_topic_score_codex":0.0004887374,"about_ca_topic_score_gemma":0.00013470415,"teacher_disagreement_score":0.706606,"about_ca_system_score_codex":0.0001896514,"about_ca_system_score_gemma":0.00037473213,"threshold_uncertainty_score":0.9990167},"labels":[],"label_agreement":null},{"id":"W1994943036","doi":"10.1111/j.1365-2141.2006.06097.x","title":"Long‐term results of an ultra low‐dose cytarabine‐based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Children's Hospital of Michigan; BC Children's Hospital; McMaster University","keywords":"Cytarabine; Medicine; Acute megakaryoblastic leukemia; Chemotherapy; Vincristine; Regimen; Internal medicine; Oncology; Cyclophosphamide; Leukemia","score_opus":0.009147530093686669,"score_gpt":0.26980514214674023,"score_spread":0.26065761205305354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994943036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996268,0.0010586458,0.00081904384,0.00046938655,0.000055600216,0.0010491479,0.00019756015,0.000009943687,0.00007271396],"genre_scores_gemma":[0.99779254,0.00033786963,0.0015053755,0.00004090017,0.00008081875,0.000035193483,0.00009369527,0.000036098354,0.000077533514],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99732596,0.00015440409,0.0012431055,0.00028850252,0.0005173357,0.00047069445],"domain_scores_gemma":[0.99751526,0.0007213827,0.0007909707,0.00039392887,0.00041850872,0.00015997021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004432349,0.00023559936,0.0012640404,0.00033511582,0.000059844566,0.000019192854,0.00034054078,0.00018222167,0.000018769098],"category_scores_gemma":[0.000139883,0.00016465064,0.00022592276,0.00031500604,0.0005080742,0.00013488712,0.000010870466,0.0002531128,0.0000011824947],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13444278,0.027757848,0.31325987,0.0023101447,0.014136,0.417828,0.0014111731,0.008811561,0.02599617,0.00030691572,0.0079740435,0.04576551],"study_design_scores_gemma":[0.044240236,0.011536168,0.49489322,0.0012565489,0.0009906609,0.4283116,0.00003578109,0.00068542967,0.017799616,0.00006600994,0.000014526373,0.00017021527],"about_ca_topic_score_codex":0.0010928271,"about_ca_topic_score_gemma":0.00044343885,"teacher_disagreement_score":0.18163335,"about_ca_system_score_codex":0.00041140622,"about_ca_system_score_gemma":0.001074118,"threshold_uncertainty_score":0.6714258},"labels":[],"label_agreement":null},{"id":"W1995739599","doi":"10.1111/j.1365-2141.2005.05761.x","title":"Haemolytic uraemic syndrome is an immune‐mediated disease: role of anti‐CD36 antibodies","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Western University; Children's Hospital of Eastern Ontario; Ottawa Hospital","funders":"","keywords":"Antibody; CD36; Platelet; Pathogenesis; Monoclonal antibody; Western blot; Immune system; Antigen; Biology; Immune complex; Immunology; Chemistry; Molecular biology; Receptor; Biochemistry","score_opus":0.010795721815098937,"score_gpt":0.2481235718067625,"score_spread":0.23732784999166356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995739599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90348613,0.095037065,0.000019837928,0.00037504671,0.00047638456,0.00021252356,0.00026999824,0.000037632577,0.00008538223],"genre_scores_gemma":[0.9984376,0.0009954687,0.00010893073,0.00014046537,0.000046946992,0.000006104347,0.000100502315,0.000032344797,0.00013165356],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99715185,0.000467079,0.0014653542,0.00028024122,0.00012532882,0.0005101617],"domain_scores_gemma":[0.99791706,0.00022373912,0.0010341126,0.0003668604,0.00033786913,0.00012033869],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038828643,0.0002427048,0.0012324027,0.00031419523,0.0001599048,0.000027746948,0.00066775194,0.00019428912,0.0019803073],"category_scores_gemma":[0.00029330465,0.00026480018,0.0003371523,0.00015960446,0.00046428834,0.0003645601,0.00013696017,0.0003508466,0.0002465915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018405752,0.006305803,0.3578257,0.0014145381,0.0054121325,0.048317466,0.0023665265,0.0001615454,0.47972834,0.0018187532,0.06719539,0.027613238],"study_design_scores_gemma":[0.0058166133,0.00075881777,0.39030254,0.0021007797,0.0007610193,0.54632163,0.0016065807,0.00006256461,0.029447898,0.0011578335,0.020876888,0.00078685966],"about_ca_topic_score_codex":0.000113649716,"about_ca_topic_score_gemma":0.00004018734,"teacher_disagreement_score":0.49800414,"about_ca_system_score_codex":0.00004494514,"about_ca_system_score_gemma":0.00020757454,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W1996289772","doi":"10.1111/bjh.13372","title":"Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents","year":2015,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hodgkin lymphoma; Radiation therapy; Clinical trial; Lymphoma; Intensive care medicine; Oncology; Pediatrics; Internal medicine","score_opus":0.045654852384713486,"score_gpt":0.3155238752040581,"score_spread":0.2698690228193446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996289772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.103923574,0.89495754,0.000001981789,0.000024874664,0.00010674847,0.0008962026,0.00003322614,0.0000020464997,0.00005381895],"genre_scores_gemma":[0.05236366,0.94733745,0.00014574578,0.000012336358,0.000050311784,0.000041790478,0.000026532736,0.00002009543,0.0000020832051],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9974431,0.0005108178,0.0012084866,0.00024374404,0.0003430502,0.0002508366],"domain_scores_gemma":[0.99857706,0.0000624552,0.0009972715,0.00020956888,0.000054305918,0.00009931621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093479204,0.0002594922,0.0024624541,0.00031889402,0.000020547184,0.000022222732,0.00025832056,0.00017771276,0.0000039268443],"category_scores_gemma":[0.000034542125,0.00018304405,0.000307859,0.00024197203,0.00011815614,0.000043797114,0.0000949203,0.00032799994,0.0000033650288],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028366601,0.001755115,0.03618501,0.009585867,0.00044491034,0.013056507,0.00007448398,2.95817e-7,5.472078e-10,0.000048861788,0.0003625273,0.938458],"study_design_scores_gemma":[0.010250563,0.00033118945,0.33174697,0.18260029,0.0034720248,0.42865193,0.00014241386,0.0000023624443,3.227567e-7,0.0001659298,0.04237184,0.00026416584],"about_ca_topic_score_codex":0.00009897865,"about_ca_topic_score_gemma":0.000034552824,"teacher_disagreement_score":0.93819386,"about_ca_system_score_codex":0.00022219669,"about_ca_system_score_gemma":0.0002884037,"threshold_uncertainty_score":0.74643195},"labels":[],"label_agreement":null},{"id":"W1996399705","doi":"10.1046/j.1365-2141.2003.04271.x","title":"Platelets may inhibit leucotriene biosynthesis by human neutrophils at the integrin level","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Platelet; Chemistry; Biochemistry; Lipoxygenase; Arachidonate 5-lipoxygenase; Leukotriene B4; Arachidonic acid; Integrin; Platelet activation; Chemotaxis; Metabolite; Inflammation; Immunology; Biology; Enzyme; Receptor","score_opus":0.017597820731875328,"score_gpt":0.23742325087976054,"score_spread":0.21982543014788522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996399705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788135,0.018101277,0.00011748795,0.0012506483,0.0006439683,0.00012820026,0.000018923974,0.000015414184,0.0009105399],"genre_scores_gemma":[0.9952673,0.00086194027,0.000037337086,0.00024075857,0.000025220479,0.000005621531,0.000020535797,0.000021752083,0.0035195411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975186,0.0009894735,0.0008441628,0.00017682373,0.0000651206,0.0004058071],"domain_scores_gemma":[0.9986808,0.0003399011,0.0005752911,0.00020483206,0.00016836044,0.000030870102],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009167048,0.00017823138,0.0005716735,0.00013953303,0.00047534943,0.000036337355,0.0003288029,0.00034987292,0.0015007737],"category_scores_gemma":[0.0004687114,0.00014711282,0.00020562866,0.00012672102,0.00040972876,0.00016054197,0.00006693397,0.0006161702,0.00031717846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026318867,0.00014359222,0.00028345687,0.000019371158,0.00032984035,0.0027592587,0.00020905731,0.0000033441686,0.88621175,0.0025306966,0.09828379,0.008962667],"study_design_scores_gemma":[0.0010970904,0.00015113028,0.00064931036,0.0000960348,0.000048442438,0.20716509,0.00015527196,1.15885605e-7,0.6230074,0.00028259453,0.1672112,0.0001362978],"about_ca_topic_score_codex":0.00008472203,"about_ca_topic_score_gemma":0.00006065489,"teacher_disagreement_score":0.2632043,"about_ca_system_score_codex":0.00007318587,"about_ca_system_score_gemma":0.00008147332,"threshold_uncertainty_score":0.999412},"labels":[],"label_agreement":null},{"id":"W1996671618","doi":"10.1111/j.1365-2141.2009.07942.x","title":"Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R‐CHOP)","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Fidelity Foundation","keywords":"International Prognostic Index; Vincristine; Lymphoma; CHOP; Medicine; Internal medicine; Univariate analysis; Diffuse large B-cell lymphoma; Autocrine signalling; Cyclophosphamide; Chemotherapy; Oncology; Rituximab; Vascular endothelial growth factor; Cancer research; Pathology; VEGF receptors; Receptor; Multivariate analysis","score_opus":0.004486132184889379,"score_gpt":0.22257870626120538,"score_spread":0.218092574076316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996671618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97974217,0.018470801,0.000035399706,0.00025656982,0.00011542923,0.00036657974,0.0000509722,0.00005091892,0.0009111308],"genre_scores_gemma":[0.9958898,0.0025802716,0.0005174822,0.00042147486,0.00006870041,0.000020268719,0.00007749482,0.000056864523,0.0003676413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972364,0.00017644111,0.0009937878,0.00042138222,0.0004947627,0.00067726924],"domain_scores_gemma":[0.9982846,0.00012555855,0.0006765735,0.00035061024,0.0002525048,0.0003101959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021494406,0.00041821055,0.0012900794,0.00018641459,0.00012393274,0.00006155622,0.00027467075,0.00037501723,0.00009349144],"category_scores_gemma":[0.000052159965,0.00037563735,0.0002586128,0.00022663352,0.00010222676,0.00017965888,0.000034146226,0.00021982809,0.0000088209235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0096748555,0.063027814,0.046205528,0.0003259427,0.0004249839,0.14134379,0.0005968273,0.0000031475806,0.70432186,0.000007259044,0.0116221,0.02244588],"study_design_scores_gemma":[0.16112891,0.0026286342,0.13447146,0.0017150389,0.0002495935,0.09055218,0.00017921606,0.00003634312,0.60740733,0.000034232373,0.00110793,0.0004891179],"about_ca_topic_score_codex":0.00021916935,"about_ca_topic_score_gemma":0.000012983088,"teacher_disagreement_score":0.15145406,"about_ca_system_score_codex":0.0006225643,"about_ca_system_score_gemma":0.00043756576,"threshold_uncertainty_score":0.9998696},"labels":[],"label_agreement":null},{"id":"W1996885889","doi":"10.1111/j.1365-2141.2005.05418.x","title":"Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McMaster University; London Health Sciences Centre; Canadian Blood Services; Health Sciences Centre; Ottawa Hospital; University Health Network; Dalhousie University; University of Ottawa","funders":"Canadian Institutes of Health Research; Bayer Canada","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Von Willebrand factor; Platelet; Internal medicine; Fresh frozen plasma; Gastroenterology; Protease; Prospective cohort study; Immunology; Surgery; Enzyme; Chemistry","score_opus":0.014143581743104523,"score_gpt":0.26736600149495676,"score_spread":0.2532224197518522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996885889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881306,0.005428516,0.000026632135,0.0009980405,0.0044052023,0.00034758277,0.00011242145,0.00003249864,0.00051850494],"genre_scores_gemma":[0.99812984,0.0003456267,0.00033117714,0.00028550625,0.00014444956,0.0000151801605,0.000021553678,0.000032018394,0.00069466286],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99676967,0.00045360666,0.001681163,0.00033845598,0.000112505426,0.0006446133],"domain_scores_gemma":[0.9984415,0.00032642306,0.00062304386,0.00030737242,0.00023253643,0.000069098016],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005896599,0.00026044867,0.0013289398,0.00024383352,0.00012606492,0.000054638844,0.00073859096,0.0002670586,0.0044434355],"category_scores_gemma":[0.00045608854,0.00020850159,0.00027536918,0.0001248869,0.00028863005,0.0003942467,0.00018833744,0.0006532585,0.00084548804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018590944,0.004741907,0.5615574,0.00096338976,0.0030882002,0.06595163,0.0014716876,0.00015193915,0.18474439,0.005432408,0.13184033,0.038197603],"study_design_scores_gemma":[0.028341014,0.0017014417,0.21591717,0.002479437,0.00065112027,0.5253027,0.0023815515,0.000079078585,0.03350207,0.0019930946,0.18560849,0.0020428037],"about_ca_topic_score_codex":0.00016858372,"about_ca_topic_score_gemma":0.0011960141,"teacher_disagreement_score":0.4593511,"about_ca_system_score_codex":0.00014463674,"about_ca_system_score_gemma":0.0001440453,"threshold_uncertainty_score":0.99993247},"labels":[],"label_agreement":null},{"id":"W1998101000","doi":"10.1046/j.1365-2141.2002.03778.x","title":"Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B‐cell lymphoma*","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Pure red cell aplasia; Rituximab; Medicine; Parvovirus; CHOP; Prednisone; Lymphoma; Cyclophosphamide; Vincristine; Non-Hodgkin's lymphoma; Immunology; Gastroenterology; Chemotherapy; Bone marrow; Internal medicine; Virus","score_opus":0.020000952522845467,"score_gpt":0.257714748392153,"score_spread":0.23771379586930755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998101000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834748,0.011481118,0.00068700407,0.0011512403,0.00028831928,0.0005242709,0.000014286572,0.000028975011,0.0023499893],"genre_scores_gemma":[0.99333465,0.0012886851,0.0038235348,0.00047052983,0.00014086426,0.000056412762,0.0000017564416,0.000038404472,0.000845181],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9985912,0.00006288714,0.0005258354,0.00024810032,0.00020328279,0.00036868957],"domain_scores_gemma":[0.9989598,0.0001758616,0.00027723235,0.00013330406,0.00018765763,0.00026616998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015929052,0.00021190286,0.0011314852,0.00019561942,0.0001926882,0.00004160503,0.000069363945,0.00012344548,0.000058014706],"category_scores_gemma":[0.00009758064,0.00019066529,0.00021024216,0.00015277772,0.000076994016,0.000113247785,0.000026867983,0.00011726761,0.000051851013],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004505053,0.014577577,0.05093512,0.0012957418,0.003474136,0.49149814,0.0039267913,0.000023601466,0.007003088,0.00008741787,0.24805936,0.17461395],"study_design_scores_gemma":[0.06314056,0.0036130885,0.0040462725,0.0006574818,0.0011752094,0.81091946,0.00065684866,0.000050941402,0.011591614,0.00009914926,0.103599824,0.0004495584],"about_ca_topic_score_codex":0.000043751315,"about_ca_topic_score_gemma":0.0001190989,"teacher_disagreement_score":0.3194213,"about_ca_system_score_codex":0.00012941305,"about_ca_system_score_gemma":0.000060451555,"threshold_uncertainty_score":0.7775105},"labels":[],"label_agreement":null},{"id":"W1998104145","doi":"10.1111/j.1365-2141.2008.07317.x","title":"Treating TTP/HUS with plasma exchange: a single centre’s 25‐year experience","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Thrombotic microangiopathy; Internal medicine; Pediatrics; Retrospective cohort study; Mortality rate; Cohort; Disease; Platelet","score_opus":0.02106473146596851,"score_gpt":0.2333997671468564,"score_spread":0.21233503568088788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998104145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027944,0.0073945755,0.0001088795,0.00013801467,0.0005212018,0.00015608755,0.000025557114,0.00003747244,0.0013387996],"genre_scores_gemma":[0.99833894,0.00014335006,0.00044152085,0.00006527012,0.00006272712,0.000009138153,0.000013156701,0.000022247537,0.00090364204],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982889,0.00031232426,0.0006308318,0.00022647412,0.000089641966,0.00045177352],"domain_scores_gemma":[0.99880725,0.00019474741,0.00054441195,0.00017258202,0.00021606668,0.00006492786],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013417122,0.00017195423,0.0006343194,0.00013485856,0.00028182162,0.00002138708,0.00032113944,0.00012579652,0.002168719],"category_scores_gemma":[0.00019810308,0.00016871456,0.0001250577,0.0001285373,0.00039475443,0.00016746874,0.00007622427,0.00024886793,0.00013362309],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002863705,0.00415001,0.38271865,0.00058054,0.0022684021,0.24638718,0.018585851,0.000052630756,0.06187125,0.0011118236,0.25498322,0.024426747],"study_design_scores_gemma":[0.006387921,0.00086084806,0.009807317,0.0010576306,0.00011421037,0.93089384,0.004489263,0.0000034990073,0.017984118,0.00004198724,0.027955072,0.00040428876],"about_ca_topic_score_codex":0.00007651188,"about_ca_topic_score_gemma":0.00023092932,"teacher_disagreement_score":0.68450665,"about_ca_system_score_codex":0.00005394521,"about_ca_system_score_gemma":0.00010022231,"threshold_uncertainty_score":0.9987434},"labels":[],"label_agreement":null},{"id":"W1998297722","doi":"10.1111/j.1365-2141.2008.07409.x","title":"High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Neutropenia; Refractory (planetary science); Discontinuation; Internal medicine; Adverse effect; Gastroenterology; Progressive disease; Peripheral neuropathy; Surgery; Toxicity; Chemotherapy; Endocrinology","score_opus":0.03682708077172939,"score_gpt":0.3573689208051373,"score_spread":0.3205418400334079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998297722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971184,0.00016862754,0.00009683376,0.0003418451,0.00007276825,0.001976234,0.00016792967,0.00003391431,0.000023419101],"genre_scores_gemma":[0.9832666,0.000107282875,0.016193429,0.000097962016,0.000033230983,0.00008630593,0.000044151617,0.000043885255,0.00012714478],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99601233,0.0008672127,0.0012200831,0.00044355448,0.0007910706,0.00066573784],"domain_scores_gemma":[0.99647623,0.00069804315,0.000811182,0.00037657074,0.0010042614,0.00063373323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000907905,0.0003091929,0.0016065709,0.0003408412,0.00010645109,0.000036863607,0.00031960243,0.00018236277,0.00004975035],"category_scores_gemma":[0.0042624483,0.00020618529,0.00009667409,0.00090405415,0.00037008768,0.00036439943,0.00008754931,0.00048451108,0.000004417522],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5152639,0.005612306,0.34403744,0.00007725646,0.0003577929,0.11731515,0.00015405464,0.000007356769,0.000094814764,5.7221297e-7,0.000537017,0.016542314],"study_design_scores_gemma":[0.15016882,0.03077304,0.75084674,0.0015017468,0.00011912943,0.064891644,0.000105985506,0.000030401534,0.0011166551,0.0000029836144,0.00023063897,0.00021221329],"about_ca_topic_score_codex":0.00082635396,"about_ca_topic_score_gemma":0.0031889314,"teacher_disagreement_score":0.4068093,"about_ca_system_score_codex":0.00028473933,"about_ca_system_score_gemma":0.0014155797,"threshold_uncertainty_score":0.8407992},"labels":[],"label_agreement":null},{"id":"W1999820147","doi":"10.1111/j.1365-2141.2005.05528.x","title":"Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute protocols: effect of age and risk stratification of disease","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster Children's Hospital","funders":"Dana-Farber Cancer Institute; Heart and Stroke Foundation of Canada","keywords":"Medicine; Internal medicine; Population; Incidence (geometry); Pediatrics; Concomitant; Dosing; Disease","score_opus":0.009706532239913534,"score_gpt":0.3029912028632998,"score_spread":0.29328467062338626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999820147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954271,0.00048438288,0.00011015813,0.00012155803,0.000024595507,0.0036721507,0.00006657742,0.000008352378,0.00008512991],"genre_scores_gemma":[0.9983209,0.0007607878,0.0003845276,0.000029839539,0.00007679819,0.00036231527,0.000016577676,0.000026808842,0.000021477883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980207,0.00025490738,0.00076259143,0.00024395596,0.00044234048,0.0002755039],"domain_scores_gemma":[0.9985047,0.0001866775,0.0006512055,0.00021333917,0.00021267957,0.0002313882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036181166,0.00019213141,0.0011052414,0.00030302856,0.000042023323,0.000016658942,0.00016418708,0.00013557306,0.000031445867],"category_scores_gemma":[0.00032538787,0.00015329645,0.00008567149,0.00027549797,0.0005176182,0.00019306866,0.00003305413,0.00036541707,0.0000015729529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015971778,0.001306547,0.8922372,0.0011164034,0.002650782,0.02672318,0.0003112097,0.0011878001,0.0037478441,0.00028809984,0.0010110345,0.053448126],"study_design_scores_gemma":[0.01940415,0.0028009682,0.9185596,0.0036705139,0.0010998603,0.04282445,0.000013564003,0.00063385075,0.010713664,0.00006345548,0.00003769172,0.000178206],"about_ca_topic_score_codex":0.00091986853,"about_ca_topic_score_gemma":0.00054486154,"teacher_disagreement_score":0.05326992,"about_ca_system_score_codex":0.00030249485,"about_ca_system_score_gemma":0.00088705734,"threshold_uncertainty_score":0.6251248},"labels":[],"label_agreement":null},{"id":"W1999911646","doi":"10.1046/j.0007-1048.2001.03306.x","title":"The pharmacodynamics of tinzaparin in healthy volunteers","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Partial thromboplastin time; Pharmacodynamics; Medicine; Heparin; Antithrombotic; Pharmacology; Pharmacokinetics; Low molecular weight heparin; Antithrombin; Anticoagulant; Pulmonary embolism; Anesthesia; Internal medicine; Coagulation","score_opus":0.01690104651463139,"score_gpt":0.2762180930453465,"score_spread":0.25931704653071513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999911646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98162615,0.011032195,0.000055220484,0.004573938,0.0003890766,0.00016837487,0.0000017436934,0.0000046434193,0.0021486399],"genre_scores_gemma":[0.9817755,0.017096942,0.00023271638,0.00072518317,0.0000538559,0.0000037085358,5.611632e-7,0.000011039691,0.000100487174],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9987317,0.00008467015,0.0006795216,0.00008185225,0.00018885767,0.00023343087],"domain_scores_gemma":[0.9992893,0.00010901953,0.0002994831,0.00009814135,0.00012213094,0.00008193466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004672481,0.00006790505,0.0005891019,0.000112844165,0.00005287237,0.000010861724,0.00014824768,0.000050989074,0.00015159753],"category_scores_gemma":[0.00014851564,0.00005945763,0.00010979186,0.00013452237,0.0001221505,0.00004691705,0.000034933837,0.00028510278,0.000009095259],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014078731,0.007971351,0.047178425,0.0015631669,0.0014703468,0.09674795,0.0023309756,0.0005262808,0.0006392936,0.014203097,0.36944523,0.456516],"study_design_scores_gemma":[0.026302733,0.006101967,0.22407529,0.0036548285,0.0010048345,0.53877103,0.0035721809,0.013266362,0.0007546145,0.002206174,0.17962451,0.00066546863],"about_ca_topic_score_codex":0.00018899073,"about_ca_topic_score_gemma":0.00041044588,"teacher_disagreement_score":0.45585054,"about_ca_system_score_codex":0.000045404297,"about_ca_system_score_gemma":0.000035057845,"threshold_uncertainty_score":0.24246117},"labels":[],"label_agreement":null},{"id":"W2000087371","doi":"10.1046/j.1365-2141.2002.03240.x","title":"T‐cell analysis in identical twins reveals an impaired anti‐follicular lymphoma immune response in the patient but not in the healthy twin","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"College of Science and Health; Medical Research Council; Cancer Care Ontario","keywords":"Immune system; Immunology; Biology; Lymphoma; T cell; Cell; Follicular lymphoma; Cytokine; Cancer research; Genetics","score_opus":0.015201620299912524,"score_gpt":0.24909748779367663,"score_spread":0.23389586749376412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000087371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878911,0.008719029,0.000037667687,0.002239278,0.0007630622,0.00025095188,0.0000042761635,0.0000070964843,0.000087551176],"genre_scores_gemma":[0.99694794,0.000733007,0.000019894824,0.0021282346,0.000017752518,0.000014728886,0.000016362532,0.000011714616,0.00011033933],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9917389,0.0058323904,0.0016021632,0.00024087512,0.00012240701,0.00046327352],"domain_scores_gemma":[0.9982919,0.00068532676,0.0005571419,0.0003341477,0.00010516922,0.00002629118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030814586,0.000175335,0.00081421813,0.00077276415,0.00014641993,0.000060193124,0.0005154292,0.00029372706,0.00052333315],"category_scores_gemma":[0.00051757833,0.00013617506,0.00031783376,0.00085464044,0.00016977653,0.00025452176,0.000042523225,0.0006590686,0.00008061601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0459376,0.03529661,0.13607283,0.00027002,0.0026539266,0.19038272,0.07279986,0.0015440783,0.41847,0.0009698893,0.06727431,0.02832815],"study_design_scores_gemma":[0.0074597937,0.0022214365,0.80736095,0.0002019431,0.00024568135,0.15862189,0.012943117,0.00023443434,0.004272954,0.00008749775,0.006005587,0.000344685],"about_ca_topic_score_codex":0.001097129,"about_ca_topic_score_gemma":0.00044169516,"teacher_disagreement_score":0.67128813,"about_ca_system_score_codex":0.00011568633,"about_ca_system_score_gemma":0.000053199783,"threshold_uncertainty_score":0.5730131},"labels":[],"label_agreement":null},{"id":"W2001771356","doi":"10.1111/j.1365-2141.2006.06322.x","title":"High dose calcitriol may reduce thrombosis in cancer patients","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Sanofi","keywords":"Calcitriol; Medicine; Antithrombotic; Docetaxel; Thrombosis; Placebo; Internal medicine; Calcitriol receptor; Vitamin D and neurology; Gastroenterology; Vitamin K antagonist; Cancer; Oncology; Atrial fibrillation; Pathology; Warfarin","score_opus":0.025992419118825712,"score_gpt":0.33889614562035203,"score_spread":0.3129037265015263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001771356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932287,0.0032782925,0.0000068425647,0.0023820533,0.00047018408,0.00019649688,0.000012989057,0.000009798198,0.00041467237],"genre_scores_gemma":[0.9974373,0.0011554697,0.00020990214,0.00088885496,0.00020638177,0.000010954752,0.0000031283396,0.000010583637,0.000077397446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987201,0.00011235928,0.00055532757,0.00013729464,0.00019658326,0.00027834644],"domain_scores_gemma":[0.99929166,0.00012816598,0.00025120142,0.000047266254,0.00019452223,0.00008717291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019206427,0.0001090662,0.0007805817,0.00011447311,0.00005509936,0.000012240341,0.000088863555,0.000110007335,0.0002020158],"category_scores_gemma":[0.00019866045,0.00009514923,0.00011577928,0.00016559946,0.0001296504,0.00007244344,0.000040509094,0.0003775193,0.0000059753215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012894343,0.007771442,0.63647395,0.0005405838,0.0007102111,0.09408682,0.00019109595,0.00016461955,0.010751642,0.00081597373,0.20866872,0.038535524],"study_design_scores_gemma":[0.0069288225,0.0006387633,0.9733303,0.0005602932,0.00015530805,0.011957869,0.000024973737,0.000012365263,0.003547614,0.000602068,0.0020992926,0.00014230766],"about_ca_topic_score_codex":0.0020455348,"about_ca_topic_score_gemma":0.00030915003,"teacher_disagreement_score":0.3368564,"about_ca_system_score_codex":0.00009508488,"about_ca_system_score_gemma":0.00006422061,"threshold_uncertainty_score":0.3880073},"labels":[],"label_agreement":null},{"id":"W2002155898","doi":"10.1111/bjh.12673","title":"Autologous stem cell transplant is an effective therapy for carefully selected patients with <scp>AL</scp> amyloidosis: experience of a single institution","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Autologous stem-cell transplantation; Troponin; Amyloidosis; Transplantation; Stem cell; AL amyloidosis; Gastroenterology; Troponin T; Surgery; Immunology; Biology","score_opus":0.00715454681679543,"score_gpt":0.22397015222085948,"score_spread":0.21681560540406405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002155898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945964,0.0028008854,0.0013799546,0.000045915716,0.00013937146,0.0009102829,0.00009152513,0.000012286646,0.000023356339],"genre_scores_gemma":[0.9976493,0.00066409295,0.0010008004,0.00031316123,0.000028599588,0.0002382649,0.000055548906,0.000032959728,0.000017279948],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984038,0.00018321094,0.00053005485,0.00033745298,0.00019107162,0.00035440884],"domain_scores_gemma":[0.99813527,0.000093781535,0.0006073345,0.00019120432,0.00083697634,0.00013541334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009207154,0.0002378126,0.0006022644,0.00009547904,0.00010768081,0.00003628875,0.00027085026,0.00022478183,0.0000074503605],"category_scores_gemma":[0.000054339478,0.00021332213,0.00018291268,0.00013358824,0.00021382592,0.000043205215,0.000021364705,0.00012017419,0.0000016536818],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012781008,0.006935646,0.5943647,0.00031086817,0.001971383,0.0009267165,0.00833731,0.00020459508,0.31622288,0.000022301127,0.005371277,0.064054266],"study_design_scores_gemma":[0.007150304,0.00913441,0.19587177,0.0002143777,0.00016286646,0.0051240386,0.0008329164,0.000020131085,0.77992773,0.000017263237,0.0013310546,0.00021315517],"about_ca_topic_score_codex":0.00011609536,"about_ca_topic_score_gemma":0.00005933402,"teacher_disagreement_score":0.46370485,"about_ca_system_score_codex":0.000041976382,"about_ca_system_score_gemma":0.00011752526,"threshold_uncertainty_score":0.8699024},"labels":[],"label_agreement":null},{"id":"W2003006151","doi":"10.1111/j.1365-2141.2009.07793.x","title":"Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital; University Health Network","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Center for Research Resources; University Health Network","keywords":"Medicine; Thalassemia; Subclinical infection; Hypoparathyroidism; Hypercalciuria; Vitamin D and neurology; Short stature; Endocrine system; Internal medicine; Pediatrics; Beta thalassemia; Hemoglobinopathy; vitamin D deficiency; Endocrinology; Physiology; Urine; Hemolytic anemia; Hormone","score_opus":0.007408288090983668,"score_gpt":0.22158673319938782,"score_spread":0.21417844510840414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003006151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98417103,0.012303202,0.000008738264,0.0029169198,0.000053164717,0.00015799182,0.0000040922837,0.000003441808,0.0003814325],"genre_scores_gemma":[0.97927403,0.020256417,0.000033962668,0.00037540102,0.000013515397,0.000002965229,7.363075e-7,0.000004521172,0.000038468013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854225,0.00025458823,0.0005949146,0.00010359849,0.00027490803,0.00022975786],"domain_scores_gemma":[0.99921024,0.00028782545,0.00027127686,0.00010035309,0.000077864504,0.000052470274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034847145,0.0001020538,0.0005391894,0.00013026128,0.000046748886,0.000017780514,0.00024537675,0.00008045453,0.000030880838],"category_scores_gemma":[0.0003678244,0.00006279888,0.00006889899,0.00025830284,0.0004370554,0.000096117576,0.000026552103,0.0005691157,4.566529e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006381364,0.00024221347,0.9550877,0.00033278955,0.0000411269,0.032761365,0.002365585,0.0000035236424,0.000006055942,0.00022408634,0.00021526498,0.008656429],"study_design_scores_gemma":[0.00086427253,0.00037413076,0.8023394,0.0005884957,0.00004832105,0.19328363,0.0020583165,0.000027451168,0.000012041586,0.0003233191,0.000027744827,0.000052902156],"about_ca_topic_score_codex":0.0005669128,"about_ca_topic_score_gemma":0.00060186733,"teacher_disagreement_score":0.16052227,"about_ca_system_score_codex":0.000011720921,"about_ca_system_score_gemma":0.000079480415,"threshold_uncertainty_score":0.25608638},"labels":[],"label_agreement":null},{"id":"W2004796866","doi":"10.1111/j.1365-2141.2008.07367.x","title":"Fluorosis detected by trephine biopsy","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Fluoride Effects and Removal","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Osteosclerosis; Trephine; Skeletal fluorosis; Biopsy; Pathology; Radiology; Surgery; Fluoride; Dental fluorosis","score_opus":0.005609643464388619,"score_gpt":0.1946915112849645,"score_spread":0.1890818678205759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004796866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966731,0.0014920424,0.00031113057,0.0002752158,0.00043120777,0.000055763863,0.000005444567,0.000016699589,0.00073936407],"genre_scores_gemma":[0.9964883,0.00044088883,0.0024712377,0.00013324207,0.000083627514,0.0000011295512,0.0000016888292,0.000014620018,0.00036531014],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9988744,0.00009351271,0.0003896703,0.00014529511,0.00024360958,0.00025349102],"domain_scores_gemma":[0.99946386,0.00006411918,0.0002161272,0.000093455186,0.000020357511,0.0001421022],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019332764,0.00010020425,0.00034714726,0.000036636196,0.00015452225,0.000015092566,0.00023344092,0.00009959329,0.0015877758],"category_scores_gemma":[0.00011738811,0.00009478626,0.000118729586,0.00015730855,0.00033496477,0.00015528272,0.000066806984,0.0002395982,0.0001374879],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001337471,0.0005330584,0.034203507,0.000025224163,0.00011476004,0.12194734,0.00023838787,0.000098081706,0.22874445,0.000020174304,0.5557283,0.058212973],"study_design_scores_gemma":[0.00094418676,0.0002249778,0.05305243,0.000041828025,0.000023439197,0.91987306,0.000017217524,0.00009068896,0.01152611,0.0001143465,0.013918255,0.00017346937],"about_ca_topic_score_codex":0.00033144615,"about_ca_topic_score_gemma":0.000040098996,"teacher_disagreement_score":0.7979257,"about_ca_system_score_codex":0.00004567476,"about_ca_system_score_gemma":0.000013695237,"threshold_uncertainty_score":0.9993249},"labels":[],"label_agreement":null},{"id":"W2005515451","doi":"10.1111/bjh.13094","title":"Phase <scp>II</scp> study of targeted therapy with temozolomide in acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients pre‐screened for low O<sup>6</sup>‐methylguanine DNA methyltransferase expression","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"Merck Canada; Merck","keywords":"Temozolomide; O-6-methylguanine-DNA methyltransferase; Myelodysplastic syndromes; Myeloid leukaemia; Medicine; Methyltransferase; Oncology; Decitabine; Cancer research; DNA methyltransferase; Internal medicine; DNA; DNA methylation; Glioblastoma; Methylation; Gene expression; Gene; Biology; Genetics; Bone marrow","score_opus":0.008527743002371874,"score_gpt":0.26581174349831876,"score_spread":0.2572840004959469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005515451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925916,0.001007441,0.0037699384,0.00010089372,0.0000881304,0.0022638731,0.00014027645,0.000029496237,0.000008349127],"genre_scores_gemma":[0.9931602,0.0012453003,0.0050856303,0.00010572037,0.0000685716,0.000106076935,0.00007073006,0.00010912057,0.000048669648],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99517184,0.0009632316,0.001638747,0.0006150076,0.0008197874,0.0007913813],"domain_scores_gemma":[0.9955745,0.0018227136,0.000856652,0.00040277993,0.0008644917,0.00047887416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001478145,0.00046014696,0.0023416553,0.0008057477,0.00022182838,0.000040274586,0.00042702275,0.00035821684,0.000020038558],"category_scores_gemma":[0.0019468393,0.00039294348,0.0001784641,0.0005238862,0.00033839396,0.00035467808,0.00011650916,0.0011409218,0.000001392553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.088862516,0.06545179,0.31348816,0.003598878,0.013482237,0.10935148,0.021157676,0.0030248654,0.2172319,0.00007860053,0.008316774,0.15595512],"study_design_scores_gemma":[0.35155678,0.15174353,0.19490077,0.0041785617,0.0022398485,0.11852423,0.0037110162,0.00652259,0.16515744,0.00042115588,0.0002970808,0.0007469972],"about_ca_topic_score_codex":0.00024913825,"about_ca_topic_score_gemma":0.00008304107,"teacher_disagreement_score":0.26269427,"about_ca_system_score_codex":0.00015417213,"about_ca_system_score_gemma":0.0003495236,"threshold_uncertainty_score":0.99985224},"labels":[],"label_agreement":null},{"id":"W2005643874","doi":"10.1111/j.1365-2141.2005.05624.x","title":"Confirmation of paternity suggests a new mutation in the factor VII gene: ‘Pater certus quouque est’ ‐ Response to Girolami <i>et al</i>","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Genetics; Allele; Biology; Proband; Mutation; Population; Amelogenin; Microsatellite; Polymerase chain reaction; X chromosome; Gene; Demography","score_opus":0.009976333942595441,"score_gpt":0.2705955202722904,"score_spread":0.26061918632969494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005643874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906448,0.0008459777,0.001558366,0.0066152713,0.00009049479,0.00015574571,0.000016361832,0.0000024648639,0.0000705163],"genre_scores_gemma":[0.99297816,0.0002757823,0.00048162896,0.006155272,0.00004747365,0.0000052123655,0.000024707484,0.000008921239,0.00002282746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99841267,0.00071541476,0.0004432458,0.00013333939,0.000116842275,0.00017848435],"domain_scores_gemma":[0.99933237,0.00008323648,0.00025156085,0.00013385309,0.00013021141,0.00006877256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057947176,0.00009345595,0.00024026695,0.00008191394,0.000042322685,0.000018278444,0.00021275185,0.00013284886,0.00003980418],"category_scores_gemma":[0.00040869054,0.00008909285,0.00008184854,0.000064840024,0.00007040711,0.000016598071,0.000031248648,0.00016782379,0.000004402252],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008207802,0.0006787949,0.009244775,0.00005584358,0.00015376264,0.0022432883,0.00358873,0.0016844298,0.89479434,0.00018260168,0.04442547,0.034740146],"study_design_scores_gemma":[0.009005406,0.0030537993,0.48889214,0.00030312093,0.00007129035,0.05999132,0.0011745807,0.00007872555,0.31036866,0.0012278206,0.12510563,0.00072750787],"about_ca_topic_score_codex":0.00030870162,"about_ca_topic_score_gemma":0.0015271337,"teacher_disagreement_score":0.5844257,"about_ca_system_score_codex":0.000011314563,"about_ca_system_score_gemma":0.00024569433,"threshold_uncertainty_score":0.3633101},"labels":[],"label_agreement":null},{"id":"W2005795414","doi":"10.1046/j.1365-2141.2001.02748.x","title":"Origins of the discipline ‘neonatal haematology’, 1925–75","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Neonatology; Hematology; Medicine; Intensive care medicine; Neonatal intensive care unit; Pediatrics; Intensive care; Pregnancy; Internal medicine; Biology","score_opus":0.005752737416438261,"score_gpt":0.2352856866267437,"score_spread":0.22953294921030545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005795414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892194,0.009140313,0.00046243973,0.000550443,0.00041623905,0.00009665945,0.000026288064,0.0000031346215,0.00038255664],"genre_scores_gemma":[0.99802184,0.0011657085,0.0004001667,0.00015282154,0.00008550604,0.0000026481675,0.000014944649,0.00001741437,0.00013896414],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.998867,0.00009812606,0.00048849965,0.00016638995,0.00014455298,0.00023547512],"domain_scores_gemma":[0.9991082,0.000018023822,0.00041694747,0.00022785236,0.000155829,0.00007316438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013095984,0.00012781883,0.0004346456,0.000042996526,0.00010303114,0.0000132015875,0.00037803067,0.00016916459,0.000059316473],"category_scores_gemma":[0.000101700614,0.00010317315,0.0002496869,0.000107935586,0.00026509064,0.000007473894,0.00014483025,0.0001626992,0.0000050825975],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020528159,0.005533132,0.6372886,0.00042752238,0.004817111,0.09190979,0.0005503649,0.0002774267,0.035072364,0.01820243,0.05280334,0.15106516],"study_design_scores_gemma":[0.004860841,0.0006819543,0.016302012,0.0002123256,0.00026942193,0.82132727,0.00027682644,0.0000143319985,0.054744016,0.0023255243,0.098665066,0.000320434],"about_ca_topic_score_codex":0.00008602985,"about_ca_topic_score_gemma":0.00035935847,"teacher_disagreement_score":0.72941744,"about_ca_system_score_codex":0.000016285348,"about_ca_system_score_gemma":0.00008737844,"threshold_uncertainty_score":0.4207279},"labels":[],"label_agreement":null},{"id":"W2005969591","doi":"10.1046/j.1365-2141.2000.01866.x","title":"Safety profile of the oral iron chelator deferiprone: a multicentre study","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Deferiprone; Neutropenia; Medicine; Discontinuation; Internal medicine; Gastroenterology; Deferasirox; Incidence (geometry); Adverse effect; Vomiting; Surgery; Thalassemia; Chemotherapy","score_opus":0.006442121639605527,"score_gpt":0.24005370813732532,"score_spread":0.2336115864977198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005969591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929091,0.004145207,0.000004381094,0.0007434273,0.00025649078,0.00047318268,0.0000073174133,0.000008930478,0.0014520054],"genre_scores_gemma":[0.99826735,0.00070319755,0.00026341362,0.00014998083,0.000035060202,0.000002634333,0.0000013656618,0.000016556553,0.0005604579],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99851984,0.00018059998,0.000692286,0.00012016004,0.0002584007,0.00022870087],"domain_scores_gemma":[0.9992663,0.000043496795,0.0002666237,0.000163861,0.00015346009,0.000106229905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027354356,0.00010544552,0.0006028489,0.000043087202,0.00009286861,0.000008607584,0.00016186373,0.00014512766,0.0015459608],"category_scores_gemma":[0.00018044996,0.00007651542,0.00019509558,0.0001816058,0.00016306725,0.000056535617,0.00003095581,0.0004769119,0.00002129527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065414556,0.0135775115,0.33621082,0.0010320479,0.0019240254,0.0646114,0.008878953,0.00027340814,0.0019530195,0.00015411394,0.023771655,0.5410716],"study_design_scores_gemma":[0.029009465,0.0027456477,0.38256228,0.0020524939,0.0015179489,0.54621905,0.012361428,0.00028044297,0.001297315,0.000081193706,0.021457246,0.00041549397],"about_ca_topic_score_codex":0.000103476355,"about_ca_topic_score_gemma":0.0000631761,"teacher_disagreement_score":0.5406561,"about_ca_system_score_codex":0.000031938365,"about_ca_system_score_gemma":0.00015204164,"threshold_uncertainty_score":0.99936676},"labels":[],"label_agreement":null},{"id":"W2006019871","doi":"10.1111/j.1365-2141.2007.06692.x","title":"<i>Viscum album</i> agglutinin‐I induces degradation of cytoskeletal proteins in leukaemia PLB‐985 cells differentiated toward neutrophils: cleavage of non‐muscle myosin heavy chain‐IIA by caspases","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Cytoskeleton; Myosin; Cell biology; Actin; Apoptosis; Vimentin; Gelsolin; Molecular biology; Biology; Chemistry; Cell; Immunology; Biochemistry","score_opus":0.010004128645493639,"score_gpt":0.2275923674933682,"score_spread":0.21758823884787457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006019871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940945,0.006575199,0.0023563912,0.00012832883,0.00084240094,0.0004407175,0.00012494354,0.000017976767,0.00010462299],"genre_scores_gemma":[0.9982883,0.0008265849,0.00054427073,0.00008052142,0.000033150387,0.000008007269,0.00006845644,0.000040636318,0.00011009352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964801,0.000451665,0.0019103023,0.00032785037,0.00014722554,0.00068283867],"domain_scores_gemma":[0.99762964,0.00020957319,0.0015960506,0.00024715526,0.00024746367,0.00007009862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094269204,0.00031239723,0.0013736378,0.0004281651,0.00011532389,0.000020471547,0.00051903626,0.00064321107,0.00014834426],"category_scores_gemma":[0.00016005705,0.0003300083,0.0002933283,0.00030341223,0.0004379816,0.00025879403,0.00013267474,0.0009110629,0.000013832263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004797454,0.0008282982,0.00038818762,0.00013981161,0.00018585268,0.0010858562,0.00038793526,0.000004302982,0.9851963,0.00014733647,0.0020637203,0.009092648],"study_design_scores_gemma":[0.0034926757,0.0011930708,0.012939687,0.00059952744,0.00008230263,0.008732077,0.0008188152,0.0000032363716,0.9712988,0.00012369145,0.00043506647,0.00028103314],"about_ca_topic_score_codex":0.0011891914,"about_ca_topic_score_gemma":0.00043522855,"teacher_disagreement_score":0.013897489,"about_ca_system_score_codex":0.00006953943,"about_ca_system_score_gemma":0.00017745185,"threshold_uncertainty_score":0.9999152},"labels":[],"label_agreement":null},{"id":"W2006220544","doi":"10.1046/j.1365-2141.2001.02782-4.x","title":"Reply to Quintini <i>et al</i>","year":2001,"lang":"he","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Splenectomy; Transplantation; Intensive care medicine; Refractory (planetary science); Cyclophosphamide; Surgery; Internal medicine; Chemotherapy","score_opus":0.01806266742701431,"score_gpt":0.2893227986604924,"score_spread":0.2712601312334781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006220544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87996644,0.05659482,0.0005778212,0.05313392,0.0060659014,0.0005207651,0.00014283635,0.000046483405,0.0029510236],"genre_scores_gemma":[0.9217163,0.0045357454,0.00040148522,0.07056732,0.00018492751,0.000013848383,0.000028716884,0.000065454115,0.0024862],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994587,0.001633197,0.0021822008,0.0005014968,0.0001701009,0.00092602236],"domain_scores_gemma":[0.9967364,0.00058969844,0.0012816313,0.0005004755,0.000651974,0.00023979395],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001585234,0.00035819405,0.001608077,0.00038530206,0.00027387112,0.00011103758,0.0009425974,0.00024352559,0.008218179],"category_scores_gemma":[0.001229035,0.00043069434,0.00051528757,0.0003440421,0.0003108336,0.00022753348,0.00036746316,0.0008535451,0.0020489928],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006155723,0.0005582849,0.0076162107,0.0000733707,0.00068111654,0.054707244,0.0002715905,0.000010822571,0.0029938295,0.000696232,0.9254229,0.006352806],"study_design_scores_gemma":[0.0015811927,0.00052846246,0.0030773426,0.0009729982,0.00012950644,0.42138427,0.00045507212,4.9144e-7,0.00046625754,0.00018530224,0.5709798,0.00023931278],"about_ca_topic_score_codex":0.0005702244,"about_ca_topic_score_gemma":0.00040765316,"teacher_disagreement_score":0.36667702,"about_ca_system_score_codex":0.00008393714,"about_ca_system_score_gemma":0.00038183,"threshold_uncertainty_score":0.9998145},"labels":[],"label_agreement":null},{"id":"W2006456576","doi":"10.1111/j.1365-2141.2008.07054.x","title":"Rituximab in the treatment of autoimmune haematological disorders","year":2008,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Rituximab; Medicine; Thrombocytopenic purpura; Thrombotic thrombocytopenic purpura; Immunology; Adverse effect; Hematology; Haemophilia; Autoimmune hemolytic anemia; CD20; Monoclonal; Internal medicine; Monoclonal antibody; Antibody; Pediatrics; Platelet","score_opus":0.03901149715766658,"score_gpt":0.33250239081183297,"score_spread":0.29349089365416636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006456576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022014389,0.97628754,0.000006666665,0.00019283206,0.0001968058,0.00079651736,0.000024803672,0.00000789514,0.00047253867],"genre_scores_gemma":[0.003412458,0.9961174,0.0002280958,0.00003733643,0.000034870664,0.000044225715,0.00004878885,0.000033773398,0.00004300974],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99683815,0.00044486928,0.0017703566,0.00024514864,0.00032619594,0.00037525987],"domain_scores_gemma":[0.9979505,0.0004385286,0.0011591599,0.00028719552,0.000083338746,0.00008128097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001717969,0.00038951283,0.0067379107,0.00034327726,0.00006993461,0.000013964952,0.00032170533,0.0004632232,0.00006731401],"category_scores_gemma":[0.00012246282,0.00024476062,0.0013873116,0.0003403946,0.00033260003,0.000052135576,0.000021495174,0.0005177878,0.000020267533],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049900875,0.0060113026,0.0000774568,0.0017640326,0.0005965362,0.31470567,0.00012997424,1.4779633e-7,2.0700107e-8,0.00006063284,0.0007124101,0.67589194],"study_design_scores_gemma":[0.00348693,0.0009800863,0.00010160221,0.0052477345,0.00074484386,0.561516,0.000049391107,6.0500884e-7,1.937606e-7,0.00013621146,0.4276356,0.00010081748],"about_ca_topic_score_codex":0.00013363405,"about_ca_topic_score_gemma":0.00011544444,"teacher_disagreement_score":0.6757911,"about_ca_system_score_codex":0.00011045025,"about_ca_system_score_gemma":0.00040634186,"threshold_uncertainty_score":0.9981048},"labels":[],"label_agreement":null},{"id":"W2006857073","doi":"10.1111/j.1365-2141.2008.07094.x","title":"Routine bone marrow examination in the initial evaluation of paediatric Hodgkin lymphoma: the Canadian perspective","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Nova Scotia; Izaak Walton Killam Health Centre; Dalhousie University","funders":"IWK Health Centre","keywords":"Medicine; Stage (stratigraphy); Hodgkin lymphoma; Bone marrow; Lymphoma; Pediatrics; Internal medicine","score_opus":0.04361698736652288,"score_gpt":0.3087089068437661,"score_spread":0.26509191947724325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006857073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831787,0.0094011845,0.000004067116,0.004247296,0.00015086656,0.00035880922,0.00000802644,0.0000021006251,0.002648957],"genre_scores_gemma":[0.99890596,0.00052138366,0.00006576686,0.00031311056,0.00014872896,0.000022359058,0.00000735092,0.0000076203173,0.000007720261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997957,0.0006921259,0.00047994574,0.000104635146,0.00058063754,0.00018569047],"domain_scores_gemma":[0.99841666,0.00025618757,0.00033341703,0.00011781166,0.00080303155,0.000072893425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001972036,0.000086571374,0.00037575772,0.00025378037,0.00014667341,0.0000142337585,0.00011458145,0.0000926852,0.00006896974],"category_scores_gemma":[0.00089373306,0.00005981103,0.00011496629,0.00030368773,0.00016106095,0.000078444,0.0000112168955,0.00013054162,0.0000039295733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000556263,0.005141379,0.38866428,0.00010319546,0.0008689802,0.2269893,0.033256304,0.00014968168,0.000045939625,0.008425973,0.015456914,0.3203418],"study_design_scores_gemma":[0.0052110073,0.00027357525,0.73691076,0.000079923564,0.00028622587,0.25446802,0.0018470446,0.00009822153,0.00011631101,0.00055059855,0.00011069811,0.000047624675],"about_ca_topic_score_codex":0.053088143,"about_ca_topic_score_gemma":0.11420512,"teacher_disagreement_score":0.34824646,"about_ca_system_score_codex":0.0008228143,"about_ca_system_score_gemma":0.0017875376,"threshold_uncertainty_score":0.95321745},"labels":[],"label_agreement":null},{"id":"W2007047214","doi":"10.1111/j.1365-2141.2005.05849.x","title":"Lack of CD27 in myeloma delineates different presentation and outcome","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine; Presentation (obstetrics); Plasma cell; Overall survival; Gastroenterology; Pathology; Surgery","score_opus":0.061643159301632916,"score_gpt":0.37949167654108673,"score_spread":0.31784851723945384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007047214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946635,0.0034238035,0.000064058746,0.0015156103,0.000037005357,0.00014518555,0.000005604252,0.0000031515349,0.00014208276],"genre_scores_gemma":[0.997316,0.0008378112,0.0016058355,0.00006968804,0.000056151526,0.0000029239643,0.000005629968,0.000007907909,0.0000980637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988486,0.00008310955,0.0006141123,0.000087348046,0.00019591243,0.00017089988],"domain_scores_gemma":[0.9993664,0.00011238299,0.00019066292,0.00006132788,0.00014638533,0.000122854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001619866,0.00007141936,0.0005176481,0.00017329806,0.0000171893,0.000009877971,0.000051197567,0.000060665287,0.00008406383],"category_scores_gemma":[0.0003104755,0.00006264886,0.00006458398,0.000061498984,0.000080777136,0.00008651676,0.000026390158,0.00017475916,0.0000033132894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038153387,0.00041662433,0.9152541,0.00014380761,0.00010923031,0.011202388,0.0000931369,0.000007107006,0.0007300072,0.000058514128,0.00039369916,0.07120984],"study_design_scores_gemma":[0.0057910285,0.00035223566,0.91057897,0.00027880803,0.00004643305,0.07853651,0.000106781226,0.00041473645,0.0035459124,0.0001294683,0.0001679299,0.000051168507],"about_ca_topic_score_codex":0.00010875608,"about_ca_topic_score_gemma":0.00046002906,"teacher_disagreement_score":0.07115867,"about_ca_system_score_codex":0.000031637508,"about_ca_system_score_gemma":0.000033594035,"threshold_uncertainty_score":0.25547466},"labels":[],"label_agreement":null},{"id":"W2007050465","doi":"10.1111/bjh.12763","title":"<scp>MYC</scp> and <scp>BCL</scp>2 protein expression predicts survival in patients with diffuse large <scp>B</scp>‐cell lymphoma treated with rituximab","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Manitoba","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Rituximab; Lymphoma; Medicine; Internal medicine; CHOP; Oncology; Cyclophosphamide; Prednisone; Survival analysis; Cancer research; Immunology; Chemotherapy","score_opus":0.00490902539138982,"score_gpt":0.19707676294554458,"score_spread":0.19216773755415475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007050465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993879,0.0028383797,0.00011021464,0.00005949499,0.00014937483,0.0012353184,0.0000757016,0.00006739267,0.0015850981],"genre_scores_gemma":[0.9973816,0.0004272217,0.0009941729,0.0001903077,0.00013120624,0.00010834067,0.00009659273,0.00011459701,0.0005559213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956473,0.00051549834,0.0011164716,0.0007019855,0.00094249606,0.0010762513],"domain_scores_gemma":[0.99628884,0.0010151893,0.0010148322,0.00043148862,0.0005370949,0.00071257626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053918146,0.00060402905,0.0019776567,0.00043173198,0.00023591022,0.00013988513,0.0002795298,0.0004325435,0.000008442936],"category_scores_gemma":[0.0011744797,0.0004718475,0.00017352401,0.0003810667,0.00029465902,0.0004002553,0.00014410459,0.00042632164,0.000020402265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022696359,0.017484758,0.950627,0.00041463098,0.0003578266,0.022264881,0.00076084933,0.0000035141754,0.00024500678,0.00006259439,0.004852148,0.002699824],"study_design_scores_gemma":[0.12812594,0.0056067705,0.81668645,0.004024759,0.00052169454,0.027866943,0.0007680867,0.00007237169,0.010021501,0.00008640985,0.0061052097,0.00011384105],"about_ca_topic_score_codex":0.00021793549,"about_ca_topic_score_gemma":0.00022373298,"teacher_disagreement_score":0.13394053,"about_ca_system_score_codex":0.00023978106,"about_ca_system_score_gemma":0.00033922473,"threshold_uncertainty_score":0.9997733},"labels":[],"label_agreement":null},{"id":"W2007306250","doi":"10.1111/j.1365-2141.2008.07517.x","title":"The prevention of hospital‐acquired venous thromboembolism in the United Kingdom","year":2008,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Nice; Medicine; Excellence; Venous thromboembolism; Expert opinion; Dabigatran; Intensive care medicine; Family medicine; Medical emergency; Surgery; Warfarin; Internal medicine","score_opus":0.05148540768400097,"score_gpt":0.3418618845109028,"score_spread":0.2903764768269019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007306250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017931249,0.97897744,0.000021306374,0.00046289567,0.0009457669,0.0012920608,0.0000073786287,0.000009049797,0.00035282882],"genre_scores_gemma":[0.0059325476,0.99341166,0.00008966472,0.00014781693,0.00025125607,0.000054786728,0.000032987646,0.000049966464,0.000029342558],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959642,0.0008474814,0.001988746,0.000228879,0.0005486039,0.0004220584],"domain_scores_gemma":[0.99641615,0.00058347185,0.0021814955,0.0004387125,0.00030200186,0.00007817725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010908232,0.0003092576,0.004133395,0.0004214594,0.00020880993,0.00004862394,0.0007569201,0.0003307828,0.00003049564],"category_scores_gemma":[0.00047840268,0.00020022687,0.0009864216,0.00066522736,0.00038355263,0.000075222844,0.00010828142,0.0006933417,0.0000094791185],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029675,0.0039753197,0.000017454237,0.008657105,0.0019071468,0.04243157,0.00075340486,0.0000034229747,2.4088544e-7,0.0042577945,0.041974153,0.8959927],"study_design_scores_gemma":[0.00083472213,0.0010781712,0.00066728913,0.025555126,0.0017765049,0.14306529,0.00021767628,0.0000011805287,7.2728335e-7,0.0004879646,0.8261446,0.0001707679],"about_ca_topic_score_codex":0.00029574844,"about_ca_topic_score_gemma":0.00008474823,"teacher_disagreement_score":0.8958219,"about_ca_system_score_codex":0.00009660661,"about_ca_system_score_gemma":0.00045475812,"threshold_uncertainty_score":0.8165015},"labels":[],"label_agreement":null},{"id":"W2007340594","doi":"10.1046/j.1365-2141.2000.02330.x","title":"Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion-associated graft-versus-host disease from stored blood","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Immunology; Antigen; Blood transfusion; Medicine; Lymphocyte; Graft-versus-host disease; CD28; Downregulation and upregulation; CD3; Disease; Biology; Internal medicine; CD8; Biochemistry","score_opus":0.0149125471112702,"score_gpt":0.24740456202676006,"score_spread":0.23249201491548988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007340594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972781,0.0009134643,0.00042246754,0.0004240805,0.00020198034,0.0003369879,0.00022724365,0.000019777734,0.00017588987],"genre_scores_gemma":[0.99653226,0.0022036305,0.0009569635,0.00005309253,0.000056597455,0.000005638237,0.00009525997,0.000029196823,0.00006735211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742395,0.0003427693,0.0011763884,0.0002426936,0.0005358458,0.0002783473],"domain_scores_gemma":[0.9979169,0.0005544565,0.00069080136,0.00019856438,0.00037359423,0.00026572437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046454472,0.00018973241,0.0010661377,0.00019734315,0.00007081319,0.000011131134,0.00017889177,0.00022533187,0.0012663691],"category_scores_gemma":[0.0002818057,0.00021269769,0.00032219317,0.00028906457,0.00019049706,0.00021480123,0.000009906752,0.00033697742,0.0000052505957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056606572,0.020597532,0.44616064,0.005571721,0.011315619,0.13172995,0.010422516,0.00020962127,0.30163336,0.00041022958,0.0024018663,0.012940387],"study_design_scores_gemma":[0.07609499,0.0025083749,0.44943663,0.011397196,0.00939585,0.04311233,0.0010445861,0.00012655843,0.40530822,0.000592478,0.00023211844,0.000750682],"about_ca_topic_score_codex":0.001301912,"about_ca_topic_score_gemma":0.00040213697,"teacher_disagreement_score":0.10367485,"about_ca_system_score_codex":0.00004800933,"about_ca_system_score_gemma":0.00031736057,"threshold_uncertainty_score":0.9996466},"labels":[],"label_agreement":null},{"id":"W2007356942","doi":"10.1046/j.1365-2141.2000.02173.x","title":"Hereditary cyclic neutropenia in the male members of a Chinese family with inverted Y chromosome","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Cyclic neutropenia; Neutropenia; Chromosomal inversion; Medicine; Monocytosis; Immunology; Internal medicine; Gastroenterology; Chromosome; Biology; Karyotype; Genetics; Chemotherapy; Bone marrow","score_opus":0.004606163107937626,"score_gpt":0.21488953232984356,"score_spread":0.21028336922190594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007356942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99145794,0.006562918,0.0000047731623,0.00021342922,0.000044005443,0.00010698847,0.000011177134,0.0000013471846,0.0015974334],"genre_scores_gemma":[0.9982194,0.0010646217,0.00018023083,0.00038810886,0.00004332314,0.000005604252,0.000017247128,0.000012348929,0.00006912959],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9991287,0.00012583153,0.00032698186,0.00012803265,0.000120790144,0.00016968492],"domain_scores_gemma":[0.9996037,0.000014858407,0.00015134415,0.00014244123,0.00004533058,0.000042344946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001112545,0.0001081264,0.00032699102,0.00003968056,0.000034196033,0.000011729534,0.00024499642,0.00009433324,0.00012649794],"category_scores_gemma":[0.000014735522,0.00007782068,0.00008742669,0.00012688266,0.00013090282,0.0000091344145,0.00001877268,0.00013386979,0.0000028324641],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005656684,0.008345825,0.5671505,0.0004064784,0.0033961588,0.23705766,0.0019001696,0.0012045752,0.05143298,0.00015945079,0.03782658,0.08546298],"study_design_scores_gemma":[0.015164195,0.0034659116,0.21675596,0.00033962543,0.00021507234,0.7511534,0.00073952705,0.000039806746,0.004699412,0.000778914,0.0061526573,0.00049550366],"about_ca_topic_score_codex":0.00029915076,"about_ca_topic_score_gemma":0.00095577806,"teacher_disagreement_score":0.5140958,"about_ca_system_score_codex":0.0000039942965,"about_ca_system_score_gemma":0.000063233136,"threshold_uncertainty_score":0.31734353},"labels":[],"label_agreement":null},{"id":"W2007570437","doi":"10.1111/j.1365-2141.2012.09179.x","title":"Guideline for the diagnosis and management of myelofibrosis","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University","funders":"Wellcome Trust","keywords":"Guideline; Medicine; Myelofibrosis; MEDLINE; Family medicine; Intensive care medicine; Internal medicine; Pathology; Political science","score_opus":0.03466921393699031,"score_gpt":0.32107679877100503,"score_spread":0.28640758483401474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007570437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92814726,0.060708486,0.0019584992,0.0078122537,0.0003316054,0.00071027427,0.00003187914,0.0000054121297,0.00029432596],"genre_scores_gemma":[0.95148593,0.029355537,0.018283006,0.0005544856,0.0001442834,0.000108136286,0.0000048294223,0.000014214725,0.000049562157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989243,0.000039219874,0.0006059687,0.00008115588,0.00015084121,0.00019848572],"domain_scores_gemma":[0.99890184,0.00034890242,0.00031088485,0.00009547684,0.00023157995,0.000111302536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045715683,0.0000912338,0.00049872196,0.00005404928,0.0000744615,0.000010814683,0.000064404005,0.000051589872,0.00010770662],"category_scores_gemma":[0.00010108508,0.000064821885,0.00014065295,0.00006171797,0.000097188844,0.0000691816,0.00003680806,0.00007850215,0.0000015521308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006136099,0.0021202634,0.4910034,0.0013042125,0.0036516371,0.003679221,0.0004251685,0.0000075582984,0.000097281365,0.013204134,0.17391346,0.30998006],"study_design_scores_gemma":[0.01115247,0.0021439653,0.4619917,0.002747833,0.00393072,0.2173419,0.0011990617,0.00006776626,0.014365428,0.00082754844,0.28393984,0.0002917827],"about_ca_topic_score_codex":0.000021586206,"about_ca_topic_score_gemma":0.000010573498,"teacher_disagreement_score":0.30968827,"about_ca_system_score_codex":0.000018557352,"about_ca_system_score_gemma":0.000020108142,"threshold_uncertainty_score":0.264336},"labels":[],"label_agreement":null},{"id":"W2007713019","doi":"10.1111/bjh.12303","title":"Ticlopidine‐associated <scp>ADAMTS</scp>13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (<scp>SONAR</scp>)","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Apheresis Group; London Health Sciences Centre","funders":"Centers for Disease Control and Prevention; National Cancer Institute; National Heart, Lung, and Blood Institute; Takeda Science Foundation","keywords":"ADAMTS13; Thrombotic thrombocytopenic purpura; Ticlopidine; Von Willebrand factor; Medicine; ADAMTS; Microangiopathic hemolytic anemia; Internal medicine; Platelet; Thrombospondin; Immunology; Metalloproteinase; Clopidogrel; Myocardial infarction","score_opus":0.022371537804919666,"score_gpt":0.24378552643378523,"score_spread":0.22141398862886558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007713019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97094685,0.007688688,0.000016055692,0.015538549,0.003062384,0.0013514636,0.00059653184,0.0000677149,0.0007317872],"genre_scores_gemma":[0.9764123,0.0004957537,0.000047891877,0.01752701,0.0008887812,0.00021918587,0.0008687105,0.00017347829,0.0033668694],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99121547,0.0033858714,0.0024368723,0.00095661846,0.00038826087,0.0016169361],"domain_scores_gemma":[0.9885176,0.006664977,0.0035093024,0.00087674276,0.00033987654,0.000091511116],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0015167554,0.0007669442,0.0028202042,0.0004424908,0.00047577082,0.00012803427,0.0013513318,0.001740271,0.0006299693],"category_scores_gemma":[0.0033910142,0.0007227744,0.000795675,0.0005999526,0.00056816166,0.0002494759,0.0003673268,0.0054857177,0.00059882045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022434268,0.0006548545,0.028257007,0.00007916653,0.0011588865,0.033062264,0.0008979259,0.00019320344,0.0004602999,0.000020772959,0.93502337,0.00016983192],"study_design_scores_gemma":[0.0076169157,0.0007029884,0.35471195,0.0075925956,0.0014794194,0.2200205,0.012535537,0.000049025435,0.00016024233,0.0012589174,0.39321518,0.000656729],"about_ca_topic_score_codex":0.0075996644,"about_ca_topic_score_gemma":0.0077814134,"teacher_disagreement_score":0.5418082,"about_ca_system_score_codex":0.0006926307,"about_ca_system_score_gemma":0.00066401716,"threshold_uncertainty_score":0.9995557},"labels":[],"label_agreement":null},{"id":"W2007719100","doi":"10.1111/j.1365-2141.2007.06495.x","title":"Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti‐red blood cell antibodies in a mouse model of immune thrombocytopenic purpura","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"Canadian Blood Services","keywords":"Immunology; Cytokine; Antibody; Thrombocytopenic purpura; Medicine; Immune system; Proinflammatory cytokine; Immunoglobulin G; Mononuclear phagocyte system; Inflammation","score_opus":0.017259447643849696,"score_gpt":0.27159370250798914,"score_spread":0.25433425486413946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007719100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299085,0.0056430027,0.0008740353,0.000043190536,0.00006796139,0.00028045473,0.000015970234,0.000005065816,0.000079481615],"genre_scores_gemma":[0.99442464,0.0031765176,0.0023217713,0.000015823018,0.000006633313,9.795691e-7,0.0000093855115,0.00001928467,0.000024978772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778676,0.000057432168,0.0014824591,0.00013646344,0.00028288498,0.00025401253],"domain_scores_gemma":[0.9984613,0.000096646196,0.0009965127,0.00016360519,0.00023497196,0.00004698112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047941477,0.0001486788,0.0014832794,0.0003075224,0.000032388234,0.0000052125774,0.00015140668,0.00015666873,0.000019723167],"category_scores_gemma":[0.00008744166,0.00013545222,0.00023483334,0.0002356961,0.00011535009,0.00014452322,0.000044359564,0.00022053637,4.0250276e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013220331,0.0024476172,0.02501069,0.0004202625,0.0005081368,0.017522847,0.000718459,0.00089075504,0.9447796,0.00003292707,0.000003138427,0.0063435393],"study_design_scores_gemma":[0.019181056,0.0023940732,0.1661057,0.0025746159,0.00060046883,0.06562181,0.0007717283,0.0027261337,0.7388223,0.000940328,0.0000019884678,0.0002597957],"about_ca_topic_score_codex":0.00034866467,"about_ca_topic_score_gemma":0.00011857524,"teacher_disagreement_score":0.2059573,"about_ca_system_score_codex":0.00002925992,"about_ca_system_score_gemma":0.00015897278,"threshold_uncertainty_score":0.55235815},"labels":[],"label_agreement":null},{"id":"W2007761452","doi":"10.1046/j.1365-2141.2002.03394.x","title":"Impaired gut function as risk factor for invasive candidiasis in neutropenic patients","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk factor; Medicine; Function (biology); Neutropenia; Internal medicine; Invasive candidiasis; Intensive care medicine; Oncology; Biology; Dermatology; Antifungal; Chemotherapy; Fluconazole; Genetics","score_opus":0.06718444693364929,"score_gpt":0.3655161815047349,"score_spread":0.29833173457108564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007761452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02891393,0.96669936,0.0000086450955,0.00008374001,0.0014293081,0.002390011,0.0004182384,0.000011818083,0.00004492807],"genre_scores_gemma":[0.0095842965,0.9893126,0.00021938223,0.00017445034,0.0002910195,0.00018028212,0.000065350585,0.00008233401,0.00009026908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639744,0.00041493028,0.0019636636,0.00035415488,0.0003062964,0.00056353566],"domain_scores_gemma":[0.9962297,0.0005267382,0.0022688517,0.00021821003,0.00040006105,0.00035644637],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000271829,0.00037136188,0.0038791092,0.0004866953,0.000089849644,0.000029912568,0.00018052594,0.0005347657,0.00042481],"category_scores_gemma":[0.0007619136,0.000343032,0.00082586985,0.00026181815,0.00006829754,0.00013974676,0.000038714894,0.000885346,0.000056415625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024673375,0.0004058822,0.0019569073,0.013240524,0.00046103672,0.0076549756,0.0000443916,2.3061133e-7,1.8558229e-8,0.0000023977966,0.003563082,0.9724238],"study_design_scores_gemma":[0.0105122095,0.0070993453,0.008617115,0.059604086,0.0049355025,0.15962194,0.000043120803,0.0000011475049,0.0000016007787,0.0001611245,0.74893004,0.00047278096],"about_ca_topic_score_codex":0.00057810696,"about_ca_topic_score_gemma":0.000984583,"teacher_disagreement_score":0.97195107,"about_ca_system_score_codex":0.001309361,"about_ca_system_score_gemma":0.0014953493,"threshold_uncertainty_score":0.9999022},"labels":[],"label_agreement":null},{"id":"W2007794249","doi":"10.1046/j.1365-2141.2000.02098.x","title":"Autologous stem cell transplantation for anaplastic large‐cell lymphomas: results of a prospective trial","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Internal medicine; Etoposide; Autologous stem-cell transplantation; Transplantation; Melphalan; Large cell; Oncology; Lymphoma; Chemotherapy; Gastroenterology; Chemotherapy regimen; Surgery; Cancer; Adenocarcinoma","score_opus":0.010019238523221258,"score_gpt":0.2515401976893634,"score_spread":0.24152095916614216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007794249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392605,0.00260742,0.00017787142,0.00015695122,0.00026163372,0.0008349317,0.00022932811,0.000013586707,0.0017922325],"genre_scores_gemma":[0.9971673,0.0012263148,0.0009760346,0.00006098396,0.00010264055,0.000040790615,0.000030843767,0.00001789597,0.00037720994],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99828374,0.00009537051,0.0009388068,0.0001999181,0.0002108421,0.00027129866],"domain_scores_gemma":[0.9986683,0.0003598424,0.000501769,0.00010503783,0.00024549698,0.000119545526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026866928,0.00013884706,0.0008607314,0.000114784845,0.00006749712,0.000014455027,0.00008485121,0.00015303429,0.00008300034],"category_scores_gemma":[0.00004375134,0.00013090324,0.0002831372,0.00010390924,0.000065720706,0.00007896278,0.0000048632664,0.00009503058,0.00000834779],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61481816,0.023473972,0.0074212444,0.0027014986,0.0014298718,0.1516171,0.0050872094,0.00012654121,0.0005652902,0.00061461213,0.0141471075,0.17799743],"study_design_scores_gemma":[0.6301929,0.018939996,0.0325743,0.0011685175,0.001916931,0.27719778,0.00046516416,0.00012807296,0.033755038,0.0004750131,0.00288856,0.0002977695],"about_ca_topic_score_codex":0.000044600292,"about_ca_topic_score_gemma":0.00006413498,"teacher_disagreement_score":0.17769966,"about_ca_system_score_codex":0.000120372344,"about_ca_system_score_gemma":0.00038596374,"threshold_uncertainty_score":0.53380793},"labels":[],"label_agreement":null},{"id":"W2007880821","doi":"10.1111/bjh.12199","title":"How I manage priapism due to sickle cell disease","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Priapism; Medicine; Intensive care medicine; Erectile dysfunction; Disease; Clinical trial; Internal medicine; Surgery","score_opus":0.05314092594757469,"score_gpt":0.3171925218703542,"score_spread":0.2640515959227795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007880821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016162732,0.99274665,0.000927758,0.0013034296,0.002343029,0.0007725633,0.000019797873,0.00003713853,0.0016880014],"genre_scores_gemma":[0.00003938019,0.97478306,0.00061073387,0.0009855112,0.00075344136,0.000054708205,0.000022056973,0.000064887965,0.022686193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977883,0.00020963255,0.0009506035,0.00032285857,0.00037870376,0.0003498818],"domain_scores_gemma":[0.99760705,0.00019412574,0.0007841573,0.00027630595,0.00044885787,0.0006894872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024698346,0.0003449283,0.0033983977,0.00045735826,0.00010930451,0.000120099394,0.0001945267,0.000249368,0.00061573973],"category_scores_gemma":[0.00059455825,0.00030092054,0.00073757133,0.00028697136,0.000091129834,0.00012245544,0.00011872058,0.00071209617,0.00059282524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000483805,0.00019050001,0.0000069112943,0.011836325,0.0003862637,0.080045454,0.00001936713,1.3703242e-7,3.505566e-7,0.000095195035,0.26139745,0.6459737],"study_design_scores_gemma":[0.00057304534,0.0001993804,0.00003275261,0.0064394944,0.0014091665,0.21907018,0.00008252945,2.2418517e-7,5.540362e-7,0.000040710824,0.7719654,0.00018655435],"about_ca_topic_score_codex":0.000013966453,"about_ca_topic_score_gemma":0.00000401278,"teacher_disagreement_score":0.6457871,"about_ca_system_score_codex":0.000083289175,"about_ca_system_score_gemma":0.0002645465,"threshold_uncertainty_score":0.99994427},"labels":[],"label_agreement":null},{"id":"W2008081777","doi":"10.1111/j.1365-2141.2008.07362.x","title":"MOZ/TIF2‐induced acute myeloid leukaemia in transgenic fish","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"Fondation de France; Ligue Contre le Cancer","keywords":"Fusion gene; Biology; Transgene; Cancer research; Myeloid; Zebrafish; Gene; Molecular biology; Genetics","score_opus":0.01630303349721894,"score_gpt":0.2551407057771832,"score_spread":0.23883767227996422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008081777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430525,0.003909444,0.000765099,0.00022141659,0.00027737144,0.00008627094,0.00000971957,0.0000038045437,0.0004215931],"genre_scores_gemma":[0.99269307,0.0060684085,0.0007563854,0.00017376947,0.00015319463,0.0000039430374,0.000020974747,0.000021779413,0.0001084655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986405,0.00013987912,0.000594994,0.00020195707,0.00015137812,0.00027130762],"domain_scores_gemma":[0.9993336,0.000020736561,0.00024167325,0.0001462091,0.00015442443,0.000103316794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002789205,0.00012533969,0.0003821477,0.00010454718,0.00007272298,0.000014883776,0.00023025059,0.00026281955,0.000039055805],"category_scores_gemma":[0.0001044322,0.00014977522,0.00017043279,0.000114324976,0.00008545348,0.000009247798,0.000034499142,0.00026124727,0.0000040899254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002626374,0.00025918844,0.014494426,0.000038085644,0.0002522478,0.01789684,0.00022500157,0.00018642712,0.9458063,0.000041940326,0.0032970528,0.01723984],"study_design_scores_gemma":[0.0037775168,0.0009857394,0.06353241,0.00012428408,0.0000786521,0.13294291,0.00007880055,0.0000361137,0.7865515,0.0005217234,0.010880111,0.0004902555],"about_ca_topic_score_codex":0.000057814414,"about_ca_topic_score_gemma":0.00037614166,"teacher_disagreement_score":0.15925482,"about_ca_system_score_codex":0.00001828761,"about_ca_system_score_gemma":0.00015162858,"threshold_uncertainty_score":0.61076564},"labels":[],"label_agreement":null},{"id":"W2008411546","doi":"10.1111/j.1365-2141.2012.09176.x","title":"<scp><i>MYD88</i></scp> somatic mutations in <scp>MALT</scp> lymphomas","year":2012,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Associazione Italiana per la Ricerca sul Cancro; Oncosuisse","keywords":"MALT lymphoma; Mucosa-associated lymphoid tissue; Macroglobulinemia; Cancer research; Lymphoma; Waldenstrom macroglobulinemia; Germline mutation; B cell; Biology; Marginal zone; Chromosomal translocation; Mutation; Immunology; Gene; Genetics; Antibody; Multiple myeloma","score_opus":0.01721686155693252,"score_gpt":0.257928519284201,"score_spread":0.2407116577272685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008411546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8558575,0.060746904,0.000045013243,0.07074915,0.0026524684,0.0010772139,0.00014924127,0.00008278126,0.008639718],"genre_scores_gemma":[0.5948832,0.011563747,0.0056910953,0.36635715,0.010401099,0.00047696248,0.0012799959,0.0006314864,0.008715282],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9946813,0.0004778287,0.0021350565,0.0005026675,0.00089252496,0.00131065],"domain_scores_gemma":[0.9941281,0.0028413495,0.001708666,0.00047853572,0.00040549485,0.00043784673],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005666564,0.0006443686,0.0028552383,0.0009293336,0.00015913113,0.00013670273,0.00045401245,0.0014485987,0.00015532099],"category_scores_gemma":[0.001845646,0.0006599498,0.0008081637,0.0003666954,0.00030956152,0.00031683437,0.000115360686,0.0018142211,0.0003963646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037113412,0.0008528945,0.02146626,0.0006618396,0.0007060837,0.2789344,0.00054906245,0.000002674479,0.000012714224,0.00005835637,0.6942148,0.0025371956],"study_design_scores_gemma":[0.005505711,0.0003299847,0.02763659,0.002528229,0.0012191,0.55407035,0.0003870926,0.000007969827,0.0002929325,0.0007929275,0.40713385,0.000095263604],"about_ca_topic_score_codex":0.000246987,"about_ca_topic_score_gemma":0.00014605529,"teacher_disagreement_score":0.29560798,"about_ca_system_score_codex":0.00075056317,"about_ca_system_score_gemma":0.0012571561,"threshold_uncertainty_score":0.9998477},"labels":[],"label_agreement":null},{"id":"W2008552288","doi":"10.1046/j.1365-2141.2000.02062.x","title":"Leucocyte Depletion Of The Blood Supply – How Will Patients Benefit?","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buffy coat; Residual risk; Immunology; Medicine; Hematology; Transmission (telecommunications); Transfusion medicine; Infectivity; Cytomegalovirus; Apheresis; Virology; Disease; Blood transfusion; Platelet; Human immunodeficiency virus (HIV); Internal medicine; Virus; Viral disease; Herpesviridae","score_opus":0.00933888290141784,"score_gpt":0.24342304423973551,"score_spread":0.23408416133831766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008552288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056588717,0.94258,0.000012627471,0.00003877641,0.00030001753,0.0002845371,0.00016168621,0.000002118066,0.00003154041],"genre_scores_gemma":[0.007598995,0.99181944,0.00011067571,0.000052766958,0.00019387361,0.000010183098,0.00009051459,0.00003832063,0.000085198844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982731,0.00027563184,0.0007497406,0.00023367126,0.0002226617,0.00024520242],"domain_scores_gemma":[0.998106,0.000027425462,0.0012609494,0.00029162486,0.00021659868,0.00009739018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018713993,0.00023409714,0.001157178,0.00007348523,0.00008375559,0.000037125472,0.0006252674,0.0004160692,0.00007118039],"category_scores_gemma":[0.00019267882,0.00019565584,0.0009617391,0.000108544766,0.00011831435,0.000008778141,0.00014661152,0.00030844114,0.0000015835125],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028890772,0.00014860106,0.0002135747,0.002044577,0.0003687393,0.00039939224,0.0000031074828,0.0000018253638,0.000026642285,0.000021528369,0.0019285704,0.9948146],"study_design_scores_gemma":[0.0006720779,0.0002297329,0.00010422806,0.007397674,0.00075471814,0.032299686,0.000003081859,1.5390103e-7,0.00034530007,0.000077962046,0.9578952,0.00022015249],"about_ca_topic_score_codex":0.000010093036,"about_ca_topic_score_gemma":0.000012708289,"teacher_disagreement_score":0.9945944,"about_ca_system_score_codex":0.0000135752025,"about_ca_system_score_gemma":0.00024440876,"threshold_uncertainty_score":0.79786134},"labels":[],"label_agreement":null},{"id":"W2008959642","doi":"10.1046/j.1365-2141.2000.02093.x","title":"A combination of anti‐interleukin 6 murine monoclonal antibody with dexamethasone and high‐dose melphalan induces high complete response rates in advanced multiple myeloma","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Melphalan; Multiple myeloma; Dexamethasone; Medicine; Monoclonal antibody; Autologous stem-cell transplantation; Regimen; Monoclonal; Combination therapy; Transplantation; Internal medicine; Pharmacology; Immunology; Oncology; Antibody","score_opus":0.018043425714160972,"score_gpt":0.3049105630567748,"score_spread":0.2868671373426138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008959642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735755,0.0014714386,0.000032349715,0.00063511403,0.000038673606,0.00038744838,0.00004378462,0.000010234892,0.000023436469],"genre_scores_gemma":[0.9939597,0.0008204421,0.005031304,0.000040122057,0.000018691326,0.000009440217,0.00004792968,0.0000239297,0.000048391834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979191,0.000449576,0.00069921376,0.00023890044,0.00035271823,0.0003405271],"domain_scores_gemma":[0.9983822,0.0006533212,0.0003356915,0.00013947632,0.0002879625,0.00020136738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052599865,0.00017981233,0.0010165944,0.00039510027,0.000059354006,0.000024229712,0.00012338665,0.00010115249,0.00018240129],"category_scores_gemma":[0.00045023902,0.00016082457,0.00006557662,0.00025420781,0.00029172158,0.00021636607,0.00003404301,0.00035756163,0.0000035371943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060501948,0.0030879555,0.5233951,0.00039068167,0.000781922,0.14314629,0.00045265528,0.00006250322,0.13948661,0.00010704059,0.00006536077,0.12852192],"study_design_scores_gemma":[0.02361308,0.0027130349,0.8708298,0.0010060277,0.000052370702,0.086938195,0.00012490965,0.00024318049,0.014179408,0.00013468285,0.000045983026,0.000119309225],"about_ca_topic_score_codex":0.0008075311,"about_ca_topic_score_gemma":0.00030783648,"teacher_disagreement_score":0.3474347,"about_ca_system_score_codex":0.00006109843,"about_ca_system_score_gemma":0.00014560984,"threshold_uncertainty_score":0.6558235},"labels":[],"label_agreement":null},{"id":"W2010371929","doi":"10.1046/j.1365-2141.2001.03176.x","title":"The −1185 A/G and −1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarction","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Haplotype; Von Willebrand factor; Medicine; Myocardial infarction; Odds ratio; Internal medicine; Case-control study; Risk factor; Von Willebrand disease; Gastroenterology; Coronary artery disease; Cardiology; Platelet; Endocrinology; Genotype; Gene; Genetics; Biology","score_opus":0.008497404060586028,"score_gpt":0.23667828044883332,"score_spread":0.2281808763882473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010371929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894964,0.008756538,0.000022090439,0.0013386006,0.000093618175,0.0001868629,0.000008125463,0.0000019475215,0.00009577891],"genre_scores_gemma":[0.97525173,0.02450828,0.00007339503,0.000101747464,0.000036826023,0.0000029921346,0.0000017992986,0.0000064622172,0.000016743643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991742,0.00014325755,0.00031983177,0.00008377821,0.00013740516,0.00014157571],"domain_scores_gemma":[0.99947524,0.0001352271,0.00021368943,0.00007133444,0.00005859441,0.00004588943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027310627,0.00007551826,0.00039160316,0.00005856007,0.00009362598,0.000024021203,0.000051439376,0.00006890542,0.000009863188],"category_scores_gemma":[0.000121291545,0.000046378773,0.000058819867,0.000068681875,0.00017661275,0.00007283372,0.000016553578,0.00021941157,5.3705696e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093968847,0.00036958006,0.81045437,0.000047818183,0.0007340987,0.04402452,0.0010598782,0.000001988516,0.0005361803,0.00005461448,0.0009600514,0.14081721],"study_design_scores_gemma":[0.0034912226,0.00041267538,0.574134,0.00009763615,0.0001617504,0.41831616,0.00019170113,0.000017090622,0.00012324115,0.0010306046,0.0019755196,0.000048422942],"about_ca_topic_score_codex":0.00014756685,"about_ca_topic_score_gemma":0.00021771928,"teacher_disagreement_score":0.37429166,"about_ca_system_score_codex":0.000009142254,"about_ca_system_score_gemma":0.000026540676,"threshold_uncertainty_score":0.18912715},"labels":[],"label_agreement":null},{"id":"W2011435372","doi":"10.1111/bjh.13088","title":"Safety and efficacy of thrombopoietin‐receptor agonists in myelodysplastic syndromes: a systematic review and meta‐analysis of randomized controlled trials","year":2014,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Romiplostim; Eltrombopag; Medicine; Placebo; Randomized controlled trial; Relative risk; Thrombopoietin receptor; Meta-analysis; Internal medicine; Myelodysplastic syndromes; Thrombopoietin; Confidence interval; Platelet; Bone marrow; Pathology; Haematopoiesis","score_opus":0.053660986097755686,"score_gpt":0.38175215643695076,"score_spread":0.3280911703391951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011435372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016784397,0.98931515,0.00017458138,0.00023252516,0.0000704216,0.009882119,0.000109413355,0.000005970585,0.000041944797],"genre_scores_gemma":[0.0005076156,0.99847466,0.0004845364,0.00007038487,0.000026297776,0.00025669095,0.00004168694,0.000054943208,0.000083163155],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96556526,0.01840317,0.014389782,0.00044622013,0.00078771455,0.0004078349],"domain_scores_gemma":[0.94172204,0.04329975,0.013402589,0.00045384423,0.0008341905,0.00028757416],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.03955325,0.0006381729,0.16118641,0.0020429296,0.00004155757,0.000034819685,0.00040890445,0.0005734025,0.00040915053],"category_scores_gemma":[0.08263625,0.00039572286,0.010106843,0.0010977652,0.0008112997,0.00006727778,0.00014154158,0.0010723309,0.000003429621],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00670146,0.00012037184,4.0933875e-7,0.6408758,0.3494522,0.0017854739,0.000026959475,4.7664153e-7,3.867713e-7,0.00007358924,0.00009953232,0.00086332555],"study_design_scores_gemma":[0.090564586,0.00015449672,0.0000011286508,0.24139218,0.60122985,0.06615736,0.000013649088,0.000011178338,2.0917606e-7,0.000009229452,0.00031903587,0.00014711129],"about_ca_topic_score_codex":0.000058128084,"about_ca_topic_score_gemma":0.000017538041,"teacher_disagreement_score":0.39948365,"about_ca_system_score_codex":0.00012838293,"about_ca_system_score_gemma":0.0009513093,"threshold_uncertainty_score":0.99984944},"labels":[],"label_agreement":null},{"id":"W2012354044","doi":"10.1111/j.1365-2141.2007.06506.x","title":"Pregnancy after bone marrow transplantation in Fanconi anaemia","year":2007,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Pregnancy; Fanconi anemia; Savior sibling; Transplantation; Bone marrow failure; Fertility; Haematopoiesis; Bone marrow transplantation; Stem cell; Fertility preservation; Pediatrics; Obstetrics; Gynecology; Hematopoietic stem cell transplantation; Surgery; Population; Biology","score_opus":0.012234155559459482,"score_gpt":0.26020414453170887,"score_spread":0.2479699889722494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012354044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58806,0.14348531,0.00276823,0.256551,0.0029803587,0.000985772,0.00024321866,0.0000788469,0.0048472565],"genre_scores_gemma":[0.5177512,0.020030672,0.008028186,0.44807273,0.0037931625,0.000040619852,0.000626104,0.00019627169,0.0014610327],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9977744,0.00012969114,0.0010179607,0.00022646217,0.00039664414,0.00045482515],"domain_scores_gemma":[0.99874604,0.00031317218,0.00048477505,0.00014826405,0.00018815843,0.00011961491],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002723764,0.00021998915,0.0011293143,0.000465306,0.000023922907,0.000026771455,0.00014214127,0.001055614,0.00016987148],"category_scores_gemma":[0.00031538887,0.00024449526,0.00023684434,0.00015894494,0.0001203367,0.00010921553,0.00001816394,0.0027348571,0.000017769975],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023910486,0.000051574098,0.005065405,0.00080205966,0.000056121462,0.7154413,0.000052563304,0.0000010145063,0.0000060702478,0.0000028339036,0.27122393,0.0070580044],"study_design_scores_gemma":[0.00323841,0.00035241025,0.021189654,0.021096766,0.00037376705,0.9095196,0.000016540991,0.0000035217633,0.0001760045,0.00018969021,0.04356276,0.0002808773],"about_ca_topic_score_codex":0.00017748593,"about_ca_topic_score_gemma":0.00032998377,"teacher_disagreement_score":0.22766118,"about_ca_system_score_codex":0.0000777349,"about_ca_system_score_gemma":0.00018403408,"threshold_uncertainty_score":0.9995659},"labels":[],"label_agreement":null},{"id":"W2012785890","doi":"10.1111/bjh.12451","title":"Autologous haematopoietic cell transplantation for non‐<scp>H</scp>odgkin lymphoma with secondary <scp>CNS</scp> involvement","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Lymphoma; Internal medicine; Transplantation; Oncology; Autologous stem-cell transplantation; Hematology; Hematopoietic stem cell transplantation; Non-Hodgkin's lymphoma; Haematopoiesis; Immunology; Stem cell; Biology","score_opus":0.008601899706633009,"score_gpt":0.2250511375397899,"score_spread":0.2164492378331569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012785890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989567,0.0049559004,0.0015478291,0.00048281281,0.00039645005,0.0013901533,0.000056811525,0.0000469175,0.0015561143],"genre_scores_gemma":[0.9897739,0.001762092,0.006199343,0.0010808972,0.00015560449,0.00030788782,0.000104612234,0.000083827406,0.000531819],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9971844,0.00011250065,0.0011178893,0.0004243146,0.00044811144,0.00071279245],"domain_scores_gemma":[0.9969965,0.0009558006,0.00078248995,0.00026701525,0.00057683536,0.0004213482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030671144,0.00038315504,0.001379869,0.00031356516,0.0001998468,0.00012124921,0.0002351217,0.00029306664,0.00009405509],"category_scores_gemma":[0.00016032976,0.0003473242,0.00038762885,0.0001981371,0.00021132916,0.00028893945,0.000031974258,0.0002469774,0.00008369508],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003883408,0.011654256,0.078224525,0.008087316,0.0039598374,0.2697017,0.007657819,0.00009866276,0.005080141,0.0008587702,0.3866353,0.22765334],"study_design_scores_gemma":[0.023914732,0.0044121216,0.31811383,0.0018967793,0.0016380168,0.58782476,0.0027261155,0.0001466921,0.04596709,0.0010992165,0.012098677,0.0001619751],"about_ca_topic_score_codex":0.00026729406,"about_ca_topic_score_gemma":0.0001777701,"teacher_disagreement_score":0.37453663,"about_ca_system_score_codex":0.00019241401,"about_ca_system_score_gemma":0.0005553506,"threshold_uncertainty_score":0.9998979},"labels":[],"label_agreement":null},{"id":"W2013079949","doi":"10.1046/j.1365-2141.2003.04333.x","title":"Six Characters in Search of An Author: The History of the Nomenclature of Coagulation Factors","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Public Health Service; Ryerson University","keywords":"Nomenclature; Coagulation; Medicine; Internal medicine; Biology; Taxonomy (biology); Zoology","score_opus":0.029392037531131513,"score_gpt":0.2740248050317564,"score_spread":0.2446327675006249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013079949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940678,0.004604339,0.000020442261,0.00037993907,0.00053329975,0.00016261193,0.0000062716667,0.000002462057,0.00022282216],"genre_scores_gemma":[0.9994198,0.00010067719,0.000115573064,0.000060186445,0.000029367468,7.440364e-7,0.0000039756073,0.000011328801,0.00025834824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983505,0.00030305068,0.00077744364,0.00009410369,0.00032042057,0.00015448127],"domain_scores_gemma":[0.9986196,0.00017635408,0.00069103803,0.00018206157,0.00027049019,0.000060434795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068922294,0.00008751751,0.0005769351,0.00015065786,0.00003023619,0.0000031170484,0.0001676735,0.00013549723,0.00010464623],"category_scores_gemma":[0.0003200372,0.00006340834,0.0001794006,0.00017944264,0.0003282138,0.00011212464,0.000017590814,0.00030772208,2.534143e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004293669,0.0009302833,0.94930834,0.0005458455,0.00026884355,0.0007574183,0.012547103,0.00015455374,0.01861959,0.0072737676,0.0023183376,0.006846542],"study_design_scores_gemma":[0.0012644879,0.00024013082,0.9766848,0.0005092064,0.000086677195,0.009894884,0.0008314716,0.0000740729,0.008715352,0.00047783635,0.0011506678,0.00007042735],"about_ca_topic_score_codex":0.00024392197,"about_ca_topic_score_gemma":0.00017381251,"teacher_disagreement_score":0.027376436,"about_ca_system_score_codex":0.000088702844,"about_ca_system_score_gemma":0.00038552404,"threshold_uncertainty_score":0.2585717},"labels":[],"label_agreement":null},{"id":"W2013230705","doi":"10.1111/bjh.12248","title":"Multiple osteochondromas following irradiation‐containing conditioning in severe combined immunodeficiency","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Immune dysregulation; Total body irradiation; Severe combined immunodeficiency; Immunodeficiency; Wiskott–Aldrich syndrome; Population; Failure to thrive; Bone marrow; Pathology; Immunology; Internal medicine; Immune system; Chemotherapy; Cyclophosphamide","score_opus":0.013160400645741107,"score_gpt":0.24647362767544992,"score_spread":0.2333132270297088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013230705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92196083,0.010782133,0.000011231292,0.064657256,0.0012317352,0.00052868115,0.00002717472,0.000026642196,0.00077428675],"genre_scores_gemma":[0.9498667,0.00029355157,0.0007599678,0.047776617,0.00032979992,0.00005225091,0.0003303705,0.00008048865,0.00051026326],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99712646,0.00023493794,0.001366099,0.00032129794,0.0003933086,0.0005578864],"domain_scores_gemma":[0.9978714,0.00053334056,0.0010395321,0.00022100462,0.00023348146,0.00010126139],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029572795,0.00031984542,0.0018175596,0.0005037685,0.00014177024,0.000106120024,0.00021743507,0.00060660235,0.00031383187],"category_scores_gemma":[0.0005444139,0.0003557021,0.000518507,0.00020723024,0.00008154431,0.00029660572,0.000050752325,0.0021779581,0.00006637667],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084748826,0.00042155132,0.076085076,0.00027992093,0.00072724017,0.59949946,0.00023308018,0.0000137973775,0.000041472,0.000029591285,0.3201998,0.0023842426],"study_design_scores_gemma":[0.019786082,0.001567367,0.10240031,0.008708058,0.00089301204,0.8401598,0.00034647284,0.00009311107,0.00003881568,0.0007017478,0.024636064,0.0006691909],"about_ca_topic_score_codex":0.0005751389,"about_ca_topic_score_gemma":0.000070111426,"teacher_disagreement_score":0.29556373,"about_ca_system_score_codex":0.00026602525,"about_ca_system_score_gemma":0.00029716347,"threshold_uncertainty_score":0.9998895},"labels":[],"label_agreement":null},{"id":"W2014089652","doi":"10.1111/j.1365-2141.2004.04996.x","title":"Correlation of <i>TACC3, FGFR3, MMSET</i> and <i>p21</i> expression with the t(4;14)(p16·3;q32) in multiple myeloma","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast","keywords":"Chromosomal translocation; Multiple myeloma; Breakpoint; Gene; Polymerase chain reaction; Gene expression; Fusion gene; Medicine; Biology; Cancer research; Internal medicine; Genetics","score_opus":0.013295273796492525,"score_gpt":0.25969547780080554,"score_spread":0.246400204004313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014089652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934865,0.003671148,0.0009913208,0.0012303179,0.0000625455,0.00033335824,0.000010663554,0.0000066866023,0.00020741561],"genre_scores_gemma":[0.99713933,0.0006271367,0.0019888806,0.00013242911,0.000036402158,0.000008808696,0.0000102254635,0.000016984131,0.00003980115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985974,0.0001293898,0.00048415086,0.00015683853,0.0003657159,0.00026651408],"domain_scores_gemma":[0.9989033,0.00023478521,0.00033999662,0.00014145354,0.00022651463,0.00015396206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031848863,0.0001235287,0.00055403204,0.00015569308,0.00008999586,0.00001938097,0.00010828014,0.000109147026,0.00002660073],"category_scores_gemma":[0.00030214648,0.00008588572,0.000073134885,0.00018092175,0.00025560166,0.00016978143,0.000044266122,0.00040999806,0.0000037558736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007901186,0.0021893468,0.7911143,0.00058092806,0.00048979215,0.10959376,0.0016905206,0.00071979023,0.020445846,0.000269134,0.0038300809,0.061175328],"study_design_scores_gemma":[0.04072737,0.0025028747,0.51551735,0.0037049262,0.00018852318,0.40644574,0.0012178086,0.0002724414,0.027391993,0.0006020924,0.0011761814,0.0002527046],"about_ca_topic_score_codex":0.00036169976,"about_ca_topic_score_gemma":0.0007060943,"teacher_disagreement_score":0.29685196,"about_ca_system_score_codex":0.000048514426,"about_ca_system_score_gemma":0.00016280838,"threshold_uncertainty_score":0.3502318},"labels":[],"label_agreement":null},{"id":"W2014717400","doi":"10.1046/j.1365-2141.2001.02962.x","title":"Henry Bence Jones – physician, chemist, scientist and biographer: A man for all seasons","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Chemist; Bence Jones protein; Medicine; Chemistry; Immunology; Organic chemistry","score_opus":0.022731071670530404,"score_gpt":0.3205165059369347,"score_spread":0.2977854342664043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014717400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877525,0.00861063,0.00048576744,0.0021320253,0.00010187738,0.00026667918,0.000030924835,0.000011542897,0.00060805015],"genre_scores_gemma":[0.99295366,0.0020776056,0.00403147,0.00039840114,0.00012186852,0.0000149668485,0.000016672879,0.000016098078,0.000369232],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99898,0.000032421874,0.00023928417,0.00017582896,0.00021801972,0.00035447668],"domain_scores_gemma":[0.99911356,0.00009004661,0.00015245406,0.00009947012,0.00025135206,0.0002931185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001886165,0.000100785124,0.00044167085,0.00012588469,0.00012289407,0.00005011343,0.00010225561,0.00006269944,0.000036902464],"category_scores_gemma":[0.00016565756,0.00009859574,0.00015609403,0.00016109526,0.00026421878,0.00010424683,0.000026320206,0.00014800981,0.000003796852],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026581993,0.002773591,0.32107294,0.0011604928,0.0023458952,0.25406367,0.00024183163,0.000001426941,0.01969846,0.00092845596,0.09498382,0.3000712],"study_design_scores_gemma":[0.012727085,0.0011963767,0.10963889,0.0011599752,0.00039462108,0.81800586,0.0003405574,0.00021217667,0.004741485,0.0016482393,0.049656745,0.0002779861],"about_ca_topic_score_codex":0.000051876406,"about_ca_topic_score_gemma":0.00008219812,"teacher_disagreement_score":0.5639422,"about_ca_system_score_codex":0.000020958307,"about_ca_system_score_gemma":0.00007642152,"threshold_uncertainty_score":0.40206176},"labels":[],"label_agreement":null},{"id":"W2015701553","doi":"10.1111/j.1365-2141.2007.06649.x","title":"Aberrant nuclear p53 protein expression detected by immunohistochemistry is associated with hemizygous <i>P53</i> deletion and poor survival for multiple myeloma","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Research; Cancer Research Society","keywords":"Immunohistochemistry; Fluorescence in situ hybridization; Multiple myeloma; Biology; Nuclear protein; Cancer research; Pathology; Internal medicine; Gene; Medicine; Transcription factor; Immunology; Genetics","score_opus":0.010967042469762468,"score_gpt":0.2638467855076395,"score_spread":0.252879743037877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015701553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955071,0.0022573194,0.0010381121,0.00025926135,0.000053030824,0.00069692096,0.00007656432,0.00003092103,0.00008076533],"genre_scores_gemma":[0.996653,0.000106961365,0.0027754307,0.00009105634,0.000050203635,0.000021110445,0.000056760473,0.000048117396,0.00019734155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981873,0.00008047669,0.0005740141,0.00025198876,0.00040898568,0.0004972191],"domain_scores_gemma":[0.99834067,0.00024708352,0.00043663225,0.000125189,0.0005307738,0.00031963058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005167011,0.00018870163,0.0006850924,0.00009110698,0.00020415938,0.000036181118,0.000110132256,0.0002441781,0.00005533192],"category_scores_gemma":[0.0009277118,0.0001726608,0.00012088277,0.0001090275,0.00017768155,0.00010187281,0.000034772474,0.00039363065,0.0000019215458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075319824,0.00095823884,0.0035765741,0.00025760717,0.00052111247,0.021390079,0.0001343119,3.1406907e-7,0.9466941,0.0000018030617,0.0057513765,0.013182534],"study_design_scores_gemma":[0.039705314,0.0029016961,0.020361578,0.0032129749,0.00028393173,0.19041349,0.0004978432,0.00030308237,0.7399727,0.000055620072,0.0018181362,0.00047361708],"about_ca_topic_score_codex":0.0001009273,"about_ca_topic_score_gemma":0.00005413283,"teacher_disagreement_score":0.20672135,"about_ca_system_score_codex":0.0001348463,"about_ca_system_score_gemma":0.000101793965,"threshold_uncertainty_score":0.7040903},"labels":[],"label_agreement":null},{"id":"W2016466547","doi":"10.1046/j.1365-2141.2000.01950.x","title":"Low prevalence of chronic hepatitis C virus infection in B‐cell non‐Hodgkin's lymphoma patients from a population with a high prevalence of healthy Hepatitis c virus carriers","year":2000,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatitis C virus; Population; Immunology; Lymphoma; Hepatitis C; Asymptomatic; Lymphoproliferative disorders; Virology; Virus; Internal medicine","score_opus":0.004974546936898927,"score_gpt":0.2252995049284209,"score_spread":0.220324957991522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016466547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98767567,0.008110428,0.00006534961,0.0016365483,0.00059525383,0.00078278844,0.0010695723,0.000015040358,0.000049322487],"genre_scores_gemma":[0.8928475,0.099321604,0.00014313532,0.0069314875,0.00030215946,0.00003483466,0.00028686918,0.000076777615,0.00005564889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957537,0.00043570905,0.0018513127,0.000496429,0.000899483,0.0005633702],"domain_scores_gemma":[0.9958852,0.00013644998,0.0029787594,0.00031941914,0.0005334888,0.00014666258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022900496,0.00041040644,0.001970885,0.00054944505,0.00007322271,0.000020961632,0.0002591575,0.0009820608,0.0004616237],"category_scores_gemma":[0.00013506571,0.00045782267,0.00031105708,0.00040700936,0.00026109055,0.0002896102,0.000036505702,0.0011141767,0.0000037628902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001245126,0.00079507567,0.9410082,0.008667301,0.00029571488,0.007851469,0.00025228216,0.00017992702,0.00005543216,5.7653966e-7,0.025437446,0.01421145],"study_design_scores_gemma":[0.011433789,0.005813325,0.96341944,0.012384231,0.00084809895,0.00407713,0.0000063000007,0.000076994744,0.00067929155,0.00015500867,0.00064915756,0.00045721134],"about_ca_topic_score_codex":0.25865436,"about_ca_topic_score_gemma":0.043897245,"teacher_disagreement_score":0.21475711,"about_ca_system_score_codex":0.001043253,"about_ca_system_score_gemma":0.0010683284,"threshold_uncertainty_score":0.99978733},"labels":[],"label_agreement":null},{"id":"W2016490813","doi":"10.1111/j.1365-2141.2007.06643.x","title":"The linear effects of <i>α</i>‐thalassaemia, the <i>UGT1A1</i> and <i>HMOX1</i> polymorphisms on cholelithiasis in sickle cell disease","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council","keywords":"Gallstones; Bilirubin; Internal medicine; HMOX1; Genotype; Glucuronosyltransferase; Endocrinology; Biology; Unconjugated hyperbilirubinemia; Gastroenterology; Medicine; Heme; Gene; Heme oxygenase; Genetics; Enzyme; Biochemistry","score_opus":0.0038476320325057656,"score_gpt":0.24390715270320387,"score_spread":0.2400595206706981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016490813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620643,0.03372183,0.00002178247,0.0031752589,0.0002408218,0.00025880733,0.00000745368,0.000005260412,0.00050444924],"genre_scores_gemma":[0.9942191,0.002979564,0.00010932212,0.0023455436,0.00017647691,0.0000036409963,0.0000021404262,0.00001541133,0.00014877488],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841255,0.00009902828,0.00066443835,0.0001486032,0.00031175313,0.0003636048],"domain_scores_gemma":[0.9980101,0.00096199475,0.00037655732,0.0001981547,0.00012438823,0.00032877625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008300905,0.00012737977,0.00045020075,0.00006076619,0.00011784506,0.0000117688005,0.00018550621,0.00012203826,0.000005753517],"category_scores_gemma":[0.00042737377,0.00008486067,0.000120712044,0.00016116953,0.0003366884,0.000038674687,0.000045993937,0.0006510651,0.0000027841377],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021162892,0.0046336874,0.15530863,0.011503334,0.00035618665,0.35041454,0.0009217236,0.000011499677,0.061194956,0.0008617945,0.03757658,0.35605416],"study_design_scores_gemma":[0.018206516,0.0026190998,0.16957726,0.0066633117,0.00048659992,0.24904881,0.0010273029,0.00004318091,0.52444494,0.0010181167,0.02631664,0.00054823485],"about_ca_topic_score_codex":0.000094486655,"about_ca_topic_score_gemma":0.00005199241,"teacher_disagreement_score":0.46324998,"about_ca_system_score_codex":0.000029692987,"about_ca_system_score_gemma":0.00018671974,"threshold_uncertainty_score":0.34605175},"labels":[],"label_agreement":null},{"id":"W2016812202","doi":"10.1111/bjh.12620","title":"Activated prothrombin complex concentrate for dabigatran‐associated bleeding","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; McMaster University","funders":"","keywords":"Dabigatran; Prothrombin complex concentrate; Medicine; Internal medicine; PROTHROMBIN COMPLEX; Gastroenterology; Warfarin; Coagulation; Atrial fibrillation","score_opus":0.10344261414363952,"score_gpt":0.33750554170602143,"score_spread":0.2340629275623819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016812202","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16954643,0.0011877891,0.0004972765,0.82178736,0.0022415286,0.003521123,0.00008385003,0.0001081772,0.0010264586],"genre_scores_gemma":[0.33707485,0.0018929576,0.007898246,0.6041629,0.026730869,0.00008222095,0.003011945,0.0006209149,0.018525094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735826,0.00017167912,0.0012524987,0.00026206305,0.00040834476,0.0005471645],"domain_scores_gemma":[0.99693,0.00040570917,0.0016278396,0.00013378881,0.00078878575,0.00011389251],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003961281,0.0002924512,0.0019565283,0.00024379787,0.0001345704,0.00011799992,0.00022360435,0.00081553723,0.00073251495],"category_scores_gemma":[0.0006494049,0.00030190902,0.00061893504,0.00016666428,0.0001640097,0.00018747327,0.000039453418,0.0012256218,0.000022354207],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011750241,0.000016175494,0.00080125,0.00061985874,0.0011872101,0.014333856,0.000029668663,0.0000017457809,0.0025290297,0.00006241794,0.9791789,0.0011223948],"study_design_scores_gemma":[0.008216051,0.0006859332,0.0024540764,0.0024203272,0.001592236,0.080642655,0.00008416054,0.00011895963,0.0014805181,0.0010659418,0.9007063,0.0005328571],"about_ca_topic_score_codex":0.000035793884,"about_ca_topic_score_gemma":0.000004412134,"teacher_disagreement_score":0.21762447,"about_ca_system_score_codex":0.00013569217,"about_ca_system_score_gemma":0.00019044106,"threshold_uncertainty_score":0.9999433},"labels":[],"label_agreement":null},{"id":"W2016969352","doi":"10.1111/j.1365-2141.2005.05576.x","title":"Factors predicting development of chronic disease in Nordic children with acute onset of idiopathic thrombocytopenic purpura","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prospective cohort study; Disease; Thrombocytopenic purpura; Cohort; Autoantibody; Platelet; Pediatrics; Immunology; Internal medicine; Antibody","score_opus":0.01525597533152777,"score_gpt":0.2585459557642339,"score_spread":0.2432899804327061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016969352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803377,0.012501211,0.00003087198,0.0063256924,0.00012041279,0.0005170386,0.00013205278,0.000009063446,0.000025970006],"genre_scores_gemma":[0.9954304,0.0012109875,0.00036921035,0.0024054765,0.00018563271,0.000011041719,0.00029039796,0.000062439605,0.00003442732],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99694365,0.00013341356,0.00155708,0.00030676107,0.0005822122,0.00047687153],"domain_scores_gemma":[0.99773866,0.00006444736,0.0016110785,0.0002288707,0.00020415279,0.00015277472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021677888,0.00036937103,0.0026447205,0.00046773965,0.000056916488,0.000013784632,0.00029229384,0.00044894533,0.00007878327],"category_scores_gemma":[0.000075287244,0.00031632857,0.0002706234,0.00021028284,0.00022786573,0.00012959944,0.000068616806,0.0015498642,0.0000024741469],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005470386,0.0011292959,0.4710576,0.0014114789,0.005285243,0.4997308,0.00040978083,0.000016918562,0.000025540494,0.0000011909701,0.012455886,0.007929214],"study_design_scores_gemma":[0.008323369,0.0012546759,0.559913,0.012234621,0.002193845,0.41399089,0.00004763518,0.000010671599,0.00047229344,0.000034107088,0.0011067672,0.0004181431],"about_ca_topic_score_codex":0.00010263239,"about_ca_topic_score_gemma":0.00032591037,"teacher_disagreement_score":0.088855386,"about_ca_system_score_codex":0.00025448305,"about_ca_system_score_gemma":0.002187805,"threshold_uncertainty_score":0.9999289},"labels":[],"label_agreement":null},{"id":"W2017608397","doi":"10.1111/j.1365-2141.2008.07042.x","title":"Cytogenetic abnormalities and clinical correlations in peripheral T‐cell lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; Lymphoma; Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; T-cell lymphoma; Medicine; Internal medicine; Pathology; Angioimmunoblastic T-cell lymphoma; Not Otherwise Specified; Karyotype; Cytogenetics; Oncology; T cell; Biology; Immunology; Chromosome; Genetics","score_opus":0.02616071682398868,"score_gpt":0.2891621206018354,"score_spread":0.2630014037778467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017608397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854119,0.012908152,0.000021647162,0.00038558073,0.00020482102,0.00009604033,0.0000036527588,0.0000056199565,0.00096262427],"genre_scores_gemma":[0.9909522,0.0074302754,0.001021864,0.00026531456,0.00008571729,0.0000037244529,0.000002834624,0.000009342828,0.00022875739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879384,0.000112110385,0.00068417215,0.000113585455,0.00012464498,0.00017162344],"domain_scores_gemma":[0.9993303,0.00017432815,0.00018447077,0.00007239148,0.000095073156,0.00014347964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016808104,0.00008395825,0.0005545841,0.00009005091,0.000068603236,0.000011411367,0.000045587985,0.00011063745,0.0000749056],"category_scores_gemma":[0.00010178305,0.0000833866,0.00012882573,0.00006529495,0.00022271229,0.00006953171,0.000022280357,0.00011170541,0.000007028987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007401232,0.0009572273,0.88881534,0.000022732533,0.000062043386,0.100864775,0.00024663887,0.0000034082332,0.0000037883208,0.0000714611,0.0011389196,0.0077396617],"study_design_scores_gemma":[0.0052168425,0.00028681193,0.5700423,0.00010857647,0.000056765715,0.42325714,0.000115647454,0.00002661925,0.000045937322,0.000055726152,0.0007432929,0.000044358876],"about_ca_topic_score_codex":0.00015917908,"about_ca_topic_score_gemma":0.00012972312,"teacher_disagreement_score":0.32239234,"about_ca_system_score_codex":0.00007715534,"about_ca_system_score_gemma":0.00031879867,"threshold_uncertainty_score":0.34004068},"labels":[],"label_agreement":null},{"id":"W2018244566","doi":"10.1111/j.1365-2141.2008.07381.x","title":"Striking bone marrow plasmacytosis in a patient with sickle cell anaemia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Medicine; Bone marrow; Pathology; Pancytopenia; Gastroenterology; Internal medicine","score_opus":0.0071577117922863994,"score_gpt":0.20473003272391382,"score_spread":0.19757232093162744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018244566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901944,0.006816078,0.00005222192,0.0006284245,0.00011513233,0.0001425394,0.0000025740524,0.000011177787,0.0020374812],"genre_scores_gemma":[0.99592924,0.0023914962,0.0012401664,0.00031835047,0.000028002003,0.0000025167044,0.0000025828929,0.000020905523,0.00006674873],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99864453,0.00006789069,0.00059419393,0.00013930941,0.0002477578,0.00030630507],"domain_scores_gemma":[0.9992554,0.000048886508,0.0003072216,0.00009180859,0.00013754347,0.00015912624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001238049,0.00011712821,0.00064047734,0.00021285578,0.000075697484,0.000008896167,0.0000696081,0.0001579143,0.0000915334],"category_scores_gemma":[0.00007244556,0.00010636285,0.000100662604,0.00025240023,0.0001413077,0.000081167345,0.000022845565,0.000591539,0.000004276555],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000845611,0.0008449568,0.04874298,0.000183154,0.000107173764,0.92396635,0.001116889,0.00020321953,0.00085331895,0.000025282667,0.00848533,0.014625725],"study_design_scores_gemma":[0.00533922,0.0011054589,0.004934832,0.00091318064,0.00007646368,0.9797549,0.001169874,0.00006426772,0.0024784359,0.000033020267,0.003979761,0.00015054773],"about_ca_topic_score_codex":0.00011430796,"about_ca_topic_score_gemma":0.00010420522,"teacher_disagreement_score":0.05578858,"about_ca_system_score_codex":0.000057262543,"about_ca_system_score_gemma":0.00023531319,"threshold_uncertainty_score":0.4337351},"labels":[],"label_agreement":null},{"id":"W2019016630","doi":"10.1111/j.1365-2141.2005.05633.x","title":"<i>Viscum album</i> agglutinin‐I induces apoptosis and degradation of cytoskeletal proteins via caspases in human leukaemia eosinophil AML14.3D10 cells: differences with purified human eosinophils","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Apoptosis; Biology; Caspase; Gelsolin; Cell biology; Eosinophil; Inhibitor of apoptosis domain; Programmed cell death; Molecular biology; Immunology; Biochemistry; Actin","score_opus":0.011763441451814408,"score_gpt":0.22529496941808788,"score_spread":0.21353152796627348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019016630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938648,0.0048640408,0.0002641175,0.00021661831,0.00022184497,0.00037744455,0.000029956866,0.000021127375,0.00014005325],"genre_scores_gemma":[0.99822545,0.00035178993,0.001049336,0.00007583942,0.00005702784,0.000021247515,0.000028183833,0.000031652406,0.00015948465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973384,0.00043767397,0.001228211,0.00035756433,0.00012709416,0.00051106355],"domain_scores_gemma":[0.9983011,0.000112338894,0.0011230462,0.00020967517,0.00019234714,0.00006149289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044686825,0.0003181548,0.0011606559,0.00039772378,0.0003158388,0.00005260704,0.00040157256,0.00046516536,0.00017846437],"category_scores_gemma":[0.000052098014,0.00029777054,0.00013360838,0.00018238624,0.0006577535,0.00040365243,0.00009805853,0.00081317,0.000007534756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001534076,0.00051559537,0.0011626548,0.00008351245,0.00019489089,0.00039517586,0.00030656465,0.000005329204,0.9872659,0.00081285636,0.00020199663,0.008902105],"study_design_scores_gemma":[0.00374206,0.0017948259,0.010876352,0.0006740199,0.0001323785,0.030293772,0.00044084172,0.0000016965973,0.950748,0.0007192366,0.00019468147,0.00038211688],"about_ca_topic_score_codex":0.00089323893,"about_ca_topic_score_gemma":0.0011392758,"teacher_disagreement_score":0.036517892,"about_ca_system_score_codex":0.000048880167,"about_ca_system_score_gemma":0.000105347484,"threshold_uncertainty_score":0.9999474},"labels":[],"label_agreement":null},{"id":"W2019239152","doi":"10.1111/j.1365-2141.2009.07790.x","title":"Common genetic variants in candidate genes and risk of familial lymphoid malignancies","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; McMaster University","keywords":"Chronic lymphocytic leukemia; Genetics; Biology; Germline; Allele; Lymphoma; Gene; Single-nucleotide polymorphism; Immunology; Family aggregation; Leukemia; Medicine; Genotype; Disease; Internal medicine","score_opus":0.010635021783382229,"score_gpt":0.27334576001617544,"score_spread":0.26271073823279323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019239152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97895086,0.020402655,0.0000641811,0.00014925377,0.00010124464,0.00014383467,0.000013226471,0.0000045475063,0.00017022411],"genre_scores_gemma":[0.97942007,0.019234505,0.00113119,0.00010098639,0.00006648653,0.0000012586468,0.0000016638975,0.000010952621,0.000032918975],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982933,0.00019568509,0.0007491627,0.00014898992,0.00029643497,0.00031643047],"domain_scores_gemma":[0.99906224,0.0001408468,0.00032987818,0.00014815586,0.00016992162,0.00014898473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047647493,0.00010723833,0.00082887575,0.00022369847,0.000038252754,0.000014953437,0.00014411344,0.00013305045,0.000033333574],"category_scores_gemma":[0.00031153427,0.00010813881,0.000080712714,0.00016199735,0.0002220189,0.00006864296,0.000044676075,0.00023840231,0.0000021344981],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024042092,0.00086423167,0.38365963,0.00068121165,0.00047105848,0.3715512,0.0008857873,0.00015738393,0.015641259,0.00027112378,0.0023311854,0.22108172],"study_design_scores_gemma":[0.015692776,0.0006965882,0.29782444,0.0007352993,0.0001263348,0.6786348,0.00012753558,0.00084713724,0.0041117403,0.0009579298,0.00014074842,0.00010463882],"about_ca_topic_score_codex":0.003267734,"about_ca_topic_score_gemma":0.0009010732,"teacher_disagreement_score":0.30708364,"about_ca_system_score_codex":0.0006220746,"about_ca_system_score_gemma":0.0017934727,"threshold_uncertainty_score":0.49398583},"labels":[],"label_agreement":null},{"id":"W2019760292","doi":"10.1046/j.1365-2141.2002.03524.x","title":"Two new molecular bases for the Dombrock null phenotype","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Proband; Exon; Genetics; Phenotype; Nonsense mutation; Mutation; Biology; Null allele; Molecular biology; Nonsense; Gene; Missense mutation","score_opus":0.01984605660688836,"score_gpt":0.26159780919677533,"score_spread":0.24175175258988696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019760292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87115294,0.07254809,0.036005687,0.016919924,0.00084716396,0.00054104225,0.000008998439,0.00002552833,0.0019506594],"genre_scores_gemma":[0.99100643,0.001702637,0.004284698,0.0022606659,0.0003311754,0.0000035296064,0.0000016511112,0.000022887896,0.0003862922],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99914974,0.000035875044,0.00035461652,0.000101347934,0.00015872826,0.00019971034],"domain_scores_gemma":[0.99928385,0.00017454832,0.00013669368,0.000114074974,0.00015895623,0.00013186838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013284678,0.000085030595,0.00040201016,0.000048244616,0.000087873035,0.00002152931,0.00011999635,0.00006605502,0.0005339355],"category_scores_gemma":[0.00014481453,0.00006643587,0.0002164557,0.000082122824,0.00005696859,0.000053204072,0.00001272739,0.00023798471,0.000014619888],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012487856,0.0015138095,0.0019864633,0.00045826394,0.0014444126,0.094563305,0.0005035461,0.00009986987,0.011764394,0.011956813,0.39536366,0.47909668],"study_design_scores_gemma":[0.016400067,0.0014305768,0.0017998593,0.00079967873,0.0013951727,0.8418452,0.00018950735,0.0006106329,0.0058568567,0.004961873,0.12446449,0.00024605927],"about_ca_topic_score_codex":0.00011696831,"about_ca_topic_score_gemma":0.00006947998,"teacher_disagreement_score":0.7472819,"about_ca_system_score_codex":0.000008787617,"about_ca_system_score_gemma":0.000042991225,"threshold_uncertainty_score":0.58462197},"labels":[],"label_agreement":null},{"id":"W2020198050","doi":"10.1046/j.1365-2141.2002.3242_2.x","title":"THE USE OF ORAL VITAMIN K FOR REVERSAL OF OVER‐WARFARINIZATION","year":2002,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Warfarin; Medicine; Oral anticoagulant; Vitamin k; Vitamin; Dosing; Route of administration; Oral administration; Internal medicine; Surgery; Atrial fibrillation","score_opus":0.12578546430776633,"score_gpt":0.3273402323763966,"score_spread":0.20155476806863026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020198050","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15964672,0.0075066844,0.012904275,0.8096908,0.0065692086,0.0029781545,0.00024417153,0.0000419884,0.00041803418],"genre_scores_gemma":[0.26715088,0.047093898,0.12221403,0.41165897,0.04301045,0.00003190464,0.0018285059,0.0010836128,0.10592777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981244,0.0001238795,0.0011195157,0.00011198523,0.00033420604,0.00018599522],"domain_scores_gemma":[0.9968886,0.0007661209,0.0016209488,0.00015930872,0.0005346928,0.0000303594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031376767,0.00012879897,0.0010341951,0.00018450158,0.000054956192,0.000024760613,0.00014847174,0.00036665605,0.00009940479],"category_scores_gemma":[0.0011390791,0.000109921224,0.000439327,0.00012306102,0.0001566487,0.00011406501,0.00004020421,0.0004192398,0.0000014857159],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018669924,0.000009007125,0.0060422616,0.0004946206,0.000424538,0.001782619,0.000020361509,0.000012677935,0.000021457166,0.00017203073,0.98580945,0.0050242655],"study_design_scores_gemma":[0.0018622171,0.00032401562,0.0031034031,0.0005594698,0.00071136403,0.011231306,0.00001540015,0.00009172997,0.00006661351,0.00019558519,0.9817369,0.000101973244],"about_ca_topic_score_codex":0.00003759564,"about_ca_topic_score_gemma":0.000014173389,"teacher_disagreement_score":0.3980318,"about_ca_system_score_codex":0.000027591923,"about_ca_system_score_gemma":0.00006241917,"threshold_uncertainty_score":0.44824573},"labels":[],"label_agreement":null},{"id":"W2020428172","doi":"10.1111/bjh.13100","title":"Phase I‐<scp>II</scp> trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"Celgene","keywords":"Medicine; Lenalidomide; Prednisone; Refractory (planetary science); Cyclophosphamide; Internal medicine; Regimen; Multiple myeloma; Surgery; Gastroenterology; Chemotherapy","score_opus":0.018161703457920467,"score_gpt":0.28916118427606546,"score_spread":0.270999480818145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020428172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401665,0.0041875443,0.00020327706,0.00011159332,0.000108634966,0.0012576643,0.00007986726,0.000004990741,0.000029788445],"genre_scores_gemma":[0.9955913,0.002222702,0.0019371257,0.000020264188,0.000053453794,0.00004095686,0.000022890186,0.000022864819,0.00008847783],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984328,0.00014688571,0.00065949064,0.00018270985,0.00030643123,0.00027168417],"domain_scores_gemma":[0.9971907,0.0014061454,0.0006260976,0.00016936548,0.0004031788,0.00020448402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032573854,0.00016358141,0.00097254047,0.000111902125,0.0001266712,0.000013159043,0.00008017944,0.00010292891,0.0000048058255],"category_scores_gemma":[0.0012320997,0.0001072647,0.00013362868,0.000073850875,0.00036428706,0.00009285661,0.000021991435,0.000121678335,2.307304e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24247071,0.0243666,0.2142536,0.00076103583,0.004221422,0.0029332084,0.0013824446,0.00000802053,0.0011976983,0.00009052639,0.0016744513,0.50664026],"study_design_scores_gemma":[0.74050856,0.08286479,0.14878914,0.0005395299,0.0009245558,0.007489505,0.00022151152,0.0003205119,0.010459978,0.00015066599,0.0076330155,0.0000982433],"about_ca_topic_score_codex":0.00014632517,"about_ca_topic_score_gemma":0.00009326551,"teacher_disagreement_score":0.506542,"about_ca_system_score_codex":0.000036338242,"about_ca_system_score_gemma":0.00010440068,"threshold_uncertainty_score":0.43741274},"labels":[],"label_agreement":null},{"id":"W2020964516","doi":"10.1111/j.1365-2141.2006.05981.x","title":"Intravenous immunoglobulin inhibits anti‐glycoprotein IIb‐induced platelet apoptosis in a murine model of immune thrombocytopenia","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"Platelet; Apoptosis; Phosphatidylserine; Antibody; Immunology; Immune system; Medicine; Platelet membrane glycoprotein; Membrane glycoproteins; Pharmacology; Glycoprotein; Chemistry; Molecular biology; Biology; Biochemistry","score_opus":0.012844846432987621,"score_gpt":0.2429940948551032,"score_spread":0.2301492484221156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020964516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374646,0.004651794,0.0001302773,0.00038844877,0.0001067927,0.0004240877,0.000022691986,0.0000132269,0.0005162454],"genre_scores_gemma":[0.9968899,0.0008080299,0.0020901824,0.000058111833,0.000029875193,0.0000086031705,0.000024905692,0.000034932866,0.000055485398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745494,0.0000838579,0.0015024802,0.00022358734,0.00030435727,0.00043075334],"domain_scores_gemma":[0.9987286,0.000045827717,0.00070899003,0.00019570468,0.00023166403,0.00008921784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032230653,0.00022704064,0.0020029603,0.00032180006,0.00005694009,0.000020054194,0.00018751966,0.00024868705,0.00007973568],"category_scores_gemma":[0.00009326103,0.00023427236,0.0002462116,0.00027997576,0.00011850301,0.00016167972,0.00006389303,0.0004920886,0.000009802359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003328656,0.01073295,0.008007416,0.00093158183,0.0013156085,0.29966983,0.00058521214,0.0018426586,0.63439506,0.00083431596,0.0011451937,0.037211515],"study_design_scores_gemma":[0.021882897,0.0015465738,0.021897046,0.0023546354,0.00024393901,0.4661512,0.00016341089,0.0007114388,0.48128098,0.0033261264,0.00004606479,0.00039567487],"about_ca_topic_score_codex":0.00212062,"about_ca_topic_score_gemma":0.00026455658,"teacher_disagreement_score":0.16648138,"about_ca_system_score_codex":0.00008443377,"about_ca_system_score_gemma":0.00024111157,"threshold_uncertainty_score":0.95533496},"labels":[],"label_agreement":null},{"id":"W2021186137","doi":"10.1111/j.1365-2141.2008.07375.x","title":"The presence of α‐thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council","keywords":"Hydroxycarbamide; Medicine; Mean corpuscular volume; Fetal hemoglobin; Hemoglobinopathy; Disease; Internal medicine; BETA (programming language); Clinical trial; Gastroenterology; Immunology; Fetus; Hemoglobin; Biology; Genetics; Pregnancy","score_opus":0.004404148868553122,"score_gpt":0.20414189710301134,"score_spread":0.19973774823445822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021186137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371374,0.0027045326,0.000014118983,0.0028520394,0.00010848465,0.00034168724,0.000009267096,0.0000043601367,0.0002517543],"genre_scores_gemma":[0.99895376,0.0004464179,0.00006496025,0.00027872116,0.000014970955,0.000005129683,0.0000011385758,0.000015366113,0.00021952145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998382,0.000299852,0.0005416088,0.00012199096,0.0003792549,0.00027531412],"domain_scores_gemma":[0.9987079,0.00039356903,0.000268187,0.00020116783,0.00022706184,0.00020210579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048416393,0.00010289581,0.00039480982,0.00008703197,0.00013588897,0.000009299791,0.00024181757,0.00007663262,0.000018092951],"category_scores_gemma":[0.0007716387,0.000061267994,0.00009733797,0.00024776073,0.00037013908,0.00005848367,0.000040543266,0.000417967,0.0000038939897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042679373,0.0027085803,0.816959,0.0002716863,0.00031318987,0.09304453,0.0038901176,0.0014568343,0.00061091554,0.00008372144,0.028676856,0.009305147],"study_design_scores_gemma":[0.005634526,0.0010471096,0.9667107,0.0007375479,0.0000958175,0.02195639,0.00054264895,0.000051115374,0.00026254347,0.00009059363,0.0027526938,0.00011835213],"about_ca_topic_score_codex":0.000064247775,"about_ca_topic_score_gemma":0.000047315192,"teacher_disagreement_score":0.14975162,"about_ca_system_score_codex":0.00003091518,"about_ca_system_score_gemma":0.00031653652,"threshold_uncertainty_score":0.24984364},"labels":[],"label_agreement":null},{"id":"W2021294789","doi":"10.1111/j.1365-2141.2007.06941.x","title":"Arsenic trioxide induces <i>de novo</i> protein synthesis of annexin‐1 in neutrophils: association with a heat shock‐like response and not apoptosis","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"National Research Council Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Annexin A1; Annexin; Arsenic trioxide; Apoptosis; Heat shock protein; Cell biology; Chemistry; Molecular biology; Biology; Biochemistry; Gene","score_opus":0.006654030443037917,"score_gpt":0.2267698239768873,"score_spread":0.22011579353384939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021294789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975059,0.0015598339,0.00015882314,0.00049127213,0.000039956103,0.00018043589,0.000016097234,0.0000034492632,0.00004420629],"genre_scores_gemma":[0.9980988,0.000366787,0.0012142204,0.00018071651,0.00006242339,0.000011244064,0.0000018880689,0.00001972056,0.000044230477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843633,0.00029449223,0.0005704492,0.00019863794,0.00017755516,0.00032252807],"domain_scores_gemma":[0.9990715,0.00014082948,0.0003903411,0.0001150712,0.0001858071,0.00009646388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017149516,0.00013137044,0.0004649215,0.00016867308,0.000046769757,0.00002358975,0.00014726515,0.0002677828,0.000005925191],"category_scores_gemma":[0.0007380609,0.00013439717,0.00009050493,0.00015000507,0.00009830056,0.000015341511,0.00004382969,0.00023509706,3.9263855e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004053779,0.00016453145,0.007228395,0.000052861713,0.00010238277,0.0016495894,0.000069850634,0.000013654349,0.9840493,0.000010840553,0.00018325263,0.0024215134],"study_design_scores_gemma":[0.001449151,0.00088277296,0.021209873,0.00039959748,0.00003951205,0.019144738,0.00029710488,0.0000025231907,0.9557927,0.000028172035,0.00058598764,0.00016782348],"about_ca_topic_score_codex":0.00011152121,"about_ca_topic_score_gemma":0.00031245823,"teacher_disagreement_score":0.028256606,"about_ca_system_score_codex":0.000047125533,"about_ca_system_score_gemma":0.00016693129,"threshold_uncertainty_score":0.54805577},"labels":[],"label_agreement":null},{"id":"W2021580696","doi":"10.1046/j.1365-2141.2000.01961.x","title":"Relapse after bone marrow transplantation: evidence for distinct immunological mechanisms between adult and paediatric populations","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Cancer Research Society","keywords":"Medicine; Immunology; Transplantation; Donor lymphocyte infusion; Hematopoietic stem cell transplantation; Bone marrow; Haematopoiesis; Lymphocyte; Natural killer cell; Immune system; Progenitor cell; Stem cell; Internal medicine; Gastroenterology; Cytotoxic T cell; Biology","score_opus":0.03475342023049308,"score_gpt":0.294834983272305,"score_spread":0.2600815630418119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021580696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961299,0.006330142,0.030369503,0.0013258212,0.00013849385,0.00038584974,0.00006133832,0.00002187953,0.00006797295],"genre_scores_gemma":[0.9761807,0.0039483462,0.019428754,0.00013789094,0.0001261868,0.00003231784,0.000037460413,0.000019142492,0.000089251575],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99837875,0.00014987966,0.0008152519,0.00019726432,0.00022350987,0.00023534836],"domain_scores_gemma":[0.99876153,0.0005661754,0.00020654728,0.00009526115,0.00022183378,0.0001486191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043843352,0.00013310794,0.0006074485,0.00012015873,0.00010127032,0.000028359911,0.00007346253,0.00019750185,0.00040647038],"category_scores_gemma":[0.0002589775,0.00013288367,0.00015350405,0.00013113962,0.000097729564,0.00022421218,0.0000050739786,0.00025409658,0.000011572469],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017938726,0.0011950048,0.35372558,0.009442336,0.0010905885,0.22918701,0.0034456765,0.00002873515,0.0047831,0.008909092,0.0020213118,0.36823282],"study_design_scores_gemma":[0.0052421456,0.0009646683,0.37369153,0.0024888497,0.0015283817,0.6065226,0.00009821838,0.00005337186,0.00074847566,0.008235694,0.0001577096,0.00026836566],"about_ca_topic_score_codex":0.00002177211,"about_ca_topic_score_gemma":0.00003197076,"teacher_disagreement_score":0.37733558,"about_ca_system_score_codex":0.00002515482,"about_ca_system_score_gemma":0.00006111273,"threshold_uncertainty_score":0.5418839},"labels":[],"label_agreement":null},{"id":"W2022816298","doi":"10.1111/j.1365-2141.2008.07266.x","title":"ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Von Willebrand factor; ADAMTS13; Cleavage (geology); Sequence (biology); Genetics; Biology; Molecular biology; Chemistry; Immunology; Platelet","score_opus":0.026153280497387178,"score_gpt":0.2615444333792809,"score_spread":0.23539115288189372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022816298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96805626,0.030115323,0.000051826395,0.0010434597,0.0001844031,0.00029027654,0.0002232953,0.00000579268,0.000029378658],"genre_scores_gemma":[0.9976819,0.0017348606,0.000031841504,0.00045566284,0.00001779626,0.000010159842,0.0000074579693,0.000010636074,0.000049663453],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99838585,0.00044537205,0.0005578876,0.00021855115,0.000079334306,0.0003130213],"domain_scores_gemma":[0.99913263,0.00024574256,0.00034593398,0.00016164711,0.00006593799,0.000048128328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029213788,0.00014638406,0.0005907137,0.00017049396,0.00014767474,0.000014944453,0.0003219785,0.00011195391,0.0002043997],"category_scores_gemma":[0.00012331925,0.00012673075,0.000067809306,0.00013714186,0.0004027339,0.00008114486,0.00009397912,0.00021823615,0.0000063487996],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014347169,0.0014960842,0.23878436,0.00069318677,0.0007773981,0.017506264,0.01838254,0.0000032661749,0.6268654,0.0004974165,0.073380485,0.020178892],"study_design_scores_gemma":[0.009311436,0.0020761187,0.2802607,0.0014005217,0.000191996,0.6421662,0.004521132,0.000005394817,0.048296843,0.0002848471,0.010805052,0.00067976874],"about_ca_topic_score_codex":0.00023475642,"about_ca_topic_score_gemma":0.00044100886,"teacher_disagreement_score":0.6246599,"about_ca_system_score_codex":0.000017049506,"about_ca_system_score_gemma":0.000053365013,"threshold_uncertainty_score":0.516793},"labels":[],"label_agreement":null},{"id":"W2023110459","doi":"10.1111/j.1365-2141.2009.07692.x","title":"Bone marrow cells from patients with Shwachman‐Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Ribosome biogenesis; Gene; Biology; RNA; Gene expression; Ribosome; Downregulation and upregulation; Ribosomal protein; Messenger RNA; Transcription (linguistics); Molecular biology; Genetics","score_opus":0.004222464171878309,"score_gpt":0.19123282394750035,"score_spread":0.18701035977562205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023110459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737373,0.025860203,0.00006506571,0.00007523173,0.00005529317,0.00013119244,0.000044626842,0.0000038126925,0.000027294707],"genre_scores_gemma":[0.99627614,0.0016244572,0.0018182872,0.00015908541,0.000027112714,0.00000426054,0.00006184579,0.000018353945,0.000010428801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988583,0.00007026435,0.00040820029,0.0002590641,0.00014080758,0.00026336484],"domain_scores_gemma":[0.99934655,0.000009763174,0.00029704205,0.000113178365,0.00012127913,0.00011216907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077324476,0.0001727791,0.0004466725,0.00010345781,0.00006674864,0.00005283746,0.00014274889,0.00016828996,0.000008407172],"category_scores_gemma":[0.0000134062075,0.00016938057,0.000059770027,0.000087713925,0.00008809315,0.00002693494,0.0000416138,0.00010422339,8.4063305e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013794914,0.0034954075,0.6521822,0.00017249947,0.000613105,0.039686773,0.00023332419,0.00007372411,0.13802287,0.000010330239,0.001046434,0.1630838],"study_design_scores_gemma":[0.023732616,0.0044829487,0.6592786,0.0012367325,0.0004442777,0.036231264,0.0003671736,0.000030693667,0.2707022,0.0009669955,0.0012063397,0.0013201912],"about_ca_topic_score_codex":0.00011071927,"about_ca_topic_score_gemma":0.0003734656,"teacher_disagreement_score":0.16176362,"about_ca_system_score_codex":0.0000085633465,"about_ca_system_score_gemma":0.000059699887,"threshold_uncertainty_score":0.6907139},"labels":[],"label_agreement":null},{"id":"W2023591243","doi":"10.1111/j.1365-2141.2008.07345.x","title":"A family with hereditary hyperferritinaemia cataract syndrome: evidence of incomplete penetrance and clinical heterogeneity","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ferritin; Untranslated region; Penetrance; Gene; Genetics; Medicine; Biology; Mutation; Molecular biology; Messenger RNA; Pathology; Phenotype","score_opus":0.03893172973317715,"score_gpt":0.2984226482130131,"score_spread":0.25949091847983596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023591243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92531663,0.063662075,0.00028441128,0.010200615,0.00026751644,0.00014781291,0.000088683424,0.0000031976301,0.000029042696],"genre_scores_gemma":[0.9230659,0.044718638,0.0015648407,0.029564261,0.0008895262,0.000010284025,0.00007900875,0.000050298466,0.000057236277],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99761385,0.00032878993,0.0010505872,0.00043270056,0.00028362553,0.00029047317],"domain_scores_gemma":[0.99785674,0.00010995743,0.0009961922,0.0003749077,0.0005602304,0.00010196622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035620015,0.00024771763,0.0010261447,0.00008098342,0.000087294946,0.000023140106,0.00047246015,0.0007180927,0.000009100201],"category_scores_gemma":[0.00016787839,0.00025052365,0.00025741357,0.00007647388,0.0007184535,0.000017205813,0.000090706504,0.0011124647,0.0000013971071],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006591712,0.0002272882,0.019518267,0.0009685844,0.0011608099,0.15518636,0.000015626283,0.000016864626,0.0035540815,0.000002655371,0.8116579,0.007032374],"study_design_scores_gemma":[0.0010800665,0.0021219945,0.05323179,0.001786734,0.00021547762,0.87422466,0.000017889346,0.000004628802,0.00064302195,0.000016093169,0.06625493,0.00040269122],"about_ca_topic_score_codex":0.00019258677,"about_ca_topic_score_gemma":0.0001297711,"teacher_disagreement_score":0.745403,"about_ca_system_score_codex":0.000017277996,"about_ca_system_score_gemma":0.00044808257,"threshold_uncertainty_score":0.9999947},"labels":[],"label_agreement":null},{"id":"W2023816137","doi":"10.1111/bjh.12468","title":"Disseminated histoplasmosis diagnosed by peripheral blood film in a patient with chronic lymphocytic leukaemia","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lymphocytosis; Pancytopenia; Neutropenia; Schistocyte; Chronic lymphocytic leukemia; Gastroenterology; Internal medicine; Pathology; Hemophagocytosis; Surgery; Leukemia; Bone marrow; Chemotherapy","score_opus":0.0036001682148560712,"score_gpt":0.2058655726754294,"score_spread":0.20226540446057334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023816137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860997,0.01268267,0.000027307105,0.00038199977,0.00014715984,0.00022382985,0.0000052140126,0.0000132423465,0.00041886212],"genre_scores_gemma":[0.99796665,0.0013385037,0.00021584936,0.00016656956,0.0000292367,0.000046402558,0.0000052480755,0.000018352413,0.00021316283],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988443,0.00006241258,0.0005065433,0.00014551937,0.00015776338,0.00028343452],"domain_scores_gemma":[0.9992394,0.000104541316,0.00021938216,0.00009072814,0.00022699316,0.00011896952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071807066,0.00013319026,0.00064651726,0.00011418858,0.000079054174,0.000026448532,0.00006282451,0.0000970797,0.00042133286],"category_scores_gemma":[0.00014702894,0.00011649365,0.00009063381,0.00018371867,0.0001416338,0.0001189456,0.00002303352,0.00029646896,0.000007940293],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072939566,0.0031379196,0.19747603,0.0009125752,0.0016692062,0.4121972,0.0023862193,0.0005524409,0.012393243,0.0000937589,0.3332582,0.035193816],"study_design_scores_gemma":[0.010648519,0.0049046543,0.03733724,0.0024900767,0.00031319106,0.9357288,0.0008121687,0.0006278786,0.0038240626,0.00004285183,0.0029264379,0.0003441292],"about_ca_topic_score_codex":0.0016411552,"about_ca_topic_score_gemma":0.0008558069,"teacher_disagreement_score":0.5235316,"about_ca_system_score_codex":0.00062637613,"about_ca_system_score_gemma":0.0003005108,"threshold_uncertainty_score":0.47504732},"labels":[],"label_agreement":null},{"id":"W2024903169","doi":"10.1111/bjh.13263","title":"Paediatric acute lymphoblastic leukaemia mimicking Langerhans cell histiocytosis of bone","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pelvis; Bone marrow; Pathology; Bone pain; Langerhans cell histiocytosis; Histiocytosis; Immunophenotyping; White blood cell; Radiology; Internal medicine","score_opus":0.006083556415049535,"score_gpt":0.2231461231124344,"score_spread":0.21706256669738486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024903169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98837596,0.006316779,0.0018437555,0.00019399414,0.00030625248,0.000097036966,0.000013478939,0.000012918534,0.0028398242],"genre_scores_gemma":[0.99625415,0.00089701155,0.002288258,0.0001615908,0.00009910041,0.0000026537718,0.000009148905,0.000023634526,0.0002644781],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99860406,0.00007624959,0.0006875352,0.00014207789,0.00024495582,0.0002451252],"domain_scores_gemma":[0.9987784,0.00014998806,0.00056185597,0.00013263605,0.0002225941,0.00015449387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021624044,0.00012839994,0.00088283286,0.00022602528,0.00005638248,0.000011152487,0.00009570641,0.00012482934,0.00012253308],"category_scores_gemma":[0.00023162359,0.000130712,0.00022449554,0.00016118286,0.000109379485,0.000059021626,0.000026975165,0.00016899475,0.00002507035],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027879663,0.008507364,0.17700848,0.0045942785,0.004293782,0.34183806,0.0023125126,0.00023109703,0.016394775,0.0016975979,0.10416879,0.33616528],"study_design_scores_gemma":[0.027092468,0.0035143006,0.018557176,0.0020608187,0.005599555,0.91705513,0.0004063651,0.0006965787,0.0095619075,0.0013856043,0.013459618,0.0006104766],"about_ca_topic_score_codex":0.0000855118,"about_ca_topic_score_gemma":0.000023564773,"teacher_disagreement_score":0.57521707,"about_ca_system_score_codex":0.00009745964,"about_ca_system_score_gemma":0.00018683418,"threshold_uncertainty_score":0.53302807},"labels":[],"label_agreement":null},{"id":"W2025366996","doi":"10.1111/j.1365-2141.2007.06906.x","title":"Considerations in the approach to invasive fungal infection in patients with haematological malignancies","year":2007,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Intensive care medicine; Medicine; Empiric treatment; Invasive candidiasis; Antifungal; Biology; Dermatology; Antibiotics; Fluconazole","score_opus":0.06451927805154582,"score_gpt":0.3313548320321513,"score_spread":0.2668355539806055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025366996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2624733,0.7350255,0.00018006041,0.000081926424,0.00011004492,0.0014095876,0.000013357989,0.0000071648133,0.0006990121],"genre_scores_gemma":[0.18278037,0.8154198,0.0011023225,0.00049904955,0.00006820008,0.00005115862,0.000033610362,0.000027236343,0.000018247669],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9969117,0.0006072536,0.001404691,0.00029487014,0.00042230025,0.00035916705],"domain_scores_gemma":[0.9980354,0.00072929077,0.0005499619,0.00021117418,0.00036233893,0.00011185625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012025022,0.00025564013,0.0025563205,0.00047078976,0.00007678218,0.000047462854,0.00014919136,0.00039879908,0.00002686468],"category_scores_gemma":[0.0017809437,0.00016863988,0.00028368726,0.0005544904,0.00021271713,0.00010672578,0.000035947534,0.001210421,0.000008895769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006513787,0.0053301197,0.6873222,0.024136644,0.00044171844,0.14480218,0.00083890883,0.000010756445,1.9966997e-7,0.0031214913,0.0068987533,0.12644567],"study_design_scores_gemma":[0.0029520444,0.0013556704,0.45042324,0.041046694,0.0007484448,0.46505463,0.00034191893,4.031041e-7,0.0000011382364,0.00033002748,0.03726758,0.00047818312],"about_ca_topic_score_codex":0.00007174827,"about_ca_topic_score_gemma":0.0019654576,"teacher_disagreement_score":0.32025245,"about_ca_system_score_codex":0.00015059563,"about_ca_system_score_gemma":0.00066512526,"threshold_uncertainty_score":0.6876934},"labels":[],"label_agreement":null},{"id":"W2025391163","doi":"10.1111/j.1365-2141.2009.07697.x","title":"Mutations of polycomb‐associated gene <i>ASXL1</i> in myelodysplastic syndromes and chronic myelomonocytic leukaemia","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":556,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Myelodysplastic syndromes; Haematopoiesis; Myeloid; Chronic myelomonocytic leukemia; Biology; Epigenetics; Cancer research; Gene; Comparative genomic hybridization; Mutation; Genetics; Genome; Immunology; Stem cell; Bone marrow","score_opus":0.014716156334597125,"score_gpt":0.2851794044656786,"score_spread":0.27046324813108147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025391163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890302,0.008661968,0.00015397025,0.0015246626,0.00009667638,0.00022623716,0.000012564761,0.00001399686,0.000279748],"genre_scores_gemma":[0.996962,0.0017884218,0.0008339847,0.00021592437,0.0000506362,0.0000029994512,0.000013354044,0.00002083782,0.00011180477],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.997878,0.00018373156,0.00097111403,0.0001944092,0.00033252983,0.0004401881],"domain_scores_gemma":[0.9985558,0.00034979812,0.00044188567,0.00013936705,0.0003007569,0.00021244174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005130639,0.00015313645,0.0010629247,0.0005131112,0.000058535166,0.000021831347,0.00017831563,0.00021505315,0.0000638581],"category_scores_gemma":[0.0010649704,0.00016826444,0.00012112527,0.00046366564,0.00028415042,0.00015470621,0.000043356576,0.0007302713,0.000006099793],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021771463,0.0030497278,0.059940305,0.0016141975,0.0020308318,0.66345274,0.001858513,0.00056892354,0.12791926,0.002551991,0.015231361,0.119605005],"study_design_scores_gemma":[0.011074738,0.002475328,0.19624354,0.0019371194,0.00030532407,0.7779471,0.000252522,0.0009918751,0.006300251,0.0020432253,0.00016782258,0.0002611413],"about_ca_topic_score_codex":0.0001211525,"about_ca_topic_score_gemma":0.00014506854,"teacher_disagreement_score":0.13630323,"about_ca_system_score_codex":0.00053831766,"about_ca_system_score_gemma":0.0010839739,"threshold_uncertainty_score":0.6861625},"labels":[],"label_agreement":null},{"id":"W2025701448","doi":"10.1111/bjh.12339","title":"Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; Kræftens Bekæmpelse; Aarhus Universitetshospital","keywords":"Thrombocytosis; Stem cell; Myeloid; Vincristine; Anagrelide; Medicine; Progenitor cell; Haematopoiesis; Bone marrow; Immunology; Hematology; Internal medicine; Cyclophosphamide; Biology; Cancer research; Pathology; Essential thrombocythemia; Platelet; Chemotherapy","score_opus":0.019931176247564228,"score_gpt":0.2603717279615163,"score_spread":0.24044055171395207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025701448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90293765,0.056372736,0.00019141607,0.036352847,0.0010952634,0.0015694301,0.000097446406,0.0001180299,0.0012651997],"genre_scores_gemma":[0.8431469,0.011381389,0.004549203,0.10632886,0.016498303,0.00022985395,0.00085988175,0.0011542519,0.015851365],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9940638,0.0006501902,0.002229288,0.0009219159,0.0005875467,0.0015472588],"domain_scores_gemma":[0.9943932,0.00054282736,0.0029486993,0.0007008229,0.0010407069,0.0003737021],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.000463461,0.0008789095,0.0037028482,0.00060096435,0.00026725768,0.00012879782,0.00055907335,0.0024153474,0.0007746527],"category_scores_gemma":[0.00010994212,0.00082153647,0.0005842487,0.00037484846,0.00038972398,0.000307799,0.00022171297,0.006462008,0.00018571167],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076642646,0.00009240484,0.0002872571,0.0025491186,0.0012123269,0.7178897,0.000112931135,0.000012105515,0.00039364042,0.0000027875235,0.27444857,0.0029224958],"study_design_scores_gemma":[0.008238016,0.0014683031,0.000025889682,0.004195076,0.0016116132,0.9098111,0.00008952934,0.00021520838,0.0014889119,0.000024758987,0.07222106,0.00061053503],"about_ca_topic_score_codex":0.0008261607,"about_ca_topic_score_gemma":0.00014143475,"teacher_disagreement_score":0.2022275,"about_ca_system_score_codex":0.0022627271,"about_ca_system_score_gemma":0.0030799308,"threshold_uncertainty_score":0.99942356},"labels":[],"label_agreement":null},{"id":"W2026187531","doi":"10.1046/j.1365-2141.2002.03509.x","title":"Natural history of juvenile haemochromatosis","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hemochromatosis; Internal medicine; Medicine; Disease; Juvenile; Natural history; Cirrhosis; Gastroenterology; Genetics; Biology","score_opus":0.03336989373666223,"score_gpt":0.2922507126913472,"score_spread":0.258880818954685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026187531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028086535,0.99399805,0.000011875372,0.000042236934,0.0023950806,0.00025125255,0.000017574093,0.000013157453,0.0029899152],"genre_scores_gemma":[0.00015084176,0.9961262,0.000747984,0.00011544082,0.00022369597,0.0000054238803,0.000021009613,0.00006094751,0.0025485093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968613,0.00025777484,0.001941122,0.00021553811,0.00040593222,0.0003183496],"domain_scores_gemma":[0.99706316,0.0001459565,0.0020534568,0.00025883128,0.0003016666,0.0001769032],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033072548,0.00030304655,0.0055542635,0.0004797627,0.000025395495,0.000007639985,0.00032109968,0.0004572557,0.001112534],"category_scores_gemma":[0.00044903244,0.00029003937,0.0013692839,0.00016737705,0.00033209135,0.00009095995,0.000054405147,0.0009837832,0.000044359644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017038898,0.00022338501,0.0000039680267,0.027648048,0.00021645892,0.02672486,0.000055586883,3.9436312e-8,9.804145e-7,0.00010261619,0.18913099,0.755876],"study_design_scores_gemma":[0.0006425553,0.00007262459,0.0000065452787,0.0121272635,0.0017536733,0.3752332,0.000016362175,3.3104783e-7,7.773867e-7,0.000015077821,0.6100043,0.00012728541],"about_ca_topic_score_codex":0.000038588754,"about_ca_topic_score_gemma":0.000008105755,"teacher_disagreement_score":0.75574875,"about_ca_system_score_codex":0.00019203241,"about_ca_system_score_gemma":0.0009982175,"threshold_uncertainty_score":0.9999552},"labels":[],"label_agreement":null},{"id":"W2027327114","doi":"10.1111/bjh.12033","title":"Phage display generation of a novel human anti‐<scp>CD</scp>1<scp>A</scp> monoclonal antibody with potent cytolytic activity","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Allergy and Infectious Diseases; Cancer Research Institute; Foundation for the National Institutes of Health","keywords":"Antibody-dependent cell-mediated cytotoxicity; Monoclonal antibody; Antibody; Phage display; Avidity; Antigen; Biology; Cytotoxicity; Cytolysis; Molecular biology; Cell culture; Immunology; In vitro; Biochemistry","score_opus":0.029270119024475735,"score_gpt":0.2986538871679408,"score_spread":0.26938376814346504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027327114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909242,0.0024961967,0.004619375,0.00006803535,0.00027929017,0.0002966321,0.0000451194,0.00001563444,0.0012555153],"genre_scores_gemma":[0.99696976,0.00020869698,0.001997392,0.000079488906,0.00024599265,0.0000073798888,0.00005388548,0.00004147523,0.00039594955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799514,0.00009659597,0.0006664941,0.00023426389,0.00048631636,0.00052117364],"domain_scores_gemma":[0.9981982,0.00018817958,0.0007827879,0.00020264272,0.00030602582,0.0003221469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033186117,0.00025138838,0.0010876365,0.00021637039,0.00018277705,0.00003432163,0.00013863397,0.00018027467,0.000019691384],"category_scores_gemma":[0.00035702594,0.00022656478,0.00022365879,0.00018871798,0.0002373299,0.00034450018,0.000041176056,0.0003618105,0.000010331189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025883768,0.032042302,0.5313729,0.0014573028,0.0058909953,0.079478964,0.0036743463,0.00027760165,0.30771312,0.0032978086,0.021658871,0.012876942],"study_design_scores_gemma":[0.020201879,0.0027076916,0.51028144,0.0014062608,0.0021311336,0.4335542,0.000893934,0.000985802,0.025279425,0.00007406349,0.0023078162,0.000176328],"about_ca_topic_score_codex":0.00015928212,"about_ca_topic_score_gemma":0.000073494244,"teacher_disagreement_score":0.35407525,"about_ca_system_score_codex":0.000094971954,"about_ca_system_score_gemma":0.0002163215,"threshold_uncertainty_score":0.92390436},"labels":[],"label_agreement":null},{"id":"W2027774332","doi":"10.1111/j.1365-2141.2009.07728.x","title":"Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University Health Network; Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Discontinuation; Dexamethasone; Internal medicine; Multiple myeloma; Adverse effect; Thalidomide; Refractory (planetary science); Gastroenterology; Surgery","score_opus":0.03021112419302469,"score_gpt":0.31823097306370635,"score_spread":0.28801984887068166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027774332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573106,0.0022826432,0.00043752548,0.0006443878,0.00007921308,0.00038947733,0.0000060105285,0.000021100805,0.00040861446],"genre_scores_gemma":[0.991525,0.0008815451,0.0068984954,0.000303131,0.00006833558,0.0000128001475,0.0000074445547,0.000021869933,0.00028137257],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99758524,0.0002515791,0.0008307929,0.00027683625,0.00050998456,0.0005455969],"domain_scores_gemma":[0.99834174,0.00042371775,0.00035161612,0.0002323058,0.00026636355,0.00038423343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041567374,0.00019681922,0.0010582795,0.00029698564,0.00009343252,0.000030350788,0.00019629503,0.00016154777,0.00024340338],"category_scores_gemma":[0.001502321,0.00015343321,0.00012158402,0.0003161366,0.00020229578,0.00019838636,0.000027676599,0.00063412957,0.000011319669],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05118662,0.0016335323,0.080615364,0.00010252398,0.0002868691,0.70530516,0.0013888995,0.00003996122,0.0040345653,0.000039513776,0.0007435131,0.15462348],"study_design_scores_gemma":[0.045207467,0.004299832,0.36445165,0.0017245725,0.00006833209,0.57617915,0.0011229744,0.00023950498,0.005366721,0.00008015348,0.0010051833,0.00025446477],"about_ca_topic_score_codex":0.00020632845,"about_ca_topic_score_gemma":0.00078217196,"teacher_disagreement_score":0.28383628,"about_ca_system_score_codex":0.00026048243,"about_ca_system_score_gemma":0.0005213931,"threshold_uncertainty_score":0.6256825},"labels":[],"label_agreement":null},{"id":"W2028313456","doi":"10.1111/j.1365-2141.2006.06080.x","title":"Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma*","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Transplantation; Lymphoma; Stem cell; Haematopoiesis; Internal medicine; Chemoradiotherapy; Oncology; Hematology; Chemotherapy; Hematopoietic stem cell transplantation; Disease; Gastroenterology; Biology","score_opus":0.006630559670720683,"score_gpt":0.2195492214605781,"score_spread":0.2129186617898574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028313456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722733,0.024209276,0.000075272575,0.0004453089,0.00019674128,0.0002484549,0.000014885198,0.000015572929,0.0025212248],"genre_scores_gemma":[0.9868671,0.011803404,0.0006338885,0.0003919691,0.00008970649,0.000009072405,0.000028691311,0.000025614585,0.00015055729],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99818766,0.000097708435,0.0009241277,0.00017115369,0.00037884832,0.00024050551],"domain_scores_gemma":[0.9986743,0.000117488955,0.00061995804,0.00014362053,0.00032861292,0.00011604071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017206758,0.00016729845,0.0009312721,0.00016605621,0.00005242126,0.00001851033,0.00011480832,0.0001486699,0.000088460365],"category_scores_gemma":[0.000007472883,0.00015662902,0.00029011111,0.00013557052,0.0001262628,0.00010724194,0.000007888881,0.000092323135,0.00001802633],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031080463,0.011907773,0.19650874,0.002566716,0.000935668,0.5371978,0.0012812988,0.000039791394,0.0076375296,0.003834834,0.013038802,0.22194296],"study_design_scores_gemma":[0.016049996,0.001060457,0.25417486,0.0011117973,0.00033419183,0.6577309,0.0001539517,0.0000049882324,0.06704409,0.00092854904,0.0012273652,0.00017888559],"about_ca_topic_score_codex":0.00052261725,"about_ca_topic_score_gemma":0.000028565784,"teacher_disagreement_score":0.22176407,"about_ca_system_score_codex":0.00012418565,"about_ca_system_score_gemma":0.00041063564,"threshold_uncertainty_score":0.6387146},"labels":[],"label_agreement":null},{"id":"W2029045196","doi":"10.1111/bjh.13176","title":"Thalidomide‐prednisone maintenance following autologous stem cell transplant for <scp>M</scp>ultiple <scp>M</scp>yeloma: effect on thrombin generation and procoagulant markers in <scp>NCIC CTG MY</scp>.10","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Queen's University; London Health Sciences Centre","funders":"Canadian Cancer Society Research Institute; Celgene; Amgen; National Cancer Institute; National Institutes of Health; Cancer Research Institute","keywords":"Medicine; Thalidomide; Prednisone; Internal medicine; Autologous stem-cell transplantation; Gastroenterology; Multiple myeloma; Incidence (geometry); Oncology; Surgery","score_opus":0.01678841548025037,"score_gpt":0.2652000940276421,"score_spread":0.24841167854739174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029045196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98957515,0.0049272943,0.0015016522,0.00014116662,0.0005423471,0.0023013945,0.00009445518,0.000064881315,0.0008516867],"genre_scores_gemma":[0.9949137,0.0008102617,0.002085821,0.00017851991,0.00023306783,0.0002452009,0.00012265953,0.000109919674,0.0013008451],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9947518,0.0009255815,0.0013523106,0.0007943308,0.00075563096,0.0014203128],"domain_scores_gemma":[0.99276924,0.005269057,0.0006968943,0.0003573733,0.00028036907,0.0006270358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002141335,0.0005803694,0.002149165,0.00054565095,0.0003110705,0.00014680029,0.00034200647,0.0004900231,0.0000063385505],"category_scores_gemma":[0.0033723053,0.00052973116,0.0005224829,0.0002954434,0.0002314323,0.00028530273,0.000066855806,0.0008291677,0.000027894957],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040046875,0.007616415,0.26484627,0.010820753,0.0060933847,0.28428805,0.0088793915,0.0007126314,0.15157455,0.0008567995,0.15963823,0.100668855],"study_design_scores_gemma":[0.13603836,0.02660608,0.2063358,0.009777976,0.0021786436,0.38612238,0.0042801816,0.025804173,0.18904944,0.0008316575,0.012443116,0.00053221674],"about_ca_topic_score_codex":0.00014961636,"about_ca_topic_score_gemma":0.00040438204,"teacher_disagreement_score":0.14719512,"about_ca_system_score_codex":0.00024084526,"about_ca_system_score_gemma":0.0002747526,"threshold_uncertainty_score":0.99971545},"labels":[],"label_agreement":null},{"id":"W2029092443","doi":"10.1046/j.1365-2141.2003.04603.x","title":"Louis Diamond and His Contribution To Haematology","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of California, San Francisco","keywords":"Medicine; Pediatrics; Classics; Family medicine; Gerontology; History","score_opus":0.004418746664078501,"score_gpt":0.2243062754297625,"score_spread":0.21988752876568401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029092443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816777,0.0156179555,0.0016636241,0.00032750677,0.00022866695,0.00011765847,0.000011455672,0.0000032117766,0.00035223324],"genre_scores_gemma":[0.997403,0.00091737695,0.0010785809,0.0004605554,0.000032872795,0.00000635446,0.000010815852,0.000013317545,0.00007707761],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99902016,0.00013598714,0.0003337722,0.00018693005,0.000077235636,0.00024588857],"domain_scores_gemma":[0.99937075,0.000019884774,0.00016901494,0.000106232415,0.00017881031,0.00015531483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017988464,0.000113124916,0.00039790117,0.00006155558,0.00007911663,0.000028933617,0.00009183019,0.00016880372,0.000032121097],"category_scores_gemma":[0.00038771395,0.00012274265,0.000081688035,0.000062627674,0.00009067194,0.000005849893,0.000037676105,0.00009611285,0.000007885338],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018472886,0.004815286,0.38913155,0.00038088756,0.0045773783,0.18144724,0.00055848353,0.000103134495,0.06490568,0.062344372,0.1890399,0.10084882],"study_design_scores_gemma":[0.0058691194,0.0016408637,0.00551383,0.00010887225,0.00020334178,0.76064235,0.00014739897,0.000002961598,0.075249426,0.004048054,0.14613827,0.00043551452],"about_ca_topic_score_codex":0.000018584655,"about_ca_topic_score_gemma":0.00008810707,"teacher_disagreement_score":0.57919514,"about_ca_system_score_codex":0.000007715599,"about_ca_system_score_gemma":0.000059062717,"threshold_uncertainty_score":0.50053},"labels":[],"label_agreement":null},{"id":"W2029230582","doi":"10.1111/j.1365-2141.2007.06764.x","title":"IgG‐mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti‐D in the prevention of haemolytic disease of the newborn?","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Opsonin; Immune system; Phagocytosis; Antibody; Immunology; Humoral immunity; Antigen; Immunosuppression; Antibody opsonization; Biology","score_opus":0.04960957571744798,"score_gpt":0.3315587411966382,"score_spread":0.28194916547919024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029230582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98954767,0.0019467539,0.0043469477,0.0031203965,0.00018633208,0.00079442735,0.000041551324,0.000002879166,0.000013064821],"genre_scores_gemma":[0.9971078,0.0024488356,0.00025250588,0.000128334,0.000026177042,0.000010759149,0.0000043684618,0.000009865811,0.000011334286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982342,0.00018099559,0.0009822244,0.00012590029,0.00032040727,0.00015624895],"domain_scores_gemma":[0.9978042,0.0006211433,0.0009149595,0.00030238013,0.00032218397,0.000035091358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009315633,0.000098268996,0.00052762835,0.000098570286,0.000089871304,0.0000039775914,0.000294211,0.00013584085,0.00002958175],"category_scores_gemma":[0.00037216823,0.000052395724,0.00029013495,0.00024181219,0.0002031937,0.0000652071,0.000035653076,0.0003179268,2.452752e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032232482,0.0075586108,0.008818996,0.001781943,0.0007891596,0.0006763095,0.0014742818,0.000110059795,0.77665025,0.0072925105,0.00045459892,0.16216081],"study_design_scores_gemma":[0.0056670993,0.0017255661,0.7175614,0.0026751268,0.00058273296,0.01062081,0.00080436975,0.000109285436,0.2576435,0.0024341545,0.00009788612,0.00007804904],"about_ca_topic_score_codex":0.000068527035,"about_ca_topic_score_gemma":0.000079299425,"teacher_disagreement_score":0.70874244,"about_ca_system_score_codex":0.000019946192,"about_ca_system_score_gemma":0.0001276097,"threshold_uncertainty_score":0.21366356},"labels":[],"label_agreement":null},{"id":"W2029490929","doi":"10.1111/j.1365-2141.2008.07388.x","title":"Paraneoplastic pemphigus associated with follicular lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Paraneoplastic pemphigus; Medicine; Skin biopsy; Pemphigus; Pathology; Lymphoma; Acantholysis; Biopsy; Rituximab; Dermatology; Prednisolone; Vincristine; Leukemia cutis; Cyclophosphamide; Antibody; Chemotherapy; Gastroenterology; Autoantibody; Internal medicine; Immunology","score_opus":0.011386215643355065,"score_gpt":0.22030430871596593,"score_spread":0.20891809307261086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029490929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988991,0.009700499,0.00025534947,0.0002820332,0.0001616237,0.00014451363,0.000006184569,0.000042652166,0.0004161458],"genre_scores_gemma":[0.99838513,0.00047704822,0.00041235477,0.0003041809,0.0000649131,0.000004623946,0.000010970297,0.00003785075,0.000302907],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983526,0.00012454137,0.0005925974,0.00015901458,0.00042314726,0.00034812785],"domain_scores_gemma":[0.9984848,0.0002146288,0.00050029776,0.00015480349,0.00043084752,0.00021463471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016030193,0.00015671735,0.0009358151,0.00014029712,0.00014975804,0.000013553843,0.00014765222,0.0001379978,0.00020790838],"category_scores_gemma":[0.0011535517,0.00014818045,0.00021430518,0.00020049626,0.00031278795,0.00008644974,0.000025651823,0.00020092716,0.000029466177],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005050068,0.0012157969,0.07396745,0.00006252989,0.0007667144,0.9105203,0.0001233234,0.00003477321,0.000072092116,0.000063075895,0.011120775,0.0015481254],"study_design_scores_gemma":[0.0044032433,0.0004607343,0.303492,0.0006751162,0.00028959743,0.6894914,0.00004363615,0.0000201014,0.00014234347,0.00006583212,0.0008037856,0.00011219882],"about_ca_topic_score_codex":0.00004599081,"about_ca_topic_score_gemma":0.000026409323,"teacher_disagreement_score":0.22952455,"about_ca_system_score_codex":0.000086543056,"about_ca_system_score_gemma":0.00056405173,"threshold_uncertainty_score":0.60426235},"labels":[],"label_agreement":null},{"id":"W2030675928","doi":"10.1046/j.1365-2141.2003.04636.x","title":"Heparin‐induced thrombocytopenia: pathogenesis and management – Response to Rasheed Saad","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton General Hospital","funders":"","keywords":"Lepirudin; Partial thromboplastin time; Medicine; Heparin-induced thrombocytopenia; Anesthesia; Dosing; Heparin; Anticoagulant; Thrombosis; Thromboelastography; Surgery; Intensive care medicine; Platelet; Discovery and development of direct thrombin inhibitors; Internal medicine; Thrombin","score_opus":0.024551106283788635,"score_gpt":0.28960149812861324,"score_spread":0.2650503918448246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030675928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926272,0.0009554245,0.00025802894,0.0017374716,0.00045111266,0.0005910757,0.0000051688603,0.000030179996,0.0033443104],"genre_scores_gemma":[0.99072117,0.0010800572,0.006719353,0.0010768038,0.000054844895,0.00001939863,0.0000016523418,0.000052068415,0.0002746324],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99715686,0.00057648175,0.0009398622,0.0004078042,0.000366975,0.0005520078],"domain_scores_gemma":[0.99828446,0.00018997543,0.00029051854,0.00034200665,0.00028287907,0.00061014947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014331618,0.0002712503,0.0015524228,0.00040107477,0.0001881287,0.000082410086,0.0002153402,0.00022709413,0.00024690977],"category_scores_gemma":[0.00066619646,0.0002892308,0.0002099232,0.00040080168,0.00013272243,0.00017162247,0.0001262546,0.00039082012,0.00007617521],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064093485,0.0020526322,0.04101816,0.0009687256,0.0031836901,0.3152144,0.0012307131,0.000007690878,0.5467456,0.011914071,0.011204115,0.060050875],"study_design_scores_gemma":[0.0071110697,0.0015856603,0.41583422,0.0009126937,0.0007680497,0.5236755,0.00062097394,0.000003085671,0.028475204,0.00065607857,0.019847617,0.00050985056],"about_ca_topic_score_codex":0.000042588606,"about_ca_topic_score_gemma":0.00006133942,"teacher_disagreement_score":0.5182704,"about_ca_system_score_codex":0.00011926658,"about_ca_system_score_gemma":0.00021107215,"threshold_uncertainty_score":0.999956},"labels":[],"label_agreement":null},{"id":"W2030904107","doi":"10.1046/j.1365-2141.2003.04615.x","title":"William Osler's Legacy and his Contribution to Haematology","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"History of Medical Practice","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; History of medicine; Classics; Humanism; Pediatrics; Family medicine; History; Philosophy; Theology","score_opus":0.012112095616201591,"score_gpt":0.2790182631522199,"score_spread":0.2669061675360183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030904107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706958,0.011276112,0.0047229636,0.009598051,0.0010911896,0.0002693182,0.0000028464551,0.000024548688,0.0023191995],"genre_scores_gemma":[0.9908455,0.0005044498,0.004568747,0.0036624516,0.00011631206,0.0000049136956,0.0000023151247,0.000022342021,0.00027298793],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99787897,0.00042093344,0.000772089,0.00021924305,0.0003354322,0.0003733374],"domain_scores_gemma":[0.9979699,0.0003985874,0.00040466234,0.00015141904,0.00047480632,0.00060062826],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001148623,0.0001404547,0.0010537305,0.00021399601,0.00012759397,0.000028705752,0.00011106051,0.00024463973,0.00047069477],"category_scores_gemma":[0.01059475,0.00015331135,0.00011077293,0.0001591619,0.0003214528,0.0002962406,0.000027699261,0.00070264697,0.00008337026],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013904488,0.0012731582,0.009268217,0.0004887725,0.0007194275,0.56573325,0.00066749624,0.0000052944965,0.003687495,0.025676997,0.35413498,0.036954433],"study_design_scores_gemma":[0.0020520359,0.00040649672,0.0015214466,0.00023558948,0.00014168813,0.6082531,0.00008317145,0.000002569213,0.00041942307,0.00044126355,0.38635164,0.00009156811],"about_ca_topic_score_codex":0.000023646155,"about_ca_topic_score_gemma":0.00003761638,"teacher_disagreement_score":0.04251982,"about_ca_system_score_codex":0.00010976101,"about_ca_system_score_gemma":0.00027971805,"threshold_uncertainty_score":0.99773943},"labels":[],"label_agreement":null},{"id":"W2030973337","doi":"10.1046/j.1365-2141.2001.03227.x","title":"Towards molecular medicine; reminiscences of the haemoglobin field, 1960–2000","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council","keywords":"Miller; Classics; Medicine; Disease; History; Psychoanalysis; Psychology; Family medicine; Pathology","score_opus":0.009398847257013827,"score_gpt":0.2601621112331468,"score_spread":0.25076326397613297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030973337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94075096,0.019359099,0.00031522886,0.019844802,0.0007303444,0.00015956337,0.0000018438615,0.000009695027,0.018828485],"genre_scores_gemma":[0.9925161,0.0047710133,0.0003957911,0.0018780085,0.00009128878,0.0000012692577,9.489988e-7,0.000013841154,0.00033173148],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9982783,0.00013182366,0.00080194965,0.00013126041,0.0003981684,0.00025847863],"domain_scores_gemma":[0.9988416,0.0000857028,0.00045676695,0.00020103324,0.00027991048,0.00013501057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039070385,0.00012315162,0.0007272121,0.00010264847,0.000071450726,0.000007544027,0.0002907643,0.00023250945,0.00048673252],"category_scores_gemma":[0.0008039206,0.000085393556,0.0002522147,0.00031693536,0.00040209206,0.00004876112,0.00005067187,0.00052490237,0.000004213184],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013786615,0.0012508415,0.049153343,0.00084687554,0.0013831838,0.27537435,0.0034652883,0.00009076305,0.019280981,0.0047857007,0.13803661,0.5049534],"study_design_scores_gemma":[0.0038741191,0.0011977194,0.00703214,0.003165669,0.0004422323,0.93146175,0.0023009607,0.000034150762,0.0100644585,0.0023044916,0.037935324,0.00018696653],"about_ca_topic_score_codex":0.00031658076,"about_ca_topic_score_gemma":0.00003181212,"teacher_disagreement_score":0.6560874,"about_ca_system_score_codex":0.000026288431,"about_ca_system_score_gemma":0.00034867768,"threshold_uncertainty_score":0.53293794},"labels":[],"label_agreement":null},{"id":"W2032765229","doi":"10.1111/bjh.12785","title":"Long‐term follow‐up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Neutropenia; Cytopenia; Internal medicine; Rituximab; Febrile neutropenia; Gastroenterology; Phases of clinical research; Multiple myeloma; Oncology; Toxicity; Lymphoma; Bone marrow","score_opus":0.0249349140721326,"score_gpt":0.2948622606583417,"score_spread":0.2699273465862091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032765229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906674,0.004269833,0.00008947859,0.0021959639,0.00064340787,0.0019416872,0.000047965576,0.000013899668,0.00013038993],"genre_scores_gemma":[0.99110967,0.00089293206,0.00014645225,0.0057487004,0.0011490033,0.000046017805,0.00033295542,0.00017835446,0.00039592062],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930096,0.00076026196,0.0030426346,0.0005507273,0.001608839,0.001027885],"domain_scores_gemma":[0.9942323,0.0006649171,0.002984668,0.00068565406,0.001167853,0.00026459023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089486956,0.00053919636,0.004179374,0.0009621936,0.00004084453,0.00003586742,0.0006650753,0.0011083652,0.00026478866],"category_scores_gemma":[0.0010111058,0.00049388397,0.0006607119,0.00047404977,0.0007304905,0.00013944259,0.00013848522,0.0016995925,0.000010513908],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.19883288,0.00392038,0.0025774164,0.01680352,0.0040714797,0.49452037,0.0004829837,0.00008018413,0.00037708887,0.000005321702,0.2625773,0.015751084],"study_design_scores_gemma":[0.7829068,0.016519265,0.00019973045,0.017172936,0.001415949,0.17600372,0.00000941483,0.000117943586,0.0017482197,0.0000238786,0.0034392478,0.00044291676],"about_ca_topic_score_codex":0.001432093,"about_ca_topic_score_gemma":0.00056548795,"teacher_disagreement_score":0.5840739,"about_ca_system_score_codex":0.023873933,"about_ca_system_score_gemma":0.025040003,"threshold_uncertainty_score":0.99975127},"labels":[],"label_agreement":null},{"id":"W2032888836","doi":"10.1111/j.1365-2141.2004.05296.x","title":"Severe FVII deficiency caused by a new point mutation combined with a previously undetected gene deletion","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; University of British Columbia","funders":"","keywords":"Proband; Point mutation; Genetics; Mutation; Gene; Allele; Biology; Compound heterozygosity; Gene mutation; Molecular biology","score_opus":0.013243894189483548,"score_gpt":0.2657986263926563,"score_spread":0.2525547322031727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032888836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98825794,0.004003015,0.0017227106,0.005337517,0.000042719534,0.00037341524,0.0000036362374,0.000026785954,0.00023223036],"genre_scores_gemma":[0.9954331,0.00054055516,0.002933186,0.00021221023,0.00008921826,0.0000052399355,0.000029467643,0.000022364784,0.0007346507],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99856013,0.00011528748,0.00046819012,0.00016121466,0.0003727366,0.00032242277],"domain_scores_gemma":[0.9989937,0.000065096785,0.00023608265,0.000105545514,0.00033233236,0.00026726606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023448834,0.0001228936,0.0004935807,0.0001555487,0.000089934205,0.000031958116,0.0000879223,0.00012462,0.00021088097],"category_scores_gemma":[0.00015193598,0.000103450024,0.00008994578,0.00022548506,0.000086075575,0.00014403959,0.000015231659,0.00031486974,0.000024598168],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01108369,0.0064379326,0.022867374,0.0010052652,0.0020531102,0.3372953,0.0030831567,0.0003215425,0.05180259,0.00034130563,0.16592963,0.3977791],"study_design_scores_gemma":[0.019798193,0.0063491543,0.008018826,0.00083632005,0.0004029788,0.9458273,0.00021751819,0.00031396167,0.0162458,0.00034114879,0.001382905,0.00026588456],"about_ca_topic_score_codex":0.000087530316,"about_ca_topic_score_gemma":0.00022034925,"teacher_disagreement_score":0.608532,"about_ca_system_score_codex":0.00014178724,"about_ca_system_score_gemma":0.00045781126,"threshold_uncertainty_score":0.42185697},"labels":[],"label_agreement":null},{"id":"W2033740080","doi":"10.1046/j.1365-2141.2000.02179.x","title":"Monoclonal antibody‐mediated inhibition of the human HLA alloimmune response to platelet transfusion is antigen specific and independent of Fcγ receptor‐mediated immune suppression","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Blood Services","keywords":"Immunology; Monoclonal antibody; Human leukocyte antigen; Antigen; Immune system; Platelet; Antibody; Isoantibodies; Receptor; Medicine; Internal medicine","score_opus":0.009127417119653662,"score_gpt":0.24934381693030203,"score_spread":0.24021639981064835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033740080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243927,0.0048582866,0.000041909363,0.0018170474,0.00021084379,0.00047421383,0.000087299115,0.000011082605,0.00006003885],"genre_scores_gemma":[0.98518926,0.014260401,0.00023895496,0.0001248394,0.0000476972,0.0000024345832,0.00005486124,0.000029660148,0.00005190128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99725497,0.00038339355,0.0013016537,0.0002443866,0.000542481,0.00027312664],"domain_scores_gemma":[0.99872017,0.00016185749,0.00043008424,0.00023081768,0.0002926533,0.00016439517],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008761651,0.00019243176,0.0009708119,0.0002627625,0.00014947196,0.000015243007,0.00017110263,0.00030639526,0.0012305664],"category_scores_gemma":[0.00008089335,0.00016264473,0.0002401882,0.00035310228,0.0002471381,0.00012877937,0.000044734632,0.0005651738,0.000006599093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005311542,0.00058161834,0.0062296405,0.00010691113,0.00012168858,0.0019116671,0.0011486578,0.000003973634,0.9761919,0.0000107020005,0.0006265467,0.007755167],"study_design_scores_gemma":[0.009795134,0.0015386945,0.43777165,0.0034008294,0.000095604264,0.045153476,0.0003203171,0.000011795922,0.4956394,0.00005597081,0.006004977,0.00021213955],"about_ca_topic_score_codex":0.00022243956,"about_ca_topic_score_gemma":0.000028156897,"teacher_disagreement_score":0.48055246,"about_ca_system_score_codex":0.000025321306,"about_ca_system_score_gemma":0.000094739415,"threshold_uncertainty_score":0.9996824},"labels":[],"label_agreement":null},{"id":"W2033788627","doi":"10.1111/bjh.13104","title":"Genetic polymorphisms influencing total and γ′ fibrinogen levels and fibrin clot properties in <scp>A</scp>fricans","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; McMaster University; South African Medical Research Council; Hamilton Health Sciences","keywords":"Fibrinogen; Turbidimetry; Fibrin; Single-nucleotide polymorphism; Factor XIII; SNP; Genetics; Biology; Genotype; Gene; Immunology; Molecular biology; Biochemistry","score_opus":0.017443288764823078,"score_gpt":0.2166131003874923,"score_spread":0.19916981162266922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033788627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832744,0.015855849,0.00009278133,0.0003831897,0.000071958355,0.00013269005,0.0000016609015,0.000009539401,0.00017794674],"genre_scores_gemma":[0.9982107,0.00028438136,0.0010220498,0.00023419714,0.00011701941,0.000003023637,3.769424e-7,0.00001797876,0.00011023562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988359,0.00010596193,0.000504994,0.00015704769,0.0001534253,0.00024263194],"domain_scores_gemma":[0.9994121,0.0000886346,0.00018469915,0.00008149512,0.000097632335,0.00013540837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022262466,0.000113568756,0.0005356497,0.0001344912,0.000060236966,0.00004309837,0.000053746528,0.000106989566,0.000008744855],"category_scores_gemma":[0.000374181,0.000106051266,0.000045448727,0.00008103756,0.00014722353,0.0001291379,0.000059864637,0.00021679996,0.0000016433361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023321358,0.00028182913,0.7152855,0.0010503565,0.00032329073,0.01275129,0.0046240375,0.00019997153,0.09927902,0.0003779644,0.0008639981,0.16472952],"study_design_scores_gemma":[0.001577561,0.00055357395,0.69275767,0.0007799711,0.00007583525,0.29825076,0.00045915743,0.00050246314,0.0044119083,0.00021994338,0.00034505402,0.00006609511],"about_ca_topic_score_codex":0.00026363973,"about_ca_topic_score_gemma":0.00007331983,"teacher_disagreement_score":0.28549948,"about_ca_system_score_codex":0.000017927934,"about_ca_system_score_gemma":0.00006850735,"threshold_uncertainty_score":0.4324645},"labels":[],"label_agreement":null},{"id":"W2034676735","doi":"10.1111/j.1365-2141.2006.06354.x","title":"Globin gene expression in Hb Lepore‐BAC transgenic mice","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Transgene; Biology; Gene; Genetically modified mouse; Context (archaeology); Genetics; Fusion gene; Gene expression; Molecular biology; Gene cluster; Globin","score_opus":0.006557056724864285,"score_gpt":0.2328605151002298,"score_spread":0.2263034583753655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034676735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976833,0.01807487,0.0011869507,0.0013988584,0.00037841566,0.00014740547,0.0000042887373,0.000014891098,0.001961306],"genre_scores_gemma":[0.99373907,0.0017596042,0.0037773424,0.00028026098,0.0001533808,0.0000024253036,0.000009855024,0.000023189983,0.0002548739],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983521,0.00010556703,0.00083973067,0.00016369035,0.00021614776,0.00032273354],"domain_scores_gemma":[0.99937165,0.000041420044,0.00025702594,0.00009761439,0.00011736808,0.00011493511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029192338,0.00012340561,0.0006378675,0.00018218598,0.000051004205,0.000015211457,0.00011646167,0.00027792295,0.00016125824],"category_scores_gemma":[0.00005538874,0.000121063335,0.00019404765,0.0002021692,0.00008474844,0.00008867427,0.000016759963,0.0005316441,0.000014290061],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017373674,0.0034960778,0.045524776,0.0007866127,0.0003004968,0.42943,0.0006657226,0.0010138012,0.3444146,0.0005923363,0.11830538,0.053732827],"study_design_scores_gemma":[0.008564215,0.0003796305,0.019305399,0.0015765874,0.0001481689,0.91592556,0.0003873757,0.00008677329,0.039213862,0.0012591492,0.012892251,0.00026104334],"about_ca_topic_score_codex":0.0002866945,"about_ca_topic_score_gemma":0.00016955161,"teacher_disagreement_score":0.48649552,"about_ca_system_score_codex":0.000048857823,"about_ca_system_score_gemma":0.00014500527,"threshold_uncertainty_score":0.49368197},"labels":[],"label_agreement":null},{"id":"W2035772349","doi":"10.1046/j.1365-2141.2000.01954.x","title":"Mutation analysis in the HFE gene in patients with hereditary haemochromatosis in Saguenay–Lac‐Saint‐Jean (Quebec, Canada)","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cégep de Chicoutimi; Université du Québec à Chicoutimi","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Genetics; Mutation; Founder effect; Gene; Biology; Proband; Gene mutation; Genotype; Haplotype","score_opus":0.003951972211433462,"score_gpt":0.2029711715499368,"score_spread":0.19901919933850334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035772349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951285,0.0020266734,0.000021817423,0.0023651696,0.00006094053,0.00020090655,0.0000066725597,0.0000032225516,0.00018609353],"genre_scores_gemma":[0.99855375,0.00017994792,0.00018568354,0.0009525074,0.000029412831,0.000004518017,0.000046232915,0.000013103372,0.00003486587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980872,0.00028497362,0.0007134536,0.00016577395,0.00044996993,0.00029858248],"domain_scores_gemma":[0.9993923,0.000095628675,0.00019442425,0.00014412683,0.00009171864,0.00008183133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003495296,0.00012697795,0.0007307812,0.0004449295,0.000036547528,0.000018558057,0.00016428388,0.00009160695,0.000338211],"category_scores_gemma":[0.000111817346,0.000106374355,0.00008306046,0.00087306724,0.000081756974,0.00013872146,0.000008878966,0.00036479722,0.0000021349324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063586415,0.00067035604,0.8947106,0.00007007909,0.00014051014,0.07505687,0.0006660361,0.0024838832,0.0000028360998,0.000016395821,0.0028965105,0.022650046],"study_design_scores_gemma":[0.004785733,0.00009238946,0.9850247,0.00014469815,0.00023368999,0.008620683,0.0006727054,0.00008567569,0.00001707479,0.000046656085,0.00016537987,0.000110608096],"about_ca_topic_score_codex":0.66015214,"about_ca_topic_score_gemma":0.97009724,"teacher_disagreement_score":0.30994508,"about_ca_system_score_codex":0.00012773245,"about_ca_system_score_gemma":0.00029169608,"threshold_uncertainty_score":0.433782},"labels":[],"label_agreement":null},{"id":"W2036291732","doi":"10.1111/j.1365-2141.2005.05493.x","title":"The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cerebrospinal fluid; Multiple myeloma; Central nervous system; Medicine; Pathology; Cancer research; Immunology; Internal medicine","score_opus":0.01725287106537729,"score_gpt":0.2623310306521224,"score_spread":0.2450781595867451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036291732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928294,0.0040593534,0.000026520382,0.0020307275,0.00018426104,0.0004904591,0.00003057203,0.0000050158033,0.00034370157],"genre_scores_gemma":[0.99816525,0.0010734363,0.0004030829,0.00015856758,0.000112421905,0.0000118073585,0.0000020053783,0.000016591066,0.000056829253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714255,0.00047166037,0.0009842496,0.00017013526,0.0006947478,0.0005366499],"domain_scores_gemma":[0.997672,0.0010401598,0.00056621444,0.00033203783,0.0002591725,0.00013042032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009399572,0.00016134536,0.00063788064,0.00010491944,0.00019618141,0.00003792465,0.0005495495,0.00010199625,0.000026756281],"category_scores_gemma":[0.00041067836,0.00008744413,0.0002452561,0.00019273943,0.0003631284,0.00007801269,0.00006398307,0.00047786577,0.000009555618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016100924,0.005959268,0.41727307,0.0040706457,0.003315788,0.16023646,0.012560604,0.0013530129,0.049743507,0.011750858,0.035377678,0.28225818],"study_design_scores_gemma":[0.011786832,0.0025723903,0.66218776,0.0065581896,0.0001986824,0.23827334,0.008656681,0.010014645,0.05657158,0.0001330174,0.0027588736,0.00028798726],"about_ca_topic_score_codex":0.0005433018,"about_ca_topic_score_gemma":0.0007808994,"teacher_disagreement_score":0.2819702,"about_ca_system_score_codex":0.000109021144,"about_ca_system_score_gemma":0.0002018546,"threshold_uncertainty_score":0.3565868},"labels":[],"label_agreement":null},{"id":"W2036346083","doi":"10.1046/j.1365-2141.2003.04242.x","title":"William Bosworth Castle: Pioneer of Haematological Clinical Investigation","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"American Society of Hematology","keywords":"Medicine; Gerontology","score_opus":0.028859312657685144,"score_gpt":0.302369718254535,"score_spread":0.27351040559684986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036346083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886307,0.007385584,0.0005069427,0.00090505165,0.0006425857,0.0001505349,0.000002792221,0.000013655672,0.0017621242],"genre_scores_gemma":[0.9933158,0.002614195,0.0033233138,0.0005603579,0.00005094034,0.0000014795488,0.000003953434,0.000016737473,0.00011322891],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99747163,0.0003528133,0.0014770529,0.00016486064,0.00027960492,0.0002540635],"domain_scores_gemma":[0.99832094,0.00018525432,0.0006680382,0.0001396871,0.0004123903,0.00027369967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092025875,0.0001235169,0.0010689863,0.00012320923,0.000056670528,0.000010095755,0.0001003319,0.00040795645,0.0002448358],"category_scores_gemma":[0.0020938052,0.00010990117,0.00030919816,0.00022400003,0.0005079833,0.00008467248,0.00001959226,0.0007045708,0.000016118605],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060885365,0.0022540803,0.70642364,0.00080356945,0.0011009417,0.16635431,0.00046548212,0.00006480961,0.0006978839,0.013716964,0.08030165,0.0272078],"study_design_scores_gemma":[0.0046434584,0.0011332326,0.04163336,0.0010050465,0.0003507529,0.9297714,0.00046015982,0.000034338937,0.0012338648,0.0031742596,0.016364338,0.00019576322],"about_ca_topic_score_codex":0.000012947766,"about_ca_topic_score_gemma":0.000010994176,"teacher_disagreement_score":0.7634171,"about_ca_system_score_codex":0.000017759543,"about_ca_system_score_gemma":0.00030343386,"threshold_uncertainty_score":0.44816396},"labels":[],"label_agreement":null},{"id":"W2036730592","doi":"10.1111/j.1365-2141.2004.05006.x","title":"Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t‐AML/MDS","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency","keywords":"Telomere; Haematopoiesis; Biology; Chemotherapy; Myeloid; Immunology; Stem cell; Myeloid leukemia; Internal medicine; Oncology; Cancer research; Medicine; Genetics; Gene","score_opus":0.015975350026451687,"score_gpt":0.26162338482845204,"score_spread":0.24564803480200037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036730592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971016,0.0014501725,0.00054310693,0.00046198544,0.00004445441,0.00029548857,0.000053259537,0.000012896266,0.00003701299],"genre_scores_gemma":[0.99542665,0.00033011028,0.0028515637,0.0012972349,0.00003295927,0.000010384703,0.0000122094925,0.000027040314,0.0000118658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981018,0.00025614715,0.00062323804,0.00027430328,0.0004023615,0.0003421599],"domain_scores_gemma":[0.9987487,0.0001842729,0.00040928766,0.00012667969,0.00031228526,0.00021875286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008365449,0.00020555404,0.00086094067,0.00029842145,0.00012337368,0.000064921565,0.00014161965,0.00017459953,0.00007561518],"category_scores_gemma":[0.00021810333,0.00016846842,0.00008787091,0.0003995715,0.00021561173,0.00022209424,0.000027106142,0.00044645712,8.7396865e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067096613,0.0020601645,0.8655531,0.00045453332,0.0013759065,0.06938719,0.007547562,0.0000429126,0.025065618,0.0015939627,0.0004737836,0.0197356],"study_design_scores_gemma":[0.010276103,0.0022654624,0.8204092,0.0024321908,0.00030200664,0.14042042,0.001958278,0.000060547147,0.019382328,0.0020945827,0.000036251346,0.00036261813],"about_ca_topic_score_codex":0.00041391657,"about_ca_topic_score_gemma":0.00074860797,"teacher_disagreement_score":0.07103324,"about_ca_system_score_codex":0.000054353706,"about_ca_system_score_gemma":0.00024471548,"threshold_uncertainty_score":0.6869943},"labels":[],"label_agreement":null},{"id":"W2036925454","doi":"10.1111/j.1365-2141.2005.05805.x","title":"Annexin A2 may not play a role as a plasminogen receptor","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Annexin A2; Plasmin; Annexin; Angiostatin; Cell biology; Receptor; Chemistry; Tissue plasminogen activator; Plasminogen activator; Cell; Molecular biology; Biology; Biochemistry; Cancer research; Angiogenesis; Enzyme; Genetics","score_opus":0.00858794577405199,"score_gpt":0.23777451485373644,"score_spread":0.22918656907968443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036925454","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.712329,0.029974308,0.00011353066,0.24916054,0.0018516815,0.0005919224,0.0005261982,0.000032906013,0.0054199123],"genre_scores_gemma":[0.15891352,0.008265616,0.0058639655,0.7698016,0.03224383,0.00009549417,0.0012756598,0.00047571832,0.023064548],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971759,0.0002852192,0.000964376,0.00052254595,0.00038060214,0.0006713548],"domain_scores_gemma":[0.9981713,0.000044581946,0.0009202997,0.00036603262,0.00032913775,0.00016859017],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034096828,0.00041875368,0.0010199281,0.00019255432,0.00012679963,0.00010456359,0.00079232577,0.0017905851,0.0007504701],"category_scores_gemma":[0.00028053476,0.00046916667,0.0005784949,0.00008502961,0.0002199982,0.00001158129,0.00018656996,0.0016861485,0.00016937018],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016737898,0.000083174586,0.000035012617,0.00006566548,0.00034421615,0.026413854,0.000028626066,0.00000420089,0.016355691,0.000020835367,0.95079404,0.005687284],"study_design_scores_gemma":[0.0007822806,0.0005580492,0.00001773978,0.0002529976,0.0000685566,0.19581474,0.00003501338,0.0000013427477,0.03391478,0.00008262645,0.76808214,0.0003897137],"about_ca_topic_score_codex":0.00009101059,"about_ca_topic_score_gemma":0.000074649106,"teacher_disagreement_score":0.5534155,"about_ca_system_score_codex":0.000037008216,"about_ca_system_score_gemma":0.00042178217,"threshold_uncertainty_score":0.999776},"labels":[],"label_agreement":null},{"id":"W2037703099","doi":"10.1046/j.1365-2141.2000.02109.x","title":"Dyskeratosis congenita in all its forms","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":572,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imperial College London; Wellcome Trust","keywords":"Dyskeratosis congenita; Medicine; Dyskeratosis; Dermatology; Hyperkeratosis; Genetics; Biology; Telomere","score_opus":0.07197924257499881,"score_gpt":0.3577913086233197,"score_spread":0.2858120660483209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037703099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061286143,0.9915334,0.000003899686,0.00015156518,0.000423648,0.0005388857,0.000041136023,0.000019837747,0.0011590208],"genre_scores_gemma":[0.0008574238,0.99778056,0.00020637937,0.0003793457,0.00023076223,0.00001841476,0.00004514778,0.000076818294,0.00040517413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99613565,0.00028590826,0.0022249767,0.00035535087,0.00038892493,0.0006092032],"domain_scores_gemma":[0.9980077,0.0002402383,0.00091481686,0.00026554495,0.00022042045,0.00035123492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049135607,0.0004210843,0.005002536,0.00070739456,0.000049921466,0.00005236077,0.00042385876,0.00070284045,0.000827908],"category_scores_gemma":[0.00032681224,0.00038799955,0.0008354512,0.00042728722,0.00013986405,0.00017449686,0.000049631704,0.0015298617,0.00015755318],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048760976,0.00020560077,0.000041302275,0.007592871,0.0003308928,0.1520988,0.00004246614,9.2550565e-8,6.7195407e-7,0.000049237562,0.0042943363,0.83529496],"study_design_scores_gemma":[0.0007318831,0.00013413861,0.00002459703,0.020229328,0.00058731384,0.43795887,0.000015925087,6.328388e-7,0.000003313612,0.000030108842,0.54009366,0.00019024007],"about_ca_topic_score_codex":0.00003879862,"about_ca_topic_score_gemma":0.00014315247,"teacher_disagreement_score":0.8351047,"about_ca_system_score_codex":0.00014075454,"about_ca_system_score_gemma":0.00081339217,"threshold_uncertainty_score":0.9998572},"labels":[],"label_agreement":null},{"id":"W2037713259","doi":"10.1111/j.1365-2141.2009.08027.x","title":"Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single‐lineage marrow failure: a pilot study and a survey from the EBMT WPSAA","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Università degli Studi di Napoli Federico II","keywords":"Alemtuzumab; Medicine; Regimen; Aplastic anemia; Bone marrow failure; Internal medicine; Pure red cell aplasia; Gastroenterology; Adverse effect; Aplasia; Immunology; Bone marrow; Toxicity; Immunosuppression; Oncology; Transplantation; Stem cell; Haematopoiesis; Biology","score_opus":0.023065172866176084,"score_gpt":0.2834789399436454,"score_spread":0.2604137670774693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037713259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906421,0.006351397,0.0006351625,0.00076220115,0.00009099494,0.0013526473,0.00012756443,0.000008192993,0.000029743795],"genre_scores_gemma":[0.9981226,0.00072397105,0.00075150456,0.0002545352,0.000059318943,0.00002540829,0.000022528448,0.000018165374,0.000022002121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983609,0.00044816485,0.000522562,0.000270958,0.00017724482,0.00022020945],"domain_scores_gemma":[0.99654555,0.0027084479,0.00029348035,0.0001243892,0.00018650811,0.00014161917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049213856,0.00019942787,0.0008374737,0.00007253233,0.0001471797,0.00007235933,0.00006774143,0.00008377598,0.000025167437],"category_scores_gemma":[0.00048417496,0.00015603687,0.000053466058,0.000071548166,0.00015189093,0.00008897383,0.000015497384,0.00019103882,0.000001194159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0481571,0.012061808,0.4842834,0.0013135606,0.009069612,0.1272482,0.044545963,0.0000071377676,0.049856897,0.00021806444,0.008442971,0.21479529],"study_design_scores_gemma":[0.022610812,0.031529292,0.70617646,0.0012004115,0.0015139253,0.22908172,0.001984728,0.000077791694,0.0049733203,0.0004612726,0.00014004784,0.00025023255],"about_ca_topic_score_codex":0.00065877935,"about_ca_topic_score_gemma":0.000878356,"teacher_disagreement_score":0.22189306,"about_ca_system_score_codex":0.000051725587,"about_ca_system_score_gemma":0.00007543207,"threshold_uncertainty_score":0.6362999},"labels":[],"label_agreement":null},{"id":"W2038519972","doi":"10.1111/j.1365-2141.2007.06541.x","title":"Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Bone marrow; Promyelocyte; Daunorubicin; Myeloid; Pathology; Chromosomal translocation; Medicine; Acute promyelocytic leukemia; Cancer research; Biology; Retinoic acid; Leukemia; Immunology; Cell culture; Genetics","score_opus":0.007216984125317701,"score_gpt":0.25628441028898274,"score_spread":0.24906742616366503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038519972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731323,0.023380032,0.0030316624,0.000043657958,0.00009837513,0.00021600086,0.000019838135,0.0000016794854,0.000076447264],"genre_scores_gemma":[0.9939104,0.003473163,0.0024179784,0.000052848012,0.00006499223,0.000010275964,0.000005845485,0.000016213737,0.000048325426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988004,0.00004774158,0.00061264384,0.00018436083,0.00012835386,0.0002265302],"domain_scores_gemma":[0.99893886,0.00004424834,0.00044873953,0.00014157913,0.00035034306,0.000076216966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004993121,0.000118707314,0.00042179157,0.000047135036,0.00004513902,0.000010074092,0.00019019085,0.000177336,0.000012496844],"category_scores_gemma":[0.00007771467,0.00012012676,0.00024955568,0.00005738543,0.00030685193,0.000007723229,0.00004289635,0.000099572746,1.5225855e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007978743,0.0010441766,0.09904256,0.003275984,0.0031153576,0.0049324115,0.0009677355,0.00056076184,0.8282521,0.0001759928,0.0014202872,0.04923392],"study_design_scores_gemma":[0.0027913535,0.0020338178,0.01702522,0.00026025763,0.00025090325,0.031899985,0.00021260661,0.000036067555,0.9428561,0.00026674874,0.0021011038,0.00026586204],"about_ca_topic_score_codex":0.000012573346,"about_ca_topic_score_gemma":0.000029238703,"teacher_disagreement_score":0.114604004,"about_ca_system_score_codex":0.000015022657,"about_ca_system_score_gemma":0.00015416546,"threshold_uncertainty_score":0.4898627},"labels":[],"label_agreement":null},{"id":"W2038613090","doi":"10.1111/j.1365-2141.2009.07712.x","title":"Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Regimen; Internal medicine; Acute lymphocytic leukemia; Dosing; Adverse effect; Transplantation; Asparaginase; White blood cell; Pediatrics; Gastroenterology; Surgery; Lymphoblastic Leukemia; Leukemia","score_opus":0.009140938515400598,"score_gpt":0.25592856217296367,"score_spread":0.24678762365756307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038613090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930956,0.0017098694,0.002479969,0.00096228643,0.000059141614,0.00056855055,0.000022427941,0.00002517188,0.001077004],"genre_scores_gemma":[0.99041575,0.0015013599,0.0074828593,0.00013999462,0.00015408224,0.000014728312,0.000009597907,0.000039451646,0.00024215433],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99736875,0.00015435625,0.0008246058,0.00033265428,0.00073963037,0.0005799811],"domain_scores_gemma":[0.99722415,0.000420309,0.0007851973,0.00029080946,0.0008750534,0.0004044931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015148462,0.0003023539,0.0015058587,0.00040207265,0.00008182946,0.00002669433,0.00023055122,0.00020007156,0.00004945038],"category_scores_gemma":[0.00020864932,0.00022007654,0.00018350444,0.00056259637,0.00037676663,0.00017506813,0.000024512514,0.00028738964,0.000008907629],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07335558,0.0044725495,0.0059312033,0.0005737377,0.0052331137,0.8194254,0.0037268589,0.0006266899,0.0014308869,0.0007230787,0.0065989364,0.077901945],"study_design_scores_gemma":[0.045753848,0.029039936,0.009618838,0.0015859638,0.0014731603,0.905388,0.0006164481,0.0010798232,0.00473404,0.00030565457,0.000103739745,0.000300581],"about_ca_topic_score_codex":0.00019837104,"about_ca_topic_score_gemma":0.000049372702,"teacher_disagreement_score":0.08596254,"about_ca_system_score_codex":0.00079736905,"about_ca_system_score_gemma":0.0020345862,"threshold_uncertainty_score":0.8974461},"labels":[],"label_agreement":null},{"id":"W2038650283","doi":"10.1111/j.1365-2141.2012.09182.x","title":"Treatment of Philadelphia chromosome‐positive acute lymphoblastic leukaemia with imatinib combined with a paediatric‐based protocol","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Imatinib; Medicine; Philadelphia chromosome; Lymphoblastic Leukemia; Oncology; Acute lymphocytic leukemia; Internal medicine; Protocol (science); Cancer research; Pediatrics; Genetics; Leukemia; Chromosomal translocation; Biology; Pathology; Gene","score_opus":0.013685615612186989,"score_gpt":0.2904975436426154,"score_spread":0.27681192803042837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038650283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707063,0.00045430678,0.0037615406,0.0011008902,0.00010188993,0.023280334,0.00008002508,0.000041698,0.00047304868],"genre_scores_gemma":[0.98701185,0.000047170623,0.008040904,0.00012568562,0.00024146048,0.004384699,0.00002286088,0.00007727055,0.00004812073],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9968938,0.00023241733,0.0009900548,0.0002598348,0.0008492423,0.0007746348],"domain_scores_gemma":[0.9966984,0.00054996804,0.0010022715,0.00028984845,0.00088612083,0.0005734262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026057876,0.00035186493,0.0016069917,0.00037171805,0.0001008742,0.000027991226,0.00021531711,0.00021022289,0.000186125],"category_scores_gemma":[0.00014805519,0.0002516256,0.00021732728,0.0005104202,0.00055564503,0.00026330657,0.000040325423,0.0003004241,0.000015670475],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17026217,0.028278373,0.15416698,0.0050598965,0.014096966,0.58440334,0.00307916,0.0004007534,0.00957865,0.00077567116,0.011739189,0.01815887],"study_design_scores_gemma":[0.076758154,0.037602555,0.013049959,0.0019334031,0.0019263313,0.8442491,0.0002255475,0.00081772014,0.022457277,0.000028114007,0.0005384484,0.00041336368],"about_ca_topic_score_codex":0.00006831266,"about_ca_topic_score_gemma":0.000015280539,"teacher_disagreement_score":0.25984582,"about_ca_system_score_codex":0.00089646154,"about_ca_system_score_gemma":0.0025460206,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W2038880599","doi":"10.1111/j.1365-2141.2005.05755.x","title":"Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma*","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Lymphoma; Medicine; Stem cell; Refractory (planetary science); Transplantation; Hematopoietic stem cell transplantation; Histology; Haematopoiesis; Non-Hodgkin's lymphoma; Aggressive lymphoma; Oncology; Hematology; Hodgkin lymphoma; Internal medicine; Pathology; Cancer research; Biology; Rituximab","score_opus":0.010519418045095994,"score_gpt":0.2520527148463884,"score_spread":0.24153329680129243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038880599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96635425,0.030507931,0.0005737829,0.0015766532,0.00028719113,0.00040806519,0.000023977625,0.0000144187725,0.00025374716],"genre_scores_gemma":[0.9875548,0.007538231,0.0038001735,0.0006399786,0.00013693038,0.000043981287,0.00002140543,0.000030352667,0.0002341348],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9983921,0.0001048645,0.00076142413,0.0002507827,0.0001767417,0.00031408563],"domain_scores_gemma":[0.9983321,0.00030800657,0.00078738685,0.00013156608,0.00023332084,0.00020765811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002295416,0.00018737323,0.00091462454,0.00017898002,0.00011433058,0.000021997677,0.00009680712,0.00023895243,0.000045826837],"category_scores_gemma":[0.00005124572,0.00018417387,0.00021205228,0.00006177922,0.00015733122,0.00012881237,0.000013984064,0.00011662893,0.000011151537],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031238422,0.004208424,0.026858086,0.0019981777,0.001124921,0.22612682,0.0030416057,0.00003169876,0.004900881,0.0006361621,0.020930655,0.70701873],"study_design_scores_gemma":[0.021412777,0.001835172,0.0451713,0.0009709816,0.0011731309,0.9022434,0.00022552647,0.00005624089,0.01326232,0.00024070409,0.013148354,0.00026012913],"about_ca_topic_score_codex":0.00003107085,"about_ca_topic_score_gemma":0.00008194389,"teacher_disagreement_score":0.7067586,"about_ca_system_score_codex":0.0002113563,"about_ca_system_score_gemma":0.00031611155,"threshold_uncertainty_score":0.75103927},"labels":[],"label_agreement":null},{"id":"W2039715247","doi":"10.1046/j.1365-2141.2002.03554.x","title":"The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"Ministero della Salute; Chiesi Farmaceutici","keywords":"Deferiprone; Medicine; Discontinuation; Neutropenia; Incidence (geometry); Adverse effect; Internal medicine; Christian ministry; Pediatrics; Surgery; Thalassemia; Chemotherapy","score_opus":0.005380835945948151,"score_gpt":0.22928291459355865,"score_spread":0.2239020786476105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039715247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328446,0.005759836,0.0000074305976,0.00014036545,0.00009855265,0.00037460288,0.0000033377237,0.000002063007,0.0003293269],"genre_scores_gemma":[0.99781364,0.002109106,0.000026126161,0.000020982714,0.000005456534,0.0000028462991,7.669357e-7,0.000008485342,0.000012608993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867207,0.00034353518,0.00055091415,0.0000961533,0.00014465966,0.00019269616],"domain_scores_gemma":[0.9994582,0.0001545662,0.00016021889,0.00007275013,0.0000967956,0.000057450052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074224034,0.000070461014,0.00052049465,0.00010595593,0.00004444075,0.000007413204,0.00006609967,0.00009440926,0.000020061112],"category_scores_gemma":[0.00026666134,0.00005588912,0.000048766717,0.00019894405,0.00010212013,0.000047298607,0.00003257155,0.00032813757,0.0000014956345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006527164,0.0015102808,0.98567945,0.00012784784,0.00005657951,0.0050309952,0.0009188518,0.0000046548644,0.000010535288,0.000033342712,0.00006380415,0.0059109516],"study_design_scores_gemma":[0.01094168,0.0009074574,0.97361237,0.00077973533,0.000036904683,0.010379819,0.0029821538,0.00003508717,0.000014762786,0.00008702774,0.00016561784,0.000057364832],"about_ca_topic_score_codex":0.00007117426,"about_ca_topic_score_gemma":0.0005068898,"teacher_disagreement_score":0.01206705,"about_ca_system_score_codex":0.000030227062,"about_ca_system_score_gemma":0.000018730301,"threshold_uncertainty_score":0.2279092},"labels":[],"label_agreement":null},{"id":"W2040316233","doi":"10.1046/j.1365-2141.2002.03282.x","title":"Single‐centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched‐related and matched‐unrelated donor transplants","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Medicine; Bone marrow; Etoposide; Total body irradiation; Internal medicine; Transplantation; Incidence (geometry); Cumulative incidence; Graft-versus-host disease; Surgery; Acute lymphocytic leukemia; Gastroenterology; Chemotherapy; Leukemia; Cyclophosphamide; Lymphoblastic Leukemia","score_opus":0.010798388676998434,"score_gpt":0.23163032715861318,"score_spread":0.22083193848161475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040316233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930162,0.0027380926,0.0025658917,0.00060985796,0.00021291923,0.00065273844,0.00008383964,0.000033312735,0.000087141765],"genre_scores_gemma":[0.99374473,0.0030184677,0.0028298087,0.00015640844,0.00002987401,0.000031591306,0.000052376934,0.00006187426,0.00007488749],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99742186,0.00017067781,0.0011603215,0.00038021992,0.00035448847,0.00051243434],"domain_scores_gemma":[0.9987824,0.0003078284,0.00035821533,0.00013481069,0.00016617558,0.0002505829],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003047137,0.00030680557,0.0011343169,0.0002748044,0.000070359914,0.000041770563,0.00011344714,0.00034970744,0.00023879546],"category_scores_gemma":[0.000039394916,0.00030604133,0.0001363198,0.00025625958,0.00018968667,0.00024897372,0.00000601063,0.00034096092,0.0000071667478],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016095933,0.0036118557,0.2331091,0.00561493,0.0030856351,0.5915434,0.06334818,0.00036636827,0.07047628,0.00012796755,0.00022226069,0.012398117],"study_design_scores_gemma":[0.023660922,0.0009841209,0.09425864,0.005773937,0.0021286372,0.8569422,0.0013364117,0.0005901522,0.013523097,0.00015563236,0.000039712835,0.00060654135],"about_ca_topic_score_codex":0.000022941413,"about_ca_topic_score_gemma":0.00027331518,"teacher_disagreement_score":0.26539883,"about_ca_system_score_codex":0.00008288536,"about_ca_system_score_gemma":0.00007221231,"threshold_uncertainty_score":0.99993914},"labels":[],"label_agreement":null},{"id":"W2040339484","doi":"10.1046/j.1365-2141.2001.02543.x","title":"Progressive reduction in treatment‐related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Measles; Pediatrics; Incidence (geometry); Mortality rate; Internal medicine; Vaccination; Immunology","score_opus":0.06803960230585933,"score_gpt":0.3645700482302487,"score_spread":0.2965304459243894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040339484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833597,0.010356069,0.000040079605,0.0044116303,0.00028173643,0.0009986194,0.000025058655,0.000019543004,0.0005075567],"genre_scores_gemma":[0.9930413,0.0055039288,0.0006191447,0.00013644589,0.0003752909,0.00007313353,0.000022449163,0.000048280384,0.00018002876],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99222136,0.0017435412,0.0019943048,0.000556088,0.0025708992,0.0009138128],"domain_scores_gemma":[0.99501985,0.0023819583,0.00039949737,0.00025262352,0.0011387974,0.0008072869],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0075477054,0.0002660146,0.0019749526,0.000908405,0.00010971651,0.00007550433,0.00030917965,0.00063923566,0.00077674666],"category_scores_gemma":[0.022939922,0.00024301781,0.00015745679,0.001066612,0.00048792304,0.00019327315,0.00014644889,0.0011613464,0.000064420754],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0071443166,0.0029276353,0.013727083,0.00009718274,0.00073493365,0.8354448,0.004278194,0.000036755275,0.0012146346,0.00016508711,0.013489797,0.1207396],"study_design_scores_gemma":[0.03902267,0.00283716,0.03269226,0.004746266,0.00017550886,0.9125346,0.0012488303,0.0007987147,0.00057183177,0.0015586423,0.003530407,0.00028314188],"about_ca_topic_score_codex":0.0025882355,"about_ca_topic_score_gemma":0.0017327754,"teacher_disagreement_score":0.12045646,"about_ca_system_score_codex":0.005530371,"about_ca_system_score_gemma":0.0086597735,"threshold_uncertainty_score":0.9982872},"labels":[],"label_agreement":null},{"id":"W2040671376","doi":"10.1046/j.1365-2141.2002.03402.x","title":"Regulation of plasminogen activator inhibitor‐1 secretion by urokinase and tissue plasminogen activator in rat epithelioid‐type smooth muscle cells","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"MAPK/ERK pathway; Protein kinase C; Plasminogen activator; Signal transduction; Cell biology; Activator (genetics); Kinase; Protein kinase A; Tyrosine kinase; Secretion; Proto-oncogene tyrosine-protein kinase Src; Proteases; Mitogen-activated protein kinase; Biology; Chemistry; Receptor; Biochemistry; Endocrinology; Enzyme","score_opus":0.008473699515964111,"score_gpt":0.21506683101008406,"score_spread":0.20659313149411995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040671376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445474,0.0045744474,0.00023731234,0.000081211176,0.0003257292,0.00020152566,0.00004616152,0.000004618642,0.000074223106],"genre_scores_gemma":[0.9979311,0.001209233,0.0004758985,0.00007401866,0.00015644074,0.0000054637244,0.000033560136,0.000027418728,0.000086823915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854565,0.0001889444,0.00056973536,0.0002634265,0.00018238497,0.00024985275],"domain_scores_gemma":[0.9990694,0.000031244395,0.00047627793,0.00015451405,0.0001401408,0.00012841144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024604224,0.0001671605,0.00041462254,0.00011932232,0.000058429763,0.000022666252,0.00014685738,0.0003176258,0.00011700161],"category_scores_gemma":[0.00013011819,0.00019240542,0.00006616373,0.00011996354,0.000106463405,0.000036949292,0.000069257105,0.00020315286,0.0000042213283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016190122,0.00015511643,0.000111646405,0.00004743072,0.000027033739,0.00036605363,0.000052656378,0.000008636362,0.98479915,0.000017744187,0.008810005,0.0054426366],"study_design_scores_gemma":[0.0012594584,0.00070118514,0.00027108277,0.00013999452,0.000023887258,0.0032797353,0.00006000445,0.00004665189,0.98062223,0.00014330365,0.013271942,0.00018049644],"about_ca_topic_score_codex":0.000037303224,"about_ca_topic_score_gemma":0.000018855417,"teacher_disagreement_score":0.00526214,"about_ca_system_score_codex":0.00002417569,"about_ca_system_score_gemma":0.00004990588,"threshold_uncertainty_score":0.7846065},"labels":[],"label_agreement":null},{"id":"W2040852160","doi":"10.1111/bjh.13016","title":"A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Merck","keywords":"Decitabine; Vorinostat; Medicine; Tolerability; Myelodysplastic syndromes; Internal medicine; Oncology; Refractory (planetary science); Myeloid leukemia; Pharmacology; Adverse effect; Histone deacetylase; Bone marrow; Biology","score_opus":0.012352795511653919,"score_gpt":0.3094381602760078,"score_spread":0.2970853647643539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040852160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986221,0.00007620069,0.0006734573,0.000047855323,0.00017374259,0.0003598714,0.000017162325,0.00000206479,0.000027534516],"genre_scores_gemma":[0.9987947,0.00009681451,0.00092951435,0.000023221295,0.000044814737,0.000011125739,0.000044493016,0.00002358839,0.000031744734],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976286,0.0004507368,0.001031858,0.00025348057,0.00034533968,0.00028997668],"domain_scores_gemma":[0.99867433,0.00015839862,0.0005105371,0.00017561836,0.00036168183,0.000119453136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008408233,0.00013865653,0.0007164507,0.00023738136,0.000026779519,0.000014356056,0.0002339098,0.00020280949,0.000013312671],"category_scores_gemma":[0.00089634367,0.00011885595,0.00007281143,0.00023485029,0.00027424842,0.000018036499,0.000057018755,0.00039320157,0.0000016228364],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6813918,0.025713772,0.16629687,0.00038968274,0.0009426746,0.062296234,0.00020456074,0.00019912119,0.0043477356,0.00012910774,0.0022991272,0.055789363],"study_design_scores_gemma":[0.6966017,0.122334875,0.09234643,0.0013958464,0.00015304232,0.076896496,0.00006446612,0.00014981236,0.008419693,0.000075950906,0.000958537,0.0006031405],"about_ca_topic_score_codex":0.000032406304,"about_ca_topic_score_gemma":0.0005627611,"teacher_disagreement_score":0.0966211,"about_ca_system_score_codex":0.000035623318,"about_ca_system_score_gemma":0.0003529823,"threshold_uncertainty_score":0.4846805},"labels":[],"label_agreement":null},{"id":"W2040910538","doi":"10.1046/j.1365-2141.2000.01882.x","title":"New genotypes in Fy(a− b−) individuals: nonsense mutations (Trp to stop) in the coding sequence of either <i>FY A</i> or <i>FY B</i>","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Nonsense mutation; Coding region; Genetics; Stop codon; Nonsense; Biology; Genotype; Phenotype; Genotype-phenotype distinction; Gene; Mutation; Nonsense-mediated decay; Molecular biology; Nucleotide; Point mutation; RNA splicing; Missense mutation; RNA","score_opus":0.028225948320547332,"score_gpt":0.30216181671561354,"score_spread":0.27393586839506623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040910538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217445,0.0016517537,0.00027914188,0.004676572,0.0000752056,0.0003051201,0.000020685875,0.0000073675837,0.00080970844],"genre_scores_gemma":[0.9942919,0.0011303498,0.0026046478,0.0017568127,0.00006318477,0.000005003261,0.000005873807,0.000015050232,0.0001271534],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.998316,0.00021675859,0.00074230944,0.00015328568,0.000290612,0.00028104326],"domain_scores_gemma":[0.9992285,0.00027056146,0.00015803264,0.00013960089,0.00008829381,0.000115022405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067398086,0.00011564634,0.00059526594,0.00026798176,0.000053475054,0.00002121099,0.00019973645,0.00012035132,0.000525356],"category_scores_gemma":[0.0001403242,0.00009275391,0.00009280012,0.0006340027,0.0000853369,0.000099823075,0.000015237887,0.00044836698,0.00001775169],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032017292,0.0023147892,0.10167603,0.00070708885,0.0004404873,0.27946222,0.03243317,0.0013787979,0.01542242,0.0014616624,0.026771238,0.5347304],"study_design_scores_gemma":[0.013697656,0.0019683477,0.16887426,0.004768275,0.00044639345,0.7823262,0.0039032819,0.00009298819,0.00417225,0.0023439848,0.016919717,0.00048664695],"about_ca_topic_score_codex":0.00081373216,"about_ca_topic_score_gemma":0.0017632525,"teacher_disagreement_score":0.5342437,"about_ca_system_score_codex":0.000021731219,"about_ca_system_score_gemma":0.0002646345,"threshold_uncertainty_score":0.5752279},"labels":[],"label_agreement":null},{"id":"W2041006251","doi":"10.1111/j.1365-2141.2006.06069.x","title":"Shwachman–Diamond syndrome: an inherited model of aplastic anaemia with accelerated angiogenesis","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Institute of Infection and Immunity; Population Health Research Institute; University of Toronto","funders":"","keywords":"Angiogenesis; Bone marrow; Medicine; Stromal cell; Bone marrow failure; Vascular endothelial growth factor; Myeloid; Neovascularization; Cancer research; Immunology; Pathology; Stem cell; Haematopoiesis; Biology; VEGF receptors","score_opus":0.009851187868672031,"score_gpt":0.21971111407312666,"score_spread":0.20985992620445462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041006251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369574,0.0044765053,0.0014915128,0.000023331364,0.00004302945,0.00008881709,0.000044852502,0.0000052594655,0.00013094988],"genre_scores_gemma":[0.9970856,0.00020540555,0.0024653866,0.0000421324,0.00002627568,0.0000045968923,0.00008974544,0.000027629136,0.000053285796],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9989473,0.00006757643,0.0004294021,0.00019714958,0.00013366346,0.00022488504],"domain_scores_gemma":[0.9991687,0.0000087902035,0.00033243565,0.00015056468,0.00025429364,0.00008519798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007727062,0.00014773283,0.00043150623,0.000089958725,0.000056443558,0.000022483906,0.0001830293,0.00017496245,0.000017696628],"category_scores_gemma":[0.000017646567,0.00014629157,0.00010415666,0.0001341445,0.00012714816,0.000015242785,0.00003115087,0.000083163235,8.692015e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004011829,0.011524147,0.33358848,0.000596383,0.0050232788,0.086587444,0.00017299477,0.04850037,0.46891156,0.0007138748,0.01664569,0.023723926],"study_design_scores_gemma":[0.020241264,0.009750786,0.10443329,0.0005838578,0.0014413613,0.5796911,0.00035196432,0.00372267,0.27552855,0.0021380805,0.00056348345,0.00155358],"about_ca_topic_score_codex":0.00018505627,"about_ca_topic_score_gemma":0.00057711813,"teacher_disagreement_score":0.49310365,"about_ca_system_score_codex":0.000007312776,"about_ca_system_score_gemma":0.00012263712,"threshold_uncertainty_score":0.5965597},"labels":[],"label_agreement":null},{"id":"W2041060786","doi":"10.1046/j.1365-2141.2000.01797.x","title":"CAN WE PREVENT CYTOTOXIC DISASTERS?","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"IWK Health Centre","keywords":"Harm; Medicine; Human error; Intensive care medicine; Accidental; Risk analysis (engineering); Computer science; Psychology","score_opus":0.09885099792456978,"score_gpt":0.4400634920469776,"score_spread":0.34121249412240784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041060786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016588706,0.9938671,0.00009034442,0.0012342572,0.0021203482,0.00087994867,0.00011128719,0.000021710559,0.0015090924],"genre_scores_gemma":[0.00010308743,0.9965469,0.00011628084,0.00035852502,0.00046202724,0.000091376205,0.000062251456,0.000053433247,0.0022060901],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939973,0.002189852,0.002645929,0.00024662723,0.00034806618,0.000572232],"domain_scores_gemma":[0.9952133,0.0006364018,0.0033764963,0.00026520572,0.00014211758,0.00036645427],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007818936,0.00028428482,0.0029181489,0.00029560097,0.00034378946,0.0000026788737,0.000570164,0.00075501704,0.0018266373],"category_scores_gemma":[0.0003911645,0.00026593122,0.0006192776,0.00022333312,0.00015127074,0.00008848094,0.00008054092,0.0022706862,0.00039320783],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014214876,0.00015478136,0.0000054150028,0.016571738,0.00021911433,0.0068817027,0.00061180635,9.1814996e-7,1.7164371e-8,0.00013003644,0.026128478,0.94928175],"study_design_scores_gemma":[0.00038668583,0.000071015864,0.0000034033512,0.08044953,0.00045558083,0.06479867,0.00021633653,2.1895072e-7,5.4569114e-8,0.0003088789,0.85313535,0.0001742556],"about_ca_topic_score_codex":0.0000270001,"about_ca_topic_score_gemma":0.00014020113,"teacher_disagreement_score":0.9491075,"about_ca_system_score_codex":0.00021841981,"about_ca_system_score_gemma":0.0020180114,"threshold_uncertainty_score":0.9999793},"labels":[],"label_agreement":null},{"id":"W2041284044","doi":"10.1046/j.1365-2141.2002.03291.x","title":"ETV6 (TEL)‐AML1 pre‐B acute lymphoblastic leukaemia cells are associated with a distinct antigen‐presenting phenotype","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Immunophenotyping; ETV6; Biology; Antigen; Chromosomal translocation; Molecular biology; Immunology; Phenotype; Genetics; Gene","score_opus":0.01604182755766061,"score_gpt":0.2549685026487497,"score_spread":0.23892667509108909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041284044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252194,0.002353184,0.0019854128,0.0004944189,0.00031604868,0.00037101592,0.000044562672,0.000072519186,0.0018408925],"genre_scores_gemma":[0.9962235,0.0006844584,0.0010634382,0.00029275005,0.00027475125,0.000009495288,0.000015232742,0.0001005158,0.0013358495],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99597204,0.00033331855,0.0011193691,0.00044549754,0.0011047617,0.0010250247],"domain_scores_gemma":[0.9961519,0.0008277102,0.0011454818,0.00034052072,0.0009908368,0.0005435137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055370503,0.0003527279,0.0015197027,0.00033402597,0.0002549319,0.00012668797,0.00048234043,0.00036523692,0.00060463493],"category_scores_gemma":[0.0018853421,0.00032808457,0.00028083494,0.00062595546,0.00050096476,0.00026597964,0.0001728316,0.000979319,0.00011279597],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018927272,0.0020202654,0.058082625,0.0004877182,0.004379368,0.8069249,0.0009408151,0.00018724528,0.0062366608,0.00007767852,0.11262385,0.006146189],"study_design_scores_gemma":[0.020274568,0.0018546196,0.12938787,0.003980346,0.0015062039,0.8281723,0.00034229312,0.008095296,0.003106698,0.00017970167,0.0023228747,0.0007771857],"about_ca_topic_score_codex":0.00008097618,"about_ca_topic_score_gemma":0.000104374805,"teacher_disagreement_score":0.11030097,"about_ca_system_score_codex":0.00067026535,"about_ca_system_score_gemma":0.0005573297,"threshold_uncertainty_score":0.99991715},"labels":[],"label_agreement":null},{"id":"W2041513065","doi":"10.1046/j.1365-2141.2003.04160.x","title":"Long‐term follow‐up of granulocyte colony‐stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Amgen","keywords":"Congenital Neutropenia; Neutropenia; Granulocyte colony-stimulating factor; Mutation; Granulocyte colony-stimulating factor receptor; Medicine; Myeloid; Immunology; Internal medicine; Granulocyte; Myeloid leukemia; Cancer research; Chemotherapy; Biology; Genetics; Gene","score_opus":0.01145178917496193,"score_gpt":0.2460621192961925,"score_spread":0.2346103301212306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041513065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962969,0.002744935,0.0003278124,0.000036065743,0.00006109246,0.00037471202,0.000134462,0.0000015497843,0.000022497252],"genre_scores_gemma":[0.9982817,0.0003295706,0.0012145082,0.000030475074,0.000008374557,0.000022796148,0.000076558725,0.00001711945,0.000018854356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992536,0.000063261425,0.0003261207,0.0001515885,0.000054864588,0.0001505909],"domain_scores_gemma":[0.9993092,0.00003704709,0.0002535884,0.00008414822,0.00026106712,0.000054974054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053897842,0.00010285909,0.0003017308,0.000050887604,0.0000750182,0.000015826496,0.00007358004,0.00009383,0.000009524362],"category_scores_gemma":[0.000065488086,0.00010014597,0.000072563394,0.00006296036,0.000078490426,0.000012558233,0.0000124103435,0.000051642593,1.8153797e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037603066,0.00030317766,0.98730266,0.000017857721,0.00025019425,0.000024995803,0.00003964328,0.00001573094,0.0019421643,0.00002798375,0.000059982656,0.00963958],"study_design_scores_gemma":[0.015539046,0.0015108731,0.9719587,0.00004801749,0.00008373624,0.002498961,0.000039474937,0.0000011222222,0.007919405,0.000113203336,0.00011504663,0.00017239906],"about_ca_topic_score_codex":0.000017936665,"about_ca_topic_score_gemma":0.00022811323,"teacher_disagreement_score":0.015343945,"about_ca_system_score_codex":0.0000082188035,"about_ca_system_score_gemma":0.000082159706,"threshold_uncertainty_score":0.4083834},"labels":[],"label_agreement":null},{"id":"W2042224959","doi":"10.1046/j.1365-2141.2003.04235.x","title":"Clinical manifestations associated with the aberrant expression of the soluble granulocyte–macrophage colony‐stimulating factor receptor in patients presenting with haematological malignancies","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Mount Sinai Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Myeloid; Immunology; Haematopoiesis; Population; Medicine; Internal medicine; Granulocyte macrophage colony-stimulating factor; CD64; Biology; Cytokine; Stem cell; Flow cytometry","score_opus":0.0138217327615872,"score_gpt":0.25475931577350863,"score_spread":0.24093758301192142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042224959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986841,0.00060075294,0.000118569194,0.00007958808,0.0001169313,0.00028168198,0.000015529242,0.0000025720403,0.00010028847],"genre_scores_gemma":[0.99919134,0.00006128618,0.00058542343,0.000053986852,0.000009524605,0.000009480266,0.00001174901,0.000014851865,0.00006233786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825406,0.0005522761,0.00056022714,0.0001813348,0.00021226097,0.00023982913],"domain_scores_gemma":[0.9987022,0.00013507673,0.00071139476,0.0001484482,0.00025534988,0.000047499947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031086756,0.0001275456,0.000399065,0.000024651587,0.00017308361,0.000022296987,0.00020694734,0.00015561636,0.00001643569],"category_scores_gemma":[0.000588489,0.00007319293,0.000113667425,0.00011509094,0.00026389735,0.00001206312,0.000055434233,0.0002380061,4.1377993e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015895287,0.0007049301,0.9965838,0.00001784348,0.00012732629,0.00048275158,0.00008701351,0.000116865,0.0009080804,0.000025876894,0.00063053885,0.00015602303],"study_design_scores_gemma":[0.009268369,0.0016084446,0.95700824,0.00056850084,0.00014527449,0.0056064557,0.00045487756,0.000020110021,0.024638785,0.00011649605,0.00029729487,0.0002671534],"about_ca_topic_score_codex":0.00002116335,"about_ca_topic_score_gemma":0.00033389992,"teacher_disagreement_score":0.03957556,"about_ca_system_score_codex":0.000009928625,"about_ca_system_score_gemma":0.000099760095,"threshold_uncertainty_score":0.29847214},"labels":[],"label_agreement":null},{"id":"W2043234509","doi":"10.1111/bjh.12447","title":"How I manage heavy menstrual bleeding","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Menstrual bleeding; Etiology; Intensive care medicine; Clinical research; Population; Menstruation; Pediatrics; Gynecology; Internal medicine; Environmental health","score_opus":0.04806445549984252,"score_gpt":0.32276994094456163,"score_spread":0.2747054854447191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043234509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001079372,0.9962663,0.000033345525,0.00037842948,0.0007712492,0.0004485171,0.000016772712,0.000018014523,0.0009880156],"genre_scores_gemma":[0.0002294853,0.99476105,0.002223357,0.000058126545,0.00045468257,0.0000189449,0.000026637774,0.00006886392,0.002158872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804837,0.000119216405,0.00092546624,0.00024274277,0.00027838102,0.00038585212],"domain_scores_gemma":[0.99823165,0.000081385246,0.0010412564,0.00019270474,0.00018653975,0.00026645596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016998347,0.00033962828,0.0038957337,0.00031703134,0.000066254055,0.00014061683,0.0002171865,0.0003555593,0.00020569665],"category_scores_gemma":[0.0000970219,0.00028716406,0.00083479047,0.00014873406,0.00009901625,0.00015901214,0.000100092264,0.0007117359,0.00006443685],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007470859,0.00010539153,0.000011612283,0.007941136,0.0011308643,0.18155539,0.0000063786006,5.395261e-9,1.952078e-7,0.00011070415,0.008100675,0.80103016],"study_design_scores_gemma":[0.0005324104,0.00018967969,0.0000051744314,0.014499976,0.001427101,0.47941616,0.0000115551575,2.4697022e-7,9.388212e-7,0.00002865834,0.50378865,0.000099432975],"about_ca_topic_score_codex":0.000032114258,"about_ca_topic_score_gemma":0.000005529068,"teacher_disagreement_score":0.80093074,"about_ca_system_score_codex":0.00010169146,"about_ca_system_score_gemma":0.00016860358,"threshold_uncertainty_score":0.99995804},"labels":[],"label_agreement":null},{"id":"W2043688074","doi":"10.1111/j.1365-2141.2008.07418.x","title":"Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine <i>in vitro</i>","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; CancerCare Manitoba; Jewish General Hospital","funders":"Leukemia and Lymphoma Society; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Chlorambucil; Fludarabine; Dasatinib; Chronic lymphocytic leukemia; Cancer research; Medicine; Immunology; Internal medicine; Leukemia; Chemotherapy; Imatinib; Myeloid leukemia","score_opus":0.015242801933903328,"score_gpt":0.25840118592357314,"score_spread":0.24315838398966982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043688074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805494,0.017031917,0.000078421865,0.0006636988,0.00034116907,0.00045806935,0.000012270783,0.000035649926,0.0008293958],"genre_scores_gemma":[0.989882,0.0052395463,0.0023717806,0.001496038,0.00038615701,0.000015097804,0.000014556876,0.000065550164,0.0005292985],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9964781,0.00020620367,0.0012385071,0.00046471553,0.0007565541,0.0008559572],"domain_scores_gemma":[0.99785006,0.00046157153,0.0003155819,0.00034938194,0.00041487973,0.0006085343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079244346,0.00030128073,0.0016431604,0.00051776035,0.00014946969,0.000044902532,0.00026528773,0.00027549342,0.000070628696],"category_scores_gemma":[0.00086289336,0.00032200618,0.00019788579,0.0005171359,0.0005479483,0.00022053294,0.00022009922,0.00054484716,0.000056800192],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0060495217,0.00037660872,0.0013197244,0.0016505857,0.00041091506,0.87175745,0.0013548201,0.00034143138,0.06822539,0.00007896883,0.018447502,0.02998709],"study_design_scores_gemma":[0.033082508,0.0006934299,0.0031500433,0.0010759688,0.00007899472,0.929069,0.000125079,0.0013251724,0.028739229,0.00007960654,0.0022926843,0.00028832324],"about_ca_topic_score_codex":0.00078232033,"about_ca_topic_score_gemma":0.00016555123,"teacher_disagreement_score":0.05731152,"about_ca_system_score_codex":0.023466107,"about_ca_system_score_gemma":0.023490002,"threshold_uncertainty_score":0.9999232},"labels":[],"label_agreement":null},{"id":"W2043758540","doi":"10.1111/j.1365-2141.1991.tb08631.x","title":"DETECTION OF ABNORMAL HAEMOGLOBINS BY THE SYSMEX NE-8000 AUTOMATED CELL COUNTER","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Kingston General Hospital","funders":"","keywords":"Freedman; General hospital; Citation; Medicine; Library science; Pediatrics; Family medicine; Law; Political science; Computer science","score_opus":0.006511642704602737,"score_gpt":0.2197549949642122,"score_spread":0.21324335225960944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043758540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6849935,0.07952638,0.00056014507,0.22252807,0.0045296103,0.0012439056,0.0002770569,0.0002493917,0.0060919356],"genre_scores_gemma":[0.7345846,0.021755582,0.00016486693,0.23887683,0.0015760078,0.00001626823,0.00019202543,0.00021345606,0.0026203129],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9966399,0.00032749554,0.0015267176,0.0002736536,0.00065831013,0.0005738941],"domain_scores_gemma":[0.9972814,0.00017075126,0.0015065973,0.00031419427,0.0006033101,0.00012377313],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00033948757,0.00035881842,0.0016077426,0.00026102597,0.0001904257,0.000034454493,0.0003937546,0.0016921784,0.00017579384],"category_scores_gemma":[0.0001229799,0.00028834332,0.0005925454,0.0002654205,0.000591232,0.000108995155,0.000059804384,0.003759955,0.000032401596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011500835,0.00014325097,0.00008672726,0.00054614944,0.00036238556,0.087952204,0.00011357613,0.000011655659,0.00051905884,4.8498237e-7,0.9085608,0.0015886691],"study_design_scores_gemma":[0.0019644077,0.00044388734,0.0001324693,0.00087170844,0.00046495258,0.59904444,0.00012416764,0.00017687639,0.0015162801,0.00000865003,0.39505532,0.00019685196],"about_ca_topic_score_codex":0.0004529202,"about_ca_topic_score_gemma":0.000026405509,"teacher_disagreement_score":0.5135055,"about_ca_system_score_codex":0.00011503701,"about_ca_system_score_gemma":0.0004095086,"threshold_uncertainty_score":0.99995685},"labels":[],"label_agreement":null},{"id":"W2043759160","doi":"10.1111/j.1365-2141.2006.06405.x","title":"A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; Windsor Regional Hospital; BC Cancer Agency; St. John’s Health Sciences Centre; Royal Victoria Hospital; Moncton Hospital; Humber River Regional Hospital; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Dexamethasone; Medicine; Prednisone; Melphalan; Induction therapy; Multiple myeloma; Internal medicine; Oncology; Maintenance therapy; Chemotherapy","score_opus":0.06670175160755294,"score_gpt":0.33168352285355823,"score_spread":0.2649817712460053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043759160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899784,0.007565316,0.00039301906,0.0006134193,0.000070283975,0.0012881628,0.000008547726,0.000018068702,0.0000648103],"genre_scores_gemma":[0.98559636,0.0044354154,0.009445923,0.00009820446,0.00007507678,0.000064536136,0.000024118186,0.00003978531,0.000220552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971727,0.00045587795,0.0010716743,0.0003133634,0.00054242584,0.00044396857],"domain_scores_gemma":[0.99750054,0.0008084878,0.0007986974,0.00019325841,0.0005118506,0.00018717289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007484893,0.0002521473,0.0014931149,0.00033885695,0.000093774586,0.000037924117,0.0001377634,0.00021072179,0.00014604266],"category_scores_gemma":[0.0010742176,0.00017542191,0.000110815585,0.0004688789,0.00032770928,0.0002558925,0.000022407614,0.00047380652,0.0000028672678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2242934,0.0034242962,0.49021086,0.00021147463,0.0007715448,0.023942549,0.0007858768,0.000041403386,0.014845432,0.000052902462,0.00046747093,0.24095279],"study_design_scores_gemma":[0.18572095,0.00844631,0.6429376,0.0012928181,0.00009452472,0.12784891,0.0009737207,0.00059136853,0.031183437,0.00029226608,0.00036785004,0.00025026203],"about_ca_topic_score_codex":0.003160865,"about_ca_topic_score_gemma":0.0023329766,"teacher_disagreement_score":0.24070252,"about_ca_system_score_codex":0.00010316724,"about_ca_system_score_gemma":0.00043454225,"threshold_uncertainty_score":0.7153498},"labels":[],"label_agreement":null},{"id":"W2043995760","doi":"10.1111/bjh.12714","title":"Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the <scp>IELSG</scp> 14 study)","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Internal medicine; Radiation therapy; Stage (stratigraphy); Oncology; Pathology","score_opus":0.012666216875482599,"score_gpt":0.27175735920211574,"score_spread":0.25909114232663316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043995760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489367,0.0013900098,0.000017455222,0.00023608621,0.0007255212,0.0022136394,0.0000067561377,0.000011420212,0.0005054268],"genre_scores_gemma":[0.9988709,0.00027872104,0.000331992,0.00014479281,0.0001506093,0.00010113338,0.000002504989,0.000027086333,0.000092271264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958587,0.00083091616,0.0015810151,0.00042965516,0.001025272,0.0002743962],"domain_scores_gemma":[0.9971744,0.0007038297,0.0011379408,0.00039636358,0.00045066013,0.00013681251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017319103,0.00025591106,0.0014340499,0.00016576725,0.0001558273,0.000042822016,0.00044248975,0.00011974131,0.000009403047],"category_scores_gemma":[0.00060890475,0.00017053635,0.0003335107,0.0002315044,0.00034866855,0.000096024596,0.0003913086,0.00022593176,0.0000016332883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030964048,0.047563974,0.8839264,0.0000659849,0.0030046315,0.0064783935,0.002011927,0.0000011252614,0.000009063927,0.00011483986,0.0012881025,0.0552259],"study_design_scores_gemma":[0.032167215,0.0068860454,0.9247859,0.00029101537,0.001568499,0.025255201,0.008520368,0.000014460806,0.000037100715,0.00006140275,0.00035327577,0.000059481164],"about_ca_topic_score_codex":0.0003094659,"about_ca_topic_score_gemma":0.0005659744,"teacher_disagreement_score":0.05516642,"about_ca_system_score_codex":0.00020687009,"about_ca_system_score_gemma":0.00011378011,"threshold_uncertainty_score":0.69542706},"labels":[],"label_agreement":null},{"id":"W2044479160","doi":"10.1111/bjh.12878","title":"Guidelines for the first line management of classical Hodgkin lymphoma","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Hematology; Medicine; Hodgkin lymphoma; Internal medicine; Lymphoma; Oncology; Medical physics","score_opus":0.04588011173821988,"score_gpt":0.3272710597969642,"score_spread":0.2813909480587443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044479160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9049603,0.017772388,0.012540555,0.061775893,0.00095320033,0.0007525933,0.00001997496,0.000018769191,0.0012063519],"genre_scores_gemma":[0.98697305,0.002837905,0.008171688,0.0014424805,0.0003028153,0.000030914045,0.0000038462335,0.000016429438,0.00022090245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987207,0.00003314403,0.0007427274,0.00011521987,0.00020739643,0.00018082981],"domain_scores_gemma":[0.9985224,0.00035672,0.0003679095,0.00016324851,0.0005108125,0.00007892528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004289786,0.00010133873,0.0005980365,0.00005418553,0.00007734827,0.000014735872,0.00015002249,0.000073206735,0.00003539764],"category_scores_gemma":[0.00026894672,0.000069776484,0.00027800942,0.00006842986,0.00011249509,0.000031322445,0.000042117044,0.000047967897,0.000004787624],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004822715,0.0014912293,0.0069958935,0.00055777177,0.0014983439,0.009978862,0.000052787265,0.000044228862,0.0000140946095,0.010217275,0.13301256,0.8356547],"study_design_scores_gemma":[0.023246419,0.0021996512,0.111869924,0.0027914606,0.002037211,0.26973623,0.00020648475,0.0013576739,0.002109859,0.0026337085,0.5816014,0.0002099783],"about_ca_topic_score_codex":0.000027827644,"about_ca_topic_score_gemma":0.000044866993,"teacher_disagreement_score":0.8354447,"about_ca_system_score_codex":0.000050796854,"about_ca_system_score_gemma":0.00006530297,"threshold_uncertainty_score":0.28454024},"labels":[],"label_agreement":null},{"id":"W2044894710","doi":"10.1046/j.1365-2141.2002.03694.x","title":"Treatment of life‐threatening post‐haemorrhagic anaemia with cell‐free haemoglobin solution in an adolescent Jehovah's Witness","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Blood transfusion; Intensive care medicine; Pediatrics; Witness; Surgery","score_opus":0.024128540577014513,"score_gpt":0.22619717560941469,"score_spread":0.20206863503240016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044894710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927605,0.0029165829,0.00048691078,0.0020608737,0.00020845453,0.0002081307,0.000004310916,0.000024009307,0.001330247],"genre_scores_gemma":[0.998048,0.00051819335,0.00076731964,0.0004242854,0.00017011106,0.0000052883024,0.000008890647,0.000024273011,0.00003361663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983957,0.00006918898,0.0007326943,0.00021820003,0.00030568393,0.00027858053],"domain_scores_gemma":[0.99839234,0.000048400078,0.0008705947,0.00017626554,0.00046664564,0.000045779954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023556853,0.00018247965,0.0006175023,0.0004489853,0.00011612414,0.00013038529,0.00027439755,0.00011422855,0.0003684459],"category_scores_gemma":[0.0000817621,0.00017212564,0.00010166882,0.00040186616,0.000121486235,0.0016034978,0.000034244742,0.00020977385,0.000015743639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038246757,0.01941064,0.5152261,0.002183107,0.0005677411,0.104524896,0.0013326628,0.002154466,0.003455725,0.008303857,0.0040633176,0.3349528],"study_design_scores_gemma":[0.12727273,0.0063752555,0.4934194,0.0051280996,0.0034761154,0.27695128,0.010534225,0.03937664,0.0058583277,0.0053808074,0.022006901,0.004220192],"about_ca_topic_score_codex":0.00092121045,"about_ca_topic_score_gemma":0.0022212593,"teacher_disagreement_score":0.3307326,"about_ca_system_score_codex":0.000040572257,"about_ca_system_score_gemma":0.000046396675,"threshold_uncertainty_score":0.70190805},"labels":[],"label_agreement":null},{"id":"W2046494527","doi":"10.1046/j.1365-2141.2001.03004.x","title":"Novel treatment modalities: new platelet preparations and subsititutes","year":2001,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"","keywords":"Medicine; Modalities; Platelet; Internal medicine","score_opus":0.0723685864242695,"score_gpt":0.348856371472046,"score_spread":0.2764877850477765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046494527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032924974,0.9956843,0.0009150073,0.00041096637,0.00028643207,0.0006539974,0.000029128118,0.00001867062,0.0016722361],"genre_scores_gemma":[0.000023263936,0.9930037,0.0018624339,0.00014436634,0.00023326828,0.000017408942,0.000037981907,0.000030520507,0.0046470435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984055,0.00006327057,0.000925679,0.0002137983,0.00016844162,0.00022331781],"domain_scores_gemma":[0.998949,0.00012755506,0.00041622174,0.00015529509,0.000083755345,0.00026817978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012790282,0.00025329087,0.0024011813,0.00025189738,0.000072544215,0.00005150912,0.00009641941,0.00024052513,0.000313431],"category_scores_gemma":[0.000052093303,0.00022343898,0.00044011042,0.00013457445,0.000086240645,0.000079906815,0.00002574445,0.00027644396,0.000012348454],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025527741,0.00038291386,0.0000017497817,0.0044650626,0.0011735838,0.031160152,0.000084369225,4.2314412e-7,2.9023167e-7,0.0011531203,0.0140383495,0.9475145],"study_design_scores_gemma":[0.0013651244,0.0002396605,0.0000029148348,0.0076032877,0.0016040567,0.41936228,0.000031510986,5.9665916e-7,8.872895e-7,0.000061226805,0.5696392,0.00008928795],"about_ca_topic_score_codex":0.00027689835,"about_ca_topic_score_gemma":0.00040402825,"teacher_disagreement_score":0.9474252,"about_ca_system_score_codex":0.00007347535,"about_ca_system_score_gemma":0.0006768154,"threshold_uncertainty_score":0.9111577},"labels":[],"label_agreement":null},{"id":"W2047370882","doi":"10.1111/j.1365-2141.2006.06245.x","title":"Reversal of immune thrombocytopenia in mice by cross‐linking human immunoglobulin G with a high‐affinity monoclonal antibody","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"Canadian Blood Services","keywords":"Monoclonal antibody; Antibody; Immunology; Immune system; Thrombocytopenic purpura; In vivo; Monoclonal; Immunoglobulin G; Ex vivo; Medicine; Biology","score_opus":0.007130359630702071,"score_gpt":0.276273425371694,"score_spread":0.26914306574099195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047370882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227095,0.006822829,0.000054425953,0.00017242815,0.0000798855,0.00017259376,0.00003186984,0.000008534746,0.00038650076],"genre_scores_gemma":[0.9976583,0.00028142528,0.0017800353,0.00004685059,0.000029977717,0.0000019622746,0.000105802224,0.000022289794,0.00007336648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981772,0.000087703935,0.0009948027,0.00017925238,0.00025434466,0.00030670996],"domain_scores_gemma":[0.9988879,0.00006362469,0.0006693273,0.000111347734,0.00020907163,0.000058727423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028783374,0.00016468982,0.001325813,0.00014095055,0.000088149296,0.000029539415,0.00016603965,0.00015835799,0.00007984681],"category_scores_gemma":[0.000033579967,0.00015963774,0.00013840962,0.00018188744,0.00023388394,0.00016884379,0.00003822671,0.0004270199,0.0000037652587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027825867,0.004484932,0.41571534,0.00040652257,0.00093725836,0.37786394,0.00017738284,0.00008802938,0.19381174,0.00057909876,0.0018071308,0.0013460333],"study_design_scores_gemma":[0.018686572,0.0013458158,0.53256917,0.0018551339,0.00024712883,0.41291732,0.00009650501,0.000007380714,0.030785859,0.0010776018,0.00016043699,0.0002511091],"about_ca_topic_score_codex":0.004701731,"about_ca_topic_score_gemma":0.00060163497,"teacher_disagreement_score":0.16302589,"about_ca_system_score_codex":0.00006167134,"about_ca_system_score_gemma":0.00014134058,"threshold_uncertainty_score":0.71076417},"labels":[],"label_agreement":null},{"id":"W2047634988","doi":"10.1111/j.1365-2141.2009.07836.x","title":"Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non‐Hodgkin lymphoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Cancer Institute; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Bortezomib; Mantle cell lymphoma; Fludarabine; Medicine; Rituximab; Internal medicine; Chronic lymphocytic leukemia; Follicular lymphoma; Lymphoma; Regimen; Oncology; Aggressive lymphoma; Gastroenterology; Multiple myeloma; Chemotherapy; Leukemia; Cyclophosphamide","score_opus":0.014462302663390188,"score_gpt":0.315413557958335,"score_spread":0.30095125529494476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047634988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876523,0.010593859,0.0002159538,0.00045334242,0.00014532165,0.00062658737,0.000018684801,0.000006123426,0.0002878052],"genre_scores_gemma":[0.99368376,0.0042053144,0.0016509101,0.0001661661,0.00015317205,0.0000065801764,0.000005690462,0.000019220488,0.00010919549],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982802,0.00009172938,0.00079566333,0.00023373953,0.00028287835,0.00031577153],"domain_scores_gemma":[0.998621,0.00031098945,0.000412443,0.00014910092,0.00024432415,0.00026213186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006949386,0.00014673172,0.0010429655,0.00020860232,0.00006749342,0.000029127355,0.000092374954,0.0002058445,0.000019211753],"category_scores_gemma":[0.0004365077,0.0001467461,0.00010068624,0.00008240281,0.00029407392,0.00012346958,0.000044020937,0.00022000085,7.1244466e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19637725,0.013863035,0.00017334832,0.0027095163,0.0005109161,0.06320931,0.0011067619,9.231519e-7,0.022057718,0.00034843854,0.020431893,0.6792109],"study_design_scores_gemma":[0.7686094,0.011171654,0.00078535004,0.0005162828,0.00024150696,0.20741254,0.00016791679,0.00057315844,0.0078012734,0.0005532177,0.0020150852,0.00015263117],"about_ca_topic_score_codex":0.00006632738,"about_ca_topic_score_gemma":0.000012007681,"teacher_disagreement_score":0.67905825,"about_ca_system_score_codex":0.00036839928,"about_ca_system_score_gemma":0.0014172327,"threshold_uncertainty_score":0.5984132},"labels":[],"label_agreement":null},{"id":"W2047649402","doi":"10.1046/j.1365-2141.2002.03492.x","title":"Antithrombotic effect of PMC, a potent α‐tocopherol analogue on platelet plug formation <i>in vivo</i>","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"National Science Council","keywords":"Medicine; Bleeding time; Aspirin; Platelet; Saline; Pharmacology; Thrombosis; In vivo; Anesthesia; Antithrombotic; Surgery; Internal medicine; Platelet aggregation","score_opus":0.00995421963956499,"score_gpt":0.23301067206485912,"score_spread":0.22305645242529412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047649402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885016,0.010078343,0.00025434844,0.00019050844,0.00014787732,0.00033586132,0.000008854847,0.00001042397,0.0004721455],"genre_scores_gemma":[0.99598324,0.0036273615,0.00011409631,0.00016725447,0.0000635791,0.000005460366,0.0000032776193,0.000017176708,0.000018530583],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983777,0.00027582963,0.000653981,0.00012581784,0.00033448538,0.00023223362],"domain_scores_gemma":[0.99920213,0.000116762145,0.00032355968,0.00014588436,0.00010233008,0.000109306864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039497184,0.00013838697,0.0010730217,0.00020570123,0.000037363807,0.000012027577,0.0001068783,0.0001327112,0.00026071872],"category_scores_gemma":[0.00012749448,0.00012835613,0.00047496028,0.00017879419,0.00009802356,0.00014331142,0.000012335243,0.00028529204,0.000018551053],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075709173,0.003625077,0.039453506,0.0040128953,0.0040703057,0.61763215,0.0007976488,0.0022460395,0.01676861,0.00037680124,0.02332622,0.28011984],"study_design_scores_gemma":[0.021041922,0.0054504806,0.017313879,0.004638164,0.0006079092,0.8397799,0.00013695098,0.0005422425,0.10887454,0.00015733237,0.0011516099,0.00030507162],"about_ca_topic_score_codex":0.00001688481,"about_ca_topic_score_gemma":0.000010414554,"teacher_disagreement_score":0.27981478,"about_ca_system_score_codex":0.000037362544,"about_ca_system_score_gemma":0.000022620005,"threshold_uncertainty_score":0.5234211},"labels":[],"label_agreement":null},{"id":"W2047750426","doi":"10.1046/j.1365-2141.2003.04502.x","title":"Multicolour fluorescence <i>in situ</i> hybridization analysis of t(14;18)‐positive follicular lymphoma and correlation with gene expression data and clinical outcome","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Chromosomal translocation; Comparative genomic hybridization; Fluorescence in situ hybridization; Biology; Gene duplication; Karyotype; Breakpoint; Follicular lymphoma; Chromosome; Cytogenetics; Genetics; Molecular biology; Gene; Chromosomal rearrangement; Gene dosage; Lymphoma; Gene expression; Immunology","score_opus":0.028809754963868794,"score_gpt":0.3193472609882517,"score_spread":0.29053750602438294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047750426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945286,0.0030442248,0.0019740923,0.0001320075,0.00005960541,0.00019307017,0.000024951769,0.0000032399676,0.000040195802],"genre_scores_gemma":[0.9880209,0.0016612393,0.01014978,0.0000855205,0.000011970299,0.00000230503,0.000053729364,0.000008635509,0.0000059387585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831855,0.0002567282,0.0008339813,0.00025389198,0.00020384019,0.00013300455],"domain_scores_gemma":[0.9986378,0.00030611732,0.00054302765,0.00018915541,0.00020086115,0.00012305622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055415113,0.000107473,0.0008857916,0.00020135164,0.000043098462,0.00001790929,0.00006628625,0.00010650197,0.000009519755],"category_scores_gemma":[0.00053554977,0.000091255446,0.000077013174,0.00024634987,0.00013381743,0.00016247485,0.000043414064,0.000087925764,3.338946e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002520405,0.0007294207,0.98036283,0.000028253331,0.00066072174,0.0113292225,0.000065717424,0.000044527595,0.0005965108,0.0000327992,0.00009414443,0.005803804],"study_design_scores_gemma":[0.0077031963,0.00042675118,0.93906814,0.00043812455,0.0024345666,0.043964393,0.00009606376,0.0015909726,0.004141776,0.000014316349,0.0000312058,0.00009048844],"about_ca_topic_score_codex":0.00006095925,"about_ca_topic_score_gemma":0.00015817078,"teacher_disagreement_score":0.041294694,"about_ca_system_score_codex":0.000049572212,"about_ca_system_score_gemma":0.00011854937,"threshold_uncertainty_score":0.3721289},"labels":[],"label_agreement":null},{"id":"W2048115478","doi":"10.1111/j.1365-2141.2004.05105.x","title":"Tetramolecular immune complexes are more efficient than IVIg to prevent antibody‐dependent <i>in vitro</i> and <i>in vivo</i> phagocytosis of blood cells","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"Canadian Institutes of Health Research; Bayer Canada","keywords":"Phagocytosis; In vivo; Opsonin; In vitro; Antibody; Immune system; Thrombocytopenic purpura; Immunology; Monoclonal antibody; Platelet; Immunoglobulin G; Pharmacology; Medicine; Chemistry; Biology; Biochemistry","score_opus":0.005985135252188746,"score_gpt":0.2504104959760597,"score_spread":0.24442536072387094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048115478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698896,0.0116844615,0.00008436096,0.00060969597,0.00009971029,0.0004230372,0.000053537093,0.000005745828,0.00005048857],"genre_scores_gemma":[0.9978262,0.0009473066,0.00097399356,0.00019553119,0.000011481255,0.000006046583,0.0000058452183,0.000022087332,0.000011496158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981966,0.00007282953,0.0008294918,0.00023811887,0.00030918064,0.00035374938],"domain_scores_gemma":[0.9991873,0.000043545595,0.0003597499,0.0001453111,0.00009751041,0.00016660754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002276897,0.00018462581,0.0012496602,0.0002917757,0.000034161258,0.000016034694,0.00013208175,0.000109449655,0.000014539379],"category_scores_gemma":[0.000047745594,0.00018982483,0.0001604252,0.00022237534,0.00010374881,0.00004430288,0.00006088266,0.00025537796,0.0000017957556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006249451,0.005595835,0.0045614555,0.00029267796,0.0003201923,0.25372624,0.00033351415,0.00078598596,0.7331453,0.000016233704,0.000041412248,0.0005562361],"study_design_scores_gemma":[0.009334327,0.0005267135,0.012019142,0.0018341292,0.00025398983,0.17031743,0.0003936498,0.000013198713,0.80501217,0.00010969275,0.000025050509,0.00016049514],"about_ca_topic_score_codex":0.00042741047,"about_ca_topic_score_gemma":0.00019179092,"teacher_disagreement_score":0.08340882,"about_ca_system_score_codex":0.00004927947,"about_ca_system_score_gemma":0.00008768462,"threshold_uncertainty_score":0.7740832},"labels":[],"label_agreement":null},{"id":"W2048905154","doi":"10.1046/j.1365-2141.2001.03127.x","title":"Multilineage glycosylphosphatidylinositol anchor‐deficient haematopoiesis in untreated aplastic anaemia","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Cancer Institute","keywords":"Aerolysin; Aplastic anemia; CD59; Haematopoiesis; Paroxysmal nocturnal hemoglobinuria; Flow cytometry; Immunology; Biology; Stem cell; Medicine; Cell biology; Antibody; Genetics; Bone marrow; Gene","score_opus":0.011159427765263179,"score_gpt":0.24713699721212826,"score_spread":0.23597756944686507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048905154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97479975,0.0227647,0.00036173925,0.00016514429,0.0012285676,0.00030288284,0.000045260873,0.00004027875,0.00029164756],"genre_scores_gemma":[0.9988618,0.0005776442,0.0001420922,0.00010470112,0.000042483924,0.000015752792,0.000036688692,0.000025864269,0.00019297274],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9970417,0.00045966567,0.0014621153,0.0003144677,0.000107789936,0.0006142871],"domain_scores_gemma":[0.9982319,0.0005007997,0.00067909685,0.00024588848,0.00026449058,0.00007783442],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044511416,0.00024698628,0.0010706756,0.0004097615,0.00015137126,0.00003921975,0.0004736741,0.00025783916,0.0017719044],"category_scores_gemma":[0.0006130814,0.00026948203,0.00022232147,0.00039179044,0.00023098954,0.00016884616,0.000079786805,0.00044849087,0.00019668294],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002518675,0.0036263338,0.64847153,0.00046108407,0.001111887,0.23609816,0.0008401907,0.0007821574,0.02627036,0.0013816651,0.057041,0.021396948],"study_design_scores_gemma":[0.015062662,0.00080917706,0.15695536,0.0025603909,0.00036419294,0.77812606,0.0017627091,0.00017513246,0.020548731,0.00036004395,0.02237525,0.00090027583],"about_ca_topic_score_codex":0.00034571017,"about_ca_topic_score_gemma":0.00090146036,"teacher_disagreement_score":0.5420279,"about_ca_system_score_codex":0.00011576742,"about_ca_system_score_gemma":0.00013585272,"threshold_uncertainty_score":0.99997574},"labels":[],"label_agreement":null},{"id":"W2049005290","doi":"10.1111/j.1365-2141.2005.05954.x","title":"Immunohistochemical analysis of the antiapoptotic Mcl‐1 and Bcl‐2 proteins in follicular lymphoma","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV; Cancer Research UK","keywords":"Immunohistochemistry; Follicular lymphoma; Lymphoma; Medicine; Pathology; High-power field; Internal medicine","score_opus":0.004807008348192153,"score_gpt":0.22816037746805634,"score_spread":0.2233533691198642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049005290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870215,0.011955122,0.000020608953,0.0005864144,0.000050664454,0.0001805305,0.000005696468,0.0000028428142,0.00017658641],"genre_scores_gemma":[0.9991506,0.00026380032,0.00044474518,0.00007288145,0.000020641373,0.00000698497,0.0000040700565,0.000007366923,0.000028924149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988247,0.00007870617,0.0006131882,0.00012074055,0.00020059354,0.00016205951],"domain_scores_gemma":[0.99931216,0.00006762614,0.00031669636,0.00014368861,0.000111734196,0.000048099282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016785643,0.00009184539,0.0008032249,0.0002110748,0.000035891237,0.000011196059,0.00009110552,0.0000938671,0.000026138368],"category_scores_gemma":[0.00009519314,0.00007095785,0.00029979105,0.00041047035,0.00016716575,0.00003925851,0.000036976453,0.0000812635,6.0219463e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017599633,0.002558315,0.951268,0.00014439058,0.0021789055,0.023636844,0.0001359704,0.0000424427,0.009059402,0.0010513498,0.0007641533,0.008984237],"study_design_scores_gemma":[0.0037605711,0.00011444282,0.90410805,0.00038693438,0.0016586265,0.07775119,0.000036039724,0.00006924453,0.011596722,0.00024343825,0.00020584177,0.00006888659],"about_ca_topic_score_codex":0.0010328795,"about_ca_topic_score_gemma":0.00024003471,"teacher_disagreement_score":0.05411434,"about_ca_system_score_codex":0.000113640155,"about_ca_system_score_gemma":0.00014106576,"threshold_uncertainty_score":0.28935772},"labels":[],"label_agreement":null},{"id":"W2049601701","doi":"10.1111/j.1365-2141.2012.09196.x","title":"Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term","year":2012,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Anticoagulant therapy; Venous thromboembolism; Anticoagulant; Intensive care medicine; Risk factor; Surgery; Internal medicine; Thrombosis","score_opus":0.07509890017562146,"score_gpt":0.33232762533072274,"score_spread":0.2572287251551013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049601701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06941629,0.92816913,0.000057482408,0.0002709753,0.00055710104,0.0014345852,0.000029913614,0.000007618112,0.00005687076],"genre_scores_gemma":[0.03462082,0.9644715,0.00011996107,0.00025611764,0.00039482885,0.00004903611,0.000025344252,0.00005480673,0.000007550131],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99783635,0.00016326124,0.0011872335,0.00020556965,0.00026895007,0.0003386575],"domain_scores_gemma":[0.99755573,0.00042597466,0.0014707694,0.0002252633,0.00021086594,0.00011137755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008366494,0.00027765826,0.0037066722,0.00019821832,0.00012652608,0.000044031665,0.00020708318,0.0002407577,0.000041250154],"category_scores_gemma":[0.00013896868,0.00019169305,0.00048382476,0.00010092738,0.00012252356,0.00008033141,0.000049893104,0.00038306156,0.0000029387973],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032443244,0.0008045262,0.00012230835,0.009334516,0.0011248083,0.0009897035,0.00013766231,4.0358952e-7,0.000004307101,0.0015875396,0.0011820107,0.98467976],"study_design_scores_gemma":[0.0051701055,0.0051911618,0.045335818,0.1729149,0.015688248,0.41063285,0.00019060874,0.0000068764934,0.00023756149,0.0003289461,0.3432955,0.0010074303],"about_ca_topic_score_codex":0.00002057364,"about_ca_topic_score_gemma":0.0000138614405,"teacher_disagreement_score":0.9836723,"about_ca_system_score_codex":0.000042955817,"about_ca_system_score_gemma":0.00014517138,"threshold_uncertainty_score":0.78170156},"labels":[],"label_agreement":null},{"id":"W2049797387","doi":"10.1046/j.1365-2141.2000.02342.x","title":"Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute","keywords":"Progenitor cell; Haematopoiesis; Immunology; White blood cell; Biology; Blood cell; Internal medicine; Stem cell; Andrology; Medicine; Cell biology","score_opus":0.005327753068103107,"score_gpt":0.2057229196985517,"score_spread":0.2003951666304486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049797387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947103,0.0027366779,0.0000068865425,0.00086386706,0.000050673094,0.0008935088,0.00002022447,0.000007791286,0.0007100376],"genre_scores_gemma":[0.9984962,0.000376804,0.00032851918,0.0006568835,0.000020443173,0.000017325458,0.000008463021,0.000024118592,0.00007126038],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982417,0.0001983487,0.0006584607,0.00017209059,0.0004081385,0.00032121356],"domain_scores_gemma":[0.9990294,0.00008134549,0.00023592508,0.00018290745,0.00024068418,0.00022975069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022841354,0.00014890745,0.00065864605,0.00013231083,0.00006314254,0.0000142596555,0.00020150584,0.0000867225,0.00025111713],"category_scores_gemma":[0.000109160595,0.000107213076,0.00015316317,0.0002990694,0.00018944399,0.00006335873,0.000019046834,0.00037114276,0.000008734509],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020624666,0.04284879,0.41403162,0.0036842672,0.0018466451,0.4240129,0.03095929,0.00087254576,0.0011023137,0.000387714,0.0053755906,0.05425366],"study_design_scores_gemma":[0.10002869,0.019869605,0.3925627,0.00827749,0.006030771,0.42492464,0.021423195,0.00006414648,0.008888381,0.00065558346,0.015456264,0.0018185433],"about_ca_topic_score_codex":0.000060522943,"about_ca_topic_score_gemma":0.0000275748,"teacher_disagreement_score":0.07940403,"about_ca_system_score_codex":0.000019729034,"about_ca_system_score_gemma":0.00023328644,"threshold_uncertainty_score":0.43720224},"labels":[],"label_agreement":null},{"id":"W2050235018","doi":"10.1046/j.1365-2141.2003.04188.x","title":"Maxwell Wintrobe, in his own words","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Johns Hopkins University; University of Utah","keywords":"Medicine; Physics; Psychology","score_opus":0.02983480536067098,"score_gpt":0.3797622386518316,"score_spread":0.34992743329116066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050235018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8944087,0.014117044,0.0004916796,0.010410649,0.004052459,0.00042732854,0.000011485217,0.000033348828,0.0760473],"genre_scores_gemma":[0.962514,0.0039143283,0.0036383837,0.025887921,0.0003723684,0.000023825773,0.0000073437172,0.000049348128,0.0035924765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640524,0.0011537467,0.0014043623,0.00015400245,0.00020585654,0.0006767732],"domain_scores_gemma":[0.9981988,0.00059364346,0.0006221182,0.00015945535,0.00022279423,0.0002031965],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015657754,0.00012264254,0.0008656158,0.0002635419,0.00023709674,0.000008877905,0.00024095715,0.00029550653,0.0023825702],"category_scores_gemma":[0.0009094931,0.00012974086,0.00012768284,0.00023402783,0.000073048825,0.00017832938,0.00004586253,0.0013829463,0.0001191004],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018281424,0.00028518387,0.18690883,0.0006572222,0.00007436101,0.06117294,0.001464531,0.0000061957167,0.000060434773,0.01766171,0.7126022,0.018923579],"study_design_scores_gemma":[0.00372564,0.0001625034,0.033645876,0.00060136686,0.000032758246,0.06715101,0.0013297831,0.000001984742,0.000031815725,0.010539422,0.8825451,0.00023270767],"about_ca_topic_score_codex":0.00026795306,"about_ca_topic_score_gemma":0.0017238435,"teacher_disagreement_score":0.16994293,"about_ca_system_score_codex":0.000335449,"about_ca_system_score_gemma":0.0015588474,"threshold_uncertainty_score":0.9985294},"labels":[],"label_agreement":null},{"id":"W2050746746","doi":"10.1046/j.1365-2141.2003.04551.x","title":"Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"MLH1; Biology; Genetics; Genotype; Odds ratio; DNA repair; Gene; Cancer research; DNA mismatch repair; Medicine; Internal medicine","score_opus":0.005387028440765084,"score_gpt":0.22429209580105292,"score_spread":0.21890506736028784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050746746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852928,0.013316849,0.00006266472,0.00009705523,0.00025901053,0.00025480983,0.000016531229,0.000007347921,0.0006929146],"genre_scores_gemma":[0.99460036,0.0013887795,0.0037753407,0.00014173749,0.000043987384,0.000006750376,0.0000010801518,0.00002466759,0.000017293714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752426,0.00043964546,0.0011241706,0.00018036939,0.0004289178,0.00030262597],"domain_scores_gemma":[0.9982515,0.0003133759,0.00081815396,0.0002890844,0.00022923615,0.00009866631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000617651,0.0001580781,0.0009349042,0.00019303763,0.00003668652,0.00000671608,0.0002795793,0.00018310838,0.000176698],"category_scores_gemma":[0.0008176843,0.00013518338,0.00032785337,0.00030429228,0.00026712462,0.000035758007,0.00003052748,0.00041101107,0.0000034666089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019636925,0.0040119374,0.8133741,0.00069396215,0.0035239863,0.04965728,0.008046975,0.0007560105,0.084277675,0.00078582414,0.008851528,0.024056992],"study_design_scores_gemma":[0.0034737606,0.0015544603,0.5144532,0.00067868066,0.00074012164,0.43901145,0.00067492714,0.000043358774,0.03635928,0.002565023,0.0002888103,0.00015696179],"about_ca_topic_score_codex":0.00016511184,"about_ca_topic_score_gemma":0.000120991506,"teacher_disagreement_score":0.38935417,"about_ca_system_score_codex":0.000067053326,"about_ca_system_score_gemma":0.0004792904,"threshold_uncertainty_score":0.5512618},"labels":[],"label_agreement":null},{"id":"W2050880574","doi":"10.1111/bjh.13271","title":"Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Histiocytosis; Bone marrow; Gastroenterology; Spleen; Internal medicine; Pathology; White blood cell; Disease","score_opus":0.025507890528389605,"score_gpt":0.2769840257622621,"score_spread":0.2514761352338725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050880574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969241,0.0017494534,0.00004414944,0.00030979599,0.00007019909,0.00020099862,0.00006364205,0.0000066582984,0.00063101656],"genre_scores_gemma":[0.99893034,0.00028922633,0.00040106082,0.00012897256,0.000011387644,0.000010615994,0.000012626843,0.000021577098,0.00019419912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983095,0.00012306367,0.0009714571,0.00013573776,0.0002575943,0.00020264846],"domain_scores_gemma":[0.998422,0.00023021529,0.00086678646,0.00013770255,0.0002328133,0.0001104436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025337012,0.00012874228,0.0013319609,0.00020638315,0.000038467275,0.000004384215,0.000078980505,0.00013823937,0.00013831702],"category_scores_gemma":[0.00046045706,0.00011711317,0.00016579546,0.0001735802,0.00011567931,0.000044471253,0.00002945999,0.00017004431,0.0000063883213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011039558,0.0018731433,0.9877547,0.00027536397,0.00023750884,0.005715627,0.00054212054,0.000008186604,0.00010115319,0.000019234676,0.0011499241,0.002212641],"study_design_scores_gemma":[0.017377008,0.0015937813,0.94375587,0.003840696,0.00076844846,0.028455079,0.00026934946,0.0000453637,0.003090781,0.000038716338,0.0005648389,0.00020008183],"about_ca_topic_score_codex":0.00046498343,"about_ca_topic_score_gemma":0.0010287563,"teacher_disagreement_score":0.043998845,"about_ca_system_score_codex":0.00012855914,"about_ca_system_score_gemma":0.00009301625,"threshold_uncertainty_score":0.47757366},"labels":[],"label_agreement":null},{"id":"W2050970566","doi":"10.1111/j.1365-2141.2008.07384.x","title":"Thrombin activatable fibrinolysis inhibitor gene polymorphisms are associated with antigenic levels in the Asian‐Indian population but may not be a risk for stroke","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"University Grants Commission; Council of Scientific and Industrial Research, India; Indian Council of Medical Research","keywords":"Fibrinolysis; Haplotype; Population; Immunology; Antigen; Medicine; Plasmin; Fibrin; Carboxypeptidase; Biology; Internal medicine; Allele; Gene; Genetics; Biochemistry","score_opus":0.03733150681311397,"score_gpt":0.24932326097333418,"score_spread":0.2119917541602202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050970566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942875,0.0008915204,0.00014260024,0.0040302253,0.00009912851,0.00040025404,0.00011358694,0.0000117468135,0.000023476292],"genre_scores_gemma":[0.9984886,0.00013261892,0.0006414732,0.0003729663,0.00013873828,0.000013728757,0.000033097163,0.00002662465,0.00015215439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836886,0.00021198258,0.0005728857,0.00017628036,0.000352633,0.00031733504],"domain_scores_gemma":[0.9987161,0.00011597924,0.00073914375,0.0001472121,0.00020743211,0.00007411167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041799876,0.00013984213,0.0006938843,0.0001664059,0.00024460125,0.000030634623,0.00012340893,0.00017959275,0.00003408675],"category_scores_gemma":[0.0002992576,0.00010999266,0.00016737204,0.00021760724,0.00008285643,0.00016968712,0.000017597042,0.00036977316,0.0000011170895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018009206,0.0010953326,0.93952084,0.000115210954,0.0012342529,0.026169436,0.00205699,0.0002037348,0.013342913,0.00005205886,0.0025556234,0.011852701],"study_design_scores_gemma":[0.0035130307,0.00055421353,0.8566949,0.0003807432,0.00023919626,0.12435018,0.00049436913,0.0000772358,0.013488701,0.000038431557,0.000043190685,0.00012582194],"about_ca_topic_score_codex":0.0008969087,"about_ca_topic_score_gemma":0.0008326223,"teacher_disagreement_score":0.09818075,"about_ca_system_score_codex":0.00007351547,"about_ca_system_score_gemma":0.0001303403,"threshold_uncertainty_score":0.44853705},"labels":[],"label_agreement":null},{"id":"W2051548025","doi":"10.1111/j.1365-2141.2009.07739.x","title":"The significance of <i>TP53</i> in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target","year":2009,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer; Mutation; Suppressor; Genome instability; Biology; Clinical significance; Cancer research; Lymphatic system; Immunology; Medicine; Oncology; Internal medicine; Genetics; Gene; DNA damage","score_opus":0.012685747631319109,"score_gpt":0.2977313816382422,"score_spread":0.28504563400692307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051548025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008648679,0.98923045,0.000417809,0.00008857623,0.00021170243,0.0013040474,0.000025798812,0.000008881489,0.00006404107],"genre_scores_gemma":[0.039208457,0.9602647,0.0002583846,0.000047149493,0.00008096789,0.00003215136,0.00001914736,0.000041324613,0.00004775726],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9968484,0.0005212884,0.0016115509,0.00026762678,0.00041779788,0.0003333315],"domain_scores_gemma":[0.9971229,0.00031643565,0.0018082204,0.00021662396,0.0004163268,0.00011949929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007791663,0.0002828714,0.001990368,0.00029037232,0.00007545879,0.00004344504,0.00021475664,0.00036637584,0.00003243206],"category_scores_gemma":[0.0006065858,0.00022560327,0.00047809316,0.00041826823,0.00028926844,0.000094180374,0.000025649118,0.0005525318,0.0000027730775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025417385,0.00023910058,0.00013138582,0.012410937,0.00060325925,0.024861775,0.00011425703,0.00007190152,0.00011366575,0.0001231801,0.00058232376,0.96049404],"study_design_scores_gemma":[0.0018751243,0.0011438878,0.0013803496,0.04855566,0.0021186087,0.899208,0.00003871993,0.000042734668,0.000057067584,0.001772285,0.04353888,0.00026868412],"about_ca_topic_score_codex":0.00003322492,"about_ca_topic_score_gemma":0.000015030133,"teacher_disagreement_score":0.96022534,"about_ca_system_score_codex":0.00019786679,"about_ca_system_score_gemma":0.0017940961,"threshold_uncertainty_score":0.91998345},"labels":[],"label_agreement":null},{"id":"W2051996643","doi":"10.1111/j.1365-2141.2008.07001.x","title":"Detection of WT1‐specific T cells in paediatric acute lymphoblastic leukaemia patients in first remission","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; ELISPOT; Immunology; Immune system; Peripheral blood mononuclear cell; Bone marrow; Antigen; Transplantation; T cell; Internal medicine; Biology","score_opus":0.010293047939670993,"score_gpt":0.23554803089381587,"score_spread":0.22525498295414487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051996643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840041,0.0037322165,0.00023997379,0.009676356,0.0013712021,0.0007056839,0.00006455533,0.000016927872,0.00018898558],"genre_scores_gemma":[0.9380475,0.042384725,0.0009781107,0.0152954105,0.002390725,0.000035161105,0.00017048251,0.00026577682,0.00043205763],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99444795,0.00043075052,0.0024598807,0.00051896716,0.001286735,0.0008557377],"domain_scores_gemma":[0.9963386,0.00089874835,0.001489717,0.00035863218,0.00069913594,0.00021518761],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00050088915,0.00042378495,0.0023173178,0.0021584646,0.00006880972,0.000023237693,0.00050661725,0.0017863676,0.00010513385],"category_scores_gemma":[0.0007744327,0.00045068373,0.00040123385,0.0009872047,0.0003176753,0.0001730255,0.0001670062,0.0036523542,0.000035169585],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009516971,0.00043768875,0.006732998,0.0011304327,0.00015786798,0.39890468,0.00014545054,0.000041607655,0.0006664022,3.214122e-7,0.5854903,0.005340541],"study_design_scores_gemma":[0.034419004,0.0026849934,0.029322136,0.011355625,0.0005286945,0.7827401,0.000071661336,0.00048449336,0.0068353373,0.00012496018,0.13041867,0.0010143161],"about_ca_topic_score_codex":0.00037573164,"about_ca_topic_score_gemma":0.00013625545,"teacher_disagreement_score":0.45507166,"about_ca_system_score_codex":0.0024459797,"about_ca_system_score_gemma":0.0014123962,"threshold_uncertainty_score":0.9997945},"labels":[],"label_agreement":null},{"id":"W2052229400","doi":"10.1111/j.1365-2141.2006.06237.x","title":"Significant increase of <i>CKS1B</i> amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence <i>in situ</i> hybridisation","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Cancer Research Society","keywords":"Monoclonal gammopathy of undetermined significance; Plasma cell dyscrasia; Multiple myeloma; Fluorescence in situ hybridization; Plasma cell neoplasm; Plasma cell; Plasma cell leukemia; Pathology; Molecular biology; Monoclonal; Medicine; Cancer research; Plasmacytoma; Biology; Monoclonal antibody; Internal medicine; Immunology; Antibody; Immunoglobulin light chain; Genetics","score_opus":0.008814553048158688,"score_gpt":0.2486277847795551,"score_spread":0.2398132317313964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052229400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997227,0.000791231,0.0008822996,0.00013241799,0.000045182805,0.0005190108,0.00025292562,0.000009005959,0.00014094275],"genre_scores_gemma":[0.9953296,0.00020247235,0.0041955076,0.000037774396,0.000029162919,0.000017410373,0.0001415668,0.000020597,0.000025861245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763966,0.00021999085,0.0011347542,0.00031101416,0.00038856413,0.0003060303],"domain_scores_gemma":[0.9980781,0.000482897,0.00064284983,0.00017649712,0.00033345766,0.00028620803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029829793,0.00018713111,0.0007964549,0.00024361536,0.000040402363,0.000022563036,0.00016376015,0.00011969626,0.000022566828],"category_scores_gemma":[0.0004428261,0.0002004726,0.000100689744,0.00023425394,0.000248479,0.00015152243,0.000039226823,0.0002508654,0.0000047003196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032116044,0.0010146793,0.11234073,0.00013223293,0.000054192256,0.0075283796,0.00008102487,0.000018205126,0.86616474,0.000014480682,0.00077376986,0.008665936],"study_design_scores_gemma":[0.0076250527,0.00088014384,0.111316666,0.0006434346,0.000088164146,0.008075487,0.00017100053,0.000843831,0.8699839,0.00016122607,0.000050455412,0.00016062385],"about_ca_topic_score_codex":0.006410452,"about_ca_topic_score_gemma":0.0008249064,"teacher_disagreement_score":0.008505313,"about_ca_system_score_codex":0.00011433367,"about_ca_system_score_gemma":0.00033734794,"threshold_uncertainty_score":0.9690728},"labels":[],"label_agreement":null},{"id":"W2052845801","doi":"10.1046/j.1365-2141.2001.02806.x","title":"Lack of CD40‐dependent B‐cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B‐cell lymphocytosis","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Lymphocytosis; Polyclonal antibodies; B cell; Immunology; Medicine; Polyclonal B cell response; Antibody; B-cell receptor","score_opus":0.010351784704576584,"score_gpt":0.2045439477257558,"score_spread":0.1941921630211792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052845801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834918,0.0148988,0.000116284195,0.00011121969,0.00059644866,0.000252602,0.000056345005,0.00001638935,0.00046010944],"genre_scores_gemma":[0.9977453,0.0011962231,0.00018808081,0.00015750543,0.000027544804,0.0000078928515,0.000119065684,0.000026323965,0.0005320666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973488,0.00047034508,0.0012005933,0.00033741337,0.00012677127,0.00051607087],"domain_scores_gemma":[0.9981802,0.00018197052,0.00097549066,0.00021084434,0.00039915068,0.00005232221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023597824,0.00027220394,0.0010228966,0.0003304393,0.000120501325,0.000024089864,0.0004125082,0.0004971482,0.0007342725],"category_scores_gemma":[0.00004817444,0.00026200496,0.00022326269,0.00022862905,0.00033001872,0.00019994615,0.00009351449,0.00045752,0.00008023022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008634477,0.005761662,0.35610273,0.00011912503,0.0009808295,0.0068871155,0.0012795898,0.00020512102,0.6125961,0.00004584831,0.0019984213,0.0053889505],"study_design_scores_gemma":[0.075767204,0.007371787,0.050341345,0.0011754332,0.00085459824,0.11615796,0.0025333967,0.00008428165,0.7397347,0.0003592308,0.004195336,0.0014246894],"about_ca_topic_score_codex":0.0011365894,"about_ca_topic_score_gemma":0.00047253512,"teacher_disagreement_score":0.3057614,"about_ca_system_score_codex":0.00017411723,"about_ca_system_score_gemma":0.00031008018,"threshold_uncertainty_score":0.9999832},"labels":[],"label_agreement":null},{"id":"W2052918149","doi":"10.1111/bjh.12249","title":"The molecular characterization of von <scp>W</scp>illebrand disease: good in parts","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Canadian Hemophilia Society; Heart and Stroke Foundation of Canada","keywords":"Von Willebrand disease; Von Willebrand factor; Disease; Molecular pathology; Molecular genetics; Biology; Locus (genetics); Genetics; Immunology; Gene; Medicine; Pathology; Platelet","score_opus":0.015149623365299061,"score_gpt":0.2799725958858673,"score_spread":0.26482297252056824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052918149","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10478072,0.89411974,0.00002255559,0.00007944206,0.00020408549,0.0005889469,0.000036224432,0.0000040020063,0.00016430671],"genre_scores_gemma":[0.0035317515,0.9959765,0.00003177814,0.000036634534,0.00003826627,0.000034032,0.00012568678,0.00003679786,0.00018857334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979162,0.00025372734,0.0011405471,0.00016855229,0.0002478277,0.00027309865],"domain_scores_gemma":[0.998065,0.00024298178,0.0011888635,0.00017947267,0.0001613763,0.00016230709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022259417,0.00022351227,0.002393711,0.00017886705,0.000047707646,0.000029013898,0.00016356926,0.00018958184,0.000019667294],"category_scores_gemma":[0.0004316596,0.00016491806,0.00044223518,0.00017719898,0.00010823642,0.0000809051,0.000035847348,0.0003901447,0.000013710444],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002143308,0.0005069902,0.00031589033,0.007697908,0.000829612,0.17347498,0.000030655276,2.2290608e-7,0.000009491222,0.00030100756,0.00089847215,0.8159133],"study_design_scores_gemma":[0.001531604,0.00013574741,0.0008082909,0.022284497,0.0013343733,0.19783129,0.000018478648,0.000002451099,0.000010539788,0.00018875617,0.77577907,0.00007491393],"about_ca_topic_score_codex":0.0000136153885,"about_ca_topic_score_gemma":0.000011314538,"teacher_disagreement_score":0.8158384,"about_ca_system_score_codex":0.00003808443,"about_ca_system_score_gemma":0.0003082614,"threshold_uncertainty_score":0.67251635},"labels":[],"label_agreement":null},{"id":"W2053445686","doi":"10.1111/j.1365-2141.2006.06474.x","title":"Biomolecular characterisation of leucocytes by infrared spectroscopy","year":2007,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"","keywords":"Hematology; Infrared spectroscopy; Spectroscopy; Personalized medicine; Chemotherapy; Medicine; Immunology; Chemistry; Biology; Bioinformatics; Internal medicine","score_opus":0.042035958297221496,"score_gpt":0.38413949484269605,"score_spread":0.34210353654547454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053445686","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041817566,0.99375975,0.00056784577,0.000027022166,0.00030508742,0.0005066951,0.00006625961,0.000012251044,0.00057331077],"genre_scores_gemma":[0.00019566478,0.998052,0.00096364197,0.000056622015,0.00022731569,0.000007230571,0.000137625,0.00007425825,0.00028562284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99612504,0.00028705952,0.002127011,0.00027409266,0.00069818227,0.00048861693],"domain_scores_gemma":[0.9967142,0.00034013527,0.0018754208,0.0003253442,0.0004889249,0.0002559798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009502877,0.0003053555,0.0039440105,0.00062345533,0.000038989878,0.000032035656,0.00038380898,0.00063771533,0.00027950996],"category_scores_gemma":[0.0007552283,0.00030039265,0.00080548594,0.00043955175,0.00033639334,0.0000967678,0.00009049491,0.000921637,0.00002521541],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002080395,0.00040617297,0.0000061680694,0.039297845,0.0013436525,0.1246712,0.000050683164,4.4109214e-8,0.000648331,0.000058240243,0.029011678,0.8042979],"study_design_scores_gemma":[0.0027614462,0.00032247585,0.000002283764,0.019741364,0.0006371615,0.44932747,0.0000108704135,0.0000029017408,0.0011334678,0.00003157923,0.5258942,0.00013474881],"about_ca_topic_score_codex":0.000098368735,"about_ca_topic_score_gemma":0.000004299748,"teacher_disagreement_score":0.8041632,"about_ca_system_score_codex":0.0032506313,"about_ca_system_score_gemma":0.008235598,"threshold_uncertainty_score":0.9999448},"labels":[],"label_agreement":null},{"id":"W2053633180","doi":"10.1111/j.1365-2141.2004.04867.x","title":"The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Multiple myeloma; Medicine; Stem cell; Autologous stem-cell transplantation; Oncology; Internal medicine; Hematology; Biology","score_opus":0.013867100637654962,"score_gpt":0.2478277717385602,"score_spread":0.23396067110090524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053633180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960463,0.00167612,0.000034289755,0.0014227856,0.00008964399,0.0004223687,0.00002160422,0.000014944032,0.00027194453],"genre_scores_gemma":[0.99871397,0.00076126837,0.00021741509,0.00014868837,0.000015829364,0.000016529002,0.000011670083,0.000024169807,0.00009046885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807835,0.0001711033,0.0005767358,0.00017894668,0.00047492978,0.0005199237],"domain_scores_gemma":[0.99878114,0.00031022396,0.00032680336,0.00008643724,0.00029287723,0.00020252758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029354866,0.00015059284,0.0005908502,0.00014035076,0.00017316612,0.000046782894,0.00016160219,0.00013349419,0.00001612243],"category_scores_gemma":[0.00012060652,0.000107176056,0.00011990594,0.00021678855,0.00014819547,0.0000999204,0.000019888601,0.0004657714,0.000009742645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019995903,0.0027013777,0.6801942,0.0001947593,0.00090942904,0.2714495,0.0009240394,0.00002261889,0.00007324943,0.000057026158,0.00076913566,0.040705085],"study_design_scores_gemma":[0.035675094,0.004616516,0.78613394,0.0034789902,0.00026946788,0.16274838,0.00046141012,0.00003774032,0.005929459,0.00027135146,0.00012979307,0.00024786833],"about_ca_topic_score_codex":0.0000992531,"about_ca_topic_score_gemma":0.0014374657,"teacher_disagreement_score":0.10870111,"about_ca_system_score_codex":0.00022076606,"about_ca_system_score_gemma":0.00043545416,"threshold_uncertainty_score":0.43705127},"labels":[],"label_agreement":null},{"id":"W2053876119","doi":"10.1046/j.1365-2141.2003.03849.x","title":"The role of hydroxyurea in sickle cell disease","year":2003,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imperial College London","keywords":"Medicine; Hydroxycarbamide; Disease; Acute chest syndrome; Clinical trial; Intensive care medicine; Sickle cell anemia; Pediatrics; Internal medicine","score_opus":0.008760281200906848,"score_gpt":0.2659662079715537,"score_spread":0.25720592677064685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053876119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090583257,0.9949741,0.0000025050817,0.000103076054,0.00028894015,0.00034441362,0.000011568815,0.0000038119686,0.003365772],"genre_scores_gemma":[0.0009949482,0.9985688,0.000042967295,0.00005552151,0.000041107,0.0000067183123,0.0000076265537,0.000036638412,0.0002456718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754375,0.0003297455,0.0014194807,0.00015014713,0.0002412476,0.00031560994],"domain_scores_gemma":[0.9982105,0.00021773261,0.0010091972,0.00021290885,0.00013124803,0.00021839612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047631116,0.00020716376,0.0022495985,0.00018490186,0.000058473204,0.000015258778,0.00024515006,0.00035941935,0.000059354355],"category_scores_gemma":[0.00027321264,0.00014861638,0.00070483756,0.000255452,0.00021919381,0.000033713142,0.000035761354,0.001041261,0.000014645361],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052981126,0.0004046861,0.000108757595,0.008641451,0.00020860996,0.04262968,0.00003261706,0.0000019533175,4.3586618e-7,0.00021940595,0.0035883838,0.94411105],"study_design_scores_gemma":[0.0007172371,0.000095177726,0.000009119619,0.016271861,0.00086691265,0.1081757,0.00012609983,0.0000023392852,0.0000015453601,0.00045718535,0.8731643,0.000112546666],"about_ca_topic_score_codex":0.000024663274,"about_ca_topic_score_gemma":0.00001632273,"teacher_disagreement_score":0.9439985,"about_ca_system_score_codex":0.000048495607,"about_ca_system_score_gemma":0.00087431114,"threshold_uncertainty_score":0.60604006},"labels":[],"label_agreement":null},{"id":"W2054001622","doi":"10.1111/j.1365-2141.2009.07734.x","title":"Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?","year":2009,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Aspirin; Warfarin; Venous thromboembolism; Heparin; Randomized controlled trial; Intensive care medicine; Placebo; Salicylic acid; Anticoagulant; Low molecular weight heparin; Clinical trial; Internal medicine; Alternative medicine; Thrombosis; Atrial fibrillation","score_opus":0.02887187761625183,"score_gpt":0.33777563567307356,"score_spread":0.30890375805682174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054001622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062508867,0.99035597,0.00002295122,0.00048168018,0.00040829563,0.0013132055,0.000018541683,0.000011484333,0.0011369647],"genre_scores_gemma":[0.008702076,0.99014145,0.00029462288,0.00032717176,0.000338377,0.000050226387,0.000031020798,0.00005023429,0.00006484752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99585193,0.0007387581,0.0020661247,0.00031782564,0.00055554643,0.00046982805],"domain_scores_gemma":[0.99704945,0.00017658174,0.0020236184,0.00043736908,0.00020066892,0.0001122813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001352455,0.00037765596,0.006159642,0.0005045304,0.00007271262,0.000051578776,0.0006422354,0.00045425596,0.00011861532],"category_scores_gemma":[0.00026947432,0.00023664115,0.0011457731,0.00033589418,0.00016877786,0.00012225531,0.00009207351,0.0010179982,0.000012850355],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020630145,0.002565345,0.000011616541,0.009406691,0.0007460174,0.0140294535,0.0004989661,8.4556405e-7,0.0000035545206,0.0005289402,0.0050957277,0.9670922],"study_design_scores_gemma":[0.0014851467,0.001963884,0.0011042767,0.060481306,0.005241322,0.17947283,0.0007676517,0.0000011251806,0.000019985297,0.0024668504,0.74665403,0.00034156442],"about_ca_topic_score_codex":0.0001315844,"about_ca_topic_score_gemma":0.00028897906,"teacher_disagreement_score":0.9667506,"about_ca_system_score_codex":0.00011045842,"about_ca_system_score_gemma":0.0004384915,"threshold_uncertainty_score":0.9649946},"labels":[],"label_agreement":null},{"id":"W2054346225","doi":"10.1111/bjh.12233","title":"Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta‐analysis","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; SickKids Foundation; Public Health Ontario; Hospital for Sick Children; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Idarubicin; Daunorubicin; Internal medicine; Anthracycline; Confidence interval; Relative risk; Meta-analysis; Gastroenterology; Randomized controlled trial; Myeloid leukemia; Chemotherapy; Cytarabine; Cancer; Breast cancer","score_opus":0.06713767490013349,"score_gpt":0.3773710469999473,"score_spread":0.3102333720998138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054346225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017322348,0.99440557,0.000012661878,0.00062770984,0.00007265762,0.0030890105,0.00002164384,0.000017054437,0.000021445703],"genre_scores_gemma":[0.00007211274,0.9983171,0.0004573326,0.00023278965,0.00008685847,0.00035485788,0.000027749806,0.00007811828,0.00037306664],"study_design_codex":"systematic_review","study_design_gemma":"case_report","domain_scores_codex":[0.9935019,0.0015140821,0.003449,0.0004895466,0.0005276301,0.000517832],"domain_scores_gemma":[0.9956662,0.00043220024,0.002554159,0.00049090665,0.0005725485,0.00028397114],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0017956097,0.0005534415,0.01996777,0.0016692181,0.000087963665,0.000086254455,0.00043463559,0.00066367874,0.000301375],"category_scores_gemma":[0.0007677356,0.00040719548,0.002628195,0.0015674375,0.00021943919,0.0003026349,0.00013284427,0.0022577494,0.000026938433],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015449861,0.00009045931,0.0000045123097,0.7743171,0.17821565,0.034313325,0.00002031324,1.3550525e-7,0.0000014541597,0.000005409088,0.00038714308,0.0126290675],"study_design_scores_gemma":[0.0005175714,0.000090966954,0.000009923209,0.10956148,0.4432787,0.44455606,0.000018712783,8.6898075e-7,0.000001846269,0.000009555058,0.0017650151,0.00018929614],"about_ca_topic_score_codex":0.00013565077,"about_ca_topic_score_gemma":0.00004408559,"teacher_disagreement_score":0.6647556,"about_ca_system_score_codex":0.00031574763,"about_ca_system_score_gemma":0.0006129162,"threshold_uncertainty_score":0.999838},"labels":[],"label_agreement":null},{"id":"W2054603081","doi":"10.1111/bjh.12903","title":"Variance of pain prevalence and associated severity during the transfusion cycle of adult thalassaemia patients","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health; Translational Cancer Research Network; National Center for Research Resources; Harvard Catalyst","keywords":"Medicine; Blood transfusion; Observational study; Incidence (geometry); Thalassemia; Ineffective erythropoiesis; Anemia; Internal medicine; Pediatrics; Physical therapy; Erythropoiesis","score_opus":0.0038851346201163118,"score_gpt":0.2027078690148284,"score_spread":0.1988227343947121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054603081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96674925,0.002630621,0.00006151734,0.029832132,0.00023865921,0.00028898445,0.000048654645,0.000007638408,0.00014253553],"genre_scores_gemma":[0.96704537,0.010499276,0.00008877768,0.022037264,0.00013984233,0.0000032301166,0.000019554596,0.00003627218,0.00013041984],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9974907,0.0006522426,0.0009804628,0.0001839826,0.0004288735,0.00026372675],"domain_scores_gemma":[0.99759036,0.00031067853,0.0012357862,0.00016504187,0.0006379421,0.000060204035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067599997,0.0001773466,0.0011078377,0.0000932713,0.00008047332,0.000008840481,0.00020078794,0.00084371795,0.00004618926],"category_scores_gemma":[0.0011053041,0.00014390037,0.00022588823,0.00011866204,0.0003193822,0.00005301615,0.000035943893,0.0016978107,5.2942045e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010691485,0.0013149844,0.38272092,0.033755433,0.002649022,0.03978519,0.0018695672,0.00003460942,0.0007119201,0.000023891529,0.51481485,0.021250486],"study_design_scores_gemma":[0.021858968,0.0031737923,0.65387875,0.052374955,0.0031536913,0.24596356,0.00031523916,0.0004972601,0.0011157535,0.00097167434,0.01564224,0.0010541001],"about_ca_topic_score_codex":0.00016815824,"about_ca_topic_score_gemma":0.00002305535,"teacher_disagreement_score":0.4991726,"about_ca_system_score_codex":0.000045693225,"about_ca_system_score_gemma":0.000116450305,"threshold_uncertainty_score":0.7376237},"labels":[],"label_agreement":null},{"id":"W2054709506","doi":"10.1111/j.1365-2141.2012.09170.x","title":"Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20‐year cohort","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Transplantation; Medicine; Cohort; Hematology; Oncology; Immunology; Hematopoietic stem cell transplantation; Internal medicine; Biology; Genetics","score_opus":0.024302804094947922,"score_gpt":0.30568320253903714,"score_spread":0.28138039844408924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054709506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809106,0.015538895,0.0015099839,0.00016979115,0.00049896596,0.0009224198,0.000019958952,0.000021394211,0.0004079937],"genre_scores_gemma":[0.99556535,0.0021356887,0.0012679453,0.00017494783,0.0003118611,0.00006639834,0.000023294637,0.00006404718,0.00039044028],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9966476,0.00020104092,0.001386657,0.0002660418,0.0005395874,0.0009590956],"domain_scores_gemma":[0.9982329,0.00044711583,0.00042138968,0.00025092563,0.00025695958,0.00039073438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014786088,0.00023156726,0.0012728182,0.00037978697,0.000076287666,0.00003215858,0.00027736888,0.00035079248,0.00013211693],"category_scores_gemma":[0.00012690153,0.00024390192,0.00032982265,0.0002675403,0.00017987502,0.00026254586,0.000039006532,0.0004953792,0.000059041933],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.007138298,0.0024790026,0.65462536,0.029694902,0.0016560783,0.24868922,0.003934012,0.0017028709,0.009459208,0.0021638623,0.01478321,0.023673972],"study_design_scores_gemma":[0.05335283,0.0008311925,0.016839456,0.0015186972,0.0007101521,0.91369396,0.00042433589,0.0014756827,0.008765803,0.00016542916,0.001802901,0.00041958553],"about_ca_topic_score_codex":0.0002052051,"about_ca_topic_score_gemma":0.00017337473,"teacher_disagreement_score":0.66500473,"about_ca_system_score_codex":0.014457931,"about_ca_system_score_gemma":0.007173934,"threshold_uncertainty_score":0.99845445},"labels":[],"label_agreement":null},{"id":"W2055566240","doi":"10.1111/j.1365-2141.2005.05638.x","title":"Transfusion related acute lung injury (TRALI)","year":2005,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Seriousness; Intensive care medicine; Consensus conference; Acute respiratory distress; Chest radiograph; Blood transfusion; Lung; Internal medicine; Pulmonary edema","score_opus":0.007921628867928887,"score_gpt":0.26014014864279816,"score_spread":0.25221851977486925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055566240","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045219846,0.009503746,0.00040196293,0.9352668,0.0024432484,0.00081107096,0.000052041458,0.000088895875,0.0062123984],"genre_scores_gemma":[0.013249307,0.05853383,0.002159047,0.90895575,0.0034984138,0.00001975161,0.00024015832,0.00022412,0.01311965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681365,0.00021677426,0.0014630109,0.00034985607,0.0006317773,0.00052493054],"domain_scores_gemma":[0.99861115,0.000058852605,0.0005822909,0.00027790302,0.00028402449,0.00018578007],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0003836347,0.0003417523,0.0017246226,0.0005314218,0.000102016245,0.00004482684,0.00031693396,0.0013496242,0.0018857884],"category_scores_gemma":[0.000037132802,0.0003574896,0.0007325424,0.00022203717,0.00015755226,0.00012853161,0.000039621256,0.0043064523,0.0000581194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012448082,0.00012709886,0.0000265507,0.00034763152,0.0010281681,0.2882956,0.00005515083,3.9018013e-7,0.00007506997,0.000025169906,0.6912055,0.018689169],"study_design_scores_gemma":[0.002321228,0.00030123894,0.00014221674,0.0013952065,0.0020100742,0.42923495,0.000013220046,0.000005535661,0.00013092064,0.00007515026,0.564173,0.00019725642],"about_ca_topic_score_codex":0.000050622468,"about_ca_topic_score_gemma":0.000025756837,"teacher_disagreement_score":0.14093935,"about_ca_system_score_codex":0.000086314234,"about_ca_system_score_gemma":0.00019647792,"threshold_uncertainty_score":0.99994683},"labels":[],"label_agreement":null},{"id":"W2056075603","doi":"10.1046/j.1365-2141.2002.03657.x","title":"Glycophorin A‐mediated haemolysis of normal human erythrocytes: evidence for antigen aggregation in the pathogenesis of immune haemolysis","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"McMaster University; University of Calgary","keywords":"Haemolysis; Glycophorin; Concanavalin A; Red blood cell; Biochemistry; Biology; Hemolysis; Autoantibody; Antigen; Lectin; Immunology; Chemistry; Antibody; In vitro","score_opus":0.06167586477753055,"score_gpt":0.3061833449068399,"score_spread":0.24450748012930934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056075603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752392,0.023088297,0.00053549674,0.00047281556,0.00020694092,0.0003580228,0.00002219463,0.000007689407,0.00006933187],"genre_scores_gemma":[0.9872532,0.011113565,0.0012156673,0.00019657522,0.000121482604,0.000018480987,0.000022749013,0.000019825124,0.00003848122],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99719626,0.00036865586,0.0016098088,0.00020250106,0.000337739,0.00028506518],"domain_scores_gemma":[0.99693483,0.0007803187,0.0012957868,0.00027394592,0.000642949,0.00007218014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009350667,0.00016387843,0.0012576494,0.0004062544,0.00009730972,0.000010202662,0.00028306988,0.00021597753,0.0003262154],"category_scores_gemma":[0.0013480317,0.00014547847,0.00049212686,0.0005822367,0.0002904249,0.00017373924,0.000034575256,0.00028798814,0.000005234879],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041520037,0.0038098744,0.07058586,0.0029599858,0.0014402883,0.020949429,0.0054970155,0.00020756572,0.7880475,0.0004367293,0.012213373,0.08970041],"study_design_scores_gemma":[0.021678833,0.010208077,0.43238395,0.008066166,0.0022278572,0.34811395,0.005284617,0.0014760138,0.16597289,0.00098219,0.002682963,0.00092248496],"about_ca_topic_score_codex":0.0001952916,"about_ca_topic_score_gemma":0.00012768504,"teacher_disagreement_score":0.6220746,"about_ca_system_score_codex":0.00003917834,"about_ca_system_score_gemma":0.00008005183,"threshold_uncertainty_score":0.59324396},"labels":[],"label_agreement":null},{"id":"W2056118078","doi":"10.1046/j.1365-2141.2001.03080.x","title":"Hb H hydrops foetalis syndrome: a case report and review of literature","year":2001,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.016308857000320923,"score_gpt":0.31110944823553205,"score_spread":0.29480059123521113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056118078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006290847,0.997251,0.0000072920757,0.000357693,0.00036133052,0.00060559646,0.000043471482,0.000010391047,0.0007341849],"genre_scores_gemma":[0.000049417387,0.9988046,0.00028519926,0.00023489911,0.000070679984,0.000007881186,0.00007343985,0.000054100004,0.00041977735],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9961807,0.00030947692,0.0026062012,0.00030238312,0.0002998913,0.00030130686],"domain_scores_gemma":[0.996408,0.000119556025,0.0023828014,0.00032391268,0.0004776934,0.00028806456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086086785,0.00034793987,0.005713869,0.00032169407,0.000059404916,0.000025336882,0.00014147487,0.00079007033,0.00016652653],"category_scores_gemma":[0.0009658433,0.00028473683,0.0010205496,0.0006166086,0.0002342897,0.00008591064,0.00006986463,0.0014654701,0.000004063904],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000044545177,0.000065206485,0.0000023172786,0.14758536,0.00037537017,0.5690435,0.000009020524,7.016609e-9,1.7606476e-8,0.000009850685,0.0075462298,0.27535865],"study_design_scores_gemma":[0.00023813266,0.0001147999,4.618502e-7,0.26815537,0.0019444838,0.40119833,0.00000968924,1.05994516e-7,3.86672e-8,0.0000116010715,0.32824224,0.00008476952],"about_ca_topic_score_codex":0.000042030802,"about_ca_topic_score_gemma":0.00000642284,"teacher_disagreement_score":0.320696,"about_ca_system_score_codex":0.000045397046,"about_ca_system_score_gemma":0.0005281667,"threshold_uncertainty_score":0.9999605},"labels":[],"label_agreement":null},{"id":"W2056575733","doi":"10.1111/j.1365-2141.2008.06979.x","title":"Valproate‐induced pure red cell aplasia and megakaryocyte dysplasia","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Pallor; Valproic Acid; Medicine; Pure red cell aplasia; Gastroenterology; Pancytopenia; Bone marrow; Pathology; Internal medicine; Epilepsy","score_opus":0.02688016103082492,"score_gpt":0.2635860535105062,"score_spread":0.23670589247968127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056575733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854671,0.0067939544,0.0000816018,0.0009260361,0.00043771125,0.0001617753,0.0000031881948,0.000033550088,0.0060951174],"genre_scores_gemma":[0.9938191,0.0042885486,0.0008507034,0.0003323841,0.00017048881,0.000005043933,0.0000015908455,0.000026043142,0.00050606026],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9984837,0.000116514195,0.00064441084,0.00019254723,0.0002676259,0.0002951739],"domain_scores_gemma":[0.9988191,0.000104133986,0.00039838464,0.00012263452,0.00033881245,0.00021690724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025332952,0.00016150491,0.0009079648,0.0002063901,0.0002183314,0.00001634798,0.000084957035,0.00017950192,0.00010873564],"category_scores_gemma":[0.00028397737,0.00016714232,0.00013919653,0.00017305306,0.00022385389,0.00014990912,0.000056150526,0.0005401831,0.00005812582],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014153711,0.001031095,0.1717402,0.0006029315,0.0011852029,0.51916265,0.0012030021,0.000006248485,0.041728657,0.00026154864,0.25355402,0.008109027],"study_design_scores_gemma":[0.003514794,0.00030538827,0.047582865,0.00018042464,0.00016969083,0.92606807,0.00012743469,0.000007576316,0.012331613,0.00012700514,0.009441037,0.0001440964],"about_ca_topic_score_codex":0.000026962647,"about_ca_topic_score_gemma":0.000019229967,"teacher_disagreement_score":0.40690538,"about_ca_system_score_codex":0.00004361455,"about_ca_system_score_gemma":0.00015017496,"threshold_uncertainty_score":0.6815866},"labels":[],"label_agreement":null},{"id":"W2056793347","doi":"10.1111/j.1365-2141.2004.04804.x","title":"Intravenous (IV) anti‐D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti‐D by Fc<i>γ</i>RIIa and Fc<i>γ</i>RIIIa polymorphisms","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cytokine; Platelet; Immunology; Monocyte; Antibody; CD16; Internal medicine; Receptor; Medicine; Tumor necrosis factor alpha; Endocrinology; Immune system","score_opus":0.006039635380252142,"score_gpt":0.23073422710106847,"score_spread":0.22469459172081632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056793347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829533,0.012963886,0.0009604992,0.0015233718,0.00011391782,0.00052918494,0.0009153227,0.000026153335,0.000014336402],"genre_scores_gemma":[0.9858145,0.011853169,0.0015133849,0.00050628046,0.000029845887,0.000008338609,0.0001866088,0.00005291839,0.00003493059],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99748373,0.00016168729,0.0010224758,0.00044651583,0.00037711946,0.0005084636],"domain_scores_gemma":[0.9984575,0.00016778187,0.0005893423,0.0001999408,0.00016780444,0.00041762876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027523603,0.0004141269,0.001831285,0.00030285935,0.00019770076,0.00007659885,0.00012801659,0.00029350395,0.00003089221],"category_scores_gemma":[0.00014750738,0.00039383722,0.00011336087,0.00018076514,0.00028513288,0.00024290151,0.00013561155,0.0003756023,0.0000034197296],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019917836,0.0052830805,0.015352491,0.00063157635,0.00496192,0.21254487,0.0012729338,0.000035447643,0.67996675,0.000543742,0.0062102424,0.05327912],"study_design_scores_gemma":[0.024224961,0.008352869,0.07128649,0.0017086858,0.0008885809,0.83045614,0.000260814,0.000077429264,0.05790842,0.0036226355,0.000495859,0.0007171108],"about_ca_topic_score_codex":0.00068147166,"about_ca_topic_score_gemma":0.00007684322,"teacher_disagreement_score":0.62205833,"about_ca_system_score_codex":0.00006400401,"about_ca_system_score_gemma":0.00009875804,"threshold_uncertainty_score":0.99985135},"labels":[],"label_agreement":null},{"id":"W2057626036","doi":"10.1111/bjh.12348","title":"Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with <scp>D</scp>own syndrome","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Deutsche Kinderkrebsstiftung; Deutsche Krebshilfe","keywords":"Medicine; Internal medicine; Chemotherapy; Cohort; Clinical trial; Adverse effect; Population; Down syndrome; Pediatrics","score_opus":0.010784235844708775,"score_gpt":0.26481597854033706,"score_spread":0.2540317426956283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057626036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681556,0.00063931086,0.0007447771,0.0003418548,0.00009925321,0.0011408572,0.00003812078,0.000016686003,0.00016356765],"genre_scores_gemma":[0.9941914,0.0003090774,0.004455192,0.00014036268,0.00004029474,0.00009200662,0.00001972235,0.000058127618,0.0006938318],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9975093,0.00010671129,0.0010531516,0.000282826,0.0004195612,0.0006284479],"domain_scores_gemma":[0.9973707,0.0010034435,0.0005802888,0.0002621466,0.0004825019,0.00030090552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026403894,0.00026364208,0.001707007,0.00046348383,0.00005502512,0.00003119343,0.0002838272,0.0002437071,0.00006869768],"category_scores_gemma":[0.0008570086,0.00020746305,0.00026767838,0.00028154266,0.00030535905,0.00020365235,0.00005441285,0.00028042172,0.000025926196],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068103074,0.0016865672,0.91392493,0.0003366772,0.0063966773,0.053830963,0.0004984083,0.00013173839,0.0011341722,0.00025864897,0.013829665,0.007290527],"study_design_scores_gemma":[0.01991838,0.00447277,0.40114725,0.00053807616,0.00049440813,0.57190204,0.0001485757,0.00021170081,0.0007287497,0.00025114353,0.000106051804,0.00008088274],"about_ca_topic_score_codex":0.0006462932,"about_ca_topic_score_gemma":0.000075612465,"teacher_disagreement_score":0.51807106,"about_ca_system_score_codex":0.0009049364,"about_ca_system_score_gemma":0.0013896732,"threshold_uncertainty_score":0.84600973},"labels":[],"label_agreement":null},{"id":"W2057629675","doi":"10.1046/j.1365-2141.2003.04541.x","title":"A selective history of the therapy of Hodgkin's disease","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ABVD; Procarbazine; Medicine; Dacarbazine; Vinblastine; Disease; Oncology; Bleomycin; Radiation therapy; Chemotherapy; Combination chemotherapy; Internal medicine; Intensive care medicine; Vincristine; Cyclophosphamide","score_opus":0.015480755791139101,"score_gpt":0.23823477701964668,"score_spread":0.22275402122850757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057629675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9533531,0.044129044,0.000010748204,0.0003533003,0.0003032755,0.00014228806,0.00000473365,0.0000021209737,0.0017013947],"genre_scores_gemma":[0.997403,0.0019605728,0.00018383256,0.00024459453,0.000018976116,0.0000045806605,3.9938624e-7,0.000008266798,0.0001757736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990967,0.00016117087,0.000379498,0.00007366653,0.00018104713,0.000107938984],"domain_scores_gemma":[0.9990016,0.00009250492,0.00043438908,0.00012108075,0.00026258422,0.000087803666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014810113,0.000068530906,0.00047713896,0.000054397653,0.000017449138,0.0000016404653,0.00007608264,0.000044874956,0.000117348616],"category_scores_gemma":[0.00026233165,0.000049648675,0.0002471901,0.00007120905,0.00017415089,0.000030754276,0.000008664614,0.00009383087,8.932126e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001865552,0.008056396,0.82206315,0.00037696198,0.0022025073,0.035680953,0.0018766772,0.000011988723,0.0026782323,0.008494674,0.08178694,0.034905963],"study_design_scores_gemma":[0.010934529,0.0011401718,0.7817154,0.0011121683,0.00039340972,0.14585589,0.00014452962,0.0000032957873,0.019960558,0.0020131744,0.036595065,0.00013183762],"about_ca_topic_score_codex":0.000055464596,"about_ca_topic_score_gemma":0.000011189606,"teacher_disagreement_score":0.11017494,"about_ca_system_score_codex":0.00020450389,"about_ca_system_score_gemma":0.0010282823,"threshold_uncertainty_score":0.20246142},"labels":[],"label_agreement":null},{"id":"W2058886769","doi":"10.1111/j.1365-2141.2008.07419.x","title":"Improved prospective identification of megakaryocyte–erythrocyte progenitor cells","year":2008,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Megakaryocyte; Progenitor cell; Identification (biology); Immunology; Medicine; Biology; Cell biology; Stem cell","score_opus":0.012403684601254529,"score_gpt":0.24943634696682762,"score_spread":0.2370326623655731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058886769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8165847,0.023662787,0.014727629,0.12460396,0.010016529,0.007603903,0.0007075636,0.00020700054,0.0018859297],"genre_scores_gemma":[0.87187535,0.0193999,0.017073741,0.073301315,0.010857078,0.00023978301,0.0008071606,0.0007262872,0.0057193693],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9958545,0.0002785045,0.0023452619,0.0003881571,0.00072291057,0.00041063977],"domain_scores_gemma":[0.99533594,0.000272572,0.0025713446,0.0003274105,0.0013715122,0.00012121078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004963683,0.00032804054,0.0019297673,0.0004240922,0.00007777405,0.000028931323,0.00030251173,0.0010483407,0.00010094382],"category_scores_gemma":[0.00020744377,0.0003618412,0.00052937004,0.0002336281,0.00035749457,0.000154368,0.000025364987,0.0018802889,0.000025903375],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071718317,0.00053607865,0.0008678264,0.008178151,0.0017756997,0.29803604,0.00096201216,0.000002327697,0.07430198,0.000016359983,0.61269706,0.0019092901],"study_design_scores_gemma":[0.0027164211,0.00047511343,0.0006995164,0.0019722378,0.0009809515,0.7262736,0.000074605654,0.000025308367,0.2522993,0.0000931417,0.014103316,0.00028644723],"about_ca_topic_score_codex":0.000045743724,"about_ca_topic_score_gemma":0.0000080622,"teacher_disagreement_score":0.5985938,"about_ca_system_score_codex":0.0001597455,"about_ca_system_score_gemma":0.0007014837,"threshold_uncertainty_score":0.99988335},"labels":[],"label_agreement":null},{"id":"W2059028235","doi":"10.1046/j.1365-2141.2003.04082.x","title":"Complete remission of tumour with interleukin 2 therapy in a patient with non‐Hodgkin's lymphoma post allogeneic bone marrow transplant associated with polyclonal T‐cell bone marrow lymphocytosis","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Bone marrow; Lymphoma; Lymphocytosis; Pathology","score_opus":0.009166110864208193,"score_gpt":0.2111154780458491,"score_spread":0.20194936718164092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059028235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935995,0.004835842,0.00004663755,0.00047016804,0.000069435504,0.0005323648,0.00009302495,0.00001417948,0.000338888],"genre_scores_gemma":[0.99663305,0.0009800742,0.0017107929,0.00045888408,0.000016368129,0.000033342076,0.000063626416,0.00006610652,0.0000377307],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9969289,0.00033586737,0.0010994911,0.00038945494,0.00068261195,0.00056368223],"domain_scores_gemma":[0.9977143,0.00019220663,0.0010759371,0.00021939246,0.0004815962,0.00031658745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033835924,0.00040749204,0.0017192422,0.00035834324,0.00008699569,0.000030249534,0.00014296372,0.00019673858,0.0001103994],"category_scores_gemma":[0.000049047037,0.00029116936,0.00020640054,0.00037751716,0.00024037992,0.00011914738,0.000015870199,0.00021158847,0.000002106114],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02209809,0.010441438,0.34820208,0.00029873784,0.0017412108,0.549883,0.0016915356,0.00007414257,0.052771155,0.000045966983,0.00058579934,0.012166842],"study_design_scores_gemma":[0.04902805,0.015203626,0.19575024,0.006636464,0.00050033006,0.6641863,0.0005064045,0.000025820176,0.06742276,0.000019407344,0.00028047338,0.00044012448],"about_ca_topic_score_codex":0.0006395673,"about_ca_topic_score_gemma":0.0011741059,"teacher_disagreement_score":0.15245184,"about_ca_system_score_codex":0.0005464117,"about_ca_system_score_gemma":0.0011706799,"threshold_uncertainty_score":0.99995404},"labels":[],"label_agreement":null},{"id":"W2060670573","doi":"10.1111/j.1365-2141.2007.06924.x","title":"Genomic profiling reveals different genetic aberrations in systemic ALK‐positive and ALK‐negative anaplastic large cell lymphomas","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Generalitat de Catalunya","keywords":"Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Comparative genomic hybridization; Biology; Chromosomal translocation; Cancer research; Fluorescence in situ hybridization; Lymphoma; Molecular biology; Gene; Chromosome; Genetics; Pathology; Medicine; Immunology","score_opus":0.010674375375968518,"score_gpt":0.2332291182757592,"score_spread":0.2225547428997907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060670573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98248905,0.01619316,0.00012752354,0.00014690576,0.00015165396,0.0004577333,0.00003580222,0.000008875602,0.0003893035],"genre_scores_gemma":[0.9949216,0.0037048282,0.0010293451,0.0001403631,0.0000658811,0.000031763077,0.0000097677785,0.000021587635,0.00007486371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982494,0.00020322221,0.0007930487,0.00023661395,0.00018547024,0.00033220486],"domain_scores_gemma":[0.9988324,0.00030372088,0.0003936255,0.00010690343,0.0001697177,0.00019360155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012881642,0.00018342272,0.00091311784,0.00021204709,0.00014170667,0.000021231006,0.00007194783,0.0001241442,0.000027887216],"category_scores_gemma":[0.00012497265,0.00017309719,0.000117834796,0.00011210088,0.00009649357,0.00007470625,0.00004236065,0.00017482882,0.000009169828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000366089,0.0024852154,0.78405035,0.00042689388,0.00045077474,0.20210536,0.0023401119,0.000036208927,0.0049340515,0.00037600298,0.0008424032,0.0015865747],"study_design_scores_gemma":[0.0073940214,0.00054603204,0.55170745,0.0009558051,0.00018787672,0.43533564,0.000342283,0.00011190356,0.0031421117,0.00014201074,0.000014153004,0.00012069658],"about_ca_topic_score_codex":0.00008858528,"about_ca_topic_score_gemma":0.00016984061,"teacher_disagreement_score":0.23323028,"about_ca_system_score_codex":0.00033869885,"about_ca_system_score_gemma":0.0002908534,"threshold_uncertainty_score":0.7058698},"labels":[],"label_agreement":null},{"id":"W2061022771","doi":"10.1111/bjh.13209","title":"LMWH to prevent placenta‐mediated pregnancy complications: an update","year":2014,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pregnancy; Medicine; Placenta; Placental abruption; Preeclampsia; Obstetrics; Intrauterine growth restriction; Low molecular weight heparin; Placental insufficiency; Heparin; Gestation; Fetus; Surgery","score_opus":0.05485541388276022,"score_gpt":0.3644749037831243,"score_spread":0.3096194899003641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061022771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015241264,0.99548304,0.0016996494,0.000604755,0.00059212313,0.0011372705,0.000043679676,0.000044710014,0.00024238296],"genre_scores_gemma":[0.0002800476,0.99473584,0.0034331286,0.00084987056,0.00018408203,0.000064652,0.000242419,0.000079519625,0.00013046301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966265,0.0005440937,0.0017716407,0.0003550619,0.00036155747,0.000341145],"domain_scores_gemma":[0.99708706,0.00014510023,0.0013678039,0.0004388011,0.00039533907,0.0005658692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047015463,0.00032166234,0.0034566883,0.00039626585,0.00009169385,0.00005350409,0.00041406238,0.00041492382,0.00033730778],"category_scores_gemma":[0.00031109524,0.0003183194,0.00053479197,0.00030452872,0.00005899758,0.00010365019,0.00008138878,0.0006713314,0.00031402567],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014717534,0.00095727324,0.000004120644,0.008152968,0.00057348784,0.004203789,0.000030663596,6.2168476e-7,0.000002899713,0.002144487,0.007819937,0.976095],"study_design_scores_gemma":[0.0006320783,0.0004024326,0.00002422146,0.05921708,0.0013327702,0.22730444,0.0000107041005,0.000005087865,0.000005892292,0.0002703216,0.71057564,0.00021934573],"about_ca_topic_score_codex":0.000008564792,"about_ca_topic_score_gemma":0.000027261376,"teacher_disagreement_score":0.9758757,"about_ca_system_score_codex":0.0000850794,"about_ca_system_score_gemma":0.00042784828,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W2061175590","doi":"10.1111/j.1365-2141.2005.05857.x","title":"Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Western University","funders":"Canadian Institutes of Health Research","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Logistic regression; Internal medicine; Creatinine; Population; Gastroenterology; Retrospective cohort study; Platelet; Pediatrics","score_opus":0.01700635865591939,"score_gpt":0.26432345110619965,"score_spread":0.24731709245028025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061175590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826649,0.012173069,0.00043300717,0.002473975,0.0013677798,0.0006080291,0.000052996926,0.00007680722,0.00014945026],"genre_scores_gemma":[0.9975157,0.00013166062,0.00040997186,0.0004592646,0.00014869102,0.00002029674,0.000014516094,0.0000515631,0.0012483763],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.996169,0.0009843798,0.0014448144,0.00041180346,0.00017107381,0.00081893196],"domain_scores_gemma":[0.997674,0.0007474411,0.00075702596,0.00038553562,0.00021206959,0.00022391141],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001067371,0.00031613393,0.0013171646,0.00047561488,0.00026314132,0.0000769958,0.0008866883,0.00030780054,0.0038225693],"category_scores_gemma":[0.0012035174,0.00035654378,0.0002937278,0.0003243169,0.00019079114,0.00035368727,0.00031601492,0.0006485873,0.0011045337],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010424721,0.0019445183,0.055326853,0.0007163761,0.0042730337,0.09477314,0.0047669294,0.00094670977,0.08601853,0.00032556,0.6623397,0.078143954],"study_design_scores_gemma":[0.006185354,0.0010640927,0.058085438,0.0015948996,0.00027167957,0.89588284,0.0006570998,0.000029055223,0.0024375196,0.00019294552,0.03311972,0.0004793559],"about_ca_topic_score_codex":0.00017563178,"about_ca_topic_score_gemma":0.00050616515,"teacher_disagreement_score":0.8011097,"about_ca_system_score_codex":0.0002436161,"about_ca_system_score_gemma":0.00049815985,"threshold_uncertainty_score":0.99988866},"labels":[],"label_agreement":null},{"id":"W2061303590","doi":"10.1046/j.1365-2141.2001.02556.x","title":"Engagement of the CrkL adaptor in interferon α signalling in BCR–ABL‐expressing cells","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"breakpoint cluster region; STAT5; Signal transducing adaptor protein; Cancer research; Chemistry; Chronic myelogenous leukemia; K562 cells; Interferon; ABL; Phosphorylation; Biology; Cell biology; Signal transduction; Leukemia; Virology; Cell; Immunology; Receptor; Tyrosine kinase; Biochemistry","score_opus":0.02612113893396738,"score_gpt":0.2746797086129177,"score_spread":0.2485585696789503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061303590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951955,0.0032472347,0.0001193503,0.00041450973,0.00026918473,0.00021576548,0.0000021339943,0.0000042457773,0.00053204095],"genre_scores_gemma":[0.99803233,0.0007555371,0.000906186,0.00012494414,0.00005852615,0.000003969492,9.0652486e-7,0.000017736607,0.000099875215],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998105,0.00028705766,0.00091895135,0.00014751869,0.00025681753,0.00028465426],"domain_scores_gemma":[0.9990714,0.00017899573,0.00044495985,0.00014835759,0.0000882164,0.000068080946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006119359,0.00011879452,0.00066805515,0.00019792597,0.000033317785,0.000012702538,0.00020782459,0.00010857235,0.00016642448],"category_scores_gemma":[0.00019380881,0.000104563886,0.00013420828,0.00020125664,0.000096743,0.000093929826,0.00008135943,0.0006374735,0.0000032184355],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003722558,0.005016614,0.27250546,0.0013998447,0.00085049827,0.32679245,0.005778193,0.0036788126,0.27469838,0.00019344654,0.007230659,0.098133065],"study_design_scores_gemma":[0.041934144,0.0020384248,0.12163235,0.03491947,0.00051396445,0.48554388,0.0036359357,0.0018511548,0.3007547,0.0009173803,0.005594658,0.00066394533],"about_ca_topic_score_codex":0.00037135658,"about_ca_topic_score_gemma":0.00048828058,"teacher_disagreement_score":0.15875141,"about_ca_system_score_codex":0.00045426394,"about_ca_system_score_gemma":0.0003291038,"threshold_uncertainty_score":0.42639914},"labels":[],"label_agreement":null},{"id":"W2061322150","doi":"10.1111/j.1365-2141.2006.06377.x","title":"Identification of transcripts modulated by ETV6 expression","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"ETV6; Gene; Biology; Transcription factor; Gene expression; Real-time polymerase chain reaction; Genetics; Reverse transcription polymerase chain reaction; Polymerase chain reaction; Regulation of gene expression; Cancer research; Molecular biology; Chromosomal translocation","score_opus":0.007440739157703324,"score_gpt":0.25954879732504743,"score_spread":0.2521080581673441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061322150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867019,0.003133551,0.0090613905,0.0005338834,0.00015653526,0.000134298,0.000018170076,0.0000111949885,0.00024906817],"genre_scores_gemma":[0.9986694,0.0002142429,0.00056967075,0.0000466959,0.00006736303,0.0000023541998,0.00001887659,0.000018472669,0.00039291574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981641,0.00011493318,0.00094732165,0.0001293267,0.00043316046,0.00021115791],"domain_scores_gemma":[0.9987651,0.00008810882,0.00045114922,0.00013011703,0.00046960512,0.000095892734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036240058,0.000083080165,0.0005208369,0.00015672755,0.0000405599,0.000015035546,0.00015277948,0.00016199955,0.00009536893],"category_scores_gemma":[0.00021985878,0.00008424251,0.00012572863,0.00016415576,0.00016152555,0.00012121377,0.000016645918,0.00024945737,0.0000071252234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025938958,0.00032779426,0.0007503302,0.00015274268,0.00005105504,0.007880978,0.00004284877,0.00002210996,0.92029244,0.00006491386,0.067872636,0.0022827508],"study_design_scores_gemma":[0.006006547,0.00031007145,0.010468468,0.00080267363,0.00013191738,0.29064053,0.00008406217,0.00082444964,0.68820256,0.00092214596,0.0014864829,0.000120061864],"about_ca_topic_score_codex":0.00014255328,"about_ca_topic_score_gemma":0.000007857918,"teacher_disagreement_score":0.28275955,"about_ca_system_score_codex":0.000096729236,"about_ca_system_score_gemma":0.000205962,"threshold_uncertainty_score":0.34353098},"labels":[],"label_agreement":null},{"id":"W2062191416","doi":"10.1111/j.1365-2141.2005.05893.x","title":"Differential immune effects mediated by Toll‐like receptors stimulation in precursor B‐cell acute lymphoblastic leukaemia","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"TLR9; TLR2; Immune system; Immunology; Receptor; T cell; Immunogenicity; Toll-like receptor; Biology; Immune tolerance; Cancer research; Innate immune system; Medicine; Internal medicine; Gene expression","score_opus":0.002975571795830646,"score_gpt":0.20532692617898107,"score_spread":0.20235135438315044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062191416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98435646,0.012351559,0.0006741733,0.00022442908,0.0020027542,0.0002494379,0.000007520569,0.00002760367,0.00010604405],"genre_scores_gemma":[0.9974604,0.0010754502,0.00011426503,0.000075471435,0.000049808215,0.000011154672,0.000162024,0.000026242747,0.001025175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974166,0.000736124,0.0011126541,0.00020550942,0.000083887426,0.00044517993],"domain_scores_gemma":[0.9984486,0.00058505475,0.0006550368,0.00013809821,0.00013377822,0.000039436374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032809124,0.00021498442,0.0007852145,0.00031030958,0.00011592553,0.00003097989,0.0002850591,0.00049276033,0.00066634046],"category_scores_gemma":[0.00027337743,0.0002320434,0.00017129164,0.00016705637,0.00015020919,0.00034207947,0.000056825604,0.000538734,0.00029796676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017857766,0.00054437586,0.00065683434,0.00008563937,0.00037015293,0.0017626454,0.0004473554,0.00008866807,0.94447714,0.00003248323,0.029364811,0.020384097],"study_design_scores_gemma":[0.018127708,0.001091024,0.011771916,0.0007952338,0.00035095302,0.06817986,0.00010937448,0.00026540528,0.87971896,0.00009813749,0.018864324,0.0006271259],"about_ca_topic_score_codex":0.00004656801,"about_ca_topic_score_gemma":0.000036616795,"teacher_disagreement_score":0.06641722,"about_ca_system_score_codex":0.00014790184,"about_ca_system_score_gemma":0.00013208162,"threshold_uncertainty_score":0.9462455},"labels":[],"label_agreement":null},{"id":"W2062277180","doi":"10.1111/j.1365-2141.2010.08281.x","title":"Microangiopathic haemolytic anaemia and hyposplenism in angiosarcoma","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Pathology; Medicine; Angiosarcoma; Bone marrow; Microangiopathic hemolytic anemia; CD34; Lymph node; Biology; Internal medicine; Thrombotic thrombocytopenic purpura; Platelet; Stem cell","score_opus":0.005165440566828386,"score_gpt":0.23161382019209106,"score_spread":0.22644837962526268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062277180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98776776,0.010042901,0.00004898198,0.0014855809,0.00028471145,0.00011934181,0.00000252574,0.000010712702,0.00023749135],"genre_scores_gemma":[0.9959089,0.000543998,0.0029231422,0.00038323744,0.00014597976,0.0000018599601,0.000002345137,0.000022702898,0.00006784256],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998747,0.00006782482,0.0005474294,0.00016653263,0.00017311516,0.00029811123],"domain_scores_gemma":[0.99927676,0.00006117357,0.00019244605,0.00014379356,0.00012273794,0.00020310737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039429558,0.00012377469,0.0006950862,0.00025717713,0.00005015613,0.000031202788,0.00012095035,0.000172613,0.000064685126],"category_scores_gemma":[0.00027247448,0.00012825923,0.00020847056,0.00015364776,0.00019274568,0.00010010939,0.00004840114,0.0008023728,0.0000071740474],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019733305,0.000644295,0.22154298,0.0003259509,0.00019583323,0.64231277,0.00042834686,7.9896336e-7,0.060179695,0.0021161085,0.0039109257,0.06814499],"study_design_scores_gemma":[0.0024558597,0.00020008342,0.15811911,0.00041574624,0.00008174121,0.8336917,0.000079093035,0.000036130412,0.0017654117,0.0010556717,0.0019783177,0.000121116864],"about_ca_topic_score_codex":0.000091325026,"about_ca_topic_score_gemma":0.000256882,"teacher_disagreement_score":0.19137898,"about_ca_system_score_codex":0.000014549672,"about_ca_system_score_gemma":0.00012105595,"threshold_uncertainty_score":0.52302593},"labels":[],"label_agreement":null},{"id":"W2063319055","doi":"10.1111/j.1365-2141.2004.04955.x","title":"Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Medicine; Internal medicine; Framingham Risk Score; Transplantation; Oncology; Population; Hematopoietic stem cell transplantation; Chronic myeloid leukaemia; Disease","score_opus":0.009854361523955739,"score_gpt":0.21968413883645418,"score_spread":0.20982977731249844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063319055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939785,0.004124523,0.0006481119,0.00013444044,0.00021419364,0.00082571874,0.000044594795,0.000010714894,0.000019230942],"genre_scores_gemma":[0.9965329,0.0017315384,0.0015454328,0.000043099702,0.000049779068,0.0000123969,0.000016723083,0.00004005926,0.000028072962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981935,0.00012097778,0.0007390232,0.00026767468,0.00036578346,0.000313047],"domain_scores_gemma":[0.9981884,0.00015019285,0.0009163902,0.0002490425,0.00036682567,0.00012917716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003043282,0.00020030997,0.00077989715,0.00010656218,0.00015632351,0.000017583263,0.00015650774,0.00016903094,0.000014659401],"category_scores_gemma":[0.00007964437,0.00015151933,0.00016751113,0.00013549905,0.00019255043,0.00013213891,0.000032575117,0.00032379475,0.0000014222869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003897528,0.0023823804,0.88877606,0.0060033426,0.0015254027,0.007036219,0.0021163337,0.0019186866,0.013715543,0.00012509523,0.00056325493,0.07194015],"study_design_scores_gemma":[0.05555196,0.0047676004,0.6348669,0.012195583,0.0026247369,0.18595567,0.00022081514,0.00007252837,0.10240193,0.0007397531,0.00012366554,0.00047883615],"about_ca_topic_score_codex":0.000099785546,"about_ca_topic_score_gemma":0.00014746837,"teacher_disagreement_score":0.25390914,"about_ca_system_score_codex":0.00045399353,"about_ca_system_score_gemma":0.0006709134,"threshold_uncertainty_score":0.61787784},"labels":[],"label_agreement":null},{"id":"W2064827504","doi":"10.1046/j.1365-2141.2002.03233.x","title":"Mechanisms responsible for the failure of protamine 
to inactivate low‐molecular‐weight heparin","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University","funders":"Medical Research Council; Canadian Institutes of Health Research","keywords":"Protamine; Protamine sulfate; Low molecular weight heparin; Heparin; Molecular mass; Chemistry; Anticoagulant; Fractionation; Pharmacology; Chromatography; Biochemistry; Internal medicine; Medicine; Enzyme","score_opus":0.03502419630825718,"score_gpt":0.2988683484815472,"score_spread":0.26384415217329005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064827504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9043617,0.0015104073,0.050659433,0.04097502,0.0004245652,0.0015415035,0.000007308078,0.000018060038,0.00050197047],"genre_scores_gemma":[0.983914,0.00012211414,0.014076868,0.0005077499,0.00014146324,0.000007512346,0.0000015090872,0.000019675817,0.0012090973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998872,0.00007448396,0.00054195867,0.00010763043,0.00022062642,0.000183335],"domain_scores_gemma":[0.9989167,0.000256586,0.00033184022,0.00014207466,0.0002707413,0.00008208875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042206567,0.000091158974,0.00054089876,0.00016941485,0.00006451283,0.000017707538,0.00013994273,0.00007492912,0.00022741017],"category_scores_gemma":[0.0006997735,0.00007268421,0.0002185483,0.00020933739,0.000044828772,0.00007199595,0.000047873804,0.00013164053,0.000009242245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009580344,0.0004993151,0.010415131,0.0023019747,0.0037151773,0.03460928,0.001246377,0.0005006757,0.4145046,0.17399752,0.22219335,0.12643628],"study_design_scores_gemma":[0.0191915,0.0053203423,0.020805443,0.0026279418,0.0018597208,0.17953138,0.0011590496,0.001537349,0.49821818,0.020867486,0.24805844,0.0008231833],"about_ca_topic_score_codex":0.000008841281,"about_ca_topic_score_gemma":0.000016043703,"teacher_disagreement_score":0.15313002,"about_ca_system_score_codex":0.000021994521,"about_ca_system_score_gemma":0.000034932,"threshold_uncertainty_score":0.2963976},"labels":[],"label_agreement":null},{"id":"W2064866439","doi":"10.1046/j.1365-2141.2001.02953.x","title":"Transcript profiling of human dendritic cells maturation‐induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Research Resources","keywords":"Biology; Chemokine; CD40; Tumor necrosis factor alpha; Interferon gamma; Cell biology; Gene expression; Dendritic cell; Interferon; Phenotype; Gene expression profiling; Immunology; Molecular biology; Cytokine; Gene; Inflammation; In vitro; Immune system; Genetics; Cytotoxic T cell","score_opus":0.01872965282265199,"score_gpt":0.27515903059516444,"score_spread":0.25642937777251246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064866439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635863,0.03505035,0.00012952165,0.00009424884,0.0007937105,0.00029413402,0.000021002215,0.00000633792,0.000024408964],"genre_scores_gemma":[0.9988104,0.0007816337,0.000069763715,0.00004098612,0.000010353173,0.0000055152113,0.000011149452,0.000016488899,0.00025367955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979921,0.00053154747,0.0010375361,0.00013620664,0.000066857516,0.0002357679],"domain_scores_gemma":[0.9983817,0.00032483242,0.00086383324,0.00014127015,0.00026897763,0.000019423489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018304931,0.00016932252,0.000950228,0.00013792355,0.00018418557,0.000015960006,0.0002600781,0.0002940419,0.00006920244],"category_scores_gemma":[0.00012526628,0.00014209439,0.0002362239,0.00012891353,0.00043907415,0.0001465447,0.00003306445,0.00043988889,0.0000015530477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083656784,0.00036069477,0.000805091,0.00026645677,0.00042622947,0.000049834784,0.0013532327,0.0000019269232,0.99478734,0.00019151537,0.0005057042,0.00041541018],"study_design_scores_gemma":[0.0033759647,0.0012214594,0.00861211,0.0010147006,0.000192997,0.010584959,0.0007728503,0.0000011510787,0.97368956,0.00031121648,0.00010291894,0.00012011981],"about_ca_topic_score_codex":0.00014664857,"about_ca_topic_score_gemma":0.00005552963,"teacher_disagreement_score":0.035224147,"about_ca_system_score_codex":0.000022364964,"about_ca_system_score_gemma":0.00011770582,"threshold_uncertainty_score":0.5794441},"labels":[],"label_agreement":null},{"id":"W2064929711","doi":"10.1111/bjh.13112","title":"Long‐acting recombinant factor IX Fc fusion protein (<scp>rFIXF</scp>c) for perioperative management of subjects with haemophilia B in the phase 3 <scp>B‐LONG</scp> study","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"Novo Nordisk; Swedish Orphan Biovitrum; CSL Behring; Amgen; Pfizer; GlaxoSmithKline; Biogen; Biogen Idec; Bristol-Myers Squibb","keywords":"Medicine; Haemophilia B; Haemophilia; Perioperative; Dosing; Factor IX; Pharmacokinetics; Population; Surgery; Haemophilia A; Anesthesia; Internal medicine","score_opus":0.031366387462393626,"score_gpt":0.32556108692500857,"score_spread":0.29419469946261495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064929711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937118,0.0009632034,0.00040778244,0.0005269867,0.00018691806,0.0035486403,0.000011680324,0.000013378626,0.00062959036],"genre_scores_gemma":[0.99757564,0.00023004806,0.0008784865,0.000043746,0.00010592442,0.00016571127,0.000014626706,0.000044100747,0.0009417171],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9966851,0.00064564316,0.00094427867,0.00037388975,0.00072515063,0.00062594394],"domain_scores_gemma":[0.99748164,0.0009247019,0.0005670434,0.0003055412,0.000529598,0.00019149328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017001214,0.00028626394,0.0011715416,0.00033244657,0.00024587972,0.00007496139,0.0003610437,0.00014929,0.000019740268],"category_scores_gemma":[0.00109656,0.00019204336,0.0001991748,0.0003832179,0.00020554004,0.00018687712,0.00009020265,0.00064742716,0.000006637991],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040452196,0.044314127,0.29457164,0.0073122545,0.005421574,0.37311816,0.041273978,0.000044204477,0.009697977,0.0009723667,0.005095376,0.21413313],"study_design_scores_gemma":[0.1544152,0.09664226,0.32177663,0.01715191,0.0020893752,0.21306485,0.12425877,0.0006331833,0.06273349,0.0007207119,0.0060174917,0.0004961129],"about_ca_topic_score_codex":0.00007670178,"about_ca_topic_score_gemma":0.0003766543,"teacher_disagreement_score":0.21363701,"about_ca_system_score_codex":0.000097374716,"about_ca_system_score_gemma":0.00017656943,"threshold_uncertainty_score":0.78313005},"labels":[],"label_agreement":null},{"id":"W2065665685","doi":"10.1046/j.1365-2141.2001.03060.x","title":"A comparison of three rapid D‐dimer methods for the diagnosis of venous thromboembolism","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre","funders":"London Health Sciences Centre","keywords":"D-dimer; Pulmonary embolism; Medicine; Deep vein; Thrombosis; Venous thromboembolism; Venous thrombosis; Pre- and post-test probability; Vein; Radiology; Internal medicine","score_opus":0.07319588517560331,"score_gpt":0.40756343188394045,"score_spread":0.3343675467083371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065665685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8946705,0.06799867,0.03168356,0.0029347297,0.00094552885,0.0010012257,0.000013172004,0.000013320081,0.00073931215],"genre_scores_gemma":[0.9675536,0.011217513,0.020546561,0.00039484864,0.00017275782,0.00006178051,0.000003243709,0.000033969758,0.000015689244],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977672,0.00017937661,0.0012793045,0.00016841572,0.00027773358,0.0003279774],"domain_scores_gemma":[0.99676025,0.0011849916,0.0011112152,0.00028923916,0.00054833636,0.000105958505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012784164,0.00015938075,0.00232659,0.00017625939,0.00010754472,0.0000144272135,0.00034175388,0.00014190903,0.00032060366],"category_scores_gemma":[0.0006236216,0.00013023893,0.0004966944,0.00022290216,0.00030613595,0.000075739124,0.00008061374,0.00028477283,0.0000021261267],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005283903,0.007600032,0.039011996,0.001066557,0.0040542004,0.0018431797,0.0015294707,0.00013293482,0.0011883948,0.005397848,0.058425218,0.8792218],"study_design_scores_gemma":[0.013765584,0.01180483,0.5703024,0.0043272865,0.011673064,0.12448896,0.003860173,0.0013868512,0.038027942,0.013170049,0.20641702,0.0007757812],"about_ca_topic_score_codex":0.00024565923,"about_ca_topic_score_gemma":0.00011066239,"teacher_disagreement_score":0.878446,"about_ca_system_score_codex":0.000026329697,"about_ca_system_score_gemma":0.00010754159,"threshold_uncertainty_score":0.5310989},"labels":[],"label_agreement":null},{"id":"W2066107675","doi":"10.1111/j.1365-2141.2006.06105.x","title":"Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Karyotype; Monosomy; Trisomy 8; Trisomy; Abnormality; Cytogenetics; Clinical significance; Aneuploidy; Chromosome 7 (human); Aplastic anemia; Medicine; Internal medicine; Chromosomal Abnormality; Pediatrics; Pathology; Gastroenterology; Immunology; Chromosome; Biology; Bone marrow; Genetics","score_opus":0.016547343313685896,"score_gpt":0.2875936727352343,"score_spread":0.2710463294215484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066107675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298275,0.0058216164,0.00025849816,0.00010752223,0.00023852882,0.00017712162,0.000023819479,0.0000055208875,0.00038461873],"genre_scores_gemma":[0.99360836,0.004170375,0.0020416407,0.00003647286,0.00006971774,0.000006461643,0.000010022454,0.00001729194,0.000039640374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969346,0.00025639162,0.002114935,0.0001547904,0.00031141657,0.00022787917],"domain_scores_gemma":[0.99736035,0.0012768857,0.0008551519,0.00013413254,0.00028845415,0.00008500634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006418479,0.000113335635,0.0011276263,0.0001927018,0.000018253762,0.0000031926513,0.0001248116,0.0001934649,0.00013157244],"category_scores_gemma":[0.0005920639,0.00012457266,0.00019994681,0.00017366855,0.0003114326,0.00006379222,0.000020833304,0.00013399984,0.0000044402864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010891046,0.00049570866,0.9727701,0.002098187,0.00007493433,0.018661847,0.00020727068,0.000072997034,0.0006418097,0.00020831502,0.00088232674,0.0027974087],"study_design_scores_gemma":[0.0075156773,0.00094146805,0.7800454,0.009486773,0.00025662128,0.17174597,0.00022168846,0.0000757806,0.028939262,0.00048323203,0.00012994747,0.00015818527],"about_ca_topic_score_codex":0.0002593308,"about_ca_topic_score_gemma":0.00067405845,"teacher_disagreement_score":0.1927247,"about_ca_system_score_codex":0.000043480348,"about_ca_system_score_gemma":0.00013052468,"threshold_uncertainty_score":0.50799257},"labels":[],"label_agreement":null},{"id":"W2066131474","doi":"10.1046/j.1365-2141.2003.04346.x","title":"The molecular basis for the thalassaemias in Sri Lanka","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Toronto General Hospital; Hospital for Sick Children","funders":"Medical Research Council; Hospital for Sick Children; Leverhulme Trust; Ministry Of Health, Nutrition and Indigenous Medicine; Wellcome Trust","keywords":"Genetics; Gene; Biology; Allele; Phenotype; Mutation; Globin; Thalassemia; Hemoglobinopathy; Molecular biology; Hemolytic anemia; Immunology","score_opus":0.008703283845785625,"score_gpt":0.2535034113074311,"score_spread":0.24480012746164548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066131474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9142836,0.06891411,0.0006867821,0.011453884,0.00053808064,0.00035250094,0.0000027231076,0.0000066466014,0.0037617215],"genre_scores_gemma":[0.9926142,0.005953197,0.00037746585,0.00091107737,0.000027599763,0.000010470652,5.29494e-7,0.000012100216,0.00009336355],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9989697,0.00013035917,0.00041677814,0.0000818955,0.00014255826,0.00025876143],"domain_scores_gemma":[0.99901086,0.00050803233,0.00016206784,0.000120870136,0.0001345149,0.000063636464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007726742,0.00007492081,0.0003185736,0.00004734445,0.00013855637,0.000025124597,0.0001355781,0.00012945317,0.00003501177],"category_scores_gemma":[0.0013872884,0.000045634526,0.00017631048,0.00013051946,0.0001408753,0.000027711909,0.00001153487,0.00041234188,0.000003912211],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021610442,0.0020983263,0.041047223,0.0008444795,0.0035406803,0.31479955,0.005975778,0.0009722145,0.0031363554,0.12989748,0.15473802,0.34078884],"study_design_scores_gemma":[0.005502189,0.0004364863,0.002916118,0.00066923944,0.00032275898,0.6928315,0.00744274,0.00014232458,0.0017762112,0.0043552634,0.2834262,0.00017897064],"about_ca_topic_score_codex":0.000028857621,"about_ca_topic_score_gemma":0.00007063383,"teacher_disagreement_score":0.37803194,"about_ca_system_score_codex":0.000026002697,"about_ca_system_score_gemma":0.00015078824,"threshold_uncertainty_score":0.1860922},"labels":[],"label_agreement":null},{"id":"W2066286024","doi":"10.1111/j.1365-2141.2008.07337.x","title":"A multicentre randomised clinical endpoint study of <scp>parma</scp> 5 computer‐assisted oral anticoagulant dosage","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Deep vein; Oral anticoagulant; Thrombosis; Clinical trial; Pulmonary embolism; Clinical endpoint; Emergency medicine; Surgery; Internal medicine; Warfarin","score_opus":0.11317277180393226,"score_gpt":0.37187592069718417,"score_spread":0.2587031488932519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066286024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618876,0.0006954769,0.0010347917,0.00027639102,0.0008353313,0.0008027985,0.0000033754031,0.000025730536,0.00013735061],"genre_scores_gemma":[0.99520695,0.0005953077,0.0033552444,0.00016502997,0.00049169274,8.987004e-7,0.0000065569784,0.000020100548,0.00015819349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646246,0.00060415023,0.0020237265,0.00020720552,0.00042775992,0.0002746962],"domain_scores_gemma":[0.9971447,0.000981681,0.0011542471,0.00018089691,0.00032961115,0.00020886393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000949164,0.00016585222,0.0019038249,0.00021454295,0.000096278636,0.000018013357,0.00016802669,0.0001303293,0.000060136466],"category_scores_gemma":[0.001056167,0.0001533048,0.00052281725,0.00018558,0.000174767,0.00010623606,0.00009180913,0.0003448758,0.000011524961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038232526,0.0015032106,0.83794916,0.00020749762,0.001925181,0.1269749,0.0012918379,0.00007446162,0.0001912982,0.000037087644,0.014449995,0.011572128],"study_design_scores_gemma":[0.09935817,0.001694832,0.7843527,0.00026718277,0.00093263004,0.10856485,0.0013648858,0.00088631513,0.0001470124,0.000016170841,0.0023238142,0.000091388494],"about_ca_topic_score_codex":0.000041282234,"about_ca_topic_score_gemma":0.000032807366,"teacher_disagreement_score":0.09553492,"about_ca_system_score_codex":0.000020136255,"about_ca_system_score_gemma":0.000098112985,"threshold_uncertainty_score":0.62515885},"labels":[],"label_agreement":null},{"id":"W2067792512","doi":"10.1046/j.1365-2141.2001.03046.x","title":"Glycoconjugate abnormalities in patients with congenital dyserythropoietic anaemia type I, II and III","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glycoconjugate; Glycophorin; Internal medicine; Erythrocyte membrane; Biology; Membrane; Biochemistry; Endocrinology; Immunology; Pathology; Molecular biology; Medicine","score_opus":0.00824839023504261,"score_gpt":0.2277147774359792,"score_spread":0.21946638720093659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067792512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676955,0.0016169753,0.000016691823,0.00029733716,0.00031790027,0.00013451203,0.0000027486929,0.000010275982,0.0008340379],"genre_scores_gemma":[0.99786234,0.00097178493,0.00025619988,0.0005443231,0.00007054544,0.000001583754,0.00001020471,0.000014534895,0.00026849628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989803,0.00007488514,0.00043802307,0.00013479826,0.00013747124,0.0002345531],"domain_scores_gemma":[0.999239,0.000044937406,0.00019441238,0.00008243589,0.00031146998,0.00012771224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001223787,0.00011298445,0.00058011356,0.00015404874,0.00007904726,0.000012152784,0.000051548708,0.000120036006,0.00037726577],"category_scores_gemma":[0.000076611825,0.0001036528,0.000042634136,0.00015459288,0.00026281716,0.00013849369,0.00003444831,0.000325958,0.0000063348252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010713805,0.0009208912,0.89422566,0.00016594333,0.00042770183,0.07528331,0.00090936344,0.0000111375775,0.00021649651,0.00040083038,0.004451678,0.012273203],"study_design_scores_gemma":[0.014112789,0.005707329,0.65103096,0.0003775233,0.0001397937,0.32383528,0.0005958392,0.000013341991,0.00006810429,0.00021170979,0.003701266,0.00020606969],"about_ca_topic_score_codex":0.00008652566,"about_ca_topic_score_gemma":0.00017710107,"teacher_disagreement_score":0.24855196,"about_ca_system_score_codex":0.000027603799,"about_ca_system_score_gemma":0.00009627615,"threshold_uncertainty_score":0.42268384},"labels":[],"label_agreement":null},{"id":"W2067920937","doi":"10.1111/j.1365-2141.2005.05639.x","title":"Transfusion‐related acute lung injury – response to Urbaniak","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Intensive care medicine; Age limit; Pediatrics; Lung; Internal medicine; Pulmonary edema","score_opus":0.005761890945050774,"score_gpt":0.2664000473537781,"score_spread":0.26063815640872734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067920937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962726,0.0018428606,0.0014520339,0.031951472,0.00041088203,0.00037533182,0.000008287222,0.00004132139,0.0011917861],"genre_scores_gemma":[0.9874884,0.0018005404,0.003174757,0.0050940374,0.00010589828,0.000006751276,0.0000019436106,0.0000312173,0.0022964932],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.998278,0.000176945,0.00075800257,0.00018270136,0.00030739297,0.00029694612],"domain_scores_gemma":[0.9990963,0.00006487908,0.00013654355,0.0001597109,0.00019764005,0.00034495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069403567,0.00013235804,0.0006377259,0.0003380938,0.00008589041,0.000023405388,0.00016259415,0.00014795143,0.0011894658],"category_scores_gemma":[0.000118068165,0.00013825687,0.00022286334,0.0002732636,0.00005817419,0.00011113093,0.000031364027,0.00044592656,0.000092292954],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02040956,0.0021939971,0.0013848742,0.00022427774,0.0023271977,0.2435734,0.0022490884,0.000044546305,0.060585793,0.0015599002,0.39646092,0.26898646],"study_design_scores_gemma":[0.008626614,0.0016799865,0.012349703,0.000906757,0.0010784419,0.6425245,0.00020391475,0.0000669307,0.006790325,0.000117803036,0.32536072,0.00029435728],"about_ca_topic_score_codex":0.00001876394,"about_ca_topic_score_gemma":0.00004754122,"teacher_disagreement_score":0.39895105,"about_ca_system_score_codex":0.000053743675,"about_ca_system_score_gemma":0.00011766823,"threshold_uncertainty_score":0.99972355},"labels":[],"label_agreement":null},{"id":"W2068331840","doi":"10.1111/bjh.12244","title":"Modern management of lymphocyte predominant <scp>H</scp>odgkin lymphoma","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"CD15; CD30; Lymphoma; CD20; Medicine; Lymphocyte; Pathological; Stage (stratigraphy); Hodgkin lymphoma; Pathology; Immunology; Biology; CD34","score_opus":0.03051863911245825,"score_gpt":0.30376686698209776,"score_spread":0.27324822786963954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068331840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062792487,0.9892507,0.00008842981,0.000025618205,0.00058045686,0.0012952015,0.000052068757,0.000019616129,0.0024086183],"genre_scores_gemma":[0.0009130968,0.9948492,0.002435219,0.000051064217,0.0001587392,0.00016119669,0.00004598759,0.00010315557,0.0012823372],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953965,0.00033465854,0.0025673027,0.00046480793,0.00063147146,0.0006052786],"domain_scores_gemma":[0.9954973,0.00052180426,0.0027053936,0.0005148194,0.000398461,0.0003622289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049317966,0.0005929604,0.005947391,0.00045368914,0.00007264821,0.00005661973,0.00049080147,0.000562419,0.00013692606],"category_scores_gemma":[0.00016248088,0.00049953244,0.0016697581,0.00027102264,0.00021693687,0.00011696178,0.00021623197,0.00023164706,0.00015377297],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013221709,0.0011225787,0.00003025079,0.021961793,0.003251131,0.11766483,0.00004856388,5.8127677e-7,2.2962784e-7,0.00023680624,0.00916649,0.84650356],"study_design_scores_gemma":[0.003928658,0.0002837402,0.000106886386,0.05344594,0.005287422,0.41023362,0.000053475316,0.000006665211,0.00002468387,0.0001511351,0.52636784,0.00010990752],"about_ca_topic_score_codex":0.000089431946,"about_ca_topic_score_gemma":0.0000054762518,"teacher_disagreement_score":0.84639364,"about_ca_system_score_codex":0.000769099,"about_ca_system_score_gemma":0.0011516822,"threshold_uncertainty_score":0.9997456},"labels":[],"label_agreement":null},{"id":"W2071152504","doi":"10.1111/j.1365-2141.2008.07389.x","title":"Outcomes of older patients (≥60 years) with acquired aplastic anaemia treated with immunosuppressive therapy","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Confidence interval; Tolerability; Cumulative incidence; Incidence (geometry); Surgery; Toxicity; Single Center; Gastroenterology; Ciclosporin; Adverse effect; Chemotherapy; Transplantation","score_opus":0.010762798218822294,"score_gpt":0.2361154553272821,"score_spread":0.2253526571084598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071152504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983092,0.00065381353,0.00041061072,0.000048875263,0.00006693397,0.00029091537,0.000014150141,0.000013005151,0.00019250685],"genre_scores_gemma":[0.9980598,0.0005602005,0.0011702328,0.000077643774,0.000014993879,0.0000056122553,0.00001962429,0.000031247397,0.000060614155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854344,0.000102155005,0.0005972899,0.00014459196,0.0003970169,0.0002155182],"domain_scores_gemma":[0.99857306,0.00018320346,0.000529849,0.00013954975,0.0004669854,0.000107351196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008868671,0.0001505285,0.0009057172,0.00015722719,0.000045218152,0.0000067269034,0.0001087378,0.00011116081,0.00014005204],"category_scores_gemma":[0.000048255868,0.00011519421,0.00009364104,0.00015927083,0.00025400252,0.00010897101,0.000006603731,0.00014885899,0.0000044400267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020743648,0.0006365137,0.908342,0.00013860589,0.0007460352,0.08446764,0.0010494053,0.000013850509,0.0007059635,0.00000962846,0.0003710278,0.001444967],"study_design_scores_gemma":[0.010797955,0.0013556465,0.7980679,0.0008907366,0.00017187464,0.18290453,0.000110335866,0.000004438711,0.0055685346,0.0000052094674,0.000020460544,0.000102343976],"about_ca_topic_score_codex":0.000059120255,"about_ca_topic_score_gemma":0.000012257324,"teacher_disagreement_score":0.11027407,"about_ca_system_score_codex":0.000024354356,"about_ca_system_score_gemma":0.0001484843,"threshold_uncertainty_score":0.46974835},"labels":[],"label_agreement":null},{"id":"W2071523584","doi":"10.1111/bjh.12492","title":"Genome‐wide genotype‐based risk model for survival in acute myeloid leukaemia patients with normal karyotype","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Chonnam National University Hwasun Hospital","keywords":"Single-nucleotide polymorphism; SNP; Genotyping; Oncology; SNP array; Genotype; Tag SNP; Internal medicine; Genome-wide association study; SNP genotyping; Biology; Medicine; Genetics; Gene","score_opus":0.012529249896750734,"score_gpt":0.25487343524030087,"score_spread":0.24234418534355015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071523584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835275,0.00046909213,0.013986489,0.00061317976,0.0001287796,0.0009670909,0.00006626047,0.000018143173,0.00022347104],"genre_scores_gemma":[0.978843,0.0002502789,0.019904459,0.0004757628,0.000088270586,0.000052538286,0.000073005234,0.000072777926,0.00023995376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740344,0.00017114372,0.0008679448,0.00029838397,0.0005252125,0.0007338481],"domain_scores_gemma":[0.9973995,0.00033700324,0.0004784281,0.0002531461,0.001181527,0.00035038104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005953358,0.00023141853,0.0010383647,0.00039373635,0.00011145935,0.000050041628,0.00034631052,0.000248164,0.00018866247],"category_scores_gemma":[0.0005948844,0.00021462693,0.00018365511,0.00026611582,0.00020775585,0.00032117707,0.00007291101,0.0009896198,0.000047860296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065674856,0.0009714698,0.95428866,0.00038118532,0.0009273043,0.013295995,0.0003183804,0.0041032718,0.00070141227,0.00005414125,0.008195141,0.010195537],"study_design_scores_gemma":[0.025702264,0.0020817036,0.91330254,0.0003632222,0.00041472315,0.019100528,0.000091008595,0.037069935,0.00035073332,0.0005633664,0.0005023002,0.00045766277],"about_ca_topic_score_codex":0.00035647675,"about_ca_topic_score_gemma":0.00036554027,"teacher_disagreement_score":0.04098613,"about_ca_system_score_codex":0.00034018353,"about_ca_system_score_gemma":0.0010562841,"threshold_uncertainty_score":0.87522316},"labels":[],"label_agreement":null},{"id":"W2072018052","doi":"10.1111/j.1365-2141.2004.05207.x","title":"A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Incidence (geometry); Population; Epidemiology; Multiple myeloma; Cancer registry; Demography; Clinical trial; Pediatrics; Internal medicine; Environmental health","score_opus":0.042833296858364185,"score_gpt":0.3484106212694448,"score_spread":0.3055773244110806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072018052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935992,0.0007680492,0.000056190096,0.0050131665,0.000035090627,0.0005104682,0.000003238099,0.000002121631,0.000012476369],"genre_scores_gemma":[0.9989654,0.00011645316,0.0006172917,0.0002601097,0.000018495051,0.000009103427,0.000004567651,0.000006184707,0.0000023925957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985518,0.00022417954,0.00055368204,0.000117912066,0.00037243322,0.00018000565],"domain_scores_gemma":[0.99923646,0.00018001809,0.00020561636,0.00006879665,0.00020270784,0.00010641565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080631796,0.00006684389,0.000446815,0.00026145088,0.000039838957,0.000009172363,0.00007897672,0.000032577776,0.000003542208],"category_scores_gemma":[0.00089137995,0.000056998626,0.000027206115,0.0003552963,0.000029512144,0.00006786437,0.00004337823,0.00020572476,0.0000010352667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060550985,0.00054484454,0.9860469,0.00005945256,0.000030380736,0.007870803,0.00104965,0.00009753367,0.00003008731,0.000076698234,0.000020721523,0.0035674288],"study_design_scores_gemma":[0.0065029683,0.0006864399,0.9518962,0.00055459625,0.000005327732,0.038852334,0.0008619734,0.000060282604,0.000018181854,0.0005243304,0.00000295304,0.00003443126],"about_ca_topic_score_codex":0.014877303,"about_ca_topic_score_gemma":0.10899626,"teacher_disagreement_score":0.09411895,"about_ca_system_score_codex":0.00015699971,"about_ca_system_score_gemma":0.0002708037,"threshold_uncertainty_score":0.9916827},"labels":[],"label_agreement":null},{"id":"W2072135692","doi":"10.1046/j.1365-2141.2002.03407.x","title":"Fluoro‐deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Positron emission tomography; Medicine; Occult; Multiple myeloma; Magnetic resonance imaging; Deoxyglucose; Radiology; Nuclear medicine; Plasmacytoma; Transplantation; Pathology; Internal medicine","score_opus":0.019733550068863362,"score_gpt":0.27477393162081304,"score_spread":0.2550403815519497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072135692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750088,0.022179788,0.0012742751,0.00084332906,0.00012991925,0.00050351775,0.000022409007,0.000008713948,0.000029285025],"genre_scores_gemma":[0.99816865,0.0010040565,0.0006178936,0.000060514212,0.00006500225,0.000024717283,0.0000056869944,0.000016253756,0.000037251844],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986684,0.00011234148,0.0005152395,0.00014321128,0.0002636287,0.00029719368],"domain_scores_gemma":[0.99875975,0.00036814107,0.0002466426,0.00014072978,0.00025930806,0.00022543933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026869125,0.000107701206,0.00041609397,0.0002575708,0.000114442155,0.000018637369,0.00012371496,0.000054710003,0.00004754293],"category_scores_gemma":[0.00084245537,0.00008501985,0.00026298114,0.00019618757,0.00012449897,0.0001192796,0.000027843884,0.00024609212,0.0000021595886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036204937,0.0013974339,0.45376518,0.00041191955,0.0003314544,0.024423817,0.00022024485,0.000019041001,0.0326887,0.000011052789,0.0012603366,0.48185033],"study_design_scores_gemma":[0.017954662,0.0008399991,0.8541409,0.0014940439,0.00035507706,0.06654283,0.0002780249,0.021859968,0.03442277,0.00026529914,0.0016410922,0.00020535759],"about_ca_topic_score_codex":0.00014231644,"about_ca_topic_score_gemma":0.0000861679,"teacher_disagreement_score":0.48164496,"about_ca_system_score_codex":0.000049661427,"about_ca_system_score_gemma":0.00003935512,"threshold_uncertainty_score":0.3467009},"labels":[],"label_agreement":null},{"id":"W2073345996","doi":"10.1046/j.1365-2141.2001.02642.x","title":"Myristoylated alanine‐rich C kinase substrate phosphorylation is involved in thrombin‐induced serotonin release from platelets","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Heart and Stroke Foundation of Canada","keywords":"MARCKS; Phosphorylation; Protein kinase C; Biology; Biochemistry; Thrombin; Platelet activation; Cell biology; Platelet; Chemistry","score_opus":0.020294200464926526,"score_gpt":0.2641070788124191,"score_spread":0.2438128783474926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073345996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933827,0.0046980665,0.000015750988,0.0009215423,0.00022263425,0.00034563904,0.000018495079,0.000026700347,0.0003685062],"genre_scores_gemma":[0.9967661,0.0021615054,0.00030389705,0.00051646563,0.00004146483,0.000008285724,0.00008738319,0.000035615172,0.00007932195],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.997988,0.00011621841,0.0009050142,0.00029173688,0.00029467625,0.0004043503],"domain_scores_gemma":[0.9988007,0.000085603955,0.00048649992,0.00017860132,0.00022125986,0.00022733118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020083803,0.00022667424,0.0010859062,0.00022989258,0.00007553367,0.00003752848,0.00013296501,0.00030633103,0.0005044713],"category_scores_gemma":[0.000127796,0.0002439085,0.00014570465,0.00036207933,0.000061940984,0.00022270528,0.00002383935,0.00057204766,0.0000599229],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014908799,0.0014139761,0.16156153,0.00004326195,0.00044448554,0.8143892,0.0004838628,0.000016266476,0.010134408,0.000023741148,0.0038949815,0.0061034025],"study_design_scores_gemma":[0.029284328,0.0013639326,0.40925604,0.0017216306,0.000467534,0.49344054,0.00070095813,0.00071039103,0.05765263,0.004050517,0.0007404862,0.0006110229],"about_ca_topic_score_codex":0.002009343,"about_ca_topic_score_gemma":0.0009720164,"teacher_disagreement_score":0.32094866,"about_ca_system_score_codex":0.00011690252,"about_ca_system_score_gemma":0.0001842823,"threshold_uncertainty_score":0.99463},"labels":[],"label_agreement":null},{"id":"W2073378227","doi":"10.1046/j.1365-2141.2001.02867.x","title":"Characterization of a partial prostaglandin endoperoxide H synthase‐1 deficiency in a patient with a bleeding disorder","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Medical Research Council","keywords":"Prostaglandin H2; Thromboxane A2; Platelet; Thromboxane-A synthase; Western blot; Chemistry; Prostaglandin; Enzyme; Northern blot; Platelet activation; Blot; Internal medicine; Arachidonic acid; Endocrinology; Molecular biology; Biochemistry; Messenger RNA; Medicine; Biology; Gene","score_opus":0.006901339428721705,"score_gpt":0.22349779098483108,"score_spread":0.21659645155610938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073378227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982421,0.00049967744,0.00055888336,0.00013227791,0.00013631264,0.00030743302,0.000003959046,0.0000066736084,0.00011267633],"genre_scores_gemma":[0.9994705,0.00021702026,0.00015920762,0.000055170338,0.000055895067,0.000013351146,0.000005467616,0.000014909238,0.00000848372],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9986864,0.00008812231,0.00062330964,0.00011614377,0.00024161945,0.00024441653],"domain_scores_gemma":[0.99919033,0.00005327945,0.00042653148,0.00007091998,0.00016182892,0.00009711194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029328934,0.000099588346,0.0005648224,0.00021163197,0.000032782216,0.000010456167,0.000054993576,0.00007851574,0.000057859328],"category_scores_gemma":[0.00018286271,0.00008621121,0.00006234878,0.00022376055,0.000082019724,0.00013164734,0.0000154919,0.00021690728,0.0000017587749],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032024367,0.0013269322,0.6477224,0.00062483683,0.00009273844,0.22523284,0.0017662134,0.00003188646,0.09638187,0.0001901195,0.00005832719,0.023369357],"study_design_scores_gemma":[0.008415674,0.003398061,0.09805878,0.004030014,0.00016495846,0.8383517,0.00057105377,0.00032863027,0.045388546,0.000027537622,0.0010062722,0.00025873006],"about_ca_topic_score_codex":0.000049886068,"about_ca_topic_score_gemma":0.00009085525,"teacher_disagreement_score":0.6131189,"about_ca_system_score_codex":0.000033883396,"about_ca_system_score_gemma":0.00013753858,"threshold_uncertainty_score":0.3515591},"labels":[],"label_agreement":null},{"id":"W2073497841","doi":"10.1046/j.1365-2141.2002.03507.x","title":"DDAVP challenge tests in boys with mild/moderate haemophilia A*","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Haemophilia; Desmopressin; Haemophilia A; Internal medicine; Gastroenterology; Pediatrics","score_opus":0.04605492140485093,"score_gpt":0.2975334411994076,"score_spread":0.2514785197945567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073497841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715638,0.013405038,0.000011733556,0.0100951595,0.00009344741,0.00023907577,0.0000028402474,0.000014238628,0.0045746714],"genre_scores_gemma":[0.9929349,0.0048421216,0.0007623225,0.00019761286,0.0001325951,0.0000076808465,0.0000024023025,0.000028006387,0.0010923595],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983415,0.00012409725,0.00052050315,0.0001986961,0.00036924865,0.00044593107],"domain_scores_gemma":[0.9991161,0.000101390186,0.00015622945,0.00015450398,0.00022382152,0.0002479584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028926617,0.00014968953,0.0007937155,0.00030207066,0.00006977747,0.00002767451,0.00013656658,0.00016311745,0.00050496485],"category_scores_gemma":[0.00014470251,0.00012447039,0.00010806383,0.0002268524,0.00017895723,0.00013431245,0.000029072153,0.0006317097,0.00006597469],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092560577,0.0025565957,0.04893942,0.00035833206,0.00038615783,0.89032257,0.000725032,0.000016689788,0.00026844727,0.00024522815,0.014459741,0.040796187],"study_design_scores_gemma":[0.012562697,0.0028838494,0.034187574,0.0021831659,0.00012703131,0.9415183,0.00023258962,0.0005297043,0.0010110241,0.00089608383,0.0035772682,0.0002907003],"about_ca_topic_score_codex":0.000045121116,"about_ca_topic_score_gemma":0.0002848578,"teacher_disagreement_score":0.051195752,"about_ca_system_score_codex":0.000070054935,"about_ca_system_score_gemma":0.000096731375,"threshold_uncertainty_score":0.5529011},"labels":[],"label_agreement":null},{"id":"W2074559183","doi":"10.1046/j.1365-2141.2001.02657.x","title":"Transient adhesion refractoriness of circulating platelets under shear stress: the role of partial activation and microaggregate formation by suboptimal ADP concentration","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Platelet; Refractory period; Adhesion; Transient (computer programming); Chemistry; Shear stress; Biophysics; Cell biology; Immunology; Medicine; Internal medicine; Materials science; Biology; Composite material; Organic chemistry","score_opus":0.010230121453233688,"score_gpt":0.24375439460473622,"score_spread":0.23352427315150254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074559183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956491,0.0027609896,0.0010051429,0.00029584084,0.00004445294,0.00016894238,0.000010714186,0.000003453126,0.00006136303],"genre_scores_gemma":[0.99859214,0.001183847,0.0001325782,0.000027381771,0.000019891635,0.0000017438476,0.000031971907,0.000007499856,0.0000029487949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990346,0.00006629338,0.0005183213,0.00007800189,0.0001747869,0.0001280053],"domain_scores_gemma":[0.9991257,0.00006398888,0.00053935015,0.000053752046,0.00017167843,0.000045526227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013220466,0.00007702046,0.0003769172,0.00003950124,0.000058138827,0.0000111809695,0.000037891266,0.00008385256,0.000017963903],"category_scores_gemma":[0.000042184336,0.00006438217,0.00005736449,0.00007691346,0.00007305577,0.00024496042,0.0000069411317,0.00012532609,2.4725082e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038049892,0.0020702959,0.06551487,0.0006607823,0.0008256451,0.008436519,0.003281229,0.00080154854,0.7197729,0.00037824636,0.00045960565,0.19399337],"study_design_scores_gemma":[0.009981474,0.0011842462,0.05316019,0.002170759,0.00041178387,0.20800318,0.0026976266,0.0033807142,0.717465,0.0006446536,0.00069064205,0.00020974025],"about_ca_topic_score_codex":0.00009592151,"about_ca_topic_score_gemma":0.0000105124545,"teacher_disagreement_score":0.19956666,"about_ca_system_score_codex":0.000024177298,"about_ca_system_score_gemma":0.000039066166,"threshold_uncertainty_score":0.26254287},"labels":[],"label_agreement":null},{"id":"W2074599609","doi":"10.1111/j.1365-2141.2009.07814.x","title":"Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib <i>in vitro</i>","year":2009,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; CancerCare Manitoba; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Jewish General Hospital; McGill University","keywords":"Dasatinib; Chronic lymphocytic leukemia; Lymphocyte; Immunology; Tyrosine kinase; Cancer research; Cytotoxicity; Biology; Medicine; Leukemia; In vitro; Internal medicine; Receptor","score_opus":0.0155208006435872,"score_gpt":0.2702042294054852,"score_spread":0.25468342876189803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074599609","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64838547,0.07682139,0.0002275029,0.25681046,0.00252069,0.0038807876,0.00036157132,0.00020911275,0.010783016],"genre_scores_gemma":[0.08260843,0.0057069403,0.004037592,0.8926246,0.009571351,0.00008128799,0.0004964869,0.0004771731,0.0043961313],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9920651,0.000642899,0.0024554513,0.001045344,0.0018248694,0.0019663554],"domain_scores_gemma":[0.9949801,0.0010471395,0.0014416443,0.000849191,0.0010621913,0.0006197462],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0010393158,0.0008483679,0.0044336673,0.001429944,0.00014378355,0.00013655004,0.0009151734,0.0020532284,0.00014772348],"category_scores_gemma":[0.0012505023,0.0009463483,0.0008587877,0.00079476775,0.00048820028,0.00023398975,0.00030289855,0.0041974816,0.00022863795],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00080006797,0.000071384144,0.000011268316,0.0008501734,0.00025076594,0.4812354,0.00009057794,0.00007286645,0.00051604887,0.0000015028075,0.5078107,0.0082892105],"study_design_scores_gemma":[0.027374035,0.00084058987,0.00025980105,0.0075788726,0.0004291318,0.818171,0.00013657894,0.00037990173,0.0026362813,0.00008870498,0.14136279,0.00074228033],"about_ca_topic_score_codex":0.0010463994,"about_ca_topic_score_gemma":0.00022985793,"teacher_disagreement_score":0.63581413,"about_ca_system_score_codex":0.113647476,"about_ca_system_score_gemma":0.05895922,"threshold_uncertainty_score":0.9992987},"labels":[],"label_agreement":null},{"id":"W2074668374","doi":"10.1111/bjh.12237","title":"Selective triggering of platelet apoptosis, platelet activation or both","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; Pediatric Oncology Group; St. Michael's Hospital","funders":"","keywords":"Platelet; Platelet activation; Apoptosis; Chemistry; Depolarization; Thrombin; Stimulation; Biophysics; Membrane potential; Cell biology; Immunology; Biochemistry; Endocrinology; Medicine; Biology","score_opus":0.01393741326774213,"score_gpt":0.2614926709717485,"score_spread":0.24755525770400638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074668374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976291,0.00065601896,0.00020072219,0.0003795727,0.00012366788,0.00031254627,0.0000055546534,0.000013634397,0.00067915046],"genre_scores_gemma":[0.9976892,0.00070310896,0.0012323186,0.00014990428,0.00004508239,0.0000104293,0.000009405013,0.000022007669,0.00013852712],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9986767,0.000058337755,0.00065015804,0.00013902134,0.0002153173,0.000260468],"domain_scores_gemma":[0.99881065,0.00013638214,0.0005399486,0.00008979023,0.00030058553,0.00012261631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001282495,0.00013511696,0.0009567282,0.00019393745,0.000057925827,0.00002063901,0.00009138161,0.00015718032,0.00040296282],"category_scores_gemma":[0.00022569823,0.00011770354,0.00014045986,0.00019800148,0.000075284726,0.00027011923,0.000020180512,0.00029323684,0.000016302658],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008277878,0.006986468,0.011823113,0.0019178254,0.008144749,0.19693352,0.0021607394,0.00011679411,0.07305091,0.00051172345,0.10786257,0.5822137],"study_design_scores_gemma":[0.012622492,0.0021714442,0.016948879,0.0015345095,0.00019625915,0.7465896,0.0005322018,0.000099714496,0.21573824,0.0013504572,0.0019301344,0.00028604604],"about_ca_topic_score_codex":0.00027475128,"about_ca_topic_score_gemma":0.000020820105,"teacher_disagreement_score":0.58192766,"about_ca_system_score_codex":0.000056183027,"about_ca_system_score_gemma":0.00016235409,"threshold_uncertainty_score":0.4799811},"labels":[],"label_agreement":null},{"id":"W2074710972","doi":"10.1046/j.1365-2141.2002.03450.x","title":"Transfusion‐associated graft‐versus‐host disease","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Graft-versus-host disease; Medicine; Host (biology); Disease; Blood transfusion; Intensive care medicine; Immunology; Internal medicine; Biology","score_opus":0.026815588356179927,"score_gpt":0.26026873665430017,"score_spread":0.23345314829812025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074710972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892255,0.004075795,0.0007710616,0.0024764878,0.0006745734,0.00019827124,0.000021627906,0.000035423855,0.0025212422],"genre_scores_gemma":[0.99532884,0.003495828,0.00041018965,0.00029186616,0.00008786806,0.000003489668,0.00001095803,0.000025069785,0.00034591116],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99839115,0.00016347611,0.0006557786,0.00014761815,0.00036984097,0.0002721188],"domain_scores_gemma":[0.99879,0.0002480765,0.00023811971,0.00011220496,0.00024849354,0.0003630854],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030280903,0.00012167022,0.00058136514,0.0001364103,0.00008337275,0.000021319636,0.00010778417,0.00013090845,0.0017738384],"category_scores_gemma":[0.00045326832,0.00013164202,0.00023657478,0.00017930106,0.00010373553,0.00010575402,0.0000066277476,0.00033498206,0.00007485361],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036552357,0.0037738583,0.041071717,0.001471623,0.0015274914,0.8695019,0.0024619664,0.000017472134,0.0060203806,0.0012756264,0.046211936,0.02301078],"study_design_scores_gemma":[0.03498034,0.0014436224,0.09524255,0.0045915977,0.0024951634,0.8490891,0.00061325484,0.0007288321,0.0026416385,0.00051372923,0.007003996,0.00065620535],"about_ca_topic_score_codex":0.000022135322,"about_ca_topic_score_gemma":0.000048205497,"teacher_disagreement_score":0.054170836,"about_ca_system_score_codex":0.000050391005,"about_ca_system_score_gemma":0.00006556671,"threshold_uncertainty_score":0.99913865},"labels":[],"label_agreement":null},{"id":"W2074887437","doi":"10.1111/bjh.12480","title":"Cellular immune dysfunction in immune thrombocytopenia (<scp>ITP</scp>)","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Immune system; Immunology; Disease; Immune thrombocytopenia; Immune dysregulation; Autoimmune disease; Autoimmunity; Medicine; Biology; Antibody; Pathology","score_opus":0.027055765429861607,"score_gpt":0.29156114893024004,"score_spread":0.26450538350037844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074887437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045673307,0.9513071,0.000031230527,0.00004826133,0.0009306783,0.0009166137,0.000014740922,0.000018500692,0.0010595531],"genre_scores_gemma":[0.0019517695,0.9964057,0.00032474022,0.00004130004,0.00013063525,0.00004599063,0.0001477953,0.0000948386,0.00085719366],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99609095,0.00033393977,0.0022917623,0.00035996916,0.00034708244,0.0005762975],"domain_scores_gemma":[0.99729943,0.0002706034,0.0016723849,0.00033175392,0.0002287422,0.00019708628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047324182,0.00049234676,0.007212214,0.00056275475,0.00008379478,0.0000709797,0.0003307261,0.0007851372,0.00024691995],"category_scores_gemma":[0.0003585852,0.0004493999,0.0010458233,0.0003743773,0.00013852827,0.00021892073,0.00009935836,0.0014475812,0.00036133235],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015683188,0.0007253931,0.000036791578,0.0068438104,0.0012041832,0.34408197,0.000038246053,3.3886488e-7,0.000025678695,0.00004257841,0.004100446,0.6428849],"study_design_scores_gemma":[0.002644516,0.0003293857,0.00011668735,0.02034404,0.0014468344,0.5378514,0.000060447397,0.0000013724576,0.0000326042,0.00013937075,0.4369161,0.00011722303],"about_ca_topic_score_codex":0.0003012739,"about_ca_topic_score_gemma":0.000036580554,"teacher_disagreement_score":0.64276767,"about_ca_system_score_codex":0.0002104584,"about_ca_system_score_gemma":0.00049090455,"threshold_uncertainty_score":0.9997958},"labels":[],"label_agreement":null},{"id":"W2075128381","doi":"10.1111/j.1365-2141.2004.05240.x","title":"Effect of IL‐2R<i>β</i>‐binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"CD80; CD86; Immunology; CD38; Immunotherapy; Cancer research; Chronic lymphocytic leukemia; CD40; Biology; T cell; Immune system; Cytotoxic T cell; Cell biology; Leukemia; Stem cell; In vitro","score_opus":0.02028842482611792,"score_gpt":0.30829855182407145,"score_spread":0.28801012699795353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075128381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867103,0.011360736,0.00045960114,0.00019141647,0.0002355693,0.0009146739,0.00003439653,0.000016259144,0.00007701811],"genre_scores_gemma":[0.99770916,0.001563245,0.00036473788,0.00006797214,0.00014239164,0.00004548677,0.000006036638,0.000055735003,0.00004522559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771816,0.00015262251,0.0011019199,0.00022937264,0.00036241248,0.0004355377],"domain_scores_gemma":[0.9976516,0.00059980183,0.0007068385,0.0003479858,0.00055525335,0.00013851534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008673544,0.00020845892,0.0012813295,0.00032068253,0.00009863259,0.00001605719,0.00033509574,0.0002093131,0.00002345203],"category_scores_gemma":[0.0005673525,0.00018520362,0.00040249206,0.00022829381,0.0004718036,0.00010721697,0.00004527674,0.00028611868,0.0000068963245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006825401,0.0005830451,0.00026679185,0.006360497,0.0010241899,0.0024113045,0.00032028212,0.0049755904,0.95020276,0.00075880374,0.0011018566,0.025169455],"study_design_scores_gemma":[0.044774804,0.0061669215,0.00013890977,0.0043684244,0.00022249435,0.08551467,0.000038723672,0.00044118465,0.85759467,0.0001949562,0.00038288973,0.00016132343],"about_ca_topic_score_codex":0.00024392124,"about_ca_topic_score_gemma":0.000022057291,"teacher_disagreement_score":0.09260809,"about_ca_system_score_codex":0.010309751,"about_ca_system_score_gemma":0.010548179,"threshold_uncertainty_score":0.9950611},"labels":[],"label_agreement":null},{"id":"W2075300818","doi":"10.1111/bjh.13404","title":"Circulating proplatelets in a patient with acute blood loss following liver transplantation","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Platelet; Thrombopoiesis; Medicine; Disseminated intravascular coagulation; Coagulopathy; Liver transplantation; Thrombopoietin; Pathology; Transplantation; Immunology; Internal medicine; Megakaryocyte; Biology; Stem cell; Cell biology; Haematopoiesis","score_opus":0.012200297397103153,"score_gpt":0.24426516971646695,"score_spread":0.2320648723193638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075300818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972354,0.0018856133,0.00016087205,0.00012377561,0.000082929524,0.00019257124,0.000003182504,0.000008032518,0.00030761142],"genre_scores_gemma":[0.99778694,0.00033835787,0.001738563,0.00008740637,0.000012919476,0.000004483424,0.000010053279,0.000014069453,0.000007214733],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99903834,0.000052116735,0.00037245746,0.00011268546,0.00022781389,0.00019659768],"domain_scores_gemma":[0.9995069,0.000024397348,0.00019245036,0.000048688566,0.00010586574,0.00012167869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012135769,0.000093099596,0.000508684,0.00011642268,0.00002931565,0.000015634008,0.00003931416,0.00007349093,0.0000071480613],"category_scores_gemma":[0.000032100514,0.00008281448,0.00007723365,0.000116572905,0.000029067729,0.00015104855,0.000006068209,0.00019560826,0.0000030506014],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003579143,0.00035914627,0.0030880924,0.000055817465,0.00036225904,0.9890027,0.0008114628,0.000021170714,0.00008050747,0.0000082354345,0.000029106332,0.005823607],"study_design_scores_gemma":[0.007644454,0.00086867064,0.0009180402,0.0007750841,0.00047711088,0.98832154,0.00018370138,0.00004570965,0.00055479736,0.00010747616,0.000023919989,0.00007947662],"about_ca_topic_score_codex":0.00011569293,"about_ca_topic_score_gemma":0.00016379714,"teacher_disagreement_score":0.0072865398,"about_ca_system_score_codex":0.00003335069,"about_ca_system_score_gemma":0.00015089962,"threshold_uncertainty_score":0.33770764},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"case_report","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"case_report","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2075340069","doi":"10.1046/j.1365-2141.2001.02996.x","title":"Immune function in patients with Shwachman–Diamond syndrome","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cytopenia; Immunology; Neutropenia; Immune system; Lymphocyte; Lymphopoiesis; Bone marrow; Medicine; Biology; Haematopoiesis; Stem cell; Internal medicine; Toxicity","score_opus":0.003034333140689503,"score_gpt":0.18720479620723968,"score_spread":0.18417046306655016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075340069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950091,0.004307738,0.00014398895,0.000046288616,0.0001286957,0.00008622794,0.000003884352,0.000002193086,0.00027184785],"genre_scores_gemma":[0.9992913,0.00033992835,0.00014757583,0.00007817294,0.000018908071,0.000003384692,0.000034997756,0.00001377022,0.00007197727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992517,0.000049710754,0.00028830458,0.00013096114,0.00009915311,0.00018012097],"domain_scores_gemma":[0.9995753,0.000004924854,0.00017476738,0.000095646,0.00009936542,0.00004999593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007766549,0.000090639776,0.00025830427,0.000065577864,0.000037376987,0.0000151726135,0.00009628706,0.0001046951,0.000035654542],"category_scores_gemma":[0.000020907046,0.00008879785,0.000061516184,0.00008279298,0.000049244944,0.000009899666,0.00002547001,0.000106322834,0.0000046095965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084785034,0.0011876096,0.96843976,0.000016172486,0.00029018387,0.0122486595,0.00001402129,0.000030193132,0.00021514516,0.000026336262,0.00075443805,0.01592963],"study_design_scores_gemma":[0.0073729455,0.002324895,0.9210016,0.000101563346,0.000068615554,0.06569314,0.00004632767,0.0000012680881,0.0004501552,0.00022225275,0.0025439188,0.0001733267],"about_ca_topic_score_codex":0.00004569966,"about_ca_topic_score_gemma":0.00019390721,"teacher_disagreement_score":0.053444482,"about_ca_system_score_codex":0.000008269475,"about_ca_system_score_gemma":0.000034867284,"threshold_uncertainty_score":0.36210713},"labels":[],"label_agreement":null},{"id":"W2075365678","doi":"10.1111/j.1365-2141.2000.02416.x","title":"Rapid flow cytometric test for the diagnosis of membrane cytoskeleton‐associated haemolytic anaemia","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Hereditary spherocytosis; Spherocytosis; Spectrin; Molecular biology; Medicine; Band 3; Polyacrylamide gel electrophoresis; Flow cytometry; Pathology; Chemistry; Biology; Membrane protein; Immunology; Internal medicine; Biochemistry; Membrane; Cytoskeleton; Enzyme","score_opus":0.022412945853514072,"score_gpt":0.2678358312813185,"score_spread":0.2454228854278044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075365678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856238,0.01043454,0.00023661999,0.0021268795,0.0005320187,0.00043689035,0.000071493676,0.00002343359,0.00051433005],"genre_scores_gemma":[0.98203343,0.015001405,0.0008735933,0.0012124638,0.00026153523,0.000030595013,0.000022321694,0.000032465086,0.0005322011],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99817467,0.00014520863,0.00090480363,0.00017948006,0.00025317742,0.00034266835],"domain_scores_gemma":[0.99608976,0.0025264872,0.0005245477,0.00019690984,0.0005161192,0.00014616827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005804758,0.0001568922,0.0010963088,0.0003002303,0.00013700682,0.000014073818,0.00021431339,0.0002405124,0.0024177805],"category_scores_gemma":[0.0029741179,0.00012974703,0.00043580274,0.00069663144,0.00025367577,0.0000766834,0.000018490615,0.00041307372,0.000022210754],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027503332,0.0032448296,0.026327109,0.0010080195,0.0021480855,0.02007506,0.00038062438,0.00034555263,0.0052189813,0.000091602844,0.1750006,0.7634092],"study_design_scores_gemma":[0.030886518,0.01303813,0.17736652,0.0026269038,0.0033255813,0.62870055,0.00054418814,0.0033368904,0.024610389,0.00078920205,0.11393389,0.000841227],"about_ca_topic_score_codex":0.00005032879,"about_ca_topic_score_gemma":0.000038316455,"teacher_disagreement_score":0.762568,"about_ca_system_score_codex":0.000056393696,"about_ca_system_score_gemma":0.00018962093,"threshold_uncertainty_score":0.99849415},"labels":[],"label_agreement":null},{"id":"W2075365709","doi":"10.1111/bjh.12688","title":"Genome‐wide <scp>DNA</scp> profiling identifies clonal heterogeneity in marginal zone lymphomas","year":2013,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Oncosuisse","keywords":"Biology; Genome; Somatic evolution in cancer; SNP array; Genetics; Cancer; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.01687744581327626,"score_gpt":0.25179646801281375,"score_spread":0.23491902219953747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075365709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93374836,0.023544824,0.000030117857,0.0403214,0.0010686378,0.0006678116,0.00006888539,0.00002869304,0.0005212855],"genre_scores_gemma":[0.71750224,0.011507642,0.0051888474,0.2513606,0.0074227713,0.00039517926,0.0012390637,0.0004304013,0.0049532535],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99528027,0.00038177578,0.0018779767,0.0006103488,0.0008550399,0.0009945916],"domain_scores_gemma":[0.99682325,0.0006847915,0.0013141636,0.00038178003,0.0005215026,0.0002745131],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005165021,0.00057046366,0.002589933,0.00069170404,0.00012366696,0.00019506554,0.00043649445,0.0011599421,0.00021037781],"category_scores_gemma":[0.0005057342,0.00057938794,0.0007460149,0.00022180082,0.00029930368,0.00025011224,0.00016375737,0.0016203395,0.00017332517],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038921815,0.00058712286,0.07542245,0.0008092861,0.00097387936,0.56854326,0.00008061861,0.000003394877,0.00018298312,0.000014235292,0.35223088,0.0011129972],"study_design_scores_gemma":[0.0056263935,0.00042274466,0.16804126,0.0020156023,0.00062209886,0.6699031,0.000087976376,0.000006065776,0.0026182472,0.00026814197,0.15016595,0.00022241239],"about_ca_topic_score_codex":0.00034849774,"about_ca_topic_score_gemma":0.0001599768,"teacher_disagreement_score":0.2162461,"about_ca_system_score_codex":0.0007628076,"about_ca_system_score_gemma":0.0009656625,"threshold_uncertainty_score":0.99966574},"labels":[],"label_agreement":null},{"id":"W2075456403","doi":"10.1111/j.1365-2141.2012.09247.x","title":"Impact of central nervous system (<scp>CNS</scp>) prophylaxis on the incidence and risk factors for <scp>CNS</scp> relapse in patients with diffuse large <scp>B</scp>‐cell lymphoma treated in the rituximab era: a single centre experience and review of the literature","year":2012,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rituximab; Vincristine; Diffuse large B-cell lymphoma; Prednisone; Internal medicine; Methotrexate; Cyclophosphamide; Lymphoma; Chemotherapy; Gastroenterology; Surgery","score_opus":0.012507581673858459,"score_gpt":0.2506385733961153,"score_spread":0.23813099172225682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075456403","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51340145,0.48401803,6.301757e-7,0.000009948458,0.00008466504,0.0020700775,0.00039389735,0.0000050678004,0.000016217518],"genre_scores_gemma":[0.49458876,0.50512165,0.000021413001,0.00003731544,0.00003269328,0.00009091778,0.000046249967,0.000047046648,0.000013963213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944185,0.0015021949,0.001927812,0.0005491995,0.0007123121,0.0008900077],"domain_scores_gemma":[0.99175364,0.0037351272,0.0031204321,0.0006555462,0.0004575649,0.00027766285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008161624,0.0007799626,0.0039460524,0.00030678016,0.00018837512,0.00010451332,0.00056376384,0.0005010996,0.0000021349324],"category_scores_gemma":[0.0029156026,0.000374792,0.00085151265,0.00086967443,0.00035109583,0.00021451092,0.00014472405,0.00079113425,8.05453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010127733,0.018192958,0.8021034,0.073244296,0.0013716944,0.005277297,0.011916718,9.19369e-7,0.0000021215333,0.00006749002,0.0022298377,0.08549196],"study_design_scores_gemma":[0.017043171,0.003867906,0.5945236,0.32859978,0.003987519,0.03835834,0.0025890348,0.000005123611,0.000059560847,0.000009853719,0.010793628,0.00016244533],"about_ca_topic_score_codex":0.00033161623,"about_ca_topic_score_gemma":0.00014225241,"teacher_disagreement_score":0.2553555,"about_ca_system_score_codex":0.00052735384,"about_ca_system_score_gemma":0.00040693066,"threshold_uncertainty_score":0.9998704},"labels":[],"label_agreement":null},{"id":"W2075626785","doi":"10.1046/j.1365-2141.2003.04229.x","title":"Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21","year":2003,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Disease; Trisomy; Down syndrome; Rash; Hematology; Preleukemia; Leukemia; Pathology; Pediatrics; Immunology; Internal medicine; Biology","score_opus":0.027749685117960436,"score_gpt":0.3250905824510643,"score_spread":0.29734089733310387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075626785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012187821,0.9837465,0.0005714238,0.00007391121,0.00021979347,0.0013062358,0.000053072963,0.000012183265,0.0018290236],"genre_scores_gemma":[0.0012357442,0.99433786,0.003773677,0.00009051685,0.000115582174,0.00004590862,0.000034577813,0.00013505387,0.00023110802],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9936903,0.00055111415,0.0032270756,0.00050338573,0.0011015944,0.0009265127],"domain_scores_gemma":[0.9957763,0.00068316533,0.001917277,0.00047293646,0.0006644094,0.00048592823],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012183365,0.0005884363,0.0072225323,0.0012496739,0.000053176886,0.000030904008,0.0006232685,0.0009984946,0.00020511063],"category_scores_gemma":[0.00064147956,0.00049664016,0.00089566456,0.0010863658,0.00048211022,0.0001920347,0.000073414616,0.0023361258,0.000015924245],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006689622,0.00046362204,0.00014435149,0.022796882,0.0009952799,0.18430212,0.0001895817,0.0000031226891,0.0000025169031,0.00009078255,0.0062591047,0.78408366],"study_design_scores_gemma":[0.0066915248,0.0009040277,0.00005278411,0.05098025,0.00120466,0.5669172,0.00007400846,0.000005652566,0.000012458861,0.00005538239,0.37282717,0.00027492322],"about_ca_topic_score_codex":0.00019107336,"about_ca_topic_score_gemma":0.00025326226,"teacher_disagreement_score":0.78380877,"about_ca_system_score_codex":0.0013093152,"about_ca_system_score_gemma":0.010232476,"threshold_uncertainty_score":0.99996555},"labels":[],"label_agreement":null},{"id":"W2075864830","doi":"10.1111/bjh.13085","title":"<scp>CD</scp>30 expression in <i>de novo</i> diffuse large B‐cell lymphoma: a population‐based study from British Columbia","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Tissue microarray; Lymphoma; CHOP; Rituximab; Medicine; International Prognostic Index; Immunohistochemistry; Population; Internal medicine; Germinal center; Cancer research; Oncology; Cyclophosphamide; Pathology; Immunology; Antibody; B cell; Chemotherapy","score_opus":0.007589520789091803,"score_gpt":0.2362843618387992,"score_spread":0.2286948410497074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075864830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624085,0.0024356938,0.00012345072,0.00009626835,0.00028250884,0.00044082408,0.00006341638,0.000031859963,0.00028509737],"genre_scores_gemma":[0.99741757,0.0001450586,0.001190629,0.0007614293,0.00016872321,0.00004430195,0.00005319615,0.00004457505,0.00017454519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972552,0.00044668588,0.0009881,0.00036447417,0.00043460593,0.00051091117],"domain_scores_gemma":[0.9981548,0.0005579972,0.0005244529,0.00027100724,0.0001763599,0.0003153815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005110098,0.00018072689,0.0011471782,0.00012615614,0.00015763886,0.00021767756,0.00020392881,0.00022014558,0.00017859487],"category_scores_gemma":[0.0006254937,0.0002526144,0.00022863859,0.00017997969,0.000038412596,0.00014252312,0.000071430455,0.00021284384,0.000021339614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034631026,0.019929782,0.89029706,0.0000520623,0.0000733255,0.07314353,0.00021341302,0.000004731364,0.00013108188,0.0000020634518,0.012579564,0.003538738],"study_design_scores_gemma":[0.051848207,0.0006249421,0.912077,0.00093983137,0.00023461644,0.030624678,0.00031368763,0.000070965936,0.00027987553,0.00019736153,0.0026880093,0.0001007994],"about_ca_topic_score_codex":0.0158536,"about_ca_topic_score_gemma":0.034193918,"teacher_disagreement_score":0.051813573,"about_ca_system_score_codex":0.00034276012,"about_ca_system_score_gemma":0.00026288573,"threshold_uncertainty_score":0.9999926},"labels":[],"label_agreement":null},{"id":"W2076241720","doi":"10.1111/bjh.12656","title":"Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Child and Family Research Institute; BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"National Institute of General Medical Sciences; National Institutes of Health; Canadian Institutes of Health Research; Terry Fox Foundation; National Institute for Health and Care Research","keywords":"Medicine; Telomere; Paroxysmal nocturnal hemoglobinuria; Confidence interval; Lymphocyte; Odds ratio; Immunology; Aplastic anemia; Internal medicine; Bone marrow failure; Gastroenterology; Bone marrow; Biology; Haematopoiesis; Stem cell; Gene; Genetics","score_opus":0.007951439306216525,"score_gpt":0.22396972605112442,"score_spread":0.2160182867449079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076241720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505776,0.002706968,0.00033419378,0.0004905892,0.00043861716,0.0003986906,0.000014628125,0.000018881125,0.0005396801],"genre_scores_gemma":[0.99603295,0.0008730831,0.002597291,0.000254783,0.00014047469,0.000008725751,0.000011213564,0.000036263227,0.000045216566],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9976771,0.00020969215,0.0010525801,0.00026264394,0.0003319488,0.0004660606],"domain_scores_gemma":[0.9986285,0.00028457632,0.00040056105,0.00014371327,0.00021905905,0.00032357342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041597467,0.00022602212,0.0010124304,0.0002762954,0.00006877672,0.000065936554,0.00015700665,0.0002571516,0.0005472387],"category_scores_gemma":[0.00017211086,0.00023133906,0.00011652529,0.00021639232,0.00018782607,0.00026946826,0.000027746837,0.00047057497,0.00006531528],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030828468,0.003621743,0.3205307,0.0053871316,0.0020114523,0.39129114,0.009811387,0.00025359823,0.09506121,0.0014501752,0.027985573,0.13951305],"study_design_scores_gemma":[0.008224311,0.00055807177,0.42524981,0.0018490815,0.00028290518,0.5519589,0.0005479685,0.00021638072,0.009792312,0.0007567812,0.0002279707,0.00033548995],"about_ca_topic_score_codex":0.00018408691,"about_ca_topic_score_gemma":0.00013086376,"teacher_disagreement_score":0.16066779,"about_ca_system_score_codex":0.000068886424,"about_ca_system_score_gemma":0.00023697206,"threshold_uncertainty_score":0.9433733},"labels":[],"label_agreement":null},{"id":"W2076443949","doi":"10.1046/j.1365-2141.2000.01923.x","title":"Haemophagocytic lymphohistiocytosis in X‐linked severe combined immunodeficiency","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Medical Research Council; Hospital for Sick Children","keywords":"Hemophagocytic lymphohistiocytosis; Immunology; Immune system; Immunodeficiency; Biology; Flow cytometry; Medicine; Internal medicine","score_opus":0.012800641419438761,"score_gpt":0.2701111359028205,"score_spread":0.2573104944833817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076443949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774684,0.012999958,0.00002073103,0.000679724,0.0001151256,0.00020507092,0.0000028926206,0.000018481169,0.008489646],"genre_scores_gemma":[0.9944611,0.0034259572,0.00021842563,0.0003353196,0.000028492383,0.000006452313,0.000005906278,0.000024413323,0.0014939201],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9978093,0.00016885597,0.0010920432,0.00017474765,0.00032141447,0.0004336644],"domain_scores_gemma":[0.9991541,0.00008536049,0.00021982258,0.00020255722,0.00021919332,0.000118984535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056514714,0.00014029595,0.00095979567,0.00029612964,0.00010096869,0.000033163167,0.00026016965,0.000180039,0.0033934717],"category_scores_gemma":[0.00027334134,0.00015242254,0.0002052215,0.00036669892,0.00022564208,0.00019541045,0.00003302537,0.0005546075,0.00015036679],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005289885,0.0033208753,0.042904757,0.0008079746,0.00046818337,0.3068281,0.0012873339,0.00028547188,0.0028929512,0.00079720153,0.0156179005,0.6194993],"study_design_scores_gemma":[0.018377412,0.0012834307,0.14708516,0.0014062591,0.000108133194,0.81628925,0.0005839636,0.00059091847,0.00042304216,0.0012186653,0.012264594,0.00036918433],"about_ca_topic_score_codex":0.00017253654,"about_ca_topic_score_gemma":0.00002443885,"teacher_disagreement_score":0.6191302,"about_ca_system_score_codex":0.00015285585,"about_ca_system_score_gemma":0.0005806879,"threshold_uncertainty_score":0.9975176},"labels":[],"label_agreement":null},{"id":"W2076575287","doi":"10.1111/j.1365-2141.2006.06332.x","title":"Increased prevalence of iron‐overload associated endocrinopathy in thalassaemia <i>versus</i> sickle‐cell disease","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; NIH Clinical Center; National Institutes of Health","keywords":"Medicine; Internal medicine; Hemoglobinopathy; Gastroenterology; Odds ratio; Transfusion therapy; Diabetes mellitus; Complication; Thalassemia; Sickle cell anemia; Disease; Blood transfusion; Endocrinology","score_opus":0.005310286519819731,"score_gpt":0.22123580054918715,"score_spread":0.2159255140293674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076575287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780401,0.018028693,0.000013985831,0.0004209843,0.00030372612,0.00022442728,0.000047160374,0.000017241007,0.002903689],"genre_scores_gemma":[0.9965805,0.0027879414,0.000108561246,0.00013085119,0.00005103067,0.0000036231243,0.000015327198,0.000025052092,0.00029712275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976945,0.00023268229,0.0010420423,0.00020818293,0.0004036883,0.0004189047],"domain_scores_gemma":[0.9984441,0.0002133929,0.000690401,0.00016936554,0.00025409894,0.00022863348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034796435,0.00017713537,0.0008230865,0.00020911504,0.00004503929,0.000012926053,0.0001914113,0.00019565762,0.00014841168],"category_scores_gemma":[0.00060429744,0.0001870377,0.00025877685,0.00028225064,0.00022022772,0.0001265179,0.000045747773,0.0005898437,0.000008426095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004973249,0.006183635,0.6851483,0.0031310616,0.00022902645,0.26078722,0.0002074082,0.00034629815,0.007943463,0.00042069296,0.027574787,0.003054838],"study_design_scores_gemma":[0.052872058,0.0019877315,0.836245,0.006032982,0.0017397464,0.08916498,0.00072923576,0.00033084897,0.0068608853,0.0011539587,0.0020844487,0.0007981047],"about_ca_topic_score_codex":0.000682405,"about_ca_topic_score_gemma":0.00013945352,"teacher_disagreement_score":0.17162223,"about_ca_system_score_codex":0.00010520321,"about_ca_system_score_gemma":0.00038265222,"threshold_uncertainty_score":0.7627176},"labels":[],"label_agreement":null},{"id":"W2077022406","doi":"10.1111/j.1365-2141.2009.07985.x","title":"Successful correction of murine sickle cell disease with reduced stem cell requirements reinforced by fractionated marrow infusions","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Stem cell; Medicine; Bone marrow; Haematopoiesis; Transplantation; Genetic enhancement; Hematopoietic stem cell transplantation; Immunology; Therapeutic effect; Internal medicine; Biology","score_opus":0.005915678126429018,"score_gpt":0.22930286685783216,"score_spread":0.22338718873140315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077022406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264735,0.0024621026,0.00021722878,0.0009801477,0.0004352513,0.0002559664,0.000010841846,0.000024635065,0.002966453],"genre_scores_gemma":[0.99589455,0.0014505006,0.00014259234,0.00029324897,0.000033373497,0.0000022098334,0.000034447763,0.000019048804,0.0021300428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983592,0.00008427088,0.0007715415,0.0001660954,0.0003584038,0.000260506],"domain_scores_gemma":[0.9982929,0.000045870896,0.00075130834,0.00015163381,0.00045293718,0.00030534487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016401165,0.00015149175,0.00057866314,0.0001763847,0.000111502326,0.0000161375,0.00010998705,0.00016295021,0.00022898159],"category_scores_gemma":[0.00005679069,0.0001401276,0.00013236704,0.00028019003,0.00010332559,0.00019443779,0.000017244216,0.0005092278,0.0000064834803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017290214,0.006865674,0.02116617,0.0017909255,0.00086695416,0.08545526,0.0010279829,0.0046083434,0.44599158,0.00009735513,0.3464912,0.06834838],"study_design_scores_gemma":[0.07104575,0.018417444,0.056139212,0.012203881,0.004156831,0.34351975,0.009267997,0.006531537,0.45228454,0.00033332978,0.023866551,0.0022331928],"about_ca_topic_score_codex":0.00010302226,"about_ca_topic_score_gemma":0.00000644518,"teacher_disagreement_score":0.32262462,"about_ca_system_score_codex":0.00005714211,"about_ca_system_score_gemma":0.0002778945,"threshold_uncertainty_score":0.57142377},"labels":[],"label_agreement":null},{"id":"W2077192057","doi":"10.1046/j.1365-2141.2000.01827.x","title":"THE INTRODUCTION OF CITRATE AS AN ANTICOAGULANT FOR TRANSFUSION AND OF GLUCOSE AS A RED CELL PRESERVATIVE","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Calcium oxalate; Oxalate; Preservative; Red Cell; Clotting time; Blood product; Red blood cell; Anticoagulant; Fibrin; Calcium; Surgery; Platelet; Internal medicine; Chemistry; Food science; Immunology","score_opus":0.03145102258703633,"score_gpt":0.3233955673657478,"score_spread":0.29194454477871146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077192057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.089499295,0.9087875,0.000056505574,0.0002880725,0.0003842419,0.00078860647,0.000039395323,0.00000479504,0.00015161964],"genre_scores_gemma":[0.0013388891,0.9976366,0.00032591904,0.0000431769,0.00034356688,0.000014355092,0.00005309134,0.000027778533,0.00021663423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976994,0.00048109872,0.0012445605,0.00022629215,0.00016107672,0.00018758565],"domain_scores_gemma":[0.9977516,0.00033669217,0.0011871011,0.00019339152,0.00042764872,0.000103573075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005338144,0.00019044217,0.0023481539,0.0001626625,0.000087349545,0.0000099316085,0.00013797899,0.00033022658,0.00010211134],"category_scores_gemma":[0.00026124157,0.00014162897,0.000405538,0.00014701435,0.00029388012,0.00007642458,0.000016084767,0.00044530642,0.00000142159],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032964176,0.0006264378,0.000008930124,0.022211839,0.000608632,0.0019928901,0.00026571556,0.0000015318208,0.0014232418,0.00034130906,0.004610973,0.96461207],"study_design_scores_gemma":[0.0024917424,0.005295732,0.000049382797,0.007296475,0.0018421931,0.2731571,0.00017815961,0.000009515172,0.0012895539,0.0012964885,0.7069286,0.00016509974],"about_ca_topic_score_codex":0.000059439237,"about_ca_topic_score_gemma":0.000029084957,"teacher_disagreement_score":0.96444696,"about_ca_system_score_codex":0.000016670076,"about_ca_system_score_gemma":0.00037619466,"threshold_uncertainty_score":0.57754624},"labels":[],"label_agreement":null},{"id":"W2077344703","doi":"10.1046/j.1365-2141.2002.03232.x","title":"THE LANGERHANS CELL HISTIOCYTOSIS X FILES REVEALED","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"Louisiana State University; Yale University","keywords":"Langerhans cell histiocytosis; Histiocytosis X; Histiocytosis; Medicine; Dermatology; Pathology","score_opus":0.013810031497288955,"score_gpt":0.2260560722221078,"score_spread":0.21224604072481884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077344703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93048,0.03967629,0.00008921496,0.0035338383,0.00040055616,0.0001537592,0.000012630278,0.000017105685,0.025636613],"genre_scores_gemma":[0.9874977,0.004829655,0.0006011912,0.00032219695,0.00007780879,0.000004756138,0.000002761044,0.000014390624,0.006649579],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99912536,0.00005899167,0.0003687375,0.000084993066,0.00016747398,0.00019444806],"domain_scores_gemma":[0.9993024,0.00012906174,0.00021610569,0.0001135319,0.00013372539,0.00010521469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012763172,0.00007823573,0.00036361566,0.000048174465,0.0001653752,0.000024967738,0.00010288317,0.00006612509,0.0006207724],"category_scores_gemma":[0.00017764099,0.000060592178,0.0001409906,0.00007596292,0.00011706015,0.000038002272,0.000013586679,0.00018109988,0.000096472846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017606931,0.001293685,0.0076987045,0.00016157508,0.00044686688,0.1303351,0.00051321014,0.0000029376754,0.00016224803,0.00039598858,0.71524405,0.14356953],"study_design_scores_gemma":[0.007590182,0.00092049624,0.0054052994,0.0005953386,0.0006252513,0.6313886,0.00061029295,0.0001357862,0.00050971034,0.00076638337,0.35123053,0.00022211488],"about_ca_topic_score_codex":0.000042043877,"about_ca_topic_score_gemma":0.000049275917,"teacher_disagreement_score":0.5010535,"about_ca_system_score_codex":0.00005162409,"about_ca_system_score_gemma":0.000039775783,"threshold_uncertainty_score":0.6797023},"labels":[],"label_agreement":null},{"id":"W2077392272","doi":"10.1046/j.1365-2141.2000.02165-1.x","title":"Compound Heterozygosity For Triplicated α‐Globin Gene and (– –<sup>SEA</sup>) α‐Globin Gene Deletion: Implication For Thalassaemia Screening","year":2000,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Hydrops fetalis; Mean corpuscular volume; Thalassemia; Prenatal diagnosis; Fetus; Medicine; In utero; Obstetrics; Genetics; Pregnancy; Hematocrit; Pediatrics; Internal medicine; Biology","score_opus":0.01802994836608749,"score_gpt":0.26315364478069503,"score_spread":0.24512369641460754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077392272","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3548903,0.04768171,0.13556136,0.4524922,0.0007562968,0.0063852044,0.0017346336,0.00019217341,0.00030612646],"genre_scores_gemma":[0.13443147,0.041205604,0.23515344,0.55092335,0.015046373,0.0013310901,0.017415306,0.0013914199,0.0031019717],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9961101,0.00020575401,0.0016919127,0.000725559,0.0004064544,0.0008602352],"domain_scores_gemma":[0.99703586,0.00038097362,0.0011250676,0.0003760691,0.0007857438,0.00029631387],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00062468887,0.0005304802,0.0021375043,0.00037640962,0.00041228006,0.00012816655,0.00035963565,0.0020705133,0.0000675014],"category_scores_gemma":[0.0001464072,0.0005680688,0.00070403196,0.00022945716,0.0002404528,0.00014723348,0.000065852815,0.0019094459,0.000006658146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001056204,0.00019651112,0.0002901572,0.0010473223,0.0009854075,0.011729476,0.000063378044,0.00016549206,0.0006504519,0.000016152857,0.94716364,0.036635816],"study_design_scores_gemma":[0.008192843,0.0008121518,0.00035024856,0.00092105276,0.0011314347,0.53282166,0.00004044421,0.002337151,0.00074709096,0.00044427748,0.45171413,0.00048750517],"about_ca_topic_score_codex":0.00014497215,"about_ca_topic_score_gemma":0.0000075086614,"teacher_disagreement_score":0.5210922,"about_ca_system_score_codex":0.00016355817,"about_ca_system_score_gemma":0.00030042962,"threshold_uncertainty_score":0.99967706},"labels":[],"label_agreement":null},{"id":"W2077869291","doi":"10.1111/j.1365-2141.2005.05768.x","title":"Fetal haemoglobin augmentation in E/<i>β</i><sup>0</sup> thalassaemia: clinical and haematological outcome","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Medicine; Fetal hemoglobin; Erythropoietin; Hydroxycarbamide; Toxicity; Hemoglobinopathy; Gastroenterology; Fetus; Internal medicine; Anemia; Pediatrics; Disease; Pregnancy; Biology","score_opus":0.026093110987352258,"score_gpt":0.32471704026329834,"score_spread":0.29862392927594605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077869291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98029363,0.008796913,0.00021055884,0.00919199,0.00023803131,0.00027022354,0.0000044566054,0.000025703408,0.00096847053],"genre_scores_gemma":[0.9911254,0.0033361202,0.0035614783,0.0016047892,0.00017588065,0.0000046353202,0.000006701853,0.000023404336,0.0001615694],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99671865,0.00032421423,0.0019742288,0.0002952343,0.00026631137,0.00042136348],"domain_scores_gemma":[0.9987368,0.00022657531,0.00043703162,0.00013667368,0.00015089152,0.00031201838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011848975,0.00020100428,0.001349855,0.00022740061,0.00008045634,0.000038050413,0.00014100778,0.00058205565,0.00020673175],"category_scores_gemma":[0.00069004955,0.00018534012,0.0002736049,0.00020712324,0.00048132858,0.0002752747,0.00007339302,0.0012952266,0.000035525958],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007327072,0.0013527318,0.74060357,0.00022178509,0.00026236696,0.11008217,0.00033877298,0.0002660356,0.00004330952,0.0009258721,0.01611196,0.1290587],"study_design_scores_gemma":[0.013369777,0.0007372116,0.091426015,0.00065845915,0.0002513982,0.8814659,0.0012352313,0.0016049022,0.00006935587,0.0007153758,0.008170401,0.00029596977],"about_ca_topic_score_codex":0.000034427543,"about_ca_topic_score_gemma":0.000076638746,"teacher_disagreement_score":0.77138376,"about_ca_system_score_codex":0.000057429952,"about_ca_system_score_gemma":0.00013450233,"threshold_uncertainty_score":0.7557951},"labels":[],"label_agreement":null},{"id":"W2078841730","doi":"10.1111/j.1365-2141.2007.06494.x","title":"Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non‐Hodgkin’s lymphoma receiving combination chemotherapy","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Lymphoma; Chemotherapy; Population; Anemia; Erythropoietin; Surgery","score_opus":0.012435657114650878,"score_gpt":0.2832025753712983,"score_spread":0.2707669182566474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078841730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798703,0.000529236,0.00011233977,0.00024586622,0.00020603342,0.0008087973,0.000017594171,0.000009346353,0.00008377724],"genre_scores_gemma":[0.9981102,0.00017965965,0.0015377098,0.00005529677,0.000039941027,0.000006086421,0.000009816737,0.00003793043,0.000023400245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975265,0.00012191843,0.0012782079,0.00024241558,0.00050325244,0.0003277045],"domain_scores_gemma":[0.9965956,0.00018543939,0.002129903,0.00019476458,0.00075846934,0.00013579043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005891502,0.00022228494,0.0013256844,0.00034474963,0.000077604505,0.000008659752,0.00015878805,0.00017143738,0.00015799302],"category_scores_gemma":[0.00025985253,0.00020248718,0.00012114065,0.00034068478,0.00025089036,0.00014055573,0.000040685736,0.0002667209,9.585465e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009261657,0.0588654,0.5910959,0.00029656463,0.0008596307,0.01374128,0.005178106,0.0000027375406,0.006888137,0.000015387583,0.00089288934,0.3129023],"study_design_scores_gemma":[0.13992639,0.03993635,0.7677085,0.0042661396,0.00023340406,0.014393377,0.005063424,0.0000065509357,0.028075794,0.000059119397,0.000050567785,0.00028037906],"about_ca_topic_score_codex":0.00028348315,"about_ca_topic_score_gemma":0.0003602429,"teacher_disagreement_score":0.31262192,"about_ca_system_score_codex":0.00018122277,"about_ca_system_score_gemma":0.00018717724,"threshold_uncertainty_score":0.82571876},"labels":[],"label_agreement":null},{"id":"W2079462672","doi":"10.1111/bjh.13451","title":"Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Multivariate analysis; Stage (stratigraphy); Internal medicine; International Prognostic Index; Young adult; Retrospective cohort study; Lymphoma; Surgery; B symptoms; Pediatrics; Rituximab","score_opus":0.027510097228572006,"score_gpt":0.3125271388128811,"score_spread":0.28501704158430907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079462672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562657,0.003426857,0.000005048483,0.00035353025,0.000279534,0.00016973543,0.000010211525,0.0000042520564,0.00012427321],"genre_scores_gemma":[0.997077,0.0020632953,0.0006907622,0.000060952283,0.00005330752,0.00000633197,0.0000034346085,0.000010907936,0.000034017183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840486,0.00011127815,0.000999161,0.00013714092,0.00017948334,0.00016809971],"domain_scores_gemma":[0.9988786,0.00013973717,0.0004345888,0.00011099796,0.00020423466,0.0002318206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030350988,0.00011752451,0.0012491127,0.00010693465,0.000014480687,0.000012608793,0.00005300733,0.00012506917,0.0000066623006],"category_scores_gemma":[0.0003319381,0.00009680769,0.00018801936,0.000058608424,0.00010923363,0.000061899125,0.000024315057,0.00006123221,0.0000031413438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000324718,0.0015545615,0.8981791,0.000025850451,0.00027028145,0.045105323,0.00025909333,7.34055e-8,0.0000018690621,0.000055580673,0.00008756675,0.054135967],"study_design_scores_gemma":[0.014893763,0.0018876315,0.87429243,0.00039042335,0.00020519459,0.10776291,0.0001210666,0.000005367699,0.00006936505,0.00006122554,0.0002496719,0.000060974744],"about_ca_topic_score_codex":0.0007221069,"about_ca_topic_score_gemma":0.00018309052,"teacher_disagreement_score":0.06265759,"about_ca_system_score_codex":0.00013380578,"about_ca_system_score_gemma":0.0002622363,"threshold_uncertainty_score":0.3947703},"labels":[],"label_agreement":null},{"id":"W2079838949","doi":"10.1046/j.1365-2141.2002.03511.x","title":"Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA‐100<sup>®</sup>)*","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Platelet; Medicine; Platelet disorder; Blood Platelet Disorders; Mean platelet volume; Platelet transfusion; Nuclear medicine; Spectrum analyzer; Internal medicine; Platelet aggregation; Physics; Optics","score_opus":0.02679226782795243,"score_gpt":0.2961434745761081,"score_spread":0.2693512067481557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079838949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902389,0.0054380307,0.002001088,0.00077742455,0.00017111527,0.00022896176,0.000008435205,0.000009596982,0.001126436],"genre_scores_gemma":[0.99634486,0.0022494763,0.000970291,0.00028477891,0.00004611481,0.0000028751413,0.0000057180555,0.000023121636,0.00007277919],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9983441,0.00014198651,0.00071835896,0.00016683801,0.00034097082,0.00028771532],"domain_scores_gemma":[0.99892557,0.00010248948,0.0005151422,0.00018382787,0.00017331145,0.000099635676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027459464,0.00015737249,0.00094959495,0.00015852097,0.00014125358,0.00002719308,0.00014638052,0.00013229107,0.0008054524],"category_scores_gemma":[0.000057406385,0.00012472393,0.00028570462,0.00024330203,0.00018213518,0.00017013014,0.000028909093,0.0003890075,0.000007789551],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015087281,0.0135538755,0.24220629,0.0012462604,0.017466662,0.27279803,0.002042671,0.01389111,0.0032374035,0.002299734,0.043118298,0.38663095],"study_design_scores_gemma":[0.014929819,0.0025295487,0.08172424,0.0011002794,0.0020429015,0.8556669,0.0016380495,0.03157379,0.0004267334,0.002934881,0.0049594664,0.00047338704],"about_ca_topic_score_codex":0.00014852898,"about_ca_topic_score_gemma":0.000057912835,"teacher_disagreement_score":0.5828689,"about_ca_system_score_codex":0.00006581057,"about_ca_system_score_gemma":0.00008371611,"threshold_uncertainty_score":0.8819139},"labels":[],"label_agreement":null},{"id":"W2080155184","doi":"10.1111/j.1365-2141.2007.06810.x","title":"Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours","year":2007,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; McMaster University","keywords":"Chronic lymphocytic leukemia; Lymphocytosis; Lymphoma; Immunology; Family aggregation; Lymphoproliferative disorders; Population; Medicine; Biology; Genetics; Leukemia","score_opus":0.1723417138094271,"score_gpt":0.4585856399438753,"score_spread":0.2862439261344482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080155184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01733799,0.9807636,0.00001542355,0.000019394272,0.00042938697,0.0008845493,0.000016729993,0.000017869193,0.0005150136],"genre_scores_gemma":[0.0012935274,0.997139,0.00026689476,0.00025820214,0.0005681776,0.000038615493,0.000006212708,0.00012722418,0.00030216435],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99484384,0.0005600999,0.0023908326,0.00055478036,0.0007123226,0.00093812286],"domain_scores_gemma":[0.9965465,0.0011854954,0.0011112401,0.0003307924,0.00045453454,0.00037141878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018973281,0.0005782012,0.006281924,0.0011362721,0.00008848842,0.00005524717,0.00038678636,0.0007518504,0.000046439993],"category_scores_gemma":[0.001122178,0.00051812455,0.0005914161,0.000633231,0.0011265515,0.00012755315,0.00024042978,0.0013230874,0.00004318578],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00018597078,0.000082577666,0.000030983934,0.043297153,0.0013659595,0.38421825,0.0002746631,0.0000052661508,0.0000012377121,0.00015379822,0.0033620908,0.567022],"study_design_scores_gemma":[0.009815827,0.00037858498,0.000007841019,0.0710085,0.0007882923,0.6685167,0.00023829735,0.000044670236,0.000004455182,0.000082942024,0.24882771,0.0002861502],"about_ca_topic_score_codex":0.0005476623,"about_ca_topic_score_gemma":0.00033339797,"teacher_disagreement_score":0.5667359,"about_ca_system_score_codex":0.07193649,"about_ca_system_score_gemma":0.056765657,"threshold_uncertainty_score":0.999727},"labels":[],"label_agreement":null},{"id":"W2081076752","doi":"10.1046/j.1365-2141.2000.01826.x","title":"Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a ‘graft vs. myelofibrosis’ effect","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Myelofibrosis; Medicine; Transplantation; Haematopoiesis; Graft-versus-host disease; Stem cell; Disease; Internal medicine; Gastroenterology; Surgery; Bone marrow","score_opus":0.02444582817807832,"score_gpt":0.306062339335051,"score_spread":0.28161651115697267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081076752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95296526,0.04305809,0.0008078433,0.0010676981,0.00029795378,0.0017542368,0.00003306247,0.000009652297,0.000006192861],"genre_scores_gemma":[0.96413296,0.03320634,0.0018176093,0.00006027733,0.00019114806,0.00048700703,0.000018356544,0.000030933345,0.000055369004],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978134,0.00022230652,0.0010946239,0.00028070976,0.0003042992,0.00028464675],"domain_scores_gemma":[0.99769086,0.0011193359,0.00057074364,0.0002062009,0.0002758609,0.00013699374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058929133,0.000248456,0.0012239283,0.0001434812,0.00017579304,0.000019734716,0.00011073632,0.00021588309,0.00008684564],"category_scores_gemma":[0.00022862465,0.00017552591,0.00082263123,0.00016870863,0.000115100804,0.00017339642,0.000006868728,0.00012514548,0.0000014329764],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081967734,0.0026303406,0.08066964,0.0062149754,0.0035365478,0.004329126,0.0030186975,0.0004306662,0.10764172,0.000055963385,0.0008291638,0.70867544],"study_design_scores_gemma":[0.03757538,0.06186261,0.16929632,0.02537168,0.007967716,0.055743523,0.00011643317,0.00032201517,0.63654983,0.0001633663,0.0045572296,0.0004738967],"about_ca_topic_score_codex":0.000069308735,"about_ca_topic_score_gemma":0.00008433266,"teacher_disagreement_score":0.7082015,"about_ca_system_score_codex":0.00021833582,"about_ca_system_score_gemma":0.00033851495,"threshold_uncertainty_score":0.7157739},"labels":[],"label_agreement":null},{"id":"W2081222723","doi":"10.1046/j.1365-2141.2001.02705.x","title":"Autotransplants for histologically transformed follicular non‐Hodgkin's lymphoma","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Surgery; Melphalan; Follicular lymphoma; Internal medicine; Etoposide; Lymphoma; Total body irradiation; Progressive disease; Chemotherapy; B symptoms; Transplantation; Gastroenterology; Salvage therapy; Cyclophosphamide","score_opus":0.016168254243755266,"score_gpt":0.2685698339200709,"score_spread":0.2524015796763156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081222723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865239,0.005179749,0.003935785,0.0023196172,0.00035863966,0.00047720253,0.000023062259,0.000024757179,0.0011572707],"genre_scores_gemma":[0.99142593,0.0031364004,0.00419878,0.0008322705,0.000121953744,0.000046376183,0.000019941986,0.000022808143,0.00019554047],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983799,0.000047606845,0.0007265366,0.00020362451,0.00023783544,0.00040451853],"domain_scores_gemma":[0.99895155,0.0001660996,0.00025722565,0.00012228449,0.00025205515,0.00025076643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024275194,0.00017548415,0.0009941426,0.00012419527,0.00011112638,0.000024128898,0.00014298692,0.00021208856,0.00015180247],"category_scores_gemma":[0.00010037329,0.00015486979,0.00050270115,0.00010448978,0.00010510883,0.000095944364,0.000007317394,0.00009312988,0.000013229993],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002840632,0.0042488836,0.043240406,0.0004095919,0.0015672377,0.62519187,0.00038585532,0.000013791551,0.0010278655,0.00088149915,0.013805178,0.30638722],"study_design_scores_gemma":[0.017058171,0.0015365408,0.08045715,0.00055691856,0.0006605773,0.84620947,0.000044847577,0.000042424996,0.0021157342,0.0006206849,0.050519347,0.00017813643],"about_ca_topic_score_codex":0.000051739702,"about_ca_topic_score_gemma":0.000060377493,"teacher_disagreement_score":0.3062091,"about_ca_system_score_codex":0.00018229279,"about_ca_system_score_gemma":0.0003415054,"threshold_uncertainty_score":0.63154066},"labels":[],"label_agreement":null},{"id":"W2082706184","doi":"10.1111/bjh.12015","title":"Algorithm for initial management of priapism in chronic myeloid leukaemia","year":2012,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Priapism; Medicine; Intensive care medicine; Apheresis; Myeloproliferative neoplasm; Pediatrics; Immunology; Surgery; Bone marrow","score_opus":0.018972193019164155,"score_gpt":0.26949717154262,"score_spread":0.25052497852345584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082706184","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02091115,0.89561564,0.012141581,0.036916554,0.02665162,0.0036966337,0.0008395854,0.000051994553,0.0031752682],"genre_scores_gemma":[0.5515524,0.07897666,0.08267508,0.13865922,0.06688595,0.0027037803,0.007945488,0.0023574438,0.06824398],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966247,0.0006260528,0.001591547,0.00037384857,0.00009126188,0.0006925852],"domain_scores_gemma":[0.9975875,0.00021227881,0.0015631245,0.00031850862,0.00029597324,0.000022608909],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008879294,0.0003079846,0.0017419048,0.00036823264,0.00006718271,0.000013298296,0.0005784311,0.0014142343,0.00030746404],"category_scores_gemma":[0.000046916168,0.00033556728,0.00042302805,0.00011637331,0.0003208839,0.00014540607,0.00011743418,0.0017013177,0.000048883554],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008459072,0.00016836394,0.00010342561,0.0037314184,0.0021640107,0.03012161,0.00019293814,0.000002073401,0.000983185,0.0002161127,0.716523,0.24570926],"study_design_scores_gemma":[0.005049251,0.0005538451,0.0006486125,0.006026403,0.0004532378,0.29504865,0.000091285634,4.07988e-7,0.005479014,0.0014564774,0.6847008,0.00049200654],"about_ca_topic_score_codex":0.00006627091,"about_ca_topic_score_gemma":0.000014096744,"teacher_disagreement_score":0.81663895,"about_ca_system_score_codex":0.00018996402,"about_ca_system_score_gemma":0.00026509762,"threshold_uncertainty_score":0.99990964},"labels":[],"label_agreement":null},{"id":"W2082863510","doi":"10.1111/j.1365-2141.2012.09232.x","title":"An open‐label, single‐arm, phase 2 study of single‐agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"Onyx Pharmaceuticals; Exelixis; National Cancer Institute; Celgene; Bristol-Myers Squibb","keywords":"Carfilzomib; Medicine; Bortezomib; Nausea; Refractory (planetary science); Proteasome inhibitor; Adverse effect; Multiple myeloma; Internal medicine; Regimen; Phases of clinical research; Oncology; Clinical trial; Surgery","score_opus":0.04593809647162775,"score_gpt":0.33000503209728976,"score_spread":0.284066935625662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082863510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651355,0.00107154,0.000013579104,0.000034276814,0.00003897535,0.0021633937,0.000046401063,0.000014089483,0.00010421561],"genre_scores_gemma":[0.9983135,0.00009727148,0.0012657403,0.00004434099,0.000041774038,0.000044782362,0.000057159108,0.00006671128,0.00006871683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967397,0.00054516835,0.0010086849,0.0003691786,0.00064491277,0.00069237844],"domain_scores_gemma":[0.9973976,0.00019471232,0.0007497709,0.0003600993,0.00059742446,0.00070041866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048017304,0.00031491634,0.001538935,0.00036145526,0.00011272455,0.00006803144,0.00028512656,0.00015119888,0.00006767943],"category_scores_gemma":[0.0003530142,0.00023374385,0.000041007548,0.00026506014,0.00022678534,0.00072582375,0.00010333015,0.00044696764,0.000001452249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027984045,0.06932086,0.8501759,0.0001228172,0.00073048077,0.021977598,0.0012487059,0.0000014286552,0.0006407889,0.0000010088065,0.000121389305,0.02767495],"study_design_scores_gemma":[0.14049602,0.10660033,0.72686094,0.0014838306,0.00047005,0.020828672,0.0015803146,0.00003965203,0.0012663638,0.0000017632943,0.00009249482,0.00027959564],"about_ca_topic_score_codex":0.0009906247,"about_ca_topic_score_gemma":0.0024836035,"teacher_disagreement_score":0.123315014,"about_ca_system_score_codex":0.00021907578,"about_ca_system_score_gemma":0.00019515882,"threshold_uncertainty_score":0.9531797},"labels":[],"label_agreement":null},{"id":"W2083073031","doi":"10.1111/bjh.12985","title":"Use of <scp>JAK</scp> inhibitors in the management of myelofibrosis: a revision of the <scp>B</scp>ritish <scp>C</scp>ommittee for <scp>S</scp>tandards in <scp>H</scp>aematology <scp>G</scp>uidelines for <scp>I</scp>nvestigation and <scp>M</scp>anagement of <scp>M</scp>yelofibrosis 2012","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Medical Research Council; Public Health Agency","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Hazard ratio; Internal medicine; Calreticulin; Confidence interval; Hematology; Oncology; Biology; Bone marrow; Genetics","score_opus":0.02982384085572492,"score_gpt":0.2775194712061712,"score_spread":0.24769563035044628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083073031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9021619,0.056845874,0.002951602,0.005818865,0.004772181,0.018356042,0.0052498486,0.0003826954,0.0034609728],"genre_scores_gemma":[0.6544998,0.14528409,0.059955016,0.06474387,0.014033929,0.01471782,0.010915792,0.0063195904,0.029530056],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95717275,0.005767922,0.016636636,0.0058272667,0.007328216,0.007267183],"domain_scores_gemma":[0.9015496,0.06693833,0.018030249,0.00471344,0.006736278,0.0020321382],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","sts","scholarly_communication","open_science","research_integrity"],"consensus_categories":["metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.010967672,0.006090469,0.016360257,0.0062675816,0.0016124492,0.0012715211,0.0055929963,0.006518305,0.000028783223],"category_scores_gemma":[0.06557375,0.005593022,0.00540672,0.005230776,0.0046075936,0.002779252,0.0028608076,0.0072355294,0.00008149924],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062822,0.004241833,0.045022972,0.019860925,0.00728742,0.006000411,0.008434408,0.0005776739,0.0018625833,0.0019366894,0.901417,0.0032952686],"study_design_scores_gemma":[0.027862469,0.007288249,0.03278524,0.03562881,0.011388106,0.024170807,0.03381183,0.0008332692,0.034931768,0.0046386113,0.7861739,0.00048696768],"about_ca_topic_score_codex":0.0011653947,"about_ca_topic_score_gemma":0.0013342374,"teacher_disagreement_score":0.24766208,"about_ca_system_score_codex":0.0014805316,"about_ca_system_score_gemma":0.0021267636,"threshold_uncertainty_score":0.9997872},"labels":[],"label_agreement":null},{"id":"W2083141185","doi":"10.1046/j.1365-2141.2002.03910.x","title":"Telomere maintenance in human B lymphocytes","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"Deutsche Forschungsgemeinschaft; European Commission","keywords":"Telomere; Biology; CD19; Haematopoiesis; Senescence; Lymphocyte; Flow cytometry; Molecular biology; Immunology; Cell biology; Stem cell; Genetics; DNA","score_opus":0.019966626141806516,"score_gpt":0.2570709779284967,"score_spread":0.23710435178669018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083141185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826784,0.012784083,0.00003980844,0.0011083708,0.0002576986,0.00011473308,0.0000033015433,0.000020907242,0.002992668],"genre_scores_gemma":[0.99509364,0.0024920572,0.0007665041,0.0007118228,0.00014431738,0.0000029448734,0.0000015391051,0.000023543585,0.00076364464],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99820536,0.000094994684,0.00082281616,0.00019420129,0.0002598819,0.0004227494],"domain_scores_gemma":[0.99903846,0.00008354099,0.0003155635,0.00016601804,0.00020345444,0.0001929949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027480736,0.00014429323,0.00084250694,0.00029461057,0.00007603129,0.000026172802,0.00020461688,0.00014714414,0.00080653734],"category_scores_gemma":[0.00034809127,0.0001506597,0.00015846537,0.0002783826,0.0002170846,0.00014970441,0.00003166042,0.0004346164,0.000046951507],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002841134,0.0015542649,0.13812537,0.00052132475,0.00020140925,0.6547589,0.0010446535,0.000012281105,0.0079259975,0.0024700877,0.07731315,0.11578848],"study_design_scores_gemma":[0.0055719693,0.00044334482,0.06531543,0.0017561612,0.00005798379,0.911555,0.0004518953,0.00008825873,0.0027189897,0.00077419623,0.0110036675,0.00026308428],"about_ca_topic_score_codex":0.00013772544,"about_ca_topic_score_gemma":0.00017427818,"teacher_disagreement_score":0.25679615,"about_ca_system_score_codex":0.00010694322,"about_ca_system_score_gemma":0.00006663696,"threshold_uncertainty_score":0.8831018},"labels":[],"label_agreement":null},{"id":"W2083377554","doi":"10.1111/j.1365-2141.2007.06733.x","title":"Childhood acute lymphoblastic leukaemia simulating multifocal osteomyelitis","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Orthopedic Infections and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Erythrocyte sedimentation rate; Immunophenotyping; White blood cell; Bone marrow; Bone pain; Absolute neutrophil count; Rib cage; Complete blood count; Leukocytosis; Osteomyelitis; Nuclear medicine; Pathology; Internal medicine; Surgery; Neutropenia; Chemotherapy; Anatomy; Immunology","score_opus":0.007311494748825923,"score_gpt":0.27155236412734934,"score_spread":0.2642408693785234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083377554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918076,0.0010150402,0.004049895,0.00016421595,0.0005862316,0.00015096439,0.000007868644,0.000027967624,0.0021902393],"genre_scores_gemma":[0.99498457,0.00016295398,0.0039789905,0.00020099206,0.00048365,0.0000013787336,0.000007748852,0.0000260083,0.00015370907],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9984256,0.000045129553,0.00075728755,0.00015381703,0.00024333173,0.0003748287],"domain_scores_gemma":[0.9988251,0.0002091728,0.00032929107,0.00011153728,0.00027594643,0.00024898155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036562755,0.00013731566,0.0006032598,0.00020696665,0.00015107558,0.000024387315,0.00005108991,0.00016003761,0.0001943733],"category_scores_gemma":[0.00034203535,0.00013821293,0.00022910097,0.00017029801,0.000101929385,0.000118454715,0.00003223786,0.00034617775,0.000038721548],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029701975,0.00067396485,0.114331655,0.00007990578,0.001186966,0.44340575,0.0002638057,0.00005992165,0.00025609572,0.00019290083,0.0006208487,0.43863115],"study_design_scores_gemma":[0.0055138557,0.000662255,0.16044797,0.0004984588,0.0004664264,0.8302316,0.00010958397,0.00009159889,0.00043743383,0.000106370695,0.0013201699,0.0001142436],"about_ca_topic_score_codex":0.000075314696,"about_ca_topic_score_gemma":0.00005538132,"teacher_disagreement_score":0.4385169,"about_ca_system_score_codex":0.00011474536,"about_ca_system_score_gemma":0.00017502216,"threshold_uncertainty_score":0.5636159},"labels":[],"label_agreement":null},{"id":"W2083617340","doi":"10.1111/bjh.12931","title":"Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University Health Centre; University of Ottawa; Memorial University of Newfoundland; Dalhousie University; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Princess Margaret Cancer Centre; University of Calgary; CancerCare Manitoba; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Medicine; Referral; Incidence (geometry); Epidemiology; Pediatrics; Cohort; Cancer registry; Acute promyelocytic leukemia; Cohort study; Malignancy; Internal medicine; Family medicine","score_opus":0.011995909131393642,"score_gpt":0.250683099887268,"score_spread":0.23868719075587436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083617340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741817,0.0010338043,0.0003133494,0.00030184508,0.00019772969,0.00059138844,0.000051899737,0.0000069467737,0.00008487897],"genre_scores_gemma":[0.9969139,0.0013247314,0.00037326125,0.0010393049,0.000074600175,0.000038489015,0.00005715214,0.00002854077,0.00015001895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708885,0.0006516354,0.00082413096,0.0005575262,0.00022889345,0.00064893736],"domain_scores_gemma":[0.99855435,0.00010390336,0.0004411825,0.00026608512,0.00024747293,0.00038703365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006668128,0.00028325105,0.0008859489,0.00015982284,0.0001323117,0.00008779776,0.00049908576,0.00036707896,0.00003222076],"category_scores_gemma":[0.0009504244,0.00028044518,0.000100799974,0.00020019856,0.00012616471,0.00003219582,0.00019369807,0.00047011388,0.0000045667434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001849569,0.0007222106,0.85568553,0.00027650042,0.0006282913,0.0046126344,0.00069874193,0.00000342721,0.09593507,0.000018333956,0.016637089,0.022932613],"study_design_scores_gemma":[0.025708484,0.009119235,0.810614,0.0009822977,0.00062880415,0.02050804,0.0017015575,0.00026923034,0.08420855,0.0006994357,0.0428792,0.002681188],"about_ca_topic_score_codex":0.0037802628,"about_ca_topic_score_gemma":0.0048161205,"teacher_disagreement_score":0.045071542,"about_ca_system_score_codex":0.00011839427,"about_ca_system_score_gemma":0.00029411176,"threshold_uncertainty_score":0.9999648},"labels":[],"label_agreement":null},{"id":"W2084346498","doi":"10.1111/bjh.13261","title":"c.1058C&gt;T variant in the <i>SERPINC1</i> gene is pathogenic for antithrombin deficiency","year":2014,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster Children's Hospital; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Serpin; Antithrombin; Thrombophilia; Medicine; Venous thrombosis; Thrombosis; Internal medicine; Genetics; Immunology; Biology; Gene; Heparin","score_opus":0.029427371689610897,"score_gpt":0.27374433843586793,"score_spread":0.24431696674625702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084346498","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11346724,0.014163514,0.010227498,0.8557788,0.002980001,0.001999749,0.00014683127,0.000042779808,0.0011935955],"genre_scores_gemma":[0.15118837,0.0012184721,0.0036582863,0.8413917,0.0020171176,0.00004568164,0.000121984325,0.00010735694,0.00025103395],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99670744,0.00041831797,0.0013262955,0.00037480812,0.00060211157,0.00057101075],"domain_scores_gemma":[0.99777657,0.000341534,0.0009822687,0.00041271426,0.0004017359,0.00008515969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013865293,0.00031020795,0.0016570624,0.00032891915,0.00013154004,0.000081693965,0.00057146844,0.00093038956,0.00017683007],"category_scores_gemma":[0.0002560764,0.00026744447,0.00058721565,0.00025089915,0.00013515132,0.00007897152,0.00004550524,0.0017465502,0.000023631392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044059554,0.00025657815,0.00003898375,0.00045546115,0.00015559688,0.095054455,0.00021144185,7.747716e-7,0.00077169744,0.00058296067,0.9014773,0.00095073576],"study_design_scores_gemma":[0.0030776027,0.0006971829,0.00025066294,0.00084143924,0.0006115611,0.7210825,0.000040295385,0.000075582655,0.00045094333,0.0048484653,0.26775816,0.0002655815],"about_ca_topic_score_codex":0.00003150279,"about_ca_topic_score_gemma":0.000024169893,"teacher_disagreement_score":0.6337191,"about_ca_system_score_codex":0.000048883412,"about_ca_system_score_gemma":0.00033142485,"threshold_uncertainty_score":0.99997777},"labels":[],"label_agreement":null},{"id":"W2084978878","doi":"10.1046/j.1365-2141.2003.04389.x","title":"The trouble with consent","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Medical Malpractice and Liability Issues","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Law; Sign (mathematics); Power (physics); Certainty; Criminal law; Subject (documents); Liability; Political science; Psychology; Computer science; Philosophy","score_opus":0.05842515429108066,"score_gpt":0.4069596284499723,"score_spread":0.34853447415889166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084978878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477704,0.00427177,0.0005344576,0.024154034,0.0010696447,0.00024342192,0.0000012540042,0.000012494988,0.021942528],"genre_scores_gemma":[0.9942683,0.0012080373,0.0010335249,0.0015506664,0.000138961,0.00001153069,3.235167e-7,0.000010966007,0.0017777215],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972766,0.0014513463,0.000625743,0.00008053118,0.00022568852,0.0003401044],"domain_scores_gemma":[0.9950309,0.0038523176,0.00050315366,0.00012968342,0.0003301791,0.00015378934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020881041,0.00006314493,0.00033972194,0.000024309862,0.0005866598,0.00001607411,0.00015579711,0.00010417697,0.0009111698],"category_scores_gemma":[0.0056453682,0.00004004562,0.00005025099,0.000079123995,0.00024401711,0.00008877953,0.000016313337,0.00088191713,0.000085762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008722638,0.00054577825,0.06887233,0.0005665723,0.00040541176,0.044958744,0.0026642343,0.0000050342687,0.000050395764,0.23005565,0.6412842,0.009719359],"study_design_scores_gemma":[0.0013897261,0.00023355866,0.0013835025,0.00042679426,0.00004705109,0.08104712,0.008097581,0.0000012973728,0.000031993746,0.0042162086,0.9030564,0.00006880019],"about_ca_topic_score_codex":0.00010108399,"about_ca_topic_score_gemma":0.0006984935,"teacher_disagreement_score":0.26177213,"about_ca_system_score_codex":0.000025949692,"about_ca_system_score_gemma":0.00066469493,"threshold_uncertainty_score":0.997667},"labels":[],"label_agreement":null},{"id":"W2085164828","doi":"10.1046/j.0007-1048.2002.03354.x","title":"<i>Ex vivo</i> expansion of megakaryocyte progenitor cells from normal bone marrow and peripheral blood and from patients with haematological malignancies","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Megakaryocyte; Bone marrow; Progenitor cell; Haematopoiesis; Thrombopoietin; CD34; Multiple myeloma; Medicine; Immunology; Myeloid; Ex vivo; Stem cell; Transplantation; Neutropenia; Cytokine; Stem cell factor; Interleukin 3; Cancer research; Biology; Internal medicine; In vivo; Chemotherapy; T cell; Immune system","score_opus":0.007064586933197078,"score_gpt":0.19004046394547114,"score_spread":0.18297587701227405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085164828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98139304,0.017906018,0.00002281151,0.00014802207,0.000099896795,0.00022929136,0.00012683225,0.000010095613,0.00006399403],"genre_scores_gemma":[0.9943692,0.0016140818,0.0037672268,0.00013513434,0.000035352376,0.0000039930464,0.000019338484,0.000019913148,0.00003574539],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99858505,0.00007656167,0.00056518696,0.00023434288,0.0002829394,0.00025594057],"domain_scores_gemma":[0.99904555,0.000086009146,0.00039062678,0.000105795174,0.00017511536,0.00019687427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056065062,0.00019270724,0.001136397,0.00006504865,0.0000717682,0.000027343156,0.00006667819,0.0001654222,0.00029952207],"category_scores_gemma":[0.000038140905,0.00015695687,0.000083616775,0.000060210437,0.00026943622,0.00017238795,0.000047689336,0.00020485205,0.0000019574895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025516988,0.003538635,0.6589124,0.00028731083,0.0016493927,0.3015816,0.00092905,0.0000021060662,0.016935382,0.000027198821,0.0032979643,0.010287234],"study_design_scores_gemma":[0.059328042,0.007505027,0.2506483,0.0032693308,0.003162577,0.5687302,0.0007565924,0.00016771903,0.10406828,0.00058668846,0.000880605,0.0008966531],"about_ca_topic_score_codex":0.00019522688,"about_ca_topic_score_gemma":0.00005957381,"teacher_disagreement_score":0.40826416,"about_ca_system_score_codex":0.00001043431,"about_ca_system_score_gemma":0.000027829505,"threshold_uncertainty_score":0.64005154},"labels":[],"label_agreement":null},{"id":"W2085190236","doi":"10.1111/j.1365-2141.2004.05199.x","title":"Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fluorescence in situ hybridization; Multiple myeloma; Biology; Chromosomal translocation; Pathology; Immunoglobulin heavy chain; Central nervous system; Immunofluorescence; Chromosome 13; Interphase; Immunoglobulin light chain; Cancer research; Molecular biology; Antibody; Chromosome; Genetics; Immunology; Gene; Medicine; Endocrinology","score_opus":0.015568707168997865,"score_gpt":0.2584159840179656,"score_spread":0.24284727684896776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085190236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916598,0.006040802,0.00070072815,0.000517196,0.00038247276,0.00035288936,0.00006176782,0.000033526685,0.00025081672],"genre_scores_gemma":[0.9917085,0.0005203896,0.007418657,0.00005111004,0.0001893053,0.0000116533665,0.00003293635,0.00003330786,0.000034142962],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99750197,0.00015193093,0.0010037211,0.00021517779,0.0005059897,0.0006212067],"domain_scores_gemma":[0.9980838,0.00014331909,0.00050638727,0.00022567615,0.00057174877,0.0004691277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002353324,0.00018342392,0.0010126893,0.00028274377,0.00014561016,0.00002857726,0.00022348294,0.00017980336,0.00011476142],"category_scores_gemma":[0.0006720608,0.00018270526,0.00028746141,0.00024610988,0.00023243505,0.0001941755,0.00005413517,0.00045203074,0.000025522451],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090052444,0.003325274,0.24083258,0.003236593,0.0025580355,0.6611275,0.00067270745,0.00031491445,0.05293812,0.010613661,0.0013191587,0.022160945],"study_design_scores_gemma":[0.012807667,0.00096987217,0.3098903,0.003440262,0.00028992546,0.65945953,0.0004666453,0.00007770906,0.011568369,0.0007312038,0.00008037019,0.00021815037],"about_ca_topic_score_codex":0.0025045038,"about_ca_topic_score_gemma":0.0006864447,"teacher_disagreement_score":0.06905771,"about_ca_system_score_codex":0.00033578323,"about_ca_system_score_gemma":0.0005448145,"threshold_uncertainty_score":0.74505043},"labels":[],"label_agreement":null},{"id":"W2085230960","doi":"10.1046/j.1365-2141.2002.03479.x","title":"Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen‐induced platelet aggregation by nitroprusside*","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Heart and Stroke Foundation of Canada","keywords":"Adenylyl cyclase; Protein kinase A; Platelet; Chemistry; Soluble guanylyl cyclase; Internal medicine; Endocrinology; cGMP-dependent protein kinase; Cyclic nucleotide; Forskolin; Kinase; Biochemistry; Enzyme; Biology; Receptor; Nucleotide; Guanylate cyclase; Mitogen-activated protein kinase kinase; Medicine","score_opus":0.020051450754191,"score_gpt":0.2610448748605599,"score_spread":0.24099342410636887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085230960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991257,0.0067403903,0.00006230591,0.0013546402,0.000044421347,0.00034401944,0.000024084435,0.0000042566326,0.00016885636],"genre_scores_gemma":[0.9972579,0.0020673547,0.00027846883,0.0002938033,0.000025541789,0.000013140454,0.000022677163,0.000012130248,0.00002901792],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9989656,0.0000904068,0.00050097064,0.0001112643,0.00015615368,0.000175559],"domain_scores_gemma":[0.9993035,0.00014388711,0.00035736884,0.00007152764,0.000070553615,0.000053153595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021735382,0.00009669391,0.0005435154,0.00012580582,0.00006183616,0.000018910087,0.000051335337,0.00011899256,0.00003079616],"category_scores_gemma":[0.00015562585,0.00008114778,0.00008086722,0.000117737785,0.00007790381,0.00010439663,0.0000086181335,0.00012427983,0.0000019139952],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028607599,0.008389457,0.050722364,0.0014688662,0.0017151849,0.1632721,0.0066701993,0.000020425725,0.13265492,0.0011270687,0.12913185,0.50196683],"study_design_scores_gemma":[0.031840708,0.0027175322,0.026294906,0.002152541,0.0005029534,0.8798705,0.0016110784,0.0002610896,0.041832052,0.008338038,0.0041655237,0.00041311444],"about_ca_topic_score_codex":0.000075935655,"about_ca_topic_score_gemma":0.00028774524,"teacher_disagreement_score":0.7165984,"about_ca_system_score_codex":0.000022056773,"about_ca_system_score_gemma":0.00001929926,"threshold_uncertainty_score":0.33091104},"labels":[],"label_agreement":null},{"id":"W2085276059","doi":"10.1111/bjh.12343","title":"<scp>B</scp>‐cell lymphoma, unclassifiable, with features intermediate between diffuse large <scp>B</scp>‐cell lymphoma and burkitt lymphoma: study of 39 cases","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"BCL6; Lymphoma; Medicine; International Prognostic Index; Diffuse large B-cell lymphoma; Immunohistochemistry; Fluorescence in situ hybridization; Pathology; Stage (stratigraphy); B-cell lymphoma; Internal medicine; Oncology; B cell; Gastroenterology; Immunology; Biology; Gene; Antibody; Chromosome","score_opus":0.010707840875849922,"score_gpt":0.2343592752815923,"score_spread":0.2236514344057424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085276059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97909594,0.017032426,0.0000215575,0.0001261235,0.0003688533,0.001280653,0.00012488554,0.00006268353,0.0018868804],"genre_scores_gemma":[0.9946997,0.0022101952,0.00045609812,0.0003726368,0.00030014984,0.00011385287,0.000049757884,0.00013349649,0.0016640911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948747,0.00042701242,0.0017516712,0.0007845625,0.0009625584,0.0011994719],"domain_scores_gemma":[0.9932388,0.0027186144,0.0016779682,0.000614845,0.0008262998,0.0009234596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004739237,0.0007724576,0.0028654127,0.0006122615,0.0003048194,0.00022309345,0.0004992434,0.00047868097,0.00003429087],"category_scores_gemma":[0.00083794777,0.00064495276,0.00037398734,0.00046750103,0.0004885881,0.00048498804,0.00032084994,0.00026610526,0.00004597712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018866293,0.04422823,0.71987563,0.0009915882,0.0024491833,0.14343035,0.0043192003,0.0000033692313,0.0002730055,0.00006561539,0.064993285,0.019181892],"study_design_scores_gemma":[0.07550513,0.0061775544,0.7145088,0.001113072,0.0019879404,0.17857783,0.011849265,0.000017887722,0.0048113638,0.00013704455,0.0051061907,0.00020796334],"about_ca_topic_score_codex":0.0018548981,"about_ca_topic_score_gemma":0.00045389193,"teacher_disagreement_score":0.075316474,"about_ca_system_score_codex":0.0003706935,"about_ca_system_score_gemma":0.00075384695,"threshold_uncertainty_score":0.9996002},"labels":[],"label_agreement":null},{"id":"W2085359619","doi":"10.1111/j.1365-2141.2007.06913.x","title":"The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Applied Materials","keywords":"Aurora inhibitor; Aurora B kinase; Aurora kinase; Multiple myeloma; Plasma Cell Myeloma; Aurora A kinase; Cancer research; Apoptosis; Kinase; Medicine; Cell cycle; Biology; Internal medicine; Cell; Cancer; Cytokinesis; Cell biology; Cell division; Biochemistry","score_opus":0.007704250812778182,"score_gpt":0.24970108456124435,"score_spread":0.24199683374846617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085359619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669009,0.0064689815,0.025296053,0.00041990317,0.00053244235,0.00028539627,0.000032471937,0.0000044862322,0.00005939804],"genre_scores_gemma":[0.99361205,0.001520739,0.0030055277,0.00032048332,0.000805729,0.000008097077,0.000020905054,0.000027988279,0.00067846203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998833,0.00005109416,0.00045777916,0.00019725533,0.000094511095,0.00036633972],"domain_scores_gemma":[0.9990867,0.00006658618,0.0002926466,0.000140204,0.00026970726,0.00014417025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027709999,0.00014295295,0.00028458086,0.000044247077,0.00021604824,0.000048048812,0.00019631944,0.00019295531,0.0000062262193],"category_scores_gemma":[0.00017102392,0.00012449591,0.00028589406,0.000057040128,0.00009258619,0.0000062068225,0.00004282454,0.00011464395,0.0000025373529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029280582,0.00055441045,0.0011757942,0.000039166207,0.0009700386,0.005060345,0.00029552137,0.000034741508,0.6160345,0.0001803838,0.12420518,0.24852188],"study_design_scores_gemma":[0.005314565,0.0022606878,0.0010348026,0.00006689485,0.00014940514,0.07750937,0.00030454574,0.00007091448,0.66669935,0.00045954582,0.24584194,0.00028800702],"about_ca_topic_score_codex":0.00007594815,"about_ca_topic_score_gemma":0.0011598554,"teacher_disagreement_score":0.24823387,"about_ca_system_score_codex":0.000041424526,"about_ca_system_score_gemma":0.00024162525,"threshold_uncertainty_score":0.50767964},"labels":[],"label_agreement":null},{"id":"W2085371417","doi":"10.1046/j.1365-2141.2003.04068.x","title":"Hemolink™, an <i>o</i>‐raffinose cross‐linked haemoglobin‐based oxygen carrier, does not affect activation and function of human platelets in whole blood <i>in vitro</i>","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Whole blood; Platelet activation; Chemistry; Flow cytometry; Annexin; Andrology; Phosphatidylserine; CD63; In vitro; Blood substitute; Hemoglobin; Immunology; Endocrinology; Biochemistry; Medicine; Phospholipid; Membrane","score_opus":0.00817003747731621,"score_gpt":0.2516014473007202,"score_spread":0.243431409823404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085371417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984852,0.00060849875,0.00031468424,0.00005127133,0.00027238662,0.00017948654,0.000022987822,0.0000053402578,0.000060133672],"genre_scores_gemma":[0.99907124,0.000066728906,0.00037794828,0.00025940404,0.00009251305,0.000004682432,0.000078312216,0.000021943764,0.000027199489],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832135,0.00030396905,0.0006563128,0.00029911945,0.00015117292,0.00026808184],"domain_scores_gemma":[0.9991037,0.00003322518,0.0003955976,0.00016907869,0.0001999182,0.00009845062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005023384,0.00017357897,0.00048765438,0.00016759525,0.00007534838,0.00003619897,0.00011852061,0.00038035796,0.000011812197],"category_scores_gemma":[0.00021639981,0.00017826067,0.00009034898,0.00015990355,0.00014042083,0.000038008122,0.000023408156,0.00028785662,2.7888848e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007375467,0.00022263397,0.005529169,0.00006885014,0.000043538952,0.0006336476,0.000037016336,0.00016141609,0.99006295,0.00003067307,0.00009248376,0.0023800565],"study_design_scores_gemma":[0.004254493,0.00080441043,0.015780168,0.00011766569,0.000039527975,0.007215925,0.00007067732,0.00002397648,0.97052395,0.00024640202,0.0007268119,0.00019597176],"about_ca_topic_score_codex":0.00007126599,"about_ca_topic_score_gemma":0.00028263437,"teacher_disagreement_score":0.019538997,"about_ca_system_score_codex":0.000019151612,"about_ca_system_score_gemma":0.00012759907,"threshold_uncertainty_score":0.7269259},"labels":[],"label_agreement":null},{"id":"W2087700674","doi":"10.1111/bjh.12274","title":"The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo‐controlled, Phase <scp>III</scp> study in patients with myelofibrosis","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Placebo; Internal medicine; Randomization; International Prognostic Scoring System; Population; Polycythaemia; Gastroenterology; Clinical trial; Surgery; Myelodysplastic syndromes; Bone marrow; Pathology","score_opus":0.01525759521435154,"score_gpt":0.31945351406109845,"score_spread":0.3041959188467469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087700674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964891,0.0012000373,0.00001685894,0.00012202079,0.00011594541,0.0018998309,0.00006574833,0.0000048702423,0.000085595464],"genre_scores_gemma":[0.99901766,0.0003861478,0.00026690724,0.00008547468,0.000028360135,0.00015236744,0.000016971137,0.000021436712,0.000024700243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99539286,0.00047052524,0.0027364357,0.0003020692,0.00064807927,0.0004500165],"domain_scores_gemma":[0.9937144,0.0023875595,0.0019962427,0.00031345803,0.0013534701,0.00023488683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009733957,0.0002473009,0.0029285864,0.00028988157,0.00011503801,0.00004426667,0.00020462889,0.00014126478,0.000044980643],"category_scores_gemma":[0.0010558286,0.00016235841,0.00057567057,0.0005677966,0.00032425963,0.00013588945,0.000075213895,0.0003730443,0.0000029724047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040404215,0.011724816,0.9575634,0.000033601,0.006253044,0.0012478161,0.0013346917,0.000035446097,0.0000047810763,0.00004740422,0.00032806484,0.017386533],"study_design_scores_gemma":[0.07965677,0.011116095,0.90121263,0.00036467746,0.0024581943,0.000904132,0.0038193727,0.00008552207,0.00022987831,0.000038773494,0.000044571574,0.00006936784],"about_ca_topic_score_codex":0.0004298924,"about_ca_topic_score_gemma":0.0012782605,"teacher_disagreement_score":0.07561635,"about_ca_system_score_codex":0.00005775711,"about_ca_system_score_gemma":0.00012450875,"threshold_uncertainty_score":0.6620784},"labels":[],"label_agreement":null},{"id":"W2088430322","doi":"10.1111/j.1365-2141.2006.06259.x","title":"JSI‐124 (cucurbitacin I) inhibits Janus kinase‐3/signal transducer and activator of transcription‐3 signalling, downregulates nucleophosmin‐anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK‐positive anaplastic large cell lymphoma cells","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Janus kinase; STAT protein; Cancer research; Lymphoma; Apoptosis; Nucleophosmin; Kinase; Anaplastic thyroid cancer; Janus kinase 2; STAT3; Medicine; Chemistry; Biology; Immunology; Internal medicine; Cell biology; Lung cancer; Cancer","score_opus":0.007720805082192493,"score_gpt":0.21861174935908956,"score_spread":0.21089094427689706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088430322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929325,0.0052138735,0.00054779486,0.00021100027,0.0002749291,0.00034035151,0.00021551125,0.00001985365,0.00024420823],"genre_scores_gemma":[0.99846965,0.0005711745,0.0005694532,0.00011144306,0.00014762566,0.0000107736605,0.000029533208,0.00005570094,0.00003467207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969651,0.000218327,0.0014089615,0.00045525507,0.00039348495,0.00055884314],"domain_scores_gemma":[0.99807495,0.0004812947,0.0006610738,0.00012478889,0.0003639704,0.00029390928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036226577,0.00039282194,0.0013465254,0.00068994676,0.00016757316,0.00008123305,0.00013593094,0.00032092314,0.00016675051],"category_scores_gemma":[0.000064864354,0.00041684962,0.0002412289,0.00038958335,0.0003185898,0.0004141629,0.00003379274,0.00037738658,0.0000035376938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018495631,0.0026876507,0.0007569305,0.00056465156,0.0002169342,0.005878907,0.0008775016,0.00007645702,0.9813222,0.00014818914,0.00056930777,0.005051708],"study_design_scores_gemma":[0.014663907,0.0023668841,0.014128216,0.0029312968,0.0005620531,0.036582492,0.00093124295,0.00038310204,0.9264068,0.0002682605,0.0003458379,0.00042991765],"about_ca_topic_score_codex":0.0007788328,"about_ca_topic_score_gemma":0.0005365416,"teacher_disagreement_score":0.05491541,"about_ca_system_score_codex":0.00011393025,"about_ca_system_score_gemma":0.00024571194,"threshold_uncertainty_score":0.99982834},"labels":[],"label_agreement":null},{"id":"W2089213155","doi":"10.1046/j.1365-2141.2001.02833.x","title":"The storage defects in grey platelet syndrome and αδ‐storage pool deficiency affect α‐granule factor V and multimerin storage without altering their proteolytic processing","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Platelet; Platelet factor 4; Immunology; Biology","score_opus":0.013293789583400353,"score_gpt":0.2573305787923217,"score_spread":0.24403678920892133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089213155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774732,0.021178544,0.00034021688,0.00014727918,0.00009835067,0.00067791913,0.000007375391,0.000021947022,0.00005515835],"genre_scores_gemma":[0.9981324,0.0014459321,0.0002574474,0.00005547048,0.000018584375,0.000020177804,0.0000027060707,0.000036170055,0.000031088824],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983683,0.00014946787,0.0005096307,0.00027849752,0.00021134013,0.00048274724],"domain_scores_gemma":[0.9991114,0.00014464886,0.00034478636,0.00012737373,0.00008080595,0.00019095655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035517057,0.00024837028,0.00091332296,0.0001890502,0.00026629318,0.00011844427,0.000119417804,0.00013513968,0.0000134499705],"category_scores_gemma":[0.00019675415,0.00019118447,0.00008098727,0.00018223064,0.00021626463,0.0002786197,0.000057151425,0.00048154686,0.000002221736],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009840726,0.00080533384,0.15848035,0.0008472215,0.00025742207,0.6974438,0.0020321445,0.00006277773,0.0029501861,0.000012065058,0.000049209335,0.13607544],"study_design_scores_gemma":[0.004792185,0.00075450446,0.17997488,0.0011480841,0.0000705064,0.8108396,0.00035239354,0.0013546303,0.00027970484,0.00013922482,0.000079753234,0.00021452823],"about_ca_topic_score_codex":0.00012880888,"about_ca_topic_score_gemma":0.00031361918,"teacher_disagreement_score":0.13586092,"about_ca_system_score_codex":0.00007093827,"about_ca_system_score_gemma":0.00009668631,"threshold_uncertainty_score":0.7796277},"labels":[],"label_agreement":null},{"id":"W2089259280","doi":"10.1111/bjh.13294","title":"A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Phlebotomy; Observational study; Intensive care medicine; Disease; Blood transfusion; Internal medicine","score_opus":0.010601842450553662,"score_gpt":0.26473717627003096,"score_spread":0.2541353338194773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089259280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92442876,0.056428943,0.000004669652,0.017701617,0.00043219485,0.0005187189,0.00007648281,0.000028618939,0.0003800144],"genre_scores_gemma":[0.97635955,0.012348507,0.00013238944,0.010047115,0.00037114773,0.0000097816455,0.00033851815,0.00009751808,0.00029544998],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973446,0.00026618515,0.0012253114,0.00027331893,0.00047709185,0.0004134785],"domain_scores_gemma":[0.99838716,0.000061107814,0.0008095766,0.00016440188,0.0003296121,0.00024812092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023767739,0.00026875318,0.001644217,0.00038965142,0.000039950235,0.00001468604,0.00015843147,0.0008951247,0.00010171489],"category_scores_gemma":[0.00006915048,0.000272657,0.00019562306,0.0001685495,0.00019536259,0.00006751426,0.000051850373,0.0018429935,0.000003870061],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046733738,0.0024549018,0.02157251,0.006395869,0.00013957845,0.10027965,0.00062597916,0.000013066413,0.00011523256,2.6757544e-7,0.8652931,0.0026425137],"study_design_scores_gemma":[0.18333219,0.023754546,0.06261178,0.0421293,0.012751609,0.21027085,0.0019742628,0.0050905105,0.0026910224,0.0003566321,0.45137995,0.0036573405],"about_ca_topic_score_codex":0.00014035277,"about_ca_topic_score_gemma":0.000052549512,"teacher_disagreement_score":0.41391313,"about_ca_system_score_codex":0.00008167577,"about_ca_system_score_gemma":0.0004146516,"threshold_uncertainty_score":0.9999726},"labels":[],"label_agreement":null},{"id":"W2089776693","doi":"10.1111/j.1365-2141.2008.07243.x","title":"Clinical features and outcome of pulmonary embolism in children","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Medicine; Pulmonary embolism; Thrombolysis; Deep vein; Thrombosis; Surgery; Prospective cohort study; Pediatrics; Venous thrombosis; Inferior vena cava; Coagulopathy; Inferior vena cava filter; Internal medicine","score_opus":0.023713961668551435,"score_gpt":0.3164160708316388,"score_spread":0.29270210916308737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089776693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887364,0.009484287,0.000013691691,0.0007827142,0.00017950371,0.00016660376,0.0000030366464,0.000005061906,0.00062868884],"genre_scores_gemma":[0.9861877,0.012432136,0.0006436753,0.0005440689,0.00011350491,0.0000017853469,0.000002185184,0.000011828512,0.000063143554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998455,0.00010277453,0.0009613959,0.00013296283,0.00017110903,0.00017674672],"domain_scores_gemma":[0.99926275,0.00008337984,0.0003464777,0.000103078135,0.00009006533,0.00011427099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044933675,0.0000870688,0.0012032224,0.00017289135,0.000033509594,0.000004789259,0.00010038196,0.00012714863,0.000040878185],"category_scores_gemma":[0.00022425347,0.00008599823,0.00015361916,0.0000851,0.00023612587,0.00006528921,0.000064314314,0.00036190907,0.0000019559866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053160136,0.0007772363,0.9493388,0.00006592207,0.00014128987,0.029261908,0.000064050764,0.0000014163725,0.000011818982,0.0002970546,0.0051078643,0.0148794865],"study_design_scores_gemma":[0.0010456949,0.00014274781,0.6615705,0.00017299924,0.00006952313,0.3365363,0.00003373502,0.000001952183,0.00001680223,0.00013064666,0.00023450988,0.000044631495],"about_ca_topic_score_codex":0.00018994325,"about_ca_topic_score_gemma":0.00003071687,"teacher_disagreement_score":0.30727437,"about_ca_system_score_codex":0.000010447545,"about_ca_system_score_gemma":0.000044868968,"threshold_uncertainty_score":0.35069063},"labels":[],"label_agreement":null},{"id":"W2089902119","doi":"10.1111/j.1365-2141.2006.06325.x","title":"Multiple myeloma patients with <i>CKS1B</i> gene amplification have a shorter progression‐free survival post‐autologous stem cell transplantation","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"Cancer Research Society","keywords":"Multiple myeloma; Gastroenterology; Fluorescence in situ hybridization; Internal medicine; Transplantation; Autologous stem-cell transplantation; Medicine; Bone marrow; Beta-2 microglobulin; Pathology; Biology; Oncology; Immunology; Chromosome; Gene","score_opus":0.011202216900912006,"score_gpt":0.251527055066778,"score_spread":0.24032483816586603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089902119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585605,0.0008375514,0.001675096,0.00027712522,0.00013369077,0.0006668938,0.00015629394,0.000030242616,0.00036707125],"genre_scores_gemma":[0.9949982,0.00013468432,0.0041495916,0.00007538598,0.000085715394,0.000026450203,0.00037566503,0.000038009486,0.00011629549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767387,0.00019771617,0.00069544575,0.00027930466,0.00071645255,0.00043723042],"domain_scores_gemma":[0.99811697,0.00015567685,0.00044167836,0.00023768337,0.0008219893,0.00022600302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021414929,0.00020370235,0.0006349496,0.00019886774,0.00014563499,0.00005202816,0.00018921973,0.00016103566,0.00004043293],"category_scores_gemma":[0.00004556121,0.00017163201,0.00013790253,0.00012277246,0.00014569069,0.00019902187,0.000024582163,0.0003142214,0.000013136779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050704223,0.002350723,0.8571279,0.0003235913,0.00025298444,0.06861195,0.00015168844,0.000016454773,0.0024739308,0.000022221706,0.001141101,0.062457036],"study_design_scores_gemma":[0.014467488,0.001448634,0.9115669,0.00035795322,0.00023053467,0.06117533,0.00008876955,0.00006465228,0.0101786535,0.00005898486,0.00017333285,0.00018875363],"about_ca_topic_score_codex":0.00021777525,"about_ca_topic_score_gemma":0.00049478986,"teacher_disagreement_score":0.062268283,"about_ca_system_score_codex":0.000081111495,"about_ca_system_score_gemma":0.00016817031,"threshold_uncertainty_score":0.699895},"labels":[],"label_agreement":null},{"id":"W2091264926","doi":"10.1111/j.1365-2141.2010.08387.x","title":"Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Clofarabine; Medicine; Cytarabine; Internal medicine; Refractory (planetary science); Nucleoside analogue; Fludarabine; Oncology; Regimen; Gastroenterology; Chemotherapy; Nucleoside; Biology","score_opus":0.02900181210569678,"score_gpt":0.37947960225634775,"score_spread":0.35047779015065095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091264926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507976,0.0008520437,0.00023432994,0.000353974,0.0011644033,0.0021355862,0.000051939995,0.000023563101,0.00010438281],"genre_scores_gemma":[0.99512976,0.00069784216,0.002971125,0.0001750162,0.0005696701,0.00008628649,0.000021958118,0.00006784611,0.000280492],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961395,0.0003124361,0.0018951778,0.00043621752,0.000593227,0.0006234157],"domain_scores_gemma":[0.9958457,0.001424488,0.001067252,0.00043516647,0.00075529405,0.0004721028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021205049,0.00028601632,0.002220821,0.00042179303,0.00013412136,0.000036414232,0.00036984158,0.00050030026,0.00020412065],"category_scores_gemma":[0.0031422332,0.0002504231,0.0003067627,0.00028120462,0.00072105933,0.00019154577,0.00014100772,0.0010338635,0.0000057015277],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63807434,0.014403164,0.0003750248,0.0010415161,0.0029852414,0.22963148,0.0016920109,0.0000032179498,0.033194266,0.00026457643,0.0073825056,0.07095263],"study_design_scores_gemma":[0.5507755,0.0402341,0.00015209941,0.0002278473,0.0009766091,0.40124667,0.00058943394,0.00040693762,0.0008167915,0.00013151034,0.004256583,0.00018590606],"about_ca_topic_score_codex":0.00055397896,"about_ca_topic_score_gemma":0.0010994553,"teacher_disagreement_score":0.1716152,"about_ca_system_score_codex":0.0026296866,"about_ca_system_score_gemma":0.012276506,"threshold_uncertainty_score":0.9999948},"labels":[],"label_agreement":null},{"id":"W2091563004","doi":"10.1111/j.1365-2141.2005.05782.x","title":"Inhibition and reversal of platelet aggregation by <i>α</i>IIb<i>β</i>3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban","year":2005,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Abciximab; Platelet aggregation; Platelet; Anticoagulant; Medicine; Pharmacology; Differential effects; Differential (mechanical device); Internal medicine; Physics","score_opus":0.004715397502538273,"score_gpt":0.22600456104123742,"score_spread":0.22128916353869915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091563004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462,0.0040921625,0.00007800867,0.0008556829,0.00005466806,0.00020442174,0.00005991452,0.0000038873086,0.000031225954],"genre_scores_gemma":[0.99488974,0.004671849,0.00020923441,0.00015310512,0.000021717899,0.0000023703346,0.00003364029,0.000009363172,0.000008994844],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99915934,0.00008077438,0.00036564676,0.00011756435,0.00015451181,0.00012214422],"domain_scores_gemma":[0.9992878,0.00019839998,0.0003138022,0.00006015368,0.00007345844,0.000066381515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009406215,0.000105481224,0.00055523263,0.00008079597,0.000072656956,0.000016108206,0.000026208598,0.000093008726,0.0000135035925],"category_scores_gemma":[0.000084644766,0.0000856766,0.000046768066,0.00004608905,0.00023326205,0.00010166279,0.000018704386,0.00015102848,3.5989538e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063592247,0.007986079,0.04080557,0.005822502,0.0040876647,0.12221867,0.0027517101,0.000012463378,0.33604112,0.00396673,0.03860921,0.43133906],"study_design_scores_gemma":[0.025547057,0.0031732186,0.039288003,0.0044946587,0.0008974138,0.5113832,0.0002592013,0.0006072414,0.4117916,0.0018824476,0.00037985417,0.00029611742],"about_ca_topic_score_codex":0.000025767486,"about_ca_topic_score_gemma":0.000020326695,"teacher_disagreement_score":0.43104294,"about_ca_system_score_codex":0.000011426019,"about_ca_system_score_gemma":0.000022860106,"threshold_uncertainty_score":0.34937903},"labels":[],"label_agreement":null},{"id":"W2092353327","doi":"10.1046/j.1365-2141.2000.01935.x","title":"Mastocytosis cells bearing a c‐<i>kit</i> activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Stem cell factor; Cutaneous Mastocytosis; Systemic mastocytosis; Proto-Oncogene Proteins c-kit; Stem cell; Bone marrow; Progenitor cell; Cancer research; Immunology; Tryptase; Biology; Mast cell; Pathology; Medicine; Cell biology","score_opus":0.007191897665352768,"score_gpt":0.18969529693887657,"score_spread":0.1825033992735238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092353327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997121,0.001575956,0.000240097,0.00018628438,0.00019848143,0.00024084422,0.00013527433,0.000022949023,0.00027916537],"genre_scores_gemma":[0.99839,0.0003048516,0.00032964355,0.00033223737,0.000033816108,0.000008642526,0.000018808007,0.000026189222,0.0005557809],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835414,0.00034897588,0.0005931687,0.0002715064,0.00006394754,0.00036827778],"domain_scores_gemma":[0.9989877,0.00019434723,0.00048258263,0.000109316985,0.00012658979,0.00009949794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025648874,0.00019701137,0.0007786382,0.00013017641,0.00022217809,0.00005646798,0.00012555093,0.00022432746,0.0006775787],"category_scores_gemma":[0.000023221539,0.0002224843,0.00011611167,0.00010453326,0.000108207685,0.00018625525,0.000048610244,0.00041300486,0.00006242577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034631795,0.00016882838,0.00019518078,0.00008785942,0.0000879108,0.00082861114,0.00037339612,0.0000017469849,0.88942003,0.0000016814618,0.0008795294,0.10760893],"study_design_scores_gemma":[0.003242334,0.00036333915,0.0032629329,0.00031708076,0.00008283536,0.03930249,0.000757055,0.00000452424,0.93529147,0.0000062550353,0.01701431,0.0003553589],"about_ca_topic_score_codex":0.0002537256,"about_ca_topic_score_gemma":0.000031659074,"teacher_disagreement_score":0.10725357,"about_ca_system_score_codex":0.000045180124,"about_ca_system_score_gemma":0.000035443332,"threshold_uncertainty_score":0.90726465},"labels":[],"label_agreement":null},{"id":"W2093653074","doi":"10.1111/j.1365-2141.2010.08076.x","title":"The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases","year":2010,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research","keywords":"Rituximab; Immunology; Autoimmunity; Medicine; CD20; Immune system; Antibody; Immunity","score_opus":0.012633628985397128,"score_gpt":0.3038136764428474,"score_spread":0.2911800474574503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093653074","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.405357,0.5941245,9.1042885e-8,0.000021805608,0.00011054153,0.00031837425,0.000030975443,0.0000021625729,0.000034562883],"genre_scores_gemma":[0.104358,0.8955437,0.000002236893,0.000005885649,0.000031921696,0.000014672797,0.000021007298,0.0000139180365,0.000008682917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793416,0.0008266668,0.0008088137,0.00010546425,0.0001670734,0.00015780645],"domain_scores_gemma":[0.9972563,0.0015636479,0.0008645475,0.00018166994,0.000055443135,0.000078388024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003824898,0.00020560807,0.0020815963,0.00016793728,0.000097606455,0.000016876764,0.000103088874,0.00026849913,0.000008107901],"category_scores_gemma":[0.00030938155,0.00010299232,0.00036261982,0.0001309656,0.00043963944,0.000029036344,0.000020753727,0.0005737102,8.0857325e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005046269,0.0018128912,0.0029840132,0.007381639,0.00048751934,0.0061882576,0.000089368994,1.6062646e-7,0.00000866659,0.000020866632,0.000093606744,0.9804284],"study_design_scores_gemma":[0.02992353,0.02691755,0.09990858,0.068209805,0.022692747,0.36044243,0.00012478992,0.000012507529,0.0002257812,0.00017935464,0.39074832,0.0006146069],"about_ca_topic_score_codex":0.0003483855,"about_ca_topic_score_gemma":0.00005872371,"teacher_disagreement_score":0.97981375,"about_ca_system_score_codex":0.000027174714,"about_ca_system_score_gemma":0.000153899,"threshold_uncertainty_score":0.4199905},"labels":[],"label_agreement":null},{"id":"W2094323365","doi":"10.1111/j.1365-2141.2006.06134.x","title":"The status of new anticoagulants","year":2006,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Intensive care medicine; Internal medicine","score_opus":0.04987724414517279,"score_gpt":0.3572936881835021,"score_spread":0.3074164440383293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094323365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044454122,0.99700487,0.00004149161,0.00011345147,0.0006811844,0.0004263173,0.000014074625,0.000006538323,0.0012675542],"genre_scores_gemma":[0.00007833543,0.99866545,0.00031458595,0.000055735985,0.0003001496,0.0000040818923,0.000013539403,0.0000397242,0.0005283778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722755,0.00015883184,0.0015768466,0.00015143253,0.00034304446,0.000542297],"domain_scores_gemma":[0.9973955,0.00024323905,0.0016801807,0.00024638968,0.00019346493,0.00024120668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003578746,0.00021238094,0.0041619153,0.00017606263,0.00007672052,0.000037530564,0.00029002075,0.00021352347,0.00006471989],"category_scores_gemma":[0.00032085142,0.0001530604,0.00076063763,0.00016607123,0.00015059399,0.000037542744,0.00008238467,0.00048370476,0.000015018832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007011772,0.00019179414,0.000022330609,0.005894811,0.00067241146,0.013680389,0.000009910909,2.389441e-7,6.338496e-8,0.00034105912,0.15600201,0.82317793],"study_design_scores_gemma":[0.00048207925,0.00018770112,0.000299583,0.019731866,0.0025418487,0.14320704,0.00001811319,1.9636043e-7,0.0000010070501,0.00015305444,0.83328277,0.00009476903],"about_ca_topic_score_codex":0.00049787894,"about_ca_topic_score_gemma":0.00012357417,"teacher_disagreement_score":0.82308316,"about_ca_system_score_codex":0.000072556475,"about_ca_system_score_gemma":0.0009909688,"threshold_uncertainty_score":0.6241622},"labels":[],"label_agreement":null},{"id":"W2094898938","doi":"10.1111/j.1365-2141.2009.07844.x","title":"International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Children’s Oncology Group","keywords":"Cog; Medicine; Myeloid leukaemia; Randomized controlled trial; Pediatrics; Internal medicine; Family medicine","score_opus":0.009429926794853348,"score_gpt":0.29878695222045226,"score_spread":0.28935702542559893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094898938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465966,0.00022291849,0.0016343149,0.001233841,0.00050407543,0.00034489343,0.000028790922,0.000011515204,0.0013599966],"genre_scores_gemma":[0.9974006,0.00046873096,0.0015390473,0.00026565685,0.00020271946,0.000018673118,0.00005279991,0.0000093188255,0.00004248522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991161,0.0000434979,0.00040139403,0.000121793135,0.00016972919,0.00014747608],"domain_scores_gemma":[0.99825555,0.00007360481,0.00074233464,0.00005632898,0.0008037783,0.00006837673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011033236,0.00007890522,0.00030439204,0.0002648093,0.00006849405,0.000032470587,0.000060391027,0.000078810845,0.00006347625],"category_scores_gemma":[0.00025271004,0.000077605895,0.00008755464,0.00019869667,0.000026145972,0.00036855374,0.000008456838,0.00026703448,0.000002303093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019252063,0.0011879848,0.9098227,0.00009238358,0.00054334285,0.0063309683,0.0006708482,0.000074926385,0.0001897772,0.0007116239,0.005400497,0.07304972],"study_design_scores_gemma":[0.007134136,0.00220125,0.9202591,0.00019968118,0.0005248462,0.05972718,0.00014754327,0.000011923856,0.00025051343,0.0003182719,0.00909373,0.00013178482],"about_ca_topic_score_codex":0.00010560345,"about_ca_topic_score_gemma":0.00031927525,"teacher_disagreement_score":0.07291793,"about_ca_system_score_codex":0.00016168332,"about_ca_system_score_gemma":0.00028008316,"threshold_uncertainty_score":0.31646767},"labels":[],"label_agreement":null},{"id":"W2095095686","doi":"10.1046/j.1365-2141.2000.02064.x","title":"Management of kostmann syndrome in the g‐csf era","year":2000,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"University of Washington","keywords":"Neutropenia; Medicine; Absolute neutrophil count; Internal medicine; Granulocyte colony-stimulating factor; Transplantation; Congenital Neutropenia; Hematopoietic stem cell transplantation; Gastroenterology; Immunology; Chemotherapy","score_opus":0.013670857495450436,"score_gpt":0.2834793716767484,"score_spread":0.269808514181298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095095686","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007846801,0.99028677,0.0000062754348,0.000033186643,0.00011481632,0.00028423348,0.00002789499,0.0000010381574,0.0013990096],"genre_scores_gemma":[0.0053968923,0.9941152,0.00018578522,0.0000470542,0.000033290387,0.000019703053,0.000060245133,0.000023329692,0.000118546544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983536,0.00025651685,0.0008268283,0.00019617994,0.00015111532,0.00021573964],"domain_scores_gemma":[0.9991078,0.000021160913,0.00054900977,0.0002419966,0.00004304914,0.00003699901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025337955,0.00020214422,0.00121575,0.00010095246,0.00003050928,0.000020016287,0.0005222591,0.00026994638,0.00004071565],"category_scores_gemma":[0.000010518163,0.00016101894,0.00046932095,0.00013326397,0.00008804414,0.0000036281433,0.000063159736,0.00027361227,0.000008457652],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014802388,0.0003844849,0.000013388073,0.002848189,0.00079823,0.05220847,0.000008045029,0.0000010932835,1.0052696e-7,0.0000854412,0.0021531826,0.9414846],"study_design_scores_gemma":[0.0007092693,0.0002700044,0.00004564456,0.0063325074,0.0006693834,0.3012634,0.000034573244,5.440736e-8,0.0000025623688,0.00017450353,0.6903547,0.00014339642],"about_ca_topic_score_codex":0.000016956714,"about_ca_topic_score_gemma":0.000022091026,"teacher_disagreement_score":0.94134116,"about_ca_system_score_codex":0.000008213355,"about_ca_system_score_gemma":0.00008719061,"threshold_uncertainty_score":0.65661615},"labels":[],"label_agreement":null},{"id":"W2096608457","doi":"10.1111/bjh.12529","title":"Concurrent and separate inside‐out transition of platelet apoptosis and activation markers to the platelet surface","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; Pediatric Oncology Group; St. Michael's Hospital","funders":"","keywords":"Phosphatidylserine; Platelet; Chemistry; Apoptosis; Platelet activation; Thrombin; Stimulation; Biophysics; Membrane; Immunology; Endocrinology; Biochemistry; Phospholipid; Biology","score_opus":0.012785506952164629,"score_gpt":0.2571666617906231,"score_spread":0.24438115483845846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096608457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949013,0.0014202156,0.00027638488,0.0028277754,0.000101872516,0.0003585391,0.000012333326,0.000004752075,0.00009684645],"genre_scores_gemma":[0.99803054,0.0012972142,0.00024905676,0.00036489242,0.000015437476,0.0000045463853,0.000008233139,0.000009825709,0.00002027941],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.999143,0.00007444917,0.00037955336,0.000114646544,0.00013619749,0.00015212523],"domain_scores_gemma":[0.99935734,0.00010211298,0.00021234395,0.000058982172,0.00015417287,0.00011505839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015252113,0.00010074556,0.0005186859,0.000064689724,0.00006174366,0.000026500791,0.00004106428,0.00008322983,0.00005522622],"category_scores_gemma":[0.000045342942,0.00008124528,0.000050744235,0.00007069565,0.00009481354,0.00015443073,0.000015261263,0.00016284891,0.000005228049],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002274705,0.001510878,0.00718551,0.0010256743,0.003334394,0.018556174,0.01034733,0.00029487687,0.04411993,0.00022443234,0.056165557,0.85496056],"study_design_scores_gemma":[0.027775848,0.004936586,0.094312064,0.0037624983,0.00072643755,0.67678046,0.0058502876,0.0013292438,0.17505334,0.0015493339,0.0071259853,0.0007979352],"about_ca_topic_score_codex":0.00018568659,"about_ca_topic_score_gemma":0.000031019357,"teacher_disagreement_score":0.8541626,"about_ca_system_score_codex":0.000016083859,"about_ca_system_score_gemma":0.00003514713,"threshold_uncertainty_score":0.3313086},"labels":[],"label_agreement":null},{"id":"W2097952279","doi":"10.1111/bjh.12594","title":"Moderate endurance exercise in patients with sickle cell anaemia: effects on oxidative stress and endothelial activation","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agence Universitaire de la Francophonie","keywords":"Oxidative stress; Nitric oxide; Endothelial dysfunction; Medicine; Malondialdehyde; Endothelial activation; Internal medicine; Endothelium; Endocrinology; Cell adhesion molecule; Immunology","score_opus":0.002943902337246819,"score_gpt":0.19241244101686236,"score_spread":0.18946853867961555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097952279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983142,0.0006278197,0.000058013906,0.00024535906,0.00007370771,0.0004273375,0.000004572272,0.000005949511,0.00024306242],"genre_scores_gemma":[0.9989535,0.0005839145,0.0002380358,0.0001463427,0.000017096037,0.000009045182,0.000005207597,0.000014715297,0.000032119995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991722,0.000069060414,0.0002760299,0.00013148451,0.00016190222,0.0001893075],"domain_scores_gemma":[0.9993827,0.00007765671,0.00021161101,0.00006211645,0.00016770928,0.000098206714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005754415,0.00010806096,0.00044222135,0.000116666306,0.000044836383,0.000021318603,0.000044293967,0.00013010134,0.000024697109],"category_scores_gemma":[0.000060061568,0.00008990898,0.000030822834,0.00008981307,0.00006970326,0.00018100724,0.000012033769,0.00040178234,0.0000053240583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012857036,0.006739305,0.47346509,0.004018492,0.0005208477,0.032665413,0.003765208,0.0009802489,0.009045032,0.00019422878,0.0054203966,0.4503287],"study_design_scores_gemma":[0.038732406,0.003534942,0.82035357,0.014029444,0.00019287161,0.00727751,0.0008995633,0.00032388867,0.113553174,0.0005570018,0.00006362674,0.0004820285],"about_ca_topic_score_codex":0.00011458792,"about_ca_topic_score_gemma":0.0000099930085,"teacher_disagreement_score":0.44984666,"about_ca_system_score_codex":0.000028537743,"about_ca_system_score_gemma":0.000046275385,"threshold_uncertainty_score":0.36663815},"labels":[],"label_agreement":null},{"id":"W2101808775","doi":"10.1111/bjh.12076","title":"Increased leucocyte apoptosis in transfused β‐thalassaemia patients","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Victoria","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Deferasirox; Deferoxamine; Apoptosis; Medicine; DNA fragmentation; Deferiprone; Chelation therapy; Hematology; Immunology; Caspase 3; Gastroenterology; Blood transfusion; Internal medicine; Thalassemia; Programmed cell death; Biology; Biochemistry","score_opus":0.008318224324515469,"score_gpt":0.23547474104876845,"score_spread":0.22715651672425297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101808775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281615,0.004507891,0.000046140376,0.0004178594,0.00046891966,0.00016478068,0.0000038229305,0.000011988514,0.0015624443],"genre_scores_gemma":[0.9977999,0.0013102047,0.00033113387,0.0004283907,0.000071258066,0.000003148427,0.0000075084763,0.000021844195,0.000026644291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984174,0.00014340934,0.000683709,0.00010137954,0.00023482433,0.0004192916],"domain_scores_gemma":[0.9991976,0.00006814679,0.00021040849,0.000090774745,0.00015167998,0.000281405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038155692,0.00011887257,0.0006573895,0.00022011057,0.000044140947,0.000010561017,0.00009379507,0.0002543164,0.00017347738],"category_scores_gemma":[0.00027833236,0.00011854776,0.0001744306,0.00021552351,0.0000916393,0.0001788308,0.000014412604,0.0005652035,0.000019814881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006487971,0.0025967688,0.9487234,0.00023718702,0.00023316627,0.0066032307,0.00070243876,0.0000049533437,0.0009395322,0.00010922687,0.0072016255,0.031999696],"study_design_scores_gemma":[0.029768718,0.0010983817,0.71253836,0.002052353,0.00051651517,0.23447831,0.0011031096,0.000031725813,0.006483492,0.00018331996,0.011248585,0.0004971154],"about_ca_topic_score_codex":0.00019923136,"about_ca_topic_score_gemma":0.000030884494,"teacher_disagreement_score":0.23618501,"about_ca_system_score_codex":0.00007239528,"about_ca_system_score_gemma":0.00010624966,"threshold_uncertainty_score":0.48342374},"labels":[],"label_agreement":null},{"id":"W2102791712","doi":"10.1111/bjh.12709","title":"Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through <i><scp>MYC</scp></i> and <i><scp>NFE</scp>2</i> downregulation","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; F. M. Kirby Foundation","keywords":"Megakaryocyte; Downregulation and upregulation; Cell biology; Chemistry; Kinase; Transcription factor; Biology; Haematopoiesis; Gene; Biochemistry; Stem cell","score_opus":0.007804593438874412,"score_gpt":0.22587183485504694,"score_spread":0.21806724141617254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102791712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98764753,0.005451464,0.0049230345,0.00047548558,0.00014438356,0.00040438626,0.000013440745,0.00004210906,0.0008981815],"genre_scores_gemma":[0.9919382,0.0048730155,0.002216459,0.00061334646,0.00011410313,0.000010875129,0.00012923649,0.000032736305,0.00007203096],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99820924,0.00016895223,0.00072620076,0.00025763747,0.00030286895,0.00033513232],"domain_scores_gemma":[0.99850744,0.00024317941,0.00066324224,0.00011986637,0.00028414506,0.00018210182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003258163,0.00022874033,0.00076698366,0.00019520045,0.00024476423,0.000110494446,0.000051168347,0.00024843743,0.000004812455],"category_scores_gemma":[0.00054952054,0.00022894575,0.00009108367,0.0001948945,0.00018927875,0.0010586944,0.000043809454,0.00027736442,0.0000072762555],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011459744,0.0067338427,0.09568997,0.007895849,0.0032916805,0.16314934,0.021438334,0.00057352375,0.17206605,0.021024102,0.15018639,0.35680494],"study_design_scores_gemma":[0.016555775,0.002062806,0.03682783,0.0019498612,0.0007759009,0.8490611,0.0011042447,0.0022714683,0.05620803,0.01563466,0.017349038,0.00019934462],"about_ca_topic_score_codex":0.000050798713,"about_ca_topic_score_gemma":0.00005358125,"teacher_disagreement_score":0.6859117,"about_ca_system_score_codex":0.00004210434,"about_ca_system_score_gemma":0.00005456303,"threshold_uncertainty_score":0.9336137},"labels":[],"label_agreement":null},{"id":"W2104365621","doi":"10.1111/j.1365-2141.2004.05106.x","title":"Effects of genetic fusion of factor IX to albumin on <i>in vivo</i> clearance in mice and rabbits","year":2004,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"","keywords":"Factor IX; Recombinant DNA; Albumin; Fusion protein; In vivo; Coagulation; Blood proteins; Medicine; Pharmacology; Immunology; Internal medicine; Chemistry; Biochemistry; Biology; Biotechnology","score_opus":0.010107355210831967,"score_gpt":0.2762570932542004,"score_spread":0.26614973804336844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104365621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948321,0.0039085,0.00001323299,0.00081983104,0.00005849685,0.0002885873,0.0000032734129,0.000001530708,0.0000744709],"genre_scores_gemma":[0.99763906,0.0016152814,0.0005845458,0.000095284624,0.000019902238,0.000002377039,2.3534832e-7,0.000009339844,0.000033972705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99896604,0.00008612947,0.00044375673,0.00011395958,0.00020474473,0.00018536493],"domain_scores_gemma":[0.9994696,0.00016099366,0.00012306117,0.00005668746,0.000080529535,0.00010915922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014654527,0.00007553532,0.0005883113,0.00027229104,0.000011579006,0.000003115092,0.00006778295,0.00009396718,0.000015456328],"category_scores_gemma":[0.00024983787,0.00006992999,0.000053534604,0.00017341426,0.00007853726,0.000029322478,0.000024404206,0.00020704493,0.000002541853],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047419136,0.0031590448,0.099585734,0.0031972586,0.00014220613,0.15346318,0.0017391884,0.0001370647,0.6806827,0.00012013578,0.0005588952,0.052472666],"study_design_scores_gemma":[0.008902216,0.0022431621,0.5260217,0.0052894154,0.000026690033,0.030920252,0.00005611808,0.0000054342377,0.4262243,0.00015643556,0.00007542547,0.00007885625],"about_ca_topic_score_codex":0.00018188093,"about_ca_topic_score_gemma":0.00019465199,"teacher_disagreement_score":0.42643595,"about_ca_system_score_codex":0.000038669154,"about_ca_system_score_gemma":0.000086358494,"threshold_uncertainty_score":0.28516623},"labels":[],"label_agreement":null},{"id":"W2104980846","doi":"10.1111/bjh.12177","title":"Pain in thalassaemia: the effects of age on pain frequency and severity","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; Harvard Catalyst; Research England; National Institutes of Health; New England Research Institutes; University Health Network","keywords":"Medicine; Observational study; Etiology; Prospective cohort study; Physical therapy; Internal medicine; Pediatrics","score_opus":0.005705330211282905,"score_gpt":0.22958228046926962,"score_spread":0.2238769502579867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104980846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742629,0.023541348,0.00006432619,0.0010496001,0.00022220542,0.00016613636,0.0000010124446,0.0000042956967,0.0006881988],"genre_scores_gemma":[0.9967896,0.0021338454,0.00018714617,0.00080942217,0.000046310743,0.0000025256327,8.3767765e-7,0.000009867231,0.000020498866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845505,0.0006899493,0.00039824715,0.000070651084,0.0001453701,0.00024074064],"domain_scores_gemma":[0.9988406,0.00071900006,0.00019900962,0.00008802996,0.00004738907,0.00010601258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022635602,0.00008477018,0.0004817236,0.0000833559,0.00003737506,0.0000059212393,0.00007210799,0.0001878497,0.000019114963],"category_scores_gemma":[0.00219575,0.00006266481,0.000082351246,0.000110859786,0.00017594872,0.000056279725,0.000018941908,0.0005833222,0.0000016048724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028000955,0.001631177,0.5290255,0.0023715652,0.00033818316,0.09081732,0.0020893356,0.0000027160906,0.0024972523,0.0014893801,0.018250749,0.35120684],"study_design_scores_gemma":[0.008154139,0.0041132974,0.59896916,0.007715867,0.0002994092,0.36926532,0.0017701077,0.00005347104,0.0011783246,0.0042220643,0.0039239535,0.00033489944],"about_ca_topic_score_codex":0.00009644972,"about_ca_topic_score_gemma":0.00004438226,"teacher_disagreement_score":0.35087195,"about_ca_system_score_codex":0.000022648328,"about_ca_system_score_gemma":0.000044838936,"threshold_uncertainty_score":0.26286763},"labels":[],"label_agreement":null},{"id":"W2106732574","doi":"10.1111/j.1365-2141.2010.08531.x","title":"No association of HLA‐A supertype with outcome in childhood acute lymphoblastic leukaemia: results of the UKALL XI trial","year":2011,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Cancer Research UK; Wellcome Trust","keywords":"Human leukocyte antigen; Genetics; Allele; Biology; Antigen; Gene","score_opus":0.010698586326282974,"score_gpt":0.21347533302510857,"score_spread":0.2027767466988256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106732574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.913941,0.003668988,0.000052415864,0.03808189,0.037130848,0.0012344474,0.00020985637,0.000029797933,0.005650708],"genre_scores_gemma":[0.89762056,0.002366274,0.0001516037,0.049536165,0.0013634718,0.000034039203,0.0005466194,0.0001752842,0.048206013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996295,0.00092674117,0.0020337647,0.0002357348,0.00014568257,0.0003630886],"domain_scores_gemma":[0.9950515,0.00051707635,0.0034734008,0.0002754813,0.0006692869,0.000013241367],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006762846,0.00025532953,0.0014751867,0.00031006205,0.000068136345,0.000012299466,0.0005062802,0.0015664895,0.0004162453],"category_scores_gemma":[0.0011418875,0.00019717928,0.00042018606,0.00017018065,0.00020419784,0.00014276979,0.00007751811,0.002595015,0.00006777241],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020362765,0.00048305976,0.002208909,0.00012647614,0.0018136798,0.0019296277,0.0002520385,0.0000032558212,0.0014197703,0.000021227557,0.9711336,0.00024560303],"study_design_scores_gemma":[0.14669794,0.0057845344,0.016500127,0.0033652321,0.0020751702,0.18671699,0.00016891133,0.0000015050134,0.010352261,0.00012781893,0.62740284,0.000806661],"about_ca_topic_score_codex":0.00055154425,"about_ca_topic_score_gemma":0.00020402847,"teacher_disagreement_score":0.34373072,"about_ca_system_score_codex":0.00019411246,"about_ca_system_score_gemma":0.00035805657,"threshold_uncertainty_score":0.9997297},"labels":[],"label_agreement":null},{"id":"W2106736124","doi":"10.1111/bjh.12014","title":"Cytoadherence in paediatric malaria:<scp>ABO</scp>blood group,<scp>CD</scp>36, and<scp>ICAM</scp>1 expression and severe<i><scp>P</scp>lasmodium falciparum</i>infection","year":2012,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Malaria Research and Control","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Johnson Cancer Research Center, Kansas State University; Massachusetts General Hospital; University of California, San Francisco; University of Toronto; Masimo; National Blood Foundation","keywords":"Plasmodium falciparum; Malaria; Cerebral Malaria; Immunology; CD36; ABO blood group system; Biology; Platelet; Odds ratio; Case fatality rate; Internal medicine; Endothelial activation; Medicine; Receptor; Inflammation; Epidemiology","score_opus":0.011995810952829734,"score_gpt":0.2499905163482136,"score_spread":0.23799470539538387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106736124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566409,0.03648463,0.0008952629,0.00041962456,0.0010000982,0.0011939348,0.00006829689,0.00010843243,0.0031888478],"genre_scores_gemma":[0.9813445,0.013684026,0.0014392029,0.0005055337,0.0013047417,0.00014420883,0.00003873744,0.00013016177,0.0014088944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920488,0.0013140219,0.001948262,0.00093896146,0.0013230827,0.0024268518],"domain_scores_gemma":[0.99141294,0.0041795117,0.0012951804,0.00056334963,0.00068355317,0.0018654843],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0028609734,0.0007761994,0.0023415682,0.0012051805,0.00043738494,0.00032992775,0.0005507129,0.0011466554,0.000054917284],"category_scores_gemma":[0.011802062,0.00079090206,0.00045556802,0.0009548902,0.0004915219,0.0013441594,0.000503184,0.00282192,0.00007471146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000366918,0.005770052,0.7154008,0.0029239985,0.0016932563,0.053234205,0.0034677258,0.000047311965,0.05184554,0.0032712766,0.1490597,0.01291921],"study_design_scores_gemma":[0.024526829,0.0028999131,0.58408225,0.002016046,0.0012828493,0.3332684,0.0027221444,0.00032275266,0.010934275,0.0020509376,0.035675686,0.00021790409],"about_ca_topic_score_codex":0.0003978561,"about_ca_topic_score_gemma":0.00025594447,"teacher_disagreement_score":0.28003418,"about_ca_system_score_codex":0.00015586769,"about_ca_system_score_gemma":0.00043604625,"threshold_uncertainty_score":0.99947864},"labels":[],"label_agreement":null},{"id":"W2108233576","doi":"10.1111/bjh.13320","title":"Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Surrey Memorial Hospital; BC Cancer Agency","funders":"BC Cancer Agency; University of British Columbia","keywords":"Medicine; Splenic marginal zone lymphoma; Splenectomy; Rituximab; Chemoimmunotherapy; Internal medicine; Gastroenterology; Hazard ratio; Chemotherapy; Lymphoma; Surgery; Confidence interval; Spleen","score_opus":0.014724133313153866,"score_gpt":0.25854078237018446,"score_spread":0.2438166490570306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108233576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662286,0.0026672995,0.000003120018,0.0001290311,0.00012743991,0.00021418514,0.00005784507,0.0000066376106,0.00017158934],"genre_scores_gemma":[0.9989767,0.0004153679,0.00025721983,0.000100602694,0.000013483087,0.000012316108,0.00005109089,0.00001585084,0.00015737428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764436,0.00017641002,0.0012381631,0.00021673806,0.0004001182,0.00032419528],"domain_scores_gemma":[0.99855757,0.00012604178,0.00053136685,0.00015243846,0.00040917148,0.0002233876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003593188,0.00012200484,0.0018969111,0.00052128395,0.000021606991,0.000047960322,0.00013190892,0.00015698787,0.00017535263],"category_scores_gemma":[0.00034104887,0.0001714965,0.0003347716,0.0008565812,0.00011022863,0.00012583238,0.000042533127,0.000115650364,0.000004715091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013611763,0.0038124998,0.9162403,0.00003242036,0.0010045297,0.06104972,0.00008914797,0.000010360556,0.0000016121273,0.0000033511303,0.0012574692,0.016362522],"study_design_scores_gemma":[0.019641753,0.00060523296,0.95025027,0.00044138083,0.0010923975,0.027470905,0.00014276252,0.000043688382,0.000021533016,0.00003570209,0.0001391226,0.00011523217],"about_ca_topic_score_codex":0.062434103,"about_ca_topic_score_gemma":0.2563383,"teacher_disagreement_score":0.1939042,"about_ca_system_score_codex":0.00047327747,"about_ca_system_score_gemma":0.0003030217,"threshold_uncertainty_score":0.9438092},"labels":[],"label_agreement":null},{"id":"W2109363414","doi":"10.1111/j.1365-2141.2009.07859.x","title":"Multiple isoforms of <i>PAX5</i> are expressed in both lymphomas and normal B‐cells","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Atlantic Cancer Research Institute; Dr. Georges-L.-Dumont University Hospital Centre; Université de Moncton; Fisheries and Oceans Canada","funders":"Canadian Institutes of Health Research","keywords":"Gene isoform; PAX5; B cell; Biology; Alternative splicing; Gene expression; Molecular biology; RNA splicing; Transcription factor; Gene; Lymphoma; Antibody; RNA; Genetics; Immunology","score_opus":0.007966033997693042,"score_gpt":0.22840499862092944,"score_spread":0.2204389646232364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109363414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158704,0.0071084886,0.00001802774,0.00069151906,0.00009333578,0.00014067847,0.000014409519,0.0000057915786,0.00034069575],"genre_scores_gemma":[0.996014,0.002450283,0.001003105,0.0004459234,0.000038555667,0.0000027712463,0.0000026612815,0.000008681933,0.000033991797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880296,0.000043385386,0.0006213854,0.00012890814,0.00017369118,0.00022969977],"domain_scores_gemma":[0.99916154,0.00010671731,0.000394306,0.00010197178,0.000100091755,0.00013536318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015932141,0.000114472154,0.0007830236,0.00013859897,0.000029785971,0.000013932221,0.00007458504,0.00010939895,0.000033956596],"category_scores_gemma":[0.000096370044,0.000094068295,0.00011543927,0.00008996934,0.00008252108,0.00012225965,0.000020597412,0.000107100794,0.000002097824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011510486,0.0036949534,0.6911224,0.00033015962,0.00024999387,0.15673442,0.00070321537,0.00002530451,0.0091479905,0.00020374029,0.0068553616,0.12978137],"study_design_scores_gemma":[0.015391258,0.0009907028,0.7513172,0.0013981134,0.000115576186,0.1907217,0.00029331018,0.000045262623,0.03802481,0.0003576222,0.0012065523,0.00013791396],"about_ca_topic_score_codex":0.00012706376,"about_ca_topic_score_gemma":0.00010386781,"teacher_disagreement_score":0.12964346,"about_ca_system_score_codex":0.0000606682,"about_ca_system_score_gemma":0.00012417391,"threshold_uncertainty_score":0.38359937},"labels":[],"label_agreement":null},{"id":"W2110168457","doi":"10.1111/j.1365-2141.2006.06200.x","title":"The post‐thrombotic syndrome: progress and pitfalls","year":2006,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Compression stockings; Thrombosis; Deep vein; Complication; Thrombolysis; Venous thrombosis; Intermittent pneumatic compression; Incidence (geometry); Intensive care medicine; Surgery; May–Thurner syndrome; Internal medicine","score_opus":0.01758684991946817,"score_gpt":0.31146394584604553,"score_spread":0.29387709592657735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110168457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002342092,0.9951086,0.0000056598924,0.0006658413,0.00065394095,0.0008522886,0.0000100089155,0.000016295273,0.00034526928],"genre_scores_gemma":[0.0005141976,0.99859166,0.000248425,0.00014085014,0.0001697657,0.00003476879,0.000016893582,0.00006323186,0.00022021559],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99733424,0.000258816,0.0013566407,0.00025858905,0.00034915205,0.00044254333],"domain_scores_gemma":[0.9978388,0.00029539168,0.0011635853,0.00025842118,0.0002659474,0.00017786297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066283875,0.00031434235,0.0039930753,0.00020065301,0.00022006675,0.00015712297,0.00031850018,0.00029777177,0.000037632763],"category_scores_gemma":[0.00016971238,0.00022531315,0.000578124,0.00016443734,0.00045050913,0.000069999056,0.00014782322,0.0007378874,0.000021959393],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054332054,0.00031357037,0.000025151849,0.012312334,0.0009503916,0.09985246,0.00001041639,6.187289e-8,1.5609556e-8,0.0006857953,0.026444262,0.8594001],"study_design_scores_gemma":[0.00028773912,0.00031320725,0.0007210973,0.016655507,0.0021978233,0.46261677,0.000014798984,1.9356816e-7,4.0873378e-8,0.000083388986,0.51699424,0.0001151959],"about_ca_topic_score_codex":0.000045382614,"about_ca_topic_score_gemma":0.000052320673,"teacher_disagreement_score":0.85928494,"about_ca_system_score_codex":0.00006813589,"about_ca_system_score_gemma":0.00030963254,"threshold_uncertainty_score":0.91880035},"labels":[],"label_agreement":null},{"id":"W2110310627","doi":"10.1111/bjh.13024","title":"Systemic mastocytosis emerging after azacitidine treatment of refractory anaemia with excess blasts type 2","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Systemic mastocytosis; Medicine; Bone marrow; Pathology; Pancytopenia; Myeloid; Granulopoiesis; Tryptase; Azacitidine; Haematopoiesis; Internal medicine; Immunology; Mast cell; Biology; Stem cell","score_opus":0.006874578529180452,"score_gpt":0.21217701214683735,"score_spread":0.2053024336176569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110310627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788471,0.019472733,0.0003941261,0.00006213979,0.0005630092,0.000099442615,0.000014603551,0.000011057993,0.000535818],"genre_scores_gemma":[0.9977395,0.0012443269,0.00020637792,0.000029206281,0.00005977348,0.0000062073627,0.000011981045,0.000021766356,0.00068084773],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.998612,0.00023119945,0.00064158166,0.00017595045,0.000055700813,0.00028358708],"domain_scores_gemma":[0.99879754,0.00010211091,0.000608378,0.00016864623,0.00028004826,0.000043259763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018205792,0.00016711857,0.0008775841,0.00017011748,0.00006914872,0.000010150972,0.00015608335,0.00018630859,0.0007256619],"category_scores_gemma":[0.000036814246,0.00014420386,0.00011562875,0.000110291054,0.00023405153,0.000080128004,0.00002367237,0.00018219154,0.000033079832],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017084708,0.0053029023,0.08724899,0.002980853,0.0065806224,0.05513796,0.005147771,0.00026598584,0.46725717,0.0021400503,0.014307595,0.33654538],"study_design_scores_gemma":[0.013329199,0.012411472,0.0141816735,0.002888515,0.00087707903,0.7365517,0.00091299106,0.000015512835,0.058069795,0.000111378286,0.15986365,0.0007870443],"about_ca_topic_score_codex":0.0001288696,"about_ca_topic_score_gemma":0.00020639531,"teacher_disagreement_score":0.6814137,"about_ca_system_score_codex":0.00005264247,"about_ca_system_score_gemma":0.000073409574,"threshold_uncertainty_score":0.7945489},"labels":[],"label_agreement":null},{"id":"W2111030516","doi":"10.1111/j.1365-2141.2009.07946.x","title":"<i>IRF4</i> polymorphism rs872071 and risk of Hodgkin lymphoma","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK","keywords":"IRF4; Odds ratio; Genotype; Lymphoma; Chronic lymphocytic leukemia; Hematology; Oncology; Confidence interval; Internal medicine; Genetics; Biology; Medicine; Immunology; Gene; Transcription factor; Leukemia","score_opus":0.008592146408013122,"score_gpt":0.2646952606401587,"score_spread":0.25610311423214555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111030516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787813,0.01860589,0.00015310764,0.0007476952,0.00013725799,0.00014004207,0.000009922761,0.000011448555,0.0014133642],"genre_scores_gemma":[0.9896354,0.0079181725,0.0017556289,0.00035553926,0.00014507488,9.037463e-7,0.0000018445012,0.00001752856,0.00016987036],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9980379,0.00017394422,0.0007945711,0.00018071648,0.00044595049,0.0003669407],"domain_scores_gemma":[0.9984487,0.0002336137,0.00052063743,0.00020654229,0.0003094108,0.00028104568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006708633,0.00013269857,0.00093677023,0.00022457147,0.000060821912,0.000020473912,0.00018216338,0.00018390597,0.00009825823],"category_scores_gemma":[0.0007198655,0.00013279871,0.00017851724,0.00019099523,0.00033094652,0.00010244028,0.000051751143,0.00030304733,0.000008101319],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025221612,0.0016002663,0.013902999,0.000611097,0.0012470752,0.34696713,0.00069643557,0.000010518192,0.007325056,0.002774149,0.03396701,0.5883761],"study_design_scores_gemma":[0.022316584,0.0010789525,0.0234515,0.0006915079,0.00027952128,0.9411096,0.00009697404,0.00020371344,0.006338902,0.0023447636,0.0019531385,0.00013481772],"about_ca_topic_score_codex":0.00047885726,"about_ca_topic_score_gemma":0.00003279619,"teacher_disagreement_score":0.5941425,"about_ca_system_score_codex":0.00065112684,"about_ca_system_score_gemma":0.002071437,"threshold_uncertainty_score":0.54153746},"labels":[],"label_agreement":null},{"id":"W2113950318","doi":"10.1111/bjh.13493","title":"A phase <scp>II</scp> trial of <scp>RCHOP</scp> followed by radioimmunotherapy for early stage (stages I/<scp>II</scp>) diffuse large B‐cell non‐Hodgkin lymphoma: <scp>ECOG</scp>3402","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pharmacyclics; Genentech; ECOG-ACRIN Cancer Research Group; Roche; American College of Radiology Imaging Network; Spectrum Pharmaceuticals; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Radioimmunotherapy; Medicine; Diffuse large B-cell lymphoma; Rituximab; Chemoimmunotherapy; Internal medicine; Phases of clinical research; Lymphoma; Nuclear medicine; Clinical trial; Immunology","score_opus":0.019109684220618747,"score_gpt":0.2890661712795868,"score_spread":0.269956487058968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113950318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95129293,0.03861298,0.0008067782,0.00026305678,0.0024469742,0.0033846973,0.0015198622,0.00015040314,0.001522329],"genre_scores_gemma":[0.97313803,0.008922633,0.002566486,0.0010590487,0.0010511685,0.00052437437,0.0003615887,0.0004212033,0.011955444],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98966885,0.0008254601,0.003821282,0.0013283263,0.001785117,0.0025709982],"domain_scores_gemma":[0.9866834,0.0053879847,0.0036079218,0.0011968026,0.0014511435,0.0016727238],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0026712099,0.0013703301,0.0050213686,0.00095192506,0.00071686355,0.00031220884,0.0012066803,0.0012445978,0.000019510413],"category_scores_gemma":[0.00677033,0.0013643844,0.0020938583,0.0007999142,0.0006083658,0.0008200918,0.0003727892,0.0008668744,0.00006383607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003519906,0.099974014,0.014086407,0.0010943922,0.006468135,0.04577371,0.013773711,0.000012209106,0.01599582,0.00039146407,0.7879365,0.010973722],"study_design_scores_gemma":[0.5351607,0.024705356,0.0023124067,0.0010496753,0.0019759762,0.027325774,0.004240017,0.0001046406,0.0931066,0.00038589677,0.30943346,0.0001994597],"about_ca_topic_score_codex":0.0005391206,"about_ca_topic_score_gemma":0.00013986991,"teacher_disagreement_score":0.5316408,"about_ca_system_score_codex":0.00084172824,"about_ca_system_score_gemma":0.0020788063,"threshold_uncertainty_score":0.99990475},"labels":[],"label_agreement":null},{"id":"W2114637038","doi":"10.1111/bjh.12999","title":"A transgenic zebrafish model expressing <i><scp>KIT</scp></i>‐<scp>D</scp>816<scp>V</scp> recapitulates features of aggressive systemic mastocytosis","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton; Atlantic Cancer Research Institute; University of New Brunswick; Dalhousie University; Montfort Hospital; Izaak Walton Killam Health Centre; University of Ottawa","funders":"Canadian Institutes of Health Research; Université Laval; Abramson Family Cancer Research Institute; University of Pennsylvania","keywords":"Zebrafish; Systemic mastocytosis; Biology; Transgene; Phenotype; Cancer research; Proto-Oncogene Proteins c-kit; Genetically modified mouse; Mutation; Immunology; Mast cell; Progenitor cell; Genetics; Stem cell factor; Stem cell; Gene","score_opus":0.009126055458390034,"score_gpt":0.2112625725921467,"score_spread":0.20213651713375666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114637038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9074458,0.083381414,0.0030167382,0.000086754364,0.0014436884,0.0004428334,0.00018952733,0.000089558795,0.0039037177],"genre_scores_gemma":[0.9887332,0.0039342367,0.0012563652,0.00029736708,0.00020831403,0.000034491255,0.00008776783,0.00013469867,0.0053135715],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9941462,0.0011387652,0.002258541,0.0007834362,0.00028912345,0.0013839041],"domain_scores_gemma":[0.9916275,0.0028160426,0.003960681,0.0005945678,0.0007590751,0.00024212904],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011008668,0.00070750026,0.0027534638,0.000625661,0.0005207118,0.0001325221,0.0012229104,0.0012994122,0.000070213115],"category_scores_gemma":[0.0032873948,0.00074464054,0.0008805466,0.00034415608,0.000955009,0.00040629442,0.00021843177,0.0016853919,0.000074020674],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012619975,0.0011211351,0.0013335984,0.0022100438,0.0024114167,0.005062483,0.008735338,0.0017051069,0.7017192,0.0020366265,0.26714587,0.0063929176],"study_design_scores_gemma":[0.013061041,0.0017112929,0.0019911595,0.008524176,0.0017104747,0.47105965,0.0072575146,0.00047565164,0.43224734,0.003146025,0.05840152,0.00041417396],"about_ca_topic_score_codex":0.00015517705,"about_ca_topic_score_gemma":0.00014805794,"teacher_disagreement_score":0.46599716,"about_ca_system_score_codex":0.00008530798,"about_ca_system_score_gemma":0.0003108148,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W2117641266","doi":"10.1111/j.1365-2141.2007.06900.x","title":"Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Overweight; Stem cell; Medicine; Transplantation; Pediatrics; Oncology; Internal medicine; Obesity; Biology; Genetics","score_opus":0.013378450368468981,"score_gpt":0.2699723408139908,"score_spread":0.25659389044552183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117641266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8999673,0.0010329831,0.09752279,0.00023407837,0.00032337348,0.0004265182,0.000022721511,0.000022253871,0.00044796884],"genre_scores_gemma":[0.9906127,0.00087816635,0.007882291,0.00032618397,0.00009866427,0.0000048045495,0.00003421823,0.000035240577,0.00012771602],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99818295,0.000068588044,0.00096055807,0.0001703172,0.00027806807,0.00033949633],"domain_scores_gemma":[0.9984002,0.00069763995,0.00041719156,0.00009987914,0.00021313425,0.00017192101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083064777,0.0001520783,0.00069318636,0.00021632556,0.00008553434,0.000023955463,0.0001099251,0.00018689974,0.00004868781],"category_scores_gemma":[0.000042651354,0.00015711431,0.0002590156,0.0001025678,0.000055733497,0.00012958651,0.0000052945275,0.00021263336,0.000008551976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019179295,0.0009033696,0.8637466,0.004235662,0.0010119721,0.07268888,0.0019042181,0.000046839807,0.01758472,0.0015030499,0.0011885128,0.033268288],"study_design_scores_gemma":[0.007386401,0.00048610335,0.38913918,0.0008258558,0.0006924425,0.55421597,0.0002509378,0.000008693204,0.04635081,0.00022570092,0.0001990952,0.00021878547],"about_ca_topic_score_codex":0.000017997327,"about_ca_topic_score_gemma":0.00013050632,"teacher_disagreement_score":0.4815271,"about_ca_system_score_codex":0.000053086533,"about_ca_system_score_gemma":0.00019434447,"threshold_uncertainty_score":0.6406936},"labels":[],"label_agreement":null},{"id":"W2117761540","doi":"10.1046/j.1365-2141.2001.03136.x","title":"IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Mononuclear phagocyte system; Immunology; Idiotype; Immune system; Immune thrombocytopenia; Medicine; Hematology; Antibody; Monoclonal antibody","score_opus":0.01003274467971319,"score_gpt":0.23822193987193285,"score_spread":0.22818919519221967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117761540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936919,0.004941518,0.00011440649,0.000302305,0.00030990192,0.00021499774,0.00001110249,0.00001561665,0.00039821022],"genre_scores_gemma":[0.997028,0.002663662,0.00014232428,0.000033879718,0.00006151179,0.0000026812884,0.0000080520695,0.000018591483,0.00004132538],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99857587,0.00011553902,0.0006525285,0.00017665655,0.00025992858,0.00021949802],"domain_scores_gemma":[0.9987613,0.00006483323,0.00063490006,0.00012363355,0.00030129103,0.00011405711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002315837,0.00014816386,0.001255913,0.00015270541,0.0000753251,0.000021957781,0.00006416082,0.00015216283,0.000046831414],"category_scores_gemma":[0.000110606896,0.00013718069,0.00012033104,0.00015037872,0.00013339694,0.00017371583,0.00004494462,0.0003042698,0.00000684047],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060201385,0.0036145563,0.20101954,0.0016895893,0.0025170504,0.5253665,0.00031920837,0.000014019618,0.1869002,0.0012325238,0.0013179271,0.06998878],"study_design_scores_gemma":[0.0068950113,0.0012675944,0.21230137,0.0014065852,0.00045242743,0.75717646,0.0003594076,0.000023882112,0.01942417,0.00028071651,0.00027472648,0.00013764505],"about_ca_topic_score_codex":0.00024742004,"about_ca_topic_score_gemma":0.00007617355,"teacher_disagreement_score":0.23180999,"about_ca_system_score_codex":0.00005029507,"about_ca_system_score_gemma":0.00010145699,"threshold_uncertainty_score":0.55940664},"labels":[],"label_agreement":null},{"id":"W2118281789","doi":"10.1111/bjh.12584","title":"How I treat children and adolescents with acute promyelocytic leukaemia","year":2013,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; American Lebanese Syrian Associated Charities","keywords":"Medicine; Acute promyelocytic leukemia; Cytarabine; Arsenic trioxide; Anthracycline; Idarubicin; Internal medicine; Pediatrics; Tretinoin; Myeloid leukaemia; Leukemia; Oncology; Retinoic acid; Cancer","score_opus":0.008127734421031584,"score_gpt":0.2432180593678311,"score_spread":0.23509032494679952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118281789","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04736998,0.951807,0.00020276975,0.000019681265,0.00009918537,0.000424376,0.000021864107,0.000005740802,0.000049373615],"genre_scores_gemma":[0.0045217075,0.9938861,0.00052927935,0.000027169697,0.0002927912,0.000026204929,0.00008848848,0.000074551615,0.0005536701],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9982814,0.00019505237,0.0005660509,0.00041537217,0.00018911483,0.0003529647],"domain_scores_gemma":[0.99843454,0.000011305827,0.0009151236,0.00024477678,0.00021629916,0.00017795297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013430674,0.00040696203,0.0016916799,0.000102416736,0.00008364946,0.0001899858,0.00045849083,0.0006060388,0.0000065888057],"category_scores_gemma":[0.000072754316,0.00032740008,0.00029076723,0.000095522286,0.0002918731,0.000015518115,0.00013474257,0.0005411239,0.000004136629],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004769702,0.00008244838,0.00015659859,0.008827997,0.0010938181,0.011250958,0.0000080490445,1.8894255e-7,0.00009457846,0.000008828009,0.0049629402,0.9734659],"study_design_scores_gemma":[0.00092470023,0.000542643,0.000022128344,0.013158256,0.0015482695,0.8046499,0.000010405729,2.1382637e-7,0.00050645554,0.000020587284,0.17817268,0.00044376316],"about_ca_topic_score_codex":0.000009604732,"about_ca_topic_score_gemma":0.0000065949885,"teacher_disagreement_score":0.97302216,"about_ca_system_score_codex":0.000034328034,"about_ca_system_score_gemma":0.00058821414,"threshold_uncertainty_score":0.9999178},"labels":[],"label_agreement":null},{"id":"W2119853530","doi":"10.1111/bjh.12917","title":"Evaluation of the validity of Hb A<sub>2</sub> and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in <scp>E</scp>ngland","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; False positive paradox; Mean corpuscular volume; Population; Pediatrics; Internal medicine; Hemoglobin; Statistics; Mathematics; Environmental health","score_opus":0.031433122151947906,"score_gpt":0.28139491739196143,"score_spread":0.24996179524001352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119853530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954135,0.002880213,0.00066280784,0.00021492518,0.00026584417,0.00046979912,0.000013142387,0.000003958958,0.00007584035],"genre_scores_gemma":[0.9988859,0.00078335183,0.00022862677,0.000034787685,0.000036263864,0.000005756582,0.000006732967,0.000016131855,0.0000024075737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976788,0.0006322262,0.00077700254,0.00016626652,0.0005120568,0.00023362001],"domain_scores_gemma":[0.9982501,0.0003545198,0.0006374944,0.00013135794,0.00054582494,0.00008069143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037094015,0.00012170967,0.00072409125,0.00021681355,0.000058117832,0.000010063852,0.000110898334,0.0002489012,0.000001993031],"category_scores_gemma":[0.0029370699,0.00010456334,0.00017009549,0.00021982586,0.0002517604,0.00011971301,0.000038217648,0.00038949918,1.1525466e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057811657,0.00078613526,0.7150455,0.0020285863,0.00085754343,0.0018255139,0.004301682,0.0034575695,0.09022604,0.00032634143,0.0018862892,0.17868067],"study_design_scores_gemma":[0.03133751,0.0014992679,0.602171,0.0068226717,0.0020467066,0.108171366,0.009561063,0.022874579,0.20976736,0.0052916245,0.00021094167,0.0002458765],"about_ca_topic_score_codex":0.00013816927,"about_ca_topic_score_gemma":0.0005448896,"teacher_disagreement_score":0.1784348,"about_ca_system_score_codex":0.000059581012,"about_ca_system_score_gemma":0.00018962238,"threshold_uncertainty_score":0.42639694},"labels":[],"label_agreement":null},{"id":"W2120523756","doi":"10.1111/j.1365-2141.2008.07527.x","title":"Fluorescence‐activated cell sorting (FACS) of whole mount <i>in situ</i> hybridization (WISH) labelled haematopoietic cell populations in the zebrafish","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Cell sorting; In situ hybridization; Biology; Haematopoiesis; Fluorescence in situ hybridization; Cell biology; Embryonic stem cell; Cell; Stem cell; Messenger RNA; Genetics; Gene","score_opus":0.014605188190065212,"score_gpt":0.2806999816855471,"score_spread":0.2660947934954819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120523756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949242,0.0011364123,0.0011329901,0.0018613207,0.00004887714,0.00031916308,0.000013321199,0.0000045519528,0.00055917585],"genre_scores_gemma":[0.9976765,0.00028744826,0.0014869891,0.00037000392,0.000052928917,0.000011967534,0.000074262396,0.000014305658,0.000025609781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977138,0.00034127026,0.00097279996,0.0002371636,0.00036446267,0.00037052555],"domain_scores_gemma":[0.99878585,0.0000810651,0.0005243099,0.00024909,0.00025549316,0.000104188584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085584214,0.00013282793,0.00040193382,0.00018467498,0.00008330591,0.000040356877,0.00052822457,0.00018496868,0.000015956393],"category_scores_gemma":[0.0006276146,0.00012995777,0.00011459578,0.0005096109,0.00015960011,0.000022547174,0.000060535152,0.00040727764,0.000004436246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048659058,0.00066347996,0.0012969894,0.00004788816,0.000008486175,0.0007431827,0.0001032879,0.000113049275,0.9914552,0.00022009104,0.0039244005,0.0013753129],"study_design_scores_gemma":[0.0045470926,0.0007856997,0.04301463,0.00043204747,0.000050912568,0.011449439,0.00093874463,0.0002336191,0.92985195,0.004963971,0.003309104,0.00042280677],"about_ca_topic_score_codex":0.00009053533,"about_ca_topic_score_gemma":0.00024785596,"teacher_disagreement_score":0.06160324,"about_ca_system_score_codex":0.00003849362,"about_ca_system_score_gemma":0.00018975367,"threshold_uncertainty_score":0.5299524},"labels":[],"label_agreement":null},{"id":"W2129168589","doi":"10.1046/j.0007-1048.2001.03300.x","title":"Cytotoxicity of 2‐chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Fondation pour la Recherche Médicale; University of Alberta","keywords":"Lymphoblast; Nucleoside analogue; Nucleoside transporter; Cytotoxicity; Nucleoside; Cladribine; Transporter; Chemistry; Medicine; Biology; Biochemistry; Cell culture; In vitro; Internal medicine; Gene; Genetics","score_opus":0.01967873500142383,"score_gpt":0.22021659962444393,"score_spread":0.2005378646230201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129168589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903657,0.007963301,0.00070326385,0.0003027904,0.00011258414,0.00038509423,0.00009835973,0.0000071627046,0.00006177874],"genre_scores_gemma":[0.99625754,0.0025421246,0.0009245755,0.00013153891,0.0000745639,0.0000055123337,0.000012655794,0.000032676704,0.00001881381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689734,0.00016461854,0.0016683051,0.0002884117,0.00059281883,0.00038853104],"domain_scores_gemma":[0.9977781,0.0003837053,0.00083172804,0.00020657858,0.00056921475,0.00023068301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031491285,0.000205949,0.0014656268,0.00039784363,0.000027181846,0.000009535405,0.00023191237,0.00023831562,0.0002522008],"category_scores_gemma":[0.0004704206,0.00021005554,0.00018378993,0.00035336526,0.00044824075,0.00017423887,0.00004828441,0.00041683603,0.000003964966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003258464,0.004439015,0.7086435,0.0016783329,0.00060861796,0.044094574,0.0013751574,0.000052696574,0.22014943,0.00009186552,0.0035471139,0.012061211],"study_design_scores_gemma":[0.0420021,0.0027528577,0.7538554,0.0035604122,0.0005950643,0.035599273,0.00044882728,0.0014534126,0.15878943,0.0003581131,0.000085015,0.0005000974],"about_ca_topic_score_codex":0.00080079347,"about_ca_topic_score_gemma":0.00010652395,"teacher_disagreement_score":0.061360005,"about_ca_system_score_codex":0.00024649745,"about_ca_system_score_gemma":0.00019572639,"threshold_uncertainty_score":0.8565816},"labels":[],"label_agreement":null},{"id":"W2129806364","doi":"10.1046/j.1365-2141.2002.03469.x","title":"Receptor tyrosine kinase mutations in myeloid neoplasms","year":2002,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Receptor tyrosine kinase; Platelet-derived growth factor receptor; Tyrosine kinase; ROR1; Biology; Proto-oncogene tyrosine-protein kinase Src; Cell biology; Cancer research; Tropomyosin receptor kinase C; GRB2; Growth factor receptor; Epidermal growth factor; SH2 domain; Signal transduction; Biochemistry; Growth factor; Receptor","score_opus":0.036678624574928306,"score_gpt":0.31797710477744523,"score_spread":0.2812984802025169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129806364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002460034,0.99518204,0.000013022726,0.00017305618,0.00074389915,0.00066588173,0.00006985542,0.000021846581,0.0006703943],"genre_scores_gemma":[0.0001325775,0.99615896,0.002013156,0.00007595213,0.00029921663,0.000042462954,0.00015960983,0.00009567269,0.0010223704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632645,0.00033809795,0.0021089783,0.0003581072,0.00036898474,0.00049937813],"domain_scores_gemma":[0.9974615,0.00038742536,0.0013284594,0.0003032144,0.00022333446,0.00029606576],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032849205,0.00042177123,0.0043504005,0.00073008187,0.00006210868,0.00003866039,0.0002816826,0.00062035245,0.0015899776],"category_scores_gemma":[0.00073143205,0.00042210054,0.00079619925,0.000563541,0.00017703864,0.00012045619,0.00006196622,0.001454336,0.00035110873],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022329961,0.00044821616,0.000030943094,0.0066044065,0.00039536305,0.14959385,0.000041956097,9.302049e-7,6.111538e-7,0.00003266268,0.012449401,0.83037937],"study_design_scores_gemma":[0.002086137,0.00018901758,0.000014678486,0.032807074,0.0009375381,0.44846603,0.000015080279,0.0000022174634,0.0000021555297,0.000019602116,0.515297,0.00016349257],"about_ca_topic_score_codex":0.00009135814,"about_ca_topic_score_gemma":0.00010947867,"teacher_disagreement_score":0.8302159,"about_ca_system_score_codex":0.0012724828,"about_ca_system_score_gemma":0.0014001215,"threshold_uncertainty_score":0.9998231},"labels":[],"label_agreement":null},{"id":"W2131149366","doi":"10.1046/j.0007-1048.2001.03302.x","title":"A novel immunocytochemical assay for the detection of serotonin in platelets","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"University of British Columbia; Canadian Blood Services; Hermansky-Pudlak Syndrome Network","keywords":"Serotonin; Platelet; Calcium; Chemistry; High-performance liquid chromatography; Chromatography; Neurotransmitter; Molecular biology; Biochemistry; Internal medicine; Medicine; Biology; Receptor","score_opus":0.016291734690072276,"score_gpt":0.22394802230371186,"score_spread":0.20765628761363958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131149366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580758,0.033000756,0.007394246,0.00035936697,0.00062928436,0.0002788956,0.000020214888,0.000005855595,0.0002355785],"genre_scores_gemma":[0.99880576,0.0005659427,0.0002510163,0.000046002806,0.000022176057,0.000013428219,0.000002638173,0.00000932717,0.0002837262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990104,0.00008262173,0.0005738312,0.000095772564,0.000029477442,0.00020793547],"domain_scores_gemma":[0.9990074,0.00040847473,0.00035884965,0.00009079488,0.00012269868,0.00001175867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043275053,0.000080046535,0.00042765154,0.00009021687,0.00007151364,0.0000071549734,0.0002076637,0.00020867297,0.0003331544],"category_scores_gemma":[0.00022774727,0.00007018366,0.00013161219,0.00008251356,0.00019751812,0.00004580187,0.000028786504,0.00036145494,0.000009343354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026600403,0.0003070987,0.000105560626,0.00005497773,0.00014702599,0.00042216032,0.00019024774,0.000011489866,0.9636478,0.0002235774,0.0012955222,0.03332855],"study_design_scores_gemma":[0.0084265685,0.0006198638,0.0020624984,0.00029402968,0.00010418819,0.3862756,0.0003064507,0.0002276253,0.5331041,0.00022646942,0.06813474,0.00021788481],"about_ca_topic_score_codex":0.00011490533,"about_ca_topic_score_gemma":0.00018754226,"teacher_disagreement_score":0.4305437,"about_ca_system_score_codex":0.000021304011,"about_ca_system_score_gemma":0.000016899041,"threshold_uncertainty_score":0.3647807},"labels":[],"label_agreement":null},{"id":"W2132062481","doi":"10.1111/j.1365-2141.2005.05947.x","title":"Autotransplantation <i>versus</i> HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research","year":2006,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Transplantation; Internal medicine; Single Center; Retrospective cohort study; Surgery; Autotransplantation; Myeloid; Oncology; Gastroenterology","score_opus":0.02031420621659094,"score_gpt":0.31000582067879745,"score_spread":0.2896916144622065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132062481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9320792,0.00062375894,0.061043136,0.0018680047,0.0006875643,0.0010157345,0.0024712402,0.000027763223,0.00018360447],"genre_scores_gemma":[0.9878739,0.003013244,0.00615715,0.000111078676,0.0003591912,0.00008853274,0.0023008639,0.000037120626,0.00005888458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974054,0.0002572244,0.0010246229,0.00037552562,0.00054819824,0.000388996],"domain_scores_gemma":[0.9962702,0.0016990491,0.0003867548,0.00013716499,0.0013964336,0.00011042181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012413427,0.00020370452,0.0008146609,0.00035941965,0.00024932605,0.00009451069,0.00021222827,0.00028674604,0.000051046747],"category_scores_gemma":[0.00015080615,0.00018412484,0.00038538966,0.000393688,0.00020024266,0.00021887412,0.0000061849773,0.00048380208,0.0000016192369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10376575,0.004046485,0.5462104,0.0036924682,0.07750555,0.05474277,0.023835655,0.0006800336,0.15252116,0.009952248,0.014651885,0.00839557],"study_design_scores_gemma":[0.12697798,0.0034702793,0.476322,0.004148135,0.07863053,0.209676,0.0020039324,0.004952364,0.08174411,0.008676379,0.0021165228,0.0012817729],"about_ca_topic_score_codex":0.00043707193,"about_ca_topic_score_gemma":0.0015183291,"teacher_disagreement_score":0.15493323,"about_ca_system_score_codex":0.000091911155,"about_ca_system_score_gemma":0.0001394248,"threshold_uncertainty_score":0.75083935},"labels":[],"label_agreement":null},{"id":"W2132834885","doi":"10.1046/j.1365-2141.2002.03444.x","title":"Cell‐specific abnormal prenylation of Rab proteins in platelets and melanocytes of the gunmetal mouse","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Medical Research Council; Canadian Institutes of Health Research; National Eye Institute; Johns Hopkins University","keywords":"Prenylation; Rab; Platelet; Geranylgeranylation; Biology; Cell biology; Organelle; Biochemistry; Immunology; Enzyme; GTPase","score_opus":0.007727659738770571,"score_gpt":0.18190158192110287,"score_spread":0.1741739221823323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132834885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854994,0.013548732,0.0006157178,0.000034431338,0.000050985447,0.00011035282,0.000007662258,7.896885e-7,0.00013196141],"genre_scores_gemma":[0.9971594,0.0024442605,0.0002827942,0.000006741501,0.000024926547,0.0000013124105,0.000018568335,0.000006795469,0.000055196822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923825,0.00006818071,0.00041221472,0.000086161715,0.00009867903,0.00009652643],"domain_scores_gemma":[0.9995176,0.00000846802,0.00029334644,0.00008379964,0.000072104485,0.00002466821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001552579,0.00006189976,0.00022757481,0.000046546957,0.000022220936,0.000005066646,0.00010504853,0.00011614593,0.000034275177],"category_scores_gemma":[0.000019955201,0.00005724829,0.00008151251,0.000052656105,0.00011371329,0.000007596827,0.000021375346,0.00011080502,2.423573e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000987404,0.00014723666,0.01575411,0.00008468973,0.000028383614,0.00031158383,0.00016368977,0.00005851381,0.9818286,0.000051358955,0.000105068175,0.0013680813],"study_design_scores_gemma":[0.0014999392,0.00027514712,0.02139264,0.000096922835,0.000022058804,0.011019784,0.00007168177,0.00006320417,0.96361506,0.00006387775,0.0017847299,0.000094945055],"about_ca_topic_score_codex":0.00001865159,"about_ca_topic_score_gemma":0.000057630903,"teacher_disagreement_score":0.018213475,"about_ca_system_score_codex":0.0000035239877,"about_ca_system_score_gemma":0.000014472507,"threshold_uncertainty_score":0.23345174},"labels":[],"label_agreement":null},{"id":"W2135471715","doi":"10.1111/j.1365-2141.2010.08331.x","title":"Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B‐cell lymphoma treated with R‐CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E‐IPI)","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"International Prognostic Index; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Prednisone; Vincristine; Population; CHOP; Rituximab; Oncology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.011323437320668489,"score_gpt":0.26909237899233773,"score_spread":0.25776894167166925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135471715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842095,0.00016812116,0.0000034795066,0.00003352569,0.00006652069,0.0012642678,0.000021484902,0.0000056526274,0.00001600326],"genre_scores_gemma":[0.99969876,0.0000108116155,0.000089512214,0.00003545797,0.000014819883,0.00007192794,0.000051472343,0.000023422803,0.000003808271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976089,0.00036989638,0.0009913127,0.00026114273,0.0004709987,0.00029773178],"domain_scores_gemma":[0.9986218,0.00020804662,0.0006879056,0.00018213851,0.00020701818,0.00009309469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003285461,0.00020425324,0.000953469,0.0004450706,0.000029449677,0.000045293218,0.00016788323,0.00015349673,0.000029487494],"category_scores_gemma":[0.000076121716,0.00015231286,0.00007288083,0.0002924293,0.00019237166,0.00018973536,0.000030604984,0.00031469157,0.0000010913627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010130821,0.031145737,0.93596506,0.000076723496,0.0001379002,0.026567992,0.0040986342,0.0000052607215,0.000021219552,0.0000068590043,0.00001994322,0.0009416089],"study_design_scores_gemma":[0.04296666,0.0067027225,0.94252217,0.0010129453,0.00020091583,0.0047192164,0.0015373873,0.000037867296,0.00015550842,0.000012699125,0.0000025230047,0.00012936599],"about_ca_topic_score_codex":0.0011290722,"about_ca_topic_score_gemma":0.023967313,"teacher_disagreement_score":0.04195358,"about_ca_system_score_codex":0.000069479116,"about_ca_system_score_gemma":0.00020581813,"threshold_uncertainty_score":0.9938427},"labels":[],"label_agreement":null},{"id":"W2137364453","doi":"10.1111/bjh.13341","title":"Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Azacitidine; Medicine; Pyoderma gangrenosum; Cytopenia; Myelodysplastic syndromes; Trisomy 8; Dysplasia; Dermatology; Prednisone; Leukocytosis; Surgery; Internal medicine; Gastroenterology; Bone marrow; Disease","score_opus":0.016075887073292428,"score_gpt":0.2564479097958372,"score_spread":0.24037202272254476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137364453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906348,0.0041828826,0.0002703952,0.0016821685,0.00047004732,0.00016445121,0.0000044678086,0.000018235616,0.0025725286],"genre_scores_gemma":[0.9978107,0.00011520679,0.0005996905,0.0011064134,0.000051454957,0.000004926478,0.000005550976,0.00002614614,0.00027987346],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983495,0.0000896843,0.0008255394,0.0001472426,0.00025369794,0.00033436847],"domain_scores_gemma":[0.99902445,0.00005683421,0.00022537062,0.00013201809,0.00024199103,0.00031931026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042315744,0.00013189898,0.00084792107,0.00036894158,0.000030363197,0.00002049706,0.00015811258,0.00013225047,0.00028212127],"category_scores_gemma":[0.0005319439,0.00014599717,0.00010839225,0.00024025621,0.00009173172,0.00019680595,0.00005379429,0.0004979595,0.00012560829],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091511616,0.00059959106,0.030911587,0.00039714717,0.00025972817,0.85554665,0.0011849733,0.00019618955,0.0006937857,0.0003996955,0.08434636,0.024549149],"study_design_scores_gemma":[0.0047694505,0.000906357,0.06889044,0.0008962726,0.000060906335,0.9056129,0.0009368574,0.00002848208,0.00020531556,0.0005970078,0.016915815,0.00018022361],"about_ca_topic_score_codex":0.000043124393,"about_ca_topic_score_gemma":0.00006974956,"teacher_disagreement_score":0.06743055,"about_ca_system_score_codex":0.00007271786,"about_ca_system_score_gemma":0.0004975061,"threshold_uncertainty_score":0.5953592},"labels":[],"label_agreement":null},{"id":"W2137460829","doi":"10.1111/bjh.13310","title":"Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Deutsche Forschungsgemeinschaft","keywords":"Histiocyte; Lymphoma; Comparative genomic hybridization; Pathology; Biology; Locus (genetics); Medicine; Gene; Genetics; Chromosome","score_opus":0.027286588475523964,"score_gpt":0.26722657711876363,"score_spread":0.23993998864323968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137460829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647492,0.031757418,0.0010746347,0.00030872415,0.0003299411,0.00047919113,0.0001377206,0.000030569943,0.0011325544],"genre_scores_gemma":[0.99329036,0.0022946324,0.0033172795,0.00034668966,0.0002931604,0.000023784622,0.00007952512,0.00004855348,0.0003060052],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99691063,0.00038053817,0.0012318068,0.00042517087,0.00047435818,0.0005775163],"domain_scores_gemma":[0.9973264,0.0002600819,0.00093562214,0.00026693562,0.0006471368,0.000563849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007438213,0.00036855787,0.0017596725,0.00026796243,0.00021825137,0.00011324128,0.00020138112,0.00024195794,0.000037806014],"category_scores_gemma":[0.0001387269,0.00037096383,0.00021492198,0.00019291465,0.00023367166,0.00024730258,0.00009642164,0.00011774188,0.000042375137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003935308,0.015020949,0.65008277,0.0021782634,0.0030130986,0.1896683,0.011476111,0.0001484002,0.008341904,0.00080134545,0.08244452,0.032889012],"study_design_scores_gemma":[0.112181805,0.0031523122,0.34581015,0.0017816689,0.0028113017,0.3759948,0.003149492,0.00024664614,0.11928005,0.0012177278,0.033159822,0.0012142339],"about_ca_topic_score_codex":0.00015268153,"about_ca_topic_score_gemma":0.000035352165,"teacher_disagreement_score":0.30427265,"about_ca_system_score_codex":0.0010100269,"about_ca_system_score_gemma":0.0011531113,"threshold_uncertainty_score":0.99987423},"labels":[],"label_agreement":null},{"id":"W2139789114","doi":"10.1111/bjh.13389","title":"Response‐adapted therapy for aggressive non‐Hodgkin's lymphomas based on early [18F] FDG‐PET scanning: ECOG‐ACRIN Cancer Research Group study (E3404)","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"U.S. Public Health Service; ECOG-ACRIN Cancer Research Group; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; American College of Radiology Imaging Network","keywords":"Medicine; Vincristine; Internal medicine; Positron emission tomography; Confidence interval; Rituximab; Lymphoma; Nuclear medicine; Prednisone; Etoposide; PET-CT; Oncology; Cyclophosphamide; Chemotherapy","score_opus":0.08657996483546601,"score_gpt":0.39282087888565004,"score_spread":0.30624091405018405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139789114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98857164,0.004960472,0.000041576543,0.0038469974,0.0005928464,0.001609199,0.00005687668,0.000026101217,0.0002942933],"genre_scores_gemma":[0.99704874,0.0004188736,0.0007935206,0.0007593999,0.0002617512,0.00041939088,0.000012010952,0.00007148847,0.00021482192],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99573916,0.0011193358,0.00086963194,0.0004724556,0.0010655267,0.0007338929],"domain_scores_gemma":[0.99534166,0.0013506484,0.0006960936,0.00038463456,0.0016503241,0.0005766605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029348177,0.00029605205,0.0012473362,0.00061672414,0.00026074657,0.00011600037,0.00033688213,0.00014254906,0.000100439],"category_scores_gemma":[0.0014105834,0.00026243823,0.00030156958,0.00038897368,0.00022609449,0.00014361551,0.00005719466,0.00040290487,0.000019818772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08611124,0.015892914,0.2299553,0.000107023356,0.001953629,0.5217435,0.0027983522,0.00012819833,0.00047888115,0.00015233841,0.09087623,0.049802415],"study_design_scores_gemma":[0.13152882,0.061992403,0.5899019,0.004369862,0.000542831,0.1814815,0.004109634,0.00050665304,0.0052806586,0.00060758274,0.018950425,0.00072772586],"about_ca_topic_score_codex":0.0013993317,"about_ca_topic_score_gemma":0.00035686322,"teacher_disagreement_score":0.3599466,"about_ca_system_score_codex":0.00083514664,"about_ca_system_score_gemma":0.00206832,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2142086292","doi":"10.1111/bjh.12631","title":"Validation and reliability of a disease‐specific quality of life measure (the <scp>T</scp>ran<scp>Q</scp>ol) in adults and children with thalassaemia major","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; BC Children's Hospital; St. Paul's Hospital; Hospital for Sick Children; Ottawa Hospital; Children's Hospital of Eastern Ontario","funders":"National Center for Research Resources","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Limits of agreement; Gastroenterology; Nuclear medicine","score_opus":0.008488720035266033,"score_gpt":0.2236597595770129,"score_spread":0.21517103954174685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142086292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433596,0.014008847,0.00006079768,0.00069797214,0.000060438353,0.0006276678,0.000023226537,0.000008567063,0.00017655094],"genre_scores_gemma":[0.9962255,0.003338108,0.0002532571,0.00008819185,0.000033743374,0.000009603472,0.000010648784,0.00001924605,0.000021709942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975783,0.0004191877,0.0010642342,0.00025276572,0.00041628926,0.00026920417],"domain_scores_gemma":[0.99738055,0.00077013404,0.00079329684,0.00023158583,0.00054384687,0.0002805816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009661609,0.00017172283,0.0009375123,0.00013610329,0.000067659785,0.000024626594,0.00013447348,0.00022415644,0.00001401343],"category_scores_gemma":[0.0036759377,0.00012760621,0.00011476428,0.00024254908,0.0005838904,0.00018005099,0.0000494699,0.00054032716,0.0000015993812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022985303,0.00053520047,0.98954886,0.0008190708,0.00021872122,0.0002846411,0.001519282,0.000029609208,0.0002666138,0.00010593124,0.0035150354,0.0029271774],"study_design_scores_gemma":[0.0055908556,0.0003578792,0.9787164,0.0013925706,0.00015699191,0.009386012,0.0033756895,0.000030680658,0.0002350325,0.00063954847,0.000078218334,0.000040165603],"about_ca_topic_score_codex":0.00056066434,"about_ca_topic_score_gemma":0.00006928434,"teacher_disagreement_score":0.011889559,"about_ca_system_score_codex":0.000023923923,"about_ca_system_score_gemma":0.00018461666,"threshold_uncertainty_score":0.52036303},"labels":[],"label_agreement":null},{"id":"W2142098084","doi":"10.1111/bjh.13825","title":"From <scp>CLL</scp> to Multiple Myeloma ‐ Spleen Tyrosine Kinase (<scp>SYK</scp>) influences multiple myeloma cell survival and migration","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Syk; Cancer research; CD38; CXCR4; Multiple myeloma; Downregulation and upregulation; Chronic lymphocytic leukemia; Medicine; Chemistry; Immunology; Tyrosine kinase; Leukemia; Receptor; Biology; Chemokine; Stem cell; Cell biology; Immune system; Internal medicine; CD34","score_opus":0.028114109119932396,"score_gpt":0.2817599126208232,"score_spread":0.25364580350089083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142098084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95907664,0.013491871,0.00017100683,0.02269161,0.0014620897,0.0013467852,0.0011903434,0.00008329058,0.00048633313],"genre_scores_gemma":[0.91070706,0.004190449,0.015262866,0.04611491,0.0126965605,0.00023219865,0.0040662955,0.00056335225,0.0061662993],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926379,0.00088077574,0.0019331722,0.0011044572,0.0018871564,0.0015565912],"domain_scores_gemma":[0.9913442,0.0035828764,0.0013628943,0.0006816383,0.001632372,0.0013959978],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00085768197,0.0009359765,0.0030340368,0.0011583641,0.00029816263,0.00037089677,0.0007403426,0.0015309385,0.000050786435],"category_scores_gemma":[0.008219411,0.00093255227,0.0005077693,0.000571766,0.00047539524,0.0004769485,0.00037313846,0.002947961,0.00021218494],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017223277,0.00042641594,0.089705996,0.0005030334,0.00081088097,0.1446619,0.00062609377,0.000008510507,0.0021585335,0.0000016352121,0.7558938,0.0050309594],"study_design_scores_gemma":[0.020229854,0.002608818,0.14369924,0.0027700292,0.0010934129,0.09592083,0.001455579,0.00037311122,0.008681189,0.00030062773,0.7224431,0.00042420803],"about_ca_topic_score_codex":0.004183298,"about_ca_topic_score_gemma":0.0027186337,"teacher_disagreement_score":0.053993244,"about_ca_system_score_codex":0.0002915101,"about_ca_system_score_gemma":0.00080782315,"threshold_uncertainty_score":0.9997653},"labels":[],"label_agreement":null},{"id":"W2142599682","doi":"10.1046/j.1365-2141.2003.04203.x","title":"Autologous stem cell transplant for relapsed and refractory peripheral T‐cell lymphoma: variable outcome according to pathological subtype","year":2003,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Etoposide; Lymphoma; Univariate analysis; Internal medicine; Melphalan; Diffuse large B-cell lymphoma; Autologous stem-cell transplantation; Gastroenterology; Large-cell lymphoma; Aggressive lymphoma; Survival analysis; Chemotherapy; Surgery; Oncology; Rituximab; Multivariate analysis","score_opus":0.020477174359010752,"score_gpt":0.2595813583051911,"score_spread":0.23910418394618033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142599682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990267,0.0060836817,0.0013259267,0.00034478668,0.00046171815,0.0003895929,0.00002702225,0.000022548764,0.0010777301],"genre_scores_gemma":[0.98878145,0.00045120515,0.009615234,0.0006124566,0.000048935806,0.000029508103,0.000005678146,0.000027161625,0.00042834767],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982461,0.00015805966,0.0007356188,0.00028309313,0.00016544698,0.0004117071],"domain_scores_gemma":[0.99885553,0.00025710964,0.00028542962,0.00013455265,0.00016137694,0.00030600425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044381368,0.00019721632,0.0010219712,0.000104738065,0.00013427569,0.000042155887,0.00009577161,0.00024116671,0.000051312654],"category_scores_gemma":[0.00010052504,0.00017493071,0.00018647581,0.00009354414,0.00006498207,0.000085170366,0.00001767407,0.00015188206,0.00000756856],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034424602,0.008266003,0.61200005,0.001388063,0.0005159344,0.30857584,0.0016767548,0.00004736071,0.007627052,0.0029700964,0.006834152,0.046656244],"study_design_scores_gemma":[0.02993106,0.005951093,0.073005706,0.00055220706,0.00096149044,0.8531897,0.0011783496,0.000040980234,0.006751284,0.00043218757,0.027468331,0.0005375982],"about_ca_topic_score_codex":0.000023717783,"about_ca_topic_score_gemma":0.000005749342,"teacher_disagreement_score":0.5446139,"about_ca_system_score_codex":0.00018561327,"about_ca_system_score_gemma":0.00027222486,"threshold_uncertainty_score":0.7133467},"labels":[],"label_agreement":null},{"id":"W2149252069","doi":"10.1111/j.1365-2141.2006.06133.x","title":"Acquired and inherited disorders of cobalamin and folate in children","year":2006,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"Medical Research Council; Cancer Research Society; McGill University","keywords":"Cobalamin; Methionine synthase; Megaloblastic anemia; Malabsorption; Internal medicine; Methylenetetrahydrofolate reductase; Intrinsic factor; Medicine; Endocrinology; Biology; Vitamin B12; Methionine; Allele; Genetics; Gene","score_opus":0.018494374297071604,"score_gpt":0.32437645443380336,"score_spread":0.30588208013673174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149252069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2555514,0.7439447,0.000002424016,0.000035455923,0.000031212643,0.00032224882,0.000018571101,0.0000027785725,0.00009120309],"genre_scores_gemma":[0.013944118,0.9857397,0.00012963524,0.000012279985,0.00003794551,0.0000041747808,0.000030991185,0.000030813324,0.00007033288],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9980018,0.00022816546,0.0010918803,0.00019957461,0.00020795841,0.0002705823],"domain_scores_gemma":[0.9990203,0.00013034108,0.0005275529,0.000108444525,0.000098780554,0.00011457591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004066525,0.0001970815,0.002682536,0.00052398094,0.000025709156,0.000021001966,0.00012214377,0.00037826368,0.000021157019],"category_scores_gemma":[0.00015915926,0.00018409891,0.00020031304,0.00028850845,0.00031183191,0.00007120208,0.00008630372,0.00048550364,0.0000010584056],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003845869,0.00017680557,0.009507201,0.0074225743,0.00035197526,0.0074162367,0.000016582304,3.685674e-8,0.0000030682563,0.000019158815,0.0006756138,0.97437227],"study_design_scores_gemma":[0.00400497,0.00092070526,0.053556625,0.035501763,0.001007971,0.7973466,0.000027421167,0.000005244865,0.000002046507,0.00019747403,0.10713221,0.00029698477],"about_ca_topic_score_codex":0.00035020983,"about_ca_topic_score_gemma":0.00023191594,"teacher_disagreement_score":0.9740753,"about_ca_system_score_codex":0.000028048793,"about_ca_system_score_gemma":0.00020246864,"threshold_uncertainty_score":0.75073355},"labels":[],"label_agreement":null},{"id":"W2158060003","doi":"10.1111/j.1365-2141.2007.06909.x","title":"Familial myelodysplasia and acute myeloid leukaemia – a review","year":2007,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"Cancer Research UK; Lady Tata Memorial Trust","keywords":"CEBPA; Medicine; Myeloid; Germline; Pedigree chart; RUNX1; Germline mutation; Myelodysplastic syndromes; Oncology; Internal medicine; Mutation; Genetics; Gene; Biology; Haematopoiesis; Bone marrow; Stem cell","score_opus":0.04561530417102781,"score_gpt":0.3816885380774147,"score_spread":0.3360732339063869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158060003","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022672933,0.9960555,0.00007865914,0.0004291833,0.0004981455,0.0013063077,0.00006016735,0.000031980097,0.0013133525],"genre_scores_gemma":[0.0000033037402,0.99501276,0.0020593929,0.0010730644,0.0006826812,0.00002767787,0.00007431879,0.0001461069,0.0009206649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99417424,0.00057262223,0.0029057583,0.0005787224,0.000852665,0.0009159987],"domain_scores_gemma":[0.9957051,0.0006226812,0.0017168912,0.00047604766,0.00070982915,0.0007694222],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002289641,0.0006465088,0.008320081,0.00079101557,0.00013134333,0.00006408576,0.00063033524,0.0010674511,0.00028207526],"category_scores_gemma":[0.0012574465,0.0005881499,0.0012586104,0.0006923691,0.00057004445,0.00017320063,0.000311337,0.0037984487,0.00012653961],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052588144,0.000049102273,0.0000034143493,0.06476572,0.0009802302,0.22035466,0.000007479655,3.6846461e-9,8.502999e-7,0.00004024484,0.052454717,0.661291],"study_design_scores_gemma":[0.0006780461,0.00020431001,0.000006351746,0.11018413,0.0031122677,0.44044897,0.0000057284024,3.0216117e-7,8.6662e-7,0.000015973299,0.44515795,0.00018509863],"about_ca_topic_score_codex":0.000037045695,"about_ca_topic_score_gemma":0.000017975877,"teacher_disagreement_score":0.6611059,"about_ca_system_score_codex":0.0005422579,"about_ca_system_score_gemma":0.0030732546,"threshold_uncertainty_score":0.999657},"labels":[],"label_agreement":null},{"id":"W2160457008","doi":"10.1111/j.1365-2141.2009.07881.x","title":"Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Pyrogenesis (Canada); Princess Margaret Cancer Centre; Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; D. Warren Brown Family Foundation; Leukemia and Lymphoma Society","keywords":"Fludarabine; Medicine; Chronic lymphocytic leukemia; Rituximab; Internal medicine; Concomitant; Histone deacetylase inhibitor; Histone deacetylase; Tolerability; Gastroenterology; Pharmacokinetics; Toxicity; Refractory (planetary science); Oncology; Pharmacology; Lymphoma; Leukemia; Chemotherapy; Adverse effect; Histone; Biology; Cyclophosphamide","score_opus":0.009130678814489193,"score_gpt":0.29054384125824373,"score_spread":0.2814131624437545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160457008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563426,0.0027713906,0.0000047809795,0.000117020994,0.0001240408,0.0012263862,0.0000047161802,0.000012704666,0.00010467824],"genre_scores_gemma":[0.9994753,0.000107330154,0.00005375635,0.00010072775,0.000074928335,0.0000101443475,0.00000469968,0.000030091534,0.00014299767],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99685633,0.0003103668,0.001184719,0.0002837692,0.0008275681,0.00053722446],"domain_scores_gemma":[0.9980873,0.00010313309,0.00066001556,0.00042582228,0.0005048175,0.00021892831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046862074,0.00022388397,0.0011828637,0.00029118737,0.000116276155,0.000016327613,0.00036574612,0.00016034134,0.0000671148],"category_scores_gemma":[0.00040636343,0.00016851985,0.0001548441,0.0005860933,0.0002671132,0.00014816086,0.00009374249,0.00056751946,0.0000035587498],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.06390862,0.14224957,0.09328916,0.0028878867,0.0032668393,0.38632533,0.012747583,0.001726574,0.0053300485,0.00014881627,0.025424942,0.26269463],"study_design_scores_gemma":[0.6420203,0.09107033,0.043954276,0.0054224622,0.0008946304,0.20543061,0.0005905585,0.0009535858,0.008825337,0.000063796266,0.00026200485,0.0005121101],"about_ca_topic_score_codex":0.0008165148,"about_ca_topic_score_gemma":0.000755989,"teacher_disagreement_score":0.57811165,"about_ca_system_score_codex":0.01790298,"about_ca_system_score_gemma":0.010022774,"threshold_uncertainty_score":0.9955895},"labels":[],"label_agreement":null},{"id":"W2162350156","doi":"10.1111/bjh.12630","title":"Phase <scp>IA</scp>/<scp>II</scp>, multicentre, open‐label study of the <scp>CD</scp>40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐<scp>H</scp>odgkin or <scp>H</scp>odgkin lymphoma","year":2013,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Lymphoma; Medicine; Follicular lymphoma; Internal medicine; Monoclonal antibody; Radioimmunotherapy; Refractory (planetary science); Gastroenterology; MALT lymphoma; Antibody; Immunology; Biology","score_opus":0.013425289530544553,"score_gpt":0.29821879913674515,"score_spread":0.2847935096062006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162350156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433876,0.0043484755,0.00006666086,0.00017775511,0.001723741,0.007227615,0.0004623556,0.00011598202,0.0015386479],"genre_scores_gemma":[0.99078834,0.0021945548,0.0021676817,0.001187337,0.0003559034,0.00069816696,0.00029964058,0.0003787225,0.0019296698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98608786,0.0012893309,0.0046449495,0.0021230236,0.0027309048,0.003123929],"domain_scores_gemma":[0.9815181,0.0072567747,0.004786855,0.0018041312,0.0030347097,0.0015994688],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010942278,0.0019470053,0.005241566,0.0011838649,0.0010482261,0.00062181894,0.0027106854,0.0009683497,0.000040562376],"category_scores_gemma":[0.012564307,0.0015430908,0.00078262883,0.0020595524,0.000995573,0.001697843,0.0013683153,0.0015327312,0.00018519915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000495609,0.15289359,0.66912735,0.0012961986,0.0057917424,0.06326319,0.01512446,0.0002271396,0.0022256842,0.00020720207,0.063922405,0.025425443],"study_design_scores_gemma":[0.20629421,0.016770348,0.68126464,0.0055740774,0.0032001499,0.040121995,0.024636408,0.0010080098,0.011311188,0.00023686732,0.009305326,0.00027679544],"about_ca_topic_score_codex":0.0022084266,"about_ca_topic_score_gemma":0.0016051361,"teacher_disagreement_score":0.2057986,"about_ca_system_score_codex":0.0011806118,"about_ca_system_score_gemma":0.0024100281,"threshold_uncertainty_score":0.9993273},"labels":[],"label_agreement":null},{"id":"W2164957039","doi":"10.1046/j.1365-2141.2001.02763.x","title":"Technetium‐99m‐sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P‐glycoprotein expression, multidrug resistance‐related protein expression and other prognosis factors","year":2001,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"Taichung Veterans General Hospital","keywords":"Chemotherapy; P-glycoprotein; Medicine; Immunohistochemistry; Biopsy; Multiple drug resistance; Internal medicine; Lymphoma; Incidence (geometry); Gastroenterology; Pathology; Nuclear medicine; Oncology; Drug resistance; Biology","score_opus":0.009495923457740786,"score_gpt":0.24353561889019243,"score_spread":0.23403969543245165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164957039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993921,0.003505941,0.00047068187,0.00036781823,0.00005701164,0.0014590907,0.000028832092,0.00004681553,0.0001428015],"genre_scores_gemma":[0.9881021,0.00030847968,0.010762386,0.000051001745,0.000023105747,0.00007383233,0.000006813985,0.00007569925,0.0005965967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968142,0.0004133526,0.0012965183,0.00041343385,0.0005957193,0.0004667629],"domain_scores_gemma":[0.9980557,0.0001294454,0.000953164,0.0002714933,0.0003144303,0.00027574558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009008564,0.00033064012,0.0014025853,0.000482922,0.00010259062,0.00002779246,0.00022970748,0.00033908765,0.00021718608],"category_scores_gemma":[0.00021473468,0.0002617814,0.00015484747,0.0004926325,0.00040482133,0.00017164872,0.000027734843,0.00045655924,9.033871e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051317025,0.0017099611,0.10234011,0.0006404647,0.00019786367,0.030266711,0.0023885337,0.000014566192,0.8099672,0.000080461614,0.00024066516,0.0008363899],"study_design_scores_gemma":[0.02370313,0.0018860714,0.06488395,0.026452085,0.00014857772,0.04335151,0.0033935201,0.000034931523,0.83156,0.0006687071,0.0033708832,0.0005466034],"about_ca_topic_score_codex":0.00012512448,"about_ca_topic_score_gemma":0.00019147305,"teacher_disagreement_score":0.037456166,"about_ca_system_score_codex":0.000090040594,"about_ca_system_score_gemma":0.00036655169,"threshold_uncertainty_score":0.99998343},"labels":[],"label_agreement":null},{"id":"W2166156877","doi":"10.1111/bjh.12842","title":"Clinical presentation and molecular basis of congenital antithrombin deficiency in children: a cohort study","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; McMaster Children's Hospital","funders":"","keywords":"Medicine; Cohort; Pedigree chart; Pediatrics; Family history; Antithrombin III deficiency; Internal medicine; Antithrombin; Genetics; Gene; Heparin","score_opus":0.014809815999926068,"score_gpt":0.311962380162508,"score_spread":0.2971525641625819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166156877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977437,0.0006253504,0.00088395143,0.000105770116,0.00013503876,0.0003415488,0.0000013034257,0.0000047199,0.00015860671],"genre_scores_gemma":[0.9988091,0.000113815324,0.0009512901,0.000087474116,0.000021550184,0.0000023782018,0.0000020880532,0.000009176485,0.000003132204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983629,0.0003324379,0.00082048756,0.00014565181,0.00022445562,0.00011404559],"domain_scores_gemma":[0.99922097,0.00009799296,0.00033721386,0.0000952012,0.0001664119,0.000082200815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097166863,0.000070256116,0.00069648854,0.00014830707,0.00002123397,0.000010891793,0.00006508774,0.00008744796,0.000035918936],"category_scores_gemma":[0.00043606732,0.00007551498,0.00008277355,0.00012412535,0.00011202435,0.00006759287,0.00002915241,0.00020115636,0.0000013275405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040322204,0.0010025107,0.9935521,0.000018261751,0.0001366613,0.0008406266,0.00005262831,0.0000015529528,0.00059105246,0.00054909004,0.000038405553,0.0031767746],"study_design_scores_gemma":[0.004086606,0.0012017555,0.95309,0.000090336194,0.00023832705,0.039512463,0.00014719275,0.00008552955,0.0011171963,0.00037121962,0.0000022910654,0.000057089663],"about_ca_topic_score_codex":0.000076213,"about_ca_topic_score_gemma":0.00005409491,"teacher_disagreement_score":0.04046212,"about_ca_system_score_codex":0.0000063556145,"about_ca_system_score_gemma":0.0000447812,"threshold_uncertainty_score":0.30794117},"labels":[],"label_agreement":null},{"id":"W2166273322","doi":"10.1111/bjh.13452","title":"Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institutes of Health; Translational Cancer Research Network; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Georgia Clinical and Translational Science Alliance","keywords":"Medicine; Internal medicine; Cardiology; Pulmonary hypertension; Haemolysis; Immunology","score_opus":0.006200360883476113,"score_gpt":0.20430049996936722,"score_spread":0.1981001390858911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166273322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888149,0.009547103,0.00003262794,0.0005154305,0.00027732848,0.00014533082,0.0000025570466,0.000010259332,0.00065447827],"genre_scores_gemma":[0.9990473,0.00038166693,0.0003139128,0.00013475661,0.000039468803,0.0000014379341,0.00000952904,0.00001658904,0.00005536586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895716,0.00008652161,0.00039949728,0.0001235587,0.0002403664,0.00019288309],"domain_scores_gemma":[0.9992085,0.000017180151,0.00018862092,0.000075506134,0.00031003685,0.00020014668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026011828,0.00010266262,0.00061667763,0.00017315267,0.000026927788,0.00001204044,0.000042149317,0.0001656138,0.000013966164],"category_scores_gemma":[0.00011830675,0.000086009015,0.00004857201,0.00018292866,0.00011439016,0.0001244039,0.000020735535,0.00038597573,0.0000025840075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032319394,0.00071242324,0.88817394,0.00012457604,0.0004739455,0.05649404,0.00038432688,0.00015203169,0.000036466543,0.00010546238,0.0066349376,0.04347592],"study_design_scores_gemma":[0.015026593,0.0007622282,0.79200697,0.00051275996,0.00023720102,0.18767281,0.00043376262,0.000055197164,0.000030928073,0.00019343973,0.0029331862,0.00013490746],"about_ca_topic_score_codex":0.00007196388,"about_ca_topic_score_gemma":0.000017211214,"teacher_disagreement_score":0.13117877,"about_ca_system_score_codex":0.000033913682,"about_ca_system_score_gemma":0.00012069376,"threshold_uncertainty_score":0.3507346},"labels":[],"label_agreement":null},{"id":"W2167591463","doi":"10.1046/j.1365-2141.2000.01920.x","title":"A new mutation (G51C) in the iron‐responsive element (IRE) of <scp>l</scp>‐ferritin associated with hyperferritinaemia–cataract syndrome decreases the binding affinity of the mutated IRE for iron‐regulatory proteins","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ferritin; Point mutation; Mutation; Chemistry; Gene; Molecular biology; Cell biology; Biology; Genetics; Biochemistry","score_opus":0.009340888441430854,"score_gpt":0.22319651720773828,"score_spread":0.21385562876630743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167591463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965834,0.0016507526,0.00026279283,0.0003803196,0.000048436777,0.00092554814,0.00007674509,0.0000040360273,0.00006797143],"genre_scores_gemma":[0.99877167,0.00014223212,0.0006305074,0.00014585789,0.000041091433,0.000060637187,0.00003502435,0.000027259266,0.00014569497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974677,0.0009044494,0.0007497386,0.00021676303,0.00033823107,0.00032311722],"domain_scores_gemma":[0.9980064,0.0005458434,0.0008731219,0.00027687053,0.00023127171,0.000066504435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001244803,0.00019156917,0.00049489696,0.00007125101,0.0001855563,0.00002964038,0.0005850388,0.00020728618,0.000035133773],"category_scores_gemma":[0.0012121818,0.00012724985,0.00022482855,0.00020880815,0.0002202634,0.000018986788,0.000044609846,0.00024119104,7.035514e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037739847,0.0034601404,0.009083288,0.0010313133,0.0020083117,0.0108373,0.004730739,0.0018109434,0.8790031,0.0013587889,0.0064010127,0.07650107],"study_design_scores_gemma":[0.0055233147,0.0034932052,0.059180338,0.002167249,0.0004753717,0.09972234,0.0054269517,0.00004392648,0.8208527,0.0015505749,0.0012439378,0.000320073],"about_ca_topic_score_codex":0.00030212983,"about_ca_topic_score_gemma":0.0005546718,"teacher_disagreement_score":0.08888504,"about_ca_system_score_codex":0.000031613217,"about_ca_system_score_gemma":0.0004269378,"threshold_uncertainty_score":0.5189099},"labels":[],"label_agreement":null},{"id":"W2167772724","doi":"10.1111/j.1365-2141.2007.06897.x","title":"Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia","year":2007,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Congenital Neutropenia; Neutropenia; Medicine; Internal medicine; Neutrophil elastase; Cyclic neutropenia; Bone marrow failure; Absolute neutrophil count; Bone marrow; Granulocyte colony-stimulating factor; Immunology; Myeloid; Chemotherapy; Haematopoiesis; Biology; Genetics; Inflammation; Stem cell","score_opus":0.004255106154128514,"score_gpt":0.22641033152833667,"score_spread":0.22215522537420815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167772724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185216,0.00753394,0.00015892973,0.000031861913,0.00006969783,0.000070934424,0.00003875615,0.0000011737327,0.00024254153],"genre_scores_gemma":[0.99746555,0.0017047543,0.00072454836,0.000031383934,0.000027212149,0.0000010899644,0.000015484351,0.000009989783,0.000019980158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991882,0.000068416266,0.00039647287,0.00011813815,0.00006625701,0.00016254892],"domain_scores_gemma":[0.99945176,0.00002932974,0.00026564323,0.000073033574,0.000107284686,0.00007296579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019232612,0.00008171559,0.00026239955,0.000073935866,0.00003791191,0.000010127933,0.00008190719,0.000110533896,0.000010150893],"category_scores_gemma":[0.00008546439,0.000089311274,0.000069221554,0.00006404348,0.000127668,0.000007938832,0.00003938154,0.00013384782,8.560598e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012308038,0.0012789433,0.87653035,0.00009213829,0.0012066269,0.03137123,0.0002410534,0.00020374834,0.021336375,0.0004027082,0.0016689284,0.06443712],"study_design_scores_gemma":[0.01898939,0.0024320835,0.559335,0.00018499553,0.00059020636,0.35802972,0.0012430536,0.000018326411,0.05435583,0.0020573684,0.0022164548,0.00054755516],"about_ca_topic_score_codex":0.00019077527,"about_ca_topic_score_gemma":0.0017846953,"teacher_disagreement_score":0.3266585,"about_ca_system_score_codex":0.000005892808,"about_ca_system_score_gemma":0.00005993655,"threshold_uncertainty_score":0.36420083},"labels":[],"label_agreement":null},{"id":"W2170261953","doi":"10.1111/j.1365-2141.2008.06999.x","title":"Toll‐like receptor 4 ligand can differentially modulate the release of cytokines by human platelets","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Platelet; Angiogenin; TLR4; Platelet activation; Cytokine; Receptor; Toll-like receptor; Monoclonal antibody; Lipopolysaccharide; Growth factor; Chemistry; Platelet-derived growth factor receptor; Biology; Cell biology; Molecular biology; Immunology; Biochemistry; Antibody; Cancer research; Innate immune system; Angiogenesis","score_opus":0.009058776191474764,"score_gpt":0.2116198140966306,"score_spread":0.20256103790515584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170261953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897714,0.008589668,0.00008001235,0.00057422277,0.00071651954,0.000119970646,0.000023981076,0.00001258687,0.000111609355],"genre_scores_gemma":[0.9969015,0.001941732,0.000021981348,0.000102939004,0.000041090396,0.0000032051494,0.000048121845,0.000017071077,0.00092234503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981933,0.00044210255,0.0008785278,0.00013382923,0.000070143426,0.0002820858],"domain_scores_gemma":[0.9987077,0.00014478553,0.0007253239,0.0001786835,0.00021605144,0.000027432914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028939274,0.00014710141,0.00063237024,0.000113634596,0.0003451129,0.000012762562,0.00034806202,0.00025814035,0.00024368984],"category_scores_gemma":[0.000110744935,0.00012277355,0.00018482578,0.00008532848,0.0004602525,0.00010859458,0.00005628108,0.0004321501,0.000027155915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047613797,0.00022454855,0.0004212671,0.00003009132,0.00036424748,0.0020625233,0.00044620785,0.0000059072645,0.9393733,0.00013988938,0.0519818,0.004474041],"study_design_scores_gemma":[0.0028058125,0.00056029717,0.0038480773,0.0002182577,0.00009128603,0.25112557,0.00013811019,0.0000026914713,0.7173748,0.00021383246,0.023414742,0.00020651985],"about_ca_topic_score_codex":0.00018977698,"about_ca_topic_score_gemma":0.00006112659,"teacher_disagreement_score":0.24906304,"about_ca_system_score_codex":0.000019600338,"about_ca_system_score_gemma":0.00009554236,"threshold_uncertainty_score":0.500656},"labels":[],"label_agreement":null},{"id":"W2171267773","doi":"10.1046/j.1365-2141.2002.03973.x","title":"Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Total body irradiation; Cyclophosphamide; Medicine; Internal medicine; Bone marrow; Busulfan; Transplantation; Gastroenterology; Surgery; Chemotherapy","score_opus":0.026056513904695936,"score_gpt":0.30676602770503475,"score_spread":0.2807095138003388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171267773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889233,0.0028632758,0.0062891156,0.00035363028,0.0005912533,0.00070846605,0.000048823622,0.000028036438,0.00019411415],"genre_scores_gemma":[0.99163646,0.00084262004,0.007091488,0.000049731192,0.000056771358,0.000031593874,0.0001677136,0.000053763248,0.00006987482],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99681926,0.00017284136,0.001792245,0.00028927877,0.0004897106,0.00043667058],"domain_scores_gemma":[0.99764496,0.0006849389,0.001063758,0.0001690195,0.00025169292,0.00018564491],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069932675,0.0002612239,0.0014259776,0.0003353437,0.00020122487,0.000024747507,0.00012790466,0.00029449296,0.00006363003],"category_scores_gemma":[0.0002126993,0.00028317617,0.00027938953,0.000318364,0.00010457456,0.00025271985,0.000007881858,0.00048400744,0.000004013255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017051002,0.0023887462,0.7681172,0.005840231,0.002795437,0.10406389,0.012670146,0.004409114,0.07442445,0.00033756773,0.0012965163,0.006605705],"study_design_scores_gemma":[0.07126883,0.006723744,0.35217255,0.010436281,0.006235852,0.45897064,0.0028186706,0.0027403608,0.08693928,0.00024337045,0.00022007829,0.0012303496],"about_ca_topic_score_codex":0.00012223431,"about_ca_topic_score_gemma":0.00026251306,"teacher_disagreement_score":0.41594464,"about_ca_system_score_codex":0.00020519234,"about_ca_system_score_gemma":0.00009904135,"threshold_uncertainty_score":0.99996203},"labels":[],"label_agreement":null},{"id":"W2173155709","doi":"10.1111/bjh.13810","title":"Laboratory measurement of the direct oral anticoagulants","year":2015,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Rivaroxaban; Edoxaban; Apixaban; Dabigatran; Medicine; Anticoagulant; Discovery and development of direct thrombin inhibitors; Pharmacology; Coagulation; Direct thrombin inhibitor; Drug; Warfarin; Thrombin; Internal medicine; Atrial fibrillation","score_opus":0.1989839693630975,"score_gpt":0.39664341475641934,"score_spread":0.19765944539332184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173155709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044313498,0.99707156,0.0000077631275,0.0001726467,0.0011397784,0.0004251701,0.000019369232,0.000007802368,0.0007127423],"genre_scores_gemma":[0.0009768902,0.99822253,0.00015208518,0.00004005168,0.0003878701,7.9756643e-7,0.000003904948,0.000028359049,0.00018752705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971854,0.00050871744,0.0012578801,0.00012687466,0.0007454517,0.00017567142],"domain_scores_gemma":[0.9970994,0.00008147424,0.0016195644,0.00021984996,0.0008773241,0.000102408005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016802122,0.00018546444,0.0035711941,0.00017589613,0.000038812665,0.000016720947,0.00025411497,0.00020492073,0.00005486049],"category_scores_gemma":[0.0009456982,0.00012740227,0.00076933095,0.00030393127,0.00011628139,0.00005299755,0.000090160065,0.00033951056,0.000011325747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000702318,0.000058902308,0.002196948,0.019750584,0.0025530804,0.008857153,0.000027968921,0.0000011039776,0.000003642437,0.00015457177,0.058323994,0.90800184],"study_design_scores_gemma":[0.0005909615,0.00007802971,0.00024095461,0.01693979,0.0029744143,0.030545097,0.000012786943,3.4072207e-7,0.0000077132445,0.000025804908,0.9484808,0.00010330381],"about_ca_topic_score_codex":0.000011188687,"about_ca_topic_score_gemma":0.000013423946,"teacher_disagreement_score":0.9078985,"about_ca_system_score_codex":0.00010131374,"about_ca_system_score_gemma":0.000880924,"threshold_uncertainty_score":0.51953137},"labels":[],"label_agreement":null},{"id":"W2182872902","doi":"10.1111/bjh.13855","title":"A phase <scp>II</scp> study of cyclophosphamide, etoposide, vincristine and prednisone ( <scp>CEOP</scp> ) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T‐cell lymphoma ( <scp>PTCL</scp> ): final results from the T‐ cell consortium trial","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Genentech; Spectrum Pharmaceuticals","keywords":"Vincristine; Etoposide; Medicine; Cyclophosphamide; Prednisone; Lymphoma; Internal medicine; Chemotherapy","score_opus":0.02110693813914477,"score_gpt":0.2709042396403967,"score_spread":0.24979730150125196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182872902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98543257,0.009261117,0.000074712116,0.00016377789,0.00047935935,0.0036103353,0.0005022511,0.000039468705,0.00043640152],"genre_scores_gemma":[0.9943722,0.0009057304,0.0029151195,0.00030382635,0.00041896696,0.00019124402,0.00017424877,0.000109440436,0.0006092112],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99485713,0.0004514326,0.0020424353,0.00078107615,0.0010728285,0.00079507835],"domain_scores_gemma":[0.9917262,0.002934227,0.002845283,0.00050908077,0.001384823,0.0006003625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085035356,0.0006534888,0.0021015347,0.00016106527,0.00035424702,0.00015396421,0.0004131451,0.00025481725,0.000004936053],"category_scores_gemma":[0.0019189498,0.0004537181,0.00025577072,0.00021941404,0.000363376,0.00029070248,0.00015129618,0.0003496464,0.000002972196],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09949318,0.16341233,0.54609615,0.0004385498,0.007707365,0.050182696,0.04471727,0.00033931702,0.00050779234,0.00003289124,0.05932038,0.027752094],"study_design_scores_gemma":[0.7962459,0.107599705,0.051316004,0.0010854178,0.001861348,0.016524965,0.008501696,0.00026602703,0.011055872,0.00014392385,0.0052457717,0.00015341816],"about_ca_topic_score_codex":0.0020901777,"about_ca_topic_score_gemma":0.0005028191,"teacher_disagreement_score":0.69675267,"about_ca_system_score_codex":0.0002289505,"about_ca_system_score_gemma":0.0010329293,"threshold_uncertainty_score":0.99979144},"labels":[],"label_agreement":null},{"id":"W2214404358","doi":"10.1111/bjh.13876","title":"Relative frequency of non‐Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases","year":2015,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Epidemiology; Internal medicine; Follicular lymphoma; Gastroenterology","score_opus":0.06435771200033749,"score_gpt":0.29654128465463137,"score_spread":0.23218357265429387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214404358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10795533,0.8908171,2.8197144e-7,0.000091414346,0.000065240376,0.00079555943,0.000098901706,0.0000022926563,0.00017388152],"genre_scores_gemma":[0.047442265,0.9522212,0.00016489743,0.000032710173,0.000028781842,0.000040009603,0.000036646972,0.000024055806,0.000009439398],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9965336,0.0006775419,0.0019545252,0.00023396505,0.00031632546,0.00028405982],"domain_scores_gemma":[0.9965459,0.0006520831,0.0019347769,0.0002041093,0.0005342628,0.00012884686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058627845,0.00029364374,0.004323175,0.00037753856,0.000023069564,0.000008261087,0.00019739187,0.00024731757,0.000031308526],"category_scores_gemma":[0.0013246194,0.00020542534,0.00032337382,0.00091085915,0.000236777,0.00008643898,0.00006280332,0.000325679,0.0000025885527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105661864,0.0021563314,0.057739917,0.1078513,0.0014268644,0.15118553,0.0017529749,1.4392289e-7,2.4049024e-7,0.0001707132,0.0020068313,0.6756035],"study_design_scores_gemma":[0.0042025046,0.0008350295,0.050762612,0.4418879,0.0029222057,0.463151,0.00024128915,5.2646726e-7,0.0000022948414,0.00008193358,0.03565916,0.00025354215],"about_ca_topic_score_codex":0.0008719615,"about_ca_topic_score_gemma":0.002111536,"teacher_disagreement_score":0.67534995,"about_ca_system_score_codex":0.00036030303,"about_ca_system_score_gemma":0.0018880063,"threshold_uncertainty_score":0.83770025},"labels":[],"label_agreement":null},{"id":"W2220332556","doi":"10.1111/bjh.13885","title":"Non‐Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non‐Hodgkin Lymphoma Classification Project","year":2015,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; University of Nebraska Medical Center","keywords":"Lymphoma; Hodgkin lymphoma; Epidemiology; Medicine; Follicular lymphoma; Internal medicine; Demography; Human immunodeficiency virus (HIV); Oncology; Immunology","score_opus":0.0644318610691131,"score_gpt":0.3120596814207806,"score_spread":0.24762782035166753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220332556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481785,0.044671807,0.00003241506,0.0045268903,0.00045223106,0.00051270536,0.00010184981,0.000009434497,0.0015141674],"genre_scores_gemma":[0.9879562,0.009972459,0.000737153,0.00088685617,0.0002139963,0.00005456445,0.00005485019,0.000024677038,0.000099241865],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99755275,0.00021069315,0.0011797631,0.00024465655,0.00056446274,0.0002476871],"domain_scores_gemma":[0.9976826,0.0003952939,0.00091942464,0.00027859924,0.00059331633,0.00013082127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082810095,0.0001906882,0.00097311195,0.00016160063,0.0000409415,0.000035267512,0.00036657418,0.00013806227,0.00009210833],"category_scores_gemma":[0.0009873385,0.00014551767,0.00025566536,0.0002627234,0.00015129328,0.0001251146,0.00007698106,0.00011170851,0.00003803161],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016667446,0.006898042,0.31390575,0.0012973105,0.001756972,0.115159646,0.0064147143,0.000004626595,0.0004778578,0.0003640234,0.21389987,0.33815446],"study_design_scores_gemma":[0.031180397,0.0017691862,0.3934801,0.038250726,0.0013304054,0.46959716,0.008467563,0.00033041264,0.001908595,0.0007401075,0.052387204,0.0005581502],"about_ca_topic_score_codex":0.0028648167,"about_ca_topic_score_gemma":0.0005188333,"teacher_disagreement_score":0.35443753,"about_ca_system_score_codex":0.00042775687,"about_ca_system_score_gemma":0.0012071322,"threshold_uncertainty_score":0.5934038},"labels":[],"label_agreement":null},{"id":"W2224902945","doi":"10.1111/bjh.13903","title":"Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the <scp>BC</scp> Cancer Agency Centre for Lymphoid Cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"Canadian Cancer Society Research Institute; University of British Columbia; Canadian Cancer Society; Cancer Research Institute","keywords":"Medicine; Hazard ratio; Malignancy; Standardized mortality ratio; Cancer registry; Cancer; Pediatrics; Incidence (geometry); Confidence interval; Radiation therapy; Internal medicine; Proportional hazards model; Young adult","score_opus":0.02136133460009234,"score_gpt":0.3242810595503829,"score_spread":0.30291972495029057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224902945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96281135,0.02874335,0.000016630467,0.0050109373,0.00088487274,0.0020314194,0.00033904324,0.0000162575,0.00014616485],"genre_scores_gemma":[0.95893794,0.04002488,0.00011302444,0.00022783664,0.00022268617,0.00017489413,0.000007703223,0.000059780024,0.00023122533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493927,0.0009868349,0.0019049639,0.0005676086,0.00092227844,0.0006790532],"domain_scores_gemma":[0.9953535,0.0007233393,0.0016899221,0.00041842993,0.0015881687,0.00022662479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031947836,0.00032795974,0.0014726577,0.00025272006,0.00021892639,0.000054433378,0.0003457227,0.0002828812,0.00002373328],"category_scores_gemma":[0.0020454489,0.00022324015,0.00024709827,0.0004623562,0.0015995789,0.0003019,0.00023782293,0.0004174373,1.5099066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020824604,0.00046373776,0.964087,0.0016741855,0.00046923908,0.0008555025,0.0061939387,0.0000019231904,0.00020015908,0.00032343835,0.0012395709,0.024283022],"study_design_scores_gemma":[0.010693658,0.00019642765,0.9586764,0.0077004484,0.00029866752,0.01737632,0.002182867,0.000029734718,0.0014049653,0.0011190184,0.00017303448,0.00014848406],"about_ca_topic_score_codex":0.13501796,"about_ca_topic_score_gemma":0.27052075,"teacher_disagreement_score":0.13550277,"about_ca_system_score_codex":0.00019539897,"about_ca_system_score_gemma":0.0010391107,"threshold_uncertainty_score":0.91034687},"labels":[],"label_agreement":null},{"id":"W22346506","doi":"10.1155/1994/587573","title":"Hormonal replacement therapy, prothromboic mutations and the risk of venous thrombosis","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Venous thrombosis; Thrombosis; Venous thromboembolism; Hormonal therapy; Internal medicine; Intensive care medicine; Cancer; Breast cancer","score_opus":0.020574201144031377,"score_gpt":0.25487942168497907,"score_spread":0.23430522054094768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W22346506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756037,0.018900517,0.00013167787,0.0036021557,0.00013897289,0.0006368137,0.000007970383,0.0000086389955,0.00096955465],"genre_scores_gemma":[0.96053237,0.03823393,0.0005995169,0.00048269925,0.0000613502,0.000028636377,0.0000015100002,0.000015417982,0.000044585635],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99853027,0.00021418786,0.00065062294,0.00013302545,0.00028233754,0.00018953993],"domain_scores_gemma":[0.99873203,0.00020039194,0.0006222971,0.00016561389,0.0002013949,0.00007829525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067700347,0.000108751716,0.0009122347,0.00010305511,0.00015004772,0.000025206737,0.0001196621,0.00004574998,0.0003942982],"category_scores_gemma":[0.00019456682,0.00008055832,0.00018699591,0.00011761562,0.00045967204,0.00007047027,0.00004316673,0.0002598958,0.0000053684107],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004261542,0.035162818,0.06202398,0.0022623534,0.02919852,0.033605438,0.030881824,0.00029150152,0.0017017467,0.038856998,0.3241816,0.43757167],"study_design_scores_gemma":[0.049520798,0.011126976,0.5143512,0.002021791,0.0048286994,0.3750868,0.0041163107,0.0009242343,0.0018787265,0.012385205,0.023131415,0.00062785833],"about_ca_topic_score_codex":0.00018162972,"about_ca_topic_score_gemma":0.000029371393,"teacher_disagreement_score":0.4523272,"about_ca_system_score_codex":0.0000217345,"about_ca_system_score_gemma":0.000032146796,"threshold_uncertainty_score":0.43172887},"labels":[],"label_agreement":null},{"id":"W2240689260","doi":"10.1111/bjh.13848","title":"<scp>ROR</scp>1‐based immunomagnetic protocol allows efficient separation of <scp>CLL</scp> and healthy B cells","year":2015,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Agentura Pro Zdravotnický Výzkum České Republiky","keywords":"Immunomagnetic separation; Protocol (science); Medicine; Chemistry; Chromatography; Pathology","score_opus":0.024498568174911556,"score_gpt":0.32620084715174036,"score_spread":0.3017022789768288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240689260","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85550684,0.017306335,0.00052949303,0.033923328,0.0018135112,0.084346056,0.00018454326,0.000109302535,0.006280564],"genre_scores_gemma":[0.2036219,0.004639275,0.030308316,0.626697,0.02353021,0.06913857,0.0018966867,0.0030932096,0.037074827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99311996,0.0008854227,0.0023884345,0.0006271177,0.0018191127,0.0011599691],"domain_scores_gemma":[0.9931053,0.0017979135,0.002168277,0.00062672864,0.0017876021,0.00051415863],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0019232667,0.00053888065,0.0026339858,0.00078471116,0.00013108345,0.00011058202,0.00058400433,0.0014564457,0.00006434573],"category_scores_gemma":[0.002121701,0.0005539841,0.00041859012,0.0003823846,0.0008168944,0.00010581691,0.00019000696,0.0030803788,0.000053720258],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016015973,0.00039713396,0.00004304035,0.00519032,0.00025460453,0.077504374,0.00024574652,0.00017141667,0.0005574183,0.000005325276,0.91492265,0.00054781866],"study_design_scores_gemma":[0.0357236,0.004589022,0.00012897461,0.0033155726,0.00041038255,0.34357375,0.00017148926,0.0043218406,0.002394924,0.000085380816,0.6051562,0.00012888343],"about_ca_topic_score_codex":0.00051093835,"about_ca_topic_score_gemma":0.000038031234,"teacher_disagreement_score":0.651885,"about_ca_system_score_codex":0.0032833538,"about_ca_system_score_gemma":0.017893957,"threshold_uncertainty_score":0.9998399},"labels":[],"label_agreement":null},{"id":"W2292975070","doi":"10.1111/bjh.14007","title":"Rituximab extended schedule or retreatment trial for low tumour burden non‐follicular indolent B‐cell non‐Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Clinical endpoint; Randomization; Lymphoma; Randomized controlled trial; Oncology; Asymptomatic; Gastroenterology; Surgery","score_opus":0.02048215489209315,"score_gpt":0.3183431877896765,"score_spread":0.29786103289758337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292975070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94015646,0.0006444985,0.0015907951,0.0020579975,0.0006502581,0.054364383,0.000065674976,0.000034413235,0.00043551013],"genre_scores_gemma":[0.947897,0.00026309557,0.0060899197,0.00041592625,0.00088766316,0.04347297,0.000017094078,0.00008409535,0.00087221287],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962071,0.0003492709,0.0016070924,0.0005926762,0.0004990352,0.00074478384],"domain_scores_gemma":[0.9968409,0.00049344107,0.0011168529,0.0003378486,0.0007282406,0.00048274343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061561284,0.0004708032,0.0023527038,0.00024693232,0.00019605902,0.000073900344,0.00029470725,0.0004267196,0.00039257176],"category_scores_gemma":[0.00039356426,0.00030754873,0.000637696,0.000170877,0.00023834614,0.00023388631,0.00010635243,0.00021013813,0.00009533826],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2839782,0.049986884,0.002472485,0.0011334057,0.003941828,0.35420993,0.0011821054,0.000010951395,0.006427307,0.0002761199,0.016995782,0.27938503],"study_design_scores_gemma":[0.70162374,0.046156507,0.0012260297,0.003482685,0.000996463,0.18969573,0.00048549622,0.00011622915,0.038782258,0.00017768299,0.01674488,0.0005122722],"about_ca_topic_score_codex":0.000092727976,"about_ca_topic_score_gemma":0.00012920743,"teacher_disagreement_score":0.41764557,"about_ca_system_score_codex":0.0011831552,"about_ca_system_score_gemma":0.0021156098,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W2298793090","doi":"10.1111/bjh.14033","title":"Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an <scp>MDS</scp>‐<scp>CAN</scp> prospective study","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Statistics Canada; Queen Elizabeth II Health Sciences Centre; Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre; Dalhousie University; University of Ottawa; Vancouver General Hospital; Princess Margaret Cancer Centre; Alberta Hospital Edmonton; Hamilton Health Sciences; Dr. Georges-L.-Dumont University Hospital Centre; Saskatchewan Cancer Agency; CancerCare Manitoba; Ottawa Hospital; Health Sciences Centre; University of Alberta Hospital; University Health Network; Nova Scotia Health Authority; St. Paul's Hospital; University of British Columbia; Juravinski Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Celgene","keywords":"Medicine; Comorbidity; Hazard ratio; Proportional hazards model; Internal medicine; Myelodysplastic syndromes; International Prognostic Scoring System; Prospective cohort study; Confidence interval; Multivariate analysis; Grip strength; Physical therapy","score_opus":0.011184719016116514,"score_gpt":0.26630601102931284,"score_spread":0.25512129201319633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298793090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722326,0.00028968765,0.000040506562,0.000043031254,0.0004574368,0.0015316472,0.00011315107,0.000050538198,0.0002507435],"genre_scores_gemma":[0.9993503,0.00008562629,0.0000797926,0.00003653878,0.00005734756,0.000023946575,0.00003279823,0.00012331174,0.00021030981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941202,0.0008685062,0.0014691947,0.00068377145,0.0016275663,0.0012307696],"domain_scores_gemma":[0.9947188,0.0018747824,0.0009672222,0.00043405365,0.0011781227,0.0008270481],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007483936,0.0005322826,0.0019042308,0.0009619781,0.00014768292,0.00009957743,0.0004901442,0.0004181913,0.000102878425],"category_scores_gemma":[0.004984117,0.00037673887,0.0002391959,0.0006562224,0.00037185504,0.0007587727,0.0001948808,0.0015905931,0.000034800527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030450558,0.0029302696,0.94679415,0.000060781957,0.0010526594,0.04459875,0.0025065804,0.000018515582,0.00006797696,0.000014770088,0.00081092597,0.00084011455],"study_design_scores_gemma":[0.022373559,0.012986897,0.92086995,0.0008035727,0.00020168071,0.038740456,0.0035428829,0.000010325963,0.0001348497,0.00018905463,0.00003701725,0.00010978746],"about_ca_topic_score_codex":0.0005037499,"about_ca_topic_score_gemma":0.00048407566,"teacher_disagreement_score":0.025924228,"about_ca_system_score_codex":0.0012701459,"about_ca_system_score_gemma":0.0011052309,"threshold_uncertainty_score":0.99986845},"labels":[],"label_agreement":null},{"id":"W2300177903","doi":"10.1111/bjh.14038","title":"Increased microcirculation detected by dynamic contrast‐enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"Dietmar Hopp Stiftung; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Monoclonal gammopathy of undetermined significance; Asymptomatic; Magnetic resonance imaging; Multiple myeloma; Hazard ratio; Radiology; Bone marrow; Nuclear medicine; Dynamic contrast; Clinical significance; Univariate analysis; Internal medicine; Multivariate analysis; Confidence interval; Monoclonal; Monoclonal antibody","score_opus":0.006446553114684086,"score_gpt":0.25826079424191345,"score_spread":0.2518142411272294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300177903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98358613,0.013788788,0.0015270113,0.0004378047,0.00004385544,0.00051839364,0.000047609887,0.000012878516,0.000037527727],"genre_scores_gemma":[0.9978973,0.0005331639,0.0013990459,0.000060682283,0.000012390011,0.00002444468,0.0000072977205,0.000023126875,0.00004252264],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797046,0.00022770793,0.00085494877,0.0002199043,0.00033504007,0.0003919314],"domain_scores_gemma":[0.9984243,0.00045510425,0.00042907536,0.00014606475,0.00037720014,0.0001682827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027138364,0.00014569837,0.00070645584,0.00022982949,0.000036050318,0.000013945299,0.00013682933,0.00008495397,0.00014741562],"category_scores_gemma":[0.0010995927,0.00012644651,0.00010507605,0.00022931692,0.00021910343,0.00013660769,0.000021219477,0.00017891546,0.000010006944],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006207553,0.0003709515,0.17039622,0.00019703608,0.000059222595,0.008229288,0.00007311568,2.1141705e-7,0.59028137,0.0000030291467,0.00023820355,0.22953059],"study_design_scores_gemma":[0.011415097,0.00045557896,0.85744387,0.0033207878,0.00007926397,0.036761258,0.000047135043,0.0004758809,0.08959733,0.00023823419,0.000029008535,0.000136563],"about_ca_topic_score_codex":0.00015409912,"about_ca_topic_score_gemma":0.00010795103,"teacher_disagreement_score":0.68704766,"about_ca_system_score_codex":0.00014852728,"about_ca_system_score_gemma":0.00022621194,"threshold_uncertainty_score":0.5156339},"labels":[],"label_agreement":null},{"id":"W2305844465","doi":"10.1111/bjh.13993","title":"Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bortezomib; Medicine; Thrombotic thrombocytopenic purpura; Rituximab; Internal medicine; Refractory (planetary science); Gastroenterology; Surgery; Multiple myeloma; Platelet; Lymphoma","score_opus":0.024693447355493295,"score_gpt":0.27605972359650444,"score_spread":0.25136627624101116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305844465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97540396,0.022703802,0.000048212863,0.0006608487,0.0006106244,0.0002598417,0.000033831086,0.0000068329273,0.00027201168],"genre_scores_gemma":[0.9972899,0.0024544946,0.000032700405,0.00005437725,0.000033493892,0.000013269145,0.000004470982,0.000010771987,0.00010652915],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9978704,0.0007133406,0.0009080135,0.00014958803,0.00006884469,0.0002898442],"domain_scores_gemma":[0.9983455,0.00065628754,0.0006052714,0.00025987814,0.00011284847,0.000020213189],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037913726,0.00013351349,0.00079302624,0.00013391484,0.000061863124,0.000010016587,0.00044923427,0.000118885066,0.001081778],"category_scores_gemma":[0.00014281843,0.00008117901,0.00021618877,0.00009688921,0.00031369465,0.000119805154,0.000028039822,0.00011112925,0.0000685793],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021149714,0.016806018,0.24264936,0.0004222679,0.0044891518,0.054472584,0.005973597,0.0000107685,0.32350165,0.012147284,0.10464199,0.23277037],"study_design_scores_gemma":[0.021042569,0.0065063853,0.4155133,0.0021871855,0.00058981637,0.42600998,0.0030956648,4.982097e-7,0.02525456,0.0042684516,0.09495818,0.0005733877],"about_ca_topic_score_codex":0.00011456143,"about_ca_topic_score_gemma":0.00030017205,"teacher_disagreement_score":0.3715374,"about_ca_system_score_codex":0.00008568688,"about_ca_system_score_gemma":0.000121354766,"threshold_uncertainty_score":0.9998314},"labels":[],"label_agreement":null},{"id":"W2335871284","doi":"10.1111/bjh.14074","title":"Adolescent and young adult non‐Hodgkin lymphoma","year":2016,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Young adult; Lymphoblastic lymphoma; Incidence (geometry); Population; Anaplastic large-cell lymphoma; Oncology; Internal medicine; Pediatrics; Immunology; T cell; Environmental health","score_opus":0.01933729423817133,"score_gpt":0.3062607323202361,"score_spread":0.2869234380820648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335871284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022440795,0.9957588,0.0000206206,0.000226983,0.0007451699,0.00046155447,0.000043664175,0.000011978015,0.00048718732],"genre_scores_gemma":[0.0013652632,0.99740326,0.0002975719,0.00020323628,0.00038537307,0.000029506295,0.000012984972,0.000056885423,0.00024594142],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99754924,0.00016994488,0.0012918343,0.00031737983,0.0002928309,0.00037875798],"domain_scores_gemma":[0.99788886,0.00015016104,0.0010722048,0.00022195205,0.00032107413,0.00034575275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022017732,0.00037500056,0.0037391342,0.00025152834,0.00007207857,0.000051458683,0.00016715971,0.0004317188,0.000091645146],"category_scores_gemma":[0.000207674,0.00027209384,0.00074320275,0.00010091752,0.00016329908,0.00007536907,0.00008313531,0.0002266718,0.00007600163],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022272687,0.00039266987,0.0005041203,0.006656553,0.00063077087,0.12402835,0.000014659743,1.2768131e-9,1.0908882e-7,0.00007864473,0.0085888095,0.85908306],"study_design_scores_gemma":[0.0023000163,0.00018601831,0.0007921027,0.07678282,0.0013481084,0.5261073,0.000007443161,1.1228503e-7,0.0000024168487,0.000021654147,0.39231446,0.00013750765],"about_ca_topic_score_codex":0.00005727236,"about_ca_topic_score_gemma":0.000028429497,"teacher_disagreement_score":0.85894555,"about_ca_system_score_codex":0.00035692437,"about_ca_system_score_gemma":0.0008973934,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W2336690489","doi":"10.1111/bjh.14093","title":"Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the <scp>NOPHO</scp>‐<scp>AML</scp> 2004 study","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Stiftelsen Assar Gabrielssons Fond","keywords":"Flow cytometry; Myeloid leukaemia; Minimal residual disease; Myeloid; Residual; Disease; Medicine; Immunology; Oncology; Cancer research; Internal medicine; Leukemia; Computer science","score_opus":0.012338223372052443,"score_gpt":0.26754120234998485,"score_spread":0.2552029789779324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336690489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932238,0.0027260918,0.000086692235,0.00057555723,0.0005038503,0.001148249,0.0015573218,0.000032245942,0.00014618729],"genre_scores_gemma":[0.99756587,0.0009880139,0.0002874977,0.00012733508,0.00025345388,0.000023773067,0.000029468098,0.00009526228,0.0006293403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99214315,0.0014533661,0.002505826,0.00069860934,0.0021902332,0.0010087934],"domain_scores_gemma":[0.9934481,0.0020630222,0.0015216646,0.0009857866,0.0011459837,0.00083549356],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024909633,0.00043853564,0.0019116227,0.00085761957,0.00013091836,0.00004248963,0.0013563909,0.00047282892,0.000043302756],"category_scores_gemma":[0.0130246775,0.00032749062,0.00038129493,0.0011274982,0.00066763384,0.00039093607,0.000503688,0.0015862299,0.000011377095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029051057,0.009634334,0.72344023,0.0005421722,0.0035073282,0.06510905,0.006550867,0.00002980518,0.051390294,0.0000146019265,0.12915854,0.0077176727],"study_design_scores_gemma":[0.031478405,0.0029502525,0.89905715,0.0015470053,0.0006440002,0.030854372,0.0029291455,0.000040337887,0.029819895,0.00016638463,0.00039958465,0.00011344124],"about_ca_topic_score_codex":0.00036629612,"about_ca_topic_score_gemma":0.00038514458,"teacher_disagreement_score":0.17561695,"about_ca_system_score_codex":0.00046079865,"about_ca_system_score_gemma":0.0021939566,"threshold_uncertainty_score":0.9999177},"labels":[],"label_agreement":null},{"id":"W2337251176","doi":"10.1111/bjh.14084","title":"Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atrial fibrillation; Internal medicine; Confidence interval; Vitamin K antagonist; Warfarin; Concordance; Cardiology; Gastroenterology","score_opus":0.023763203230809004,"score_gpt":0.31243937967231206,"score_spread":0.28867617644150306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337251176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981288,0.00012161633,0.0001617808,0.0011183615,0.00010639725,0.0001831237,0.000002978262,0.000003327025,0.00017367117],"genre_scores_gemma":[0.99896246,0.00016776369,0.00070441165,0.000041285755,0.000023084633,8.2954494e-7,0.0000049153546,0.000006172527,0.00008906819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888,0.00008128815,0.00066161354,0.00009139842,0.00017593682,0.000109715715],"domain_scores_gemma":[0.9991961,0.00018442995,0.00040471047,0.000048712154,0.0001235092,0.00004249894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017795949,0.00007346214,0.0006146433,0.00026763472,0.00001232682,0.00001014018,0.000056589088,0.00006156811,0.000059290447],"category_scores_gemma":[0.00027060948,0.000055177465,0.00004863402,0.000099567274,0.00007331364,0.00012759294,0.00002142556,0.00008400198,0.0000010274097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018300301,0.00006004249,0.9918485,0.000024832936,0.00008193148,0.0008989711,0.000078824116,0.000009903231,0.00033344177,0.00005947346,0.00025376826,0.0045202523],"study_design_scores_gemma":[0.015515606,0.00055081176,0.9789978,0.000616747,0.000048113325,0.0015750877,0.000101153135,0.00006586983,0.002206494,0.000027905515,0.00021977194,0.000074585725],"about_ca_topic_score_codex":0.00005560532,"about_ca_topic_score_gemma":0.00016025202,"teacher_disagreement_score":0.013685576,"about_ca_system_score_codex":0.00003356637,"about_ca_system_score_gemma":0.000029412959,"threshold_uncertainty_score":0.22500716},"labels":[],"label_agreement":null},{"id":"W2337260374","doi":"10.1111/bjh.14076","title":"Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Terry Fox Research Institute; Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"Canadian Cancer Society; European Society for Medical Oncology; Genome British Columbia; Canadian Centre for Applied Research in Cancer Control","keywords":"Transplantation; Medicine; Quality of life (healthcare); Myeloid leukaemia; Oncology; Cost effectiveness; Cost-effectiveness analysis; Intensive care medicine; Internal medicine; Risk analysis (engineering)","score_opus":0.01220701428138869,"score_gpt":0.310135410717287,"score_spread":0.2979283964358983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337260374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940627,0.0020855477,0.002066386,0.00046956752,0.00041955398,0.00038079516,0.0004135393,0.0000121457,0.00008971327],"genre_scores_gemma":[0.980392,0.01698718,0.0018929174,0.00006726502,0.00041514463,0.00001329466,0.000010384301,0.000055770055,0.00016608622],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99786514,0.00012816746,0.0010946294,0.00022063366,0.00017055363,0.0005209041],"domain_scores_gemma":[0.9968066,0.0012773814,0.0009198217,0.0002549283,0.00041302774,0.00032820576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006986012,0.00018727031,0.0012244717,0.00032240208,0.000055468554,0.000019225376,0.00038003875,0.00023299958,0.0003843501],"category_scores_gemma":[0.0014984466,0.00014444653,0.00063083577,0.00005734337,0.00038863477,0.00016692346,0.000112520975,0.00042167006,0.000069485126],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008187911,0.0004965486,0.2311017,0.0005642405,0.008145468,0.058115985,0.00042888988,0.00006723961,0.073135406,0.0005059552,0.34327507,0.27597558],"study_design_scores_gemma":[0.023812758,0.0073224558,0.2560585,0.0016484014,0.0014276917,0.68227243,0.00013226469,0.00026410265,0.019959712,0.0031344446,0.00346061,0.0005065941],"about_ca_topic_score_codex":0.00016397265,"about_ca_topic_score_gemma":0.000072230345,"teacher_disagreement_score":0.6241565,"about_ca_system_score_codex":0.0011306138,"about_ca_system_score_gemma":0.0019797927,"threshold_uncertainty_score":0.5890358},"labels":[],"label_agreement":null},{"id":"W2339180098","doi":"10.1111/bjh.14100","title":"Outcomes of <scp>MYC</scp>‐associated lymphomas after R‐<scp>CHOP</scp> with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup <scp>SWOG</scp> S9704","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Cancer Institute; National Institutes of Health; Bristol-Myers Squibb","keywords":"Vincristine; CHOP; Rituximab; Medicine; Cyclophosphamide; Autologous stem-cell transplantation; Lymphoma; Internal medicine; Prednisolone; Stem cell; Oncology; Immunology; Chemotherapy; Biology","score_opus":0.008891470140877315,"score_gpt":0.24090978472075344,"score_spread":0.23201831457987612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339180098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075305,0.006144248,0.00031543622,0.00015118725,0.00031371275,0.0012062127,0.00061386736,0.000038343205,0.00046396718],"genre_scores_gemma":[0.995739,0.0029506541,0.0003060342,0.00015294025,0.000050623366,0.00012288612,0.00004876634,0.00006377341,0.0005653128],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941858,0.0010147913,0.0026645083,0.00059150194,0.0007899208,0.00075348304],"domain_scores_gemma":[0.988015,0.007223729,0.003097379,0.0003804265,0.00083011726,0.0004533506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012732268,0.00061235204,0.007059227,0.00092935754,0.00009796925,0.00005673006,0.0003093032,0.00050489587,0.000036585898],"category_scores_gemma":[0.0014310508,0.0004103944,0.0013547986,0.00059787615,0.0010728507,0.00026041584,0.000074050135,0.00028795135,0.000006051437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037732217,0.003981703,0.8836417,0.00037935938,0.040490776,0.02301942,0.0063040378,0.000007196629,0.0005117464,0.00018088696,0.0020415601,0.0017093593],"study_design_scores_gemma":[0.7029486,0.002615869,0.23194216,0.0020187723,0.024506625,0.022538127,0.0016243336,0.000046813508,0.0113340905,0.00012670102,0.00018792223,0.000110024754],"about_ca_topic_score_codex":0.0003352417,"about_ca_topic_score_gemma":0.0006477388,"teacher_disagreement_score":0.6652163,"about_ca_system_score_codex":0.00024660485,"about_ca_system_score_gemma":0.00051278097,"threshold_uncertainty_score":0.9998348},"labels":[],"label_agreement":null},{"id":"W2339455879","doi":"10.1111/bjh.14090","title":"Molecular structural analysis of a novel and de‐novo mutation in the <i><scp>SERPINC</scp>1</i> gene associated with type 1 antithrombin deficiency","year":2016,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Thrombophilia; Medicine; Antithrombin III deficiency; Antithrombin; Internal medicine; Protein S deficiency; Protein S; Protein C deficiency; Gastroenterology; Thrombosis; Venous thrombosis; Heparin","score_opus":0.017174447786262006,"score_gpt":0.26308198930510557,"score_spread":0.24590754151884356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339455879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847479,0.0017592799,0.0015663482,0.011492997,0.00010834007,0.00019593857,0.000039593775,0.000007054391,0.00008258152],"genre_scores_gemma":[0.9662351,0.00017643157,0.0008891705,0.03248577,0.00007726832,0.0000027647723,0.000088234636,0.000028719827,0.000016544544],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979978,0.00028201725,0.00070720987,0.00021514093,0.0004905227,0.00030728366],"domain_scores_gemma":[0.99796546,0.00031072827,0.0009942712,0.00016694858,0.00051014003,0.00005246731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055357633,0.00018956326,0.0012340989,0.00058442797,0.00004908124,0.000034221353,0.00019265486,0.0004630955,0.00002146189],"category_scores_gemma":[0.00047957164,0.00013916162,0.00017806319,0.0008243623,0.0001745025,0.000074749936,0.000025007308,0.00075302995,5.0454383e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036127173,0.002228092,0.08722054,0.0020325845,0.034055788,0.66063815,0.005580939,0.0007542517,0.113048874,0.0044352124,0.083432436,0.0062118676],"study_design_scores_gemma":[0.014821403,0.0028227018,0.17199622,0.003976201,0.019301154,0.77333426,0.0006244519,0.0012113214,0.007882588,0.002333988,0.0012618747,0.00043384623],"about_ca_topic_score_codex":0.000054946227,"about_ca_topic_score_gemma":0.00010311014,"teacher_disagreement_score":0.112696104,"about_ca_system_score_codex":0.00004937787,"about_ca_system_score_gemma":0.00023376389,"threshold_uncertainty_score":0.5674846},"labels":[],"label_agreement":null},{"id":"W2366481835","doi":"10.1111/bjh.14125","title":"A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Takeda Oncology","keywords":"Ixazomib; Medicine; Multiple myeloma; Renal function; Pharmacokinetics; Urology; End stage renal disease; Adverse effect; Internal medicine; Gastroenterology; Pharmacology; Proteasome inhibitor; Hemodialysis; Carfilzomib","score_opus":0.019561755818772963,"score_gpt":0.3082482007602953,"score_spread":0.28868644494152235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2366481835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982251,0.00043597078,0.000115183015,0.00019152017,0.000032317887,0.0008236329,0.0001608479,0.000007211179,0.000008234199],"genre_scores_gemma":[0.99855995,0.00042394354,0.00084317685,0.000027966513,0.000030297717,0.000015988686,0.000013262729,0.000023992103,0.00006142762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977235,0.00027242955,0.0007944684,0.00029713105,0.0005184454,0.00039401665],"domain_scores_gemma":[0.9983963,0.00022955322,0.00039497836,0.00016488545,0.00027160326,0.00054271513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003608882,0.00020392163,0.0009059998,0.000307836,0.00008091137,0.000022854989,0.00010010325,0.000058514917,0.00013228404],"category_scores_gemma":[0.00038403904,0.00013455341,0.000070077396,0.00016869293,0.00023714647,0.00020837644,0.00010986029,0.0002155407,7.095215e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043323282,0.006816638,0.8057331,0.00015504741,0.00070777093,0.053467453,0.00028174065,0.000006083233,0.0003261593,0.0000016221279,0.000088353816,0.089092754],"study_design_scores_gemma":[0.15796302,0.007238457,0.8229841,0.0010986412,0.00042026423,0.00929147,0.00022521192,0.00015217799,0.00035400616,0.000010544461,0.00009037904,0.00017170276],"about_ca_topic_score_codex":0.00015224653,"about_ca_topic_score_gemma":0.00058097887,"teacher_disagreement_score":0.114639744,"about_ca_system_score_codex":0.00009566955,"about_ca_system_score_gemma":0.00018256911,"threshold_uncertainty_score":0.5486929},"labels":[],"label_agreement":null},{"id":"W2419183473","doi":"10.1111/bjh.14131","title":"Clinical utility of next‐generation sequencing in the diagnosis of hereditary haemolytic anaemias","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"DNA sequencing; Haemolytic disease; Gene; Medicine; Biology; Computational biology; Genetics; Bioinformatics; Pregnancy","score_opus":0.12277414179609776,"score_gpt":0.3655510035409665,"score_spread":0.24277686174486873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419183473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246526,0.005333813,0.000077324075,0.0016577673,0.00022610833,0.00011254213,0.000014290419,0.0000020743787,0.00011082287],"genre_scores_gemma":[0.9969616,0.0019077982,0.0005103466,0.0003651344,0.00023500064,0.0000027549324,0.0000031568575,0.000005066832,0.000009164112],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9980842,0.00021916229,0.0011931378,0.000111775094,0.00022966597,0.00016209576],"domain_scores_gemma":[0.99852115,0.00051167863,0.0004956912,0.00014746311,0.00022863195,0.00009536302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014001115,0.000066307184,0.0005863744,0.00005305113,0.000020249783,0.0000028558923,0.00014196271,0.00016253398,0.00008295089],"category_scores_gemma":[0.0012696681,0.000043813747,0.00014877235,0.00010646956,0.0002529301,0.00007586234,0.000021212596,0.00028120953,9.344742e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007945058,0.0007718949,0.41276968,0.0016137656,0.00011983391,0.04934422,0.00020569385,6.570056e-7,0.012206118,0.000085950116,0.023457952,0.49862975],"study_design_scores_gemma":[0.007960072,0.0020590608,0.29052243,0.006936189,0.00025689948,0.55860126,0.0011756351,0.0002272813,0.13000724,0.0012597747,0.0007666047,0.00022755044],"about_ca_topic_score_codex":0.00022712839,"about_ca_topic_score_gemma":0.00014290768,"teacher_disagreement_score":0.5092571,"about_ca_system_score_codex":0.000038828835,"about_ca_system_score_gemma":0.00046858093,"threshold_uncertainty_score":0.17866726},"labels":[],"label_agreement":null},{"id":"W2462737759","doi":"10.1111/bjh.14199","title":"Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium","year":2016,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Public Health Ontario; Toronto Public Health; University of Saskatchewan; Saskatchewan Health Authority","funders":"National Cancer Institute; National Institutes of Health; Fondation de France; University of Alabama; National Institute of Environmental Health Sciences; American Cancer Society; University of Southern California; Brown University","keywords":"Medicine; Odds ratio; Family history; Multiple myeloma; Relative risk; Confidence interval; Internal medicine; Etiology; First-degree relatives; Oncology; Cancer; Demography; Family aggregation; Disease","score_opus":0.051699426396183724,"score_gpt":0.3146568069504227,"score_spread":0.26295738055423895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462737759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015344859,0.9800159,0.00003205207,0.0003051018,0.0014667645,0.0007792403,0.0013882136,0.000017880704,0.0006500321],"genre_scores_gemma":[0.013614446,0.98409414,0.0007029505,0.0001449611,0.00042960982,0.00004547638,0.00018065769,0.00007457228,0.00071316276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99532825,0.0005160034,0.0023006478,0.00052894844,0.000819544,0.0005066147],"domain_scores_gemma":[0.9924785,0.0037138131,0.002253737,0.00050995225,0.0006583833,0.00038565334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007032205,0.00046011453,0.0033364536,0.0003264242,0.00008260267,0.0000376198,0.0007067018,0.0004507005,0.00017521474],"category_scores_gemma":[0.0042061596,0.00031569766,0.000781726,0.00012061003,0.00088198116,0.00014681203,0.00025762012,0.0006883189,0.000036154343],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012069892,0.00022522536,0.0010697983,0.002106579,0.0027616525,0.03537647,0.00017482453,1.5413899e-7,0.000033380013,0.000022377179,0.029149348,0.9278732],"study_design_scores_gemma":[0.00946492,0.0002856228,0.0023534717,0.036183048,0.00091509335,0.13327569,0.00012513319,0.000024299463,0.000019910043,0.000043889984,0.8170407,0.00026822006],"about_ca_topic_score_codex":0.0016354976,"about_ca_topic_score_gemma":0.0005097976,"teacher_disagreement_score":0.927605,"about_ca_system_score_codex":0.0012450072,"about_ca_system_score_gemma":0.0031034069,"threshold_uncertainty_score":0.9999295},"labels":[],"label_agreement":null},{"id":"W2466421941","doi":"10.1111/bjh.14201","title":"The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Helse Sør-Øst RHF; Norges Forskningsråd; Kreftforeningen","keywords":"Follicular lymphoma; CD68; CD163; Tumor microenvironment; Rituximab; Medicine; FOXP3; CD20; Lymphoma; CD8; Internal medicine; Oncology; Survival analysis; Pathology; Immunology; Cancer research; Immunohistochemistry; Cancer; Biology; Macrophage; Antigen; Immune system","score_opus":0.0067823435448768855,"score_gpt":0.228218332319174,"score_spread":0.2214359887742971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466421941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97438693,0.0035655624,0.000014317843,0.021582376,0.000041916104,0.00024104286,0.000003743385,0.0000018919519,0.00016224489],"genre_scores_gemma":[0.9975561,0.0018432288,0.00007192114,0.00046022589,0.000025046375,0.000019754956,6.618189e-7,0.000005007298,0.0000180678],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99891585,0.0001791572,0.00043693735,0.00008997705,0.00019100634,0.0001870833],"domain_scores_gemma":[0.9994884,0.000251418,0.000102552396,0.00007454723,0.000024559225,0.000058519166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586238,0.00008079339,0.00033072816,0.00007021378,0.000062364685,0.00003314842,0.00010509546,0.00004490521,0.000023680257],"category_scores_gemma":[0.00007436484,0.000041423904,0.00006013304,0.000074278,0.000089267065,0.0000989601,0.000014527344,0.00005658509,0.000027286429],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001389306,0.0036987686,0.18217102,0.00011162008,0.0003676892,0.085589096,0.0042021126,0.000021961932,0.006227176,0.0016310323,0.0045351014,0.7100551],"study_design_scores_gemma":[0.011661442,0.00047629536,0.8301774,0.00075465365,0.00006419729,0.1471919,0.00045997283,0.00001053576,0.0015091737,0.00046510334,0.007135433,0.00009387001],"about_ca_topic_score_codex":0.000089761765,"about_ca_topic_score_gemma":0.00018398644,"teacher_disagreement_score":0.70996124,"about_ca_system_score_codex":0.00011369337,"about_ca_system_score_gemma":0.00006539727,"threshold_uncertainty_score":0.16892178},"labels":[],"label_agreement":null},{"id":"W2488556807","doi":"10.1111/bjh.14238","title":"Increased plasminogen activator inhibitor results in a hypofibrinolytic state in adolescents with obesity: <i>in vivo</i> and <i>ex vivo</i> evidence","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"In vivo; Ex vivo; Plasminogen activator inhibitor-1; Medicine; Obesity; Plasminogen activator; Internal medicine; Biology; Genetics","score_opus":0.015534032394573948,"score_gpt":0.2305116104448712,"score_spread":0.21497757805029724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488556807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996031,0.0027057675,0.000020087195,0.000827346,0.000059455248,0.00030039682,0.000009028456,0.000007252613,0.000039704228],"genre_scores_gemma":[0.9984285,0.0010199718,0.00013452809,0.0003013955,0.000045753903,0.000005255813,2.3991828e-7,0.000019314155,0.000045044002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815196,0.00019134971,0.0007937274,0.00025700015,0.00026422826,0.00034174667],"domain_scores_gemma":[0.9991662,0.00012064586,0.00032097803,0.00012685756,0.00011042185,0.00015487889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047685122,0.00014862354,0.0006944948,0.00026865216,0.000022228918,0.000023761648,0.00009550988,0.00011418919,0.000009292377],"category_scores_gemma":[0.00035820433,0.00011478326,0.00004042055,0.00022011784,0.00012278519,0.0003832941,0.000052905038,0.00028037012,0.0000025381266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00999612,0.0005070237,0.9073205,0.00040015686,0.000036207493,0.03936265,0.00032088303,0.000006210065,0.03181065,0.000004591143,0.0003922362,0.009842803],"study_design_scores_gemma":[0.025437228,0.0014368665,0.7219114,0.054316327,0.00007643548,0.1332293,0.00017976995,0.00005775018,0.0626606,0.00017721558,0.00018214047,0.00033497982],"about_ca_topic_score_codex":0.0012322648,"about_ca_topic_score_gemma":0.0028869216,"teacher_disagreement_score":0.18540908,"about_ca_system_score_codex":0.000104869934,"about_ca_system_score_gemma":0.00022488536,"threshold_uncertainty_score":0.46807256},"labels":[],"label_agreement":null},{"id":"W2496211488","doi":"10.1111/bjh.14229","title":"Site of central nervous system (CNS) relapse in patients with diffuse large B‐cell lymphoma (DLBCL) by the CNS‐IPI risk model","year":2016,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; University of British Columbia","keywords":"Diffuse large B-cell lymphoma; Medicine; Central nervous system; Lymphoma; Rituximab; Oncology; Internal medicine","score_opus":0.004372215322738275,"score_gpt":0.19078944596344047,"score_spread":0.1864172306407022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496211488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752696,0.006604316,0.00012411938,0.015338579,0.00041718903,0.0007333823,0.0012966981,0.000018343857,0.00019774359],"genre_scores_gemma":[0.98209226,0.0015934824,0.00016404863,0.015077475,0.00041622375,0.000035089506,0.00019806223,0.00012697959,0.0002963712],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99598116,0.00042910452,0.0014763552,0.0004299508,0.00079809787,0.0008853148],"domain_scores_gemma":[0.9965486,0.00031656216,0.002028198,0.00050706306,0.00039671466,0.00020287084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003178762,0.00047533977,0.002103677,0.0002645672,0.00011076142,0.00004087326,0.00035074484,0.0007385273,0.000031550775],"category_scores_gemma":[0.00007931794,0.0003068211,0.00047359764,0.0001518448,0.00020540165,0.0001152,0.00009763532,0.0008925379,0.000016919952],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009086172,0.006161025,0.14998876,0.0009012935,0.00083504507,0.08911629,0.00024595106,0.000010223209,0.000003263946,0.000022681405,0.7429429,0.00886392],"study_design_scores_gemma":[0.23968185,0.003950386,0.33797738,0.024409147,0.0060012094,0.3034969,0.00028098383,0.0006017733,0.00028332113,0.00010577256,0.0815889,0.0016223828],"about_ca_topic_score_codex":0.00051160814,"about_ca_topic_score_gemma":0.00013299129,"teacher_disagreement_score":0.661354,"about_ca_system_score_codex":0.00055554364,"about_ca_system_score_gemma":0.00036929833,"threshold_uncertainty_score":0.99993837},"labels":[],"label_agreement":null},{"id":"W2521880072","doi":"10.1111/bjh.14313","title":"Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panel","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; Medicine; Anthracycline; Internal medicine; Oncology; Cog; Retinoic acid; Pediatrics; Cancer; Biology; Gene","score_opus":0.010244343041789608,"score_gpt":0.2641757588843881,"score_spread":0.2539314158425985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521880072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316204,0.0031750167,0.0022455268,0.0005945894,0.000327653,0.0000694423,0.000035995803,0.000004119165,0.00038559316],"genre_scores_gemma":[0.97604054,0.01887352,0.0046239397,0.00009868566,0.00013571836,0.0000064138467,0.00005360777,0.000014969059,0.00015262766],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990491,0.00008285356,0.00042638014,0.00019735133,0.00011911474,0.0001251666],"domain_scores_gemma":[0.9992573,0.000023357701,0.00034228375,0.00015265908,0.00015280537,0.00007155381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015014318,0.00009495821,0.00023099453,0.000045986955,0.000043359738,0.000017959912,0.00028040208,0.00013754476,0.00007133122],"category_scores_gemma":[0.00005657408,0.00008353909,0.000064349195,0.000029621353,0.00012414643,0.000028426117,0.0000950542,0.00010200796,0.0000013657963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006480267,0.0010455496,0.005499637,0.00011945464,0.002992588,0.009137606,0.000510556,0.0000030503036,0.45606658,0.0009593373,0.010265437,0.5127522],"study_design_scores_gemma":[0.01577204,0.002792216,0.033976123,0.0031616506,0.0006108507,0.14476696,0.001947026,0.000018004506,0.6909133,0.007050695,0.09785519,0.0011359481],"about_ca_topic_score_codex":0.000011850459,"about_ca_topic_score_gemma":0.0000056654367,"teacher_disagreement_score":0.51161623,"about_ca_system_score_codex":0.000020656462,"about_ca_system_score_gemma":0.00007854877,"threshold_uncertainty_score":0.34066254},"labels":[],"label_agreement":null},{"id":"W2525561810","doi":"10.1111/bjh.14325","title":"Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B‐cell lymphoma is associated with poor outcomes and a high frequency of secondary <scp>CNS</scp> involvement","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal","keywords":"Medicine; Diffuse large B-cell lymphoma; Hazard ratio; Concomitant; Rituximab; Oncology; Internal medicine; Uterus; Lymphoma; Confidence interval; Gynecology","score_opus":0.011641997026197897,"score_gpt":0.24066100495847698,"score_spread":0.22901900793227908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525561810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994443,0.0021998829,0.0000626837,0.0019696648,0.00017722459,0.000514074,0.000523609,0.000018203857,0.000091660826],"genre_scores_gemma":[0.9957,0.0009785854,0.000634315,0.0009803057,0.000048443475,0.00004034299,0.00006415223,0.00003856348,0.0015153165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976253,0.00016584068,0.00090534985,0.00043752676,0.0004727623,0.00039325212],"domain_scores_gemma":[0.99762344,0.0003165687,0.0010662451,0.00027093405,0.00049558654,0.00022721903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035220291,0.00026507338,0.0010914191,0.00015021698,0.00011128822,0.000029216473,0.00012495003,0.00015031232,0.00013999177],"category_scores_gemma":[0.00033346988,0.00019263105,0.00013790271,0.00012581566,0.00018149114,0.00023405725,0.00012129307,0.00009311788,0.0000059744484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002719533,0.010742512,0.91975355,0.0003650459,0.0025952843,0.018308677,0.0016853091,7.943789e-8,0.022249416,0.00018769152,0.019450366,0.004390118],"study_design_scores_gemma":[0.04885909,0.0015211542,0.683638,0.00081182574,0.0005722579,0.016758777,0.0006860667,0.0000012234437,0.24605764,0.0002076957,0.0007487833,0.00013748041],"about_ca_topic_score_codex":0.0007304664,"about_ca_topic_score_gemma":0.00035997288,"teacher_disagreement_score":0.23611555,"about_ca_system_score_codex":0.00044475106,"about_ca_system_score_gemma":0.00029344353,"threshold_uncertainty_score":0.78552663},"labels":[],"label_agreement":null},{"id":"W2531432151","doi":"10.1111/bjh.14392","title":"Diffuse large B‐cell lymphoma with testicular involvement: outcome and risk of <scp>CNS</scp> relapse in the rituximab era","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Roche","keywords":"Rituximab; Medicine; Diffuse large B-cell lymphoma; International Prognostic Index; Internal medicine; Vincristine; Prednisone; Lymphoma; Cyclophosphamide; Hazard ratio; Oncology; CHOP; Chemotherapy; Confidence interval","score_opus":0.00952445031165164,"score_gpt":0.22998264182981218,"score_spread":0.22045819151816054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531432151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901553,0.008492053,0.00008310314,0.00069598947,0.00006686746,0.00025960937,0.000038115195,0.000006576985,0.00020240713],"genre_scores_gemma":[0.9945372,0.004180221,0.00074836944,0.00039832134,0.000039721723,0.000015537265,0.0000025497313,0.000018768182,0.000059343343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982454,0.0002227354,0.00070859096,0.00018701403,0.00032168007,0.0003145585],"domain_scores_gemma":[0.99811095,0.0008075641,0.00056457595,0.00021969876,0.00016432928,0.00013286462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000571511,0.00016657193,0.0008349078,0.00014297757,0.00006718721,0.00002285589,0.00014450158,0.00010770336,0.000012187733],"category_scores_gemma":[0.0005736087,0.000091499045,0.00012675906,0.00013346778,0.00018988684,0.000110177985,0.000046972105,0.00014088243,0.000007003844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007344748,0.0073712273,0.9363514,0.00012004881,0.00023608198,0.04996559,0.0004271925,2.0329173e-7,0.00006734949,0.00025761852,0.0015410356,0.0035887635],"study_design_scores_gemma":[0.071075864,0.0013759442,0.74071807,0.0011970064,0.00073558005,0.18054682,0.0005830734,0.000005763444,0.001151701,0.0003882392,0.0021501854,0.00007177707],"about_ca_topic_score_codex":0.00013403388,"about_ca_topic_score_gemma":0.00024072705,"teacher_disagreement_score":0.1956334,"about_ca_system_score_codex":0.00008358026,"about_ca_system_score_gemma":0.00015027622,"threshold_uncertainty_score":0.37312227},"labels":[],"label_agreement":null},{"id":"W2539269622","doi":"10.1111/bjh.14404","title":"Outcome of primary cutaneous anaplastic large cell lymphoma: a 20‐year British Columbia Cancer Agency experience","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Chemotherapy; Stage (stratigraphy); Cancer; Oncology; Radiation therapy; Lymphoproliferative disorders; Surgery","score_opus":0.017728846321293696,"score_gpt":0.29263374925412733,"score_spread":0.27490490293283365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539269622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898837,0.007450416,0.00038066698,0.00023327362,0.00035932334,0.00036201073,0.00020641042,0.000020893458,0.0011033041],"genre_scores_gemma":[0.9913073,0.003716814,0.00047815734,0.00026728972,0.000103791586,0.000023697236,0.000004800081,0.00005285177,0.004045288],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9967536,0.00019930398,0.0012505255,0.00035548385,0.0007462002,0.0006948856],"domain_scores_gemma":[0.9975812,0.00031688702,0.0005652451,0.00024910897,0.0009389811,0.0003485862],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028926108,0.00017082326,0.0013474652,0.00014925613,0.0001431221,0.000080368576,0.00036698615,0.00021092998,0.0029626067],"category_scores_gemma":[0.0009133321,0.00020741396,0.000299412,0.00027586316,0.0004878416,0.00016876111,0.000135015,0.00023437198,0.000026989477],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000803951,0.0022110569,0.65479326,0.00076404517,0.00023423262,0.27565658,0.00046428558,0.0000012328964,0.008418289,0.000012879524,0.020431781,0.036208376],"study_design_scores_gemma":[0.011190616,0.001093485,0.042963415,0.0015275318,0.00012897336,0.93799645,0.00037385838,0.000014892415,0.0009766404,0.00019306876,0.0032479125,0.00029313215],"about_ca_topic_score_codex":0.0035823819,"about_ca_topic_score_gemma":0.018538466,"teacher_disagreement_score":0.66233987,"about_ca_system_score_codex":0.00030648985,"about_ca_system_score_gemma":0.00087898056,"threshold_uncertainty_score":0.99937063},"labels":[],"label_agreement":null},{"id":"W2550146082","doi":"10.1111/bjh.14450","title":"Spleen hypofunction in eosinophilic gastrointestinal disease","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Pathology; Spleen; Gastroenterology; Eosinophilia; Eosinophil; Eosinophilic gastroenteritis; Eosinophilic; Internal medicine; Asthma","score_opus":0.011734813129516058,"score_gpt":0.24498675998251715,"score_spread":0.2332519468530011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550146082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892033,0.0026490928,0.0006641833,0.007010067,0.0002657605,0.00014653304,0.000014444177,0.000021660166,0.00030793375],"genre_scores_gemma":[0.9976684,0.0002673813,0.0012313287,0.00038520602,0.00023582633,0.0000043961277,0.000003099903,0.000019692858,0.00018468041],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99833053,0.00012443066,0.00072104344,0.00019829412,0.00028314674,0.00034254405],"domain_scores_gemma":[0.9987384,0.00017930195,0.00030483204,0.00016620828,0.00025610824,0.0003551565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033828767,0.000130123,0.00057740934,0.00028667695,0.000034580044,0.0000151846425,0.00012940112,0.00006257813,0.00038148844],"category_scores_gemma":[0.001366151,0.00011210133,0.00015608835,0.00016091287,0.0002163734,0.00020546907,0.00003770242,0.0002987067,0.00006810095],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010738965,0.00058348244,0.4757774,0.00015055938,0.000052937117,0.46348965,0.000028284585,0.0000022745123,0.006154722,0.00045586057,0.010635932,0.041594997],"study_design_scores_gemma":[0.0027453296,0.00036750583,0.3721942,0.0019267604,0.00005559207,0.6206201,0.000013908629,0.000004084812,0.00025541888,0.001363976,0.0003735516,0.00007958411],"about_ca_topic_score_codex":0.000033173164,"about_ca_topic_score_gemma":0.000041904765,"teacher_disagreement_score":0.15713042,"about_ca_system_score_codex":0.00011866109,"about_ca_system_score_gemma":0.00025119682,"threshold_uncertainty_score":0.45713595},"labels":[],"label_agreement":null},{"id":"W2558083009","doi":"10.1111/bjh.14437","title":"The evolutionary and clinical implications of the uneven distribution of the frequency of the inherited haemoglobin variants over short geographical distances","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute for Health and Care Research; Wellcome Trust; Medical Research Council; Wellcome; University of Oxford; World Health Organization","keywords":"Ethnic group; Malaria; Consanguinity; Distribution (mathematics); Variation (astronomy); Geography; Altitude (triangle); Demography; Heterozygote advantage; Evolutionary biology; Biology; Genetics; Allele; Immunology; Gene","score_opus":0.010724204692361674,"score_gpt":0.27337346438821475,"score_spread":0.26264925969585307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558083009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97487676,0.0065176594,0.00017012523,0.01750732,0.00038906795,0.0002737663,0.00015388103,0.000002961836,0.00010845876],"genre_scores_gemma":[0.9960068,0.0038029666,0.000033705543,0.000088963345,0.000031876913,0.0000030941844,0.0000019422407,0.000007065092,0.00002358776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979599,0.00042062643,0.0010436804,0.0001214577,0.00028010693,0.0001742377],"domain_scores_gemma":[0.998146,0.000422332,0.000667712,0.00033892042,0.00036468217,0.000060371243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006115034,0.00008966325,0.0004260055,0.000021441007,0.00022424372,0.0000058182213,0.000385006,0.00020455255,0.000013677805],"category_scores_gemma":[0.0011036199,0.000036700283,0.00035932078,0.00033364526,0.0021534974,0.000055535053,0.00012622346,0.00038839248,1.5979002e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011445428,0.00032189672,0.9731592,0.0000491709,0.00031432815,0.000040042814,0.000033598237,0.0000010668048,0.0013445668,0.010389195,0.0042197346,0.010012743],"study_design_scores_gemma":[0.00088415976,0.00009253392,0.97617453,0.00077713805,0.00021833926,0.011712732,0.00009092368,0.0000091178335,0.00012583142,0.009079958,0.0007906698,0.000044089033],"about_ca_topic_score_codex":0.00010150803,"about_ca_topic_score_gemma":0.00016085812,"teacher_disagreement_score":0.021130038,"about_ca_system_score_codex":0.000025495774,"about_ca_system_score_gemma":0.0002476866,"threshold_uncertainty_score":0.79346514},"labels":[],"label_agreement":null},{"id":"W2558735096","doi":"10.1111/bjh.14424","title":"The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study","year":2016,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Magnetic resonance imaging; Cerebral blood flow; Cardiology; Pathophysiology; Stroke (engine); Internal medicine; Disease; Anemia; Gastroenterology; Radiology","score_opus":0.0051466232312964485,"score_gpt":0.22645350098786787,"score_spread":0.22130687775657143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558735096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9115885,0.0872698,0.00003230149,0.00063463784,0.00005209301,0.00035593408,0.0000097329175,0.0000066016655,0.00005042092],"genre_scores_gemma":[0.9968836,0.0027730097,0.00021913202,0.000044660464,0.00001463985,0.0000066626985,7.6075526e-7,0.000020430774,0.000037117312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998309,0.0003103877,0.0005823114,0.00018806988,0.00032076883,0.00028945238],"domain_scores_gemma":[0.9988445,0.00023636772,0.00030769766,0.0002262289,0.0002519328,0.0001332794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056461093,0.00012573547,0.00053877773,0.000102959704,0.000092410126,0.000014033685,0.00019764886,0.000053644024,0.000024614073],"category_scores_gemma":[0.00042871787,0.00007657,0.00012062751,0.00021316383,0.00041729523,0.00010881252,0.000053930806,0.00032368634,0.0000022951024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004906204,0.00045523432,0.9799109,0.00004151835,0.00008322766,0.0065545468,0.0001821796,0.0000034492,0.000042655847,0.000042097243,0.00049034576,0.011703232],"study_design_scores_gemma":[0.0056880307,0.0007631863,0.97070223,0.0009981813,0.00017457685,0.019634377,0.0014193306,0.00002384794,0.00009601047,0.00017001135,0.0002186081,0.000111601],"about_ca_topic_score_codex":0.00033900703,"about_ca_topic_score_gemma":0.00031755067,"teacher_disagreement_score":0.0852951,"about_ca_system_score_codex":0.000039749466,"about_ca_system_score_gemma":0.00022792825,"threshold_uncertainty_score":0.31224343},"labels":[],"label_agreement":null},{"id":"W2559321616","doi":"10.1111/bjh.14454","title":"C‐reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early‐ and long‐term mortality","year":2016,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Imperial College Healthcare NHS Trust; National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust","keywords":"Medicine; Transplantation; Internal medicine; Hematology; Cohort; Hematopoietic stem cell transplantation; Comorbidity; C-reactive protein; Oncology","score_opus":0.013685764641273707,"score_gpt":0.25854568144354284,"score_spread":0.24485991680226912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559321616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898303,0.00077138736,0.0014228412,0.005096237,0.00035436486,0.0017732242,0.0005901611,0.00001767374,0.00014376779],"genre_scores_gemma":[0.9929589,0.0010524637,0.00065885513,0.004081792,0.00035083984,0.00006262932,0.00020236474,0.00010946878,0.0005226721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557626,0.0007277315,0.0017646896,0.00052868377,0.0008991246,0.00050352723],"domain_scores_gemma":[0.9959507,0.0004910623,0.0021398703,0.00030149214,0.0008801205,0.00023677816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006521148,0.0004408085,0.0019187293,0.00045342845,0.000120602395,0.00003825462,0.00023941531,0.00083321385,0.0001428159],"category_scores_gemma":[0.00017605374,0.00041408144,0.0003486878,0.00014983187,0.00034401834,0.00021383584,0.00004946665,0.0010582836,0.00002962243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038652816,0.00077470246,0.69214845,0.031087212,0.0038397352,0.20674112,0.009477801,0.0000019101958,0.026138721,0.00001324088,0.0201008,0.005811025],"study_design_scores_gemma":[0.0065938756,0.0012937251,0.7943047,0.012406561,0.0031471893,0.09843565,0.000055255357,5.097e-7,0.08239424,0.0002843254,0.00044662834,0.0006373401],"about_ca_topic_score_codex":0.00013735666,"about_ca_topic_score_gemma":0.00012605319,"teacher_disagreement_score":0.10830547,"about_ca_system_score_codex":0.00015200801,"about_ca_system_score_gemma":0.00020804994,"threshold_uncertainty_score":0.9998311},"labels":[],"label_agreement":null},{"id":"W2561128146","doi":"10.1111/bjh.14449","title":"Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma","year":2016,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Ifosfamide; Salvage therapy; Internal medicine; Cytarabine; Oncology; Melphalan; Autologous stem-cell transplantation; Chemotherapy; Carboplatin; Surgery; Refractory (planetary science); Cisplatin","score_opus":0.008487921881119955,"score_gpt":0.23021511396207464,"score_spread":0.22172719208095468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561128146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80620587,0.0028350411,0.0000026895814,0.19008534,0.00025338057,0.00046848756,0.00011760987,0.00001251065,0.000019058361],"genre_scores_gemma":[0.8876316,0.0015816474,0.0009629198,0.10787575,0.001195007,0.000041382496,0.00019996276,0.00015331483,0.0003584324],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99708396,0.0004637401,0.000943783,0.00048943184,0.0004946949,0.00052438106],"domain_scores_gemma":[0.99759597,0.0005406256,0.0009886038,0.0003034353,0.000430477,0.00014089134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041452557,0.0004110988,0.0018077542,0.00041265762,0.000066558016,0.000051362244,0.00017696945,0.00048520768,0.00013366812],"category_scores_gemma":[0.00024175229,0.00031194097,0.0001346211,0.00013036875,0.00028499204,0.00012383322,0.00004966097,0.0005775323,0.000010771939],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012279464,0.0020724088,0.18007591,0.0005168487,0.0010259739,0.24628364,0.00014162884,1.5621859e-7,0.000057713423,0.0000055777928,0.47715732,0.08038337],"study_design_scores_gemma":[0.03554742,0.0026602892,0.66444427,0.004139508,0.0002500969,0.10092612,0.000008468862,3.570512e-7,0.0001881955,0.00004676349,0.19146556,0.00032294978],"about_ca_topic_score_codex":0.00013519294,"about_ca_topic_score_gemma":0.000027347916,"teacher_disagreement_score":0.48436835,"about_ca_system_score_codex":0.00042084677,"about_ca_system_score_gemma":0.00058148353,"threshold_uncertainty_score":0.99993324},"labels":[],"label_agreement":null},{"id":"W2562513582","doi":"10.1111/bjh.14482","title":"How do we approach thrombocytopenia in critically ill patients?","year":2016,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Platelet; Von Willebrand factor; Etiology; Platelet transfusion; Heparin-induced thrombocytopenia; Incidence (geometry); Internal medicine; Immunology; Intensive care medicine; Gastroenterology","score_opus":0.03016398038053072,"score_gpt":0.3095621459360054,"score_spread":0.2793981655554747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562513582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012320344,0.9956059,0.00007090416,0.0008084376,0.0003055165,0.00062095874,0.000060469043,0.0000091203165,0.0012866448],"genre_scores_gemma":[0.00049669796,0.99761724,0.001216929,0.00020222642,0.00009247802,0.000023588449,0.000037162583,0.000063318075,0.00025034935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974213,0.00026322497,0.0011419086,0.0003437225,0.00034590365,0.00048392912],"domain_scores_gemma":[0.99785596,0.00018955315,0.0006698682,0.00021821752,0.00083360466,0.00023280075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022619468,0.00036711528,0.0053185034,0.0003716235,0.000048171052,0.00008273305,0.00028586568,0.000543056,0.000109533066],"category_scores_gemma":[0.0010123,0.00027343293,0.00067634473,0.00018730269,0.00017274034,0.0001728839,0.000074706906,0.00075754937,0.000039073984],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002694451,0.00082011794,0.00006317134,0.005600844,0.00037081682,0.13814893,0.000012007557,4.5522217e-9,3.3630425e-8,0.00014649493,0.003589244,0.8512214],"study_design_scores_gemma":[0.0026113736,0.00025422938,0.00003838007,0.035878282,0.00061093085,0.38955954,0.00002570204,1.2518488e-7,1.7072689e-7,0.0003595158,0.5704815,0.00018024961],"about_ca_topic_score_codex":0.000007462152,"about_ca_topic_score_gemma":0.000008535789,"teacher_disagreement_score":0.85104114,"about_ca_system_score_codex":0.00014911796,"about_ca_system_score_gemma":0.0003780433,"threshold_uncertainty_score":0.9999718},"labels":[],"label_agreement":null},{"id":"W2587140037","doi":"10.1111/bjh.14542","title":"Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid‐derived suppressor cells","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Canadian Blood Services; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute; Health Canada","keywords":"Spleen; Antibody; Immune system; Immunology; Immune thrombocytopenia; Medicine; Myeloid; Immunoglobulin G; Immunoglobulin M; Platelet","score_opus":0.009655386263604453,"score_gpt":0.21536055519606812,"score_spread":0.20570516893246366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587140037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95477366,0.035456147,0.000019835396,0.0030924373,0.002853359,0.0009884433,0.0026867043,0.000013803593,0.00011558685],"genre_scores_gemma":[0.9872031,0.0073759407,0.0003752531,0.0026309886,0.00038869702,0.000033183696,0.0011793073,0.00016295949,0.0006505674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99492604,0.0012916292,0.0021860024,0.00054420636,0.0002613206,0.00079081237],"domain_scores_gemma":[0.99184453,0.0009983989,0.0051623676,0.0012827168,0.00067353644,0.000038460967],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031246673,0.00071235874,0.0038753175,0.00020467828,0.00035166976,0.00006657064,0.0021577643,0.0014028721,0.0017298519],"category_scores_gemma":[0.000076523545,0.0005449453,0.000695374,0.000068374015,0.0023286932,0.00017068714,0.00026543086,0.001817676,0.00006244204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035870834,0.002985202,0.0009083276,0.0005613754,0.01112161,0.02206272,0.0019850805,0.000017313278,0.69502693,0.0000037671837,0.2550039,0.006736671],"study_design_scores_gemma":[0.010871804,0.0034023013,0.010871667,0.0019543478,0.0022932824,0.014776084,0.00039610808,2.5601807e-7,0.85673463,0.00005449748,0.09787134,0.0007736734],"about_ca_topic_score_codex":0.008260644,"about_ca_topic_score_gemma":0.00015655441,"teacher_disagreement_score":0.16170768,"about_ca_system_score_codex":0.00019814158,"about_ca_system_score_gemma":0.0005622141,"threshold_uncertainty_score":0.99989355},"labels":[],"label_agreement":null},{"id":"W2590943925","doi":"10.1111/bjh.14508","title":"The <scp>JAK</scp>2 blocker <scp>TG</scp>101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemia","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Austrian Science Fund","keywords":"CFU-GM; Progenitor cell; Clonogenic assay; Progenitor; Myeloid; Cancer research; Medicine; Cell; Stem cell; Biology; Cell biology","score_opus":0.0073944042852346435,"score_gpt":0.22014401739104578,"score_spread":0.21274961310581114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590943925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635737,0.017546227,0.000006464006,0.015159108,0.0010466899,0.001980169,0.0002175298,0.000020034067,0.000450071],"genre_scores_gemma":[0.9606683,0.007873277,0.0008621507,0.02244293,0.004531373,0.0004237689,0.00030681447,0.00037726862,0.0025141193],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939015,0.00045867424,0.0021453307,0.0007955689,0.0014184829,0.001280431],"domain_scores_gemma":[0.99278206,0.00108097,0.0034276284,0.0007512431,0.0016125619,0.0003455489],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005472895,0.0008673395,0.0029293734,0.00048674128,0.0004016785,0.00018752206,0.000830212,0.0012584846,0.00003193973],"category_scores_gemma":[0.00084962475,0.00064726337,0.00079245254,0.00023714498,0.00068183895,0.00021680852,0.00021528304,0.003292294,0.000050137238],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001027965,0.0011775367,0.23228125,0.0010863383,0.0016131697,0.05355451,0.0003134901,0.0000012991533,0.000038835504,0.000008927514,0.7082556,0.0015662516],"study_design_scores_gemma":[0.044619642,0.014250454,0.28253126,0.014546138,0.004699148,0.18494958,0.00031063045,0.000015152627,0.053627856,0.00033194234,0.3994772,0.0006409737],"about_ca_topic_score_codex":0.00019248016,"about_ca_topic_score_gemma":0.00020581778,"teacher_disagreement_score":0.30877838,"about_ca_system_score_codex":0.0006565738,"about_ca_system_score_gemma":0.0017342832,"threshold_uncertainty_score":0.99959785},"labels":[],"label_agreement":null},{"id":"W2592575030","doi":"10.1111/bjh.14610","title":"Large scale studies assessing anti‐factor <scp>VIII</scp> antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Haemophilia; Medicine; Clinical trial; Population; Immunogenicity; Intensive care medicine; Randomized controlled trial; Scale (ratio); Immunology; Pediatrics; Internal medicine; Antibody; Environmental health","score_opus":0.15076785362023828,"score_gpt":0.43635405741611977,"score_spread":0.2855862037958815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592575030","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26281422,0.7319223,0.00001272673,0.003147028,0.00044772428,0.0016000286,0.000014183808,0.000020991241,0.000020777186],"genre_scores_gemma":[0.0038504023,0.99229103,0.0011179558,0.00016980585,0.00026711563,0.000059694168,0.0000913679,0.00013134933,0.002021302],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947086,0.00065159966,0.0015145971,0.00090255303,0.0008856534,0.0013369758],"domain_scores_gemma":[0.9960167,0.00067277544,0.0010507761,0.00050835597,0.00086649944,0.00088490424],"candidate_categories":["metaepi_narrow","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0016279742,0.0007873307,0.006653706,0.0012700628,0.0006221475,0.0019476734,0.00059164705,0.00074178836,0.000020226693],"category_scores_gemma":[0.002663399,0.00065748463,0.00048105608,0.0005036707,0.00040703535,0.0014368218,0.00065001636,0.0015599057,0.000062100175],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028467104,0.0003997138,0.0029424313,0.012221732,0.0015748435,0.084732234,0.00321501,4.798045e-7,0.000009664051,0.0000014467665,0.0027494796,0.8921245],"study_design_scores_gemma":[0.0025005273,0.0005841683,0.0031473567,0.19324057,0.00090060214,0.12572865,0.0054642977,0.0000013577659,0.00006234175,0.000010818276,0.6680193,0.0003400258],"about_ca_topic_score_codex":0.00002331412,"about_ca_topic_score_gemma":0.00029747846,"teacher_disagreement_score":0.8917845,"about_ca_system_score_codex":0.00046294453,"about_ca_system_score_gemma":0.0016062987,"threshold_uncertainty_score":0.99958766},"labels":[],"label_agreement":null},{"id":"W2594701169","doi":"10.1111/bjh.14460","title":"Incidence and outcomes of paediatric myelodysplastic syndrome in the United States","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Medicine; Myelodysplastic syndromes; Pediatrics; Intensive care medicine; Internal medicine; Bone marrow","score_opus":0.018600780384170408,"score_gpt":0.29613254222005475,"score_spread":0.27753176183588435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594701169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7716071,0.0044032694,0.000022065886,0.22340909,0.00019654876,0.00027034315,0.000036280522,0.0000044841254,0.000050809464],"genre_scores_gemma":[0.84820545,0.014348107,0.0006289801,0.13529128,0.0007040109,0.000020832524,0.00016183115,0.00009883483,0.00054068246],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9969826,0.0005297113,0.0010496938,0.00022745559,0.0007433078,0.00046726115],"domain_scores_gemma":[0.9956289,0.0022924505,0.0011553466,0.00038183096,0.00044939847,0.00009205612],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012426266,0.00023786232,0.0017542168,0.0010825015,0.000087293505,0.000067957415,0.0008040322,0.0006305938,0.000047258454],"category_scores_gemma":[0.0030179792,0.000181545,0.00017835632,0.00028473072,0.0006705866,0.00011973595,0.00016602826,0.0039742794,0.0000072969224],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000566476,0.000042900985,0.027498804,0.00078057585,0.00021262099,0.6139461,0.00014158984,0.000002526995,0.0000022088816,0.00000778527,0.35672414,0.000584138],"study_design_scores_gemma":[0.0019271241,0.000445561,0.11496983,0.00128118,0.00031029215,0.85924965,0.00012972254,0.00003749106,0.0000034202048,0.00045438524,0.02104371,0.00014761559],"about_ca_topic_score_codex":0.0007858553,"about_ca_topic_score_gemma":0.00007379148,"teacher_disagreement_score":0.33568043,"about_ca_system_score_codex":0.00009991198,"about_ca_system_score_gemma":0.00054850493,"threshold_uncertainty_score":0.9983236},"labels":[],"label_agreement":null},{"id":"W2603924317","doi":"10.1111/bjh.14569","title":"A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Leukemia and Lymphoma Society; National Cancer Institute; Rally Foundation","keywords":"Temsirolimus; Medicine; Mucositis; Internal medicine; Toxicity; Regimen; Induction chemotherapy; Sirolimus; Clinical endpoint; Chemotherapy; Gastroenterology; Oncology; Clinical trial; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Biology","score_opus":0.023863981803932538,"score_gpt":0.336079125056828,"score_spread":0.31221514325289546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603924317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677974,0.00061959506,0.000709998,0.00021954729,0.00080841687,0.0007617499,0.000076121214,0.0000034629659,0.00002134621],"genre_scores_gemma":[0.9977774,0.000682224,0.000849148,0.000111526555,0.00043205413,0.000037876183,0.000012558564,0.000035561607,0.00006167224],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982083,0.00016740734,0.000886109,0.00032759167,0.00015570366,0.0002549233],"domain_scores_gemma":[0.9971172,0.000070054986,0.0016945301,0.0003457121,0.0006765574,0.00009591532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054650556,0.00019399002,0.0009781725,0.00011083759,0.0001354545,0.000028749198,0.00036530822,0.00035020633,0.000017328106],"category_scores_gemma":[0.0007281057,0.00018258797,0.00020721566,0.000040199575,0.00045178743,0.000022270364,0.00010258131,0.00019552337,2.0892816e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41630656,0.0068177683,0.0057087895,0.00031963762,0.008223558,0.0072831507,0.0015896527,0.000016118873,0.47568816,0.000052537434,0.012936216,0.065057844],"study_design_scores_gemma":[0.45748,0.12513745,0.005200957,0.0006583366,0.0020446244,0.19185454,0.0012343203,0.000047073197,0.21313486,0.0004905116,0.001990749,0.00072657276],"about_ca_topic_score_codex":0.00009095475,"about_ca_topic_score_gemma":0.00010120597,"teacher_disagreement_score":0.2625533,"about_ca_system_score_codex":0.00004315626,"about_ca_system_score_gemma":0.00026016735,"threshold_uncertainty_score":0.74457216},"labels":[],"label_agreement":null},{"id":"W2604750786","doi":"10.1111/bjh.14603","title":"The unique immunological features of heparin‐induced thrombocytopenia","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Canadian Blood Services; McMaster University","funders":"","keywords":"Platelet factor 4; Immune system; Immunology; Heparin-induced thrombocytopenia; Heparin; Antibody; Monocyte; Chemokine; Platelet; Platelet activation; Antigen; Tissue factor; Medicine; Internal medicine; Coagulation","score_opus":0.1509917286448088,"score_gpt":0.4198737521707472,"score_spread":0.2688820235259384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604750786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010137887,0.9828211,0.000005437407,0.00035619648,0.0012162297,0.0009141595,0.00002376933,0.000024023724,0.0045011677],"genre_scores_gemma":[0.013864706,0.98487604,0.00029861616,0.000049573144,0.00028609458,0.00002928081,0.000019588877,0.00009033984,0.00048578216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947234,0.00095327874,0.0026598778,0.00044852204,0.00050795457,0.00070699723],"domain_scores_gemma":[0.9929009,0.0009243558,0.0040505324,0.0011231435,0.00070609763,0.00029495033],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0015604682,0.00060593185,0.008940923,0.00027808815,0.0005669789,0.00018707705,0.001776427,0.0013519024,0.00012030298],"category_scores_gemma":[0.0020975599,0.00041423316,0.0019672017,0.00022459522,0.0008918334,0.00017961048,0.00046406093,0.0029965437,0.000041761657],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093013055,0.00026711516,0.000022873603,0.0039786883,0.00241071,0.021229772,0.00003359461,1.7862613e-8,0.000067144414,0.0025951054,0.0020590913,0.9672429],"study_design_scores_gemma":[0.0007989329,0.0005742493,0.0010786259,0.019131167,0.0020800459,0.40649393,0.000030276247,8.671631e-8,0.000120254874,0.0003333773,0.5690914,0.00026767977],"about_ca_topic_score_codex":0.00025454152,"about_ca_topic_score_gemma":0.00018019261,"teacher_disagreement_score":0.9669752,"about_ca_system_score_codex":0.00017604054,"about_ca_system_score_gemma":0.0019640517,"threshold_uncertainty_score":0.99994457},"labels":[],"label_agreement":null},{"id":"W2606563895","doi":"10.1111/bjh.14667","title":"Long‐term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non‐Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; Health Sciences North; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; Dalhousie University","funders":"National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries","keywords":"Bendamustine; Medicine; Mantle cell lymphoma; Internal medicine; Lymphoma; Rituximab; Follicular lymphoma; Oncology; Surgery","score_opus":0.009923570703720143,"score_gpt":0.24021416140833168,"score_spread":0.23029059070461155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606563895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714696,0.0017191574,0.000006449192,0.00021336209,0.00019477015,0.00041510304,0.000010489415,0.000008952435,0.00028472324],"genre_scores_gemma":[0.9990793,0.00027562512,0.00021663657,0.00010508493,0.000019722978,0.000015137981,0.000011685733,0.000022987322,0.00025380618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868417,0.000059775146,0.0005404734,0.00021085338,0.00021788215,0.00028682686],"domain_scores_gemma":[0.99886376,0.00006108246,0.00057670823,0.00019450196,0.00014831245,0.00015566648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017016302,0.00018542263,0.0009402813,0.0001658929,0.00022468025,0.000100168436,0.000107133026,0.00011796305,0.000021795111],"category_scores_gemma":[0.000041064268,0.00015504999,0.00013069824,0.00006373678,0.0000882761,0.00024097208,0.00004803853,0.00011234543,0.0000021700148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030915986,0.00082338013,0.93456584,0.00012356287,0.00022518462,0.041691925,0.0001557049,3.4961113e-7,0.000010283476,0.000001384865,0.00031311726,0.02178012],"study_design_scores_gemma":[0.024914559,0.0011175759,0.9378808,0.0012119068,0.00032572958,0.033742875,0.000037212765,0.0000027010287,0.00059908826,0.0000044819867,0.000034640467,0.00012839041],"about_ca_topic_score_codex":0.00030158603,"about_ca_topic_score_gemma":0.00063111103,"teacher_disagreement_score":0.024605399,"about_ca_system_score_codex":0.00021107798,"about_ca_system_score_gemma":0.0002554806,"threshold_uncertainty_score":0.63227546},"labels":[],"label_agreement":null},{"id":"W2606741855","doi":"10.1111/bjh.14646","title":"Acquired blue sclerae in <scp>POEMS</scp> syndrome","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"POEMS syndrome; Medicine; Organomegaly; Blurred vision; Polyneuropathy; Pathology; Skin hyperpigmentation; Dermatology; Hyperpigmentation; Surgery","score_opus":0.02254611917426599,"score_gpt":0.2754709675557134,"score_spread":0.2529248483814474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606741855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914817,0.004166084,0.00003265915,0.001187135,0.00072525296,0.00011658276,0.0000042500787,0.000013048252,0.002273288],"genre_scores_gemma":[0.99703217,0.0013344483,0.00027588356,0.0007848112,0.00008452071,0.0000028028246,0.0000014069667,0.00002447975,0.00045947914],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998581,0.000083587984,0.00058411894,0.00017226326,0.0002186879,0.00036034684],"domain_scores_gemma":[0.9988306,0.00009623579,0.000471148,0.00026950715,0.00013681817,0.00019565165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029349656,0.00012777148,0.00078908645,0.00013829515,0.00017076348,0.00008862298,0.0003255985,0.00014669531,0.00007747842],"category_scores_gemma":[0.0016852345,0.00013720467,0.00017279744,0.0000628179,0.00025827633,0.0002517206,0.000083924584,0.00032898382,0.000020629412],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012717435,0.000607993,0.0538013,0.00023215135,0.00013037011,0.8835978,0.00037985746,0.000018882003,0.002203347,0.00024433355,0.04231147,0.016345305],"study_design_scores_gemma":[0.0039652,0.0004720681,0.25813964,0.000765342,0.000044492943,0.7254843,0.0005005511,0.00003667062,0.00021414872,0.00049797667,0.009818411,0.00006116951],"about_ca_topic_score_codex":0.00014902689,"about_ca_topic_score_gemma":0.00044162926,"teacher_disagreement_score":0.20433834,"about_ca_system_score_codex":0.00002679723,"about_ca_system_score_gemma":0.000119238226,"threshold_uncertainty_score":0.55950445},"labels":[],"label_agreement":null},{"id":"W2606884609","doi":"10.1111/bjh.14609","title":"Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Agence Nationale de la Recherche","keywords":"Medicine; Confidence interval; Autoantibody; Red Cell; Fetal hemoglobin; Internal medicine; Pediatrics; Antibody; Blood transfusion; Red blood cell; Immunology; Pregnancy; Fetus","score_opus":0.005022565778677179,"score_gpt":0.19242971326490899,"score_spread":0.1874071474862318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606884609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980685,0.0012201647,0.00006680287,0.0001692483,0.000032077292,0.00032768224,0.000052079322,0.0000041542517,0.000059278143],"genre_scores_gemma":[0.9948642,0.0045092534,0.0005248071,0.000004760736,0.000011143775,4.761388e-7,0.000013603504,0.000009035259,0.00006269142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931335,0.000060774433,0.0002053593,0.00016102128,0.00009843564,0.00016106763],"domain_scores_gemma":[0.99929786,0.000042130872,0.00030172672,0.00013945831,0.00010141106,0.00011739898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011454708,0.00008942634,0.0003145362,0.00008690539,0.00012100003,0.000023632887,0.00014085173,0.00008012789,0.000012624972],"category_scores_gemma":[0.00008107539,0.00008830329,0.000038615068,0.000044510616,0.00009614512,0.00019008652,0.00003157827,0.0002660202,2.052604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018552759,0.0005595593,0.99572146,0.00014801105,0.000028102346,0.0027383477,0.00025325464,0.000005576778,0.00004351678,0.000008624005,0.000026167836,0.00028187007],"study_design_scores_gemma":[0.0069197877,0.0004272605,0.9898668,0.0005929449,0.0003220609,0.0012864049,0.00011313464,0.000030240775,0.0002837734,0.000048235885,0.00001584094,0.00009354144],"about_ca_topic_score_codex":0.0012053382,"about_ca_topic_score_gemma":0.001112184,"teacher_disagreement_score":0.00673426,"about_ca_system_score_codex":0.00001489713,"about_ca_system_score_gemma":0.00007911555,"threshold_uncertainty_score":0.36009037},"labels":[],"label_agreement":null},{"id":"W2607531045","doi":"10.1111/bjh.14720","title":"Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Barncancerfonden; International Business Machines Corporation","keywords":"Medicine; Myeloid leukaemia; Hematology; Stem cell; Myeloid; Oncology; Internal medicine; Intensive care medicine","score_opus":0.029290773422042834,"score_gpt":0.29209955568642304,"score_spread":0.2628087822643802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607531045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863784,0.0097569,0.000073295996,0.0028978935,0.000420217,0.00032158077,0.000013224639,0.000010779842,0.00012772315],"genre_scores_gemma":[0.9818004,0.016465949,0.00053506333,0.00058502884,0.00019057491,0.000014019918,0.0000040059913,0.000037021142,0.00036796115],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9978941,0.00020775874,0.00085448986,0.0002887538,0.00031760207,0.00043729783],"domain_scores_gemma":[0.9983839,0.00010851301,0.0005104618,0.00031868022,0.00044028813,0.00023817476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073329825,0.00019390078,0.00097481784,0.00038510057,0.00014359165,0.00007938279,0.00029453242,0.00032789793,0.000051554867],"category_scores_gemma":[0.00012664458,0.00018164598,0.00017579274,0.00010051425,0.00028984362,0.00028873576,0.000072967094,0.0012314735,0.000013165338],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005421761,0.00021547319,0.41747206,0.0003292316,0.00040997952,0.4881253,0.0013755244,0.0000034339587,0.017352596,0.000028579816,0.0025721595,0.06669392],"study_design_scores_gemma":[0.013116939,0.0009500263,0.29955518,0.00041536934,0.00026083452,0.67557144,0.000571008,0.000038151207,0.00816632,0.00015119542,0.0009087492,0.0002947731],"about_ca_topic_score_codex":0.00014386358,"about_ca_topic_score_gemma":0.000104371786,"teacher_disagreement_score":0.18744618,"about_ca_system_score_codex":0.00018235113,"about_ca_system_score_gemma":0.0002853805,"threshold_uncertainty_score":0.7407308},"labels":[],"label_agreement":null},{"id":"W2608927536","doi":"10.1111/bjh.14664","title":"The effect of rituximab on anti‐platelet autoantibody levels in patients with immune thrombocytopenia","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research; Canadian Blood Services; McMaster University","keywords":"Rituximab; Autoantibody; Medicine; Platelet; Immunology; Internal medicine; Immune thrombocytopenia; Adjuvant; Placebo; Gastroenterology; Antibody; Pathology","score_opus":0.007389295413148649,"score_gpt":0.2695791835000823,"score_spread":0.26218988808693366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608927536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976587,0.0009892003,0.0000034890695,0.0003219819,0.00019235881,0.00032849103,0.000013502425,0.0000037690377,0.00048850477],"genre_scores_gemma":[0.99962986,0.00021716977,0.000062345236,0.00002451837,0.000012656905,0.0000023789369,0.000005184701,0.000017056698,0.000028816987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871933,0.00011131224,0.0005113299,0.00012882301,0.0002700034,0.00025919857],"domain_scores_gemma":[0.9986422,0.00016798668,0.00070853654,0.00029041962,0.00013014679,0.00006067641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036163564,0.00014114454,0.0013088451,0.00008110836,0.00022464556,0.000049319944,0.00026435338,0.00009467087,0.000023955772],"category_scores_gemma":[0.0002847513,0.00008902634,0.00011788784,0.000046052806,0.00024755904,0.00013732792,0.00004284283,0.0003218511,0.000009439323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036835247,0.0014499157,0.8149372,0.00015690234,0.0007874375,0.12613155,0.00005821175,0.000004690452,0.0001708365,0.00009347938,0.00043940343,0.052086897],"study_design_scores_gemma":[0.024785992,0.0035781334,0.92768717,0.0010703848,0.000102334234,0.03912864,0.000009743417,0.0000050042368,0.0033628498,0.00006779111,0.00012110636,0.000080823775],"about_ca_topic_score_codex":0.00012534064,"about_ca_topic_score_gemma":0.000070159724,"teacher_disagreement_score":0.11275004,"about_ca_system_score_codex":0.00002750761,"about_ca_system_score_gemma":0.000062728715,"threshold_uncertainty_score":0.36303887},"labels":[],"label_agreement":null},{"id":"W2609884290","doi":"10.1111/bjh.14698","title":"A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; McGill University; University of Ottawa; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Mirati Therapeutics","keywords":"Medicine; Internal medicine; Histone deacetylase inhibitor; Follicular lymphoma; Oncology; Adverse effect; Diffuse large B-cell lymphoma; Refractory (planetary science); Lymphoma; Aggressive lymphoma; Gastroenterology; Histone deacetylase; Rituximab; Biology; Histone","score_opus":0.022412711113689827,"score_gpt":0.3520875203780766,"score_spread":0.3296748092643868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609884290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965086,0.0024035047,0.000021183008,0.00011145135,0.00037280712,0.00033178096,0.000022410111,0.0000043898804,0.00022386329],"genre_scores_gemma":[0.99870026,0.00038483765,0.0002552532,0.00003531375,0.00017306513,0.000015310323,0.000007730476,0.00004140802,0.00038682407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972474,0.00043261022,0.0011417142,0.00035745994,0.0004091566,0.0004116425],"domain_scores_gemma":[0.9975137,0.00006653096,0.0011424352,0.00063587114,0.0004442926,0.00019714946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009342746,0.00020074492,0.0008065532,0.00026399086,0.00020974502,0.000048292954,0.0007333386,0.00027330808,0.00004477249],"category_scores_gemma":[0.002418958,0.00021449623,0.00016412363,0.00010183131,0.00042900245,0.00002202216,0.00026061133,0.00035849639,0.0000056533413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012602759,0.033709355,0.003599337,0.0003473029,0.0005253345,0.20712496,0.0018081744,0.00003084862,0.62783134,0.00002070806,0.039487753,0.07291212],"study_design_scores_gemma":[0.10562414,0.029534558,0.007829427,0.001221012,0.00016147137,0.21021836,0.003413745,0.000058741287,0.6245759,0.00006022783,0.016289802,0.001012634],"about_ca_topic_score_codex":0.0006239584,"about_ca_topic_score_gemma":0.0024758675,"teacher_disagreement_score":0.09302138,"about_ca_system_score_codex":0.00009390646,"about_ca_system_score_gemma":0.00065851543,"threshold_uncertainty_score":0.8746903},"labels":[],"label_agreement":null},{"id":"W2610591083","doi":"10.1111/bjh.14605","title":"“On‐demand” treatment with Thrombopoietin mimetics as “bridge to recovery” from chemotherapy in chronic immune thrombocytopenia patients with cancer. A single centre experience in nine patients","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Splenectomy; Thrombopoietin; Chemotherapy; Cancer; Platelet; Internal medicine; Surgery; Spleen","score_opus":0.015444520703470169,"score_gpt":0.2739747162665569,"score_spread":0.2585301955630867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610591083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760465,0.0029157791,0.0000045713773,0.019058771,0.00029613473,0.0012924254,0.00021144602,0.000009946206,0.00016444983],"genre_scores_gemma":[0.97295237,0.002825452,0.00042573336,0.022245232,0.00023798876,0.0000923387,0.00063404744,0.00016021669,0.00042661544],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9969447,0.00014614809,0.00094271835,0.00064133754,0.0006031529,0.00072188914],"domain_scores_gemma":[0.99785125,0.00012551875,0.0010903004,0.00048627553,0.0002789828,0.00016768757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006844671,0.00060038565,0.002887841,0.00032455657,0.000098073404,0.00008675641,0.000368323,0.00050066866,0.0004352975],"category_scores_gemma":[0.000066769746,0.00048030113,0.00017413453,0.00017340113,0.00018262476,0.00017315886,0.000047894362,0.0009276729,0.000021517411],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011086384,0.009880223,0.26947236,0.00030209526,0.0029597778,0.55686384,0.003171848,0.00007686417,0.00008380772,0.0000010851451,0.10598294,0.0401188],"study_design_scores_gemma":[0.15180609,0.05622379,0.6768487,0.03609716,0.0012269118,0.024316862,0.00018103092,0.000012110932,0.0024269416,0.000209368,0.048403222,0.002247782],"about_ca_topic_score_codex":0.0049272915,"about_ca_topic_score_gemma":0.00465893,"teacher_disagreement_score":0.53254694,"about_ca_system_score_codex":0.001496468,"about_ca_system_score_gemma":0.00058431324,"threshold_uncertainty_score":0.99976486},"labels":[],"label_agreement":null},{"id":"W2610626477","doi":"10.1111/bjh.14623","title":"Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Centre Hospitalier Universitaire Sainte-Justine; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Thrombasthenia; Platelet; Glanzmann's thrombasthenia; Medicine; Platelet transfusion; Blood Platelet Disorders; Immunology; Platelet aggregation","score_opus":0.01912580188991389,"score_gpt":0.28541380140699174,"score_spread":0.2662879995170778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610626477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92141736,0.004444347,0.00012768238,0.07160518,0.00039003592,0.00095271826,0.0004041363,0.000028755996,0.0006297648],"genre_scores_gemma":[0.97993356,0.0042843074,0.0008229703,0.013507641,0.000584539,0.000022453658,0.00034026863,0.00023519862,0.00026908464],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99585885,0.00032037834,0.0015654943,0.00050861086,0.00084959774,0.0008970482],"domain_scores_gemma":[0.99610585,0.00051474344,0.0019473747,0.0007615266,0.0004411187,0.00022940987],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004242845,0.000717956,0.0039512273,0.0003874714,0.00047672843,0.00011742362,0.0007726058,0.00095440785,0.0003741664],"category_scores_gemma":[0.000116673196,0.00048333968,0.001118868,0.0001869654,0.00087474746,0.00023242629,0.000036008627,0.0036757425,0.000012805442],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009933409,0.0003666226,0.00033373048,0.0005543451,0.0049675917,0.72811675,0.00068426,0.00004522625,0.00015249803,0.000004022059,0.25656322,0.007218384],"study_design_scores_gemma":[0.010191896,0.0028173765,0.0027781713,0.005020989,0.0018498068,0.96077144,0.00009442519,0.000028385333,0.00049452315,0.00018291852,0.0153084,0.00046168416],"about_ca_topic_score_codex":0.0013785769,"about_ca_topic_score_gemma":0.00022856555,"teacher_disagreement_score":0.24125482,"about_ca_system_score_codex":0.00013686257,"about_ca_system_score_gemma":0.0010547499,"threshold_uncertainty_score":0.9997618},"labels":[],"label_agreement":null},{"id":"W2611251974","doi":"10.1111/bjh.14702","title":"Physical activity, obesity and survival in diffuse large B‐cell and follicular lymphoma cases","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Royal Jubilee Hospital; Public Health Ontario; University of Toronto; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; National Health and Medical Research Council; Canadian Institutes of Health Research; Killam Trusts; Michael Smith Health Research BC","keywords":"Follicular lymphoma; Medicine; Lymphoma; Hazard ratio; Internal medicine; Diffuse large B-cell lymphoma; Body mass index; Confidence interval; International Prognostic Index; Non-Hodgkin's lymphoma; Oncology; Obesity; Proportional hazards model; Gastroenterology","score_opus":0.01669004799159555,"score_gpt":0.28590569905521374,"score_spread":0.26921565106361817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611251974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961283,0.0028662987,0.0000051542547,0.0005671787,0.000102778366,0.000109930676,0.000011659515,0.0000042305423,0.0002044205],"genre_scores_gemma":[0.99828094,0.00148363,0.00006872086,0.000049221402,0.00007147152,0.0000033874576,9.789752e-7,0.000009883656,0.00003178938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923164,0.00007869926,0.00017674494,0.00015885991,0.00014279044,0.00021128406],"domain_scores_gemma":[0.99925095,0.00015327733,0.00023043905,0.00014987093,0.000056113575,0.00015933171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001630282,0.000110792505,0.00069757993,0.000057591064,0.00016029846,0.00007623051,0.000072033225,0.00007995187,0.0000050784033],"category_scores_gemma":[0.00019390066,0.00010290129,0.000088490815,0.000020058515,0.00014070935,0.00015687819,0.00010755016,0.00009407246,0.000001806298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015789807,0.0089732045,0.7093137,0.00010302004,0.00009416156,0.2585207,0.00012890667,3.7307665e-8,0.00016133353,0.00022796071,0.00018469073,0.02213442],"study_design_scores_gemma":[0.015688777,0.00026969722,0.77507657,0.00021420828,0.00011845535,0.2064664,0.00005035828,0.000026418862,0.0016524825,0.00015050973,0.00021083473,0.00007531106],"about_ca_topic_score_codex":0.0005937216,"about_ca_topic_score_gemma":0.0006354333,"teacher_disagreement_score":0.06576288,"about_ca_system_score_codex":0.000051466304,"about_ca_system_score_gemma":0.000085563915,"threshold_uncertainty_score":0.4196193},"labels":[],"label_agreement":null},{"id":"W2613509107","doi":"10.1111/bjh.14592","title":"Turf wars: exploring splenomegaly in sickle cell disease in malaria‐endemic regions","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; AGE-WELL; Wellcome Trust; Wellcome","keywords":"Malaria; Disease; Medicine; Severe Malaria; Immunology; Pediatrics; Internal medicine; Plasmodium falciparum","score_opus":0.10019103310777724,"score_gpt":0.3359890896213423,"score_spread":0.23579805651356503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613509107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054250043,0.99180865,0.000008289403,0.00048149817,0.0007638335,0.0005517301,0.000020156767,0.000013884884,0.0009269767],"genre_scores_gemma":[0.005922534,0.9932903,0.00011928848,0.000064409745,0.00016878331,0.00003983221,0.000028864912,0.00007740916,0.0002885535],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965694,0.00032018908,0.0018810004,0.0003731943,0.00026195144,0.0005942988],"domain_scores_gemma":[0.9975941,0.00016007785,0.0012888599,0.00043463017,0.000106711894,0.00041558055],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00065709755,0.00036926955,0.0037723633,0.0008339932,0.00008775459,0.00005280988,0.00048906566,0.0006053372,0.00008143104],"category_scores_gemma":[0.00057173375,0.00036044396,0.00079779763,0.00025917342,0.00019081349,0.00023563395,0.000121705816,0.0025220583,0.000043617245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010033894,0.00061488233,0.0007160153,0.021232082,0.00019342305,0.5015115,0.0001740729,0.000010634272,2.9807333e-7,0.00019370209,0.002584922,0.4726681],"study_design_scores_gemma":[0.0021389143,0.00010528803,0.00030909188,0.09263311,0.0009210935,0.1781832,0.0001480626,0.0000057203597,2.310594e-7,0.0002816071,0.7249347,0.00033898556],"about_ca_topic_score_codex":0.00020867669,"about_ca_topic_score_gemma":0.00011460563,"teacher_disagreement_score":0.72234976,"about_ca_system_score_codex":0.00021700807,"about_ca_system_score_gemma":0.0012320131,"threshold_uncertainty_score":0.9998847},"labels":[],"label_agreement":null},{"id":"W2614011808","doi":"10.1111/bjh.14733","title":"Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Takeda Pharmaceutical Company","keywords":"Medicine; Lenalidomide; Ixazomib; Nausea; Adverse effect; Multiple myeloma; Rash; Placebo; Internal medicine; Mucositis; Dexamethasone; Vomiting; Thalidomide; Gastroenterology; Surgery; Chemotherapy; Carfilzomib","score_opus":0.029417235466169988,"score_gpt":0.30637939824332555,"score_spread":0.2769621627771556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614011808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722046,0.0009524489,0.00006686321,0.00023377754,0.00014371259,0.00046559417,0.000022310289,0.000009142906,0.0008857092],"genre_scores_gemma":[0.9965659,0.0006519755,0.0022136914,0.000025767655,0.000028585291,0.000014682918,0.000013004476,0.00003068276,0.00045570967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769264,0.00022414692,0.00079221575,0.00023582732,0.0005972769,0.00045789903],"domain_scores_gemma":[0.9976658,0.00023715784,0.0011191851,0.00038359544,0.0003407488,0.00025351558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007393947,0.00018298005,0.0011018183,0.00026688055,0.00014133567,0.000011049026,0.0003461572,0.00015909328,0.00010315568],"category_scores_gemma":[0.001084616,0.00016771125,0.0001905624,0.000112152244,0.00026467757,0.00020524146,0.00011758727,0.00050017616,0.000011397475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063781114,0.0018432564,0.6293304,0.00034845888,0.0021706782,0.33738473,0.00015539484,0.00003934271,0.00025738668,0.00004910334,0.00025404448,0.021789087],"study_design_scores_gemma":[0.042167295,0.00094989006,0.922021,0.0042503127,0.00022583854,0.028893141,0.0003175533,0.00015529073,0.00068550365,0.000101484016,0.00008970243,0.0001430452],"about_ca_topic_score_codex":0.000419893,"about_ca_topic_score_gemma":0.00073600304,"teacher_disagreement_score":0.3084916,"about_ca_system_score_codex":0.00026026188,"about_ca_system_score_gemma":0.00020937875,"threshold_uncertainty_score":0.6839066},"labels":[],"label_agreement":null},{"id":"W2616337382","doi":"10.1111/bjh.14756","title":"Incidental finding of recent parvovirus infection","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Parvovirus; Medicine; Bone marrow; Asymptomatic; Pathology; Erythropoiesis; Bone marrow examination; Platelet; Serology; Ineffective erythropoiesis; Immunology; Anemia; Gastroenterology; Internal medicine; Virus","score_opus":0.0710185415896461,"score_gpt":0.3736143194802201,"score_spread":0.302595777890574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616337382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096733,0.001195565,0.0002542134,0.00040498408,0.0011130075,0.000095975745,0.0000037437076,0.000011486944,0.005953682],"genre_scores_gemma":[0.99413204,0.005199355,0.00031676728,0.000093596944,0.00017239836,0.000002521826,9.214359e-7,0.000012163415,0.00007020446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987612,0.00007221439,0.00065157353,0.000102281956,0.00023632597,0.00017643263],"domain_scores_gemma":[0.99801904,0.00007208796,0.0012002352,0.00017416461,0.00044151174,0.000092961665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046947287,0.000091610964,0.00068987056,0.00017567305,0.00027442104,0.000034085635,0.00011060409,0.00010649645,0.00031981035],"category_scores_gemma":[0.0017261975,0.0000985481,0.00016973408,0.000060541726,0.000268674,0.00023558743,0.00008742236,0.00032187422,0.00004927877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000346501,0.0004016424,0.89727604,0.00017786694,0.0005638245,0.020786256,0.00016676102,0.0000057524176,0.004606157,0.00025793584,0.016652746,0.058758512],"study_design_scores_gemma":[0.0023461422,0.00020138994,0.5559546,0.00047978258,0.00018825398,0.4113008,0.0000629561,0.000004865545,0.013291275,0.0003080692,0.015759932,0.000101946156],"about_ca_topic_score_codex":0.00039191623,"about_ca_topic_score_gemma":0.0002596583,"teacher_disagreement_score":0.39051455,"about_ca_system_score_codex":0.00007386273,"about_ca_system_score_gemma":0.00010289463,"threshold_uncertainty_score":0.40186748},"labels":[],"label_agreement":null},{"id":"W2616381323","doi":"10.1111/j.1365-2141.2000.02342.x","title":"Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health; Associazione Italiana per la Ricerca sul Cancro","keywords":"Progenitor cell; Haematopoiesis; Immunology; Biology; White blood cell; Blood cell; Stem cell; Internal medicine; Andrology; Medicine; Cell biology","score_opus":0.005327753068103107,"score_gpt":0.2057229196985517,"score_spread":0.2003951666304486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616381323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947103,0.0027366779,0.0000068865425,0.00086386706,0.000050673094,0.0008935088,0.00002022447,0.000007791286,0.0007100376],"genre_scores_gemma":[0.9984962,0.000376804,0.00032851918,0.0006568835,0.000020443173,0.000017325458,0.000008463021,0.000024118592,0.00007126038],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982417,0.0001983487,0.0006584607,0.00017209059,0.0004081385,0.00032121356],"domain_scores_gemma":[0.9990294,0.00008134549,0.00023592508,0.00018290745,0.00024068418,0.00022975069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022841354,0.00014890745,0.00065864605,0.00013231083,0.00006314254,0.0000142596555,0.00020150584,0.0000867225,0.00025111713],"category_scores_gemma":[0.000109160595,0.000107213076,0.00015316317,0.0002990694,0.00018944399,0.00006335873,0.000019046834,0.00037114276,0.000008734509],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020624666,0.04284879,0.41403162,0.0036842672,0.0018466451,0.4240129,0.03095929,0.00087254576,0.0011023137,0.000387714,0.0053755906,0.05425366],"study_design_scores_gemma":[0.10002869,0.019869605,0.3925627,0.00827749,0.006030771,0.42492464,0.021423195,0.00006414648,0.008888381,0.00065558346,0.015456264,0.0018185433],"about_ca_topic_score_codex":0.000060522943,"about_ca_topic_score_gemma":0.0000275748,"teacher_disagreement_score":0.07940403,"about_ca_system_score_codex":0.000019729034,"about_ca_system_score_gemma":0.00023328644,"threshold_uncertainty_score":0.43720224},"labels":[],"label_agreement":null},{"id":"W2620016413","doi":"10.1111/bjh.14780","title":"Recent progress in relapsed multiple myeloma therapy: implications for treatment decisions","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Amgen","keywords":"Multiple myeloma; Medicine; Intensive care medicine; Oncology; Internal medicine","score_opus":0.2364325585495828,"score_gpt":0.4665470139031241,"score_spread":0.23011445535354128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620016413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018338511,0.99331576,0.000025645484,0.00084408204,0.0002338094,0.0033769377,0.00026274976,0.000014110888,0.000093069575],"genre_scores_gemma":[0.00052565546,0.9949676,0.0028037403,0.000023140396,0.00015681045,0.0009991205,0.00023532477,0.00007744422,0.00021118035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970235,0.00028353097,0.0014755384,0.0004020093,0.00023694489,0.000578449],"domain_scores_gemma":[0.99605036,0.0011427494,0.0012767798,0.0006007831,0.00053584046,0.00039347186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043649922,0.0003784043,0.0037254628,0.00054948777,0.00024800407,0.00008480877,0.0004306447,0.0004329865,0.000045728266],"category_scores_gemma":[0.0016571918,0.0002954148,0.0010144737,0.00017516971,0.00020505201,0.00006980122,0.000054885535,0.00038084033,0.000021262278],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003241172,0.0013229157,0.0017118738,0.0007508319,0.00091707025,0.014963967,0.00001778978,5.007545e-8,1.5406745e-7,0.000019466792,0.0014578061,0.97851396],"study_design_scores_gemma":[0.008586287,0.0011544303,0.003804236,0.013442567,0.0004799525,0.15711397,0.0000066568837,0.0000029101811,0.0000017502934,0.000104870094,0.8151387,0.00016366858],"about_ca_topic_score_codex":0.000025624999,"about_ca_topic_score_gemma":0.00027829516,"teacher_disagreement_score":0.9783503,"about_ca_system_score_codex":0.0004827038,"about_ca_system_score_gemma":0.0015762846,"threshold_uncertainty_score":0.9999498},"labels":[],"label_agreement":null},{"id":"W2621898599","doi":"10.1111/bjh.14641","title":"Impact of red blood cell transfusion strategies in haemato‐oncological patients: a systematic review and meta‐analysis","year":2017,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Leids Universitair Medisch Centrum; McMaster University","keywords":"Medicine; Observational study; Meta-analysis; CINAHL; Relative risk; Randomized controlled trial; MEDLINE; Confidence interval; Blood transfusion; Red Blood Cell Transfusion; Intensive care medicine; Pediatrics; Internal medicine; Psychological intervention","score_opus":0.0673367142916423,"score_gpt":0.37788481544982205,"score_spread":0.31054810115817977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621898599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086516084,0.99547684,0.00003524921,0.00009449619,0.000044786684,0.0030682208,0.000050295905,0.000008618105,0.00035633624],"genre_scores_gemma":[0.0027625682,0.99674475,0.00021797238,0.00006505338,0.000009794077,0.00009070227,0.000027692606,0.000031002473,0.00005045668],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945177,0.0010278884,0.003347011,0.000368668,0.0004254766,0.00031329688],"domain_scores_gemma":[0.9956766,0.00024118846,0.0030094981,0.00047420757,0.00038116964,0.00021734273],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0013653707,0.00046775086,0.019862434,0.0008190971,0.00006272065,0.00005639194,0.00040145952,0.00043496027,0.00032601831],"category_scores_gemma":[0.00029057162,0.0003171323,0.004715244,0.00046536134,0.00016907755,0.00015546264,0.000069601825,0.0007712892,0.0000019468682],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023646062,0.0012849726,0.000029228102,0.88001823,0.10102844,0.014921636,0.000025639843,3.6341362e-7,1.3942204e-7,0.000024271125,0.00016460997,0.0024788412],"study_design_scores_gemma":[0.0016376583,0.0008406176,0.00011306247,0.15839204,0.79106146,0.046727236,0.000027371045,3.5509868e-7,2.2488412e-7,0.000021785969,0.00097397726,0.00020419716],"about_ca_topic_score_codex":0.00015697136,"about_ca_topic_score_gemma":0.00018901956,"teacher_disagreement_score":0.72162616,"about_ca_system_score_codex":0.000046410973,"about_ca_system_score_gemma":0.0003821552,"threshold_uncertainty_score":0.99992806},"labels":[],"label_agreement":null},{"id":"W2725925241","doi":"10.1111/bjh.14820","title":"Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab <i>versus</i> chemotherapy plus rituximab for relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Pfizer","keywords":"Rituximab; Medicine; Calicheamicin; Internal medicine; Oncology; Hazard ratio; Interim analysis; Refractory (planetary science); CD22; Clinical endpoint; Aggressive lymphoma; Lymphoma; CD20; Clinical trial; Confidence interval","score_opus":0.02536001530919176,"score_gpt":0.31448059661853234,"score_spread":0.2891205813093406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725925241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7910817,0.061441064,0.0009505249,0.11238959,0.015673976,0.013548487,0.00173564,0.00009936605,0.003079606],"genre_scores_gemma":[0.742249,0.062503226,0.008830369,0.1483318,0.02574653,0.0020959673,0.0027673333,0.0012923426,0.006183433],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9929563,0.00065729214,0.0033253748,0.0008758436,0.0011269358,0.0010582791],"domain_scores_gemma":[0.98480177,0.0028112698,0.009792496,0.0010451085,0.0012221072,0.00032724996],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012362752,0.0010205639,0.009829811,0.0006746379,0.00031692698,0.00015417827,0.00097256206,0.0021971262,0.00021024991],"category_scores_gemma":[0.0016665857,0.0009518191,0.0032142466,0.00012359272,0.0011024575,0.00029692697,0.00012569844,0.0014392012,0.000033334618],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4713548,0.0044172513,0.0000021430772,0.0008347275,0.002345419,0.114623375,0.00018581499,9.1526414e-7,0.0000170943,0.000007875259,0.39224324,0.013967324],"study_design_scores_gemma":[0.75931036,0.0055730077,0.0000033769406,0.0033228567,0.00402947,0.09210863,0.000049085702,0.000045776065,0.0019070012,0.00015319447,0.13295224,0.0005449891],"about_ca_topic_score_codex":0.0006358624,"about_ca_topic_score_gemma":0.00003947219,"teacher_disagreement_score":0.28795555,"about_ca_system_score_codex":0.0015206975,"about_ca_system_score_gemma":0.0045467876,"threshold_uncertainty_score":0.9992932},"labels":[],"label_agreement":null},{"id":"W2726575446","doi":"10.1111/bjh.14767","title":"British Committee for Standards in Haematology guidelines for aplastic anaemia: single centre retrospective review finds no compelling evidence for the recommended higher platelet count threshold of 20 × 10<sup>9</sup>/l","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Platelet; Platelet transfusion; Aplastic anemia; Retrospective cohort study; Internal medicine; Pharmacy; Hematology; Absolute neutrophil count; Pediatrics; Neutropenia; Chemotherapy; Family medicine; Bone marrow","score_opus":0.10077469349514713,"score_gpt":0.3586829078346189,"score_spread":0.2579082143394718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726575446","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001572623,0.15670286,0.010592943,0.8171572,0.0029183773,0.008430728,0.0022572195,0.000040641153,0.00032740325],"genre_scores_gemma":[0.008023866,0.24480006,0.03496441,0.69010144,0.008605261,0.001453858,0.0016268896,0.0007403055,0.009683933],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944588,0.00021292082,0.0030163254,0.00067282526,0.00078043394,0.00085871015],"domain_scores_gemma":[0.9884631,0.0026813569,0.0023985691,0.00063834304,0.0056871665,0.0001314496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028539244,0.00052768877,0.0043229177,0.00026283987,0.000282853,0.00011949635,0.0009549399,0.00097182055,0.00075222476],"category_scores_gemma":[0.0053508477,0.00050657947,0.0010187504,0.00014660902,0.00038170646,0.00018597617,0.00011877627,0.0016943975,0.0000029533253],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009747716,0.00021360721,0.00012159518,0.015671875,0.0008762115,0.011469006,0.00003724957,0.00002585197,0.0000045750207,0.00007131768,0.966317,0.004216914],"study_design_scores_gemma":[0.008256815,0.001297944,0.000060331004,0.062048238,0.0020887256,0.04338362,0.000051982057,0.00058621354,0.000037942806,0.0008422211,0.88092446,0.0004214759],"about_ca_topic_score_codex":0.00014846721,"about_ca_topic_score_gemma":0.0008832669,"teacher_disagreement_score":0.12705578,"about_ca_system_score_codex":0.0003061437,"about_ca_system_score_gemma":0.0005183657,"threshold_uncertainty_score":0.9997386},"labels":[],"label_agreement":null},{"id":"W2727740953","doi":"10.1111/bjh.14825","title":"Overall survival in lower <scp>IPSS</scp> risk <scp>MDS</scp> by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an <scp>MDS</scp>‐<scp>CAN</scp> analysis","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; Foothills Medical Centre; Université Laval; Centre hospitalier universitaire de Québec; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University of Saskatchewan; Leukemia & Lymphoma Society of Canada; CancerCare Manitoba; Ottawa Hospital; Health Sciences Centre; University Health Network; University of Alberta Hospital; University of Alberta; Jewish General Hospital; Sunnybrook Health Science Centre; Université de Moncton; University of Toronto; McMaster University; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Celgene","keywords":"Medicine; Comorbidity; Hazard ratio; Internal medicine; Multivariate analysis; Proportional hazards model; International Prognostic Scoring System; Prospective cohort study; Myelodysplastic syndromes; Physical therapy; Confidence interval","score_opus":0.016676949285730536,"score_gpt":0.2494884291091361,"score_spread":0.23281147982340555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727740953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900584,0.0067244894,0.00039825164,0.00007710198,0.00036223064,0.0012138641,0.0005957627,0.000047793008,0.00052209524],"genre_scores_gemma":[0.9889618,0.008791879,0.0012804467,0.000031429856,0.00013402954,0.00002512826,0.00030676357,0.00015166825,0.00031686554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923013,0.001074148,0.0027642157,0.0010479579,0.001562243,0.0012501541],"domain_scores_gemma":[0.9879989,0.0055044824,0.0036914162,0.0008772714,0.0012477344,0.0006802086],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026718224,0.0007143789,0.003063349,0.0011390806,0.0005991948,0.00017402112,0.00093526277,0.0011863983,0.00004483638],"category_scores_gemma":[0.01124492,0.00073697005,0.00078520796,0.00069082173,0.0005545864,0.00091091666,0.00022431747,0.0019826938,0.0000035925182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020457398,0.0020929521,0.8735395,0.00065300154,0.0031493213,0.0030198835,0.010979472,0.0006296265,0.09884621,0.0000057348,0.003111838,0.0037678757],"study_design_scores_gemma":[0.033799652,0.0044800728,0.7440381,0.0024510594,0.005112659,0.0048690964,0.00957668,0.0077090356,0.18620367,0.0005992209,0.0009215123,0.00023923388],"about_ca_topic_score_codex":0.004713892,"about_ca_topic_score_gemma":0.0019269539,"teacher_disagreement_score":0.1295014,"about_ca_system_score_codex":0.00028557467,"about_ca_system_score_gemma":0.00044100313,"threshold_uncertainty_score":0.99950814},"labels":[],"label_agreement":null},{"id":"W2731162750","doi":"10.1111/bjh.14741","title":"Acute myeloid leukemia with mutated <i><scp>NPM</scp>1</i> demonstrating multilineage dysplasia and marked thrombocytosis","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Thrombocytosis; NPM1; Dysplasia; Myeloid; Pathology; Trisomy 8; Polycythemia vera; Medicine; Bone marrow; Internal medicine; Karyotype; Immunology; Biology; Platelet; Genetics; Chromosome","score_opus":0.01509676414474175,"score_gpt":0.2863323800750135,"score_spread":0.27123561593027173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731162750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362963,0.0013972528,0.00050117046,0.00074337283,0.00015949478,0.0004040883,0.000027416641,0.000042109736,0.0030954485],"genre_scores_gemma":[0.9819173,0.0021937124,0.014663927,0.00033226103,0.00018680177,0.000010798333,0.000010941489,0.00007535372,0.00060887967],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99714464,0.00020534266,0.00091793225,0.00042173092,0.0005634692,0.0007468964],"domain_scores_gemma":[0.9966797,0.00054032844,0.0010873525,0.00048456862,0.00066123356,0.00054676394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076820276,0.0003197954,0.0014347323,0.00023953809,0.0006628135,0.00030734966,0.0005351901,0.0003345736,0.000040868916],"category_scores_gemma":[0.0019091761,0.00029406988,0.00016529545,0.00014488923,0.0010792741,0.0005381755,0.00022847272,0.0014755664,0.000015124294],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018073214,0.00039914544,0.13024345,0.0008597412,0.004081182,0.7069366,0.00077407726,0.000016010808,0.07063985,0.00016104431,0.029844938,0.054236665],"study_design_scores_gemma":[0.011088737,0.0009797027,0.08498549,0.0013567487,0.0006815289,0.87380385,0.0006857638,0.0011523688,0.024017012,0.00007989474,0.0009995855,0.00016929989],"about_ca_topic_score_codex":0.00021333407,"about_ca_topic_score_gemma":0.00025483104,"teacher_disagreement_score":0.1668673,"about_ca_system_score_codex":0.00023520672,"about_ca_system_score_gemma":0.0010555064,"threshold_uncertainty_score":0.9999511},"labels":[],"label_agreement":null},{"id":"W2732548543","doi":"10.1111/bjh.14787","title":"Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: <scp>ELOQUENT</scp>‐2 follow‐up and <i>post‐hoc</i> analyses on progression‐free survival and tumour growth","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Dalhousie University","funders":"AbbVie Biotherapeutics; Bristol-Myers Squibb","keywords":"Lenalidomide; Medicine; Dexamethasone; Hazard ratio; Internal medicine; Multiple myeloma; Progression-free survival; Post-hoc analysis; Oncology; Interim analysis; Refractory (planetary science); Gastroenterology; Surgery; Chemotherapy; Randomized controlled trial; Confidence interval; Biology","score_opus":0.07180174197422885,"score_gpt":0.37094425773124934,"score_spread":0.2991425157570205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732548543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886025,0.008266667,0.00014452456,0.0009546297,0.00047361435,0.0009424997,0.00014004133,0.00003174447,0.0004437709],"genre_scores_gemma":[0.99084467,0.0025819975,0.0050628483,0.00013042774,0.00022340857,0.00006949802,0.000033080705,0.00007108247,0.0009829914],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9967931,0.0003452893,0.00087219285,0.00052886095,0.0007165252,0.0007440685],"domain_scores_gemma":[0.99457663,0.0023897057,0.0010254422,0.000490163,0.0007899368,0.00072813494],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010082845,0.00036743836,0.0016119061,0.0003378125,0.00073343766,0.0002560825,0.00043652646,0.0002874579,0.000025392274],"category_scores_gemma":[0.017049687,0.0002928939,0.0002977821,0.00009734171,0.00057265826,0.00038122627,0.00023911597,0.00063611334,0.0000057121706],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06769958,0.0050800657,0.17527393,0.0040135146,0.009964434,0.4149601,0.002024928,0.0000035054668,0.029923366,0.0011210807,0.049552854,0.24038264],"study_design_scores_gemma":[0.18233825,0.017784411,0.49362013,0.004945728,0.0016214459,0.27520025,0.0022328508,0.00033706112,0.016550515,0.0012756233,0.0035541814,0.00053955667],"about_ca_topic_score_codex":0.0004890104,"about_ca_topic_score_gemma":0.0006638705,"teacher_disagreement_score":0.3183462,"about_ca_system_score_codex":0.00013637672,"about_ca_system_score_gemma":0.00050340424,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W2735244554","doi":"10.1111/bjh.14844","title":"Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Vetenskapsrådet","keywords":"Medicine; Pediatrics; Haemophilia; Prophylactic treatment; Intracranial haemorrhage; Haemophilia A; Coagulopathy; Intensive care medicine; Surgery; Complication","score_opus":0.018531424079559787,"score_gpt":0.31708270752871165,"score_spread":0.2985512834491519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735244554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997461,0.0009119711,0.0000029746025,0.000902386,0.00003332851,0.00059828523,0.000012944851,0.0000032147166,0.00007388535],"genre_scores_gemma":[0.99891055,0.0006836534,0.00015756245,0.000010573925,0.00009005064,0.0000054452703,0.0000018970323,0.000017087297,0.00012318268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998838,0.00011000675,0.0003830463,0.0001531437,0.00023483465,0.00028094646],"domain_scores_gemma":[0.999011,0.000047035177,0.0003833415,0.00026127114,0.00014484076,0.00015253498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023035576,0.00015293086,0.00074241747,0.00012367709,0.00016336064,0.000057270106,0.00019199564,0.000099497636,0.000047656915],"category_scores_gemma":[0.0002326354,0.00006942773,0.0001318293,0.00006864381,0.00044104605,0.00014198704,0.000046750778,0.00031870115,0.0000021294416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036931415,0.0008654648,0.8773083,0.000103092134,0.00035932954,0.060954288,0.0001829967,0.0000028699476,0.00009631925,0.0000021644992,0.00005939027,0.056372657],"study_design_scores_gemma":[0.005825374,0.0025611764,0.5946276,0.0005929641,0.000104362174,0.39601666,0.000034956498,0.000022435008,0.00012935021,0.000034210712,0.0000014972403,0.000049393482],"about_ca_topic_score_codex":0.0011410007,"about_ca_topic_score_gemma":0.00044160886,"teacher_disagreement_score":0.33506235,"about_ca_system_score_codex":0.00009842048,"about_ca_system_score_gemma":0.0004274673,"threshold_uncertainty_score":0.28311807},"labels":[],"label_agreement":null},{"id":"W2735470706","doi":"10.1111/bjh.14833","title":"Expansion of <i><scp>BCR</scp>/<scp>ABL</scp>1</i><sup>+</sup> cells requires <scp>PAK</scp>2 but not <scp>PAK</scp>1","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Austrian Science Fund","keywords":"Haematopoiesis; Cell biology; Microvesicles; Gene isoform; Cell growth; Cell culture; Exosome; Motility; Biology; Chemistry; Cancer research; Stem cell; Biochemistry; microRNA","score_opus":0.012674225525350899,"score_gpt":0.2513405071914531,"score_spread":0.2386662816661022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735470706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96527296,0.025635444,0.0015560498,0.0001426097,0.0015279108,0.0007171817,0.00047497745,0.00007223186,0.0046006325],"genre_scores_gemma":[0.9793868,0.007966161,0.003729511,0.0008831859,0.0014529421,0.00005038137,0.0001876366,0.00031680253,0.006026567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9908756,0.0009858159,0.0029805317,0.001596196,0.0013699186,0.0021919073],"domain_scores_gemma":[0.9893655,0.0014927655,0.003929465,0.002439343,0.0014807368,0.0012921669],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001986557,0.0011523888,0.0024212792,0.0004791767,0.0009610105,0.00054520374,0.003542001,0.0016863587,0.0000287328],"category_scores_gemma":[0.013895339,0.0013398079,0.0014060123,0.00030409388,0.001864163,0.00021883243,0.0014494606,0.001522845,0.00015547755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052016072,0.0010722652,0.0038722022,0.0007463894,0.00088439236,0.017949853,0.0006688767,0.00059213466,0.7642741,0.00027215836,0.20700581,0.0026097693],"study_design_scores_gemma":[0.0042782556,0.0010625024,0.0023422984,0.0009272401,0.00055969146,0.035631932,0.0026133438,0.00028591763,0.8620117,0.0011022922,0.08898079,0.00020405966],"about_ca_topic_score_codex":0.00019797072,"about_ca_topic_score_gemma":0.000085596286,"teacher_disagreement_score":0.11802503,"about_ca_system_score_codex":0.00010554315,"about_ca_system_score_gemma":0.0009667584,"threshold_uncertainty_score":0.99960965},"labels":[],"label_agreement":null},{"id":"W2735850899","doi":"10.1111/bjh.14829","title":"Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from <scp>ENEST</scp>xtnd","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Medicine; Adverse effect; Rash; Internal medicine; Clinical endpoint; Nausea; Clinical trial; Oncology; Myeloid leukemia; Imatinib","score_opus":0.02974140965789916,"score_gpt":0.31044792188506387,"score_spread":0.2807065122271647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735850899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832616,0.0133633865,0.0002763187,0.00075556536,0.00066702615,0.00061638496,0.000097162396,0.000030391457,0.0009321892],"genre_scores_gemma":[0.98885787,0.007086261,0.0024983077,0.0001307092,0.000773505,0.000029988054,0.00021099678,0.00007369236,0.00033868276],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9957653,0.00027940382,0.0019464564,0.00062219746,0.00052686373,0.0008597723],"domain_scores_gemma":[0.9961553,0.0007982704,0.0017476263,0.0007447267,0.00023417595,0.00031985602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007758042,0.00039441616,0.0016307946,0.00046069326,0.00021573853,0.00015083585,0.000655604,0.00050090405,0.00018706567],"category_scores_gemma":[0.0037876097,0.00044778248,0.00024685508,0.00023417229,0.00034799858,0.0005821934,0.0001562617,0.0012069012,0.000050594568],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029526518,0.0037268656,0.05773425,0.00064523355,0.0008750662,0.7187152,0.0014762017,0.027881268,0.0042029177,0.000099147015,0.021885596,0.15980563],"study_design_scores_gemma":[0.3479252,0.004734063,0.39001825,0.012717501,0.00064728723,0.20817864,0.0003612739,0.019629193,0.005452146,0.0005675941,0.009139381,0.00062948413],"about_ca_topic_score_codex":0.0040251743,"about_ca_topic_score_gemma":0.009828035,"teacher_disagreement_score":0.51053655,"about_ca_system_score_codex":0.0038732702,"about_ca_system_score_gemma":0.0037502213,"threshold_uncertainty_score":0.9999507},"labels":[],"label_agreement":null},{"id":"W2736240933","doi":"10.1111/bjh.14852","title":"A proposed treatment algorithm for adults with Haemoglobin <scp>SC</scp> disease","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"","keywords":"Disease; Algorithm; Medicine; Computer science; Computational biology; Internal medicine; Biology","score_opus":0.011003561486876026,"score_gpt":0.2485203128074188,"score_spread":0.23751675132054276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736240933","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15215604,0.10084306,0.006759424,0.7194693,0.0050844764,0.010730536,0.0021668796,0.00024805358,0.0025422305],"genre_scores_gemma":[0.0423387,0.06797115,0.1017963,0.6555288,0.03404768,0.001426811,0.0072273593,0.0027451299,0.08691808],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686307,0.00014195159,0.0010065525,0.00055599905,0.0005528893,0.0008795142],"domain_scores_gemma":[0.9963626,0.00024987204,0.0015487043,0.00053692586,0.000793598,0.0005082997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020272964,0.00057762733,0.002286729,0.00030389748,0.0003332886,0.00013467135,0.0004100354,0.0011785617,0.000039381768],"category_scores_gemma":[0.00050173595,0.00045502518,0.00080281723,0.00008707558,0.0004947974,0.00013576556,0.000044192613,0.0016770272,0.000017102555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022496942,0.0003334327,0.00009593599,0.00068460545,0.00092016713,0.38823673,0.000116781,0.0000010480034,0.0000012765769,0.000002784737,0.5471421,0.06224016],"study_design_scores_gemma":[0.011528227,0.0027617824,0.0001369267,0.0052818162,0.0019378657,0.40417403,0.00015915677,0.000119312026,0.000043860953,0.00016934951,0.5735084,0.00017925737],"about_ca_topic_score_codex":0.00016425483,"about_ca_topic_score_gemma":0.000037738857,"teacher_disagreement_score":0.10981735,"about_ca_system_score_codex":0.0002457081,"about_ca_system_score_gemma":0.0016067929,"threshold_uncertainty_score":0.99979013},"labels":[],"label_agreement":null},{"id":"W2747789314","doi":"10.1111/bjh.14903","title":"Role of mitochondrial membrane permeabilization and depolarization in platelet apoptosis","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Metropolitan University; St. Michael's Hospital","funders":"","keywords":"Depolarization; Apoptosis; Mitochondrion; Membrane potential; Cell biology; Mitochondrial apoptosis-induced channel; Platelet; Inner mitochondrial membrane; Chemistry; Biophysics; Medicine; Biology; Internal medicine; Biochemistry","score_opus":0.005555728466858051,"score_gpt":0.21560429992831207,"score_spread":0.210048571461454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747789314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822384,0.007665072,0.0012402998,0.0075502996,0.0008295714,0.00029329106,0.000037532765,0.0000029920081,0.00014253832],"genre_scores_gemma":[0.97116005,0.013994122,0.0034689005,0.006196546,0.0035472852,0.000012905849,0.0011280408,0.000111618676,0.00038054565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998769,0.00013268793,0.0005668783,0.00021273684,0.00015667175,0.00016206529],"domain_scores_gemma":[0.9987381,0.00001834148,0.00085712015,0.00016541165,0.00018985101,0.000031179676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014957509,0.00014012189,0.0005113127,0.00014342024,0.000057727957,0.000038688937,0.00018183928,0.0009387417,0.000014588569],"category_scores_gemma":[0.00015303183,0.00015893212,0.000109708984,0.000032952565,0.000105207415,0.000011407369,0.000057376838,0.00037850937,3.0668255e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016907812,0.000083137435,0.00038869446,0.00045904293,0.00016384745,0.0019637006,0.00008155201,0.000096928525,0.94623834,0.000047809015,0.029607983,0.02069987],"study_design_scores_gemma":[0.005125689,0.0009887624,0.0014726258,0.0015313255,0.00029528182,0.14271778,0.000096856806,0.00034248544,0.6246649,0.002949881,0.2189386,0.0008758165],"about_ca_topic_score_codex":0.00007556926,"about_ca_topic_score_gemma":0.00009609238,"teacher_disagreement_score":0.32157347,"about_ca_system_score_codex":0.000011034161,"about_ca_system_score_gemma":0.00008912134,"threshold_uncertainty_score":0.7240436},"labels":[],"label_agreement":null},{"id":"W2762525341","doi":"10.1111/bjh.14954","title":"Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematology; Hematopoietic cell; Population; Retrospective cohort study; Regimen; Clinical endpoint; Confidence interval; Gastroenterology; Haematopoiesis; Oncology; Clinical trial; Stem cell","score_opus":0.013372610641705326,"score_gpt":0.3078861006597773,"score_spread":0.294513490018072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762525341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540806,0.00059396337,0.0011027463,0.00043926536,0.000289027,0.001737678,0.000110691246,0.000017317996,0.0003012556],"genre_scores_gemma":[0.99692917,0.0007124952,0.001839038,0.00008829849,0.00009168638,0.00006755042,0.000019876688,0.000056237714,0.00019566227],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99740314,0.0002764387,0.0008522076,0.00036314025,0.00053538993,0.0005696746],"domain_scores_gemma":[0.9962356,0.0007753698,0.0009486947,0.0003179316,0.0013846825,0.0003377312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002880759,0.00026059276,0.0012445448,0.00024599806,0.0006089287,0.00020606896,0.0004106567,0.000080548925,0.000044626835],"category_scores_gemma":[0.0011005591,0.00027915734,0.00021118735,0.00018914166,0.0005092854,0.00020796283,0.000046825542,0.0004407458,0.000024618193],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009591301,0.008066616,0.59119296,0.0029833717,0.00087963993,0.35996455,0.0119249765,0.00020918295,0.0025444962,0.000021302125,0.0030030515,0.009618582],"study_design_scores_gemma":[0.04154426,0.010364794,0.19718005,0.00078299845,0.0019337193,0.70842814,0.024244586,0.0015420408,0.012715714,0.00007989223,0.00039736606,0.00078645],"about_ca_topic_score_codex":0.00019292282,"about_ca_topic_score_gemma":0.0071036112,"teacher_disagreement_score":0.3940129,"about_ca_system_score_codex":0.00011199803,"about_ca_system_score_gemma":0.00069203257,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W2765257980","doi":"10.1111/bjh.14993","title":"Approach to transfusion in pregnant women with sickle cell disease: a survey of physicians","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"University of Toronto; Canadian Blood Services","keywords":"Medicine; Specialty; Transfusion medicine; Pregnancy; Disease; Randomized controlled trial; Maternal-fetal medicine; Family medicine; Pediatrics; Blood transfusion; MEDLINE; Obstetrics; Intensive care medicine; Obstetrics and gynaecology; Internal medicine","score_opus":0.011877538619092676,"score_gpt":0.23153924607189982,"score_spread":0.21966170745280714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765257980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93474233,0.010940071,0.00034085996,0.050371572,0.0003287852,0.000976571,0.00017432823,0.000012120627,0.0021133577],"genre_scores_gemma":[0.9199313,0.00812953,0.00084072875,0.06803712,0.0005495767,0.00006707855,0.0002448481,0.00022148585,0.0019783205],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9976866,0.0002865033,0.00076880405,0.0003037442,0.00044590278,0.00050842727],"domain_scores_gemma":[0.9983778,0.0000796207,0.0007141396,0.0003341254,0.0003277391,0.00016659184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044267045,0.00025163332,0.0017216518,0.00029272115,0.00006222435,0.000024755598,0.00034423705,0.0005397935,0.000026879117],"category_scores_gemma":[0.00012938691,0.00021929364,0.00015355863,0.00017878223,0.00022641648,0.00006743117,0.00003560024,0.0018240637,0.0000034187017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002975894,0.0024445087,0.0074171587,0.005776829,0.0005089463,0.30136922,0.0018981701,0.00011836315,0.00010522314,0.0000023524674,0.6606451,0.016738208],"study_design_scores_gemma":[0.03189613,0.008905011,0.2555595,0.07340127,0.0019929386,0.41820377,0.0017296145,0.00013852431,0.0003125062,0.00019950577,0.20520052,0.002460705],"about_ca_topic_score_codex":0.0008925484,"about_ca_topic_score_gemma":0.0001721252,"teacher_disagreement_score":0.4554446,"about_ca_system_score_codex":0.000077282675,"about_ca_system_score_gemma":0.00054135924,"threshold_uncertainty_score":0.8942535},"labels":[],"label_agreement":null},{"id":"W2765461391","doi":"10.1111/bjh.14985","title":"A highly purified form of staphylococcal protein A alleviates murine immune thrombocytopenia (<scp>ITP</scp>)","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Toronto; Innovative Research Group (Canada); St. Michael's Hospital","funders":"Health Canada; Canadian Blood Services","keywords":"Platelet; Immunology; Immune system; Antibody; Medicine; Autoimmune thrombocytopenia; Phagocytosis","score_opus":0.01638865244362331,"score_gpt":0.26062624106426396,"score_spread":0.24423758862064066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765461391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92357004,0.017549403,0.00002088896,0.05540438,0.0004698249,0.0012064009,0.00014659791,0.000026020898,0.0016064312],"genre_scores_gemma":[0.9495955,0.006615049,0.0031692076,0.02834183,0.002165467,0.00017147994,0.0007159064,0.0003860819,0.008839447],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9961654,0.00017537236,0.0017655944,0.0004312504,0.00067295705,0.00078943424],"domain_scores_gemma":[0.99540675,0.0002153056,0.0029223566,0.00061994797,0.0006467865,0.00018883376],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041372367,0.00054228154,0.0045446823,0.00041333414,0.00017683688,0.00009808528,0.0007233509,0.0012363888,0.00011194961],"category_scores_gemma":[0.00063945015,0.00051053194,0.0008748587,0.000104093946,0.0004526785,0.00025745973,0.00017232473,0.0024874418,0.00003783297],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014779036,0.00056290283,0.00022085903,0.0013539697,0.002126815,0.5955574,0.00011388447,1.94261e-7,0.0010539328,0.000025344021,0.39705262,0.0017843],"study_design_scores_gemma":[0.011773115,0.002189096,0.0025326218,0.0062937513,0.0012547058,0.7228327,0.000080902326,0.00000413625,0.007666196,0.0029611357,0.24213047,0.00028118922],"about_ca_topic_score_codex":0.0004259871,"about_ca_topic_score_gemma":0.00007301805,"teacher_disagreement_score":0.15492214,"about_ca_system_score_codex":0.00008727098,"about_ca_system_score_gemma":0.0005317651,"threshold_uncertainty_score":0.99981385},"labels":[],"label_agreement":null},{"id":"W2765486607","doi":"10.1111/bjh.14951","title":"Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted <scp>EPOCH</scp>‐R","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hyundai Hope On Wheels; Lymphoma Foundation; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Epoch (astronomy); Vincristine; Etoposide; Confidence interval; Rituximab; Prednisone; Lymphoma; Internal medicine; Chemotherapy; Pediatrics; Cyclophosphamide; Surgery","score_opus":0.008756289721170108,"score_gpt":0.225588035526222,"score_spread":0.2168317458050519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765486607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487156,0.0034071628,0.0000092769005,0.00025621787,0.000055346456,0.0003320157,0.000029796434,0.000014332627,0.0010242916],"genre_scores_gemma":[0.99709517,0.0008486264,0.0017034855,0.00012892192,0.000052094547,0.000010629366,0.000020408776,0.000031809872,0.00010887834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839854,0.00006439954,0.000578522,0.00025551286,0.00038234834,0.00032068047],"domain_scores_gemma":[0.9977184,0.00020255688,0.0011319229,0.0003071674,0.00035891976,0.0002810114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014223097,0.00024727944,0.0013265675,0.00013736117,0.00014796006,0.000055094286,0.00019326844,0.00013680004,0.000011961626],"category_scores_gemma":[0.00018869228,0.00017392673,0.00012033534,0.000061007962,0.00046472804,0.00018201012,0.000059383183,0.00013034255,0.0000026999146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054219324,0.0013042751,0.9448641,0.00013745738,0.0008615934,0.037678603,0.00018224271,5.634449e-7,0.000037196252,0.00001897922,0.00040411568,0.013968702],"study_design_scores_gemma":[0.022019798,0.0017479733,0.68576586,0.000903471,0.0006426315,0.28687188,0.0000955715,0.000002155691,0.0018567014,0.000009350292,0.000026397895,0.000058198522],"about_ca_topic_score_codex":0.00066483323,"about_ca_topic_score_gemma":0.00024129862,"teacher_disagreement_score":0.25909823,"about_ca_system_score_codex":0.00007350734,"about_ca_system_score_gemma":0.0003540808,"threshold_uncertainty_score":0.70925266},"labels":[],"label_agreement":null},{"id":"W2766892765","doi":"10.1111/bjh.14977","title":"Autoantibodies in immune thrombocytopenia affect the physiological interaction between megakaryocytes and bone marrow extracellular matrix proteins","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Consejo Nacional de Investigaciones Científicas y Técnicas; Fondazione Cariplo","keywords":"Thrombopoiesis; Platelet; Autoantibody; Platelet membrane glycoprotein; Platelet Glycoprotein GPIb-IX Complex; Immunology; Von Willebrand factor; Bone marrow; Platelet disorder; Receptor; Immune system; Chemistry; Megakaryocyte; Biology; Cell biology; Antibody; Medicine; Internal medicine; Haematopoiesis; Stem cell","score_opus":0.028583414062916063,"score_gpt":0.32188685528518873,"score_spread":0.2933034412222727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766892765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762632,0.021071121,0.000023224575,0.0020549486,0.000118853575,0.00034101665,0.0000050057033,0.000007975323,0.00011461467],"genre_scores_gemma":[0.9973222,0.0020509888,0.00040171048,0.000019530487,0.00006527688,0.000007548531,0.0000059808026,0.000011569591,0.00011521455],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9989114,0.0001326693,0.0004533687,0.00015010305,0.0001322591,0.00022019754],"domain_scores_gemma":[0.9990842,0.00011235875,0.00050045486,0.00018084137,0.000061141174,0.00006100173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003697416,0.0001306012,0.001021216,0.000073094685,0.00026507152,0.00009503431,0.00015863944,0.00012071717,0.000044881457],"category_scores_gemma":[0.00031737486,0.00009222296,0.00012451547,0.000031261214,0.00027622483,0.00024333996,0.0000885257,0.000442294,0.0000068519153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015320755,0.0014531744,0.30036494,0.0005710039,0.00148413,0.562131,0.00060869474,0.0000064848196,0.068265505,0.00078274193,0.0017574864,0.061042804],"study_design_scores_gemma":[0.0034306187,0.00061961135,0.7344199,0.00080905436,0.0001870004,0.2557321,0.00018207039,0.000036813446,0.002898519,0.0012115808,0.00035784312,0.00011489439],"about_ca_topic_score_codex":0.00026593896,"about_ca_topic_score_gemma":0.00010581752,"teacher_disagreement_score":0.43405497,"about_ca_system_score_codex":0.000027200174,"about_ca_system_score_gemma":0.000038949238,"threshold_uncertainty_score":0.3760743},"labels":[],"label_agreement":null},{"id":"W2768619340","doi":"10.1111/bjh.15016","title":"Castleman disease: delineating the spectrum","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Disease; Proinflammatory cytokine; Immunology; Etiology; Context (archaeology); Pathology; Inflammation; Biology","score_opus":0.01937286626686992,"score_gpt":0.28459061686732234,"score_spread":0.26521775060045244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768619340","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021793988,0.03127054,0.00008260757,0.9425753,0.0014728269,0.00025255926,0.000059309517,0.000018867038,0.002474021],"genre_scores_gemma":[0.14997463,0.0064068683,0.00023789161,0.8213923,0.014095807,0.000018455883,0.00016781663,0.00019318749,0.0075130532],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997907,0.00015905498,0.0007387862,0.00022040907,0.0004885089,0.00048627882],"domain_scores_gemma":[0.9976571,0.000117306045,0.0014478643,0.0003775936,0.00025438285,0.0001457428],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00037443856,0.000230734,0.0011088911,0.00011504905,0.0003548299,0.00013511616,0.00047541343,0.0004862769,0.0003294299],"category_scores_gemma":[0.0008050138,0.00018935499,0.0005334978,0.000055232,0.0002733917,0.00008315734,0.00006492725,0.0029048307,0.00002499675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005044781,0.000021088274,0.00051660335,0.00015597357,0.00023525553,0.2613962,0.0000223606,0.0000018301641,7.622784e-7,0.000008929759,0.73507017,0.0025203538],"study_design_scores_gemma":[0.0017711424,0.00016020931,0.0010467389,0.0017200444,0.00080264214,0.33895838,0.000070624796,0.000022704531,0.000003699174,0.0011694888,0.65407443,0.00019987083],"about_ca_topic_score_codex":0.00027308508,"about_ca_topic_score_gemma":0.00014647035,"teacher_disagreement_score":0.12818064,"about_ca_system_score_codex":0.0001117735,"about_ca_system_score_gemma":0.0006517846,"threshold_uncertainty_score":0.9993955},"labels":[],"label_agreement":null},{"id":"W2777932111","doi":"10.1111/bjh.15063","title":"Frequent somatic mutations of <i><scp>KMT</scp>2D</i> (<i><scp>MLL</scp>2</i>) and <i><scp>CARD</scp>11</i> genes in primary cold agglutinin disease","year":2017,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Helse Sør-Øst RHF; Kreftforeningen","keywords":"Lymphoplasmacytic Lymphoma; Bone marrow; Lymphoproliferative disorders; Immunophenotyping; Immunology; Lymphoma; Medicine; Pathology; Biology; Waldenstrom macroglobulinemia; Antigen","score_opus":0.012194398042926761,"score_gpt":0.23674013307369834,"score_spread":0.22454573503077158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777932111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9154619,0.0616634,0.00021080415,0.017202694,0.0015867373,0.0014992622,0.0006023422,0.00007275509,0.0017000843],"genre_scores_gemma":[0.7305946,0.057206366,0.008160367,0.18600294,0.008519081,0.00046962127,0.0023060108,0.0012402039,0.0055008526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99244803,0.00069531373,0.0030529187,0.0009913839,0.0014279229,0.0013844045],"domain_scores_gemma":[0.9918563,0.0025323045,0.0030712942,0.0009664167,0.00075169926,0.0008219921],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0011191324,0.00096106005,0.0041451473,0.0010291336,0.0004269348,0.00024096061,0.00093479967,0.0016176783,0.00001654052],"category_scores_gemma":[0.0022756841,0.0010353768,0.0009850856,0.0003539337,0.0011489439,0.0005154891,0.00026919862,0.003545741,0.000022953724],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025897214,0.0011464937,0.044394687,0.007406098,0.0011062314,0.28307712,0.00075966795,0.000016864613,0.0024034327,0.00010090448,0.6576537,0.0019089486],"study_design_scores_gemma":[0.019370118,0.0014269131,0.118739024,0.019403666,0.0069187367,0.35666677,0.00081061356,0.00006748565,0.0036673485,0.0032707416,0.4692402,0.00041838796],"about_ca_topic_score_codex":0.00048304853,"about_ca_topic_score_gemma":0.00031100286,"teacher_disagreement_score":0.18841347,"about_ca_system_score_codex":0.00016463747,"about_ca_system_score_gemma":0.0013607577,"threshold_uncertainty_score":0.99967843},"labels":[],"label_agreement":null},{"id":"W2782718700","doi":"10.1111/bjh.15082","title":"Comparing transfusion reaction risks for various plasma products – an analysis of 7 years of ISTARE haemovigilance data","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Apheresis; Confidence interval; Interquartile range; Transfusion reaction; Blood transfusion; Odds ratio; Intensive care medicine; Allergic reaction; Emergency medicine; Internal medicine; Immunology; Platelet; Allergy; Lung","score_opus":0.09132004440978062,"score_gpt":0.34373763768618787,"score_spread":0.2524175932764072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782718700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940863,0.00033935584,0.004459876,0.00032885862,0.00029908417,0.0002952795,0.000049241076,0.000009655307,0.00013234727],"genre_scores_gemma":[0.9935722,0.00064964686,0.00550597,0.000060758754,0.00008994419,0.000001882691,0.000082030274,0.00001261033,0.000024981238],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986377,0.00006753206,0.0006874787,0.0002247466,0.00023330952,0.00014926652],"domain_scores_gemma":[0.9985539,0.000051338877,0.00044849014,0.00036880557,0.0004998351,0.00007768007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005818387,0.000079320416,0.0008922595,0.00033438727,0.00004490335,0.000008174887,0.0002374428,0.00007927474,0.000028389859],"category_scores_gemma":[0.00015723088,0.000089287314,0.0001217851,0.00035615044,0.00014199528,0.00015511099,0.00003388235,0.0001493117,5.485518e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018490484,0.0110077085,0.16251777,0.006785214,0.022427872,0.02139132,0.006672093,0.0004808553,0.10652515,0.003262789,0.023546608,0.6168921],"study_design_scores_gemma":[0.017989168,0.0053278627,0.7955366,0.0022310864,0.021798216,0.079591915,0.0018622355,0.018998183,0.032914203,0.00025199816,0.022968136,0.00053043594],"about_ca_topic_score_codex":0.0007261664,"about_ca_topic_score_gemma":0.0028089343,"teacher_disagreement_score":0.6330188,"about_ca_system_score_codex":0.000015337919,"about_ca_system_score_gemma":0.0000736432,"threshold_uncertainty_score":0.3641031},"labels":[],"label_agreement":null},{"id":"W2789240070","doi":"10.1111/bjh.15142","title":"Cord gas parameters in infants born to women with sickle cell disease: a retrospective matched cohort study","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"University of Toronto","keywords":"Retrospective cohort study; Medicine; Disease; Pediatrics; Cohort; Cohort study; Internal medicine","score_opus":0.006370689200937249,"score_gpt":0.23693625296035564,"score_spread":0.2305655637594184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789240070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9494196,0.001092433,0.000020393061,0.046838347,0.00060402346,0.0015401122,0.00003956381,0.000025409043,0.00042011013],"genre_scores_gemma":[0.89809227,0.00073307584,0.0005758832,0.09897383,0.00063567195,0.0001302899,0.000036907095,0.00016544176,0.00065662805],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9963443,0.00031989563,0.0011137234,0.00057068805,0.00078245683,0.00086892647],"domain_scores_gemma":[0.9977508,0.00012946028,0.0007464237,0.00041059867,0.0004939027,0.00046881134],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005895169,0.00041922514,0.002350765,0.0005492846,0.00007803198,0.00006591873,0.0002884307,0.00062827073,0.00021876753],"category_scores_gemma":[0.00037608095,0.0003831146,0.00016227216,0.0004758396,0.0002941984,0.000090808004,0.00009366538,0.002872298,0.00005053235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024064328,0.000629141,0.17600268,0.00023777457,0.0005820466,0.43175885,0.0007203353,0.000005223943,0.0000028956442,2.3651086e-7,0.38726833,0.000386063],"study_design_scores_gemma":[0.016934667,0.017880235,0.58809084,0.0060800663,0.0018360345,0.31184676,0.004521588,0.000010026403,0.000028066846,0.00033923017,0.05106721,0.0013652595],"about_ca_topic_score_codex":0.0003373349,"about_ca_topic_score_gemma":0.00016843238,"teacher_disagreement_score":0.41208816,"about_ca_system_score_codex":0.00044961539,"about_ca_system_score_gemma":0.00055614347,"threshold_uncertainty_score":0.9998621},"labels":[],"label_agreement":null},{"id":"W2789551032","doi":"10.1111/bjh.15165","title":"Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Autoantibody; Thrombopoietin; Medicine; Immune thrombocytopenia; Thrombopoietin receptor; Immunology; Eltrombopag; Romiplostim; Internal medicine; Thrombocytopenic purpura; Immune system; Antibody; Biology; Haematopoiesis","score_opus":0.005093820726147307,"score_gpt":0.2361385386775163,"score_spread":0.231044717951369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789551032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993737,0.0016710697,0.000023555705,0.003170915,0.0001857877,0.00046577188,0.000007674529,0.000009463455,0.00072876696],"genre_scores_gemma":[0.9970669,0.000416229,0.0018287147,0.0005478613,0.000045631958,0.000005811391,0.0000062938157,0.000022038406,0.000060499962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985823,0.00013603197,0.00054382643,0.00018838733,0.00024762438,0.00030180998],"domain_scores_gemma":[0.99908435,0.000103955084,0.00025955657,0.00015371594,0.00028973698,0.0001086709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003867935,0.00015878884,0.0012166584,0.00011537429,0.00013007203,0.000041114392,0.00014314712,0.00008912031,0.00019684271],"category_scores_gemma":[0.00020072152,0.00010455634,0.000074692194,0.0001869863,0.00061462214,0.00011538839,0.0000754782,0.00027094677,0.000037403704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024855746,0.004523741,0.8298418,0.00034499392,0.0028563838,0.046770968,0.008756448,0.000003363176,0.000735751,0.0025512595,0.034142595,0.044616986],"study_design_scores_gemma":[0.029115897,0.0029005324,0.9100139,0.001207997,0.00021811193,0.05276621,0.0005337954,0.0000044106687,0.0005746734,0.00073039666,0.0017210555,0.00021301395],"about_ca_topic_score_codex":0.0001988149,"about_ca_topic_score_gemma":0.00028078028,"teacher_disagreement_score":0.08017214,"about_ca_system_score_codex":0.000032873937,"about_ca_system_score_gemma":0.00007747006,"threshold_uncertainty_score":0.4263684},"labels":[],"label_agreement":null},{"id":"W2791254844","doi":"10.1111/bjh.15118","title":"Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Vincristine; Rituximab; Autologous stem-cell transplantation; Cyclophosphamide; Follicular lymphoma; Etoposide; Anthracycline; Progression-free survival; Salvage therapy; Transplantation; Chemotherapy; Gastroenterology; Surgery; Lymphoma; Cancer","score_opus":0.009935397769000119,"score_gpt":0.24685820627028415,"score_spread":0.23692280850128403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791254844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762488,0.01184927,0.0000107554615,0.011268216,0.000104038416,0.00047211995,0.000025697687,0.000005139427,0.000015944659],"genre_scores_gemma":[0.9903288,0.003220618,0.0002975256,0.0060258796,0.000041536627,0.000011960666,0.0000349399,0.000029923172,0.000008829834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979983,0.0003194984,0.00092817866,0.00029593302,0.0002466848,0.00021139612],"domain_scores_gemma":[0.9987214,0.00016470942,0.00066958694,0.00013437445,0.00021612598,0.00009378659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002765288,0.00022987615,0.001456425,0.00017991234,0.000042819545,0.00002578087,0.00008291932,0.0006002465,0.000005926194],"category_scores_gemma":[0.000019829808,0.00018702255,0.000094566676,0.00006185472,0.0004297634,0.00006635081,0.000028861152,0.00043543358,2.3626872e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035600774,0.005915845,0.7372287,0.0016159066,0.0018529503,0.14473747,0.0010680268,9.42803e-8,0.0001016679,0.000018618066,0.012525494,0.09137514],"study_design_scores_gemma":[0.067493916,0.01046676,0.7861495,0.0068373694,0.0010424332,0.123575315,0.000069316324,0.000008753993,0.0013898993,0.00015170118,0.0024330672,0.0003819857],"about_ca_topic_score_codex":0.000046867728,"about_ca_topic_score_gemma":0.000011410512,"teacher_disagreement_score":0.09099316,"about_ca_system_score_codex":0.00004764841,"about_ca_system_score_gemma":0.00018010697,"threshold_uncertainty_score":0.76265585},"labels":[],"label_agreement":null},{"id":"W2792936122","doi":"10.1111/bjh.15124","title":"A phase 1 dose‐finding study of intravenous L‐citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Citrulline; Arginase; Medicine; Arginine; Argininosuccinate synthase; Nitric oxide; Enos; Sickle cell anemia; Endothelial dysfunction; Endothelium; Nitric oxide synthase; Pharmacology; Disease; Internal medicine; Chemistry; Biochemistry; Amino acid","score_opus":0.015996054661994757,"score_gpt":0.27746972086424265,"score_spread":0.2614736662022479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792936122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94511145,0.012433059,0.0023759208,0.036837153,0.000967628,0.0019872524,0.00021180075,0.000020923126,0.00005483054],"genre_scores_gemma":[0.9486876,0.0026844945,0.00092331716,0.044903588,0.0020907584,0.000057594123,0.00020224182,0.00018693157,0.0002634614],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958816,0.00041456745,0.001891773,0.0004954792,0.0005734676,0.00074309256],"domain_scores_gemma":[0.99712145,0.0002721695,0.0014737892,0.00033779867,0.0005554275,0.00023935351],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011164333,0.0004482797,0.0022152974,0.00065447454,0.00012088258,0.000044618737,0.0004093887,0.00090449094,0.00019576222],"category_scores_gemma":[0.00019484958,0.0004416533,0.00059167476,0.00030113687,0.00020825678,0.000082217404,0.000059716716,0.0020603444,0.0000042942747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048823776,0.026721327,0.00018829809,0.0026176486,0.000847527,0.1779859,0.002147919,0.00004908852,0.0016767858,0.0000015248783,0.7734102,0.009471385],"study_design_scores_gemma":[0.3708583,0.08630844,0.0006020846,0.009911817,0.0069940835,0.1932056,0.021079252,0.0019136874,0.002884691,0.00098923,0.3017691,0.003483699],"about_ca_topic_score_codex":0.00028375382,"about_ca_topic_score_gemma":0.000040503684,"teacher_disagreement_score":0.4716411,"about_ca_system_score_codex":0.00008895307,"about_ca_system_score_gemma":0.00053749705,"threshold_uncertainty_score":0.99980354},"labels":[],"label_agreement":null},{"id":"W2793922029","doi":"10.1111/bjh.15100","title":"Diagnostic approach to pulmonary embolism in pregnancy: are the winds of change upon us or is it <i>déjà vu</i> all over again?","year":2018,"lang":"en","type":"editorial","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Déjà vu; Pulmonary embolism; Pregnancy; Medicine; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.04307367623126506,"score_gpt":0.30824436508397146,"score_spread":0.2651706888527064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793922029","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20298687,0.07235127,0.00008562994,0.0104665,0.6998835,0.0068296515,0.0008191045,0.00005672332,0.0065207556],"genre_scores_gemma":[0.1727787,0.11458701,0.0008162347,0.016196508,0.6924148,0.0009910465,0.000326839,0.00048231185,0.0014065335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952656,0.00035484973,0.0017221476,0.0006109508,0.0012546376,0.0007917978],"domain_scores_gemma":[0.9955142,0.001201194,0.0016599434,0.000630245,0.0006873563,0.00030707408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009924677,0.0005108532,0.0032499745,0.00052753463,0.00009330058,0.00006525125,0.0008949934,0.0009956645,0.00024982876],"category_scores_gemma":[0.002757873,0.00041225788,0.00045200632,0.00040819554,0.00023087964,0.00017163456,0.00040714152,0.0014347846,0.000024979317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028003834,0.0020048073,0.0006631661,0.0018032423,0.0005887119,0.0364274,0.0013618942,0.0000036249996,0.0000031233535,0.000029328809,0.9532602,0.0035744868],"study_design_scores_gemma":[0.0030923141,0.0013616752,0.017220607,0.024683636,0.0015263715,0.024843693,0.00070270896,0.00001785744,0.000032571144,0.00015655931,0.92581373,0.0005482523],"about_ca_topic_score_codex":0.00086836156,"about_ca_topic_score_gemma":0.0008631282,"teacher_disagreement_score":0.042235736,"about_ca_system_score_codex":0.00017455035,"about_ca_system_score_gemma":0.0004139431,"threshold_uncertainty_score":0.9998329},"labels":[],"label_agreement":null},{"id":"W2799318639","doi":"10.1111/bjh.15255","title":"Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University; Juravinski Hospital","funders":"Leukemia and Lymphoma Society","keywords":"Medicine; Stage (stratigraphy); Positron emission tomography; Quality of life (healthcare); Lymphoma; Internal medicine; Hodgkin lymphoma; Oncology; Nuclear medicine; Pediatrics","score_opus":0.029527695126070064,"score_gpt":0.30520773175521354,"score_spread":0.2756800366291435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799318639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860068,0.0008460045,0.01102254,0.0014654249,0.00020057191,0.00033129158,0.000007895056,0.000009290261,0.00011019778],"genre_scores_gemma":[0.9966176,0.00010383467,0.0015972826,0.0015116195,0.0000961643,0.000013450318,0.0000044494664,0.000018334855,0.000037266804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837995,0.00012871907,0.0007039721,0.00017991682,0.0003246816,0.00028279005],"domain_scores_gemma":[0.99899805,0.00016102818,0.00024782456,0.00018227145,0.00028610343,0.00012475379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706093,0.00014484613,0.0005693164,0.00016706312,0.00008582957,0.000054666973,0.00013450092,0.00009471877,0.000028625756],"category_scores_gemma":[0.0000945577,0.00010948917,0.00015622201,0.00013265779,0.00005105728,0.00011385231,0.00003700395,0.00011027436,0.000024896472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078947854,0.0022289287,0.5939404,0.00006463791,0.00036229484,0.087442055,0.006348124,0.036225878,0.000028780756,0.00013307457,0.00050920417,0.27192718],"study_design_scores_gemma":[0.008107208,0.0018883034,0.8854449,0.0007993251,0.00021672841,0.06460953,0.00019022921,0.036991816,0.00048418462,0.0005631439,0.0004534992,0.00025116905],"about_ca_topic_score_codex":0.0003403777,"about_ca_topic_score_gemma":0.0002263014,"teacher_disagreement_score":0.2915045,"about_ca_system_score_codex":0.00014851881,"about_ca_system_score_gemma":0.000118939555,"threshold_uncertainty_score":0.44648388},"labels":[],"label_agreement":null},{"id":"W2799800445","doi":"10.1111/bjh.15250","title":"Novel findings from the multinational <scp>DOVE</scp> study on geographic and age‐related differences in pain perception and analgesic usage in children with sickle cell anaemia","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Daiichi-Sankyo; Eli Lilly and Company","keywords":"Medicine; Analgesic; Placebo; Clinical endpoint; Clinical trial; Chronic pain; Young adult; Pediatrics; Physical therapy; Internal medicine; Anesthesia; Alternative medicine","score_opus":0.008639105925011607,"score_gpt":0.21354663254713646,"score_spread":0.20490752662212486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799800445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98506147,0.002258623,0.000017753497,0.0118787,0.00007918066,0.00061655935,0.00003313296,0.000008628711,0.000045958204],"genre_scores_gemma":[0.9847041,0.001079162,0.00010757247,0.013769928,0.00015188736,0.000009224274,0.00009569958,0.0000338379,0.00004858564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764025,0.00049500045,0.0007086968,0.00040007383,0.00041015903,0.00034581058],"domain_scores_gemma":[0.99856883,0.00068694504,0.00043768054,0.00013020774,0.0000984628,0.00007789274],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00084144715,0.0002919415,0.0009639555,0.00050053856,0.000120715675,0.00007537544,0.00018281484,0.0007072444,0.000029026158],"category_scores_gemma":[0.00028689767,0.00021504097,0.000082283615,0.00030569918,0.00051117886,0.000078828,0.000051575626,0.0026571017,0.0000018263798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042650765,0.0004909492,0.9693556,0.00004554197,0.00028768068,0.013559682,0.0017352963,0.0000016900267,0.000040213246,0.0000011062878,0.012904344,0.0015352324],"study_design_scores_gemma":[0.005771649,0.0012936749,0.96651524,0.0011921658,0.00024108891,0.022377077,0.002177359,0.00006793125,0.0000015142821,0.00008667483,0.00015812289,0.000117510725],"about_ca_topic_score_codex":0.0013728153,"about_ca_topic_score_gemma":0.0006490608,"teacher_disagreement_score":0.012746221,"about_ca_system_score_codex":0.000042121883,"about_ca_system_score_gemma":0.000068943904,"threshold_uncertainty_score":0.9996438},"labels":[],"label_agreement":null},{"id":"W2800507359","doi":"10.1111/bjh.15262","title":"Excellent real‐world outcomes of adults with Burkitt lymphoma treated with <scp>CODOX</scp>‐M/<scp>IVAC</scp> plus or minus rituximab","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Vincristine; Regimen; Hazard ratio; Oncology; Cytarabine; Methotrexate; Population; Progression-free survival; Cyclophosphamide; Folinic acid; Chemotherapy; Lymphoma; Gastroenterology; Confidence interval; Fluorouracil","score_opus":0.014055335191638763,"score_gpt":0.25617953853306774,"score_spread":0.24212420334142898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800507359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902233,0.0034177764,0.000046150755,0.00032184986,0.00024473362,0.00067852024,0.000058414782,0.000059539903,0.0049497364],"genre_scores_gemma":[0.99152356,0.0015608771,0.0028137392,0.00034262295,0.00022516507,0.000048349662,0.000028251938,0.000097356344,0.003360088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623924,0.00018688879,0.0013900251,0.00054686837,0.0008123036,0.0008246635],"domain_scores_gemma":[0.99536043,0.0010826372,0.0013614129,0.0005190643,0.0011169646,0.00055948156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027088835,0.0005429819,0.002681111,0.00049768644,0.00017597123,0.00006215917,0.00035070913,0.0002546832,0.000094847754],"category_scores_gemma":[0.0004912383,0.00037142404,0.0003391638,0.0005637461,0.00069921196,0.00020478682,0.00009029348,0.00022857629,0.000052686406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025544232,0.0079424,0.63311654,0.00067444274,0.0044312454,0.29175824,0.0024961005,0.0000056803688,0.000078824705,0.00023323843,0.039105717,0.017603148],"study_design_scores_gemma":[0.06881993,0.011265914,0.52895486,0.0044726147,0.0020741916,0.35846218,0.0028843307,0.000041888612,0.013643638,0.000051542473,0.009153873,0.00017502725],"about_ca_topic_score_codex":0.002479293,"about_ca_topic_score_gemma":0.004604651,"teacher_disagreement_score":0.10416166,"about_ca_system_score_codex":0.00043024292,"about_ca_system_score_gemma":0.0010464764,"threshold_uncertainty_score":0.99987376},"labels":[],"label_agreement":null},{"id":"W2800635168","doi":"10.1111/bjh.15215","title":"Unifying the diagnosis of isolated central nervous system relapse in acute lymphoblastic leukaemia based on minimal residual disease testing","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cog; Minimal residual disease; Lymphoblast; Cerebrospinal fluid; White blood cell; Internal medicine; Immunophenotyping; Acute lymphocytic leukemia; Central nervous system; Pediatrics; Bone marrow; Gastroenterology; Lymphoblastic Leukemia; Leukemia; Immunology; Antigen","score_opus":0.022616446444059947,"score_gpt":0.2689461117619998,"score_spread":0.24632966531793984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800635168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89841586,0.0019375545,0.00034429523,0.096137844,0.0012772132,0.0011810003,0.0003072302,0.00006809572,0.0003309142],"genre_scores_gemma":[0.9536444,0.00020744062,0.0012658212,0.041442756,0.0028628618,0.00006880866,0.00012138434,0.00022951,0.00015700125],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9929892,0.0012066095,0.0023203539,0.0006113065,0.0015473542,0.0013252196],"domain_scores_gemma":[0.9910911,0.0049849413,0.0017926281,0.0006518726,0.001048013,0.00043149077],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001072008,0.0005539808,0.0022405256,0.00090985734,0.0001867946,0.00008952355,0.0009531137,0.001076061,0.00008243504],"category_scores_gemma":[0.005535015,0.0004685012,0.00045183089,0.00080242456,0.0008613695,0.00012303428,0.00020244712,0.003487071,0.000022458837],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024818096,0.00019356544,0.0090836715,0.0022838586,0.00045162384,0.5817426,0.00007697759,0.00021596311,0.000026930084,0.000006614221,0.40263334,0.0008030349],"study_design_scores_gemma":[0.020202572,0.0050965175,0.038828783,0.07168308,0.0044017616,0.8125619,0.00033832644,0.038703647,0.00029575272,0.00006866933,0.0066874726,0.0011314927],"about_ca_topic_score_codex":0.00042465885,"about_ca_topic_score_gemma":0.000036830912,"teacher_disagreement_score":0.39594588,"about_ca_system_score_codex":0.0020082905,"about_ca_system_score_gemma":0.0050378344,"threshold_uncertainty_score":0.99977666},"labels":[],"label_agreement":null},{"id":"W2801066337","doi":"10.1111/bjh.15182","title":"Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (<scp>REDS</scp>‐<scp>III</scp>) database","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Epidemiology; Medicine; Immunology; Internal medicine","score_opus":0.03952452172693926,"score_gpt":0.31286146532190967,"score_spread":0.2733369435949704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801066337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991069,0.0047936556,0.0015006822,0.00028211638,0.00055726775,0.0015636276,0.000034847035,0.000012190806,0.00018661204],"genre_scores_gemma":[0.9955412,0.0024462545,0.0013274433,0.00025975413,0.00022552439,0.000041131418,0.00008724823,0.000028430803,0.000042973876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961842,0.001546731,0.001176128,0.0003488736,0.00032749807,0.00041662581],"domain_scores_gemma":[0.9948363,0.0032807486,0.0008145547,0.00030592002,0.00062192144,0.00014056975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006133759,0.00020375916,0.0009334984,0.00026167344,0.00026709808,0.000029998078,0.00023055518,0.00022160403,0.000011828587],"category_scores_gemma":[0.007842102,0.00016450702,0.00013460296,0.0002664598,0.00020824063,0.00018975025,0.00005522835,0.0005718527,0.0000025909571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032045803,0.0064968136,0.9442951,0.00028110223,0.000852471,0.0029674966,0.014373743,0.00004098768,0.002772885,0.00022642453,0.018912183,0.008460301],"study_design_scores_gemma":[0.031832714,0.008914855,0.86245996,0.00064277335,0.0043052067,0.057420533,0.022212492,0.001418204,0.0044327984,0.0019959153,0.0042324928,0.0001320372],"about_ca_topic_score_codex":0.0004605094,"about_ca_topic_score_gemma":0.0007425844,"teacher_disagreement_score":0.08183516,"about_ca_system_score_codex":0.000031238094,"about_ca_system_score_gemma":0.00011949127,"threshold_uncertainty_score":0.93882954},"labels":[],"label_agreement":null},{"id":"W2801087080","doi":"10.1111/bjh.15173","title":"Frequency of bowel perforation and impact of bowel rest in aggressive non‐Hodgkin lymphoma with gastrointestinal involvement","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Perforation; Chemoimmunotherapy; Gastrointestinal perforation; Surgery; Chemotherapy; Parenteral nutrition; Internal medicine; General surgery; Peritonitis; Cyclophosphamide","score_opus":0.012665597507818975,"score_gpt":0.27455599387412577,"score_spread":0.2618903963663068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801087080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934335,0.0014566599,0.00011973203,0.008205724,0.00014807629,0.00031963803,0.000053809148,0.0000041511403,0.00034886948],"genre_scores_gemma":[0.99160355,0.0006744363,0.0018753533,0.0048890854,0.0007654678,0.000016595774,0.00005398446,0.000050614817,0.000070930415],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99794966,0.00014105525,0.0010239105,0.00023101034,0.0003492464,0.00030510416],"domain_scores_gemma":[0.99671555,0.00008530981,0.0020889265,0.00018828175,0.0008237334,0.00009818904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002549264,0.00023777293,0.001180412,0.0004647867,0.000045728506,0.00002032381,0.00014062131,0.0002507391,0.00013267214],"category_scores_gemma":[0.00014139168,0.00021049625,0.00019511532,0.00017508486,0.00049603014,0.00014341185,0.000035829627,0.000805258,0.0000014027678],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012430663,0.000636153,0.55263186,0.0021774964,0.0007525966,0.21480605,0.00035669692,0.000018825001,0.004138568,0.00003294953,0.22103643,0.0021693318],"study_design_scores_gemma":[0.004729508,0.006137836,0.25359935,0.013375114,0.00036446765,0.7199868,0.00009733895,0.000011252729,0.0009939829,0.00013898146,0.00037933077,0.00018601077],"about_ca_topic_score_codex":0.0017138825,"about_ca_topic_score_gemma":0.000902648,"teacher_disagreement_score":0.5051808,"about_ca_system_score_codex":0.00020213753,"about_ca_system_score_gemma":0.0010200826,"threshold_uncertainty_score":0.85837877},"labels":[],"label_agreement":null},{"id":"W2801354368","doi":"10.1111/bjh.15232","title":"A tale of two antibodies: obinutuzumab <i>versus</i> rituximab","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Centers for Disease Control and Prevention","keywords":"Obinutuzumab; Rituximab; Medicine; CD20; Clinical trial; Immunology; Oncology; Context (archaeology); Dosing; Lymphoma; Internal medicine; Biology","score_opus":0.06548623625567729,"score_gpt":0.39946261266057015,"score_spread":0.33397637640489286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801354368","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017224326,0.9919973,0.000033985816,0.000041574625,0.0012336584,0.0006567418,0.00007848397,0.000017702787,0.004218129],"genre_scores_gemma":[0.00009794803,0.9963118,0.0010618458,0.000047110712,0.0008397003,0.000011587095,0.00003766678,0.00011350961,0.0014788447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99542505,0.0005419766,0.0022267466,0.0003887295,0.0007939721,0.0006235484],"domain_scores_gemma":[0.9956473,0.0006492973,0.0018456717,0.00052520516,0.0010207955,0.00031171815],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011379508,0.00041730527,0.006536482,0.00063502253,0.00007962186,0.000044648543,0.0006663426,0.0005341556,0.0034700262],"category_scores_gemma":[0.00070402585,0.0004026787,0.001762258,0.00047967202,0.00089065253,0.000116489566,0.00019783684,0.0014988545,0.00012644114],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007113132,0.0005348206,0.000007220005,0.030338656,0.0024716763,0.08166056,0.000079983656,9.1928705e-8,0.000028233973,0.00010529557,0.042593595,0.8414686],"study_design_scores_gemma":[0.004850871,0.0008275688,5.202619e-7,0.02596785,0.0011199246,0.39171532,0.000029561963,9.2285023e-7,0.000032922246,0.000055205983,0.5752349,0.00016444316],"about_ca_topic_score_codex":0.00012567101,"about_ca_topic_score_gemma":0.00007163855,"teacher_disagreement_score":0.8413041,"about_ca_system_score_codex":0.00038394373,"about_ca_system_score_gemma":0.0025950456,"threshold_uncertainty_score":0.9998425},"labels":[],"label_agreement":null},{"id":"W2802234447","doi":"10.1111/bjh.15226","title":"Abstracts","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Tyrosine-kinase inhibitor; Tyrosine kinase; Imatinib; Molecular biomarkers","score_opus":0.015911102005050557,"score_gpt":0.2857256306784795,"score_spread":0.2698145286734289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802234447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872907,0.0019018439,0.000081774786,0.00064803474,0.00046900037,0.000074084695,0.0000019018543,0.000013545176,0.009519151],"genre_scores_gemma":[0.9957182,0.00022483004,0.002638056,0.00046185392,0.00047067396,8.938376e-7,0.0000018517828,0.000014900473,0.00046875633],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989874,0.000033122487,0.00048359265,0.000098094984,0.00018400894,0.0002137795],"domain_scores_gemma":[0.9990899,0.000052211628,0.00028091605,0.000114075745,0.00030215108,0.00016074406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019885904,0.00007584749,0.00044000664,0.00008606662,0.000048981863,0.000013905422,0.000090219226,0.00009792458,0.00078056304],"category_scores_gemma":[0.00023599163,0.0000767423,0.00011078384,0.00007605315,0.0001842843,0.00007576024,0.0000213003,0.0002373545,0.00021321891],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006894999,0.00093343464,0.013703212,0.00019474364,0.0009039337,0.6518944,0.00035876074,0.000001776269,0.002788009,0.00040054083,0.15010229,0.17802943],"study_design_scores_gemma":[0.0033197284,0.00067108555,0.028419888,0.00037734784,0.000117505966,0.93984663,0.000043247805,0.000007540755,0.0047514513,0.00037320814,0.022007827,0.00006452198],"about_ca_topic_score_codex":0.000058386868,"about_ca_topic_score_gemma":0.000052681477,"teacher_disagreement_score":0.28795227,"about_ca_system_score_codex":0.00013586869,"about_ca_system_score_gemma":0.00034492492,"threshold_uncertainty_score":0.8546618},"labels":[],"label_agreement":null},{"id":"W2803157865","doi":"10.1111/bjh.15274","title":"How i treat primary haemophagocytic lymphohistiocytosis","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Hemophagocytic lymphohistiocytosis; Transplantation; Hematopoietic stem cell transplantation; Pediatrics; Immunology; Pathology; Internal medicine","score_opus":0.04900986726128549,"score_gpt":0.33305637764447515,"score_spread":0.2840465103831897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803157865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032666148,0.9952296,0.000072647796,0.00020110403,0.0004332923,0.0005521535,0.000024185518,0.000029017181,0.0031313165],"genre_scores_gemma":[0.000042953896,0.99336267,0.00037493982,0.00013663097,0.00052028877,0.000026193888,0.00006327645,0.00011285368,0.005360191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962489,0.00044999731,0.0016964349,0.00037449156,0.0006279662,0.0006021931],"domain_scores_gemma":[0.99685115,0.00023356362,0.0015242142,0.00044865746,0.0006332918,0.00030913574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006808279,0.0004488877,0.0060200565,0.0006585116,0.00016296982,0.0001514067,0.00054605614,0.000756412,0.00032541496],"category_scores_gemma":[0.0007876624,0.00040793375,0.0015583328,0.00038012836,0.00058759673,0.00022637896,0.00015470156,0.0010733358,0.00015985871],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052031402,0.00015540136,0.0000067994233,0.025904898,0.00059676665,0.093020596,0.000015093066,1.00599475e-8,7.2055286e-7,0.000024316856,0.04988553,0.8303378],"study_design_scores_gemma":[0.0009022357,0.00029639475,0.000008253488,0.018323278,0.0011607341,0.4339892,0.000018550598,4.6468833e-7,0.000003088892,0.00002872701,0.5451029,0.0001661792],"about_ca_topic_score_codex":0.000017087385,"about_ca_topic_score_gemma":0.0000047735184,"teacher_disagreement_score":0.83017164,"about_ca_system_score_codex":0.00050141354,"about_ca_system_score_gemma":0.0031890916,"threshold_uncertainty_score":0.9998373},"labels":[],"label_agreement":null},{"id":"W2804149848","doi":"10.1111/bjh.15230","title":"Machine learning algorithms for accurate differential diagnosis of lymphocytosis based on cell population data","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphocytosis; Algorithm; Population; Differential diagnosis; Medicine; Computer science; Artificial intelligence; Pathology","score_opus":0.06015985908385949,"score_gpt":0.3357553190887895,"score_spread":0.27559546000492996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804149848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70022964,0.018978685,0.030400652,0.2265621,0.009029033,0.006819728,0.00688455,0.00021440361,0.0008811975],"genre_scores_gemma":[0.858997,0.006489125,0.014755538,0.0844737,0.015724298,0.00018668245,0.017138537,0.000701434,0.0015337153],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99569565,0.00046186167,0.0015236706,0.0005927136,0.0010721738,0.00065391586],"domain_scores_gemma":[0.9949087,0.0016547438,0.0017544708,0.0007583802,0.0007547049,0.00016901807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075492123,0.00037799423,0.0020366758,0.0006008608,0.00013682255,0.000068023895,0.00092889665,0.0010080193,0.0005535849],"category_scores_gemma":[0.0017428192,0.0003792397,0.00045751638,0.00020082157,0.00024581913,0.00014395529,0.00025110698,0.0017371641,0.000012986299],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014801569,0.00048570076,0.001150317,0.0043545165,0.00058358774,0.043834396,0.000031036678,0.00009025504,0.000030464893,0.0000023561424,0.9324747,0.0154825635],"study_design_scores_gemma":[0.09093821,0.0071475073,0.0008467786,0.012293742,0.0036819833,0.18779457,0.00003760692,0.35787085,0.004728917,0.00017876207,0.33321935,0.0012617225],"about_ca_topic_score_codex":0.0015395341,"about_ca_topic_score_gemma":0.00006334603,"teacher_disagreement_score":0.59925526,"about_ca_system_score_codex":0.0025432536,"about_ca_system_score_gemma":0.0032419907,"threshold_uncertainty_score":0.99986595},"labels":[],"label_agreement":null},{"id":"W2804724049","doi":"10.1111/bjh.15273","title":"Azacitidine in the ‘real‐world’: an evaluation of 1101 higher‐risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Sunnybrook Foundation; Cancer Care Ontario; Celgene","keywords":"Medicine; Azacitidine; Myelodysplastic syndromes; Internal medicine; Dosing; Myeloid leukaemia; Confidence interval; International Prognostic Scoring System; Cohort; Surgery; Pediatrics; Bone marrow","score_opus":0.017853528374629706,"score_gpt":0.2824927445244323,"score_spread":0.26463921614980257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804724049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973795,0.00018163853,0.000013167475,0.00030818212,0.00050721905,0.00063428073,0.000049342372,0.000005462031,0.0009212169],"genre_scores_gemma":[0.99896497,0.00022701226,0.0002227193,0.00025858614,0.000106445215,0.000022926184,0.000060505135,0.000033243432,0.00010362234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994908,0.0009874842,0.0013985806,0.00031795067,0.0017728416,0.00061514304],"domain_scores_gemma":[0.9966674,0.0003949195,0.0007721035,0.00034933575,0.0015904706,0.00022577058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027533118,0.0002357705,0.0010724107,0.0005722067,0.00010325108,0.00003386908,0.0005261143,0.00017850607,0.00079046626],"category_scores_gemma":[0.00061911513,0.00021044309,0.000096826014,0.0006807138,0.00035796204,0.00027357126,0.000077711826,0.0013723988,0.000008028284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016797979,0.0011313461,0.9200469,0.0001846632,0.0004794157,0.053319223,0.0012896289,0.00018194954,0.00027593874,0.00013852637,0.012779642,0.008492968],"study_design_scores_gemma":[0.007904619,0.001363269,0.94350797,0.0008997383,0.0003442637,0.043948665,0.00023286075,0.0006642809,0.00023732675,0.0002486537,0.00047193575,0.00017641262],"about_ca_topic_score_codex":0.87887126,"about_ca_topic_score_gemma":0.9949127,"teacher_disagreement_score":0.11604139,"about_ca_system_score_codex":0.0031504645,"about_ca_system_score_gemma":0.0067732823,"threshold_uncertainty_score":0.9988574},"labels":[],"label_agreement":null},{"id":"W2807264331","doi":"10.1111/bjh.15275","title":"Spectral domain optical coherence tomography interpretation","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Optical coherence tomography; Choroid; Retinal pigment epithelium; Retina; Ophthalmology; Medicine; Physics; Computer science; Optics","score_opus":0.010479355440735543,"score_gpt":0.2602983928789914,"score_spread":0.24981903743825587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807264331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6759097,0.008368459,0.0005532709,0.30926552,0.0018108833,0.00048578426,0.000045532553,0.00003627822,0.0035245442],"genre_scores_gemma":[0.52655303,0.0016249546,0.020135734,0.4409195,0.009785141,0.000058771977,0.0002844145,0.00017408533,0.0004643556],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99791104,0.00013566721,0.0008539539,0.00027779717,0.00042944835,0.00039208084],"domain_scores_gemma":[0.99850225,0.00020867541,0.00057821843,0.00020229144,0.00036310678,0.00014545125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020633028,0.00025163335,0.0012722197,0.00032149933,0.00005677643,0.000072369774,0.00019830873,0.0006398224,0.00057800446],"category_scores_gemma":[0.00012796113,0.0002450634,0.000592979,0.00013884534,0.00036993853,0.00007671096,0.000038622213,0.0011292755,0.00006820074],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116382136,0.0001838202,0.0011267615,0.00012879742,0.0004929134,0.31214356,0.00004595452,7.712798e-8,0.0000123004265,0.000034846013,0.67677647,0.0089381365],"study_design_scores_gemma":[0.0020578038,0.0014532739,0.0090105,0.00259149,0.00067198876,0.8392277,0.000032959026,0.000003203776,0.00034597085,0.0016418798,0.14274575,0.00021752519],"about_ca_topic_score_codex":0.000036346155,"about_ca_topic_score_gemma":0.00003365102,"teacher_disagreement_score":0.5340307,"about_ca_system_score_codex":0.00013275322,"about_ca_system_score_gemma":0.00023021454,"threshold_uncertainty_score":0.9993395},"labels":[],"label_agreement":null},{"id":"W2807483925","doi":"10.1111/bjh.15414","title":"Viral lymphomagenesis: beyond the usual suspects","year":2018,"lang":"en","type":"editorial","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoma; Follicular lymphoma; Medicine; Mantle cell lymphoma; Immunology; Diffuse large B-cell lymphoma; Virology","score_opus":0.006608023363758983,"score_gpt":0.2643054942354318,"score_spread":0.25769747087167283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807483925","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07269043,0.043822214,0.000025423065,0.0015114183,0.8764425,0.00029658407,0.00011732947,0.00003655903,0.005057549],"genre_scores_gemma":[0.033488303,0.01059195,0.00016321841,0.0012819074,0.95163745,0.000015544172,0.00012322095,0.00015109332,0.00254733],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967454,0.00026928654,0.0010376255,0.00031923896,0.0010489722,0.0005794457],"domain_scores_gemma":[0.99667823,0.00039478458,0.0012875658,0.00028999208,0.0011312037,0.00021821362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008228335,0.0003268975,0.001603591,0.00018891874,0.00024762904,0.000115149465,0.0005201833,0.0011999158,0.0003810566],"category_scores_gemma":[0.0019656648,0.0002760418,0.0005902538,0.00019168788,0.0005135266,0.00011734681,0.00009637034,0.0013495078,0.00005375102],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043633,0.00014131458,0.00006988623,0.00012153171,0.0006068794,0.035038453,0.00009771144,4.4545527e-7,0.000013494382,0.000037935573,0.9601769,0.00325912],"study_design_scores_gemma":[0.006946314,0.0013512016,0.0002099592,0.00084357767,0.001156119,0.10447997,0.00038147962,0.0000031252189,0.00007569988,0.0016048213,0.8826295,0.00031824433],"about_ca_topic_score_codex":0.00029882492,"about_ca_topic_score_gemma":0.000420893,"teacher_disagreement_score":0.07754741,"about_ca_system_score_codex":0.00030156263,"about_ca_system_score_gemma":0.0022030254,"threshold_uncertainty_score":0.9999692},"labels":[],"label_agreement":null},{"id":"W2883619056","doi":"10.1111/bjh.15509","title":"Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta‐analysis of prospective studies","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Ottawa; McMaster University","funders":"Physicians' Services Incorporated Foundation; Hamilton Health Sciences","keywords":"Medicine; Apixaban; Head injury; Dabigatran; Rivaroxaban; Glasgow Coma Scale; Warfarin; Prospective cohort study; Incidence (geometry); Edoxaban; Stroke (engine); Anesthesia; Surgery; Internal medicine; Atrial fibrillation","score_opus":0.05319414739067776,"score_gpt":0.3596773635940956,"score_spread":0.30648321620341784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883619056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05882021,0.9392068,0.0000068717018,0.000022222177,0.000049558425,0.001836135,0.000049972543,0.0000039377474,0.000004291382],"genre_scores_gemma":[0.027891325,0.97164685,0.00032575303,0.000043019503,0.000011881096,0.0000481617,0.000006234701,0.000022252005,0.000004556489],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99547195,0.0006843225,0.0028937405,0.00030491978,0.00044530322,0.00019978188],"domain_scores_gemma":[0.99436665,0.00055288203,0.0037336887,0.00025234872,0.0010190794,0.00007536051],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012632265,0.0003281535,0.016824877,0.0006703061,0.000032049797,0.000010475682,0.0002121279,0.00016535448,0.00002053001],"category_scores_gemma":[0.0015098308,0.00022285433,0.0011283824,0.0012093947,0.0004956944,0.00012546907,0.00006106544,0.0004054661,4.1775579e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007069384,0.00025251423,0.0005672069,0.8259869,0.17053999,0.0014038287,0.0001702425,9.474983e-8,1.2802168e-7,0.000013729742,0.000025667232,0.0009690044],"study_design_scores_gemma":[0.000506273,0.00069580926,0.0008207488,0.3720779,0.6087243,0.016971637,0.000039941326,6.853896e-7,0.000002588596,0.000013802978,0.000016269041,0.00013003542],"about_ca_topic_score_codex":0.0000260547,"about_ca_topic_score_gemma":0.000117390424,"teacher_disagreement_score":0.45390898,"about_ca_system_score_codex":0.000044708828,"about_ca_system_score_gemma":0.00015750535,"threshold_uncertainty_score":0.9977714},"labels":[],"label_agreement":null},{"id":"W2885321887","doi":"10.1111/bjh.15518","title":"The <scp>MCL</scp>35 gene expression proliferation assay predicts high‐risk <scp>MCL</scp> patients in a Norwegian cohort of younger patients given intensive first line therapy","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Cytarabine; International Prognostic Index; Oncology; Proliferation index; Cohort; Alemtuzumab; Rituximab; Chemotherapy; Immunohistochemistry; Lymphoma; Transplantation","score_opus":0.008423637202699478,"score_gpt":0.2330102971033561,"score_spread":0.22458665990065663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885321887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951232,0.0020225646,0.00008693296,0.00028339447,0.0009332597,0.001258548,0.00010060496,0.000017859104,0.00017364888],"genre_scores_gemma":[0.99137765,0.007110956,0.000400281,0.00044092923,0.0003257031,0.00008965513,0.00013027775,0.000048969065,0.00007556039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964403,0.00046171143,0.0014131038,0.0003905871,0.00076147227,0.00053283904],"domain_scores_gemma":[0.9943633,0.0008857104,0.0015036565,0.00033699925,0.0026512516,0.00025909176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006488417,0.00032217405,0.0010970812,0.00024559328,0.0002901165,0.00006414416,0.0002794412,0.00031735166,0.00001899566],"category_scores_gemma":[0.0034629533,0.00023941141,0.00023329351,0.0002514742,0.00034197496,0.0002823979,0.000107417756,0.0003948777,0.000017159113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019492241,0.0022272682,0.967366,0.00004730131,0.00046455444,0.0011350602,0.0015287824,0.000007197443,0.0001702712,0.00001209104,0.017249415,0.009597184],"study_design_scores_gemma":[0.01297945,0.0038791262,0.94914675,0.0012970841,0.00023555597,0.0036265475,0.0002742994,0.000055080534,0.025552845,0.00016096277,0.0027328192,0.000059501337],"about_ca_topic_score_codex":0.00037301666,"about_ca_topic_score_gemma":0.0002993761,"teacher_disagreement_score":0.025382575,"about_ca_system_score_codex":0.0002593244,"about_ca_system_score_gemma":0.0002670748,"threshold_uncertainty_score":0.97629136},"labels":[],"label_agreement":null},{"id":"W2886638978","doi":"10.1111/bjh.15519","title":"Validation of the <scp>MCL</scp>35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Mantle cell lymphoma; Medicine; International Prognostic Index; Oncology; Lymphoma; Clinical trial; Internal medicine; Proliferation index; Cancer research; Immunohistochemistry; Diffuse large B-cell lymphoma","score_opus":0.021410796049099793,"score_gpt":0.2683324955108397,"score_spread":0.24692169946173992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886638978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938104,0.0027127294,0.0002532581,0.00025871908,0.00059932383,0.00074634707,0.0000074072373,0.0000037443554,0.0016080526],"genre_scores_gemma":[0.998159,0.0005026947,0.0007698517,0.000114397546,0.00033610183,0.000012700977,0.0000049647233,0.000015571915,0.00008470011],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99356824,0.00427318,0.0015509396,0.00012404154,0.00031442643,0.0001691867],"domain_scores_gemma":[0.9963079,0.0012071864,0.0019302267,0.00021177277,0.0002941653,0.00004875176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056549325,0.00011277126,0.0013432922,0.00006980121,0.000081556995,0.000017684975,0.00018035322,0.00009165797,0.00002466672],"category_scores_gemma":[0.0030079829,0.00006458152,0.00044452757,0.00016866591,0.00020165266,0.00006808489,0.00006906188,0.00008715328,0.0000030775134],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028340513,0.01458619,0.48960456,0.0013552768,0.0028008665,0.008583326,0.007966569,0.0011706938,0.2371081,0.0012405287,0.12813637,0.07910701],"study_design_scores_gemma":[0.12672083,0.00022648495,0.04746202,0.0020796112,0.0005369804,0.014947033,0.00008107023,0.00006501183,0.8067971,0.00065614155,0.00038741497,0.000040334435],"about_ca_topic_score_codex":0.000039664974,"about_ca_topic_score_gemma":0.000017434113,"teacher_disagreement_score":0.569689,"about_ca_system_score_codex":0.000059950435,"about_ca_system_score_gemma":0.00021804926,"threshold_uncertainty_score":0.36010537},"labels":[],"label_agreement":null},{"id":"W2887374999","doi":"10.1111/bjh.15499","title":"Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin–Frankfürt–Münster (I‐<scp>BFM</scp>) study group","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Antibiotic prophylaxis; Internal medicine; Myeloid leukaemia; Pediatrics; Family medicine; Antibiotics","score_opus":0.02458430059342628,"score_gpt":0.2832823376880826,"score_spread":0.25869803709465633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887374999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955084,0.00051226065,0.00021726979,0.00025402434,0.002086911,0.0010532775,0.000008551775,0.000033168697,0.00032614684],"genre_scores_gemma":[0.9978785,0.00019892692,0.00005681401,0.00016369917,0.0014899935,0.000076570854,0.000004174079,0.00003102485,0.00010033168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967883,0.0005839817,0.001175631,0.00035685676,0.0007588799,0.00033635728],"domain_scores_gemma":[0.99804723,0.0003133003,0.000679147,0.00023749856,0.0005769052,0.00014590127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014014747,0.00024475917,0.00092074607,0.0004868965,0.00028465147,0.00015579542,0.0004131054,0.00016013316,0.000055951325],"category_scores_gemma":[0.00043783197,0.00018914707,0.00019765462,0.0005719773,0.0002700617,0.0003369106,0.00014047684,0.0011162733,0.000027972254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012310395,0.0011265012,0.9849854,0.000019577279,0.000864907,0.0039050446,0.0021943261,0.0000018839099,0.000121665624,0.000025325517,0.0009177063,0.0057145674],"study_design_scores_gemma":[0.0044061667,0.006092664,0.9519059,0.00013317035,0.0006586474,0.03337118,0.002538494,0.0000067447163,0.00015936798,0.0002668061,0.0003597884,0.000101054444],"about_ca_topic_score_codex":0.0009854387,"about_ca_topic_score_gemma":0.0068337196,"teacher_disagreement_score":0.033079475,"about_ca_system_score_codex":0.00020628145,"about_ca_system_score_gemma":0.00023531199,"threshold_uncertainty_score":0.7713194},"labels":[],"label_agreement":null},{"id":"W2888250172","doi":"10.1111/bjh.15533","title":"Predictive value of venous thromboembolism (<scp>VTE</scp>)‐<scp>BLEED</scp> to predict major bleeding and other adverse events in a practice‐based cohort of patients with <scp>VTE</scp>: results of the <scp>XALIA</scp> study","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bundesministerium für Bildung und Forschung","keywords":"Medicine; Bleed; Interquartile range; Hazard ratio; Internal medicine; Prospective cohort study; Confidence interval; Rivaroxaban; Incidence (geometry); Cohort; Anticoagulant; Adverse effect; Warfarin; Surgery; Atrial fibrillation","score_opus":0.009358130126132092,"score_gpt":0.26053678341756376,"score_spread":0.2511786532914317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888250172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897891,0.0009039036,0.00019789867,0.00011230106,0.0009792397,0.0042267786,0.00039589146,0.00004127225,0.0033535787],"genre_scores_gemma":[0.9971941,0.0002932482,0.001180008,0.00062859576,0.00026698443,0.00011598443,0.000021776123,0.00015052372,0.00014879221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919106,0.0010124245,0.002905907,0.0009377807,0.0020751709,0.0011581398],"domain_scores_gemma":[0.9893122,0.0032608027,0.0039051094,0.00087545044,0.0021034337,0.00054300996],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029757356,0.0006936147,0.0034540116,0.0009092707,0.00025673097,0.00003566669,0.0008936088,0.0004440074,0.000008785413],"category_scores_gemma":[0.011729852,0.0006030137,0.00038838526,0.0011650705,0.00083980197,0.00054088567,0.00051853934,0.00097379816,0.0000083472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004204428,0.02121231,0.92147356,0.0011912708,0.0061935214,0.0023419643,0.022131968,0.000763118,0.00052410073,0.00026035774,0.023019785,0.00046760304],"study_design_scores_gemma":[0.017859472,0.012191237,0.93588066,0.004081855,0.00403334,0.0025434108,0.016691562,0.00018236999,0.0028271955,0.00016854893,0.0034561758,0.00008416547],"about_ca_topic_score_codex":0.0015120879,"about_ca_topic_score_gemma":0.0005125736,"teacher_disagreement_score":0.019563608,"about_ca_system_score_codex":0.0002342786,"about_ca_system_score_gemma":0.00061146443,"threshold_uncertainty_score":0.99964213},"labels":[],"label_agreement":null},{"id":"W2888530710","doi":"10.1111/bjh.15530","title":"Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Von Willebrand factor; Internal medicine; Pulmonary hypertension; Cardiology; Thrombosis; Bleeding diathesis; Platelet; Von Willebrand disease; Gastroenterology","score_opus":0.012181626432528406,"score_gpt":0.24752354220710415,"score_spread":0.23534191577457575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888530710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963891,0.0017485799,0.00003751971,0.0006182009,0.0004799683,0.0006255791,0.000035160287,0.000018883873,0.000047035333],"genre_scores_gemma":[0.99778235,0.0004202037,0.0011265563,0.00045237693,0.00008759814,0.000010577701,0.00003546126,0.000051920615,0.000032939915],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99767566,0.00025120226,0.0009739306,0.00032501412,0.00033982084,0.00043440048],"domain_scores_gemma":[0.99869025,0.00007731504,0.0004297242,0.00022757018,0.00029902402,0.00027613112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032801993,0.00024647752,0.0017757728,0.00041240538,0.0000765243,0.00002251293,0.00015129596,0.00024173083,0.00016105188],"category_scores_gemma":[0.00039396342,0.00023996492,0.00016094632,0.00031404544,0.00019395615,0.00016136785,0.000052279476,0.00020693733,0.00006416859],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013395628,0.0036780357,0.02862704,0.0003222854,0.0014488619,0.90292895,0.00052189024,0.000018647408,0.012963907,0.00003835288,0.0020084376,0.03404795],"study_design_scores_gemma":[0.013744321,0.0026892745,0.18437624,0.0023785483,0.0003838231,0.7926565,0.00005024805,0.0000425834,0.002264002,0.0011851153,0.000021012487,0.00020834581],"about_ca_topic_score_codex":0.00083206047,"about_ca_topic_score_gemma":0.00021076875,"teacher_disagreement_score":0.15574919,"about_ca_system_score_codex":0.00006492189,"about_ca_system_score_gemma":0.0002043748,"threshold_uncertainty_score":0.9785485},"labels":[],"label_agreement":null},{"id":"W2891438885","doi":"10.1111/bjh.15579","title":"Extreme hyperferritinaemia, soluble interleukin‐2 receptor, and haemophagocytic lymphohistiocytosis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ferritin; Hemophagocytic lymphohistiocytosis; Medicine; Malignancy; Pathognomonic; Histiocyte; Internal medicine; Immunology; Gastroenterology; Disease; Pediatrics","score_opus":0.034040019876605224,"score_gpt":0.2753757449316984,"score_spread":0.2413357250550932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891438885","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4910028,0.10626883,0.00024049004,0.38824323,0.0038098055,0.0010580383,0.000067358545,0.00012105572,0.009188387],"genre_scores_gemma":[0.12098301,0.050688587,0.0062991614,0.7506628,0.017496971,0.000118432414,0.0005950816,0.00090980646,0.052246172],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961806,0.00032072098,0.0015554117,0.0004579225,0.0007117572,0.0007736225],"domain_scores_gemma":[0.9973423,0.00021470462,0.00090439996,0.00038669384,0.0009306955,0.00022122402],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070146297,0.00040175833,0.0022601872,0.0005722128,0.00021640607,0.00013432732,0.00045561907,0.0012962067,0.0018737847],"category_scores_gemma":[0.0007655635,0.00043777862,0.00041903285,0.00018496047,0.0009778409,0.00022967083,0.00022216346,0.0029114732,0.00016623824],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016982606,0.00006951166,0.0003613486,0.00093128544,0.0003479181,0.116674505,0.00007804102,4.35014e-8,0.00015313858,0.0000081093385,0.8699566,0.011249684],"study_design_scores_gemma":[0.0020202636,0.00062517455,0.00015396251,0.0020404693,0.00021676141,0.41894045,0.00008770448,0.00001207054,0.00028925747,0.00016309448,0.5752048,0.00024597338],"about_ca_topic_score_codex":0.00016001154,"about_ca_topic_score_gemma":0.000019555306,"teacher_disagreement_score":0.3700198,"about_ca_system_score_codex":0.00028337867,"about_ca_system_score_gemma":0.0010626712,"threshold_uncertainty_score":0.9998074},"labels":[],"label_agreement":null},{"id":"W2891826418","doi":"10.1111/bjh.15571","title":"Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Medicine; Refractory (planetary science); Internal medicine; Oncology; Myeloid leukaemia; Vismodegib; Clinical trial","score_opus":0.017307318351377894,"score_gpt":0.28590158929735987,"score_spread":0.268594270945982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891826418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98104817,0.01016932,0.000116391646,0.0067534554,0.0008172988,0.00038162575,0.0004597051,0.000004409713,0.0002496047],"genre_scores_gemma":[0.95074886,0.021475693,0.0018655272,0.01811827,0.0062732603,0.000020229252,0.0006264654,0.0002206701,0.00065103755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611115,0.00051565253,0.0021760042,0.00046602418,0.000324442,0.00040674637],"domain_scores_gemma":[0.99660707,0.00027582736,0.0021723164,0.00035688092,0.0005098746,0.0000780515],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009917429,0.00033311098,0.0018357696,0.00028663222,0.00005435771,0.000013977763,0.00045665095,0.0013982393,0.000008770829],"category_scores_gemma":[0.0014614217,0.00036324264,0.00035433786,0.00012482841,0.0007581215,0.0000073421443,0.00021573433,0.0012958398,0.0000011567593],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10572625,0.0012399682,0.00004483877,0.0007485049,0.0026511808,0.044403482,0.00048565015,0.000014368193,0.06374792,0.00000616043,0.7712802,0.009651455],"study_design_scores_gemma":[0.30001384,0.016342083,0.00018597575,0.0037007455,0.0010594588,0.085363016,0.00011464393,0.000010218927,0.060688045,0.00017398971,0.5312347,0.0011132885],"about_ca_topic_score_codex":0.000065095934,"about_ca_topic_score_gemma":0.000057990834,"teacher_disagreement_score":0.24004552,"about_ca_system_score_codex":0.000034461576,"about_ca_system_score_gemma":0.00042930568,"threshold_uncertainty_score":0.99989814},"labels":[],"label_agreement":null},{"id":"W2891925028","doi":"10.1111/bjh.15592","title":"Plasma metabolomics analysis in sickle cell disease patients with albuminuria – an exploratory study","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Common Fund; National Institutes of Health","keywords":"Albuminuria; Renal function; Medicine; Kidney disease; Creatinine; Internal medicine; Urology","score_opus":0.007541269113817907,"score_gpt":0.22518261481236326,"score_spread":0.21764134569854535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891925028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98798066,0.0023539504,0.000015754864,0.008411779,0.00053264387,0.00055190036,0.000063826104,0.000016372063,0.00007309275],"genre_scores_gemma":[0.9566906,0.00063587824,0.00039706883,0.040577177,0.00084659865,0.000024424027,0.0004376772,0.00015354411,0.0002370286],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99660236,0.0005785068,0.001178257,0.0004745672,0.0006473496,0.0005189506],"domain_scores_gemma":[0.99753135,0.000099628654,0.00097515836,0.00043012036,0.00062090316,0.0003428245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003915385,0.0003811613,0.0021710477,0.0009798346,0.000082145954,0.000054771746,0.00033619127,0.00066690246,0.00020269373],"category_scores_gemma":[0.00013845586,0.0003383912,0.0003652099,0.0006704172,0.000266048,0.0002102404,0.000060904298,0.002248933,0.000018797005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014944648,0.004760843,0.26324347,0.00035008113,0.0037437496,0.40834874,0.0011621268,0.000055573008,0.000001268754,6.180198e-7,0.31592873,0.000910339],"study_design_scores_gemma":[0.12260654,0.027026312,0.3355313,0.005455576,0.11854688,0.077259146,0.016947972,0.0005206187,0.00007593438,0.000254816,0.29018882,0.0055860775],"about_ca_topic_score_codex":0.00007226328,"about_ca_topic_score_gemma":0.00057016587,"teacher_disagreement_score":0.3310896,"about_ca_system_score_codex":0.0000863329,"about_ca_system_score_gemma":0.00046710117,"threshold_uncertainty_score":0.99990684},"labels":[],"label_agreement":null},{"id":"W2892009646","doi":"10.1111/bjh.15552","title":"An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Gilead Sciences","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Gastroenterology; Neutropenia; Follicular lymphoma; Lymphoma; Marginal zone B-cell lymphoma; Nausea; Non-Hodgkin's lymphoma; Adverse effect; Chemotherapy; Immunology; Marginal zone; B cell","score_opus":0.02868457587111895,"score_gpt":0.3463085454962921,"score_spread":0.31762396962517314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892009646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958366,0.0016447769,0.000023497896,0.00031402666,0.00037554363,0.0006132026,0.000026512313,0.0000053992544,0.0011604372],"genre_scores_gemma":[0.9969458,0.00096164166,0.0014852576,0.00030379955,0.0002006918,0.00002182653,0.000010444111,0.000023972754,0.00004658632],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979348,0.00018533765,0.0010219542,0.000268067,0.00027228068,0.0003175518],"domain_scores_gemma":[0.99855214,0.000113718655,0.00060517737,0.00023021574,0.00023809055,0.00026064826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056224153,0.0001786684,0.0011367087,0.00022469796,0.00006197524,0.000058487163,0.00027337027,0.00016604678,0.00016262666],"category_scores_gemma":[0.000100703655,0.00017290209,0.00007935353,0.00015742524,0.00025535168,0.00019665626,0.000111654386,0.00007350078,0.000010200497],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076522596,0.08152458,0.024810683,0.00035297722,0.0004925295,0.12070855,0.0018767884,4.2887868e-7,0.005460644,0.00034235328,0.006751944,0.6811559],"study_design_scores_gemma":[0.7267432,0.022237608,0.04976437,0.0009179304,0.00031441406,0.15370047,0.00036468997,0.00008140652,0.042258617,0.00023555792,0.0031322746,0.00024945752],"about_ca_topic_score_codex":0.0005610934,"about_ca_topic_score_gemma":0.0002498229,"teacher_disagreement_score":0.6809065,"about_ca_system_score_codex":0.00012791758,"about_ca_system_score_gemma":0.0004835604,"threshold_uncertainty_score":0.70507425},"labels":[],"label_agreement":null},{"id":"W2897944648","doi":"10.1111/bjh.15572","title":"Primary cutaneous acral <scp>CD</scp>8<sup>+</sup> T‐cell lymphomas relapse more frequently in younger patients","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Immunology; Cancer research; Dermatology","score_opus":0.02208848779556157,"score_gpt":0.3066862042369397,"score_spread":0.28459771644137816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897944648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.119336285,0.87478477,0.000006944049,0.00006112221,0.00047228267,0.0017323677,0.00016775471,0.000038167902,0.0034003202],"genre_scores_gemma":[0.0013896229,0.99404943,0.00063831836,0.00049024087,0.0004714713,0.0000772049,0.00037467215,0.0002940111,0.0022150276],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99130976,0.0012007141,0.0034037896,0.00097154884,0.0016007613,0.0015134001],"domain_scores_gemma":[0.99415165,0.0010519355,0.0018632568,0.0007054602,0.0015073776,0.0007203365],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0008031487,0.00096207275,0.0065898946,0.0014250329,0.00019042367,0.00014954114,0.0010521386,0.0014757978,0.00029599786],"category_scores_gemma":[0.002904611,0.00095924264,0.0015204509,0.00087497575,0.0008539748,0.00030328962,0.00038919362,0.0023490195,0.0003195015],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025982712,0.003074358,0.0046172165,0.029826952,0.0012409,0.66483176,0.00073335675,0.000005587364,0.0000024965186,0.000026225784,0.059424143,0.23595716],"study_design_scores_gemma":[0.0033183962,0.00094420195,0.00011337537,0.018968923,0.0008250977,0.6464267,0.00018810802,0.000013330818,0.0000032691541,0.000100127574,0.32883617,0.00026231792],"about_ca_topic_score_codex":0.0001602458,"about_ca_topic_score_gemma":0.00005736865,"teacher_disagreement_score":0.269412,"about_ca_system_score_codex":0.001682474,"about_ca_system_score_gemma":0.0036808143,"threshold_uncertainty_score":0.9999526},"labels":[],"label_agreement":null},{"id":"W2898342993","doi":"10.1111/bjh.15605","title":"Angiogenin‐mediated <scp>tRNA</scp> cleavage as a novel feature of stored red blood cells","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; World Anti-Doping Agency; Duke University; National Science Foundation","keywords":"Cleavage (geology); Angiogenin; Transfer RNA; Chemistry; Molecular biology; Biochemistry; Biology; Genetics; RNA; Gene; Angiogenesis","score_opus":0.006408275870990761,"score_gpt":0.2148371617211662,"score_spread":0.20842888585017544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898342993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97182465,0.015387534,0.00021044673,0.009636926,0.001315015,0.00043152933,0.00073673663,0.00001734206,0.00043983592],"genre_scores_gemma":[0.64155436,0.009178111,0.028301727,0.25456882,0.03726456,0.00009116053,0.012470006,0.0015299543,0.015041307],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972,0.00028694162,0.0010002545,0.00050982385,0.00045474403,0.0005482055],"domain_scores_gemma":[0.9963347,0.00011543327,0.0020469744,0.0004943261,0.0008355739,0.00017303092],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032991162,0.00040973717,0.0011130528,0.00026375047,0.00007460823,0.000048331098,0.0007432915,0.0022263878,0.000046933288],"category_scores_gemma":[0.0009710299,0.00048303904,0.0006967177,0.00017851093,0.00040006073,0.000011416645,0.00018139556,0.0009989135,0.000016793188],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037072325,0.00011315972,0.00005860545,0.00018095718,0.0006937856,0.009348506,0.000017442393,0.0000018233227,0.3323184,0.0000010568125,0.6571822,0.000046935573],"study_design_scores_gemma":[0.0021607094,0.00062512496,0.00044455644,0.00053486484,0.00066374656,0.13863109,0.000025609184,0.0000029684168,0.37486583,0.000043753356,0.48177287,0.00022888134],"about_ca_topic_score_codex":0.00002795295,"about_ca_topic_score_gemma":0.00002056953,"teacher_disagreement_score":0.3302703,"about_ca_system_score_codex":0.000033838453,"about_ca_system_score_gemma":0.000497948,"threshold_uncertainty_score":0.9997621},"labels":[],"label_agreement":null},{"id":"W2899858024","doi":"10.1111/bjh.15657","title":"The incidence of symptomatic osteonecrosis after allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia – controversy on dexamethasone as a risk factor","year":2018,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prednisone; Cumulative incidence; Incidence (geometry); Dexamethasone; Hematopoietic stem cell transplantation; Transplantation; Population; Internal medicine; Hematology; Risk factor; Disease; Pediatrics; Immunology","score_opus":0.0060447181095238415,"score_gpt":0.2398717343043126,"score_spread":0.23382701619478877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899858024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901538,0.0018202052,0.00036600206,0.005666025,0.00023523404,0.0013975152,0.00028218725,0.000019615221,0.000059418737],"genre_scores_gemma":[0.9823881,0.004222219,0.00054347207,0.012105585,0.00024940647,0.00008582821,0.00003835348,0.0001469202,0.00022011013],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9938926,0.0009993692,0.0018665005,0.00060684734,0.0016894682,0.0009452108],"domain_scores_gemma":[0.9934249,0.0028566536,0.0021771083,0.0006094751,0.00069244235,0.00023941175],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007565593,0.00060516555,0.002402768,0.0006332397,0.00012899701,0.00010453808,0.00079136895,0.00093122234,0.00019374205],"category_scores_gemma":[0.00028916603,0.00045377278,0.0004195371,0.00043746387,0.00092893397,0.00017077578,0.000085075,0.0024885142,0.000084169405],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023134714,0.0008441741,0.16511728,0.0059097917,0.009607309,0.72091514,0.0023591125,0.000103803766,0.001338734,0.000015144364,0.06432234,0.006332492],"study_design_scores_gemma":[0.016022602,0.0054351073,0.05514216,0.00996499,0.0030320915,0.9047845,0.00015178554,0.00011479446,0.0043423586,0.00012456132,0.00027571098,0.0006093236],"about_ca_topic_score_codex":0.00056013913,"about_ca_topic_score_gemma":0.00029773873,"teacher_disagreement_score":0.18386939,"about_ca_system_score_codex":0.0009231222,"about_ca_system_score_gemma":0.0021123176,"threshold_uncertainty_score":0.9998128},"labels":[],"label_agreement":null},{"id":"W2901969852","doi":"10.1111/bjh.15654","title":"Aplastic anaemia in pregnancy – a single centre, North American series","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Tertiary care; Postpartum period; Pediatrics; Gynecology; Surgery","score_opus":0.007528069294928242,"score_gpt":0.2294438928388538,"score_spread":0.22191582354392556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901969852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348843,0.0038545993,0.00006932278,0.00094974175,0.00031355763,0.00010599957,0.00000357195,0.000013831808,0.0012009267],"genre_scores_gemma":[0.99756825,0.0011512035,0.0008198292,0.00021371328,0.00008361049,0.0000010010488,0.0000028862776,0.000017264429,0.00014222604],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99880326,0.00007179235,0.0005193642,0.00013250331,0.00015069572,0.00032241395],"domain_scores_gemma":[0.9992172,0.000039828483,0.00028903954,0.00009147275,0.00021184926,0.00015057319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007082608,0.00010323894,0.0005879603,0.00016467902,0.000052424253,0.000016254455,0.00009244308,0.00007726485,0.000098912285],"category_scores_gemma":[0.00032659032,0.00010203328,0.00008774367,0.00038133794,0.00048773264,0.00010150041,0.000026075037,0.00034304283,0.000021667987],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009773311,0.0014216962,0.52123076,0.00034854122,0.00029636617,0.24359801,0.0013826767,0.000015702033,0.00038817408,0.00019494975,0.011465161,0.21868066],"study_design_scores_gemma":[0.0054016323,0.004116824,0.25156528,0.004508064,0.00021499759,0.72018564,0.0020932707,0.000058309077,0.00074537407,0.00027181293,0.010487991,0.00035084112],"about_ca_topic_score_codex":0.00011851329,"about_ca_topic_score_gemma":0.0033958901,"teacher_disagreement_score":0.4765876,"about_ca_system_score_codex":0.0000441576,"about_ca_system_score_gemma":0.00012922102,"threshold_uncertainty_score":0.41607964},"labels":[],"label_agreement":null},{"id":"W2902815908","doi":"10.1111/bjh.15690","title":"Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Ibrutinib; Medicine; Discontinuation; Internal medicine; Population; Confidence interval; Oncology; Gastroenterology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.014358552172936766,"score_gpt":0.2956627147591522,"score_spread":0.28130416258621543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902815908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987119,0.00022950325,0.0006307192,0.00001610961,0.000024991172,0.00030533466,0.000049925035,0.0000067086457,0.000024810097],"genre_scores_gemma":[0.997635,0.00010331675,0.0021449116,0.000016624128,0.000023136812,0.0000037973757,0.000030858202,0.000017884284,0.000024486106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983623,0.00017686415,0.0006725774,0.00021113917,0.000289935,0.0002872052],"domain_scores_gemma":[0.99789107,0.00031589132,0.0005007411,0.00016948103,0.00093521806,0.00018761728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048339344,0.00012648113,0.0009768814,0.0005433418,0.00005191816,0.000018983606,0.00014516567,0.00013177458,0.00006731237],"category_scores_gemma":[0.0011985861,0.000102028716,0.00010099555,0.0006880989,0.00046253882,0.00015613013,0.000033171385,0.00024318162,6.7284594e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024022246,0.0003522683,0.9868171,0.000108026245,0.0008074441,0.0036459253,0.00044870895,0.000009858362,0.000035952347,0.0000074754244,0.00011548926,0.005249476],"study_design_scores_gemma":[0.03870507,0.0080814995,0.9055678,0.0007397735,0.002108035,0.030519549,0.0009509993,0.008337872,0.0046616746,0.000057954145,0.000044683064,0.00022508494],"about_ca_topic_score_codex":0.0052997926,"about_ca_topic_score_gemma":0.004279118,"teacher_disagreement_score":0.08124934,"about_ca_system_score_codex":0.0006141263,"about_ca_system_score_gemma":0.0010455571,"threshold_uncertainty_score":0.8011736},"labels":[],"label_agreement":null},{"id":"W2906950405","doi":"10.1111/bjh.15732","title":"Health‐related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study","year":2018,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Novartis; Wellcome Trust; GlaxoSmithKline","keywords":"Eltrombopag; Immune thrombocytopenia; Medicine; Quality of life (healthcare); Health related quality of life; Pediatrics; Platelet; Interquartile range; Internal medicine; Disease","score_opus":0.01754459785667855,"score_gpt":0.2984179456191908,"score_spread":0.28087334776251227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906950405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291295,0.0052525834,0.0000037086295,0.00088305987,0.000023845632,0.00078635686,0.0000065278773,0.0000063718894,0.00012456987],"genre_scores_gemma":[0.9994592,0.00030383636,0.00007509165,0.00009358811,0.000018751249,0.000009221153,0.000011651433,0.00001791392,0.0000107276755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975529,0.0005252348,0.0011242284,0.00018503537,0.00030254797,0.0003101068],"domain_scores_gemma":[0.9987177,0.000088067885,0.0007488025,0.00020997481,0.00015202595,0.00008339492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081197213,0.00015600304,0.0017807011,0.00017688719,0.000062531,0.000013878989,0.00018826865,0.000077148536,0.000074304764],"category_scores_gemma":[0.00009111315,0.000102057595,0.00006437416,0.0004279926,0.00026837987,0.000094426774,0.000020649626,0.00041416893,0.0000045954653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011711741,0.0026538447,0.97730064,0.00004349403,0.0006632766,0.016063564,0.000741959,0.0000039744714,0.000025102727,0.00002490061,0.00007369076,0.0012343569],"study_design_scores_gemma":[0.0165743,0.0069862325,0.82298756,0.00050592964,0.00008891241,0.15210406,0.00060502376,0.0000028981724,0.000036454305,0.000028805607,0.0000033884508,0.00007644975],"about_ca_topic_score_codex":0.010697532,"about_ca_topic_score_gemma":0.021598186,"teacher_disagreement_score":0.15431312,"about_ca_system_score_codex":0.00009312795,"about_ca_system_score_gemma":0.00047319787,"threshold_uncertainty_score":0.9962551},"labels":[],"label_agreement":null},{"id":"W2910201624","doi":"10.1111/bjh.15734","title":"Mature B‐<scp>NHL</scp> in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Lymphoma; Clinical trial; Oncology; Chemotherapy; Immunotherapy; Internal medicine; Disease; Intensive care medicine; Cancer","score_opus":0.02410139797830113,"score_gpt":0.30930287162341014,"score_spread":0.285201473645109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910201624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06577402,0.93261576,0.0000058278383,0.0000164509,0.00029672548,0.0011231211,0.000045956076,0.0000105461995,0.000111568035],"genre_scores_gemma":[0.036881793,0.9626423,0.00011066613,0.000022633732,0.00013330599,0.000053575543,0.00007673425,0.0000503313,0.000028658156],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.997643,0.00023423239,0.001016003,0.00045132713,0.00024388915,0.00041156588],"domain_scores_gemma":[0.99865395,0.00009074044,0.00078259566,0.00019369571,0.00008625893,0.00019275682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016601002,0.0005034986,0.0033081777,0.00035064775,0.000061461156,0.000118395736,0.00012420958,0.00036896943,0.00000387988],"category_scores_gemma":[0.00003390132,0.00038882688,0.000384611,0.00015254485,0.000111865134,0.00013383654,0.000058945385,0.00055370765,0.000004314372],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001963225,0.0011049516,0.026707755,0.012365221,0.00089916633,0.0047408952,0.00024949282,2.5488654e-7,4.6689802e-8,0.00006717854,0.00012663443,0.9537188],"study_design_scores_gemma":[0.0083362,0.00078576244,0.038638216,0.09557129,0.004535308,0.75047266,0.00056180806,0.0000071399663,7.9318824e-7,0.000051363582,0.100804865,0.00023456653],"about_ca_topic_score_codex":0.00012583991,"about_ca_topic_score_gemma":0.000037782473,"teacher_disagreement_score":0.9534842,"about_ca_system_score_codex":0.0002648478,"about_ca_system_score_gemma":0.0005206484,"threshold_uncertainty_score":0.99985635},"labels":[],"label_agreement":null},{"id":"W2913619907","doi":"10.1111/bjh.15748","title":"Decision‐analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injury","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; National Institute on Handicapped Research","keywords":"Lower limb; Medicine; Physical medicine and rehabilitation; Intensive care medicine; Physical therapy; Surgery","score_opus":0.010277512491547531,"score_gpt":0.24476669273344612,"score_spread":0.23448918024189858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913619907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87446624,0.003286923,0.0991625,0.017615566,0.0017635152,0.003535219,0.00012674312,0.0000072747757,0.000035999747],"genre_scores_gemma":[0.96380603,0.0017093802,0.010025973,0.023031173,0.0007973149,0.00017469785,0.00009525459,0.00012354743,0.0002366461],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976487,0.00009462907,0.0011338472,0.00029078752,0.0005309261,0.00030110072],"domain_scores_gemma":[0.9952625,0.0013375385,0.0018508221,0.00044182295,0.0010682383,0.00003905228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046870892,0.00023684469,0.0029031078,0.0004483218,0.000067745226,0.000019519315,0.0003444427,0.00043724047,0.000034591583],"category_scores_gemma":[0.00043552666,0.00017421896,0.001244979,0.00034207682,0.00012563932,0.0000725144,0.00006328442,0.0005326437,8.468179e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002079605,0.0015868584,0.0018479618,0.022085961,0.017743766,0.0014639192,0.00041081337,0.004835639,0.00022401915,0.00014553506,0.94175786,0.005818048],"study_design_scores_gemma":[0.05680442,0.12753187,0.04414108,0.088846676,0.2912588,0.06098247,0.0010835241,0.022482729,0.02243246,0.01806414,0.26148522,0.0048865797],"about_ca_topic_score_codex":0.00011938241,"about_ca_topic_score_gemma":0.000081365746,"teacher_disagreement_score":0.68027264,"about_ca_system_score_codex":0.000058414815,"about_ca_system_score_gemma":0.00021912459,"threshold_uncertainty_score":0.7104443},"labels":[],"label_agreement":null},{"id":"W2919311410","doi":"10.1111/bjh.15813","title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Canadian Blood Services; Canadian Red Cross Society; Université de Montréal; McMaster University; Centre Hospitalier Universitaire Sainte-Justine; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children; St. Michael's Hospital","funders":"Canadian Blood Services","keywords":"Neonatal alloimmune thrombocytopenia; Medicine; Obstetrics; Pregnancy; Fetus; Platelet transfusion; Gestation; Pediatrics; Platelet; Immunology; Biology","score_opus":0.12097169493317016,"score_gpt":0.41695698924584124,"score_spread":0.29598529431267107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919311410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036199897,0.9948976,0.0015937067,0.0011289824,0.0006235922,0.0009974331,0.00012822819,0.00000947304,0.00025900928],"genre_scores_gemma":[0.00019628773,0.97308016,0.025460074,0.0002559418,0.00011502099,0.000047193123,0.0006712169,0.00004352737,0.00013056197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811614,0.00020421781,0.0009343734,0.00030290266,0.0002234417,0.00021895231],"domain_scores_gemma":[0.99750495,0.0006635881,0.0011267583,0.00018028103,0.00039197766,0.00013244501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051533064,0.0002473481,0.0026281415,0.00024322626,0.000085559244,0.00009661553,0.00025134571,0.0003001785,0.000081486796],"category_scores_gemma":[0.0007276867,0.00022814707,0.00043557785,0.00009097797,0.000088547145,0.00077346875,0.000054747943,0.0005290407,0.000008343302],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016349982,0.00053422817,0.0000104459605,0.003744466,0.0013165722,0.013656963,0.000019608955,3.8397243e-7,1.5994284e-7,0.00014129667,0.0019746216,0.9784378],"study_design_scores_gemma":[0.0016314294,0.00040451542,0.000007962324,0.009100738,0.002068196,0.43132436,0.00004982179,0.000037979895,3.0979854e-7,0.000018557103,0.55524445,0.00011164531],"about_ca_topic_score_codex":0.000029284221,"about_ca_topic_score_gemma":0.0000070392975,"teacher_disagreement_score":0.9783261,"about_ca_system_score_codex":0.00008976322,"about_ca_system_score_gemma":0.00059914426,"threshold_uncertainty_score":0.93035674},"labels":[],"label_agreement":null},{"id":"W2920983629","doi":"10.1111/bjh.15860","title":"Identification of high‐risk <i> <scp>DUSP</scp> 22 </i> ‐rearranged <scp>ALK</scp> ‐negative anaplastic large cell lymphoma","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Francis Xavier University; University Health Network; Spinal Cord Injury BC","funders":"National Cancer Institute; Michael Smith Health Research BC; Terry Fox Research Institute; Mayo Clinic","keywords":"Anaplastic lymphoma kinase; Identification (biology); Lymphoma; Anaplastic large-cell lymphoma; Cancer research; Biology; Medicine; Immunology; Internal medicine; Lung cancer","score_opus":0.007333538314844853,"score_gpt":0.22504839674683372,"score_spread":0.21771485843198887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920983629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96910316,0.01344859,0.00026622275,0.010151468,0.0027005025,0.0011449433,0.0013746284,0.000052928805,0.0017575329],"genre_scores_gemma":[0.9444769,0.008086648,0.00053300045,0.03777113,0.0022221047,0.00008972625,0.0007349106,0.00026113904,0.005824432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937523,0.0007592717,0.002509861,0.00077441946,0.0011930746,0.0010110714],"domain_scores_gemma":[0.9891499,0.0038783695,0.0047936323,0.0007009582,0.0012084334,0.00026869628],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00078344904,0.00069273286,0.0032999371,0.0007186255,0.00019085956,0.00012369809,0.00058993377,0.0015140346,0.00007868741],"category_scores_gemma":[0.0025137183,0.00071286625,0.0009800857,0.0004160132,0.00032347563,0.0002543336,0.00013981182,0.0014623065,0.00030360027],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037694695,0.0019133319,0.0063408785,0.001194672,0.001543384,0.072323464,0.00038696002,0.000006109405,0.00019352276,0.00003346216,0.9142628,0.0017637798],"study_design_scores_gemma":[0.048224237,0.0032026798,0.07285414,0.0051979376,0.00808938,0.31840602,0.0009731333,0.00006147422,0.03267308,0.0013200146,0.5086103,0.00038762734],"about_ca_topic_score_codex":0.0004251931,"about_ca_topic_score_gemma":0.00008770742,"teacher_disagreement_score":0.40565246,"about_ca_system_score_codex":0.00051531405,"about_ca_system_score_gemma":0.0010226553,"threshold_uncertainty_score":0.9997822},"labels":[],"label_agreement":null},{"id":"W2921063124","doi":"10.1111/bjh.15865","title":"Expression and function of phosphoinositide 3‐kinase delta in mesenchymal stromal cells from normal and leukaemic bone marrow","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Leukemia and Lymphoma Society of Canada; CancerCare Manitoba Foundation; Research Manitoba","keywords":"Idelalisib; Mesenchymal stem cell; Bone marrow; Stromal cell; PI3K/AKT/mTOR pathway; Haematopoiesis; Cancer research; Chronic lymphocytic leukemia; Phosphoinositide 3-kinase; Medicine; Biology; Immunology; Pathology; Leukemia; Stem cell; Cell biology; Signal transduction; Ibrutinib","score_opus":0.007748141663317778,"score_gpt":0.23961043869336562,"score_spread":0.23186229703004785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921063124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893028,0.009996977,0.000061761464,0.00008513911,0.00019035321,0.00019809032,0.000017969462,0.0000049332725,0.00014197647],"genre_scores_gemma":[0.9978918,0.0009643232,0.00092980865,0.00006069701,0.000060912775,0.0000020309203,0.000009544369,0.000017252292,0.00006366849],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99836487,0.0001273448,0.00065340684,0.000217771,0.00034161258,0.00029500466],"domain_scores_gemma":[0.99899477,0.0002454285,0.00029477465,0.00014273742,0.00014024517,0.00018203747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039142912,0.000121813275,0.0007452882,0.000192676,0.000027628532,0.000019001991,0.000082847815,0.00018118536,0.00025200573],"category_scores_gemma":[0.00012411825,0.00012567065,0.000069163405,0.000101433616,0.00017875106,0.00020483986,0.000116876596,0.00043312125,0.000005280304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061044665,0.00040226727,0.090130776,0.0009479202,0.00017344819,0.07820905,0.00041578786,0.000042862957,0.80243504,0.00008897213,0.0032361583,0.017813224],"study_design_scores_gemma":[0.066397674,0.0024974484,0.10782899,0.0048886403,0.00024037201,0.4403512,0.0011541316,0.0029685793,0.3723516,0.0005435081,0.00040697548,0.00037089366],"about_ca_topic_score_codex":0.0015901346,"about_ca_topic_score_gemma":0.00018640356,"teacher_disagreement_score":0.43008348,"about_ca_system_score_codex":0.00045953476,"about_ca_system_score_gemma":0.00095173845,"threshold_uncertainty_score":0.51247},"labels":[],"label_agreement":null},{"id":"W2921129431","doi":"10.1111/bjh.15839","title":"<scp>UK</scp> results from the myeloproliferative neoplasms (<scp>MPN</scp>) landmark survey on the symptom, emotional and economic burden of <scp>MPN</scp>","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; Cancer Research UK","keywords":"Presenteeism; Medicine; Absenteeism; Disease burden; Quality of life (healthcare); Productivity; Burden of disease; Disease; Demography; Gerontology; Physical therapy; Family medicine; Internal medicine; Psychology","score_opus":0.02177184820432684,"score_gpt":0.2481609981325034,"score_spread":0.22638914992817655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921129431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9183061,0.0068320846,0.000024155457,0.06265788,0.0018543169,0.0017151693,0.0058216667,0.000032497162,0.0027561423],"genre_scores_gemma":[0.7898784,0.023574581,0.00078748335,0.15470563,0.012940503,0.00027826475,0.006431256,0.0005729224,0.010830932],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99130034,0.0023772037,0.002740515,0.0012262173,0.0012051809,0.0011505684],"domain_scores_gemma":[0.95451814,0.039996352,0.003205266,0.0009426615,0.0010142061,0.00032338712],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002322631,0.0011329774,0.0037135063,0.00041350396,0.0004700064,0.00033163076,0.0009738298,0.0015400527,0.00011571059],"category_scores_gemma":[0.008683732,0.0007905158,0.000797613,0.0002527875,0.0008616824,0.00020460646,0.00030655786,0.004028109,0.00023280374],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108156884,0.0002435196,0.048160937,0.00014093594,0.0032982987,0.010047325,0.0014166101,0.00011244937,0.000014369107,0.00020961823,0.9359962,0.0002516265],"study_design_scores_gemma":[0.01762529,0.0035329151,0.43113053,0.0068909135,0.002104006,0.098725766,0.0016841377,0.0002587216,0.001883273,0.0015401035,0.43428743,0.0003369076],"about_ca_topic_score_codex":0.002139123,"about_ca_topic_score_gemma":0.0011935568,"teacher_disagreement_score":0.50170875,"about_ca_system_score_codex":0.00031660628,"about_ca_system_score_gemma":0.0012248607,"threshold_uncertainty_score":0.99975616},"labels":[],"label_agreement":null},{"id":"W2921300961","doi":"10.1111/bjh.15825","title":"Headache: an important symptom possibly linked to white matter lesions in thalassaemia","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council","keywords":"Headaches; Medicine; Magnetic resonance imaging; Internal medicine; White matter; Hyperintensity; Thalassemia; Pediatrics; Surgery; Radiology","score_opus":0.008028939191389672,"score_gpt":0.26102565662082805,"score_spread":0.25299671742943836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921300961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888931,0.0019455313,0.000025636833,0.0062875086,0.0003887123,0.0002960018,0.0000056629337,0.000014502245,0.0021433556],"genre_scores_gemma":[0.995312,0.00041730748,0.0008142414,0.0027108446,0.000060840546,0.000003122597,0.0000074422987,0.000031999916,0.0006422199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980854,0.00011232435,0.0009366197,0.00021945282,0.00024274582,0.0004034895],"domain_scores_gemma":[0.9989759,0.000041722058,0.00025775318,0.00021085583,0.00016275127,0.0003510173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004154658,0.00014639433,0.00079447613,0.00031081645,0.000042705684,0.000032609856,0.00017117689,0.0003023094,0.0008905812],"category_scores_gemma":[0.000085455984,0.00013900019,0.00015273609,0.00027212035,0.00005669817,0.00014516685,0.000044351505,0.00074233185,0.00018967537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026896264,0.00046983606,0.9288347,0.0001272339,0.00008942982,0.049954757,0.0005325882,0.000049802708,0.0013970884,0.000110630775,0.014421374,0.0037436273],"study_design_scores_gemma":[0.0030367316,0.00075869326,0.6258677,0.0012826149,0.00007064468,0.36499193,0.0010937086,0.00007347961,0.00007381465,0.0002487342,0.002304363,0.00019756993],"about_ca_topic_score_codex":0.00012519649,"about_ca_topic_score_gemma":0.0001454132,"teacher_disagreement_score":0.3150372,"about_ca_system_score_codex":0.000059522627,"about_ca_system_score_gemma":0.0002387756,"threshold_uncertainty_score":0.975124},"labels":[],"label_agreement":null},{"id":"W2921370113","doi":"10.1111/bjh.15846","title":"Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Case fatality rate; Serotype; Pediatrics; Pneumococcal conjugate vaccine; Meningitis; Pneumococcal disease; Streptococcus pneumoniae; Conjugate vaccine; Disease; Respiratory tract infections; Confidence interval; Internal medicine; Immunology; Immunization; Antibiotics; Epidemiology; Respiratory system; Antibody","score_opus":0.006269978456085123,"score_gpt":0.2448178869222165,"score_spread":0.2385479084661314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921370113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06768777,0.9278448,8.3613565e-7,0.00021653665,0.00008080418,0.0039163297,0.00022815859,0.0000020184364,0.000022701695],"genre_scores_gemma":[0.0471551,0.952518,0.000010658683,0.00016075574,0.000021734795,0.00004320933,0.000039371243,0.0000358538,0.000015336245],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99430406,0.001949746,0.0027660227,0.00024311303,0.00047453024,0.00026252464],"domain_scores_gemma":[0.9941573,0.0005311083,0.0041361414,0.0006270516,0.0003900922,0.00015827446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010401648,0.00036020033,0.0054801367,0.00021876473,0.000027796632,0.0000131807055,0.00065214944,0.00026237813,0.000019478077],"category_scores_gemma":[0.0016408992,0.00018079791,0.0010704384,0.0008104148,0.00020687564,0.00007079098,0.00008149658,0.0017521472,0.0000021314036],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011290763,0.00054758723,0.008854241,0.9837653,0.0005483341,0.0045812344,0.0001905182,0.0000080773725,2.5883804e-7,0.000022923143,0.00014638389,0.0012222488],"study_design_scores_gemma":[0.0016710282,0.00020848402,0.0036236607,0.9523209,0.010513896,0.031160265,0.000101629266,0.0000018189867,7.4763125e-7,0.00003430898,0.00020567249,0.00015763236],"about_ca_topic_score_codex":0.00007683838,"about_ca_topic_score_gemma":0.000028724793,"teacher_disagreement_score":0.03144443,"about_ca_system_score_codex":0.000039853894,"about_ca_system_score_gemma":0.0013943327,"threshold_uncertainty_score":0.76123047},"labels":[],"label_agreement":null},{"id":"W2921403167","doi":"10.1111/bjh.15827","title":"Genomic data in prognostic models—what is lost in translation? The case of deletion 17p and mutant<i>TP53</i>in chronic lymphocytic leukaemia","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Copy-number variation; Chronic lymphocytic leukemia; Genomics; Mutation; Cytogenetics; Clinical significance; Bioinformatics; Medicine; Biology; Oncology; Chromosome; Computational biology; Internal medicine; Genetics; Leukemia; Gene; Genome","score_opus":0.09968734266479744,"score_gpt":0.3740238798445964,"score_spread":0.27433653717979894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921403167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14449234,0.85346,0.000040702704,0.000101594094,0.00014356572,0.0016549117,0.000067411216,0.000003085536,0.000036378115],"genre_scores_gemma":[0.0953211,0.90426177,0.000118745396,0.000048805952,0.000081899285,0.000021540622,0.0000664739,0.000065303124,0.000014371158],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99515694,0.0007459117,0.0024972036,0.00058793114,0.00040245467,0.00060954504],"domain_scores_gemma":[0.9965957,0.0014044751,0.0009288431,0.00078564725,0.00014808994,0.00013727893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021235596,0.0003679114,0.0033938312,0.0008361835,0.000033441585,0.00007266549,0.0007143468,0.00058257516,0.00006277456],"category_scores_gemma":[0.00032028527,0.0003179349,0.00023833883,0.00065372617,0.00037317106,0.00050302217,0.0002681982,0.0013215898,0.000015745863],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0001446256,0.000111714166,0.000042622527,0.034327924,0.0001969927,0.27690282,0.00033090025,0.00024817407,0.0000038202343,0.000042851243,0.00009705049,0.6875505],"study_design_scores_gemma":[0.012176086,0.00020959588,0.000014919533,0.06313621,0.00074499426,0.8751987,0.00019300672,0.041831493,0.000002693434,0.00019074086,0.006066529,0.00023500354],"about_ca_topic_score_codex":0.0030190437,"about_ca_topic_score_gemma":0.0064591267,"teacher_disagreement_score":0.6873155,"about_ca_system_score_codex":0.01695847,"about_ca_system_score_gemma":0.034849294,"threshold_uncertainty_score":0.9999273},"labels":[],"label_agreement":null},{"id":"W2921964142","doi":"10.1111/bjh.15859","title":"Comparison of the NCCN‐IPI, the IPI and PIT scores as prognostic tools in peripheral T‐cell lymphomas","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Hematology; Internal medicine; Medicine; Oncology; Hematology analyzer; Medical physics","score_opus":0.025382776882994854,"score_gpt":0.29401247669001146,"score_spread":0.2686296998070166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921964142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85489494,0.027465459,0.0000011142195,0.11536755,0.0005900563,0.0007526639,0.000025012583,0.000005053509,0.00089814176],"genre_scores_gemma":[0.94751674,0.0011557661,0.00008263863,0.050187957,0.00048321512,0.00002886283,0.000019505456,0.000041486306,0.00048385118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739116,0.00036240445,0.0010895872,0.00026590595,0.00050592684,0.0003850248],"domain_scores_gemma":[0.99745667,0.00089547416,0.0010517752,0.00033105596,0.00020523394,0.0000597633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026202304,0.00028945855,0.001702826,0.00012382632,0.00008369424,0.00008752224,0.00037368824,0.0005027125,0.00013618683],"category_scores_gemma":[0.00034327718,0.00018086577,0.000352752,0.00013029556,0.00039273233,0.00008001505,0.00013061483,0.0010386279,0.000011599741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012498879,0.0005907533,0.5590387,0.0006652299,0.00033234578,0.035480488,0.0004682571,0.0000063601706,0.000016282675,0.00003988011,0.39953926,0.0036974102],"study_design_scores_gemma":[0.008963801,0.0013945443,0.43919313,0.0062310547,0.001168215,0.43758228,0.00035390438,0.000039744908,0.0008329369,0.00032420078,0.103577495,0.00033868974],"about_ca_topic_score_codex":0.000380752,"about_ca_topic_score_gemma":0.000115338524,"teacher_disagreement_score":0.40210178,"about_ca_system_score_codex":0.00018870896,"about_ca_system_score_gemma":0.0007329311,"threshold_uncertainty_score":0.7375492},"labels":[],"label_agreement":null},{"id":"W2922836953","doi":"10.1111/bjh.15866","title":"Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Leukemia and Lymphoma Society","keywords":"Medicine; Incidence (geometry); Cumulative incidence; Transplantation; Thrombosis; Bone marrow transplant; Venous thrombosis; Surgery; Internal medicine; Pediatrics; Intensive care medicine; Bone marrow transplantation","score_opus":0.025093660341219015,"score_gpt":0.26659780407166417,"score_spread":0.24150414373044515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922836953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95164704,0.0025060114,0.000028292443,0.040246796,0.0016448573,0.0028603643,0.00060599647,0.000059892434,0.0004007377],"genre_scores_gemma":[0.93204343,0.008732055,0.00021653798,0.054763734,0.0021536571,0.00016199022,0.00063783536,0.000328012,0.00096276077],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99148095,0.001315739,0.0030370133,0.0011778844,0.0017031175,0.0012853069],"domain_scores_gemma":[0.99473715,0.0013511718,0.0020132463,0.0012805484,0.00038783136,0.00023007047],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021781607,0.000987463,0.006380675,0.00040409583,0.0002116409,0.00018262395,0.0011484284,0.0010478095,0.000914695],"category_scores_gemma":[0.00019814754,0.00064991973,0.00060301245,0.0004895376,0.00035958423,0.00021574569,0.0001010974,0.004175353,0.000021924412],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009413673,0.0055877618,0.12908703,0.0010303592,0.008144985,0.78196555,0.0013843689,0.000016689455,0.000018732437,0.000005089961,0.071629584,0.00018846645],"study_design_scores_gemma":[0.01185591,0.004923758,0.3469989,0.0071639284,0.019946942,0.5911164,0.0010003613,0.0000049530304,0.00007158882,0.000053216092,0.015810248,0.0010537839],"about_ca_topic_score_codex":0.029099308,"about_ca_topic_score_gemma":0.098651655,"teacher_disagreement_score":0.21791187,"about_ca_system_score_codex":0.0000876188,"about_ca_system_score_gemma":0.0010531811,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W2936779111","doi":"10.1111/bjh.15919","title":"Bortezomib reinduction chemotherapy in high‐risk <scp>ALL</scp> in first relapse: a report from the Children's Oncology Group","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hyundai Hope On Wheels; Hospital for Sick Children; NIH Clinical Center; National Cancer Institute; National Institutes of Health; St. Baldrick's Foundation; Children's Hospital of Philadelphia; New York University","keywords":"Bortezomib; Medicine; Internal medicine; Chemotherapy; Oncology; Minimal residual disease; Proteasome inhibitor; Induction chemotherapy; Multiple myeloma; Bone marrow","score_opus":0.008315574203433823,"score_gpt":0.26377815723717574,"score_spread":0.2554625830337419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936779111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066514,0.0020912483,0.00015395421,0.005227833,0.00072310114,0.0006358872,0.000012851501,0.00001768245,0.0004723338],"genre_scores_gemma":[0.99234056,0.004259508,0.0015934063,0.0009319529,0.0004635899,0.00001852069,0.000048758353,0.00005355626,0.00029017232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965656,0.00049436354,0.0013874386,0.000425214,0.0005498281,0.00057757064],"domain_scores_gemma":[0.99671435,0.0015075231,0.00096559414,0.00043554534,0.00020135895,0.0001755997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018012469,0.0002080331,0.0012129422,0.0003147171,0.000064695356,0.00003572986,0.00040391728,0.0005277481,0.00016621027],"category_scores_gemma":[0.0023921558,0.00018008731,0.00018279583,0.00043466818,0.00023656491,0.00019963084,0.00010132115,0.0018936555,0.000054467433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007656471,0.0008985562,0.70372325,0.000052580293,0.00056644756,0.21787256,0.0009914582,0.000070491995,0.00057222776,0.00014738772,0.05706874,0.017270658],"study_design_scores_gemma":[0.012211049,0.00064706214,0.50175494,0.0005050413,0.0000763551,0.4717425,0.00036309243,0.000101509875,0.00017340192,0.00080855965,0.011546974,0.00006949425],"about_ca_topic_score_codex":0.009440081,"about_ca_topic_score_gemma":0.0032841607,"teacher_disagreement_score":0.25386995,"about_ca_system_score_codex":0.00097642536,"about_ca_system_score_gemma":0.0008105002,"threshold_uncertainty_score":0.99715614},"labels":[],"label_agreement":null},{"id":"W2946051233","doi":"10.1111/bjh.15954","title":"Next generation sequencing redefines a triple negative essential thrombocythaemia as double‐positive with rare mutations on <i><scp>JAK</scp>2 </i>V617 and <i><scp>MPL</scp></i> W515 hotspots","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Institut National Du Cancer","keywords":"Medicine; Genetics; Biology","score_opus":0.03528295247028962,"score_gpt":0.2704517237881554,"score_spread":0.2351687713178658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946051233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95798737,0.0052890866,0.0001712701,0.02996541,0.001132148,0.002086862,0.00039816785,0.000055028362,0.0029146792],"genre_scores_gemma":[0.78412634,0.007890648,0.0051236902,0.18775952,0.0072320085,0.00050588715,0.0026377044,0.00048768392,0.0042365305],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99512976,0.00054427324,0.0014173018,0.0009975197,0.001052746,0.0008583731],"domain_scores_gemma":[0.9938714,0.002068312,0.0019367143,0.0003984676,0.0014242514,0.000300854],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003406948,0.0008901497,0.0028231165,0.0006389649,0.0004925485,0.00044588544,0.00025209447,0.0011358161,0.000050894003],"category_scores_gemma":[0.0008764793,0.0008043615,0.00043263065,0.00042221643,0.000477351,0.00051901233,0.000087599736,0.0026891206,0.00006601288],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000273735,0.00046220253,0.0023955866,0.00067156064,0.0031804787,0.19729987,0.0025310505,0.00010367228,0.0018978937,0.0002836985,0.7899618,0.0009384447],"study_design_scores_gemma":[0.027046345,0.007180839,0.005174893,0.009531446,0.0045540747,0.84964824,0.0023443794,0.00015014263,0.059305552,0.0006321919,0.033868525,0.0005633701],"about_ca_topic_score_codex":0.0006023378,"about_ca_topic_score_gemma":0.0004912577,"teacher_disagreement_score":0.75609326,"about_ca_system_score_codex":0.0003756931,"about_ca_system_score_gemma":0.0014261442,"threshold_uncertainty_score":0.99961174},"labels":[],"label_agreement":null},{"id":"W2946281117","doi":"10.1111/bjh.15990","title":"Longitudinal sequencing of <i><scp>RUNX</scp>1</i> familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Ontario Institute for Cancer Research; Fundação de Amparo à Pesquisa do Estado de São Paulo; Southeastern Ontario Academic Medical Organization; European Hematology Association","keywords":"Transformation (genetics); Myeloid; Cancer research; Genetics; Immunology; Medicine; Gene; Biology","score_opus":0.03612463633027961,"score_gpt":0.3049050492315919,"score_spread":0.26878041290131227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946281117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0724735,0.9087917,0.016397072,0.00008960719,0.0004964374,0.0015144079,0.000045570036,0.000017088569,0.00017456726],"genre_scores_gemma":[0.0073744874,0.9844884,0.0074826768,0.000085152875,0.00021187669,0.000020832582,0.00005843703,0.000108533044,0.0001695656],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99419194,0.00040255254,0.0032499365,0.0004395181,0.001063956,0.000652066],"domain_scores_gemma":[0.9957371,0.0005486767,0.0019592198,0.0004273987,0.0008635783,0.00046404396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067926326,0.0005397547,0.0056213867,0.0011913143,0.000080483216,0.000035100296,0.0007645127,0.0007962009,0.000042376567],"category_scores_gemma":[0.0007941456,0.00051240285,0.001022862,0.000786983,0.00021985118,0.00025295312,0.00016351069,0.0013028979,0.00004448444],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013099799,0.00018809641,0.000021507967,0.067301,0.0013731914,0.017735444,0.0022036952,0.000082279505,0.0012290562,0.00081669685,0.0038380905,0.90507996],"study_design_scores_gemma":[0.005018125,0.003326736,0.00010035049,0.08066278,0.0031717648,0.51459897,0.0012595606,0.00005474947,0.0045569306,0.0017262973,0.38503516,0.00048858876],"about_ca_topic_score_codex":0.0006337415,"about_ca_topic_score_gemma":0.00022458835,"teacher_disagreement_score":0.9045914,"about_ca_system_score_codex":0.0005336185,"about_ca_system_score_gemma":0.0046096523,"threshold_uncertainty_score":0.99973273},"labels":[],"label_agreement":null},{"id":"W2947003039","doi":"10.1111/bjh.15994","title":"Large deletions of the 5′ region of <i><scp>IKZF</scp>1</i> lead to haploinsufficiency in B‐cell precursor acute lymphoblastic leukaemia","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Ligue Contre le Cancer; Institute of Cancer Research; Université de Strasbourg; Agence Nationale de la Recherche","keywords":"Multiplex ligation-dependent probe amplification; Exon; Haploinsufficiency; Breakpoint; Biology; Genetics; Molecular biology; Locus (genetics); Gene; Chromosomal translocation; Phenotype","score_opus":0.01334823704894283,"score_gpt":0.2596701559756887,"score_spread":0.24632191892674588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947003039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92364603,0.004154281,0.0038006094,0.06181187,0.0017650479,0.0017826984,0.00031208707,0.000024031637,0.0027033647],"genre_scores_gemma":[0.8565286,0.0026781114,0.0016978454,0.12664835,0.0016377359,0.000068989975,0.00009760251,0.00035991299,0.010282896],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99407554,0.0005868304,0.0022459733,0.00053897104,0.0014530959,0.0010995674],"domain_scores_gemma":[0.9940421,0.0018224169,0.0019502266,0.000803959,0.0011992782,0.0001819911],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00066261,0.00045053088,0.0025483463,0.0010129155,0.0000811404,0.000029397537,0.0013583833,0.0013055215,0.000035517864],"category_scores_gemma":[0.0028060006,0.00039581832,0.0007278341,0.0010456099,0.0005274255,0.00013058267,0.0004335355,0.0029832448,0.00006351848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014110586,0.0005598473,0.0009418676,0.0017472777,0.00028069527,0.054549545,0.00048494196,0.000060222268,0.0018139741,0.000038564205,0.93917745,0.0002045269],"study_design_scores_gemma":[0.01397752,0.0028259736,0.0021312456,0.0140228765,0.0014997469,0.75096166,0.0004907622,0.0004062786,0.008567933,0.0003122679,0.20440146,0.00040223793],"about_ca_topic_score_codex":0.0001459486,"about_ca_topic_score_gemma":0.00008264366,"teacher_disagreement_score":0.73477596,"about_ca_system_score_codex":0.0008249113,"about_ca_system_score_gemma":0.0038527483,"threshold_uncertainty_score":0.999991},"labels":[],"label_agreement":null},{"id":"W2947079603","doi":"10.1111/bjh.15970","title":"Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (<scp>GVHD</scp>) in the absence of <scp>GVHD</scp> prophylaxis","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Fonds de Recherche du Québec - Santé; Kiadis Pharma; George Washington University","keywords":"Immunosuppression; Medicine; Graft-versus-host disease; Immunology; Stem cell; Transplantation; Hematopoietic stem cell transplantation; Haematopoiesis; Donor lymphocyte infusion; Immunotherapy; Internal medicine; Immune system; Biology","score_opus":0.00918680580712249,"score_gpt":0.24160085263505504,"score_spread":0.23241404682793254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947079603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908826,0.0038819963,0.0016169056,0.00017054785,0.00070897874,0.0014412801,0.00010452275,0.000038278806,0.0011549336],"genre_scores_gemma":[0.9954095,0.0025121202,0.00093281333,0.00028468078,0.000061940205,0.000056973808,0.00004432202,0.00009477663,0.00060288474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99482137,0.00082127587,0.001848428,0.00053691224,0.0012223436,0.00074965565],"domain_scores_gemma":[0.9960691,0.0016754507,0.0009140156,0.00053700805,0.00045458326,0.00034987563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011140567,0.00046976315,0.0014975078,0.00041531544,0.00009139223,0.00009801038,0.00059721625,0.00040039903,0.0001606583],"category_scores_gemma":[0.00013859181,0.00041736482,0.00049767975,0.00050136773,0.0003402013,0.0004011565,0.000030269344,0.0010165004,0.00010404144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007275034,0.0059923315,0.51739734,0.024997018,0.00213392,0.29374722,0.048978087,0.0003059138,0.08996443,0.0005579436,0.0020948548,0.006555902],"study_design_scores_gemma":[0.037285328,0.003297058,0.6599882,0.0041068047,0.002296433,0.23710395,0.009811481,0.00046876294,0.044113696,0.00043848978,0.0006002039,0.0004895602],"about_ca_topic_score_codex":0.00008542471,"about_ca_topic_score_gemma":0.00007801278,"teacher_disagreement_score":0.14259088,"about_ca_system_score_codex":0.00010316273,"about_ca_system_score_gemma":0.0004261004,"threshold_uncertainty_score":0.9998278},"labels":[],"label_agreement":null},{"id":"W2947314253","doi":"10.1111/bjh.15996","title":"The effects of hydroxycarbamide on the plasma proteome of children with sickle cell anaemia","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"King's College London; Stroke Association","keywords":"Haptoglobin; Blood proteins; Protein S; Medicine; Internal medicine; Endocrinology; Immunology; Protein C","score_opus":0.0021332309815199285,"score_gpt":0.18401204221340262,"score_spread":0.18187881123188268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947314253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931228,0.0034110595,0.0000062188938,0.00088186556,0.0001576629,0.00064773706,0.0000024549895,0.000004802076,0.0017653893],"genre_scores_gemma":[0.99858063,0.0009925362,0.000061100705,0.00013058234,0.000023814404,0.000004021299,9.785132e-7,0.000017763392,0.00018859006],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988016,0.0001362301,0.00045846173,0.00010049821,0.00029111988,0.00021212107],"domain_scores_gemma":[0.9986219,0.00039795385,0.0005568802,0.00020667064,0.00015136648,0.00006522649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031898773,0.00010703142,0.0005559643,0.0000643081,0.000065273096,0.000008472908,0.00020378511,0.0001252443,0.000026804028],"category_scores_gemma":[0.00021452666,0.000057179983,0.00014105879,0.00015177365,0.0002764387,0.000031296822,0.000027036336,0.0005179458,0.000008713084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015053635,0.0077057057,0.5735239,0.0103138825,0.011096294,0.057522308,0.005192883,0.0015087577,0.1454849,0.010098136,0.06469949,0.09780012],"study_design_scores_gemma":[0.025083618,0.019509742,0.132637,0.010707486,0.0012568141,0.38736936,0.0018029817,0.00026059922,0.41790622,0.0009408138,0.001972869,0.0005524872],"about_ca_topic_score_codex":0.00006509184,"about_ca_topic_score_gemma":0.000014049465,"teacher_disagreement_score":0.44088688,"about_ca_system_score_codex":0.000014429119,"about_ca_system_score_gemma":0.00013434482,"threshold_uncertainty_score":0.2331732},"labels":[],"label_agreement":null},{"id":"W2947829757","doi":"10.1111/bjh.15963","title":"Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ontario Institute for Regenerative Medicine; Ege Üniversitesi","keywords":"Glutathione; Medicine; Confidence interval; Red blood cell; Gastroenterology; Adverse effect; Crossover study; Internal medicine; Immunology; Pharmacology; Surgery; Biology; Pathology; Biochemistry; Placebo; Enzyme","score_opus":0.006364015243809111,"score_gpt":0.22784146049325704,"score_spread":0.22147744524944793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947829757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98476565,0.010494896,0.000295818,0.0016010295,0.0009377734,0.0007113679,0.000043730146,0.000025589396,0.0011241612],"genre_scores_gemma":[0.992483,0.0050241644,0.0012960386,0.0003757761,0.00011838348,0.000008289588,0.000034671404,0.000042714477,0.0006169241],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9980135,0.00009999696,0.00088659563,0.0002573248,0.00029497597,0.00044760594],"domain_scores_gemma":[0.99863666,0.0001296125,0.00040111618,0.00015806593,0.00042006612,0.00025446343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039933165,0.00018799186,0.00091578875,0.000118606775,0.000093182534,0.000030322,0.00015775215,0.00036534062,0.0003849038],"category_scores_gemma":[0.0001370307,0.00017991588,0.00037157678,0.00013334444,0.00009216676,0.00009598326,0.000021222464,0.0005423593,0.000020389984],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024727532,0.0033303099,0.010206646,0.0021234439,0.0012218932,0.09090443,0.0012452807,0.00022843506,0.85942566,0.00053002744,0.012991923,0.01531917],"study_design_scores_gemma":[0.03885984,0.0035582047,0.0021286842,0.00197318,0.0017533165,0.84077233,0.003822014,0.0003397524,0.09601683,0.0008218428,0.009316215,0.00063781143],"about_ca_topic_score_codex":0.000024563044,"about_ca_topic_score_gemma":0.000010040991,"teacher_disagreement_score":0.76340884,"about_ca_system_score_codex":0.000032489992,"about_ca_system_score_gemma":0.0002920561,"threshold_uncertainty_score":0.73367566},"labels":[],"label_agreement":null},{"id":"W2947924227","doi":"10.1111/bjh.15965","title":"Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Key (lock); Element (criminal law); Precision medicine; Medicine; Data science; Computer science; Computational biology; Intensive care medicine; Biology; Pathology; Political science; Computer security; Law","score_opus":0.10610159408223732,"score_gpt":0.4056930360424656,"score_spread":0.29959144196022824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947924227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003105065,0.9933547,0.00002812713,0.0005522092,0.0005600757,0.0018810591,0.00019856205,0.00000812338,0.00031207537],"genre_scores_gemma":[0.0004495008,0.9967139,0.0014276346,0.00018951859,0.00031434177,0.00007448397,0.00037220266,0.000057020905,0.0004014036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960056,0.000266373,0.0022614447,0.0005808081,0.0004448203,0.00044094483],"domain_scores_gemma":[0.99626726,0.0009938583,0.0016887322,0.00057555875,0.00023398038,0.00024060826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014716794,0.00039766158,0.0054084095,0.00063627545,0.00005130197,0.00004499709,0.0004553202,0.00024279012,0.00011303316],"category_scores_gemma":[0.0007145967,0.0003118055,0.00034643747,0.00025498483,0.0001675282,0.00013471827,0.00026530304,0.00024527297,0.000017882272],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016963664,0.000489545,0.000560663,0.011389063,0.00079555035,0.030742873,0.000049231876,9.218964e-8,8.497761e-7,0.00032649926,0.01860547,0.9368705],"study_design_scores_gemma":[0.0054855007,0.0010202166,0.0003045752,0.08056799,0.003112329,0.27351174,0.000040944262,0.0000034939858,0.0000022763925,0.00018799082,0.6355691,0.00019381865],"about_ca_topic_score_codex":0.0008990129,"about_ca_topic_score_gemma":0.0007851492,"teacher_disagreement_score":0.9366767,"about_ca_system_score_codex":0.00039587464,"about_ca_system_score_gemma":0.001328249,"threshold_uncertainty_score":0.9999334},"labels":[],"label_agreement":null},{"id":"W2949084717","doi":"10.1111/bjh.16014","title":"Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Lymphoma; Hodgkin lymphoma; Oncology; Internal medicine; Pediatric oncology; Pediatrics; Cancer","score_opus":0.010637086228555123,"score_gpt":0.25825139555063376,"score_spread":0.24761430932207862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949084717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97499746,0.017823365,0.0001427229,0.004184598,0.00035170847,0.0022361318,0.00022361903,0.000018051662,0.000022315398],"genre_scores_gemma":[0.98392355,0.012844882,0.002043843,0.0005644271,0.0002462405,0.00017867729,0.000096548145,0.00004860115,0.000053227668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972926,0.00059008435,0.0009949562,0.00037258473,0.00037427395,0.0003755505],"domain_scores_gemma":[0.9936756,0.0037847743,0.0015116014,0.00060350116,0.00028547965,0.00013903664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006818473,0.00030435002,0.0014254373,0.00009189829,0.00019322585,0.00003709018,0.00029901322,0.00021232695,0.00012794383],"category_scores_gemma":[0.0002650065,0.00016082573,0.0004963958,0.00015488591,0.0002721332,0.00007365618,0.000025806517,0.00014159564,0.000007359442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01573894,0.0044511235,0.7268975,0.0000045459824,0.0057913116,0.0153418565,0.00062162516,0.000022191696,0.00007611839,0.00007518295,0.003244645,0.22773498],"study_design_scores_gemma":[0.036472186,0.011718609,0.7598177,0.00016680123,0.0010206858,0.1829293,0.00015650284,0.000008007757,0.0010139197,0.00010359431,0.0064669317,0.00012574397],"about_ca_topic_score_codex":0.008697747,"about_ca_topic_score_gemma":0.0010708071,"teacher_disagreement_score":0.22760925,"about_ca_system_score_codex":0.0003674177,"about_ca_system_score_gemma":0.00073184504,"threshold_uncertainty_score":0.9979034},"labels":[],"label_agreement":null},{"id":"W2949223966","doi":"10.1111/bjh.16063","title":"Hydroxycarbamide treatment in children with Sickle Cell Anaemia is associated with more intact white matter integrity: a quantitative MRI study","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hydroxycarbamide; Medicine; White matter; Internal medicine; White blood cell; Cerebral blood flow; Gastroenterology; Cardiology; Magnetic resonance imaging; Radiology","score_opus":0.006736400016567123,"score_gpt":0.2464130421419799,"score_spread":0.2396766421254128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949223966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958805,0.0011692645,0.000017346953,0.0012085687,0.00006526795,0.00086971483,0.000015203413,0.000014193469,0.0007599746],"genre_scores_gemma":[0.99851245,0.00022249091,0.00030557014,0.00048551627,0.000012164061,0.000009892809,0.000015948894,0.000041196807,0.00039475076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982718,0.00019727468,0.00057592854,0.00028516972,0.00030482037,0.00036499096],"domain_scores_gemma":[0.9989488,0.00008140575,0.000446253,0.00017761321,0.0002050249,0.00014089857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023580914,0.0002423085,0.0011460987,0.00025689602,0.00004620112,0.000031536667,0.00012098067,0.00019433648,0.00026191684],"category_scores_gemma":[0.000033702763,0.00017526966,0.000114517876,0.00034343728,0.00012213537,0.00013375154,0.000025586087,0.0008227253,0.00003924092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005948991,0.0019347824,0.9713934,0.00002522584,0.0009882823,0.020393932,0.0033409537,0.000082344464,0.000016227468,0.000003126265,0.0009680483,0.00025877001],"study_design_scores_gemma":[0.016343687,0.009113263,0.8698483,0.0011556098,0.0005727771,0.090423666,0.011994115,0.00009611218,0.00012942062,0.00001818691,0.000042670483,0.00026220063],"about_ca_topic_score_codex":0.001063008,"about_ca_topic_score_gemma":0.0009453642,"teacher_disagreement_score":0.10154512,"about_ca_system_score_codex":0.00019626251,"about_ca_system_score_gemma":0.0002632921,"threshold_uncertainty_score":0.7147289},"labels":[],"label_agreement":null},{"id":"W2949605560","doi":"10.1111/bjh.16065","title":"EBV‐associated hydroa vacciniforme‐like T‐cell lymphoma","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Université de Montréal","funders":"","keywords":"Medicine; Vincristine; CHOP; CD30; Rituximab; Internal medicine; Pathology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.0059180207982115615,"score_gpt":0.22864097923278534,"score_spread":0.2227229584345738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949605560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97892565,0.0061630122,0.000019076237,0.00073218596,0.00089571084,0.0001966812,0.000009995635,0.000032197273,0.013025489],"genre_scores_gemma":[0.9948529,0.0012488414,0.00011896238,0.0014258142,0.00007524649,0.0000025050676,0.000014110861,0.000037989877,0.002223617],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99814,0.00009663866,0.0007345051,0.00019516582,0.00036052347,0.0004732142],"domain_scores_gemma":[0.99854857,0.00007656657,0.00069403206,0.00015313941,0.0003118594,0.0002158453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037366984,0.00016613503,0.0009822113,0.00016351992,0.00007741414,0.000037542,0.0001866681,0.00029490617,0.00077503436],"category_scores_gemma":[0.00018139379,0.00017821677,0.0003444889,0.00022791696,0.000049136685,0.000166565,0.000038219965,0.00034087026,0.0001849854],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021646174,0.005699826,0.3048397,0.0008507284,0.0023872785,0.12290218,0.0010873394,0.00009810177,0.004284952,0.00049223,0.49557188,0.05962115],"study_design_scores_gemma":[0.115778,0.0054488783,0.1927319,0.0028415944,0.0014767022,0.596311,0.0039067855,0.0005802652,0.0029942489,0.003959398,0.07249204,0.0014792096],"about_ca_topic_score_codex":0.00015520421,"about_ca_topic_score_gemma":0.000105885025,"teacher_disagreement_score":0.4734088,"about_ca_system_score_codex":0.00020058265,"about_ca_system_score_gemma":0.00041796465,"threshold_uncertainty_score":0.8486083},"labels":[],"label_agreement":null},{"id":"W2956596030","doi":"10.1111/bjh.16099","title":"Langerhans cell histiocytosis: progress and controversies","year":2019,"lang":"en","type":"editorial","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Langerhans cell histiocytosis; Histiocytosis; Medicine; Pathology; Disease","score_opus":0.0038619294494136886,"score_gpt":0.24047414007037163,"score_spread":0.23661221062095794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956596030","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0662041,0.16048653,0.000028741071,0.0007668863,0.7667113,0.0006389932,0.00032019205,0.000032154716,0.0048111062],"genre_scores_gemma":[0.19383608,0.043188244,0.0024037834,0.0006638639,0.7360369,0.000054516746,0.0007290142,0.00033606178,0.022751542],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848086,0.00006560303,0.00053128676,0.00022160352,0.00043896068,0.0002616936],"domain_scores_gemma":[0.99817586,0.00044418548,0.00063400617,0.00013526191,0.00045268858,0.00015799001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016478616,0.00021210001,0.0014032332,0.0001555179,0.00005957224,0.00005079374,0.000118590804,0.00058366114,0.00008275689],"category_scores_gemma":[0.0006034467,0.00021233552,0.0001932853,0.000048671653,0.00022192656,0.0000675203,0.000039876923,0.00067144254,0.000028124903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000261481,0.0002754767,0.00042858603,0.0007312224,0.0003842683,0.044692904,0.00007475642,1.0541095e-7,0.0000020590758,0.000009206585,0.94906354,0.0040764],"study_design_scores_gemma":[0.007636318,0.00095808046,0.00007381003,0.0016204617,0.001216274,0.057395447,0.00015190574,0.0000025492634,0.000018311903,0.000055359633,0.9306945,0.00017697983],"about_ca_topic_score_codex":0.000079762125,"about_ca_topic_score_gemma":0.00003478427,"teacher_disagreement_score":0.12763198,"about_ca_system_score_codex":0.00012172912,"about_ca_system_score_gemma":0.0006265921,"threshold_uncertainty_score":0.8658791},"labels":[],"label_agreement":null},{"id":"W2966178814","doi":"10.1111/bjh.16116","title":"Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with <i>NPM1</i> mutation: from definition of molecular relapse to MRD‐driven salvage approach","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Minimal residual disease; NPM1; Medicine; Myeloid leukaemia; Oncology; Mutation; Salvage therapy; Residual; Internal medicine; Disease; Leukemia; Genetics; Chemotherapy; Biology; Karyotype; Gene","score_opus":0.0277667867759721,"score_gpt":0.2855302546066979,"score_spread":0.2577634678307258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966178814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9177329,0.0031141473,0.0014982603,0.07459714,0.00025715976,0.0017194785,0.00042736533,0.000020318263,0.0006332585],"genre_scores_gemma":[0.83337814,0.00076512335,0.068215504,0.08721285,0.0024225004,0.00030195256,0.0070064683,0.00042573415,0.00027170108],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99315697,0.0011163887,0.0017558208,0.0008390209,0.0023870561,0.00074473553],"domain_scores_gemma":[0.99566126,0.0005005259,0.0013150673,0.00062584615,0.0015662969,0.00033102685],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011601993,0.0005110371,0.0021886323,0.0011026736,0.00006745792,0.00007087873,0.0005843523,0.0009805424,0.00018201978],"category_scores_gemma":[0.0009743574,0.0005355554,0.00035338034,0.000607763,0.00041270495,0.00030623103,0.00017470735,0.0037331423,0.000047772955],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057809106,0.00037719004,0.0059701083,0.0011566163,0.0015008919,0.53291625,0.0003796165,0.0004321487,0.0011719334,0.000037989455,0.44880334,0.0014730229],"study_design_scores_gemma":[0.04282041,0.0061533167,0.08572163,0.016227208,0.0112638585,0.8213377,0.0008464948,0.0013837843,0.0026993933,0.0025176983,0.00670752,0.0023209786],"about_ca_topic_score_codex":0.00033192337,"about_ca_topic_score_gemma":0.00006737056,"teacher_disagreement_score":0.44209582,"about_ca_system_score_codex":0.00087013334,"about_ca_system_score_gemma":0.0032971594,"threshold_uncertainty_score":0.9997096},"labels":[],"label_agreement":null},{"id":"W2978510275","doi":"10.1111/bjh.16213","title":"Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University Health Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Lenalidomide; Pomalidomide; Medicine; Bortezomib; Multiple myeloma; Dexamethasone; Internal medicine; Clinical endpoint; Thalidomide; Oncology; Adverse effect; Refractory (planetary science); Population; Surgery; Clinical trial","score_opus":0.015517708207336058,"score_gpt":0.2802767169421137,"score_spread":0.26475900873477765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978510275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923647,0.0053802812,0.00003009365,0.0007074538,0.00027848507,0.00088328077,0.000028648601,0.000023549685,0.00030348919],"genre_scores_gemma":[0.99416256,0.0008286289,0.0035494545,0.00020749071,0.00013261766,0.000059508082,0.000023682454,0.000060140483,0.00097591826],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99678737,0.0004335943,0.0010843527,0.00041157662,0.000532442,0.0007506509],"domain_scores_gemma":[0.99782914,0.00058659056,0.0004308587,0.00038472042,0.00028575235,0.0004829561],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048155824,0.0003226753,0.0015906019,0.00052049616,0.000054156968,0.000048628594,0.00019930105,0.00031085435,0.0009681592],"category_scores_gemma":[0.00075129524,0.0002931293,0.0004157142,0.000262405,0.00015436426,0.00021591851,0.000069803624,0.0006747066,0.00026578968],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02184726,0.0027283602,0.39485198,0.00038740443,0.0011212747,0.5307688,0.00059646444,0.00007430132,0.0068748915,0.000022486125,0.0013267379,0.039400034],"study_design_scores_gemma":[0.11870524,0.0048300633,0.45726007,0.0031343042,0.0003017279,0.40094775,0.00072365795,0.0005555393,0.0070805894,0.00016635387,0.0057236985,0.0005709905],"about_ca_topic_score_codex":0.00061091105,"about_ca_topic_score_gemma":0.0017933472,"teacher_disagreement_score":0.12982105,"about_ca_system_score_codex":0.0007204358,"about_ca_system_score_gemma":0.000583811,"threshold_uncertainty_score":0.9999521},"labels":[],"label_agreement":null},{"id":"W2979071352","doi":"10.1111/bjh.16201","title":"Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation","year":2019,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Takeda Pharmaceutical Company","keywords":"Brentuximab vedotin; Medicine; Autologous stem-cell transplantation; Oncology; Transplantation; Lymphoma; Refractory (planetary science); Stem cell; Internal medicine; Hematopoietic stem cell transplantation; Chemotherapy; Surgery; Hodgkin lymphoma; Biology","score_opus":0.027315288273761344,"score_gpt":0.2859260486957481,"score_spread":0.2586107604219868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979071352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07945052,0.9172902,0.000048445898,0.00003218829,0.00048756512,0.0022361889,0.00041826707,0.000008890369,0.000027704775],"genre_scores_gemma":[0.018303152,0.98042256,0.00037783277,0.000034761288,0.00007750912,0.00029087934,0.00017039606,0.00006977938,0.00025315216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975036,0.00022549897,0.0013219424,0.00030723808,0.00032667886,0.00031507833],"domain_scores_gemma":[0.9964857,0.001040762,0.0017427786,0.00030229767,0.0003165561,0.000111918336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013934805,0.00041226918,0.0033102743,0.00018561166,0.000063325664,0.000024274086,0.0001683764,0.0003483237,0.00005966968],"category_scores_gemma":[0.000014415066,0.00022251013,0.0008672526,0.00012266496,0.00011460613,0.00006695638,0.000009247942,0.00011948302,0.000010695336],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002875811,0.004108381,0.00073460134,0.011973547,0.00156731,0.01702133,0.00019773588,5.166672e-7,4.3104052e-8,0.0000037600762,0.00033403537,0.96118295],"study_design_scores_gemma":[0.034652147,0.01895328,0.011472289,0.026727434,0.025037618,0.15037945,0.00006665734,0.000002154437,0.000029421002,0.000003766301,0.7322788,0.00039697383],"about_ca_topic_score_codex":0.000036849597,"about_ca_topic_score_gemma":0.00004780462,"teacher_disagreement_score":0.960786,"about_ca_system_score_codex":0.00049265503,"about_ca_system_score_gemma":0.0012066942,"threshold_uncertainty_score":0.90737},"labels":[],"label_agreement":null},{"id":"W2979227727","doi":"10.1111/bjh.16214","title":"Pomalidomide in lenalidomide‐refractory multiple myeloma: Far from futile","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pomalidomide; Lenalidomide; Multiple myeloma; Medicine; Oncology; Refractory (planetary science); Internal medicine; Biology","score_opus":0.024522558363938365,"score_gpt":0.2838409606787506,"score_spread":0.25931840231481224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979227727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85972106,0.025673062,0.0000603199,0.109812446,0.0018306493,0.0011504027,0.000556475,0.000040660438,0.0011549195],"genre_scores_gemma":[0.73814106,0.006966143,0.0034075975,0.23811808,0.007137369,0.00007852606,0.0017996184,0.00039927877,0.0039523025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99498135,0.0006772395,0.0017005992,0.0005993182,0.0010094839,0.0010320254],"domain_scores_gemma":[0.9960701,0.0015878229,0.0010762442,0.0005377371,0.00046149077,0.0002665904],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0004758973,0.00050803117,0.002963409,0.0008195513,0.00007192002,0.000087302506,0.00054463383,0.0014600595,0.0012397794],"category_scores_gemma":[0.0015812924,0.0005134428,0.0007034866,0.00021070566,0.00024249402,0.00023143801,0.00015687663,0.0048499187,0.00042098243],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080985925,0.00028275276,0.015703216,0.00026251137,0.00067866594,0.48261642,0.000039548842,0.0000014095923,0.00018090126,0.0000011753807,0.4926486,0.0067749466],"study_design_scores_gemma":[0.023696916,0.0007208477,0.032904632,0.0032998163,0.00038800505,0.31355816,0.00008735219,0.000069677204,0.00046374544,0.00021051026,0.62406707,0.0005332758],"about_ca_topic_score_codex":0.0024363312,"about_ca_topic_score_gemma":0.0006684791,"teacher_disagreement_score":0.16905825,"about_ca_system_score_codex":0.00040947276,"about_ca_system_score_gemma":0.00083369657,"threshold_uncertainty_score":0.99983627},"labels":[],"label_agreement":null},{"id":"W2981250529","doi":"10.1111/bjh.16236","title":"Cystic lung disease with kappa light chain deposition in newly diagnosed multiple myeloma","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"Immunoglobulin light chain; Medicine; Multiple myeloma; Immunofixation; Pathology; Kappa; Bence Jones protein; Plasma cell dyscrasia; Gastroenterology; Internal medicine; Antibody; Monoclonal; Immunology","score_opus":0.003587835730124114,"score_gpt":0.21839081380507439,"score_spread":0.21480297807495027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981250529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004906,0.007808537,0.00081973034,0.00064811774,0.00020981206,0.00035200198,0.000019776668,0.0000087981825,0.00008413375],"genre_scores_gemma":[0.9975533,0.0008372113,0.00093163026,0.00037730386,0.000094209645,0.000040740906,0.000050182247,0.000038361886,0.00007704274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845433,0.0001993066,0.00049908506,0.00031105292,0.0001832947,0.0003529421],"domain_scores_gemma":[0.99898314,0.000105525,0.00036059605,0.00022844158,0.00012197917,0.00020032382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016431625,0.00020262382,0.0005005855,0.00012876387,0.000053250315,0.000040734474,0.00022871669,0.0001588483,0.000040926283],"category_scores_gemma":[0.00027114718,0.00020157019,0.00015132623,0.000116993906,0.000067974885,0.000020145377,0.00006527175,0.00018404503,0.0000171797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012577508,0.00075349375,0.9300644,0.0001636766,0.00032086016,0.044175904,0.0000849849,0.00047200403,0.014897067,0.00006127677,0.002632558,0.005116018],"study_design_scores_gemma":[0.023602504,0.0018833037,0.800726,0.0019825252,0.00047153851,0.099672265,0.00048257434,0.0007301162,0.06658695,0.00013759377,0.002541845,0.0011828223],"about_ca_topic_score_codex":0.00007626865,"about_ca_topic_score_gemma":0.00060479343,"teacher_disagreement_score":0.12933844,"about_ca_system_score_codex":0.00005276653,"about_ca_system_score_gemma":0.00015359333,"threshold_uncertainty_score":0.82197934},"labels":[],"label_agreement":null},{"id":"W2985152406","doi":"10.1111/bjh.16332","title":"Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Alpha interferon; Internal medicine; Gastroenterology; Discontinuation; Immunology; Methotrexate; Hypereosinophilic syndrome; Population; Interferon; Eosinophilia","score_opus":0.0165750259208535,"score_gpt":0.2646448905418397,"score_spread":0.2480698646209862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985152406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9200824,0.0113549335,0.00011461821,0.06514415,0.0010568394,0.0019297283,0.00015005645,0.000038514503,0.00012874362],"genre_scores_gemma":[0.8702923,0.0065345275,0.0007143037,0.11732239,0.0010723021,0.00014953005,0.0010950518,0.00028223047,0.0025373737],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9969939,0.00031609036,0.0011114939,0.0006466214,0.00033194013,0.0005999585],"domain_scores_gemma":[0.99780995,0.00029690543,0.0008374407,0.00035156304,0.0005158675,0.00018826796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002995974,0.0005632718,0.0027305668,0.00049276365,0.00013559217,0.00012936656,0.00021622282,0.0012867599,0.00022586851],"category_scores_gemma":[0.00007429789,0.0005310473,0.00041227476,0.00013665087,0.00021632115,0.00023079426,0.000045258923,0.00094139954,0.00003677139],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026429633,0.0015038102,0.00037331716,0.003113306,0.005051583,0.47829846,0.0012972063,0.000007463834,0.00052842445,0.000037412978,0.4444426,0.062703475],"study_design_scores_gemma":[0.0105334185,0.015044616,0.001414688,0.0021782257,0.0014335917,0.88910365,0.00013504204,0.00030068608,0.0001481073,0.00029093772,0.07894187,0.00047517705],"about_ca_topic_score_codex":0.00024871744,"about_ca_topic_score_gemma":0.000022090353,"teacher_disagreement_score":0.4108052,"about_ca_system_score_codex":0.00034979513,"about_ca_system_score_gemma":0.0003248741,"threshold_uncertainty_score":0.99971414},"labels":[],"label_agreement":null},{"id":"W2990892067","doi":"10.1111/bjh.16307","title":"Prognostic relevance of CD123 expression in adult AML with normal karyotype","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada; University Health Network","funders":"University Health Network","keywords":"Karyotype; Medicine; Internal medicine; Oncology; Biology; Cancer research; Genetics; Chromosome; Gene","score_opus":0.011060819117868426,"score_gpt":0.26246253753529375,"score_spread":0.2514017184174253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990892067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8576304,0.0052479752,0.00021122907,0.13396375,0.0005431202,0.0010766991,0.000045506145,0.000019479989,0.0012618932],"genre_scores_gemma":[0.5837287,0.013603054,0.03533227,0.35028267,0.0067408057,0.00012099023,0.00052582374,0.0007824031,0.0088833],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99651027,0.0003278807,0.0012322695,0.00035214578,0.0009272781,0.00065013074],"domain_scores_gemma":[0.99644697,0.00078013056,0.0011206483,0.00036953294,0.0011751396,0.00010758632],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041709,0.00029089718,0.0019441845,0.00060098217,0.000030085157,0.000020584679,0.00048058297,0.0009713425,0.00017050865],"category_scores_gemma":[0.0016983387,0.00025895314,0.00019601517,0.0003154032,0.0003360352,0.00017414628,0.000121983925,0.0051885336,0.00003955202],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009882088,0.000115220864,0.01588839,0.0021878479,0.00013657047,0.3463651,0.000062425686,0.000008607106,0.0003727795,0.0000034726565,0.63208306,0.001788352],"study_design_scores_gemma":[0.007883683,0.0024623324,0.010626086,0.024613593,0.00026720576,0.8894907,0.00007787609,0.000053127453,0.0021651932,0.00006940515,0.061887316,0.00040346448],"about_ca_topic_score_codex":0.0001267855,"about_ca_topic_score_gemma":0.00006983613,"teacher_disagreement_score":0.57019573,"about_ca_system_score_codex":0.00019951504,"about_ca_system_score_gemma":0.0013071186,"threshold_uncertainty_score":0.9999863},"labels":[],"label_agreement":null},{"id":"W2992515443","doi":"10.1111/bjh.16319","title":"Poor outcomes for double‐hit lymphoma patients treated with curative‐intent second‐line immunochemotherapy following failure of intensive front‐line immunochemotherapy","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Front line; Second line; Oncology; Internal medicine; Refractory (planetary science); Lymphoma; Progression-free survival; Overall survival; Salvage therapy; First line; Chemotherapy","score_opus":0.010816700181680735,"score_gpt":0.2613074448371707,"score_spread":0.25049074465549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992515443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239355,0.0033516407,0.00019183634,0.0021958821,0.00036583294,0.0013198662,0.00006697311,0.000020726733,0.00009367395],"genre_scores_gemma":[0.9947937,0.00030761122,0.00234922,0.0016719837,0.00004555905,0.00004780757,0.00011029237,0.00007277774,0.00060103415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975882,0.0000725756,0.0012016939,0.00033467697,0.00037556858,0.0004272731],"domain_scores_gemma":[0.9959886,0.00022718436,0.0010992085,0.0002918332,0.0022443167,0.00014883492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018972009,0.0003822773,0.00213619,0.00022601482,0.00007605158,0.000036279987,0.00021648362,0.00021103931,0.0003548106],"category_scores_gemma":[0.000114236034,0.00029248063,0.00075612776,0.00013569527,0.00011921633,0.00021097633,0.00003061044,0.00015733867,0.000011446324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02030149,0.006608661,0.8958729,0.000512236,0.015336691,0.008079061,0.001979544,0.000010431226,0.0081849005,0.00013437601,0.007163848,0.035815865],"study_design_scores_gemma":[0.335747,0.026296435,0.34325936,0.0062078726,0.002183137,0.07214216,0.0044354624,0.00012815863,0.20212513,0.00023580196,0.0060425517,0.0011969013],"about_ca_topic_score_codex":0.0002201103,"about_ca_topic_score_gemma":0.00011208102,"teacher_disagreement_score":0.5526135,"about_ca_system_score_codex":0.0002816537,"about_ca_system_score_gemma":0.00031285512,"threshold_uncertainty_score":0.99995273},"labels":[],"label_agreement":null},{"id":"W2993178565","doi":"10.1111/bjh.16306","title":"Day 15 bone marrow minimal residual disease predicts response to blinatumomab in relapsed/refractory paediatric B‐ALL","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Blinatumomab; Medicine; Minimal residual disease; Refractory (planetary science); Bone marrow; Bone marrow failure; Immunology; Internal medicine; Oncology; Antibody; Stem cell; CD19; Haematopoiesis; Biology","score_opus":0.014262885081018549,"score_gpt":0.2729198481157316,"score_spread":0.2586569630347131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993178565","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6153192,0.0113836825,0.000022573682,0.3701826,0.001526572,0.0010278138,0.00029185106,0.00005052591,0.00019514927],"genre_scores_gemma":[0.42540625,0.0020649033,0.002207488,0.5408762,0.0132944165,0.00012643795,0.00054587226,0.00069836195,0.014780033],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99028045,0.0024595016,0.0024054295,0.00093177013,0.002315688,0.0016071746],"domain_scores_gemma":[0.99221075,0.003972255,0.0011636119,0.0008519146,0.00086476933,0.0009367196],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0033451626,0.000644351,0.0028328511,0.0029190774,0.000075264834,0.00010414611,0.0009761595,0.0019174055,0.00034856814],"category_scores_gemma":[0.01455813,0.00069897756,0.0005390704,0.0007797078,0.0003596082,0.00020809133,0.00048683627,0.007394317,0.00040327094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008418959,0.0002169042,0.0008693445,0.0005956151,0.00014800814,0.46135,0.00008103659,0.000005231029,0.000101283375,9.799727e-7,0.52779984,0.00041278152],"study_design_scores_gemma":[0.016303172,0.002971659,0.01699486,0.004017398,0.00074556883,0.46081617,0.000060087605,0.000061561106,0.00004083139,0.00007854342,0.49721283,0.0006973162],"about_ca_topic_score_codex":0.00007501745,"about_ca_topic_score_gemma":0.0000333497,"teacher_disagreement_score":0.18991296,"about_ca_system_score_codex":0.0017548319,"about_ca_system_score_gemma":0.007800391,"threshold_uncertainty_score":0.9995461},"labels":[],"label_agreement":null},{"id":"W2995451675","doi":"10.1111/bjh.16334","title":"Increased cytotoxic potential of CD8<sup>+ </sup>T cells in immune thrombocytopenia","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Health Canada; Canadian Blood Services","keywords":"Cytotoxic T cell; Degranulation; CD8; Immunology; Autoantibody; MHC class I; Major histocompatibility complex; Immune system; Immunosurveillance; Platelet; T cell; Biology; Chemistry; Antibody; In vitro; Biochemistry","score_opus":0.009302029730761411,"score_gpt":0.23881200488243873,"score_spread":0.22950997515167731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995451675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96858644,0.0063544703,0.000018807339,0.023311362,0.00047477943,0.00059226836,0.00013557819,0.0000102021395,0.0005160884],"genre_scores_gemma":[0.9530752,0.0026089577,0.00060706504,0.042141095,0.0005430821,0.000009286541,0.00028790048,0.000117539545,0.0006098935],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9965316,0.00030971586,0.0016790967,0.0003465859,0.0005517066,0.00058130734],"domain_scores_gemma":[0.99783915,0.00018727338,0.0012444509,0.00035345604,0.00028119588,0.00009449917],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00033106803,0.00038474947,0.003936429,0.00057619467,0.00003921519,0.00003115746,0.0003931104,0.0011447421,0.0005936869],"category_scores_gemma":[0.00011976785,0.00039677048,0.0006272356,0.0001989585,0.00020583972,0.00013402957,0.000094457675,0.0023100385,0.000084144165],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035818422,0.00052001805,0.0005776313,0.0007641693,0.00079072657,0.71993506,0.000052866126,0.000026067455,0.0025502273,0.0000023060395,0.2737562,0.0006665287],"study_design_scores_gemma":[0.015289109,0.0011729546,0.0026253082,0.0041759354,0.0010697977,0.9447567,0.00010230404,0.000080772086,0.003769351,0.00028806014,0.026198745,0.00047098089],"about_ca_topic_score_codex":0.0008131701,"about_ca_topic_score_gemma":0.000028525914,"teacher_disagreement_score":0.24755745,"about_ca_system_score_codex":0.000115839524,"about_ca_system_score_gemma":0.0005291845,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W2995608308","doi":"10.1111/bjh.16325","title":"Mixed phenotype acute leukaemia with predominant myeloid blasts and a small subset of B/myeloid blasts shares the same mutation profile","year":2019,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; University of Ottawa","funders":"Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Myeloid leukaemia; Myeloid; Phenotype; Mutation; Medicine; Cancer research; Immunology; Biology; Gene; Genetics","score_opus":0.018643480693947053,"score_gpt":0.25187470689634,"score_spread":0.23323122620239295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995608308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8878495,0.0052140495,0.00024264025,0.103627436,0.00046380732,0.0018202565,0.0004518146,0.000029860177,0.0003006495],"genre_scores_gemma":[0.6831047,0.016196921,0.032631587,0.23160602,0.010790421,0.0005584905,0.0038450214,0.0017261821,0.019540673],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99525744,0.00064160477,0.0014880361,0.00062274025,0.0010832342,0.00090695464],"domain_scores_gemma":[0.99481833,0.0010221491,0.0019183524,0.0005944435,0.0014536794,0.00019304935],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00092120946,0.0005637659,0.0024917414,0.0005432848,0.0001433788,0.00011365976,0.00074511534,0.0010931,0.0003428725],"category_scores_gemma":[0.0007256545,0.0004166134,0.0003212889,0.00037453885,0.0009891408,0.00019853181,0.00026800227,0.0042956215,0.00005161579],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029588065,0.00013358047,0.0009204788,0.0027483853,0.0023723107,0.16695085,0.00058593345,0.000009067779,0.0017488567,0.000022604469,0.8128464,0.008702719],"study_design_scores_gemma":[0.00948677,0.0036543082,0.0075335964,0.0061852965,0.002085634,0.9199549,0.00040825497,0.00026401735,0.004614192,0.0001784884,0.044984926,0.0006496279],"about_ca_topic_score_codex":0.0002776384,"about_ca_topic_score_gemma":0.00031261297,"teacher_disagreement_score":0.7678615,"about_ca_system_score_codex":0.00029588246,"about_ca_system_score_gemma":0.0022311134,"threshold_uncertainty_score":0.9998286},"labels":[],"label_agreement":null},{"id":"W2996675598","doi":"10.1111/bjh.16293","title":"Validation of a simplified international prognostic score (IPS‐3) in patients with advanced‐stage classic Hodgkin lymphoma","year":2019,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Francis Xavier University; Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Vinblastine; Stage (stratigraphy); Medicine; Bleomycin; Internal medicine; Oncology; Brentuximab vedotin; Lymphoma; Neoplasm staging; Hodgkin lymphoma; Chemotherapy; Vincristine; Cancer; Cyclophosphamide","score_opus":0.00815239974218571,"score_gpt":0.23888078609825175,"score_spread":0.23072838635606605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996675598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984226,0.0003186314,0.0000234472,0.00017907377,0.00025073855,0.00041661394,0.000017872911,0.0000057271477,0.00036527528],"genre_scores_gemma":[0.99902374,0.00006430014,0.0006846107,0.00008489605,0.000021391237,0.000010658745,0.000042260403,0.000015027876,0.00005309169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870557,0.00005505614,0.0005774184,0.00015460727,0.0003391807,0.00016818214],"domain_scores_gemma":[0.9988114,0.00010958796,0.00053980807,0.000109131404,0.00035644326,0.0000736068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001231374,0.00010929936,0.00055662217,0.00020141079,0.0000146429265,0.000015319203,0.0001043164,0.0000757267,0.00013312946],"category_scores_gemma":[0.00015288602,0.00009633429,0.00008454086,0.0001294883,0.000056367637,0.00016917738,0.000027344066,0.000084777996,0.000010413268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006720249,0.0014528988,0.96921974,0.00009504146,0.00015618945,0.0038384153,0.00008452363,0.000042672305,0.000056036344,0.00016861424,0.000095248506,0.024118578],"study_design_scores_gemma":[0.016117964,0.0012793604,0.96941125,0.0013805705,0.00007765132,0.009644096,0.000081306636,0.000017141125,0.0016268999,0.000069393696,0.00020850777,0.00008582906],"about_ca_topic_score_codex":0.00002447993,"about_ca_topic_score_gemma":0.000019375053,"teacher_disagreement_score":0.02403275,"about_ca_system_score_codex":0.00017557506,"about_ca_system_score_gemma":0.00023942714,"threshold_uncertainty_score":0.39283982},"labels":[],"label_agreement":null},{"id":"W2999009584","doi":"10.1111/j.1365-2141.2000.02330.x","title":"Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion‐associated graft‐versus‐host disease from stored blood","year":2000,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canadian Blood Services; University of Toronto; University Health Network","funders":"","keywords":"Antigen; Immunology; Blood transfusion; Graft-versus-host disease; Medicine; Lymphocyte; CD28; CD3; Downregulation and upregulation; Disease; Biology; Internal medicine; CD8; Biochemistry","score_opus":0.015869114739918148,"score_gpt":0.24838151109196852,"score_spread":0.23251239635205037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999009584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729913,0.00086679624,0.00040260184,0.00045763768,0.0001939083,0.00033703528,0.00023083527,0.000019753174,0.00019227972],"genre_scores_gemma":[0.9965771,0.0021099169,0.0009884213,0.000055461773,0.00005663395,0.000005569456,0.000098844146,0.000028248765,0.00007979253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974233,0.00035085646,0.0011739734,0.00024068181,0.000533262,0.0002779588],"domain_scores_gemma":[0.9979289,0.00054325565,0.00069087493,0.00019663367,0.0003745813,0.00026573314],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045975603,0.00018955198,0.0010650697,0.00019689955,0.00007073099,0.000011101156,0.00017655818,0.00022851958,0.0013367244],"category_scores_gemma":[0.00029311134,0.00021134656,0.00032185274,0.0002878476,0.00019271007,0.0002094593,0.000009734108,0.0003414856,0.0000052664955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053327702,0.019449163,0.41963702,0.0055508143,0.011310309,0.13295306,0.010784263,0.00020300674,0.33197042,0.00044501806,0.0023663612,0.012002859],"study_design_scores_gemma":[0.07406924,0.0023800328,0.43186206,0.010679564,0.009471995,0.04592678,0.0010234783,0.00011437667,0.42291158,0.0005858997,0.00024207021,0.00073291943],"about_ca_topic_score_codex":0.001216932,"about_ca_topic_score_gemma":0.00038949552,"teacher_disagreement_score":0.09094116,"about_ca_system_score_codex":0.00004819375,"about_ca_system_score_gemma":0.0003106144,"threshold_uncertainty_score":0.9995762},"labels":[],"label_agreement":null},{"id":"W3001673888","doi":"10.1111/bjh.16338","title":"Experience with ponatinib in paediatric patients with leukaemia","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; BC Children's Hospital","funders":"","keywords":"Ponatinib; Medicine; Chronic myeloid leukaemia; Pediatrics; Cohort; Lymphoblastic Leukemia; Internal medicine; Disease; Leukemia; Myeloid leukemia; Dasatinib","score_opus":0.010286206791769429,"score_gpt":0.23234594625693816,"score_spread":0.22205973946516874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001673888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740255,0.0011681878,0.00007747728,0.0006760113,0.000054590153,0.00023058195,0.0000046991563,0.000012807728,0.00037311472],"genre_scores_gemma":[0.9967929,0.0001232799,0.0022489056,0.00070716575,0.000071581184,0.000007792277,0.00000742311,0.000023881512,0.000017065444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860233,0.00006041152,0.0004911422,0.00019902203,0.00037638855,0.00027071653],"domain_scores_gemma":[0.9990505,0.0000735121,0.0003241339,0.00009891181,0.00021217355,0.00024079894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007596076,0.00013683704,0.00063628814,0.000108949804,0.000030494992,0.000014816168,0.00013094483,0.00008122767,0.00015283824],"category_scores_gemma":[0.0002207304,0.00011206927,0.000052786007,0.00034427748,0.00011260356,0.00015219301,0.000030503103,0.0004127534,0.000011111655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001367891,0.0003530037,0.88398165,0.00010283981,0.000103988095,0.10339217,0.0010303026,0.000029588515,0.000016572574,0.000020717882,0.0010966983,0.008504594],"study_design_scores_gemma":[0.039292723,0.0047644135,0.69943666,0.001086843,0.00022472607,0.25214216,0.00078819395,0.000081629696,0.00046298525,0.000026110169,0.0013609107,0.00033261755],"about_ca_topic_score_codex":0.00005181069,"about_ca_topic_score_gemma":0.00006331193,"teacher_disagreement_score":0.18454495,"about_ca_system_score_codex":0.00020896102,"about_ca_system_score_gemma":0.00048747327,"threshold_uncertainty_score":0.4570052},"labels":[],"label_agreement":null},{"id":"W3002741063","doi":"10.1111/bjh.16347","title":"Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Medical Research Council; National Institute for Health and Care Research; Cancer Research UK; Australian and New Zealand Society of Blood Transfusion","keywords":"Medicine; Confidence interval; Myelodysplastic syndromes; Population; Quality of life (healthcare); Randomized controlled trial; Blood transfusion; Red Cell; Pediatrics; Internal medicine","score_opus":0.039661416918017875,"score_gpt":0.2762267365054811,"score_spread":0.23656531958746319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002741063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955463,0.0013266465,0.0004435465,0.0012916062,0.000097878365,0.0011522253,0.000005477401,0.000012405124,0.00012392804],"genre_scores_gemma":[0.99791545,0.000936996,0.00076601707,0.0002546392,0.00006890111,0.000017376185,0.0000039427414,0.0000248391,0.0000118287335],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99784577,0.00040848326,0.0007899974,0.0002695331,0.00039238762,0.0002938487],"domain_scores_gemma":[0.9987649,0.0002850336,0.0002453821,0.00010692419,0.00021131505,0.00038647643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006024528,0.00014538116,0.0010881774,0.00016764739,0.00004787328,0.000023105553,0.00012548939,0.00014737244,0.000081846316],"category_scores_gemma":[0.00089848874,0.00013008174,0.00010014949,0.00025897633,0.00019010369,0.00015651903,0.00003664376,0.0007652326,0.0000043616214],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7964966,0.0009090273,0.015353866,0.0010115228,0.00016244229,0.1766988,0.002196034,0.000016509086,0.002276782,0.0000045802003,0.0019090218,0.0029647755],"study_design_scores_gemma":[0.8481026,0.008084973,0.005408803,0.00096046505,0.00019940203,0.1346123,0.0010255078,0.00031208727,0.00085731567,0.00005658691,0.00017091236,0.00020904046],"about_ca_topic_score_codex":0.000024679455,"about_ca_topic_score_gemma":0.00005425254,"teacher_disagreement_score":0.051605977,"about_ca_system_score_codex":0.000124038,"about_ca_system_score_gemma":0.0005357197,"threshold_uncertainty_score":0.530458},"labels":[],"label_agreement":null},{"id":"W3004714210","doi":"10.1111/bjh.16462","title":"Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"AOP Orphan; Incyte; Baxalta; Pfizer; Novartis Pharmaceuticals Corporation; Celgene; Alexion Pharmaceuticals; Amgen; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Gilead Sciences; Sanofi; Bristol-Myers Squibb","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Discontinuation; Internal medicine; Cohort; Adverse effect; Bone marrow","score_opus":0.04091387740162374,"score_gpt":0.35841570427673825,"score_spread":0.3175018268751145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004714210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839467,0.00068375346,0.000042184085,0.00016660799,0.000016534323,0.00057357247,0.000035575307,0.0000031018199,0.000084020045],"genre_scores_gemma":[0.9992554,0.00020046669,0.00034038513,0.00014573858,0.000016033384,0.000009110701,0.000019059655,0.000012069397,0.0000017166617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835527,0.0002024115,0.0007027248,0.00017577317,0.0004184175,0.00014541985],"domain_scores_gemma":[0.9984869,0.00035091452,0.00063861994,0.00010198517,0.00033053444,0.000091054295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037337505,0.0001268501,0.001097293,0.00016551884,0.000056962275,0.000018296912,0.000100965946,0.0000411332,0.000058203754],"category_scores_gemma":[0.00019380465,0.00008320615,0.00007152757,0.00046423246,0.000113398404,0.00009360556,0.00005668812,0.00018920563,2.8229414e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059372084,0.00249704,0.9706956,0.00015172649,0.0020316988,0.0018460938,0.0013904584,0.000108658234,0.000028440234,0.000009967633,0.00003819806,0.015264875],"study_design_scores_gemma":[0.022793058,0.0065348553,0.9657765,0.00097456976,0.0016921153,0.0011540216,0.00041767387,0.0001658,0.0003936437,0.000003696993,0.000006305396,0.0000877791],"about_ca_topic_score_codex":0.00004162349,"about_ca_topic_score_gemma":0.000053422053,"teacher_disagreement_score":0.016855849,"about_ca_system_score_codex":0.000030267289,"about_ca_system_score_gemma":0.00014570307,"threshold_uncertainty_score":0.33930483},"labels":[],"label_agreement":null},{"id":"W3007287792","doi":"10.1111/bjh.16377","title":"Advances in knowledge of inhibitor formation in severe haemophilia A","year":2020,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Haemophilia; Haemophilia A; Medicine; Antibody; Immunology; Alloimmunity; Bioinformatics; Biology; Pediatrics","score_opus":0.04295337339649063,"score_gpt":0.37313078340151085,"score_spread":0.3301774100050202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007287792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002534737,0.9953747,0.0000047293483,0.00020480026,0.00019025723,0.00059761386,0.0000149799425,0.000004697659,0.0010735254],"genre_scores_gemma":[0.004545931,0.99497604,0.00018565958,0.000010014999,0.00015735663,0.000017004519,0.00002535155,0.000026681355,0.000055975757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722475,0.0003506193,0.0017299283,0.00017844365,0.00023388286,0.00028237962],"domain_scores_gemma":[0.9986042,0.00023525767,0.0007130719,0.00010840232,0.00019392476,0.00014518386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040886502,0.00021276817,0.0034481313,0.0007593779,0.000017974098,0.000010440766,0.00019037045,0.0003646099,0.00005620018],"category_scores_gemma":[0.0004944402,0.00018566415,0.00043305967,0.00062366267,0.00011392413,0.00024383642,0.000067427165,0.0009941092,0.000024268784],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069117596,0.0003000131,0.00009287447,0.030800948,0.000054485678,0.059024766,0.00014990314,2.0980958e-7,8.0193644e-7,0.000023927769,0.00057670457,0.9089062],"study_design_scores_gemma":[0.0020165988,0.0004098762,0.000026512054,0.085283704,0.00020662334,0.3646678,0.00008941831,0.000006357419,0.000012999378,0.00014850686,0.5470021,0.00012953664],"about_ca_topic_score_codex":0.000011265421,"about_ca_topic_score_gemma":0.0001804804,"teacher_disagreement_score":0.9087767,"about_ca_system_score_codex":0.00020725299,"about_ca_system_score_gemma":0.00067828625,"threshold_uncertainty_score":0.7571164},"labels":[],"label_agreement":null},{"id":"W3007882742","doi":"10.1111/bjh.16533","title":"Anti‐myeloma potential of ruxolitinib in co‐existing <i>JAK2V617F</i>‐positive smouldering myeloma and polycythaemia vera","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Polycythaemia; Polycythemia vera; Multiple myeloma; Ruxolitinib; Medicine; Internal medicine; Oncology; Cancer research; Dermatology; Myelofibrosis; Bone marrow","score_opus":0.020054852191899845,"score_gpt":0.2821120807715569,"score_spread":0.2620572285796571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007882742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85908896,0.0071258415,0.0000692586,0.13134494,0.0005110739,0.00058411603,0.00023021841,0.000021848895,0.0010237453],"genre_scores_gemma":[0.9140998,0.0025953383,0.001817649,0.079237565,0.0018208546,0.000023690027,0.0002065366,0.00012060742,0.00007793015],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9960103,0.00038709186,0.0017935043,0.0005462441,0.0006212732,0.00064159976],"domain_scores_gemma":[0.9972801,0.0004970769,0.0013927224,0.00018736396,0.00039902952,0.00024366392],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002704002,0.00050340715,0.0030822514,0.00046126946,0.000121792276,0.00007367284,0.00021105213,0.00075303065,0.00012341634],"category_scores_gemma":[0.00043109158,0.0005398595,0.00040176,0.00021222352,0.00040199744,0.00014584865,0.000121892146,0.0026625104,0.0000070799747],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004646651,0.00027789283,0.02288155,0.0015500374,0.001096973,0.8369761,0.00044536524,0.0000037045563,0.0008740898,0.000078223566,0.12623107,0.009120309],"study_design_scores_gemma":[0.008550452,0.0018551686,0.07366087,0.01005743,0.0011337335,0.87145907,0.00031230552,0.00004736803,0.01174738,0.00030839298,0.020167882,0.0006999445],"about_ca_topic_score_codex":0.00018854711,"about_ca_topic_score_gemma":0.000032671658,"teacher_disagreement_score":0.10606319,"about_ca_system_score_codex":0.00013912942,"about_ca_system_score_gemma":0.00042856706,"threshold_uncertainty_score":0.9997053},"labels":[],"label_agreement":null},{"id":"W3008934723","doi":"10.1111/bjh.16304","title":"Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; CancerCare Manitoba; University of Alberta; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network; University of Toronto; Spinal Cord Injury BC","funders":"Alberta Innovates - Health Solutions; European Hematology Association","keywords":"Rituximab; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Post-transplant lymphoproliferative disorder; CHOP; Lymphoma; Gastroenterology; Induction chemotherapy; Oncology; Chemotherapy","score_opus":0.009618416916319015,"score_gpt":0.23823553398621125,"score_spread":0.22861711706989224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008934723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889747,0.0036348265,0.000105299456,0.0065627345,0.00008041378,0.00025836352,0.0001787064,0.00001783963,0.00018710065],"genre_scores_gemma":[0.99448013,0.00052968954,0.00015276637,0.0046774806,0.000028399145,0.0000043269156,0.000036524518,0.000039610008,0.00005106013],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978274,0.00016027375,0.0009292524,0.0002395914,0.00039904288,0.0004444488],"domain_scores_gemma":[0.9984022,0.000086605934,0.00068068126,0.000094388844,0.000512374,0.00022374313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022279499,0.00022142731,0.0014733578,0.0001512191,0.00006090726,0.000020870057,0.00017312741,0.0002628311,0.00014709208],"category_scores_gemma":[0.00033537514,0.00020482832,0.0002145337,0.00046525194,0.00011473872,0.00014464547,0.000027501335,0.0003626026,0.000007421931],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073853973,0.016550919,0.8730108,0.0007663405,0.0012819568,0.080681324,0.008168295,0.000018022585,0.0012177071,0.00012870508,0.00947624,0.00131428],"study_design_scores_gemma":[0.6425246,0.013725453,0.19992107,0.0050960677,0.0025642014,0.108800285,0.015998807,0.0010380703,0.004552806,0.00042442253,0.0035623426,0.0017918587],"about_ca_topic_score_codex":0.00027638886,"about_ca_topic_score_gemma":0.0011450453,"teacher_disagreement_score":0.67308974,"about_ca_system_score_codex":0.000117917836,"about_ca_system_score_gemma":0.00048936834,"threshold_uncertainty_score":0.83526564},"labels":[],"label_agreement":null},{"id":"W3009416494","doi":"10.1111/bjh.16553","title":"Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"ADAMTS13; Von Willebrand factor; Thrombotic thrombocytopenic purpura; Platelet; Platelet factor 4; Thrombus; Chemistry; Internal medicine; Immunology; Molecular biology; Medicine; Biology","score_opus":0.017537134773179575,"score_gpt":0.23606936631349137,"score_spread":0.2185322315403118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009416494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884012,0.009587332,0.00018569807,0.00087604567,0.00026093217,0.00021473982,0.00045107858,0.000014266227,0.000008750987],"genre_scores_gemma":[0.99956536,0.0002697489,0.000017719813,0.000058707185,0.0000309575,0.0000028381455,0.000030978787,0.000010144103,0.000013559927],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985944,0.00040725616,0.00054888666,0.00016490296,0.00006377035,0.00022076513],"domain_scores_gemma":[0.9987016,0.00035607698,0.0006451363,0.000101422534,0.00014436923,0.000051446998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118888354,0.00013827266,0.0006286602,0.000035937373,0.0001347775,0.00001950322,0.00020758863,0.00013480149,0.0003784531],"category_scores_gemma":[0.00040539732,0.000114967326,0.00012838199,0.00009789584,0.00032846237,0.00014361701,0.00010238668,0.00028277762,0.000010598558],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027609242,0.00070664496,0.06486087,0.0008404882,0.0022629376,0.002516854,0.002409153,0.000028134506,0.781565,0.00033443113,0.03716264,0.104551926],"study_design_scores_gemma":[0.006784191,0.001027039,0.47005665,0.00063344475,0.00021604581,0.08008849,0.000697732,0.00005444857,0.4277628,0.00018147641,0.012049008,0.0004486605],"about_ca_topic_score_codex":0.00007266301,"about_ca_topic_score_gemma":0.000028447297,"teacher_disagreement_score":0.40519577,"about_ca_system_score_codex":0.000016712735,"about_ca_system_score_gemma":0.000054220465,"threshold_uncertainty_score":0.46882313},"labels":[],"label_agreement":null},{"id":"W3010413675","doi":"10.1111/bjh.16445","title":"Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Centre hospitalier universitaire de Québec; Janeway Children's Health and Rehabilitation Centre; Princess Margaret Cancer Centre; Kingston General Hospital; Centre Hospitalier Universitaire de Sherbrooke; McMaster University; London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; Children's Hospital of Eastern Ontario; CancerCare Manitoba; Capital District Health Authority; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Toronto; Royal University Hospital; Montreal Children's Hospital; University of Manitoba; BC Children's Hospital; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cytopenia; Medicine; Danazol; Bone marrow failure; Bone marrow; Bone Marrow Aplasia; Internal medicine; Endometriosis; Biology; Genetics","score_opus":0.012986223251701196,"score_gpt":0.22505769687738678,"score_spread":0.21207147362568557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010413675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9668675,0.022980472,0.00004069761,0.0096505135,0.000059463222,0.00017129524,0.000164665,0.00000612372,0.000059236798],"genre_scores_gemma":[0.9954106,0.0013225921,0.00054357236,0.002271455,0.000095378244,0.000010260289,0.00029008248,0.000030092911,0.000025926698],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982458,0.00027196627,0.0005667116,0.00034947952,0.00018705099,0.00037903216],"domain_scores_gemma":[0.9989044,0.0000279646,0.000338247,0.0002723074,0.00015920497,0.00029787002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016608632,0.00022289093,0.0006741273,0.00011940651,0.0001455605,0.000109048364,0.00044231093,0.0003819308,0.00017481548],"category_scores_gemma":[0.00015006626,0.00020383632,0.00031038767,0.0006056852,0.00014932653,0.000014525763,0.00005722873,0.00038206612,0.000005825904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079740677,0.0006916886,0.7515662,0.000059866234,0.0111671705,0.09101021,0.0011771624,0.00022793816,0.01598297,0.000051632676,0.11175288,0.015514906],"study_design_scores_gemma":[0.038815666,0.004096604,0.33520684,0.00075777347,0.0038188663,0.1915057,0.009235299,0.00043428378,0.018498478,0.0017231217,0.39242935,0.0034780037],"about_ca_topic_score_codex":0.032554045,"about_ca_topic_score_gemma":0.53857887,"teacher_disagreement_score":0.50602484,"about_ca_system_score_codex":0.000029043007,"about_ca_system_score_gemma":0.0003237749,"threshold_uncertainty_score":0.9738883},"labels":[],"label_agreement":null},{"id":"W3016576844","doi":"10.1111/bjh.16635","title":"Statin and cyclooxygenase‐2 inhibitors improve survival in newly diagnosed diffuse large B‐cell lymphoma: a large population‐based study of 4913 subjects","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Institute of Chemical and Engineering Sciences; Ontario Ministry of Health and Long-Term Care","keywords":"Diffuse large B-cell lymphoma; Cyclooxygenase; Statin; Medicine; Lymphoma; Internal medicine; Population; Oncology; Chemistry; Enzyme","score_opus":0.007064698358016912,"score_gpt":0.23354987644474418,"score_spread":0.22648517808672727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016576844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934211,0.0039991722,0.0002733772,0.000097898184,0.0017763661,0.00029351443,0.000116722505,0.00000510108,0.000016785663],"genre_scores_gemma":[0.99766546,0.000525936,0.00020308208,0.00026330608,0.0012538502,0.000010005637,0.00003814319,0.00002919393,0.000011022912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807036,0.0003190402,0.00077025103,0.0002987426,0.00020764749,0.00033394014],"domain_scores_gemma":[0.99895734,0.000070465365,0.0004961969,0.00014070689,0.00014871162,0.00018655673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035633406,0.00017585364,0.0006873094,0.00010095669,0.000056814286,0.000025744323,0.00017278691,0.00016045057,0.000010234423],"category_scores_gemma":[0.00043250734,0.00020042258,0.00011730541,0.00015555335,0.000036772144,0.0000147375285,0.00010136802,0.00015359011,5.800434e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040617185,0.03476398,0.7445761,0.001303063,0.00056740496,0.0036870895,0.004860687,0.00019090566,0.16783398,0.00015029595,0.026182657,0.011822123],"study_design_scores_gemma":[0.22867918,0.0074822907,0.6743169,0.0004212015,0.00045238645,0.0037020142,0.012618651,0.00038255105,0.04014124,0.0001242155,0.030101279,0.0015781255],"about_ca_topic_score_codex":0.000576597,"about_ca_topic_score_gemma":0.005697282,"teacher_disagreement_score":0.22461747,"about_ca_system_score_codex":0.00001518119,"about_ca_system_score_gemma":0.00019814192,"threshold_uncertainty_score":0.8172996},"labels":[],"label_agreement":null},{"id":"W3018389620","doi":"10.1111/bjh.16694","title":"Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Thrombotic microangiopathy; ADAMTS13; HELLP syndrome; Medicine; Thrombotic thrombocytopenic purpura; Preeclampsia; Pregnancy; Eclampsia; Acute kidney injury; Antiphospholipid syndrome; Gastroenterology; Alternative complement pathway; Nephropathy; Internal medicine; Immunology; Complement system; Platelet; Endocrinology; Disease; Biology; Thrombosis; Immune system","score_opus":0.026115423843351925,"score_gpt":0.24706009837492884,"score_spread":0.22094467453157693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018389620","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036398444,0.27770317,0.00006259677,0.6792037,0.004683264,0.0011961095,0.00036882554,0.00006293022,0.00032094808],"genre_scores_gemma":[0.33798045,0.0033562025,0.00036513715,0.6530316,0.002108573,0.00013313908,0.0006395068,0.00030889758,0.0020764703],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947931,0.001979477,0.0017678471,0.0004960351,0.0001522734,0.00081125775],"domain_scores_gemma":[0.9971135,0.0008093497,0.0013334601,0.00046637945,0.00023035087,0.000046932244],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034336493,0.00045620816,0.0020295472,0.00027547032,0.00020343425,0.00008928808,0.0012099415,0.0008631455,0.0021386193],"category_scores_gemma":[0.00051081367,0.0004124962,0.0005866002,0.00015859459,0.0006997715,0.00013033058,0.00030438582,0.0034617973,0.00045216602],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004107975,0.00008278354,0.001362706,0.0003171448,0.00061159255,0.10417778,0.00032923179,9.969328e-7,0.00027472025,0.00003964461,0.89218324,0.0005790739],"study_design_scores_gemma":[0.0023520684,0.00024851543,0.0012064142,0.0047816914,0.00043837389,0.39962962,0.00032005526,5.2324e-7,0.00028299657,0.0027700353,0.58749187,0.0004778554],"about_ca_topic_score_codex":0.00022282395,"about_ca_topic_score_gemma":0.0001837436,"teacher_disagreement_score":0.3046914,"about_ca_system_score_codex":0.000102173486,"about_ca_system_score_gemma":0.0004380357,"threshold_uncertainty_score":0.9998327},"labels":[],"label_agreement":null},{"id":"W3022891390","doi":"10.1111/bjh.16768","title":"Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID‐19 and acute promyelocytic leukaemia","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acute promyelocytic leukemia; Concomitant; Ecchymosis; Gastroenterology; Internal medicine; Coagulopathy; Pallor; Atypical pneumonia; Pathology; Pneumonia","score_opus":0.039895434079188434,"score_gpt":0.34992987390033903,"score_spread":0.3100344398211506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022891390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52485013,0.0034960136,0.000054293596,0.47024128,0.0002766581,0.0009586427,0.00009440461,0.000015672738,0.000012895906],"genre_scores_gemma":[0.53547066,0.013689902,0.0010531645,0.4488797,0.0006282774,0.000089034926,0.000055199267,0.000099113895,0.000034927427],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9959975,0.00050117256,0.0014191368,0.0006785287,0.0007608348,0.00064284046],"domain_scores_gemma":[0.9947062,0.0030977172,0.00088524463,0.00022046908,0.0004804451,0.00060992804],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00038281656,0.00042448682,0.0032204248,0.00034815882,0.00011716048,0.000082790415,0.00019920377,0.0005026578,0.00006437326],"category_scores_gemma":[0.0108251115,0.00036454343,0.00018371154,0.00022889487,0.0011709338,0.000105867715,0.00033224284,0.003691185,0.000004685213],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001104559,0.00008952341,0.00073028257,0.0028867847,0.0008865912,0.8407527,0.00040967335,6.2125855e-7,0.000021020916,0.0000036408856,0.15038507,0.0027295337],"study_design_scores_gemma":[0.00956425,0.0089631425,0.004114947,0.006151228,0.0013422758,0.920348,0.00023103434,0.00006658065,0.000009020512,0.0007369048,0.047965877,0.00050674647],"about_ca_topic_score_codex":0.00013281358,"about_ca_topic_score_gemma":0.00007291622,"teacher_disagreement_score":0.1024192,"about_ca_system_score_codex":0.00042664507,"about_ca_system_score_gemma":0.0017501144,"threshold_uncertainty_score":0.9998807},"labels":[],"label_agreement":null},{"id":"W3024646314","doi":"10.1111/bjh.16731","title":"Thromboprophylaxis in patients with multiple myeloma","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Aspirin; Internal medicine; Malignancy; Cancer; Population; Ambulatory; Low molecular weight heparin; Randomized controlled trial; Intensive care medicine; Heparin; Surgery; Warfarin","score_opus":0.008775893951695805,"score_gpt":0.21603038267171465,"score_spread":0.20725448872001884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024646314","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67935085,0.001531549,0.000043418808,0.31675974,0.0007358521,0.00090575975,0.00003790026,0.00002687988,0.0006080118],"genre_scores_gemma":[0.49294809,0.0006017578,0.0014183399,0.5032866,0.001342199,0.000021036883,0.00015788052,0.0001313929,0.00009271885],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99756634,0.00013068157,0.0009065031,0.00033336252,0.0006169094,0.00044619536],"domain_scores_gemma":[0.9985003,0.00010026885,0.00071927655,0.00021559886,0.0003366324,0.00012791113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000115144256,0.00028565066,0.00223659,0.0003212815,0.000049019654,0.00004390813,0.00027037947,0.00041609223,0.00022399669],"category_scores_gemma":[0.0002177403,0.00026792157,0.00022777412,0.00021836768,0.00014935357,0.00009855797,0.00008902622,0.0021831,0.000036723544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012455454,0.0004279909,0.02729174,0.0006058676,0.0003941279,0.24491104,0.0000631625,0.0000012321555,9.830312e-7,0.0000042622114,0.72220016,0.0039748577],"study_design_scores_gemma":[0.00955146,0.0040011727,0.5080932,0.0039026923,0.00065922906,0.046673745,0.000055251712,0.000004901927,0.000024916211,0.00016497065,0.42635262,0.0005158678],"about_ca_topic_score_codex":0.00012274562,"about_ca_topic_score_gemma":0.00008609951,"teacher_disagreement_score":0.48080143,"about_ca_system_score_codex":0.000107427564,"about_ca_system_score_gemma":0.00017464272,"threshold_uncertainty_score":0.9999773},"labels":[],"label_agreement":null},{"id":"W3024682048","doi":"10.1111/bjh.16695","title":"Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase‐based therapy","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pulmonary embolism; Deep vein; Thrombosis; Asparaginase; Odds ratio; Low molecular weight heparin; Internal medicine; Cohort; Venous thrombosis; Confidence interval; Incidence (geometry); Chemotherapy; Surgery; Retrospective cohort study; Complication; Lymphoblastic Leukemia; Leukemia","score_opus":0.01907587033070731,"score_gpt":0.2739000290572717,"score_spread":0.2548241587265644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024682048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947873,0.00084785017,0.0010004696,0.0025627804,0.0000782212,0.00053966086,0.000012671524,0.000041856878,0.00012918617],"genre_scores_gemma":[0.99682975,0.0005689866,0.0011836425,0.0011430086,0.00015692628,0.000016016473,0.000022201008,0.00006138515,0.000018069135],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9973602,0.00034946107,0.00083073665,0.0003686946,0.00055551325,0.00053537835],"domain_scores_gemma":[0.99799114,0.00026313422,0.00046628044,0.00017302872,0.0007444581,0.00036196545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002902194,0.00026611538,0.0013987336,0.00031121497,0.0000854822,0.00006672668,0.00026180677,0.00023965,0.000086975284],"category_scores_gemma":[0.00051455945,0.00023002412,0.00013376375,0.00073410274,0.00033354064,0.00022070188,0.000031608575,0.0006094396,0.000023209492],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022423226,0.0027963487,0.029049981,0.0008140891,0.0021119586,0.8086036,0.0016369597,0.0020034846,0.085529,0.00015166601,0.004910827,0.03996886],"study_design_scores_gemma":[0.07117464,0.024475673,0.18275,0.0041826335,0.00084451825,0.55015844,0.0005436243,0.0263724,0.13802764,0.00021486299,0.00024447197,0.0010111023],"about_ca_topic_score_codex":0.00018197863,"about_ca_topic_score_gemma":0.000026248987,"teacher_disagreement_score":0.25844517,"about_ca_system_score_codex":0.00036093974,"about_ca_system_score_gemma":0.0017443477,"threshold_uncertainty_score":0.9380111},"labels":[],"label_agreement":null},{"id":"W3025928387","doi":"10.1111/bjh.16815","title":"COVID‐19 and myeloma: what are the implications for now and in the future?","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Multiple myeloma; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Intensive care medicine; Health care; Disease; Virology; Immunology; Internal medicine; Economic growth; Economics; Infectious disease (medical specialty)","score_opus":0.06370502020138194,"score_gpt":0.3764738029191794,"score_spread":0.3127687827177975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025928387","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43892434,0.031851668,0.0001979585,0.5286966,0.00006209258,0.00024896237,0.000008670547,0.0000032431728,0.000006483305],"genre_scores_gemma":[0.91477954,0.014528543,0.00014773417,0.070205316,0.00031593675,0.000010896678,0.000002044814,0.000006782729,0.0000032074827],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992826,0.000097461074,0.0002886541,0.000099188306,0.00007675355,0.00015533014],"domain_scores_gemma":[0.99879384,0.00056910934,0.00017513608,0.00008019342,0.00010214635,0.00027955265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000407611,0.00006105804,0.00031854643,0.00004098076,0.00014721158,0.000068630514,0.00009946637,0.00007064836,0.000007926272],"category_scores_gemma":[0.0010623154,0.000040632814,0.000046585763,0.00010295815,0.000111562906,0.00011023858,0.000022221793,0.00028149856,5.452632e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018159128,0.00033722533,0.3448484,0.0042624758,0.0002526395,0.020808568,0.013014532,0.000005652354,0.00034729697,0.0067384928,0.26153544,0.3460334],"study_design_scores_gemma":[0.0022684485,0.00033416186,0.5485714,0.00024196642,0.000083680694,0.31314293,0.00813656,0.000017819655,0.00000822338,0.0031935922,0.12393493,0.00006629673],"about_ca_topic_score_codex":0.00002076182,"about_ca_topic_score_gemma":0.001213689,"teacher_disagreement_score":0.4758552,"about_ca_system_score_codex":0.000023637393,"about_ca_system_score_gemma":0.0003255016,"threshold_uncertainty_score":0.16569582},"labels":[],"label_agreement":null},{"id":"W3026628563","doi":"10.1111/bjh.16736","title":"Triage tool for the rationing of blood for massively bleeding patients during a severe national blood shortage: guidance from the National Blood Transfusion Committee","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Economic shortage; Triage; Rationing; Medicine; Blood transfusion; Pandemic; Intensive care medicine; Medical emergency; Transfusion medicine; Blood supply; Business; Health care; Coronavirus disease 2019 (COVID-19); Emergency medicine; Surgery; Economics","score_opus":0.026887631576474176,"score_gpt":0.24674203496198513,"score_spread":0.21985440338551096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026628563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98057944,0.00090570387,0.0033195121,0.01341138,0.00039034567,0.0008152915,0.00018235751,0.000022525915,0.00037347391],"genre_scores_gemma":[0.99490184,0.00016082081,0.001689246,0.0020849102,0.0010140222,0.000057076995,0.00004772074,0.000026120635,0.000018243372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784166,0.000058480728,0.000986057,0.00022528917,0.00068773254,0.00020078482],"domain_scores_gemma":[0.99523944,0.0016247132,0.0011442521,0.00006134237,0.0019096569,0.000020599955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009879671,0.00015869366,0.00040431492,0.000097566175,0.00070518424,0.00028759323,0.0004645881,0.00010236376,0.00017670282],"category_scores_gemma":[0.0027788088,0.00013090053,0.00026914303,0.00027512823,0.00007949911,0.0011716933,0.000054481236,0.00029706248,0.0000018664358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012744749,0.012409215,0.5431782,0.0059938594,0.0213892,0.0016878472,0.0060414583,0.0080463225,0.059536617,0.20315686,0.093936376,0.03187929],"study_design_scores_gemma":[0.20210455,0.0013331233,0.58434844,0.0042786496,0.023024222,0.013245493,0.0056890496,0.02232611,0.028256815,0.03827774,0.0737694,0.0033463761],"about_ca_topic_score_codex":0.000055306227,"about_ca_topic_score_gemma":0.000091745496,"teacher_disagreement_score":0.18935981,"about_ca_system_score_codex":0.000007972208,"about_ca_system_score_gemma":0.00010227845,"threshold_uncertainty_score":0.5423778},"labels":[],"label_agreement":null},{"id":"W3026834368","doi":"10.1111/bjh.16711","title":"Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Alexion Pharmaceuticals","keywords":"Eculizumab; Pharmacodynamics; Pharmacokinetics; Medicine; Complement component 5; Pharmacology; Internal medicine; Antibody; Immunology; Complement system","score_opus":0.015201525832797956,"score_gpt":0.29815317506785755,"score_spread":0.2829516492350596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026834368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96287286,0.0350559,0.000056217224,0.00044775594,0.0002966792,0.0010650571,0.0001764597,0.000009470355,0.000019577154],"genre_scores_gemma":[0.99726844,0.0023611174,0.00016506235,0.00010855082,0.000029932351,0.000018011446,0.000027900098,0.000017573706,0.000003396857],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99679685,0.00087670673,0.001524197,0.00032287123,0.00013803733,0.00034133633],"domain_scores_gemma":[0.99729985,0.000995164,0.001249588,0.00010668337,0.00024586727,0.00010283745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003332619,0.00027602512,0.0015641071,0.00018254688,0.00007348522,0.000009438117,0.00022130489,0.00006630304,0.00005117401],"category_scores_gemma":[0.00029174853,0.0002480136,0.0001142423,0.00012432048,0.0005073583,0.00008276155,0.00013185327,0.00035604433,0.0000017314559],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58541995,0.0077529587,0.0108706625,0.018969033,0.010813559,0.060253683,0.017558958,0.0012376468,0.19956595,0.00026564932,0.008530422,0.0787615],"study_design_scores_gemma":[0.8402094,0.0068510007,0.0047822213,0.009049191,0.001301354,0.050370306,0.002994247,0.000748394,0.08249488,0.00006065099,0.0005957289,0.00054261915],"about_ca_topic_score_codex":0.00009427076,"about_ca_topic_score_gemma":0.000110985755,"teacher_disagreement_score":0.25478944,"about_ca_system_score_codex":0.00004455485,"about_ca_system_score_gemma":0.00007080739,"threshold_uncertainty_score":0.9999972},"labels":[],"label_agreement":null},{"id":"W3027036348","doi":"10.1111/bjh.16756","title":"Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Pharmacyclics; Genentech; Incyte; Astex Pharmaceuticals; Adaptive Biotechnologies; Gilead Sciences; Celgene; AstraZeneca; Bristol-Myers Squibb; TG Therapeutics; Pfizer; Regeneron Pharmaceuticals; American Cancer Society","keywords":"Medicine; Internal medicine; Refractory (planetary science); Regimen; Salvage therapy; Chemotherapy; Oncology; Lymphoma; Surgery","score_opus":0.03151984129911549,"score_gpt":0.275926385001685,"score_spread":0.24440654370256948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027036348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764278,0.00839219,0.00006984572,0.013698802,0.0003223789,0.00048581223,0.00002230195,0.00003557483,0.00054527825],"genre_scores_gemma":[0.9884191,0.0056059053,0.0015437417,0.003833448,0.00041407286,0.000028803295,0.000011436716,0.00004461164,0.00009886648],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979054,0.00012853886,0.0008612877,0.00033579837,0.00035203935,0.0004169634],"domain_scores_gemma":[0.9982991,0.00012463753,0.00037148982,0.00020581529,0.0002552287,0.0007437145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014236858,0.00028695134,0.0012423211,0.00013158808,0.00009732425,0.00005033499,0.00013125752,0.00016257515,0.00022852152],"category_scores_gemma":[0.00014768045,0.00025159545,0.0004578511,0.00018630884,0.000086647415,0.00009053846,0.000039280596,0.00012978121,0.00012562166],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026262228,0.004991686,0.017848797,0.00009815455,0.001986576,0.5767145,0.00273893,0.000032714473,0.015588413,0.00006585976,0.01386098,0.3634472],"study_design_scores_gemma":[0.028834652,0.014150721,0.10007461,0.0007637657,0.00054389006,0.6079746,0.0005123241,0.000033629472,0.15300289,0.000071451774,0.09357872,0.00045875728],"about_ca_topic_score_codex":0.00032152736,"about_ca_topic_score_gemma":0.000059251135,"teacher_disagreement_score":0.3629884,"about_ca_system_score_codex":0.0005353657,"about_ca_system_score_gemma":0.00061720645,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W3028582164","doi":"10.1111/bjh.16750","title":"Genotype–phenotype correlation in children with hereditary spherocytosis","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Hospital for Sick Children; SickKids Foundation; University of Toronto; London Health Sciences Centre; St. Michael's Hospital; Western University","funders":"Hospital for Sick Children","keywords":"Splenectomy; Hereditary spherocytosis; Spherocytosis; Medicine; Phenotype; Genotype; Gastroenterology; Hemolytic anemia; Internal medicine; Immunology; Pediatrics; Genetics; Spleen; Biology; Gene","score_opus":0.012775078847471243,"score_gpt":0.22471166352952437,"score_spread":0.21193658468205312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028582164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944661,0.001984927,0.0014345144,0.0013722732,0.00018897383,0.00014012112,0.0000031162576,0.000017175042,0.00039276734],"genre_scores_gemma":[0.9951272,0.00025219694,0.0020397115,0.0022037476,0.00031835726,0.0000015171668,0.000016405354,0.000018242685,0.000022613334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904764,0.000091040856,0.00040883222,0.00014444102,0.00014208531,0.0001659517],"domain_scores_gemma":[0.9993845,0.000039003673,0.00022047939,0.000065176435,0.00014077338,0.00015006264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008718444,0.000094809075,0.0005265142,0.000068097324,0.000032182368,0.0000072012613,0.00006861379,0.00013028731,0.0004318375],"category_scores_gemma":[0.00012282038,0.00009093144,0.00007187908,0.00019966115,0.00007640094,0.000090022586,0.000017349052,0.00046173893,0.0000484175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057668244,0.00055917166,0.8704925,0.00018932806,0.0006671987,0.06555998,0.0007451889,0.0010376549,0.0028215803,0.00026821616,0.021763442,0.030128917],"study_design_scores_gemma":[0.0046788747,0.0019784295,0.6030208,0.00022044648,0.00014301401,0.38825837,0.00017082205,0.00021125525,0.00024038217,0.00010999217,0.00082738895,0.00014026347],"about_ca_topic_score_codex":0.000055332457,"about_ca_topic_score_gemma":0.00006409091,"teacher_disagreement_score":0.32269838,"about_ca_system_score_codex":0.000026234298,"about_ca_system_score_gemma":0.00013055305,"threshold_uncertainty_score":0.4728318},"labels":[],"label_agreement":null},{"id":"W3029104222","doi":"10.1111/bjh.16724","title":"The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Agios Pharmaceuticals; American Society of Hematology; National Hemophilia Foundation","keywords":"Pyruvate kinase; Hexokinase; Pyruvate kinase deficiency; Enzyme; Phenotype; Biochemistry; Chemistry; Endocrinology; Internal medicine; Glycolysis; Medicine; Gene","score_opus":0.04615363799648283,"score_gpt":0.2771513698068661,"score_spread":0.23099773181038327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029104222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791271,0.005576852,0.00046921265,0.014142103,0.000112043745,0.0004629029,0.000013605763,0.000006582258,0.00008957742],"genre_scores_gemma":[0.99562186,0.0018604981,0.00030505762,0.0020574771,0.00009625539,0.00002779946,0.0000012624178,0.00001211978,0.000017662378],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985196,0.00035798104,0.0004854806,0.00020088023,0.00019772633,0.00023832619],"domain_scores_gemma":[0.99886405,0.0003828138,0.00029768166,0.0001331834,0.00016870667,0.00015356329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052002334,0.00013241581,0.00057729403,0.000075984724,0.00015641643,0.000030977993,0.00014210521,0.00010394289,0.00003234585],"category_scores_gemma":[0.0010667947,0.0000945945,0.00007302163,0.00025124272,0.00029145496,0.000100856,0.0000747958,0.00044689223,0.000003537402],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016478145,0.003182817,0.034060806,0.0033595334,0.00054311496,0.06489226,0.016428573,0.00012719847,0.48786798,0.010379684,0.03443616,0.3282437],"study_design_scores_gemma":[0.022005208,0.018808074,0.5633704,0.0036448252,0.0007646326,0.1818798,0.008404625,0.00084409694,0.16880873,0.004565312,0.025640612,0.0012636482],"about_ca_topic_score_codex":0.00013569264,"about_ca_topic_score_gemma":0.00032393172,"teacher_disagreement_score":0.52930963,"about_ca_system_score_codex":0.000017826764,"about_ca_system_score_gemma":0.00012637742,"threshold_uncertainty_score":0.38574517},"labels":[],"label_agreement":null},{"id":"W3030042359","doi":"10.1111/bjh.16888","title":"Haemoglobin oxygen affinity in patients with severe COVID‐19 infection","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"British Heart Foundation; Heart and Stroke Foundation of British Columbia and Yukon","keywords":"ARDS; Hydroxychloroquine; Lung; Coronavirus; Hypoxia (environmental); Medicine; Pandemic; Docking (animal); Immunology; Receptor; Coronavirus disease 2019 (COVID-19); Biology; Virology; Disease; Pathology; Internal medicine; Chemistry; Infectious disease (medical specialty); Oxygen","score_opus":0.03523524728419551,"score_gpt":0.34575688320529274,"score_spread":0.3105216359210972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030042359","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19982444,0.00056891167,0.00020496837,0.79762405,0.0004571003,0.00092532265,0.000107017426,0.000043944656,0.0002442221],"genre_scores_gemma":[0.17787944,0.0017928123,0.00044028985,0.81789565,0.0014496205,0.000025635578,0.00016713566,0.00008996727,0.00025942433],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595845,0.0006268964,0.0012876485,0.0004640647,0.0010670295,0.00059589796],"domain_scores_gemma":[0.99491,0.0027204326,0.0009009805,0.0002480204,0.0007611063,0.0004594839],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00060502806,0.00032225373,0.002171234,0.0004358311,0.00011308562,0.00004722844,0.00029204093,0.0007188234,0.00031722162],"category_scores_gemma":[0.038372867,0.0003021519,0.00032871118,0.00043538396,0.00040865323,0.00013233388,0.00023704529,0.005632028,0.000040472438],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000787446,0.0002335962,0.12906551,0.001798742,0.0003699588,0.21424451,0.000046758792,0.000013903443,3.1029987e-7,0.0000016538622,0.65165186,0.0017857617],"study_design_scores_gemma":[0.012410747,0.003203957,0.19994862,0.0026100946,0.0004123698,0.039831713,0.000014214177,0.0000073431743,0.0000025243423,0.00061539037,0.7404813,0.00046173047],"about_ca_topic_score_codex":0.00065424043,"about_ca_topic_score_gemma":0.00032628598,"teacher_disagreement_score":0.1744128,"about_ca_system_score_codex":0.0005822643,"about_ca_system_score_gemma":0.0018820157,"threshold_uncertainty_score":0.9999431},"labels":[],"label_agreement":null},{"id":"W3032347427","doi":"10.1111/bjh.16784","title":"<i>Clostridium perfringens</i> sepsis with spherocytosis and green neutrophil inclusions","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Clostridium perfringens; Hereditary spherocytosis; Sepsis; Medicine; Microbiology; Immunology; Biology; Internal medicine; Bacteria; Genetics","score_opus":0.04286148041934137,"score_gpt":0.2746661956047065,"score_spread":0.23180471518536513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032347427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635892,0.0075212065,0.000038748498,0.028278349,0.00005406175,0.00014424538,0.000009894443,0.000016700016,0.00034762887],"genre_scores_gemma":[0.99128884,0.00262395,0.0017597259,0.0041125,0.00016480067,0.000005115358,0.0000031429806,0.000024729348,0.000017215072],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998942,0.00005530996,0.00038640588,0.00018891324,0.00021918352,0.0002081861],"domain_scores_gemma":[0.99904215,0.000088922825,0.00021765339,0.00008757001,0.00018316717,0.00038053418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006985857,0.00013764422,0.00070297247,0.00005313408,0.000117911615,0.000026483538,0.00008035942,0.00008395565,0.00018559674],"category_scores_gemma":[0.00008120589,0.00011744476,0.00011625702,0.00014728119,0.00011146831,0.00007835717,0.00008273135,0.0002718625,0.000008772757],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002323211,0.0021645778,0.3706431,0.000759962,0.0030853671,0.4952079,0.001991979,0.00003136209,0.0047583804,0.0003532124,0.049726445,0.068954505],"study_design_scores_gemma":[0.01127929,0.0055305697,0.06837693,0.0012211535,0.0018724636,0.87719536,0.00081229385,0.000055270215,0.013866783,0.00016502326,0.019251933,0.0003729522],"about_ca_topic_score_codex":0.00014274777,"about_ca_topic_score_gemma":0.00006882304,"teacher_disagreement_score":0.38198742,"about_ca_system_score_codex":0.00003109339,"about_ca_system_score_gemma":0.000099106175,"threshold_uncertainty_score":0.47892585},"labels":[],"label_agreement":null},{"id":"W3033465546","doi":"10.1111/bjh.16777","title":"Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University Health Network","funders":"Princess Margaret Cancer Foundation; Genome Canada","keywords":"Medicine; Biomarker; Oncology; Lymphoma; Internal medicine; Transplantation; Cohort; Autologous stem-cell transplantation; Biology","score_opus":0.02296941156267117,"score_gpt":0.26572079870523535,"score_spread":0.24275138714256417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033465546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350953,0.0016121465,0.00058912614,0.0032874674,0.00021164237,0.0005001593,0.00003891641,0.000010349487,0.00024063872],"genre_scores_gemma":[0.99816257,0.00008820334,0.0012178386,0.00034928808,0.00007887354,0.000023561386,0.000020508307,0.00001883476,0.00004031118],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987195,0.00010079224,0.0005925823,0.00015377143,0.00026543357,0.00016791178],"domain_scores_gemma":[0.9986244,0.0003151585,0.0005327516,0.000114690534,0.0002744082,0.00013858154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018345696,0.00011178089,0.000521488,0.000048546306,0.00005424322,0.000036715617,0.0001305558,0.00010867486,0.00003432381],"category_scores_gemma":[0.0017030236,0.00008227359,0.00029619577,0.0001263857,0.00008523138,0.00012491514,0.000049972205,0.00005982898,0.0000065246973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045722625,0.0061020674,0.50672174,0.001262429,0.0022015993,0.041054703,0.0015514506,0.000027822847,0.098946996,0.0006290534,0.071232036,0.26569784],"study_design_scores_gemma":[0.022861067,0.0024005692,0.17124112,0.0025109916,0.00096707605,0.29501253,0.0002567302,0.00015803464,0.49757516,0.0010910309,0.00565621,0.00026948345],"about_ca_topic_score_codex":0.000009671038,"about_ca_topic_score_gemma":8.547318e-7,"teacher_disagreement_score":0.39862818,"about_ca_system_score_codex":0.0000605149,"about_ca_system_score_gemma":0.0003014501,"threshold_uncertainty_score":0.33550197},"labels":[],"label_agreement":null},{"id":"W3033518311","doi":"10.1111/bjh.16812","title":"Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Children's Hospital of Michigan; Children’s Hospital of Michigan Foundation","keywords":"Eltrombopag; Bernard–Soulier syndrome; Romiplostim; Thrombopoietin receptor; Platelet; Platelet Glycoprotein GPIb-IX Complex; Ristocetin; Medicine; Platelet disorder; Thrombopoietin; Platelet membrane glycoprotein; Megakaryocyte; Platelet transfusion; Internal medicine; Bone marrow failure; Bone marrow; Mean platelet volume; Pediatrics; Gastroenterology; Von Willebrand factor; Biology; Genetics; Haematopoiesis","score_opus":0.015400076659829294,"score_gpt":0.25664684406926347,"score_spread":0.24124676740943418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033518311","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4901304,0.0030209264,0.00012840384,0.50397587,0.00032223968,0.00078308384,0.00017163735,0.000035921763,0.0014315345],"genre_scores_gemma":[0.09600665,0.0008912689,0.008232368,0.89179915,0.0010249584,0.000031935862,0.00025042085,0.00023415976,0.0015290949],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9971938,0.00017669649,0.0008651478,0.0004882316,0.0006384209,0.0006377036],"domain_scores_gemma":[0.99806,0.00020260124,0.00066472415,0.00026572723,0.00047368678,0.00033324742],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00011366691,0.00043482796,0.002618672,0.0003303143,0.0001330603,0.00008172773,0.00036417792,0.0006117539,0.00041343403],"category_scores_gemma":[0.00032191948,0.00039525775,0.00028848174,0.00031641164,0.0001657545,0.00011721492,0.000095888005,0.0023894748,0.00023932732],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007324191,0.00007417338,0.000073333635,0.00015715447,0.00033934478,0.51884395,0.00006906617,0.0000031174757,0.00001738468,0.0000028345078,0.47853708,0.0011501078],"study_design_scores_gemma":[0.0035822343,0.0022164609,0.00020322013,0.001500799,0.00048028593,0.7708152,0.00005659666,0.0000019292142,0.00013035846,0.00019979695,0.22049198,0.00032112977],"about_ca_topic_score_codex":0.00007233596,"about_ca_topic_score_gemma":0.000053545013,"teacher_disagreement_score":0.39412373,"about_ca_system_score_codex":0.0001329651,"about_ca_system_score_gemma":0.0007488939,"threshold_uncertainty_score":0.999912},"labels":[],"label_agreement":null},{"id":"W3033592362","doi":"10.1111/bjh.16751","title":"Fatigue in children and adolescents with immune thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"National Heart, Lung, and Blood Institute; Vanderbilt University","keywords":"Medicine; Immune thrombocytopenia; Quality of life (healthcare); Cohort; Platelet; Observational study; Pediatrics; Cohort study; Internal medicine","score_opus":0.011942441310740555,"score_gpt":0.24611527355799226,"score_spread":0.23417283224725172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033592362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323416,0.0052979058,0.000042998905,0.0011721028,0.00001737591,0.00015076429,0.0000032717217,0.0000049068335,0.000076515345],"genre_scores_gemma":[0.9983581,0.0008074619,0.00036785193,0.0004301363,0.000017288361,8.830622e-7,0.0000040544032,0.000010743186,0.0000035259704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933994,0.000031151245,0.00028132077,0.00010447815,0.00010297791,0.0001401212],"domain_scores_gemma":[0.99965936,0.000006651248,0.00013276715,0.000040719624,0.000043064454,0.000117431635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048420672,0.00007835474,0.0006730986,0.00004688985,0.000023131188,0.000013918169,0.000053940385,0.000053222564,0.000022246068],"category_scores_gemma":[0.000036455036,0.00006908562,0.000036236892,0.000085797765,0.000065258086,0.0000782362,0.000020993864,0.00022173632,0.0000032319606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052528776,0.000307628,0.81215173,0.00007603249,0.00019480476,0.17828704,0.0001616992,0.000002563103,0.00016382613,0.000017645454,0.00034222813,0.0077695204],"study_design_scores_gemma":[0.005662314,0.00042616166,0.5768485,0.00060819945,0.000059244507,0.41608354,0.000040857798,0.0000067887713,0.00016473733,0.00003305537,0.00001732931,0.000049255697],"about_ca_topic_score_codex":0.00008585351,"about_ca_topic_score_gemma":0.000041071722,"teacher_disagreement_score":0.23779649,"about_ca_system_score_codex":0.000010276536,"about_ca_system_score_gemma":0.000048505648,"threshold_uncertainty_score":0.28172296},"labels":[],"label_agreement":null},{"id":"W3033832930","doi":"10.1111/bjh.16740","title":"Long‐term follow‐up of neonatal intracranial haemorrhage in children with severe haemophilia","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"Vetenskapsrådet; Bayer HealthCare","keywords":"Intracranial haemorrhage; Medicine; Haemophilia; Pediatrics; Term (time); Haemophilia A; Intracranial bleeding; Intensive care medicine; Surgery; Complication","score_opus":0.015836447458398996,"score_gpt":0.26451536946000614,"score_spread":0.24867892200160716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033832930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8332318,0.004495808,0.000050005507,0.16069089,0.0003902129,0.0007998418,0.00014532948,0.00001928464,0.00017684969],"genre_scores_gemma":[0.91635317,0.0026029507,0.0022278393,0.07081298,0.005103162,0.000027399745,0.0009360985,0.000289901,0.0016465283],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99617517,0.0002856322,0.0013238728,0.00047306306,0.0010250672,0.0007172187],"domain_scores_gemma":[0.9980443,0.00018278451,0.00077958335,0.0003146538,0.00040207742,0.00027661695],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00025467455,0.0004513811,0.0026525755,0.00059004617,0.00006695711,0.00004439792,0.00052790635,0.00093981874,0.0005645588],"category_scores_gemma":[0.0002732356,0.00039752093,0.00050045346,0.00038915523,0.0005086762,0.00016340356,0.00012928859,0.0043592574,0.000027958675],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096227706,0.00016345382,0.111956574,0.0007461193,0.0010695102,0.67951,0.00013672399,6.4091984e-7,0.000015988233,0.0000014162852,0.18741886,0.018018454],"study_design_scores_gemma":[0.01182042,0.0016983356,0.044509858,0.0028390726,0.00064215553,0.93581116,0.000034486035,0.0000059039935,0.00019344922,0.000090339876,0.0020020185,0.00035280117],"about_ca_topic_score_codex":0.00013566935,"about_ca_topic_score_gemma":0.00014324166,"teacher_disagreement_score":0.2563012,"about_ca_system_score_codex":0.00011151801,"about_ca_system_score_gemma":0.00087523967,"threshold_uncertainty_score":0.99984765},"labels":[],"label_agreement":null},{"id":"W3034037943","doi":"10.1111/bjh.16793","title":"Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Merck Sharp and Dohme; Myeloma UK; University of Leeds; National Institute for Health and Care Research; Institute of Cancer Research; Cancer Research UK; Royal Marsden NHS Foundation Trust; National Cancer Research Institute; Celgene; University of Birmingham; Cancer Research Institute","keywords":"Medicine; Multiple myeloma; Melphalan; Oncology; Stem cell; Internal medicine; Disease; Transplantation; Overall survival; Surgery; Biology","score_opus":0.011623310942427956,"score_gpt":0.22495124785147702,"score_spread":0.21332793690904905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034037943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106896,0.0041758334,0.00006152958,0.00324897,0.00006521251,0.0005869006,0.0007534839,0.000031931722,0.0000071941263],"genre_scores_gemma":[0.99680185,0.0023113186,0.00041303772,0.00023213003,0.00007394994,0.000033557135,0.000055758963,0.000049852704,0.000028546385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728215,0.0005431475,0.0006616405,0.00044483074,0.0005379087,0.00053035247],"domain_scores_gemma":[0.997302,0.0003836096,0.00027807514,0.00016063628,0.00019622837,0.0016794752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025194173,0.000287657,0.0010240441,0.00015656036,0.00008834283,0.00007868169,0.00012731335,0.00015848187,0.00006421065],"category_scores_gemma":[0.00033175832,0.00025322498,0.00009384964,0.0001608082,0.0003044382,0.00017034162,0.00007527244,0.0006201131,0.0000052645446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009894913,0.00030422237,0.67245746,0.00023685445,0.00033840354,0.31123066,0.00059709826,0.000012062942,0.00006822503,0.000014068579,0.00004251942,0.0048035407],"study_design_scores_gemma":[0.018836092,0.0015303954,0.97101736,0.00078038,0.0005829721,0.0061179856,0.00006573605,0.0006788816,0.00007610033,0.00008259099,0.000015399151,0.00021610834],"about_ca_topic_score_codex":0.0009134391,"about_ca_topic_score_gemma":0.0003804764,"teacher_disagreement_score":0.30511266,"about_ca_system_score_codex":0.000052555548,"about_ca_system_score_gemma":0.00033071538,"threshold_uncertainty_score":0.999992},"labels":[],"label_agreement":null},{"id":"W3037719485","doi":"10.1111/bjh.16961","title":"Amelioration of COVID‐19‐related cytokine storm syndrome: parallels to chimeric antigen receptor‐T cell cytokine release syndrome","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Vancouver Coastal Health Research Institute","keywords":"Cytokine release syndrome; Cytokine storm; Chimeric antigen receptor; Cytokine; Coronavirus disease 2019 (COVID-19); Immunology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cytokine receptor; Medicine; Receptor; 2019-20 coronavirus outbreak; Virology; Immunotherapy; Immune system; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.025521533568235832,"score_gpt":0.2938366043423085,"score_spread":0.2683150707740727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037719485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490083,0.0036775044,0.00088362413,0.009136616,0.00024930306,0.000733129,0.000060172973,0.000048702794,0.00031012952],"genre_scores_gemma":[0.9935689,0.0026426353,0.0017755294,0.0012708975,0.000091767026,0.000010502541,0.00005274993,0.00007357542,0.0005134305],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9963639,0.00040784356,0.0014823988,0.00039936198,0.0008177093,0.0005288172],"domain_scores_gemma":[0.9969529,0.00017580268,0.0007872014,0.0003005973,0.0005115891,0.0012719153],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076061126,0.00026338032,0.0016583388,0.00046600978,0.00010377618,0.00003656743,0.00039921535,0.00027764062,0.005428517],"category_scores_gemma":[0.0010436815,0.00029262106,0.00033353342,0.0011372461,0.00023183116,0.0001877336,0.00011764494,0.00090892805,0.00016750407],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061628995,0.0016315741,0.013911732,0.0018231212,0.0013311568,0.3837421,0.0026981337,0.0008344194,0.5239218,0.0000990369,0.050642367,0.013201684],"study_design_scores_gemma":[0.009994654,0.008728452,0.011234384,0.0007896531,0.00028381552,0.9015717,0.0007086725,0.00018547311,0.022366311,0.00014899192,0.043466702,0.0005212079],"about_ca_topic_score_codex":0.00020961277,"about_ca_topic_score_gemma":0.00002858631,"teacher_disagreement_score":0.5178296,"about_ca_system_score_codex":0.00018580508,"about_ca_system_score_gemma":0.0007076073,"threshold_uncertainty_score":0.9999526},"labels":[],"label_agreement":null},{"id":"W3037948978","doi":"10.1111/bjh.16891","title":"Clinical value of next‐generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Cytogenetics; Myelodysplastic syndromes; Internal medicine; Oncology; Predictive value; DNA sequencing; Pathology; Bone marrow; Biology; Chromosome; Gene; Genetics","score_opus":0.07179874823036245,"score_gpt":0.3178360345580713,"score_spread":0.24603728632770885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037948978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967153,0.0001955119,0.0017546955,0.000818328,0.00011270464,0.00035379443,0.000009623851,0.000008522789,0.000031502273],"genre_scores_gemma":[0.99033576,0.000052643958,0.008950619,0.00051034236,0.00010051376,0.000002370082,0.00001744755,0.00002598413,0.000004321491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751467,0.00029998904,0.0012114627,0.00021541472,0.00047280453,0.00028567857],"domain_scores_gemma":[0.99824446,0.00019866673,0.00037449904,0.0001238376,0.0006871418,0.00037141275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039583517,0.00012045432,0.001041779,0.00020599233,0.000029996663,0.000019473973,0.0001909591,0.00013331088,0.00005658302],"category_scores_gemma":[0.0014335671,0.00012000308,0.00008510771,0.00046212377,0.00013503685,0.00008902084,0.000069806294,0.000610403,0.000010116604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028579764,0.00050181017,0.9104889,0.0003152751,0.00037061662,0.07207284,0.0004587337,0.0024549407,0.0049837157,0.00008990568,0.0023190829,0.0030861986],"study_design_scores_gemma":[0.013737797,0.006362297,0.880032,0.0011248774,0.00019911148,0.08901442,0.0002544697,0.007317906,0.0016162448,0.000025361764,0.00008099149,0.00023453076],"about_ca_topic_score_codex":0.00006000407,"about_ca_topic_score_gemma":0.00007924767,"teacher_disagreement_score":0.030456908,"about_ca_system_score_codex":0.00019905338,"about_ca_system_score_gemma":0.0006686849,"threshold_uncertainty_score":0.48935837},"labels":[],"label_agreement":null},{"id":"W3043437003","doi":"10.1111/bjh.16945","title":"Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Leeds; National Institute for Health and Care Research; Institute of Cancer Research; Cancer Research UK; Royal Marsden NHS Foundation Trust; National Cancer Research Institute; Celgene; University of Birmingham; Cancer Research Institute; Merck; Myeloma UK","keywords":"Medicine; Lenalidomide; Thalidomide; Multiple myeloma; Tolerability; Internal medicine; Discontinuation; Maintenance therapy; Cyclophosphamide; Dexamethasone; Oncology; Dosing; Surgery; Chemotherapy; Adverse effect","score_opus":0.02275721751476278,"score_gpt":0.28080097173672386,"score_spread":0.2580437542219611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043437003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953282,0.0014143862,0.00012135207,0.0006370802,0.00012810738,0.0021827845,0.00015299412,0.000009593713,0.00002549021],"genre_scores_gemma":[0.9966001,0.0008522776,0.0022279352,0.00009186988,0.0000880594,0.00003305283,0.00007004935,0.000029960607,0.000006729764],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970222,0.00039860906,0.0012879834,0.00036076942,0.0004838523,0.00044656786],"domain_scores_gemma":[0.997765,0.00066439586,0.00076040596,0.00019602201,0.0003110134,0.00030317117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005508579,0.00022729374,0.001177598,0.00016265981,0.00015768119,0.00007270904,0.00029196564,0.00012715916,0.000014910339],"category_scores_gemma":[0.0012243678,0.00017008066,0.00009590897,0.00026723172,0.00022291132,0.00035789836,0.00010321311,0.00055905303,0.0000011411544],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9400816,0.0024514543,0.011417207,0.00013580668,0.0007189075,0.018906653,0.003628743,0.00014394689,0.0023501557,0.0000040259138,0.00010806045,0.020053418],"study_design_scores_gemma":[0.9168784,0.0016115456,0.0702452,0.0016567115,0.00021778543,0.0035007598,0.0007037989,0.0017386292,0.0032502778,0.000011193006,0.000021704951,0.00016398112],"about_ca_topic_score_codex":0.0016431414,"about_ca_topic_score_gemma":0.00018826028,"teacher_disagreement_score":0.058827993,"about_ca_system_score_codex":0.000083271196,"about_ca_system_score_gemma":0.00023172243,"threshold_uncertainty_score":0.69356877},"labels":[],"label_agreement":null},{"id":"W3044441835","doi":"10.1111/bjh.16959","title":"Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Immune thrombocytopenia; Second-line therapy; Second line; Second line treatment; Post-hoc analysis; Syk; Post hoc; Internal medicine; Line (geometry); Platelet; Oncology; First line; Chemotherapy; Receptor; Mathematics","score_opus":0.013784286313514221,"score_gpt":0.25728712456209923,"score_spread":0.243502838248585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044441835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966346,0.0017956335,0.00002487043,0.00081101834,0.000052962965,0.00047551462,0.000021107078,0.000008923207,0.0001753722],"genre_scores_gemma":[0.9976442,0.00020850144,0.00046683502,0.0015943123,0.00002511006,0.0000059816757,0.000023208522,0.000022561562,0.000009287531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891776,0.000097819975,0.00043849155,0.00016336673,0.00017970773,0.00020282887],"domain_scores_gemma":[0.99926716,0.00004233194,0.0002684197,0.00008803545,0.00018382326,0.0001502225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009601297,0.00013307587,0.0010323256,0.00006992559,0.00003762143,0.000019678626,0.00009744287,0.00008594817,0.0004336555],"category_scores_gemma":[0.000047373942,0.000111372065,0.000080034726,0.00014198346,0.000061741084,0.00019412102,0.000017617409,0.00030447223,0.000011275961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012888492,0.0054988908,0.50925565,0.0002568519,0.001628114,0.24960582,0.004219383,0.0000066209423,0.0007126566,0.000038596154,0.0022047025,0.21368422],"study_design_scores_gemma":[0.037593864,0.013958561,0.891256,0.00042864212,0.000092114795,0.052937225,0.00022141168,0.000030429186,0.002659766,0.00021195563,0.00041832236,0.00019176543],"about_ca_topic_score_codex":0.000034553123,"about_ca_topic_score_gemma":0.000049352595,"teacher_disagreement_score":0.3820003,"about_ca_system_score_codex":0.000025606947,"about_ca_system_score_gemma":0.00006180329,"threshold_uncertainty_score":0.47482237},"labels":[],"label_agreement":null},{"id":"W3045194329","doi":"10.1111/bjh.16940","title":"Building Canadian capacity for CAR‐T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Manitoba; Ottawa Public Health; Canada's Michael Smith Genome Sciences Centre; University of Ottawa","funders":"","keywords":"Medicine; Chimeric antigen receptor; Malignancy; Progenitor cell; Hematopoietic stem cell transplantation; Stem cell; Internal medicine; Immunology; Haematopoiesis; Oncology; Transplantation; Immunotherapy; Cancer; Biology","score_opus":0.02159558664857928,"score_gpt":0.2844037094014702,"score_spread":0.2628081227528909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045194329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9277073,0.0009582689,0.00013140758,0.06519049,0.0020384933,0.0031475364,0.00041124612,0.000029094934,0.00038617442],"genre_scores_gemma":[0.7867849,0.0014096351,0.003661273,0.19644403,0.008198084,0.0003965786,0.00016552626,0.0006810291,0.002258971],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99501,0.00058220356,0.001460547,0.0007572188,0.001002144,0.0011878975],"domain_scores_gemma":[0.99649477,0.0008072927,0.0007767743,0.00040045736,0.00092183065,0.00059889903],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00106819,0.00048094316,0.0032155819,0.0011454509,0.00016143374,0.00009630125,0.00059718534,0.0012004195,0.0005918989],"category_scores_gemma":[0.0012484582,0.00056809734,0.00057456025,0.00047082538,0.00030935148,0.00010179768,0.00008476113,0.00658676,0.00001590432],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004257225,0.00017320615,0.016595338,0.0003166897,0.0015800493,0.48572585,0.00024681204,0.0000030132805,0.0013116924,0.0000048395013,0.4930441,0.00057266554],"study_design_scores_gemma":[0.017512,0.006712193,0.023229554,0.0026909034,0.0026963698,0.6072628,0.000314538,0.000074831056,0.00087564124,0.0007376716,0.33670267,0.0011908566],"about_ca_topic_score_codex":0.04230548,"about_ca_topic_score_gemma":0.055299588,"teacher_disagreement_score":0.15634146,"about_ca_system_score_codex":0.0040670815,"about_ca_system_score_gemma":0.0031230524,"threshold_uncertainty_score":0.99975616},"labels":[],"label_agreement":null},{"id":"W3081654405","doi":"10.1111/bjh.17039","title":"Measurement of long‐term iron absorption and loss during iron supplementation using a stable isotope of iron (<sup>57</sup>Fe)","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"Bill and Melinda Gates Foundation","keywords":"Iron deficiency; Micronutrient; Population; Iron status; Interquartile range; Chemistry; Animal science; Absorption (acoustics); Radiochemistry; Anemia; Medicine; Internal medicine; Materials science; Biology","score_opus":0.024900412390044226,"score_gpt":0.2700254076746449,"score_spread":0.24512499528460066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081654405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908661,0.0069331485,0.0012800532,0.00047519032,0.00007863424,0.00029293806,0.000018695633,0.000007013472,0.00004819131],"genre_scores_gemma":[0.9972706,0.0014563119,0.0010403869,0.00009486082,0.00009232303,0.0000019832546,0.000011606631,0.000023092007,0.000008847285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979991,0.00013265664,0.0009249701,0.00018644513,0.0005034462,0.0002533894],"domain_scores_gemma":[0.9987598,0.000018379327,0.0006616652,0.00010086983,0.00029941092,0.00015988383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003966797,0.00014452796,0.0007507029,0.00014846261,0.000062468986,0.000017287748,0.00009030853,0.00010191411,0.00019644307],"category_scores_gemma":[0.00013447915,0.00016108349,0.000112520946,0.0001228706,0.00014034029,0.00024215228,0.000049529513,0.00020794827,0.0000013859802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004934418,0.0013738035,0.5051154,0.018191814,0.0002735546,0.010774214,0.006001964,0.0023480577,0.43240932,0.00020541434,0.0010913763,0.017280655],"study_design_scores_gemma":[0.035472542,0.0023760926,0.7158476,0.004214299,0.0021801046,0.110962465,0.0055372827,0.0010417058,0.12133146,0.00014675054,0.00016329312,0.00072638475],"about_ca_topic_score_codex":0.00018172326,"about_ca_topic_score_gemma":0.00005213693,"teacher_disagreement_score":0.31107786,"about_ca_system_score_codex":0.00005206385,"about_ca_system_score_gemma":0.00011800193,"threshold_uncertainty_score":0.6568794},"labels":[],"label_agreement":null},{"id":"W3086825036","doi":"10.1111/bjh.17073","title":"Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Medical Research Council; Takeda Oncology; Blood Cancer UK; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Bloodwise; King’s College London; Health Research","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Adverse effect; Confidence interval; Classical Hodgkin lymphoma; Oncology; Surgery; Gastroenterology; Lymphoma; Hodgkin lymphoma","score_opus":0.2288983498756854,"score_gpt":0.4219077485188068,"score_spread":0.19300939864312142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086825036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994249,0.00036079696,0.00032187524,0.002743665,0.000044727472,0.002039083,0.0002323025,0.0000034746959,0.000005087641],"genre_scores_gemma":[0.9974693,0.00014530112,0.0020390556,0.00015949616,0.000045900295,0.00010444747,0.000012835671,0.000017010152,0.0000066569137],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99722093,0.0005375979,0.0010219284,0.00024598298,0.00071919995,0.00025434262],"domain_scores_gemma":[0.9969632,0.0011684189,0.0005649241,0.00014436251,0.001036798,0.00012229102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009486576,0.0001607646,0.0011512567,0.0002541472,0.00010768847,0.00001195169,0.00017338658,0.00008079801,0.000015480317],"category_scores_gemma":[0.0011151915,0.00010794626,0.00011159766,0.0006415374,0.00017894326,0.00006808083,0.000036694375,0.000092177674,1.6294835e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62408346,0.18273357,0.037598822,0.0006258381,0.002950219,0.032855064,0.017412046,0.0017920462,0.0015781753,0.00006791106,0.0050142603,0.093288586],"study_design_scores_gemma":[0.42061824,0.21603203,0.3263671,0.0032293256,0.0008060602,0.0074175405,0.0014722407,0.0008698948,0.017550895,0.00008545835,0.005199217,0.00035200425],"about_ca_topic_score_codex":0.0010475548,"about_ca_topic_score_gemma":0.0023962928,"teacher_disagreement_score":0.28876826,"about_ca_system_score_codex":0.00042291702,"about_ca_system_score_gemma":0.001647955,"threshold_uncertainty_score":0.44019207},"labels":[],"label_agreement":null},{"id":"W3087694498","doi":"10.1111/bjh.17095","title":"Microcytosis in patients with haemoglobin C trait: is α‐thalassaemia trait to blame?","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University Health Network; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; Thrombosis and Atherosclerosis Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Microcytosis; Sickle cell trait; Medicine; Mean corpuscular volume; Population; Red Cell; Asymptomatic; Immunology; Iron deficiency; Genetics; Internal medicine; Hematocrit; Biology; Disease; Anemia","score_opus":0.00793975500152309,"score_gpt":0.21870849919555127,"score_spread":0.2107687441940282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087694498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473376,0.00070826244,0.00014374992,0.013349001,0.00010840461,0.00035352638,0.00003691977,0.000017046563,0.0005493055],"genre_scores_gemma":[0.9901425,0.00012886302,0.0016988255,0.007892863,0.00005299942,0.0000036980255,0.000007934206,0.000036544647,0.00003573486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814194,0.000073142895,0.0007703563,0.00026751528,0.00033622864,0.00041080924],"domain_scores_gemma":[0.99888706,0.000036876456,0.000246524,0.00010489517,0.000246655,0.00047799916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013710871,0.00018839022,0.0009554981,0.00018115554,0.0000493248,0.000027230868,0.0001901603,0.00023914971,0.00029343853],"category_scores_gemma":[0.00018799733,0.00017536801,0.00016501865,0.00046462507,0.00010457594,0.0001050872,0.000037786285,0.0006792752,0.000026957838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008298079,0.003119884,0.5067381,0.0010925214,0.0012871027,0.12110501,0.009970574,0.00017655238,0.0025292635,0.00012035458,0.19065677,0.15490578],"study_design_scores_gemma":[0.04515854,0.00933313,0.7343336,0.0045076413,0.0007329152,0.15782645,0.0027329973,0.000062177714,0.005359737,0.00015660355,0.038715713,0.0010805111],"about_ca_topic_score_codex":0.00006338993,"about_ca_topic_score_gemma":0.000060340157,"teacher_disagreement_score":0.22759546,"about_ca_system_score_codex":0.00006500249,"about_ca_system_score_gemma":0.00019056513,"threshold_uncertainty_score":0.71513003},"labels":[],"label_agreement":null},{"id":"W3091505034","doi":"10.1111/bjh.17125","title":"Use of an anti‐CD200‐blocking antibody improves immune responses to AML <i>in vitro</i> and <i>in vivo</i>","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"European Regional Development Fund; Medical Research Council; Blood Cancer UK; Cardiff University; Cancer Research UK; Cancer Research Wales; National Cancer Research Institute","keywords":"In vivo; Immune system; In vitro; Antibody; Immunology; Medicine; Effector; Cancer research; Blocking antibody; Myeloid; Biology","score_opus":0.0376269655903632,"score_gpt":0.28235328763955914,"score_spread":0.24472632204919592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091505034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975121,0.000132038,0.00027386233,0.0016281162,0.00020140575,0.00019598425,0.000024114555,0.000016720092,0.000015669111],"genre_scores_gemma":[0.9951125,0.0003689648,0.0013164381,0.0031232478,0.0000352497,0.0000019154757,6.7224465e-7,0.000022102442,0.000018918268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976432,0.0006014814,0.00094677875,0.0003151322,0.00024093504,0.00025251103],"domain_scores_gemma":[0.99889046,0.00031902877,0.0004125961,0.00012501795,0.000075587515,0.00017728428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031757867,0.00013465201,0.00058507285,0.00029456706,0.000061319,0.00010284833,0.00024147858,0.00006945078,0.000016449245],"category_scores_gemma":[0.001660739,0.00015807123,0.0000634298,0.0004009049,0.000088644614,0.0005799006,0.00008511962,0.00028949973,0.0000021749397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005349805,0.00007933274,0.00017487835,0.000030088295,0.0000017292257,0.011865198,0.00015767153,0.00012371944,0.9855512,0.0001750481,0.00006042391,0.0012457308],"study_design_scores_gemma":[0.0008303564,0.0002843765,0.00151387,0.00008504203,0.000005779265,0.027408548,0.000039625527,0.00091198157,0.96824574,0.000050947958,0.00049617316,0.00012752597],"about_ca_topic_score_codex":0.000023995399,"about_ca_topic_score_gemma":0.000025893345,"teacher_disagreement_score":0.017305426,"about_ca_system_score_codex":0.000008990311,"about_ca_system_score_gemma":0.000070606424,"threshold_uncertainty_score":0.6445958},"labels":[],"label_agreement":null},{"id":"W3093987483","doi":"10.1111/bjh.16922","title":"Treatment patterns and outcomes among mantle cell lymphoma patients treated with ibrutinib in the United States: a retrospective electronic medical record database and chart review study","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca Canada","keywords":"Ibrutinib; Medicine; Discontinuation; Hazard ratio; Mantle cell lymphoma; Internal medicine; Retrospective cohort study; Proportional hazards model; Database; Oncology; Medical record; Population; Confidence interval; Survival analysis; Lymphoma","score_opus":0.012567597786852335,"score_gpt":0.2618785143198141,"score_spread":0.24931091653296178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093987483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919115,0.004482786,0.0000024897088,0.0026397102,0.000017912766,0.0008740486,0.00004183436,0.000008121838,0.000021607264],"genre_scores_gemma":[0.9572387,0.041076127,0.000014685621,0.0015039812,0.000015937125,0.000047423873,0.00008253482,0.000015428224,0.0000052358614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829066,0.00030721695,0.0005306594,0.00025858244,0.00034594207,0.00026695413],"domain_scores_gemma":[0.999061,0.00019782675,0.00028363883,0.0001280941,0.00010773937,0.00022169008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021424638,0.00019528481,0.00092833274,0.00008408692,0.00006561874,0.000026674748,0.00008830872,0.000052257383,0.000050409668],"category_scores_gemma":[0.0001478704,0.000116897616,0.00005997581,0.00019386924,0.00009719953,0.00007675122,0.00003529138,0.00015266567,0.0000015479293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023522788,0.0028908034,0.9486643,0.00017324358,0.00028505002,0.041832834,0.0006968348,3.227392e-8,9.6439166e-8,0.000003757475,0.0003156995,0.004902114],"study_design_scores_gemma":[0.019741619,0.007651726,0.9492914,0.0013865517,0.0006003838,0.02002646,0.0008472093,0.000021815924,0.0000098358305,0.0000033813035,0.00031598166,0.0001036369],"about_ca_topic_score_codex":0.0022442527,"about_ca_topic_score_gemma":0.0016201283,"teacher_disagreement_score":0.03659334,"about_ca_system_score_codex":0.00016734697,"about_ca_system_score_gemma":0.00014663911,"threshold_uncertainty_score":0.47669464},"labels":[],"label_agreement":null},{"id":"W3094397867","doi":"10.1111/bjh.17094","title":"The evolution of clinical research in thalassaemia: where has all the funding gone?","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Pediatrics; Blood transfusion; Thalassemia; Hematology; Hemoglobinopathy; Internal medicine; Demography; Hemolytic anemia","score_opus":0.12268476347597426,"score_gpt":0.39009002098155554,"score_spread":0.2674052575055813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094397867","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047797795,0.07175981,0.000027792768,0.8772445,0.0013143424,0.00038806707,0.000008338617,0.000008038784,0.0014513544],"genre_scores_gemma":[0.76046085,0.088368386,0.0002430157,0.14356479,0.0058338298,0.000024294402,0.00003130229,0.0001631003,0.0013104441],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99392694,0.0020968958,0.0021506823,0.00027976956,0.0008867534,0.0006589407],"domain_scores_gemma":[0.9954799,0.0025111549,0.0010299223,0.00031673917,0.0005339224,0.00012840226],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0045353146,0.00018540754,0.0014282424,0.00021923559,0.00027318465,0.00007087719,0.0006522927,0.0014549047,0.00004897912],"category_scores_gemma":[0.0022854812,0.00011938279,0.0005281551,0.00040403928,0.0015473518,0.000058002704,0.00017136858,0.013210448,0.000022979726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019634067,0.000073716765,0.0025597983,0.00036658277,0.0003234081,0.1002483,0.00013165658,0.0000029376945,0.0000066473985,0.000111584945,0.8903437,0.0056352834],"study_design_scores_gemma":[0.0018813085,0.00050996704,0.0013703132,0.0030610787,0.00020769626,0.18998224,0.0014446628,0.0000475748,0.0000032114738,0.002498565,0.79888016,0.000113252914],"about_ca_topic_score_codex":0.0005691396,"about_ca_topic_score_gemma":0.0003821537,"teacher_disagreement_score":0.73367965,"about_ca_system_score_codex":0.00018491418,"about_ca_system_score_gemma":0.0013028515,"threshold_uncertainty_score":0.9998414},"labels":[],"label_agreement":null},{"id":"W3102807271","doi":"10.1111/bjh.17226","title":"The need for locally generated data in haematology: a real‐world experience of aplastic anaemia in Nepal","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Internal medicine; Cyclophosphamide; Regimen; Transplantation; Gastroenterology; Population; Bone marrow; Pancytopenia; Incidence (geometry); Hematology; Survival rate; Surgery; Chemotherapy","score_opus":0.04732333201275769,"score_gpt":0.3179674115005981,"score_spread":0.2706440794878404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102807271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98848027,0.0014493677,0.006607867,0.002610054,0.00021138346,0.0004665382,0.000028723069,0.000009630526,0.00013614881],"genre_scores_gemma":[0.99478877,0.0008423195,0.003889896,0.0003417915,0.000055165925,0.000016653341,0.000031835007,0.00002096538,0.000012583413],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99757266,0.00022455613,0.0013882002,0.00024925562,0.00024034802,0.00032500722],"domain_scores_gemma":[0.9980399,0.00091245945,0.00045301305,0.00023907899,0.0002099507,0.00014558011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007215009,0.000130328,0.0009776823,0.00018173284,0.000044183955,0.000018173949,0.00044781776,0.00013075565,0.000026494212],"category_scores_gemma":[0.00124462,0.00011890207,0.00007062216,0.0004971637,0.00023680966,0.0001239375,0.000053330088,0.0003603097,0.0000021700705],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01717911,0.0015258994,0.46426386,0.0073034493,0.00079763285,0.40028676,0.0163782,0.0008008325,0.033131417,0.008207294,0.018816039,0.031309515],"study_design_scores_gemma":[0.04242974,0.0026886305,0.08376284,0.0099244295,0.000733285,0.73202246,0.011226529,0.081557855,0.02904419,0.0013638037,0.004234985,0.0010112164],"about_ca_topic_score_codex":0.00026540295,"about_ca_topic_score_gemma":0.0033263494,"teacher_disagreement_score":0.380501,"about_ca_system_score_codex":0.00003495408,"about_ca_system_score_gemma":0.0003801582,"threshold_uncertainty_score":0.48486856},"labels":[],"label_agreement":null},{"id":"W3103119508","doi":"10.1111/bjh.17119","title":"Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Québec International; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Vitamin D and neurology; Placebo; Internal medicine; Hypercalciuria; vitamin D deficiency; Gastroenterology; Bolus (digestion); Vitamin; Randomized controlled trial; Endocrinology; Urinary system","score_opus":0.009141292289453234,"score_gpt":0.28979639465249035,"score_spread":0.28065510236303715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103119508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079037,0.0048662485,0.00071544317,0.0013932834,0.00007562969,0.0018641115,0.00000831514,0.000007371765,0.0002792136],"genre_scores_gemma":[0.99873734,0.0005116494,0.000490305,0.0001328145,0.000056614746,0.000023750335,0.000023779603,0.000012884104,0.000010884105],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978718,0.0003668536,0.0012152107,0.000118187585,0.00025739108,0.00017052797],"domain_scores_gemma":[0.9987153,0.00017511158,0.0007630122,0.00005411992,0.00013498012,0.00015748243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039584306,0.00011671931,0.0022605008,0.000107443535,0.000026956,0.000020921265,0.0000789375,0.00006731994,0.00014773599],"category_scores_gemma":[0.0002209205,0.00009100855,0.00026553182,0.00013862771,0.00017505181,0.00009464651,0.000012813075,0.00031591643,0.0000015614529],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97242457,0.00083924073,0.020830728,0.00011910446,0.00048253292,0.0025799018,0.0005892155,0.00044454934,0.00014465614,0.00022363957,0.00087149907,0.00045037284],"study_design_scores_gemma":[0.99001783,0.0011358607,0.0010216734,0.00026256754,0.00081445783,0.004018864,0.001736838,0.00052164536,0.0002483508,0.00012269,0.000012185327,0.00008700755],"about_ca_topic_score_codex":0.000091429596,"about_ca_topic_score_gemma":0.00003900629,"teacher_disagreement_score":0.019809054,"about_ca_system_score_codex":0.00001384225,"about_ca_system_score_gemma":0.00032798472,"threshold_uncertainty_score":0.3711221},"labels":[],"label_agreement":null},{"id":"W3107023394","doi":"10.1111/bjh.17238","title":"Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft‐<i>versus</i>‐host disease: An exploratory analysis","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; NIH Clinical Center; Minnesota Obesity Center, University of Minnesota; Danone Institute of Canada","keywords":"Microbiome; Shotgun sequencing; Medicine; Disease; Gastrointestinal disease; Gut microbiome; Host (biology); Biology; Immunology; Gastroenterology; Internal medicine; Bioinformatics; DNA sequencing; Genetics","score_opus":0.009531421034147669,"score_gpt":0.23473800465536365,"score_spread":0.22520658362121598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107023394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728274,0.00017739045,0.00021738811,0.02462744,0.00026143956,0.0004055307,0.0014759143,0.000004866899,0.0000026633768],"genre_scores_gemma":[0.9017553,0.000027133308,0.0015242072,0.09516393,0.00047169108,0.000020153147,0.0008688163,0.00010055583,0.00006821731],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9969404,0.0007593604,0.0009013244,0.00053920684,0.0003309759,0.0005287871],"domain_scores_gemma":[0.9980176,0.000043729287,0.000624066,0.00046981752,0.00048213237,0.00036265302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030301255,0.0003363236,0.00096319854,0.00038983033,0.00008004185,0.000046994282,0.00078900234,0.0002678485,0.000044095104],"category_scores_gemma":[0.0002420158,0.0003022224,0.00033876332,0.0005925396,0.00015890886,0.000016603575,0.00027927218,0.0009451751,0.0000035797066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03897372,0.0005385083,0.06941914,0.00048472354,0.0023954092,0.053438663,0.00045523923,0.000284215,0.20538233,5.3077724e-7,0.6285145,0.00011301045],"study_design_scores_gemma":[0.03183588,0.05231664,0.6296276,0.013109066,0.0100798635,0.07685881,0.0009534957,0.000032055832,0.016007377,0.000019742232,0.16409865,0.005060808],"about_ca_topic_score_codex":0.000025283172,"about_ca_topic_score_gemma":0.00036048752,"teacher_disagreement_score":0.5602085,"about_ca_system_score_codex":0.0001249443,"about_ca_system_score_gemma":0.0009045156,"threshold_uncertainty_score":0.999943},"labels":[],"label_agreement":null},{"id":"W3107310190","doi":"10.1111/bjh.17168","title":"COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial","year":2020,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Centre For Medical Engineering, King’s College London; University College London; King's College London; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Wellcome Trust; Canada Economic Development for Quebec Regions; University College London Hospitals NHS Foundation Trust; Amgen","keywords":"Medicine; Clinical trial; Pandemic; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Health care; Isolation (microbiology); Transplantation; Medical emergency; Internal medicine; Disease","score_opus":0.4888445932700773,"score_gpt":0.5790517989394028,"score_spread":0.09020720566932555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107310190","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2788444,0.009574424,0.000039096918,0.7080262,0.0026276687,0.00072345976,0.00006517325,0.000019654603,0.000079967416],"genre_scores_gemma":[0.06827673,0.012716171,0.00028664205,0.8899227,0.028508995,0.000017658462,0.000052392847,0.00006368669,0.0001550225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98851746,0.005400769,0.003255003,0.0007258428,0.0013254787,0.00077545363],"domain_scores_gemma":[0.97842216,0.017543653,0.00117753,0.0005520676,0.0007138078,0.0015908028],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005873579,0.00028950896,0.0029044352,0.00017289915,0.00036329144,0.00014911333,0.00072133314,0.0018315644,0.00036012864],"category_scores_gemma":[0.058329955,0.00023274533,0.0007395567,0.0002488541,0.0021124706,0.000094367795,0.00032998738,0.013548246,0.000035960922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081438115,0.00007500309,0.006114102,0.0002051255,0.0001910522,0.26100662,0.0003530525,1.5982238e-8,5.5662656e-7,0.00000554757,0.7110068,0.012898273],"study_design_scores_gemma":[0.022586996,0.003188956,0.008580587,0.00079224847,0.00023759424,0.12798998,0.000321255,0.0000034311402,0.0000010543567,0.00073126744,0.835395,0.00017164926],"about_ca_topic_score_codex":0.0016816492,"about_ca_topic_score_gemma":0.000399182,"teacher_disagreement_score":0.21056767,"about_ca_system_score_codex":0.00017406659,"about_ca_system_score_gemma":0.0071287975,"threshold_uncertainty_score":0.9994643},"labels":[],"label_agreement":null},{"id":"W3111110582","doi":"10.1111/bjh.17141","title":"Clinical and biological features of B‐cell neoplasms with <i>CDK6</i> translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and <i>TP53</i> abnormalities","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Splenic marginal zone lymphoma; Biology; CD5; IGHV@; Chronic lymphocytic leukemia; Gene rearrangement; Mantle cell lymphoma; Prolymphocytic leukemia; Molecular biology; Cancer research; B cell; Pathology; Lymphoma; Antibody; Immunology; Leukemia; Genetics; Medicine; Gene","score_opus":0.01806354584269679,"score_gpt":0.26378142896968043,"score_spread":0.24571788312698364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111110582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046504,0.0077375253,0.00079107255,0.00042991873,0.000044909182,0.00039316955,0.000036788362,0.000013884262,0.00008766689],"genre_scores_gemma":[0.989385,0.004040475,0.006158529,0.00024671262,0.00008719963,0.000011628026,0.000014474915,0.000027223005,0.000028727605],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99720174,0.0004182578,0.001086118,0.00033763848,0.0005941152,0.0003621118],"domain_scores_gemma":[0.9974987,0.0006265182,0.0008514582,0.00015993262,0.0004724547,0.00039092274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082099764,0.00020924723,0.0012293601,0.00010518418,0.00008461137,0.000035085435,0.00017578463,0.00027691398,0.000024099587],"category_scores_gemma":[0.00024556663,0.0001597299,0.00010517443,0.0002135091,0.00073381653,0.0002312693,0.00005586287,0.0004452153,4.736127e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053405777,0.0054414016,0.6882725,0.014072066,0.0026898973,0.06767018,0.01217496,0.000233705,0.13249403,0.0012728701,0.0042689284,0.018003715],"study_design_scores_gemma":[0.13587156,0.022905752,0.06807215,0.0066601066,0.0017211286,0.5869971,0.00750825,0.0016792379,0.16674523,0.00021273602,0.000671065,0.0009556913],"about_ca_topic_score_codex":0.00029434293,"about_ca_topic_score_gemma":0.00012159352,"teacher_disagreement_score":0.62020034,"about_ca_system_score_codex":0.00044373618,"about_ca_system_score_gemma":0.0027088183,"threshold_uncertainty_score":0.6513596},"labels":[],"label_agreement":null},{"id":"W3112370628","doi":"10.1111/bjh.17273","title":"Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID‐19): evidence of acute and sustained endothelial cell activation","year":2020,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"3M Foundation; Health Service Executive; Royal College of Surgeons in Ireland; Wellcome Trust; Canadian Institute for Theoretical Astrophysics","keywords":"Von Willebrand factor; Coagulopathy; Endothelial activation; Medicine; Internal medicine; Pathogenesis; Sepsis; Endothelial dysfunction; Coronavirus disease 2019 (COVID-19); Immunology; Endocrinology; Gastroenterology; Endothelium; Platelet; Disease","score_opus":0.0719022932819618,"score_gpt":0.4038994174974825,"score_spread":0.3319971242155207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112370628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97849375,0.0028846613,0.00042540283,0.017561669,0.00005494402,0.00049831194,0.000056843088,0.000009531463,0.000014867815],"genre_scores_gemma":[0.99092954,0.006926453,0.00020372172,0.0017068541,0.0000901509,0.0000057311695,0.000002983609,0.000014980341,0.000119607445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803835,0.000253238,0.0007696906,0.00024236203,0.0004253518,0.00027100253],"domain_scores_gemma":[0.99615365,0.0023770235,0.00041068165,0.000105208026,0.0003258837,0.0006275465],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00040774085,0.0001288831,0.0008236715,0.00012162059,0.000051875606,0.00002138501,0.00015427449,0.00008627001,0.00011227413],"category_scores_gemma":[0.02832868,0.000119498014,0.00012757168,0.00017514122,0.00029133423,0.0002603382,0.00015404346,0.0005030188,0.0000029924463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05568509,0.0013295737,0.6500875,0.015282322,0.0009775159,0.17057101,0.0027656415,0.00023850286,0.05439296,0.00012751292,0.0065203453,0.042022035],"study_design_scores_gemma":[0.08718064,0.017920598,0.78530407,0.017277395,0.002043171,0.03147211,0.0020716111,0.0017119881,0.0233339,0.0035580494,0.02637102,0.0017554277],"about_ca_topic_score_codex":0.00017176887,"about_ca_topic_score_gemma":0.000021144513,"teacher_disagreement_score":0.13909891,"about_ca_system_score_codex":0.000107534135,"about_ca_system_score_gemma":0.0011020524,"threshold_uncertainty_score":0.97985613},"labels":[],"label_agreement":null},{"id":"W3112534080","doi":"10.1111/bjh.17247","title":"Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities","year":2020,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Genetic predisposition; Malignancy; Germline; Haematopoiesis; Myeloid; Medicine; Genetic testing; Genetics; Biology; Immunology; Bioinformatics; Disease; Stem cell; Pathology; Gene","score_opus":0.13372246372914656,"score_gpt":0.34408265996454523,"score_spread":0.21036019623539867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112534080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009190455,0.9882203,0.00021496587,0.0009849461,0.00034002285,0.0007956546,0.00006135274,0.000038881873,0.0001534417],"genre_scores_gemma":[0.00037081927,0.9969127,0.0015828395,0.0004498136,0.00034980435,0.000088972476,0.000028980874,0.00011383623,0.00010223257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965773,0.00042209012,0.0015603971,0.0003930316,0.000513193,0.00053394795],"domain_scores_gemma":[0.9972362,0.00032313782,0.0006837519,0.00022463448,0.00036739293,0.001164881],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006516478,0.0004045902,0.0040589827,0.00065423944,0.00014937572,0.0001272321,0.00032522142,0.00038901618,0.00014456635],"category_scores_gemma":[0.0014903409,0.0004205407,0.0004773458,0.0004020593,0.00023552388,0.00029021138,0.00028122967,0.0013909726,0.000018881654],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106986634,0.000029488427,0.000011597356,0.027983513,0.00061317824,0.28521323,0.00050289585,2.8490587e-7,0.000010483267,0.00017030399,0.009279649,0.6760784],"study_design_scores_gemma":[0.00048541112,0.00029223718,0.0000051014945,0.042034782,0.0007257942,0.4601102,0.00069470884,0.0000041004328,0.000005929929,0.000024533085,0.49542782,0.00018940898],"about_ca_topic_score_codex":0.000032689364,"about_ca_topic_score_gemma":0.0000058822015,"teacher_disagreement_score":0.67588896,"about_ca_system_score_codex":0.00039395774,"about_ca_system_score_gemma":0.0017738781,"threshold_uncertainty_score":0.99982464},"labels":[],"label_agreement":null},{"id":"W3127209017","doi":"10.1111/bjh.17281","title":"Outcome of relapsed and refractory nodular lymphocyte‐predominant Hodgkin lymphoma: a North American analysis","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"NIH Clinical Center; Lymphoma Research Foundation","keywords":"Medicine; Internal medicine; Lenalidomide; Oncology; Refractory (planetary science); Rituximab; Chemotherapy; Chlorambucil; Brentuximab vedotin; Progression-free survival; Lymphoma; Salvage therapy; Surgery; Hodgkin lymphoma; Multiple myeloma; Cyclophosphamide","score_opus":0.011420359829982848,"score_gpt":0.2678203961424771,"score_spread":0.25640003631249425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127209017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852261,0.013839654,0.00010948053,0.00046101617,0.000118346754,0.00009022502,0.000029568138,0.00000823585,0.00011740875],"genre_scores_gemma":[0.992717,0.0045444537,0.0022558628,0.00032204945,0.000043758562,0.0000053270037,0.000018511886,0.000018870325,0.00007411212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785787,0.00019321605,0.0010835343,0.00026934576,0.00032785148,0.00026820292],"domain_scores_gemma":[0.99794173,0.00021904048,0.00084958324,0.0002729548,0.0004711173,0.00024555394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023640411,0.0001739656,0.0019025395,0.00031141573,0.00006134659,0.000023058938,0.00009697004,0.00008338605,0.000086944274],"category_scores_gemma":[0.00039007163,0.00016544251,0.0004994222,0.0006997516,0.00029182027,0.00007639769,0.00006732701,0.00010569879,0.0000041061594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028005874,0.0012664502,0.7901995,0.00010002932,0.002839513,0.14920665,0.00014340512,0.000008541905,0.0001970409,0.00004138295,0.00033193443,0.055385467],"study_design_scores_gemma":[0.006921193,0.0005615517,0.7673137,0.0001566444,0.0032381308,0.21811001,0.0002460773,0.000040718583,0.0018440426,0.000016005426,0.001423488,0.00012841927],"about_ca_topic_score_codex":0.0006246458,"about_ca_topic_score_gemma":0.0010137475,"teacher_disagreement_score":0.068903364,"about_ca_system_score_codex":0.00022899806,"about_ca_system_score_gemma":0.0004934828,"threshold_uncertainty_score":0.67465496},"labels":[],"label_agreement":null},{"id":"W3127479238","doi":"10.1111/bjh.17350","title":"Real‐world outcomes with bortezomib‐containing regimens and lenalidomide plus dexamethasone for the treatment of transplant‐ineligible multiple myeloma: a multi‐institutional report from the Canadian Myeloma Research Group database","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; Hôpital Maisonneuve-Rosemont; University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital; CancerCare Manitoba; Ottawa Regional Cancer Foundation; Ottawa Hospital; Saskatchewan Cancer Agency; Alberta Cancer Foundation; Canadian Institutes of Health Research; Université de Montréal; University of Saskatchewan; University of Alberta; McGill University","funders":"","keywords":"Bortezomib; Lenalidomide; Multiple myeloma; Dexamethasone; Medicine; Regimen; Melphalan; Prednisone; Internal medicine; Oncology; Thalidomide; Cyclophosphamide; Chemotherapy","score_opus":0.09525598580510063,"score_gpt":0.36691124114013407,"score_spread":0.27165525533503343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127479238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98073786,0.011019836,0.0009202962,0.005207242,0.00013136929,0.0011143732,0.00071674754,0.000009557179,0.00014271872],"genre_scores_gemma":[0.9835927,0.003717204,0.011620672,0.00010580002,0.00013580777,0.0001231357,0.00036305079,0.00003184246,0.00030978382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971425,0.00034143924,0.00080171437,0.0003961841,0.0006674325,0.0006507307],"domain_scores_gemma":[0.9944469,0.0033970855,0.00032349574,0.00045797564,0.0009010407,0.00047350844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012099583,0.00023748568,0.0010482991,0.00024674792,0.00077328767,0.00008496416,0.0002046212,0.000107709224,0.000044871456],"category_scores_gemma":[0.0011471722,0.00013793125,0.00022825977,0.00031339496,0.00072173297,0.00013620812,0.000036567184,0.00043735828,0.0000013983688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056494502,0.0008633297,0.6600329,0.00013226681,0.0038521516,0.31454322,0.0010432042,0.000031306914,0.0010446083,0.00055356376,0.00113,0.011123983],"study_design_scores_gemma":[0.035756126,0.0015332444,0.66406524,0.0013304088,0.0009926294,0.28249326,0.0018231755,0.0010497863,0.0033604822,0.00012871304,0.007222545,0.00024438786],"about_ca_topic_score_codex":0.26605496,"about_ca_topic_score_gemma":0.854928,"teacher_disagreement_score":0.588873,"about_ca_system_score_codex":0.000443416,"about_ca_system_score_gemma":0.0027835304,"threshold_uncertainty_score":0.7388325},"labels":[],"label_agreement":null},{"id":"W3129079371","doi":"10.1111/bjh.17322","title":"Patients with haemophilia A with inhibitors in China: a national real‐world analysis and follow‐up","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Haemophilia; Haemophilia A; Interquartile range; Internal medicine; Odds ratio; Population; Gastroenterology; Confidence interval; Surgery; Complication; Pediatrics","score_opus":0.010520812217706822,"score_gpt":0.27333180635112164,"score_spread":0.2628109941334148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129079371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965963,0.0007976369,0.000013025,0.0014685412,0.000045050576,0.00013848468,0.000009403596,0.000005236201,0.00092636124],"genre_scores_gemma":[0.99792725,0.0003458846,0.0009317808,0.000071224975,0.00004638612,0.000005007055,0.000034716537,0.000013879482,0.0006238912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984835,0.00011060435,0.0003996699,0.0002008907,0.0005702003,0.00023517945],"domain_scores_gemma":[0.9988578,0.00008074221,0.0001652795,0.00008228842,0.000641886,0.0001720304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024276329,0.00011315371,0.0007199828,0.00065001147,0.000062825864,0.00003257512,0.000050990657,0.00006960386,0.000093333234],"category_scores_gemma":[0.00015353768,0.00008705843,0.00010091418,0.0011673775,0.00014597437,0.000115828836,0.00003101564,0.00032575682,0.0000014872987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005713278,0.0004343172,0.9379503,0.00005430828,0.0009970991,0.056468688,0.00012017088,0.000006019078,0.000017958859,0.000050493338,0.00053316227,0.002796141],"study_design_scores_gemma":[0.008210223,0.00051704654,0.9529297,0.00055070716,0.00049497554,0.036453582,0.00008133451,0.000020356569,0.0003170437,0.00015741379,0.00016465527,0.000103000035],"about_ca_topic_score_codex":0.00020677605,"about_ca_topic_score_gemma":0.005468809,"teacher_disagreement_score":0.020015107,"about_ca_system_score_codex":0.000084899155,"about_ca_system_score_gemma":0.00042924887,"threshold_uncertainty_score":0.355014},"labels":[],"label_agreement":null},{"id":"W3130331670","doi":"10.1111/bjh.17326","title":"Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"F. Hoffmann-La Roche","keywords":"Bendamustine; Medicine; Internal medicine; Chlorambucil; Fludarabine; Neutropenia; Obinutuzumab; Gastroenterology; Cyclophosphamide; Chemotherapy; Adverse effect; Oncology; Chronic lymphocytic leukemia; Surgery; Leukemia","score_opus":0.018755368573689667,"score_gpt":0.3081063094491247,"score_spread":0.28935094087543506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130331670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537265,0.0036689767,0.00002948053,0.00010702699,0.000053387932,0.0007080404,0.00002422902,0.000006348377,0.000029869596],"genre_scores_gemma":[0.99731064,0.0021221822,0.00013519707,0.0000752805,0.00003203047,0.0000071053164,0.000018134686,0.000033627362,0.0002658089],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99637777,0.000560246,0.0015578344,0.00035070104,0.00074042275,0.00041305544],"domain_scores_gemma":[0.99678105,0.0008443827,0.00095585576,0.000485817,0.00076400075,0.00016886444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006342216,0.0002278177,0.0020530063,0.00041350847,0.00006632231,0.000016159122,0.0002969224,0.0001674284,0.00041396194],"category_scores_gemma":[0.0011279631,0.00015020106,0.00022881926,0.0018425988,0.00046160718,0.0001161584,0.00011880858,0.0004541221,7.2822553e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.25143188,0.023493417,0.18839009,0.0043867324,0.035017308,0.33676723,0.010776161,0.0030778227,0.0014369566,0.0000344157,0.0012181808,0.14396982],"study_design_scores_gemma":[0.6035818,0.019194828,0.18524055,0.0047266716,0.006779458,0.17010356,0.0015103462,0.005310004,0.0027850212,0.000009439639,0.00033972145,0.00041860924],"about_ca_topic_score_codex":0.0026767065,"about_ca_topic_score_gemma":0.008157609,"teacher_disagreement_score":0.3521499,"about_ca_system_score_codex":0.011867622,"about_ca_system_score_gemma":0.026709344,"threshold_uncertainty_score":0.99192566},"labels":[],"label_agreement":null},{"id":"W3135026042","doi":"10.1111/bjh.17404","title":"The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Positron emission tomography; Clinical trial; Lymphoma; Medical physics; Intensive care medicine; Oncology; Pathology; Radiology","score_opus":0.045986671335053575,"score_gpt":0.3238952963564847,"score_spread":0.2779086250214311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135026042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027951722,0.9956058,0.000001945851,0.00078686915,0.00032015564,0.00038660795,0.00001200745,0.000005236158,0.00008619666],"genre_scores_gemma":[0.0047016866,0.99492997,0.00007096421,0.00005958243,0.00012352999,0.000043591135,0.0000069026955,0.000038243368,0.000025527335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764335,0.0004450166,0.001116626,0.00022914517,0.0002932931,0.00027256558],"domain_scores_gemma":[0.9956855,0.0026834877,0.0009975579,0.00026563377,0.00021630022,0.00015150242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003877538,0.00027964276,0.003342937,0.000108683256,0.000101027705,0.0000381401,0.0001839208,0.0002903589,0.000016669994],"category_scores_gemma":[0.00060328696,0.00018596627,0.0008288518,0.000115165014,0.00024482986,0.000025743224,0.00007196075,0.00020447613,0.0000033424958],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000051874795,0.000420893,0.000065434135,0.0047059986,0.0019595856,0.06640697,0.000039378465,2.7262535e-8,5.7024646e-8,0.0019044598,0.00033819163,0.9241538],"study_design_scores_gemma":[0.0011230614,0.00021864973,0.0005764488,0.02739885,0.0032805318,0.48190737,0.0000702667,1.7276274e-7,0.000004191332,0.00019184737,0.48513213,0.0000965047],"about_ca_topic_score_codex":0.00002459459,"about_ca_topic_score_gemma":0.000030946925,"teacher_disagreement_score":0.9240573,"about_ca_system_score_codex":0.00010569283,"about_ca_system_score_gemma":0.0007353973,"threshold_uncertainty_score":0.75834846},"labels":[],"label_agreement":null},{"id":"W3138534794","doi":"10.1111/bjh.17338","title":"Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Hotel Dieu Hospital","funders":"Instituto de Salud Carlos III","keywords":"Medicine; Bortezomib; Multiple myeloma; Lenalidomide; Thalidomide; Regimen; Autologous stem-cell transplantation; Internal medicine; Oncology; Etoposide; Melphalan; Cyclophosphamide; Population; Dexamethasone; Surgery; Chemotherapy","score_opus":0.12401649811821401,"score_gpt":0.4253183885157965,"score_spread":0.3013018903975825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138534794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004858223,0.99643123,0.000020072031,0.001086645,0.00016836902,0.0014765419,0.00016414517,0.000012844991,0.00015431587],"genre_scores_gemma":[0.0007932255,0.99513525,0.0027731718,0.00036174105,0.000128211,0.0003332378,0.00036172973,0.000053684773,0.0000597743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99633473,0.00084992195,0.0015096425,0.00045606686,0.00043260946,0.00041700914],"domain_scores_gemma":[0.99681395,0.0013214701,0.00061629957,0.00030845706,0.00030467397,0.0006351327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003107299,0.00043626383,0.0040077176,0.00038162307,0.0001495867,0.0000734603,0.000087239074,0.0002067433,0.00040007464],"category_scores_gemma":[0.0015688757,0.0003709089,0.0005141315,0.0002028997,0.00015547346,0.000091404094,0.00005857335,0.00061207975,0.00002234749],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004059198,0.0010727146,0.00019667427,0.009461509,0.0005657996,0.32021093,0.00001289273,1.4951743e-7,2.0117741e-7,0.00016533447,0.0034600676,0.66481316],"study_design_scores_gemma":[0.004462852,0.00074610277,0.0005530049,0.18956396,0.0013696237,0.38345036,0.000021179641,0.0000045577794,0.0000023881184,0.00011360381,0.4194423,0.0002700649],"about_ca_topic_score_codex":0.000069119786,"about_ca_topic_score_gemma":0.00021211563,"teacher_disagreement_score":0.6645431,"about_ca_system_score_codex":0.0005480591,"about_ca_system_score_gemma":0.0023673584,"threshold_uncertainty_score":0.9998743},"labels":[],"label_agreement":null},{"id":"W3155637160","doi":"10.1111/bjh.17447","title":"Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Toronto General Hospital; University of Alberta; London Health Sciences Centre; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; McGill University Health Centre; University of Ottawa; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; CancerCare Manitoba; University Health Network; Ottawa Hospital; Dalhousie University; Western University; University of Toronto; University of British Columbia","funders":"","keywords":"Discontinuation; Imatinib; Medicine; Internal medicine; Tyrosine-kinase inhibitor; Imatinib mesylate; Gastroenterology; Cancer","score_opus":0.013217752408859433,"score_gpt":0.27940593252199886,"score_spread":0.26618818011313944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155637160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034095,0.0037750048,0.0014939439,0.0021227961,0.00042622763,0.0013118518,0.0004642868,0.000014500327,0.000050439015],"genre_scores_gemma":[0.9779558,0.00024728777,0.020108795,0.00006903418,0.00031062952,0.000170118,0.00078212493,0.000052858923,0.00030334023],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969823,0.0004539479,0.001465605,0.00037945193,0.0003381168,0.00038061087],"domain_scores_gemma":[0.99726325,0.00040820046,0.00096151576,0.00040992143,0.0006152984,0.0003418402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037148787,0.00029842125,0.0012039919,0.00026366874,0.000106549116,0.00006788363,0.00010748328,0.00025923178,0.00028738764],"category_scores_gemma":[0.002117758,0.0002835775,0.000467382,0.00019064323,0.0000960316,0.00029087358,0.000026653654,0.0001176116,0.0000042971997],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38897467,0.009002653,0.0045018583,0.0002804591,0.0036275894,0.13609323,0.0051926523,0.00019576776,0.2661242,0.00016518547,0.002739008,0.18310276],"study_design_scores_gemma":[0.40676433,0.01871253,0.012854302,0.003327511,0.0038238645,0.04718472,0.0013842721,0.00255603,0.49930102,0.0005329976,0.0028146186,0.0007438119],"about_ca_topic_score_codex":0.0060105724,"about_ca_topic_score_gemma":0.01809353,"teacher_disagreement_score":0.23317681,"about_ca_system_score_codex":0.0015357779,"about_ca_system_score_gemma":0.0023364706,"threshold_uncertainty_score":0.9999616},"labels":[],"label_agreement":null},{"id":"W3155962936","doi":"10.1111/bjh.17444","title":"How much imatinib is enough?","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Imatinib; Discontinuation; Dasatinib; Medicine; Tyrosine kinase; Hematology; Tyrosine-kinase inhibitor; Internal medicine; Oncology; Imatinib mesylate; Myeloid leukemia; Cancer","score_opus":0.023454219672114904,"score_gpt":0.26698682004997143,"score_spread":0.2435326003778565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155962936","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048898052,0.038103513,0.000077648234,0.9087967,0.0017313578,0.00034251282,0.00010971872,0.000032907963,0.0019075515],"genre_scores_gemma":[0.01178727,0.00794927,0.00928282,0.9301463,0.010119207,0.000027133685,0.00060045056,0.00028664048,0.029800937],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9967274,0.0002636497,0.0010501584,0.00044969353,0.0008278913,0.0006812182],"domain_scores_gemma":[0.997032,0.0002602882,0.0012484835,0.00048930116,0.00077262014,0.00019733007],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00022694937,0.00042062337,0.0025528485,0.0002857729,0.000088616514,0.0001659311,0.0003561696,0.0015396981,0.0018838975],"category_scores_gemma":[0.00056274293,0.00045135443,0.0007861175,0.00019036094,0.00020305418,0.00014408167,0.000111055175,0.0044118166,0.00006894397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001711277,0.00006629793,0.000053898777,0.00050348166,0.00066884526,0.4428977,0.000054250988,2.3522817e-8,0.000021175063,0.00000497634,0.551577,0.0041352618],"study_design_scores_gemma":[0.0023691838,0.00017403335,0.000041267504,0.0017388491,0.00052937184,0.5169383,0.000065304,0.0000018489586,0.00045786452,0.00012496828,0.4773953,0.00016369538],"about_ca_topic_score_codex":0.00007191483,"about_ca_topic_score_gemma":0.000016155638,"teacher_disagreement_score":0.074181676,"about_ca_system_score_codex":0.0006360683,"about_ca_system_score_gemma":0.0018035866,"threshold_uncertainty_score":0.9997938},"labels":[],"label_agreement":null},{"id":"W3157181626","doi":"10.1111/bjh.17450","title":"Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Janssen Research and Development; National Institutes of Health","keywords":"Ibrutinib; Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Rituximab; Concordance; CHOP; Oncology; Medicine; Hazard ratio; Immunohistochemistry; Lymphoma; Cyclophosphamide; Subtyping; Confidence interval; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.05427044841385749,"score_gpt":0.41826787618117156,"score_spread":0.3639974277673141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157181626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824736,0.0165447,0.00016316118,0.0001469455,0.0002021729,0.0003807891,0.000024005021,0.0000022857653,0.00006232808],"genre_scores_gemma":[0.99611753,0.0010312432,0.0026316287,0.000058472837,0.000098059965,0.000018976449,0.000023852423,0.000009935281,0.000010270675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783397,0.00019134789,0.0014529162,0.00016205396,0.00018060899,0.00017910774],"domain_scores_gemma":[0.9979858,0.00068309304,0.0008735254,0.00016591151,0.00022367413,0.00006799322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007909611,0.00010077453,0.0011242739,0.000047579655,0.00005288971,0.000011567625,0.00010111152,0.00015331668,0.000011482844],"category_scores_gemma":[0.0005960032,0.00008305579,0.00025521574,0.000072895535,0.00010716427,0.000039658375,0.00004543583,0.00013652115,1.5035216e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14302708,0.19062702,0.16918345,0.0029449235,0.0009694885,0.0396529,0.0034061933,0.0000030196957,0.3818193,0.0003109297,0.0042054825,0.06385017],"study_design_scores_gemma":[0.46060827,0.001582721,0.0034520344,0.0011403082,0.0003325566,0.028340345,0.0012833964,0.00007586227,0.50278515,0.000058873276,0.00025047612,0.00009005037],"about_ca_topic_score_codex":0.0000113619235,"about_ca_topic_score_gemma":0.00000376527,"teacher_disagreement_score":0.31758118,"about_ca_system_score_codex":0.00003718383,"about_ca_system_score_gemma":0.0003610299,"threshold_uncertainty_score":0.33869168},"labels":[],"label_agreement":null},{"id":"W3157661441","doi":"10.1111/bjh.17438","title":"Viral hepatitis in haemophilia: historical perspective and current management","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Grifols; Universitair Medisch Centrum Utrecht; Swedish Orphan Biovitrum; CSL Behring; Gilead Sciences; Sanofi; Pfizer","keywords":"Haemophilia; Clotting factor; Medicine; Blood clotting; Immunology; Viral hepatitis; Transmission (telecommunications); Virology; Hepatitis C virus; Vaccination; Viral disease; Hepatitis C; Natural history; Hepatitis; Human immunodeficiency virus (HIV); Virus; Pediatrics; Internal medicine","score_opus":0.060529879623563654,"score_gpt":0.39718481629393415,"score_spread":0.3366549366703705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157661441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038001145,0.9965903,0.000042985197,0.00041200628,0.0007039864,0.0006254577,0.000020120735,0.000008635866,0.0012164642],"genre_scores_gemma":[0.00012473509,0.99860054,0.00063751667,0.000035937686,0.00024706227,0.00004046261,0.00001582184,0.000054599055,0.0002433315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963568,0.00067613524,0.0014596743,0.00044567866,0.0005923125,0.00046944033],"domain_scores_gemma":[0.99832284,0.00019029366,0.0005196887,0.00022271322,0.00043166414,0.00031277712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061889255,0.00030612297,0.0041839373,0.0008438966,0.00006108716,0.00005247952,0.00023150205,0.00034092486,0.00016218753],"category_scores_gemma":[0.0006409125,0.00032437322,0.0005614594,0.0004148768,0.0001597341,0.000096457545,0.00025024376,0.002034939,0.00001791287],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010071031,0.00021078355,0.00019363503,0.0079213,0.000254399,0.27612978,0.0000353946,2.422833e-8,1.4705755e-8,0.00067490136,0.0068010613,0.7077686],"study_design_scores_gemma":[0.0007449843,0.00016532172,0.00012228717,0.035638742,0.0005289979,0.2617297,0.000030853927,0.0000013523384,8.031731e-8,0.0002448874,0.70062697,0.0001658277],"about_ca_topic_score_codex":0.00051774265,"about_ca_topic_score_gemma":0.0003709542,"teacher_disagreement_score":0.7076028,"about_ca_system_score_codex":0.002364243,"about_ca_system_score_gemma":0.0007157116,"threshold_uncertainty_score":0.99992085},"labels":[],"label_agreement":null},{"id":"W3160548032","doi":"","title":"The psychological impact of the COVID-19 pandemic on multiple myeloma patients","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interquartile range; Quality of life (healthcare); Family medicine; Patient satisfaction; Observational study; Internal medicine; Surgery; Nursing","score_opus":0.041681356166496396,"score_gpt":0.35497236904638124,"score_spread":0.31329101287988487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160548032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949224,0.0022590691,0.000022183453,0.0015079755,0.0008131605,0.00010565548,0.00002420745,0.000006242738,0.0003391032],"genre_scores_gemma":[0.9973741,0.0006786072,0.000013352382,0.001762358,0.00008242603,0.000002621728,0.0000033933136,0.00000929236,0.000073809904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860066,0.00032711073,0.00045976104,0.00012202607,0.00029235883,0.0001980524],"domain_scores_gemma":[0.99830264,0.0006335785,0.00033916032,0.00022086361,0.00033834597,0.00016544227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031658082,0.00008698957,0.00042037867,0.000029941017,0.00012786327,0.000016647096,0.0002025067,0.00011827113,0.0001827957],"category_scores_gemma":[0.0029180285,0.00005034165,0.0004197116,0.00015954344,0.00020894826,0.000024723164,0.000048392343,0.00045011847,0.0000030782096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000701135,0.00033901838,0.9530577,0.000038057107,0.00015423622,0.0050037657,0.00021377973,0.000009945707,0.00016852694,0.00007014379,0.017914327,0.022329342],"study_design_scores_gemma":[0.0031345843,0.0007519429,0.80126315,0.00019281519,0.00006862289,0.18587922,0.00026127705,0.000004773141,0.0001645602,0.00044972816,0.0077590155,0.00007033377],"about_ca_topic_score_codex":0.00017380941,"about_ca_topic_score_gemma":0.0014841188,"teacher_disagreement_score":0.18087545,"about_ca_system_score_codex":0.00010986753,"about_ca_system_score_gemma":0.0002913122,"threshold_uncertainty_score":0.34933636},"labels":[],"label_agreement":null},{"id":"W3162049986","doi":"10.1111/bjh.17420","title":"A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study)","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Novartis Pharma","keywords":"Ofatumumab; Bendamustine; Medicine; Rituximab; Internal medicine; Clinical endpoint; Neutropenia; Adverse effect; Combination therapy; Chemoimmunotherapy; Oncology; Randomized controlled trial; Chemotherapy; Lymphoma","score_opus":0.021369117207070507,"score_gpt":0.31655173029278194,"score_spread":0.2951826130857114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162049986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995099,0.002868061,0.00001997175,0.00031447876,0.00014915853,0.0013916772,0.000010639496,0.000008071865,0.00013895203],"genre_scores_gemma":[0.9991592,0.00014845103,0.00045669184,0.00007138705,0.00002777114,0.00008051651,0.000011961445,0.000020895655,0.000023099346],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967849,0.0006980245,0.0015015615,0.00025778275,0.0004919989,0.00026573308],"domain_scores_gemma":[0.99780726,0.000491953,0.0007474303,0.00023417447,0.0005695037,0.0001496763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073566637,0.00020018732,0.0027800712,0.0002663842,0.000048311944,0.000022119291,0.000110232606,0.000057222023,0.00024878234],"category_scores_gemma":[0.00044360314,0.00016484012,0.00020119794,0.00029931392,0.00011562794,0.000081242055,0.00006888182,0.000267651,0.000002181635],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11992283,0.2642514,0.08810932,0.00016413191,0.0029601853,0.51276463,0.0032209565,0.000007388088,0.00008398521,0.00007903695,0.00039496765,0.008041122],"study_design_scores_gemma":[0.8586747,0.0188702,0.035632428,0.00076711184,0.0013008511,0.078080185,0.0060100206,0.000019010458,0.00039103473,0.000037455564,0.00008644785,0.00013054015],"about_ca_topic_score_codex":0.00054124364,"about_ca_topic_score_gemma":0.0027073794,"teacher_disagreement_score":0.7387519,"about_ca_system_score_codex":0.0001461978,"about_ca_system_score_gemma":0.0005368551,"threshold_uncertainty_score":0.67219853},"labels":[],"label_agreement":null},{"id":"W3164281877","doi":"10.1111/bjh.17537","title":"Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatoon Medical Imaging; Université Laval; Royal Victoria Hospital; Royal Victoria Regional Health Centre; Vancouver General Hospital; Princess Margaret Cancer Centre; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; Centre hospitalier de l'Université Laval; Alberta Hospital Edmonton; University of British Columbia; Sunnybrook Health Science Centre; Jewish General Hospital; McGill University Health Centre; University of Ottawa; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; Saskatchewan Cancer Agency; University of Alberta Hospital; Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"International Prognostic Scoring System; Medicine; Myelodysplastic syndromes; Quality of life (healthcare); Internal medicine; Rating scale; Risk assessment; Disease; Physical therapy; Psychology; Bone marrow","score_opus":0.052329744327299005,"score_gpt":0.31594641755058034,"score_spread":0.2636166732232813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164281877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925252,0.0033642815,0.000025429921,0.0027170242,0.0005538014,0.0005188893,0.000019201707,0.000030274792,0.0002458888],"genre_scores_gemma":[0.99727446,0.00084651913,0.0011676475,0.00018379281,0.0001183759,0.000048785994,0.000016681382,0.00005404413,0.0002896769],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9957576,0.00074800785,0.0016551138,0.00044197412,0.0007769633,0.0006203829],"domain_scores_gemma":[0.9969862,0.000586377,0.0007779462,0.00030210032,0.0010123963,0.00033495022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006807613,0.000249766,0.001492968,0.0005185748,0.000112466594,0.000073590214,0.00022184446,0.00022590812,0.000507422],"category_scores_gemma":[0.0036796713,0.0002565165,0.00021627442,0.00091554265,0.00018042754,0.00015465742,0.00018227448,0.0013478183,0.0000124851],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030381343,0.0016905996,0.31576124,0.00016902346,0.0006533225,0.66317666,0.00047549582,0.000013253723,0.00024612405,0.0000203782,0.0048012715,0.012688799],"study_design_scores_gemma":[0.0058992305,0.001812861,0.37301514,0.0010708498,0.00036011403,0.61444366,0.0016373384,0.000038328235,0.00062603696,0.00014159273,0.00074116467,0.00021368949],"about_ca_topic_score_codex":0.0006098346,"about_ca_topic_score_gemma":0.0008467647,"teacher_disagreement_score":0.057253905,"about_ca_system_score_codex":0.00027877247,"about_ca_system_score_gemma":0.0010880348,"threshold_uncertainty_score":0.99998873},"labels":[],"label_agreement":null},{"id":"W3165141334","doi":"10.1111/bjh.17551","title":"Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR‐T‐cell therapies","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mass cytometry; Immune system; Medicine; Immunology; Cytometry; Flow cytometry; Immunotherapy; Cancer research; Biology","score_opus":0.06295627033005305,"score_gpt":0.3147752223489589,"score_spread":0.2518189520189058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165141334","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24579962,0.47273666,0.0055145635,0.26238045,0.0076191165,0.0035089436,0.00039016778,0.000054453267,0.0019960385],"genre_scores_gemma":[0.28426626,0.21016376,0.041613467,0.3477644,0.060604528,0.00066379126,0.00115188,0.0023260254,0.051445875],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968151,0.00021144883,0.0012017699,0.00029400672,0.0008381618,0.00063953036],"domain_scores_gemma":[0.99398667,0.0024199388,0.0010744991,0.00048092334,0.0019471395,0.000090810194],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000579611,0.00033003956,0.0021553335,0.00044913264,0.0001696954,0.00009858777,0.0006424121,0.0007889879,0.00078698207],"category_scores_gemma":[0.00023845461,0.00028234816,0.00096250686,0.00032942934,0.00047890932,0.000089031055,0.000111482506,0.003396608,0.00000328975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013355727,0.0002152733,0.0003857822,0.0040923795,0.005812296,0.15375334,0.0007021,0.000029584486,0.05100097,0.000017029395,0.7570225,0.02563319],"study_design_scores_gemma":[0.0048342566,0.0009978365,0.00024942865,0.0023385072,0.000758443,0.34440628,0.002449804,0.000029177214,0.011361309,0.00022154157,0.6320243,0.0003291512],"about_ca_topic_score_codex":0.00015768607,"about_ca_topic_score_gemma":0.000012388877,"teacher_disagreement_score":0.26257288,"about_ca_system_score_codex":0.0001681034,"about_ca_system_score_gemma":0.0006334516,"threshold_uncertainty_score":0.99996287},"labels":[],"label_agreement":null},{"id":"W3165234271","doi":"10.1111/bjh.17541","title":"Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Amgen","keywords":"Lenalidomide; Daratumumab; Carfilzomib; Medicine; Multiple myeloma; Bortezomib; Oncology; Internal medicine; Dexamethasone; Proteasome inhibitor; Ixazomib","score_opus":0.039036589010301034,"score_gpt":0.33193391277954026,"score_spread":0.2928973237692392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165234271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603329,0.022710253,0.0000028205736,0.014806256,0.00030325569,0.0014005848,0.0004033336,0.0000055691035,0.000035086283],"genre_scores_gemma":[0.98959315,0.0051633473,0.00042116997,0.0034530957,0.0003055373,0.000040081897,0.00012805172,0.00006687974,0.0008287138],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951295,0.0011786821,0.0019657756,0.0004370962,0.0008218101,0.00046712518],"domain_scores_gemma":[0.9955363,0.0013797339,0.001659673,0.00050256704,0.00076753896,0.00015417427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081532245,0.00034934506,0.0026028755,0.00034905548,0.00009118201,0.000025362688,0.00036116698,0.0005843626,0.0000616063],"category_scores_gemma":[0.0029614286,0.00024328295,0.00028948832,0.00037429002,0.00043098113,0.00007177692,0.00013141315,0.002250977,4.152996e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047303036,0.009468746,0.023058176,0.0011615963,0.003698523,0.4254831,0.0017923099,0.0000011288824,0.0054116785,3.2734206e-7,0.40869537,0.07392598],"study_design_scores_gemma":[0.5735141,0.016860403,0.045666877,0.009343752,0.0011917704,0.2576673,0.0024692726,0.00006616149,0.018244436,0.00001962395,0.074151136,0.0008051654],"about_ca_topic_score_codex":0.0025102214,"about_ca_topic_score_gemma":0.0024993003,"teacher_disagreement_score":0.5262111,"about_ca_system_score_codex":0.00011052682,"about_ca_system_score_gemma":0.00094214326,"threshold_uncertainty_score":0.9920791},"labels":[],"label_agreement":null},{"id":"W3168080535","doi":"10.1111/bjh.17507","title":"Thrombosis and myeloma: it is time to get the elephant out of the room","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Cancer; Hazard ratio; Thrombosis; Pulmonary embolism; Malignancy; Deep vein; Incidence (geometry); Gastroenterology; Surgery; Oncology; Confidence interval","score_opus":0.02268384006164728,"score_gpt":0.272954111887821,"score_spread":0.2502702718261737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168080535","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049260825,0.0066011334,0.000023113113,0.9409572,0.00085040217,0.00053516496,0.000052873136,0.000006697259,0.0017125993],"genre_scores_gemma":[0.010171803,0.0054778885,0.0003106631,0.97923493,0.0015565158,0.000021417947,0.000015333422,0.00007433581,0.003137135],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752253,0.00027858932,0.0009255021,0.00028832367,0.00059355126,0.00039148214],"domain_scores_gemma":[0.9980432,0.00022397582,0.00078970974,0.00045953738,0.00038667803,0.00009692018],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000482513,0.00025425592,0.0019010131,0.00012464476,0.0001345094,0.00006930519,0.0004919364,0.00039856936,0.0012930119],"category_scores_gemma":[0.00022935402,0.00017292384,0.00045181595,0.00014920253,0.00020753828,0.000047958114,0.00036681705,0.0012944486,0.00004973717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009747455,0.00013320208,0.00011455946,0.00036101058,0.0009363439,0.010265818,0.00042335188,6.760104e-7,0.000074559044,0.0000104954015,0.98579675,0.0018734712],"study_design_scores_gemma":[0.0006464683,0.00025830703,0.0070172874,0.002672071,0.00139299,0.053698327,0.0001635969,0.0000027411472,0.00034661547,0.00014329159,0.93348247,0.00017585763],"about_ca_topic_score_codex":0.000069970425,"about_ca_topic_score_gemma":0.00007581223,"teacher_disagreement_score":0.05231432,"about_ca_system_score_codex":0.000048013255,"about_ca_system_score_gemma":0.00021151941,"threshold_uncertainty_score":0.99961996},"labels":[],"label_agreement":null},{"id":"W3168255462","doi":"10.1111/bjh.17476","title":"Thromboembolic risk in patients with lung cancer receiving systemic therapy","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"U.S. Department of Veterans Affairs","keywords":"Medicine; Internal medicine; Thrombosis; Incidence (geometry); Chemotherapy; Retrospective cohort study; Confounding; Cancer; Lung cancer; Oncology; Cohort; Immunotherapy; Cohort study; Surgery","score_opus":0.007592728411007423,"score_gpt":0.2574933553613805,"score_spread":0.2499006269503731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168255462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751385,0.023469016,0.00006512406,0.0003295414,0.0003803899,0.00029034153,0.000006840508,0.000010664313,0.00030956793],"genre_scores_gemma":[0.9752112,0.023821132,0.00031966978,0.00048217617,0.00009119137,0.000015742728,0.0000047565495,0.000028478291,0.000025633255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843436,0.00019306366,0.00058362365,0.00019615468,0.0002963098,0.00029650002],"domain_scores_gemma":[0.9987969,0.000064324886,0.00044629388,0.00015874175,0.00042889427,0.000104884515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002973898,0.00012918179,0.0010916311,0.00014302194,0.00006521565,0.000034692635,0.00010525788,0.00008934251,0.00027664838],"category_scores_gemma":[0.000120843964,0.00011845949,0.00010573618,0.00024296521,0.000050902276,0.00011831659,0.000036345235,0.0003809792,0.0000029073985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011656047,0.0010406703,0.9538214,0.00024361475,0.0006046966,0.016506681,0.0003614312,0.00007810856,0.000037230067,0.00006870169,0.0045099533,0.02261091],"study_design_scores_gemma":[0.00544761,0.00027118454,0.96734214,0.0033137328,0.00022084812,0.022370512,0.00020664083,0.000016103593,0.00016236545,0.00004573413,0.0004755378,0.00012759515],"about_ca_topic_score_codex":0.00039239926,"about_ca_topic_score_gemma":0.0004807819,"teacher_disagreement_score":0.022483315,"about_ca_system_score_codex":0.000115793955,"about_ca_system_score_gemma":0.00023378106,"threshold_uncertainty_score":0.4830638},"labels":[],"label_agreement":null},{"id":"W3168576198","doi":"10.1111/bjh.17617","title":"Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Hazard ratio; Internal medicine; Myelofibrosis; Retrospective cohort study; Cohort; Proportional hazards model; Incidence (geometry); Cumulative incidence; Cohort study; Confidence interval; Surgery; Bone marrow","score_opus":0.02073554156395444,"score_gpt":0.3295500093735605,"score_spread":0.30881446780960603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168576198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734515,0.0005340515,0.000021199054,0.0011937508,0.00019837554,0.00036429905,0.000011832192,0.0000050469785,0.0003262822],"genre_scores_gemma":[0.9980914,0.0005368801,0.0009825623,0.00014040087,0.000045073994,0.00002144619,0.000004376724,0.000012602397,0.00016524956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767053,0.00041379198,0.0010645767,0.00021446025,0.0004587198,0.00017792014],"domain_scores_gemma":[0.9975673,0.0005387744,0.00076094415,0.00012922162,0.00091033825,0.0000934007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008870792,0.00011467892,0.0016633972,0.00009623216,0.000031362724,0.000015893793,0.000055448734,0.00013029328,0.00014009958],"category_scores_gemma":[0.0019366947,0.00009752783,0.000191605,0.00020068929,0.00005449678,0.000074049756,0.000027974545,0.0004070388,0.000003147607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021919938,0.0038789704,0.9591286,0.000021731197,0.0017454297,0.033459924,0.00015171412,0.0000013649815,0.000008140198,0.00005019647,0.00078459736,0.000550098],"study_design_scores_gemma":[0.006821424,0.0020421178,0.96737355,0.00037389214,0.0005014413,0.02190838,0.00046378066,0.0000019109968,0.0003094935,0.000079136524,0.000053185202,0.00007167849],"about_ca_topic_score_codex":0.00012221503,"about_ca_topic_score_gemma":0.002273477,"teacher_disagreement_score":0.011551544,"about_ca_system_score_codex":0.00019834905,"about_ca_system_score_gemma":0.00030825057,"threshold_uncertainty_score":0.39770696},"labels":[],"label_agreement":null},{"id":"W3168849811","doi":"10.1111/bjh.17448","title":"Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Merck","keywords":"Carfilzomib; Medicine; Pembrolizumab; Dexamethasone; Daratumumab; Multiple myeloma; Cohort; Oncology; Refractory (planetary science); Lenalidomide; Internal medicine; Cancer; Immunotherapy; Materials science","score_opus":0.030762873772526903,"score_gpt":0.31395151268870836,"score_spread":0.28318863891618146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168849811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765977,0.0034620552,0.00006618955,0.015991561,0.00043955498,0.0031024304,0.00029413402,0.000015735674,0.000030587158],"genre_scores_gemma":[0.98706484,0.0008159484,0.0017776102,0.0078604175,0.0005912812,0.0002088027,0.00024637277,0.00016254303,0.0012722146],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99573165,0.0007764337,0.0012908772,0.00055302813,0.0009836562,0.0006643376],"domain_scores_gemma":[0.9945433,0.0019792977,0.001296182,0.00061446783,0.001294879,0.0002718343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006031342,0.00045919587,0.0027649684,0.00029966774,0.00020466092,0.000060671442,0.00038581598,0.0006193231,0.00012545905],"category_scores_gemma":[0.0029381812,0.00031042146,0.0004055174,0.00028748915,0.0005312653,0.000113267095,0.00016120727,0.0022451452,0.0000014653468],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050909676,0.0074489894,0.058232352,0.0031235362,0.009287623,0.61068994,0.00044218468,0.0000020817586,0.00045684748,0.0000020260338,0.24532773,0.014077],"study_design_scores_gemma":[0.2621207,0.03364827,0.0816758,0.006509176,0.0049390956,0.5883959,0.0009373393,0.00015859862,0.0014592715,0.00003898035,0.019353695,0.000763164],"about_ca_topic_score_codex":0.0002851253,"about_ca_topic_score_gemma":0.0005678608,"teacher_disagreement_score":0.22597404,"about_ca_system_score_codex":0.00016668465,"about_ca_system_score_gemma":0.0013023448,"threshold_uncertainty_score":0.9999348},"labels":[],"label_agreement":null},{"id":"W3170560832","doi":"10.1111/bjh.17615","title":"Treatment of lymphocyte‐variant hypereosinophilic syndrome (L‐HES): what to consider after confirming the elusive diagnosis","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hypereosinophilic syndrome; Alemtuzumab; Discontinuation; Internal medicine; Mepolizumab; Monoclonal; Monoclonal antibody; Immunology; Gastroenterology; Oncology; Eosinophilia; Antibody; Eosinophil","score_opus":0.04424739997915796,"score_gpt":0.3373157517829593,"score_spread":0.29306835180380136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170560832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027844375,0.96800023,0.0000065443187,0.0018793014,0.0009474323,0.00116373,0.000065249274,0.000008929702,0.00008419653],"genre_scores_gemma":[0.008455835,0.9900574,0.00025821422,0.00054233114,0.00014492395,0.00023564303,0.000025739879,0.00008758207,0.00019231715],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9958176,0.0005617895,0.002141628,0.00047128423,0.00048820052,0.000519497],"domain_scores_gemma":[0.99629503,0.0010368162,0.001228012,0.0005705657,0.0005295747,0.000340009],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031711528,0.0005618064,0.0067502325,0.00039012657,0.0001113623,0.00015221903,0.0003317673,0.00048524525,0.0007776245],"category_scores_gemma":[0.000407069,0.00040617408,0.0016628298,0.000411004,0.00035222052,0.00016842883,0.00012874987,0.00040761378,0.000036771795],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034077984,0.0005566728,0.0000380959,0.0035188657,0.0017808888,0.35440412,0.00039050065,3.933581e-7,2.2791838e-7,0.000059190195,0.00086582,0.63835114],"study_design_scores_gemma":[0.00095362606,0.0007780821,0.000055038043,0.037550915,0.0026658485,0.5581383,0.00052950456,2.1465867e-7,0.0000035560795,0.000027671927,0.39910552,0.00019169235],"about_ca_topic_score_codex":0.00014033531,"about_ca_topic_score_gemma":0.000062177176,"teacher_disagreement_score":0.63815945,"about_ca_system_score_codex":0.00028324928,"about_ca_system_score_gemma":0.0015501517,"threshold_uncertainty_score":0.999839},"labels":[],"label_agreement":null},{"id":"W3171915784","doi":"10.1111/bjh.17566","title":"Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Autoantibody; Medicine; Immune thrombocytopenia; Platelet; Confidence interval; Immunology; Internal medicine; Gastroenterology; Predictive value of tests; Immunopathology; Antibody","score_opus":0.08226177243990211,"score_gpt":0.37258094884522674,"score_spread":0.2903191764053246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171915784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945469,0.004372441,0.00018569277,0.00017976291,0.00042235534,0.00019172725,0.000060120106,0.0000037170714,0.000037316742],"genre_scores_gemma":[0.9905246,0.003249499,0.006048724,0.000060536473,0.000073745214,0.0000032931246,0.000014075675,0.000016964126,0.000008555962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804384,0.000105989806,0.001371954,0.00012059845,0.00015743451,0.00020018916],"domain_scores_gemma":[0.9968859,0.0011901902,0.0010190769,0.0001463579,0.00070135243,0.0000571422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062106946,0.00010585291,0.0014117168,0.00005446811,0.000088724235,0.000015360201,0.00012856296,0.00011281759,0.00006813871],"category_scores_gemma":[0.0019326239,0.00008862155,0.00025356736,0.00015915497,0.00016157873,0.000087437154,0.000052704443,0.00022956882,6.204743e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008924416,0.0019516947,0.78082967,0.0011863931,0.0017607053,0.05718597,0.00013440593,0.000012911486,0.008122658,0.000036227913,0.0006371867,0.14724974],"study_design_scores_gemma":[0.0046214038,0.001174954,0.67813,0.0020479194,0.00084922434,0.29848364,0.0001433458,0.002202952,0.011921837,0.000050597653,0.00026100743,0.00011315473],"about_ca_topic_score_codex":0.000045232016,"about_ca_topic_score_gemma":0.000004764239,"teacher_disagreement_score":0.24129768,"about_ca_system_score_codex":0.000016182912,"about_ca_system_score_gemma":0.0002895079,"threshold_uncertainty_score":0.36138818},"labels":[],"label_agreement":null},{"id":"W3172175561","doi":"10.1111/bjh.17582","title":"Marginal zone lymphoma transdifferentiated to histiocytic sarcoma","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Histiocytic sarcoma; Lymphoma; Histiocyte; Cancer research; Pathology","score_opus":0.016339959070728813,"score_gpt":0.2503002997237911,"score_spread":0.23396034065306226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172175561","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52657294,0.026961917,0.0023903183,0.43779022,0.0027947181,0.00075687235,0.00019187403,0.000063028325,0.0024781313],"genre_scores_gemma":[0.29397032,0.0024771788,0.005939562,0.6700741,0.0035796773,0.000059701215,0.0015021518,0.00040596136,0.02199131],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99706924,0.00020829674,0.0011025347,0.00040516327,0.0006241139,0.00059065805],"domain_scores_gemma":[0.9982652,0.00010761036,0.00048679445,0.0002969875,0.00054804684,0.00029535123],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013045936,0.00038461798,0.0021599527,0.0004279103,0.000104082865,0.00007167762,0.00026001182,0.00076093274,0.0015125029],"category_scores_gemma":[0.00016503506,0.00041819157,0.00059132656,0.00025636726,0.00014209136,0.000054310145,0.000041146952,0.0010907454,0.00011066248],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013129544,0.0003194288,0.000074975454,0.00033019035,0.00067252736,0.48233557,0.000050711733,5.369099e-7,0.000010625122,0.0000070220626,0.50241834,0.0136488],"study_design_scores_gemma":[0.0051481146,0.00053369824,0.0010045229,0.0020201579,0.0010968718,0.5678285,0.000032865824,0.0000058264854,0.000031249507,0.000064697255,0.42200044,0.00023305706],"about_ca_topic_score_codex":0.0001649345,"about_ca_topic_score_gemma":0.00007666711,"teacher_disagreement_score":0.2326026,"about_ca_system_score_codex":0.0003863926,"about_ca_system_score_gemma":0.00089425204,"threshold_uncertainty_score":0.99982697},"labels":[],"label_agreement":null},{"id":"W3172711549","doi":"10.1111/bjh.17607","title":"Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Gestational age; Cohort; Fetus; Acute chest syndrome; Disease; Pediatrics; Internal medicine; Sickle cell anemia","score_opus":0.019933002517142286,"score_gpt":0.285798374809486,"score_spread":0.2658653722923437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172711549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98716146,0.0111737335,0.000032971162,0.0010961824,0.000127396,0.00011774667,0.0002562455,0.000008625946,0.000025655929],"genre_scores_gemma":[0.9967671,0.0021355778,0.00070218276,0.00028289168,0.000030081612,9.954774e-7,0.000021647646,0.000019854491,0.000039649178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846,0.00018737835,0.0006465123,0.00025585876,0.00017917219,0.00027105398],"domain_scores_gemma":[0.9989516,0.00007628541,0.00024070917,0.00019447558,0.0001496409,0.00038725394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028036622,0.0001263992,0.0007253631,0.00006417304,0.000057662954,0.00003855179,0.00009743209,0.00011557634,0.00003826059],"category_scores_gemma":[0.00034755302,0.00010880062,0.000028087372,0.000121738034,0.0003139848,0.00012830562,0.00015482499,0.0004538013,1.5520098e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003510291,0.00029420148,0.8767674,0.00024844607,0.000118957745,0.11880577,0.00010868354,0.00000175412,0.000024288849,0.000004139607,0.00009914842,0.0031761962],"study_design_scores_gemma":[0.008160352,0.0002883791,0.91772693,0.002024573,0.00026521622,0.0701259,0.00067480106,0.00035624823,0.000027577058,0.000039347484,0.00016827456,0.00014242301],"about_ca_topic_score_codex":0.00008009137,"about_ca_topic_score_gemma":0.00018025763,"teacher_disagreement_score":0.048679873,"about_ca_system_score_codex":0.000025706915,"about_ca_system_score_gemma":0.00054583437,"threshold_uncertainty_score":0.44367602},"labels":[],"label_agreement":null},{"id":"W3174565213","doi":"10.1111/bjh.17654","title":"Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Bristol-Myers Squibb","keywords":"Dasatinib; Medicine; Cumulative incidence; Clinical endpoint; Internal medicine; Incidence (geometry); Pleural effusion; Adverse effect; Tyrosine-kinase inhibitor; Gastroenterology; Oncology; Myeloid leukemia; Randomized controlled trial; Imatinib; Cohort; Cancer","score_opus":0.019886682977544506,"score_gpt":0.29675663241679906,"score_spread":0.2768699494392546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174565213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289805,0.0052734255,0.000014547032,0.00059570075,0.000677989,0.00027071912,0.0000051042307,0.000019323275,0.0002451362],"genre_scores_gemma":[0.9973313,0.0009376135,0.001102487,0.0001792142,0.00023904102,0.000013507386,0.000049946502,0.00003783586,0.0001090613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766135,0.00033212465,0.00085225725,0.00030344506,0.00046684165,0.00038396474],"domain_scores_gemma":[0.99854666,0.00029800294,0.0004652417,0.00020862874,0.00032645886,0.00015501073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003328731,0.00021666888,0.0007434476,0.00023618684,0.00009714887,0.000047106027,0.00014054427,0.0001634099,0.00020132979],"category_scores_gemma":[0.00036364864,0.00022451156,0.00017259203,0.00027093972,0.0000809493,0.00017082832,0.0000410054,0.0006298909,0.00001592197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026298056,0.0032673248,0.53959376,0.0008360216,0.0005606874,0.10899235,0.0012589133,0.0061095254,0.033575308,0.00004414811,0.001777715,0.3013544],"study_design_scores_gemma":[0.039728962,0.0016492819,0.7281352,0.0075699557,0.0003232085,0.047068883,0.0005298656,0.0038052946,0.17012385,0.00017224686,0.00038968038,0.0005035608],"about_ca_topic_score_codex":0.00009045871,"about_ca_topic_score_gemma":0.00005774944,"teacher_disagreement_score":0.30085087,"about_ca_system_score_codex":0.0018323312,"about_ca_system_score_gemma":0.0014587578,"threshold_uncertainty_score":0.9155316},"labels":[],"label_agreement":null},{"id":"W3181697634","doi":"10.1111/bjh.17694","title":"Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI)","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Debriefing; Immune thrombocytopenia; Medicine; Content validity; Health related quality of life; Quality of life (healthcare); Recall; Anxiety; Qualitative research; Clinical psychology; Internal medicine; Psychology; Physical therapy; Psychometrics; Psychiatry; Disease; Platelet","score_opus":0.16145510285626585,"score_gpt":0.4023588061605687,"score_spread":0.24090370330430283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181697634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923042,0.0015229818,0.00007982995,0.00481774,0.0003961481,0.0005231796,0.00003589172,0.0000050869658,0.00031493275],"genre_scores_gemma":[0.9985855,0.00011996944,0.000081571896,0.00093643006,0.00003154276,0.000008488791,0.0000047506655,0.000013946361,0.00021777085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965086,0.0014075148,0.0011483055,0.00018293741,0.00050884945,0.00024376814],"domain_scores_gemma":[0.99765897,0.00042841717,0.0006768668,0.0003419752,0.00074564223,0.00014815513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015853683,0.00014315809,0.001440852,0.000044133394,0.00014653859,0.000027620861,0.0002846033,0.000070475144,0.0002574425],"category_scores_gemma":[0.0016941116,0.00009238239,0.00033507906,0.0002366231,0.00019251063,0.00007503143,0.00017307787,0.0004075389,0.000010554066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037708,0.028065605,0.46582526,0.0005982126,0.010979146,0.31258586,0.1361529,0.000023465842,0.0049821734,0.0025367518,0.023512622,0.010967201],"study_design_scores_gemma":[0.008905378,0.0020638164,0.687291,0.00036134716,0.0006265773,0.16399877,0.13024819,0.0000017343206,0.0046619843,0.0010646775,0.0005923771,0.00018415423],"about_ca_topic_score_codex":0.0006648117,"about_ca_topic_score_gemma":0.0010003893,"teacher_disagreement_score":0.22146575,"about_ca_system_score_codex":0.000047392467,"about_ca_system_score_gemma":0.00051031687,"threshold_uncertainty_score":0.37672445},"labels":[],"label_agreement":null},{"id":"W3191805895","doi":"10.1111/bjh.17677","title":"Current status of haemophilia inhibitor management in mainland China: a haemophilia treatment centres survey on treatment preferences and real‐world clinical practices","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; Alberta Health Services","funders":"National Key Research and Development Program of China; Tianjin Science and Technology Committee; National Natural Science Foundation of China","keywords":"Haemophilia; Medicine; Haemophilia A; Clinical Practice; Surgery; Family medicine; Internal medicine; Intensive care medicine","score_opus":0.10675397024042184,"score_gpt":0.4209203461063319,"score_spread":0.31416637586591006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191805895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97829264,0.018356228,0.0000014685174,0.0011280983,0.00044997237,0.00063985656,0.000100516496,0.000009578917,0.0010216094],"genre_scores_gemma":[0.807237,0.191501,0.00042691408,0.00001877819,0.0001380657,0.000016470705,0.00007317488,0.000020885245,0.000567657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957967,0.001146843,0.0014254807,0.0004993804,0.0005091271,0.0006224738],"domain_scores_gemma":[0.99717885,0.00086823315,0.0009121133,0.0002912234,0.00028552674,0.00046407353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082982396,0.00031158575,0.0016571757,0.00045520486,0.00008367668,0.00005485783,0.00011176835,0.00014615279,0.00010987506],"category_scores_gemma":[0.0006437822,0.00023614244,0.00026365762,0.00038620495,0.00029290025,0.00012354112,0.000085559695,0.0003901737,0.00000670386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019237362,0.005381769,0.7302833,0.00023753932,0.0008823626,0.05526438,0.00022680062,0.0000027758947,0.000016932847,0.00010470578,0.00093721476,0.20473844],"study_design_scores_gemma":[0.010701471,0.004105899,0.9672232,0.0014987865,0.0004129403,0.009584268,0.00026433016,0.00001656744,0.00081419933,0.00034875842,0.0048559434,0.00017362782],"about_ca_topic_score_codex":0.0026962012,"about_ca_topic_score_gemma":0.01326172,"teacher_disagreement_score":0.23693986,"about_ca_system_score_codex":0.00035904977,"about_ca_system_score_gemma":0.00064512074,"threshold_uncertainty_score":0.96296096},"labels":[],"label_agreement":null},{"id":"W3195024161","doi":"10.1111/bjh.17811","title":"Molecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes?","year":2021,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"Medical Research Council; National Institute for Health and Care Research; Michael Smith Health Research BC; Cancer Research UK; NIHR Cambridge Biomedical Research Centre; Wellcome Trust","keywords":"Subtyping; Computational biology; Lymphoma; Profiling (computer programming); Precision medicine; Diffuse large B-cell lymphoma; Clinical trial; Bioinformatics; Biology; Medicine; Computer science; Pathology","score_opus":0.018647779673183526,"score_gpt":0.3013110141533433,"score_spread":0.2826632344801598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195024161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042748176,0.9561073,0.000025809728,0.000061627274,0.00028369154,0.00041708487,0.000041729178,0.0000069492958,0.00030761227],"genre_scores_gemma":[0.010436652,0.988443,0.0007065525,0.00013785613,0.00007321276,0.000027078175,0.00006886002,0.000060183043,0.00004660446],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9970078,0.00035072002,0.0016016288,0.00031412492,0.00032720141,0.0003985441],"domain_scores_gemma":[0.9978776,0.00020420886,0.0011900365,0.00027924305,0.0002852164,0.00016368285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003695635,0.0003286722,0.004404874,0.00037095638,0.000036716618,0.000034876164,0.00021255892,0.00044902563,0.00007373502],"category_scores_gemma":[0.00024317246,0.00030335164,0.00096702756,0.00031275387,0.000091124966,0.000055000866,0.00010287662,0.0003218758,0.000014023596],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046065576,0.012835767,0.0009797426,0.024921285,0.0011667736,0.58133924,0.000060949606,4.895992e-7,0.0000047552753,0.00097444135,0.001381911,0.37628856],"study_design_scores_gemma":[0.014830773,0.0003338461,0.000121360725,0.062283155,0.0033659616,0.46313772,0.000059976348,0.0000034843758,0.0004553157,0.00005677025,0.45502487,0.00032676946],"about_ca_topic_score_codex":0.00007124153,"about_ca_topic_score_gemma":0.000037704216,"teacher_disagreement_score":0.45364296,"about_ca_system_score_codex":0.00026282977,"about_ca_system_score_gemma":0.0016601938,"threshold_uncertainty_score":0.9999419},"labels":[],"label_agreement":null},{"id":"W3195636258","doi":"10.1111/bjh.17789","title":"Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Snowdome Foundation; Peter MacCallum Cancer Centre","keywords":"Lymphoma; Immune checkpoint; Immune system; Cancer research; Follicular lymphoma; Context (archaeology); T cell; Immunohistochemistry; Immunology; Biology; Medicine; Immunotherapy","score_opus":0.00913646912819125,"score_gpt":0.25974973975312615,"score_spread":0.2506132706249349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195636258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757072,0.022152549,0.000115684525,0.0012536689,0.0005683266,0.00009551043,0.000005409014,0.0000048260317,0.000096837204],"genre_scores_gemma":[0.9973851,0.0017926978,0.00022926717,0.00031222883,0.000042455817,0.000002750122,0.000013211755,0.000014364767,0.00020793827],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99842846,0.00014791227,0.0009019085,0.00012111765,0.00022506894,0.00017555579],"domain_scores_gemma":[0.9990777,0.00003305319,0.00047893185,0.000117662494,0.00025004568,0.00004261359],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043217637,0.000088301975,0.00066808483,0.00017119401,0.00002745615,0.000023979786,0.000092603485,0.00012078366,0.00093525345],"category_scores_gemma":[0.00008946162,0.000097811586,0.00024392053,0.00019630948,0.000110951376,0.00014913444,0.000025291498,0.00024437785,0.000008255622],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032237407,0.0010357072,0.012787296,0.00046920462,0.001205189,0.22036994,0.0008469954,0.0000034415875,0.7273219,0.000050221654,0.00039810917,0.032288242],"study_design_scores_gemma":[0.0031863516,0.00024494002,0.40015835,0.0007151732,0.000083575724,0.5524667,0.0003265362,0.000007738815,0.041854106,0.0005655638,0.0003108817,0.000080110534],"about_ca_topic_score_codex":0.00013416502,"about_ca_topic_score_gemma":0.00004096652,"teacher_disagreement_score":0.68546784,"about_ca_system_score_codex":0.00004456274,"about_ca_system_score_gemma":0.00022016029,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W3196277711","doi":"10.1111/bjh.17778","title":"Statins in mature B‐cell lymphomas and leukaemias","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; B cell; Cancer research; Internal medicine; Oncology; Immunology; Statin; Antibody","score_opus":0.006973920958572838,"score_gpt":0.2218642614538068,"score_spread":0.21489034049523398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196277711","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4812311,0.39069942,0.0002068034,0.09974573,0.025149392,0.0003903998,0.00035819018,0.000012377243,0.0022065984],"genre_scores_gemma":[0.020413352,0.18437502,0.0052976375,0.6442184,0.12882158,0.000044194603,0.0014797461,0.0003868153,0.01496327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981466,0.000249642,0.0006550942,0.0003642276,0.00019387309,0.00039054427],"domain_scores_gemma":[0.9989598,0.000038554543,0.0004976945,0.00021230958,0.00020559748,0.00008608736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022258695,0.00024726006,0.00090279366,0.00013637595,0.000042488875,0.00006825085,0.0002604544,0.0011761806,0.0000666901],"category_scores_gemma":[0.00013846565,0.00026313195,0.00020737557,0.00008079892,0.00014915908,0.0000066085227,0.00012589373,0.0012034079,0.0000018719071],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035103832,0.000036391553,0.00017093738,0.0002552524,0.000071417926,0.0061140726,0.000041934683,0.0000023739458,0.0022535608,0.0000055625305,0.98825306,0.0027603323],"study_design_scores_gemma":[0.0012198501,0.00007721016,0.00027039138,0.00024933676,0.00005781282,0.17686503,0.00007231451,5.835188e-7,0.0010459665,0.00009052722,0.8198197,0.00023129802],"about_ca_topic_score_codex":0.00010797755,"about_ca_topic_score_gemma":0.00040379862,"teacher_disagreement_score":0.54447263,"about_ca_system_score_codex":0.000027938211,"about_ca_system_score_gemma":0.0005396977,"threshold_uncertainty_score":0.9999821},"labels":[],"label_agreement":null},{"id":"W3197298513","doi":"10.1111/bjh.17806","title":"Convalescent plasma and remdesivir for protracted COVID‐19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; IGHV@; Rituximab; Fludarabine; Internal medicine; Case fatality rate; Immunology; Cyclophosphamide; Antibody; Chronic lymphocytic leukemia; Chemotherapy; Epidemiology; Leukemia","score_opus":0.025218921200069765,"score_gpt":0.302841886507987,"score_spread":0.27762296530791725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197298513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641221,0.010570421,0.000056666322,0.022406157,0.0002621718,0.0024352935,0.000108171276,0.000016942087,0.000022056487],"genre_scores_gemma":[0.9632439,0.0018757209,0.0015886612,0.031157078,0.0007373659,0.0005382925,0.00019171413,0.000229056,0.0004381817],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9937957,0.00115721,0.002503317,0.00074120203,0.00091550057,0.0008870614],"domain_scores_gemma":[0.99409056,0.0019191816,0.0018442601,0.0005778974,0.0011173369,0.00045079124],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018199305,0.00047576716,0.0026221238,0.00079058955,0.000082146544,0.00006166697,0.0001960047,0.0013298301,0.00016241663],"category_scores_gemma":[0.004508461,0.00046388878,0.0003477973,0.0003629756,0.000854153,0.00014147638,0.00016237983,0.002614312,0.0000021184585],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.026735991,0.00016203527,0.00006547494,0.0064143515,0.0005338522,0.92474866,0.0003729587,0.00002231025,0.00009684344,9.004187e-7,0.03903206,0.001814587],"study_design_scores_gemma":[0.04439185,0.0034249066,0.000061358616,0.007972266,0.0005213888,0.9051614,0.0001191628,0.00040391085,0.0006424786,0.000018326851,0.03693091,0.00035204698],"about_ca_topic_score_codex":0.00091697375,"about_ca_topic_score_gemma":0.0009002731,"teacher_disagreement_score":0.06796244,"about_ca_system_score_codex":0.025607098,"about_ca_system_score_gemma":0.09356954,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W3197361064","doi":"10.1111/bjh.17807","title":"<i>BCR–ABL1</i> transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Toronto General Hospital; University of Alberta; London Health Sciences Centre; Hôpital de l'Enfant-Jésus; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; McGill University Health Centre; University of Ottawa; Calgary Laboratory Services; CancerCare Manitoba; Ottawa Hospital; University Health Network; Western University; University of Toronto; University of British Columbia","funders":"Bristol-Myers Squibb Canada; Princess Margaret Cancer Foundation; Novartis","keywords":"Discontinuation; Imatinib; Chronic myeloid leukaemia; Internal medicine; Medicine; Doubling time; Imatinib mesylate; Gastroenterology; breakpoint cluster region; Oncology; Immunology; Myeloid leukemia; Biology; Cell; Genetics; Receptor","score_opus":0.013792805251477757,"score_gpt":0.2961651463502976,"score_spread":0.28237234109881987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197361064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717005,0.024519106,0.0002816589,0.0018780269,0.00023046331,0.0010642388,0.00009963477,0.000030189785,0.00019617668],"genre_scores_gemma":[0.99319226,0.0020329123,0.0025990321,0.00014870042,0.00046957756,0.0002115883,0.000247382,0.00008268721,0.0010158547],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9966066,0.00022546703,0.0015382997,0.00052557775,0.0003905159,0.00071354245],"domain_scores_gemma":[0.9983206,0.00022878946,0.00051655096,0.00040135917,0.0002621428,0.0002705748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043534877,0.00036683795,0.0015277792,0.0003672359,0.00007308625,0.000070225455,0.00021724317,0.00038315458,0.00082594366],"category_scores_gemma":[0.00050404435,0.00037276495,0.0004147504,0.00038885762,0.00011046482,0.00044600692,0.00004794743,0.00047468737,0.000021401896],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013574895,0.0074695013,0.008333931,0.002952104,0.001909086,0.39733383,0.0038909144,0.00052277173,0.35199916,0.00018211153,0.013633519,0.19819817],"study_design_scores_gemma":[0.3296621,0.012152625,0.005342887,0.021044683,0.0017427804,0.47917572,0.00072117016,0.0073461914,0.11260811,0.0015597844,0.027452009,0.0011919113],"about_ca_topic_score_codex":0.00021496006,"about_ca_topic_score_gemma":0.0030505601,"teacher_disagreement_score":0.31608722,"about_ca_system_score_codex":0.0063186055,"about_ca_system_score_gemma":0.005188233,"threshold_uncertainty_score":0.99987245},"labels":[],"label_agreement":null},{"id":"W3197660694","doi":"10.1111/bjh.17643","title":"Flow adhesion of whole blood to P‐selectin: a prognostic biomarker for vaso‐occlusive crisis in sickle cell disease","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Hazard ratio; Internal medicine; E-selectin; Biomarker; White blood cell; Confidence interval; Gastroenterology; Vaso-occlusive crisis; Proportional hazards model; Endothelial activation; Immunology; Cell adhesion; Sickle cell anemia; Endothelium; Cell; Disease; Chemistry; Biochemistry","score_opus":0.00919731736547448,"score_gpt":0.2549882324553377,"score_spread":0.24579091508986323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197660694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98019034,0.014685101,0.00048705592,0.0038049794,0.00022985692,0.00042660368,0.00003305263,0.0000077756495,0.00013524115],"genre_scores_gemma":[0.9950426,0.0006918913,0.003427081,0.00062956393,0.000040628584,0.000014729479,0.00001666847,0.000026068243,0.00011076827],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99846846,0.00011188478,0.0007000016,0.00020919488,0.00020066886,0.00030976904],"domain_scores_gemma":[0.9985681,0.00017761016,0.0002403842,0.00012628526,0.00059574,0.000291837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002525709,0.00012111659,0.0006925188,0.00020496942,0.000052939242,0.000014372781,0.00009347657,0.00015009851,0.000080894075],"category_scores_gemma":[0.0012249432,0.00012512165,0.00024475832,0.00039643064,0.000048909133,0.000057311005,0.000051371455,0.0002477779,0.0000057656866],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063128914,0.01517671,0.11994377,0.0075986376,0.0013780224,0.55563515,0.003084625,0.00076975743,0.07242473,0.00013473023,0.16325027,0.054290727],"study_design_scores_gemma":[0.06166647,0.007908189,0.12586913,0.01746328,0.0065447823,0.6159319,0.01381494,0.003419323,0.11785245,0.0041190656,0.023806255,0.0016042022],"about_ca_topic_score_codex":0.000035530473,"about_ca_topic_score_gemma":0.00006874204,"teacher_disagreement_score":0.13944401,"about_ca_system_score_codex":0.000026065229,"about_ca_system_score_gemma":0.00048887165,"threshold_uncertainty_score":0.51023126},"labels":[],"label_agreement":null},{"id":"W3198972272","doi":"10.1111/bjh.17793","title":"9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Deutsche Krebshilfe; European Hematology Association","keywords":"Lymphoma; Cancer research; Classical Hodgkin lymphoma; Aggressive lymphoma; Stage (stratigraphy); Pathology; Biology; Oncology; Medicine; Hodgkin lymphoma; Rituximab","score_opus":0.02258221528194429,"score_gpt":0.30006858239557443,"score_spread":0.2774863671136302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198972272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552315,0.0028130966,0.00010628016,0.00066446635,0.00015685182,0.0006416509,0.000035570654,0.0000128216225,0.00004611013],"genre_scores_gemma":[0.9978337,0.00042224297,0.0012032227,0.00014761236,0.00017268679,0.00006259883,0.00006799857,0.000019986344,0.000069900445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728817,0.0007804388,0.00084708515,0.0003847805,0.00037954305,0.00031999193],"domain_scores_gemma":[0.99846435,0.00044337998,0.00036251626,0.00030228597,0.00017260262,0.00025484574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048449342,0.00019638016,0.0010603308,0.00017382804,0.00019109217,0.00024627912,0.00014399471,0.0001467314,0.00006227519],"category_scores_gemma":[0.00014926401,0.00015235259,0.00023274326,0.0003815823,0.000084720596,0.00022273391,0.00007788005,0.0002393637,0.0000021608832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043638526,0.016442528,0.8351545,0.000025516272,0.0012516658,0.12880386,0.0032951662,0.00001407847,0.0008286108,0.000084863204,0.0004724072,0.009262948],"study_design_scores_gemma":[0.08460159,0.002769618,0.8928693,0.00023702654,0.0020943994,0.01128132,0.0021438322,0.00024578883,0.002843215,0.00019088852,0.00051650516,0.00020654661],"about_ca_topic_score_codex":0.0015801481,"about_ca_topic_score_gemma":0.004906862,"teacher_disagreement_score":0.117522545,"about_ca_system_score_codex":0.00013097576,"about_ca_system_score_gemma":0.00029851487,"threshold_uncertainty_score":0.62127584},"labels":[],"label_agreement":null},{"id":"W3200216624","doi":"10.1111/bjh.17842","title":"Refusing blood transfusions from COVID‐19‐vaccinated donors: are we repeating history?","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Blood transfusion; Donation; Lesbian; Blood donor; Pandemic; Disease; Family medicine; Infectious disease (medical specialty); Immunology; Coronavirus disease 2019 (COVID-19); Gender studies; Political science; Internal medicine; Law; Sociology","score_opus":0.05385048798505866,"score_gpt":0.29416421446839464,"score_spread":0.240313726483336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200216624","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1348593,0.12108109,0.0004097696,0.73661524,0.004163427,0.00026604466,0.00010312927,0.000095496995,0.0024065047],"genre_scores_gemma":[0.0328972,0.14630896,0.004452177,0.77996325,0.02638839,0.000029657898,0.00031971786,0.0003374585,0.00930316],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950142,0.0016458001,0.0014047887,0.00053934316,0.0006877358,0.00070812873],"domain_scores_gemma":[0.99599826,0.0007962448,0.0018665192,0.00030729227,0.0006916319,0.00034005553],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00081817165,0.00032353128,0.0016296232,0.00032017057,0.0008401902,0.0002100991,0.0007832574,0.0014108638,0.006135446],"category_scores_gemma":[0.0024046248,0.00041177467,0.00062246504,0.0002833618,0.000085387364,0.00036126684,0.0000780193,0.0032795807,0.000010643133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001150997,0.000058369955,0.00066821754,0.00011095089,0.00020317557,0.31155574,0.0027692884,0.0000015859254,0.00002201113,0.00004591521,0.68350613,0.0010471202],"study_design_scores_gemma":[0.001036246,0.000046942605,0.0001431072,0.0021392235,0.0005376538,0.05772824,0.0023243595,9.828816e-7,0.000012307089,0.0012703994,0.93435425,0.00040629448],"about_ca_topic_score_codex":0.011335015,"about_ca_topic_score_gemma":0.019340495,"teacher_disagreement_score":0.2538275,"about_ca_system_score_codex":0.0009162746,"about_ca_system_score_gemma":0.002632688,"threshold_uncertainty_score":0.9998855},"labels":[],"label_agreement":null},{"id":"W3202137838","doi":"10.1111/bjh.17884","title":"CD4<sup>+</sup> T cells from patients with glucocorticoid‐refractory immune thrombocytopenia have altered cytokine expression","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Moorfields Eye Hospital NHS Foundation Trust; British Medical Association; Research for Patient Benefit Programme; Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Glucocorticoid; Refractory (planetary science); Cytokine; Immune system; Immunology; Medicine; Immune thrombocytopenia; Internal medicine; Biology; Platelet","score_opus":0.010789824943499804,"score_gpt":0.22841076869098798,"score_spread":0.21762094374748817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202137838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978187,0.0076036723,0.000064487416,0.011989566,0.0007508869,0.0006721128,0.0004610623,0.000022771426,0.0002484246],"genre_scores_gemma":[0.86094356,0.0045345807,0.0040991814,0.117913045,0.002560085,0.00004690052,0.0073991544,0.00048686462,0.0020166116],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9959357,0.00032204812,0.0014861481,0.0006431927,0.0009230773,0.0006898537],"domain_scores_gemma":[0.99667466,0.00027490218,0.0015921122,0.0005853444,0.00067836425,0.00019460969],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010525014,0.0006057415,0.0038146174,0.00025994223,0.00011957275,0.000110869885,0.0003745323,0.001078264,0.0012801446],"category_scores_gemma":[0.00010202719,0.00053417543,0.0005125521,0.00012409432,0.00018427659,0.0002554619,0.00015171074,0.002837712,0.00007439285],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071407354,0.00114394,0.003971776,0.00033497778,0.0016975721,0.6129018,0.00013961908,0.000011386951,0.0014430385,2.458615e-7,0.37537232,0.002269256],"study_design_scores_gemma":[0.061381552,0.0053448286,0.023075135,0.024447883,0.0054163192,0.47204238,0.0004473613,0.00006485327,0.025855286,0.00021223296,0.37947664,0.0022355432],"about_ca_topic_score_codex":0.00031340463,"about_ca_topic_score_gemma":0.000027774955,"teacher_disagreement_score":0.14085941,"about_ca_system_score_codex":0.0001758716,"about_ca_system_score_gemma":0.00046796072,"threshold_uncertainty_score":0.999711},"labels":[],"label_agreement":null},{"id":"W3202152517","doi":"10.1111/bjh.17845","title":"Guidelines: the same evidence but different conclusions — relaxation of indications for irradiation of cellular blood components?","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transplantation; Stem cell; Total body irradiation; Fludarabine; Hematology; Internal medicine; Graft-versus-host disease; Surgery; Chemotherapy","score_opus":0.10102457520370553,"score_gpt":0.35122052373425006,"score_spread":0.2501959485305445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202152517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5427571,0.03508281,0.004537012,0.41528052,0.00069961627,0.0013749753,0.00021178309,0.000009639076,0.00004653992],"genre_scores_gemma":[0.790095,0.052935988,0.008325709,0.13092892,0.007436211,0.00029491005,0.0026634922,0.00034056715,0.006979238],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99600697,0.00056666357,0.0020217565,0.00023992459,0.0008852806,0.0002794202],"domain_scores_gemma":[0.9921551,0.0020912024,0.002497667,0.00043190716,0.0027411832,0.00008299265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000982931,0.00019424183,0.0014052071,0.0003483049,0.00012718767,0.00002487128,0.00045436868,0.0005598285,0.00064894714],"category_scores_gemma":[0.0036937061,0.00016652724,0.000561847,0.00022868489,0.0003496833,0.00007682699,0.000110585825,0.0014389667,0.0000015077824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004037712,0.0007658248,0.0020806293,0.003212453,0.0026743526,0.010150028,0.00059728936,0.000020029764,0.28365856,0.00022760709,0.68921936,0.0069900877],"study_design_scores_gemma":[0.018843861,0.005057988,0.020376662,0.048046693,0.012777415,0.4749801,0.0017049625,0.0010678915,0.10486841,0.004513827,0.30648515,0.0012770635],"about_ca_topic_score_codex":0.00021752063,"about_ca_topic_score_gemma":0.000036503196,"teacher_disagreement_score":0.46483004,"about_ca_system_score_codex":0.00009571645,"about_ca_system_score_gemma":0.000652976,"threshold_uncertainty_score":0.7105516},"labels":[],"label_agreement":null},{"id":"W3202720100","doi":"10.1111/bjh.17862","title":"Superior outcomes with paediatric protocols in adolescents and young adults with aggressive B‐cell non‐Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Institute for Work & Health; Hospital for Sick Children; Public Health Ontario","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario; Pediatric Oncology Group of Ontario; C17 Council; Institute of Chemical and Engineering Sciences; Canadian Institutes of Health Research; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medicine; Hazard ratio; Young adult; Confidence interval; Pediatrics; Internal medicine; Lymphoma; Rituximab; Oncology","score_opus":0.007072907837043763,"score_gpt":0.26216951484127204,"score_spread":0.25509660700422826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202720100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480313,0.0017394795,0.00014518495,0.00035625813,0.000058869853,0.0027601453,0.000008104933,0.00000941827,0.00011943147],"genre_scores_gemma":[0.9965172,0.00034349036,0.0023345423,0.00023616571,0.00007515533,0.0003318061,0.0000039113,0.00004469349,0.00011305584],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9977418,0.0001750348,0.0006464009,0.00032476295,0.0006056015,0.00050636346],"domain_scores_gemma":[0.99826294,0.00010666884,0.00047239548,0.00019310259,0.0006516332,0.00031324197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023952113,0.00021549327,0.0010831143,0.0002754847,0.0000630006,0.000065781824,0.00016537974,0.00017527747,0.000036389614],"category_scores_gemma":[0.00043203658,0.00017138309,0.00007856508,0.00041694698,0.0002442922,0.00017484013,0.000101132515,0.00042706463,0.000005944567],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017576332,0.00047739645,0.5837246,0.0007508526,0.00007724554,0.40624616,0.0002794526,0.000002040478,0.00009638498,0.0000019812485,0.0003225933,0.0062636593],"study_design_scores_gemma":[0.028530186,0.0010083723,0.36072627,0.0065956204,0.000085774314,0.6009145,0.0007242425,0.00006632888,0.0011273954,0.000008464221,0.000054762484,0.00015811928],"about_ca_topic_score_codex":0.00016925746,"about_ca_topic_score_gemma":0.00061288197,"teacher_disagreement_score":0.22299834,"about_ca_system_score_codex":0.00023709278,"about_ca_system_score_gemma":0.0018360254,"threshold_uncertainty_score":0.69887996},"labels":[],"label_agreement":null},{"id":"W3203015600","doi":"10.1111/bjh.17847","title":"Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Mace; Ticagrelor; Cilostazol; Conventional PCI; Internal medicine; Aspirin; Randomized controlled trial; Antithrombotic; Clinical trial; Cardiology; Myocardial infarction","score_opus":0.015220089550454327,"score_gpt":0.2512518552541826,"score_spread":0.23603176570372825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203015600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606615,0.0026391484,0.00007567297,0.00018086111,0.00030986711,0.0006488908,0.000017315495,0.000008399061,0.000053670545],"genre_scores_gemma":[0.99287677,0.0062544984,0.00053413265,0.00016818762,0.000042746677,0.000014073246,0.000036336514,0.000029434499,0.00004379754],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9980691,0.00033383636,0.0006493763,0.00025692486,0.00043383404,0.0002569325],"domain_scores_gemma":[0.9989639,0.00007186951,0.00033972185,0.00027020267,0.00027503222,0.000079299716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025346794,0.00021296329,0.0010296418,0.0001165775,0.000050954135,0.000026882186,0.00011246443,0.000107246415,0.00019497449],"category_scores_gemma":[0.000023468474,0.00015188099,0.00048721788,0.00016441835,0.00016831329,0.000100343306,0.00003717122,0.00026770437,0.0000043625496],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19947056,0.0075541786,0.0149310175,0.00018138644,0.006726511,0.60967946,0.00024675883,0.0002937029,0.00007277612,0.00005666115,0.00015723675,0.16062972],"study_design_scores_gemma":[0.17930722,0.01817214,0.46308333,0.003596192,0.001024745,0.32923105,0.0010793802,0.000031473468,0.0035711895,0.000093776645,0.00045742778,0.00035209188],"about_ca_topic_score_codex":0.000039494196,"about_ca_topic_score_gemma":0.000018928009,"teacher_disagreement_score":0.4481523,"about_ca_system_score_codex":0.0000926277,"about_ca_system_score_gemma":0.000090321475,"threshold_uncertainty_score":0.6193527},"labels":[],"label_agreement":null},{"id":"W3204177860","doi":"10.1111/bjh.17673","title":"Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"Gilead Sciences","keywords":"Medicine; Cytokine release syndrome; Tocilizumab; Adverse effect; Internal medicine; Corticosteroid; Lymphoma; Gastroenterology; Surgery; Oncology; Chimeric antigen receptor; Cancer; Immunotherapy; Rheumatoid arthritis","score_opus":0.02358306920221175,"score_gpt":0.29881096608573343,"score_spread":0.27522789688352167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204177860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945989,0.001091868,0.0023581777,0.00029187105,0.00044066776,0.00093866035,0.000041427662,0.000007692113,0.00023069051],"genre_scores_gemma":[0.98810875,0.0012497024,0.0055372776,0.00063413597,0.00009541067,0.00006638968,0.000051690582,0.000055629625,0.0042010136],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99783814,0.00013236945,0.00085771194,0.00026903927,0.0003587347,0.0005440249],"domain_scores_gemma":[0.9984425,0.00023026418,0.0002917884,0.0002126987,0.00062809134,0.00019466989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000612439,0.00013845107,0.00067515264,0.00021653752,0.000072911505,0.000038906674,0.00014059979,0.00012549099,0.00034979105],"category_scores_gemma":[0.00040837034,0.00016247372,0.00031996623,0.00016592312,0.00003490188,0.00014316567,0.00009854413,0.00017996566,0.000006633758],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012539557,0.021407943,0.17436637,0.0040274686,0.00201835,0.14053823,0.0010275742,0.00004975593,0.018086784,0.000394761,0.041635416,0.5839078],"study_design_scores_gemma":[0.16727798,0.0030316461,0.5523684,0.0030652555,0.00072802335,0.06824176,0.0014726645,0.0006374526,0.023608042,0.00063735375,0.17813711,0.00079433736],"about_ca_topic_score_codex":0.000010635985,"about_ca_topic_score_gemma":0.00009951318,"teacher_disagreement_score":0.58311343,"about_ca_system_score_codex":0.00021622163,"about_ca_system_score_gemma":0.0001700006,"threshold_uncertainty_score":0.6625486},"labels":[],"label_agreement":null},{"id":"W3204995219","doi":"10.1111/bjh.17866","title":"Targeted treatment of immune thrombocytopenia in CTLA‐4 insufficiency: a case report","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Common variable immunodeficiency; Immunology; Thrombocytopenic purpura; Evans syndrome; Thrombopoietin; Splenectomy; Immune system; Rituximab; Internal medicine; Antibody; Gastroenterology; Autoimmune hemolytic anemia","score_opus":0.02228561532827067,"score_gpt":0.28378276830608007,"score_spread":0.2614971529778094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204995219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91670144,0.04336867,0.000009745771,0.038404644,0.00051270676,0.0003833184,0.00005612653,0.000008354026,0.0005550264],"genre_scores_gemma":[0.96426857,0.009277214,0.0018269393,0.022007998,0.0005077006,0.000033696364,0.0007219794,0.00012634073,0.0012295418],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9966838,0.00019508133,0.0019694425,0.00035178277,0.0003613763,0.00043851297],"domain_scores_gemma":[0.99755585,0.00012682824,0.0014736631,0.00035247215,0.00039868127,0.00009251102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002089382,0.000327363,0.0037047784,0.00041923043,0.000049593986,0.000022786613,0.00012764301,0.0007215155,0.00030968816],"category_scores_gemma":[0.00022806163,0.0003116187,0.0005910676,0.00029449761,0.00017077703,0.00007703354,0.00003879685,0.0009288512,0.000005274766],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008822044,0.0019830093,0.0006391845,0.0002419424,0.0007722691,0.9459113,0.00015444163,0.0000013511199,0.00010290388,0.0000020342445,0.047968782,0.002134586],"study_design_scores_gemma":[0.005254125,0.0016196407,0.00073948543,0.0011975045,0.00059346936,0.96119344,0.00011820159,0.000003695052,0.0008242294,0.00006702898,0.028202554,0.00018661148],"about_ca_topic_score_codex":0.001668152,"about_ca_topic_score_gemma":0.0003509584,"teacher_disagreement_score":0.04756718,"about_ca_system_score_codex":0.00022868183,"about_ca_system_score_gemma":0.00090932794,"threshold_uncertainty_score":0.9999336},"labels":[],"label_agreement":null},{"id":"W3208273355","doi":"10.1111/bjh.17946","title":"The future of myeloma research in Canada and beyond: results of a James Lind Alliance priority setting partnership","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of New Brunswick; Princess Margaret Cancer Centre; Essar Steel Algoma (Canada); Saint John Regional Hospital; Vancouver General Hospital; Université de Moncton; Horizon Health Network","funders":"","keywords":"Multiple myeloma; Medicine; General partnership; Alliance; Quality of life (healthcare); Disease; Intensive care medicine; Internal medicine; Political science; Nursing","score_opus":0.03986587115633533,"score_gpt":0.33406215830674396,"score_spread":0.29419628715040863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208273355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5793024,0.08671689,4.3297067e-7,0.3326671,0.0003529705,0.00044156206,0.00015113183,0.0000019607892,0.00036558628],"genre_scores_gemma":[0.9441172,0.03596138,0.0012810801,0.014921855,0.0026074767,0.0000271041,0.00016245547,0.00007836941,0.0008431126],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951712,0.00125671,0.0013076493,0.0003075885,0.0012543824,0.000702475],"domain_scores_gemma":[0.99514544,0.0020130123,0.00082471065,0.00032976817,0.0015055314,0.00018152867],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020001407,0.00018906714,0.001317468,0.00019303821,0.00011952244,0.000034963494,0.00031133523,0.00043796207,0.000013770555],"category_scores_gemma":[0.0022445293,0.00015609669,0.00013981044,0.0003284049,0.00044951646,0.00005556317,0.00014572659,0.0037020063,3.916744e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092246506,0.00007910882,0.021309221,0.0014181271,0.0004371486,0.33569616,0.00022281401,3.430205e-7,0.000019446177,0.000012977743,0.5796018,0.060280353],"study_design_scores_gemma":[0.015900655,0.0012383696,0.11191802,0.012997476,0.00024290397,0.31452164,0.0060653803,0.00003418548,0.0014256309,0.0009182178,0.5342951,0.00044243474],"about_ca_topic_score_codex":0.2172512,"about_ca_topic_score_gemma":0.7094859,"teacher_disagreement_score":0.49223468,"about_ca_system_score_codex":0.00029022893,"about_ca_system_score_gemma":0.006240364,"threshold_uncertainty_score":0.99939334},"labels":[],"label_agreement":null},{"id":"W3211066619","doi":"10.1111/bjh.17684","title":"The impact of surveillance imaging after curative‐intent radiotherapy for limited‐stage follicular lymphoma","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Asymptomatic; Radiology; Positron emission tomography; Biopsy; Follicular lymphoma; Radiation therapy; Cancer; Lymphoma; Surgery; Internal medicine","score_opus":0.014292579778912665,"score_gpt":0.29188823638578976,"score_spread":0.2775956566068771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211066619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45697436,0.27053565,0.00062072277,0.26897526,0.0011688228,0.0011372482,0.00045463466,0.000017359414,0.000115952666],"genre_scores_gemma":[0.74064326,0.0638385,0.003354185,0.1834629,0.004656029,0.0004891215,0.00053159636,0.00040828716,0.0026161165],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.997315,0.00032581386,0.0011302049,0.0003103105,0.00039229137,0.0005263718],"domain_scores_gemma":[0.9963355,0.00092134543,0.0012240226,0.00036940424,0.0010342194,0.00011548543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039873112,0.0003631225,0.0018981802,0.00015254557,0.00011103557,0.00010641143,0.00024406271,0.00033162656,0.00012579729],"category_scores_gemma":[0.0003242487,0.0002531151,0.0017562732,0.00013083954,0.00025251167,0.00007914191,0.000039347648,0.00042623508,0.0000014665194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005171243,0.00040117322,0.029137207,0.00028873698,0.0039446424,0.2493448,0.000105280735,0.000004266949,0.0000511422,0.00001169073,0.696846,0.01934795],"study_design_scores_gemma":[0.009242424,0.0009128283,0.050000362,0.0023100032,0.00043807103,0.4894343,0.00009109883,0.00009098136,0.0003948741,0.000079253216,0.4466724,0.0003333737],"about_ca_topic_score_codex":0.000251081,"about_ca_topic_score_gemma":0.000037996444,"teacher_disagreement_score":0.2836689,"about_ca_system_score_codex":0.00059572724,"about_ca_system_score_gemma":0.0009541845,"threshold_uncertainty_score":0.99999213},"labels":[],"label_agreement":null},{"id":"W3216554864","doi":"10.1111/bjh.17956","title":"Outcome predictors for maternal red blood cell alloimmunisation with anti‐K and anti‐D managed with intrauterine blood transfusion","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Gestational age; Obstetrics; Fetus; Pregnancy; Blood transfusion; In utero; Blood product; Red blood cell; Adverse effect; Pediatrics; Gynecology; Internal medicine; Surgery","score_opus":0.007742638810525106,"score_gpt":0.21788436055000948,"score_spread":0.21014172173948437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216554864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405044,0.0015204487,0.0027032762,0.0010582827,0.00013884947,0.00036683402,0.00001906111,0.00002373201,0.00011908773],"genre_scores_gemma":[0.9834733,0.0046438538,0.011529061,0.00014562575,0.000069809386,0.0000068913346,0.00002592645,0.00004221896,0.00006331279],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99847573,0.0000786034,0.0006449856,0.0002555633,0.0002710709,0.00027406696],"domain_scores_gemma":[0.9990615,0.00005661894,0.000254605,0.00015141233,0.00031837693,0.00015746424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025805453,0.00018627981,0.0008502223,0.00012803284,0.0001335684,0.00005732506,0.00008757072,0.00014295292,0.000060569277],"category_scores_gemma":[0.000020967842,0.00015507823,0.00010781798,0.00013675609,0.00011835233,0.00016762147,0.000020320596,0.0003616246,3.0455178e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023174405,0.0021736631,0.7402887,0.00254116,0.0016309738,0.15983924,0.00041045903,0.000021725768,0.08528432,0.00025841824,0.00009460563,0.0051393346],"study_design_scores_gemma":[0.0211912,0.002243344,0.31189537,0.001234847,0.0023932785,0.6079646,0.0001913971,0.000028957065,0.05227156,0.00006389334,0.00031817865,0.00020342496],"about_ca_topic_score_codex":0.0000669559,"about_ca_topic_score_gemma":0.00016405655,"teacher_disagreement_score":0.4481253,"about_ca_system_score_codex":0.0000075448183,"about_ca_system_score_gemma":0.00008579785,"threshold_uncertainty_score":0.6323907},"labels":[],"label_agreement":null},{"id":"W4200448701","doi":"10.1111/bjh.17999","title":"The safety and acceptability of twice‐daily deferiprone for transfusional iron overload: A multicentre, open‐label, phase 2 study","year":2021,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); Altasciences (Canada); St. Paul's Hospital","funders":"","keywords":"Deferiprone; Medicine; Pharmacokinetics; Deferoxamine; Regimen; Pharmacology; Clinical trial; Thalassemia; Internal medicine","score_opus":0.023291634809372845,"score_gpt":0.31673040661311025,"score_spread":0.2934387718037374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200448701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80236566,0.04524281,0.00023136383,0.14716886,0.0012221164,0.003180615,0.0003141786,0.000010635478,0.0002637732],"genre_scores_gemma":[0.6298474,0.12666157,0.012174895,0.2225755,0.0037693675,0.00033831946,0.0010350492,0.0006279786,0.0029699078],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965601,0.00048473143,0.0016329442,0.00040627702,0.0004586707,0.00045730046],"domain_scores_gemma":[0.99705774,0.0009641517,0.00086819485,0.0003104551,0.00065077754,0.00014869185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009915222,0.00029679947,0.0018780016,0.000092357615,0.0003047499,0.00009267938,0.0004215901,0.0007037442,0.00036954708],"category_scores_gemma":[0.00082274317,0.00023556566,0.00028597531,0.00015876799,0.00042889593,0.0001167832,0.0001578983,0.0019445233,7.9114795e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021058602,0.011893689,0.0021213314,0.0042604497,0.0040050303,0.11291477,0.0022649583,0.000003248956,0.00033976385,0.000045542092,0.47800657,0.36308604],"study_design_scores_gemma":[0.090744816,0.007641552,0.0029444227,0.0015731693,0.0035004136,0.23459585,0.0066426373,0.000080058286,0.00007930464,0.00016464741,0.6514716,0.0005615131],"about_ca_topic_score_codex":0.00019156687,"about_ca_topic_score_gemma":0.0002141531,"teacher_disagreement_score":0.36252454,"about_ca_system_score_codex":0.000065428736,"about_ca_system_score_gemma":0.000545269,"threshold_uncertainty_score":0.9606089},"labels":[],"label_agreement":null},{"id":"W4205536854","doi":"10.1111/bjh.18016","title":"Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter?","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden; Kræftens Bekæmpelse","keywords":"Medicine; Positron emission tomography; Lymphoma; Standardized uptake value; Thresholding; Nuclear medicine; Bone marrow; Follicular lymphoma; Stage (stratigraphy); Diffuse large B-cell lymphoma; Receiver operating characteristic; Radiology; Pathology; Internal medicine; Biology","score_opus":0.02800837093846967,"score_gpt":0.31771224054511343,"score_spread":0.28970386960664374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205536854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08019291,0.917205,0.0000010864934,0.00012425173,0.0013261584,0.00078466366,0.000121385754,0.00001650168,0.00022809293],"genre_scores_gemma":[0.0064342986,0.9920212,0.00017670543,0.000077403805,0.00022412134,0.00023546745,0.00008244061,0.00007653932,0.0006717913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960857,0.00059111946,0.001887869,0.00046855476,0.00043501996,0.0005317498],"domain_scores_gemma":[0.997703,0.000341513,0.001290674,0.00032309038,0.00008455132,0.00025714075],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003554904,0.00053930946,0.0059297006,0.0005678399,0.00011536429,0.000073361814,0.00026765736,0.00030000374,0.0016811668],"category_scores_gemma":[0.00012801583,0.00040173528,0.0015203493,0.00031617578,0.000113077826,0.00012580017,0.00014527566,0.00034909655,0.0000911325],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005601956,0.0027962893,0.008054934,0.003408194,0.0014352079,0.20624998,0.000069811904,4.6800517e-7,1.0801526e-7,0.00008133799,0.0018107772,0.77603686],"study_design_scores_gemma":[0.0026719456,0.00038010234,0.0099645965,0.005631787,0.0025725162,0.47367018,0.000036841207,6.453664e-7,0.0000037664747,0.000025273483,0.5048356,0.00020673798],"about_ca_topic_score_codex":0.0014981412,"about_ca_topic_score_gemma":0.0004244228,"teacher_disagreement_score":0.77583015,"about_ca_system_score_codex":0.0011792198,"about_ca_system_score_gemma":0.0017210963,"threshold_uncertainty_score":0.9998435},"labels":[],"label_agreement":null},{"id":"W4213039994","doi":"10.1111/bjh.18077","title":"Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for <scp>haemoglobin‐H</scp> fraction and “functional” haemoglobin level","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario; BC Children's Hospital","funders":"","keywords":"Hydrops fetalis; Medicine; Haemolysis; Transfusion therapy; Lactate dehydrogenase; Thalassemia; Hemoglobinopathy; Exchange transfusion; Gastroenterology; Soluble transferrin receptor; Pathophysiology; Blood transfusion; Internal medicine; Pediatrics; Anemia; Immunology; Hemolytic anemia; Chemistry; Gestation; Iron deficiency; Pregnancy; Enzyme; Biology; Biochemistry","score_opus":0.018837968156403755,"score_gpt":0.24838748924528548,"score_spread":0.22954952108888171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213039994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9382684,0.035234775,0.020969354,0.0022293928,0.001193909,0.0015554347,0.0003456424,0.000033869834,0.00016919001],"genre_scores_gemma":[0.98734844,0.0060288915,0.005145346,0.00075191504,0.000088614084,0.0001667046,0.00015301109,0.00009089844,0.00022619119],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9968454,0.00032863385,0.0012666509,0.00041353586,0.0005620892,0.0005836811],"domain_scores_gemma":[0.9970575,0.0011213971,0.0008960591,0.00022573622,0.0004976372,0.0002016765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017617521,0.00031841904,0.0012702117,0.0003216237,0.0009893676,0.00005214194,0.00024477084,0.00029096974,0.00010561627],"category_scores_gemma":[0.0006399646,0.00028596423,0.0005969882,0.0003950939,0.00031731633,0.00023979359,0.00008310506,0.000838878,0.000001144245],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01836596,0.011097364,0.03238126,0.0068897223,0.014760018,0.040356405,0.018921757,0.04357611,0.07309218,0.01689898,0.29414886,0.4295114],"study_design_scores_gemma":[0.030351978,0.0076303883,0.012341839,0.0012290145,0.0014675055,0.8026853,0.019651666,0.0050714626,0.010472611,0.005436786,0.10306053,0.0006009077],"about_ca_topic_score_codex":0.00039838385,"about_ca_topic_score_gemma":0.000101177,"teacher_disagreement_score":0.7623289,"about_ca_system_score_codex":0.00012688605,"about_ca_system_score_gemma":0.00034530068,"threshold_uncertainty_score":0.99995923},"labels":[],"label_agreement":null},{"id":"W4213141299","doi":"10.1111/bjh.18085","title":"Cardiovascular disease in hereditary haemophilia: The challenges of longevity","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Medical Research Council; Department of Health and Aged Care, Australian Government; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Medicine; Haemophilia; Life expectancy; Antithrombotic; Disease; Coronary artery disease; Atrial fibrillation; Stroke (engine); Secondary prevention; Population; Longevity; Intensive care medicine; Pediatrics; Internal medicine; Gerontology","score_opus":0.09147133416868582,"score_gpt":0.3427219267745441,"score_spread":0.2512505926058583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213141299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019866447,0.995625,8.720462e-7,0.00083050283,0.00040807526,0.00077342667,0.000044868084,0.000005943633,0.00032462183],"genre_scores_gemma":[0.0021296663,0.99733454,0.000025781193,0.000015233651,0.00031760597,0.000052531348,0.000021998758,0.000047185218,0.00005543097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99589807,0.001314861,0.0012322833,0.00030149688,0.00088430796,0.0003689777],"domain_scores_gemma":[0.99797136,0.00058741355,0.00049907673,0.000563413,0.00013778966,0.000240957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018779493,0.0002731098,0.0041761575,0.00039473904,0.000083060506,0.000010146013,0.0004919732,0.00024488225,0.00031043633],"category_scores_gemma":[0.00069772545,0.00019301675,0.0023504342,0.00032792802,0.0003294242,0.000059357208,0.00021018805,0.0016341953,0.0000074633112],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005015488,0.00033564217,0.000056921377,0.015579138,0.0020429546,0.3008607,0.00003356408,0.0000024281976,8.150064e-9,0.000053736923,0.0006115822,0.6803732],"study_design_scores_gemma":[0.00086782716,0.00022171282,0.0002722767,0.015260742,0.0031253004,0.31523836,0.0000906314,0.0000012547755,2.1882991e-7,0.00018835986,0.6646024,0.00013092009],"about_ca_topic_score_codex":0.00009363468,"about_ca_topic_score_gemma":0.000030712035,"teacher_disagreement_score":0.68024224,"about_ca_system_score_codex":0.00016241217,"about_ca_system_score_gemma":0.0010990769,"threshold_uncertainty_score":0.7870995},"labels":[],"label_agreement":null},{"id":"W4214843492","doi":"10.1111/bjh.18116","title":"<scp>KIT D816V</scp> is dimerization‐independent and activates downstream pathways frequently perturbed in mastocytosis","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Sunnybrook Hospital; Sunnybrook Health Science Centre; University of Ottawa; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Receptor tyrosine kinase; Tyrosine kinase; Signal transduction; Stem cell factor; Proto-Oncogene Proteins c-kit; Systemic mastocytosis; Mutant; Biology; Proto-oncogene tyrosine-protein kinase Src; Cancer research; MAPK/ERK pathway; Cell biology; Chemistry; Haematopoiesis; Biochemistry; Mast cell; Immunology; Stem cell; Gene","score_opus":0.008797379183238982,"score_gpt":0.19460889825290079,"score_spread":0.1858115190696618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214843492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98269,0.015012511,0.000055424844,0.00034928237,0.00064112165,0.00015159967,0.000115119015,0.000015185228,0.0009697576],"genre_scores_gemma":[0.9971454,0.0011019264,0.00010525305,0.0004025606,0.000025592164,0.00001930529,0.0000494187,0.000022509072,0.0011280348],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9982239,0.0003656524,0.0006615859,0.000269296,0.000093891664,0.00038569962],"domain_scores_gemma":[0.9990086,0.00024575708,0.00047293358,0.00013021668,0.00008976524,0.00005271543],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033273967,0.00017269427,0.0006502141,0.0002855362,0.00031569484,0.00003413715,0.00028547464,0.00017844503,0.0017818765],"category_scores_gemma":[0.0001459455,0.00019629265,0.0001167139,0.0001785296,0.00020357243,0.00013047656,0.00020194385,0.0007711815,0.000019149675],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004995457,0.002887317,0.05460503,0.00032088129,0.0013385501,0.042620648,0.011693964,0.00015964355,0.7469556,0.004672314,0.08934503,0.04490152],"study_design_scores_gemma":[0.010659967,0.0016787142,0.029875457,0.0002656718,0.00022367736,0.64151824,0.009000778,0.000032048134,0.0778567,0.0019322648,0.22651173,0.00044473665],"about_ca_topic_score_codex":0.0002499518,"about_ca_topic_score_gemma":0.000100183686,"teacher_disagreement_score":0.66909885,"about_ca_system_score_codex":0.000068756824,"about_ca_system_score_gemma":0.000106935804,"threshold_uncertainty_score":0.9991306},"labels":[],"label_agreement":null},{"id":"W4220926328","doi":"10.1111/bjh.18145","title":"Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"Fonds de dotation CSL Behring pour la recherche; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Bayer Schering; European Hematology Association; Swedish Orphan Biovitrum; CSL Behring; Baxter International; Landsteiner Foundation for Blood Transfusion Research; Novo Nordisk; Sanofi","keywords":"Von Willebrand factor; Von Willebrand disease; Platelet; Degranulation; Immunology; Medicine; Phenotype; Platelet factor 4; Coagulopathy; Cohort; Internal medicine; Biology; Genetics; Gene; Receptor","score_opus":0.006303401762602738,"score_gpt":0.2324116702544911,"score_spread":0.22610826849188836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220926328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962643,0.003160028,0.000015167809,0.00012710934,0.00010093474,0.00019285596,0.000037197588,0.0000030060614,0.00009945114],"genre_scores_gemma":[0.9994273,0.000340048,0.000080086706,0.000078651065,0.0000086600285,0.0000050080102,0.000039325034,0.000009363368,0.000011559483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991099,0.000059945232,0.00038666744,0.00009827499,0.0002002617,0.00014491189],"domain_scores_gemma":[0.99952614,0.00003721084,0.00023014213,0.000043694447,0.00007377853,0.00008904825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019167253,0.000065989996,0.00048123437,0.00015614726,0.00006696995,0.0000057248058,0.000038498332,0.000030965555,0.00009946689],"category_scores_gemma":[0.00008903333,0.00007170913,0.000052871932,0.00011153514,0.000032099575,0.00007896819,0.000036724912,0.00017207461,4.1673914e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005792806,0.0006185449,0.965483,0.00006950048,0.00009039616,0.02870008,0.000108465654,0.00001398031,0.000018796,0.00006032504,0.0002286742,0.004028951],"study_design_scores_gemma":[0.0100349365,0.0003567998,0.959899,0.00019768265,0.00013799504,0.028017176,0.00011545137,0.00019000104,0.000024145273,0.0006370835,0.00031782026,0.00007192512],"about_ca_topic_score_codex":0.000042773645,"about_ca_topic_score_gemma":0.000027102365,"teacher_disagreement_score":0.009455656,"about_ca_system_score_codex":0.000033868015,"about_ca_system_score_gemma":0.00005095422,"threshold_uncertainty_score":0.29242134},"labels":[],"label_agreement":null},{"id":"W4223450106","doi":"10.1111/bjh.18170","title":"International guidelines regarding the role of IVIG in the management of Rh‐ and ABO‐mediated haemolytic disease of the newborn","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa; Hospital for Sick Children; St. Michael's Hospital; University Health Network; University of Toronto; Mount Sinai Hospital; Canadian Blood Services; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Health Canada; National Center for Advancing Translational Sciences; Canadian Blood Services; Australian Government","keywords":"Medicine; ABO incompatibility; ABO blood group system; Haemolytic disease; Exchange transfusion; Disease; Intensive care medicine; Pediatrics; Immunology; Internal medicine; Pregnancy","score_opus":0.013885008988860513,"score_gpt":0.2885092310104996,"score_spread":0.27462422202163905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223450106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811306,0.010158419,0.000007799472,0.0077786953,0.00014929428,0.00016853481,0.000039800765,0.0000011949126,0.0005656403],"genre_scores_gemma":[0.9982331,0.0010299587,0.00019527768,0.00043639564,0.00004308896,0.0000053440726,0.0000048681527,0.000004587702,0.000047392223],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99873936,0.00009983855,0.00062425574,0.000071184266,0.0003626884,0.00010269769],"domain_scores_gemma":[0.99909925,0.00011039519,0.00045052273,0.00012899883,0.00016602104,0.000044820794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006477415,0.000052594398,0.00025758144,0.00004633743,0.00005014946,0.0000035937444,0.00030616033,0.000022430657,0.000042970998],"category_scores_gemma":[0.00020113743,0.000032168628,0.00008530713,0.00013766423,0.0001522748,0.000021184771,0.00014642428,0.00023570757,8.985465e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008306763,0.002952478,0.33586097,0.008689404,0.001993095,0.04644234,0.0029072617,0.00030322207,0.011639363,0.006845389,0.037939344,0.53612036],"study_design_scores_gemma":[0.016682819,0.0008629699,0.44907528,0.008906054,0.0012256755,0.35063195,0.034406573,0.0020863009,0.012526655,0.00961169,0.11359555,0.00038849385],"about_ca_topic_score_codex":0.00007774149,"about_ca_topic_score_gemma":0.00001089673,"teacher_disagreement_score":0.53573185,"about_ca_system_score_codex":0.00001913282,"about_ca_system_score_gemma":0.00010832217,"threshold_uncertainty_score":0.13117987},"labels":[],"label_agreement":null},{"id":"W4223488219","doi":"10.1111/bjh.18153","title":"How to dose and monitor argatroban for treatment of <scp>HIT</scp>","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Argatroban; Heparin-induced thrombocytopenia; Dosing; Medicine; Heparin; Discovery and development of direct thrombin inhibitors; Direct thrombin inhibitor; Pharmacology; Intensive care medicine; Thrombin; Internal medicine; Platelet; Warfarin","score_opus":0.032393869956374305,"score_gpt":0.29219900362419793,"score_spread":0.25980513366782365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223488219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941425,0.0024101397,0.00010991803,0.0022254388,0.00038359984,0.000491371,0.00005313109,0.000009169661,0.00017474063],"genre_scores_gemma":[0.9962967,0.0004198421,0.0025583329,0.00016110997,0.00015357113,0.000049268554,0.000006456562,0.000026545535,0.00032819656],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9987838,0.00009591653,0.00045506522,0.00018426043,0.0001945175,0.00028643903],"domain_scores_gemma":[0.9988845,0.0002321766,0.00030142674,0.00013783645,0.0001809388,0.00026313454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020296196,0.00013238458,0.0010830418,0.00018729856,0.00014475413,0.000028987484,0.00011429347,0.000071424365,0.00002824156],"category_scores_gemma":[0.00021912479,0.00013659928,0.00020199799,0.00013700606,0.00007210303,0.00007189389,0.000063290485,0.000126393,0.0000012933455],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022729028,0.011159963,0.14176002,0.0019337403,0.0076219533,0.09831314,0.0107321525,0.000075958465,0.32779235,0.007285289,0.067106664,0.32394585],"study_design_scores_gemma":[0.019220352,0.023247253,0.119318336,0.0004225434,0.0014383765,0.61732155,0.006063246,0.000030605155,0.07906023,0.001459569,0.13218117,0.00023677954],"about_ca_topic_score_codex":0.0000681064,"about_ca_topic_score_gemma":0.000033802822,"teacher_disagreement_score":0.5190084,"about_ca_system_score_codex":0.00010964646,"about_ca_system_score_gemma":0.00014290087,"threshold_uncertainty_score":0.5570357},"labels":[],"label_agreement":null},{"id":"W4223998135","doi":"10.1111/bjh.18167","title":"Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada; Action Medical Research","keywords":"Biology; Progenitor cell; Erythropoiesis; Haematopoiesis; Mutation; Cell biology; Genetics; Stem cell; Gene; Anemia","score_opus":0.03746162389033963,"score_gpt":0.269505748988604,"score_spread":0.2320441250982644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223998135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8300809,0.013778548,0.000023575047,0.14900517,0.0058158454,0.00070363045,0.00022307431,0.000021070839,0.0003481843],"genre_scores_gemma":[0.5378145,0.011856488,0.0013883687,0.4139924,0.011837343,0.00024662836,0.0021966815,0.0005022439,0.020165361],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.996383,0.0005953878,0.0014478475,0.0003693258,0.00072302495,0.00048141985],"domain_scores_gemma":[0.99729526,0.00046734308,0.001186755,0.0003418093,0.00061034353,0.00009851487],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004615216,0.00033545992,0.00163419,0.00041822082,0.00019928117,0.00001688956,0.00028566187,0.0006851691,0.011223848],"category_scores_gemma":[0.00034641573,0.0002918753,0.00054629793,0.00040141368,0.0008059446,0.00007048547,0.00022506354,0.0028704796,0.000047993126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013704884,0.0002996439,0.0025099597,0.00040716954,0.0006811832,0.060417347,0.00011947221,0.00001594236,0.00034535027,0.0000075843077,0.9331233,0.0007025424],"study_design_scores_gemma":[0.003583928,0.0035336479,0.016134005,0.00041504667,0.00076371065,0.6080775,0.0006533825,0.000006222185,0.00041763546,0.00016446799,0.36589903,0.00035139386],"about_ca_topic_score_codex":0.0002292736,"about_ca_topic_score_gemma":0.00024262552,"teacher_disagreement_score":0.5672243,"about_ca_system_score_codex":0.00041834384,"about_ca_system_score_gemma":0.0009212653,"threshold_uncertainty_score":0.9999533},"labels":[],"label_agreement":null},{"id":"W4224085202","doi":"10.1111/bjh.18172","title":"Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Saskatchewan Cancer Agency; CancerCare Manitoba; Ottawa Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; University of Calgary; Vancouver General Hospital; McGill University; Saint John Regional Hospital; BC Cancer Agency; Canadian Institutes of Health Research; Juravinski Cancer Centre; University of Saskatchewan; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Daratumumab; Lenalidomide; Medicine; Pomalidomide; Multiple myeloma; Bortezomib; Internal medicine; Retrospective cohort study; Cohort; Progression-free survival; Oncology; Overall survival","score_opus":0.055654552876401295,"score_gpt":0.35681313966272865,"score_spread":0.30115858678632734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224085202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274665,0.0028492066,0.0000019715296,0.0013958385,0.00013792618,0.0019203352,0.00065096124,0.0000032098355,0.0002938771],"genre_scores_gemma":[0.9991133,0.00029044336,0.00014691752,0.000055183704,0.00004882308,0.00019135224,0.00009224747,0.000020199728,0.000041491105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948514,0.0020101846,0.00083264586,0.00028864786,0.0014937463,0.0005233721],"domain_scores_gemma":[0.9971171,0.0013164517,0.00033240693,0.00057917106,0.0004466415,0.00020820944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024658262,0.00016272046,0.0011015877,0.00042308235,0.00053233263,0.00002919317,0.0005653022,0.00005976447,0.00025976947],"category_scores_gemma":[0.0011072232,0.000106864994,0.00020351075,0.0006213412,0.00039520397,0.00007986287,0.000118879754,0.00082393404,0.000003129196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007849081,0.003810249,0.9272573,0.000011974785,0.0009418902,0.060902692,0.002661051,0.000002090771,0.000052979583,0.000086017426,0.0009978806,0.0024909652],"study_design_scores_gemma":[0.008539368,0.004050561,0.96393645,0.00006315901,0.00014936745,0.013440281,0.0089852875,0.000032576914,0.0000839311,0.00013955962,0.0005119842,0.00006749499],"about_ca_topic_score_codex":0.4378802,"about_ca_topic_score_gemma":0.7330236,"teacher_disagreement_score":0.29514337,"about_ca_system_score_codex":0.0009076223,"about_ca_system_score_gemma":0.00074584363,"threshold_uncertainty_score":0.565863},"labels":[],"label_agreement":null},{"id":"W4225014393","doi":"10.1111/bjh.18213","title":"Myeloproliferative neoplasms – a global view","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Phlebotomy; Presentation (obstetrics); Medicine; Disease; Schedule; Intensive care medicine; Surgery; Pathology; Management; Economics","score_opus":0.017986190241884616,"score_gpt":0.2806940402939551,"score_spread":0.2627078500520705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225014393","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0716541,0.057182033,0.00008425526,0.86003554,0.003164144,0.0015608616,0.0006576541,0.000070266506,0.0055911453],"genre_scores_gemma":[0.013743703,0.016079117,0.0031800359,0.9588329,0.0049378416,0.0003288991,0.00067969796,0.00018161828,0.0020361813],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954002,0.000663629,0.0015729966,0.0005684945,0.0010754095,0.0007192714],"domain_scores_gemma":[0.99694425,0.0003748023,0.0013578318,0.00034502574,0.0007096027,0.0002685021],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040205815,0.00057557935,0.0030831813,0.0002454853,0.00027738695,0.00011002757,0.00038372233,0.00080945017,0.0052376594],"category_scores_gemma":[0.00039877364,0.00056655746,0.0008729336,0.00035578074,0.00023911039,0.00012978898,0.00017262985,0.0036613543,0.000095788746],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016725501,0.00025257742,0.001494482,0.00028244194,0.0010740722,0.40434012,0.00005032336,0.0000016378032,6.258685e-7,0.00018493785,0.58791286,0.0042386474],"study_design_scores_gemma":[0.0018843585,0.0013083302,0.00053330127,0.0007366391,0.00063612347,0.4917506,0.000038056693,0.0000025887978,0.000027124315,0.0005060419,0.5023483,0.00022852911],"about_ca_topic_score_codex":0.000090282185,"about_ca_topic_score_gemma":0.0000770105,"teacher_disagreement_score":0.09879737,"about_ca_system_score_codex":0.00063384115,"about_ca_system_score_gemma":0.0012965517,"threshold_uncertainty_score":0.9996786},"labels":[],"label_agreement":null},{"id":"W4226363923","doi":"10.1111/bjh.18188","title":"The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Aging; National Institutes of Health; American Society of Hematology; National Heart, Lung, and Blood Institute; Andrew W. Mellon Foundation","keywords":"Montreal Cognitive Assessment; Medicine; Interquartile range; Health literacy; Cognition; Cognitive test; Population; Gerontology; Generalizability theory; Clinical psychology; Physical therapy; Internal medicine; Cognitive impairment; Psychiatry; Psychology; Developmental psychology; Environmental health; Health care","score_opus":0.011125609341265216,"score_gpt":0.28689932632623594,"score_spread":0.2757737169849707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226363923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886655,0.0019333219,0.0017780224,0.0018262322,0.00014248535,0.0008377032,0.00025937575,0.000019023795,0.004538338],"genre_scores_gemma":[0.99729437,0.0010475994,0.00022412374,0.00094296725,0.000055109307,0.0000904363,0.00009358797,0.00003586913,0.0002159575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651283,0.0009783603,0.0010237055,0.00029565298,0.0007015269,0.00048789446],"domain_scores_gemma":[0.9952126,0.002916269,0.00088363665,0.00008534275,0.0006753913,0.00022675359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014050683,0.00019356806,0.00074325677,0.00015038479,0.00070013374,0.00006748816,0.00015339855,0.00010993498,0.00014765664],"category_scores_gemma":[0.0017374756,0.00016301995,0.0002364913,0.00037640193,0.00038423785,0.00011010784,0.000114958726,0.0016231088,0.000005767056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023190135,0.00917095,0.4386276,0.00017518083,0.0034589733,0.35661307,0.00379213,0.0003649909,0.00006460887,0.0009873107,0.002788597,0.16076644],"study_design_scores_gemma":[0.042710435,0.008891824,0.7851414,0.0033491591,0.0032560395,0.050684128,0.10148478,0.00094461755,0.000046349705,0.0022749805,0.0004649479,0.0007513154],"about_ca_topic_score_codex":0.0002750501,"about_ca_topic_score_gemma":0.00016211848,"teacher_disagreement_score":0.3465138,"about_ca_system_score_codex":0.00012558483,"about_ca_system_score_gemma":0.0011323054,"threshold_uncertainty_score":0.705169},"labels":[],"label_agreement":null},{"id":"W4247323900","doi":"10.1046/j.0007-1048.2001.03282.x","title":"Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants","year":2002,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Bone marrow transplantation; Acute lymphocytic leukemia; Transplantation; Bone marrow; Transplantation Chimera; Hematology; Childhood leukaemia; Hematopoietic cell; Oncology; Lymphoblastic Leukemia; Leukemia; Immunology; Internal medicine; Pediatrics; Haematopoiesis; Stem cell; Biology; Genetics","score_opus":0.011556599870816127,"score_gpt":0.23077006236579145,"score_spread":0.21921346249497534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247323900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932561,0.0024373212,0.0025883869,0.0005826682,0.00021332594,0.00072146486,0.000083961044,0.00003420721,0.00008258764],"genre_scores_gemma":[0.99441755,0.0024571172,0.0027200123,0.00015201837,0.000029246834,0.000036444686,0.000051226656,0.00006160844,0.000074799966],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9974139,0.00017479257,0.0011671715,0.00037842322,0.00035486437,0.00051085965],"domain_scores_gemma":[0.9987703,0.00031434157,0.00036186853,0.00013291201,0.00016976756,0.00025079394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031441415,0.00030529778,0.0011336545,0.00027652676,0.000071838054,0.00004164794,0.00011311463,0.0003511884,0.0002320113],"category_scores_gemma":[0.00003884077,0.0003049382,0.00013577996,0.0002611724,0.00018992301,0.00024719292,0.000005989498,0.00033907703,0.000007217972],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016377322,0.004008657,0.25928482,0.0057856985,0.0031120651,0.57264674,0.059468832,0.00038480488,0.06630008,0.00012900778,0.0002510276,0.012250944],"study_design_scores_gemma":[0.027277434,0.001083254,0.096789815,0.0062596747,0.0022376857,0.8518113,0.0012953635,0.00069187646,0.011734073,0.00014371557,0.0000414805,0.0006343474],"about_ca_topic_score_codex":0.000022403985,"about_ca_topic_score_gemma":0.0003026681,"teacher_disagreement_score":0.27916455,"about_ca_system_score_codex":0.000086772874,"about_ca_system_score_gemma":0.000075623575,"threshold_uncertainty_score":0.9999403},"labels":[],"label_agreement":null},{"id":"W4280582101","doi":"10.1111/bjh.18241","title":"Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"Servier; Gilead Sciences; AstraZeneca","keywords":"Medicine; ABVD; Internal medicine; Cohort; Population; Chronic lymphocytic leukemia; Gastroenterology; Oncology; Surgery; Chemotherapy; Leukemia; Vincristine; Cyclophosphamide","score_opus":0.013864597988323587,"score_gpt":0.2579462476717944,"score_spread":0.24408164968347082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280582101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990846,0.008692565,0.00009128148,0.00014379449,0.00024499142,0.0006205589,0.000032922148,0.000014642912,0.0002508141],"genre_scores_gemma":[0.99727744,0.0017961847,0.00036229478,0.00024236087,0.00004380383,0.00005538622,0.00001588114,0.000048850106,0.00015782051],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99573183,0.00052976824,0.0019160095,0.00036312966,0.0007450536,0.00071420026],"domain_scores_gemma":[0.99835014,0.0004254417,0.00055078976,0.00025534042,0.00019340802,0.00022487718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016828952,0.00019253507,0.0016392645,0.00054713804,0.0001260232,0.00010413385,0.0003763131,0.00021267457,0.00042541197],"category_scores_gemma":[0.0004151423,0.00030436018,0.00022097281,0.00070940534,0.0003139744,0.00024833312,0.000197837,0.0005036241,0.0000036236415],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0019305253,0.0014280762,0.09964208,0.003870545,0.00089160784,0.7091481,0.0035016434,0.0043370537,0.0009310088,0.00027322388,0.002367606,0.1716785],"study_design_scores_gemma":[0.070770875,0.00093919004,0.12293754,0.00112389,0.00013718715,0.7876686,0.00089299347,0.0140574025,0.00012919394,0.0005438947,0.0005111776,0.00028809666],"about_ca_topic_score_codex":0.0786786,"about_ca_topic_score_gemma":0.09392884,"teacher_disagreement_score":0.1713904,"about_ca_system_score_codex":0.050017115,"about_ca_system_score_gemma":0.023502886,"threshold_uncertainty_score":0.9999409},"labels":[],"label_agreement":null},{"id":"W4281550684","doi":"10.1111/bjh.18276","title":"Unanswered questions in cancer‐associated thrombosis","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Intensive care medicine; Observational study; Cancer; Venous thromboembolism; Anticoagulant; Thrombosis; Disease; Clinical trial; Randomized controlled trial; MEDLINE; Anticoagulant therapy; Internal medicine","score_opus":0.08788620242320794,"score_gpt":0.39159304090842745,"score_spread":0.3037068384852195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281550684","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012001321,0.99584615,0.000003340345,0.00033864932,0.0010533057,0.0006537476,0.000067411704,0.000021132277,0.0008161147],"genre_scores_gemma":[0.00030780697,0.99882287,0.0000854737,0.00024185656,0.00011306186,0.00016730285,0.000062291896,0.00006758801,0.00013177165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677444,0.0005380904,0.0016132286,0.00028027603,0.00037821496,0.0004157557],"domain_scores_gemma":[0.9979032,0.00025986464,0.0013604243,0.00020131012,0.00012330005,0.00015186684],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007278417,0.0002826928,0.005222224,0.00061467045,0.00011317981,0.00003425846,0.00032809682,0.00021017234,0.0023426346],"category_scores_gemma":[0.00053386035,0.0003008331,0.0007990261,0.00061014615,0.00008930987,0.00007262574,0.00013877706,0.0012684284,0.000012177887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007210221,0.0020279721,0.000091471855,0.009332113,0.001846615,0.08436506,0.000070678594,0.000005184442,9.71726e-8,0.0004461416,0.040670108,0.86113733],"study_design_scores_gemma":[0.0007591,0.0002555247,0.0005588659,0.036333848,0.0031298532,0.08207502,0.00006184149,9.230825e-7,1.0625785e-7,0.00011160397,0.8765026,0.0002107597],"about_ca_topic_score_codex":0.0012302957,"about_ca_topic_score_gemma":0.0012411438,"teacher_disagreement_score":0.86092657,"about_ca_system_score_codex":0.00070211507,"about_ca_system_score_gemma":0.00095006905,"threshold_uncertainty_score":0.9999444},"labels":[],"label_agreement":null},{"id":"W4281910137","doi":"10.1111/bjh.18286","title":"Early integration of palliative care for patients with haematological malignancies","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"University of Toronto; University Health Network","keywords":"Palliative care; Medicine; Specialty; Cancer; Intensive care medicine; Quality of life (healthcare); MEDLINE; Clinical trial; Oncology; Internal medicine; Family medicine; Nursing","score_opus":0.14447986898910548,"score_gpt":0.4147919607515019,"score_spread":0.2703120917623964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281910137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03022834,0.9677073,0.00045638232,0.000016972524,0.00025143824,0.000892804,0.0003160556,0.000007585432,0.00012313991],"genre_scores_gemma":[0.0031848173,0.9911181,0.0052066105,0.00002315124,0.00005788866,0.00007006496,0.00027192902,0.000040675928,0.000026798263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737,0.00024572317,0.0014829353,0.0002290214,0.00043431082,0.0002380109],"domain_scores_gemma":[0.99525696,0.00077992526,0.0024242613,0.00015488933,0.0012878627,0.00009609756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019747236,0.00028541303,0.004326553,0.00027944378,0.00006338515,0.0000104358605,0.00024639015,0.0002899752,0.00010693675],"category_scores_gemma":[0.0011613384,0.00021866069,0.0007552781,0.00024280595,0.00024347533,0.0000740733,0.000055752604,0.00052969164,9.9851e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089080725,0.0008219509,0.01141565,0.06995498,0.0021881296,0.009786155,0.0028791511,8.0939066e-7,8.876519e-7,0.0010016997,0.002053464,0.8990063],"study_design_scores_gemma":[0.0031924685,0.005408268,0.0012346705,0.12729457,0.0034973903,0.011568882,0.0020085748,5.162695e-7,0.0000361786,0.00014198196,0.845259,0.000357506],"about_ca_topic_score_codex":0.00003534459,"about_ca_topic_score_gemma":0.000027270335,"teacher_disagreement_score":0.8986488,"about_ca_system_score_codex":0.00011844999,"about_ca_system_score_gemma":0.0004658769,"threshold_uncertainty_score":0.89167243},"labels":[],"label_agreement":null},{"id":"W4283369873","doi":"10.1111/bjh.18333","title":"Sequential loss of B‐cell target antigens in multiply relapsed high‐grade B‐cell lymphoma treated with targeted therapies","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Lymphoma; Medicine; B cell; Antigen; B-cell lymphoma; Oncology; Immunology; Cancer research; Internal medicine; Antibody","score_opus":0.016211989628227813,"score_gpt":0.25931032101338936,"score_spread":0.24309833138516154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283369873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577745,0.011652263,0.00003677531,0.028321095,0.00051506463,0.00095933076,0.00025736596,0.00003921681,0.00044437475],"genre_scores_gemma":[0.9414624,0.008000628,0.0044424664,0.033633042,0.001537745,0.000079255675,0.0011778052,0.0005613255,0.0091053145],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9936348,0.0013134409,0.0018765965,0.0006330045,0.0014921351,0.0010500008],"domain_scores_gemma":[0.9965258,0.00045326026,0.0016176567,0.00055231864,0.0006430268,0.00020793888],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007827203,0.0005962791,0.003147029,0.0013428007,0.00012441861,0.00005353936,0.0007261032,0.0010665653,0.007497017],"category_scores_gemma":[0.00009600166,0.0005923075,0.00062512,0.0007670362,0.000716245,0.00013594427,0.00013887178,0.0036416883,0.000010247812],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046429355,0.0017612189,0.0100779915,0.0013664992,0.0012631858,0.74037415,0.0006722312,0.000038375572,0.03939537,0.000002810883,0.19964738,0.0007578558],"study_design_scores_gemma":[0.051739823,0.006422299,0.004980949,0.0019456252,0.000753093,0.5882111,0.0006957158,0.000057550653,0.08442375,0.00016508902,0.25940087,0.0012041302],"about_ca_topic_score_codex":0.0016314771,"about_ca_topic_score_gemma":0.0001260479,"teacher_disagreement_score":0.15216304,"about_ca_system_score_codex":0.00042535545,"about_ca_system_score_gemma":0.0011578619,"threshold_uncertainty_score":0.99965286},"labels":[],"label_agreement":null},{"id":"W4283516342","doi":"10.1111/bjh.18329","title":"Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment <scp>(COMFORT)‐I</scp> study","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Janus; Quality of life (healthcare); Janus kinase 2; Oncology; Internal medicine; Key (lock); Cancer research; Biology; Nanotechnology; Materials science","score_opus":0.03137900389653403,"score_gpt":0.2793989253585921,"score_spread":0.2480199214620581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747208,0.007243893,0.000005844054,0.009729809,0.0010651214,0.0064650476,0.0005740795,0.000033223252,0.00016223501],"genre_scores_gemma":[0.9851122,0.00075079803,0.00013106514,0.011094001,0.0011117198,0.0011473319,0.00031762134,0.00014940387,0.00018589669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9861765,0.005274213,0.0039835586,0.0010878124,0.002646923,0.0008310154],"domain_scores_gemma":[0.98927826,0.005214478,0.0035374733,0.0008942872,0.0006966963,0.00037878484],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013048378,0.0011044053,0.0075018494,0.0005944561,0.00033597497,0.00017719339,0.0006824324,0.0006720405,0.00020945257],"category_scores_gemma":[0.0012945397,0.00075422437,0.0009024209,0.00040387938,0.00030918085,0.00024055665,0.00029498583,0.0028364283,0.000005519029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008586106,0.019878132,0.76166236,0.00019364816,0.012477073,0.14858821,0.006288309,0.000044447417,0.000022911012,0.000012852846,0.041788895,0.00045705147],"study_design_scores_gemma":[0.15607162,0.045904186,0.7601773,0.001707432,0.004936457,0.009081952,0.0126501145,0.00001021477,0.00015163505,0.000103739134,0.008686656,0.00051870075],"about_ca_topic_score_codex":0.010096279,"about_ca_topic_score_gemma":0.014958841,"teacher_disagreement_score":0.14748552,"about_ca_system_score_codex":0.00073092093,"about_ca_system_score_gemma":0.0015099646,"threshold_uncertainty_score":0.99949086},"labels":[],"label_agreement":null},{"id":"W4285591962","doi":"10.1111/bjh.18355","title":"Diversity in the bone marrow niche: Classic and novel strategies to uncover niche composition","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"American Society of Hematology; Medical Research Council Canada; Cancer Research UK; Leukaemia UK; Medical Research Council; Barts Charity","keywords":"Niche; Biology; Haematopoiesis; Stem cell; Bone marrow; Stromal cell; Cell biology; Stem cell niche; Mesenchymal stem cell; Progenitor cell; Immunology; Cancer research; Ecology","score_opus":0.07090257376211874,"score_gpt":0.3278305803355364,"score_spread":0.2569280065734177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285591962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014302443,0.9828347,0.0007212069,0.00047787174,0.00030913658,0.00072017394,0.000050311846,0.000008672007,0.0005754723],"genre_scores_gemma":[0.010114306,0.9889256,0.00040526327,0.00036368283,0.000070310074,0.000017761033,0.000050880266,0.00002469009,0.000027530692],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9976235,0.00054792326,0.00090725854,0.0002306012,0.00045416722,0.00023655378],"domain_scores_gemma":[0.998448,0.0006919801,0.0005244196,0.000157008,0.00007050344,0.00010808177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00115152,0.00021517504,0.0018277459,0.0002900302,0.00022368258,0.000049568243,0.00025082505,0.00022629178,0.00014244099],"category_scores_gemma":[0.000082489,0.00018743626,0.00026053208,0.00031063208,0.00009693778,0.000108211294,0.00016540354,0.000985867,0.0000055007117],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006588591,0.0019061577,0.0014228361,0.100075215,0.0014831137,0.38558877,0.00644733,0.000020954007,0.00007999427,0.00431442,0.0142274825,0.48377487],"study_design_scores_gemma":[0.0013195333,0.00025713354,0.00058242766,0.012991115,0.0014075937,0.77378345,0.0007952169,0.0000017912798,0.0000015732649,0.00014159932,0.208532,0.00018654692],"about_ca_topic_score_codex":0.00007919252,"about_ca_topic_score_gemma":0.00012768286,"teacher_disagreement_score":0.48358834,"about_ca_system_score_codex":0.00012922898,"about_ca_system_score_gemma":0.00036348472,"threshold_uncertainty_score":0.7643429},"labels":[],"label_agreement":null},{"id":"W4286491901","doi":"10.1111/bjh.18368","title":"A phase 2, multicentre, open‐label trial (<scp>ACE‐LY</scp>‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"AstraZeneca","keywords":"Medicine; Internal medicine; Gastroenterology; Neutropenia; Adverse effect; Discontinuation; Refractory (planetary science); Hazard ratio; Febrile neutropenia; Phases of clinical research; Progression-free survival; Surgery; Confidence interval; Toxicity; Chemotherapy","score_opus":0.03317684450859787,"score_gpt":0.33373213869567864,"score_spread":0.30055529418708077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286491901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590725,0.0013284803,0.000038560516,0.00016019058,0.00049595215,0.0016252293,0.00007541175,0.000012760844,0.0003561898],"genre_scores_gemma":[0.9963971,0.00023067111,0.0018781383,0.00023944465,0.00010996508,0.000063405896,0.00005117593,0.00007029279,0.00095981837],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949856,0.0007908477,0.0016435152,0.00042291588,0.0013960617,0.00076110684],"domain_scores_gemma":[0.9964952,0.00094388064,0.001229969,0.00039945327,0.0005458718,0.00038561568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014815994,0.00026023557,0.0016836752,0.00050389767,0.00016000391,0.000048424394,0.0008021461,0.00019769513,0.0005818077],"category_scores_gemma":[0.0025597538,0.00024035848,0.00013187548,0.0007695113,0.0003469529,0.00029461892,0.00054655166,0.0009603167,0.000009352802],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.5117402,0.06107184,0.005914886,0.0008330291,0.001188724,0.3173925,0.0015101654,0.000034468867,0.00035560984,0.00011942456,0.037311364,0.06252775],"study_design_scores_gemma":[0.8603944,0.017691996,0.0021358684,0.00077556976,0.0002164053,0.10642839,0.0009549347,0.0004975585,0.0002937744,0.000021452523,0.010453196,0.00013644987],"about_ca_topic_score_codex":0.0006278935,"about_ca_topic_score_gemma":0.00018538833,"teacher_disagreement_score":0.34865418,"about_ca_system_score_codex":0.0042950604,"about_ca_system_score_gemma":0.010627944,"threshold_uncertainty_score":0.9995273},"labels":[],"label_agreement":null},{"id":"W4287510456","doi":"10.1111/bjh.18331","title":"Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and <scp>meta‐analysis</scp>","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Ottawa Hospital; Princess Margaret Cancer Centre; Thrombosis and Atherosclerosis Research Institute; University of Ottawa; University of Toronto; University Health Network; University of Calgary; Impact; McGill University; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Discontinuation; Meta-analysis; Incidence (geometry); Confidence interval; Cohort study; Venous thromboembolism; Internal medicine; Systematic review; Prospective cohort study; Hazard ratio; Relative risk; Randomized controlled trial; MEDLINE; Obstetrics; Thrombosis","score_opus":0.05127652155252074,"score_gpt":0.3320020267003685,"score_spread":0.2807255051478478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287510456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0115398,0.985037,0.000023422252,0.00010985123,0.00011649297,0.0030853334,0.00005135396,0.000015560281,0.000021171962],"genre_scores_gemma":[0.0055321106,0.99307823,0.00005844028,0.0005025871,0.00003771845,0.0006598713,0.000032202333,0.00004869183,0.000050147264],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9930978,0.002659313,0.002467628,0.000572285,0.00053054374,0.0006724454],"domain_scores_gemma":[0.9950415,0.0007315977,0.003175425,0.00035645155,0.00039397227,0.00030105846],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0033540414,0.0004700868,0.018680323,0.0006870674,0.00011142214,0.000052496096,0.0002357231,0.0002726214,0.00015594842],"category_scores_gemma":[0.0023040168,0.00038137657,0.0008021147,0.001246824,0.0001756099,0.00016239598,0.000067940455,0.0015083399,0.000004440526],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009845995,0.0008377955,0.00010919438,0.8736452,0.075036794,0.03660498,0.0004229731,5.516795e-7,8.071077e-8,0.0000083008945,0.00016367297,0.0130719915],"study_design_scores_gemma":[0.0016801951,0.0014906771,0.00179592,0.32080892,0.47311768,0.19482736,0.00034909847,0.0000025727716,3.5672578e-8,0.000036315887,0.005653521,0.00023768951],"about_ca_topic_score_codex":0.00004921645,"about_ca_topic_score_gemma":0.00008433287,"teacher_disagreement_score":0.5528363,"about_ca_system_score_codex":0.00034494145,"about_ca_system_score_gemma":0.0006764764,"threshold_uncertainty_score":0.9998638},"labels":[],"label_agreement":null},{"id":"W4288067544","doi":"10.1111/bjh.18388","title":"The potential impact of monkeypox infection and vaccination on blood donor deferrals and the blood supply","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Monkeypox; Virology; Vaccination; Medicine; Blood supply; Blood donor; Immunology; Biology; Surgery; Vaccinia; Genetics","score_opus":0.009241911725103361,"score_gpt":0.25566603833240276,"score_spread":0.2464241266072994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288067544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.925651,0.036885858,0.000007677064,0.03605295,0.0006750603,0.0003759946,0.00016440265,0.000008641269,0.00017840049],"genre_scores_gemma":[0.9590238,0.033210725,0.000007446569,0.0066599865,0.00032877928,0.000028675515,0.00009418146,0.000035474284,0.00061095203],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99671715,0.001809335,0.00068857195,0.00021467556,0.00013246693,0.0004377868],"domain_scores_gemma":[0.9975803,0.0011483366,0.0008427172,0.00019125931,0.00020698883,0.000030405148],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010777471,0.00021558217,0.00080983486,0.00023341645,0.00057424477,0.000086227825,0.0003409324,0.00056669925,0.000412873],"category_scores_gemma":[0.0005810303,0.00013956125,0.00035288165,0.00009510072,0.0005747675,0.00009331619,0.00018366908,0.0028414598,0.0000047845992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040399893,0.00037478522,0.0027791993,0.00023399123,0.007918894,0.017333739,0.00029871947,0.000015816562,0.003643188,0.0005525224,0.9320792,0.030729987],"study_design_scores_gemma":[0.015147537,0.004020099,0.024226783,0.00024041728,0.00148958,0.8644026,0.00007398698,0.000004030684,0.0022563683,0.003327777,0.08445624,0.00035456583],"about_ca_topic_score_codex":0.0012143061,"about_ca_topic_score_gemma":0.00014625864,"teacher_disagreement_score":0.84762293,"about_ca_system_score_codex":0.000029595365,"about_ca_system_score_gemma":0.00018012006,"threshold_uncertainty_score":0.999459},"labels":[],"label_agreement":null},{"id":"W4291019328","doi":"10.1111/bjh.18401","title":"Quality of <scp>end‐of‐life</scp> care in multiple myeloma: A <scp>13‐year</scp> analysis of a population‐based cohort in Ontario, Canada","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; McMaster University; Queen's University","funders":"Canadian Cancer Society Research Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Palliative care; End-of-life care; Emergency department; Cohort; Intensive care unit; Population; Emergency medicine; Multiple myeloma; Internal medicine; Family medicine; Nursing; Environmental health","score_opus":0.048865337670489034,"score_gpt":0.33041631312927544,"score_spread":0.2815509754587864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291019328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338263,0.005502643,0.000039564038,0.000052109415,0.00015328637,0.0002267201,0.00027469514,0.0000037336679,0.00036459998],"genre_scores_gemma":[0.9985284,0.00011020228,0.00095274654,0.000108163964,0.000015369433,0.000011405731,0.00021385364,0.000016225347,0.000043630414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960982,0.00054224045,0.0020351834,0.00022814279,0.0007947985,0.00030142252],"domain_scores_gemma":[0.99600065,0.0013900448,0.0015764604,0.00024108747,0.00064348016,0.00014825117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086570025,0.000162921,0.0023521031,0.00087936874,0.000040545103,0.000003863745,0.00025024085,0.00012094843,0.0001309154],"category_scores_gemma":[0.0037719926,0.00019427923,0.00036627825,0.0011160639,0.0001233581,0.000067375375,0.00007783398,0.00054492685,1.3984379e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009578234,0.00027858757,0.9895361,0.0003535376,0.00079328846,0.0025226618,0.0020845118,0.0029806274,0.0001730311,0.000034018918,0.0009356688,0.00021219786],"study_design_scores_gemma":[0.0033901278,0.0002289384,0.9831942,0.00051787664,0.00047099084,0.00053730403,0.009845227,0.00019970823,0.0007187724,0.000035474226,0.00081807695,0.000043319014],"about_ca_topic_score_codex":0.9456469,"about_ca_topic_score_gemma":0.99028146,"teacher_disagreement_score":0.044634584,"about_ca_system_score_codex":0.0005650573,"about_ca_system_score_gemma":0.0021216786,"threshold_uncertainty_score":0.79224765},"labels":[],"label_agreement":null},{"id":"W4291111788","doi":"10.1111/bjh.18399","title":"Clinicopathological characteristics and long‐term outcomes of plasmablastic lymphoma in British Columbia","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Plasmablastic lymphoma; Internal medicine; Vincristine; Prednisone; Cohort; Cyclophosphamide; Population; Confidence interval; Immunosuppression; Lymphoma; Chemotherapy; Surgery; Gastroenterology","score_opus":0.04128212699196619,"score_gpt":0.32728726184317536,"score_spread":0.28600513485120915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291111788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.320482,0.67855924,0.0000029291741,0.000017359866,0.00045754854,0.00027529613,0.00014693792,0.000007378919,0.000051332747],"genre_scores_gemma":[0.01601179,0.98346275,0.000059635186,0.00013925215,0.00005568448,0.000022091237,0.00006385056,0.000049076356,0.0001358767],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9962203,0.0004241872,0.0023110255,0.0003195533,0.00034117978,0.0003837391],"domain_scores_gemma":[0.9969162,0.00054671295,0.0020973133,0.00014831685,0.000113283095,0.0001782021],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067523535,0.0002243966,0.005542499,0.00018887418,0.00007781516,0.00008966319,0.0002451529,0.0005222249,0.0006420098],"category_scores_gemma":[0.0015508452,0.00031905758,0.00064963044,0.00024381025,0.00030037403,0.00006413807,0.00014811706,0.00087458856,0.000002188694],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000335928,0.00042169172,0.116469145,0.0055485424,0.00020346975,0.12878492,0.000014748684,4.1418105e-8,3.4679235e-8,0.0000016993341,0.00083224906,0.74768984],"study_design_scores_gemma":[0.0046200138,0.00093817024,0.32295704,0.019070307,0.0016885705,0.5841148,0.00006665055,9.4859683e-7,1.8521847e-8,0.000058891557,0.06617415,0.00031043534],"about_ca_topic_score_codex":0.00060455984,"about_ca_topic_score_gemma":0.0048835315,"teacher_disagreement_score":0.7473794,"about_ca_system_score_codex":0.00019161476,"about_ca_system_score_gemma":0.0007405106,"threshold_uncertainty_score":0.99992615},"labels":[],"label_agreement":null},{"id":"W4295755071","doi":"10.1111/bjh.18449","title":"Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pregnancy; Gestation; Fetus; Gestational age; Obstetrics; Antibody; Blood transfusion; Pediatrics; Immunology","score_opus":0.007553665406260023,"score_gpt":0.21575638122413276,"score_spread":0.20820271581787275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295755071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938095,0.0038003833,0.000026431186,0.0009900854,0.00013450152,0.000252267,0.000009684808,0.000003935203,0.00097319833],"genre_scores_gemma":[0.9976144,0.0012674087,0.000843066,0.00018297326,0.00001565654,0.000008266031,0.000011065274,0.000010578605,0.000046595185],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9985984,0.00025133285,0.00058272696,0.000091940106,0.0003191575,0.00015646715],"domain_scores_gemma":[0.9994371,0.000048149766,0.00027003261,0.00015234626,0.00006438992,0.000028010772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071474625,0.00007296961,0.00038299517,0.000110136425,0.00009729296,0.000010385548,0.00023159749,0.00004799554,0.00019015672],"category_scores_gemma":[0.000007139547,0.000069364374,0.00011342565,0.00019576005,0.000047913996,0.000043125652,0.000053959197,0.0005136754,0.000001223464],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005813559,0.020549068,0.090898745,0.0028486752,0.0030192966,0.7502924,0.017180482,0.0005339223,0.009161601,0.002930847,0.005045338,0.09172605],"study_design_scores_gemma":[0.008820328,0.0021149702,0.37146336,0.0004834424,0.0006429362,0.60922116,0.004223914,0.000007417231,0.00070586003,0.0009863427,0.0012104457,0.00011983506],"about_ca_topic_score_codex":0.0002668508,"about_ca_topic_score_gemma":0.000027066117,"teacher_disagreement_score":0.2805646,"about_ca_system_score_codex":0.000022132603,"about_ca_system_score_gemma":0.000049174425,"threshold_uncertainty_score":0.2828597},"labels":[],"label_agreement":null},{"id":"W4303986419","doi":"10.1111/bjh.18486","title":"Dasatinib plus <scp>Peg‐Interferon</scp> alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (<scp>DASA‐PegIFN</scp> study)","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Merck KGaA","keywords":"Dasatinib; Medicine; Internal medicine; Neutropenia; Gastroenterology; Clinical endpoint; Adverse effect; Pegylated interferon; PEG ratio; Phases of clinical research; Immunology; Imatinib; Myeloid leukemia; Toxicity; Virus; Clinical trial","score_opus":0.02136001394846421,"score_gpt":0.3168797094254256,"score_spread":0.2955196954769614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303986419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98469704,0.0089366445,0.00007887174,0.00021373878,0.0013378534,0.004080316,0.00021487525,0.00007287352,0.0003677862],"genre_scores_gemma":[0.9973153,0.00075397245,0.00016264251,0.00013709281,0.0003185798,0.0003788175,0.00020085358,0.00014652568,0.0005862561],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9905971,0.001697479,0.0038142416,0.0010420127,0.0015824976,0.0012666512],"domain_scores_gemma":[0.99292403,0.0023367454,0.002755871,0.0008902608,0.0006021818,0.0004908864],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002332291,0.00071468326,0.0029532455,0.0011794178,0.00034003673,0.00008549172,0.0009582025,0.0002874861,0.00020852688],"category_scores_gemma":[0.0033824379,0.00081693666,0.0005012407,0.001005605,0.0003368346,0.0004914904,0.00059331075,0.002347235,0.000028971723],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009224632,0.1708561,0.051217135,0.0016908604,0.0069799274,0.5901578,0.037723806,0.0019742984,0.006952646,0.00005615807,0.058262717,0.0649039],"study_design_scores_gemma":[0.7055778,0.11051385,0.028175388,0.0020743825,0.0022393754,0.09894437,0.038077876,0.0038700663,0.0037656515,0.000064101005,0.006336928,0.00036019686],"about_ca_topic_score_codex":0.0014787388,"about_ca_topic_score_gemma":0.0026086557,"teacher_disagreement_score":0.6963532,"about_ca_system_score_codex":0.0073662866,"about_ca_system_score_gemma":0.0034316194,"threshold_uncertainty_score":0.9999544},"labels":[],"label_agreement":null},{"id":"W4306743619","doi":"10.1111/bjh.18519","title":"<scp>Real‐world</scp> experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The <scp>SCHOLAR</scp>‐2 retrospective chart review study","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); Precision Nanosystems (Canada)","funders":"National Cancer Institute; Allergan; Incyte; Genentech; Sunesis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; National Cancer Research Institute; Gilead Sciences; Sanofi; Amgen; Pfizer; MorphoSys; Celgene; BeiGene; Patient-Centered Outcomes Research Institute","keywords":"Mantle cell lymphoma; Medicine; Bruton's tyrosine kinase; Refractory (planetary science); Chart; Cancer research; Ibrutinib; Tyrosine kinase; Internal medicine; Lymphoma; Oncology; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.006174186714432873,"score_gpt":0.22688186975725133,"score_spread":0.22070768304281846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306743619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737216,0.023489697,8.7864055e-7,0.00021204706,0.00045811906,0.0014240324,0.00005352334,0.000025338626,0.0006147543],"genre_scores_gemma":[0.9939524,0.003882888,0.00007101538,0.0008316036,0.000110983055,0.00040742618,0.000027526996,0.00007336701,0.0006427711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958832,0.0008499392,0.0011105353,0.0005606734,0.0010065443,0.00058908673],"domain_scores_gemma":[0.9972907,0.00040348247,0.00096226885,0.00047320465,0.0005940057,0.00027637728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007928484,0.00038232215,0.0013167089,0.00028457286,0.00037181613,0.00008463518,0.00037981576,0.000082785315,0.00012134029],"category_scores_gemma":[0.0008307354,0.00029685962,0.00019659147,0.0010196762,0.0002208438,0.00040588863,0.0002750156,0.00082995003,0.00002123408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008047604,0.0069525787,0.9021914,0.0001889914,0.00014483406,0.06868185,0.0021054104,0.0000018524773,0.000016624892,0.000008803067,0.018844062,0.00078314386],"study_design_scores_gemma":[0.011184326,0.002671718,0.9438116,0.0020254666,0.00036162502,0.01308276,0.002398943,0.0000016427135,0.00025465203,0.000006281215,0.024120588,0.00008039992],"about_ca_topic_score_codex":0.0003162796,"about_ca_topic_score_gemma":0.00060149847,"teacher_disagreement_score":0.05559909,"about_ca_system_score_codex":0.0007243969,"about_ca_system_score_gemma":0.00037751495,"threshold_uncertainty_score":0.9999484},"labels":[],"label_agreement":null},{"id":"W4306912135","doi":"10.1111/bjh.18510","title":"Clinical significance of mitochondrial <scp>DNA</scp> content in acute promyelocytic leukaemia","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Mitochondrial DNA; Cumulative incidence; Clinical significance; Incidence (geometry); Internal medicine; Proportional hazards model; Medicine; Mitochondrion; Multivariate analysis; Oncology; Immunology; Biology; Genetics; Gene","score_opus":0.019354211405302055,"score_gpt":0.2738056603305992,"score_spread":0.25445144892529714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306912135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917006,0.006199149,0.00052107696,0.000066259454,0.0009332513,0.00020665041,0.000022812885,0.000003558221,0.0003466741],"genre_scores_gemma":[0.9963296,0.0013150842,0.0013403817,0.00018031421,0.00023855416,0.000030306157,0.000021673342,0.000023796887,0.00052031066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974428,0.00048278653,0.0012071802,0.00029247752,0.0002745263,0.0003002395],"domain_scores_gemma":[0.99854356,0.0001240302,0.0008049673,0.00019556069,0.00023316016,0.00009873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007039095,0.00013835134,0.000665127,0.00008262869,0.00007577253,0.000016478472,0.0005500215,0.00018961445,0.00003338499],"category_scores_gemma":[0.0008271965,0.00015953246,0.00027051094,0.00013676738,0.00027588892,0.000007215141,0.0002113086,0.00056443905,0.0000016489428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008662241,0.0012393168,0.035097603,0.0003632166,0.00083007856,0.034526464,0.00025938178,0.00041218146,0.86588174,0.00035675868,0.050005887,0.010161161],"study_design_scores_gemma":[0.011790372,0.005419847,0.0060641314,0.0003467178,0.000322777,0.261584,0.0021000474,0.00007116828,0.62533635,0.0013416385,0.08521667,0.00040629265],"about_ca_topic_score_codex":0.00003168346,"about_ca_topic_score_gemma":0.000024712557,"teacher_disagreement_score":0.24054539,"about_ca_system_score_codex":0.000046014753,"about_ca_system_score_gemma":0.0006346538,"threshold_uncertainty_score":0.6505545},"labels":[],"label_agreement":null},{"id":"W4307972632","doi":"10.1111/bjh.18536","title":"The second revision of the International Staging System (R2‐ISS) stratifies progression‐free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Pharmaceutical Company; Celgene; Bristol-Myers Squibb Canada; Gilead Sciences; AbbVie; Sanofi; Janssen Research and Development; Novartis; Amgen","keywords":"Multiple myeloma; Staging system; Medicine; Progression-free survival; Overall survival; Oncology; Internal medicine; Population; Cancer; Environmental health","score_opus":0.07219630896276948,"score_gpt":0.3477075047314594,"score_spread":0.27551119576868993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307972632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9295179,0.0008641505,4.5601948e-7,0.068118006,0.00034739135,0.0005509449,0.0005316413,0.000005548904,0.00006390895],"genre_scores_gemma":[0.9947334,0.0008981512,0.00049893314,0.0007617749,0.000487182,0.000006388536,0.0009443248,0.000034706263,0.0016351655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968781,0.000669221,0.00107171,0.00035176985,0.00072839274,0.00030082208],"domain_scores_gemma":[0.99785304,0.0005667866,0.00086869317,0.00049204077,0.0001121014,0.000107361375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012735449,0.00017900857,0.000734344,0.0002991969,0.00013350355,0.00013217096,0.0006252248,0.00014866877,0.000025956697],"category_scores_gemma":[0.000598614,0.00012674069,0.000054151355,0.00014891484,0.00016203825,0.0002558668,0.000469781,0.0014369296,1.2107294e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022063006,0.000103907434,0.7759554,0.0005903713,0.00019983709,0.029708654,0.00020775794,0.0000031115446,0.000023921579,0.00003185951,0.16598846,0.024980418],"study_design_scores_gemma":[0.009325655,0.00031597793,0.9296601,0.004017378,0.00006467565,0.020669786,0.00040834743,0.00036263288,0.000019567478,0.00014043489,0.034858245,0.00015720425],"about_ca_topic_score_codex":0.0061626933,"about_ca_topic_score_gemma":0.057979163,"teacher_disagreement_score":0.15370469,"about_ca_system_score_codex":0.00015123952,"about_ca_system_score_gemma":0.00021053095,"threshold_uncertainty_score":0.9592103},"labels":[],"label_agreement":null},{"id":"W4308325444","doi":"10.1111/bjh.18531","title":"Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Kawasaki Disease and Coronary Complications","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Basic and Applied Basic Research Foundation of Guangdong Province","keywords":"Mitophagy; Platelet activation; Thymic stromal lymphopoietin; Medicine; Platelet; Immunology; Thrombosis; Thrombopoiesis; Pharmacology; Autophagy; Internal medicine; Chemistry; Biology; Cytokine; Apoptosis; Cell biology; Biochemistry; Haematopoiesis","score_opus":0.01629557942302739,"score_gpt":0.26820816001799036,"score_spread":0.25191258059496296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308325444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865109,0.009957389,0.000007689751,0.0029904621,0.000121524485,0.00021388628,0.000041475603,0.000014080033,0.00014263435],"genre_scores_gemma":[0.9987204,0.00036326938,0.0002447118,0.0004984752,0.000065831046,0.000036541598,0.000017365468,0.000017897391,0.00003548564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986397,0.00017943628,0.00049455697,0.00020114917,0.00024551354,0.00023963679],"domain_scores_gemma":[0.9992311,0.00008642888,0.00022571516,0.00013642256,0.00007084409,0.0002494978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019412459,0.000111405796,0.0004803756,0.00020047072,0.00016732926,0.000023116712,0.00016073276,0.00004193247,0.0004422745],"category_scores_gemma":[0.00009998887,0.00012897224,0.00010836944,0.00019508215,0.00011446125,0.00008542212,0.00012520663,0.00034319158,0.0000036626366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025857778,0.006736041,0.6137727,0.000776236,0.0007915483,0.29479173,0.0013130016,0.00015892014,0.009934296,0.002658253,0.016251998,0.05022948],"study_design_scores_gemma":[0.0030048853,0.0005096879,0.7873094,0.00024033728,0.00012951998,0.20439348,0.0008119749,0.000118878066,0.00018030638,0.002211668,0.0009212626,0.00016857123],"about_ca_topic_score_codex":0.000069751535,"about_ca_topic_score_gemma":0.000021098516,"teacher_disagreement_score":0.17353672,"about_ca_system_score_codex":0.00006848509,"about_ca_system_score_gemma":0.00033703775,"threshold_uncertainty_score":0.52593356},"labels":[],"label_agreement":null},{"id":"W4308548721","doi":"10.1111/bjh.18545","title":"Evaluating the impact of thrombopoietin receptor agonist medications on patient outcomes and quality of life in paediatric immune thrombocytopenia through <scp>semi‐structured</scp> interviews","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; SickKids Foundation; University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Thrombopoietin; Thrombopoietin receptor; Quality of life (healthcare); Immune thrombocytopenia; Dosing; Eltrombopag; Romiplostim; Cohort; Adverse effect; Pediatrics; Agonist; Internal medicine; Platelet; Receptor","score_opus":0.055446450926084745,"score_gpt":0.37886493924155773,"score_spread":0.323418488315473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308548721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844428,0.013833442,0.0000075326366,0.00084014836,0.00019495082,0.00041070415,0.000094257965,0.000004268331,0.00017191682],"genre_scores_gemma":[0.99776435,0.0014719861,0.0004887909,0.00019179484,0.000014155945,0.000014581179,0.000027182323,0.00001575935,0.000011402158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967147,0.0008368966,0.0015684398,0.0001747434,0.00048252643,0.00022269941],"domain_scores_gemma":[0.99706966,0.00081958587,0.0016427491,0.00022417105,0.00016259069,0.00008127508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011961815,0.00016096234,0.0016371461,0.0001317671,0.00014701787,0.00001144391,0.00021847068,0.000077667784,0.00019883417],"category_scores_gemma":[0.0017705077,0.00011573179,0.0003226203,0.00029474648,0.00021792544,0.000073497235,0.00014916396,0.0005372834,0.0000011407114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016131991,0.0072739096,0.882155,0.00091001665,0.005199836,0.00465568,0.025674125,0.00089112855,0.010175597,0.0009281397,0.013890726,0.046632662],"study_design_scores_gemma":[0.010002178,0.005417539,0.9488059,0.0004586817,0.0003839625,0.024063537,0.007303521,0.00007445155,0.0008751916,0.002302552,0.00018754227,0.00012488833],"about_ca_topic_score_codex":0.0012355258,"about_ca_topic_score_gemma":0.00009219482,"teacher_disagreement_score":0.06665098,"about_ca_system_score_codex":0.00010579834,"about_ca_system_score_gemma":0.00034091703,"threshold_uncertainty_score":0.47194055},"labels":[],"label_agreement":null},{"id":"W4310086091","doi":"10.1111/bjh.18579","title":"Treatment response in acute myeloid leukaemia—Clues in the biopsy core","year":2022,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukaemia; Medicine; Bone marrow; Transcriptome; Myeloid; Biopsy; Core biopsy; Internal medicine; Myeloid cells; Oncology; Pathology; Cancer research; Biology; Gene; Cancer; Gene expression; Breast cancer","score_opus":0.03624912448035942,"score_gpt":0.3255512199774176,"score_spread":0.28930209549705815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310086091","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.604769,0.0046098656,0.0000035354071,0.38931683,0.00031730477,0.00058954285,0.000084677566,0.000011383639,0.00029783574],"genre_scores_gemma":[0.21396698,0.027071789,0.0022571718,0.74012643,0.0048442385,0.0006811429,0.00094478944,0.0005384642,0.009568991],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9938522,0.0022219985,0.0014873453,0.000468838,0.0010476089,0.0009220299],"domain_scores_gemma":[0.9967359,0.001698571,0.00069170684,0.0005582687,0.00019669943,0.00011889547],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020736735,0.00042004057,0.0020845952,0.0013699955,0.00012604102,0.00007066642,0.0009670637,0.0008800466,0.00073330075],"category_scores_gemma":[0.0007906543,0.00034333082,0.00047694513,0.0007405207,0.00038817685,0.00010802084,0.00019386249,0.0072657876,0.000033438857],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033512332,0.00015617041,0.000887909,0.000078598125,0.00023589666,0.5998923,0.00047066898,0.0000022442907,0.000083965504,0.000006019913,0.39322877,0.001606214],"study_design_scores_gemma":[0.0043189307,0.0019808838,0.0035253128,0.00044280977,0.0001861667,0.6751807,0.000509192,0.000011911667,0.000025668822,0.00013056435,0.3135054,0.00018246741],"about_ca_topic_score_codex":0.0007230651,"about_ca_topic_score_gemma":0.00014501433,"teacher_disagreement_score":0.39080203,"about_ca_system_score_codex":0.0023467746,"about_ca_system_score_gemma":0.0023033852,"threshold_uncertainty_score":0.9999019},"labels":[],"label_agreement":null},{"id":"W4310705764","doi":"10.1111/bjh.18586","title":"Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle cell trait","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"Agence Nationale de la Recherche","keywords":"Adenosine; Pathophysiology; Red blood cell; Hypoxia (environmental); Sickle cell trait; Internal medicine; Nucleoside; Immunology; Endocrinology; Medicine; Biology; Disease; Chemistry; Biochemistry","score_opus":0.007203260723477073,"score_gpt":0.2207642883257057,"score_spread":0.21356102760222861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310705764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806628,0.016592164,0.000059190053,0.0010125724,0.00021895666,0.00020928057,0.000023879104,0.000012878333,0.0012082567],"genre_scores_gemma":[0.9976051,0.0011528208,0.00034802017,0.00055839715,0.000033144424,0.0000055455366,0.000014259283,0.000027701268,0.00025501515],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99860567,0.00015167546,0.000535792,0.0001963851,0.0002339485,0.00027650731],"domain_scores_gemma":[0.9993074,0.000055919743,0.00022146196,0.000096343836,0.0000630349,0.00025586013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019414205,0.00012986654,0.0005342403,0.00014508278,0.00011931327,0.000015345755,0.000107135944,0.00009030002,0.00091082207],"category_scores_gemma":[0.000028869788,0.00013241652,0.0001165641,0.00017726059,0.00012458411,0.00013489606,0.000053139087,0.00068623875,0.0000037563416],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012480757,0.007582026,0.031051705,0.0024149464,0.00031104102,0.7394009,0.0175245,0.0012263866,0.09827672,0.00024484046,0.07277001,0.016716124],"study_design_scores_gemma":[0.084074676,0.012282398,0.11731991,0.0053156456,0.0024766778,0.5821479,0.06815733,0.0024007559,0.047242165,0.0071261306,0.06853089,0.0029255296],"about_ca_topic_score_codex":0.000030364712,"about_ca_topic_score_gemma":0.000017313221,"teacher_disagreement_score":0.15725306,"about_ca_system_score_codex":0.000036808826,"about_ca_system_score_gemma":0.00021100139,"threshold_uncertainty_score":0.99728626},"labels":[],"label_agreement":null},{"id":"W4310786296","doi":"10.1111/bjh.18582","title":"Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Syk; Immune thrombocytopenia; Adverse effect; Internal medicine; Placebo group; Gastroenterology; Double blind; Platelet; Tyrosine kinase; Receptor; Pathology","score_opus":0.02356153659679367,"score_gpt":0.2988072891600148,"score_spread":0.27524575256322115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310786296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862674,0.007846749,0.000047406418,0.00029859753,0.00022467501,0.005113345,0.00007514427,0.0000088571915,0.0001178303],"genre_scores_gemma":[0.99817526,0.00038852572,0.00038457228,0.00007446856,0.000029994366,0.00072196324,0.000073994364,0.000033651406,0.00011754583],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979249,0.00017005832,0.00094804895,0.00021052962,0.00044565802,0.0003008077],"domain_scores_gemma":[0.9980624,0.00047026787,0.00088466343,0.00023889105,0.0002495755,0.00009420622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035045788,0.000221709,0.0021449,0.00012899621,0.00032564782,0.000023830056,0.00019895406,0.000049129034,0.0001399187],"category_scores_gemma":[0.000038183432,0.00014461746,0.00034972836,0.00014848636,0.00010777532,0.00009618407,0.000046257122,0.0001968787,0.0000012104346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7597956,0.107924506,0.014190719,0.00020444144,0.013586536,0.06771688,0.007516801,0.00016337668,0.00008150911,0.00004130959,0.001071922,0.027706414],"study_design_scores_gemma":[0.859147,0.055102505,0.008099356,0.000102399885,0.0030748085,0.0668576,0.0064165955,0.000043433665,0.000022891683,0.000043223234,0.00089907396,0.00019112542],"about_ca_topic_score_codex":0.00019044825,"about_ca_topic_score_gemma":0.000117565796,"teacher_disagreement_score":0.099351406,"about_ca_system_score_codex":0.00012914005,"about_ca_system_score_gemma":0.0001503027,"threshold_uncertainty_score":0.5897328},"labels":[],"label_agreement":null},{"id":"W4311027234","doi":"10.1111/bjh.18568","title":"Time‐to‐event surrogate end‐points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis","year":2022,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Queen's University","funders":"","keywords":"Surrogate endpoint; Medicine; Confidence interval; Hazard ratio; Internal medicine; Progression-free survival; Clinical endpoint; Multiple myeloma; Oncology; Clinical trial; Proportional hazards model; Pearson product-moment correlation coefficient; Overall survival; Statistics; Mathematics","score_opus":0.07511153867178022,"score_gpt":0.38234383984500037,"score_spread":0.30723230117322015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311027234","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017082538,0.9764308,0.00006785241,0.00048251523,0.0003681081,0.0040486236,0.0013879229,0.00002434948,0.00010731418],"genre_scores_gemma":[0.00065881805,0.994707,0.0014772005,0.00017693073,0.00027350397,0.0004021113,0.0011067807,0.0001120105,0.0010856718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9871503,0.005213629,0.0045499303,0.0008059021,0.0012007717,0.0010794296],"domain_scores_gemma":[0.9891696,0.0065710363,0.0020016478,0.00060923456,0.0002625691,0.0013859379],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0063952873,0.00065662747,0.01368169,0.0031162545,0.00014270503,0.0000963881,0.00072023954,0.00040858833,0.020983303],"category_scores_gemma":[0.014191195,0.00060215715,0.003758385,0.001758094,0.00010057155,0.00011747689,0.0003421308,0.0013356949,0.0009740976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005801916,0.0010000523,0.00019442906,0.0010685924,0.013087318,0.16332234,0.00008935899,0.00002643933,0.000004015356,6.972259e-7,0.015350761,0.8000541],"study_design_scores_gemma":[0.04460682,0.00055820553,0.0005270035,0.009500762,0.011384364,0.045830145,0.000045341043,0.000054423017,0.000010543608,0.000014924217,0.886947,0.00052049273],"about_ca_topic_score_codex":0.0013702442,"about_ca_topic_score_gemma":0.001494833,"teacher_disagreement_score":0.8715962,"about_ca_system_score_codex":0.0007676554,"about_ca_system_score_gemma":0.001417958,"threshold_uncertainty_score":0.9998038},"labels":[],"label_agreement":null},{"id":"W4311416811","doi":"10.1111/bjh.18580","title":"Bone marrow carcinomatosis with carcinocythemia clinically mimicking thrombotic thrombocytopenic purpura","year":2022,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Purpura (gastropod); Pathology; Bone marrow; Thrombocytopenic purpura; Hematology; Platelet; Internal medicine","score_opus":0.027468090686141422,"score_gpt":0.2872243090484477,"score_spread":0.2597562183623063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311416811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831361,0.009320796,0.00027164022,0.0053263395,0.0005578057,0.00022343382,0.00001017989,0.000036592053,0.0011170816],"genre_scores_gemma":[0.9926006,0.00050920935,0.0038764684,0.0025599836,0.00015163026,0.000019716765,0.000008246047,0.000040626288,0.00023352118],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99709284,0.00041355117,0.001106151,0.00031549777,0.00058745244,0.00048447662],"domain_scores_gemma":[0.998165,0.00035574156,0.0006804468,0.00026053842,0.00028191798,0.00025636004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012065544,0.00020115534,0.0016066607,0.00018042146,0.00040408113,0.0000252921,0.0002818091,0.000101478145,0.0005572038],"category_scores_gemma":[0.00053229625,0.0001845211,0.0002615617,0.00025684675,0.0006181128,0.00008436614,0.00022371551,0.0014684146,0.000011083857],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011311987,0.00076592964,0.4527073,0.00037377156,0.0010136693,0.491653,0.0012180716,0.000032968976,0.0018980945,0.00016602797,0.04201924,0.007020752],"study_design_scores_gemma":[0.003951557,0.0016705523,0.043430135,0.0004302255,0.00065315404,0.9454934,0.0016327548,0.000036832902,0.00022416271,0.00022933571,0.0020423566,0.00020554234],"about_ca_topic_score_codex":0.0000640795,"about_ca_topic_score_gemma":0.000022759112,"teacher_disagreement_score":0.4538404,"about_ca_system_score_codex":0.00009758408,"about_ca_system_score_gemma":0.00043847255,"threshold_uncertainty_score":0.7524552},"labels":[],"label_agreement":null},{"id":"W4313453615","doi":"10.1111/bjh.18638","title":"Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Infectious Encephalopathies and Encephalitis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cytotoxic T cell; Inflammation; Internal medicine; Immunology; Endocrinology; Biology; Biochemistry","score_opus":0.012982937393231187,"score_gpt":0.24195513876052482,"score_spread":0.22897220136729363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313453615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950212,0.003652062,0.00003235446,0.040929437,0.0023174977,0.00081216684,0.0008877497,0.000040072435,0.0011166846],"genre_scores_gemma":[0.9484437,0.006065775,0.00054469076,0.038371455,0.0015969835,0.00012102715,0.00039063903,0.00023543046,0.004230276],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9965596,0.0002397776,0.0015762364,0.0003750424,0.00063229346,0.0006170072],"domain_scores_gemma":[0.9974104,0.00029848045,0.0012791661,0.00033168728,0.0004342685,0.00024600115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039839634,0.00036251242,0.0024022195,0.001009548,0.000048481186,0.000019510882,0.00031901782,0.0006761719,0.00049212313],"category_scores_gemma":[0.00034114064,0.00038896353,0.0005237919,0.00040993455,0.00019988045,0.00013690874,0.00013477607,0.0013284694,0.000029127252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020739113,0.00036417492,0.0021552627,0.00910093,0.00014241303,0.28026736,0.0006450658,0.000007523219,0.0004508139,0.0000061726587,0.7027937,0.003859189],"study_design_scores_gemma":[0.022569051,0.008487228,0.20912312,0.033048082,0.0030800316,0.530774,0.0017668112,0.0000759185,0.0045832847,0.0027830764,0.1808069,0.0029025138],"about_ca_topic_score_codex":0.0006724972,"about_ca_topic_score_gemma":0.00016953728,"teacher_disagreement_score":0.52198684,"about_ca_system_score_codex":0.00011007954,"about_ca_system_score_gemma":0.0001856954,"threshold_uncertainty_score":0.99985623},"labels":[],"label_agreement":null},{"id":"W4315436222","doi":"10.1111/bjh.18640","title":"Long‐term follow‐up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Follicular lymphoma; Internal medicine; Oncology; Surgery; Transplantation; Confidence interval; Progression-free survival; Lymphoma; Overall survival","score_opus":0.01479505417405778,"score_gpt":0.2630927141485054,"score_spread":0.2482976599744476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315436222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384874,0.0030362858,0.0014569575,0.00045087686,0.00056115934,0.00046108826,0.00008005409,0.000029508308,0.000075299984],"genre_scores_gemma":[0.9971328,0.0018379167,0.00063105015,0.0000557398,0.00005137505,0.000033832974,0.00007872455,0.000023772614,0.00015482542],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9983754,0.00010698166,0.00079210923,0.00019190203,0.00024147195,0.00029212784],"domain_scores_gemma":[0.9986625,0.00022640762,0.0005460445,0.00010429853,0.00032947716,0.00013128138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022234293,0.00015902566,0.00086269097,0.00019849041,0.00009348677,0.00002145637,0.00010606955,0.00018232413,0.000021958142],"category_scores_gemma":[0.000032632564,0.00015191847,0.0004427219,0.0001837515,0.000109006716,0.00011808427,0.00001211523,0.00007658393,0.000009555126],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044931443,0.0032287152,0.16764933,0.002996076,0.003426696,0.5187113,0.0026638224,0.0001530821,0.014573522,0.0009174715,0.009380988,0.27180582],"study_design_scores_gemma":[0.027765019,0.0019429923,0.50990194,0.001216323,0.0017982236,0.3687993,0.00059002545,0.0001723346,0.087019876,0.00046171312,0.00009814756,0.00023411476],"about_ca_topic_score_codex":0.00003253266,"about_ca_topic_score_gemma":0.000032754517,"teacher_disagreement_score":0.3422526,"about_ca_system_score_codex":0.000078743986,"about_ca_system_score_gemma":0.00034660107,"threshold_uncertainty_score":0.6195055},"labels":[],"label_agreement":null},{"id":"W4319826332","doi":"10.1111/bjh.18685","title":"Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Myeloid leukaemia; Medicine; Disease; Myeloid; Pediatrics; Oncology; Internal medicine; Intensive care medicine; Immunology","score_opus":0.020634197476799714,"score_gpt":0.29337911821910345,"score_spread":0.2727449207423037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319826332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947796,0.0029265601,0.00002065263,0.0016974882,0.00016125102,0.00020100149,0.00007356922,0.000017474305,0.00012242513],"genre_scores_gemma":[0.9896777,0.009091733,0.00053120375,0.00023599663,0.0001241529,0.000005475753,0.00003209935,0.000030931904,0.00027069292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772817,0.00016261515,0.0011176851,0.00018957783,0.00041361983,0.00038835063],"domain_scores_gemma":[0.99850255,0.0003046075,0.00042086293,0.0001773316,0.00025596042,0.0003386621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091637735,0.00013062706,0.0010902015,0.0006658423,0.00004068478,0.00001889921,0.00018489575,0.00013685293,0.000037230435],"category_scores_gemma":[0.00115008,0.00013472605,0.00013588739,0.0005801472,0.00022955603,0.00011257918,0.00017007267,0.00068184384,0.000013260807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017956767,0.00014739714,0.63202834,0.0012154222,0.00016024362,0.3461097,0.00010886917,0.0000017888044,0.0023840833,0.00012617749,0.006120387,0.009801945],"study_design_scores_gemma":[0.0028482883,0.00023208246,0.9406062,0.0004115867,0.00020387005,0.05445486,0.000058298698,0.000087859386,0.000096102456,0.00026368618,0.00062123575,0.000115938055],"about_ca_topic_score_codex":0.000055386576,"about_ca_topic_score_gemma":0.000017536331,"teacher_disagreement_score":0.30857787,"about_ca_system_score_codex":0.00019075922,"about_ca_system_score_gemma":0.00059758837,"threshold_uncertainty_score":0.54939693},"labels":[],"label_agreement":null},{"id":"W4321004546","doi":"10.1111/bjh.18683","title":"Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult patients <scp>with acute lymphoblastic leukaemia</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Odds ratio; Incidence (geometry); Internal medicine; Asparaginase; PEG ratio; Retrospective cohort study; Confidence interval; Venous thromboembolism; Gastroenterology; Surgery; Thrombosis; Lymphoblastic Leukemia; Leukemia","score_opus":0.011295729715497825,"score_gpt":0.2880218732793905,"score_spread":0.2767261435638927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321004546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824152,0.000013382781,0.0013577999,0.00040051344,0.00004468688,0.015404988,0.00011685153,0.000095564516,0.00015099347],"genre_scores_gemma":[0.9935461,0.000007575522,0.0007819097,0.000513295,0.00004875164,0.0048163114,0.00012787088,0.00009681852,0.00006134847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942726,0.0008182844,0.0010544272,0.00073815836,0.0019863697,0.0011301527],"domain_scores_gemma":[0.99288404,0.0010918053,0.0011252688,0.00050431496,0.0038032897,0.000591281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009289346,0.0004873194,0.0023275155,0.0013765538,0.0003067879,0.00014637307,0.00070196396,0.00027272923,0.000029336194],"category_scores_gemma":[0.0027807038,0.0003376301,0.00017175531,0.0064910115,0.0005940147,0.0003862992,0.00013530995,0.0011633621,0.000024672461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011910574,0.00566939,0.5233851,0.00031973392,0.0145434495,0.4063446,0.008126211,0.02309134,0.00015516196,0.000083553954,0.005657356,0.00071354426],"study_design_scores_gemma":[0.029023923,0.012583681,0.89001065,0.0027729978,0.002401282,0.034487456,0.0015678667,0.026221875,0.0005109781,0.000078610545,0.000024915293,0.0003157871],"about_ca_topic_score_codex":0.0010964668,"about_ca_topic_score_gemma":0.007502706,"teacher_disagreement_score":0.37185714,"about_ca_system_score_codex":0.0021624642,"about_ca_system_score_gemma":0.0031186072,"threshold_uncertainty_score":0.99990755},"labels":[],"label_agreement":null},{"id":"W4322757139","doi":"10.1111/bjh.18702","title":"<scp>IVI</scp>g treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"EMDO Stiftung","keywords":"Platelet; Thrombin; Medicine; Platelet activation; Coagulation; CD63; Immunology; Flow cytometry; Internal medicine; Gastroenterology; Chemistry; Biochemistry","score_opus":0.013949139080768388,"score_gpt":0.24290575909401807,"score_spread":0.22895662001324968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322757139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759674,0.0017360765,0.0000094534,0.00008853576,0.00006405536,0.00039716996,0.000018687673,0.000013195159,0.000076101554],"genre_scores_gemma":[0.99636203,0.0031734165,0.0001851976,0.000027519545,0.000027144768,0.000011068341,0.00016106696,0.000022411466,0.000030120003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986396,0.00010724488,0.0005860945,0.00018395399,0.00024218515,0.00024096244],"domain_scores_gemma":[0.9990259,0.00017905989,0.00044347905,0.000101045094,0.00016473178,0.00008582985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000162134,0.00016258078,0.0010217325,0.00033733854,0.00006294332,0.000020210713,0.000055024717,0.0001241622,0.000014092285],"category_scores_gemma":[0.0001862292,0.00013961169,0.00007321933,0.0003690845,0.00008564962,0.00023122707,0.000027175061,0.00014061337,0.000004734759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062527234,0.0072107026,0.8845571,0.0003455516,0.001546614,0.06374921,0.0014525341,0.00020202743,0.010823276,0.00015892864,0.004326656,0.025002122],"study_design_scores_gemma":[0.016690345,0.0029714007,0.92576206,0.00039686813,0.00026250805,0.03808836,0.00031724505,0.00014034018,0.014922419,0.00030004323,0.000058405978,0.00009003133],"about_ca_topic_score_codex":0.00048165306,"about_ca_topic_score_gemma":0.0002021392,"teacher_disagreement_score":0.04120493,"about_ca_system_score_codex":0.00008163643,"about_ca_system_score_gemma":0.00012343867,"threshold_uncertainty_score":0.56931996},"labels":[],"label_agreement":null},{"id":"W4324318067","doi":"10.1111/bjh.18734","title":"Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Children’s Oncology Group","keywords":"Medicine; Risk stratification; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma; Baseline (sea); Biology","score_opus":0.012649448597859235,"score_gpt":0.28815157069404135,"score_spread":0.27550212209618213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324318067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292856,0.0046904935,0.00002820398,0.0011692906,0.00038389774,0.0006522602,0.000024576311,0.000040464056,0.00008223818],"genre_scores_gemma":[0.99572754,0.003215227,0.0005051783,0.00008687917,0.00028359794,0.000071314826,0.00004568939,0.000027728423,0.00003684365],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972811,0.0006312745,0.0010882268,0.00031548121,0.00030928673,0.00037466214],"domain_scores_gemma":[0.9984076,0.00036985878,0.00065239344,0.00020083431,0.00018733184,0.00018198582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001378456,0.00019217645,0.0011660232,0.00048797883,0.00009203989,0.000038950486,0.00017230958,0.0001554088,0.00004902279],"category_scores_gemma":[0.00075033825,0.0001828838,0.00019754695,0.00052382145,0.00008444417,0.00013261686,0.00005588823,0.00024462296,0.00005186163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000475777,0.007213274,0.4184612,0.00004044459,0.00094557443,0.11624759,0.0010776747,0.000023866158,0.00084840297,0.0002790706,0.0030451156,0.451342],"study_design_scores_gemma":[0.012001034,0.0017588602,0.8771497,0.00012243967,0.00051618996,0.10590622,0.0011810035,0.000117072814,0.00030363092,0.00025179563,0.0005636279,0.00012842241],"about_ca_topic_score_codex":0.002110511,"about_ca_topic_score_gemma":0.0012572029,"teacher_disagreement_score":0.4586885,"about_ca_system_score_codex":0.0001944356,"about_ca_system_score_gemma":0.0004259431,"threshold_uncertainty_score":0.7457785},"labels":[],"label_agreement":null},{"id":"W4327544833","doi":"10.1111/bjh.18760","title":"Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the <scp><i>ANK1</i></scp> gene: Report of two cases of hereditary spherocytosis","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"Agence Nationale de la Recherche","keywords":"Hereditary spherocytosis; Minigene; Intron; Genetics; Biology; RNA splicing; Gene; Context (archaeology); Frameshift mutation; Alternative splicing; Mutation; Exon","score_opus":0.029390138128050466,"score_gpt":0.26590050279959493,"score_spread":0.23651036467154446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327544833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858838,0.003257789,0.00016974905,0.0076694284,0.0014679182,0.0006833448,0.00076016475,0.00001147444,0.00009636066],"genre_scores_gemma":[0.9681786,0.002213577,0.0028189232,0.023156686,0.0019488566,0.00005872408,0.00027638086,0.00018046876,0.0011678301],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9945598,0.00079768035,0.0031178137,0.00035853422,0.0007582265,0.00040792834],"domain_scores_gemma":[0.9899929,0.0025101395,0.0047452566,0.0009001987,0.0017558563,0.000095631985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087075395,0.0003300658,0.0026165654,0.00032418914,0.00006989668,0.000007951571,0.00054455333,0.00071800244,0.00019098743],"category_scores_gemma":[0.0040872684,0.00026248652,0.0010172565,0.0005826143,0.00060874084,0.00007871503,0.00022260631,0.0012913846,0.000005033775],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047518252,0.00089478615,0.00824682,0.002379774,0.0043833745,0.064562164,0.0010561182,0.0004992731,0.14110692,0.0002397491,0.77440727,0.0017485772],"study_design_scores_gemma":[0.0034202281,0.0033931017,0.020338103,0.0030569609,0.004082087,0.8190761,0.0010882603,0.00004735296,0.07652593,0.0011982069,0.06752149,0.0002521458],"about_ca_topic_score_codex":0.0012397195,"about_ca_topic_score_gemma":0.00039990866,"teacher_disagreement_score":0.754514,"about_ca_system_score_codex":0.00005906833,"about_ca_system_score_gemma":0.001377212,"threshold_uncertainty_score":0.9999827},"labels":[],"label_agreement":null},{"id":"W4360600617","doi":"10.1111/bjh.18730","title":"Extensive histiocytosis masking anaplastic large‐cell lymphoma (<scp>ALCL</scp>)","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Malignancy; Lymphoma; Anaplastic large-cell lymphoma; Medicine; Pathology; Etiology; Pathological; Malignant histiocytosis; Immunology; Histiocyte","score_opus":0.013828634285665772,"score_gpt":0.2544446971270109,"score_spread":0.24061606284134512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360600617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881556,0.008047297,0.00026331813,0.0005325823,0.0007811863,0.00018611208,0.000032292457,0.000067829315,0.0019337753],"genre_scores_gemma":[0.99527013,0.002373359,0.0005921657,0.0006682931,0.00022628826,0.000016767463,0.00002739238,0.000043290347,0.00078229816],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99787927,0.000110641915,0.0007388608,0.00027526138,0.00039746508,0.00059849484],"domain_scores_gemma":[0.9979123,0.0006798468,0.00047314007,0.00018743824,0.00043037304,0.00031691353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003064174,0.00021157597,0.0009869533,0.00037034214,0.0001735183,0.00005472809,0.00015293274,0.000184359,0.00006572053],"category_scores_gemma":[0.00089027634,0.00021465271,0.00034824113,0.00040562078,0.00009712406,0.00011294707,0.000085769854,0.00016593172,0.000307053],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014517613,0.0027355272,0.03261072,0.0003763355,0.0007614557,0.7452101,0.0006695402,0.000046839228,0.0005380529,0.0006628565,0.18633735,0.029906051],"study_design_scores_gemma":[0.021295715,0.0013944556,0.16806327,0.001644714,0.0009991328,0.7485802,0.0013948352,0.00029671434,0.008339238,0.00077015324,0.0470392,0.00018235316],"about_ca_topic_score_codex":0.000042589934,"about_ca_topic_score_gemma":0.00003615775,"teacher_disagreement_score":0.13929816,"about_ca_system_score_codex":0.0002670088,"about_ca_system_score_gemma":0.0003717419,"threshold_uncertainty_score":0.87532836},"labels":[],"label_agreement":null},{"id":"W4362452432","doi":"10.1111/bjh.18773","title":"B cells and antibodies in refractory immune thrombocytopenia","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Agence Nationale de la Recherche","keywords":"Rituximab; Immunology; Autoantibody; Medicine; Syk; Antibody; Splenectomy; CD20; CD38; Immune system; B cell; Monoclonal antibody; Spleen; Biology; Stem cell; Tyrosine kinase; Internal medicine; Receptor; CD34","score_opus":0.04698228506897362,"score_gpt":0.3492826305637311,"score_spread":0.3023003454947575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362452432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034062516,0.96500915,7.0402206e-7,0.000038375394,0.00031611865,0.00030787784,0.000026752177,0.000010681811,0.00022784632],"genre_scores_gemma":[0.0006008832,0.9988554,0.00013963792,0.00002298497,0.00004320057,0.000005588038,0.000024280136,0.00004957496,0.00025845555],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9981089,0.0001444341,0.0011213026,0.00020161661,0.00015240052,0.00027131947],"domain_scores_gemma":[0.99882054,0.00019974684,0.00068858534,0.00012530618,0.0000677839,0.00009805363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028365635,0.00023722275,0.0049953293,0.00037718442,0.000040141884,0.000028481458,0.00012181143,0.00033576807,0.000043545184],"category_scores_gemma":[0.000117497846,0.00021242179,0.00033606455,0.0001821747,0.00012544321,0.00007898924,0.000072854215,0.00070327794,0.000050078557],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018167046,0.00018038476,0.0000330851,0.009602639,0.00052633206,0.5402471,0.00002770693,2.436753e-8,0.0000018884832,0.000011639675,0.0013118733,0.44803917],"study_design_scores_gemma":[0.0012975885,0.00020374887,0.0002219058,0.04349874,0.0009013692,0.6455617,0.000039807335,2.2616027e-7,0.0000025178829,0.00012193797,0.3080015,0.00014897701],"about_ca_topic_score_codex":0.000100039026,"about_ca_topic_score_gemma":0.000094169656,"teacher_disagreement_score":0.4478902,"about_ca_system_score_codex":0.00005694329,"about_ca_system_score_gemma":0.0002648177,"threshold_uncertainty_score":0.8662309},"labels":[],"label_agreement":null},{"id":"W4362454530","doi":"10.1111/bjh.18781","title":"British Society for Haematology guideline for anticoagulant management of pregnant individuals with mechanical heart valves","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Guideline; Hematology; Medicine; Anticoagulant; Internal medicine; Intensive care medicine; Cardiology; Pathology","score_opus":0.024418300005441707,"score_gpt":0.3155447000805487,"score_spread":0.291126400075107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362454530","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82866746,0.04100723,0.11921205,0.0050622076,0.0012898928,0.004196957,0.00025705455,0.00016017011,0.00014699949],"genre_scores_gemma":[0.4346887,0.012738421,0.5500207,0.0008956268,0.0004117537,0.00033748717,0.00022333373,0.00021710464,0.0004668752],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9966988,0.00010031883,0.0016291895,0.00040224483,0.00055532926,0.0006141294],"domain_scores_gemma":[0.9977252,0.00029486418,0.0006108107,0.0003573618,0.0008327444,0.00017903365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017426986,0.0002186708,0.0021824173,0.0001611849,0.00009735024,0.00003583347,0.0003016816,0.0002647442,0.000059712987],"category_scores_gemma":[0.00030857543,0.00023442497,0.0015534617,0.00031425757,0.00026978296,0.00010581005,0.00016164908,0.00026222746,0.0000031473335],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013653398,0.0018420132,0.003995191,0.017768541,0.027041772,0.19450143,0.00064715307,0.00025470112,0.0012136514,0.013564774,0.6531298,0.08467561],"study_design_scores_gemma":[0.012092196,0.0014703939,0.0015173368,0.012226137,0.0029926372,0.922836,0.000765576,0.0003642472,0.0035002446,0.0046870285,0.037210453,0.00033771692],"about_ca_topic_score_codex":0.00002055951,"about_ca_topic_score_gemma":0.000025186537,"teacher_disagreement_score":0.7283346,"about_ca_system_score_codex":0.000038974795,"about_ca_system_score_gemma":0.00018679733,"threshold_uncertainty_score":0.95595723},"labels":[],"label_agreement":null},{"id":"W4362458479","doi":"10.1111/bjh.18792","title":"A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University; St. Michael's Hospital; Health Sciences Centre; Canadian Blood Services; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Blood Services","keywords":"Iron supplementation; Iron deficiency; Medicine; Pediatrics; Internal medicine; Anemia","score_opus":0.03142566660395843,"score_gpt":0.2976678909840674,"score_spread":0.2662422243801089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362458479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880716,0.00057049864,0.00003143109,0.007843443,0.0019334531,0.0010215695,0.00016046371,0.00001342582,0.00035408116],"genre_scores_gemma":[0.97345436,0.00041084577,0.0008289979,0.022517515,0.0011247477,0.00003591584,0.0010092767,0.00016596357,0.000452383],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966096,0.0004902227,0.0012903264,0.00034862594,0.0008090006,0.00045218001],"domain_scores_gemma":[0.9980737,0.00022770948,0.0010793788,0.00026796912,0.00027319533,0.00007803528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007303518,0.00026929087,0.0013784061,0.00047650692,0.00004210656,0.00002140537,0.00023257665,0.00033807487,0.00026265465],"category_scores_gemma":[0.0005014997,0.00025912104,0.00018648688,0.00030264794,0.00023731685,0.00016366475,0.000044811783,0.0012076687,0.000009615348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11414013,0.001951579,0.08813978,0.0017445359,0.00007184981,0.013326804,0.00028304418,0.000015162365,0.000008900598,0.00001739377,0.77665395,0.003646886],"study_design_scores_gemma":[0.64059263,0.023007944,0.31419992,0.0019344548,0.0017898766,0.0043388233,0.0006023336,0.0000034723937,0.000030900268,0.00021177033,0.012385004,0.0009028471],"about_ca_topic_score_codex":0.00094133435,"about_ca_topic_score_gemma":0.0009290283,"teacher_disagreement_score":0.76426893,"about_ca_system_score_codex":0.0001294521,"about_ca_system_score_gemma":0.00041717602,"threshold_uncertainty_score":0.9999861},"labels":[],"label_agreement":null},{"id":"W4362527258","doi":"10.1111/bjh.18757","title":"Treatment patterns and outcomes in adolescents and young adults with nodular lymphocyte‐predominant Hodgkin lymphoma: an <scp>IMPACT</scp> cohort study","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Institute for Work & Health; St. Michael's Hospital; Pediatric Oncology Group; University of Toronto; SickKids Foundation; Hospital for Sick Children; Public Health Ontario","funders":"Canadian Institutes of Health Research; C17 Children's Cancer and Blood Disorders; Pediatric Oncology Group of Ontario","keywords":"Medicine; Cohort; Lymphoma; Hodgkin lymphoma; Lymphocyte; Young adult; Cohort study; Immunology; Oncology; Internal medicine","score_opus":0.009237723298726562,"score_gpt":0.269366761292752,"score_spread":0.2601290379940254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362527258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968012,0.0019405545,0.0000035412668,0.00008294111,0.00015636021,0.00094036467,0.000034449928,0.000026633006,0.000013933165],"genre_scores_gemma":[0.99649775,0.003193263,0.00006280426,0.000046847716,0.000040136114,0.00007041558,0.000016904694,0.00003881395,0.00003309272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794036,0.00019119047,0.0006466334,0.0004109175,0.00035182966,0.00045908513],"domain_scores_gemma":[0.99885565,0.00012801742,0.00030420747,0.00022223982,0.00012538867,0.00036450877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027243872,0.0003121317,0.0014058677,0.00033695414,0.00009247996,0.00007387851,0.00008859235,0.00011783843,0.0000055526475],"category_scores_gemma":[0.00012059292,0.00022935978,0.00011137591,0.00018309752,0.00010093357,0.00017597851,0.000058515172,0.00008388172,0.000005243063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000280629,0.003464012,0.8133014,0.00007416184,0.00054365426,0.16191688,0.0013667333,0.0000024274448,0.0000045597358,0.0000015435145,0.00003702728,0.019006973],"study_design_scores_gemma":[0.031228188,0.0045038005,0.7721414,0.00088189886,0.00039151087,0.18810391,0.0025061506,0.00006330553,0.000082054365,0.000005467546,0.000013838595,0.000078462734],"about_ca_topic_score_codex":0.0050589615,"about_ca_topic_score_gemma":0.004283949,"teacher_disagreement_score":0.041159976,"about_ca_system_score_codex":0.00046324855,"about_ca_system_score_gemma":0.000248002,"threshold_uncertainty_score":0.9353021},"labels":[],"label_agreement":null},{"id":"W4365479509","doi":"10.1111/bjh.18815","title":"Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Minimal residual disease; Oncology; Internal medicine; Chemotherapy; Disease; Myeloid; Clinical trial; Myeloid leukemia; Acute promyelocytic leukemia; Leukemia; Gene; Biology; Retinoic acid; Genetics","score_opus":0.023147937565040133,"score_gpt":0.2680327022710182,"score_spread":0.2448847647059781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365479509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8335639,0.0020960832,0.000047754216,0.16320772,0.00033058514,0.00035922808,0.00034367212,0.000015360914,0.0000356494],"genre_scores_gemma":[0.61956584,0.08421913,0.0027454926,0.25883576,0.011477525,0.00018770705,0.0074049137,0.0011089876,0.014454636],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99684757,0.0003469421,0.0012627288,0.0003385171,0.00071524456,0.0004889678],"domain_scores_gemma":[0.9983215,0.00018026504,0.00063508365,0.00019951128,0.00045532646,0.00020836492],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007095667,0.00024858842,0.0014723312,0.0008824975,0.00005370907,0.00003857025,0.0002738936,0.0006632086,0.00012506549],"category_scores_gemma":[0.0003174037,0.00028138893,0.00021222956,0.0002847199,0.0003313672,0.00018257707,0.00006890591,0.0027161916,0.000015561645],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001637511,0.000119899225,0.006337879,0.00255467,0.00088125165,0.5628654,0.00018239317,0.0000049763926,0.060569398,0.00003707842,0.36234954,0.0024600374],"study_design_scores_gemma":[0.009600904,0.00067039364,0.3865159,0.006585285,0.0014159185,0.52379906,0.00005767548,0.00013559638,0.0011406373,0.00086032064,0.068532154,0.0006861539],"about_ca_topic_score_codex":0.00012308892,"about_ca_topic_score_gemma":0.0000313686,"teacher_disagreement_score":0.380178,"about_ca_system_score_codex":0.00031649065,"about_ca_system_score_gemma":0.0015656656,"threshold_uncertainty_score":0.9999638},"labels":[],"label_agreement":null},{"id":"W4366602268","doi":"10.1111/bjh.18718","title":"<scp>BSH</scp> 2023 Oral abstracts book","year":2023,"lang":"ceb","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; Centre Hospitalier Universitaire de Toulouse; Universitätsklinikum Hamburg-Eppendorf; Syddansk Universitet; Université de Toulouse; Memorial Sloan-Kettering Cancer Center; Karolinska Institutet; St Vincent's Hospital Melbourne; Université de Lille; Massachusetts General Hospital; University of Alberta; Cancer Research Institute","keywords":"Medicine; Pharmacology","score_opus":0.02179639717170954,"score_gpt":0.274689843042991,"score_spread":0.25289344587128143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366602268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86612505,0.12011088,0.000025893713,0.0007933834,0.008338874,0.00045987795,0.0004492103,0.00011170096,0.0035851488],"genre_scores_gemma":[0.9628058,0.010014561,0.000064070126,0.00071827223,0.00047236864,0.000019904342,0.00019566942,0.000098756005,0.025610572],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99360925,0.0014562975,0.0026623977,0.00053878163,0.0002457598,0.0014874866],"domain_scores_gemma":[0.9948065,0.0019001482,0.002023429,0.00044668582,0.00056736136,0.0002558746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001816584,0.00047775148,0.0019702518,0.0007077518,0.00046590104,0.00014677805,0.0011292214,0.00084103586,0.0041530044],"category_scores_gemma":[0.0024115797,0.0005822999,0.00072929123,0.00056000706,0.0006798186,0.00040168763,0.00044369992,0.0014144796,0.009022347],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006492582,0.00038565468,0.0031518217,0.00037329312,0.001350599,0.085734874,0.0002786361,0.000045514564,0.002048386,0.00029692642,0.90307844,0.0031909074],"study_design_scores_gemma":[0.0036735628,0.00071196305,0.03533892,0.0016760828,0.0005061853,0.36689442,0.0022072408,0.00000618366,0.001670413,0.0008540446,0.58621746,0.00024351607],"about_ca_topic_score_codex":0.00024183355,"about_ca_topic_score_gemma":0.00031058496,"teacher_disagreement_score":0.316861,"about_ca_system_score_codex":0.00011026747,"about_ca_system_score_gemma":0.0005593778,"threshold_uncertainty_score":0.9996628},"labels":[],"label_agreement":null},{"id":"W4366775420","doi":"10.1111/bjh.18720","title":"BSH 2023 Poster Abstract Book","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Center, University of Kansas; Robert H. Lurie Comprehensive Cancer Center; Feinberg School of Medicine; University of North Carolina at Chapel Hill; Sierra Oncology; Śląski Uniwersytet Medyczny w Katowicach; Università degli Studi dell'Insubria; Oxford University Hospitals NHS Foundation Trust; Università degli Studi di Firenze; Leonard M. Miller School of Medicine; University of Toronto; Catholic University of Korea; Northwell Health; University Hospitals Plymouth NHS Trust; Eli Lilly and Company; Seoul St. Mary's Hospital, Catholic University of Korea; Uniwersytet Śląski w Katowicach; Northwestern University; University of Miami; Heart of England NHS Foundation Trust; Memorial Sloan-Kettering Cancer Center; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Moffitt Cancer Center; University of Oxford; University of Texas MD Anderson Cancer Center; Cleveland Clinic; Université de Paris; Sylvester Comprehensive Cancer Center, University of Miami Health Systems","keywords":"Medicine","score_opus":0.025355088687982207,"score_gpt":0.3179291228743691,"score_spread":0.2925740341863869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366775420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770159,0.004413455,0.000019544193,0.009124848,0.00043566612,0.00017596416,0.000012969453,0.000049319337,0.008752316],"genre_scores_gemma":[0.9776608,0.004121514,0.00036083124,0.0026666985,0.0005728413,0.000006701318,0.000023984518,0.000062221734,0.014524408],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9982666,0.00007315568,0.0006192582,0.00015890188,0.00041643466,0.0004656632],"domain_scores_gemma":[0.9987677,0.00022064609,0.00021713994,0.00016724707,0.0003578937,0.0002694283],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00068591285,0.00010821854,0.0006276762,0.00036503107,0.00007087175,0.000037651113,0.00022123012,0.00017769195,0.0017166588],"category_scores_gemma":[0.000594667,0.00011153138,0.00020316253,0.0003401523,0.00015830086,0.00016951475,0.00009161473,0.00081905175,0.0012641291],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017104908,0.000061420666,0.0011591321,0.000112048074,0.00013919461,0.3470431,0.000049379138,0.0000020114894,0.0015243349,0.000046903035,0.6351432,0.014548238],"study_design_scores_gemma":[0.0027530738,0.0003529872,0.05152406,0.00059132394,0.00007160102,0.8542133,0.00018740025,0.000028141923,0.0018244756,0.00034835574,0.08797281,0.00013249936],"about_ca_topic_score_codex":0.000049707895,"about_ca_topic_score_gemma":0.00001878025,"teacher_disagreement_score":0.5471704,"about_ca_system_score_codex":0.000101171114,"about_ca_system_score_gemma":0.0003894636,"threshold_uncertainty_score":0.9995135},"labels":[],"label_agreement":null},{"id":"W4376642978","doi":"10.1111/bjh.18870","title":"Long non‐coding <scp>RNAs</scp> associated with transcriptomic signatures and treatment outcome in diffuse large B‐cell lymphoma","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Transcriptome; Diffuse large B-cell lymphoma; Lymphoma; Cancer research; Medicine; Computational biology; Biology; Internal medicine; Gene; Gene expression; Genetics","score_opus":0.012350178188672739,"score_gpt":0.2511725602757425,"score_spread":0.23882238208706974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376642978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762619,0.012821381,0.0026887378,0.006517297,0.0006368671,0.0006642425,0.00026314112,0.000024763749,0.00012164186],"genre_scores_gemma":[0.9655187,0.009382403,0.00015979337,0.019879498,0.0008536284,0.000071413655,0.0006844868,0.0003410705,0.0031089648],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967974,0.00040630752,0.0008273504,0.0005966198,0.0004428502,0.000929482],"domain_scores_gemma":[0.99859613,0.00017247561,0.00059201627,0.00027018556,0.00021262687,0.00015654432],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00045168458,0.0004601275,0.001196903,0.00045636873,0.00011299769,0.00011822813,0.00042572807,0.0016835999,0.000007039843],"category_scores_gemma":[0.00032132847,0.00047020518,0.00031830824,0.00023703829,0.00014438495,0.000011441877,0.00011389052,0.0013280642,0.000004446719],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023519478,0.0023149012,0.00134935,0.0006567508,0.0025770543,0.58681405,0.00035486085,0.00007968169,0.051930055,0.000009115096,0.35048795,0.003191076],"study_design_scores_gemma":[0.14734358,0.009263414,0.0113408305,0.00699596,0.002247999,0.2893035,0.00089150434,0.00048827622,0.21748948,0.00028243978,0.3117828,0.002570216],"about_ca_topic_score_codex":0.0001234005,"about_ca_topic_score_gemma":0.0019019423,"teacher_disagreement_score":0.29751053,"about_ca_system_score_codex":0.00022804462,"about_ca_system_score_gemma":0.00037506054,"threshold_uncertainty_score":0.999775},"labels":[],"label_agreement":null},{"id":"W4377195778","doi":"10.1111/bjh.18863","title":"Granulocyte transfusion during cord blood transplant for relapsed, refractory <scp>AML</scp> is associated with massive <scp>CD8</scp><sup>+</sup> T‐cell expansion, significant cytokine release syndrome and induction of disease remission","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Children's Cancer and Leukaemia Group","keywords":"Medicine; Cytokine release syndrome; Internal medicine; Immunology; Hematopoietic stem cell transplantation; Gastroenterology; Transplantation; T cell; Immune system","score_opus":0.015426651381661008,"score_gpt":0.24959361001121064,"score_spread":0.23416695862954962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377195778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955977,0.0021846755,0.00016345465,0.00038488448,0.00013978315,0.0011098426,0.00029757927,0.00007407756,0.000048011385],"genre_scores_gemma":[0.9851199,0.01273008,0.00016670491,0.00006516885,0.00009714052,0.000039735056,0.00014612229,0.00012051029,0.0015146546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959674,0.00042321504,0.0012596914,0.0005946043,0.0010035639,0.00075153576],"domain_scores_gemma":[0.9960708,0.0012036958,0.00078697776,0.0003266704,0.0008093263,0.00080255116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009885607,0.00037243692,0.0014476471,0.00073536066,0.0002967848,0.000040269566,0.00022644193,0.0004187742,0.00007478133],"category_scores_gemma":[0.0012604812,0.00035530253,0.0003654754,0.0007281544,0.0003391834,0.00025682597,0.000040576877,0.0010636369,0.000003261265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061786463,0.0019554526,0.010607509,0.0033190846,0.0011528771,0.13932166,0.002992288,0.0002133925,0.82612926,0.000007895812,0.0046697888,0.003452128],"study_design_scores_gemma":[0.07034433,0.016865352,0.10256587,0.020171598,0.004955796,0.29991007,0.007580015,0.001578381,0.4724199,0.00057814067,0.0025130413,0.0005175149],"about_ca_topic_score_codex":0.00007992904,"about_ca_topic_score_gemma":0.000015954005,"teacher_disagreement_score":0.3537094,"about_ca_system_score_codex":0.00013126989,"about_ca_system_score_gemma":0.00048264812,"threshold_uncertainty_score":0.9998899},"labels":[],"label_agreement":null},{"id":"W4378348239","doi":"10.1111/bjh.18879","title":"Real‐world management of small lymphocytic lymphoma as chronic lymphocytic leukaemia versus an indolent <scp>non‐Hodgkin</scp> lymphoma","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Lymphoma; Classical Hodgkin lymphoma; Chronic lymphocytic leukemia; Hodgkin lymphoma; Medicine; Internal medicine; Oncology; Leukemia","score_opus":0.03610100405571235,"score_gpt":0.3133634652034648,"score_spread":0.27726246114775244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378348239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96232694,0.011830897,0.00008520553,0.0054042516,0.0061565833,0.002544808,0.00015644186,0.00031415414,0.011180699],"genre_scores_gemma":[0.5732708,0.17109779,0.009741577,0.1099042,0.036094904,0.0013456879,0.003975494,0.0059059607,0.088663585],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.98609763,0.0009977538,0.004501841,0.001783546,0.003470087,0.0031491267],"domain_scores_gemma":[0.98936707,0.002340478,0.0034486307,0.0022602794,0.001464616,0.0011189501],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002046639,0.0015259957,0.005495316,0.0027967487,0.00031525752,0.00026104582,0.0027755608,0.002494516,0.0002615393],"category_scores_gemma":[0.0008665537,0.0017241859,0.0016920336,0.0020236429,0.0013944244,0.00038666232,0.0011243032,0.002001305,0.00075951277],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0009633709,0.00031292095,0.00003175441,0.0086604785,0.004191971,0.60050803,0.00025618364,0.00022998867,0.000047272955,0.00013535742,0.3593483,0.02531441],"study_design_scores_gemma":[0.1583389,0.0050240974,0.0010222489,0.020111637,0.004760893,0.61852694,0.00091836095,0.004067599,0.0021474345,0.00063167163,0.1833846,0.0010656173],"about_ca_topic_score_codex":0.009577777,"about_ca_topic_score_gemma":0.001245898,"teacher_disagreement_score":0.38905615,"about_ca_system_score_codex":0.1339341,"about_ca_system_score_gemma":0.07759452,"threshold_uncertainty_score":0.9997489},"labels":[],"label_agreement":null},{"id":"W4378640330","doi":"10.1111/bjh.18883","title":"Treatment‐free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5‐year analysis of <scp>DASFREE</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Bristol-Myers Squibb","keywords":"Dasatinib; Discontinuation; Medicine; Internal medicine; Adverse effect; Drug holiday; Chronic myeloid leukaemia; Surgery; Gastroenterology; Imatinib; Immunology; Myeloid leukemia; Human immunodeficiency virus (HIV)","score_opus":0.01022971088303479,"score_gpt":0.27219947009552864,"score_spread":0.2619697592124938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378640330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957511,0.0032141928,0.000077640434,0.00015033399,0.000046192505,0.0005980046,0.00006306986,0.000025474721,0.00007402946],"genre_scores_gemma":[0.99817115,0.00051852915,0.00082478207,0.000029952562,0.00004318534,0.000051938292,0.00013786928,0.00006539404,0.00015722692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964528,0.00040666902,0.001213384,0.0004950807,0.00072347565,0.0007085718],"domain_scores_gemma":[0.99771047,0.00039791805,0.0007498418,0.0006032966,0.00027635167,0.00026212464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046879076,0.00037328573,0.0018030539,0.0016914493,0.000045261404,0.000022065546,0.00029128752,0.00026148293,0.00014128655],"category_scores_gemma":[0.0005401161,0.00031943587,0.00027976843,0.0023695948,0.0002485731,0.00018296705,0.000085959364,0.0005193984,0.000010938551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016366966,0.0019888033,0.72890264,0.00039016397,0.0040276055,0.22400972,0.00084999506,0.0029500325,0.0020048823,0.000013490823,0.00040335508,0.018092345],"study_design_scores_gemma":[0.094215214,0.01352221,0.8676493,0.0024960148,0.0024960465,0.01437442,0.00021612445,0.0012721644,0.0030958734,0.00003427498,0.0004127598,0.00021560534],"about_ca_topic_score_codex":0.00032469028,"about_ca_topic_score_gemma":0.0024898546,"teacher_disagreement_score":0.2096353,"about_ca_system_score_codex":0.0036391984,"about_ca_system_score_gemma":0.0022819636,"threshold_uncertainty_score":0.9999258},"labels":[],"label_agreement":null},{"id":"W4378952773","doi":"10.1111/bjh.18900","title":"Genome‐wide <scp>CRISPR</scp> screening uncovers potential targets and mechanisms of vincristine resistance in <scp>DLBCL</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Vincristine; CRISPR; Drug resistance; Cancer research; Biology; Medicine; Cell cycle checkpoint; Computational biology; Apoptosis; Bioinformatics; Cell cycle; Internal medicine; Genetics; Chemotherapy; Gene","score_opus":0.015495743719001967,"score_gpt":0.27458812039269387,"score_spread":0.2590923766736919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378952773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810472,0.008622298,0.007817121,0.00055474037,0.0003096772,0.00037022497,0.000038547743,0.00003821815,0.0012019366],"genre_scores_gemma":[0.98773605,0.0036986964,0.0049222317,0.00022941809,0.0001662705,0.000009296496,0.000027663737,0.00007942543,0.003130924],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9964727,0.00033390045,0.0011626286,0.00038114993,0.0008427784,0.0008068493],"domain_scores_gemma":[0.9971629,0.0011720028,0.0005767345,0.0002495615,0.00048390887,0.00035489674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018638539,0.00023975915,0.0013167361,0.00081480277,0.00011703438,0.000051601037,0.00032024537,0.00026339706,0.000118315664],"category_scores_gemma":[0.0038054432,0.0002782294,0.0002350266,0.000775897,0.00029984824,0.00017973188,0.00019534782,0.00091617584,0.00001328873],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009583322,0.0009478473,0.035955146,0.0024348607,0.0015155493,0.47933868,0.002173326,0.00045172113,0.41164777,0.0018887122,0.05559775,0.007090309],"study_design_scores_gemma":[0.038884945,0.003357628,0.33009353,0.0057762726,0.00074184756,0.3976549,0.015029029,0.0009803731,0.11057875,0.03591935,0.060560524,0.00042284714],"about_ca_topic_score_codex":0.0001950126,"about_ca_topic_score_gemma":0.00039859593,"teacher_disagreement_score":0.30106902,"about_ca_system_score_codex":0.00009791547,"about_ca_system_score_gemma":0.0002559436,"threshold_uncertainty_score":0.999967},"labels":[],"label_agreement":null},{"id":"W4384923042","doi":"10.1111/bjh.18972","title":"Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus <scp>CVP</scp> or <scp>CHOP</scp> chemoimmunotherapy in Ontario","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"American Society of Hematology","keywords":"Rituximab; Chemoimmunotherapy; Medicine; Bendamustine; CHOP; Internal medicine; Oncology; Lymphoma","score_opus":0.01750002979747422,"score_gpt":0.25031042060235265,"score_spread":0.23281039080487842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384923042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715847,0.00078912376,0.000018258335,0.0002267382,0.00018306544,0.0011494488,0.00009020885,0.00006257457,0.000322097],"genre_scores_gemma":[0.9968623,0.0002231087,0.0013035036,0.00046448648,0.000032060605,0.00009651136,0.00013617748,0.00009055961,0.0007912928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961193,0.0001426255,0.001500671,0.0005096232,0.00088096166,0.0008467776],"domain_scores_gemma":[0.9969304,0.0006688714,0.0009126132,0.00040957972,0.000676519,0.00040201453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002946199,0.0005318349,0.0031770307,0.000760494,0.00011707053,0.00006356529,0.00034637155,0.00024025654,0.00006030502],"category_scores_gemma":[0.0003384565,0.00039706499,0.00026100382,0.00088627846,0.00021663624,0.00020054841,0.00010017868,0.00034237196,0.0000408225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017744054,0.0065777665,0.9368645,0.00015984332,0.0014811081,0.04356881,0.0026855413,0.00013714116,0.000025129768,0.000016354212,0.0027831024,0.003926276],"study_design_scores_gemma":[0.109976776,0.0029616673,0.8614391,0.0016061226,0.00039546302,0.019584002,0.0008252031,0.000032392712,0.0008882537,0.000009871497,0.0021762939,0.000104837425],"about_ca_topic_score_codex":0.016331336,"about_ca_topic_score_gemma":0.045731064,"teacher_disagreement_score":0.108202375,"about_ca_system_score_codex":0.0014942351,"about_ca_system_score_gemma":0.0017307877,"threshold_uncertainty_score":0.9998481},"labels":[],"label_agreement":null},{"id":"W4385264639","doi":"10.1111/bjh.19004","title":"Human leucocyte antigen‐matched related haematopoietic stem cell transplantation using low‐dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; Western University","funders":"","keywords":"Thymoglobulin; Fludarabine; Medicine; Cyclophosphamide; Bone marrow failure; Transplantation; Fanconi anemia; Internal medicine; Immunology; Hematopoietic stem cell transplantation; Regimen; Gastroenterology; Stem cell; Oncology; Haematopoiesis; Chemotherapy; Tacrolimus; Biology","score_opus":0.01142940841902273,"score_gpt":0.24666444567627835,"score_spread":0.2352350372572556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385264639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966091,0.0017838824,0.000534205,0.00010625516,0.00011911172,0.00062725006,0.00003223044,0.00007144999,0.00011653532],"genre_scores_gemma":[0.99637663,0.0023040432,0.0010117562,0.00005474589,0.000031829873,0.000006903182,0.000089447734,0.00006963387,0.000055009823],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99708873,0.00025184933,0.0013169852,0.00038356814,0.00045575213,0.0005031098],"domain_scores_gemma":[0.99870455,0.0001610146,0.0005380899,0.00017667132,0.00017868278,0.00024097174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068177376,0.00029928092,0.001182484,0.00053228455,0.00014458873,0.0000489477,0.00014575917,0.00030656814,0.000050182058],"category_scores_gemma":[0.000024571307,0.0003093609,0.0001118416,0.0007731583,0.00019278492,0.0002404988,0.00001933074,0.0006139038,0.000015862655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011221509,0.0004923587,0.77775776,0.0037842675,0.000547958,0.1886396,0.003407234,0.0031489942,0.018420191,0.000116878604,0.00020530958,0.0023572952],"study_design_scores_gemma":[0.007980676,0.00028598387,0.47183833,0.0032283098,0.00037092002,0.51053476,0.00043047426,0.0005206242,0.004415277,0.00012192722,0.000002455003,0.00027022563],"about_ca_topic_score_codex":0.00018885656,"about_ca_topic_score_gemma":0.00013061735,"teacher_disagreement_score":0.32189518,"about_ca_system_score_codex":0.000086116,"about_ca_system_score_gemma":0.00022926851,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W4385850624","doi":"10.1111/bjh.19018","title":"<scp>ETS1</scp> phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Swiss Cancer Research Foundation; Rotary Foundation","keywords":"Diffuse large B-cell lymphoma; ETS1; Cancer research; Phosphorylation; Lymphoma; Cell growth; Threonine; Biology; Immunology; Cell biology; Transcription factor; Genetics; Gene","score_opus":0.008459143445706712,"score_gpt":0.22323029198025593,"score_spread":0.2147711485345492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385850624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338734,0.005023769,0.000010998873,0.0006992806,0.00007759049,0.00030915503,0.00010214351,0.000009399893,0.00038031672],"genre_scores_gemma":[0.99649936,0.0026855615,0.00003941117,0.00011961744,0.000023395985,0.000006806196,0.000016040985,0.000025904386,0.000583893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982704,0.00016583929,0.00067324797,0.00016038292,0.00041780248,0.00031230628],"domain_scores_gemma":[0.997061,0.00088388415,0.0011721313,0.00017293468,0.0006147943,0.00009526999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054787676,0.0001679456,0.00086212024,0.00012245649,0.00011094745,0.000012947618,0.00016574695,0.00012045771,0.000024820152],"category_scores_gemma":[0.00018948289,0.00010477418,0.00016807442,0.0004290712,0.00025550718,0.00006198365,0.000084999345,0.000120793855,0.0000033251342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007715313,0.01529478,0.78071946,0.0017151416,0.0024347429,0.031830244,0.012849998,0.00002763058,0.023740254,0.001175136,0.12827203,0.001169032],"study_design_scores_gemma":[0.028238198,0.0015918083,0.5215973,0.0007753737,0.0010864778,0.013527822,0.0032064968,0.00014205757,0.42839,0.00024105092,0.0010976535,0.00010575318],"about_ca_topic_score_codex":0.00022567685,"about_ca_topic_score_gemma":0.00015504884,"teacher_disagreement_score":0.40464973,"about_ca_system_score_codex":0.00012659261,"about_ca_system_score_gemma":0.0002796144,"threshold_uncertainty_score":0.4272567},"labels":[],"label_agreement":null},{"id":"W4386251475","doi":"10.1111/bjh.19075","title":"Refractory immune thrombocytopenia in adults: Towards a new definition","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immune thrombocytopenia; Refractory (planetary science); Medicine; Immune system; Immunology; Platelet; Intensive care medicine; Biology","score_opus":0.0744130106936674,"score_gpt":0.35112243319075204,"score_spread":0.27670942249708463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386251475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055989013,0.9924398,0.0000059757003,0.00011417604,0.0004572065,0.0004888213,0.000036633795,0.00002372497,0.00083478075],"genre_scores_gemma":[0.00023368443,0.99866897,0.00045479718,0.00005502924,0.00012425627,0.000016238037,0.00015448456,0.000077500285,0.00021502357],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99723655,0.00018529494,0.0016799379,0.0002609582,0.00027417083,0.00036310373],"domain_scores_gemma":[0.998309,0.00013985322,0.0010617133,0.00018845647,0.00011631455,0.00018465245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029712153,0.0003099089,0.0053578857,0.00051864696,0.000037933514,0.000029552619,0.00021288109,0.0005345273,0.000188849],"category_scores_gemma":[0.00039004386,0.00029161284,0.00072361017,0.0003939068,0.000066255605,0.00012103417,0.000062765015,0.0010259498,0.00020083491],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006530345,0.00022806697,0.000004857496,0.0067938236,0.0003987081,0.36085925,0.000029848203,2.3339329e-8,7.5389494e-8,0.000031797776,0.0024935054,0.6290947],"study_design_scores_gemma":[0.0030455252,0.0003985483,0.00013067339,0.11297009,0.0009486039,0.63032997,0.000040020896,2.1643916e-7,3.5688052e-7,0.0006683751,0.2512874,0.0001801936],"about_ca_topic_score_codex":0.0006707175,"about_ca_topic_score_gemma":0.00035536883,"teacher_disagreement_score":0.62891454,"about_ca_system_score_codex":0.0002016668,"about_ca_system_score_gemma":0.0013457808,"threshold_uncertainty_score":0.9999536},"labels":[],"label_agreement":null},{"id":"W4386593535","doi":"10.1111/bjh.19099","title":"Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"National Heart, Lung, and Blood Institute; American Lebanese Syrian Associated Charities; American Society of Hematology","keywords":"Medical prescription; Medicine; Demographics; Family medicine; Disease; Inclusion (mineral); MEDLINE; Internal medicine; Pharmacology; Psychology","score_opus":0.013779167626060853,"score_gpt":0.26216336592165074,"score_spread":0.2483841982955899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386593535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029705357,0.96871036,0.0000062957997,0.00007762376,0.00009329679,0.0011932084,0.00016044053,0.000008512098,0.000044914268],"genre_scores_gemma":[0.00368513,0.9960316,0.00006307926,0.00003921533,0.000015458834,0.000018044102,0.000054619257,0.000037753274,0.000055091175],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973948,0.00030231226,0.001503678,0.00026969207,0.00030418645,0.00022534945],"domain_scores_gemma":[0.99807155,0.00007302801,0.0011828035,0.00015946789,0.00022277152,0.0002903584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050818815,0.00025487816,0.0027288496,0.0003162717,0.000026345728,0.000009061276,0.00009423996,0.00028594802,0.000016944346],"category_scores_gemma":[0.00056914083,0.00020444099,0.00024490044,0.0003075874,0.00031162045,0.00011500015,0.000046777688,0.0005666668,7.100336e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039841043,0.00015794854,0.00071611925,0.80798113,0.0003658511,0.0065344055,0.0007858129,0.0000011817143,0.0000010373698,0.000011543796,0.0014517887,0.18159474],"study_design_scores_gemma":[0.003054438,0.00086358126,0.0003035942,0.92255133,0.0042518605,0.030431485,0.0013753233,0.000010389079,0.0000015549074,0.000037559163,0.036827747,0.00029115283],"about_ca_topic_score_codex":0.00013376049,"about_ca_topic_score_gemma":0.000028144259,"teacher_disagreement_score":0.18130359,"about_ca_system_score_codex":0.000035319346,"about_ca_system_score_gemma":0.0005315882,"threshold_uncertainty_score":0.8336862},"labels":[],"label_agreement":null},{"id":"W4386623512","doi":"10.1111/bjh.19058","title":"Final report of <scp>TKI</scp> discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (<scp>TRAD</scp>) study","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Toronto General Hospital; University of Alberta; London Health Sciences Centre; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; McGill University Health Centre; University of Ottawa; CancerCare Manitoba; University Health Network; Ottawa Hospital; Dalhousie University; Western University; University of Toronto; University of British Columbia","funders":"Bristol-Myers Squibb Canada; Princess Margaret Cancer Foundation","keywords":"Dasatinib; Discontinuation; Medicine; Imatinib; Internal medicine; Tyrosine-kinase inhibitor; Drug holiday; Oncology; Immunology; Myeloid leukemia; Human immunodeficiency virus (HIV); Cancer","score_opus":0.03349169713017222,"score_gpt":0.2989456162039855,"score_spread":0.2654539190738133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386623512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919352,0.0015813309,0.00017658828,0.0009002399,0.0003487949,0.0044731614,0.00027315973,0.000058556445,0.000252963],"genre_scores_gemma":[0.99382025,0.00027030113,0.0015042996,0.000055740667,0.00034873423,0.0005446125,0.00021669561,0.00013341346,0.0031059526],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99473894,0.00033218155,0.0024774864,0.0007463333,0.000991067,0.00071400835],"domain_scores_gemma":[0.9895161,0.004827657,0.0033113447,0.0014477862,0.00064473326,0.00025239628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001427992,0.00063834805,0.0021698985,0.0002643308,0.00044466543,0.000098004944,0.0006858801,0.00027719006,0.00006618341],"category_scores_gemma":[0.0029912547,0.00036282162,0.000509779,0.0005789639,0.00043421765,0.0003410706,0.00015918537,0.00046455208,0.0000030927818],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06193015,0.020255208,0.4429725,0.0027758814,0.022470517,0.08279518,0.053149696,0.00046558474,0.0066965087,0.000044127977,0.26262805,0.043816566],"study_design_scores_gemma":[0.49631372,0.06943432,0.105030484,0.007633281,0.009546848,0.2145432,0.039998688,0.00096280285,0.028572503,0.00048093434,0.026929792,0.00055342173],"about_ca_topic_score_codex":0.0004450598,"about_ca_topic_score_gemma":0.0014506916,"teacher_disagreement_score":0.43438357,"about_ca_system_score_codex":0.0006191067,"about_ca_system_score_gemma":0.0011781302,"threshold_uncertainty_score":0.9998824},"labels":[],"label_agreement":null},{"id":"W4386850841","doi":"10.1111/bjh.19107","title":"Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Instituto Nacional de Ciência e Tecnologia da Criosfera; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Institute of Cancer Research; Ontario Institute for Cancer Research; World Health Organization","keywords":"Myeloproliferative neoplasm; Interferon; Cancer research; Biology; Myeloid; Biomarker; Immunology; Stem cell; Myelofibrosis; Bone marrow; Cell biology","score_opus":0.02302117307169929,"score_gpt":0.32677305605342655,"score_spread":0.3037518829817273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386850841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365073,0.0014939368,0.0013072656,0.0023119154,0.00020362639,0.00085767044,0.000026877977,0.00001817905,0.00012978293],"genre_scores_gemma":[0.9949261,0.0005591218,0.0038740945,0.00038354108,0.00004815611,0.000071102804,0.000010706363,0.000032604574,0.00009457301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773437,0.00021246726,0.0010393598,0.00028992762,0.00040527925,0.00031857207],"domain_scores_gemma":[0.99808997,0.00029266634,0.0005112372,0.00013595357,0.00067490916,0.00029526235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049341866,0.00022971956,0.0012911049,0.00046153605,0.00008447706,0.000030414792,0.00013389756,0.00014637271,0.00010059028],"category_scores_gemma":[0.0002112333,0.0001971556,0.0001516813,0.0004796157,0.000121694364,0.0000937437,0.0001046749,0.00022563161,0.000017117314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015691532,0.0026901965,0.18421085,0.0022517976,0.008231786,0.063222185,0.017147934,0.0003229231,0.41879126,0.0020349396,0.008394902,0.2770097],"study_design_scores_gemma":[0.008917556,0.013908269,0.111996815,0.009591376,0.000991575,0.11182699,0.0021657427,0.0007723934,0.7368455,0.0012470506,0.0011420873,0.00059465226],"about_ca_topic_score_codex":0.000035635534,"about_ca_topic_score_gemma":0.000045977973,"teacher_disagreement_score":0.31805423,"about_ca_system_score_codex":0.000059588514,"about_ca_system_score_gemma":0.00026382497,"threshold_uncertainty_score":0.80397725},"labels":[],"label_agreement":null},{"id":"W4386944495","doi":"10.1111/bjh.19085","title":"In Memoriam Robert <scp>McMillan</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Citation; Library science; Tribute; Medicine; Classics; Law; History; Computer science; Political science","score_opus":0.011508388526205966,"score_gpt":0.2715650234754753,"score_spread":0.26005663494926934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386944495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909282,0.0034926783,0.000011431466,0.0011035769,0.0010284769,0.00011090511,0.0000043319333,0.000021778269,0.0032986663],"genre_scores_gemma":[0.9941707,0.0029973679,0.0002962947,0.000581414,0.00020663744,0.000004869567,0.0000129794835,0.000024539779,0.001705194],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988521,0.00005348127,0.0004609211,0.00012584213,0.00018873603,0.0003189334],"domain_scores_gemma":[0.9993743,0.00015704957,0.00016441818,0.000086369364,0.00008946065,0.0001284286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023824809,0.000097649194,0.000727931,0.00027329402,0.000036287558,0.000015798067,0.000091798625,0.00012216895,0.000063277366],"category_scores_gemma":[0.0004380562,0.000099096,0.00012659244,0.00032146464,0.000050143623,0.00008089157,0.000030089252,0.00026667397,0.00013416921],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026926535,0.00021526858,0.013117763,0.000059083137,0.00015387416,0.83848095,0.00014709198,0.000010493478,0.0001112932,0.00014044027,0.14400834,0.0035284834],"study_design_scores_gemma":[0.0051283054,0.00030504283,0.032294795,0.00036527202,0.00007997363,0.91216815,0.000315021,0.00004606947,0.00038825278,0.0036893375,0.04517129,0.000048505015],"about_ca_topic_score_codex":0.00007856969,"about_ca_topic_score_gemma":0.00014425025,"teacher_disagreement_score":0.098837055,"about_ca_system_score_codex":0.000032298183,"about_ca_system_score_gemma":0.00009073986,"threshold_uncertainty_score":0.4041018},"labels":[],"label_agreement":null},{"id":"W4386945076","doi":"10.1111/bjh.19071","title":"A tribute to Paul Imbach","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tribute; Medicine; Art; Art history","score_opus":0.016300594271200817,"score_gpt":0.294703260735729,"score_spread":0.27840266646452816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986162,0.0011764752,0.00007925628,0.0116937505,0.00024570344,0.00011551821,0.000015227987,0.00002712368,0.0004849415],"genre_scores_gemma":[0.9963945,0.00059512554,0.00056263595,0.0007374639,0.00006327778,0.0000046648556,0.0000163328,0.000015707998,0.0016102683],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991308,0.000032368098,0.00033065304,0.000098109944,0.00015917861,0.00024888277],"domain_scores_gemma":[0.99945563,0.000049162456,0.00010218212,0.00007530423,0.0001285251,0.00018917312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017870544,0.00007148302,0.0005717451,0.00017364195,0.000046185207,0.00001534815,0.0000743601,0.00006972942,0.00010777746],"category_scores_gemma":[0.00020607047,0.000070619244,0.0001236914,0.00028455778,0.000025359384,0.000045343782,0.000028288243,0.00015794176,0.00028687733],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013272342,0.00015741996,0.002098924,0.0000304714,0.00018122046,0.68057436,0.00005372168,0.000002337135,0.00019517564,0.000031445674,0.29440337,0.022138864],"study_design_scores_gemma":[0.00298662,0.00056098757,0.01389985,0.0002579996,0.00010442003,0.9336161,0.00011753705,0.000010427735,0.00042234847,0.0012766247,0.046668485,0.00007859948],"about_ca_topic_score_codex":0.000026267811,"about_ca_topic_score_gemma":0.00004587512,"teacher_disagreement_score":0.25304177,"about_ca_system_score_codex":0.000021971324,"about_ca_system_score_gemma":0.00007448921,"threshold_uncertainty_score":0.36873233},"labels":[],"label_agreement":null},{"id":"W4386945459","doi":"10.1111/bjh.19079","title":"The role of T cells and myeloid‐derived suppressor cells in refractory immune thrombocytopenia","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; National Heart, Lung, and Blood Institute; Vetenskapsrådet","keywords":"Immune system; Immunology; Immune thrombocytopenia; T cell; Medicine; Refractory (planetary science); Pathogenesis; Myeloid; Platelet; Myeloid-derived Suppressor Cell; Immune tolerance; Suppressor; Biology; Internal medicine; Cancer","score_opus":0.02207948068169229,"score_gpt":0.2982389809109268,"score_spread":0.2761595002292345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06632581,0.93258053,4.7350562e-7,0.00003938257,0.00029876665,0.000489354,0.00006203578,0.0000066334164,0.00019699255],"genre_scores_gemma":[0.0045909206,0.99503434,0.00007883856,0.000011810928,0.000035455214,0.0000136568715,0.000017112563,0.000054773987,0.00016309245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744934,0.00028455097,0.0014866235,0.00021618989,0.00022462766,0.00033866087],"domain_scores_gemma":[0.99774724,0.00058312493,0.0012225196,0.00022431153,0.00011642636,0.000106393505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004384728,0.00026568703,0.004205075,0.00021656549,0.00007390278,0.0000317463,0.00026626172,0.00035438908,0.000034400415],"category_scores_gemma":[0.00012097336,0.00019979385,0.0004183514,0.0001871823,0.000241728,0.000068569076,0.00011305535,0.00074815727,0.000021229875],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013139583,0.0004601958,0.000017549937,0.008455395,0.0015218188,0.14644156,0.00013470705,2.8205287e-7,0.0008148089,0.00003490739,0.0010830795,0.8409043],"study_design_scores_gemma":[0.0031562755,0.0005400187,0.00018555991,0.03698463,0.0018991394,0.3097692,0.00034096144,0.0000021934643,0.0013200422,0.00056106725,0.6449327,0.0003081864],"about_ca_topic_score_codex":0.00015178826,"about_ca_topic_score_gemma":0.00011917413,"teacher_disagreement_score":0.8405961,"about_ca_system_score_codex":0.00005182854,"about_ca_system_score_gemma":0.00032623205,"threshold_uncertainty_score":0.8147357},"labels":[],"label_agreement":null},{"id":"W4386945474","doi":"10.1111/bjh.19073","title":"Paediatric‐onset Evans syndrome: Breaking away from refractory immune thrombocytopenia","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fondation pour la Recherche Médicale; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Evans syndrome; Splenectomy; Medicine; Immune system; Immunology; Immune thrombocytopenia; Neutropenia; Spleen; Internal medicine; Autoimmune hemolytic anemia; Antibody; Chemotherapy","score_opus":0.025913705102565996,"score_gpt":0.3083330017252585,"score_spread":0.2824192966226925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016435655,0.9815753,0.000029937686,0.000024041874,0.0010291066,0.00031308847,0.00045809103,0.000016023556,0.00011872092],"genre_scores_gemma":[0.005827508,0.99249655,0.00022786163,0.000042297703,0.0002806365,0.00002587778,0.00076190056,0.00013535659,0.00020203942],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968533,0.00044692334,0.0014656035,0.0005074701,0.00025705312,0.00046967447],"domain_scores_gemma":[0.9975625,0.00014466903,0.0015383146,0.00043456242,0.00015663673,0.00016328729],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000350193,0.00046462432,0.003103496,0.00019645854,0.00014098355,0.0000860082,0.00070072716,0.0008851242,0.00008952835],"category_scores_gemma":[0.0001848819,0.00046533448,0.0011073373,0.00022589561,0.00013256322,0.000012323014,0.00029452218,0.0006553618,0.00012463216],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004256636,0.0005381286,0.0001048532,0.0029979113,0.0046786726,0.09487648,0.000021143711,9.859327e-7,0.000014747401,0.000011715977,0.013537973,0.88317484],"study_design_scores_gemma":[0.0011836882,0.00042055178,0.00013402673,0.006597182,0.0023076588,0.28328824,0.000036498503,1.6160499e-7,0.000024129115,0.00014825861,0.70535135,0.00050824945],"about_ca_topic_score_codex":0.00023225052,"about_ca_topic_score_gemma":0.00018454989,"teacher_disagreement_score":0.8826666,"about_ca_system_score_codex":0.00004348927,"about_ca_system_score_gemma":0.0005706168,"threshold_uncertainty_score":0.9997798},"labels":[],"label_agreement":null},{"id":"W4386994638","doi":"10.1111/bjh.19067","title":"Treatment outcomes of childhood <i>PICALM::MLLT10</i> acute leukaemias","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.020307007821183592,"score_gpt":0.31756159382189847,"score_spread":0.29725458600071486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386994638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914553,0.0011922988,0.00003753546,0.0055059334,0.000262843,0.00027360613,0.00003860282,0.000038787668,0.001195088],"genre_scores_gemma":[0.99128956,0.0049732365,0.0012591599,0.00039414756,0.00014008522,0.000009116998,0.00002024875,0.00004589941,0.0018685424],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9977098,0.00014134636,0.0009454734,0.00021003294,0.00049633824,0.0004970017],"domain_scores_gemma":[0.99834615,0.00034639798,0.0003973997,0.00027160018,0.000339836,0.00029864235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003488287,0.00018465737,0.0014719573,0.0004000557,0.00006482983,0.000018183955,0.00024408424,0.00020592257,0.00024378816],"category_scores_gemma":[0.0005065413,0.00015985707,0.0004648075,0.00045601698,0.0002468719,0.00010314326,0.00010135801,0.0004930929,0.00018883758],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068617467,0.0019895728,0.14704952,0.00027989334,0.006069388,0.65237117,0.000931317,0.000019929494,0.0053413333,0.00085624255,0.11313455,0.0712709],"study_design_scores_gemma":[0.010174301,0.0022778534,0.22382088,0.0003393217,0.0006692282,0.74531657,0.0003650422,0.000048346134,0.00719354,0.0005071781,0.009086799,0.00020097237],"about_ca_topic_score_codex":0.000089454494,"about_ca_topic_score_gemma":0.000020397156,"teacher_disagreement_score":0.104047745,"about_ca_system_score_codex":0.00021540657,"about_ca_system_score_gemma":0.0006757542,"threshold_uncertainty_score":0.6518782},"labels":[],"label_agreement":null},{"id":"W4387296226","doi":"10.1111/bjh.19121","title":"Acute myeloid leukaemia relapse after allogeneic haematopoietic stem cell transplantation: Mechanistic diversity and therapeutic directions","year":2023,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Mechanism (biology); Stem cell; Haematopoiesis; Immunology; Oncology; Donor lymphocyte infusion; Hematopoietic stem cell transplantation; Bioinformatics; Internal medicine; Biology","score_opus":0.0449286521236952,"score_gpt":0.3134743992064491,"score_spread":0.2685457470827539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387296226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013584538,0.9840942,0.00037256285,0.00014218855,0.000576785,0.00088514574,0.00016025777,0.00007186123,0.00011245048],"genre_scores_gemma":[0.0033682524,0.99418634,0.00030899132,0.00012665906,0.00017473647,0.00006501017,0.00004083559,0.00013369205,0.0015954725],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9961734,0.000647428,0.0014049849,0.00053799216,0.0006172873,0.000618941],"domain_scores_gemma":[0.9974209,0.0006391547,0.00080651935,0.0003378072,0.00034510554,0.00045052843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007388427,0.00050087937,0.0035734947,0.0007249658,0.0005477751,0.00006856795,0.0004356207,0.0007746912,0.00014503008],"category_scores_gemma":[0.000047516147,0.00048321282,0.00082142797,0.00058944075,0.00031933223,0.000110362584,0.00041577625,0.001919554,0.0001200939],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039220747,0.00019027904,0.00009380159,0.05163045,0.0034831848,0.5721619,0.000600603,5.9798856e-7,0.0000084842295,0.00011673321,0.0015668335,0.36975494],"study_design_scores_gemma":[0.0017321153,0.0003875785,0.000120038196,0.017749902,0.012441778,0.8969202,0.00011621853,0.000005303926,0.000016124352,0.00027373928,0.06980668,0.00043033442],"about_ca_topic_score_codex":0.00005000823,"about_ca_topic_score_gemma":0.000061538594,"teacher_disagreement_score":0.3693246,"about_ca_system_score_codex":0.00042872963,"about_ca_system_score_gemma":0.00094758667,"threshold_uncertainty_score":0.99976194},"labels":[],"label_agreement":null},{"id":"W4387420858","doi":"10.1111/bjh.19133","title":"Natural history of blood pressure in sickle cell disease pregnancy","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Sinai Health System; University of Toronto; University Health Network","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Andrew W. Mellon Foundation; Pfizer; Johns Hopkins University; Teva Pharmaceutical Industries; National Institute of Mental Health; Novo Nordisk","keywords":"Medicine; Blood pressure; Pregnancy; Cohort; Obstetrics; Disease; Cohort study; Internal medicine; Pediatrics","score_opus":0.007500559336759999,"score_gpt":0.22144134458821657,"score_spread":0.21394078525145657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387420858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7230168,0.27464327,0.0000018615705,0.00046839262,0.000613169,0.00012199514,0.0000054237676,0.0000153061,0.0011137519],"genre_scores_gemma":[0.9904912,0.00594118,0.00007153798,0.00008786914,0.000029901605,0.0000024821027,0.0000057612197,0.00001683223,0.0033532414],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988444,0.00007788265,0.0005376457,0.00011632947,0.00019435474,0.00022940591],"domain_scores_gemma":[0.9992982,0.000055271776,0.0002659166,0.000108790664,0.00012824507,0.00014358856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014464074,0.00008576974,0.0005155911,0.0002135061,0.000015503083,0.0000030195922,0.00011122314,0.00012071624,0.00011265394],"category_scores_gemma":[0.0002251106,0.00008635171,0.00016001987,0.00017737898,0.00013293348,0.000067011,0.00003392459,0.000458896,0.00000931979],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001081783,0.003210041,0.050916962,0.0064505325,0.0009846751,0.742752,0.0023680965,0.0003074769,0.006676073,0.0004201903,0.16458113,0.020251],"study_design_scores_gemma":[0.054638285,0.0027003356,0.24431165,0.03690895,0.0088778995,0.51748693,0.003165951,0.0019473957,0.0038216563,0.0030201501,0.12168179,0.0014389949],"about_ca_topic_score_codex":0.000050642797,"about_ca_topic_score_gemma":0.00001762278,"teacher_disagreement_score":0.2687021,"about_ca_system_score_codex":0.000021282742,"about_ca_system_score_gemma":0.00036842973,"threshold_uncertainty_score":0.35213205},"labels":[],"label_agreement":null},{"id":"W4387950790","doi":"10.1111/bjh.19153","title":"Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving <scp>bendamustine–rituximab</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Bendamustine; Mantle cell lymphoma; Rituximab; Medicine; Internal medicine; Oncology; Lymphoma","score_opus":0.043650211586456954,"score_gpt":0.33396383853634376,"score_spread":0.2903136269498868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387950790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957967,0.0026221778,0.0000020479251,0.0001494314,0.0003677147,0.00037615414,0.000016338414,0.000012101121,0.000657343],"genre_scores_gemma":[0.9973459,0.0020279386,0.00045380834,0.000066949135,0.00002273975,0.000011601037,0.000034542332,0.000018590705,0.00001792546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997273,0.00048136388,0.00119057,0.00023379372,0.0005185431,0.00030268982],"domain_scores_gemma":[0.99771947,0.00078963174,0.00058321684,0.000121874575,0.0005757776,0.00021003747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022182649,0.00013727741,0.0008993053,0.00043539674,0.000044123117,0.000020146123,0.000080213365,0.00019314009,0.000022490767],"category_scores_gemma":[0.0025659006,0.00013549055,0.00016381124,0.00035945594,0.00012729265,0.00009684646,0.000040271036,0.00011228369,0.000015837475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006226168,0.0020038295,0.79492885,0.00011500262,0.00033574074,0.007842464,0.00017193737,0.000009669348,0.000017708737,0.00000332001,0.0042504612,0.19025874],"study_design_scores_gemma":[0.029807262,0.00051440217,0.95627624,0.0009319169,0.00059897354,0.009759457,0.00031266842,0.00082902797,0.00068590697,0.00011469065,0.00011827714,0.000051160638],"about_ca_topic_score_codex":0.0011551839,"about_ca_topic_score_gemma":0.0006933743,"teacher_disagreement_score":0.19020759,"about_ca_system_score_codex":0.00016609694,"about_ca_system_score_gemma":0.00052094733,"threshold_uncertainty_score":0.55251443},"labels":[],"label_agreement":null},{"id":"W4387966857","doi":"10.1111/bjh.19166","title":"Indolent lymphoma care delivery and outcomes during the COVID‐19 pandemic in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University of Toronto","funders":"Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Foundation","keywords":"Medicine; Rituximab; Hazard ratio; Internal medicine; Regimen; Proportional hazards model; Retrospective cohort study; Pandemic; Population; Emergency department; Cohort; Neutropenia; Bendamustine; Lymphoma; Disease; Coronavirus disease 2019 (COVID-19); Chemotherapy; Confidence interval; Infectious disease (medical specialty)","score_opus":0.040712605719758654,"score_gpt":0.32196209625978983,"score_spread":0.2812494905400312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387966857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988294,0.0041508963,0.0000012599589,0.007066199,0.00027499834,0.00015785107,0.0000087385015,0.000013129552,0.000032933676],"genre_scores_gemma":[0.99348146,0.0011491756,0.00001039787,0.0051779025,0.000036414156,0.0000033566303,0.0000036214665,0.000010887817,0.00012681638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871445,0.000106737745,0.00048054606,0.00012312806,0.00025131932,0.00032384662],"domain_scores_gemma":[0.99893904,0.00035288927,0.00016882094,0.000100515994,0.00010877929,0.0003299678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031943904,0.00009661457,0.000538883,0.0001680969,0.00012918664,0.000018033823,0.00010003575,0.00009099439,0.00005207395],"category_scores_gemma":[0.000627057,0.00008094455,0.00006106151,0.00011405893,0.00006627597,0.000050590872,0.00006109442,0.00037300703,0.000001435029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010854603,0.000013001435,0.9127368,0.0002695986,0.000038524013,0.07856058,0.0016428211,0.000011753939,0.00001208099,0.0000053494273,0.001887997,0.0047129565],"study_design_scores_gemma":[0.0023213476,0.0000573375,0.78496563,0.00021777918,0.000024371824,0.20452799,0.0016705954,0.0000019346955,0.0000068727013,0.000032500313,0.006116626,0.000056983583],"about_ca_topic_score_codex":0.9601459,"about_ca_topic_score_gemma":0.9984789,"teacher_disagreement_score":0.12777112,"about_ca_system_score_codex":0.0013514368,"about_ca_system_score_gemma":0.0059102313,"threshold_uncertainty_score":0.99972534},"labels":[],"label_agreement":null},{"id":"W4388459786","doi":"10.1111/bjh.19164","title":"Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Wellcome Trust; Academy of Medical Sciences; European Hematology Association; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Guideline; Myelofibrosis; MEDLINE; Grading (engineering); Family medicine; Polycythaemia; Clinical trial; Internal medicine; Pathology","score_opus":0.04995317493433869,"score_gpt":0.34855145415029,"score_spread":0.2985982792159513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388459786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98052907,0.014931875,0.00016591756,0.0028407865,0.00019071746,0.0011265086,0.00015375896,0.000018674278,0.000042696738],"genre_scores_gemma":[0.97823733,0.011124317,0.009811615,0.00020124746,0.00009757916,0.00040579677,0.00006931329,0.00003339277,0.000019379917],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.997105,0.00018069307,0.0015804294,0.00027781865,0.00054263516,0.00031340448],"domain_scores_gemma":[0.99574465,0.0005954715,0.0009870981,0.00013230699,0.002394657,0.00014584733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017697432,0.00017054947,0.0015495778,0.00018644509,0.000091625734,0.000022267684,0.000105964864,0.00022212585,0.00013882277],"category_scores_gemma":[0.0012979674,0.00018808305,0.00053347094,0.00032932902,0.00028290178,0.00011515046,0.0000608797,0.0001563958,0.0000017519367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005923985,0.0028446198,0.39327887,0.0036616668,0.004393194,0.006039492,0.0011289517,0.00008794706,0.0012778562,0.0008652155,0.28717136,0.2986584],"study_design_scores_gemma":[0.0420671,0.0076413755,0.36926183,0.0130802,0.010907216,0.46389034,0.0030276212,0.006287422,0.06474643,0.008689346,0.009535053,0.0008660734],"about_ca_topic_score_codex":0.00016290869,"about_ca_topic_score_gemma":0.00022508929,"teacher_disagreement_score":0.45785084,"about_ca_system_score_codex":0.00005035695,"about_ca_system_score_gemma":0.00034036124,"threshold_uncertainty_score":0.7669804},"labels":[],"label_agreement":null},{"id":"W4389083699","doi":"10.1111/bjh.19214","title":"Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the <scp>EBMT</scp>","year":2023,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelofibrosis; Haematopoiesis; Stem cell; Medicine; Transplantation; Hematopoietic stem cell transplantation; Internal medicine; Oncology; Biology; Bone marrow","score_opus":0.015941105747327575,"score_gpt":0.21995706357661698,"score_spread":0.2040159578292894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389083699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327177,0.002001047,0.000007857475,0.0025319878,0.00028967374,0.0017266783,0.000113886046,0.000011717184,0.000045368863],"genre_scores_gemma":[0.99662334,0.00026804843,0.000042787393,0.0025346803,0.000105493295,0.00013298006,0.00002911963,0.00008361451,0.00017991492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639785,0.0005709431,0.001303321,0.0003650257,0.00092047843,0.0004423981],"domain_scores_gemma":[0.9969525,0.00045860073,0.0016383103,0.0005753014,0.00031795798,0.000057340236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000254178,0.00035151263,0.0012973528,0.00026787215,0.00009321897,0.000023997403,0.0005417739,0.00040257777,0.000011520671],"category_scores_gemma":[0.000034226196,0.00023900489,0.00036455432,0.00046933626,0.0003249627,0.00006417908,0.00008662813,0.0013355198,0.000007921471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002173491,0.0016357002,0.9590639,0.0028647159,0.0009758811,0.016141377,0.004564522,0.00007890421,0.000095291616,0.000004655224,0.013501439,0.0008562838],"study_design_scores_gemma":[0.0057404665,0.0012491014,0.9708979,0.012123364,0.001278281,0.007368582,0.00026653806,0.0000022769127,0.0006551344,0.000013692719,0.00031139742,0.000093238516],"about_ca_topic_score_codex":0.00018286413,"about_ca_topic_score_gemma":0.0004642091,"teacher_disagreement_score":0.013190041,"about_ca_system_score_codex":0.00047796074,"about_ca_system_score_gemma":0.00060151145,"threshold_uncertainty_score":0.9746337},"labels":[],"label_agreement":null},{"id":"W4389224369","doi":"10.1111/bjh.19186","title":"The management of myelofibrosis: A British Society for Haematology Guideline","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Wellcome Trust; Academy of Medical Sciences; European Hematology Association; National Institute for Health and Care Research; Cancer Research UK","keywords":"Myelofibrosis; Guideline; Hematology; Medicine; Internal medicine; Intensive care medicine; Family medicine; Pathology","score_opus":0.018734447172604585,"score_gpt":0.3053347433035227,"score_spread":0.28660029613091814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389224369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96671426,0.016794356,0.001717186,0.01217601,0.0007684707,0.0011565887,0.00010354302,0.000053218133,0.00051633565],"genre_scores_gemma":[0.8979995,0.054673657,0.04305016,0.0015218197,0.00041614083,0.0004111948,0.00011872962,0.000106159,0.0017026291],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99755543,0.00007477956,0.0013571713,0.00023530025,0.00032732505,0.00044996353],"domain_scores_gemma":[0.99792403,0.0004026619,0.0006282826,0.00019946025,0.00070663315,0.00013893441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008865488,0.00016164653,0.00106886,0.00007570252,0.00026526177,0.00004947461,0.00021629831,0.00014735604,0.00006989687],"category_scores_gemma":[0.0001474351,0.00014589677,0.0007324723,0.0002854017,0.00025910654,0.00006648651,0.000093591,0.00019831947,0.000012694512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005313545,0.00075939245,0.0054320088,0.0014757743,0.0055592707,0.056741357,0.00024830777,0.000029325125,0.0001408669,0.008564142,0.804001,0.116517216],"study_design_scores_gemma":[0.016434075,0.0023600375,0.026077054,0.0049470826,0.002377473,0.7123592,0.0032579426,0.0006569842,0.0032846145,0.00842842,0.21936624,0.00045087957],"about_ca_topic_score_codex":0.0000522746,"about_ca_topic_score_gemma":0.000122284,"teacher_disagreement_score":0.65561783,"about_ca_system_score_codex":0.000048122965,"about_ca_system_score_gemma":0.00013107248,"threshold_uncertainty_score":0.5949498},"labels":[],"label_agreement":null},{"id":"W4389608524","doi":"10.1111/bjh.19257","title":"Evidence creation for myelofibrosis: Challenges and opportunities","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myelofibrosis; Medicine; Hematology; Guideline; Intensive care medicine; Internal medicine; Pathology; Bone marrow","score_opus":0.17640818437281713,"score_gpt":0.34452391725671927,"score_spread":0.16811573288390214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389608524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8858301,0.095157154,0.00008283868,0.018124172,0.00015129133,0.00027098774,0.000009380749,0.000023717612,0.0003503233],"genre_scores_gemma":[0.75057364,0.2480478,0.000777442,0.0002286412,0.00010273449,0.00005032535,0.000006175448,0.000012066616,0.00020118125],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9991796,0.00006176709,0.00034076424,0.000121630175,0.0001368547,0.00015936652],"domain_scores_gemma":[0.99884677,0.0005102048,0.00018205374,0.00006017331,0.00028622424,0.000114602524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036351316,0.00008418881,0.00047265904,0.00014014998,0.00007601467,0.000023646202,0.000039087747,0.00007114543,0.000028630917],"category_scores_gemma":[0.00045549966,0.00007951554,0.00008490485,0.000040155508,0.00008514689,0.00013879078,0.0000192327,0.00008029342,0.000004627568],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071800634,0.00035775802,0.0077265226,0.0014641867,0.00070561667,0.03691658,0.0016706017,0.0000037696068,0.0003919201,0.017403113,0.025674444,0.90696746],"study_design_scores_gemma":[0.0074060024,0.006056021,0.32320824,0.013258841,0.0010082498,0.5971375,0.0048157265,0.00021742216,0.0048271613,0.008949898,0.032712825,0.00040212504],"about_ca_topic_score_codex":0.0000060803295,"about_ca_topic_score_gemma":0.000023916831,"teacher_disagreement_score":0.90656537,"about_ca_system_score_codex":0.000019637773,"about_ca_system_score_gemma":0.00009078711,"threshold_uncertainty_score":0.32425496},"labels":[],"label_agreement":null},{"id":"W4389628406","doi":"10.1111/bjh.19246","title":"Cognitive decline in thrombotic thrombocytopenic purpura survivors: The role of white matter health as assessed by <scp>MRI</scp>","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; St. Michael's Hospital; University Health Network; Western University","funders":"Physicians' Services Incorporated Foundation","keywords":"Neurocognitive; Neuropsychology; Hyperintensity; Depression (economics); Medicine; Internal medicine; Cardiology; White matter; Cognitive decline; Anterior cingulate cortex; Magnetic resonance imaging; Cognition; Psychology; Psychiatry; Radiology; Disease","score_opus":0.013546551378534152,"score_gpt":0.2885804475056531,"score_spread":0.2750338961271189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389628406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97535294,0.0206748,0.00006165998,0.0020631566,0.00061113184,0.0005072721,0.00019909877,0.00002769409,0.0005022642],"genre_scores_gemma":[0.99767345,0.0009826982,0.000017873563,0.00081052695,0.00002904501,0.000025793428,0.00013514126,0.000033589913,0.0002918971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995868,0.0015760188,0.0014787758,0.00028239656,0.00014577339,0.00064903207],"domain_scores_gemma":[0.9965367,0.001723674,0.0011676324,0.00023313874,0.00027864106,0.00006026753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014133322,0.00022030543,0.0012854973,0.00026728545,0.00023797357,0.00003538531,0.00066535705,0.00018867267,0.00089859485],"category_scores_gemma":[0.00061977643,0.00020099312,0.00021962427,0.0004749209,0.00039494337,0.00017605256,0.00035811716,0.0005429026,0.0005027806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014560018,0.0010699248,0.7988005,0.00035216438,0.0011030755,0.0026711293,0.0023400458,0.00002971243,0.007956642,0.0005123264,0.18338493,0.0016339389],"study_design_scores_gemma":[0.006830365,0.0009839855,0.84789985,0.0023798042,0.00022795088,0.09019807,0.020979911,0.000014809092,0.007944462,0.0057433783,0.01652208,0.00027530355],"about_ca_topic_score_codex":0.001237177,"about_ca_topic_score_gemma":0.0018827996,"teacher_disagreement_score":0.16686285,"about_ca_system_score_codex":0.00005213177,"about_ca_system_score_gemma":0.0003152468,"threshold_uncertainty_score":0.98389834},"labels":[],"label_agreement":null},{"id":"W4389742255","doi":"10.1111/bjh.19248","title":"Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease","year":2023,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Sinai Health System; University of Toronto; University Health Network","funders":"National Institute of Mental Health; National Institutes of Health; American Society of Hematology; National Heart, Lung, and Blood Institute; NHLBI Division of Intramural Research; Doris Duke Charitable Foundation","keywords":"Medicine; Blood pressure; Pregnancy; Proteinuria; Receiver operating characteristic; Internal medicine; Preeclampsia; Population; Cohort; Disease; Cardiology; Diastole; Eclampsia; Obstetrics; Pediatrics","score_opus":0.011915885176225341,"score_gpt":0.24638468028871924,"score_spread":0.2344687951124939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389742255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86459917,0.13150617,0.000027655167,0.0028987748,0.00022200466,0.0005481679,0.00005241043,0.000008486158,0.00013716868],"genre_scores_gemma":[0.9615603,0.038090706,0.00006978191,0.00009306918,0.000021433914,0.00003416201,0.0000055047217,0.000020793412,0.00010425808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987331,0.000060337396,0.0006400441,0.00012709964,0.00019462853,0.00024478685],"domain_scores_gemma":[0.9986525,0.0004659424,0.00037367034,0.00015684869,0.00025331342,0.000097681055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019765721,0.00010204153,0.00066459586,0.00015011859,0.000046245306,0.000004923036,0.000169759,0.00012949483,0.0000364377],"category_scores_gemma":[0.00057001464,0.000080020945,0.00027206988,0.00028914047,0.00022268413,0.000052496835,0.000042326643,0.0002481424,0.0000011896559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002578817,0.0072371345,0.78252363,0.01173911,0.003652242,0.04171267,0.0034300643,0.0041975863,0.0013186669,0.0012536363,0.061365534,0.0789909],"study_design_scores_gemma":[0.09021805,0.009084129,0.63816327,0.05267154,0.028339589,0.08388444,0.023093829,0.005528247,0.018880744,0.021035308,0.02733648,0.0017643698],"about_ca_topic_score_codex":0.00009875516,"about_ca_topic_score_gemma":0.00007856513,"teacher_disagreement_score":0.14436036,"about_ca_system_score_codex":0.000003589663,"about_ca_system_score_gemma":0.00014583381,"threshold_uncertainty_score":0.32631594},"labels":[],"label_agreement":null},{"id":"W4390561560","doi":"10.1111/bjh.19243","title":"Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"H2020 European Research Council; National Institute of Mental Health; National Institute of Nursing Research; University of Pittsburgh; Patient-Centered Outcomes Research Institute","keywords":"Medicine; Pain catastrophizing; Mood; Quality of life (healthcare); Depression (economics); Anxiety; Chronic pain; Patient Health Questionnaire; Brief Pain Inventory; Opioid; Physical therapy; Cohort; Psychiatry; Internal medicine; Depressive symptoms","score_opus":0.003023397402571859,"score_gpt":0.21802772436894566,"score_spread":0.2150043269663738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390561560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9023484,0.09425385,0.00010586654,0.0027379186,0.00016685712,0.00020798549,0.000021027292,0.000014890564,0.0001432131],"genre_scores_gemma":[0.9880521,0.011063061,0.00038421492,0.00035667358,0.000039339113,0.0000019322108,0.000010473454,0.000021924927,0.00007025707],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99885464,0.000112376154,0.00047111642,0.0001448263,0.00018523056,0.00023184103],"domain_scores_gemma":[0.9992256,0.00006039028,0.00018067998,0.000074432384,0.00008650909,0.000372347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034623023,0.00010386361,0.00048618388,0.00011456254,0.000055142773,0.000020051628,0.00005476432,0.00008065219,0.000060115053],"category_scores_gemma":[0.0000577156,0.000087858105,0.00009517981,0.00011651056,0.00020813536,0.00008007258,0.0000206982,0.0003304397,0.000002423835],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055040913,0.0029748084,0.114275806,0.029389655,0.0012641785,0.33551285,0.010962292,0.000018978071,0.00046966932,0.00029285485,0.13527085,0.36406398],"study_design_scores_gemma":[0.029546866,0.014835911,0.060232546,0.07954566,0.0012956464,0.7585062,0.020513153,0.0030365833,0.0012379301,0.0013823765,0.028817583,0.0010495777],"about_ca_topic_score_codex":0.00015386395,"about_ca_topic_score_gemma":0.00007097322,"teacher_disagreement_score":0.42299333,"about_ca_system_score_codex":0.000023473787,"about_ca_system_score_gemma":0.00035045866,"threshold_uncertainty_score":0.35827494},"labels":[],"label_agreement":null},{"id":"W4391104484","doi":"10.1111/bjh.19295","title":"New standards of care for treatment of diffuse large B‐cell lymphoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Victorian Cancer Agency","keywords":"Guideline; Medicine; Rituximab; Diffuse large B-cell lymphoma; Lymphoma; Hematology; Internal medicine; Clinical trial; CHOP; Oncology; Intensive care medicine; Pediatrics; Pathology","score_opus":0.009537349733890525,"score_gpt":0.2938472672033778,"score_spread":0.28430991746948725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391104484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8619391,0.1356218,0.00060912303,0.000296724,0.00037349595,0.00030387606,0.00044554612,0.000009895421,0.000400477],"genre_scores_gemma":[0.9925111,0.0049715564,0.0020747585,0.000028292963,0.000116433985,0.00001099083,0.000019394845,0.000022974395,0.00024449074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987469,0.000032301396,0.00062086346,0.00013922628,0.00025669302,0.00020405877],"domain_scores_gemma":[0.9989355,0.00016537473,0.00023298146,0.00012257496,0.00039475196,0.00014880067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001008732,0.00012817969,0.0010146976,0.00013965732,0.000029590698,0.0000149952575,0.00006307834,0.000100655845,0.000087157045],"category_scores_gemma":[0.000054278964,0.00010717441,0.00046724005,0.000087403176,0.000044478715,0.000048976548,0.000013784119,0.000024232246,0.0000017066267],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024244392,0.018457418,0.020316293,0.0065958244,0.0032684621,0.123244405,0.006648988,0.0000038440403,0.0009789397,0.0036520737,0.047304112,0.7671052],"study_design_scores_gemma":[0.13341305,0.020369053,0.013237786,0.0070089907,0.0045030178,0.29794273,0.002645392,0.00006210482,0.1779097,0.0009943155,0.34152615,0.00038772557],"about_ca_topic_score_codex":0.00015888887,"about_ca_topic_score_gemma":0.00012133157,"teacher_disagreement_score":0.7667175,"about_ca_system_score_codex":0.00036082324,"about_ca_system_score_gemma":0.0013283477,"threshold_uncertainty_score":0.43704456},"labels":[],"label_agreement":null},{"id":"W4391213043","doi":"10.1111/bjh.19298","title":"Past meets present: Reviving 80‐year‐old Canadian dried serum from World War <scp>II</scp> and its significance in advancing modern freeze‐dried plasma for prehospital management of haemorrhage","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Defence Research and Development Canada; University of Toronto; Canadian Armed Forces; St. Michael's Hospital","funders":"University of Toronto; Canadian Blood Services; Defence Research and Development Canada","keywords":"Resuscitation; Fresh frozen plasma; Medicine; Albumin; Saline; Blood clotting; Intensive care medicine; Surgery; Internal medicine; Platelet","score_opus":0.013647383193896856,"score_gpt":0.2558194531407312,"score_spread":0.24217206994683432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391213043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97520846,0.02015537,0.00054819044,0.0016838779,0.0006116857,0.0010557327,0.00020844862,0.00003099276,0.0004972518],"genre_scores_gemma":[0.99152136,0.0010757355,0.006627191,0.00009157962,0.00017501849,0.000043316115,0.000028790952,0.0000647764,0.00037223403],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973908,0.0001115444,0.0010675718,0.00044914687,0.00037497104,0.00060596067],"domain_scores_gemma":[0.9983408,0.00048964017,0.000370287,0.00019410341,0.00023527668,0.00036990407],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059391325,0.00023126665,0.0009190466,0.0005776814,0.00012153479,0.000059250673,0.0002180056,0.00015055964,0.000017066426],"category_scores_gemma":[0.00042981174,0.0002817909,0.00014695582,0.000370016,0.00009400161,0.0003713805,0.00008599963,0.0004711296,0.0000026557204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012375644,0.0013063414,0.09859473,0.026797736,0.0035608124,0.32575434,0.02079387,0.0027216123,0.01431944,0.007152689,0.04136994,0.45639092],"study_design_scores_gemma":[0.03969854,0.0035536815,0.5373732,0.09951744,0.003997019,0.08464206,0.020012358,0.07456143,0.08185087,0.019542485,0.033295333,0.0019555856],"about_ca_topic_score_codex":0.002240865,"about_ca_topic_score_gemma":0.044524968,"teacher_disagreement_score":0.45443535,"about_ca_system_score_codex":0.00022225772,"about_ca_system_score_gemma":0.00023861675,"threshold_uncertainty_score":0.9999634},"labels":[],"label_agreement":null},{"id":"W4391282252","doi":"10.1111/bjh.19308","title":"Variant <scp>ALK</scp>‐fusion positive anaplastic large cell lymphoma (<scp>ALCL</scp>): A population‐based paediatric study of the <scp>NHL‐BFM</scp> study group","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"Deutsche Kinderkrebsstiftung","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; NPM1; Lymphoma; Fusion gene; Population; Medicine; Cancer research; Oncology; Biology; Internal medicine; Gene; Genetics","score_opus":0.008075213031464162,"score_gpt":0.24370080411177006,"score_spread":0.2356255910803059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391282252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98263174,0.012321479,0.00017614875,0.000114079674,0.001672208,0.0021073015,0.00017680705,0.00007949962,0.00072071824],"genre_scores_gemma":[0.99815744,0.00038799262,0.00022899664,0.00028631295,0.00039886349,0.000099545265,0.000059284925,0.000112016896,0.0002695325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993816,0.0011408123,0.0019636352,0.0007862119,0.0013656564,0.0009276714],"domain_scores_gemma":[0.993255,0.003956051,0.0011815851,0.0005816817,0.0005670473,0.00045863635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011812415,0.0006037046,0.0018947455,0.00082021643,0.00045808873,0.00019609224,0.00053833,0.0003462857,0.000027301227],"category_scores_gemma":[0.0017867747,0.0004845919,0.0007149382,0.0013429576,0.000118382144,0.00027933088,0.0003158416,0.000578425,0.00005053923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008660064,0.05338889,0.7265334,0.00081518845,0.0024128214,0.18538435,0.0072004814,0.00015040081,0.00020321031,0.00043349806,0.019036837,0.004354341],"study_design_scores_gemma":[0.026004693,0.007861614,0.88711905,0.0015436966,0.0036921555,0.06309754,0.00826248,0.00063371327,0.0005247698,0.00025470305,0.0009175802,0.000088026085],"about_ca_topic_score_codex":0.0008147919,"about_ca_topic_score_gemma":0.0006267656,"teacher_disagreement_score":0.16058564,"about_ca_system_score_codex":0.0005331502,"about_ca_system_score_gemma":0.00071196596,"threshold_uncertainty_score":0.99976057},"labels":[],"label_agreement":null},{"id":"W4392168815","doi":"10.1111/bjh.19299","title":"Correlation of T‐cell receptor constant beta‐chain 1 by flow cytometry with molecular T‐cell receptor clonality for the investigation of T‐cell lymphoproliferation","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research","keywords":"Foundation (evidence); Medicine; Editorial board; Library science; Family medicine; Law; Political science; Computer science","score_opus":0.010241620617665053,"score_gpt":0.23256297959925865,"score_spread":0.22232135898159358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392168815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7259267,0.066474885,0.013393409,0.18453775,0.0024008597,0.003995292,0.0025885692,0.000049063732,0.0006335],"genre_scores_gemma":[0.9166019,0.004907661,0.020210922,0.051498428,0.0012806602,0.0002760071,0.0037793573,0.00025937962,0.0011857043],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964933,0.0003436896,0.0016362976,0.00040929002,0.0007787224,0.0003387496],"domain_scores_gemma":[0.9956498,0.000845771,0.0020558315,0.00031414488,0.0010058429,0.00012857688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006961422,0.00038760682,0.0015224107,0.0003034891,0.000089969966,0.00005152152,0.00021860682,0.0007728082,0.00012267074],"category_scores_gemma":[0.00013038245,0.00030316427,0.0004958952,0.00032550146,0.0004096408,0.000104538645,0.00003874511,0.00075278385,0.000010770987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006711643,0.00054649304,0.0032316037,0.0041281083,0.0010600366,0.0038552356,0.0003132461,0.00006614983,0.02414389,0.00005870152,0.9603746,0.0015507493],"study_design_scores_gemma":[0.018916272,0.0052815024,0.0003757362,0.0077077853,0.0078831175,0.044116586,0.00043823058,0.0013947958,0.78997624,0.0007063082,0.122236036,0.0009673966],"about_ca_topic_score_codex":0.000098663615,"about_ca_topic_score_gemma":0.000009166365,"teacher_disagreement_score":0.8381386,"about_ca_system_score_codex":0.00036089314,"about_ca_system_score_gemma":0.0011650891,"threshold_uncertainty_score":0.99994206},"labels":[],"label_agreement":null},{"id":"W4392297809","doi":"10.1111/bjh.19346","title":"Impact of elranatamab on quality of life: Patient‐reported outcomes from <scp>MagnetisMM</scp>‐3","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"Pfizer","keywords":"Medicine; Multiple myeloma; Quality of life (healthcare); Disease; Internal medicine; Physical therapy","score_opus":0.046974038907692715,"score_gpt":0.36968905573581284,"score_spread":0.32271501682812015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392297809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98803395,0.01030645,0.00004128046,0.0001902485,0.00026692773,0.00023391501,0.000267865,0.000016884058,0.0006424577],"genre_scores_gemma":[0.9986951,0.0005836099,0.0004728128,0.000047362908,0.00004737552,0.0000038944327,0.000043738917,0.000024850351,0.00008125883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708563,0.00027327324,0.0014296309,0.00021452103,0.0006781351,0.0003188078],"domain_scores_gemma":[0.9971133,0.0012224538,0.0006460915,0.00025216397,0.0004146498,0.0003513238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037208275,0.00017307627,0.0013947297,0.00032545385,0.00003032671,0.000023312392,0.00014355638,0.00014998633,0.00042969987],"category_scores_gemma":[0.0037705372,0.00014049886,0.0006301893,0.00021538901,0.00017572886,0.00011231178,0.000047431597,0.0004343619,0.000015710259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007967893,0.0016734451,0.84387904,0.00048573167,0.0051822457,0.087456144,0.00035271587,0.000008055746,0.0021717288,0.000098134464,0.010515747,0.04738021],"study_design_scores_gemma":[0.004998672,0.0022674722,0.9694501,0.00088433176,0.0002137603,0.019828124,0.00015853724,0.000042601754,0.0015371621,0.00041630768,0.00015053943,0.00005238146],"about_ca_topic_score_codex":0.0028406754,"about_ca_topic_score_gemma":0.00008847147,"teacher_disagreement_score":0.12557106,"about_ca_system_score_codex":0.000076971904,"about_ca_system_score_gemma":0.0005408267,"threshold_uncertainty_score":0.5729377},"labels":[],"label_agreement":null},{"id":"W4392788581","doi":"10.1111/bjh.19314","title":"Venetoclax resistance in acute myeloid leukaemia—Clinical and biological insights","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; Medicine; Myeloid leukemia; Clinical trial; Oncology; Immunology; Internal medicine; Leukemia; Chronic lymphocytic leukemia","score_opus":0.03499079100878444,"score_gpt":0.3486252767249856,"score_spread":0.3136344857162012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392788581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428088,0.05326316,0.00012627382,0.0023697612,0.0003583352,0.00017561622,0.0000057827424,0.000025804457,0.0008664872],"genre_scores_gemma":[0.97478044,0.021216065,0.0028273908,0.00044480088,0.00028286196,0.000006172754,0.000004772572,0.000024274754,0.00041319645],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99770826,0.00032981575,0.0010140449,0.00032642452,0.00025572928,0.00036572322],"domain_scores_gemma":[0.99875486,0.0005437368,0.00012713858,0.00014381546,0.00015930027,0.0002711314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097601267,0.00014145988,0.0009566526,0.00031064462,0.000046535235,0.000063178806,0.00019643344,0.0003668218,0.000076304445],"category_scores_gemma":[0.0007605315,0.00012365352,0.00016771349,0.00033676313,0.00060354604,0.00015088983,0.000118939184,0.0016033325,0.000029678722],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013762473,0.00013835839,0.023634419,0.0003611639,0.0004990268,0.9053338,0.00028175293,0.0000011303234,0.0013140584,0.004112483,0.03485827,0.028089257],"study_design_scores_gemma":[0.0046046376,0.0009793253,0.11198614,0.0030566128,0.00015347119,0.7977906,0.00016483292,0.00020776808,0.00041293522,0.008636818,0.071741514,0.00026538508],"about_ca_topic_score_codex":0.000024769888,"about_ca_topic_score_gemma":0.00015945481,"teacher_disagreement_score":0.10754327,"about_ca_system_score_codex":0.00020963672,"about_ca_system_score_gemma":0.00089844374,"threshold_uncertainty_score":0.69657713},"labels":[],"label_agreement":null},{"id":"W4394921808","doi":"10.1111/bjh.19470","title":"Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"BeiGene; Regeneron Pharmaceuticals; CSL Behring; AstraZeneca; Celgene; Gilead Sciences; Bristol-Myers Squibb; TG Therapeutics; Amgen","keywords":"Medicine; Vincristine; Rituximab; Internal medicine; CHOP; Diffuse large B-cell lymphoma; Oncology; Prednisolone; Radiation therapy; Chemoimmunotherapy; Gastroenterology; Retrospective cohort study; Cyclophosphamide; Lymphoma; Surgery; Chemotherapy","score_opus":0.007356814304960758,"score_gpt":0.2515189810320495,"score_spread":0.24416216672708874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394921808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706169,0.026710764,0.000058246085,0.0003688537,0.0007340847,0.00040860657,0.000026551446,0.000045543125,0.0010304708],"genre_scores_gemma":[0.99758494,0.0011464758,0.0004917632,0.00019946806,0.00019949862,0.000016453325,0.00000777981,0.000032784865,0.00032083842],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99824387,0.00012716452,0.00061013317,0.00028027673,0.00037109654,0.00036744436],"domain_scores_gemma":[0.9990669,0.00015420651,0.00019098884,0.000162176,0.00020721013,0.00021853157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002705651,0.00018041117,0.0008583952,0.00023198011,0.00008455252,0.000085915824,0.00011160193,0.000100197256,0.000121827245],"category_scores_gemma":[0.00014558267,0.00016163585,0.0002843933,0.00026667828,0.000049953866,0.00013648844,0.000066834065,0.00020943294,0.00007527725],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027125087,0.035004586,0.23445764,0.00028818366,0.00088146696,0.69941795,0.0011653462,2.8359466e-7,0.00006661428,0.00013924691,0.012584408,0.015723014],"study_design_scores_gemma":[0.032453492,0.0015955451,0.5018247,0.000744766,0.0010023892,0.45794383,0.0009916271,0.000037959257,0.00015149181,0.000077227116,0.0030253362,0.00015167933],"about_ca_topic_score_codex":0.00006250273,"about_ca_topic_score_gemma":0.00005560687,"teacher_disagreement_score":0.26736704,"about_ca_system_score_codex":0.00059402693,"about_ca_system_score_gemma":0.00044199245,"threshold_uncertainty_score":0.6591319},"labels":[],"label_agreement":null},{"id":"W4395045220","doi":"10.1111/bjh.19484","title":"Diagnostic delay of <scp><i>MYH9</i></scp>‐related disorder in Japan","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hatch (Canada)","funders":"","keywords":"Medicine; Internal medicine; Chemistry","score_opus":0.004446911528493551,"score_gpt":0.2155602980445826,"score_spread":0.21111338651608905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395045220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6816139,0.31591016,0.00010932247,0.00012407261,0.0013792749,0.00010067633,0.000013811782,0.00002300989,0.0007257724],"genre_scores_gemma":[0.99480206,0.004515499,0.000020821051,0.000059249014,0.000004535462,0.000007070729,0.000023590126,0.000028162522,0.0005389969],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99760455,0.0003517297,0.0012547862,0.00023063531,0.0000687661,0.0004895286],"domain_scores_gemma":[0.99761903,0.0017372802,0.00034614778,0.00015963243,0.00012475025,0.000013153861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006675257,0.00019144571,0.0008103366,0.00042543185,0.00009141311,0.00002826222,0.00042099316,0.00039804677,0.00028827987],"category_scores_gemma":[0.001644045,0.00020158045,0.00027618182,0.00046813564,0.000498614,0.0002090777,0.00007960225,0.00096955185,0.00015391424],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029763815,0.0067232237,0.06485845,0.0025481242,0.0050722086,0.10833024,0.025898864,0.0021646426,0.12998694,0.04498831,0.034054596,0.57507676],"study_design_scores_gemma":[0.008555157,0.001363053,0.0631592,0.0057753203,0.0005199072,0.74021596,0.010989881,0.00012191046,0.012840311,0.010512162,0.14539842,0.0005487143],"about_ca_topic_score_codex":0.0002622353,"about_ca_topic_score_gemma":0.000057901878,"teacher_disagreement_score":0.6318857,"about_ca_system_score_codex":0.000024879499,"about_ca_system_score_gemma":0.0001760308,"threshold_uncertainty_score":0.8220212},"labels":[],"label_agreement":null},{"id":"W4395670257","doi":"10.1111/bjh.19397","title":"Oral Abstracts","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Perelman School of Medicine, University of Pennsylvania; Barts Health NHS Trust; Irving Medical Center, Columbia University; Assistance publique-Hôpitaux de Paris; University College London Hospitals NHS Foundation Trust; Hospital for Sick Children; Università Cattolica del Sacro Cuore; Universität Regensburg; National and Kapodistrian University of Athens; Eberhard Karls Universität Tübingen; Imperial College London; Imperial College Healthcare NHS Trust; Ospedale Pediatrico Bambino Gesù; Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf; University of Pennsylvania; Università degli Studi di Milano; University College London; University of Toronto; University of Illinois at Urbana-Champaign; BC Children's Hospital; Vertex Pharmaceuticals; University of California, San Francisco; Children's Hospital of Philadelphia","keywords":"Medicine","score_opus":0.05628692762392688,"score_gpt":0.39107500764995873,"score_spread":0.33478808002603183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395670257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8912872,0.08010497,0.00013926765,0.012780203,0.0011653728,0.000060538612,0.0000032969472,0.000025777214,0.014433351],"genre_scores_gemma":[0.99319607,0.0047446354,0.0006497752,0.00090754626,0.00024067564,6.5787594e-7,6.3610736e-7,0.0000089905825,0.000250998],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992432,0.0000398079,0.00034523878,0.0000737559,0.0001413679,0.0001566098],"domain_scores_gemma":[0.9994558,0.00020811691,0.00008281862,0.000034210123,0.0000917285,0.0001273334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037516488,0.000053589432,0.00032562696,0.000049915918,0.00003977435,0.000048014364,0.00005221603,0.000054379492,0.0005496437],"category_scores_gemma":[0.00025364978,0.000047422516,0.00011168494,0.00008269898,0.00006923632,0.00013842779,0.000021325875,0.00045253822,0.000086702836],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019887653,0.00016515848,0.0005778792,0.00038539825,0.0005495816,0.5663581,0.000081533966,0.0000019402148,0.00045468129,0.0008730857,0.11553883,0.31481493],"study_design_scores_gemma":[0.00035189991,0.00012836074,0.0022045625,0.00032013215,0.00015434196,0.55276453,0.000045567904,0.000030905634,0.00031029407,0.00058987096,0.4430626,0.00003694601],"about_ca_topic_score_codex":0.00002640215,"about_ca_topic_score_gemma":0.000013134644,"teacher_disagreement_score":0.32752377,"about_ca_system_score_codex":0.00001692357,"about_ca_system_score_gemma":0.000072687755,"threshold_uncertainty_score":0.6018213},"labels":[],"label_agreement":null},{"id":"W4396642541","doi":"10.1111/bjh.19501","title":"Diagnosis of systemic mastocytosis with cryptic deletion of <scp>TET2</scp> and <scp>DNMT3A</scp> resulting from unbalanced translocation","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Chromosomal translocation; Gain of function; Systemic mastocytosis; Mutation; Function (biology); Biology; Neoplasm; Immunologic function; Genetics; Cancer research; Immunology; Gene; Immune system","score_opus":0.00760221591256105,"score_gpt":0.20598042527168486,"score_spread":0.1983782093591238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396642541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89658093,0.10080413,0.001711364,0.00007057706,0.0003980932,0.00017880785,0.000092466355,0.000021003032,0.00014264787],"genre_scores_gemma":[0.9911542,0.00783811,0.00071770535,0.00001951033,0.00004325088,0.0000151495615,0.000048108963,0.000027428163,0.000136538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802476,0.00027634198,0.0010462621,0.00027155288,0.00009181293,0.00028927127],"domain_scores_gemma":[0.9975994,0.0012000495,0.00071841874,0.00014054045,0.00029706198,0.000044484175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040907264,0.00018438105,0.0009359891,0.00025560084,0.00009295708,0.000028712277,0.00018851511,0.00030393447,0.000043937758],"category_scores_gemma":[0.00035047307,0.00018012802,0.00013032957,0.00021537452,0.00036799838,0.00014791239,0.000031025847,0.0004099376,0.00001042921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023297367,0.0005811447,0.020264667,0.0037839015,0.0023012466,0.004689089,0.0068671703,0.00019175073,0.89724183,0.0014066935,0.009213158,0.053226393],"study_design_scores_gemma":[0.012742987,0.002835734,0.027625948,0.027980551,0.0020482906,0.24407306,0.009922515,0.0002787796,0.65747464,0.0015162915,0.013187663,0.00031355195],"about_ca_topic_score_codex":0.00041561617,"about_ca_topic_score_gemma":0.00015581102,"teacher_disagreement_score":0.23976718,"about_ca_system_score_codex":0.000032459844,"about_ca_system_score_gemma":0.00011098047,"threshold_uncertainty_score":0.7345407},"labels":[],"label_agreement":null},{"id":"W4396847734","doi":"10.1111/bjh.19497","title":"Atrial arrhythmias following <scp>CAR‐chimeric</scp> antigen receptor T‐cell therapy: Incidence, risk factors and biomarker profile","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; Swim Across America; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Chimeric antigen receptor; Atrial fibrillation; Internal medicine; Cardiotoxicity; Cardiology; Cancer; Immunotherapy; Chemotherapy","score_opus":0.02320608738721138,"score_gpt":0.30156380719973097,"score_spread":0.2783577198125196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396847734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9282153,0.06820283,0.00011196762,0.00020972076,0.0016842148,0.00049676775,0.000032743614,0.000058183115,0.0009882728],"genre_scores_gemma":[0.97018814,0.026080197,0.0010588439,0.00006938886,0.0007774283,0.0000067746814,0.000016689266,0.00009226836,0.0017102488],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99707174,0.0004736438,0.000828503,0.00040355377,0.00064237893,0.0005801971],"domain_scores_gemma":[0.9978315,0.0011038203,0.00031139344,0.00020967968,0.00018344558,0.00036011747],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012902883,0.00027375907,0.0010772042,0.00048622533,0.00017537491,0.00020238441,0.00020694334,0.00029144477,0.0010572437],"category_scores_gemma":[0.00086952996,0.00024288648,0.00072079035,0.00051576947,0.00024172953,0.00027534348,0.000090907575,0.0010303966,0.00004939634],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009780163,0.00036499804,0.26261917,0.00064472295,0.005003915,0.1871867,0.0034816922,0.0000048229135,0.2181123,0.00004053885,0.084214546,0.23734857],"study_design_scores_gemma":[0.013743761,0.0036822013,0.06806094,0.0030701854,0.0008947635,0.4860483,0.0031500754,0.00051730004,0.084123746,0.0007592703,0.33538648,0.00056295353],"about_ca_topic_score_codex":0.00028542225,"about_ca_topic_score_gemma":0.00001950515,"teacher_disagreement_score":0.29886162,"about_ca_system_score_codex":0.00008536478,"about_ca_system_score_gemma":0.00046056343,"threshold_uncertainty_score":0.99985594},"labels":[],"label_agreement":null},{"id":"W4399032715","doi":"10.1111/bjh.19569","title":"Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A <scp>CIBMTR</scp> analysis","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Moonshot; Moonshot Research and Development Program; National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Alexion Pharmaceuticals; bluebird bio; Pharmacyclics; Takeda Oncology; AstraZeneca; Genentech; Adaptive Biotechnologies; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; Pediatric Blood and Marrow Transplant Consortium; Pediatric Transplantation and Cellular Therapy Consortium; CareDx; BeiGene; Juno Therapeutics; Swedish Orphan Biovitrum; Astellas Pharma; GlaxoSmithKline; Kiadis Pharma; Jazz Pharmaceuticals; Medical College of Wisconsin; Gateway for Cancer Research; Celgene; Omeros Corporation; Vertex Pharmaceuticals; Atara Biotherapeutics; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; CSL Behring; Bristol-Myers Squibb; Eli Lilly and Company; National Marrow Donor Program; Mallinckrodt Pharmaceuticals; Astellas Pharma US; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Amgen; Sanofi; HistoGenetics","keywords":"Chimeric antigen receptor; Medicine; Central nervous system; Lymphoma; Antigen; Receptor; Immunology; Oncology; Immunotherapy; Cancer research; Internal medicine; Immune system","score_opus":0.008835141096105326,"score_gpt":0.23265787953333253,"score_spread":0.2238227384372272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399032715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827817,0.009937558,0.00003028931,0.0043865973,0.0003662953,0.000933189,0.00041159306,0.00006397307,0.0010887856],"genre_scores_gemma":[0.9371293,0.0047757607,0.0014527172,0.034066293,0.0019461743,0.000092229246,0.00245881,0.00094290293,0.017135803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99457085,0.00059750257,0.0015839067,0.0006744463,0.0015114734,0.0010618209],"domain_scores_gemma":[0.9959761,0.0004107588,0.0015922056,0.0005999742,0.0010937481,0.0003272272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036161745,0.0006767065,0.004355193,0.0016020573,0.00009540658,0.000121341815,0.0005619578,0.0008385587,0.00090826105],"category_scores_gemma":[0.000056218672,0.0005070833,0.0010585731,0.0015237064,0.00043578306,0.00013254551,0.0000729813,0.0020635177,0.000023042261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012474431,0.0008936216,0.42268667,0.0031178368,0.03540876,0.18765771,0.00051077467,0.000012256123,0.00020645102,0.0000010366728,0.333297,0.014960427],"study_design_scores_gemma":[0.022104207,0.0071710693,0.56538576,0.004457747,0.010758682,0.15607575,0.000835717,0.000043734744,0.002246094,0.0000054049697,0.2302128,0.0007030284],"about_ca_topic_score_codex":0.0005446742,"about_ca_topic_score_gemma":0.00005965648,"teacher_disagreement_score":0.1426991,"about_ca_system_score_codex":0.00035840634,"about_ca_system_score_gemma":0.0010092632,"threshold_uncertainty_score":0.9997381},"labels":[],"label_agreement":null},{"id":"W4399045402","doi":"10.1111/bjh.19555","title":"Canadian cancer trials group <scp>LY</scp>.17: A randomized phase <scp>II</scp> study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐<scp>DICEP</scp>) versus R‐<scp>GDP</scp>","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Manitoba; Hôpital de l'Enfant-Jésus; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; University of Calgary; Princess Margaret Cancer Centre; Queen's University; Moncton Hospital; University Health Network; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"Canadian Cancer Society; Roche Canada","keywords":"Medicine; Rituximab; Gemcitabine; Autologous stem-cell transplantation; Internal medicine; Etoposide; Salvage therapy; Oncology; Diffuse large B-cell lymphoma; Interim analysis; Cyclophosphamide; Melphalan; Surgery; Lymphoma; Chemotherapy; Urology; Clinical trial","score_opus":0.04200162874759488,"score_gpt":0.33967622265958025,"score_spread":0.29767459391198536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399045402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8864257,0.10165707,0.000090425274,0.00022452793,0.0030917025,0.0061390717,0.0013798675,0.00013652802,0.0008551049],"genre_scores_gemma":[0.9821315,0.013165721,0.00054387684,0.00097168906,0.00039705983,0.0009986666,0.00018108763,0.00031901713,0.0012913855],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9840537,0.0031667766,0.0066994503,0.0016729401,0.0019031146,0.0025040533],"domain_scores_gemma":[0.9665518,0.026031846,0.0036342298,0.0008863967,0.0014020151,0.0014937061],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.007180327,0.0015719495,0.009004703,0.0018301881,0.00055472757,0.00033323545,0.00096509815,0.0011837308,0.000049662925],"category_scores_gemma":[0.0069821067,0.001423238,0.0021907506,0.001218134,0.00050824735,0.00057535066,0.00019089159,0.0016784136,0.00004369418],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021961445,0.13749649,0.09786208,0.0050392393,0.025743693,0.49164805,0.09733715,0.0003843268,0.023720466,0.000561709,0.057868253,0.040377103],"study_design_scores_gemma":[0.8925292,0.009130056,0.023795761,0.0044107996,0.006745865,0.028675256,0.016982393,0.0012360028,0.012189466,0.00020115537,0.0037988585,0.00030521723],"about_ca_topic_score_codex":0.0458193,"about_ca_topic_score_gemma":0.041981064,"teacher_disagreement_score":0.87056774,"about_ca_system_score_codex":0.002165506,"about_ca_system_score_gemma":0.004160906,"threshold_uncertainty_score":0.9997029},"labels":[],"label_agreement":null},{"id":"W4399514809","doi":"10.1111/bjh.19566","title":"A sinister case of pseudothrombocytosis","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine","score_opus":0.018063261334557216,"score_gpt":0.31474170711812055,"score_spread":0.29667844578356334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399514809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982625,0.013092873,0.0001977508,0.002249715,0.0003600259,0.00012808066,0.000021326488,0.000012169014,0.0013130311],"genre_scores_gemma":[0.9968501,0.0010664783,0.001587808,0.00026980552,0.00009057179,0.000006340536,0.000002276016,0.000017677547,0.000108961656],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99890983,0.00007004435,0.00059018226,0.00013222914,0.00014381824,0.0001538663],"domain_scores_gemma":[0.99922603,0.00020066305,0.00015208637,0.00009153136,0.00020965266,0.00012005031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001909438,0.00010091224,0.00071844796,0.0001551839,0.000036164176,0.00003072651,0.00004462175,0.00008724722,0.00050007366],"category_scores_gemma":[0.00011200541,0.00008837421,0.00024071621,0.00012503276,0.000114644085,0.000078924655,0.000020120551,0.00021830133,0.000021365202],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090313355,0.0004435873,0.00532416,0.0004190461,0.0006788717,0.9562082,0.00029042407,0.0000013818676,0.0003693229,0.0021770906,0.01441762,0.019579947],"study_design_scores_gemma":[0.0010929345,0.00077636354,0.001589652,0.0013795652,0.00036368732,0.982269,0.0001410549,0.000044384884,0.007980169,0.00035236604,0.0039464133,0.000064449516],"about_ca_topic_score_codex":0.000059044403,"about_ca_topic_score_gemma":0.000067211105,"teacher_disagreement_score":0.026060725,"about_ca_system_score_codex":0.000037620805,"about_ca_system_score_gemma":0.00017007325,"threshold_uncertainty_score":0.5475456},"labels":[],"label_agreement":null},{"id":"W4399922214","doi":"10.1111/bjh.19601","title":"Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Pyruvate kinase deficiency; Splenectomy; Pediatrics; Osteoporosis; Internal medicine; Jaundice; Disease; Pyruvate kinase; Surgery","score_opus":0.009090418354144507,"score_gpt":0.2330358204627708,"score_spread":0.2239454021086263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399922214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871689,0.010476822,0.00019395967,0.001804292,0.00010444783,0.000082034676,0.00004874944,0.0000094463185,0.00011136186],"genre_scores_gemma":[0.99687773,0.0022041672,0.00026329927,0.0005383112,0.000049695074,0.0000036206993,0.000037546306,0.0000070408164,0.000018606721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924326,0.00009215104,0.00029933485,0.00014738586,0.00010593066,0.00011192788],"domain_scores_gemma":[0.9992642,0.0002900742,0.0001236547,0.000100026286,0.00015840698,0.00006366478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010535752,0.00007473916,0.00036351228,0.00017167136,0.00007253932,0.00003628919,0.000054691027,0.00006155912,0.00003219808],"category_scores_gemma":[0.000117203854,0.00005412021,0.000054404452,0.00037062773,0.00023653408,0.000061721184,0.000024922303,0.00028673804,0.000002009943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024424435,0.00022222451,0.9768606,0.00016864754,0.00044544964,0.0070423842,0.00074442767,0.000021245525,0.00008217226,0.0011069896,0.0051599224,0.007901725],"study_design_scores_gemma":[0.0010763449,0.00020561121,0.986898,0.00023218025,0.00059824187,0.009056615,0.0004959747,0.00021481387,0.00000628164,0.00046768083,0.00068008044,0.000068143585],"about_ca_topic_score_codex":0.00031329054,"about_ca_topic_score_gemma":0.0007859031,"teacher_disagreement_score":0.010037466,"about_ca_system_score_codex":0.0000142580875,"about_ca_system_score_gemma":0.00006301184,"threshold_uncertainty_score":0.22069581},"labels":[],"label_agreement":null},{"id":"W4401045198","doi":"10.1111/bjh.19649","title":"Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Ontario Medical Association; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Malignancy; Incidence (geometry); Internal medicine; Bone marrow; Cohort; Population; Retrospective cohort study; Hematology; Surgery; Gastroenterology; Pediatrics","score_opus":0.021002577794189813,"score_gpt":0.29791286772585185,"score_spread":0.27691028993166206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401045198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886234,0.0074611194,0.001481078,0.00045796589,0.000067508714,0.0014378222,0.000104628525,0.000034708573,0.00033179688],"genre_scores_gemma":[0.991776,0.00029713413,0.007474646,0.00020069674,0.00003596602,0.000082765786,0.0000794225,0.00003806287,0.000015312853],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9970297,0.00043321482,0.0012107707,0.00037273992,0.0005406748,0.0004128979],"domain_scores_gemma":[0.99747205,0.0009182361,0.0005460594,0.00021701904,0.00059171044,0.00025489836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011149978,0.0002612216,0.002294778,0.00021397373,0.000056717163,0.000055549866,0.00017566311,0.00025747743,0.0004370297],"category_scores_gemma":[0.0012625011,0.00018876523,0.00018938213,0.0002611213,0.00033711677,0.00019627699,0.00002856477,0.00044064666,0.000008018065],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050013043,0.0093960175,0.20810683,0.005773047,0.0027054364,0.6868112,0.001699991,0.00065398193,0.0020237938,0.004931939,0.020046268,0.007838442],"study_design_scores_gemma":[0.07292563,0.018106237,0.3515261,0.023976492,0.0036933802,0.47885218,0.0015094564,0.03409449,0.0007778811,0.012989712,0.00048480663,0.0010636089],"about_ca_topic_score_codex":0.00026098007,"about_ca_topic_score_gemma":0.0009903561,"teacher_disagreement_score":0.20795901,"about_ca_system_score_codex":0.000059328486,"about_ca_system_score_gemma":0.00042617918,"threshold_uncertainty_score":0.7697623},"labels":[],"label_agreement":null},{"id":"W4401045493","doi":"10.1111/bjh.19655","title":"Rolling the <scp>DICEP</scp> on lymphoma salvage treatments? Choose wisely","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Etoposide; Medicine; Salvage therapy; Lymphoma; Internal medicine; Cyclophosphamide; Oncology; Surgery; Transplantation; Autologous stem-cell transplantation; Chemotherapy","score_opus":0.013722826710478291,"score_gpt":0.2684085778397481,"score_spread":0.2546857511292698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401045493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429345,0.048774406,0.000024403931,0.0023984958,0.0008300382,0.0002680006,0.000018261408,0.000051100793,0.004700774],"genre_scores_gemma":[0.99301636,0.0042342134,0.00020255179,0.00096030795,0.0003873116,0.000026569805,0.000009231209,0.000042623342,0.0011208433],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982288,0.00013694521,0.0006108635,0.00025990757,0.00038480034,0.00037869986],"domain_scores_gemma":[0.99844354,0.00078478863,0.0002110945,0.00021434067,0.00013002717,0.00021623247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032235926,0.0002205248,0.0007101145,0.00018008126,0.00016245777,0.0001529752,0.00016978363,0.00014338273,0.00007822161],"category_scores_gemma":[0.0002950574,0.0001522382,0.00042417814,0.0002129125,0.00012523128,0.00012667538,0.000034009947,0.00022243042,0.00021102025],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010879412,0.0024928937,0.010194588,0.00021439535,0.0031953873,0.60010535,0.001055451,0.000024629355,0.00018777675,0.0029549943,0.08151888,0.29794684],"study_design_scores_gemma":[0.0076815565,0.0016475144,0.098330334,0.0028438095,0.0015978738,0.79875,0.00051344314,0.000121964,0.003920778,0.001645535,0.08285234,0.000094849085],"about_ca_topic_score_codex":0.000080964724,"about_ca_topic_score_gemma":0.0000138174855,"teacher_disagreement_score":0.29785198,"about_ca_system_score_codex":0.00030631231,"about_ca_system_score_gemma":0.00038781986,"threshold_uncertainty_score":0.6208094},"labels":[],"label_agreement":null},{"id":"W4401045711","doi":"10.1111/bjh.19662","title":"Quality of life in childhood immune thrombocytopenia: Revision of the Kids' <scp>ITP</scp> Tools (<scp>KIT</scp>)","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Immune thrombocytopenia; Quality of life (healthcare); Proxy (statistics); Health related quality of life; Medicine; Pediatrics; Family medicine; Psychology; Immunology; Computer science; Disease; Internal medicine; Nursing; Antibody","score_opus":0.022442898658234196,"score_gpt":0.29594959649046026,"score_spread":0.2735066978322261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401045711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9364834,0.060372997,0.000035409153,0.0005254314,0.00039303015,0.00040379498,0.000041286443,0.000013434189,0.0017312518],"genre_scores_gemma":[0.9939796,0.005233666,0.00027866798,0.00019075454,0.000057647678,0.0000032164378,0.000011226674,0.00003123735,0.0002140342],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99676925,0.0003628125,0.001756297,0.000247825,0.00048557963,0.0003782595],"domain_scores_gemma":[0.99759275,0.0009352988,0.0007776346,0.00030731878,0.00024665432,0.00014035225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010569588,0.00020731718,0.002114538,0.00021192772,0.00006381433,0.000043572,0.00033293647,0.0002473539,0.000033255925],"category_scores_gemma":[0.003721519,0.00016317195,0.0005154808,0.00045553417,0.00022693082,0.00024947352,0.00014668891,0.00069671124,0.000013993806],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000479932,0.015894592,0.3279843,0.014023881,0.009989945,0.32854792,0.013071861,0.00009841399,0.025070539,0.015862387,0.114186816,0.1347894],"study_design_scores_gemma":[0.009860742,0.00097354664,0.7587011,0.008827139,0.0005639908,0.19645816,0.0025686927,0.000022434246,0.011461474,0.0036800932,0.006781199,0.000101465186],"about_ca_topic_score_codex":0.000296575,"about_ca_topic_score_gemma":0.00007649078,"teacher_disagreement_score":0.43071675,"about_ca_system_score_codex":0.000052758336,"about_ca_system_score_gemma":0.00043655053,"threshold_uncertainty_score":0.6653959},"labels":[],"label_agreement":null},{"id":"W4401189126","doi":"10.1111/bjh.19667","title":"Exploring the role of viscosity–vaso‐occlusion and haemolysis–endothelial dysfunction in pain sensitization among Jamaicans with sickle cell disease","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Haemolysis; Internal medicine; Sensitization; Endothelial dysfunction; Chronic pain; Threshold of pain; Crossover study; Disease; Sickle cell anemia; Quantitative sensory testing; Gastroenterology; Anesthesia; Physical therapy; Immunology; Pathology; Sensory system; Psychology","score_opus":0.007431630629600678,"score_gpt":0.19596107691257533,"score_spread":0.18852944628297466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401189126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894973,0.007807778,0.0009846182,0.0011898316,0.00014065247,0.00016271208,0.0000047613707,0.000011049785,0.00020131205],"genre_scores_gemma":[0.9969758,0.0027495737,0.00007978364,0.00007463602,0.00005911991,0.0000031446752,0.000004966432,0.000017680548,0.000035322144],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989566,0.00019488238,0.00037171348,0.00013311331,0.0001905508,0.0001531074],"domain_scores_gemma":[0.9994467,0.000150624,0.00013116105,0.00007685858,0.000091207636,0.000103445134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048876257,0.00009162353,0.00033252302,0.00017607502,0.000071817296,0.000028385135,0.0000421425,0.000059611342,0.000016223777],"category_scores_gemma":[0.00012065455,0.00006778687,0.000073543386,0.00024023592,0.00015937125,0.00017882817,0.00002702914,0.0003359651,0.000001078819],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004752314,0.0015765534,0.35736766,0.003847332,0.0008633768,0.21323006,0.008563282,0.005047662,0.027919041,0.0015710712,0.0014554976,0.37380615],"study_design_scores_gemma":[0.019112974,0.004085445,0.41126725,0.032205176,0.0038637805,0.38094333,0.02968742,0.08086019,0.026664546,0.0055013937,0.004543109,0.001265397],"about_ca_topic_score_codex":0.00026192816,"about_ca_topic_score_gemma":0.00019530264,"teacher_disagreement_score":0.37254074,"about_ca_system_score_codex":0.000029041355,"about_ca_system_score_gemma":0.000105147585,"threshold_uncertainty_score":0.27642682},"labels":[],"label_agreement":null},{"id":"W4401191697","doi":"10.1111/bjh.19674","title":"Automated red blood cell exchange with a post‐procedure haematocrit targeted at 34% in the chronic management of sickle cell disease","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Red blood cell; Hematocrit; Red Cell; Gastroenterology; Cell; Internal medicine; Immunology; Biology; Biochemistry","score_opus":0.004572566225777708,"score_gpt":0.22142041773291732,"score_spread":0.21684785150713962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401191697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8684976,0.12594219,0.000013203747,0.00342193,0.00015089267,0.00055280543,0.000024438641,0.00006558452,0.0013313653],"genre_scores_gemma":[0.9918673,0.0068681845,0.00024100678,0.00027692236,0.00003959939,0.000020584686,0.000024942135,0.0000425121,0.0006189219],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9981255,0.00013666981,0.00069386687,0.00024843361,0.00039463432,0.0004008942],"domain_scores_gemma":[0.999157,0.000054951986,0.00024677563,0.00021290345,0.00015272878,0.00017565611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033126786,0.00019790817,0.0006480133,0.00023510415,0.00007210579,0.00003241144,0.0002280451,0.00014926019,0.00026783595],"category_scores_gemma":[0.000023952633,0.00014396619,0.00019402686,0.00048636633,0.00016740766,0.00008811095,0.00006692907,0.00050199,0.000016962103],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013537671,0.0023433045,0.0026277816,0.027076472,0.00085370505,0.9154519,0.0016657787,0.00016011672,0.002564269,0.00021650436,0.0437126,0.0019738],"study_design_scores_gemma":[0.02674686,0.0053205537,0.030270785,0.02923409,0.0056910445,0.8623366,0.008254426,0.004274602,0.0067913467,0.00041008968,0.019655503,0.0010141305],"about_ca_topic_score_codex":0.00004601278,"about_ca_topic_score_gemma":0.000066794084,"teacher_disagreement_score":0.12336973,"about_ca_system_score_codex":0.00008758826,"about_ca_system_score_gemma":0.0002948178,"threshold_uncertainty_score":0.5870771},"labels":[],"label_agreement":null},{"id":"W4401437309","doi":"10.1111/bjh.19698","title":"Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"Leukemia and Lymphoma Society of Canada; Leukemia and Lymphoma Society","keywords":"Follicular lymphoma; Radiation therapy; Oncology; Medicine; Stage (stratigraphy); Internal medicine; Lymphoma; Cohort; Gene; Bioinformatics; Biology; Genetics","score_opus":0.015915330690542677,"score_gpt":0.25425456712591393,"score_spread":0.23833923643537125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401437309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564863,0.042016152,0.000028745433,0.0010179282,0.000051414994,0.00025159653,0.000009447381,0.000020552441,0.00011786437],"genre_scores_gemma":[0.9945357,0.00450028,0.00068481395,0.00011115774,0.000039390885,0.000030709976,0.000022116035,0.000018874147,0.000056951896],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99916184,0.000064043605,0.00033383412,0.00015194104,0.00013653706,0.00015182648],"domain_scores_gemma":[0.99956644,0.00010111348,0.00010162624,0.000052744137,0.000088100256,0.00008995316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106183885,0.0001033632,0.0003875678,0.00023215418,0.000039107243,0.000072478295,0.000029666971,0.000077651704,0.00002764446],"category_scores_gemma":[0.000033068023,0.00008466659,0.00007217201,0.00024495836,0.000063274834,0.00012608436,0.000006225612,0.00006337316,0.000002739899],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029296346,0.0018161809,0.30915236,0.00011896304,0.00076228834,0.28866914,0.00054644304,0.000013949806,0.0012280177,0.0002028139,0.0003744433,0.39682245],"study_design_scores_gemma":[0.010062907,0.002300593,0.45161498,0.0011654434,0.00030868425,0.50541824,0.00015341683,0.00025357664,0.02450974,0.000085163054,0.0039720046,0.00015523043],"about_ca_topic_score_codex":0.00014178672,"about_ca_topic_score_gemma":0.00006994554,"teacher_disagreement_score":0.3966672,"about_ca_system_score_codex":0.00014261785,"about_ca_system_score_gemma":0.00017245908,"threshold_uncertainty_score":0.34526035},"labels":[],"label_agreement":null},{"id":"W4401624983","doi":"10.1111/bjh.19696","title":"Genome‐wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"Common Fund; National Institute of Neurological Disorders and Stroke; NIH Office of the Director; National Institute on Drug Abuse; National Institutes of Health; National Cancer Institute; University of Rochester; National Institute of Mental Health; National Heart, Lung, and Blood Institute; Dana-Farber Cancer Institute; Bundesinstitut für Bau- Stadt- und Raumforschung; McMaster University; Roswell Park Alliance Foundation, Roswell Park Cancer Institute; Irving Medical Center, Columbia University; Medical Center, University of Rochester; National Human Genome Research Institute; Seagen; Rally Foundation","keywords":"Medicine; Genome-wide association study; Internal medicine; Oncology; Meta-analysis; Gene; Bioinformatics; Single-nucleotide polymorphism; Genetics; Genotype; Biology","score_opus":0.01103540603332483,"score_gpt":0.2621516035166131,"score_spread":0.2511161974832883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401624983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915662,0.0057364046,0.0013930969,0.00030565512,0.00014695864,0.0006439464,0.000037586386,0.00006214701,0.00010801407],"genre_scores_gemma":[0.998181,0.00046153605,0.0003951391,0.00012009889,0.00012549196,0.00002949484,0.000024801204,0.00008805051,0.0005743941],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9968844,0.00016803778,0.0009445788,0.0004183788,0.0009257698,0.0006588326],"domain_scores_gemma":[0.99830186,0.00050729717,0.00029679586,0.00021804469,0.00043967206,0.00023632249],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071483396,0.00030246127,0.0012893837,0.00075123017,0.00010603035,0.00021137776,0.0002962086,0.00018563593,0.000084071835],"category_scores_gemma":[0.0003828644,0.00024765177,0.00012634882,0.00076000975,0.00042330442,0.00033024678,0.00011732202,0.0007387489,0.000017249447],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018996723,0.0019569402,0.3249966,0.0002685891,0.008636035,0.65402424,0.0015411983,0.00023847702,0.0033811545,0.000051540184,0.0014173829,0.001588198],"study_design_scores_gemma":[0.008586392,0.0020673526,0.352628,0.0019002727,0.0008790039,0.6318121,0.0010735015,0.0002291337,0.0004985306,0.00005018454,0.000027368751,0.0002481489],"about_ca_topic_score_codex":0.000266974,"about_ca_topic_score_gemma":0.0010436589,"teacher_disagreement_score":0.027631413,"about_ca_system_score_codex":0.00087926193,"about_ca_system_score_gemma":0.0019565437,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W4401715291","doi":"10.1111/bjh.19706","title":"<scp>PembroWM</scp> : A phase <scp>II</scp> trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Merck Sharp and Dohme","keywords":"Medicine; Rituximab; Internal medicine; Chemoimmunotherapy; Tolerability; Refractory (planetary science); Oncology; Pembrolizumab; Gastroenterology; Phases of clinical research; Clinical trial; Adverse effect; Immunotherapy; Lymphoma","score_opus":0.01723235397203564,"score_gpt":0.3111091422852666,"score_spread":0.29387678831323094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401715291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652907,0.031163635,0.0000424275,0.0011912194,0.00053042924,0.0009609089,0.000039653005,0.000032499276,0.000748519],"genre_scores_gemma":[0.9939706,0.0041575534,0.0004204435,0.00034132885,0.00035273822,0.000018550048,0.000007467814,0.00006574913,0.00066558656],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99588203,0.00047909378,0.0016112668,0.0005230668,0.00073406624,0.00077048736],"domain_scores_gemma":[0.99503887,0.0032938365,0.00038688703,0.000361624,0.00028633897,0.0006324534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016829888,0.00032350974,0.0015755888,0.00055624836,0.00016847126,0.000117574986,0.0003795228,0.00037809968,0.000018664638],"category_scores_gemma":[0.007508528,0.00027768133,0.00023384298,0.0006355864,0.00095728965,0.0001823962,0.00038815563,0.0015071656,0.00001495466],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036703214,0.0059277997,0.0007866862,0.0058455924,0.0023968413,0.6552085,0.01670251,0.00009567094,0.008674497,0.003722104,0.11655273,0.14738382],"study_design_scores_gemma":[0.34867483,0.0046788044,0.0013278316,0.0036485684,0.0004256529,0.59691715,0.000941958,0.0014855987,0.0027393147,0.00080819934,0.038248662,0.00010339045],"about_ca_topic_score_codex":0.000395656,"about_ca_topic_score_gemma":0.00016859513,"teacher_disagreement_score":0.31197163,"about_ca_system_score_codex":0.0013674439,"about_ca_system_score_gemma":0.0047686133,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W4402528918","doi":"10.1111/bjh.19764","title":"A randomized trial of ibrutinib and R‐<scp>GDP</scp> prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Spinal Cord Injury BC; Jewish General Hospital; University of Manitoba; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Alberta Health Services; Hôpital Notre-Dame; Moncton Hospital; University of British Columbia; Université Laval; Université de Montréal; University of Saskatchewan; University of Calgary; Princess Margaret Cancer Centre; Kingston General Hospital; Simon Fraser University","funders":"Janssen Research and Development; Canadian Cancer Society; Roche Canada","keywords":"Ibrutinib; Lymphoma; Medicine; Stem cell; Oncology; Internal medicine; Cancer research; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.011479990470827229,"score_gpt":0.24372286820860742,"score_spread":0.23224287773778018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402528918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398042,0.02565251,0.00001437723,0.03024577,0.0011871975,0.0021847829,0.00030412775,0.00002014191,0.00058691436],"genre_scores_gemma":[0.9242158,0.011659657,0.0005470296,0.058146104,0.0014170236,0.00027791646,0.00012432161,0.00020858279,0.0034035635],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99506056,0.00073303614,0.002389003,0.00053241465,0.00061889214,0.0006661189],"domain_scores_gemma":[0.99618834,0.0020406472,0.0010387052,0.0002865691,0.00017134033,0.0002744147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011164244,0.00049995945,0.0047706333,0.0007411811,0.00004967871,0.00007446522,0.0002495648,0.0010299586,0.000025241741],"category_scores_gemma":[0.00019721898,0.0004343463,0.0009419421,0.0002320894,0.00016790128,0.000053091604,0.00007600219,0.0009489364,0.000025146115],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11482792,0.005328505,0.00020289535,0.0029851259,0.0008744866,0.5003769,0.0017718286,2.991174e-7,0.00003538768,0.000022864859,0.37142426,0.002149516],"study_design_scores_gemma":[0.80631685,0.001135395,0.00010232836,0.0044639586,0.0020410542,0.12350718,0.000113059585,0.000007728271,0.0009298434,0.00007382152,0.061160643,0.0001481602],"about_ca_topic_score_codex":0.0001673485,"about_ca_topic_score_gemma":0.00006830263,"teacher_disagreement_score":0.6914889,"about_ca_system_score_codex":0.00021131815,"about_ca_system_score_gemma":0.00073781435,"threshold_uncertainty_score":0.9998108},"labels":[],"label_agreement":null},{"id":"W4402816183","doi":"10.1111/bjh.19741","title":"Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"Astex Pharmaceuticals","keywords":"Decitabine; Medicine; Pharmacokinetics; Myeloid leukaemia; Crossover study; Internal medicine; Oncology; Pharmacology; Pathology","score_opus":0.029821483431669165,"score_gpt":0.36354717657950447,"score_spread":0.3337256931478353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402816183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97347945,0.011367877,0.0068032015,0.0030838114,0.0026757226,0.002027111,0.00009829619,0.00009423122,0.000370317],"genre_scores_gemma":[0.9879185,0.0035262825,0.0058598723,0.00024892716,0.0012509198,0.00012759131,0.0000623473,0.00013049327,0.0008750876],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9960139,0.00023572915,0.0016590989,0.000518438,0.0007796911,0.00079319207],"domain_scores_gemma":[0.9960408,0.0014757921,0.00040940967,0.0003291396,0.0012822874,0.00046257346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017283198,0.0003642714,0.0016247199,0.00047993113,0.00021602974,0.00028410822,0.00046371168,0.00027538193,0.00025722664],"category_scores_gemma":[0.0024881407,0.00036076663,0.0005074237,0.00058311276,0.00032474572,0.0003395852,0.00011474068,0.001292001,0.00003124693],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13406388,0.0025317292,0.00048100657,0.0010904879,0.0103917625,0.45468965,0.0012364687,0.00012128218,0.010904298,0.0009393077,0.314381,0.06916912],"study_design_scores_gemma":[0.24399848,0.009442153,0.00067929423,0.00088627916,0.005127747,0.6870215,0.00089564046,0.0021185107,0.0055242577,0.0007230353,0.04293831,0.00064481795],"about_ca_topic_score_codex":0.00007925167,"about_ca_topic_score_gemma":0.00009928119,"teacher_disagreement_score":0.2714427,"about_ca_system_score_codex":0.0005055495,"about_ca_system_score_gemma":0.0016587706,"threshold_uncertainty_score":0.9998844},"labels":[],"label_agreement":null},{"id":"W4403104246","doi":"10.1111/bjh.19816","title":"Warfarin reversal in patients with antiphospholipid syndrome: Caution required, but clear guidance not available","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Warfarin; Medicine; Antiphospholipid syndrome; Intensive care medicine; Internal medicine; Thrombosis; Atrial fibrillation","score_opus":0.009687052408266093,"score_gpt":0.215298940964952,"score_spread":0.2056118885566859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403104246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370308,0.025451133,0.00004582539,0.0352857,0.0011736432,0.00050109223,0.0001173974,0.000045235796,0.0003491854],"genre_scores_gemma":[0.71382266,0.013412348,0.0012552333,0.2609206,0.0023702122,0.000033909615,0.0004953388,0.00045992428,0.007229796],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9970046,0.00026779078,0.00094723125,0.0004662836,0.0007939729,0.0005200846],"domain_scores_gemma":[0.99870586,0.000062033316,0.0004898959,0.00033536204,0.00028542773,0.000121437624],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041247875,0.00033160957,0.001748561,0.0003343132,0.000063451575,0.00006832651,0.00025035738,0.0007745465,0.000360119],"category_scores_gemma":[0.00013872529,0.00032395983,0.00056168874,0.0002646476,0.00024391923,0.00020343173,0.00006105189,0.0023384246,0.00020075549],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001037391,0.000119543176,0.0023704516,0.00081374176,0.0007387493,0.45297053,0.00001638946,0.000003003595,0.0000061256997,0.000006779329,0.5407,0.0012172728],"study_design_scores_gemma":[0.006514852,0.0011345763,0.00809026,0.008930759,0.0010423278,0.61100316,0.000021971635,0.000004734583,0.00023284639,0.000066534056,0.36250678,0.00045118667],"about_ca_topic_score_codex":0.00010684669,"about_ca_topic_score_gemma":0.00001054909,"teacher_disagreement_score":0.2256349,"about_ca_system_score_codex":0.00017403327,"about_ca_system_score_gemma":0.00048118684,"threshold_uncertainty_score":0.9999632},"labels":[],"label_agreement":null},{"id":"W4403137636","doi":"10.1111/bjh.19814","title":"Impaired apoptosis underlying lymphoproliferative disease in a patient with haploinsufficient <scp>NFKB1</scp> deficiency","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Haploinsufficiency; Apoptosis; NFKB1; Disease; Medicine; Lymphoproliferative disease; Lymphoproliferative disorders; Immunology; Cancer research; Internal medicine; Biology; Genetics; Lymphoma; Phenotype; Gene; Transcription factor","score_opus":0.015082338120603294,"score_gpt":0.23616973204717215,"score_spread":0.22108739392656884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403137636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96645075,0.019782871,0.0007935908,0.011334496,0.0007600275,0.00045735147,0.00017647476,0.0000238946,0.00022054584],"genre_scores_gemma":[0.951947,0.0005759243,0.0006780267,0.04549286,0.0006315958,0.00007138438,0.00023020992,0.00017208162,0.00020091605],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99627686,0.0003948507,0.001136958,0.0007717863,0.00061238214,0.0008071917],"domain_scores_gemma":[0.9980567,0.000120545694,0.0008104117,0.00037238983,0.00041276973,0.0002271445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003607761,0.0005148048,0.0009997734,0.0004405859,0.0001251414,0.0001827198,0.00053514924,0.0007493683,0.000009141978],"category_scores_gemma":[0.0004698181,0.00050952676,0.00040039662,0.00031619964,0.00029641693,0.000013422904,0.00020908548,0.001431439,0.000013609939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018449951,0.00068697537,0.0010438218,0.001204541,0.00057484495,0.31278756,0.0008024273,0.0011931887,0.0056031244,0.000054747026,0.67437774,0.0014865387],"study_design_scores_gemma":[0.0058488175,0.0072208233,0.0005594986,0.010998871,0.0013501719,0.60990685,0.0015003777,0.0003789833,0.03436979,0.0015610827,0.32453367,0.0017710549],"about_ca_topic_score_codex":0.000067350746,"about_ca_topic_score_gemma":0.000074059404,"teacher_disagreement_score":0.34984404,"about_ca_system_score_codex":0.00015841358,"about_ca_system_score_gemma":0.0012136289,"threshold_uncertainty_score":0.99973565},"labels":[],"label_agreement":null},{"id":"W4403369008","doi":"10.1111/bjh.19823","title":"The value of semiquantitative <scp>PET</scp> features and end‐of‐therapy <scp>PET</scp> in grade <scp>3B</scp> follicular lymphoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"University of Melbourne","keywords":"Medicine; Lymphoma; Follicular lymphoma; Positron emission tomography; Standardized uptake value; Diffuse large B-cell lymphoma; CHOP; Nuclear medicine; Aggressive lymphoma; Chemotherapy; Internal medicine; Oncology; Rituximab","score_opus":0.012043750600632674,"score_gpt":0.2742954154243849,"score_spread":0.26225166482375223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403369008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8120514,0.18529424,0.000027559814,0.0006094995,0.0005731217,0.00051416113,0.00006541507,0.000030271709,0.00083430717],"genre_scores_gemma":[0.95309246,0.04468659,0.001059409,0.0003012251,0.00016282513,0.000052319687,0.000019458983,0.000078273246,0.00054743304],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9959891,0.0005459604,0.0014801897,0.0005110194,0.0007310488,0.00074268796],"domain_scores_gemma":[0.99256045,0.005561434,0.0008095219,0.00034945892,0.00039546343,0.00032369705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010568603,0.0004653289,0.0018097294,0.00050743215,0.00017621084,0.00014061178,0.00037553994,0.00026684263,0.0000073778965],"category_scores_gemma":[0.0020906432,0.0003642495,0.00061259285,0.0006122848,0.0006274899,0.00025481358,0.00011552932,0.0004903356,0.000009918719],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001600145,0.0073215063,0.12962197,0.0025909573,0.01081131,0.529366,0.014774356,0.00012896856,0.009546721,0.050610475,0.15224749,0.09282018],"study_design_scores_gemma":[0.013151816,0.0024814492,0.26088193,0.0050004036,0.0009165828,0.5905834,0.0064655296,0.00021957516,0.060906783,0.0081498,0.051134504,0.00010825915],"about_ca_topic_score_codex":0.00056947966,"about_ca_topic_score_gemma":0.0003101401,"teacher_disagreement_score":0.14104104,"about_ca_system_score_codex":0.00021624878,"about_ca_system_score_gemma":0.0007127246,"threshold_uncertainty_score":0.99988097},"labels":[],"label_agreement":null},{"id":"W4403796224","doi":"10.1111/bjh.19864","title":"Goodbye etoposide? Taking the leap to ruxolitinib in haemophagocytic lymphohistiocytosis","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Ruxolitinib; Medicine; Etoposide; Regimen; Malignancy; Oncology; Internal medicine; Immunology; Chemotherapy; Disease; Pediatrics; Myelofibrosis; Bone marrow","score_opus":0.025978103313114637,"score_gpt":0.33176759991438465,"score_spread":0.30578949660127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403796224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.951723,0.033395816,0.00032454802,0.008148382,0.00046561414,0.0002970006,0.0000041235853,0.000029398676,0.0056121424],"genre_scores_gemma":[0.99697596,0.000940515,0.00022384415,0.0010623337,0.00014996456,0.000015930817,0.0000019170773,0.000032226693,0.00059732643],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99793,0.00018382038,0.0008769547,0.00019460301,0.00038031876,0.00043433125],"domain_scores_gemma":[0.99906677,0.0002699038,0.00016128358,0.00018446526,0.00017371417,0.00014387385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010035932,0.00013021725,0.00067639386,0.00040240536,0.00010616556,0.00011471874,0.0002783047,0.0001260946,0.00052984495],"category_scores_gemma":[0.0009374134,0.00010987915,0.00020897495,0.0004936035,0.00016593275,0.00015600013,0.00009003848,0.0006975227,0.00014100315],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069504895,0.00042872934,0.011221854,0.001538433,0.0005907604,0.51979065,0.0032785456,0.00013529848,0.0033434443,0.012673679,0.05197516,0.3943284],"study_design_scores_gemma":[0.0028552806,0.0006695722,0.049869787,0.005198501,0.00016766174,0.852252,0.0020437562,0.00070032506,0.0025705567,0.0020888993,0.081274815,0.00030881845],"about_ca_topic_score_codex":0.0002631066,"about_ca_topic_score_gemma":0.00012946808,"teacher_disagreement_score":0.39401957,"about_ca_system_score_codex":0.00018663866,"about_ca_system_score_gemma":0.0007174582,"threshold_uncertainty_score":0.5801431},"labels":[],"label_agreement":null},{"id":"W4404196418","doi":"10.1111/bjh.19859","title":"Long‐term follow‐up of bulky classic Hodgkin lymphoma managed with ABVD and PET‐guided RT demonstrates excellent outcomes in PET‐negative cases","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"Loxo Oncology; Seagen; Veracyte; BeiGene; Regeneron Pharmaceuticals; AstraZeneca","keywords":"ABVD; Hodgkin lymphoma; Medicine; Lymphoma; Term (time); Nuclear medicine; Oncology; Internal medicine; Chemotherapy; Vincristine; Physics; Cyclophosphamide","score_opus":0.019706015738161328,"score_gpt":0.2827852178886166,"score_spread":0.26307920215045527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404196418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850432,0.012980414,0.000022869002,0.0011143122,0.00024395854,0.00031024878,0.00002266041,0.000017728356,0.00024455925],"genre_scores_gemma":[0.9962486,0.0026077884,0.000626172,0.000099285084,0.000032666125,0.000021319098,0.000006649133,0.000028765924,0.00032876924],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982118,0.00009925264,0.0008090399,0.00028340163,0.00029301483,0.00030347655],"domain_scores_gemma":[0.9986578,0.00059130194,0.0002995126,0.00013655105,0.0001525058,0.000162331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023395552,0.00023741765,0.0012126017,0.00033539083,0.00005335948,0.000078402554,0.00009753225,0.00006900685,0.000054620585],"category_scores_gemma":[0.00015457279,0.0001876379,0.00019595418,0.00019199782,0.00028828756,0.0001936911,0.00004638145,0.00015855565,0.000004316248],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032745872,0.00063420285,0.43024322,0.00042155696,0.00083853025,0.5539167,0.00026117614,0.0000015155048,0.0000703064,0.00024553182,0.00071351655,0.012326301],"study_design_scores_gemma":[0.007183524,0.00079226954,0.46600437,0.0024735513,0.00040161354,0.52054167,0.0003386185,0.000017735112,0.0019252022,0.00017546839,0.000027343107,0.000118644006],"about_ca_topic_score_codex":0.0004445501,"about_ca_topic_score_gemma":0.0014293261,"teacher_disagreement_score":0.035761137,"about_ca_system_score_codex":0.00017458247,"about_ca_system_score_gemma":0.00039416904,"threshold_uncertainty_score":0.76516515},"labels":[],"label_agreement":null},{"id":"W4404220871","doi":"10.1111/bjh.19885","title":"Genetic predisposition to vaccine‐induced immune thrombotic thrombocytopenia","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Genetic predisposition; Immune system; Immunology; Medicine; Immune thrombocytopenia; Platelet; Internal medicine; Disease","score_opus":0.018412784940449185,"score_gpt":0.296513983286822,"score_spread":0.2781011983463728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404220871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863834,0.0052763764,0.0011136135,0.0033332214,0.0019277825,0.00058125507,0.000011196004,0.00010693454,0.0012662623],"genre_scores_gemma":[0.99472547,0.0006116326,0.00337683,0.00053131394,0.00051273336,0.000017112723,0.000008800827,0.000088280256,0.00012782717],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9970033,0.00018401485,0.0013388189,0.0004481729,0.0004322303,0.0005934321],"domain_scores_gemma":[0.9983894,0.00015335025,0.00022776052,0.00035675353,0.0003801415,0.00049255794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004989421,0.0003075676,0.0017101737,0.00047247155,0.00014842348,0.00020373844,0.00034402698,0.00029759275,0.00080846564],"category_scores_gemma":[0.0002609029,0.00031394386,0.0004372087,0.00062352023,0.000059527407,0.00034234492,0.00013155688,0.0008307656,0.0004481014],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006268935,0.001196221,0.005270893,0.0016212031,0.00287715,0.22201236,0.0015482601,0.0000469983,0.68558115,0.0032100275,0.018317861,0.05769101],"study_design_scores_gemma":[0.002202246,0.002049727,0.3074935,0.0035995278,0.0010593309,0.6521797,0.00019374744,0.00015096263,0.027018305,0.0012088461,0.0023995482,0.00044454512],"about_ca_topic_score_codex":0.0001773362,"about_ca_topic_score_gemma":0.000090784866,"teacher_disagreement_score":0.65856284,"about_ca_system_score_codex":0.0001986004,"about_ca_system_score_gemma":0.0004849365,"threshold_uncertainty_score":0.9999313},"labels":[],"label_agreement":null},{"id":"W4404329246","doi":"10.1111/bjh.19837","title":"Red cell specifications for blood group matching in patients with haemoglobinopathies: An updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines","year":2024,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Université Laval; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Canadian Blood Services","funders":"Health Canada; Government of Canada; Canadian Blood Services","keywords":"Medicine; ABO blood group system; Guideline; Transfusion medicine; Observational study; Grading (engineering); Matching (statistics); Internal medicine; Intensive care medicine; Blood transfusion; Pathology","score_opus":0.054667365454976545,"score_gpt":0.38531843517732944,"score_spread":0.3306510697223529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404329246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005518432,0.9780663,0.0036087395,0.010254387,0.0006893445,0.006341751,0.00045497876,0.000017126687,0.000015477848],"genre_scores_gemma":[0.000041236708,0.97203946,0.023065133,0.0015411326,0.00051741645,0.00017104785,0.0025372498,0.00007111076,0.000016216558],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9935524,0.00053611246,0.004803201,0.00047238503,0.0004450155,0.00019092124],"domain_scores_gemma":[0.99378884,0.0012487199,0.0020260434,0.000313601,0.0024900963,0.00013267824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003578838,0.00034368926,0.0037179373,0.00019955612,0.000113319154,0.00008072802,0.00034570173,0.00032803262,0.0000249561],"category_scores_gemma":[0.0022691246,0.00021025934,0.00033212974,0.0003567549,0.00010738281,0.0002717429,0.00002932312,0.00067164254,9.1762433e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013763662,0.0034777804,0.000111490386,0.81672966,0.005083293,0.0030990634,0.00051584875,0.0000011079784,0.0000044417757,0.0005946646,0.0970738,0.071932465],"study_design_scores_gemma":[0.007878861,0.0020280308,0.000023655288,0.6383973,0.07641713,0.023908464,0.0005481127,0.00003764132,4.014291e-7,0.00027594715,0.25018927,0.0002952421],"about_ca_topic_score_codex":0.00009273015,"about_ca_topic_score_gemma":0.00046360394,"teacher_disagreement_score":0.17833243,"about_ca_system_score_codex":0.000054628075,"about_ca_system_score_gemma":0.00032878044,"threshold_uncertainty_score":0.85741276},"labels":[],"label_agreement":null},{"id":"W4404455557","doi":"10.1111/bjh.19895","title":"Somatic co‐alteration signatures are prognostic in high‐grade <scp><i>TP53</i></scp>‐mutated myeloid neoplasms","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hazard ratio; Proportional hazards model; Myeloid; Somatic cell; Internal medicine; Cohort; Medicine; Oncology; Subgroup analysis; Gene signature; Survival analysis; Gastroenterology; Gene; Biology; Genetics; Confidence interval; Gene expression","score_opus":0.013073356458643819,"score_gpt":0.28831015895985046,"score_spread":0.27523680250120663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404455557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980531,0.014967016,0.00053571246,0.0024372467,0.00059106626,0.0005843246,0.00002575144,0.00008809764,0.00023979746],"genre_scores_gemma":[0.996293,0.001113223,0.0013131716,0.00042707476,0.00032684384,0.00003062672,0.000060539238,0.000071042894,0.00036445883],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9968071,0.00040053454,0.0011257025,0.00035614113,0.00065652526,0.0006540099],"domain_scores_gemma":[0.9975241,0.0013175912,0.00033764084,0.0001845667,0.00033768575,0.0002984446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007960326,0.00025365487,0.0010687824,0.000839635,0.00009244175,0.00021585911,0.00027744268,0.00036619336,0.000097612065],"category_scores_gemma":[0.0026185617,0.00025183774,0.00019521038,0.00069905864,0.00021131424,0.00034484934,0.00005981436,0.0018624982,0.00010990123],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017945823,0.0007256878,0.022027446,0.0032677888,0.00072554994,0.84186924,0.0014073355,0.00043153632,0.020636084,0.0007078359,0.09735904,0.010663032],"study_design_scores_gemma":[0.0063387607,0.0011598013,0.059804004,0.009171137,0.0003801308,0.8884544,0.00122011,0.0070739514,0.018056244,0.003646186,0.0044489284,0.00024637836],"about_ca_topic_score_codex":0.00009398823,"about_ca_topic_score_gemma":0.00014605167,"teacher_disagreement_score":0.09291011,"about_ca_system_score_codex":0.00032896822,"about_ca_system_score_gemma":0.0008377854,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W4404865836","doi":"10.1111/bjh.19937","title":"Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; Paula and Rodger Riney Foundation; University of Texas MD Anderson Cancer Center; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","keywords":"Multiple myeloma; Medicine; Autologous stem-cell transplantation; Body mass index; Stem cell; Oncology; Internal medicine; Surgery; Biology","score_opus":0.013289545083618588,"score_gpt":0.2676295951782495,"score_spread":0.25434005009463095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404865836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880924,0.0026094646,0.00010345085,0.006469644,0.0014486447,0.00036017067,0.00069663516,0.00001887407,0.00020071134],"genre_scores_gemma":[0.9935122,0.00080897985,0.00006653749,0.0049561765,0.00025130407,0.000003912079,0.00008620434,0.000087782704,0.00022690905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996754,0.00015559881,0.0016626564,0.00031380815,0.00065001834,0.00046395385],"domain_scores_gemma":[0.9973642,0.00046804835,0.001463861,0.0002605076,0.0003044499,0.00013893166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017027301,0.0003953781,0.002702613,0.0005644678,0.000033439588,0.00002082746,0.00027404088,0.0008596683,0.000116154755],"category_scores_gemma":[0.000051796404,0.0003355932,0.0011584724,0.00012286745,0.00016353848,0.00006230796,0.00003219281,0.0021294928,0.000007323624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007655025,0.0004442951,0.61696565,0.0031935587,0.0022267026,0.09539496,0.00027796288,0.000043227115,0.000092685004,0.0000027308683,0.2764437,0.0041490123],"study_design_scores_gemma":[0.010330009,0.0069000893,0.88351303,0.010160145,0.002049724,0.07713258,0.00012405084,0.000090805705,0.0007734423,0.0001202222,0.008128815,0.0006770732],"about_ca_topic_score_codex":0.000652585,"about_ca_topic_score_gemma":0.00013217334,"teacher_disagreement_score":0.2683149,"about_ca_system_score_codex":0.00027374268,"about_ca_system_score_gemma":0.00061329536,"threshold_uncertainty_score":0.99990964},"labels":[],"label_agreement":null},{"id":"W4404910207","doi":"10.1111/bjh.19924","title":"Clinical perspectives on post‐induction maintenance therapy in patients with acute myeloid leukaemia in remission who are ineligible for allogeneic haematopoietic stem cell transplantation","year":2024,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Maintenance therapy; Transplantation; Internal medicine; Clinical trial; Oncology; Stem cell; Midostaurin; Sorafenib; Myeloid leukemia; Intensive care medicine; Chemotherapy","score_opus":0.03584553251121494,"score_gpt":0.3575606456003801,"score_spread":0.32171511308916517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404910207","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30916294,0.6881681,0.000054566863,0.0002657827,0.00028303606,0.0019170942,0.0000874303,0.00001606833,0.00004495958],"genre_scores_gemma":[0.0097670145,0.988839,0.00052469474,0.00010088397,0.00018584049,0.00010050302,0.00011517363,0.00013461921,0.00023230498],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9952947,0.0006745865,0.0021617666,0.0007353926,0.0005529007,0.0005806781],"domain_scores_gemma":[0.99719423,0.00041075316,0.0011849656,0.00028897452,0.000702973,0.00021810204],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012785988,0.000489294,0.003889221,0.0011282499,0.000059670485,0.000056458673,0.00035395968,0.0008294808,0.000014124432],"category_scores_gemma":[0.00014073441,0.0003709991,0.0006606789,0.0006323509,0.00018723153,0.00016752638,0.00003565099,0.0025787817,0.000012876296],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008547653,0.0015770654,0.0027882173,0.034381844,0.0010921054,0.11677032,0.00096523,0.000008271516,0.000007747793,0.000075752,0.00510769,0.82867813],"study_design_scores_gemma":[0.036990356,0.0132423695,0.011189487,0.43542686,0.004018336,0.4170488,0.0025285226,0.000025739366,0.000070781156,0.00018696628,0.07771614,0.0015556085],"about_ca_topic_score_codex":0.000032671545,"about_ca_topic_score_gemma":0.00005807275,"teacher_disagreement_score":0.8271225,"about_ca_system_score_codex":0.000983115,"about_ca_system_score_gemma":0.0015820711,"threshold_uncertainty_score":0.9998742},"labels":[],"label_agreement":null},{"id":"W4405309932","doi":"10.1111/bjh.19951","title":"Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open‐label study ( <scp>ACE</scp> ‐ <scp>LY</scp> ‐003)","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Medicine; Open label; Refractory (planetary science); Oncology; Internal medicine; Lymphoma; Phases of clinical research; Pharmacology; Multiple myeloma; Chemotherapy; Clinical trial; Biology","score_opus":0.022463868599533244,"score_gpt":0.31535590560799254,"score_spread":0.2928920370084593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405309932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942151,0.0030353388,0.00002072497,0.0002520104,0.00018298636,0.0019103572,0.00003568425,0.000015307709,0.0003325288],"genre_scores_gemma":[0.9986105,0.00031915322,0.00035668872,0.00009904367,0.000032448635,0.000039441988,0.00001794693,0.00006344519,0.0004613384],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99562806,0.00074983836,0.0014406639,0.00052327884,0.0010887858,0.0005694016],"domain_scores_gemma":[0.99643815,0.0017178555,0.00066235947,0.00042264862,0.00054180075,0.0002171744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00206571,0.000290103,0.0013824297,0.000500379,0.00009681207,0.00013583191,0.0005405111,0.00024218645,0.0000052093565],"category_scores_gemma":[0.004262812,0.00019765882,0.000070198155,0.0011420555,0.00045503804,0.00047422855,0.00029691,0.0008351483,0.0000035038238],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038441144,0.16436742,0.11727819,0.004576549,0.0040209615,0.55650014,0.019582944,0.00006782196,0.0005652221,0.0006638672,0.044480376,0.049455363],"study_design_scores_gemma":[0.83999234,0.013466181,0.04899014,0.008257281,0.00044337823,0.07967683,0.0040342235,0.0009893416,0.0009702831,0.00017510985,0.00287799,0.0001269156],"about_ca_topic_score_codex":0.00096678815,"about_ca_topic_score_gemma":0.0013541548,"teacher_disagreement_score":0.80155116,"about_ca_system_score_codex":0.002095711,"about_ca_system_score_gemma":0.005051577,"threshold_uncertainty_score":0.8961281},"labels":[],"label_agreement":null},{"id":"W4405585460","doi":"10.1111/bjh.19944","title":"Olutasidenib demonstrates significant clinical activity in mutated <i>IDH1</i> acute myeloid leukaemia arising from a prior myeloproliferative neoplasm","year":2024,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Myeloproliferative neoplasm; Gastroenterology; IDH1; Myeloid; Refractory (planetary science); Confidence interval; Adverse effect; Azacitidine; Myeloid leukaemia; Surgery; Oncology; Myelofibrosis; Bone marrow; Biology","score_opus":0.023683305550631133,"score_gpt":0.3325004295931669,"score_spread":0.30881712404253575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405585460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879293,0.0062389,0.00061924494,0.0033101777,0.0007814223,0.0006467599,0.00011881124,0.0000674274,0.00028797204],"genre_scores_gemma":[0.9901832,0.0046105594,0.004206907,0.0004553239,0.0003538259,0.000042898642,0.000032765132,0.000060472794,0.000054098706],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9957589,0.00066223764,0.0018244827,0.0006788938,0.00047638282,0.0005991218],"domain_scores_gemma":[0.9967664,0.0017133768,0.0005276405,0.00022063061,0.00034665293,0.0004253125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088858197,0.0004127762,0.0020744647,0.0002949525,0.00014357975,0.00022726241,0.00019498449,0.00044995395,0.00015802849],"category_scores_gemma":[0.00059824524,0.00038047513,0.0004958062,0.0004602992,0.0003596804,0.0004142591,0.00007694606,0.0017505501,0.000066378394],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017666003,0.0018182294,0.22730361,0.00020390165,0.0035528976,0.61552316,0.00086205517,0.00004725795,0.007560525,0.0002926164,0.004429532,0.1366396],"study_design_scores_gemma":[0.0134484405,0.0028323082,0.43242273,0.007332523,0.0021783118,0.45505124,0.0006480375,0.002616539,0.07750918,0.003333847,0.0016780578,0.00094876834],"about_ca_topic_score_codex":0.00038031046,"about_ca_topic_score_gemma":0.0007507143,"teacher_disagreement_score":0.20511913,"about_ca_system_score_codex":0.0002763617,"about_ca_system_score_gemma":0.0014279074,"threshold_uncertainty_score":0.9998647},"labels":[],"label_agreement":null},{"id":"W4405880619","doi":"10.1111/bjh.19969","title":"Successful autologous haematopoietic stem cell transplantation in a refractory anti‐myelin‐associated glycoprotein antibody neuropathy","year":2024,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Stem cell; Transplantation; Immunology; Haematopoiesis; Medicine; Antibody; Biology; Internal medicine; Cell biology","score_opus":0.009893368139931233,"score_gpt":0.25211610471802715,"score_spread":0.2422227365780959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405880619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8988304,0.017633509,0.00007490365,0.07998336,0.0022419,0.0005929396,0.000112218935,0.00009745927,0.00043327874],"genre_scores_gemma":[0.85110193,0.01522667,0.00010211336,0.13120452,0.0009126979,0.000023417628,0.0003138239,0.0002831604,0.00083167676],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9950668,0.0008194103,0.0019646736,0.000633966,0.00071702694,0.00079811603],"domain_scores_gemma":[0.99792105,0.00023327417,0.0011152709,0.00029484413,0.00027198857,0.00016357611],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00050542346,0.0005433547,0.0024552671,0.0007774082,0.00008872873,0.00012945288,0.00041301883,0.0013634834,0.00013548153],"category_scores_gemma":[0.00012500375,0.00057593687,0.0005914502,0.0005096741,0.00024875364,0.00020158819,0.000056967085,0.0053448062,0.000050610863],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022749582,0.0002820973,0.0010221972,0.0037142376,0.000104383624,0.80647475,0.00022492612,0.000009898034,0.0006926737,0.0000030639244,0.18573898,0.0015053205],"study_design_scores_gemma":[0.0054080747,0.0017031719,0.004447942,0.0095112715,0.001061329,0.9023372,0.0002630039,0.00012376819,0.00030972133,0.00035319428,0.073646046,0.0008352766],"about_ca_topic_score_codex":0.00027704204,"about_ca_topic_score_gemma":0.00024641037,"teacher_disagreement_score":0.112092935,"about_ca_system_score_codex":0.0001384734,"about_ca_system_score_gemma":0.00052671024,"threshold_uncertainty_score":0.99993294},"labels":[],"label_agreement":null},{"id":"W4406044641","doi":"10.1111/bjh.19972","title":"Systemic lupus erythematosus‐associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Autoantibody; Medicine; Immunology; Autoimmunity; Antiphospholipid syndrome; Disease; Autoimmune disease; Immunopathology; Systemic lupus erythematosus; Antibody; Sickle cell anemia; Internal medicine","score_opus":0.008476728864202225,"score_gpt":0.26095123016762906,"score_spread":0.25247450130342686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406044641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948298,0.049587335,0.000021969794,0.00048337036,0.00042777992,0.0007907641,0.000015231929,0.000018619832,0.00035695103],"genre_scores_gemma":[0.9943234,0.005082622,0.000077410325,0.000076508,0.000015779111,0.00003437506,0.000005216392,0.000030367812,0.00035432572],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99615294,0.0005939099,0.0017573343,0.00038209575,0.00045456627,0.00065915065],"domain_scores_gemma":[0.9984933,0.0004645693,0.000389276,0.00020934755,0.00022892987,0.0002145603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010037847,0.00024454977,0.0015255996,0.0010217675,0.00004802392,0.000030998573,0.0002468211,0.0002235299,0.000051672403],"category_scores_gemma":[0.0007866248,0.00026358227,0.00015758576,0.0007971369,0.00016593201,0.0001478714,0.00008392992,0.0007531103,0.000006937367],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013621639,0.000983749,0.59746575,0.004534333,0.000103994564,0.3882285,0.0030545979,0.00009261195,0.0023449862,0.00008270366,0.0009975351,0.0007490811],"study_design_scores_gemma":[0.0071256044,0.00019840227,0.0147950435,0.019051788,0.000086467706,0.952408,0.0047979034,0.0005812647,0.00030353712,0.00033966455,0.00007460327,0.00023771467],"about_ca_topic_score_codex":0.00039614533,"about_ca_topic_score_gemma":0.0038487024,"teacher_disagreement_score":0.5826707,"about_ca_system_score_codex":0.000359656,"about_ca_system_score_gemma":0.0006272658,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W4406114877","doi":"10.1111/bjh.19984","title":"An approach to Hemequity: Identifying the barriers and facilitators of iron deficiency reduction strategies in low‐ to middle‐income countries","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Child Nutrition and Water Access","field":"Nursing","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; McMaster University","funders":"","keywords":"Iron deficiency; Low and middle income countries; Low income; Reduction (mathematics); Medicine; Environmental health; Business; Economic growth; Internal medicine; Socioeconomics; Developing country; Economics; Anemia","score_opus":0.014712830878825264,"score_gpt":0.2915485019699765,"score_spread":0.27683567109115126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406114877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942142,0.0018852467,0.0010562845,0.0018229362,0.0005719989,0.00023516547,0.00001262459,0.000010007009,0.00019156802],"genre_scores_gemma":[0.99906486,0.00007303361,0.00057703524,0.00023619563,0.00002868696,0.00000588747,0.0000013816245,0.0000067527667,0.000006186398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985905,0.00021012845,0.00061325677,0.00018280528,0.00018236345,0.00022089986],"domain_scores_gemma":[0.9994166,0.000055882825,0.00015184045,0.000119560296,0.0001511441,0.000104973806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005919898,0.000098624965,0.0003799834,0.000385192,0.00016053212,0.00019601005,0.00027213554,0.00007631235,0.000007362802],"category_scores_gemma":[0.00014872882,0.000095483796,0.000050888866,0.00036821674,0.00018967372,0.00043709707,0.000051232844,0.00021432304,6.6816176e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013319773,0.0039455225,0.63073707,0.03344571,0.00047377072,0.00590872,0.13977821,0.015148546,0.021720491,0.084831014,0.016522137,0.034169044],"study_design_scores_gemma":[0.010059776,0.0020888778,0.5750179,0.01585246,0.00039625392,0.123093635,0.17542288,0.00039761316,0.04379737,0.050767332,0.0016138398,0.0014920516],"about_ca_topic_score_codex":0.0002471845,"about_ca_topic_score_gemma":0.00016489619,"teacher_disagreement_score":0.117184915,"about_ca_system_score_codex":0.000056481025,"about_ca_system_score_gemma":0.00005626643,"threshold_uncertainty_score":0.3893716},"labels":[],"label_agreement":null},{"id":"W4407499244","doi":"10.1111/bjh.19995","title":"Fibrosis and treatment‐free remission in chronic myeloid leukaemia","year":2025,"lang":"en","type":"letter","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont; MPB Technologies & Communications (Canada); Hôpital Charles-Le Moyne; McGill University","funders":"","keywords":"Chronic myeloid leukaemia; Medicine; Fibrosis; Hematology; Spontaneous remission; Internal medicine; Oncology; Pathology; Alternative medicine","score_opus":0.014648414883871719,"score_gpt":0.2689435423935965,"score_spread":0.2542951275097248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407499244","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4656731,0.10548139,0.000022227652,0.42254636,0.0012600422,0.0012779585,0.00017232652,0.00006708664,0.0034995188],"genre_scores_gemma":[0.10674509,0.28355902,0.0132472105,0.4928982,0.019342853,0.00032452887,0.0019682862,0.00091139,0.08100341],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99691993,0.00024471697,0.0012705326,0.00052154926,0.0004053256,0.0006379479],"domain_scores_gemma":[0.9980078,0.0003954186,0.00072904705,0.00052639295,0.00016762603,0.00017376059],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00021050616,0.00047849293,0.002334134,0.0006682846,0.00008042396,0.000052165597,0.00032096865,0.0014262518,0.0002879039],"category_scores_gemma":[0.00040815014,0.0004712334,0.00037393047,0.000247266,0.00021329852,0.00011774374,0.00015357655,0.0022712748,0.0000108260865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015171379,0.00007942187,0.0008646825,0.000805826,0.00041187712,0.2782619,0.000039047427,0.0000013416056,0.00013212129,0.000003863114,0.68528706,0.033961125],"study_design_scores_gemma":[0.012722346,0.001219231,0.0015755547,0.010021268,0.0007957715,0.47204688,0.000020896754,0.000019322852,0.00060431845,0.00026489206,0.5004087,0.00030081972],"about_ca_topic_score_codex":0.0008315776,"about_ca_topic_score_gemma":0.00042941727,"teacher_disagreement_score":0.358928,"about_ca_system_score_codex":0.0052432525,"about_ca_system_score_gemma":0.0035683205,"threshold_uncertainty_score":0.9998701},"labels":[],"label_agreement":null},{"id":"W4408162287","doi":"10.1111/bjh.20038","title":"A low lymphocyte‐to‐monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Celgene","keywords":"Follicular lymphoma; Lymphoma; Medicine; Follicular phase; Lymphocyte; Immunology; Monocyte; Oncology; Internal medicine","score_opus":0.006197750062904729,"score_gpt":0.23811405283016207,"score_spread":0.23191630276725733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408162287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896726,0.0055595,0.00028217214,0.0035952986,0.00018352109,0.0004585193,0.000021906117,0.00002705996,0.00019940655],"genre_scores_gemma":[0.99610066,0.0009887554,0.0006948428,0.0012742969,0.000056644465,0.00006110345,0.00001601793,0.000036276622,0.0007713742],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99697006,0.00025136428,0.0011833598,0.0004667927,0.0005870368,0.00054141454],"domain_scores_gemma":[0.9978899,0.00030301136,0.0006338473,0.0003105216,0.0005836681,0.00027910242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048801966,0.00031190994,0.0017013713,0.00072092086,0.00012079883,0.00010551182,0.00027479714,0.00027879325,0.000059880957],"category_scores_gemma":[0.00073652744,0.00029653718,0.0003337689,0.0011810523,0.00009822996,0.00021237967,0.00007848676,0.0002476744,0.000029051685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039169714,0.0047731996,0.3272388,0.00026326117,0.006985614,0.6068297,0.0015773488,0.00055116526,0.00067322614,0.00096344465,0.0073379995,0.038889244],"study_design_scores_gemma":[0.053150125,0.0018915103,0.81104094,0.008236833,0.002656568,0.10548423,0.00042543374,0.0003223944,0.014304735,0.0008001024,0.0010648647,0.0006222425],"about_ca_topic_score_codex":0.0025028053,"about_ca_topic_score_gemma":0.0018162439,"teacher_disagreement_score":0.5013455,"about_ca_system_score_codex":0.0016195227,"about_ca_system_score_gemma":0.001378107,"threshold_uncertainty_score":0.9999487},"labels":[],"label_agreement":null},{"id":"W4408956531","doi":"10.1111/bjh.20055","title":"The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low‐ and middle‐income countries","year":2025,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Kingston Health Sciences Centre; Queen's University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Defense","keywords":"Medicine; Disease; Intensive care medicine; Blood transfusion; Low and middle income countries; Adverse effect; Disease burden; Immunology; Developing country; Internal medicine","score_opus":0.007139800407600179,"score_gpt":0.2768393549863169,"score_spread":0.2696995545787167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408956531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028679252,0.99260205,0.00011182582,0.0020001563,0.00022864739,0.0018452497,0.00029112122,0.0000046432237,0.00004840383],"genre_scores_gemma":[0.00068402925,0.9985751,0.00024381954,0.00011633362,0.000021147865,0.00008366892,0.000052657233,0.000025554655,0.00019767147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986814,0.00009463547,0.00066496263,0.00020828008,0.00010902731,0.0002416807],"domain_scores_gemma":[0.9983584,0.00065974344,0.00033982503,0.00008773621,0.00035259925,0.00020165119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002926914,0.00018878405,0.001174652,0.00016407401,0.000262843,0.00004422797,0.00008013291,0.00019414691,0.000017225184],"category_scores_gemma":[0.00042083152,0.00013196365,0.00019379698,0.00011138471,0.00023735929,0.00007024021,0.00001928837,0.00034639475,1.8419587e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053000874,0.001203826,0.010319279,0.31209552,0.0020265854,0.0057661785,0.0017355781,0.0000030561737,4.2574797e-8,0.002904461,0.014737614,0.6439078],"study_design_scores_gemma":[0.0092327865,0.0011178466,0.00034835417,0.09294284,0.0032140478,0.0077547035,0.0014470674,0.000008999294,2.3036056e-7,0.0006536122,0.8829534,0.00032608473],"about_ca_topic_score_codex":0.000021520254,"about_ca_topic_score_gemma":0.00007890346,"teacher_disagreement_score":0.8682158,"about_ca_system_score_codex":0.00007188597,"about_ca_system_score_gemma":0.0008417972,"threshold_uncertainty_score":0.53813213},"labels":[],"label_agreement":null},{"id":"W4408957618","doi":"10.1111/bjh.20061","title":"CD19 chimeric antigen receptor‐T cell therapy in murine immune thrombocytopenia","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Natural Science Foundation of Shandong Province; National Natural Science Foundation of China","keywords":"Chimeric antigen receptor; Immunology; CD19; Antigen; Immune thrombocytopenia; Medicine; Immune system; Receptor; Virology; T cell; Antibody; Internal medicine","score_opus":0.017159117864516304,"score_gpt":0.3131646132022168,"score_spread":0.2960054953377005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408957618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609768,0.028452108,0.00004761231,0.0022258437,0.0004980719,0.00038639628,0.0000027022509,0.000015764454,0.00739472],"genre_scores_gemma":[0.9634304,0.031348705,0.0007290975,0.0005250137,0.00011131792,0.000008118508,0.0000067303786,0.000033065488,0.003807547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784267,0.0002823401,0.00089041813,0.00022491952,0.00031708428,0.00044256495],"domain_scores_gemma":[0.99893415,0.00015968518,0.0002570725,0.00026472207,0.00026532327,0.00011905273],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008046894,0.00016407826,0.0012598471,0.0004915389,0.00006670287,0.00004033249,0.00033865802,0.00017670034,0.004620112],"category_scores_gemma":[0.00013520455,0.00016977917,0.00024102221,0.000611641,0.00018804308,0.000107996246,0.000082788094,0.0008665581,0.00004297111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035569144,0.0021929974,0.066515334,0.00037585397,0.0006794908,0.058026552,0.0005636519,0.000015554262,0.6366197,0.00016787124,0.024526875,0.20675921],"study_design_scores_gemma":[0.03250423,0.0030005802,0.2489988,0.0026722376,0.00009645171,0.17972274,0.0011090472,0.00006465932,0.37757775,0.001077756,0.15257265,0.0006030887],"about_ca_topic_score_codex":0.0003218609,"about_ca_topic_score_gemma":0.00009246332,"teacher_disagreement_score":0.25904194,"about_ca_system_score_codex":0.00011050969,"about_ca_system_score_gemma":0.00042280118,"threshold_uncertainty_score":0.9962898},"labels":[],"label_agreement":null},{"id":"W4409948315","doi":"10.1111/bjh.20092","title":"Anti‐<scp>PF4</scp> mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both <scp>HIT</scp>‐like and <scp>VITT</scp>‐like characteristics","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"Public Health Agency; Canadian Institutes of Health Research; National Institute for Health and Care Research; Public Health Agency of Canada; British Heart Foundation; Heart and Stroke Foundation of Canada","keywords":"Medicine; Platelet factor 4; Immunology; Immune system; Thrombosis; Platelet; Hematology; Vaccination; Cytomegalovirus; Viral disease; Internal medicine; Herpesviridae; Virus","score_opus":0.01383163468911153,"score_gpt":0.26601613440405797,"score_spread":0.25218449971494644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409948315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916364,0.0019938874,0.00034473854,0.0003535961,0.0013412077,0.0010102331,0.00028197377,0.00019015963,0.0028478333],"genre_scores_gemma":[0.98602706,0.010779369,0.00043568775,0.0014162493,0.00021287432,0.000043185373,0.00023827891,0.00016754978,0.0006797329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937424,0.00066268025,0.0021093718,0.0010896877,0.0008710359,0.0015248096],"domain_scores_gemma":[0.9929608,0.0027172503,0.0018342017,0.0005813214,0.0009694458,0.0009369927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012653449,0.0009761467,0.004506625,0.0009886454,0.0007433483,0.0005151993,0.00047588462,0.0011834275,0.000026522614],"category_scores_gemma":[0.0033570474,0.00096346234,0.0003854036,0.0013650535,0.0010320131,0.00096042454,0.00042987452,0.0021005902,0.000041385247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010185158,0.0023660227,0.8320906,0.0011438624,0.012340871,0.030993102,0.0023248245,0.0000048317843,0.08061281,0.0008848896,0.035224266,0.0019120751],"study_design_scores_gemma":[0.008001307,0.0014749026,0.89992934,0.0024467988,0.003792585,0.06903973,0.00063912955,0.00012566154,0.0066571063,0.00028347748,0.007409709,0.00020027348],"about_ca_topic_score_codex":0.0005205232,"about_ca_topic_score_gemma":0.00085172604,"teacher_disagreement_score":0.0739557,"about_ca_system_score_codex":0.00034343274,"about_ca_system_score_gemma":0.0008817729,"threshold_uncertainty_score":0.9992816},"labels":[],"label_agreement":null},{"id":"W4409979015","doi":"10.1111/bjh.20131","title":"Acute splenomegaly, haemolysis, and thrombocytopenia following luspatercept initiation in a patient with transfusion‐dependent thalassaemia: A case report","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Haemolysis; Medicine; Splenectomy; Blood transfusion; Intensive care medicine; Internal medicine; Immunology; Spleen","score_opus":0.005748460627671056,"score_gpt":0.2516875209674015,"score_spread":0.24593906033973043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409979015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207866,0.0038982008,0.0005519445,0.0017955921,0.00022763356,0.00034312627,0.000004523155,0.00001202239,0.0010882681],"genre_scores_gemma":[0.9969647,0.001985836,0.0006214602,0.00032439167,0.000011556701,0.000008973482,0.000008230189,0.000015044512,0.000059791026],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99834543,0.00010998456,0.00084575114,0.00023432738,0.00021705728,0.0002474717],"domain_scores_gemma":[0.9992881,0.000053120737,0.00027920882,0.00012814754,0.00013865872,0.00011278136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003411345,0.00014695113,0.00086860225,0.00032184063,0.00010885666,0.000038709513,0.000055669254,0.00021734319,0.0000371968],"category_scores_gemma":[0.00009257904,0.00012977028,0.00013340883,0.00028457175,0.00008293474,0.00016002766,0.000037991187,0.00054492574,8.915015e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028675626,0.00020672174,0.009501377,0.000091758535,0.00040035334,0.9791027,0.0007531457,0.000015169166,0.0003246346,0.000028043474,0.00019917573,0.009090174],"study_design_scores_gemma":[0.004770618,0.0004240716,0.0035276094,0.0013385984,0.0006476034,0.986262,0.002086055,0.000044026998,0.00051346945,0.00010877632,0.00016113378,0.00011602185],"about_ca_topic_score_codex":0.00045786693,"about_ca_topic_score_gemma":0.0012725608,"teacher_disagreement_score":0.008974152,"about_ca_system_score_codex":0.000084302425,"about_ca_system_score_gemma":0.00027025424,"threshold_uncertainty_score":0.52918786},"labels":[],"label_agreement":null},{"id":"W4410110295","doi":"10.1111/bjh.20115","title":"An international real‐world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Celgene; Gilead Sciences; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Lymphoma; Retrospective cohort study; Primary central nervous system lymphoma; Systemic therapy; Cumulative incidence; Cohort; Cancer","score_opus":0.0103177385679048,"score_gpt":0.28765248607657906,"score_spread":0.27733474750867426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410110295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946862,0.001820936,0.0000076963925,0.0014562517,0.0003935705,0.00029183875,0.000045081666,0.0000097890725,0.0012886755],"genre_scores_gemma":[0.9968285,0.0021924532,0.000474644,0.00032019537,0.00010254049,0.000013638304,0.000012249128,0.000012910613,0.000042848278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837554,0.00017683454,0.0006997017,0.00022316784,0.00035694602,0.00016783903],"domain_scores_gemma":[0.9985699,0.0002172015,0.00041542714,0.00022377027,0.0004594759,0.000114243674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028832597,0.00014463425,0.00070629356,0.00012339007,0.00009129081,0.000057105604,0.00025135066,0.0000717077,0.000053114105],"category_scores_gemma":[0.000114835086,0.000121114004,0.00008747329,0.00027632364,0.00020150171,0.00012834571,0.00005994492,0.00008112666,0.0000011651242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007038153,0.0038084304,0.7944606,0.000035553003,0.00090980204,0.018823791,0.0003408478,0.0000018848706,0.00015220785,0.0004422297,0.0037678892,0.17655294],"study_design_scores_gemma":[0.007818326,0.00065646216,0.97120744,0.0006469564,0.0003791826,0.014735013,0.0012668732,0.00001134848,0.00047953936,0.00016620205,0.002555104,0.0000775283],"about_ca_topic_score_codex":0.0015021124,"about_ca_topic_score_gemma":0.0022442318,"teacher_disagreement_score":0.17674685,"about_ca_system_score_codex":0.00022093688,"about_ca_system_score_gemma":0.00045975376,"threshold_uncertainty_score":0.4938886},"labels":[],"label_agreement":null},{"id":"W4410110360","doi":"10.1111/bjh.20132","title":"Distinct characteristics and social determinants in adult T‐cell leukaemia/lymphoma patients at a tertiary cancer centre in Canada","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Cancer Society; Princess Margaret Cancer Foundation","keywords":"Medicine; Lymphoma; Cohort; Internal medicine; Cancer; Young adult; Malignancy; Transplantation; Population; Cohort study; Pediatrics","score_opus":0.0036334587930831486,"score_gpt":0.19961964798549622,"score_spread":0.19598618919241306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410110360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294543,0.0055493186,5.108762e-7,0.00025045266,0.0009791648,0.00008821368,0.000104082,0.0000026895686,0.00008013159],"genre_scores_gemma":[0.9982659,0.0009914483,0.0000034348338,0.00030655632,0.000014139793,0.000004339577,0.000009604564,0.000007519899,0.00039700605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865586,0.0001661608,0.0006204476,0.00016401408,0.000037322967,0.00035621194],"domain_scores_gemma":[0.9994305,0.00009965005,0.0002971484,0.000045179382,0.000109116205,0.000018405919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006942279,0.00013469081,0.000631131,0.00010907968,0.00014276335,0.000007868468,0.00013543841,0.0001631924,0.000042707718],"category_scores_gemma":[0.00007002213,0.00013526938,0.000046737314,0.000075715514,0.00015671371,0.00004188758,0.00014236353,0.00025115497,0.0000027392578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017020066,0.00013362317,0.96180093,0.00012202486,0.000047710775,0.004220009,0.00025581135,8.141393e-8,0.00054020685,0.0000057685443,0.004139806,0.02856385],"study_design_scores_gemma":[0.0036992051,0.000026447447,0.9887484,0.00037748364,0.00003693324,0.0029507626,0.00030801748,0.0000018830804,0.0017722516,0.000015822947,0.0019269497,0.00013584159],"about_ca_topic_score_codex":0.29333165,"about_ca_topic_score_gemma":0.92560875,"teacher_disagreement_score":0.6322771,"about_ca_system_score_codex":0.0003671355,"about_ca_system_score_gemma":0.00047453862,"threshold_uncertainty_score":0.7113741},"labels":[],"label_agreement":null},{"id":"W4410380473","doi":"10.1111/bjh.20153","title":"Real‐world outcomes of vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome at a tertiary referral centre","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"","keywords":"Tertiary referral centre; Referral; Medicine; Tertiary care; Vacuole; Internal medicine; Dermatology; Family medicine; Biology; Biochemistry","score_opus":0.009101618304577837,"score_gpt":0.2677795649325124,"score_spread":0.2586779466279346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410380473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98041147,0.0071256226,0.000038803264,0.0041863867,0.0055756113,0.00028276222,0.000019720688,0.000053349017,0.0023062858],"genre_scores_gemma":[0.9616008,0.0018243401,0.0020604515,0.0005328831,0.00008290305,0.0000050718854,0.00001766063,0.00004718541,0.033828717],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99698466,0.00021628784,0.0016465863,0.00024936776,0.00042471648,0.00047837046],"domain_scores_gemma":[0.9981371,0.00027372982,0.0007665853,0.0003150045,0.00024750276,0.00026006886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032243785,0.00024533033,0.0017666713,0.0006238824,0.00011262876,0.000023600041,0.00027625324,0.00028789014,0.00037962527],"category_scores_gemma":[0.00036165622,0.00023801815,0.00046341357,0.00029251113,0.00032031175,0.00012556324,0.00011898539,0.00063040014,0.000031301563],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025385973,0.0007608263,0.570898,0.002039606,0.0015304091,0.22694871,0.00035842092,0.0000038231196,0.0028288832,0.0012084026,0.18791576,0.005253287],"study_design_scores_gemma":[0.006436916,0.00025139836,0.47862393,0.008402407,0.0008735516,0.49035314,0.00022096597,0.000034723405,0.0024732556,0.00094691804,0.011092753,0.0002900402],"about_ca_topic_score_codex":0.00016986136,"about_ca_topic_score_gemma":0.0008178004,"teacher_disagreement_score":0.26340443,"about_ca_system_score_codex":0.00016488653,"about_ca_system_score_gemma":0.00039953197,"threshold_uncertainty_score":0.97060984},"labels":[],"label_agreement":null},{"id":"W4410544331","doi":"10.1111/bjh.20058","title":"Long‐term efficacy and safety of mitapivat in non‐transfusion‐dependent α‐ or β‐thalassaemia: An open‐label phase 2 study","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Haemolysis; Adverse effect; Pyruvate kinase; Pyruvate kinase deficiency; Internal medicine; Anemia; Erythropoiesis; Ineffective erythropoiesis; Gastroenterology; Immunology; Metabolism; Glycolysis","score_opus":0.019596948676217314,"score_gpt":0.34064619538657837,"score_spread":0.32104924671036106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410544331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931852,0.004123469,0.00016714064,0.0007881045,0.00031926658,0.00092648296,0.000008729826,0.0000069309317,0.0004746413],"genre_scores_gemma":[0.9946026,0.004771935,0.00022256955,0.00018367213,0.000018204033,0.0000057459315,0.000004728618,0.000016620615,0.00017389338],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99791265,0.00021255176,0.0011309757,0.0002542515,0.00022171978,0.0002678267],"domain_scores_gemma":[0.9989728,0.00017806604,0.00027403474,0.00019659831,0.00020198987,0.0001765633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069958,0.0001595301,0.0011457951,0.0002985967,0.000087572276,0.000036006062,0.000294561,0.00023975193,0.00012603012],"category_scores_gemma":[0.00030515782,0.00013880843,0.000050989733,0.00032187364,0.00016508308,0.00017789369,0.00013245901,0.0006676753,0.0000011440012],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026138818,0.046555936,0.24267127,0.0012539296,0.0013516234,0.33548358,0.0029848884,0.000021373473,0.0059973914,0.00013823311,0.0018192573,0.33558372],"study_design_scores_gemma":[0.22211666,0.014843869,0.44172448,0.0067379875,0.0011033608,0.30520824,0.006110342,0.00009216015,0.0012787567,0.00014836744,0.00022539841,0.00041036587],"about_ca_topic_score_codex":0.0002613792,"about_ca_topic_score_gemma":0.0009424106,"teacher_disagreement_score":0.33517334,"about_ca_system_score_codex":0.00004491421,"about_ca_system_score_gemma":0.00030386244,"threshold_uncertainty_score":0.56604433},"labels":[],"label_agreement":null},{"id":"W4411041284","doi":"10.1111/bjh.20178","title":"Risk factors for immediate postpartum sickle cell disease‐specific maternal morbidity","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Acute chest syndrome; Pregnancy; Complication; Hypoxia (environmental); Univariate analysis; Obstetrics; Postpartum period; Incidence (geometry); Retrospective cohort study; Vaso-occlusive crisis; Disease; Surgery; Multivariate analysis; Internal medicine; Sickle cell anemia","score_opus":0.009967978040826959,"score_gpt":0.24674437538190394,"score_spread":0.23677639734107697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411041284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97517556,0.01988367,0.0011995999,0.0013810061,0.0014726984,0.00029467136,0.00009831949,0.000022839784,0.0004716257],"genre_scores_gemma":[0.9885931,0.009896689,0.00042395166,0.00020805532,0.00011560175,0.0000057229277,0.00002043563,0.000022829747,0.00071362645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998502,0.00008922484,0.0006646733,0.00019158,0.00018700847,0.0003655011],"domain_scores_gemma":[0.9987356,0.0001774903,0.00038338554,0.0001473127,0.00027412,0.000282114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025653787,0.00015762723,0.00066719693,0.0001803942,0.00015203602,0.000039611237,0.00016415586,0.00017498473,0.00013304887],"category_scores_gemma":[0.00022813736,0.00014652222,0.00036774058,0.0001325847,0.00014895752,0.0000833891,0.00003999279,0.00047992944,0.00001284662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048696483,0.0024989697,0.5715835,0.0025701374,0.0013783305,0.06990087,0.0004392126,0.00020002492,0.0014990218,0.0020417266,0.32066515,0.022353372],"study_design_scores_gemma":[0.02131083,0.0013979445,0.7595575,0.0031439718,0.0024122319,0.060614817,0.0027098565,0.00048559485,0.009171382,0.009049746,0.1293024,0.0008437368],"about_ca_topic_score_codex":0.00009771116,"about_ca_topic_score_gemma":0.000011097235,"teacher_disagreement_score":0.19136275,"about_ca_system_score_codex":0.00004777744,"about_ca_system_score_gemma":0.00022850653,"threshold_uncertainty_score":0.59750026},"labels":[],"label_agreement":null},{"id":"W4411391466","doi":"10.1111/bjh.20203","title":"Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Taiho Oncology","keywords":"Decitabine; Chronic myelomonocytic leukemia; Medicine; Internal medicine; Myelodysplastic syndromes; Oncology; Azacitidine; Prospective cohort study; Clinical trial; International Prognostic Scoring System; Gastroenterology; Bone marrow","score_opus":0.03687991850905249,"score_gpt":0.38576371445286745,"score_spread":0.34888379594381497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411391466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94093883,0.054209065,0.00015995053,0.0042196894,0.00007645091,0.00028940255,0.000018796141,0.0000044470635,0.00008337937],"genre_scores_gemma":[0.98764706,0.011403085,0.0006669853,0.000172288,0.000050136332,0.000005388652,0.000010687087,0.000008875657,0.000035506873],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984588,0.00024155421,0.0007306767,0.000159139,0.00018860289,0.00022123476],"domain_scores_gemma":[0.99840117,0.0009560651,0.00020791765,0.00014434312,0.00022188309,0.00006865524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007132861,0.00011234729,0.0008466549,0.00026196428,0.00008626096,0.000017371456,0.00014849217,0.000096090436,0.000026208289],"category_scores_gemma":[0.0013952415,0.00009069726,0.00006049394,0.00031005297,0.0004439889,0.000091690854,0.000100397185,0.00051497575,7.066318e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01559886,0.003044355,0.18110453,0.0030070262,0.0058240294,0.12844145,0.0068626944,0.00016654353,0.012755688,0.012881431,0.047754984,0.5825584],"study_design_scores_gemma":[0.09311392,0.0024249193,0.6624396,0.0061361836,0.0014009501,0.21010026,0.0047139656,0.0014836948,0.0023281975,0.0077383374,0.007738165,0.00038180358],"about_ca_topic_score_codex":0.00027742243,"about_ca_topic_score_gemma":0.00054946454,"teacher_disagreement_score":0.5821766,"about_ca_system_score_codex":0.00020617116,"about_ca_system_score_gemma":0.0004653252,"threshold_uncertainty_score":0.3698527},"labels":[],"label_agreement":null},{"id":"W4411531910","doi":"10.1111/bjh.20221","title":"Lamotrigine and anti‐seizure medications in <scp>HLH</scp>: A systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Lamotrigine; Pathological; Medicine; Histiocytosis; Bone marrow; Pathology; Immunology; Epilepsy; Disease; Psychiatry","score_opus":0.02125405717224143,"score_gpt":0.35235695176816223,"score_spread":0.3311028945959208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411531910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057004225,0.99629354,0.00002732653,0.00046824318,0.00013387711,0.0021427113,0.000013647136,0.000014875514,0.0008487432],"genre_scores_gemma":[0.000015224004,0.99819934,0.00008914056,0.000328859,0.000046134457,0.00012378466,0.00003620685,0.000034933946,0.0011263664],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949005,0.0008428818,0.0031034006,0.00028468666,0.00046953067,0.00039895895],"domain_scores_gemma":[0.9962524,0.0012503034,0.001539358,0.00038162482,0.0003856911,0.00019062517],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001917759,0.00032246867,0.008357788,0.00087223353,0.00007467052,0.00003848346,0.00042475326,0.00045914206,0.00005413492],"category_scores_gemma":[0.007935498,0.0002751906,0.0005837011,0.0008353117,0.0002152952,0.00011200683,0.00012998101,0.0015613302,0.000028795363],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.567422e-7,0.0001026663,0.00001127506,0.9225527,0.0004672006,0.02412394,0.000020868374,1.8721728e-8,6.748599e-8,0.0001221907,0.015410068,0.037188064],"study_design_scores_gemma":[0.00041286676,0.000041517374,0.000009317265,0.5624178,0.002287334,0.22226217,0.000047694542,7.635601e-7,7.385137e-8,0.00002348478,0.2124485,0.000048468966],"about_ca_topic_score_codex":0.000013740852,"about_ca_topic_score_gemma":0.000015755295,"teacher_disagreement_score":0.36013487,"about_ca_system_score_codex":0.000079771155,"about_ca_system_score_gemma":0.002010542,"threshold_uncertainty_score":0.99997},"labels":[],"label_agreement":null},{"id":"W4411966677","doi":"10.1111/bjh.20239","title":"Therapeutic advances and gradual improvement in overall survival in mantle cell lymphoma over four decades","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Incyte; BeiGene; AstraZeneca; Celgene; Gilead Sciences; Eli Lilly and Company","keywords":"Mantle cell lymphoma; Lymphoma; Medicine; Mantle (geology); Cancer research; Oncology; Internal medicine; Intensive care medicine; Geology; Geochemistry","score_opus":0.010890812951829193,"score_gpt":0.2748953398795863,"score_spread":0.2640045269277571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411966677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94930625,0.04873625,0.000017522168,0.00082728616,0.0002453556,0.00017331637,0.00000312061,0.0000041695735,0.0006867133],"genre_scores_gemma":[0.9902739,0.008803041,0.00018290541,0.00057872373,0.000024795403,0.000011400661,0.000001537471,0.000008521563,0.00011517307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884737,0.00007649954,0.00051732606,0.0001676259,0.00015161526,0.00023958337],"domain_scores_gemma":[0.9994994,0.00015606152,0.00015349787,0.00007690445,0.000048775517,0.00006537753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021914685,0.00011979248,0.0006033166,0.0002240231,0.00002783704,0.00002582222,0.00006984427,0.00008637997,0.000023454055],"category_scores_gemma":[0.00003412501,0.00011250183,0.000078053454,0.00011528305,0.00006439031,0.00011086568,0.000037697584,0.00010919476,0.0000012915168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046499117,0.0019795122,0.69803435,0.0003576829,0.0001541075,0.05289936,0.00015390218,0.0000048898673,0.00035463163,0.0011671801,0.00045546264,0.24397394],"study_design_scores_gemma":[0.020353368,0.00053352735,0.9430735,0.00092946785,0.000106782274,0.024226472,0.0002491008,0.000034157452,0.00268687,0.0040490986,0.0036278267,0.00012979103],"about_ca_topic_score_codex":0.000375555,"about_ca_topic_score_gemma":0.0009665422,"teacher_disagreement_score":0.24503921,"about_ca_system_score_codex":0.00017519825,"about_ca_system_score_gemma":0.00021589751,"threshold_uncertainty_score":0.45876914},"labels":[],"label_agreement":null},{"id":"W4412055944","doi":"10.1111/bjh.20246","title":"Laboratory assessment of fetomaternal haemorrhage and Rh immune globulin management: Canadian practice and scoping review","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University Health Network; University of Toronto; Mount Sinai Hospital; Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre","funders":"Health Canada; University of Toronto; Canadian Blood Services; Australian Government","keywords":"Medicine; Flow cytometry; Immunology; Antibody; Test (biology); Obstetrics; Biology","score_opus":0.004839632321260927,"score_gpt":0.30907197856505975,"score_spread":0.3042323462437988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412055944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58877635,0.3992564,0.00039305328,0.0068534766,0.00025330766,0.00055993494,0.000013753957,0.0000072524263,0.0038864454],"genre_scores_gemma":[0.787157,0.20310135,0.0074328636,0.0022243573,0.000022438024,0.000004340722,0.0000030534973,0.000010226536,0.000044362754],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988291,0.00012263586,0.0006174861,0.00012428545,0.00014305898,0.00016339097],"domain_scores_gemma":[0.99916416,0.00007167109,0.0002776193,0.00009639648,0.0002476298,0.00014249858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070897146,0.000087343935,0.00067068235,0.00016760227,0.00007409575,0.000023174016,0.0000670344,0.000068276764,0.00004548769],"category_scores_gemma":[0.00010942712,0.00009184773,0.00004832511,0.00016127947,0.000089308625,0.00013373239,0.000035368503,0.00023315333,4.2826665e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046917,0.0010120948,0.064250566,0.18354599,0.0030563208,0.45627287,0.0002125813,0.0000024939638,0.0013332707,0.014280585,0.0065435506,0.2690205],"study_design_scores_gemma":[0.0068558278,0.00050725404,0.16341737,0.3471567,0.0027931277,0.47311023,0.0004150387,0.0000478624,0.00058397494,0.00024573397,0.004610055,0.00025682122],"about_ca_topic_score_codex":0.003178936,"about_ca_topic_score_gemma":0.0029799433,"teacher_disagreement_score":0.2687637,"about_ca_system_score_codex":0.000029538796,"about_ca_system_score_gemma":0.0003343115,"threshold_uncertainty_score":0.48056215},"labels":[],"label_agreement":null},{"id":"W4412184701","doi":"10.1111/bjh.70000","title":"Feasibility, safety and efficacy of intranasal fentanyl in the treatment of acute pain episodes among adults with sickle cell disease: A retrospective single‐centre study","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Retrospective cohort study; Nasal administration; Fentanyl; Disease; Acute pain; Anesthesia; Internal medicine; Pediatrics; Pharmacology","score_opus":0.005163710993248907,"score_gpt":0.23991376985284754,"score_spread":0.23475005885959863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412184701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922318,0.0056570065,0.000060618615,0.000922296,0.000051639963,0.0008932155,0.000021098178,0.00000441964,0.00015790228],"genre_scores_gemma":[0.99800056,0.0018381295,0.00007554615,0.000037658247,0.000009495426,0.0000023341004,0.0000041053563,0.000008721348,0.00002346538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983583,0.000414975,0.00065040495,0.00018434727,0.0002078371,0.00018410625],"domain_scores_gemma":[0.99898803,0.00028292587,0.0003140772,0.0001597701,0.0001701655,0.00008505473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040474712,0.0001338181,0.00081263145,0.00011893989,0.00004917236,0.000009984313,0.00009535068,0.00007706909,0.000013948685],"category_scores_gemma":[0.00014290973,0.00009120826,0.000120067525,0.00024864727,0.00035111327,0.000043842323,0.000017314353,0.00020948818,9.87924e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067980275,0.009831098,0.95584947,0.00024820748,0.0005981536,0.015482382,0.004680372,0.000013426321,0.000038066417,0.00004345168,0.00010280929,0.0063145445],"study_design_scores_gemma":[0.020606736,0.0048702783,0.9540087,0.0017391862,0.0010956287,0.0031568194,0.014097229,0.000047457204,0.00015026894,0.0001170832,0.000019994388,0.000090616784],"about_ca_topic_score_codex":0.00024024364,"about_ca_topic_score_gemma":0.00088067364,"teacher_disagreement_score":0.013808709,"about_ca_system_score_codex":0.00009521879,"about_ca_system_score_gemma":0.000120189114,"threshold_uncertainty_score":0.3719365},"labels":[],"label_agreement":null},{"id":"W4412461972","doi":"10.1111/bjh.70012","title":"Distinct patient, tumour and chimeric antigen receptor T‐cell characteristics are associated with initiating versus sustaining responses to idecabtagene vicleucel in relapsed and refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Chimeric antigen receptor; Cytokine release syndrome; Multiple myeloma; Antigen; Medicine; Cancer research; Refractory (planetary science); Immunology; T cell; Oncology; Biology; Immune system","score_opus":0.019908754751251426,"score_gpt":0.2897263368892645,"score_spread":0.2698175821380131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412461972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684185,0.0019112553,0.000025439213,0.00045455113,0.00015887567,0.00033496658,0.000028947148,0.00001651708,0.0002276246],"genre_scores_gemma":[0.99849844,0.00043782018,0.000594218,0.00019348408,0.000039208335,0.000008635672,0.000012429933,0.000032881962,0.00018286204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795294,0.0004334785,0.0006906159,0.00026305305,0.00026636,0.00039355835],"domain_scores_gemma":[0.99745274,0.0013142749,0.00051518856,0.000116697986,0.0003942334,0.00020688317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000673284,0.00016892783,0.0008157621,0.00045255796,0.00013668172,0.000060451137,0.00009760285,0.00013580172,0.00006488351],"category_scores_gemma":[0.005688026,0.00017876149,0.000047508118,0.0004387638,0.00014780364,0.0000859751,0.000106532265,0.00062730676,0.0000011533521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017306326,0.00045794758,0.82299924,0.00028727244,0.00029816467,0.041669723,0.0015086209,0.0000014974595,0.06190017,0.0000048632683,0.00052310235,0.053043053],"study_design_scores_gemma":[0.009303012,0.0018665697,0.9715003,0.0024229148,0.000067332694,0.007647402,0.0028591624,0.000073869116,0.0033871662,0.00000894255,0.00066208787,0.00020125258],"about_ca_topic_score_codex":0.0000729417,"about_ca_topic_score_gemma":0.00023488319,"teacher_disagreement_score":0.14850102,"about_ca_system_score_codex":0.00016668557,"about_ca_system_score_gemma":0.00031056118,"threshold_uncertainty_score":0.7289682},"labels":[],"label_agreement":null},{"id":"W4412522403","doi":"10.1111/bjh.70006","title":"Impact of graft‐versus‐host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Hazard ratio; Internal medicine; Transplantation; Graft-versus-host disease; Incidence (geometry); Hematopoietic stem cell transplantation; Population; Cyclophosphamide; Anti-thymocyte globulin; Immunosuppression; Gastroenterology; Complication; Immunology; Chemotherapy; Confidence interval","score_opus":0.010243267193849872,"score_gpt":0.2603578642506921,"score_spread":0.2501145970568422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412522403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239165,0.004214137,0.00096987333,0.00014975162,0.00043824292,0.0005295213,0.00014179392,0.000020129177,0.0011449016],"genre_scores_gemma":[0.99795204,0.000986049,0.00045130638,0.00016276473,0.00003692356,0.000024021778,0.00003271376,0.00003144379,0.00032272612],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99751854,0.00026626134,0.001150559,0.00028057845,0.00043778724,0.00034626378],"domain_scores_gemma":[0.9982556,0.0003795915,0.00048698072,0.0002469859,0.00038325557,0.00024756137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038724908,0.00025949065,0.001043082,0.0004409413,0.000059411173,0.000027543578,0.00017552945,0.00020562674,0.00032132838],"category_scores_gemma":[0.000043245585,0.00024797712,0.000521186,0.000292929,0.00019368771,0.00014348749,0.000014699401,0.00036459765,0.000015179153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06690126,0.005312149,0.26858392,0.058826108,0.003254527,0.4718431,0.003983857,0.00022808397,0.10275418,0.0009599731,0.0037285914,0.013624253],"study_design_scores_gemma":[0.012879991,0.0033728254,0.8254519,0.007941326,0.0017833787,0.10011362,0.00029130973,0.000015605128,0.04733388,0.0002651726,0.00010420602,0.00044679927],"about_ca_topic_score_codex":0.000019910802,"about_ca_topic_score_gemma":0.000028501652,"teacher_disagreement_score":0.55686796,"about_ca_system_score_codex":0.00014136154,"about_ca_system_score_gemma":0.00071017724,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W4412809101","doi":"10.1111/bjh.70040","title":"A new unstable haemoglobin, Hb Alger, causes a transfusion‐dependent anaemia in early childhood","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.003846316004248597,"score_gpt":0.2218219087832292,"score_spread":0.2179755927789806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412809101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98269683,0.008105102,0.0066863555,0.0003425071,0.00071089907,0.00015569854,0.0000104815745,0.000007148158,0.0012849852],"genre_scores_gemma":[0.9955797,0.002069755,0.0010061626,0.000524725,0.00016843017,0.0000038143248,0.000013270307,0.000015341508,0.0006187902],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985849,0.00011392495,0.0005850429,0.0002598694,0.00014578119,0.00031047477],"domain_scores_gemma":[0.9993925,0.000019392823,0.00016843279,0.00017046912,0.00013412419,0.00011504928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022273035,0.00015397064,0.00044747844,0.00017281061,0.00007097753,0.00004584911,0.00024372357,0.00029941773,0.0000662886],"category_scores_gemma":[0.00013695509,0.00017094307,0.00015247923,0.00022942126,0.00005348702,0.00001514972,0.000055700373,0.00032069432,0.0000034455045],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017747803,0.0010431517,0.08696234,0.00027854703,0.0014263735,0.037838187,0.0011216312,0.00048161417,0.30061296,0.0018675498,0.19763446,0.3689584],"study_design_scores_gemma":[0.01776949,0.0020141194,0.23382767,0.0016066052,0.00041230526,0.27951822,0.0007566929,0.00001192789,0.36924165,0.009434452,0.08414895,0.0012579194],"about_ca_topic_score_codex":0.00065990794,"about_ca_topic_score_gemma":0.0013129374,"teacher_disagreement_score":0.3677005,"about_ca_system_score_codex":0.000031299565,"about_ca_system_score_gemma":0.0005084534,"threshold_uncertainty_score":0.6970856},"labels":[],"label_agreement":null},{"id":"W4413035574","doi":"10.1111/bjh.70066","title":"Blood donor populations reveal a clear association between ferritin and change in haemoglobin levels","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"AABB Foundation; Stichting Sanquin Bloedvoorziening","keywords":"Ferritin; Iron deficiency; Serum ferritin; Iron status; Population; Blood donor; Medicine; Whole blood; Hemoglobin; Blood donations; Physiology; Immunology; Anemia; Internal medicine; Environmental health","score_opus":0.03860780220432686,"score_gpt":0.3182051715922488,"score_spread":0.27959736938792196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413035574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872126,0.0067150416,0.00006412159,0.005034648,0.00019805369,0.00020165811,0.000024477,0.000009239427,0.0005401862],"genre_scores_gemma":[0.9970949,0.00045895268,0.0012399661,0.0007614403,0.00013461162,0.0000055024966,0.000009191112,0.000009049464,0.0002863654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987984,0.00015304511,0.00056100363,0.00012159912,0.00014630707,0.00021967896],"domain_scores_gemma":[0.9993833,0.00009036717,0.0002523101,0.00006589863,0.00012947786,0.000078648765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052185607,0.000082571765,0.0006034875,0.00028600244,0.000066488465,0.000025754338,0.00006368887,0.00017716554,0.000039178256],"category_scores_gemma":[0.0006298839,0.000097189186,0.00007287761,0.00021716431,0.000043731583,0.00013638436,0.000032222906,0.00033330085,0.0000025516977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066158835,0.00016801963,0.96979684,0.00019295892,0.0000729009,0.003382633,0.00027086926,4.6998238e-7,0.000073441326,0.0013037637,0.003101918,0.02157],"study_design_scores_gemma":[0.0036695565,0.00008750188,0.98147976,0.00049201015,0.0003319869,0.010909479,0.00013806205,0.0000030860483,0.00006791614,0.0019699147,0.0007763806,0.00007435848],"about_ca_topic_score_codex":0.00056710205,"about_ca_topic_score_gemma":0.00064816466,"teacher_disagreement_score":0.021495642,"about_ca_system_score_codex":0.00004405309,"about_ca_system_score_gemma":0.00008873597,"threshold_uncertainty_score":0.39632598},"labels":[],"label_agreement":null},{"id":"W4413666823","doi":"10.1111/bjh.70123","title":"Outcomes and risk factors for complications in deletional haemoglobin H disease: A retrospective longitudinal cohort study in British Columbia, Canada","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; BC Children's Hospital; University of British Columbia","funders":"BC Children's Hospital","keywords":"Medicine; Retrospective cohort study; Cohort; Pediatrics; Disease; Thalassemia; Cohort study; Internal medicine","score_opus":0.0079451962729693,"score_gpt":0.2585228237179897,"score_spread":0.2505776274450204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413666823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470574,0.0028181425,0.0000986828,0.0008741286,0.00020144813,0.0010561884,0.00017110103,0.000006658471,0.00006793987],"genre_scores_gemma":[0.99876136,0.0007658336,0.00011697974,0.00013579942,0.000009382051,0.0000485807,0.000020903997,0.000011051394,0.0001301256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984086,0.000115700226,0.0007268352,0.0002670959,0.00021851184,0.00026325457],"domain_scores_gemma":[0.99899936,0.00024188896,0.00022886376,0.00010470442,0.00027443888,0.0001507714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034610834,0.00009890884,0.00081665686,0.00013791496,0.00015411714,0.00006374422,0.00009895081,0.00009592768,0.000029026593],"category_scores_gemma":[0.0010597692,0.0001447429,0.0000920691,0.00027422377,0.00013373709,0.00006303511,0.000037857626,0.0004588304,1.3716647e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053530286,0.0006039997,0.9870996,0.0000558337,0.0002557644,0.0075062034,0.000034776644,0.000015274725,3.663186e-7,0.000040211482,0.003468166,0.0008662974],"study_design_scores_gemma":[0.0042204405,0.00013073794,0.9850072,0.0004446287,0.00021955938,0.007878384,0.0010100696,0.000053498887,2.5933264e-7,0.0007528065,0.00017410709,0.00010825291],"about_ca_topic_score_codex":0.75214183,"about_ca_topic_score_gemma":0.98533726,"teacher_disagreement_score":0.23319548,"about_ca_system_score_codex":0.00032772953,"about_ca_system_score_gemma":0.00091423135,"threshold_uncertainty_score":0.5902444},"labels":[],"label_agreement":null},{"id":"W4413764907","doi":"10.1111/bjh.70124","title":"A decade of experience using <scp>ATG</scp> and <scp>PTCy</scp> for graft‐versus‐host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Graft-versus-host disease; Immunology; Transplantation; Haematopoiesis; Medicine; Host (biology); Disease; Hematopoietic cell; Stem cell; Biology; Internal medicine; Genetics","score_opus":0.019430612450783393,"score_gpt":0.28822424252731255,"score_spread":0.2687936300765292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413764907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799837,0.005596494,0.0127046425,0.000105273015,0.0003743493,0.001029925,0.000047575617,0.000022752913,0.00013531913],"genre_scores_gemma":[0.9924786,0.0019223016,0.0052840486,0.00009228997,0.0000281158,0.000049920567,0.0000301969,0.00004050292,0.000074029165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701905,0.00025773144,0.0014750271,0.00040190687,0.00035543606,0.0004908524],"domain_scores_gemma":[0.99699277,0.0015090918,0.0006355156,0.00019477306,0.0003781491,0.00028970928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058733445,0.00028605788,0.0011661244,0.00058764406,0.0001091196,0.000040589366,0.00020722512,0.00034120464,0.00000860718],"category_scores_gemma":[0.00082308997,0.00031604178,0.00022465481,0.00053851906,0.00030235603,0.00021220269,0.000024065475,0.00039892932,0.0000016372545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004225996,0.0035736766,0.28393587,0.05281534,0.0014772426,0.11525375,0.041846566,0.00083637657,0.48939344,0.0020730468,0.0006621617,0.003906549],"study_design_scores_gemma":[0.05340302,0.002325929,0.21339057,0.019050665,0.004379609,0.18704759,0.018042497,0.0026159585,0.49638486,0.0025954118,0.00033177258,0.00043211147],"about_ca_topic_score_codex":0.00010238098,"about_ca_topic_score_gemma":0.000077020486,"teacher_disagreement_score":0.07179384,"about_ca_system_score_codex":0.00008893682,"about_ca_system_score_gemma":0.00045849045,"threshold_uncertainty_score":0.9999292},"labels":[],"label_agreement":null},{"id":"W4413806777","doi":"10.1111/bjh.70131","title":"Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Hospital; Health Sciences Centre; Queen's University; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Ibrutinib; Medicine; Odds ratio; Internal medicine; Concomitant; Population; CYP3A; Oncology; Pharmacology; Chronic lymphocytic leukemia; Leukemia; Cytochrome P450","score_opus":0.005669862241993579,"score_gpt":0.2795223042852576,"score_spread":0.27385244204326403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413806777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639696,0.0009344752,0.00024053988,0.0007419899,0.00036148314,0.00051689317,0.0000033628312,0.00001938236,0.00078491017],"genre_scores_gemma":[0.99745595,0.000024163794,0.0010278069,0.00049242034,0.000034424593,0.000022285689,0.000006049282,0.000030938852,0.0009059504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780786,0.00012180312,0.00074901077,0.00027981948,0.0005224626,0.0005190563],"domain_scores_gemma":[0.9986427,0.00031359776,0.00021028638,0.00027865308,0.00033525834,0.0002194961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003306152,0.00019655646,0.0010075832,0.0005957141,0.00008850531,0.00005176579,0.0002577424,0.000076216646,0.00007197368],"category_scores_gemma":[0.00041593882,0.00016320829,0.00015386243,0.00063152413,0.00011006477,0.0002134224,0.00009499462,0.00054858654,0.000017725344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0027788796,0.0005405598,0.9010711,0.0005360978,0.0012210944,0.07622655,0.00049628026,0.0009609575,0.000035784367,0.00015368318,0.0055883513,0.010390686],"study_design_scores_gemma":[0.16214319,0.0029369544,0.71200126,0.014964906,0.00065126945,0.10176066,0.00078312686,0.00034022323,0.0007735619,0.00012407539,0.0029156972,0.00060505525],"about_ca_topic_score_codex":0.0008907072,"about_ca_topic_score_gemma":0.003242805,"teacher_disagreement_score":0.1890698,"about_ca_system_score_codex":0.016243119,"about_ca_system_score_gemma":0.013549986,"threshold_uncertainty_score":0.99204224},"labels":[],"label_agreement":null},{"id":"W4413962157","doi":"10.1111/bjh.70120","title":"Impact of red blood cell exchange on echocardiographic parameters among adults with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Cell; Disease; Red blood cell; Internal medicine; Cardiology; Red Cell; Pediatrics; Genetics; Biology","score_opus":0.0038739884766896622,"score_gpt":0.22030098693837355,"score_spread":0.2164269984616839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413962157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863495,0.010387156,0.00005224819,0.00024521718,0.00015000584,0.00031807172,0.000018572553,0.000016047765,0.0024631617],"genre_scores_gemma":[0.9952328,0.0042315396,0.00020043463,0.00013119991,0.000018856992,0.0000052302635,0.000007881375,0.000022755026,0.00014927049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854076,0.00012699956,0.00056001433,0.00020332883,0.00024984992,0.00031906666],"domain_scores_gemma":[0.99873173,0.000085822845,0.00041615096,0.00022381643,0.00024626378,0.00029622624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018090883,0.00018021934,0.0008398429,0.0004459893,0.000058207468,0.000014875844,0.00013969316,0.00017852701,0.00004778953],"category_scores_gemma":[0.00009361374,0.00014814151,0.0005439673,0.00044630902,0.00026053016,0.00006590968,0.000025323117,0.00050746254,0.0000019640117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010200352,0.0051523526,0.79318136,0.0032189186,0.002689698,0.15647817,0.00044782113,0.0009985918,0.0004551737,0.000028328008,0.01826551,0.008883721],"study_design_scores_gemma":[0.04655454,0.012504171,0.85341424,0.016464328,0.005712532,0.057179995,0.0014835921,0.00023629988,0.0047883783,0.0005704379,0.0003455062,0.0007459914],"about_ca_topic_score_codex":0.00015633117,"about_ca_topic_score_gemma":0.000015680707,"teacher_disagreement_score":0.09929817,"about_ca_system_score_codex":0.000026740152,"about_ca_system_score_gemma":0.00024594992,"threshold_uncertainty_score":0.6041035},"labels":[],"label_agreement":null},{"id":"W4414002743","doi":"10.1111/bjh.70041","title":"Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the <scp>UK</scp> Myeloma Research Alliance Frailty Group","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Guideline; Quality of life (healthcare); Gerontology; Polypharmacy; Population; Multiple myeloma; Cancer; Disease; Intensive care medicine; Internal medicine; Pathology; Environmental health","score_opus":0.04191771513113096,"score_gpt":0.3634831112193089,"score_spread":0.3215653960881779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414002743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946325,0.0027251714,0.00013281654,0.000469386,0.00011099941,0.0008197509,0.00005326072,0.0000066208363,0.0010494861],"genre_scores_gemma":[0.9941121,0.0011455223,0.004200055,0.0000756114,0.000039924445,0.000039319915,0.000012945766,0.000022896233,0.00035167538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967589,0.0004914199,0.0009858143,0.00031463406,0.0009524892,0.00049673783],"domain_scores_gemma":[0.99624395,0.00141351,0.00052158325,0.0003788812,0.0012252975,0.00021676191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007099443,0.00021262706,0.0009888391,0.00028436558,0.00019195235,0.000027978329,0.00025656965,0.00014875246,0.000034258475],"category_scores_gemma":[0.0015521422,0.00014703731,0.0001837393,0.00041864195,0.0005135075,0.0000787669,0.00014036211,0.00044406028,0.0000014817605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025729835,0.0027943237,0.9414559,0.00021164339,0.0008139024,0.0026341628,0.00021098639,0.0000073915226,0.0007037929,0.00020781622,0.002671009,0.048031762],"study_design_scores_gemma":[0.008314933,0.0048247096,0.9760822,0.0029772702,0.0001438087,0.0034346117,0.0004319831,0.00014012815,0.0021608965,0.000112673275,0.0013314456,0.00004534959],"about_ca_topic_score_codex":0.0004570354,"about_ca_topic_score_gemma":0.00079349877,"teacher_disagreement_score":0.04798641,"about_ca_system_score_codex":0.0002469285,"about_ca_system_score_gemma":0.0005206648,"threshold_uncertainty_score":0.59960073},"labels":[],"label_agreement":null},{"id":"W4414085806","doi":"10.1111/bjh.70061","title":"<scp>UK</scp> recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation <scp>(HSCT</scp> ): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies ( <scp>BSBMTCT</scp> ), <scp>NHS</scp> England Genomic Laboratory Hub ( <scp>GLH</scp> ) Haematological Malignancies Working Group, <scp>UK</scp> Cancer Genetics Group ( <scp>UKCGG</scp> ) and the <scp>UK</scp> National External Quality Assessment Service for Leucocyte Immunophenotyping ( <scp>UK NEQAS LI</scp> )","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Transplantation; Minimal residual disease; Disease; Stem cell; Hematopoietic stem cell transplantation; Audit; Clinical Practice; Dosing","score_opus":0.048372120973216054,"score_gpt":0.3135522715974631,"score_spread":0.26518015062424705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414085806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8344323,0.12296157,0.029727124,0.00067968946,0.0026746113,0.0064034015,0.0023602217,0.00032819,0.0004328744],"genre_scores_gemma":[0.8521019,0.062722385,0.07473874,0.0027899975,0.0023145196,0.0024070858,0.0012645209,0.0007493075,0.0009114998],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.97984976,0.0030952287,0.007065526,0.003479711,0.002633013,0.0038767736],"domain_scores_gemma":[0.8987217,0.08988897,0.005332003,0.0011850041,0.0036192033,0.0012531152],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.010715968,0.002886169,0.0055280523,0.0008820525,0.005044098,0.0030348515,0.0018713191,0.0023658343,0.0000048010115],"category_scores_gemma":[0.012639463,0.0028916765,0.001676214,0.0017216996,0.0017787062,0.0012439204,0.00052584766,0.0033353015,0.0000067169713],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028937767,0.0040838136,0.48122612,0.025213342,0.024041904,0.00983921,0.09094985,0.002692252,0.31969744,0.0038363347,0.029583324,0.008547059],"study_design_scores_gemma":[0.11159161,0.004594569,0.19298333,0.04389961,0.042933196,0.12073701,0.26577958,0.015883675,0.11064896,0.014696025,0.075002044,0.0012503938],"about_ca_topic_score_codex":0.0015660733,"about_ca_topic_score_gemma":0.0013451958,"teacher_disagreement_score":0.2882428,"about_ca_system_score_codex":0.0005976305,"about_ca_system_score_gemma":0.0019050038,"threshold_uncertainty_score":0.9989641},"labels":[],"label_agreement":null},{"id":"W4414160795","doi":"10.1111/bjh.70150","title":"‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"The Scarborough Hospital; Brampton Civic Hospital; Hospital for Sick Children; Centre for Addiction and Mental Health; Toronto Public Health; Queen's University; McMaster University; Thrombosis and Atherosclerosis Research Institute; Public Health Ontario; Trillium Health Centre; University Health Network; Health Sciences Centre; St. Michael's Hospital; Sunnybrook Health Science Centre; Sinai Health System; University of Toronto","funders":"","keywords":"Iron deficiency; Ferritin; Anemia; Concomitant; Intervention (counseling); Socioeconomic status; Pregnancy; Health care","score_opus":0.02318509927061853,"score_gpt":0.3091752351083233,"score_spread":0.2859901358377048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414160795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992272,0.0044938806,0.00033428226,0.002179296,0.000106468426,0.00045841135,0.000009649183,8.628676e-7,0.0001451227],"genre_scores_gemma":[0.9989071,0.00044610936,0.0003683913,0.00024424773,0.0000029461837,0.000012413585,0.000005469578,0.0000022414858,0.00001110433],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989703,0.00019739635,0.00053601305,0.0000765038,0.000118194876,0.00010157445],"domain_scores_gemma":[0.9995817,0.000038519247,0.00017841402,0.00007726301,0.00009535822,0.000028777771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010122398,0.000051862047,0.00019046802,0.00011558222,0.00008294811,0.000015919553,0.000097908545,0.000026732117,0.00002220393],"category_scores_gemma":[0.000071017836,0.000034604123,0.00005272176,0.00013933072,0.00011457758,0.00005017296,0.000046115438,0.00009415965,1.8938209e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039231702,0.00068124617,0.37410066,0.0048942636,0.00010016335,0.00022307184,0.0073510106,0.0000031330464,0.00008376949,0.00759183,0.0025838127,0.60199475],"study_design_scores_gemma":[0.001681631,0.0000699076,0.98140913,0.00096559466,0.00011612603,0.0011282994,0.0118871685,0.0000013785422,0.00015960135,0.0023836826,0.0001657187,0.000031739117],"about_ca_topic_score_codex":0.0086665675,"about_ca_topic_score_gemma":0.116341375,"teacher_disagreement_score":0.6073085,"about_ca_system_score_codex":0.000034188568,"about_ca_system_score_gemma":0.000070569964,"threshold_uncertainty_score":0.9979348},"labels":[],"label_agreement":null},{"id":"W4414168132","doi":"10.1111/bjh.70146","title":"Endothelial activation and stress index ( <scp>EASIX</scp> ) as a biomarker to predict ruxolitinib failure for steroid‐refractory acute graft‐versus‐host disease treatment","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of British Columbia; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec; Alberta University of the Arts; University of Toronto","funders":"","keywords":"Ruxolitinib; Biomarker; Disease; Transplantation; Clinical endpoint; Confidence interval","score_opus":0.015403724167790659,"score_gpt":0.2954711320915568,"score_spread":0.2800674079237661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414168132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873698,0.000605679,0.007724057,0.0017586342,0.0004546723,0.0010791724,0.000537261,0.000028910155,0.00044185968],"genre_scores_gemma":[0.9974264,0.0004484581,0.0008837133,0.00035433858,0.00012607584,0.000088049295,0.00009107694,0.00003021555,0.00055170385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830884,0.00014232744,0.0006458903,0.00028985142,0.00027337435,0.00033970628],"domain_scores_gemma":[0.9979283,0.0009318293,0.00028687486,0.00015854787,0.0002926256,0.00040179375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021076965,0.00021669535,0.0006736989,0.00034434567,0.00010967633,0.00006129285,0.00010714992,0.00017774697,0.00003142277],"category_scores_gemma":[0.00061708246,0.00021499686,0.00017795859,0.00015051664,0.00009590328,0.00017281261,0.000022923809,0.0001704965,0.000004678496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06729266,0.009928319,0.31995547,0.013045368,0.022458725,0.15126972,0.009857599,0.000044604294,0.13677453,0.005706145,0.06187729,0.20178956],"study_design_scores_gemma":[0.11080623,0.009458872,0.5199759,0.015509974,0.008577447,0.14228882,0.0064256308,0.00051175867,0.11692644,0.0018903944,0.06692964,0.0006988759],"about_ca_topic_score_codex":0.000050974602,"about_ca_topic_score_gemma":0.00006817209,"teacher_disagreement_score":0.2010907,"about_ca_system_score_codex":0.00013652297,"about_ca_system_score_gemma":0.0004338804,"threshold_uncertainty_score":0.87673175},"labels":[],"label_agreement":null},{"id":"W4414191963","doi":"10.1111/bjh.70157","title":"Incidence and impact of prior history of serious infection in paediatric lymphoma: A population‐based study","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; SickKids Foundation; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"","keywords":"Incidence (geometry); Lymphoma; Odds ratio; Hazard ratio; Confidence interval; Intensive care unit; Epidemiology; Cohort","score_opus":0.005588518299444807,"score_gpt":0.2467060650357208,"score_spread":0.24111754673627597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414191963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9190444,0.08014416,0.000055068103,0.0000148149975,0.0005445944,0.00014950336,0.0000029978924,0.0000049044434,0.00003958133],"genre_scores_gemma":[0.9995692,0.00034570275,0.000015200209,0.000013503105,0.0000010696899,0.0000032854878,0.0000036465894,0.000004882979,0.000043517794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985387,0.0003614455,0.0007976211,0.0001116232,0.00003644125,0.0001542218],"domain_scores_gemma":[0.9989559,0.0001896625,0.0006018063,0.00009974956,0.00014815634,0.0000047326234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004853884,0.00009480827,0.00061073405,0.0005468848,0.00004181471,0.0000033616936,0.00012822913,0.00014834532,0.000041737952],"category_scores_gemma":[0.00041856288,0.000101077974,0.00012991506,0.00027156313,0.00014091027,0.000109933746,0.000043226624,0.00018677326,8.2704867e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038498692,0.001388814,0.9552078,0.00012384544,0.00017224616,0.0003476516,0.00064166385,0.00022085529,0.0041514486,0.000047216505,0.00013612969,0.037177343],"study_design_scores_gemma":[0.0036579377,0.00048124196,0.99093366,0.00018359357,0.000069448826,0.004038313,0.00017341168,0.000012916744,0.00020059959,0.00010599371,0.00007023523,0.000072673494],"about_ca_topic_score_codex":0.0059815557,"about_ca_topic_score_gemma":0.000320463,"teacher_disagreement_score":0.08052482,"about_ca_system_score_codex":0.00016841803,"about_ca_system_score_gemma":0.00048046434,"threshold_uncertainty_score":0.90423626},"labels":[],"label_agreement":null},{"id":"W4414370964","doi":"10.1111/bjh.70170","title":"Can we move beyond myeloablative conditioning ( <scp>MAC</scp> )? A comparison of <scp>MAC</scp> versus reduced intensity conditioning ( <scp>RIC</scp> ) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using <scp>ATG</scp> ‐ <scp>PTCy</scp> ‐ <scp>CSA</scp> for <scp>GVHD</scp> prophylaxis","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Context (archaeology); Conditioning; Transplantation; Cyclophosphamide; Incidence (geometry); Regimen; Concomitant; Propensity score matching; Hematology","score_opus":0.020394561358424927,"score_gpt":0.28085985196928825,"score_spread":0.2604652906108633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414370964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680928,0.005678368,0.009730687,0.000112049274,0.004052644,0.00546124,0.0015374715,0.00039135548,0.0049433853],"genre_scores_gemma":[0.98432755,0.0018532294,0.007040205,0.0005673926,0.0005401484,0.00038248507,0.0028180878,0.00060981914,0.0018610575],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.97970396,0.00261019,0.00728992,0.0029410615,0.0032723243,0.0041825124],"domain_scores_gemma":[0.9589178,0.027912326,0.0066192616,0.001366837,0.0035665934,0.001617191],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.003707817,0.0025734017,0.0068025445,0.0040150993,0.0015994817,0.0007354467,0.0017786594,0.0026358971,0.000028791741],"category_scores_gemma":[0.018468486,0.0031583838,0.001869154,0.0036154191,0.0017445836,0.0019360256,0.00039230665,0.004403652,0.00008095657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007126857,0.012486152,0.3959284,0.03697291,0.0151696885,0.03900441,0.20214657,0.01657157,0.1860524,0.0030785827,0.08833783,0.0035387785],"study_design_scores_gemma":[0.070166565,0.007372995,0.27484053,0.022842718,0.011082941,0.032314625,0.15393236,0.0050106538,0.41158083,0.0071940534,0.0029883573,0.00067336264],"about_ca_topic_score_codex":0.0009397006,"about_ca_topic_score_gemma":0.0013555078,"teacher_disagreement_score":0.22552842,"about_ca_system_score_codex":0.0018057209,"about_ca_system_score_gemma":0.0027872124,"threshold_uncertainty_score":0.9997003},"labels":[],"label_agreement":null},{"id":"W4415075029","doi":"10.1111/bjh.70194","title":"Confronting medical grifting: Fraudulent and unproven products and interventions in apheresis, transfusion and biotherapies","year":2025,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Psychological intervention; Apheresis; Medical care; MEDLINE; Medical literature; Therapeutic plasma exchange","score_opus":0.03134231137536264,"score_gpt":0.30920026584264876,"score_spread":0.2778579544672861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415075029","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038030841,0.99297196,0.000083527164,0.0020404821,0.00034101107,0.0003294563,0.0000035076325,0.000013327101,0.00041362914],"genre_scores_gemma":[0.0015190211,0.9977727,0.00024178784,0.00021143224,0.00015971006,0.000009298679,0.000006758745,0.000017752953,0.00006155576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817324,0.0001301115,0.001039452,0.0002792015,0.00020995471,0.00016802904],"domain_scores_gemma":[0.99870175,0.0003009249,0.0007557459,0.00006467668,0.0001494106,0.000027464166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001201317,0.00019775867,0.0012639877,0.00055272825,0.00013281162,0.0002974348,0.00015496525,0.00026447198,0.00012923614],"category_scores_gemma":[0.0009459763,0.00018665458,0.00013464592,0.0002896269,0.0001545333,0.0005626977,0.0001058502,0.000606397,0.0000011063912],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011177943,0.000113504066,0.00026202606,0.035849724,0.0001221924,0.001350086,0.00003415143,2.326353e-8,2.7986596e-7,0.003093341,0.00035919,0.9588043],"study_design_scores_gemma":[0.0014127451,0.000025166697,0.00040925143,0.079892,0.00079538947,0.021137951,0.0002628253,0.00001148811,4.238922e-7,0.00069639616,0.89509606,0.0002603148],"about_ca_topic_score_codex":0.00027466187,"about_ca_topic_score_gemma":0.0011714405,"teacher_disagreement_score":0.958544,"about_ca_system_score_codex":0.000006942549,"about_ca_system_score_gemma":0.000103123966,"threshold_uncertainty_score":0.7611553},"labels":[],"label_agreement":null},{"id":"W4415421445","doi":"10.1111/bjh.70215","title":"Real‐world efficacy and safety of immunochemotherapy in cold agglutinin‐mediated autoimmune haemolytic anaemia","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Stichting Sanquin Bloedvoorziening","keywords":"Cold agglutinin disease; Rituximab; Cold Agglutinin; Autoantibody; Antibody; Monoclonal; Autoimmune hemolytic anemia; Autoimmune disease; Bone marrow","score_opus":0.007119306655546533,"score_gpt":0.264375483618945,"score_spread":0.2572561769633984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415421445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842338,0.012163852,0.00007123548,0.0016259511,0.0002009219,0.00027481376,0.000005995521,0.000012518416,0.0014109318],"genre_scores_gemma":[0.9877641,0.011071978,0.0006596453,0.0002727868,0.000020301315,0.0000019979582,0.0000060038033,0.000015796239,0.00018737793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982779,0.00011179439,0.001057554,0.00015857766,0.00015842129,0.00023575583],"domain_scores_gemma":[0.99899006,0.00029536706,0.0003196548,0.00015305649,0.00016697076,0.00007490199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050443463,0.00012920132,0.0010953356,0.00042693733,0.000047906065,0.000010718336,0.00011983895,0.0001614047,0.00006645317],"category_scores_gemma":[0.00016927748,0.00013523674,0.000111520916,0.0005093766,0.00021162303,0.00005974839,0.000030203499,0.00050228176,9.943244e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018928792,0.006626375,0.32422456,0.0035727336,0.003267031,0.11503325,0.0019496708,0.00003542659,0.2601179,0.015480162,0.007616186,0.24314791],"study_design_scores_gemma":[0.02753531,0.0006863753,0.9092011,0.0063393116,0.00029601404,0.04182551,0.00014170958,0.00008992062,0.010412821,0.0004020426,0.0028841358,0.00018574412],"about_ca_topic_score_codex":0.0006084396,"about_ca_topic_score_gemma":0.00037872532,"teacher_disagreement_score":0.58497655,"about_ca_system_score_codex":0.00004236987,"about_ca_system_score_gemma":0.00023476125,"threshold_uncertainty_score":0.5514794},"labels":[],"label_agreement":null},{"id":"W4415567510","doi":"10.1111/bjh.70220","title":"New cases expand the genotype, phenotype and therapeutic landscape of H syndrome","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Charles-Le Moyne; Centre Hospitalier Universitaire Sainte-Justine","funders":"CHU Sainte-Justine Foundation; Wallonie-Bruxelles International","keywords":"Hypertrichosis; Lipodystrophy; Phenotype; Etiology; Camptodactyly; Genodermatosis; Histiocyte; Targeted therapy","score_opus":0.011754095478576298,"score_gpt":0.26188175275523307,"score_spread":0.25012765727665676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415567510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93952364,0.05715471,0.0009870267,0.0013349403,0.00010745143,0.00009559455,0.0000016183279,0.0000042977513,0.00079070416],"genre_scores_gemma":[0.9978347,0.00093172904,0.00067432254,0.00027529037,0.000025288062,8.718764e-7,0.0000010633257,0.0000052743767,0.00025147572],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99938095,0.00003975419,0.0003284721,0.0000539534,0.00009712284,0.00009974033],"domain_scores_gemma":[0.9994845,0.000097791366,0.00014444772,0.00009942067,0.00012694809,0.000046919522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018245568,0.000056019624,0.0003717291,0.000111866546,0.000061052495,0.000014971434,0.000073590534,0.00005657959,0.00012589736],"category_scores_gemma":[0.00007646336,0.000041812742,0.00009266413,0.00013354818,0.00006610311,0.00004004893,0.00002512816,0.0001314198,0.0000021370709],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016686486,0.0010504675,0.13002698,0.0031753478,0.0072414996,0.13015239,0.0034706881,0.000054275362,0.0026714178,0.06467976,0.08113108,0.57467747],"study_design_scores_gemma":[0.0022567606,0.00034213366,0.15069643,0.00059235503,0.0005543042,0.8356301,0.00049562135,0.000038588827,0.0003033624,0.0026172942,0.006403379,0.000069644644],"about_ca_topic_score_codex":0.000062724605,"about_ca_topic_score_gemma":0.000047238398,"teacher_disagreement_score":0.7054778,"about_ca_system_score_codex":0.0000057154098,"about_ca_system_score_gemma":0.000147568,"threshold_uncertainty_score":0.17050742},"labels":[],"label_agreement":null},{"id":"W4416306788","doi":"10.1111/bjh.70257","title":"Return to employment outcomes in patients with multiple myeloma","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Multiple myeloma; MEDLINE; Immunopathology; Hematology","score_opus":0.010825367374835684,"score_gpt":0.2904119371044533,"score_spread":0.2795865697296176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416306788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969502,0.00030840977,0.00011365371,0.0016513737,0.00012825437,0.0004921723,0.0000113162305,0.000009004064,0.00033559656],"genre_scores_gemma":[0.9967885,0.000027347169,0.002196411,0.00051224366,0.000012247569,0.000015272206,0.0000077849845,0.000012642487,0.00042753184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985901,0.0000846762,0.0004936245,0.00016370189,0.00033396613,0.0003339002],"domain_scores_gemma":[0.9990871,0.00013507614,0.00011675558,0.00014637216,0.00029933522,0.00021533835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016400058,0.000118438875,0.00069780136,0.00039633477,0.000044952503,0.000022344613,0.00012494836,0.00007129314,0.00005476657],"category_scores_gemma":[0.00060985493,0.000096719275,0.00008680992,0.00024412079,0.00005278926,0.000072632894,0.000056510788,0.00027210708,0.000012688737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013804211,0.00083865836,0.95619434,0.000042621698,0.0002580443,0.019768074,0.00004239178,0.0000023157522,0.000014474766,0.000018683395,0.0014408389,0.019999154],"study_design_scores_gemma":[0.012368281,0.00092592917,0.9800936,0.00070198724,0.000042749773,0.004628433,0.00004421145,0.0000076831075,0.00028420705,0.000046939833,0.0007842277,0.000071767645],"about_ca_topic_score_codex":0.00017121117,"about_ca_topic_score_gemma":0.00072308106,"teacher_disagreement_score":0.02389926,"about_ca_system_score_codex":0.00013120867,"about_ca_system_score_gemma":0.00016556385,"threshold_uncertainty_score":0.39440978},"labels":[],"label_agreement":null},{"id":"W4417017262","doi":"10.1111/bjh.70275","title":"Real‐world experience with <scp>CPX</scp> ‐351 for secondary acute myeloid leukaemia: Comparison with <scp>FLAG</scp> ‐ <scp>IDA</scp> in a propensity score matching analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; Hôpital Maisonneuve-Rosemont; London Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary; University of British Columbia; Juravinski Cancer Centre; McGill University Health Centre; Jewish General Hospital; Sunnybrook Health Science Centre; University of Alberta; University of Toronto","funders":"","keywords":"Cytarabine; Daunorubicin; Propensity score matching; Induction chemotherapy; Hematopoietic stem cell transplantation; Transplantation; Myeloid leukemia; Clinical trial; Randomized controlled trial","score_opus":0.02457374611780042,"score_gpt":0.3081901246744311,"score_spread":0.28361637855663063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822481,0.0029523429,0.0068435515,0.000532974,0.00022599119,0.0017728587,0.000076579425,0.00010738132,0.005240218],"genre_scores_gemma":[0.97982585,0.0011416713,0.0113915745,0.0009905553,0.00021416714,0.0002255568,0.00012060464,0.00014691018,0.005943128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926661,0.0005963508,0.002321572,0.001220948,0.0012929643,0.0019020465],"domain_scores_gemma":[0.99223024,0.003016161,0.0015657257,0.00086713786,0.0015637417,0.0007569778],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019580622,0.00077562005,0.0042485064,0.002558276,0.0005263918,0.00033905034,0.0011858637,0.00057359587,0.000023917466],"category_scores_gemma":[0.0021941857,0.0006946677,0.00058911776,0.0038924157,0.0009836667,0.00082469854,0.00045110533,0.0035561663,0.000015250942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009338636,0.0015117689,0.7294613,0.0022764034,0.009879238,0.14187634,0.011227455,0.0009728956,0.005007249,0.00070668187,0.08969651,0.006450292],"study_design_scores_gemma":[0.034616034,0.004591897,0.5796876,0.009752598,0.00866184,0.2647383,0.033080533,0.0031088039,0.032355297,0.001169834,0.027765822,0.00047145196],"about_ca_topic_score_codex":0.0018541835,"about_ca_topic_score_gemma":0.010529813,"teacher_disagreement_score":0.1497737,"about_ca_system_score_codex":0.0009924188,"about_ca_system_score_gemma":0.0032706494,"threshold_uncertainty_score":0.99955046},"labels":[],"label_agreement":null},{"id":"W4417027289","doi":"10.1111/bjh.70269","title":"Impact of graft‐versus‐host disease prophylaxis strategies on <scp>GvHD</scp> ‐free/relapse‐free survival in young adults undergoing unrelated donor allogeneic haematopoietic cell transplantation: A propensity score‐matched analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; Health Resources and Services Administration; Office of Naval Research; National Heart, Lung, and Blood Institute; National Cancer Institute; Medical College of Wisconsin; National Marrow Donor Program","keywords":"Calcineurin; Methotrexate; Cyclophosphamide; Retrospective cohort study; Young adult; Propensity score matching; Transplantation; Population; Group B","score_opus":0.01763336043075995,"score_gpt":0.26739148718702355,"score_spread":0.2497581267562636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417027289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926073,0.0015251333,0.0026554053,0.0001624371,0.00048295307,0.0009458153,0.00016178416,0.000042637937,0.0014165607],"genre_scores_gemma":[0.99771637,0.0014773487,0.0005054119,0.000025081483,0.000030426187,0.00002096415,0.00010615926,0.00004327163,0.00007496403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99530464,0.00075333123,0.0019693943,0.000566168,0.0007941805,0.00061227364],"domain_scores_gemma":[0.99594384,0.001460948,0.000932354,0.0006350468,0.0006513779,0.0003764147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001008773,0.00045139142,0.0021231698,0.001349835,0.00012510939,0.00008548483,0.00054361834,0.00039071927,0.000083657535],"category_scores_gemma":[0.0010933852,0.00043978196,0.00084994617,0.0018254191,0.00031718976,0.00031850577,0.000053589618,0.00083067664,0.000006368395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009053885,0.0022937935,0.89188075,0.008362681,0.0046216045,0.07278013,0.003078528,0.0036950111,0.0029217121,0.0007225635,0.00022717155,0.00036214184],"study_design_scores_gemma":[0.01907747,0.001719856,0.9532005,0.003952618,0.0042631994,0.012194585,0.0016107608,0.00023490186,0.002812587,0.00070764334,8.3330013e-7,0.00022502209],"about_ca_topic_score_codex":0.0012604034,"about_ca_topic_score_gemma":0.006272983,"teacher_disagreement_score":0.06131975,"about_ca_system_score_codex":0.00026572062,"about_ca_system_score_gemma":0.0016608975,"threshold_uncertainty_score":0.9998054},"labels":[],"label_agreement":null},{"id":"W4417291333","doi":"10.1111/bjh.70278","title":"Plasma proteomic profiles of patients during oral anti‐coagulant treatment with vitamin K antagonists","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre; University of Victoria","funders":"Trombosestichting Nederland; Center for Translational Molecular Medicine; Hartstichting","keywords":"Contraindication; Adverse effect; Cohort; Cohort study; Proteomics; Vitamin k; Atrial fibrillation; Etiology; Epidemiology","score_opus":0.006310400691612768,"score_gpt":0.25042620549429795,"score_spread":0.2441158048026852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417291333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980169,0.00014682344,0.0010373448,0.00008862047,0.00002355844,0.00025357294,0.00007530721,0.000022573584,0.00033528687],"genre_scores_gemma":[0.9774402,0.00030872758,0.021972144,0.0000066940984,0.000015219612,0.00006546955,0.000015017453,0.00001551234,0.0001610538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899095,0.000019364934,0.00053063437,0.00016061259,0.000106503714,0.00019193937],"domain_scores_gemma":[0.99908197,0.000025200043,0.0005150142,0.00015156994,0.00017925729,0.000046987956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004663916,0.00013065491,0.00051371113,0.000079798374,0.00009496331,0.000017958477,0.00018676852,0.00009759549,0.00003436879],"category_scores_gemma":[0.000019380377,0.00012068429,0.00008498209,0.00009194565,0.00012676753,0.0000751729,0.000042268224,0.00016259361,8.07821e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001786963,0.0040217373,0.3864399,0.0022998147,0.001044683,0.008831997,0.00022223008,0.00014872746,0.545235,0.0038383077,0.0007379555,0.045392677],"study_design_scores_gemma":[0.0023803946,0.00019971942,0.0048692813,0.00070382917,0.00006738613,0.009954258,0.000043847645,0.00002604264,0.98055536,0.0005306591,0.00053297036,0.00013628438],"about_ca_topic_score_codex":0.000037330956,"about_ca_topic_score_gemma":0.00001770193,"teacher_disagreement_score":0.43532032,"about_ca_system_score_codex":0.00008360607,"about_ca_system_score_gemma":0.0001070277,"threshold_uncertainty_score":0.49213627},"labels":[],"label_agreement":null},{"id":"W7117297153","doi":"10.1111/bjh.70304","title":"Opportunities for improving platelet transfusion practice: A large retrospective audit across 22 hospitals","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; St. Michael's Hospital; Canadian Blood Services; University Health Network; University of Toronto; McMaster University; Queen's University","funders":"Canadian Blood Services","keywords":"Platelet transfusion; Subspecialty; Guideline; Transfusion medicine; Retrospective cohort study; Context (archaeology); Blood product; Audit","score_opus":0.01646508079470564,"score_gpt":0.31165165381882454,"score_spread":0.2951865730241189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117297153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94486743,0.0053543593,0.023005337,0.019379988,0.0012521506,0.0010822436,0.00008968644,0.000051077506,0.004917708],"genre_scores_gemma":[0.9855398,0.0063730055,0.0029630444,0.0035928297,0.00012324273,0.000031131513,0.000012472987,0.000026490206,0.0013380172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983398,0.00008500518,0.00070784765,0.00022033328,0.00024973956,0.00039731272],"domain_scores_gemma":[0.99853545,0.00016748495,0.00034758897,0.00014159855,0.000680831,0.00012701435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010819464,0.00014621738,0.0007776978,0.00016939819,0.00024517922,0.00006296983,0.00013973052,0.0001710502,0.00013002729],"category_scores_gemma":[0.00069748535,0.00015517244,0.00027722304,0.00015146492,0.00009740298,0.00026302435,0.0000474384,0.0004285245,0.0000018936818],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00660984,0.0042145643,0.0036324377,0.004707001,0.0036627466,0.21503976,0.0035571484,0.0000047481767,0.0033848707,0.06897141,0.1337541,0.5524614],"study_design_scores_gemma":[0.04111957,0.0043547535,0.021126842,0.003491132,0.0023889788,0.33766755,0.041221224,0.00012916222,0.005944175,0.00357938,0.53829217,0.00068504486],"about_ca_topic_score_codex":0.000077251054,"about_ca_topic_score_gemma":0.00014981291,"teacher_disagreement_score":0.5517763,"about_ca_system_score_codex":0.000072921306,"about_ca_system_score_gemma":0.00029320444,"threshold_uncertainty_score":0.6327749},"labels":[],"label_agreement":null},{"id":"W7117317284","doi":"10.1111/bjh.70288","title":"Philadelphia chromosome‐positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge","year":2025,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; National Institutes of Health; Pennsylvania Department of Health; Ministero della Salute; Agentura Pro Zdravotnický Výzkum České Republiky; Deutsche Krebshilfe; U.S. Department of Defense","keywords":"Chemoimmunotherapy; Chemotherapy; Transplantation; Hematopoietic stem cell transplantation; Clinical trial; Disease; Acute lymphocytic leukemia; MEDLINE","score_opus":0.017691652082967444,"score_gpt":0.3135956183861634,"score_spread":0.29590396630319593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117317284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782719,0.01751115,0.0010372051,0.0025089248,0.000080986414,0.0004280027,0.000020592468,0.000015949114,0.00012528602],"genre_scores_gemma":[0.9849208,0.013445219,0.0011681856,0.00028885558,0.00009499983,0.000016247057,0.00000763029,0.000018748879,0.00003930522],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979902,0.00034158083,0.0005903273,0.00034746953,0.0002209391,0.000509506],"domain_scores_gemma":[0.99890494,0.00042455815,0.00018965281,0.000119776305,0.00013960655,0.00022147373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052695896,0.00022121728,0.0011622035,0.0006806167,0.00009262832,0.00004040564,0.0001198678,0.00025640542,0.000026594038],"category_scores_gemma":[0.00042817547,0.00019662669,0.000105474915,0.00034737866,0.0002809416,0.000106728425,0.00016499285,0.00039377564,0.0000021853],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010046008,0.0039774645,0.3607834,0.0017083016,0.007139627,0.42250916,0.0032591724,0.000030831136,0.0032044475,0.0020156195,0.0030211294,0.18230483],"study_design_scores_gemma":[0.021689977,0.0019134404,0.2730335,0.004815295,0.0006865171,0.6953795,0.00038384163,0.00079813425,0.00049308577,0.00050983694,0.00006135075,0.00023553493],"about_ca_topic_score_codex":0.000052165175,"about_ca_topic_score_gemma":0.000027674898,"teacher_disagreement_score":0.27287033,"about_ca_system_score_codex":0.0004170065,"about_ca_system_score_gemma":0.0004191959,"threshold_uncertainty_score":0.80182034},"labels":[],"label_agreement":null}]}